Citrus Sinensis ID: 036507

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------64
Protein Sequence
MDFGRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEEccccccHHHHHHHHcccccccccccccccEEEEEEccccccccccccccEEEEEEccccEEEEEEcccccccccccccccccccccEEEEEEEEccccccccEEEEEEccccccHHHHHHHHcccHHHHHHHHccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHccccccccccccccEEEEEEEEcccEEEEEEccccccHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEccccccHHHcccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHccccccccccccccccccEHHHHHcccccccHHHHHHHHHHHcccccEEEEcccccEEEEEEccccHcccEEEEEccEEEEcccccHHHHHHHHHHcccccccccccccccccEEEEEEEccccccHHHHHHHHHccccccHHHHHHHcccccccHHcccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHccccHHcccccccccEEEEEEccccEEEEEEccccccHHHHHHHHHHHHHHcHHHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEcccccHHHEEEcccccEEEccccccEEccHHHcEccccccccccHHHccHHHcccEcccccHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccHHHHccccHcccccHHHHHHHHHHHHHHHcccHHHcccHHHHHHHHHHHc
Coil and Loop (DISEMBL)
MDFGRLHLLIWLCVLVFVSRIEslnsyrqpmnctdttRLCATFLAyemqpnqtLSVIQSMFDvlpkdvtvegneknYIFIKkncsclsttrnyvsnttftvkssggyvYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQvngivnpnnvtagdlfyiplnsvpgepypvendtlpppapapsvedfagnqvdrkarMSYGWIIGGLVVGLGLIILSIAVCIWLRssscfkeargnsakdpggrsshkfhilqkpsfccgsgrhiccksgdyiqttgevsnppitipkalgtdvfdmekpvvftyDEILfategfsdssllghgtygsvyygNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQkgslkshlhdpqnrgqtSLSWIMRVQIALDAARGLEYIHEHTKthyvhrdikssnilLDSAFRAKISDFGLAKLvgktsdgeatVTKVVGTFgylapeyltdglataksDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALrnspdsmsmsslkdyidpnmmdlyphdCLFKMAMLAKqcvdedpilrpdMKQVVISLSQIL
Flexible Loop (DISEMBL)
MDFGRLHLLIWLCVLVFVSRIESlnsyrqpmncTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVtvegneknyifikkncsclsTTRNYVSNTTftvkssggyVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCFKEArgnsakdpggrssHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATegfsdssllgHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTkthyvhrdiKSSNILLDSAFRAKISDFGLAKLvgktsdgeatvTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISgkeaiirtegmvsknqeRRSLASFMLAAlrnspdsmsMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL
Low Complexity Region (SEG)
MDFGRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWiigglvvglgliilSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL
Disordered region (IsUnstruct)
***GRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSV*******************************KARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCF******************FHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL************TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG********************************DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI******
Disordered Region (DISOPRED)
***GRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLN*****************************************IIGGLVVGLGLIILSIAVCIWLRSS************************************************************************PVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR***********RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL
Disordered Region (DISEMBL)
MDFGRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCF****************HKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK**************QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL
Disordered Region (DISPRO)
MDFGRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEP******************************MSYGWIIGGLVVGLGLIILSIAVCIWLRSSS*********************************************************************EKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL
Transmembrane Helix (TMHMM)
oooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDFGRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	639	2.2.26 [Sep-21-2011]
F4IB81	651	LysM domain receptor-like	yes	no	0.937	0.920	0.693	0.0
D7UPN3	605	Chitin elicitor receptor	no	no	0.774	0.818	0.338	9e-76
A8R7E6	617	Chitin elicitor receptor	no	no	0.697	0.722	0.362	8e-75
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.449	0.421	0.380	3e-55
O65530	731	Proline-rich receptor-lik	no	no	0.446	0.389	0.425	4e-55
Q9SX31	708	Proline-rich receptor-lik	no	no	0.605	0.546	0.328	9e-55
Q9C660	762	Proline-rich receptor-lik	no	no	0.438	0.367	0.397	1e-54
Q9LK03	717	Proline-rich receptor-lik	no	no	0.463	0.412	0.375	1e-54
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.496	0.271	0.367	1e-54
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.441	0.397	0.401	2e-54

>sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1

 Score =  814 bits (2102), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/620 (69%), Positives = 505/620 (81%), Gaps = 21/620 (3%)

Query: 29  QPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLS 88
           +PMNC+DTTRLC++FLA++   NQ+ SVIQSMFDVLP+D+T + +   Y FIKKNCSCL+
Sbjct: 20  KPMNCSDTTRLCSSFLAFKPNQNQSFSVIQSMFDVLPQDITADIS-GGYFFIKKNCSCLT 78

Query: 89  TTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLW 148
           TT  Y +NTTFT++ + GYVY+V V+AY GLA   N+TR ARAGAVVS++L CGCSSGLW
Sbjct: 79  TTHQYTTNTTFTIRQNVGYVYNVTVSAYSGLAFPPNTTRAARAGAVVSVQLLCGCSSGLW 138

Query: 149 NYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPV 208
           NYLMSYV   GD+VQSL+SRFGVSMD IE VNGI+N +N+TAGDL YIPL+SVPGEPY  
Sbjct: 139 NYLMSYVAMAGDSVQSLSSRFGVSMDRIEDVNGILNLDNITAGDLLYIPLDSVPGEPYET 198

Query: 209 ENDTLPPPAPAPSVEDFAGN----QVDRKAR----MSYGWIIGGLVVGLGLIILSIAVCI 260
                P P+PAP+     GN    QV+  A+    + Y WI+GGL V L L++L I VCI
Sbjct: 199 SKINPPAPSPAPASSLANGNISDDQVNHTAKSGSHVPYIWIVGGLGVVLALLVLCILVCI 258

Query: 261 WLRSSSCFK-EARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSN 319
            LRSSSC   E  GN          H F IL+K  F CGSGR+ CC+SGD+ QT GE   
Sbjct: 259 CLRSSSCSSSEEDGNG---------HNFQILRKSGFFCGSGRYNCCRSGDFRQTNGETQ- 308

Query: 320 PPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAI 379
             + IPKALG  +F++EKP+VFTY+EI  AT+ FSDS+LLGHG YGSVY+G +R QEVA+
Sbjct: 309 -VVAIPKALGDGMFEIEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAV 367

Query: 380 KRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQN 439
           KRMTATKTKEF AEMK+LCKVHHSNLVELIGYAAT DELF++YEY +KG LKSHLHDPQ+
Sbjct: 368 KRMTATKTKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQS 427

Query: 440 RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK 499
           +G T LSWIMR QIALDAARGLEYIHEHTKTHYVHRDIK+SNILLD AFRAKISDFGLAK
Sbjct: 428 KGNTPLSWIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAK 487

Query: 500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG 559
           LV KT +GE +VTKVVGT+GYLAPEYL+DGLAT+KSD+YAFGVVLFEIISG+EA+IRTE 
Sbjct: 488 LVEKTGEGEISVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEA 547

Query: 560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVD 619
           + +KN ERR LAS MLA L+NSPDSM+MSSLK+++DPNMMDLYPHDCLFK+A LAKQCVD
Sbjct: 548 IGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVD 607

Query: 620 EDPILRPDMKQVVISLSQIL 639
           +DPILRP+MKQVVISLSQIL
Sbjct: 608 DDPILRPNMKQVVISLSQIL 627

Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  285 bits (728), Expect = 9e-76,   Method: Compositional matrix adjust.
 Identities = 200/590 (33%), Positives = 296/590 (50%), Gaps = 95/590 (16%)

Query: 67  DVTVEGNEKNYIFIKKNCSCLSTTRNYVSN-------TTFTVKSSGGYVYDVVVNAYDGL 119
           D  V G+    + +   CSCL       S            +   GG  YD V   Y  L
Sbjct: 73  DYVVTGDR---VLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAANYADL 129

Query: 120 ---AILDNST-----RMARAGAVVSLRLFCGCS----SGLWNYLMSYVMKDGDTVQSLAS 167
              A L+ +      R+      V++ + C C     S  +   ++Y + DG+T++S+A+
Sbjct: 130 TTAAWLEATNAYPPGRIPGGDGRVNVTINCSCGDERVSPRYGLFLTYPLWDGETLESVAA 189

Query: 168 RFGVSMDSIEQVNGIVNPN--NVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDF 225
           ++G S  +  ++    NP    V+   + +IP+    G  +P+++  +            
Sbjct: 190 QYGFSSPAEMELIRRYNPGMGGVSGKGIVFIPVKDPNGSYHPLKSGGM------------ 237

Query: 226 AGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSH 285
            GN       +S G I G ++  + + I++I + I       F++A    + +    +SH
Sbjct: 238 -GNS------LSGGAIAGIVIACIAIFIVAIWLIIMFYRWQKFRKATSRPSPE---ETSH 287

Query: 286 KFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDE 345
                                  D  Q  G                   +E+ + F+Y+E
Sbjct: 288 L---------------------DDASQAEG-----------------IKVERSIEFSYEE 309

Query: 346 ILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNL 405
           I  AT+GFS    +G G +GSVYY  +R ++ AIK+M    T+EF+AE+K+L  VHH NL
Sbjct: 310 IFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHVHHLNL 369

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
           V LIGY   E+ LFL+YE+   G+L  HL   Q  G   LSW  RVQIALD+ARGLEY+H
Sbjct: 370 VRLIGYC-VENCLFLVYEFIDNGNLSQHL---QRTGYAPLSWATRVQIALDSARGLEYLH 425

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           EH    YVHRDIKS+NILLD  FRAKI+DFGLAKL    S  ++  T+V GTFGY+ PE 
Sbjct: 426 EHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMPPE- 484

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
              G  + K DVYAFGVVL+E++S K+AI+R+        E + L  F+     ++P+  
Sbjct: 485 ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRS---SESVSESKGLV-FLFEEALSAPN-- 538

Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              +L + IDP++   YP D   K+A LAK C  E+P +RP M+ VV++L
Sbjct: 539 PTEALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVAL 588

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  281 bits (720), Expect = 8e-75,   Method: Compositional matrix adjust.
 Identities = 185/511 (36%), Positives = 270/511 (52%), Gaps = 65/511 (12%)

Query: 133 AVVSLRLFCGCS----SGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNV 188
           A +++ + C C     S  +   ++Y ++  D++ S+A   GVS D +++ N  VN N  
Sbjct: 145 ATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFN-- 202

Query: 189 TAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVG 248
           +   + Y+P      +P    N   PP         F  ++ D         I+ G++V 
Sbjct: 203 SGNGIVYVPGR----DP----NGAFPP---------FKSSKQDGVGAGVIAGIVIGVIVA 245

Query: 249 LGLIILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSG 308
           L L+IL I    + ++ S     +G+S       S+   H         G G        
Sbjct: 246 L-LLILFIVYYAYRKNKS-----KGDSFSSSIPLSTKADHASSTSLQSGGLG-------- 291

Query: 309 DYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVY 368
                 G   +P        G     ++K V F+ +E+  AT+ F+ S  +G G +G+VY
Sbjct: 292 ------GAGVSP--------GIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVY 337

Query: 369 YGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG 428
           Y  +R ++ AIK+M    +K+F+AE+K+L +VHH NLV LIGY   E  LFL+YEY + G
Sbjct: 338 YAELRGEKAAIKKMDMEASKQFLAELKVLTRVHHVNLVRLIGYC-VEGSLFLVYEYVENG 396

Query: 429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF 488
           +L  HLH     G+  L W  RVQIALD+ARGLEYIHEHT   YVHRDIKS+NIL+D  F
Sbjct: 397 NLGQHLH---GSGREPLPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKF 453

Query: 489 RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
           RAK++DFGL KL   T  G +     +GTFGY+APE +  G  +AK DVYAFGVVL+E+I
Sbjct: 454 RAKVADFGLTKL---TEVGGSATRGAMGTFGYMAPETVY-GEVSAKVDVYAFGVVLYELI 509

Query: 549 SGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLF 608
           S K A+++   M     E R L      + + +       +L+  IDP + D YP D ++
Sbjct: 510 SAKGAVVK---MTEAVGEFRGLVGVFEESFKETDKE---EALRKIIDPRLGDSYPFDSVY 563

Query: 609 KMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           KMA L K C  E+  LRP M+ +V++LS + 
Sbjct: 564 KMAELGKACTQENAQLRPSMRYIVVALSTLF 594

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  217 bits (552), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 115/302 (38%), Positives = 180/302 (59%), Gaps = 15/302 (4%)

Query: 341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMT---ATKTKEFMAEMKI 396
           F+YDE+   T GFS+ +LLG G +G VY G + + +EVA+K++    +   +EF AE++I
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           + +VHH +LV L+GY  +E    L+Y+Y    +L  HLH P   G+  ++W  RV++A  
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---GRPVMTWETRVRVAAG 443

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
           AARG+ Y+HE      +HRDIKSSNILLD++F A ++DFGLAK+  +        T+V+G
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
           TFGY+APEY T G  + K+DVY++GV+L E+I+G++ +  ++ +  +     SL  +   
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDE-----SLVEWARP 558

Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS 636
            L  + ++     L   +DP +   +    +F+M   A  CV      RP M QVV +L 
Sbjct: 559 LLGQAIENEEFDEL---VDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALD 615

Query: 637 QI 638
            +
Sbjct: 616 TL 617

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65530|PEK14_ARATH Proline-rich receptor-like protein kinase PERK14 OS=Arabidopsis thaliana GN=PERK14 PE=2 SV=1

 Score =  216 bits (550), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 128/301 (42%), Positives = 183/301 (60%), Gaps = 16/301 (5%)

Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRM---TATKTKEFMAEMK 395
           +F+Y+E+  AT GFS+ +LLG G +G V+ G ++N  EVA+K++   +    +EF AE+ 
Sbjct: 376 MFSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVD 435

Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
            + +VHH +LV L+GY    D+  L+YE+  K +L+ HLH  +NRG   L W MR++IA+
Sbjct: 436 TISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLH--ENRGSV-LEWEMRLRIAV 492

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-TKV 514
            AA+GL Y+HE      +HRDIK++NILLDS F AK+SDFGLAK    T+     + T+V
Sbjct: 493 GAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRV 552

Query: 515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM 574
           VGTFGY+APEY + G  T KSDVY+FGVVL E+I+G+ +I   +   S NQ     A  +
Sbjct: 553 VGTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDS--STNQSLVDWARPL 610

Query: 575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
           L        ++S  S    +D  +   Y    +  MA  A  C+ +   LRP M QVV +
Sbjct: 611 LT------KAISGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRA 664

Query: 635 L 635
           L
Sbjct: 665 L 665

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  215 bits (547), Expect = 9e-55,   Method: Compositional matrix adjust.
 Identities = 150/456 (32%), Positives = 231/456 (50%), Gaps = 69/456 (15%)

Query: 201 VPGEPYPVEND-TLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSI-AV 258
           VPG   P +N+ TL PP  AP+  + +G        +  G ++G + V + L++ ++  +
Sbjct: 248 VPGSNNPSQNNPTLRPPLDAPNSTNNSG--------IGTGAVVG-ISVAVALVVFTLFGI 298

Query: 259 CIWLRSSSCFKEARGNSAKDPGG-----------RSSHKFHILQKPSFCCGSGRHICCKS 307
            +W     C ++     +   GG           RS   F  +Q  +    S R     S
Sbjct: 299 FVW-----CLRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSSAPVGASKR-----S 348

Query: 308 GDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV 367
           G Y   +G + N      KAL            F+Y+E++ AT GFS  +LLG G +G V
Sbjct: 349 GSYQSQSGGLGNS-----KAL------------FSYEELVKATNGFSQENLLGEGGFGCV 391

Query: 368 YYGNIRNQEV-AIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE 423
           Y G + +  V A+K++        +EF AE++ L ++HH +LV ++G+  + D   LIY+
Sbjct: 392 YKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYD 451

Query: 424 YAQKGSLKSHLHDPQNRGQTS-LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI 482
           Y     L  HLH     G+ S L W  RV+IA  AARGL Y+HE      +HRDIKSSNI
Sbjct: 452 YVSNNDLYFHLH-----GEKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNI 506

Query: 483 LLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGV 542
           LL+  F A++SDFGLA+L    +      T+V+GTFGY+APEY + G  T KSDV++FGV
Sbjct: 507 LLEDNFDARVSDFGLARLALDCN--THITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGV 564

Query: 543 VLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLY 602
           VL E+I+G++ +  ++ +  +     SL  +    + ++ ++    SL    DP +   Y
Sbjct: 565 VLLELITGRKPVDTSQPLGDE-----SLVEWARPLISHAIETEEFDSLA---DPKLGGNY 616

Query: 603 PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
               +F+M   A  CV      RP M Q+V +   +
Sbjct: 617 VESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESL 652

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  215 bits (547), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 118/297 (39%), Positives = 175/297 (58%), Gaps = 17/297 (5%)

Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEV-AIKRMT---ATKTKEFMAEMK 395
           +F+Y+E++ AT GFSD +LLG G +G VY G + ++ V A+K++        +EF AE+ 
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476

Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
            + +VHH NL+ ++GY  +E+   LIY+Y    +L  HLH     G   L W  RV+IA 
Sbjct: 477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHA---AGTPGLDWATRVKIAA 533

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
            AARGL Y+HE      +HRDIKSSNILL++ F A +SDFGLAKL    +      T+V+
Sbjct: 534 GAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT--HITTRVM 591

Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
           GTFGY+APEY + G  T KSDV++FGVVL E+I+G++ +  ++ +  +     SL  +  
Sbjct: 592 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-----SLVEWAR 646

Query: 576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
             L N+ ++   ++L    DP +   Y    +F+M   A  C+      RP M Q+V
Sbjct: 647 PLLSNATETEEFTALA---DPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIV 700

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  215 bits (547), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 119/317 (37%), Positives = 186/317 (58%), Gaps = 21/317 (6%)

Query: 320 PPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVA 378
           PP +   ALG  ++       F Y+E+  AT GFS+++LLG G +G V+ G +RN +EVA
Sbjct: 325 PPPSPGLALGLGIYQG----TFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVA 380

Query: 379 IKRM---TATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH 435
           +K++   ++   +EF AE+ I+ +VHH +LV L+GY   + +  L+YE+    +L+ HLH
Sbjct: 381 VKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLH 440

Query: 436 DPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF 495
               +G+ ++ W  R++IA+ +A+GL Y+HE+     +HRDIK+SNIL+D  F AK++DF
Sbjct: 441 ---GKGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADF 497

Query: 496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAII 555
           GLAK+   T+      T+V+GTFGYLAPEY + G  T KSDV++FGVVL E+I+G+  I 
Sbjct: 498 GLAKIASDTN--THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPID 555

Query: 556 RTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                V+      SL  +    L    +   + + +  +D  + + Y  + + +M   A 
Sbjct: 556 -----VNNVHADNSLVDWARPLLNQVSE---LGNFEVVVDKKLNNEYDKEEMARMVACAA 607

Query: 616 QCVDEDPILRPDMKQVV 632
            CV      RP M QV 
Sbjct: 608 ACVRSTAPRRPRMDQVA 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  214 bits (546), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 124/337 (36%), Positives = 191/337 (56%), Gaps = 20/337 (5%)

Query: 309  DYIQTTGEVSNPPITIPKALGTDVFDMEKPV-VFTYDEILFATEGFSDSSLLGHGTYGSV 367
            + + T+G  S    ++P+ L  +V   EKP+   T+  +L AT GFS  +++G G +G V
Sbjct: 814  ESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEV 873

Query: 368  YYGNIRNQEV-AIK---RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE 423
            Y   +R+  V AIK   R+T    +EFMAEM+ + K+ H NLV L+GY    +E  L+YE
Sbjct: 874  YKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYE 933

Query: 424  YAQKGSLKSHLHDPQNR-GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI 482
            Y + GSL++ LH+  ++ G   L+W  R +IA+ AARGL ++H     H +HRD+KSSN+
Sbjct: 934  YMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNV 993

Query: 483  LLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGV 542
            LLD  F A++SDFG+A+LV    D   +V+ + GT GY+ PEY      TAK DVY++GV
Sbjct: 994  LLDEDFEARVSDFGMARLVSAL-DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGV 1052

Query: 543  VLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLY 602
            +L E++SGK+ I    G   ++      A  +    R +          + +DP ++   
Sbjct: 1053 ILLELLSGKKPI--DPGEFGEDNNLVGWAKQLYREKRGA----------EILDPELVTDK 1100

Query: 603  PHDC-LFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
              D  LF    +A QC+D+ P  RP M Q++    ++
Sbjct: 1101 SGDVELFHYLKIASQCLDDRPFKRPTMIQLMAMFKEM 1137

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  214 bits (545), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 120/299 (40%), Positives = 178/299 (59%), Gaps = 17/299 (5%)

Query: 341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE-VAIKRM---TATKTKEFMAEMKI 396
           FTY+E+   TEGFS  ++LG G +G VY G + + + VA+K++   +    +EF AE++I
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           + +VHH +LV L+GY   + E  LIYEY    +L+ HLH    +G+  L W  RV+IA+ 
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLH---GKGRPVLEWARRVRIAIG 457

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
           +A+GL Y+HE      +HRDIKS+NILLD  F A+++DFGLAKL   T       T+V+G
Sbjct: 458 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQ--THVSTRVMG 515

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
           TFGYLAPEY   G  T +SDV++FGVVL E+I+G++ + + + +  +     SL  +   
Sbjct: 516 TFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEE-----SLVEWARP 570

Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
            L  + ++   S L   +D  +   Y  + +F+M   A  CV      RP M QVV +L
Sbjct: 571 LLHKAIETGDFSEL---VDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	639
290490570	665	LysM type receptor kinase [Lotus japonic	0.981	0.942	0.746	0.0
224059146	664	predicted protein [Populus trichocarpa]	0.982	0.945	0.770	0.0
359482890	666	PREDICTED: proline-rich receptor-like pr	0.992	0.951	0.725	0.0
255549818	632	Serine/threonine-protein kinase PBS1, pu	0.915	0.925	0.756	0.0
449466135	654	PREDICTED: proline-rich receptor-like pr	0.978	0.955	0.724	0.0
449521349	638	PREDICTED: proline-rich receptor-like pr	0.954	0.956	0.732	0.0
357513513	667	Protein kinase family protein [Medicago	0.992	0.950	0.711	0.0
356522910	641	PREDICTED: serine/threonine-protein kina	0.915	0.912	0.716	0.0
356526077	639	PREDICTED: proline-rich receptor-like pr	0.915	0.915	0.722	0.0
356557304	656	PREDICTED: proline-rich receptor-like pr	0.959	0.934	0.665	0.0

>gi|290490570|dbj|BAI79272.1| LysM type receptor kinase [Lotus japonicus]

 Score =  986 bits (2549), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/630 (74%), Positives = 548/630 (86%), Gaps = 3/630 (0%)

Query: 12  LCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVE 71
           L  LVF+    + +   +PMNCTDT+R+C +F+A++ QP QTL+ IQSMFDVLP D+TVE
Sbjct: 13  LLFLVFIHFKRTSSYPMEPMNCTDTSRVCTSFMAFKPQPKQTLAEIQSMFDVLPGDITVE 72

Query: 72  GNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARA 131
           GN  +Y+FI+KNCSC +  + YVSNTTFTVKS+ G+VYD+V++AYDGL IL N+TR AR 
Sbjct: 73  GNGWDYMFIRKNCSCAAGIKKYVSNTTFTVKSNEGWVYDLVMDAYDGLVILPNTTRRARN 132

Query: 132 GAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAG 191
           GAV+SLRLFCGCSSGLWNYLMSYVM DGD+V+SLASRFGVSM SIE VNGI +P+NVT G
Sbjct: 133 GAVISLRLFCGCSSGLWNYLMSYVMTDGDSVESLASRFGVSMGSIESVNGIGDPDNVTVG 192

Query: 192 DLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGL 251
            L+YIP+NSVPG+PYP++N + P P P PSV++F+G+QVD KA + YGWIIGGL VGL L
Sbjct: 193 SLYYIPMNSVPGDPYPLKNASPPAPVPTPSVDNFSGDQVDHKAHVPYGWIIGGLGVGLFL 252

Query: 252 IILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYI 311
           IILS+ +C+ +RSSSCF EAR +  KD  G+ SHKFHIL+ PSF CGSGR+IC K     
Sbjct: 253 IILSVMLCVCMRSSSCFGEARSHE-KDADGKISHKFHILRNPSFFCGSGRYICGKHVGQK 311

Query: 312 QTTGEVSNPPITIPKA--LGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYY 369
           Q  GE SN  ITIPKA  LG D+FDM+KPVVFTYDEI  +T+GFSDS+LLGHGTYGSVYY
Sbjct: 312 QKDGESSNHTITIPKASTLGPDIFDMDKPVVFTYDEIFPSTDGFSDSNLLGHGTYGSVYY 371

Query: 370 GNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS 429
             +R+QEVAIKRMTATKTKEFMAE+K+LCKVHH+NLVELIGYAA+ DE FL+YEYAQKGS
Sbjct: 372 CLLRDQEVAIKRMTATKTKEFMAEIKVLCKVHHANLVELIGYAASHDEFFLVYEYAQKGS 431

Query: 430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR 489
           L+SHLHDPQN+G + LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIK+SNILLD++FR
Sbjct: 432 LRSHLHDPQNKGHSPLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDASFR 491

Query: 490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           AKISDFGLAKLVGKT++GE + TKVVGT+GYLAPEYL++GLAT KSDVYAFGVVLFEIIS
Sbjct: 492 AKISDFGLAKLVGKTNEGEVSTTKVVGTYGYLAPEYLSNGLATTKSDVYAFGVVLFEIIS 551

Query: 550 GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFK 609
           GKEAIIRTEG V+KN ERRSLAS MLAALRNSPDSMSMS ++DYIDPNMM+LYPHDC+FK
Sbjct: 552 GKEAIIRTEGTVTKNPERRSLASVMLAALRNSPDSMSMSGVRDYIDPNMMNLYPHDCVFK 611

Query: 610 MAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MAMLAKQCVD+DPILRPDMKQ+VISLSQIL
Sbjct: 612 MAMLAKQCVDDDPILRPDMKQIVISLSQIL 641

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224059146|ref|XP_002299738.1| predicted protein [Populus trichocarpa] gi|222846996|gb|EEE84543.1| predicted protein [Populus trichocarpa]

 Score =  976 bits (2522), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 490/636 (77%), Positives = 554/636 (87%), Gaps = 8/636 (1%)

Query: 6   LHLLIWLCVLVFVSRIESLNSYR-QPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVL 64
           + +L +LC+     +I+ L+S+  QPMNCTDTTRLC +FLA++ Q N TL++IQSMFDVL
Sbjct: 11  IQVLCFLCL-----QIQPLHSFSTQPMNCTDTTRLCTSFLAFKPQENLTLAMIQSMFDVL 65

Query: 65  PKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDN 124
           P+DVT EGN   YIFIKKNCSCLS  + YV+N+T+TVK SGGYVYD+V+NAYDGLA L N
Sbjct: 66  PQDVTREGNGHGYIFIKKNCSCLSKDKVYVTNSTYTVKFSGGYVYDIVINAYDGLAFLPN 125

Query: 125 STRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVN 184
           +TR A+ GAVVSLRLFCGCSSGLWNYL+SYVMK+GDTVQSL+SRFGVSMD+IE VNGI N
Sbjct: 126 TTRQAKVGAVVSLRLFCGCSSGLWNYLVSYVMKEGDTVQSLSSRFGVSMDNIETVNGIQN 185

Query: 185 PNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGN-QVDRKARMSYGWIIG 243
           P+NVTAG L+YIPLNSVPGEPYP+END  P P PAP  + F+ N     KAR+ YGWIIG
Sbjct: 186 PDNVTAGALYYIPLNSVPGEPYPLENDNPPAPVPAPPDDIFSANIPTIHKARVPYGWIIG 245

Query: 244 GLVVGLGLIILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHI 303
           GL +GL LI+L I +C+ L+SSSC  E+RG+ AK P G+ S KFHIL+K SFCC S R I
Sbjct: 246 GLGIGLALIVLCIIICVSLKSSSCLSESRGSHAKPPDGKISQKFHILRKQSFCCTSRRSI 305

Query: 304 CCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGT 363
           CCKS D+ QT GE S+  ITIPK L TDVFD EKPVVFTY+EILFAT+ F DSSLLGHGT
Sbjct: 306 CCKSVDWKQTNGESSSHQITIPKGLATDVFD-EKPVVFTYEEILFATDEFLDSSLLGHGT 364

Query: 364 YGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE 423
           YGSVYYG++ +QEVAIKRMTATKTKEFMAEMKILCKVHH+NLVELIGYAA++ ELF+IYE
Sbjct: 365 YGSVYYGHLHDQEVAIKRMTATKTKEFMAEMKILCKVHHTNLVELIGYAASDAELFVIYE 424

Query: 424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL 483
           YAQKGSL+SHLHDPQN+G T LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIK+SNIL
Sbjct: 425 YAQKGSLRSHLHDPQNKGHTPLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKTSNIL 484

Query: 484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVV 543
           LD +FRAKISDFGLAKLVGKT +GEAT TKVVGT+GYLAPEYL+DGLAT KSDVYAFGVV
Sbjct: 485 LDGSFRAKISDFGLAKLVGKTGEGEATATKVVGTYGYLAPEYLSDGLATTKSDVYAFGVV 544

Query: 544 LFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYP 603
           LFEIISGKEAIIRTEG V+KN ERRSLAS MLAALRN+PDSMSMSSLKD IDPNMMDLYP
Sbjct: 545 LFEIISGKEAIIRTEGAVTKNPERRSLASTMLAALRNTPDSMSMSSLKDLIDPNMMDLYP 604

Query: 604 HDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           HDC+FK+AMLAKQCVDEDPILRPDMKQVVISLSQI+
Sbjct: 605 HDCVFKLAMLAKQCVDEDPILRPDMKQVVISLSQIV 640

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482890|ref|XP_002283628.2| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Vitis vinifera]

 Score =  961 bits (2484), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 462/637 (72%), Positives = 541/637 (84%), Gaps = 3/637 (0%)

Query: 3   FGRLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFD 62
           F  L + ++  V   VS + SL++   PMNCTDT+RLC +FLA++   NQTL++IQSM+D
Sbjct: 9   FATLSVSLFFFVFQMVS-VHSLST--TPMNCTDTSRLCTSFLAFKPTQNQTLALIQSMYD 65

Query: 63  VLPKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAIL 122
           VLPKD+TVE  + NY+F KKNCSC S T+ Y +NTTFTV+++ G++ D+V  AY GLA++
Sbjct: 66  VLPKDLTVEATDPNYVFFKKNCSCESYTKKYFTNTTFTVRANDGFISDLVAEAYGGLAVV 125

Query: 123 DNSTRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGI 182
               R AR GAVV++RL+CGCS GLWNYLMSYVM+DGD+V+SLASRFGVSM SIE VNGI
Sbjct: 126 PGYRRRARVGAVVTVRLYCGCSIGLWNYLMSYVMRDGDSVESLASRFGVSMGSIEAVNGI 185

Query: 183 VNPNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWII 242
            NP+NVT G L+YIPLNSVPGEPYP+EN   P P PA S  +F+  Q + K  + YGWII
Sbjct: 186 DNPDNVTVGALYYIPLNSVPGEPYPLENAVPPAPVPATSNSNFSVVQANHKDHVPYGWII 245

Query: 243 GGLVVGLGLIILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRH 302
           GGL VGL LI + + +C+ L+SSSCF + RG+ AKD  G++ HKF IL+  S+CCGSGR+
Sbjct: 246 GGLGVGLALIAVLLVICVCLKSSSCFAKGRGSLAKDSDGKNPHKFQILRTRSYCCGSGRY 305

Query: 303 ICCKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHG 362
            CCKS D  QT GE SN  + IPKA+GTDVFDMEKPVVFTY+EIL +T+GFSDS+LLGHG
Sbjct: 306 SCCKSADVKQTNGESSNLQMNIPKAIGTDVFDMEKPVVFTYEEILSSTDGFSDSNLLGHG 365

Query: 363 TYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY 422
           TYGSVYYG + +QEVAIK+MTATKT+EFM+EMK+LCKVHH+NLVELIGYAA++DELFLIY
Sbjct: 366 TYGSVYYGVLHDQEVAIKKMTATKTREFMSEMKVLCKVHHTNLVELIGYAASDDELFLIY 425

Query: 423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI 482
           EYAQKGSLKSHLHDPQN+G TSLSWIMRVQIALDAARG+EYIHEHTKTHYVHRDIK+SNI
Sbjct: 426 EYAQKGSLKSHLHDPQNKGHTSLSWIMRVQIALDAARGIEYIHEHTKTHYVHRDIKTSNI 485

Query: 483 LLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGV 542
           LLD AFRAKISDFGLAKLVGKT +GEA+ T+VVGTFGYLAPEYL+DGLAT KSDVYAFG+
Sbjct: 486 LLDGAFRAKISDFGLAKLVGKTGEGEASATRVVGTFGYLAPEYLSDGLATTKSDVYAFGI 545

Query: 543 VLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLY 602
           VLFEIISGKEA+ RTEGMV KN ERRSLAS MLAALRNSP+SMSMSS+KD IDPN+MDLY
Sbjct: 546 VLFEIISGKEAVTRTEGMVMKNPERRSLASIMLAALRNSPNSMSMSSMKDCIDPNLMDLY 605

Query: 603 PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           PHDCL+KMAMLAKQCVD DPILRPDMKQVVISLSQIL
Sbjct: 606 PHDCLYKMAMLAKQCVDHDPILRPDMKQVVISLSQIL 642

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549818|ref|XP_002515960.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223544865|gb|EEF46380.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  958 bits (2476), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 462/611 (75%), Positives = 519/611 (84%), Gaps = 26/611 (4%)

Query: 29  QPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLS 88
           QPMNCTDTTRLC ++LA++ Q NQ+L+VIQSMFDVLP+DVT+E N+  YIFIKKNCSCL 
Sbjct: 24  QPMNCTDTTRLCTSYLAFKPQENQSLAVIQSMFDVLPQDVTIEDNDHGYIFIKKNCSCLF 83

Query: 89  TTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLW 148
           TT+ Y SN+TFTVKS+ GYVYD+V+NAYDGLA L N+TR A+ GAV+SLRLFCGCS+GLW
Sbjct: 84  TTKVYASNSTFTVKSNEGYVYDIVINAYDGLAFLPNTTRPAKVGAVISLRLFCGCSNGLW 143

Query: 149 NYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPV 208
           NYLMSYVM++ DTV+SL+SRFGVSMDSIE VNGI NP+NVT G L+YIPLNS        
Sbjct: 144 NYLMSYVMREEDTVESLSSRFGVSMDSIESVNGIGNPDNVTVGALYYIPLNS-------- 195

Query: 209 ENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCF 268
                              N    KA + YGWIIGGL  GL LIIL IA+C+ L+SSSCF
Sbjct: 196 ------------------ANTPKNKAHVPYGWIIGGLGFGLALIILCIAICVCLKSSSCF 237

Query: 269 KEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKAL 328
            +A+ + AKD   + SHKF IL+KPSFCC SGR++  KSGD+ QT GE S+  ITIPKAL
Sbjct: 238 SKAKSDHAKDCNDKISHKFQILRKPSFCCASGRYMSGKSGDWKQTNGESSSHHITIPKAL 297

Query: 329 GTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTK 388
           GTD+ DMEKPVVFT +EI+ AT+GFSD++L GHGTYGSVYYG++ +QEV+IKRMTATKTK
Sbjct: 298 GTDMLDMEKPVVFTCEEIISATDGFSDATLTGHGTYGSVYYGHLHDQEVSIKRMTATKTK 357

Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           EFMAEMK+LCKVHH+NLVELIGYAA++DELFLIYEYAQKGSLKSHLHDPQNRG T LSWI
Sbjct: 358 EFMAEMKVLCKVHHTNLVELIGYAASDDELFLIYEYAQKGSLKSHLHDPQNRGHTPLSWI 417

Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
           MRVQIALDAARGLEYIHEHTKTHYVHRDIK+SNILLD +FRAKISDFGLAKLVGK  +GE
Sbjct: 418 MRVQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDGSFRAKISDFGLAKLVGKRGEGE 477

Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
            T TKVVGTFGYLAPEYL+DGLAT KSDVYAFGVVLFEIISGKEAIIRTEG  +KN ERR
Sbjct: 478 TTATKVVGTFGYLAPEYLSDGLATTKSDVYAFGVVLFEIISGKEAIIRTEGAATKNSERR 537

Query: 569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM 628
           SLAS MLAALRNSPDSMSMSSLKDYID NMM LYPHDC+FKMAMLAKQCVDEDPILRPDM
Sbjct: 538 SLASIMLAALRNSPDSMSMSSLKDYIDRNMMGLYPHDCVFKMAMLAKQCVDEDPILRPDM 597

Query: 629 KQVVISLSQIL 639
           KQVVISLSQIL
Sbjct: 598 KQVVISLSQIL 608

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449466135|ref|XP_004150782.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like, partial [Cucumis sativus]

 Score =  932 bits (2410), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 456/629 (72%), Positives = 530/629 (84%), Gaps = 4/629 (0%)

Query: 15  LVFVSRIESL-NSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN 73
           L F+S   SL +SY  P+NCTDTTRLC +FLA++ QPNQTLSVIQSMFDVLP+DVTVEGN
Sbjct: 2   LFFISVYHSLCSSYPMPLNCTDTTRLCTSFLAFKAQPNQTLSVIQSMFDVLPEDVTVEGN 61

Query: 74  EKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGA 133
            ++Y+FI+KNCSC S  + Y++NTTFT+KS+ G VYD+V+ AYDGLA+L N+TRMAR GA
Sbjct: 62  GQDYVFIRKNCSCASGLKKYITNTTFTIKSNRGRVYDIVMEAYDGLALLPNTTRMARNGA 121

Query: 134 VVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDL 193
           VVSLRLFC CSSGLWNYL+SYVM+DGDT++SLASRFGVSMDSIE VNGI NP NVTAG L
Sbjct: 122 VVSLRLFCACSSGLWNYLLSYVMRDGDTIESLASRFGVSMDSIESVNGIENPGNVTAGAL 181

Query: 194 FYIPLNSVPGEPYPVENDTLPPPAPAPSV--EDFAGNQVDRKARMSYGWIIGGLVVGLGL 251
           +YIPLNSVPG+PYP+E +  P P PAPS    +F+ N    K    Y WI+G L + L L
Sbjct: 182 YYIPLNSVPGDPYPLETNIFPAPTPAPSYTPNNFSDNAESPKRHPPYIWIVGSLGIILVL 241

Query: 252 IILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYI 311
           I++ I      R   CF  +R + +KDP G+ SHKFHIL K SFCC SGR+ICC S D+ 
Sbjct: 242 ILVGIVGYACFRWLKCFSRSRSSHSKDPIGKVSHKFHILGKSSFCCASGRYICCSSADWK 301

Query: 312 QTTGEVSNPPITIPKA-LGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYG 370
           Q + E S+    IPK  +  +VFD++KPVVF+ +EI+ +T+ FSDSSLLGHGTYGSVYYG
Sbjct: 302 QASRESSDNQSAIPKGTIENNVFDVDKPVVFSCEEIVSSTDSFSDSSLLGHGTYGSVYYG 361

Query: 371 NIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL 430
            +R+QEVAIKRMTATKTKEFMAEMK+LCKVHH+NLVELIGYAA+EDELFLIYEYAQKG L
Sbjct: 362 ILRDQEVAIKRMTATKTKEFMAEMKVLCKVHHANLVELIGYAASEDELFLIYEYAQKGPL 421

Query: 431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA 490
           KSHLHDP N+G T LSWIMR+QIALDAARGLEYIHEHTKTHYVHRDIK+SNILLD +FRA
Sbjct: 422 KSHLHDPLNKGHTPLSWIMRLQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDGSFRA 481

Query: 491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           KISDFGLAKLVGKT++GEATVTKVVGT+GYLAPEYL++GLAT KSDVYA+GVVLFE+I+G
Sbjct: 482 KISDFGLAKLVGKTNEGEATVTKVVGTYGYLAPEYLSNGLATTKSDVYAYGVVLFELITG 541

Query: 551 KEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKM 610
           KEAIIRTEG   KN ERRSLAS MLA LRN+PD M+M+SLKD +DP+MMDLYPHDCLFK+
Sbjct: 542 KEAIIRTEGTTMKNPERRSLASIMLAVLRNAPDPMNMASLKDQVDPSMMDLYPHDCLFKV 601

Query: 611 AMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           AMLAKQCVDED ILRPDMKQVVISLSQIL
Sbjct: 602 AMLAKQCVDEDSILRPDMKQVVISLSQIL 630

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449521349|ref|XP_004167692.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Cucumis sativus]

 Score =  927 bits (2396), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 449/613 (73%), Positives = 521/613 (84%), Gaps = 3/613 (0%)

Query: 30  PMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLST 89
           P+NCTDTTRLC +FLA++ QPNQTLSVIQSMFDVLP+DVTVEGN ++Y+FI+KNCSC S 
Sbjct: 2   PLNCTDTTRLCTSFLAFKAQPNQTLSVIQSMFDVLPEDVTVEGNGQDYVFIRKNCSCASG 61

Query: 90  TRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLWN 149
            + Y++NTTFT+KS+ G VYD+V+ AYDGLA+L N+TRMAR GAVVSLRLFC CSSGLWN
Sbjct: 62  LKKYITNTTFTIKSNRGRVYDIVMEAYDGLALLPNTTRMARNGAVVSLRLFCACSSGLWN 121

Query: 150 YLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVE 209
           YL+SYVM+DGDT++SLASRFGVSMDSIE VNGI NP NVTAG L+YIPLNSVPG+PYP+E
Sbjct: 122 YLLSYVMRDGDTIESLASRFGVSMDSIESVNGIENPGNVTAGALYYIPLNSVPGDPYPLE 181

Query: 210 NDTLPPPAPAPSV--EDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSC 267
            +  P P PAPS    +F+ N    K    Y WI+G L + L LI++ I      R   C
Sbjct: 182 TNIFPAPTPAPSYTPNNFSDNAESPKRHPPYIWIVGSLGIILVLILVGIVGYACFRWLKC 241

Query: 268 FKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKA 327
           F  +R + +KDP G+ SHKFHIL K SFCC SGR+ICC S D+ Q + E S+    IPK 
Sbjct: 242 FSRSRSSHSKDPIGKVSHKFHILGKSSFCCASGRYICCSSADWKQASRESSDNQSAIPKG 301

Query: 328 -LGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK 386
            +  +VFD++KPVVF+ +EI+ +T+ FSDSSLLGHGTYGSVYYG +R+QEVAIKRMTATK
Sbjct: 302 TIENNVFDVDKPVVFSCEEIVSSTDSFSDSSLLGHGTYGSVYYGILRDQEVAIKRMTATK 361

Query: 387 TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS 446
           TKEFMAEMK+LCKVHH+NLVELIGYAA+EDELFLIYEYAQKG LKSHLHDP N+G T LS
Sbjct: 362 TKEFMAEMKVLCKVHHANLVELIGYAASEDELFLIYEYAQKGPLKSHLHDPLNKGHTPLS 421

Query: 447 WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
           WIMR+QIALDAARGLEYIHEHTKTHYVHRDIK+SNILLD +FRAKISDFGLAKLVGKT++
Sbjct: 422 WIMRLQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDGSFRAKISDFGLAKLVGKTNE 481

Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE 566
           GEATVTKVVGT+GYLAPEYL++GLAT KSDVYA+GVVLFE+I+GKEAIIRTEG   KN E
Sbjct: 482 GEATVTKVVGTYGYLAPEYLSNGLATTKSDVYAYGVVLFELITGKEAIIRTEGTTMKNPE 541

Query: 567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
           RRSLAS MLA LRN+PD M+M+SLKD +DP+MMDLYPHDCLFK+AMLAKQCVDED ILRP
Sbjct: 542 RRSLASIMLAVLRNAPDPMNMASLKDQVDPSMMDLYPHDCLFKVAMLAKQCVDEDSILRP 601

Query: 627 DMKQVVISLSQIL 639
           DMKQVVISLSQIL
Sbjct: 602 DMKQVVISLSQIL 614

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357513513|ref|XP_003627045.1| Protein kinase family protein [Medicago truncatula] gi|355521067|gb|AET01521.1| Protein kinase family protein [Medicago truncatula]

 Score =  922 bits (2382), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 453/637 (71%), Positives = 542/637 (85%), Gaps = 3/637 (0%)

Query: 5   RLHLLIWLCVLVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVL 64
            L LL ++  L +++   S ++   PMNCTDT R+C +FLAY+ Q NQ+L VIQSMFDVL
Sbjct: 8   HLKLLQFVLFLFYLNFNRSSSNQMAPMNCTDTRRVCTSFLAYKPQQNQSLGVIQSMFDVL 67

Query: 65  PKDVTVEGNEKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDN 124
           P D+TVEGN  +YIFI+KNCSC S  + YVSNTTFTVK++ G+V D+V++AYDGL +L N
Sbjct: 68  PSDITVEGNGWDYIFIRKNCSCASGIKKYVSNTTFTVKTNEGFVDDLVMDAYDGLILLPN 127

Query: 125 STRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVN 184
           ++R AR GAV+SLRLFCGCSSGLWNYL+SYV++DGD+V+SLASRFGVSMDSIE VNG+  
Sbjct: 128 TSRKARNGAVISLRLFCGCSSGLWNYLLSYVLRDGDSVESLASRFGVSMDSIEGVNGLDG 187

Query: 185 PNNVTAGDLFYIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGG 244
           P+NVT G L+YIPL+SVPG+PYP++N + P   P PSV++ +G+Q + K  + YGWIIGG
Sbjct: 188 PDNVTVGSLYYIPLDSVPGDPYPLKNASPPASVPTPSVDNISGDQDNHKYHVPYGWIIGG 247

Query: 245 LVVGLGLIILSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHIC 304
           L VGL LIIL I +C+ LRSS+CF ++R +  KD  G+ SHKF IL+ PSF CGSGR+IC
Sbjct: 248 LGVGLILIILGIILCVCLRSSNCFSDSRSHE-KDAEGKVSHKFQILRNPSFFCGSGRYIC 306

Query: 305 CKSGDYIQTTGEVSNPPITIPKA--LGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHG 362
            K  D  QT G+ S   IT+PKA  LG DVFDM+KPVVF Y+EI  +TEGFSDS+LLGHG
Sbjct: 307 GKHVDQKQTDGDSSTHTITVPKASTLGPDVFDMDKPVVFAYEEIFSSTEGFSDSNLLGHG 366

Query: 363 TYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY 422
           TYGSVYY  +R+QEVAIKRMTATKTKEF +E+K+LCKVHH+NLVELIGYAA+ DELFL+Y
Sbjct: 367 TYGSVYYCLLRDQEVAIKRMTATKTKEFTSEIKVLCKVHHANLVELIGYAASHDELFLVY 426

Query: 423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI 482
           EYAQKGSL+SHLHDPQN+G + LSWIMRVQIALDAARGLEYIHEHTK HYVHRDIK+SNI
Sbjct: 427 EYAQKGSLRSHLHDPQNKGHSPLSWIMRVQIALDAARGLEYIHEHTKAHYVHRDIKTSNI 486

Query: 483 LLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGV 542
           LLD++F+AKISDFGLAKLVG T++G+ + TKVVGT+GYLAPEYL+DGLAT KSDVYAFGV
Sbjct: 487 LLDASFKAKISDFGLAKLVGITNEGDVSTTKVVGTYGYLAPEYLSDGLATTKSDVYAFGV 546

Query: 543 VLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLY 602
           VLFE I+GKEAIIRTEGM++KN ERRSLAS MLA LRNSPDS+SMSS+KDYIDPNMM+LY
Sbjct: 547 VLFETITGKEAIIRTEGMMTKNPERRSLASIMLAVLRNSPDSLSMSSMKDYIDPNMMNLY 606

Query: 603 PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           PHDC+FKMAMLAKQCVD+DPILRPDMK VVIS+SQIL
Sbjct: 607 PHDCVFKMAMLAKQCVDDDPILRPDMKTVVISISQIL 643

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356522910|ref|XP_003530085.1| PREDICTED: serine/threonine-protein kinase BRI1-like 1-like [Glycine max]

 Score =  914 bits (2362), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/613 (71%), Positives = 512/613 (83%), Gaps = 28/613 (4%)

Query: 29  QPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLS 88
           +PMNCTDT+R+C +F+A++  PN TL++I+SMFDVLP D+TVEGN   Y+FI+KNCSC +
Sbjct: 31  EPMNCTDTSRVCTSFMAFKRGPNHTLALIESMFDVLPGDITVEGNGWGYMFIRKNCSCAA 90

Query: 89  TTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLW 148
             + YVSNTTFTVKS+ G VYD+V++AYDGLA L N+TRMAR GAVVSLRLFCGCSSGLW
Sbjct: 91  GIKKYVSNTTFTVKSNEGLVYDMVMDAYDGLAFLPNTTRMARNGAVVSLRLFCGCSSGLW 150

Query: 149 NYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPV 208
           NYL+SYVM+DGD+V+SLASRFGVSMDSIE VNGI NP+NVT G L+YIPL+SVPG+ YP+
Sbjct: 151 NYLVSYVMRDGDSVESLASRFGVSMDSIESVNGIGNPDNVTVGSLYYIPLDSVPGDSYPL 210

Query: 209 ENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCF 268
            N     P  +PS ++F+ +QV+ KA + YGWI+G                         
Sbjct: 211 NNAAPTVPVLSPSFDNFSADQVNHKAHVPYGWIVGA------------------------ 246

Query: 269 KEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKA- 327
            + R +  KD  G+ SHKFHIL+ PSF CGSGR+IC K  D  QT GE SN  I +PKA 
Sbjct: 247 -DTRTHE-KDAEGKISHKFHILRNPSFFCGSGRYICGKHVDQKQTDGESSNHTIMVPKAS 304

Query: 328 -LGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK 386
            L  DVFDM+KPVVFTY+EI   T+GFSDSSLLGHGTYGSVYY  +R+QEVAIKRMTATK
Sbjct: 305 TLWPDVFDMDKPVVFTYEEIFSTTDGFSDSSLLGHGTYGSVYYSLLRDQEVAIKRMTATK 364

Query: 387 TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS 446
           TKEFM EMK+LCKVHH+NLVELIGYAA+ +ELFL+YEYAQKGSLKSHLHDPQN+G + LS
Sbjct: 365 TKEFMLEMKVLCKVHHANLVELIGYAASHEELFLVYEYAQKGSLKSHLHDPQNKGHSPLS 424

Query: 447 WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
           WIMRVQIA+DAARGLEYIHEHTKTHYVHRDIK+SNILLD++FRAKISDFGLAKLVGK ++
Sbjct: 425 WIMRVQIAIDAARGLEYIHEHTKTHYVHRDIKTSNILLDASFRAKISDFGLAKLVGKANE 484

Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE 566
           GE + TKVVGT+GYLAPEYL+DGLAT K+DVYAFGVVLFEIISGKEAIIR+EG +SKN +
Sbjct: 485 GEISTTKVVGTYGYLAPEYLSDGLATTKNDVYAFGVVLFEIISGKEAIIRSEGTMSKNAD 544

Query: 567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
           RRSLAS ML ALRNSPDSMSMSSL++YIDPNMMDLYPHDC+FK+AMLAKQCVDEDPILRP
Sbjct: 545 RRSLASIMLGALRNSPDSMSMSSLREYIDPNMMDLYPHDCVFKLAMLAKQCVDEDPILRP 604

Query: 627 DMKQVVISLSQIL 639
           DM+QVVISLSQIL
Sbjct: 605 DMRQVVISLSQIL 617

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356526077|ref|XP_003531646.1| PREDICTED: proline-rich receptor-like protein kinase PERK14-like [Glycine max]

 Score =  911 bits (2354), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 443/613 (72%), Positives = 516/613 (84%), Gaps = 28/613 (4%)

Query: 29  QPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEKNYIFIKKNCSCLS 88
           +PMNCTDT+R+C +F+A++  PN TL++IQSMFDVLP D+TVEG    Y+FI+KNCSC +
Sbjct: 29  EPMNCTDTSRVCTSFMAFKPGPNHTLALIQSMFDVLPGDITVEGTGWGYMFIRKNCSCAA 88

Query: 89  TTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAVVSLRLFCGCSSGLW 148
             +NYVSNTTFTVKS+ G +YD+V++AYDGLA L N+TRMAR GAVVSL LFCGCSSGLW
Sbjct: 89  GIKNYVSNTTFTVKSNEGLLYDMVMDAYDGLAFLPNTTRMARNGAVVSLTLFCGCSSGLW 148

Query: 149 NYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPV 208
           NYL+SYVM+DGD+V+SLASRFGVSMDSIE VNGI NP+NVT G L+YIPL+SVPG+PYP+
Sbjct: 149 NYLVSYVMRDGDSVESLASRFGVSMDSIESVNGIGNPDNVTVGSLYYIPLDSVPGDPYPL 208

Query: 209 ENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIILSIAVCIWLRSSSCF 268
            N   P P P+PS ++F+ +QV+ KA + YGWI+G                         
Sbjct: 209 NNAAPPVPVPSPSFDNFSADQVNHKAHVPYGWIVGA------------------------ 244

Query: 269 KEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTTGEVSNPPITIPKA- 327
            + R +  KD  G+ SHKFHIL+ PSF CGSGR+IC K  D  QT GE SN  ITIPKA 
Sbjct: 245 -DTRTHE-KDAEGKVSHKFHILRNPSFFCGSGRYICGKHVDKKQTDGESSNHTITIPKAS 302

Query: 328 -LGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK 386
            LG DVFDM+KPVVFTY+EI   T+GFSD+SLLGHGTYGSVYY  +R+QEVAIKRMTATK
Sbjct: 303 TLGPDVFDMDKPVVFTYEEIFSTTDGFSDTSLLGHGTYGSVYYSLLRDQEVAIKRMTATK 362

Query: 387 TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS 446
           TKEFM+EMK+LCKVHH+NLVELIGYAA+ +ELFL+YEYAQKGSLKSHLHDPQN+G + LS
Sbjct: 363 TKEFMSEMKVLCKVHHANLVELIGYAASHEELFLVYEYAQKGSLKSHLHDPQNKGHSPLS 422

Query: 447 WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
           WIMRVQIALDAARGLEYIHEHTKTHYVHRDIK+SNILLD++FRAKISDFGLAKLVGK ++
Sbjct: 423 WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDASFRAKISDFGLAKLVGKANE 482

Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE 566
           GE + TKVVGT+GYLAPEYL+DGLAT KSDVYAFGVVLFEIISGK+AIIR+EG +SKN +
Sbjct: 483 GEISTTKVVGTYGYLAPEYLSDGLATTKSDVYAFGVVLFEIISGKDAIIRSEGTMSKNPD 542

Query: 567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
           RRSLAS ML  LRNSPDSMSMSSL++YIDPNMMDLYPHDC+FK+AMLAKQCVDEDPILRP
Sbjct: 543 RRSLASIMLGVLRNSPDSMSMSSLREYIDPNMMDLYPHDCVFKLAMLAKQCVDEDPILRP 602

Query: 627 DMKQVVISLSQIL 639
           DM+QVVISLSQIL
Sbjct: 603 DMRQVVISLSQIL 615

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557304|ref|XP_003546957.1| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Glycine max]

 Score =  840 bits (2169), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 417/627 (66%), Positives = 513/627 (81%), Gaps = 14/627 (2%)

Query: 16  VFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNEK 75
           +F+  +   +SY  PMNCTDTTR+C +FLA++ QPNQTL+VIQSMFDVLP ++TVEGN  
Sbjct: 17  IFLLHLYCTSSYPTPMNCTDTTRVCTSFLAFKPQPNQTLAVIQSMFDVLPGEITVEGNGW 76

Query: 76  NYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNST-RMARAGAV 134
           +YIFI+KNCSC +  + YVSNTT TVKS+GG+ +D+V++AYDGLA+L N+T R AR G V
Sbjct: 77  DYIFIRKNCSCAAGMKKYVSNTTLTVKSNGGFEHDLVMDAYDGLALLPNTTTRWAREGGV 136

Query: 135 VSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLF 194
           +SL LFC CSSGLWNYLMSYV++DGD+V+SLASRFGVSMD+IE VN I NP+++T G L+
Sbjct: 137 ISLSLFCSCSSGLWNYLMSYVIRDGDSVESLASRFGVSMDNIETVNAIDNPDSLTVGSLY 196

Query: 195 YIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGNQVDRKARMSYGWIIGGLVVGLGLIIL 254
           YIPLNSVPGE Y ++NDT   P P+PSV++F+ + V +KA + + WI+GGL +GL LIIL
Sbjct: 197 YIPLNSVPGELYHLKNDTPSAPIPSPSVDNFSADHVTQKAHVPHEWIVGGLGIGLALIIL 256

Query: 255 SIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCKSGDYIQTT 314
           +I V + LRS +C  EAR N+AKD  G+ S KF++   PS  CG     C K  D  QT 
Sbjct: 257 TIIVWVALRSPNCLVEAR-NNAKDSAGKISKKFYVFGNPSLFCG-----CGKPVDQHQTY 310

Query: 315 GEVSNPPITIPKA--LGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNI 372
           GE S+  IT+ KA  L  D+ DM+KPVVF+Y+E   +T+GFSDS+LLG  TYGSVY+G +
Sbjct: 311 GESSSHQITVTKASTLMPDMLDMDKPVVFSYEETFSSTDGFSDSNLLGRRTYGSVYHGLL 370

Query: 373 RNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS 432
           R+QEVAIKR+T TKTKEFM+E+K+LCKVHH+NLVELIGYA + DE FLIYE+AQ+GSL S
Sbjct: 371 RDQEVAIKRLTTTKTKEFMSEIKVLCKVHHANLVELIGYAVSHDEFFLIYEFAQRGSLSS 430

Query: 433 HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI 492
           HLHDPQ++G + LSWI RVQIALDAARGLEYIHEHTKT YVH+DIK+SNI LD++FRAKI
Sbjct: 431 HLHDPQSKGYSPLSWITRVQIALDAARGLEYIHEHTKTRYVHQDIKTSNIFLDASFRAKI 490

Query: 493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE 552
           SDFGLAKLVG+T++GE   TKVV  +GYLAPEYL++GLAT KSDVYAFGVVLFEIISGKE
Sbjct: 491 SDFGLAKLVGETNEGEIAATKVVNAYGYLAPEYLSNGLATTKSDVYAFGVVLFEIISGKE 550

Query: 553 AIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAM 612
           AII+T+G      E+RSLAS MLA LRNSPD++SMSS ++ +DP MMDLYPHDC++KMAM
Sbjct: 551 AIIQTQG-----PEKRSLASIMLAVLRNSPDTVSMSSTRNLVDPIMMDLYPHDCVYKMAM 605

Query: 613 LAKQCVDEDPILRPDMKQVVISLSQIL 639
           LAKQCVDEDP+LRPDMKQVVI LSQIL
Sbjct: 606 LAKQCVDEDPVLRPDMKQVVIFLSQIL 632

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	639
TAIR|locus:2195814	651	LYK3 "LysM-containing receptor	0.959	0.941	0.671	2.2e-224
UNIPROTKB|D7UPN3	605	CERK1 "Chitin elicitor recepto	0.453	0.479	0.495	8.5e-77
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.463	0.479	0.464	8.6e-73
TAIR|locus:2125692	731	PERK14 "proline-rich extensin-	0.446	0.389	0.428	2e-59
TAIR|locus:2050987	664	LYK5 "LysM-containing receptor	0.452	0.435	0.351	2.9e-58
TAIR|locus:2028756	762	PERK10 "proline-rich extensin-	0.438	0.367	0.400	3.5e-58
TAIR|locus:2019938	718	PERK11 "proline-rich extensin-	0.441	0.392	0.401	1.8e-56
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.447	0.419	0.382	4.8e-56
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.486	0.476	0.376	8.8e-55
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.441	0.397	0.404	1.1e-54

TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 2166 (767.5 bits), Expect = 2.2e-224, P = 2.2e-224
 Identities = 425/633 (67%), Positives = 506/633 (79%)

Query:    15 LVFVSRIESLNSYRQPMNCTDTTRLCATFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGNE 74
             + F+S + S +S + PMNC+DTTRLC++FLA++   NQ+ SVIQSMFDVLP+D+T + + 
Sbjct:     7 IFFLSLLPSFSSSK-PMNCSDTTRLCSSFLAFKPNQNQSFSVIQSMFDVLPQDITADISG 65

Query:    75 KNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVVNAYDGLAILDNSTRMARAGAV 134
               Y FIKKNCSCL+TT  Y +NTTFT++ + GYVY+V V+AY GLA   N+TR ARAGAV
Sbjct:    66 -GYFFIKKNCSCLTTTHQYTTNTTFTIRQNVGYVYNVTVSAYSGLAFPPNTTRAARAGAV 124

Query:   135 VSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLF 194
             VS++L CGCSSGLWNYLMSYV   GD+VQSL+SRFGVSMD IE VNGI+N +N+TAGDL 
Sbjct:   125 VSVQLLCGCSSGLWNYLMSYVAMAGDSVQSLSSRFGVSMDRIEDVNGILNLDNITAGDLL 184

Query:   195 YIPLNSVPGEPYPVENDTLPPPAPAPSVEDFAGN----QVDRKAR----MSYGWXXXXXX 246
             YIPL+SVPGEPY       P P+PAP+     GN    QV+  A+    + Y W      
Sbjct:   185 YIPLDSVPGEPYETSKINPPAPSPAPASSLANGNISDDQVNHTAKSGSHVPYIWIVGGLG 244

Query:   247 XXXXXXXXSIAVCIWLRSSSCFKEARGNSAKDPGGRSSHKFHILQKPSFCCGSGRHICCK 306
                      I VCI LRSSSC      +S+++ G  + H F IL+K  F CGSGR+ CC+
Sbjct:   245 VVLALLVLCILVCICLRSSSC------SSSEEDG--NGHNFQILRKSGFFCGSGRYNCCR 296

Query:   307 SGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGS 366
             SGD+ QT GE     + IPKALG  +F++EKP+VFTY+EI  AT+ FSDS+LLGHG YGS
Sbjct:   297 SGDFRQTNGETQ--VVAIPKALGDGMFEIEKPMVFTYEEIRAATDEFSDSNLLGHGNYGS 354

Query:   367 VYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ 426
             VY+G +R QEVA+KRMTATKTKEF AEMK+LCKVHHSNLVELIGYAAT DELF++YEY +
Sbjct:   355 VYFGLLREQEVAVKRMTATKTKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVR 414

Query:   427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS 486
             KG LKSHLHDPQ++G T LSWIMR QIALDAARGLEYIHEHTKTHYVHRDIK+SNILLD 
Sbjct:   415 KGMLKSHLHDPQSKGNTPLSWIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDE 474

Query:   487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
             AFRAKISDFGLAKLV KT +GE +VTKVVGT+GYLAPEYL+DGLAT+KSD+YAFGVVLFE
Sbjct:   475 AFRAKISDFGLAKLVEKTGEGEISVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFE 534

Query:   547 IISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDC 606
             IISG+EA+IRTE + +KN ERR LAS MLA L+NSPDSM+MSSLK+++DPNMMDLYPHDC
Sbjct:   535 IISGREAVIRTEAIGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDC 594

Query:   607 LFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
             LFK+A LAKQCVD+DPILRP+MKQVVISLSQIL
Sbjct:   595 LFKIATLAKQCVDDDPILRPNMKQVVISLSQIL 627

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016998 "cell wall macromolecule catabolic process" evidence=IEA

GO:0007020 "microtubule nucleation" evidence=RCA

UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 708 (254.3 bits), Expect = 8.5e-77, Sum P(2) = 8.5e-77
 Identities = 149/301 (49%), Positives = 199/301 (66%)

Query:   335 MEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEM 394
             +E+ + F+Y+EI  AT+GFS    +G G +GSVYY  +R ++ AIK+M    T+EF+AE+
Sbjct:   299 VERSIEFSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAEL 358

Query:   395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA 454
             K+L  VHH NLV LIGY   E+ LFL+YE+   G+L  HL   Q  G   LSW  RVQIA
Sbjct:   359 KVLTHVHHLNLVRLIGYCV-ENCLFLVYEFIDNGNLSQHL---QRTGYAPLSWATRVQIA 414

Query:   455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
             LD+ARGLEY+HEH    YVHRDIKS+NILLD  FRAKI+DFGLAKL    S  ++  T+V
Sbjct:   415 LDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRV 474

Query:   515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM 574
              GTFGY+ PE    G  + K DVYAFGVVL+E++S K+AI+R+   VS   E + L  F+
Sbjct:   475 AGTFGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSESVS---ESKGLV-FL 529

Query:   575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
                  ++P+     +L + IDP++   YP D   K+A LAK C  E+P +RP M+ VV++
Sbjct:   530 FEEALSAPNPTE--ALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVA 587

Query:   635 L 635
             L
Sbjct:   588 L 588

GO:0005515 "protein binding" evidence=IPI

GO:0008061 "chitin binding" evidence=IDA

GO:0010200 "response to chitin" evidence=IDA

GO:0043621 "protein self-association" evidence=IDA

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 687 (246.9 bits), Expect = 8.6e-73, Sum P(2) = 8.6e-73
 Identities = 144/310 (46%), Positives = 197/310 (63%)

Query:   329 GTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTK 388
             G     ++K V F+ +E+  AT+ F+ S  +G G +G+VYY  +R ++ AIK+M    +K
Sbjct:   298 GIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASK 357

Query:   389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
             +F+AE+K+L +VHH NLV LIGY   E  LFL+YEY + G+L  HLH     G+  L W 
Sbjct:   358 QFLAELKVLTRVHHVNLVRLIGYCV-EGSLFLVYEYVENGNLGQHLH---GSGREPLPWT 413

Query:   449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              RVQIALD+ARGLEYIHEHT   YVHRDIKS+NIL+D  FRAK++DFGL KL   T  G 
Sbjct:   414 KRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKL---TEVGG 470

Query:   509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
             +     +GTFGY+APE +  G  +AK DVYAFGVVL+E+IS K A+++    V    E R
Sbjct:   471 SATRGAMGTFGYMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVG---EFR 526

Query:   569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM 628
              L      + + +       +L+  IDP + D YP D ++KMA L K C  E+  LRP M
Sbjct:   527 GLVGVFEESFKETDKE---EALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSM 583

Query:   629 KQVVISLSQI 638
             + +V++LS +
Sbjct:   584 RYIVVALSTL 593

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 573 (206.8 bits), Expect = 2.0e-59, Sum P(2) = 2.0e-59
 Identities = 129/301 (42%), Positives = 182/301 (60%)

Query:   340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATK---TKEFMAEMK 395
             +F+Y+E+  AT GFS+ +LLG G +G V+ G ++N  EVA+K++        +EF AE+ 
Sbjct:   376 MFSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVD 435

Query:   396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
              + +VHH +LV L+GY    D+  L+YE+  K +L+ HLH+  NRG   L W MR++IA+
Sbjct:   436 TISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHE--NRGSV-LEWEMRLRIAV 492

Query:   456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-TKV 514
              AA+GL Y+HE      +HRDIK++NILLDS F AK+SDFGLAK    T+     + T+V
Sbjct:   493 GAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRV 552

Query:   515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM 574
             VGTFGY+APEY + G  T KSDVY+FGVVL E+I+G+ +I   +   S NQ   SL  + 
Sbjct:   553 VGTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDS--STNQ---SLVDWA 607

Query:   575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
                L  +    S   L   +D  +   Y    +  MA  A  C+ +   LRP M QVV +
Sbjct:   608 RPLLTKAISGESFDFL---VDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRA 664

Query:   635 L 635
             L
Sbjct:   665 L 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 501 (181.4 bits), Expect = 2.9e-58, Sum P(2) = 2.9e-58
 Identities = 108/307 (35%), Positives = 186/307 (60%)

Query:   335 MEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEM 394
             +E   ++ ++++  AT  FSD + +     GSVY   I   + A+K     K     +E+
Sbjct:   354 IESLTLYRFNDLQSATSNFSDENRIK----GSVYRATINGDDAAVK---VIKGDVSSSEI 406

Query:   395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA 454
              +L K++HSN++ L G+   E   +L++EY++ GS+   LH   + G+ SL+W  RV+IA
Sbjct:   407 NLLKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLH---SSGKKSLTWKQRVEIA 463

Query:   455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK- 513
              D A  L+Y+H +    ++H++++S+NILLDS FRAKI++FG+A+++ +  D +  +T+ 
Sbjct:   464 RDVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDE-GDLDLQLTRH 522

Query:   514 VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF 573
             V GT GYLAPEY+ +G+ T+K DV+AFGV + E++SG+EA+      + K +E       
Sbjct:   523 VEGTQGYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVT-----IHKKKEGEEEVEM 577

Query:   574 MLAALRNSPDSMSM-SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
             +   + +     ++   LK+++DP++ + YP +  + MA LAK CV  D   RP + QV+
Sbjct:   578 LCKVINSVLGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVL 637

Query:   633 ISLSQIL 639
              +LS I+
Sbjct:   638 TTLSMIV 644

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0008061 "chitin binding" evidence=IDA

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 533 (192.7 bits), Expect = 3.5e-58, Sum P(3) = 3.5e-58
 Identities = 119/297 (40%), Positives = 176/297 (59%)

Query:   340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEV-AIKRMT---ATKTKEFMAEMK 395
             +F+Y+E++ AT GFSD +LLG G +G VY G + ++ V A+K++        +EF AE+ 
Sbjct:   417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476

Query:   396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
              + +VHH NL+ ++GY  +E+   LIY+Y    +L  HLH     G   L W  RV+IA 
Sbjct:   477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAA---GTPGLDWATRVKIAA 533

Query:   456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              AARGL Y+HE      +HRDIKSSNILL++ F A +SDFGLAKL     +   T T+V+
Sbjct:   534 GAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLA-LDCNTHIT-TRVM 591

Query:   516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
             GTFGY+APEY + G  T KSDV++FGVVL E+I+G++ +  ++ +  +     SL  +  
Sbjct:   592 GTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDE-----SLVEWAR 646

Query:   576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
               L N+ ++   ++L D   P +   Y    +F+M   A  C+      RP M Q+V
Sbjct:   647 PLLSNATETEEFTALAD---PKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIV 700

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 539 (194.8 bits), Expect = 1.8e-56, Sum P(2) = 1.8e-56
 Identities = 120/299 (40%), Positives = 180/299 (60%)

Query:   341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNI-RNQEVAIKRMTATKT---KEFMAEMKI 396
             FTY+E+   TEGF  S ++G G +G VY G +   + VAIK++ +      +EF AE++I
Sbjct:   358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417

Query:   397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
             + +VHH +LV L+GY  +E   FLIYE+    +L  HLH    +    L W  RV+IA+ 
Sbjct:   418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLH---GKNLPVLEWSRRVRIAIG 474

Query:   457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
             AA+GL Y+HE      +HRDIKSSNILLD  F A+++DFGLA+L   T+    + T+V+G
Sbjct:   475 AAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARL-NDTAQSHIS-TRVMG 532

Query:   517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
             TFGYLAPEY + G  T +SDV++FGVVL E+I+G++ +  ++ +    +E  SL  +   
Sbjct:   533 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPL---GEE--SLVEWARP 587

Query:   577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              L    +++    + + +DP + + Y    ++KM   A  CV    + RP M QVV +L
Sbjct:   588 RLI---EAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 542 (195.9 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
 Identities = 116/303 (38%), Positives = 182/303 (60%)

Query:   341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMT---ATKTKEFMAEMKI 396
             F+YDE+   T GFS+ +LLG G +G VY G + + +EVA+K++    +   +EF AE++I
Sbjct:   327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query:   397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
             + +VHH +LV L+GY  +E    L+Y+Y    +L  HLH P   G+  ++W  RV++A  
Sbjct:   387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP---GRPVMTWETRVRVAAG 443

Query:   457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
             AARG+ Y+HE      +HRDIKSSNILLD++F A ++DFGLAK+  +        T+V+G
Sbjct:   444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503

Query:   517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
             TFGY+APEY T G  + K+DVY++GV+L E+I+G++ +  ++ +  +     SL  +   
Sbjct:   504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDE-----SLVEWARP 558

Query:   577 ALRNSPDSMSMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              L  + ++     L   +DP +  +  P + +F+M   A  CV      RP M QVV +L
Sbjct:   559 LLGQAIENEEFDEL---VDPRLGKNFIPGE-MFRMVEAAAACVRHSAAKRPKMSQVVRAL 614

Query:   636 SQI 638
               +
Sbjct:   615 DTL 617

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 538 (194.4 bits), Expect = 8.8e-55, Sum P(2) = 8.8e-55
 Identities = 125/332 (37%), Positives = 191/332 (57%)

Query:   310 YIQTTG--EVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV 367
             ++ ++G  + S+ P+  P + G  V    K   FTY+E+  AT GFS+++LLG G +G V
Sbjct:   237 FMSSSGGSDYSDLPVLPPPSPGL-VLGFSKST-FTYEELSRATNGFSEANLLGQGGFGYV 294

Query:   368 YYGNIRN-QEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE 423
             + G + + +EVA+K++ A      +EF AE++I+ +VHH +LV LIGY     +  L+YE
Sbjct:   295 HKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYE 354

Query:   424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL 483
             +    +L+ HLH    +G+ ++ W  R++IAL +A+GL Y+HE      +HRDIK+SNIL
Sbjct:   355 FVPNNNLEFHLH---GKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNIL 411

Query:   484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVV 543
             +D  F AK++DFGLAK+   T+   +T  +V+GTFGYLAPEY   G  T KSDV++FGVV
Sbjct:   412 IDFKFEAKVADFGLAKIASDTNTHVST--RVMGTFGYLAPEYAASGKLTEKSDVFSFGVV 469

Query:   544 LFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYP 603
             L E+I+G+  +      V       SL  +    L  + +      L D     M + Y 
Sbjct:   470 LLELITGRRPVDANNVYVDD-----SLVDWARPLLNRASEEGDFEGLAD---SKMGNEYD 521

Query:   604 HDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              + + +M   A  CV      RP M Q+V +L
Sbjct:   522 REEMARMVACAAACVRHSARRRPRMSQIVRAL 553

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 536 (193.7 bits), Expect = 1.1e-54, Sum P(2) = 1.1e-54
 Identities = 121/299 (40%), Positives = 180/299 (60%)

Query:   341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE-VAIKRM---TATKTKEFMAEMKI 396
             FTY+E+   TEGFS  ++LG G +G VY G + + + VA+K++   +    +EF AE++I
Sbjct:   341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query:   397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
             + +VHH +LV L+GY   + E  LIYEY    +L+ HLH    +G+  L W  RV+IA+ 
Sbjct:   401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLH---GKGRPVLEWARRVRIAIG 457

Query:   457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
             +A+GL Y+HE      +HRDIKS+NILLD  F A+++DFGLAKL   T    +T  +V+G
Sbjct:   458 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVST--RVMG 515

Query:   517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
             TFGYLAPEY   G  T +SDV++FGVVL E+I+G++ + + + +    +E  SL  +   
Sbjct:   516 TFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPL---GEE--SLVEWARP 570

Query:   577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              L  + ++   S L   +D  +   Y  + +F+M   A  CV      RP M QVV +L
Sbjct:   571 LLHKAIETGDFSEL---VDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRAL 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
F4IB81	LYK3_ARATH	2, ., 7, ., 1, 1, ., -	0.6935	0.9374	0.9201	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.I.410.1 hypothetical protein (604 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	639
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-58
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-53
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-41
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-33
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-32
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-31
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-30
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-30
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-29
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-28
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-26
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-25
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-25
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-23
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-22
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-22
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-21
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-19
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-18
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-17
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-15
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-09
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
smart00257	44	smart00257, LysM, Lysin motif	2e-07
cd00118	45	cd00118, LysM, Lysine Motif is a small domain invo	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
pfam01476	43	pfam01476, LysM, LysM domain	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-04
COG3858	423	COG3858, COG3858, Predicted glycosyl hydrolase [Ge	3e-04
COG0739	277	COG0739, NlpD, Membrane proteins related to metall	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  197 bits (503), Expect = 1e-58
 Identities = 83/289 (28%), Positives = 139/289 (48%), Gaps = 50/289 (17%)

Query: 359 LGHGTYGSVYYGNIRN------QEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           LG G +G VY G ++        EVA+K +    +    +EF+ E +I+ K+ H N+V+L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +G    E+ L+++ EY + G L S+L   + +    LS    +  AL  ARG+EY+    
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLESK- 121

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             +++HRD+ + N L+      KISDFGL++ +           K+     ++APE L +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKE 177

Query: 529 GLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           G  T+KSDV++FGV+L+EI + G++                                MS 
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQ----------------------------PYPGMSN 209

Query: 588 SSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
             + +Y+ +   +   P +C  ++  L  QC  EDP  RP   ++V  L
Sbjct: 210 EEVLEYLKNGYRLPQ-PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  195 bits (498), Expect = 5e-58
 Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 47/288 (16%)

Query: 359 LGHGTYGSVYYGNIRN------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G VY G ++        EVA+K +    +  + +EF+ E +I+ K+ H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +G    E+ L ++ EY   G L  +L   + +    LS    +  AL  ARG+EY+    
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEYLESK- 122

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             +++HRD+ + N L+      KISDFGL++ +      +    K+     ++APE L +
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKE 178

Query: 529 GLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           G  T+KSDV++FGV+L+EI + G+E                                MS 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEE----------------------------PYPGMSN 210

Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
           + + +Y+        P +C  ++  L  QC  EDP  RP   ++V  L
Sbjct: 211 AEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (469), Expect = 2e-54
 Identities = 78/218 (35%), Positives = 128/218 (58%), Gaps = 21/218 (9%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTA----TKTKEFMAEMKILCKVHHSNLVELIGYA 412
           LG G +G+VY    +   ++VAIK +      +  +E + E++IL K++H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             E+ L+L+ EY + GSLK  L + + +    LS    ++I L    GLEY+H +     
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHSN---GI 113

Query: 473 VHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GL 530
           +HRD+K  NILLDS   + K++DFGL+KL+   +  ++ +  +VGT  Y+APE L   G 
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLL---TSDKSLLKTIVGTPAYMAPEVLLGKGY 170

Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
            + KSD+++ GV+L+E+   K+ I     M+ K+ E+R
Sbjct: 171 YSEKSDIWSLGVILYELPELKDLI---RKMLQKDPEKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  182 bits (465), Expect = 3e-53
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 47/288 (16%)

Query: 359 LGHGTYGSVYYGNIR------NQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           LG G +G VY G ++        +VA+K +    +    +EF+ E  I+ K+ H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +G     + L+++ EY   G L   L     +    L+    +Q+AL  A+G+EY+    
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK----LTLKDLLQMALQIAKGMEYLESK- 121

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             ++VHRD+ + N L+      KISDFGL++ + +           +    ++APE L D
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-WMAPESLKD 178

Query: 529 GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSM 587
           G  T+KSDV++FGV+L+EI +  E                             P   MS 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGE----------------------------QPYPGMSN 210

Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
             + + ++       P +C  ++  L  QC   DP  RP   ++V  L
Sbjct: 211 EEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  181 bits (461), Expect = 1e-52
 Identities = 86/291 (29%), Positives = 137/291 (47%), Gaps = 46/291 (15%)

Query: 359 LGHGTYGSVYYGNIRN-----QEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELI 409
           LG G +G VY G ++       EVA+K +    +    K+F+ E +++ K+ H N+V L+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNR----GQTSLSWIMRVQIALDAARGLEYIH 465
           G    E+ L+L+ EY + G L  +L   +       +++LS    +  A+  A+G+EY+ 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                 +VHRD+ + N L+      KISDFGL++ V             +    ++APE 
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPES 178

Query: 526 LTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
           L DG+ T+KSDV++FGV+L+EI + G        G+   N+E       +L  LR     
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPY---PGL--SNEE-------VLEYLR----- 221

Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                 K Y  P      P  C  ++  L   C   DP  RP   ++V  L
Sbjct: 222 ------KGYRLPK-----PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (422), Expect = 4e-47
 Identities = 69/200 (34%), Positives = 99/200 (49%), Gaps = 18/200 (9%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGY 411
            LG G++G VY        + VAIK +   K K+     + E+KIL K+ H N+V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              ED+L+L+ EY + G L   L     RG+ S                LEY+H      
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEA--RFYLRQILSALEYLHSK---G 117

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            VHRD+K  NILLD     K++DFGLA+ +         +T  VGT  Y+APE L     
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE----KLTTFVGTPEYMAPEVLLGKGY 173

Query: 532 TAKSDVYAFGVVLFEIISGK 551
               D+++ GV+L+E+++GK
Sbjct: 174 GKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (393), Expect = 5e-43
 Identities = 75/207 (36%), Positives = 107/207 (51%), Gaps = 19/207 (9%)

Query: 353 FSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFM-----AEMKILCKVHHSNL 405
           +     LG G++G+VY        + VA+K +     K         E++IL ++ H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
           V LI     +D L+L+ EY + G L  +L          LS     +IAL   RGLEY+H
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLH 115

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
            +     +HRD+K  NILLD     KI+DFGLAK + K S    T    VGT  Y+APE 
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLK-SSSSLTT--FVGTPWYMAPEV 169

Query: 526 LTDGL-ATAKSDVYAFGVVLFEIISGK 551
           L  G     K DV++ GV+L+E+++GK
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  149 bits (379), Expect = 5e-41
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 358 LLGHGTYGSVYYGNIRN--QEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIG 410
           LLG G++GSVY    ++  + +A+K +     +  + +    E++IL  + H N+V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 411 YAATEDELFL-IY-EYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYIHE 466
               E++  L I+ EY   GSL S L      G+     I +   QI      GL Y+H 
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKYTRQIL----EGLAYLHS 119

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
           +     VHRDIK +NIL+DS    K++DFG AK +G    GE T + V GT  ++APE +
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS-VRGTPYWMAPEVI 175

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
                   +D+++ G  + E+ +GK
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  140 bits (355), Expect = 9e-38
 Identities = 83/288 (28%), Positives = 141/288 (48%), Gaps = 47/288 (16%)

Query: 356 SSLLGHGTYGSVYYGNIRNQEVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
            + +G G +G V  G+ R Q+VA+K +   +T  + F+AE  ++  + H NLV+L+G   
Sbjct: 11  GATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
             + L+++ EY  KGSL  +L   ++RG+  ++   ++  ALD   G+EY+ E    ++V
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTDGLA 531
           HRD+ + N+L+     AK+SDFGLAK        EA+  +  G     + APE L +   
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK--------EASQGQDSGKLPVKWTAPEALREKKF 176

Query: 532 TAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
           + KSDV++FG++L+EI S G                            R     + +  +
Sbjct: 177 STKSDVWSFGILLWEIYSFG----------------------------RVPYPRIPLKDV 208

Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             +++       P  C  ++  + K C + DP  RP  KQ+   L+ I
Sbjct: 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (340), Expect = 1e-35
 Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 50/285 (17%)

Query: 358 LLGHGTYGSVY-YGNIRNQE-VAIKR-----MTATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G++G VY      + +   +K      M+  + ++ + E+KIL K++H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS----WIMRVQIALDAARGLEYIHE 466
               + +L ++ EYA  G L   +   Q +              VQ+ L     L+Y+H 
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKK-QKKEGKPFPEEQILDWFVQLCL----ALKYLHS 121

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 +HRDIK  NI L S    K+ DFG++K++  T D   T   VVGT  YL+PE  
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT---VVGTPYYLSPELC 175

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
            +     KSD+++ G VL+E+ + K              E  +L    L  L+     + 
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPF-----------EGENLLELALKILKGQYPPI- 223

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                    P+    Y  +    +  L    + +DP  RP + Q+
Sbjct: 224 ---------PSQ---YSSE----LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  133 bits (337), Expect = 3e-35
 Identities = 70/205 (34%), Positives = 112/205 (54%), Gaps = 18/205 (8%)

Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQ-EVAIKRM---TATKTKEFMAEMKILCKVHHSNLVE 407
           F     +G G +G VY   + R   EVAIK +   +  K ++ + E++IL K  H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT-SLSWIMRVQIALDAARGLEYIHE 466
             G    +DEL+++ E+   GSLK  L   ++  QT + S I    +  +  +GLEY+H 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQI--AYVCKELLKGLEYLHS 116

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
           +     +HRDIK++NILL S    K+ DFGL+  +   SD +A  T +VGT  ++APE +
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNT-MVGTPYWMAPEVI 169

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
                  K+D+++ G+   E+  GK
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 2e-33
 Identities = 69/201 (34%), Positives = 110/201 (54%), Gaps = 18/201 (8%)

Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIG 410
           L+G G +G VY G N+   + VAIK+++  K KE      M E+ +L  + H N+V+ IG
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              T D L++I EYA+ GSL+  +         SL  +   Q+     +GL Y+HE    
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQV----LQGLAYLHEQG-- 119

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             +HRDIK++NIL       K++DFG+A  +   S  +A+   VVGT  ++APE +    
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEMSG 175

Query: 531 ATAKSDVYAFGVVLFEIISGK 551
           A+  SD+++ G  + E+++G 
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (328), Expect = 4e-33
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 25/272 (9%)

Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRM------TATKTKEFMAEMKILCKV-HHSN 404
            +     LG G++G VY      + VA+K +       + + + F+ E++IL  + H  N
Sbjct: 1   SYRILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V+L  +   E  L+L+ EY   GSL+  L     +G  S S    + I       LEY+
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA--LFILAQILSALEYL 117

Query: 465 HEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGK---TSDGEATVTKVVGTFGY 520
           H       +HRDIK  NILLD      K+ DFGLAKL+     TS   A  +  VGT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 521 LAPEYLTDGL---ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA----SF 573
           +APE L       A++ SD+++ G+ L+E+++G       +   + +Q  + +       
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHD 605
           + + L  S   +   +  D +   ++   P +
Sbjct: 235 LASPLSPSNPELISKAASDLLK-KLLAKDPKN 265

Length = 384

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  124 bits (314), Expect = 7e-32
 Identities = 87/296 (29%), Positives = 138/296 (46%), Gaps = 36/296 (12%)

Query: 357 SLLGHGTYGSV----Y--YGNIRNQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVE 407
             LG G +GSV    Y    +   + VA+K++   TA   ++F  E++IL  + H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 408 LIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
             G  Y+A    L L+ EY   GSL+ +L   + R       +   QI     +G+EY+ 
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC----KGMEYL- 124

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG---TFGYLA 522
                 YVHRD+ + NIL++S  R KI DFGL K++    D E    +  G    F Y A
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVL--PQDKEYYKVREPGESPIFWY-A 179

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           PE LT+   +  SDV++FGVVL+E+ +              ++     A FM     +  
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT------------YSDKSCSPPAEFMRMMGNDKQ 227

Query: 583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             M +  L + +  N     P  C  ++  + K+C + DP  RP   ++ + +  I
Sbjct: 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  123 bits (312), Expect = 2e-31
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 34/225 (15%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHS 403
           F    ++G G++ +V     +  N+E AIK +         K K    E ++L ++  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
            +++L      E+ L+ + EYA  G L  ++         SL        A +    LEY
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEY 117

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK---------- 513
           +H       +HRD+K  NILLD     KI+DFG AK++   S  E+              
Sbjct: 118 LHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 514 -------VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
                   VGT  Y++PE L +  A   SD++A G +++++++GK
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (308), Expect = 4e-31
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 25/206 (12%)

Query: 359 LGHGTYGSVY---YGNIRNQ---EVAIKR----MTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V    Y  + +    +VA+K            +F  E++IL  + H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 409 IG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G         L LI EY   GSL+ +L   ++R Q +L  +  +  +    +G++Y+  
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRL--LLFSSQICKGMDYLGS 127

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG---TFGYLAP 523
                Y+HRD+ + NIL++S    KISDFGLAK++    D +    K  G    F Y AP
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWY-AP 181

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIIS 549
           E L     ++ SDV++FGV L+E+ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  118 bits (298), Expect = 4e-30
 Identities = 69/192 (35%), Positives = 109/192 (56%), Gaps = 14/192 (7%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G+V  G    Q+VA+K +    T + F+ E  ++ K+HH NLV L+G     + 
Sbjct: 14  IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLG-VILHNG 72

Query: 418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI 477
           L+++ E   KG+L + L   + RG+  +S I  +Q +LD A G+EY+ E  K   VHRD+
Sbjct: 73  LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYL-ESKK--LVHRDL 126

Query: 478 KSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDV 537
            + NIL+     AK+SDFGLA++     D      K      + APE L     ++KSDV
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDV 180

Query: 538 YAFGVVLFEIIS 549
           +++GV+L+E+ S
Sbjct: 181 WSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 5e-30
 Identities = 83/294 (28%), Positives = 133/294 (45%), Gaps = 47/294 (15%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIK----RMTATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G VY G  +          VAIK      +  +  EF+ E  ++ + +  ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNR---GQTSLSWIMRVQIALDAARGLE 462
           L+G  +T     ++ E   KG LKS+L    P+     G    +    +Q+A + A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+       +VHRD+ + N ++      KI DFG+ + + +T D      K +    ++A
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRWMA 189

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           PE L DG+ T KSDV++FGVVL+E+                     +LA      L N  
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMA--------------------TLAEQPYQGLSNE- 228

Query: 583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS 636
                  LK  ID   +DL P +C  K+  L + C   +P +RP   ++V SL 
Sbjct: 229 -----EVLKFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  117 bits (295), Expect = 2e-29
 Identities = 70/210 (33%), Positives = 113/210 (53%), Gaps = 26/210 (12%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G  R         +VA+K +  + +++    F+ E  I+ K +H N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR--VQIALDAARGLEYIH 465
           LIG +      F++ E    G LKS L + + R +   S  M+  +  A D A+G +Y+ 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 466 EHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI+DFG+A+ + + S    G   +  +     
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI----K 186

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   DG+ T+K+DV++FGV+L+EI S
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 2e-29
 Identities = 70/203 (34%), Positives = 104/203 (51%), Gaps = 23/203 (11%)

Query: 359 LGHGTYGSVYYGNIRNQEV--AIKRM---TATKTKEF---MAEMKILCKVHHSNLVELIG 410
           LG G++G V     ++     A+K +      K KE    + E  IL +++H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR--VQIALDAARGLEYIHEHT 468
              TE++L+L+ EYA  G L SHL      G+ S         +I L     LEY+H   
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVL----ALEYLHSL- 112

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               ++RD+K  NILLD+    K++DFGLAK +   S+G  T T   GT  YLAPE L  
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELS--SEGSRTNT-FCGTPEYLAPEVLLG 167

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
                  D ++ GV+L+E+++GK
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (293), Expect = 3e-29
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 16/201 (7%)

Query: 357 SLLGHGTYGSVYYGNIR--NQEVAIKR----MTATKTKEFMAEMKILCKVHHSNLVELIG 410
            +LG G+ G VY    +   +  A+K+          K+ + E+K L       +V+  G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
               E E+ ++ EY   GSL   L       +  L++I R QI      GL+Y+H  TK 
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLH--TKR 119

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
           H +HRDIK SN+L++S    KI+DFG++K++  T D   T    VGT  Y++PE +    
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT---FVGTVTYMSPERIQGES 176

Query: 531 ATAKSDVYAFGVVLFEIISGK 551
            +  +D+++ G+ L E   GK
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  115 bits (290), Expect = 4e-29
 Identities = 67/193 (34%), Positives = 109/193 (56%), Gaps = 14/193 (7%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIGYAATED- 416
           +G G +G V  G+ R  +VA+K +    T + F+AE  ++ ++ HSNLV+L+G    E  
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73

Query: 417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD 476
            L+++ EY  KGSL  +L   ++RG++ L     ++ +LD    +EY+  +    +VHRD
Sbjct: 74  GLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127

Query: 477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSD 536
           + + N+L+     AK+SDFGL K    T D      K      + APE L +   + KSD
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSD 181

Query: 537 VYAFGVVLFEIIS 549
           V++FG++L+EI S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (288), Expect = 2e-28
 Identities = 78/303 (25%), Positives = 131/303 (43%), Gaps = 76/303 (25%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE--FMAEMKILCKVHHSNL 405
            E + +   +G G  G VY    R   +EVAIK+M   K  +   + E+ I+    H N+
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 406 VELIGYAATEDELFLIYEYAQKGSL-------KSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           V+        DEL+++ EY   GSL          +++PQ      ++++ R  +     
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ------IAYVCREVL----- 126

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           +GLEY+H     + +HRDIKS NILL      K++DFG A  + K      +   VVGT 
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS---VVGTP 180

Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK---------EAI--IRTEGMVSKNQER 567
            ++APE +       K D+++ G++  E+  G+          A+  I T+G        
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-------- 232

Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
                  +  L+N P+  S    KD+++                    +C+ +DP  RP 
Sbjct: 233 -------IPPLKN-PEKWS-PEFKDFLN--------------------KCLVKDPEKRPS 263

Query: 628 MKQ 630
            ++
Sbjct: 264 AEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  113 bits (285), Expect = 6e-28
 Identities = 88/305 (28%), Positives = 147/305 (48%), Gaps = 60/305 (19%)

Query: 358 LLGHGTYGSVYYGNIRNQ----EVAIKRMTATKTKE----FMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+      + AIKRM    +K+    F  E+++LCK+ HH N++ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH-------DPQ----NRGQTSLSWIMRVQIALDA 457
           +G       L+L  EYA  G+L   L        DP     N   ++LS    +  A D 
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           ARG++Y+   ++  ++HRD+ + NIL+   + AKI+DFGL++  G+    E  V K +G 
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQ----EVYVKKTMGR 184

Query: 518 FG--YLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
               ++A E L   + T  SDV+++GV+L+EI+S                          
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------------------------- 218

Query: 576 AALRNSPD-SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
             L  +P   M+ + L + +        P +C  ++  L +QC  E P  RP   Q+++S
Sbjct: 219 --LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276

Query: 635 LSQIL 639
           L+++L
Sbjct: 277 LNRML 281

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 6e-28
 Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 17/197 (8%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G      +VA+K +       + F+ E +I+ K+ H  LV+L    + E
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI-MRVQIALDAARGLEYIHEHTKTHYVH 474
           + ++++ EY  KGSL   L   + +       + M  QIA     G+ Y+      +Y+H
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA----EGMAYLESR---NYIH 126

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTDGLAT 532
           RD+ + NIL+      KI+DFGLA+L+    D E T  +    F   + APE    G  T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI---EDDEYT-AREGAKFPIKWTAPEAANYGRFT 182

Query: 533 AKSDVYAFGVVLFEIIS 549
            KSDV++FG++L EI++
Sbjct: 183 IKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (282), Expect = 7e-28
 Identities = 65/213 (30%), Positives = 114/213 (53%), Gaps = 19/213 (8%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK---RMTATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G +G V+ G  +N+  VAIK        K ++F  E++ L ++ H +L+ L    + 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
            + +++I E  +KGSL + L  P+ +     S I    +A   A G+ Y+ E    + +H
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI---DMACQVAEGMAYLEEQ---NSIH 127

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + NIL+      K++DFGLA+L+ K     ++  K+   + + APE  + G  + K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKI--PYKWTAPEAASHGTFSTK 184

Query: 535 SDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQE 566
           SDV++FG++L+E+ + G+   +   GM   N E
Sbjct: 185 SDVWSFGILLYEMFTYGQ---VPYPGM--NNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  111 bits (278), Expect = 2e-27
 Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 18/198 (9%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G  R + +VAIK +   A    +F+ E K++ K+ H NLV+L G    +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F++ EY   G L ++L   + +G+    W++   +  D    +EY+  +    ++HR
Sbjct: 72  RPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLL--DMCSDVCEAMEYLESNG---FIHR 124

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L+      K+SDFGLA+ V    D + T +   GT     +  PE       +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179

Query: 533 AKSDVYAFGVVLFEIISG 550
           +KSDV++FGV+++E+ S 
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 4e-27
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 21/202 (10%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           LG GTYG VY        + VA+K++     +E      + E+ +L ++ H N+V+L+  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             TE +L+L++EY     LK +L   +  G  S + I  +   L   RGL Y H H    
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQL--LRGLAYCHSH---R 118

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL--TDG 529
            +HRD+K  NIL++     K++DFGLA+  G       T T  V T  Y APE L  +  
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---TYTHEVVTLWYRAPEILLGSKH 175

Query: 530 LATAKSDVYAFGVVLFEIISGK 551
            +TA  D+++ G +  E+I+GK
Sbjct: 176 YSTA-VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 4e-27
 Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 44/276 (15%)

Query: 358 LLGHGTYGSVYYGNIRNQ-EVAIKR----MTATKTKEFMAEMKILCKVHHSNLVELIGYA 412
            +G G +G VY G ++   EVA+K     +     ++F+ E +IL +  H N+V+LIG  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             +  ++++ E    GSL + L   +NR    L+    +Q++LDAA G+EY+      + 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLESK---NC 114

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTDGL 530
           +HRD+ + N L+      KISDFG+++   +   G  TV+  +      + APE L  G 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            T++SDV+++G++L+E  S  +      GM   NQ+ R                      
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYP--GM--SNQQTR---------------------- 205

Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
            + I+       P  C  ++  L  QC   DP  RP
Sbjct: 206 -ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRP 240

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 7e-27
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 26/206 (12%)

Query: 359 LGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G GTYG VY   N +  + VA+K++     KE      + E+K+L K+ H N+V L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 412 AATED--ELFLIYEYAQKGSLKSHLHDPQNR-GQTSLSWIMRVQIALDAARGLEYIHEHT 468
             ++    +++++EY     L   L  P+ +  ++ +   M+ Q+      GL+Y+H + 
Sbjct: 67  VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMK-QLL----EGLQYLHSN- 119

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               +HRDIK SNIL+++    K++DFGLA+    T    A  T  V T  Y  PE L  
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYTNRVITLWYRPPELLL- 174

Query: 529 GLAT---AKSDVYAFGVVLFEIISGK 551
           G AT    + D+++ G +L E+  GK
Sbjct: 175 G-ATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 8e-27
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 29/206 (14%)

Query: 359 LGHGTYGSVYYG-----NIRNQ-EVAIKRM---TATKT-KEFMAEMKILCKVHHSNLVEL 408
           LG G +G+VY G       + +  VAIK +   T+ K  KE + E  ++  V H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQIALDAARGLEYIHE 466
           +G   +  ++ LI +    G L  ++ + ++    Q  L+W   VQIA    +G+ Y+ E
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW--CVQIA----KGMSYLEE 127

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG---TFGYLAP 523
                 VHRD+ + N+L+ +    KI+DFGLAKL+    D +       G      ++A 
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL----DVDEKEYHAEGGKVPIKWMAL 180

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIIS 549
           E +   + T KSDV+++GV ++E+++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (274), Expect = 8e-27
 Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 18/196 (9%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +  +  VA+K  +    + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +     +  ++ ++ + +A   +  +EY+    K +++H
Sbjct: 74  EPPFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLA 531
           RD+ + N L+      K++DFGL++L+        T T   G      + APE L     
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNKF 182

Query: 532 TAKSDVYAFGVVLFEI 547
           + KSDV+AFGV+L+EI
Sbjct: 183 SIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 1e-26
 Identities = 84/293 (28%), Positives = 138/293 (47%), Gaps = 50/293 (17%)

Query: 359 LGHGTYGSVYYGNIR---NQE--VAIKRMTATKTK----EFMAEMKILCKVHHSNLVELI 409
           +G G +G V  G ++    +E  VAIK + A  +     +F+ E  I+ +  H N++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G       + +I EY + GSL   L   +N G+   +    V +    A G++Y+ E   
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLR--ENDGK--FTVGQLVGMLRGIASGMKYLSEMN- 126

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG--YLAPEYLT 527
             YVHRD+ + NIL++S    K+SDFGL++ +    D EAT T   G     + APE + 
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLE---DSEATYTTKGGKIPIRWTAPEAIA 181

Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
               T+ SDV++FG+V++E++S  E   R    +S NQ+                    +
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGE---RPYWDMS-NQD-------------------VI 218

Query: 588 SSLKD-YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
            +++D Y  P      P DC   +  L   C  +D   RP   Q+V +L +++
Sbjct: 219 KAVEDGYRLPP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  107 bits (269), Expect = 5e-26
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 31/215 (14%)

Query: 358 LLGHGTYGSVYYGNIRN--------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNL 405
            LG G +G VY G   +          VA+K +    T  + KEF+ E  ++   +H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDP--QNRGQTSLSWIMRVQIALDAARGLEY 463
           V+L+G     +  ++I E  + G L S+L D   +  G   L+    + I LD A+G  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 464 IHEHTKTHYVHRDIKSSNILL-----DSAFRAKISDFGLAKLVGKTS----DGEATVTKV 514
           +    + H++HRD+ + N L+     D+    KI DFGLA+ + K+     +GE  +   
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP-- 176

Query: 515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                ++APE L DG  T +SDV++FGV+++EI++
Sbjct: 177 ---VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  107 bits (269), Expect = 9e-26
 Identities = 84/315 (26%), Positives = 134/315 (42%), Gaps = 74/315 (23%)

Query: 358 LLGHGTYGSVYYGNIRN-------QEVAIKRMTATKT-KEF------MAEMKILCKVHHS 403
            LG G +G V                VA+K +    T K+       M  MK++ K  H 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HK 76

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTS---------LSWIMRVQ 452
           N++ L+G    E  L+++ EYA  G+L+  L    P     +          L+    V 
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG------KTSD 506
            A   ARG+E++    K   +HRD+ + N+L+      KI+DFGLA+ +       KT++
Sbjct: 137 FAYQVARGMEFL-ASKKC--IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE 566
           G   V        ++APE L D + T +SDV++FGV+L+EI +                 
Sbjct: 194 GRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT----------------- 229

Query: 567 RRSLASFMLAALRNSP-DSMSMSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDEDPIL 624
                      L  SP   + +  L   + +   M+  P +C  ++  L + C  E P  
Sbjct: 230 -----------LGGSPYPGIPVEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQ 277

Query: 625 RPDMKQVVISLSQIL 639
           RP  KQ+V  L ++L
Sbjct: 278 RPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  106 bits (266), Expect = 9e-26
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 19/200 (9%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK  +  +    EF+ E K++ K+ H  LV+L G    +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             ++++ EY   G L ++L +   R Q S      +++  D   G+ Y+       ++HR
Sbjct: 72  RPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L+D     K+SDFGL++ V    D E T +  VG+     +  PE L     +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV---LDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179

Query: 533 AKSDVYAFGVVLFEIIS-GK 551
           +KSDV+AFGV+++E+ S GK
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-25
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)

Query: 359 LGHGTYGSVYYG-----NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           LGHG +GSV  G     + +  EVA+K +     A   KEF+ E  ++ ++ H  +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G     + L L+ E A  G L  +L   + R +  +S +   ++A   A G+ Y+     
Sbjct: 63  G-VCKGEPLMLVMELAPLGPLLKYL---KKRREIPVSDLK--ELAHQVAMGMAYLES--- 113

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
            H+VHRD+ + N+LL +  +AKISDFG+++ +G  SD     T       + APE +  G
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 530 LATAKSDVYAFGVVLFEIIS 549
             ++KSDV+++GV L+E  S
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-25
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 13/195 (6%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMTA--TKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G   N   VA+K +       K+F+AE +I+ K+ H  L++L      E
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ E  + GSL  +L   Q     +L     + +A   A G+ Y+      +Y+HR
Sbjct: 74  EPIYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHR 127

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-TKVVGTFGYLAPEYLTDGLATAK 534
           D+ + N+L+      K++DFGLA+++ K    EA    K      + APE       + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184

Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L EI++
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (262), Expect = 3e-25
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 20/202 (9%)

Query: 359 LGHGTYGSVYYGNIRN--------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIG 410
           +G G++G V+   +R         +++ + +M   + +E + E ++L K+  S ++    
Sbjct: 8   IGKGSFGVVFKV-VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT-SLSWIMRVQIALDAARGLEYIHEHTK 469
               + +L ++ EYA+ G L   L   + R       W   +QI L    GL ++H    
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLH---S 119

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
              +HRDIKS N+ LD+    KI D G+AKL+   ++   T+   VGT  YL+PE   D 
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI---VGTPYYLSPELCEDK 176

Query: 530 LATAKSDVYAFGVVLFEIISGK 551
               KSDV+A GVVL+E  +GK
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  104 bits (260), Expect = 6e-25
 Identities = 71/196 (36%), Positives = 112/196 (57%), Gaps = 16/196 (8%)

Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAA-T 414
           LG+G +G V+ G    N +VA+K +   T + E F+ E +I+ K+ H  LV+L  YA  +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVS 71

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E+ ++++ EY  KGSL   L D + R   +L     V +A   A G+ YI    + +Y+H
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATA 533
           RD++S+NIL+      KI+DFGLA+L+    D E T  +       + APE    G  T 
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 534 KSDVYAFGVVLFEIIS 549
           KSDV++FG++L E+++
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 7e-25
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 359 LGHGTYGSVYYG-NIRN------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G GT+G VY   N+        +E+ I+       KE   EMK+L  + H NLV+  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
               +++++  EY   G+L+  L          L   +     L    GL Y+H H    
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHSH---G 119

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT-VTKVVGTFGYLAPEYLTDGL 530
            VHRDIK +NI LD     K+ DFG A  +   +      V  + GT  Y+APE +T G 
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 531 ATAK---SDVYAFGVVLFEIISGK 551
                  +D+++ G V+ E+ +GK
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  104 bits (261), Expect = 9e-25
 Identities = 81/305 (26%), Positives = 141/305 (46%), Gaps = 60/305 (19%)

Query: 358 LLGHGTYGSVYYGNIRNQ----EVAIKRM----TATKTKEFMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+        AIK +    +    ++F  E+++LCK+ HH N++ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH-------DP----QNRGQTSLSWIMRVQIALDA 457
           +G       L++  EYA  G+L   L        DP    ++   ++L+    +Q A D 
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           A G++Y+ E     ++HRD+ + N+L+     +KI+DFGL++        E  V K +G 
Sbjct: 129 ATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKKTMGR 179

Query: 518 FG--YLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
               ++A E L   + T KSDV++FGV+L+EI+S                          
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-------------------------- 213

Query: 576 AALRNSPD-SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
             L  +P   M+ + L + +        P +C  ++  L +QC  + P  RP   Q+ + 
Sbjct: 214 --LGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271

Query: 635 LSQIL 639
           LS++L
Sbjct: 272 LSRML 276

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 86/305 (28%), Positives = 144/305 (47%), Gaps = 60/305 (19%)

Query: 358 LLGHGTYGSVYYGNIRNQ----EVAIKRM----TATKTKEFMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+      + AIKRM    +    ++F  E+++LCK+ HH N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH-------DP----QNRGQTSLSWIMRVQIALDA 457
           +G       L+L  EYA  G+L   L        DP     N   ++LS    +  A D 
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           ARG++Y+ +     ++HRD+ + NIL+   + AKI+DFGL++        E  V K +G 
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 172

Query: 518 FG--YLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
               ++A E L   + T  SDV+++GV+L+EI+S                          
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------------------------- 206

Query: 576 AALRNSPD-SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
             L  +P   M+ + L + +        P +C  ++  L +QC  E P  RP   Q+++S
Sbjct: 207 --LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264

Query: 635 LSQIL 639
           L+++L
Sbjct: 265 LNRML 269

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 1e-24
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 31/207 (14%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTA--TKTKEFMA--EMKILCKV-HHSNLVELIGY 411
           LG GT+GSVY   N    E VAIK+M       +E M   E+K L K+  H N+V+L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66

Query: 412 AATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSW-----IMRVQIALDAARGLEYIH 465
               DEL+ ++EY     ++ +L+   ++R     S      I+  QI      GL +IH
Sbjct: 67  FRENDELYFVFEY-----MEGNLYQLMKDRKGKPFSESVIRSIIY-QILQ----GLAHIH 116

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE- 524
           +H    + HRD+K  N+L+      KI+DFGLA+ +          T  V T  Y APE 
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREI----RSRPPYTDYVSTRWYRAPEI 169

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            L     ++  D++A G ++ E+ + +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  103 bits (259), Expect = 1e-24
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 26/213 (12%)

Query: 359 LGHGTYGSVYYGNI-------RNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVE 407
           LG G +G VY G +           VAIK +         +EF  E +++  + H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL--HDPQN---------RGQTSLSWIMRVQIALD 456
           L+G    E    +++EY   G L   L  + P +           ++SL     + IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+EY+  H   H+VHRD+ + N L+      KISDFGL++ +  ++D     +K + 
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDI-YSADYYRVQSKSLL 188

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              ++ PE +  G  T +SD+++FGVVL+EI S
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  102 bits (255), Expect = 3e-24
 Identities = 69/199 (34%), Positives = 108/199 (54%), Gaps = 22/199 (11%)

Query: 359 LGHGTYGSV---YYGNIRNQEVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G V   YY    + +VAIK +   +   + F+AE  ++ ++ H  LV L  YA 
Sbjct: 14  LGAGQFGEVWMGYYNG--HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69

Query: 414 -TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI-MRVQIALDAARGLEYIHEHTKTH 471
            T++ +++I EY + GSL   L  P+    T    I M  QIA     G+ +I      +
Sbjct: 70  VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA----EGMAFIERK---N 122

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGL 530
           Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       + APE +  G 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 179

Query: 531 ATAKSDVYAFGVVLFEIIS 549
            T KSDV++FG++L EI++
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 37/221 (16%)

Query: 359 LGHGTYGSVYYGNIRNQE-------VAIKRMTATKT----KEFMAEMKILCKVHHSNLVE 407
           LG G +G V+ G   + E       VA+K +  T +    K+F  E ++L    H N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNR---------GQTSLSWIMRVQIALD 456
             G     D   +++EY + G L   L  H P            G+ +LS ++  QIA+ 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL--QIAVQ 130

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+ Y+      H+VHRD+ + N L+      KI DFG+++ V  T        +V G
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-----YYRVGG 182

Query: 517 T----FGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
                  ++ PE +     T +SDV++FGVVL+EI + GK+
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 25/203 (12%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYA 412
           LG G  G V     R   + +A+K +         K+ + E+ IL K +   +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
               ++ +  EY   GSL   L   + +G+     + ++ +A+   +GL Y+HE  K   
Sbjct: 69  YNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAV--LKGLTYLHE--KHKI 122

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLA-KLV---GKTSDGEATVTKVVGTFGYLAPEYLTD 528
           +HRD+K SNIL++S  + K+ DFG++ +LV    KT          VGT  Y+APE +  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---------VGTSSYMAPERIQG 173

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
              + KSD+++ G+ L E+ +G+
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 362 GTYGSVYYG--NIRNQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           G YG V+           AIK +         +  + + E  IL +     +V+L     
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW--IMRVQIALDAARGLEYIHEHTKTH 471
            +  L+L+ EY   G L S L    N G        I   +I L     LEY+H +    
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVL----ALEYLHSNG--- 113

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAK--LVGKT---SDGEATVTKVVGTFGYLAPEYL 526
            +HRD+K  NIL+DS    K++DFGL+K  LV +    +D E    ++VGT  Y+APE +
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 527 TDGLATAKSDVYAFGVVLFEIISG 550
                +   D ++ G +L+E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 99.9 bits (249), Expect = 4e-23
 Identities = 84/302 (27%), Positives = 140/302 (46%), Gaps = 51/302 (16%)

Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQE-VAIKRMTAT------KTKEFMAEMKILCKVHHSN 404
           F+D   +GHG++G+VY+  ++R  E VAIK+M+ +      K ++ + E++ L ++ H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA---LDAARGL 461
            +E  G    E   +L+ EY   GS  S + +   +       +  V+IA     A +GL
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCL-GS-ASDILEVHKKP------LQEVEIAAICHGALQGL 128

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H H +   +HRDIK+ NILL      K++DFG A LV       +     VGT  ++
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV-------SPANSFVGTPYWM 178

Query: 522 APEY---LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL 578
           APE    + +G    K DV++ G+   E+   K  +     M           S +    
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIA 227

Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMA---MLAKQCVDEDPILRPDMKQVVISL 635
           +N   ++S +   DY   N +D     CL K+      +++ +    +LR     V+I L
Sbjct: 228 QNDSPTLSSNDWSDYFR-NFVDS----CLQKIPQDRPSSEELLKHRFVLRERPPTVIIDL 282

Query: 636 SQ 637
            Q
Sbjct: 283 IQ 284

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.8 bits (246), Expect = 5e-23
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 47/294 (15%)

Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G +     R   VAIK + +  T    ++F++E  I+ +  H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + +I E+ + G+L S L   QN GQ ++  I  V +    A G++Y+ E  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTV--IQLVGMLRGIAAGMKYLSE-- 124

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG---TFGYLAPEY 525
             +YVHRD+ + NIL++S    K+SDFGL++ +   +  + T T  +G      + APE 
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS-DPTYTSSLGGKIPIRWTAPEA 182

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
           +     T+ SDV+++G+V++E++S  E                          R   D M
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGE--------------------------RPYWD-M 215

Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           S   + + I+ +     P DC   +  L   C  +D   RP   Q+V +L +++
Sbjct: 216 SNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRM---TATKTKEFMA--EMKILCKVHHSNLVELIGY 411
           +G GTYG VY     +  + VAIK++     ++     A  E+K+L +++H N+++L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              + +L+L++E+     L   L   + RG    S I          +GL + H H    
Sbjct: 67  FRHKGDLYLVFEF-MDTDLY-KLIKDRQRG-LPESLIK--SYLYQLLQGLAFCHSH---G 118

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL-TDGL 530
            +HRD+K  N+L+++    K++DFGLA+  G         T  V T  Y APE L  D  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTRWYRAPELLLGDKG 175

Query: 531 ATAKSDVYAFGVVLFEIISGK 551
            +   D+++ G +  E++S +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 76/301 (25%), Positives = 130/301 (43%), Gaps = 66/301 (21%)

Query: 358 LLGHGTYGSVYYGNIRNQE-----VAIKR----MTATKTKEFMAEMKILCKVHHSNLVEL 408
            +G G +G VY G   + E     VA+K      + +  ++F+ E  I+ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           IG   TE+ ++++ E A  G L+S+L    N+    L+ +  +  +   +  L Y+    
Sbjct: 73  IG-VITENPVWIVMELAPLGELRSYLQ--VNKYSLDLASL--ILYSYQLSTALAYLE--- 124

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
              +VHRDI + N+L+ S    K+ DFGL++ +   S  +A+  K+     ++APE +  
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINF 182

Query: 529 GLATAKSDVYAFGVVLFEIIS----------GKEAIIRTEGMVSKNQERRSLASFMLAAL 578
              T+ SDV+ FGV ++EI+             + I R E     N ER  +        
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-----NGERLPM-------- 229

Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
                                   P +C   +  L  +C   DP  RP   ++   LS I
Sbjct: 230 ------------------------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265

Query: 639 L 639
           L
Sbjct: 266 L 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.2 bits (244), Expect = 6e-23
 Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 13/195 (6%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G   N  +VA+K +       + F+ E  ++  + H  LV L      E
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I EY  KGSL   L      G+  L  +  +  +   A G+ YI    + +Y+HR
Sbjct: 74  EPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKL--IDFSAQIAEGMAYIE---RKNYIHR 127

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++N+L+  +   KI+DFGLA+++    D E T  +       + APE +  G  T K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L+EI++
Sbjct: 185 SDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 59/194 (30%), Positives = 104/194 (53%), Gaps = 12/194 (6%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G  R Q +VAIK     A   ++F+ E K++ K+ H  LV+L G    +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             L+++ E+ + G L ++L   Q +G+  LS  M + +  D   G+EY+    +  ++HR
Sbjct: 72  KPLYIVTEFMENGCLLNYLR--QRQGK--LSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+ S    K+SDFG+ + V    D   + +       +  PE       ++KS
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 536 DVYAFGVVLFEIIS 549
           DV++FGV+++E+ +
Sbjct: 183 DVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 20/220 (9%)

Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE-------VAIKRMTATKTK----EFMAEMKI 396
           F      + + LG G +G V+    +  E       V +K +  TK +    EF  E+ +
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS----LSWIMRVQ 452
             K+ H N+V L+G     +  ++I EY   G LK  L   +++ +      LS   +V 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +    A G++++       +VHRD+ + N L+ S    K+S   L+K     +     + 
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLR 176

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE 552
             +    +LAPE + +   + KSDV++FGV+++E+ +  E
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 23/205 (11%)

Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRMTATKT--------KEFMAEMKILCKVHHSNLVE 407
           LLG G++GSVY G N+ + +  A+K ++            K+   E+ +L K+ H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
            +G    ED L++  E    GSL   L    +  +  +    R QI L    GLEY+H+ 
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILL----GLEYLHDR 121

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL- 526
              + VHRDIK +NIL+D+    K++DFG+AK V +     +      G+  ++APE + 
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKSFKGSPYWMAPEVIA 174

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
             G     +D+++ G  + E+ +GK
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.3 bits (239), Expect = 3e-22
 Identities = 70/212 (33%), Positives = 114/212 (53%), Gaps = 22/212 (10%)

Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAA-T 414
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L  YA  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 71

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHY 472
           E+ ++++ EY  KGSL   L     +G+    L     V +A   A G+ Y+    + +Y
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 123

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLA 531
           VHRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 532 TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T KSDV++FG++L E+ +  +  +   GMV++
Sbjct: 181 TIKSDVWSFGILLTELTT--KGRVPYPGMVNR 210

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 96.6 bits (240), Expect = 4e-22
 Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 53/299 (17%)

Query: 359 LGHGTYGSVYYGNI------RNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG   +G +Y G++        Q VAIK +       +  EF  E  ++ ++HH N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL------------HDPQNRGQTSLSWIMRVQIALD 456
           +G    E  + +++EY  +G L   L             D     ++SL     + IA+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+EY+  H    +VH+D+ + NIL+      KISD GL++ +  ++D      K + 
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREI-YSADYYRVQPKSLL 188

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
              ++ PE +  G  ++ SD+++FGVVL+EI                        SF L 
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF-----------------------SFGLQ 225

Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                    S   + + +    +     DC  +M  L  +C  E P  RP  K +   L
Sbjct: 226 PYY----GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 97.0 bits (241), Expect = 4e-22
 Identities = 86/314 (27%), Positives = 144/314 (45%), Gaps = 72/314 (22%)

Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P    +  LS+   V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 203 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 237

Query: 568 RSLASFMLAALRNSP-DSMSMSSL-KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR 625
                     L  SP   + +  L K   + + MD  P +C  ++ M+ + C    P  R
Sbjct: 238 ----------LGGSPYPGVPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQR 286

Query: 626 PDMKQVVISLSQIL 639
           P  KQ+V  L +IL
Sbjct: 287 PTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.7 bits (238), Expect = 5e-22
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 358 LLGHGTYGSVYYGNIRN--QEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIG 410
           ++G G +G V+    +   + V IK     +MT  +      E ++L  + H N++E   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNR---GQTSLSWIMRVQIALDAARGLEYIHEH 467
               +  L ++ EYA  G+L  ++    N      T L + +++ +AL         H H
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH--------HVH 118

Query: 468 TKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
           TK   +HRD+K+ NILLD      KI DFG++K++   S        VVGT  Y++PE  
Sbjct: 119 TK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS----KAYTVVGTPCYISPELC 173

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEA 553
                  KSD++A G VL+E+ S K A
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 96.5 bits (241), Expect = 5e-22
 Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 43/295 (14%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFMA--------EMKILCKVHHSNLV 406
             LG GTY  VY        + VAIK++   + KE           E+K+L ++ H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            L+     +  + L++E+ +   L+  + D       + + I      L   RGLEY+H 
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIK--SYMLMTLRGLEYLHS 120

Query: 467 HTKTHYV-HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           +    ++ HRD+K +N+L+ S    K++DFGLA+  G  S       +VV T  Y APE 
Sbjct: 121 N----WILHRDLKPNNLLIASDGVLKLADFGLARSFG--SPNRKMTHQVV-TRWYRAPEL 173

Query: 526 LTDGLATAKS-----DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           L      A+      D+++ G +  E++     +    G    +Q  +   +       N
Sbjct: 174 LFG----ARHYGVGVDMWSVGCIFAELLLRVPFL---PGDSDIDQLGKIFEALGTPTEEN 226

Query: 581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAM-----LAKQCVDEDPILRPDMKQ 630
            P    ++SL DY++       P   +F  A      L ++ +  +P  R   +Q
Sbjct: 227 WPG---VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 97.0 bits (241), Expect = 5e-22
 Identities = 90/316 (28%), Positives = 143/316 (45%), Gaps = 76/316 (24%)

Query: 359 LGHGTYGSVY----YG-NIRNQE----VAIKRMTATKTKEFMAE-------MKILCKVHH 402
           LG G +G V     YG +    +    VA+K +    T + +A+       MK++ K  H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLH-----------DPQNRGQTSLSWIMRV 451
            N++ L+G    E  L++I EYA KG+L+  L            D     +  LS+   V
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 452 QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTS 505
             A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ V       KTS
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ 565
           +G   V        ++APE L D + T +SDV++FG++++EI +                
Sbjct: 195 NGRLPVK-------WMAPEALFDRVYTHQSDVWSFGILMWEIFT---------------- 231

Query: 566 ERRSLASFMLAALRNSP-DSMSMSSL-KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                       L  SP   + +  L K   + + MD  P +C  ++ ML ++C    P 
Sbjct: 232 ------------LGGSPYPGIPVEELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPT 278

Query: 624 LRPDMKQVVISLSQIL 639
            RP  KQ+V +L ++L
Sbjct: 279 QRPTFKQLVEALDKVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 73/298 (24%), Positives = 126/298 (42%), Gaps = 60/298 (20%)

Query: 352 GFSDSSLLGHGTYGSVYYG--NIRNQEVAIKR-----MTATKTKEFMAEMKILCKVHHSN 404
            F     LG G+YGSVY       NQ  A+K      M+  + ++ + E++IL  V+H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 405 LVE-----LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQ---TSLSWIMRVQIALD 456
           ++      L G     ++L ++ EYA  G L   +   + + +       W + +Q+   
Sbjct: 61  IISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL-- 113

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
             RGL+ +HE      +HRD+KS+NILL +    KI D G++K++ K        T  +G
Sbjct: 114 --RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKT-QIG 163

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
           T  Y+APE       + KSD+++ G +L+E                            +A
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYE----------------------------MA 195

Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
                 ++ SM  L+  +        P      +    +  +   P LRP+  +++ S
Sbjct: 196 TFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.4 bits (237), Expect = 7e-22
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 20/206 (9%)

Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRMTATKTK----EFMAEMKILCKVHHSNLVEL 408
           ++G G +G V+ G ++        VAIK +    T+    +F++E  I+ +  H N++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G         +I EY + G+L  +L D  + G+   S    V +    A G++Y+ +  
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRD--HDGE--FSSYQLVGMLRGIAAGMKYLSD-- 125

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG--YLAPEYL 526
             +YVHRD+ + NIL++S    K+SDFGL++++    D E T T   G     + APE +
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKE 552
                T+ SDV++FG+V++E++S  E
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGE 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 95.1 bits (236), Expect = 8e-22
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 45/281 (16%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGYA 412
           +G G +G V+ G +R  N  VA+K    T   +    F+ E +IL +  H N+V LIG  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             +  ++++ E  Q G   + L   +  G   L     +Q+  +AA G+EY+      H 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL---RTEG-PRLKVKELIQMVENAAAGMEYLES---KHC 115

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTDGL 530
           +HRD+ + N L+      KISDFG+++   +  DG    T  +      + APE L  G 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            +++SDV++FG++L+E                      SL +   A L N          
Sbjct: 173 YSSESDVWSFGILLWEAF--------------------SLGAVPYANLSN-------QQT 205

Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ I+  +    P  C   +  L ++C + DP  RP    V
Sbjct: 206 REAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 358 LLGHGTYGSVYYGNIRNQ-----EVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVE 407
            LG G++G V  G           VA+K     +++     +F+ E  I+  + H NL+ 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIR 60

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS--WIMRVQIALDAARGLEYIH 465
           L G   T   L ++ E A  GSL   L      G   +S      VQIA     G+ Y+ 
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDA-LGHFLISTLCDYAVQIA----NGMRYLE 114

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                 ++HRD+ + NILL S  + KI DFGL + + +  D       +   F + APE 
Sbjct: 115 S---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171

Query: 526 LTDGLATAKSDVYAFGVVLFEIIS 549
           L     +  SDV+ FGV L+E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 19/200 (9%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM-TATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
            LG G+YGSVY    +   Q VAIK +      +E + E+ IL +     +V+  G    
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGLEYIHEHTKTH 471
             +L+++ EY   GS+     D       +L+     +IA       +GLEY+H + K  
Sbjct: 70  NTDLWIVMEYCGAGSVS----DIMKITNKTLT---EEEIAAILYQTLKGLEYLHSNKK-- 120

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRDIK+ NILL+   +AK++DFG++   G+ +D  A    V+GT  ++APE + +   
Sbjct: 121 -IHRDIKAGNILLNEEGQAKLADFGVS---GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 532 TAKSDVYAFGVVLFEIISGK 551
             K+D+++ G+   E+  GK
Sbjct: 177 NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 61/196 (31%), Positives = 107/196 (54%), Gaps = 16/196 (8%)

Query: 359 LGHGTYGSVYYGNI-RNQEVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+     ++ +VA+K M   +   + F+AE  ++  + H  LV+L     T+
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL-HAVVTK 72

Query: 416 DELFLIYEYAQKGSLKSHLH-DPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           + +++I E+  KGSL   L  D  ++           QIA     G+ +I    + +Y+H
Sbjct: 73  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA----EGMAFIE---QRNYIH 125

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATA 533
           RD++++NIL+ ++   KI+DFGLA+++    D E T  +       + APE +  G  T 
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 534 KSDVYAFGVVLFEIIS 549
           KSDV++FG++L EI++
Sbjct: 183 KSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.4 bits (234), Expect = 1e-21
 Identities = 72/232 (31%), Positives = 121/232 (52%), Gaps = 18/232 (7%)

Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAA-T 414
           LG G +G V+ G      +VAIK +   T   E F+ E +I+ K+ H  LV L  YA  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVS 71

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E+ ++++ E+  KGSL   L +   +    L     V +A   A G+ YI    + +Y+H
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATA 533
           RD++++NIL+      KI+DFGLA+L+    D E T  +       + APE    G  T 
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 534 KSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
           KSDV++FG++L E+++  +  +   GMV++    +    + +   +  P+S+
Sbjct: 183 KSDVWSFGILLTELVT--KGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 83/305 (27%), Positives = 142/305 (46%), Gaps = 47/305 (15%)

Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK----EFMAEMKIL 397
           A E  + S  LG G++G VY G  +          VAIK +    +     EF+ E  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 398 CKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-----PQNRGQTSLSWIMRVQ 452
            + +  ++V L+G  +      +I E   +G LKS+L         N  Q   S    +Q
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +T D      
Sbjct: 124 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGG 179

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
           K +    +++PE L DG+ T  SDV++FGVVL+EI +  E     +GM ++    + L  
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGMSNE----QVLRF 233

Query: 573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
            M   L + PD+           P+M        LF+   L + C   +P +RP   +++
Sbjct: 234 VMEGGLLDKPDNC----------PDM--------LFE---LMRMCWQYNPKMRPSFLEII 272

Query: 633 ISLSQ 637
            S+ +
Sbjct: 273 SSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 64/227 (28%), Positives = 113/227 (49%), Gaps = 46/227 (20%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G +G V                VA+K +    ++++ ++ ++E  +L +V+H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQ-------------------NRGQTSLSWI 448
           L G  + +  L LI EYA+ GSL+S L + +                   N  + +L+  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG------ 502
             +  A   +RG++Y+ E      VHRD+ + N+L+    + KISDFGL++ V       
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           K S G   V        ++A E L D + T +SDV++FGV+L+EI++
Sbjct: 185 KRSKGRIPVK-------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 37/219 (16%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATKT----KEFMAEMKILCKVHHSN 404
           E   + S LG G  GSV    ++N     A+K +T        K+ + E++I        
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 405 LVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV------QIALD 456
           +V+  G     +   + +  EY + GSL S     + RG        R+      +IA  
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG-------GRIGEKVLGKIAES 113

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
             +GL Y+H   K   +HRDIK SNILL    + K+ DFG++        GE  V  + G
Sbjct: 114 VLKGLSYLHSR-KI--IHRDIKPSNILLTRKGQVKLCDFGVS--------GEL-VNSLAG 161

Query: 517 TFG----YLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           TF     Y+APE +     +  SDV++ G+ L E+   +
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 64/206 (31%), Positives = 111/206 (53%), Gaps = 20/206 (9%)

Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G +     R   VAIK + A  T    ++F++E  I+ +  H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + ++ EY + GSL + L   ++ GQ ++  I  V +    A G++Y+ +  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTV--IQLVGMLRGIASGMKYLSDMG 126

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG--YLAPEYL 526
              YVHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + APE +
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKE 552
                T+ SDV+++G+V++E++S  E
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGE 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 19/209 (9%)

Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKV 400
            E+    E       +G G +G V+ G    + +VAIK  R  A   ++F+ E +++ K+
Sbjct: 4   SELTLVQE-------IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL 56

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV+L G       + L++E+ + G L  +L     RG    S    + + LD   G
Sbjct: 57  SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR--AQRG--KFSQETLLGMCLDVCEG 112

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           + Y+     ++ +HRD+ + N L+      K+SDFG+ + V       +T TK      +
Sbjct: 113 MAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKW 167

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +PE  +    ++KSDV++FGV+++E+ S
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRM--TATKTKEFMAEMKILCKV-HHSNLVELIG-- 410
           ++G GTYG VY        Q VAIK M     + +E   E  IL K  +H N+    G  
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 411 ----YAATEDELFLIYEYAQKGS----LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
                   +D+L+L+ E    GS    +K      +   +  +++I+R     +  RGL 
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGLA 127

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+HE+     +HRDIK  NILL      K+ DFG++  +  T     T    +GT  ++A
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT---FIGTPYWMA 181

Query: 523 PEYLT-----DGLATAKSDVYAFGVVLFEIISGK 551
           PE +      D    A+SDV++ G+   E+  GK
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 45/265 (16%)

Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQEV-AIKRM------TATKTKEFMAEMKILCKVHHSN 404
           FSD   +GHG++G+VY+  ++RN EV AIK+M      +  K ++ + E++ L K+ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 405 LVELIGYAATEDELFLIYEYAQKGS---LKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
            ++  G    E   +L+ EY    +   L+ H        +  L  +    +   A +GL
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--------KKPLQEVEIAAVTHGALQGL 128

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H H   + +HRD+K+ NILL      K+ DFG A ++       A     VGT  ++
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANXFVGTPYWM 178

Query: 522 APEY---LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM-------------VSKNQ 565
           APE    + +G    K DV++ G+   E+   K  +     M             +    
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238

Query: 566 ERRSLASFMLAALRNSPDSMSMSSL 590
                 +F+ + L+  P     S +
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEV 263

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 28/203 (13%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMTATK---TKE---FMAEMKILCKVHHSNLVELIG 410
           LG G++G V     +      A+K ++  K    K+    + E +IL  + H  LV L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM--RVQIALDAARGLEYIHEHT 468
               +  L+L+ EY   G L SHL   +  G+           Q+ L     LEY+H   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVL----ALEYLH--- 118

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE-YLT 527
               V+RD+K  N+LLDS    KI+DFG AK V        T T + GT  YLAPE  L+
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-----KGRTYT-LCGTPEYLAPEIILS 172

Query: 528 DGLATAKSDVYAFGVVLFEIISG 550
            G   A  D +A G++++E+++G
Sbjct: 173 KGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 25/209 (11%)

Query: 359 LGHGTYGSVYYGNIR----NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G++G+V    +R     + +  K      MT  + ++ ++E+ IL ++ H N+V   
Sbjct: 8   IGKGSFGTVR--KVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 410 GYAATEDE--LFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRV--QIALDAARGLEYI 464
                     L+++ EY + G L   +    + R      +I R+  Q+ L     L   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL----ALYEC 121

Query: 465 H--EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           H         +HRD+K +NI LD+    K+ DFGLAK++G  S    T    VGT  Y++
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT---YVGTPYYMS 178

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           PE L       KSD+++ G +++E+ +  
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 76/250 (30%), Positives = 117/250 (46%), Gaps = 23/250 (9%)

Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTK----EFMA--EMKILCKVHHSNLVELIG 410
           LG G +G V    ++   +  A K++   + K    E MA  E KIL KV    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 411 YA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           YA  T+D+L L+      G LK H++   N G+        +  A     GLE++H+   
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLA-KLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
              V+RD+K  N+LLD     +ISD GLA +L G        +    GT GY+APE L  
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KIKGRAGTPGYMAPEVLQG 168

Query: 529 GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ-ERRSLASFMLAALRNSPDSMSM 587
            +     D +A G  L+E+I+G+    + +  V K + +RR+L   +    + SP++  +
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDL 228

Query: 588 SSLKDYIDPN 597
                  DP 
Sbjct: 229 CEALLQKDPE 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 81/306 (26%), Positives = 130/306 (42%), Gaps = 62/306 (20%)

Query: 358 LLGHGTYGSVYYGNIRNQE-----VAIKRM-----TATKTKEFMAEMKILCKVHHSNLVE 407
           +LG G +GSV  G +   +     VA+K M     T ++ +EF++E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 408 LIGYAATEDEL------FLIYEYAQKGSLKSHLHDPQNRGQT-SLSWIMRVQIALDAARG 460
           LIG       L       +I  + + G L S L   +  G    L     ++  +D A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGT 517
           +EY+   +  +++HRD+ + N +L       ++DFGL+K +        G      V   
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS----KNQERRSLASF 573
             ++A E L D + T+KSDV+AFGV ++EI         T G       +N E       
Sbjct: 180 -KWIAIESLADRVYTSKSDVWAFGVTMWEIA--------TRGQTPYPGVENHE------- 223

Query: 574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI 633
           +   LR+       + LK           P DCL ++  L   C   DP  RP   ++  
Sbjct: 224 IYDYLRHG------NRLKQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267

Query: 634 SLSQIL 639
            L  IL
Sbjct: 268 VLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 93.2 bits (231), Expect = 8e-21
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 32/222 (14%)

Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQEV-AIKRMTAT------KTKEFMAEMKILCKVHHSN 404
           F+D   +GHG++G+VY+  ++R  EV AIK+M+ +      K ++ + E+K L ++ H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 405 LVELIGYAATEDELFLIYEYAQKGS---LKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
            +E  G    E   +L+ EY    +   L+ H        +  L  +    I   A +GL
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVH--------KKPLQEVEIAAITHGALQGL 138

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H H     +HRDIK+ NILL    + K++DFG A +        +     VGT  ++
Sbjct: 139 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIA-------SPANSFVGTPYWM 188

Query: 522 APEY---LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
           APE    + +G    K DV++ G+   E+   K  +     M
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.0 bits (228), Expect = 9e-21
 Identities = 63/235 (26%), Positives = 118/235 (50%), Gaps = 18/235 (7%)

Query: 358 LLGHGTYGSVYYGNIRNQ-EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGYA 412
           LLG G +G V+ G ++++  VA+K       +E    F++E +IL +  H N+V+LIG  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
                ++++ E    G   S L   ++  +T       V+ ALDAA G+ Y+      + 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTK----QLVKFALDAAAGMAYLE---SKNC 114

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT-FGYLAPEYLTDGLA 531
           +HRD+ + N L+      KISDFG+++   +  DG  + + +      + APE L  G  
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 532 TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
           +++SDV+++G++L+E  S    +    GM ++    +    + ++  +  PD + 
Sbjct: 172 SSESDVWSYGILLWETFS--LGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVY 224

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 9e-21
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 357 SLLGHGTYGSVYYGNIRNQE----VAIKRMTATKTKE-----FMAEMKILCKVHHSNLVE 407
            ++G G YG V     RN+     VAIK+   ++  E      + E+K+L ++ H N+V 
Sbjct: 7   GVVGEGAYGVVL--KCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT-----SLSWIMRVQIALDAARGLE 462
           L      +  L+L++EY ++  L   L +    G       S  W    Q+     + + 
Sbjct: 65  LKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIW----QLL----QAIA 114

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y H H   + +HRDIK  NIL+  +   K+ DFG A+ +   +   + +T  V T  Y A
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL--RARPASPLTDYVATRWYRA 169

Query: 523 PEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           PE L       K  DV+A G ++ E++ G
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 92.3 bits (229), Expect = 1e-20
 Identities = 79/293 (26%), Positives = 137/293 (46%), Gaps = 48/293 (16%)

Query: 359 LGHGTYGSV--YYGNIRN----QEVAIKRMTA----TKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V  Y  +  N    + VA+K +        T  +  E+ IL  ++H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 409 IGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G  + +    L LI EY   GSL+ +L  P+++   +L+ ++    A     G+ Y+H 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLL--LFAQQICEGMAYLHS 125

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK-------TSDGEATVTKVVGTFG 519
               HY+HRD+ + N+LLD+    KI DFGLAK V +         DG++ V      F 
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV------FW 176

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           Y A E L +   +  SDV++FGV L+E+++  ++    +    K +E        +  +R
Sbjct: 177 Y-AVECLKENKFSYASDVWSFGVTLYELLTHCDS---KQSPPKKFEEMIGPKQGQMTVVR 232

Query: 580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
                     L + ++  M    P +C  ++ +L K C + +   RP  + ++
Sbjct: 233 ----------LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 357 SLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELI 409
             +G G YG V         ++VAIK+++        A     E+K+L  + H N++ L+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 410 -----GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
                      ++++++ E  +   L   +  PQ      + + +  QI     RGL+Y+
Sbjct: 66  DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL-YQIL----RGLKYL 119

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H     + +HRD+K SNIL++S    KI DFGLA+ V    D +  +T+ V T  Y APE
Sbjct: 120 HS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGK 551
            L       K+ D+++ G +  E+++ K
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 65/199 (32%), Positives = 96/199 (48%), Gaps = 24/199 (12%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKEF---MAEMKILCKVHHSNLVELIGYAA 413
           +G GTYG VY   +I   E VAIK +      +F     E+ +L +  H N+V   G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGLEYIHEHTKT 470
             D+L+++ EY   GSL+    D     +  LS    +QIA    +  +GL Y+HE   T
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----DIYQVTRGPLS---ELQIAYVCRETLKGLAYLHE---T 120

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---T 527
             +HRDIK +NILL      K++DFG++  +  T    A     +GT  ++APE      
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI---AKRKSFIGTPYWMAPEVAAVER 177

Query: 528 DGLATAKSDVYAFGVVLFE 546
            G    K D++A G+   E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 37/249 (14%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMT----ATKTKEFMAEMKILCKVHHS---NLVEL 408
           L+G G YG+VY G      + VA+K +          +   E+ +L ++  S   N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR-VQIALDAARGLEYIHEH 467
            G       L++I EYA+ GS+++ L       +  +S I+R V +AL      +YIH  
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVAL------KYIH-- 118

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
            K   +HRDIK++NIL+ +    K+ DFG+A L+ + S   +T    VGT  ++APE +T
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAPEVIT 174

Query: 528 DGLA-TAKSDVYAFGVVLFEIISG-----KEAIIRTEGMVSKNQERR--------SLASF 573
           +G     K+D+++ G+ ++E+ +G          R   ++ K++  R         L  F
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234

Query: 574 MLAALRNSP 582
           + A L   P
Sbjct: 235 VAACLDEEP 243

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 73/242 (30%), Positives = 113/242 (46%), Gaps = 24/242 (9%)

Query: 359 LGHGTYGSVYYGNIR-------NQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIG 410
           LG G +G V    +R        +++  KR+   K  E  M E +IL KVH   +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 411 YAATEDELFLIYEYAQKGSLKSHLH--DPQNRG-QTSLSWIMRVQIALDAARGLEYIHEH 467
              T+ +L L+      G L+ H++  D +N G     +     QI      GLE++H+ 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIIS----GLEHLHQR 116

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                ++RD+K  N+LLD+    +ISD GLA    +  DG++      GT G++APE L 
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAV---ELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE--RRSLASFMLAALRNSPDSM 585
                   D +A GV L+E+I+ +    R  G   +N+E  +R L   +    + SP S 
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229

Query: 586 SM 587
           S 
Sbjct: 230 SF 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 90.0 bits (223), Expect = 8e-20
 Identities = 80/299 (26%), Positives = 133/299 (44%), Gaps = 51/299 (17%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK----EFMAEMKILCKVHHSNLVE 407
           LG G++G VY GN R+         VA+K +  + +     EF+ E  ++      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL-------HDPQNRGQTSLSWIMRVQIALDAARG 460
           L+G  +      ++ E    G LKS+L        +   R   +L  +  +Q+A + A G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM--IQMAAEIADG 131

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           + Y++      +VHRD+ + N ++   F  KI DFG+ + + +T D      K +    +
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRW 187

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           +APE L DG+ T  SD+++FGVVL+EI                     SLA      L N
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEI--------------------TSLAEQPYQGLSN 227

Query: 581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                    LK  +D   +D  P +C  ++  L + C   +P +RP   ++V  L   L
Sbjct: 228 E------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 83/314 (26%), Positives = 141/314 (44%), Gaps = 72/314 (22%)

Query: 359 LGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V           + +E   VA+K +    T+    + ++EM+++  +  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           +D        +++   V  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG------KTSDG 507
               ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ V       KT++G
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+++EI +                  
Sbjct: 200 RLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------------------ 234

Query: 568 RSLASFMLAALRNSP-DSMSMSSL-KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR 625
                     L  SP   + +  L K   + + MD  P +C  ++ M+ + C    P  R
Sbjct: 235 ----------LGGSPYPGIPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAIPSHR 283

Query: 626 PDMKQVVISLSQIL 639
           P  KQ+V  L +IL
Sbjct: 284 PTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 27/206 (13%)

Query: 359 LGHGTYGSVYY--GNIRNQEVAIKRMTATK--TKEFMA---EMKILCKVHHSNLVELIGY 411
           +G G++G +Y       ++   IK +  TK   KE  A   E+ +L K+ H N+V     
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRG-----QTSLSWIMRVQIALDAARGLEYIHE 466
                 LF++ EY   G L   ++  + RG        LSW   VQI+L    GL++IH+
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRIN--RQRGVLFSEDQILSWF--VQISL----GLKHIHD 119

Query: 467 HTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                 +HRDIKS NI L      AK+ DFG+A+ +  + +   T    VGT  YL+PE 
Sbjct: 120 RK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT---CVGTPYYLSPEI 173

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
             +     K+D+++ G VL+E+ + K
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 359 LGHGTYGS-VYYGNIRN------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           LG G +G    Y    +      +EV + R++  + ++ + E+ IL  + H N++    +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 412 AATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              ++ L +  EYA  G+L   +        +  +      QI       + YIH   K 
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV----SAVSYIH---KA 120

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             +HRDIK+ NI L  A   K+ DFG++K++G       T   VVGT  Y++PE      
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET---VVGTPYYMSPELCQGVK 177

Query: 531 ATAKSDVYAFGVVLFEIISGKEA 553
              KSD++A G VL+E+++ K  
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRT 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 19/204 (9%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMAEM----KILCKVHHSNLVELIGYA 412
           +G G    VY       N++VAIKR+   K +  + E+    + + + +H N+V+     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRG---QTSLSWIMRVQIALDAARGLEYIHEHTK 469
              DEL+L+  Y   GSL   +     RG   +  ++ +++     +  +GLEY+H + +
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVLKGLEYLHSNGQ 123

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK-VVGTFGYLAPEYLTD 528
              +HRDIK+ NILL      KI+DFG++  +    D    V K  VGT  ++APE +  
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 529 GLA-TAKSDVYAFGVVLFEIISGK 551
                 K+D+++FG+   E+ +G 
Sbjct: 181 VHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 25/205 (12%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELIGY 411
           +G GTYG VY        + VA+K++     ++ +      E+ +L  + H N+VEL   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 412 AATE--DELFLIYEYAQK--GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
              +  D +FL+ EY ++   SL  ++  P +  Q          + L   RGL+Y+HE+
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLLRGLQYLHEN 127

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                +HRD+K SN+LL      KI+DFGLA+           +T  V T  Y APE L 
Sbjct: 128 ---FIIHRDLKVSNLLLTDKGCLKIADFGLART---YGLPAKPMTPKVVTLWYRAPELLL 181

Query: 528 DGLATAKS-DVYAFGVVLFEIISGK 551
                  + D++A G +L E+++ K
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 35/242 (14%)

Query: 358 LLGHGTYGSVYYG-NIRNQEV-AIKRMTATKT-------------KEFMAEMKILCKVHH 402
           L+G GTYG VY   N+   E+ A+K++    T             K   +E++ L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
            N+V+ +G+  TE+ L +  EY   GS+ S L     R +  L      Q+      GL 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVL----EGLA 122

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       +HRD+K+ N+L+D+    KISDFG++K      D +  ++ + G+  ++A
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWMA 178

Query: 523 PEYL-TDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           PE + +     +AK D+++ G V+ E+ +G+      E +          A F L   R+
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---------AMFKLGNKRS 229

Query: 581 SP 582
           +P
Sbjct: 230 AP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 59/213 (27%), Positives = 107/213 (50%), Gaps = 25/213 (11%)

Query: 377 VAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS 432
           VA+K + A  TK    +F+ E+KI+ ++ + N++ L+G   ++D L +I EY + G L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 433 HLHDPQNRGQ-------TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD 485
            L   +            S+S    + +A+  A G++Y+      ++VHRD+ + N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Query: 486 SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLF 545
           + +  KI+DFG+++ +  + D      + V    ++A E +  G  T  SDV+AFGV L+
Sbjct: 164 NHYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 546 EIIS----------GKEAIIRTEGMVSKNQERR 568
           E+ +            E +I   G   +NQ R+
Sbjct: 223 EMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ 255

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 26/221 (11%)

Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRM------TATKTKEFMAEMKILCKVHH 402
           E F     +GHG++G+VY+   +  N+ VA+K+M      T  K ++ + E+K L ++ H
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
            N +E  G    E   +L+ EY   GS    L       +  L  +    I   A +GL 
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLA 135

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H H     +HRDIK+ NILL    + K++DFG A          +     VGT  ++A
Sbjct: 136 YLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKS-------SPANSFVGTPYWMA 185

Query: 523 PEY---LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
           PE    + +G    K DV++ G+   E+   K  +     M
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 42/224 (18%)

Query: 359 LGHGTYGSVYY----GNIRNQE---VAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
           +G G +G V+     G +  +    VA+K +    +A    +F  E  ++ +  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS-----------------LSWIMR 450
           L+G  A    + L++EY   G L   L     R Q S                 LS   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV-----GKTS 505
           + IA   A G+ Y+ E     +VHRD+ + N L+      KI+DFGL++ +      K S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + +A   +      ++ PE +     T +SDV+A+GVVL+EI S
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 87.6 bits (217), Expect = 4e-19
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 24/209 (11%)

Query: 355 DSSLLGHGTYGSVYYG-NIRNQ-EVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELI 409
           +  +LG GTYG VY   ++  Q  +AIK +    ++       E+ +   + H N+V+ +
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 410 GYAATEDELFLIY-EYAQKGSLKSHLHD---PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
           G + +E+  F I+ E    GSL + L     P    + ++ +  + QI      GL+Y+H
Sbjct: 72  G-SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH 125

Query: 466 EHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           ++     VHRDIK  N+L+++ +   KISDFG +K +   +    T T   GT  Y+APE
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPE 179

Query: 525 YLTDGLA--TAKSDVYAFGVVLFEIISGK 551
            +  G     A +D+++ G  + E+ +GK
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 30/219 (13%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT----------KEFMAEMKILCKV 400
           +  + S LL  GT+G ++YG + +++   +     KT             + E  +L  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 401 HHSNLVELIGYAATEDEL--FLIYEYAQKGSLKSHLHDPQ---NRGQTSLSWIMRVQIAL 455
            H N++  I +   ED    F++Y Y   G+LK  L   +        +LS    V +A+
Sbjct: 66  SHQNILP-ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS-----DGEAT 510
             A G+ Y+H+      +H+DI + N ++D   + KI+D  L++ +         D E  
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181

Query: 511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
             K      ++A E L +   ++ SDV++FGV+L+E+++
Sbjct: 182 PVK------WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 87.7 bits (217), Expect = 4e-19
 Identities = 81/298 (27%), Positives = 141/298 (47%), Gaps = 42/298 (14%)

Query: 359 LGHGTYGSVYY------GNIRNQEVAIKRMTATKTKEFMAEMK----ILCKVHHSNLVEL 408
           LG G +G V        G+   ++VA+K +        +A++K    IL  ++H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 409 IGYAATEDE---LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR--VQIALDAARGLEY 463
            G   TED    + LI E+   GSLK +L  P+N+ + +L   ++  VQI     +G++Y
Sbjct: 72  KG-ICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQIC----KGMDY 124

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYL 521
           +       YVHRD+ + N+L++S  + KI DFGL K + +T     TV   + +  F Y 
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFWY- 179

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L        SDV++FGV L+E+++              + E   +  F L  +  +
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT------------YCDSESSPMTLF-LKMIGPT 226

Query: 582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
              M+++ L   ++       P +C  ++  L ++C +  P  R   + ++     IL
Sbjct: 227 HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 28/204 (13%)

Query: 360 GHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGY 411
           G G +G V     R   +  A+K M   K       +  + E +IL +++H  LV L  +
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--W 66

Query: 412 AATEDE--LFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
            + +DE  ++L+ +    G L+ HL      +  Q    WI   +I L     LEY+H  
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WI--CEIVL----ALEYLHSK 119

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                +HRDIK  NILLD      I+DF +A  V   +    T +   GT GY+APE L 
Sbjct: 120 ---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTS-TSGTPGYMAPEVLC 172

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
               +   D ++ GV  +E + GK
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 353 FSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFMA----EMKILCKVHHSNLV 406
           F+    +G G++G VY       NQ VAIK +   + ++ +     E++ L +     + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
           +  G      +L++I EY   GS    L  P    +T +++I+R     +   GLEY+HE
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAFILR-----EVLLGLEYLHE 116

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRDIK++NILL      K++DFG++  +  T     T    VGT  ++APE +
Sbjct: 117 EGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTPFWMAPEVI 170

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
                  K+D+++ G+   E+  G+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 87.4 bits (216), Expect = 6e-19
 Identities = 84/263 (31%), Positives = 122/263 (46%), Gaps = 39/263 (14%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK----EFMA--EMKILCKVHHSN 404
           F    +LG G +G V    +R   +  A K++   + K    E MA  E +IL KV+   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V L     T+D L L+      G LK H++   + G+        V  A +   GLE +
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV--GKTSDGEATVTKVVGTFGYLA 522
           H+      V+RD+K  NILLD     +ISD GLA  V  G+T  G       VGT GY+A
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------VGTVGYMA 169

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG-------KEAIIR--TEGMVSKNQERRSLASF 573
           PE + +   T   D +A G +L+E+I+G       K+ I R   E +V + QE  S    
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS---- 225

Query: 574 MLAALRNSPDSMSMSSLKDYIDP 596
                + SPD+ S+  +    DP
Sbjct: 226 ----EKFSPDARSLCKMLLCKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 6e-19
 Identities = 63/229 (27%), Positives = 112/229 (48%), Gaps = 28/229 (12%)

Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P    YD    F     S    LG G +G V     YG  ++    +VA+K +  T    
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80

Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS 444
           + +  M+E+KI+  + +H N+V L+G       + +I EY   G L + L   + R ++ 
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKR-ESF 137

Query: 445 LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT 504
           L+    +  +   A+G+ ++      + +HRD+ + N+LL      KI DFGLA+ +   
Sbjct: 138 LTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194

Query: 505 SD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           S+    G A +        ++APE + + + T +SDV+++G++L+EI S
Sbjct: 195 SNYVVKGNARLP-----VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 28/206 (13%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRM----------TATKTKEFMAEMKILCKVHHSNLV 406
           LG GTY +VY G  R   + VA+K +          TA +    M E+K      H N+V
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK------HENIV 61

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            L     TE++L L++EY  K  LK ++     RG    + +      L   +G+ + HE
Sbjct: 62  RLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHE 118

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
           +     +HRD+K  N+L++     K++DFGLA+  G   +   T +  V T  Y AP+ L
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN---TFSNEVVTLWYRAPDVL 172

Query: 527 TDGLATAKS-DVYAFGVVLFEIISGK 551
                 + S D+++ G ++ E+I+G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 88.2 bits (218), Expect = 7e-19
 Identities = 83/314 (26%), Positives = 141/314 (44%), Gaps = 72/314 (22%)

Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRM----TATKTKEFMAEMKILCKV-HHSN 404
           LG G +G V              +   VA+K +    T     + ++EM+++  +  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG-----------QTSLSWIMRVQI 453
           ++ L+G    +  L+++ EYA KG+L+ +L   +  G           +  L++   V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ V       KT++G
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 197 RLPVK-------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT------------------ 231

Query: 568 RSLASFMLAALRNSP-DSMSMSSL-KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR 625
                     L  SP   + +  L K   + + MD  P +C  ++ M+ ++C    P  R
Sbjct: 232 ----------LGGSPYPGIPVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQR 280

Query: 626 PDMKQVVISLSQIL 639
           P  KQ+V  L ++L
Sbjct: 281 PTFKQLVEDLDRVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 359 LGHGTYGSVYYGNIRNQE-------VAIKRM---TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N         VA+K +   T    K+F  E ++L  + H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDP-----------QNRGQTSLSWIMRVQIAL 455
            G     D L +++EY + G L   L  H P           Q +G+  LS ++   IA 
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML--HIAS 130

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
             A G+ Y+      H+VHRD+ + N L+ +    KI DFG+++ V  ++D        +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTM 186

Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
               ++ PE +     T +SDV++FGV+L+EI + GK+
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 65/232 (28%), Positives = 117/232 (50%), Gaps = 34/232 (14%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRM-------TATKTKEFM-----AEMKILCKVHH 402
           +L+G G++GSVY G      + +A+K++       ++   K  M      E+ +L ++ H
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
            N+V+ +G +   D L +  EY   GS+ + L++     +T +   +R QI     +GL 
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLN 120

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK---VVGTFG 519
           Y+H       +HRDIK +NIL+D+    KISDFG++K +   S    T      + G+  
Sbjct: 121 YLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISGK---------EAIIRTEGMVS 562
           ++APE +     T K+D+++ G ++ E+++GK         +AI +     S
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 58/255 (22%)

Query: 347 LFATEGFSDSSLLGHGTYGSVYYG----NIRNQEVAIKRMTATKTKEF---MA---EMKI 396
            +  EG      +G GTYG VY          +E AIK+    K +      +   E+ +
Sbjct: 1   KYEIEGC-----IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIAL 55

Query: 397 LCKVHHSNLVELIG--YAATEDELFLIYEYAQ----------KGSLKSHLHDPQNRGQTS 444
           L ++ H N+V L+       +  ++L+++YA+          + + +  +     +   S
Sbjct: 56  LRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK---S 112

Query: 445 LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF----RAKISDFGLAKL 500
           L W    QI L+   G+ Y+H +     +HRD+K +NIL+          KI D GLA+L
Sbjct: 113 LLW----QI-LN---GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Query: 501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLA----TAKSDVYAFGVVLFEIIS------G 550
                   A +  VV T  Y APE L   L     T   D++A G +  E+++      G
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPELL---LGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218

Query: 551 KEAIIRTEGMVSKNQ 565
           +EA I+      ++Q
Sbjct: 219 REAKIKKSNPFQRDQ 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 78/253 (30%), Positives = 120/253 (47%), Gaps = 19/253 (7%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK----EFMA--EMKILCKVHHSN 404
           F    +LG G +G V    +R   +  A KR+   + K    E MA  E +IL KV+   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V L     T+D L L+      G LK H++   N G         +  A +   GLE +
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFEEERALFYAAEILCGLEDL 118

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H     + V+RD+K  NILLD     +ISD GLA    K  +GE ++   VGT GY+APE
Sbjct: 119 HRE---NTVYRDLKPENILLDDYGHIRISDLGLAV---KIPEGE-SIRGRVGTVGYMAPE 171

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAI-IRTEGMVSKNQERRSLASFMLAALRNSPD 583
            L +   T   D +  G +++E+I G+     R E +  +  +RR L +  + + + S +
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE 231

Query: 584 SMSMSSLKDYIDP 596
           + S+  +    DP
Sbjct: 232 AKSICKMLLTKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 79/294 (26%), Positives = 134/294 (45%), Gaps = 51/294 (17%)

Query: 358 LLGHGTYGSVYYGNIRNQE----VAIKRMTATK-----TKEFMAEMKILCKVHHSNLVEL 408
           L+G G+YG V     +++E    VAIK+   ++      K  M E+++L ++ H NLV L
Sbjct: 8   LVGEGSYGMVM--KCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           I     +  L+L++E+     L      P    ++ +   +  QI     RG+E+ H H 
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQIL----RGIEFCHSH- 119

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             + +HRDIK  NIL+  +   K+ DFG A+ +   + GE   T  V T  Y APE L  
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEV-YTDYVATRWYRAPELLVG 174

Query: 529 GLATAKS-DVYAFGVVLFEIISGKE------------AIIRTEGMVSKNQERRSLASFML 575
                ++ D++A G ++ E+++G+              II+  G +    +     + + 
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234

Query: 576 AALRNSPDSMSMSSL-KDY--IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
           A +R  P+   +  L K +  +   ++D            LAKQC+  DP  RP
Sbjct: 235 AGMR-LPEVKEIEPLEKRFPKLSGLVLD------------LAKQCLRIDPDDRP 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 73/294 (24%), Positives = 123/294 (41%), Gaps = 57/294 (19%)

Query: 358 LLGHGTYGSVY---YGNIRNQEVAIKRMTAT-----KTK--------EFMAEMKILCK-V 400
            LG G +G VY     N     +A+K +        K K        + ++E+ I+ + +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS---WIMRVQIALDA 457
            H N+V         D L+++ +  +   L  H +  + + Q       W + VQ+ L  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
              L Y+H+  +   VHRD+  +NI+L    +  I+DFGLAK        E+ +T VVGT
Sbjct: 125 --ALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQP----ESKLTSVVGT 176

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
             Y  PE + +     K+DV+AFG +L++             M +      S  + ML  
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQ-------------MCTLQPPFYS--TNML-- 219

Query: 578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                 S++   ++   +P    +Y  D       +   C+  D   RPD+ QV
Sbjct: 220 ------SLATKIVEAVYEPLPEGMYSEDVTD----VITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 50/185 (27%), Positives = 93/185 (50%), Gaps = 25/185 (13%)

Query: 375 QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL- 430
           ++VA+K+M   K +       E+ I+    H N+VE+       DEL+++ E+ + G+L 
Sbjct: 45  RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104

Query: 431 ----KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS 486
                + +++ Q         I  V +A+   + L ++H       +HRDIKS +ILL S
Sbjct: 105 DIVTHTRMNEEQ---------IATVCLAV--LKALSFLHAQG---VIHRDIKSDSILLTS 150

Query: 487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
             R K+SDFG      + S        +VGT  ++APE ++      + D+++ G+++ E
Sbjct: 151 DGRVKLSDFGFC---AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207

Query: 547 IISGK 551
           ++ G+
Sbjct: 208 MVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIK--RMTATKT--KEFMAEMKILCKVHHSNL 405
            +G  D S        +    +     VA+K  R  A+    ++F+ E+KIL ++   N+
Sbjct: 26  ADGLQDFSEKAFAENDNA---DAPVL-VAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRG----QTSLSWIMRVQIALDAAR 459
             L+G    +  L +I EY + G L   L  H  +  G      SLS+   + +A   A 
Sbjct: 82  ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           G+ Y+      ++VHRD+ + N L+   +  KI+DFG+++ +  +SD      +      
Sbjct: 142 GMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSSDYYRVQGRAPLPIR 197

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++A E +  G  T KSDV+AFGV L+EI++
Sbjct: 198 WMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 40/220 (18%)

Query: 353 FSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           + + S +G G YG V          +VAIK+++  + + F    + E+KIL +  H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 407 EL--IGYAATED---ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD----- 456
            +  I    + +   +++++ E  +                T L  +++ Q   +     
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELME----------------TDLYKLIKTQHLSNDHIQY 110

Query: 457 ----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
                 RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T
Sbjct: 111 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167

Query: 513 KVVGTFGYLAPE-YLTDGLATAKSDVYAFGVVLFEIISGK 551
           + V T  Y APE  L     T   D+++ G +L E++S +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 50/256 (19%)

Query: 359 LGHGTYGSVYYGNIRNQE------------------VAIKRMTATKTK----EFMAEMKI 396
           LG G +G V+   + N +                  VA+K +     K    +F+ E+KI
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH--------------DPQNRGQ 442
           L ++   N++ L+G    ED L +I EY + G L   L                P     
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
            ++S+   + +AL  A G++Y+   +  ++VHRD+ + N L+      KI+DFG+++ + 
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL- 188

Query: 503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS----------GKE 552
              D      + V    ++A E +  G  T  SDV+AFGV L+EI+             E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Query: 553 AIIRTEGMVSKNQERR 568
            +I   G   ++Q R+
Sbjct: 249 QVIENAGEFFRDQGRQ 264

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 74/225 (32%), Positives = 107/225 (47%), Gaps = 19/225 (8%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK----EFMA--EMKILCKVHHSN 404
           F    +LG G +G V    +R   +  A K++   + K    E MA  E +IL KV+   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V L     T+D L L+      G LK H++   N G         V  A +   GLE +
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIY---NMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   +   V+RD+K  NILLD     +ISD GLA    +  +GE T+   VGT GY+APE
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAV---EIPEGE-TIRGRVGTVGYMAPE 171

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAI-IRTEGMVSKNQERR 568
            + +   T   D +  G +++E+I GK     R E +  +  ERR
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELI 409
             +G GTYG VY        + VA+K++     KE      + E+KIL +++H N+V L 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 410 GYAATEDE----------LFLIYEYAQK---GSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
                + +           +L++EY      G L+S L         S    M+ Q+ L+
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF---MK-QL-LE 127

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
              GL Y H   K +++HRDIK SNILL++  + K++DFGLA+L     +     T  V 
Sbjct: 128 ---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS--EESRPYTNKVI 179

Query: 517 TFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGK 551
           T  Y  PE L  +       DV++ G +L E+ + K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 72/286 (25%), Positives = 129/286 (45%), Gaps = 46/286 (16%)

Query: 353 FSDSSLLGHGTYGSVYYG--NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLV 406
           F+    +G G++G VY G  N   + VAIK +       + ++   E+ +L +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G      +L++I EY   GS    L  P    +T ++ I+R     +  +GL+Y+H 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILR-----EILKGLDYLHS 119

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++APE +
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEVI 173

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
                  K+D+++ G+   E+  G       E   S     R L  F++   +NSP ++ 
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKG-------EPPNSDLHPMRVL--FLIP--KNSPPTLE 222

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
               K + +                   + C+++DP  RP  K+++
Sbjct: 223 GQYSKPFKE-----------------FVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 68/288 (23%), Positives = 133/288 (46%), Gaps = 46/288 (15%)

Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G V+ G  N   + VAIK +       + ++   E+ +L +     
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           + +  G    + +L++I EY   GS    L +P    +T ++ I+R     +  +GL+Y+
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILR-----EILKGLDYL 117

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++APE
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPE 171

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +      +K+D+++ G+   E+  G+            + E   +    L   +N+P +
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGE----------PPHSELHPMKVLFLIP-KNNPPT 220

Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
           +      +Y  P             +    + C++++P  RP  K+++
Sbjct: 221 LE----GNYSKP-------------LKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 78/314 (24%), Positives = 138/314 (43%), Gaps = 68/314 (21%)

Query: 353 FSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRM-----TATKTKEFMAEMKILCKVHH 402
           F+   +LG G +GSV    +++     Q+VA+K +     +++  +EF+ E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 403 SNLVELIG---YAATEDEL---FLIYEYAQKGSLKSHL------HDPQNRGQTSLSWIMR 450
            N+++LIG    +  +  L    +I  + + G L + L       +P      +L     
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----- 115

Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG--- 507
           V+  +D A G+EY+   +  +++HRD+ + N +L+      ++DFGL+K   K   G   
Sbjct: 116 VRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK---KIYSGDYY 169

Query: 508 -EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS-KNQ 565
            +   +K+     +LA E L D + T  SDV+AFGV ++EI+        T G       
Sbjct: 170 RQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIM--------TRGQTPYAGV 219

Query: 566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR 625
           E   + ++++   R          LK           P DCL  +  L  QC   +P  R
Sbjct: 220 ENSEIYNYLIKGNR----------LKQ----------PPDCLEDVYELMCQCWSPEPKCR 259

Query: 626 PDMKQVVISLSQIL 639
           P  + +   L  I 
Sbjct: 260 PSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 32/210 (15%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G++G       +        +E+ I +M+  + +E   E+ +L  + H N+V+   Y
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---Y 64

Query: 412 AATEDE---LFLIYEYAQKGSLKSHLHDPQNRG-----QTSLSWIMRVQIALDAARGLEY 463
             + +E   L+++ +Y + G L   ++    RG        L W   VQI L     L++
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKIN--AQRGVLFPEDQILDWF--VQICL----ALKH 116

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H+      +HRDIKS NI L      K+ DFG+A+++  T +   T    +GT  YL+P
Sbjct: 117 VHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART---CIGTPYYLSP 170

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGKEA 553
           E   +     KSD++A G VL+E+ + K A
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 85.1 bits (211), Expect = 6e-18
 Identities = 78/266 (29%), Positives = 114/266 (42%), Gaps = 50/266 (18%)

Query: 357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEF----------MAEMKIL---CKVH 401
           ++LG G +G V     +   +  AIK   A K K            M E +I        
Sbjct: 5   AVLGRGHFGKVLLAEYKKTGELYAIK---ALK-KGDIIARDEVESLMCEKRIFETANSER 60

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD---PQNRGQTSLSWIMRVQIALDAA 458
           H  LV L     TED +  + EYA  G L  H+H     + R             A    
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF---------YAACVV 111

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
            GL+Y+HE+     V+RD+K  N+LLD+    KI+DFGL K       G+ T T   GT 
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST-FCGTP 165

Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK------------EAIIRTEGMVSKNQE 566
            +LAPE LT+   T   D +  GV+++E++ G+            ++I+  E    +   
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 225

Query: 567 RRSLASFMLAALRNSPDSMSMSSLKD 592
           R ++ S M   LR +P+    S  KD
Sbjct: 226 REAI-SIMRRLLRRNPERRLGSGEKD 250

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 19/225 (8%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK----EFMA--EMKILCKVHHSN 404
           F    +LG G +G V    +R   +  A K++   + K    E MA  E +IL KV+   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V L     T+D L L+      G LK H++   N G         +  A +   GLE +
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
               +   V+RD+K  NILLD     +ISD GLA    +  +GE TV   VGT GY+APE
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLAV---QIPEGE-TVRGRVGTVGYMAPE 171

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ-ERR 568
            + +   T   D +  G +++E+I G+    + +  V + + +RR
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 83.6 bits (206), Expect = 8e-18
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 27/215 (12%)

Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRM--TATKTKEFMAEMKILCKV-HHSNLVE 407
           F    L+G+GTYG VY G      Q  AIK M  T  + +E   E+ +L K  HH N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 408 LIGY------AATEDELFLIYEYAQKGSLKSHLHDPQNRGQT-SLSWIMRVQIALDAARG 460
             G          +D+L+L+ E+   GS+   + +   +G T    WI    I  +  RG
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWI--AYICREILRG 123

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L ++H+H     +HRDIK  N+LL      K+ DFG++  + +T     T    +GT  +
Sbjct: 124 LSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYW 177

Query: 521 LAPEYLT-----DGLATAKSDVYAFGVVLFEIISG 550
           +APE +      D     KSD+++ G+   E+  G
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 28/207 (13%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV-HHSN 404
           +LG G++G V    ++        + A K   K+           M E ++L     H  
Sbjct: 2   VLGKGSFGKVLLAELKGT----DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           L +L     T+D LF + EY   G L  H+     R     +     +I L    GL+++
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVL----GLQFL 112

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           HE      ++RD+K  N+LLDS    KI+DFG+ K   +   G  T +   GT  Y+APE
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPE 166

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            L+        D +A GV+L+E+++G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.3 bits (211), Expect = 8e-18
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 48/199 (24%)

Query: 367 VYYGN----IRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY 422
           V YGN    +R Q   I R           E++IL  V+H N+V+         E+ ++ 
Sbjct: 106 VIYGNHEDTVRRQ---ICR-----------EIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151

Query: 423 EYAQKGSLK-SHLHDPQNRGQTSLSWIMRVQIALDAAR----GLEYIHEHTKTHYVHRDI 477
           E+   GSL+ +H+ D Q              +A D AR    G+ Y+H   + H VHRDI
Sbjct: 152 EFMDGGSLEGTHIADEQ-------------FLA-DVARQILSGIAYLH---RRHIVHRDI 194

Query: 478 KSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDV 537
           K SN+L++SA   KI+DFG+++++ +T D        VGT  Y++PE +   L     D 
Sbjct: 195 KPSNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDG 251

Query: 538 YA-----FGVVLFEIISGK 551
           YA      GV + E   G+
Sbjct: 252 YAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.5 bits (206), Expect = 9e-18
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)

Query: 359 LGHGTYGSVYYGNIRN----QE---VAIKRM---TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N    Q+   VA+K +   + +  ++F  E ++L  + H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNR----------GQTSLSWIMRVQIALD 456
            G       L +++EY + G L   L  H P  +          GQ +L  ++   IA  
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML--AIASQ 130

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+ Y+      H+VHRD+ + N L+      KI DFG+++ +  T D      + + 
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DYYRVGGRTML 186

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
              ++ PE +     T +SD+++FGVVL+EI + GK+
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 87.2 bits (216), Expect = 1e-17
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 22/194 (11%)

Query: 375 QEVAIKRMT------ATKTKEFMAEMKILCKVHHSNLVELIGYAATEDE-LFLIYEYAQK 427
            EVAIK +         +   F  E  +  +++H N+V L+         LF ++EY   
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL--- 484
            +L+  L      G  +L      ++ L     L   H       VHRD+K  NI++   
Sbjct: 64  RTLREVL---AADG--ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115

Query: 485 DSAFRAKISDFGLAKLVGKTSDGEAT----VTKVVGTFGYLAPEYLTDGLATAKSDVYAF 540
                AK+ DFG+  L+    D +       T+V+GT  Y APE L     T  SD+YA+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 541 GVVLFEIISGKEAI 554
           G++  E ++G+  +
Sbjct: 176 GLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 54/285 (18%)

Query: 366 SVYYGNIRNQEVAIKRMTATKT------KEFMAEMKILCKVHHSNLVELIGY-AATEDEL 418
           S+Y G   N+EV I+                  E+K L ++  +N++++ G+     D+L
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 419 ---FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
               LI EY  +G L+  L   ++     LS+  ++ +A+D  +GL  ++++T   Y + 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKN- 148

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA--TA 533
            + S + L+   ++ KI   GL K++           K V    Y + + L D  +  T 
Sbjct: 149 -LTSVSFLVTENYKLKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTI 201

Query: 534 KSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDY 593
           K D+Y+ GVVL+EI +GK   I  E + +K                          + D 
Sbjct: 202 KDDIYSLGVVLWEIFTGK---IPFENLTTK-------------------------EIYDL 233

Query: 594 IDPNMMDLY-PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
           I      L  P DC  ++  + + C   D I RP++K+++ +LS 
Sbjct: 234 IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 73/273 (26%), Positives = 119/273 (43%), Gaps = 42/273 (15%)

Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTKE--FMAEMKILCKV-HHSNLVE 407
           F    ++G+GTYG VY G      Q  AIK M  T+ +E     E+ +L K  HH N+  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 408 LIGY------AATEDELFLIYEYAQKGSLKSHLHDPQNRGQT-SLSWIMRVQIALDAARG 460
             G          +D+L+L+ E+   GS+   + +   +G      WI    I  +  RG
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN--TKGNALKEDWI--AYICREILRG 133

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L ++H H     +HRDIK  N+LL      K+ DFG++  + +T     T    +GT  +
Sbjct: 134 LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYW 187

Query: 521 LAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
           +APE +      D     +SD+++ G+   E+  G   +     M       R+L  F++
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RAL--FLI 238

Query: 576 AALRNSPDSMSMSSLK----DYIDPNMMDLYPH 604
              RN P  +          D+I+  ++  Y  
Sbjct: 239 P--RNPPPKLKSKKWSKKFIDFIEGCLVKNYLS 269

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 23/202 (11%)

Query: 359 LGHGTYGSVYYGNIRNQE----VAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELI 409
           +G G+YG V+    RN+E    VAIK+   ++      K  + E+++L ++ H NLV LI
Sbjct: 9   IGEGSYGVVF--KCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
                + +L L++EY     L  +  +   RG      I +  I     + + + H+H  
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHL-IKK--IIWQTLQAVNFCHKH-- 119

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-D 528
            + +HRD+K  NIL+    + K+ DFG A+++   +      T  V T  Y APE L  D
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPELLVGD 175

Query: 529 GLATAKSDVYAFGVVLFEIISG 550
                  DV+A G V  E+++G
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELI-- 409
           LG GT+G VY    I+    VA+K++     K+        E+KIL K+ H N+V LI  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 410 ------GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
                         ++++  Y     L   L +P  +   S      +Q+ L+   G+ Y
Sbjct: 76  AVERPDKSKRKRGSVYMVTPY-MDHDLSGLLENPSVKLTESQIKCYMLQL-LE---GINY 130

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA--------KLVGKTSDGEATVTKVV 515
           +HE+   H +HRDIK++NIL+D+    KI+DFGLA           G    G    T +V
Sbjct: 131 LHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 516 GTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISGK 551
            T  Y  PE  L +   T   D++  G V  E+ + +
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 26/202 (12%)

Query: 359 LGHGTYGSVYYGNIRNQEV-AIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G VY    +   + A  ++   +++E    FM E+ IL +  H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 414 TEDELFLIYEYAQKGSLKS---HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
            E++L+++ E+   G+L S    L       Q  + ++ R          L ++H H   
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQ--IRYVCR-----QMLEALNFLHSH--- 122

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---- 526
             +HRD+K+ NILL      K++DFG++     T     T    +GT  ++APE +    
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACET 179

Query: 527 -TDGLATAKSDVYAFGVVLFEI 547
             D     K+D+++ G+ L E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 28/209 (13%)

Query: 359 LGHGTYGSVYYGNIRNQE----VAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV  G +   +    VA+K M     T ++ ++F++E   + +  H N++ LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 410 G--YAATEDELF----LIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLE 462
           G      E E +    +I  + + G L S L +         L   M V+   D A G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG----EATVTKVVGTF 518
           Y+   +   ++HRD+ + N +L+      ++DFGL+K   K  +G    +  + K+    
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK---KIYNGDYYRQGRIAKM--PV 178

Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEI 547
            ++A E L D + T KSDV++FGV ++EI
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 28/218 (12%)

Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-------NIRNQEVAIKRM---TATKT-KEFMAEM 394
           IL  TE F    +LG G +G+VY G        ++   VAIK +   T+ K  KE + E 
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEA 60

Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQ 452
            ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W   VQ
Sbjct: 61  YVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQ 117

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATV 511
           IA    +G+ Y+ E      VHRD+ + N+L+ +    KI+DFGLAKL+G    +  A  
Sbjct: 118 IA----KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 512 TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 171 GKV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 43/258 (16%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNL 405
           E       +G G+ G V     ++  ++VA+K+M   K +       E+ I+   HH N+
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           V++       DEL+++ E+ + G+L   + H   N  Q +        + L   R L Y+
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYL 134

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRDIKS +ILL S  R K+SDFG    V K      +   +VGT  ++APE
Sbjct: 135 HNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS---LVGTPYWMAPE 188

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            ++      + D+++ G+++ E+I G+                            N P  
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPPYF------------------------NEPPL 224

Query: 585 MSMSSLKDYIDPNMMDLY 602
            +M  ++D + P + D +
Sbjct: 225 QAMRRIRDNLPPRVKDSH 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 20/205 (9%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRM--------TATKTKEFMAEMKILCKVHHSNLVE 407
           LLG G +G VY  Y     +E+A+K++        T  +      E+++L  + H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 408 LIGYAATEDELFLIY-EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
             G    +DE   I+ EY   GS+K  L     +   +L+  +  +       G+EY+H 
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
           +     VHRDIK +NIL DSA   K+ DFG +K +         +  V GT  +++PE +
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
           +      K+DV++ G  + E+++ K
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 35/234 (14%)

Query: 377 VAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS 432
           VA+K +     K    +F+ E+KI+ ++   N++ L+    T D L +I EY + G L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 433 HL--HDPQNRGQ----TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS 486
            L  H+PQ   +     ++S+   + +A   A G++Y+   +  ++VHRD+ + N L+  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
            +  KI+DFG+++ +  + D      + V    +++ E +  G  T  SDV+AFGV L+E
Sbjct: 166 NYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 547 IIS----------GKEAIIRTEGMVSKNQER-----------RSLASFMLAALR 579
           I++            E +I   G   ++Q R            SL   ML+  R
Sbjct: 225 ILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWR 278

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIK---RMTATK-TKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G VY+G +     +    A+K   R+T  +  ++F+ E  I+    H N++ L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 409 IGYAATEDELFLI-YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           +G     +   L+   Y + G L++ +        T    I      L  A+G+EY+   
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLI---GFGLQVAKGMEYLASK 117

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV-GKTSDGEATVTKVVGTFGYLAPEYL 526
               +VHRD+ + N +LD +F  K++DFGLA+ +  K        T       ++A E L
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 527 TDGLATAKSDVYAFGVVLFEIIS 549
                T KSDV++FGV+L+E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)

Query: 353 FSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTAT------KTKEFMAEMKILCKVHHSN 404
                 +G GT+G V+    R  E   A+K M         + +    E ++L +V H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 405 LVELIGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
           ++ L  +    D+  L+++ EY   G L S+L   +N G+ S S    +  A +    LE
Sbjct: 63  IIRL--FWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRFSNS--TGLFYASEIVCALE 115

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       V+RD+K  NILLD     K++DFG AK   K  D   T   + GT  YLA
Sbjct: 116 YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWT---LCGTPEYLA 166

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           PE +         D +A G++++E++ G 
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 81.7 bits (201), Expect = 5e-17
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 359 LGHGTYGSVYYGNIRN----QE---VAIKRM---TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N    Q+   VA+K +   +    K+F  E ++L  + H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDP------QNRGQTSLSWIMRVQIALDAARG 460
            G     D L +++EY + G L   L  H P      +      L+    + IA   A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           + Y+      H+VHRD+ + N L+      KI DFG+++ V  T D        +    +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST-DYYRVGGHTMLPIRW 188

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
           + PE +     T +SDV++ GVVL+EI + GK+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 81.1 bits (201), Expect = 9e-17
 Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 23/201 (11%)

Query: 362 GTYGSVYYG-NIRNQE-VAIKRMTATKTKE-F----MAEMKILCKVHHSNLVEL--IGYA 412
           GTYG VY   + +  E VA+K++   K KE F    + E+ IL K+ H N+V +  +   
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 413 ATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
           +  D+++++ EY +   LKS +    Q   Q+ +  +M +Q+      G+ ++H++    
Sbjct: 76  SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHDN---W 126

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GL 530
            +HRD+K+SN+LL++    KI DFGLA+  G         T++V T  Y APE L     
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYG---SPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 531 ATAKSDVYAFGVVLFEIISGK 551
            +   D+++ G +  E+++ K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 81.7 bits (202), Expect = 9e-17
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 42/225 (18%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMA-----------------EMKILCK 399
           LG GTYG V   Y  +  + VAIK++   +    +                  E+KI+ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H N++ L+      D + L+ +      LK  +       ++ +  I+  QI      
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILL-QIL----N 130

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK------LVGKTSDGEAT--- 510
           GL  +H   K +++HRD+  +NI ++S    KI+DFGLA+           S  E     
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 511 ---VTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
               +KVV T  Y APE L        + D+++ G +  E+++GK
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 19/199 (9%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATK--TKEFMA-EMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAIK+M   +   KE +  E+ ++ +  H N+V  +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQ-NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + LE++H +     
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLHSN---QV 136

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG      + +  ++  + +VGT  ++APE +T     
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E++ G+
Sbjct: 194 PKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 26/204 (12%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRM-----TATKTKE-FMAEMKILCKVHHSNLVELIG 410
           LG G +G V       +N+  A+K +       T  +E   +E +IL + +H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 411 YAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           Y   +D+  ++++ EY   G L + L D   RG     +  R  IA       EY+H   
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRD---RGLFD-EYTARFYIAC-VVLAFEYLHNR- 112

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY-LT 527
               ++RD+K  N+LLDS    K+ DFG AK   K   G+ T T   GT  Y+APE  L 
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAK---KLKSGQKTWT-FCGTPEYVAPEIILN 166

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
            G   +  D ++ G++L+E+++G+
Sbjct: 167 KGYDFS-VDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 56/293 (19%)

Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G V+ G  N   Q VAIK +       + ++   E+ +L +     
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLH-DPQNRGQ--TSLSWIMRVQIALDAARGL 461
           + +  G      +L++I EY   GS    L   P +  Q  T L  I++         GL
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK---------GL 114

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y+H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++
Sbjct: 115 DYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWM 168

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE +      +K+D+++ G+   E+  G+            N +   +    L    N 
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGE----------PPNSDMHPMRVLFLIPKNNP 218

Query: 582 PDSMS--MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
           P          K++ID                     C+++DP  RP  K+++
Sbjct: 219 PTLTGEFSKPFKEFID--------------------ACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 69/205 (33%), Positives = 92/205 (44%), Gaps = 25/205 (12%)

Query: 358 LLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLV 406
           LLG GT+G V          YY   I  +EV I +     T   + E ++L    H  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLT 58

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            L     T D L  + EYA  G L  HL    +R +       R   A +    LEY+H 
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSALEYLHS 113

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 V+RDIK  N++LD     KI+DFGL K  G +    AT+    GT  YLAPE L
Sbjct: 114 R---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISD--GATMKTFCGTPEYLAPEVL 167

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
            D       D +  GVV++E++ G+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 23/206 (11%)

Query: 359 LGHGTYGSVYYGNI----RNQEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIG 410
           +G+G +G V  G          V +K + A+ T +    F+ E++   +++H N+++ +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ--IALDAARGLEYIHEHT 468
                    L+ E+   G LK++L    NRG  +      V   +A + A GL ++H   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT- 527
           +  ++H D+   N  L +    KI D+GLA L     D   T         +LAPE +  
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 528 --DGLATAK----SDVYAFGVVLFEI 547
               L        S++++ GV ++E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 24/203 (11%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G G +G V+    R   + VA+K++   + +       + E+K L    H  +V+L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 412 AATEDELFLIYEYAQKGSLKSHLHD---PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                   L+ EY     L   L D   P    Q      MR+ +     +G+ Y+H   
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKS--YMRMLL-----KGVAYMH--- 116

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               +HRD+K +N+L+ +    KI+DFGLA+L     +     +  V T  Y APE L  
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS--EEEPRLYSHQVATRWYRAPELLYG 174

Query: 529 GLA-TAKSDVYAFGVVLFEIISG 550
                   D++A G +  E+++G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)

Query: 345 EILFATEGFSDSSLLGHGTYGSVYYGNI-------RNQEVAIK----RMTATKTKEFMAE 393
           EI  +T  F +   LG   +G VY G++       + Q VAIK    +      +EF  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 394 MKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
             +  ++ H N+V L+G    E  L +I+ Y     L   L            D     +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
           ++L     V I    A G+E++  H   H VH+D+ + N+L+      KISD GL + V 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREV- 174

Query: 503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
             +D    +   +    +++PE +  G  +  SD++++GVVL+E+ S
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 62/243 (25%), Positives = 112/243 (46%), Gaps = 25/243 (10%)

Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V    +++  + VA+K+M   K +       E+ I+    H N+VE+     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   + L  +H       
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLHAQG---V 137

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL    R K+SDFG    V K      +   +VGT  ++APE ++     
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPELISRLPYG 194

Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E++ G+        + +    R +L   +    + SP      SLK 
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSP------SLKG 248

Query: 593 YID 595
           ++D
Sbjct: 249 FLD 251

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.0 bits (194), Expect = 4e-16
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 17/198 (8%)

Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMTATKT--KEFMA-EMKILCKVHHSNLVELIGYAA 413
           +G G  G+V+        QEVAIK++   K   KE +  E+ ++ ++ + N+V  +    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
             DELF++ EY   GSL   +       +T +       +  +  + LE++H +     +
Sbjct: 87  VGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA 533
           HRDIKS N+LL      K++DFG    +       +T   +VGT  ++APE +T      
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYGP 194

Query: 534 KSDVYAFGVVLFEIISGK 551
           K D+++ G++  E++ G+
Sbjct: 195 KVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 23/208 (11%)

Query: 358 LLGHGTYGSVYYGN-------IRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLV 406
            LG G + S Y          +  ++V   R T+++     +    E++++ +++H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 407 ELIGYAATEDELFLIY-EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            ++G A  ED  F ++ E+   GS+   L         +    + +       RGL Y+H
Sbjct: 67  RMLG-ATCEDSHFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLH 120

Query: 466 EHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLA-KLVGKTSDGEATVTKVVGTFGYLAP 523
           E+     +HRD+K +N+L+DS   R +I+DFG A +L  K +       +++GT  ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E L         DV++ G V+ E+ + K
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 79.1 bits (195), Expect = 6e-16
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 22/204 (10%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE------FMAEMKILC-KVHHSNLVEL 408
           +LG G++G V    ++  N+  AIK +      E       M E ++L     H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLEYIHEH 467
                T++ LF + EY   G L  H+   Q+ G+   +   R +  A +   GL+++H  
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHI---QSSGRFDEA---RARFYAAEIICGLQFLH-- 113

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
            K   ++RD+K  N+LLD     KI+DFG+ K      +GE   +   GT  Y+APE L 
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILK 169

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
                   D ++FGV+L+E++ G+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 20/201 (9%)

Query: 359 LGHGTYGSVYYGNIRNQ----EVAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIG 410
           LG G +G V  G  + +    +VAIK +     K    E M E +I+ ++ +  +V +IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
               E  L L+ E A  G L   L     + + ++S +  V++    + G++Y+      
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFL--SGKKDEITVSNV--VELMHQVSMGMKYLEGK--- 114

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTD 528
           ++VHRD+ + N+LL +   AKISDFGL+K +G  +D      +  G +   + APE +  
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINF 172

Query: 529 GLATAKSDVYAFGVVLFEIIS 549
              +++SDV+++G+ ++E  S
Sbjct: 173 RKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 358 LLGHGTYGS---VYYGNIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIG 410
           ++G G++G    V + N  +Q+ A+K +    +++  ++   E  +L K+ H N+V    
Sbjct: 7   VVGEGSFGRALLVQHVN-SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNR---GQTSLSWIMRVQIALDAARGLEYIHEH 467
               +  L+++ EY   G L   +   + +     T L W   VQ+ L    G+++IHE 
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCL----GVQHIHE- 118

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                +HRDIKS NI L    + K+ DFG A+L+   +   A     VGT  Y+ PE   
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL---TSPGAYACTYVGTPYYVPPEIWE 173

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
           +     KSD+++ G +L+E+ + K
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 28/200 (14%)

Query: 362 GTYGSVYYGNIR--NQEVAIK-----RMTA-TKTKEFMAEMKILCKVHHSNLVELIGYA- 412
           G +GSVY    R      AIK      M A  +     AE  I+     S  V  + Y+ 
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
            ++D L+L+ EY   G   S +   +  G     W    Q   +   G+E +H   +   
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLH---QRGI 118

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAK--LVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
           +HRDIK  N+L+D     K++DFGL++  L  K         K VGT  YLAPE +    
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---------KFVGTPDYLAPETILGVG 169

Query: 531 ATAKSDVYAFGVVLFEIISG 550
               SD ++ G V+FE + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 77.3 bits (190), Expect = 8e-16
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 20/201 (9%)

Query: 359 LGHGTYGSV---YYGNIRNQE-VAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +G+V    Y   ++++ VA+K +           E + E  ++ ++ +  +V +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-QIALDAARGLEYIHEHT 468
           G    E    L+ E A+ G L   L   +N+  T  +    V Q+++    G++Y+ E  
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQ--KNKHVTEKNITELVHQVSM----GMKYLEET- 114

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             ++VHRD+ + N+LL +   AKISDFGL+K +G   +     T       + APE +  
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 529 GLATAKSDVYAFGVVLFEIIS 549
              ++KSDV++FGV+++E  S
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 27/217 (12%)

Query: 347 LFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT----------KEFMAEMKI 396
           +          LLG G +G+V+ G    +  +IK   A KT          +E    M  
Sbjct: 3   ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62

Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMRVQ 452
           +  + H+ +V L+G       L L+ + +  GSL  H+   Q+R     Q  L+W   VQ
Sbjct: 63  MGSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVR--QHRDSLDPQRLLNWC--VQ 117

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           IA    +G+ Y+ EH     VHR++ + NILL S    +I+DFG+A L+    D +   +
Sbjct: 118 IA----KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYS 169

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +      ++A E +  G  T +SDV+++GV ++E++S
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 24/204 (11%)

Query: 359 LGHGTYGSVYYGNIRNQE----VAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELI 409
           +G GTYG VY    RN+     VA+K++      E      + E+ +L +++H N+V+L+
Sbjct: 8   IGEGTYGVVY--KARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
               TE++L+L++E+  +  LK  + D        L  I      L   +GL + H H  
Sbjct: 66  DVIHTENKLYLVFEFLHQ-DLKKFM-DASPLSGIPLPLIKSYLFQL--LQGLAFCHSH-- 119

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL--T 527
              +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y APE L   
Sbjct: 120 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGC 175

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
              +TA  D+++ G +  E+++ +
Sbjct: 176 KYYSTA-VDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 38/216 (17%)

Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTKEFM--------AEMKILCKVHH 402
           + + + +G G YG+VY        + VA+K++    ++E +        A +K L    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 403 SNLVELIGYAAT-----EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-----WIMRVQ 452
            N+V L+          E +L L++E+  +  L ++L       +  L       +MR Q
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL---SKCPKPGLPPETIKDLMR-Q 115

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +     RG++++H H     VHRD+K  NIL+ S  + KI+DFGLA    +    E  +T
Sbjct: 116 LL----RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEMALT 164

Query: 513 KVVGTFGYLAPEYL-TDGLATAKSDVYAFGVVLFEI 547
            VV T  Y APE L     AT   D+++ G +  E+
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 26/202 (12%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK--------RMTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G++G V     +   +  AIK        +M   + +    E  IL ++ H  +V +
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK--QVQHVAQEKSILMELSHPFIVNM 83

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +     E+ ++ + E+   G L +HL     R    ++     ++ L      EY+H   
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVL----AFEYLHSKD 138

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               ++RD+K  N+LLD+    K++DFG AK V      + T T + GT  YLAPE +  
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFT-LCGTPEYLAPEVIQS 189

Query: 529 GLATAKSDVYAFGVVLFEIISG 550
                  D +  GV+L+E I+G
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 69/287 (24%), Positives = 129/287 (44%), Gaps = 55/287 (19%)

Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRM---TATKTKEFMAEM--KILCKVHHSNLVELIGY 411
           +G G+YG V     R   ++  IK++    A++ +   AE   ++L ++ H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 412 AATED-ELFLIYEYAQKGSLKSHLHDPQNRGQ-----TSLSWIMRVQIALDAARGLEYIH 465
              ED  L+++  + + G L   L   + +G+       + W   VQIA+     L+Y+H
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLK--EQKGKLLPENQVVEWF--VQIAM----ALQYLH 119

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           E    H +HRD+K+ N+ L      K+ D G+A+++    D  +T   ++GT  Y++PE 
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST---LIGTPYYMSPEL 173

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
            ++     KSDV+A G  ++E+                            A L+++ ++ 
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEM----------------------------ATLKHAFNAK 205

Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
            M+SL   I    +   P D   ++  L    + + P  RP +K ++
Sbjct: 206 DMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.5 bits (190), Expect = 2e-15
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 414 TEDELFLIYEYAQKGSLKSHLHDP-QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + LE++H +     
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLHSN---QV 137

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG      + +  ++  + +VGT  ++APE +T     
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E+I G+
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 14/165 (8%)

Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           K+ + E++I+ +     +V   G    E+ + +  E+   GSL     D   +    +  
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-----DRIYKKGGPIPV 102

Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA-KLVGKTSD 506
            +  +IA+    GL Y++       +HRDIK SNIL++S  + K+ DFG++ +L+   +D
Sbjct: 103 EILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160

Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
                   VGT  Y++PE +  G  T KSDV++ G+ + E+  GK
Sbjct: 161 ------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 19/221 (8%)

Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTK----EFMA--EMKILCKVHHSNLVELIG 410
           LG G +G V    ++N  +  A K++   + K    E MA  E +IL KV+   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              ++  L L+      G LK H++   N G+  L     +  +     G+ ++H     
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             V+RD+K  N+LLD     ++SD GLA    +  DG+ T+T+  GT GY+APE L +  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGK-TITQRAGTNGYMAPEILKEEP 170

Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ-ERRSL 570
            +   D +A G  ++E+++G+      +  V+K + +RR+L
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 34/208 (16%)

Query: 359 LGHGTYGSV-----------YYGNIRNQEVAIKRMTATKTKEFMAEMKILCK-VHHSNLV 406
           +G G++G V           Y   +  ++  +K+      K  MAE  +L K V H  LV
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ---KHIMAERNVLLKNVKHPFLV 59

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGLE 462
            L     T D+L+ + +Y   G L  HL      P+ R +           A + A  L 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF---------YAAEIASALG 110

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H     + ++RD+K  NILLDS     ++DFGL K   +  +   T +   GT  YLA
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLA 164

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE L         D +  G VL+E++ G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 72/265 (27%), Positives = 112/265 (42%), Gaps = 83/265 (31%)

Query: 359 LGHGTYGSVYYGN---IRN----QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +   I      + VA+K +    TA++ K  M E+KIL  + HH N+V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 407 ELIGYAATEDE--LFLIYEYAQKGS----LKSHLH------DPQNRGQ------------ 442
            L+G A T+    L +I EY + G+    L+S         +   R +            
Sbjct: 75  NLLG-ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133

Query: 443 ---------TSLSWIMR-------------------------VQIALDAARGLEYIHEHT 468
                     S  +I                           +  +   ARG+E++    
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPE 524
               +HRD+ + NILL      KI DFGLA+ + K  D    G+A +        ++APE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP-----LKWMAPE 245

Query: 525 YLTDGLATAKSDVYAFGVVLFEIIS 549
            + D + T +SDV++FGV+L+EI S
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 358 LLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLV 406
           LLG GT+G V          YY   I  +EV + +     T   + E ++L    H  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLT 58

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            L     T D L  + EYA  G L  HL   +   +    +        +    L+Y+H 
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSALDYLH- 112

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
            ++ + V+RD+K  N++LD     KI+DFGL K      DG AT+    GT  YLAPE L
Sbjct: 113 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG-ATMKTFCGTPEYLAPEVL 168

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
            D       D +  GVV++E++ G+
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 69/205 (33%), Positives = 92/205 (44%), Gaps = 25/205 (12%)

Query: 358 LLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLV 406
           LLG GT+G V          YY   I  +EV I +     T   + E ++L    H  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT---LTESRVLQNTRHPFLT 58

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            L     T D L  + EYA  G L  HL    +R +       R   A +    L Y+H 
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGA-EIVSALGYLHS 113

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 V+RD+K  N++LD     KI+DFGL K     SDG AT+    GT  YLAPE L
Sbjct: 114 ---CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKTFCGTPEYLAPEVL 167

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
            D       D +  GVV++E++ G+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 64/302 (21%)

Query: 350 TEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKR-----MTATKTKE-FMAEMKILCKVH 401
              F     +G G +  VY     +  + VA+K+     M   K ++  + E+ +L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT---SLSWIMRVQIALDAA 458
           H N+++ +      +EL ++ E A  G L   +   + + +       W   VQ+     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGT 517
             LE++H       +HRDIK +N+ + +    K+ D GL +    KT+   +    +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGT 169

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
             Y++PE + +     KSD+++ G +L+E                            +AA
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYE----------------------------MAA 201

Query: 578 LRNSP---DSMSMSSLKDYID-----PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK 629
           L+ SP   D M++ SL   I+     P   D Y      ++  L  +C++ DP  RPD+ 
Sbjct: 202 LQ-SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE----ELRDLVSRCINPDPEKRPDIS 256

Query: 630 QV 631
            V
Sbjct: 257 YV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 23/204 (11%)

Query: 358 LLGHGTYGSVY-----YGNIRNQEVAIKRMTATKTK-----EFMAEMKILCKVHHSNLVE 407
           +LG G++G V+      G    Q  A+K +     K         E  IL +V+H  +V+
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 408 LIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
           L  YA  TE +L+LI ++ + G L + L       +  + + +  ++AL     L+++H 
Sbjct: 63  L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-AELAL----ALDHLH- 115

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 ++RD+K  NILLD     K++DFGL+K   ++ D E       GT  Y+APE +
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 527 TDGLATAKSDVYAFGVVLFEIISG 550
                T  +D ++FGV++FE+++G
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G GTYG VY    R  N+ +A+K++   +  E      + E+ +L ++ H N+V L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 412 AATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
             +E  L+L++EY     LK H+   P       L      QI     RG+ Y H H   
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIAYCHSH--- 121

Query: 471 HYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +HRD+K  N+L+D    A K++DFGLA+  G       T T  V T  Y APE L   
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---RTFTHEVVTLWYRAPEILLGS 178

Query: 530 LA-TAKSDVYAFGVVLFEIISGK 551
              +   D+++ G +  E+++ K
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 20/203 (9%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVEL 408
           +LG G++G V+   ++  NQ  AIK +           +  M E ++L     H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                T++ LF + EY   G L  H+    ++     +     +I      GL+++H   
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIIC----GLQFLHSKG 116

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               V+RD+K  NILLD+    KI+DFG+ K   +   G+A      GT  Y+APE L  
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
                  D ++FGV+L+E++ G+
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRM--------TATKTKEFMAEMKILCKVHHSNLVE 407
           LLG G +G VY  Y     +E+A K++        T+ +      E+++L  + H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 408 LIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
             G      E  L +  EY   GS+K  L     +   +L+  +  +       G+ Y+H
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILEGMSYLH 123

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
            +     VHRDIK +NIL DSA   K+ DFG +K +         +  V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS 562
           ++      K+DV++ G  + E+++ K      E M +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.3 bits (187), Expect = 4e-15
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 25/205 (12%)

Query: 358 LLGHGTYGSVYYG------NIRNQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVE 407
           +LG G +G+VY G            VAIK +  T       EFM E  I+  + H +LV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQIALDAARGLEYIH 465
           L+G   +   + L+ +    G L  ++H+ ++    Q  L+W +++      A+G+ Y+ 
Sbjct: 74  LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV-GKTSDGEATVTKVVGTFGYLAPE 524
           E      VHRD+ + N+L+ S    KI+DFGLA+L+ G   +  A   K+     ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALE 181

Query: 525 YLTDGLATAKSDVYAFGVVLFEIIS 549
            +     T +SDV+++GV ++E+++
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 20/217 (9%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRM--------TATKTKEFMAEMKILCKVHHSNLVE 407
           LLG G +G VY  Y     +E+A+K++        T+ +      E+++L  + H  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 408 LIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
             G      E +L +  EY   GS+K  L     +   +L+  +  +      +G+ Y+H
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQGVSYLH 123

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
            +     VHRDIK +NIL DSA   K+ DFG +K +         +  V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS 562
           ++      K+DV++    + E+++ K      E M +
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 19/199 (9%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAIK+M      K +  + E+ ++ +  + N+V  +    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 414 TEDELFLIYEYAQKGSLKSHLHDP-QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + L+++H +     
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALDFLHSN---QV 136

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG    +       +T   +VGT  ++APE +T     
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYG 193

Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E++ G+
Sbjct: 194 PKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 7e-15
 Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 44/235 (18%)

Query: 351 EGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRM---TATKTKE---FMAEMKILCKVHH 402
           + F    ++G G +G V+        Q  A+K +      K  +     AE  IL     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA-LDAARGL 461
             +V+L      E+ L+L+ EY   G L + L     +         R  IA L  A  L
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETA-RFYIAELVLA--L 114

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK-------- 513
           + +H   K  ++HRDIK  NIL+D+    K++DFGL K + K  D E  +          
Sbjct: 115 DSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 514 ------------------VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                              VGT  Y+APE L       + D ++ GV+L+E++ G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 17/198 (8%)

Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V     ++  ++VA+K M   K +       E+ I+    H N+VE+     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
             +EL+++ E+ Q G+L   +       QT L+      +     + L Y+H       +
Sbjct: 89  VGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQALCYLHSQG---VI 139

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA 533
           HRDIKS +ILL    R K+SDFG    + K      +   +VGT  ++APE ++      
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMAPEVISRTPYGT 196

Query: 534 KSDVYAFGVVLFEIISGK 551
           + D+++ G+++ E++ G+
Sbjct: 197 EVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           +LG G +G +  G +     R   VAI  +    +  + + F+AE   L +  HSN+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G     + + ++ EY   G+L S L   ++ GQ     +M +   L  A G++Y+ E  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGL--ASGMKYLSE-- 125

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL--APEYL 526
              YVH+ + +  +L++S    KIS F       +    EA  T + G    L  APE +
Sbjct: 126 -MGYVHKGLAAHKVLVNSDLVCKISGFRR----LQEDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKE 552
                ++ SDV++FG+V++E++S  E
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 19/205 (9%)

Query: 351 EGFSDSSLLGHGTYGSVYYG-NIRNQEVA-IKRMTATKTKEF---MAEMKILCKVHHSNL 405
           E F     +G GTYG VY   N+   E+A IK +     ++F     E+ ++    HSN+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
           V   G     D+L++  E+   GSL+   H      ++ ++++ R     +  +GL Y+H
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLH 123

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
              K   +HRDIK +NILL      K++DFG++  +  T    A     +GT  ++APE 
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATI---AKRKSFIGTPYWMAPEV 177

Query: 526 LT---DGLATAKSDVYAFGVVLFEI 547
                 G      D++A G+   E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 359 LGHGTYGSVYY------GNIRNQEVAIKRMTATKTKEF---MAEMKILCKVHHSNLVELI 409
           +G GT+G VY         I   +V  K+    K KE    + E  IL +        ++
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIV 59

Query: 410 GYA---ATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
           G      T+ +L+L+ +Y   G L  HL  + +     +  +I  + +AL      E++H
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EHLH 113

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           ++     V+RD+K  NILLD+     + DFGL+K     +D + T T   GT  YLAPE 
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNT-FCGTTEYLAPEV 167

Query: 526 LTDGLATAKS-DVYAFGVVLFEIISG 550
           L D     K  D ++ GV++FE+  G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 29/209 (13%)

Query: 359 LGHGTYGSVYY-----GNIRNQEVAIKRM------TATKTKEF-MAEMKILCKVHHSNLV 406
           LG G YG V+      G+   +  A+K +         KT E    E ++L  V     +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 407 ELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-WIMRVQIALDAARGLEYI 464
             + YA  T+ +L LI +Y   G L +HL+  ++  ++ +  +I  + +ALD        
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD-------- 119

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H H +   ++RDIK  NILLDS     ++DFGL+K     ++ E       GT  Y+APE
Sbjct: 120 HLH-QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFCGTIEYMAPE 176

Query: 525 YL---TDGLATAKSDVYAFGVVLFEIISG 550
            +   + G   A  D ++ GV+ FE+++G
Sbjct: 177 VIRGGSGGHDKA-VDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 77.1 bits (190), Expect = 1e-14
 Identities = 69/293 (23%), Positives = 117/293 (39%), Gaps = 62/293 (21%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVELI 409
           L+G G  G VY  Y  + ++ VA+K++           K F+ E KI   + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 410 GYAATEDELFLIYEYA-------------QKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
              +  D ++    Y              QK SL   L +     +TS+   + +   + 
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE-----KTSVGAFLSIFHKIC 123

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT---- 512
           A   +EY+H       +HRD+K  NILL       I D+G A       +    +     
Sbjct: 124 A--TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 513 -----------KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEI-------------- 547
                      K+VGT  Y+APE L    A+  +D+YA GV+L+++              
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 548 ISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS--MSMSSLKDYIDPNM 598
           IS ++ I+    +    +    L+   + AL   P     S+  LK  ++P++
Sbjct: 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291

Length = 932

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRM--------TATKTKEFMAEMKILCKVHHSNLVE 407
           LLG G +G VY  Y     +E+A+K++        T+ +      E+++L  + H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 408 LIGYA--ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
             G      E  L +  E+   GS+K  L     +   +L+  +  +       G+ Y+H
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILEGVSYLH 123

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
            +     VHRDIK +NIL DS    K+ DFG +K +         +  V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS 562
           ++      K+D+++ G  + E+++ K      E M +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 78/264 (29%)

Query: 358 LLGHGTYGSVYYGNI-------RNQEVAIKRM----TATKTKEFMAEMKILCKV-HHSNL 405
           +LGHG +G V   +            VA+K +    TA++ K  M+E+KIL  + +H N+
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 406 VELIGYAATEDE--LFLIYEYAQKGSLKSHLH------------DPQNRGQ-TSLSWIMR 450
           V L+G A T+    L +I E+ + G+L + L              P+ RG+  ++    R
Sbjct: 74  VNLLG-ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132

Query: 451 VQIALDAARGLEYIHEHTKTHY-------------------------------------- 472
           V   ++A +          +                                        
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192

Query: 473 ---VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEY 525
              +HRD+ + NILL      KI DFGLA+ + K  D    G A +        ++APE 
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-----PLKWMAPES 247

Query: 526 LTDGLATAKSDVYAFGVVLFEIIS 549
           + D + T +SDV++FGV+L+EI S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 357 SLLGHGTYGSVYY---------GNIRNQEVAIKRMTATKTKEFM---AEMKILCKVHHSN 404
            +LG G YG V+          G I   +V  K       K+     AE  IL  V H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMRVQIALDAARG 460
           +V+LI    T  +L+LI EY   G L  HL   +  G     T+  ++  + +AL+    
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALE---- 114

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
               H H +   ++RD+K  NILLD+    K++DFGL K      +G  T T   GT  Y
Sbjct: 115 ----HLHQQG-IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHT-FCGTIEY 166

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           +APE L         D ++ G +++++++G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 358 LLGHGTYGSVYYGNIRNQEV-----AIKRMTATKTKE---FMAEMKILCK-VHHSNLVEL 408
           ++G G++G V     + +E       +++    K KE    M+E  +L K V H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                T D+L+ + +Y   G L  HL     R +  L    R   A + A  L Y+H   
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAA-EIASALGYLHS-- 114

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             + V+RD+K  NILLDS     ++DFGL K   +  +   T +   GT  YLAPE L  
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHK 170

Query: 529 GLATAKSDVYAFGVVLFEIISG 550
                  D +  G VL+E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 358 LLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLV 406
           LLG GT+G V          YY   I  +EV I +     T   + E ++L    H  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT---LTESRVLKNTRHPFLT 58

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            L     T+D L  + EY   G L  HL   +   +    +        +    L+Y+H 
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFY-----GAEIVSALDYLHS 113

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 V+RD+K  N++LD     KI+DFGL K  G T    AT+    GT  YLAPE L
Sbjct: 114 ---GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITD--AATMKTFCGTPEYLAPEVL 167

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
            D       D +  GVV++E++ G+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 25/200 (12%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIK----RMTATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           LGHG  G+VY  Y  +  + +A+K     +T    K+ M+E++IL K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             E+ + +  E+   GSL  +   P++         +  +IA+   +GL Y+        
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEH---------VLGRIAVAVVKGLTYLW---SLKI 116

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLA-KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
           +HRD+K SN+L+++  + K+ DFG++ +LV       +     VGT  Y+APE ++    
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV------NSIAKTYVGTNAYMAPERISGEQY 170

Query: 532 TAKSDVYAFGVVLFEIISGK 551
              SDV++ G+   E+  G+
Sbjct: 171 GIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 80/288 (27%), Positives = 125/288 (43%), Gaps = 69/288 (23%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIK--------RMTATKT-KE--FMAEMKILCKVHHSNL 405
           LG G YG V+   + R +E VA+K           A +T +E  F+ E+       H N+
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNI 69

Query: 406 VELIG-YAATED-ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA------ 457
           V+L+    A  D +++L++EY +                T L  ++R  I  D       
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYME----------------TDLHAVIRANILEDVHKRYIM 113

Query: 458 ---ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE--ATVT 512
               + L+YIH     + +HRD+K SNILL+S  R K++DFGLA+ + +  +      +T
Sbjct: 114 YQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 513 KVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK------------EAIIRTEG 559
             V T  Y APE L       K  D+++ G +L E++ GK            E II   G
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230

Query: 560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCL 607
             S  ++  S+ S   A + +S  S     L + + P        D L
Sbjct: 231 PPSA-EDIESIKSPFAATMLDSLPSRPRKPLDELL-PK----ASDDAL 272

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 42/210 (20%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT------ATKTKEFMAEMKILCKVHHSNLVELIG 410
           +G G YG V+    ++    VA+KRM         + +  + E  IL       LV+L+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67

Query: 411 YAATEDE-LFLIYEYAQKGSLKSHLHDPQNRGQTSLS------WIMRVQIALDAARGLEY 463
           YA  +DE L+L  EY   G  ++ L    N G   LS      ++  +  A+DA      
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLL---NNLG--VLSEDHARFYMAEMFEAVDA------ 116

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK---VVGTFGY 520
           +HE     Y+HRD+K  N L+D++   K++DFGL+K           VT    VVG+  Y
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK---------GIVTYANSVVGSPDY 164

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           +APE L         D ++ G +L+E + G
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 21/207 (10%)

Query: 358 LLGHGTYGSVYYGNI-RNQEVAIKRM---------TATKTKEFMAEMKILCKVHHSNLVE 407
           +LG G YG+VY G   + Q +A+K++            + ++   E+ +L  + H N+V+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
            +G    ++ + +  E+   GS+ S L    NR       +   +       G+ Y+H +
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFC-KYTKQILDGVAYLHNN 121

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK---LVGKTSDGEATVTKVVGTFGYLAPE 524
                VHRDIK +N++L      K+ DFG A+    VG        +  + GT  ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            + +     KSD+++ G  +FE+ +GK
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 40/214 (18%)

Query: 357 SLLGHGTYGSVYYGNIR--NQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELI 409
           S +G G YG V         ++VAIK++     +A   K    E+++L  + H N++ L+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IALDAA 458
                A+  E F      Q   L +HL          L+ I++ Q         +     
Sbjct: 81  DVFTPASSLEDF------QDVYLVTHLMG------ADLNNIVKCQKLSDDHIQFLVYQIL 128

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           RGL+YIH       +HRD+K SNI ++     KI DFGLA+        +  +T  V T 
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT------DDEMTGYVATR 179

Query: 519 GYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            Y APE + + +   ++ D+++ G ++ E+++GK
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 30/209 (14%)

Query: 359 LGHGTYGSVY-YGNIRN-QEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G+G +G V+   + R+ + VA+K+M          K    E+K+LC   H N++  +  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 412 AATED-----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV---QIALDAARGLEY 463
                     E++++ E  Q     S LH      Q   S  ++V   QI     RGL+Y
Sbjct: 68  LQPPHIDPFEEIYVVTELMQ-----SDLHKIIVSPQPLSSDHVKVFLYQIL----RGLKY 118

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H       +HRDIK  N+L++S    KI DFGLA++  +  D    +T+ V T  Y AP
Sbjct: 119 LH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV--EEPDESKHMTQEVVTQYYRAP 173

Query: 524 EYLTDGLA-TAKSDVYAFGVVLFEIISGK 551
           E L      T+  D+++ G +  E++  +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 22/201 (10%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIK--RMTATKTKEFMA--EMKILCKVHHSNLVELIGYA 412
           LG G+Y +VY G   +  Q VA+K  R+   +   F A  E  +L  + H+N+V L    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
            T+  L L++EY     LK ++ D           +   Q+     RGL Y H   +   
Sbjct: 73  HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH---QRRV 124

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---TDG 529
           +HRD+K  N+L+      K++DFGLA+     S    T +  V T  Y  P+ L   T+ 
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLLGSTE- 180

Query: 530 LATAKSDVYAFGVVLFEIISG 550
             +   D++  G + +E+ +G
Sbjct: 181 -YSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G GTYG VY G  +   Q VA+K++     +E      + E+ +L ++ H N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR---VQIALDAARGLEYIHEHT 468
              E  L+LI+E+     LK +L D   +GQ   + +++    QI      G+ + H   
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQ----GILFCHSR- 120

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               +HRD+K  N+L+D+    K++DFGLA+  G         T  V T  Y APE L  
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLG 175

Query: 529 G-LATAKSDVYAFGVVLFEIISGK 551
               +   D+++ G +  E+ + K
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 19/197 (9%)

Query: 359 LGHGTYGSVYYG-NIRNQEVA-IKRMTATKTKEF---MAEMKILCKVHHSNLVELIGYAA 413
           +G GTYG VY   N+   E+A +K +      +F     E+ ++ +  H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++L++  EY   GSL+   H      +  ++++ R     +  +GL Y+H   K   +
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGK---M 128

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRDIK +NILL      K++DFG+A  +  T    A     +GT  ++APE      +G 
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 531 ATAKSDVYAFGVVLFEI 547
                D++A G+   E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.9 bits (179), Expect = 7e-14
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 27/212 (12%)

Query: 350 TEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHH 402
           T  + D   +G G +G V      +  Q VAIK++     T    K    E+K+L  + H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 403 SNLVEL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            N++ L  I  +  ED ++ + E      L + LH           +I          RG
Sbjct: 69  ENIISLSDIFISPLED-IYFVTEL-----LGTDLHRLLTSRPLEKQFIQ--YFLYQILRG 120

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L+Y+H       VHRD+K SNIL++     KI DFGLA++       +  +T  V T  Y
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI------QDPQMTGYVSTRYY 171

Query: 521 LAPE-YLTDGLATAKSDVYAFGVVLFEIISGK 551
            APE  LT      + D+++ G +  E++ GK
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 358 LLGHGTYGSVYYGNI--RNQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVEL 408
           +LG G++G V    +  + +  A+K +           +  M E ++L     +  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLEYIHEH 467
                T++ LF + E+   G L  H+   Q++G+  L    R    A +   GL+++H  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDL---YRATFYAAEIVCGLQFLHSK 115

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                ++RD+K  N++LD     KI+DFG+ K   +   G+   +   GT  Y+APE L 
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
               T   D ++FGV+L+E++ G+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 72.7 bits (178), Expect = 9e-14
 Identities = 73/258 (28%), Positives = 113/258 (43%), Gaps = 37/258 (14%)

Query: 358 LLGHGTYGSVYY-----GNIRNQEVAIKRMTA------TKTKEFM-AEMKILCKVHHSNL 405
           +LG G YG V+      G+   +  A+K +         KT E    E  +L  V  S  
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 406 VELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +  + YA  TE +L LI +Y   G + +HL+   N  +  +      +I L     LE++
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR-FYSGEIIL----ALEHL 121

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   K   V+RDIK  NILLDS     ++DFGL+K     S+ +       GT  Y+APE
Sbjct: 122 H---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF--LSEEKERTYSFCGTIEYMAPE 176

Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
            +       K+ D ++ G+++FE+++G       EG      ER + +      L+  P 
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFT-LEG------ERNTQSEVSRRILKCDP- 228

Query: 584 SMSMSSLKDYIDPNMMDL 601
                    +I P   DL
Sbjct: 229 -----PFPSFIGPEAQDL 241

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 72/273 (26%), Positives = 122/273 (44%), Gaps = 30/273 (10%)

Query: 347 LFATEGFSDSSLLGHGTYGSVYYGNIRN----QEVAIKRMTATK-TKEFMAEMKILCKVH 401
           LF  EG      +G GTYG VY    ++    +E A+K++  T  +     E+ +L ++ 
Sbjct: 1   LFEYEGCK----VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK 56

Query: 402 HSNLVEL--IGYAATEDELFLIYEYAQKG---SLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           H N++ L  +  + ++ +++L+++YA+      +K H     N+    L   M   +   
Sbjct: 57  HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFGLAKLVGKTSDGEATVT 512
              G+ Y+H +     +HRD+K +NIL+        R KI+D G A+L        A + 
Sbjct: 117 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 513 KVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGKEAI-IRTEGMVSKNQERRSL 570
            VV TF Y APE L       K+ D++A G +  E+++ +     R E + + N      
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN------ 227

Query: 571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYP 603
             F    L      M   + KD+ D   M  YP
Sbjct: 228 -PFHHDQLDRIFSVMGFPADKDWEDIRKMPEYP 259

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQE---VAIKRMTATK------TKEFMAEMKILCKVH 401
           E F+    LG G++G V     +N++   VAIKR   +K           +E KIL  ++
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H   V L G    E  L+L+ E+   G   + L     R    +      QI L      
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLI----F 144

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+      + V+RD+K  N+LLD     K++DFG AK+V      +     + GT  Y+
Sbjct: 145 EYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEYI 195

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE L +      +D +  G+ ++EI+ G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 20/201 (9%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYA 412
           LG GTY +V+ G  +  E  VA+K +     +      + E+ +L  + H+N+V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL-DAARGLEYIHEHTKTH 471
            T+  L L++EY  K  LK ++ D  N     +  +  V+I L    RGL Y H   +  
Sbjct: 74  HTDKSLTLVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCH---RRK 124

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRD+K  N+L++     K++DFGLA+     S    T +  V T  Y  P+ L     
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 532 -TAKSDVYAFGVVLFEIISGK 551
            + + D++  G + FE+ SG+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 26/191 (13%)

Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKE---FMA--EMKILCKVHHSNL 405
           +   + +G GT+G V+   + + ++ VA+K++     KE     A  E+KIL  + H N+
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73

Query: 406 VELI--------GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA 457
           V LI         Y   +   +L++E+ +   L   L +     + +LS I +V   L  
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV--KFTLSEIKKVMKML-- 128

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK--LVGKTSDGEATVTKVV 515
             GL YIH   +   +HRD+K++NIL+      K++DFGLA+   + K S       +VV
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 516 GTFGYLAPEYL 526
            T  Y  PE L
Sbjct: 186 -TLWYRPPELL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 32/208 (15%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIK---RMTATKTKE---FMAEMKILCK-VHHSNLVEL 408
           ++G G++G V     +      A+K   + T  K KE    MAE  +L K + H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                T ++L+ + +Y   G L  HL       +P+ R             A + A  + 
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-----------YAAEVASAIG 110

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H     + ++RD+K  NILLDS     ++DFGL K   +  + E T +   GT  YLA
Sbjct: 111 YLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLA 164

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE L         D +  G VL+E++ G
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 28/204 (13%)

Query: 359 LGHGTYGSVYYGNIRN----------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G++G+VY    +           +E+ +  +   +T +   E ++L K+ H  +V+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT-----SLSWIMRVQIALDAARGLEY 463
                  D   +I EY +   L   L + ++ G+T        W   +Q+ L    G+ Y
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF--IQLLL----GVHY 121

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H+      +HRD+K+ NI L +    KI DFG+++L+  + D   T T   GT  Y++P
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT---GTPYYMSP 174

Query: 524 EYLTDGLATAKSDVYAFGVVLFEI 547
           E L      +KSD+++ G +L+E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 26/226 (11%)

Query: 330 TDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEV--AIKRMTATKT 387
              FD +     T ++IL + +   + +++  G  G+ Y G      +   +K +    +
Sbjct: 672 LQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728

Query: 388 --KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL 445
                +A+M    K+ H N+V+LIG   +E   +LI+EY +  +L   L         +L
Sbjct: 729 IPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--------RNL 777

Query: 446 SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS 505
           SW  R +IA+  A+ L ++H       V  ++    I++D      +    L  L+    
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL---- 832

Query: 506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               T TK   +  Y+APE       T KSD+Y FG++L E+++GK
Sbjct: 833 ---CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 24/203 (11%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYA 412
           LG GTY +VY G  +  +  VA+K +     +      + E+ +L  + H+N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL-DAARGLEYIHEHTKTH 471
            TE  L L++EY  K  LK +L D  N        +  V++ L    RGL Y H   +  
Sbjct: 74  HTEKSLTLVFEYLDK-DLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCH---RRK 124

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---TD 528
            +HRD+K  N+L++     K++DFGLA+     S    T +  V T  Y  P+ L   TD
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
              + + D++  G + +E+ +G+
Sbjct: 182 --YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 34/209 (16%)

Query: 358 LLGHGTYGSV-----------YYGNIRNQEVAIKRMTATKTKEFMAEMKILCK-VHHSNL 405
           ++G G++G V           Y   +  +++ + R    + K  MAE  +L K V H  L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHPFL 58

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGL 461
           V L     T ++L+ + ++   G L  HL      P+ R         R   A + A  L
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA--------RFYAA-EIASAL 109

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H     + V+RD+K  NILLDS     ++DFGL K     SD   T T   GT  YL
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYL 163

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D +  G VL+E++ G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 33/254 (12%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQE--VAIK------RMTATKTKEFMAEMKILCKVHH 402
           E F    ++G G +G V    ++N +   A+K       +   +T  F  E  +L     
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GD 59

Query: 403 SNLVELIGYAATEDE-LFLIYEYAQKGSLKSHLHDPQNRGQTSLS--WIMRVQIALDAAR 459
           +  +  + YA  ++  L+L+ +Y   G L + L   ++R    ++  ++  + IA+D+  
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            L         HYVHRDIK  NIL+D     +++DFG    +    DG    +  VGT  
Sbjct: 120 QL---------HYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPD 168

Query: 520 YLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGK-----EAIIRTEGMVSKNQERRS 569
           Y++PE L       G    + D ++ GV ++E++ G+     E+++ T G +  ++ER  
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 228

Query: 570 LASFMLAALRNSPD 583
             + +     ++ D
Sbjct: 229 FPAQVTDVSEDAKD 242

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 29/241 (12%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNL----- 405
           + F    ++G G +G V    +++ E  I  M      E +   +  C     N+     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTE-RIYAMKILNKWEMLKRAETACFREERNVLVNGD 59

Query: 406 ---VELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +  + YA   E+ L+L+ +Y   G L + L   ++R    ++     ++ L      
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA----- 114

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
             IH   + HYVHRDIK  N+LLD     +++DFG    +    DG    +  VGT  Y+
Sbjct: 115 --IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYI 170

Query: 522 APEYLT---DGLAT--AKSDVYAFGVVLFEIISGK-----EAIIRTEGMVSKNQERRSLA 571
           +PE L    DG+     + D ++ GV ++E++ G+     E+++ T G +  ++ER    
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230

Query: 572 S 572
           S
Sbjct: 231 S 231

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 29/205 (14%)

Query: 359 LGHGTYGSVYYGNIRNQE----VAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELI 409
           +G GTYG+V+    +N+E    VA+KR+      E      + E+ +L ++ H N+V L 
Sbjct: 8   IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
               ++ +L L++EY  +  LK +           +      Q+     +GL + H H  
Sbjct: 66  DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL----KGLAFCHSH-- 118

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVG---KTSDGEATVTKVVGTFGYLAPEYL 526
            + +HRD+K  N+L++     K++DFGLA+  G   +    E      V T  Y  P+ L
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE------VVTLWYRPPDVL 171

Query: 527 TDG-LATAKSDVYAFGVVLFEIISG 550
               L +   D+++ G +  E+ + 
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 29/210 (13%)

Query: 359 LGHGTYGSVYYG-NIRN--QEVAIKRMTATKTKEFM--------AEMKILCKVHHSNLVE 407
           +G G YG V+   +++N  + VA+KR+     +E M        A ++ L    H N+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 408 L-----IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG-QTSLSWIMRVQIALDAARGL 461
           L     +     E +L L++E+  +  L ++L      G  T     M  Q+     RGL
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL----RGL 123

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H H     VHRD+K  NIL+ S+ + K++DFGLA++       +  +T VV T  Y 
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYR 176

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L         D+++ G +  E+   K
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 26/205 (12%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G GTYG VY     +  + VA+K++      E      + E+ +L +++H N+V L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 412 AATEDELFLIYEYAQ---KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
             +E++L+L++E+     K  + S      +      S++   Q+     +G+ Y H H 
Sbjct: 67  VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-SYLY--QLL----QGIAYCHSH- 118

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               +HRD+K  N+L+D     K++DFGLA+  G       T T  V T  Y APE L  
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLG 173

Query: 529 G--LATAKSDVYAFGVVLFEIISGK 551
               +T   D+++ G +  E+++ +
Sbjct: 174 SRQYSTP-VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 54/295 (18%)

Query: 358 LLGHGTYGSVYYG-------NIRNQEVAIKRM---TATKT-KEFMAEMKILCKVHHSNLV 406
           +LG G +G+VY G       N++   VAIK +   T+ K  KE + E  ++  V    + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVK-IPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQIALDAARGLEYI 464
            L+G   T   + L+ +    G L  ++ + ++R   Q  L+W   VQIA    +G+ Y+
Sbjct: 73  RLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIA----KGMSYL 125

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVTKVVGTFGYLAP 523
            E      VHRD+ + N+L+ S    KI+DFGLA+L+    ++  A   KV     ++A 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMAL 180

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
           E +     T +SDV+++GV ++E++        T G                       D
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELM--------TFGA-------------------KPYD 213

Query: 584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
            +    + D ++       P  C   + M+  +C   D   RP  +++V   S++
Sbjct: 214 GIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 70.9 bits (173), Expect = 3e-13
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 17/202 (8%)

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           +H  LV L     TE  LF + EY   G L  H+   Q +     +     +I+L     
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL----A 108

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L Y+HE      ++RD+K  N+LLDS    K++D+G+ K   +  D   T +   GT  Y
Sbjct: 109 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNY 162

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEA--IIRTEGMVSKNQERRSLASFMLAAL 578
           +APE L         D +A GV++FE+++G+    I+ +     +N E       +   +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222

Query: 579 RNSPDSMSM---SSLKDYIDPN 597
           R  P S+S+   S LK +++ +
Sbjct: 223 R-IPRSLSVKAASVLKSFLNKD 243

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)

Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+K+L + +   +V   G   ++ E+ +  E+   GSL   L   +  G+   + + ++ 
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKIS 105

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           IA+   RGL Y+ E  K   +HRD+K SNIL++S    K+ DFG++   G+  D  A   
Sbjct: 106 IAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--N 156

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK-----------EAIIRTE--G 559
             VGT  Y++PE L     T +SD+++ G+ L E+  G+           EA+       
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216

Query: 560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYI 594
             +K   R            +SP  M++  L DYI
Sbjct: 217 GEAKESHRPVSGHPP-----DSPRPMAIFELLDYI 246

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 70/294 (23%), Positives = 120/294 (40%), Gaps = 54/294 (18%)

Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSN 404
           F     +G G +  VY     +    VA+K+      M A    + + E+ +L +++H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKS---HLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           +++       ++EL ++ E A  G L     H    +        W   VQ+       L
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SAL 119

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H       +HRDIK +N+ + +    K+ D GL +     S        +VGT  Y+
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYM 173

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           +PE + +     KSD+++ G +L+E                            +AAL+ S
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE----------------------------MAALQ-S 204

Query: 582 P---DSMSMSSLKDYIDPNMMDLYPHDCLFK-MAMLAKQCVDEDPILRPDMKQV 631
           P   D M++ SL   I+       P D   + +  L   C++ DP  RPD+  V
Sbjct: 205 PFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIK--RMTATKTKEFMA--EMKILCKVHHSNLVELIGYA 412
           LG G+Y +VY G   I  Q VA+K   M   +   F A  E  +L  + H+N+V L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
            T++ L  ++EY      +  +  P      ++   M         RGL YIH     H 
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFM-----FQLLRGLAYIHGQ---HI 124

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---TDG 529
           +HRD+K  N+L+      K++DFGLA+   K+   +   ++VV T  Y  P+ L   TD 
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVV-TLWYRPPDVLLGATD- 180

Query: 530 LATAKSDVYAFGVVLFEIISGKEA 553
             ++  D++  G +  E++ G+ A
Sbjct: 181 -YSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 48/277 (17%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRMTATKT--KEFMAEMKILCKVH-HSNLVELIGY-- 411
           +G GTYG V+         + A+K +       +E  AE  IL  +  H N+V+  G   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 412 ---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                  D+L+L+ E    GS+   +     RG+  +   +   I  +A  GL+++H + 
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RMEEPIIAYILHEALMGLQHLHVN- 143

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT- 527
           KT  +HRD+K +NILL +    K+ DFG++  +  T     T    VGT  ++APE +  
Sbjct: 144 KT--IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT---SVGTPFWMAPEVIAC 198

Query: 528 ----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
               D    A+ DV++ G+   E+  G   +     M       R+L  F +   RN P 
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------RAL--FKIP--RNPPP 247

Query: 584 SMSMSSL--------------KDY-IDPNMMDLYPHD 605
           ++    L              KDY   P + DL  H 
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 358 LLGHGTYGSVYYGNIRNQE----VAIKRMTATKTKE-----FMAEMKILCKVHHSNLVEL 408
           ++G G YG V     R++E    VAIK+   ++  E      + E+K+L  +   N+VEL
Sbjct: 8   VVGEGAYGVVL--KCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL-SWIMRVQIALDAARGLEYIHEH 467
                   +L+L++EY +K  L+     P       + S+I ++         ++ IH  
Sbjct: 66  KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL---------IKAIHWC 116

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
            K   VHRDIK  N+L+      K+ DFG A+ + + S+  A  T+ V T  Y +PE L 
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLL 174

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
                   D+++ G +L E+  G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 42/216 (19%)

Query: 357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMK-------ILCKVHHS-NLV 406
             +G GT G VY    +     +A+K+M  T  KE   E K       ++ K H    +V
Sbjct: 21  GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE---ENKRILMDLDVVLKSHDCPYIV 77

Query: 407 ELIGYAATEDELFLIYEY----AQKGSLKSHLHDP---QNRGQTSLSWIMRVQIALDAAR 459
           +  GY  T+ ++F+  E       K  L   +  P      G+ +++ +          +
Sbjct: 78  KCYGYFITDSDVFICMELMSTCLDK--LLKRIQGPIPEDILGKMTVAIV----------K 125

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            L Y+ E  K   +HRD+K SNILLD++   K+ DFG++   G+  D +A  T+  G   
Sbjct: 126 ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKAK-TRSAGCAA 179

Query: 520 YLAPEYLTDGLATAK----SDVYAFGVVLFEIISGK 551
           Y+APE +       K    +DV++ G+ L E+ +G+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 18/210 (8%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSN 404
           + F   S LG G  G V     +   + + R      +      + + E+++L + +   
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V   G   ++ E+ +  E+   GSL   L + +   +  L    +V IA+   RGL Y+
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSIAV--LRGLAYL 119

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
            E  K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPE 172

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAI 554
            L     + +SD+++ G+ L E+  G+  I
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 62/292 (21%)

Query: 359 LGHGTYGSVYYGN--IRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLVELIG 410
           +G G +  VY     +  + VA+K+      M A   ++ + E+ +L +++H N+++ + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 411 YAATEDELFLIYEYAQKGSLKS---HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
               ++EL ++ E A  G L     +    +        W   VQ+       +E++H  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMHSR 125

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                +HRDIK +N+ + +    K+ D GL +     S        +VGT  Y++PE + 
Sbjct: 126 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERIH 179

Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP---DS 584
           +     KSD+++ G +L+E                            +AAL+ SP   D 
Sbjct: 180 ENGYNFKSDIWSLGCLLYE----------------------------MAALQ-SPFYGDK 210

Query: 585 MSMSSLKDYID-----PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           M++ SL   I+     P   + Y      K+  L   C+  DP  RPD+  V
Sbjct: 211 MNLFSLCQKIEQCDYPPLPTEHYSE----KLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 45/212 (21%)

Query: 359 LGHGTYGSVYYG-NIRN-QEVAIKRMT--------ATKTKEFMAEMKILCKVHHSNLVEL 408
           +G GT+  V    + +  +  AIK M             +E  A ++ L    H N++ L
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRL--SPHPNILRL 63

Query: 409 IG--YAATEDELFLI--------YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           I   +      L L+        YE  +    K  L  P+ R    +   M  Q+     
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKG--RKRPL--PEKR----VKSYMY-QLL---- 110

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           + L+++H +      HRDIK  NIL+      K++DFG  +        +   T+ + T 
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTR 162

Query: 519 GYLAPE-YLTDGLATAKSDVYAFGVVLFEIIS 549
            Y APE  LTDG    K D++A G V FEI+S
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 22/220 (10%)

Query: 347 LFATEGFSDSSLLGHGTYGSVYYGNIRN----QEVAIKRMTATK-TKEFMAEMKILCKVH 401
           LF  EG      +G GTYG VY    ++    ++ A+K++  T  +     E+ +L ++ 
Sbjct: 1   LFEYEGCK----VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELK 56

Query: 402 HSNLVEL--IGYAATEDELFLIYEYAQKG---SLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           H N++ L  +  +  + +++L+++YA+      +K H     N+    L   M   +   
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFGLAKLVGKTSDGEATVT 512
              G+ Y+H +     +HRD+K +NIL+        R KI+D G A+L        A + 
Sbjct: 117 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 513 KVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            VV TF Y APE L       K+ D++A G +  E+++ +
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)

Query: 358 LLGHGTYGSVYYGNIR-NQEV-AIKRMTATKTKE------FMAEMKILC-KVHHSNLVEL 408
           +LG G++G V    ++   EV AIK +      +       M E +IL     H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                T+D LF + EY   G L   +   +   +    +      A +    L ++H H 
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY-----AAEVTLALMFLHRHG 116

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               ++RD+K  NILLD+    K++DFG+ K   +      T T   GT  Y+APE L +
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQE 170

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
                  D +A GV+++E+++G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 35/306 (11%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSN 404
           + F   S LG G  G V+  + +   + + R      +      + + E+++L + +   
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V   G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYL 119

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
            E  K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE
Sbjct: 120 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPE 172

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAI-----IRTEGMVSKNQERRSLASFMLAALR 579
            L     + +SD+++ G+ L E+  G+  I        E M     E     S      R
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232

Query: 580 N--------SPDS---MSMSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPD 627
                     PDS   M++  L DYI        P      +      +C+ ++P  R D
Sbjct: 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD 292

Query: 628 MKQVVI 633
           +KQ+++
Sbjct: 293 LKQLMV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVH-HSNLVEL 408
           +LG G++G V    ++   +  A+K +           +  M E +IL     H  L +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLEYIHEH 467
                T D LF + E+   G L  H+   +   +       R +  A +    L ++H+ 
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEITSALMFLHDK 115

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                ++RD+K  N+LLD     K++DFG+ K      +G+ T T   GT  Y+APE L 
Sbjct: 116 G---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTST-FCGTPDYIAPEILQ 169

Query: 528 DGLATAKSDVYAFGVVLFEIISG 550
           + L     D +A GV+L+E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 20/199 (10%)

Query: 359 LGHGTYGSVYYGNIRNQEV-AIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G VY    +   V A  ++  TK++E    +M E+ IL    H N+V+L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
            E+ L+++ E+   G++ + + + + R  T     +  +  L+A   L Y+HE      +
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEA---LNYLHE---NKII 125

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL-----TD 528
           HRD+K+ NIL       K++DFG++    K +         +GT  ++APE +      D
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 529 GLATAKSDVYAFGVVLFEI 547
                K+DV++ G+ L E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
            F +  L+ H +   VY   + ++   IKR   + +  F  E  I+   +   +V+L  Y
Sbjct: 55  AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLF-Y 110

Query: 412 AATEDE-LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           A  +D  L+++ EY   G L + + +     + +  +   V +ALDA   + +IH     
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH----- 165

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT--- 527
               RD+K  N+LLD +   K++DFG    + K  +G       VGT  Y++PE L    
Sbjct: 166 ----RDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 528 -DGLATAKSDVYAFGVVLFEIISG 550
            DG    + D ++ GV L+E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G YG V         ++VAIK++       T  K  + E+KIL    H N++ +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV---QIALDAARGLEYIHEHT 468
                  F    Y     ++S LH   +  Q      +R    Q+     RGL+YIH   
Sbjct: 73  LRPPGADF-KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL----RGLKYIHS-- 125

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-TKVVGTFGYLAPE-YL 526
             + +HRD+K SN+L++     +I DFG+A+ +  +        T+ V T  Y APE  L
Sbjct: 126 -ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKE 552
           +    T   D+++ G +  E++  ++
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 27/209 (12%)

Query: 358 LLGHGTYGSVYY---------GNIRNQEVAIKRMT----ATKTKEFMAEMKILCKVHHSN 404
           +LG G YG V+          G +   +V +K+ T    A  T+    E ++L  +  S 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKV-LKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 405 LVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
            +  + YA  T+ +L LI +Y   G L +HL   +   +  +  I   +I L     LE+
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ-IYSGEIVL----ALEH 120

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H   K   ++RDIK  NILLDS     ++DFGL+K      D         GT  Y+AP
Sbjct: 121 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--HEDEVERAYSFCGTIEYMAP 175

Query: 524 EYLT--DGLATAKSDVYAFGVVLFEIISG 550
           + +   DG      D ++ GV+++E+++G
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 23/202 (11%)

Query: 359 LGHGTYGSVYYGNIRNQEV----AIKRM------TATKTKEFMAEMKILCKVHHSNLVEL 408
           +G G++G V    +R ++     A+K +      + ++    +AE  +L +V+   +V L
Sbjct: 1   IGKGSFGKVM--QVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                + ++L+L+  +   G L  HL   + R   S +     ++       LE +H+  
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLC----ALENLHKF- 112

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             + ++RD+K  NILLD      + DFGL KL  K  D         GT  YLAPE L  
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLG 167

Query: 529 GLATAKSDVYAFGVVLFEIISG 550
              T   D +  GV+L+E+++G
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 20/201 (9%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYA 412
           LG GTY +V+ G  +  E  VA+K +     +      + E+ +L  + H+N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL-DAARGLEYIHEHTKTH 471
            TE  L L++EY     LK +L +  N     L  +  V+I +    RGL Y H   K  
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCH---KRK 123

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRD+K  N+L++     K++DFGLA+     S    T +  V T  Y  P+ L     
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 532 TAKS-DVYAFGVVLFEIISGK 551
            +   D++  G +L+E+ +G+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 24/201 (11%)

Query: 359 LGHGTYGSVYYGNIRNQE---VAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGY 411
           LG G +G VY    +N+E   +A  ++  TK++E    +M E++IL   +H  +V+L+G 
Sbjct: 20  LGDGAFGKVY--KAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              + +L+++ E+   G++ + + +  +RG T        QI +   + LE +       
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLT------EPQIQVICRQMLEALQYLHSMK 130

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY-----L 526
            +HRD+K+ N+LL      K++DFG++    KT     +    +GT  ++APE      +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS---FIGTPYWMAPEVVMCETM 187

Query: 527 TDGLATAKSDVYAFGVVLFEI 547
            D     K+D+++ G+ L E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 47/217 (21%)

Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVEL--- 408
           +G G YG V     +  N++VAIK++          K  + E+K+L  + H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 409 ---IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---------- 455
                  A  D ++++YE          L D      T L  I+R    L          
Sbjct: 73  MPPPHREAFND-VYIVYE----------LMD------TDLHQIIRSSQTLSDDHCQYFLY 115

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA+    TS+    +T+ V
Sbjct: 116 QLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYV 169

Query: 516 GTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGK 551
            T  Y APE L +    T   DV++ G +  E++  K
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 29/233 (12%)

Query: 340 VFTYDEILFATEGFSDSS-------LLGHGTYGSVY-YGNIRNQEVAIKRM---TATKTK 388
           +F Y+  +   E   D +        +G GTYG VY   N ++  +A  ++    +   +
Sbjct: 4   LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63

Query: 389 EFMAEMKILCKV-HHSNLVELIGYAATED-----ELFLIYEYAQKGSLKSHLHDPQNRGQ 442
           E  AE  IL  + +H N+V+  G     D     +L+L+ E    GS+   +      GQ
Sbjct: 64  EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             L   M   I   A  GL+++H +     +HRD+K +NILL +    K+ DFG++  + 
Sbjct: 124 -RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179

Query: 503 KTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISG 550
            T     T    VGT  ++APE +      D    A+ DV++ G+   E+  G
Sbjct: 180 STRLRRNT---SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMTAT----KTKEFMAEMKI-LCKVHHSNLVELIGY 411
           LG G YG V           +A+KR+ AT    + K  + ++ I +  V     V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 412 AATEDELFLIYEYAQKGSLKS---HLHDPQNR-GQTSLSWIMRVQIALDAARGLEYIHEH 467
              E ++++  E     SL      ++D      +  L      +IA+   + LEY+H  
Sbjct: 69  LFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLHS- 121

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFG----LAKLVGKTSDGEATVTKVVGTFGYLAP 523
            K   +HRD+K SN+L++   + K+ DFG    L   V KT D         G   Y+AP
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID--------AGCKPYMAP 172

Query: 524 EYLTDGLATA----KSDVYAFGVVLFEIISGK 551
           E +   L       KSDV++ G+ + E+ +G+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 5e-12
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 32/217 (14%)

Query: 356 SSLLGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVEL 408
           S +LG G  G+V         +  A+K      M+        AE+  L      ++V+ 
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 409 IGYAATEDE--------LFLIYEYAQKGSLKSHLHDPQNRGQTSLSW------IMRVQIA 454
               A +D         + L+ +YA  G L+  +   ++R +T+ ++      ++ +Q+ 
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI---KSRAKTNRTFREHEAGLLFIQVL 153

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
           L         H H+K H +HRDIKS+NILL S    K+ DFG +K+   T   +   T  
Sbjct: 154 LAVH------HVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-F 205

Query: 515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            GT  Y+APE       + K+D+++ GV+L+E+++ K
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242

Length = 496

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 22/152 (14%)

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSH----LHDPQNRGQTSLSWIMRVQIALDAAR 459
           N+V L  Y  +ED +FL+ ++A+ G L SH    L+ P+   +    W   + +ALDA  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDA-- 100

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
               +H       V RD+  +NILLD     +++ F     V  + DGEA V  +     
Sbjct: 101 ----LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA-VENM----- 147

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           Y APE       T   D ++ G +LFE+++GK
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 359 LGHGTYGSVYYGNIRN----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIG 410
           +G+G +G V    I        V +K + A     +  EF+ +      + H N+++ +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQ-NRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
                    L++EY + G LKS+L   Q +R  + L  + R  +A + A G+ ++H+H  
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMHKH-- 118

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-- 527
            +++H D+   N  L S    K+ D+G+     K  D   T         +LAPE +   
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK-EDYIETEDDKCVPLRWLAPELVGEF 176

Query: 528 -DGLATAK----SDVYAFGVVLFEI 547
             GL TA+    S+V+A GV L+E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 50/207 (24%), Positives = 98/207 (47%), Gaps = 25/207 (12%)

Query: 359 LGHGTYGSVYYGNIRN----QEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIG 410
           +G+G +G V  G + +     +V +K +  + +     +F+ E +    + HSNL++ +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYIHEHT 468
                    L+ E+   G LK +L     R    ++       ++A + A GL ++H++ 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             +++H D+   N LL +    KI D+GL+    K  D   T  ++     ++APE L D
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK-EDYYVTPDQLWVPLRWIAPE-LVD 175

Query: 529 GL--------ATAKSDVYAFGVVLFEI 547
            +         T +S+V++ GV ++E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.3 bits (161), Expect = 8e-12
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 359 LGHGTYGSVYYGN--IRNQEVAIK--RMTATKTKEFMA--EMKILCKVHHSNLVELIGYA 412
           LG G+Y +VY G   +  + VA+K  R+   +   F A  E  +L  + H+N+V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
            T++ L L++EY      +     P      ++   +         RGL YIH+    + 
Sbjct: 73  HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL-----FQLLRGLSYIHQR---YI 124

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRD+K  N+L+      K++DFGLA+     S    T +  V T  Y  P+ L      
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 533 AKS-DVYAFGVVLFEIISGKEA 553
           +   D++  G +  E+I G  A
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)

Query: 353 FSDSSLLGHGTYGSV-----------YYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F+   +LG G++G V           Y   I  ++V I+      T   M E ++L    
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT---MVEKRVLALQD 58

Query: 402 HSN-LVELIGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIA 454
               L +L     T D L+ + EY   G L  H+       +PQ            V  A
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ-----------AVFYA 107

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
            + + GL ++H       ++RD+K  N++LDS    KI+DFG+ K      DG  T T  
Sbjct: 108 AEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRT-F 161

Query: 515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            GT  Y+APE +         D +A+GV+L+E+++G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 30/210 (14%)

Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKEFM--------AEMKILCKVHHSNLVEL 408
           +G G YG+VY     +    VA+K +     ++ +        A +K L    H N+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 409 IGYAAT-----EDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGL 461
           +   AT     E ++ L++E+  +  L+++L    P      ++  +MR  +     RGL
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL-----RGL 121

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H +     VHRD+K  NIL+ S  + K++DFGLA++       +  +T VV T  Y 
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC----QMALTPVVVTLWYR 174

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L         D+++ G +  E+   K
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 30/241 (12%)

Query: 358 LLGHGTYGSVY------YGNIRNQEVAIKRMTATKTKEFMA--EMKILCKVHHSN--LVE 407
           ++G G +G VY       G +   +   K+    K  E +A  E  +L  V   +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 408 LIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            + YA  T D+L  I +    G L  HL       +  + +      A +   GLE++H 
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGLEHMHN 115

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 V+RD+K +NILLD     +ISD GLA    K     +     VGT GY+APE L
Sbjct: 116 R---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVL 167

Query: 527 TDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
             G A  + +D ++ G +LF+++ G     +      K +++  +    L      PDS 
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ-----HKTKDKHEIDRMTLTVNVELPDSF 222

Query: 586 S 586
           S
Sbjct: 223 S 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 31/212 (14%)

Query: 359 LGHGTYGSV----YYGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVH---HSNLV 406
           LG G YG V           + VAIK++T   +K+ +A     E+K+L   H   H N+ 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLL--RHFRGHKNIT 65

Query: 407 EL----IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL-SWIMRVQIALDAARGL 461
            L    I +    +EL+L YE   +  L   +   Q        S+I   QI      GL
Sbjct: 66  CLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIY--QIL----CGL 118

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS-DGEATVTKVVGTFGY 520
           +YIH     + +HRD+K  N+L+++    KI DFGLA+   +   +    +T+ V T  Y
Sbjct: 119 KYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 521 LAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            APE +    +  K+ DV++ G +L E++  K
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 353 FSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTA------TKTKEFMAEMKILC---KVH 401
           F+   +LG G++G V     +  +   AIK +           +  M E ++L    K  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              L +L     T D L+ + EY   G L  H+   Q  G+        V  A + A GL
Sbjct: 62  F--LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGK--FKEPHAVFYAAEIAIGL 114

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            ++H       ++RD+K  N++LD+    KI+DFG+ K   +   G  T     GT  Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYI 168

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D +AFGV+L+E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 30/221 (13%)

Query: 344 DEILFATEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKR----MTATKTKEFMAEMKIL 397
           DEI    E       LG G YGSVY          +A+K     +  +K  + + E+ IL
Sbjct: 1   DEIEVLDE-------LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL 53

Query: 398 CKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA 457
            K     +V+  G    E  +++  EY   GSL   L+      +     ++R +I    
Sbjct: 54  HKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLR-RITYAV 111

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV-VG 516
            +GL+++ E  + + +HRD+K +N+L++   + K+ DFG+      + +  A++ K  +G
Sbjct: 112 VKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGV------SGNLVASLAKTNIG 163

Query: 517 TFGYLAPEYLTDGLATA------KSDVYAFGVVLFEIISGK 551
              Y+APE +  G          +SDV++ G+ + E+  G+
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 66/293 (22%), Positives = 126/293 (43%), Gaps = 60/293 (20%)

Query: 359 LGHGTYGSVY---------YGNIRNQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLV 406
           LG GT+  ++         YG +   EV +K +  +    ++ F     ++ ++ H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G     DE  ++ EY + GSL ++L   +N+   ++SW  ++++A   A  L ++ +
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLK--KNKNLINISW--KLEVAKQLAWALHFLED 118

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK-----VVGTFGYL 521
                  H ++ + N+LL      K  +    KL    SD   ++T      ++    ++
Sbjct: 119 KG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL----SDPGISITVLPKEILLERIPWV 171

Query: 522 APEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
            PE + +   L+ A +D ++FG  L+EI SG +                      L+AL 
Sbjct: 172 PPECIENPQNLSLA-ADKWSFGTTLWEIFSGGDK--------------------PLSALD 210

Query: 580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
                 S   L+ Y D + +   P     ++A L  QC+D +P  RP  + ++
Sbjct: 211 ------SQKKLQFYEDRHQL---PAPKWTELANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 43/227 (18%)

Query: 348 FATEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTAT----KTKEFMAEMKILCKVH 401
           F  E   D   +G G +G+V           +A+KR+ +T    + K  + ++ ++ +  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR-- 58

Query: 402 HSNLVELIG-YAATEDE-------------LFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
            S+   ++  Y A   E             L   Y+Y     LKS +  P+         
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-EVLKSVI--PEE-------- 107

Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
            +  +IA+   + L Y+ E  +   +HRD+K SNILLD     K+ DFG++   G+  D 
Sbjct: 108 -ILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDS 161

Query: 508 EATVTKVVGTFGYLAPEYLTDGLATA---KSDVYAFGVVLFEIISGK 551
            A  T+  G   Y+APE +          +SDV++ G+ L+E+ +GK
Sbjct: 162 IAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 358 LLGHGTYGSVY------YGNIRNQEVAIKRMTATKTKEFMAE----MKILCKVHHSNLVE 407
           ++G G +G VY       G +   +   K+    K  E +A     M  L        + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 408 LIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            + YA  T D+L  I +    G L  HL       +  + +      A +   GLE++H 
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHMHN 115

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 V+RD+K +NILLD     +ISD GLA    K     +     VGT GY+APE L
Sbjct: 116 R---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVL 167

Query: 527 TDGLATAKS-DVYAFGVVLFEIISG 550
             G+A   S D ++ G +LF+++ G
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 73/226 (32%), Positives = 107/226 (47%), Gaps = 27/226 (11%)

Query: 353 FSDSSLLGHGTYGSVYY------GNIRNQEVAIKRMT-ATKTKEFMAEMKILCKVHHSNL 405
           F   SL+G G +G V        G+I   +V  K +  A +T  F  E + +  + +S  
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 406 VELIGYAATE-DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +  + YA  + D L+L+ EY   G L S L    NR +      M  Q  L  A  +  I
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLL----NRYEDQFDEDM-AQFYL--AELVLAI 115

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFG-LAKLVGKTSDGEATVTKVVGTFGYLAP 523
           H   +  YVHRDIK  N+L+D     K++DFG  A+L   T++        VGT  Y+AP
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLPVGTPDYIAP 172

Query: 524 EYLT----DGLAT--AKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           E LT    DG  T   + D ++ GV+ +E+I G+      EG  +K
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF--HEGTSAK 216

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 53/227 (23%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK----------- 399
           E F    ++G G +G          EV + R  ++K    +  MK+L K           
Sbjct: 43  EDFDVIKVIGRGAFG----------EVQLVRHKSSKQ---VYAMKLLSKFEMIKRSDSAF 89

Query: 400 -------VHHSN---LVELIGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
                  + H+N   +V+L  + A +D+  L+++ EY   G L + + +     + +  +
Sbjct: 90  FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFY 147

Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
              V +ALDA      IH      ++HRD+K  N+LLD +   K++DFG    +    +G
Sbjct: 148 TAEVVLALDA------IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA--NG 196

Query: 508 EATVTKVVGTFGYLAPEYLT----DGLATAKSDVYAFGVVLFEIISG 550
                  VGT  Y++PE L     DG    + D ++ GV L+E++ G
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 12/100 (12%)

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 242 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)

Query: 343 YDEILFATEG-FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           YD +     G F +  L+ H +   VY   + ++   IKR   + +  F  E  I+   +
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFAN 101

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +V+L      +  L+++ EY   G L + + +     + +  +   V +ALDA   +
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
             IH         RD+K  N+LLD     K++DFG    + +T  G       VGT  Y+
Sbjct: 162 GLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDET--GMVRCDTAVGTPDYI 210

Query: 522 APEYLT----DGLATAKSDVYAFGVVLFEIISG 550
           +PE L     DG    + D ++ GV LFE++ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 72/305 (23%), Positives = 112/305 (36%), Gaps = 75/305 (24%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH----------------- 401
           LG GT+ ++Y G +R Q            +E    +K+L   H                 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVG---PGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS 59

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H +LV+L G     DE  ++ EY + G L   LH  + +   SL W + V   L  A  L
Sbjct: 60  HKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLH--REKNNVSLHWKLDVAKQL--ASAL 114

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSA--------FRAKISDFGLAKLVGKTSDGEATVTK 513
            Y+ +      VH ++   NIL+           F  K+SD G+   V    +    +  
Sbjct: 115 HYLEDKK---LVHGNVCGKNILVARYGLNEGYVPF-IKLSDPGIPITVLSREERVERIP- 169

Query: 514 VVGTFGYLAPEYLTDGLA--TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA 571
                 ++APE + +G A  T  +D ++FG  L EI S  E  + T  + S  +ER    
Sbjct: 170 ------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST--LSSSEKERFYQD 221

Query: 572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
              L     +                            +A L  QC   DP  RP  + +
Sbjct: 222 QHRLPMPDCAE---------------------------LANLINQCWTYDPTKRPSFRAI 254

Query: 632 VISLS 636
           +  L+
Sbjct: 255 LRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 11/147 (7%)

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           LV L     T   LFL+ EY   G L  H+   +   +    +      A +    L ++
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY-----AAEICIALNFL 112

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           HE      ++RD+K  N+LLD+    K++D+G+ K      D   T +   GT  Y+APE
Sbjct: 113 HERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPE 166

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            L         D +A GV++FE+++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 30/221 (13%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTA------TKTKEFMAEMKILCKVHH 402
           E F    L+ +G YG+VY    +   Q  A+K++         + ++   E  IL    +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             +V +     T+  L ++ EY + G   + L   +N G   +  + R+  A +    LE
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALPVD-MARMYFA-ETVLALE 115

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK--LVGKTSD-GEATVTK------ 513
           Y+H +     VHRD+K  N+L+ S    K++DFGL+K  L+  T++  E  + K      
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 514 ---VVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISG 550
              V GT  Y+APE  L  G      D +A G++L+E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELIG 410
            +G G YGSV    + R  E VAIK+++     E  A     E+ +L  + H N++ L+ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GLE 462
              +        ++        +L  P    QT L  IM   ++ D  +        GL+
Sbjct: 82  VFTSAVSGDEFQDF--------YLVMPYM--QTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           YIH       +HRD+K  N+ ++     KI DFGLA+        +A +T  V T  Y A
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRA 182

Query: 523 PEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           PE + + +   ++ D+++ G ++ E+++GK
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 11/150 (7%)

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  LV L     TE  LF + E+   G L  H+   Q +     +     +I+L     L
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISL----AL 109

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            ++HE      ++RD+K  N+LLD+    K++D+G+ K       G+ T T   GT  Y+
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTST-FCGTPNYI 163

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L         D +A GV++FE+++G+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 26/206 (12%)

Query: 358 LLGHGTYGSV-----------YYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSN-L 405
           +LG G++G V           Y   I  ++V I+      T   M E ++L        L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT---MVEKRVLALSGKPPFL 63

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            +L     T D L+ + EY   G L   +   Q  G+        V  A + A GL ++H
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYQI---QQVGR--FKEPHAVFYAAEIAIGLFFLH 118

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                  ++RD+K  N++LDS    KI+DFG+ K      DG  T T   GT  Y+APE 
Sbjct: 119 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKT-FCGTPDYIAPEI 172

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           +         D +AFGV+L+E+++G+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 25/207 (12%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKR-----MTATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
                   +      N  VA+K+      +    K    E+    ++ H N++  +    
Sbjct: 10  FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 414 TEDELFLIYEYAQKGS----LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
            + EL+++      GS    LK+H   P+   + ++++I++     D    L+YIH    
Sbjct: 70  VDSELYVVSPLMAYGSCEDLLKTHF--PEGLPELAIAFILK-----DVLNALDYIH---S 119

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV----TKVVGTFGYLAPEY 525
             ++HR +K+S+ILL    +  +S    +  + K    +  V       V    +L+PE 
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179

Query: 526 LTDGLA--TAKSDVYAFGVVLFEIISG 550
           L   L     KSD+Y+ G+   E+ +G
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 8e-10
 Identities = 58/236 (24%), Positives = 88/236 (37%), Gaps = 58/236 (24%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVELI 409
           LLG G  G V+   ++   +  A+K +         K K  + E +IL  + H  L  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLH-DPQNRGQTSLSWIMRVQIALDAAR--------G 460
               TE  L L+ +Y   G L   L   P               ++ + AR         
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKC------------LSEEVARFYAAEVLLA 115

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT--------SDGEATV- 511
           LEY+H       V+RD+K  NILL  +    +SDF L+K               G     
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 512 -------TKV----------VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                  T            VGT  Y+APE ++     +  D +  G++L+E++ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 44/131 (33%), Positives = 71/131 (54%), Gaps = 13/131 (9%)

Query: 422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN 481
           Y+ +    +K+ L D  + G T+L  +         ARG+E++      + VHRD+ + N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLL---SFTYQVARGMEFL---ASKNCVHRDLAARN 267

Query: 482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF---GYLAPEYLTDGLATAKSDVY 538
           +LL      KI DFGLA+ +   S+    V+K   TF    ++APE + D L T  SDV+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSN---YVSKG-STFLPVKWMAPESIFDNLYTTLSDVW 323

Query: 539 AFGVVLFEIIS 549
           ++G++L+EI S
Sbjct: 324 SYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 51/198 (25%)

Query: 392 AEMKILCKVHHSNLVELIGYAATEDE--LFLIYEYAQKGSLKSHL--HDPQNRGQTSLSW 447
           AE  IL +  +  +V+L  Y + +DE  L+LI EY   G + + L   D     +T    
Sbjct: 50  AERDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---- 103

Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK---- 503
             R  IA +    ++ IH+     Y+HRDIK  N+LLD+    K+SDFGL   + K    
Sbjct: 104 --RFYIA-ETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 504 ----------------------TSDGEATVTK---------VVGTFGYLAPEYLTDGLAT 532
                                 +S  +A   K          VGT  Y+APE        
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217

Query: 533 AKSDVYAFGVVLFEIISG 550
            + D ++ GV+++E++ G
Sbjct: 218 KECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 34/217 (15%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQ--EVAIKRMTATKTKEFMA-----EMKILCKVHHS 403
           + + D   +G G YG+V     R    +VAIK++      E  A     E+++L  + H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 404 NLVELIGYAATEDEL------FLIYEY--AQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           N++ L+     +  L      +L+  +     G L  H    ++R Q  +  +++     
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK----- 129

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
               GL+YIH       +HRD+K  N+ ++     KI DFGLA    + +D E  +T  V
Sbjct: 130 ----GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQTDSE--MTGYV 176

Query: 516 GTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGK 551
            T  Y APE + + +  T   D+++ G ++ E+++GK
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 55/220 (25%), Positives = 108/220 (49%), Gaps = 31/220 (14%)

Query: 353 FSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLV- 406
           + D   LG G+ G V+    +  ++ VA+K++  T     K  + E+KI+ ++ H N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 407 --ELIGYAATEDE-----------LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
             E++G + ++             ++++ EY     +++ L +   +G  S         
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEY-----METDLANVLEQGPLSEEHARLFMY 121

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVT 512
            L   RGL+YIH     + +HRD+K +N+ +++     KI DFGLA++V      +  ++
Sbjct: 122 QL--LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 513 KVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           + + T  Y +P  L       K+ D++A G +  E+++GK
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 39/226 (17%)

Query: 359 LGHGTYGSVYY-GNIRNQE------VAIKRMTATKTKEFMAEMKILCKVHHSNLVELIG- 410
           +G+G +G V+   + R QE      ++ + +   +  + + E+ ++ ++ H N+V  I  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 411 -YAATEDELFLIYEYAQKGSLKSHLHDPQNR-GQTSLSWIMRVQIALDAARGLEYIHE-- 466
                  +L+++ E+   G L  ++       G+     I  V I       L Y H   
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI--VDITRQLLHALAYCHNLK 138

Query: 467 --HTKTHYVHRDIKSSNILLDSAFR-----------------AKISDFGLAKLVGKTSDG 507
                   +HRD+K  NI L +  R                 AKI DFGL+K +G     
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---- 194

Query: 508 EATVTKVVGTFGYLAPEYLTDGLAT--AKSDVYAFGVVLFEIISGK 551
           E+     VGT  Y +PE L     +   KSD++A G +++E+ SGK
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 23/170 (13%)

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS--WIMRVQIALDAARGLEYIHEHTKTHY 472
           E+ L+L+ +Y   G L + L   ++R    ++  ++  + +A+D+      +H   +  Y
Sbjct: 73  ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS------VH---QLGY 123

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DG 529
           VHRDIK  N+LLD     +++DFG    +   +DG       VGT  Y++PE L    DG
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181

Query: 530 LAT--AKSDVYAFGVVLFEIISGK-----EAIIRTEGMVSKNQERRSLAS 572
                 + D ++ GV ++E++ G+     E+++ T G +  ++E      
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP 231

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 33/214 (15%)

Query: 357 SLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELI 409
            ++G G+YG V         ++VAIK++       +     + E+K+L  + H ++VE+ 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 410 GYAATED-----ELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIAL-DAARGL 461
                       ++++++E      ++S LH     N   T        Q  L    R L
Sbjct: 66  HIMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHH----QFFLYQLLRAL 116

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV--TKVVGTFG 519
           +YIH     +  HRD+K  NIL ++  + KI DFGLA++    +D    +  T  V T  
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA--FNDTPTAIFWTDYVATRW 171

Query: 520 YLAPEYLTDGLA--TAKSDVYAFGVVLFEIISGK 551
           Y APE      +  T   D+++ G +  E+++GK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 36/210 (17%)

Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G YGSV   Y     Q+VA+K+++         +    E+++L  + H N++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD- 81

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA---------ARGLE 462
                    ++  A      + ++   N     L+ I++ Q   D           RGL+
Sbjct: 82  ---------VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           YIH       +HRD+K SN+ ++     +I DFGLA    + +D E  +T  V T  Y A
Sbjct: 133 YIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA----RQADDE--MTGYVATRWYRA 183

Query: 523 PEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           PE + + +   ++ D+++ G ++ E++ GK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 21/166 (12%)

Query: 392 AEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL------HDPQNRGQTSL 445
           +E+  L    H  +V+      ++D+L LI EY   G L   +      H P    +  L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 446 SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS 505
              +  QI L     L+ +H       +HRD+KS+NI L      K+ DFG +K   + S
Sbjct: 174 ---LFYQIVL----ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK---QYS 220

Query: 506 DGEA--TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           D  +    +   GT  YLAPE       + K+D+++ GV+L+E+++
Sbjct: 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 44/189 (23%)

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEATVTK 513
           A+G+ ++      + +HRD+ + NILL      KI DFGLA+ +   S+    G A +  
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278

Query: 514 VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF 573
                 ++APE + + + T +SDV+++G++L+EI S                        
Sbjct: 279 ---PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS------------------------ 311

Query: 574 MLAALRNSP-DSMSMSSLKDY--IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
               L +SP   M + S K Y  I      L P     +M  + K C D DP+ RP  KQ
Sbjct: 312 ----LGSSPYPGMPVDS-KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQ 366

Query: 631 VVISLSQIL 639
           +V  + Q L
Sbjct: 367 IVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 47/238 (19%)

Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE----VAIKRMTATKTKEFMAEMKILCK 399
           ++I  +T+ F   SLLG GT+G V     R ++    V I R     T++   E++ + K
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181

Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR--------- 450
           V  ++        A    L  I  Y Q  +    +  P+  G   L WIM+         
Sbjct: 182 VRQAD-------PADRFPLMKIQRYFQNETGHMCIVMPK-YGPCLLDWIMKHGPFSHRHL 233

Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA----------------FRAKISD 494
            QI       L+Y H  T+ H +H D+K  NIL++++                 R +I D
Sbjct: 234 AQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
                 +G   D   + T +V T  Y +PE +  GL    S D+++ G +++E+ +GK
Sbjct: 292 ------LGGCCDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 32/103 (31%), Positives = 60/103 (58%), Gaps = 12/103 (11%)

Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD---- 506
           ++ +   A+G++++      + +HRD+ + N+LL     AKI DFGLA+ +   S+    
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           G A +        ++APE + D + T +SDV+++G++L+EI S
Sbjct: 272 GNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 9/92 (9%)

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL-VGKTSDGEATVTKVVGT 517
            GL Y+H       +HRD+K+ NI ++   +  I D G A+  V   +        + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF-----LGLAGT 219

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
               APE L      +K+D+++ G+VLFE+++
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 42/221 (19%)

Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 123

Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA+    T D    +
Sbjct: 124 FLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDD---EM 174

Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 50/223 (22%)

Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNL 405
           + +   +G G  G V   Y  +  Q VAIK+++      T  K    E+ ++  V+H N+
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77

Query: 406 VELIGYAATED-------ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           + L+    T         +++L+ E          L D  N  Q        +Q+ LD  
Sbjct: 78  IGLLN-VFTPQKSLEEFQDVYLVME----------LMD-ANLCQV-------IQMDLDHE 118

Query: 459 R----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
           R          G++++H       +HRD+K SNI++ S    KI DFGLA    +T+   
Sbjct: 119 RMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTS 171

Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
             +T  V T  Y APE +         D+++ G ++ E+I G 
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 11/93 (11%)

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
            L  +H+H   + +H DIK  N+L D A  R  + D+GL K++G  S  +       GT 
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------GTL 170

Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            Y +PE +         D +A GV+ +E+++GK
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 36/210 (17%)

Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  + ++ VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   L   L D  N  Q        +Q+ LD  R          G+
Sbjct: 85  FTPQKSL----EEFQDVYLVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 132

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 133 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYR 185

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G ++ E++  K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 16/195 (8%)

Query: 357 SLLGHGTYGSVY----YGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           S L  G+ G V+    +G+ + ++V +K +T  KT     E+ IL  + H  ++ LI +A
Sbjct: 98  SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG--REIDILKTISHRAIINLI-HA 154

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
                   +     K  L +++      G   L   + +Q  L  A  L Y+H       
Sbjct: 155 YRWKSTVCMVMPKYKCDLFTYV---DRSGPLPLEQAITIQRRLLEA--LAYLHGRG---I 206

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRD+K+ NI LD    A + DFG A  +              GT    +PE L      
Sbjct: 207 IHRDVKTENIFLDEPENAVLGDFGAACKLDA-HPDTPQCYGWSGTLETNSPELLALDPYC 265

Query: 533 AKSDVYAFGVVLFEI 547
           AK+D+++ G+VLFE+
Sbjct: 266 AKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 33/105 (31%), Positives = 61/105 (58%), Gaps = 4/105 (3%)

Query: 445 LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT 504
           LS++  V  +   A G+E++      + VHRD+ + N+L+      KI DFGLA+ + + 
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           S+  +  +  +    ++APE + + L T  SDV++FG++L+EI +
Sbjct: 293 SNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 36/210 (17%)

Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D  N  Q        +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 139

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYR 192

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G ++ E+I G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 30/210 (14%)

Query: 357 SLLGHGTYGSVYYGNI--RNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGY 411
           +++G+G++G VY       +++VAIK++      K +E +    I+  ++H N++ L  Y
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127

Query: 412 AATE------DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
             TE        +FL  + E+  +   K   H    R   +L   +    +    R L Y
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH--YARNNHALPLFLVKLYSYQLCRALAY 185

Query: 464 IHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGYL 521
           IH        HRD+K  N+L+D +    K+ DFG AK L+     G+ +V+ +   F Y 
Sbjct: 186 IHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA----GQRSVSYICSRF-YR 237

Query: 522 APEYLTDGLA-TAKSDVYAFGVVLFEIISG 550
           APE +      T   D+++ G ++ E+I G
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 26/152 (17%)

Query: 362 GTYGSVYYGNIRNQE--VAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAA 413
           G +G VY G  +N     A+K +            +  AE   L       +V L     
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 414 TEDELFLIYEYAQKGSLKSHLH-----DPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           + + ++L+ EY   G +KS LH     D +     ++ +I  V +ALD      Y+H H 
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEE----MAVKYISEVALALD------YLHRHG 124

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKL 500
               +HRD+K  N+L+ +    K++DFGL+K+
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|197609 smart00257, LysM, Lysin motif

 Score = 47.4 bits (114), Expect = 2e-07
 Identities = 15/39 (38%), Positives = 28/39 (71%)

Query: 154 YVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGD 192
           Y +K GDT+ S+A R+G+S+  + ++N I++P+N+  G 
Sbjct: 2   YTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQ 40

Length = 44

>gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan

 Score = 47.5 bits (114), Expect = 2e-07
 Identities = 14/44 (31%), Positives = 28/44 (63%)

Query: 153 SYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYI 196
           +Y +K GDT+ S+A ++GV+++ +   N ++NP+ +  G    I
Sbjct: 2   TYTVKPGDTLWSIAKKYGVTVEELAAANPLINPDCIYPGQKLKI 45

LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 36/214 (16%)

Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE-----FMAEMKILCKVHHSN-LVELIG 410
           +G GTYG VY    +N  + VA+K+      +E      + E+ +L  +  S  +V L+ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 411 YAATEDE-----LFLIYEYAQ---KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
               E++     L+L++EY     K  + S+   P              Q+      G+ 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK----GVA 124

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKL----VGKTSDGEATVTKVVGT 517
           + H+H     +HRD+K  N+L+D      KI+D GL +     V          T  + T
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-------YTHEIVT 174

Query: 518 FGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
             Y APE L      +   D+++ G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 52/220 (23%)

Query: 372 IRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLK 431
           +R  +V + R  A   K   AE  IL +  +  +V+L      +D L+ + +Y   G + 
Sbjct: 34  LRKADV-LMRNQAAHVK---AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 432 SHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK 491
           S L     R       + R  IA +    +E +H   K  ++HRDIK  NIL+D     K
Sbjct: 90  SLL----IRLGIFEEDLARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIK 141

Query: 492 ISDFGLA--------------------------KLVGKTSDGEATVTKV----------- 514
           ++DFGL                           +   +         +            
Sbjct: 142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLA 201

Query: 515 ---VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
              VGT  Y+APE L     T   D ++ GV+L+E++ G+
Sbjct: 202 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 52/242 (21%)

Query: 351 EGFSDSSLLGHGTYGSVYY------GNIRNQEVAIKR--MTATKTKEFMAEMKILCKVHH 402
           + F    ++G G +G V        G+I   ++  K   +   +     AE  IL +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARG 460
           + +V++      +  L+LI E+   G + + L   D  +   T   +I    +A+DA   
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVLAIDA--- 116

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK----------------- 503
              IH+     ++HRDIK  N+LLD+    K+SDFGL   + K                 
Sbjct: 117 ---IHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 504 ------TSDGEATVTK---------VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
                  S  +A   K          VGT  Y+APE           D ++ GV+++E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 549 SG 550
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 58/242 (23%), Positives = 96/242 (39%), Gaps = 52/242 (21%)

Query: 351 EGFSDSSLLGHGTYGSVYY------GNIRNQEVAIK--RMTATKTKEFMAEMKILCKVHH 402
           E F    ++G G +G V        G++   ++  K   +   +     AE  IL +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARG 460
             +V++      +  L+LI E+   G + + L   D     +T   +I    +A+D+   
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF-YIAETVLAIDS--- 116

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK----------------- 503
              IH+     ++HRDIK  N+LLDS    K+SDFGL   + K                 
Sbjct: 117 ---IHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 504 ------TSDGEATVTK---------VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
                  S  +A   K          VGT  Y+APE           D ++ GV+++E++
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 549 SG 550
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 28/164 (17%)

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLK----SHLHDPQNRGQTSLSWIMRVQIALD 456
           +H N+V        ++EL+++  +   GS K    +H  D  +  + ++++I+       
Sbjct: 57  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMS--ELAIAYIL-----QG 109

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
             + L+YIH      YVHR +K+S+IL+    +  +S  GL   +   + G+    +VV 
Sbjct: 110 VLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQR--LRVVH 162

Query: 517 TF--------GYLAPEYLTDGLA--TAKSDVYAFGVVLFEIISG 550
            F         +L+PE L   L    AKSD+Y+ G+   E+ +G
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 377 VAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLK 431
           VA+K+++      T  K    E+ +L  V+H N++ L+     +  L    E  Q   L 
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL----EEFQDVYLV 104

Query: 432 SHLHDPQNRGQTSLSWIMRVQIALDAAR----------GLEYIHEHTKTHYVHRDIKSSN 481
             L D  N  Q        + + LD  R          G++++H       +HRD+K SN
Sbjct: 105 MELMD-ANLCQV-------IHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN 153

Query: 482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFG 541
           I++ S    KI DFGLA    +T+     +T  V T  Y APE +         D+++ G
Sbjct: 154 IVVKSDCTLKILDFGLA----RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209

Query: 542 VVLFEIISG 550
            ++ E++ G
Sbjct: 210 CIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 28/170 (16%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEFM----------AEMKILC 398
           E F    ++G G +G V       Q+    ++ A KT  K  M          AE  +L 
Sbjct: 1   EDFHTVKVIGKGAFGEVRL----VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLA 56

Query: 399 KVHHSNLVELIGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +     +V L  Y + +D   L+LI E+   G L + L     +  T    + R  +A +
Sbjct: 57  ESDSPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML----IKYDTFSEDVTRFYMA-E 109

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
               +E +H   K  ++HRDIK  NIL+D     K+SDFGL+    K  D
Sbjct: 110 CVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 19/172 (11%)

Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E  IL  ++H ++++L G   T ++   +     K  L  +L   +N     +  I R  
Sbjct: 133 EAHILRAINHPSIIQLKG-TFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIER-- 189

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA----KLVGKTSDGE 508
                 R ++Y+HE+     +HRDIK+ NI ++      + DFG A     +      G 
Sbjct: 190 ---SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
           A      GT    APE L         D+++ G+VLFE+ +  +++   +G+
Sbjct: 244 A------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289

Length = 391

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 52/204 (25%)

Query: 392 AEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV 451
           AE  IL +  +  +V+L      +D L+ + +Y   G + S L     R +     + R 
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMEVFPEVLARF 105

Query: 452 QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL---------AKLVG 502
            IA +    +E +H   K  ++HRDIK  NIL+D     K++DFGL         +K   
Sbjct: 106 YIA-ELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161

Query: 503 KTSD--------------------GEATVT---------------KVVGTFGYLAPEYLT 527
           K S                     G+   T                +VGT  Y+APE L 
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
               T   D ++ GV+LFE++ G+
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 20/124 (16%)

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           I   A RGL Y+H++    Y+HR+IK+S+IL+       +S  GL+ L     +G+    
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQK--A 158

Query: 513 KVVGTF--------GYLAPEYLTDGLA--TAKSDVYAFGVVLFEIISGK---EAIIRTEG 559
           KVV  F         +L+PE L   L     KSD+Y+ G+   E+ +G+   + ++RT+ 
Sbjct: 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM 218

Query: 560 MVSK 563
           ++ K
Sbjct: 219 LLQK 222

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|144899 pfam01476, LysM, LysM domain

 Score = 42.0 bits (100), Expect = 1e-05
 Identities = 16/44 (36%), Positives = 30/44 (68%), Gaps = 1/44 (2%)

Query: 154 YVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIP 197
           Y +K GDT+ S+A R+G++++ + ++NG+ +P N+  G    IP
Sbjct: 1   YTVKKGDTLSSIAKRYGITVEELAELNGLSSP-NLYVGQKLKIP 43

The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 62/255 (24%), Positives = 95/255 (37%), Gaps = 68/255 (26%)

Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT---KEFM---------AEMKILCKV 400
           F     LG G +G V       ++V  K + A KT   K+ +         AE  IL + 
Sbjct: 3   FVKIKTLGIGAFGEVCLA----RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA 58

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            +  +V L      +D L+ + +Y   G + S L     R       + R  IA +    
Sbjct: 59  DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMGIFPEDLARFYIA-ELTCA 113

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE------------ 508
           +E +H   K  ++HRDIK  NIL+D     K++DFGL      T D +            
Sbjct: 114 VESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170

Query: 509 --------------------------------ATVTKVVGTFGYLAPEYLTDGLATAKSD 536
                                                +VGT  Y+APE L     T   D
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230

Query: 537 VYAFGVVLFEIISGK 551
            ++ GV+L+E++ G+
Sbjct: 231 WWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 54/251 (21%), Positives = 98/251 (39%), Gaps = 51/251 (20%)

Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
           F     ++ +V H ++V L G    + E  ++ E+ + G L   +H    R    L+   
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH----RKSDVLTTPW 106

Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL-------DSAFRAKISDFGLAKLVG 502
           + ++A   A  L Y+ +      VH ++ + NILL       +     K+SD G+   V 
Sbjct: 107 KFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV- 162

Query: 503 KTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMV 561
                  +  + V    ++APE + D    +  +D ++FG  L+EI    E  ++ + + 
Sbjct: 163 ------LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA 216

Query: 562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED 621
            K  ER      ML                    P+  +L         A L   C++ D
Sbjct: 217 EK--ERFYEGQCMLVT------------------PSCKEL---------ADLMTHCMNYD 247

Query: 622 PILRPDMKQVV 632
           P  RP  + ++
Sbjct: 248 PNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 19/245 (7%)

Query: 366 SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILC--KVHHSNLVELIGYAATEDELFLI-- 421
           S   G  + + +  KR+ A        E +IL   +++H N++++     +E   ++I  
Sbjct: 184 STNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ 243

Query: 422 -YEYAQKGSLKSHLHDPQNRGQTS-LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKS 479
            Y++     L S ++D     +   L    R  I       +EYIH+      +HRDIK 
Sbjct: 244 KYDF----DLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKL 295

Query: 480 SNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYA 539
            NI L+   +  + DFG A    K    EA     VGT    +PE L        +D+++
Sbjct: 296 ENIFLNCDGKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353

Query: 540 FGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMM 599
            G++L +++S     I   G     Q  + + S  +      PD      L DYID   +
Sbjct: 354 CGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD-EEFPD--PPCKLFDYIDSAEI 410

Query: 600 DLYPH 604
           D   H
Sbjct: 411 DHAGH 415

Length = 501

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 20/171 (11%)

Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
           F     ++ +V H +L  + G      E  ++ E+ + G L   L   + +G+  ++W +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKI 120

Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA 509
            V  A   A  L Y+ +      VH ++ + NILL    R  +++ G +  + K SD   
Sbjct: 121 TV--AQQLASALSYLEDKN---LVHGNVCAKNILLA---RLGLAE-GTSPFI-KLSDPGV 170

Query: 510 TVTKV-----VGTFGYLAPEYLTDG--LATAKSDVYAFGVVLFEIISGKEA 553
           + T +     V    ++APE +  G  L+TA +D ++FG  L EI    E 
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGNSLSTA-ADKWSFGTTLLEICFDGEV 220

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 12/123 (9%)

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           ++YIH       +HRDIK+ N+L++      + DFG A    + S        + GT   
Sbjct: 273 IDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWSTPFHYGIAGTVDT 328

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ--ERRSLASFMLAAL 578
            APE L     T   D+++ G+V+F      EA + T  + S ++  ERR   + +L  +
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIF------EAAVHTASLFSASRGDERRPYDAQILRII 382

Query: 579 RNS 581
           R +
Sbjct: 383 RQA 385

Length = 461

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 15/116 (12%)

Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P+   YD    F  +G     +LG G +G V     YG  R+Q   +VA+K +  T    
Sbjct: 23  PMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS 82

Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR 440
           + +  M+E+KI+  +  H N+V L+G       +++I EY   G L ++LH  +NR
Sbjct: 83  EKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLH--KNR 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|226376 COG3858, COG3858, Predicted glycosyl hydrolase [General function prediction only]

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 10/89 (11%)

Query: 154 YVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNS----------VPG 203
           Y +  GDT+ S+A   GV+ DS   +N ++ P  +  G   YIP              P 
Sbjct: 52  YDVGPGDTLTSIARTVGVTQDSAAIMNFVICPGYLQYGLNLYIPSARKTDGETTAYYAPR 111

Query: 204 EPYPVENDTLPPPAPAPSVEDFAGNQVDR 232
            P            P  +  D        
Sbjct: 112 PPTETGELVRRHAGPYLTYVDLFSYHAQE 140

Length = 423

>gnl|CDD|223810 COG0739, NlpD, Membrane proteins related to metalloendopeptidases [Cell envelope biogenesis, outer membrane]

 Score = 41.3 bits (96), Expect = 0.001
 Identities = 16/56 (28%), Positives = 30/56 (53%)

Query: 154 YVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVE 209
           YV+K GDT+ ++A+R G+S   + ++N ++    +  G L  +P  +  G     E
Sbjct: 4   YVVKKGDTLSAIAARLGISAKDLARLNNLLKKRLLRIGQLLRVPRAAADGAFVLDE 59

Length = 277

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 21/46 (45%), Positives = 26/46 (56%), Gaps = 3/46 (6%)

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA 498
           I  D    LEYIHEH  +H    DIK  NI++D   R  I D+G+A
Sbjct: 131 IMKDMLTTLEYIHEHGISH---GDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 12/89 (13%)

Query: 359 LGHGTYGSVY----YGNIRNQ---EVAIKRMTAT----KTKEFMAEMKILCKVH-HSNLV 406
           LG G +G V     +G   +Q   +VA+K + +T    + +  M+E+KI+  +  H N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLH 435
            L+G       +++I EY + G L  +LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	639
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK06347	592	autolysin; Reviewed	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK06347	592	autolysin; Reviewed	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
PRK10345	210	hypothetical protein; Provisional	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
smart00090	237	RIO RIO-like kinase.	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
PRK13914	481	invasion associated secreted endopeptidase; Provis	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.32
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
KOG1243	690	consensus Protein kinase [General function predict	99.13
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.12
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.12
KOG3087	229	consensus Serine/threonine protein kinase [General	99.08
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.05
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.01
PRK14125	103	cell division suppressor protein YneA; Provisional	98.99
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.95
COG4248	637	Uncharacterized protein with protein kinase and he	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.93
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.86
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.84
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.83
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.77
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.59
PRK09902	216	hypothetical protein; Provisional	98.58
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.57
smart00257	44	LysM Lysin motif.	98.52
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.49
PRK13914	481	invasion associated secreted endopeptidase; Provis	98.45
PRK11198	147	LysM domain/BON superfamily protein; Provisional	98.39
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.39
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.37
PRK14125	103	cell division suppressor protein YneA; Provisional	98.33
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.33
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.25
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	98.23
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.17
PF01636	239	APH: Phosphotransferase enzyme family This family	98.16
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
PRK10593	297	hypothetical protein; Provisional	97.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.94
PLN02876	822	acyl-CoA dehydrogenase	97.88
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.85
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.8
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.74
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.67
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.6
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.56
PRK10871	319	nlpD lipoprotein NlpD; Provisional	97.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.54
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.5
PRK05231	319	homoserine kinase; Provisional	97.45
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.41
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.31
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	97.26
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	97.2
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.19
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	97.14
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.12
PF04225	85	OapA: Opacity-associated protein A LysM-like domai	97.1

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-54  Score=445.98  Aligned_cols=284  Identities=45%  Similarity=0.780  Sum_probs=246.1

Q ss_pred             CCcccchHHHHhhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeee
Q 036507          337 KPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYA  412 (639)
Q Consensus       337 ~~~~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~  412 (639)
                      ....|+++|+..||++|...++||+|+||.||+|...+ ..||||++....   ..+|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34679999999999999999999999999999999987 789999987644   56799999999999999999999999


Q ss_pred             ecCC-eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          413 ATED-ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       413 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                      .+.+ +.+||||||++|+|.++|+.....   +++|..|++||.++|+||+|||+...++|+|||||++|||||+++++|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9988 599999999999999999874322   789999999999999999999998888999999999999999999999


Q ss_pred             EeccCCceecCCCCCCcceeeee-ccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKV-VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      |+|||+|+.....   ....... .||.+|++||+...+..+.|+|||||||+|+||+||+.+.+....     .....+
T Consensus       218 lsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-----~~~~~l  289 (361)
T KOG1187|consen  218 LSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-----RGELSL  289 (361)
T ss_pred             ccCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-----cccccH
Confidence            9999999654321   1111222 899999999999999999999999999999999999988864431     223347


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCccc-CCCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMM-DLYPH-DCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .+|....+.+.       .+.+++||.+. ..++. ++...+..++.+|++.+|++||+|.||+++|+.+
T Consensus       290 ~~w~~~~~~~~-------~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  290 VEWAKPLLEEG-------KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHHHHHHHHCc-------chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            77776666542       77899999987 55664 6888899999999999999999999999999764

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=395.66  Aligned_cols=249  Identities=35%  Similarity=0.590  Sum_probs=209.7

Q ss_pred             CCCceeecCceEEEEEEEcCce-EEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCC-eEEEEEeeccC
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQE-VAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATED-ELFLIYEYAQK  427 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~-vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  427 (639)
                      ..+.||+|+||+||+|.+.+.. ||||.+....     .++|.+|+.+|++++|||||+++|+|.+.. .+.+|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3456999999999999999988 9999997654     568999999999999999999999999877 79999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~  506 (639)
                      |+|.++++..   ....+++..+++++.|||+||+|||++++  ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       125 GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  125 GSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            9999999863   35679999999999999999999999863  99999999999999997 99999999998764321 


Q ss_pred             CcceeeeeccccccCCccccc--cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          507 GEATVTKVVGTFGYLAPEYLT--DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                        ...+...||..|||||++.  ...|+.|+||||||++||||+||+.||.....           ...+.....     
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----------~~~~~~v~~-----  260 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----------VQVASAVVV-----  260 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHh-----
Confidence              3344478999999999999  66999999999999999999999999965432           111111111     


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                 ...+...+..++..+..++.+||+.||++||++.+++..|+.+
T Consensus       261 -----------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  261 -----------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             -----------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                       1112223455778899999999999999999999999999865

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=367.54  Aligned_cols=244  Identities=27%  Similarity=0.449  Sum_probs=207.4

Q ss_pred             CCCceeecCceEEEEEEEc--CceEEEEEec----cccHHHHHHHHHHHHhcCCCCeeEEEeeeecCC-eEEEEEeeccC
Q 036507          355 DSSLLGHGTYGSVYYGNIR--NQEVAIKRMT----ATKTKEFMAEMKILCKVHHSNLVELIGYAATED-ELFLIYEYAQK  427 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  427 (639)
                      ..+.||+|..|+||++.++  ++-+|+|.+.    ....+++.+|++++++.+||+||.++|.|.+.+ ...++||||.+
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            3678999999999999987  5789999984    334678899999999999999999999999988 59999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|+.++...     ..+++....+|+.++++||.|||+.  .+|+||||||+|||++..|.+||||||.+..+..+   
T Consensus       163 GSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  163 GSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            9999999642     4588999999999999999999963  24999999999999999999999999999876432   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                        .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+-..      ......+.+.+..+..+++..   
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~------~~~~~~~~~Ll~~Iv~~ppP~---  301 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP------NPPYLDIFELLCAIVDEPPPR---  301 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc------CCCCCCHHHHHHHHhcCCCCC---
Confidence              445689999999999999999999999999999999999999998543      122334555566666554432   


Q ss_pred             cccccccCCcccCCCCh-hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPH-DCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                    .|. .+..+++.++..||++||.+||+++|+++
T Consensus       302 --------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 --------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             --------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                          233 36778999999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=384.22  Aligned_cols=247  Identities=30%  Similarity=0.524  Sum_probs=210.4

Q ss_pred             CCceeecCceEEEEEEEcCc-eEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhh
Q 036507          356 SSLLGHGTYGSVYYGNIRNQ-EVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS  432 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~-~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  432 (639)
                      .+.||+|.||.||.|.+++. .||+|.++..  ..++|.+|+++|++|+|+|||+++|+|..++.++||||||+.|+|.+
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~  290 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD  290 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence            56899999999999999986 8999999764  45789999999999999999999999999889999999999999999


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceee
Q 036507          433 HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT  512 (639)
Q Consensus       433 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  512 (639)
                      +|+.   .+...+.....+.++.|||+||+||++++   +|||||..+||||+++..+||+|||+|+...++  ......
T Consensus       291 yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~~~~  362 (468)
T KOG0197|consen  291 YLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYTASE  362 (468)
T ss_pred             Hhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC--ceeecC
Confidence            9986   34567899999999999999999999987   999999999999999999999999999954321  111222


Q ss_pred             eeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccc
Q 036507          513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLK  591 (639)
Q Consensus       513 ~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  591 (639)
                      ...-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.....                            .++.
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------------------~ev~  414 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------------------EEVL  414 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------------------HHHH
Confidence            2344668999999999999999999999999999999 7777643221                            2222


Q ss_pred             cccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          592 DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       592 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +.++...+-..|..|+.++.+++..||+.+|++|||++.+...|+++
T Consensus       415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            33334444556888999999999999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.1e-45  Score=391.84  Aligned_cols=257  Identities=29%  Similarity=0.506  Sum_probs=211.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      +.+....+.||+|+||+||+|+..+       ..||||.++...    ..+|.+|+++|..++|||||+|+|+|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3444456789999999999998643       469999998653    46899999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNR-----G----QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR  489 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~-----~----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~  489 (639)
                      +||+|||..|||.+||......     .    ..+|+..+.+.||.|||.||+||-++.   ++||||.++|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            9999999999999999753211     1    234899999999999999999999886   999999999999999999


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhh
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  568 (639)
                      |||+|||+++.+.... .......-.-+.+|||||.+..++|+.+||||||||+|||+++ |+.|+.....     +   
T Consensus       642 VKIsDfGLsRdiYssD-YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-----~---  712 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSD-YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-----Q---  712 (774)
T ss_pred             EEecccccchhhhhhh-hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----H---
Confidence            9999999999764332 2222223345679999999999999999999999999999998 8889865443     1   


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                          .+.+.++.               ..+ ...|++|+.++.+|+..||+..|++||+++||-..|+..
T Consensus       713 ----EVIe~i~~---------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  713 ----EVIECIRA---------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ----HHHHHHHc---------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                11122221               112 346899999999999999999999999999999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-44  Score=371.83  Aligned_cols=243  Identities=22%  Similarity=0.428  Sum_probs=207.6

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .+|...++||+|+|+.+|.++.  .++.||+|++...      ..+...+|++|.++|+|||||+++++|.+.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999987  4789999998652      3567889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      |+|++++|.++++.     .+++++...+.+..||+.||.|||+++   |+|||||..|+|++++.++||+|||+|..+.
T Consensus        98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence            99999999999863     467999999999999999999999988   9999999999999999999999999999885


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   ......+|||-|.|||++.....+..+||||+||+||-||.|++||+...           +-+....+...  
T Consensus       170 ~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------vkety~~Ik~~--  233 (592)
T KOG0575|consen  170 YDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------VKETYNKIKLN--  233 (592)
T ss_pred             Ccc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------HHHHHHHHHhc--
Confidence            432   33455799999999999999999999999999999999999999995422           22222222111  


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                               ++.       .|.....+..+||.++|+.||.+|||+++|+.
T Consensus       234 ---------~Y~-------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ---------EYS-------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---------Ccc-------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     111       24455667899999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=352.50  Aligned_cols=195  Identities=29%  Similarity=0.527  Sum_probs=174.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .+|...+.||+|+||+||+|+++  +..||||.+...     ..+.+..|+.||+.++|||||.+++++..++.+|||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            56777788999999999999986  578999988655     34557899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC------CCEEEeccCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA------FRAKISDFGL  497 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfgl  497 (639)
                      ||.+|+|.++++.     ...++......++.|+|.||++||+++   |+||||||.||||+..      ..+||+|||+
T Consensus        90 yC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             eCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            9999999999975     236899999999999999999999987   9999999999999765      4689999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccc
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRT  557 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~  557 (639)
                      |+.+..    .......+|++.|||||++..+.|+.|+|+||+|++||+|++|+.||...
T Consensus       162 AR~L~~----~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  162 ARFLQP----GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhCCc----hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            998753    33445679999999999999999999999999999999999999999643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-44  Score=356.96  Aligned_cols=247  Identities=28%  Similarity=0.395  Sum_probs=197.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----------TKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      +.|...+.||+|+||.|-+|..+  ++.||||+++...          .....+|++||++|+|||||++.+++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45667889999999999999764  6899999986532          12356999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC---CCEEEecc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA---FRAKISDF  495 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  495 (639)
                      |||||||+||+|.+++-..     +.+....-..++.|++.|+.|||++|   |+||||||+|||++.+   ..+||+||
T Consensus       252 YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             EEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999653     33555566788999999999999998   9999999999999766   78999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCC---CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA---TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      |+|+..+.    ...+...+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||....+..       ++.+
T Consensus       324 GlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------sl~e  392 (475)
T KOG0615|consen  324 GLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------SLKE  392 (475)
T ss_pred             chhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------cHHH
Confidence            99998642    335567899999999999976543   348899999999999999999996544311       1111


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         ++......          +    .........++..++|.+||..||++|||++|+|+
T Consensus       393 ---QI~~G~y~----------f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 ---QILKGRYA----------F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ---HHhcCccc----------c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence               11111100          0    01122355678999999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-45  Score=342.81  Aligned_cols=254  Identities=22%  Similarity=0.373  Sum_probs=201.3

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecc-----ccHHHHHHHHHHHHhcCCCCeeEEEee-eecCCe-EEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIGY-AATEDE-LFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~-~~~~~~-~~lv  421 (639)
                      .+|.+.++||+|+||+||++..  .+..+|.|.++-     ....++..|+.+|++|+|||||+++++ +.++.+ +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3466678999999999999976  468899998753     345678999999999999999999983 444444 8999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT-KTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      |||+..|+|.+.++..+ ...+.+++...++++.|++.||.++|++- +..|+||||||.||+++.+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999998754 34567899999999999999999999843 12499999999999999999999999999998


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      +...   ..-....+|||.||+||.+.+.+|+.||||||+||++|||..-++||.+.+           +.+.-..+-..
T Consensus       178 l~s~---~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----------~~~L~~KI~qg  243 (375)
T KOG0591|consen  178 LSSK---TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----------LLSLCKKIEQG  243 (375)
T ss_pred             hcch---hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----------HHHHHHHHHcC
Confidence            7532   223345799999999999999999999999999999999999999996432           22221111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                      .                +...........+..|+..|+..||+.||+.-.+++.+
T Consensus       244 d----------------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  244 D----------------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             C----------------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            0                00001144566799999999999999999965555443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=347.53  Aligned_cols=238  Identities=27%  Similarity=0.396  Sum_probs=198.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|+..++||+|+||+||.++..  ++.+|+|.+++.      +.+...+|..||.+++||+||+++-.|.+.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467889999999999999998765  578999998754      345678999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +||+.||.|..+|..     +..+++.....++..|+.||.|||+++   |+||||||+|||||++|+++|+|||+++..
T Consensus       104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999964     445888888889999999999999988   999999999999999999999999999854


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      -..   ......++||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+.           ..+...+....
T Consensus       176 ~~~---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----------~~~~~~I~~~k  241 (357)
T KOG0598|consen  176 LKD---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----------KKMYDKILKGK  241 (357)
T ss_pred             ccC---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----------HHHHHHHhcCc
Confidence            322   2233458999999999999999999999999999999999999999964332           12222222221


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP  626 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  626 (639)
                                       ....+.-...+.++++.+.+..||++|-
T Consensus       242 -----------------~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -----------------LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                             0112233455789999999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=375.05  Aligned_cols=253  Identities=28%  Similarity=0.500  Sum_probs=214.4

Q ss_pred             CCCCCCceeecCceEEEEEEEc--C---ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--N---QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ...+.++||.|.||.||+|+++  +   ..||||.++..    ...+|+.|+.||.+++||||++|.|+........+|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4456789999999999999885  2   47999999864    3567999999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      |||+||+|+.||+..    ...+.+.+...+..+||.||+||-+.+   +|||||..+|||++.+..+|++|||+++.+.
T Consensus       710 EyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             hhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence            999999999999853    345899999999999999999999887   9999999999999999999999999999886


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ++.+...+...-.=+.+|.|||.+...+++.+|||||||+||||.++ |..|+-....                      
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------------  840 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------------  840 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------------
Confidence            55433222222233578999999999999999999999999999997 8888743322                      


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                            .+..+-++..++...|.+|+..|.+|+..||++|-.+||.+.+++..|++++
T Consensus       841 ------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  841 ------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             ------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                  2222233444455568999999999999999999999999999999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-43  Score=336.95  Aligned_cols=271  Identities=24%  Similarity=0.341  Sum_probs=202.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccH-----HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT-----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      +.|+...++|+|+||.||+.+.+  ++.||||++.+.+.     +-.+||+++|++++|+|+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999875  68899999976432     447899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++..-|.++-+.     ...++.....+++.|++.|+.|+|+++   ++||||||+|||++.++.+||||||+|+.+..
T Consensus        82 ~~dhTvL~eLe~~-----p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHTVLHELERY-----PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9987666555432     233778888999999999999999988   99999999999999999999999999998753


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH---HHHHHHHhh
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL---ASFMLAALR  579 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l---~~~~~~~~~  579 (639)
                         .....+.++.|.+|+|||.+.+ .+|.+.+||||+||++.||++|.+.|-+..+..+-..-...+   .-.-..++.
T Consensus       154 ---pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  154 ---PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             ---CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence               2335567899999999999987 789999999999999999999998875443311110000111   111111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+. ...-.+.+.-++.-.+..-.....-+.+++..|++.||.+|++.+|++.
T Consensus       231 ~N~~-F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPF-FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCc-eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1110 0011111222221111111233446899999999999999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=350.48  Aligned_cols=262  Identities=29%  Similarity=0.508  Sum_probs=213.9

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      ++++...+.+...+.||+|.||+||+|.+.| .||||.++.+     ..+.|.+|+..+++-+|.||+-+.|+|..... 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            4555556666778899999999999999987 6899998754     45789999999999999999999999987766 


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      .+|..+|+|-+|..++|..+    ..++....+.||.|||+||.|||.++   |||||||..||++.+++.|||+|||++
T Consensus       463 AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence            99999999999999999643    56899999999999999999999988   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ..-... ..........|...|||||++..   .+|++.+||||||+|+|||++|..||.....                
T Consensus       536 tvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~----------------  598 (678)
T KOG0193|consen  536 TVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR----------------  598 (678)
T ss_pred             eeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh----------------
Confidence            754332 22333344567889999999863   5789999999999999999999999952111                


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                             +...+..-+.++.|.+.. ...+|++++.+|+..||..++++||.+.+++.+|++++
T Consensus       599 -------dqIifmVGrG~l~pd~s~-~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  599 -------DQIIFMVGRGYLMPDLSK-IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             -------hheEEEecccccCccchh-hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence                   111111112223333322 24678889999999999999999999999999988764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=350.57  Aligned_cols=262  Identities=28%  Similarity=0.395  Sum_probs=208.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHH--HHHHHHHHHhcC-CCCeeEEEeeeecCC-eEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKE--FMAEMKILCKVH-HSNLVELIGYAATED-ELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~--~~~E~~il~~l~-h~niv~l~~~~~~~~-~~~lv~  422 (639)
                      ++|...++||.|.||+||+|+..  ++.||||+++..  .-++  -+||+..|++|+ ||||+++.+++.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            56777889999999999999764  678999998754  2233  468999999999 999999999998887 999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||| ..+|.+++++.    ...++...++.|+.||++||+|+|.+|   ++|||+||+|||+..+..+||+|||+|+.+.
T Consensus        90 E~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   90 EFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             Hhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999 56999999863    567999999999999999999999998   9999999999999999999999999999764


Q ss_pred             CCCCCcceeeeeccccccCCcccc-ccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYL-TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .    ....|.++.|++|+|||++ ..+.|+.+.|+|++|||++|+.+-++.|-+.++        .+..-.+..+++.+
T Consensus       162 S----kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--------~Dqi~KIc~VLGtP  229 (538)
T KOG0661|consen  162 S----KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--------IDQIYKICEVLGTP  229 (538)
T ss_pred             c----CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--------HHHHHHHHHHhCCC
Confidence            3    3456778999999999986 568899999999999999999999877743322        22233344555544


Q ss_pred             CCccccc--ccccccCC--------cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMS--SLKDYIDP--------NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~--~~~~~~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+.....  .+...+.=        .+....+. +..++.+++.+|+++||++|||++|.++
T Consensus       230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             ccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            3222111  11111111        11122233 7788999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-42  Score=346.96  Aligned_cols=264  Identities=25%  Similarity=0.357  Sum_probs=206.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATE--DELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  421 (639)
                      +.|+..++||+|.||.||+|+..  ++.||+|++.-+.     ..-..+||.||++|+||||++|.+...+.  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45666789999999999999874  6789999986543     34467999999999999999999988776  689999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +|||+. +|.-++..    ..-.++..++..++.|++.||+|||+++   |+|||||.+|||||.+|.+||+|||+|+++
T Consensus       197 FeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             Eecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            999966 88888864    3446899999999999999999999988   999999999999999999999999999987


Q ss_pred             CCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....  ....+..+-|.+|+|||++.+ ..|+..+|+||.||||.||+.|++.+.+..+        ......+....+.
T Consensus       269 ~~~~--~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--------veQl~kIfklcGS  338 (560)
T KOG0600|consen  269 TPSG--SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--------VEQLHKIFKLCGS  338 (560)
T ss_pred             cCCC--CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--------HHHHHHHHHHhCC
Confidence            5433  334677889999999999987 5689999999999999999999998866543        2222333344443


Q ss_pred             CCCcccc-cccc--cccCC------cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSM-SSLK--DYIDP------NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~-~~~~--~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.+..+. ..+.  ..+.+      .+.+. -...+....+|+..+|..||.+|.|+.++|.
T Consensus       339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  339 PTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            3322221 0111  01111      11111 2234566889999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=340.51  Aligned_cols=251  Identities=29%  Similarity=0.482  Sum_probs=200.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCC--eEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATED--ELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv~e  423 (639)
                      .++...+.||+|+||+||++...  +...|||......   .+.+.+|+.+|++++|||||+++|.....+  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34555789999999999999886  4889999887654   556889999999999999999999855555  5899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~  502 (639)
                      |+++|+|.+++...   +. .++......+..||++||+|||+++   |+||||||+|||++. ++.+||+|||+++...
T Consensus        97 y~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             ccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            99999999999752   22 5999999999999999999999988   999999999999999 7999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCC-CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .............||+.|||||++..+. ..+++|||||||++.||+||+.||...          .....++..+....
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----------~~~~~~~~~ig~~~  239 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----------FEEAEALLLIGRED  239 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----------cchHHHHHHHhccC
Confidence            3122222334578999999999998643 346999999999999999999999542          11111122221111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                                  ..|    ..|...+.+..+++.+|+..||++|||++++|..
T Consensus       240 ------------~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  240 ------------SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ------------CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                        111    2455566789999999999999999999999864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=333.02  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=207.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .+.|+..+.||.|..++||+|...  ++.||||+++-+.    .+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            467888889999999999999874  6899999997553    3568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      ||.+|++.+++...-   ...+++..+..|.+++++||.|||+++   .||||||+.||||+++|.+||+|||.+..+-.
T Consensus       105 fMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999997632   233888999999999999999999998   99999999999999999999999999877655


Q ss_pred             CCCCccee-eeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          504 TSDGEATV-TKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       504 ~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      .+...... ...+||++|||||++..  ..|+.|+||||||++..||.+|..||.....+           .....-+.+
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----------kvLl~tLqn  247 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----------KVLLLTLQN  247 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----------HHHHHHhcC
Confidence            44333332 56799999999999644  57899999999999999999999999654431           112222333


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .|.......    ++..    ........+++++..||+.||.+|||++++++
T Consensus       248 ~pp~~~t~~----~~~d----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DPPTLLTSG----LDKD----EDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCccccc----CChH----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            332211111    1111    11223447999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-41  Score=317.23  Aligned_cols=263  Identities=26%  Similarity=0.353  Sum_probs=207.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccH-----HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT-----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|...++||+|.||.||+|++.  ++.||||+++-.+.     ....||++.|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            45777889999999999999874  68999999875443     357899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      ||+ .+|...+++    ....++-.....++.++++|++|||++.   |+||||||+|+|++++|.+||+|||+++.+..
T Consensus        82 fm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             ecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            995 599999975    3456888999999999999999999988   99999999999999999999999999998854


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .   ....+..+-|.+|+|||.+.| ..|+..+|+||.|||+.||+-|.+.|.+..+        .+....+-..++.+ 
T Consensus       154 p---~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--------idQL~~If~~LGTP-  221 (318)
T KOG0659|consen  154 P---NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--------IDQLSKIFRALGTP-  221 (318)
T ss_pred             C---CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--------HHHHHHHHHHcCCC-
Confidence            3   233444588999999999877 5789999999999999999999876644332        11222233333322 


Q ss_pred             CcccccccccccC---------CcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          583 DSMSMSSLKDYID---------PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       583 ~~~~~~~~~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      ....+.++..+.|         +.+.. .-..+.....+|+..++..||.+|.++.|++++
T Consensus       222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  222 TPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CcccCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2222222222211         11221 223456667999999999999999999999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.3e-41  Score=351.24  Aligned_cols=261  Identities=28%  Similarity=0.465  Sum_probs=202.1

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATE  415 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  415 (639)
                      +..++|+..++||+|+||.||+|.+.       +..||||.++..    ..+.+.+|++++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            44577888999999999999999742       257999998643    235688999999999 899999999988764


Q ss_pred             -CeEEEEEeeccCCChhhhccCCCCC------------------------------------------------------
Q 036507          416 -DELFLIYEYAQKGSLKSHLHDPQNR------------------------------------------------------  440 (639)
Q Consensus       416 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  440 (639)
                       +.++++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4589999999999999998642210                                                      


Q ss_pred             ---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccc
Q 036507          441 ---GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT  517 (639)
Q Consensus       441 ---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  517 (639)
                         ....+++.....++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.+..... ........++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~  239 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP  239 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence               0235888899999999999999999987   99999999999999999999999999986532211 1111223456


Q ss_pred             cccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCC
Q 036507          518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDP  596 (639)
Q Consensus       518 ~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~  596 (639)
                      ..|+|||++.+..++.++|||||||++|||++ |..||......       ..+    ...+....            .+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~----~~~~~~~~------------~~  296 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEF----CQRLKDGT------------RM  296 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHH----HHHHhcCC------------CC
Confidence            78999999999999999999999999999997 99998542210       011    11111110            00


Q ss_pred             cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          597 NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       597 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .    .+..++..+.+++.+||+.||++|||+.|+++.|++++
T Consensus       297 ~----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         297 R----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             C----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0    12234557899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-41  Score=341.95  Aligned_cols=249  Identities=29%  Similarity=0.425  Sum_probs=206.7

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDEL  418 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  418 (639)
                      ...++|...+.||+|+|++|++|+..  ++.||||++.+.      +.+-..+|-++|.+| .||.|++|+--|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34567888999999999999999875  689999988643      344577899999999 799999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      |+|+||+++|+|.++|+..     ..+++...+.++.+|+.||+|||++|   ||||||||+|||||+++++||+|||.|
T Consensus       150 YFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence            9999999999999999753     45888899999999999999999988   999999999999999999999999999


Q ss_pred             eecCCCCCC------c--ce--eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          499 KLVGKTSDG------E--AT--VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       499 ~~~~~~~~~------~--~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      +.+......      .  ..  ...++||..|.+||++.....++.+|+|+|||+||+|+.|++||...++        -
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------y  293 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--------Y  293 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------H
Confidence            988543221      1  11  1448999999999999999999999999999999999999999965443        1


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+.+...                 +-    .+++..++.+.+|+.+.|..||.+|++.+++-+
T Consensus       294 liFqkI~~l-----------------~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  294 LIFQKIQAL-----------------DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHHHHh-----------------cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            121211111                 11    134455567999999999999999999988754

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=336.88  Aligned_cols=263  Identities=26%  Similarity=0.432  Sum_probs=209.6

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++.+...+.++||+|.||.|.+....+ ..||||.++.+.    ..+|.+|+++|.+|+||||++++|+|..++.+++++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            455666778899999999999999987 899999998653    468999999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      |||++|+|.+++......   .+.-....+|+.||+.||+||.+.+   ++||||.++|+|++.++++||+|||+++-+.
T Consensus       615 EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999754321   1344556679999999999999977   9999999999999999999999999998663


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc--CCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS--GKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      . .+........+-+.+|||+|.+.-++++.++|||+||++|||+++  ...||....+        ....+..-..+..
T Consensus       689 s-g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--------e~vven~~~~~~~  759 (807)
T KOG1094|consen  689 S-GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--------EQVVENAGEFFRD  759 (807)
T ss_pred             c-CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--------HHHHHhhhhhcCC
Confidence            3 333333444567789999999999999999999999999999876  5567643322        1111111111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .+             ...-...|.-|+.++.+++.+||..|.++||+++++...|.+.
T Consensus       760 ~~-------------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  760 QG-------------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CC-------------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            10             1111124667888999999999999999999999999888763

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=346.26  Aligned_cols=239  Identities=29%  Similarity=0.522  Sum_probs=204.2

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhhhc
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL  434 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  434 (639)
                      +.+-||+|+.|-||+|++.++.||||+++.-+.    .+|+-|++|+|+||+.|.|+|...-.+++|||||..|.|.+.|
T Consensus       128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elkE----TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL  203 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELKE----TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL  203 (904)
T ss_pred             hhhhhccCcccceeeeeccCceehhHHHhhhhh----hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence            466799999999999999999999998765433    4688899999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeee
Q 036507          435 HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV  514 (639)
Q Consensus       435 ~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  514 (639)
                      +.     ..++.-.....|..+||.||.|||.+.   |||||||.-||||+.+..+||+|||-++...+    ..+...+
T Consensus       204 ka-----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~----~STkMSF  271 (904)
T KOG4721|consen  204 KA-----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD----KSTKMSF  271 (904)
T ss_pred             hc-----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh----hhhhhhh
Confidence            64     445777888899999999999999998   99999999999999999999999999986532    2344568


Q ss_pred             ccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccccccc
Q 036507          515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYI  594 (639)
Q Consensus       515 ~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  594 (639)
                      .||..|||||++...+.++|+|||||||||||||||..||..-+.               .+++.            .+=
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---------------sAIIw------------GVG  324 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---------------SAIIW------------GVG  324 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch---------------heeEE------------ecc
Confidence            999999999999999999999999999999999999999854322               01111            111


Q ss_pred             CCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          595 DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       595 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      .-.|....|..|+.-+.-|++.||+..|..|||+++++..|+
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            122334467888999999999999999999999999999886

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.5e-41  Score=341.88  Aligned_cols=242  Identities=28%  Similarity=0.462  Sum_probs=208.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|...+.||+|+||+||+|+.+.  +.||+|.+.+.     +.+.+.+|++|+++++||||+.++++|....++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            467778899999999999998764  68999988653     23558899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+.| +|+++|..     ...+++.....|+.++..||.|||++.   |+|||+||.|||++.++.+|+||||+|+.+..
T Consensus        82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9966 99999965     345889999999999999999999987   99999999999999999999999999997743


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                         .....+.+.|||.|||||++.+++|+..+|.||+||++|||++|++||..           .++......++.++..
T Consensus       153 ---~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----------~si~~Lv~~I~~d~v~  218 (808)
T KOG0597|consen  153 ---NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----------RSITQLVKSILKDPVK  218 (808)
T ss_pred             ---CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----------HHHHHHHHHHhcCCCC
Confidence               45567778999999999999999999999999999999999999999953           2333444444443321


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                        +|......+..++...+.+||.+|.+..+++.
T Consensus       219 ------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 ------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                              34456677999999999999999999998864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=314.11  Aligned_cols=232  Identities=28%  Similarity=0.382  Sum_probs=197.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||.|+||.|.+++.+  +..+|+|.++...      .+...+|..+|+.+.||+++++++.+.+.+.+||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45667889999999999998775  5789999997654      345778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||++||.|..+++.     ...++....+.+|.||+.||+|||+..   |++|||||+|||+|.+|.+||+|||+|+.+.
T Consensus       124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            99999999999975     345888889999999999999999987   9999999999999999999999999999763


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .      .....+|||.|+|||++....++..+|+|||||++|||+.|.+||...+.           ......++... 
T Consensus       196 ~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----------~~iY~KI~~~~-  257 (355)
T KOG0616|consen  196 G------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----------IQIYEKILEGK-  257 (355)
T ss_pred             C------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----------HHHHHHHHhCc-
Confidence            2      24568999999999999999999999999999999999999999965443           11122222211 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCC
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR  625 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  625 (639)
                                     +  .+|.....++.+|+...++.|-.+|
T Consensus       258 ---------------v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 ---------------V--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---------------c--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                           1  1355556678999999999999988

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-39  Score=333.11  Aligned_cols=243  Identities=26%  Similarity=0.458  Sum_probs=197.5

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEEEEeec
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAAT----EDELFLIYEYA  425 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~e~~  425 (639)
                      ...||+|+++.||+|.++++.||||.++...      .+.+.+|+++|++++||||+++++++.+    ....+++|||+
T Consensus        25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4679999999999999999999999986432      3567799999999999999999999876    34689999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.+++..     ...++|.....++.+++.||.|||+..  +++||||||+||++++++.+||+|||+++.+....
T Consensus       105 ~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        105 TRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            99999999964     245889999999999999999999842  38899999999999999999999999998653211


Q ss_pred             CCcceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                            ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....        ..+   ......... 
T Consensus       178 ------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~---~~~i~~~~~-  239 (283)
T PHA02988        178 ------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEI---YDLIINKNN-  239 (283)
T ss_pred             ------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHH---HHHHHhcCC-
Confidence                  23467899999999976  6889999999999999999999999964321        111   111111110 


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                 .+    ..+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       240 -----------~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        240 -----------SL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             -----------CC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                       00    12234566799999999999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=343.87  Aligned_cols=245  Identities=27%  Similarity=0.467  Sum_probs=205.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..|....+||+|+.|.||.+...  ++.||||++...   ..+-+++|+.+|+..+|+|||++++.+..++++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46777889999999999998764  578999998643   3455789999999999999999999999899999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.+.+..      ..+++.++..|+.++++||+|||.++   |+|||||.+|||++.++.+||+|||++..+....
T Consensus       353 ~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  353 EGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             CCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99999999864      33889999999999999999999988   9999999999999999999999999998775432


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         ......+||+.|||||++....|++|.||||||++++||+-|.+||...+.         ....+.   +...    
T Consensus       424 ---~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---------lrAlyL---Ia~n----  484 (550)
T KOG0578|consen  424 ---SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---------LRALYL---IATN----  484 (550)
T ss_pred             ---CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---------HHHHHH---Hhhc----
Confidence               244557999999999999999999999999999999999999999965332         111111   1111    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                              -.|.++  .++.....+.+++.+||+.|+++||++.|+|+
T Consensus       485 --------g~P~lk--~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  485 --------GTPKLK--NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --------CCCCcC--CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                    112222  24566778999999999999999999999986

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=370.94  Aligned_cols=258  Identities=31%  Similarity=0.499  Sum_probs=210.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .++.+..+.||+|+||.||.|...+       ..||||.+++.    +..+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4455567789999999999998753       24899988653    467899999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ++++|||++|+|..+|++.+..  ....++....+.++.|||+|++||+++.   +|||||..+|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999875332  2456899999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      +|+++.... .........-...|||||.+..+.++.|+|||||||+|||++| |..||...+.           .+.+.
T Consensus       848 lArDiy~~~-yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----------~~v~~  915 (1025)
T KOG1095|consen  848 LARDIYDKD-YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----------FEVLL  915 (1025)
T ss_pred             hhHhhhhch-heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----------HHHHH
Confidence            999654322 1111111234568999999999999999999999999999999 8888844322           11111


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ..++.                . +...|..|+..+.+++..||+.+|++||++..+++.+.+++
T Consensus       916 ~~~~g----------------g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  916 DVLEG----------------G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             HHHhC----------------C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence            11111                1 23358889999999999999999999999999999888763

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=337.84  Aligned_cols=244  Identities=24%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCe
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVH-HSNLVELIGYAATEDE  417 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~  417 (639)
                      ...+|...+.||+|+||+|+.|.+.  +..||+|.++..        ..+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3467888999999999999999774  689999976553        2345668999999999 9999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEeccC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFG  496 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg  496 (639)
                      +++||||+.+|+|.+++..     ...+.+.....++.|++.|++|||+++   |+||||||+|||++.+ +++||+|||
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence            9999999999999999975     345777888999999999999999988   9999999999999999 999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCC-CC-CcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL-AT-AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ++....   .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+.           ....
T Consensus       167 ~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----------~~l~  232 (370)
T KOG0583|consen  167 LSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----------PNLY  232 (370)
T ss_pred             cccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------HHHH
Confidence            998763   2233456689999999999999877 75 799999999999999999999965221           1111


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDC-LFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                      ..+.....                  .+|... ..++..|+.+|+..||.+|+++.|++
T Consensus       233 ~ki~~~~~------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  233 RKIRKGEF------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHhcCCc------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            11111110                  022223 56789999999999999999999998

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-39  Score=345.58  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=202.2

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATED  416 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  416 (639)
                      ..++|+..+.||+|+||.||+++..       +..||||.++..    ..+.+.+|++++..+ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            3456888899999999999999742       357999998643    235688999999999 8999999999999999


Q ss_pred             eEEEEEeeccCCChhhhccCCCC---------------------------------------------------------
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQN---------------------------------------------------------  439 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  439 (639)
                      ..++||||+++|+|.++++....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999999864221                                                         


Q ss_pred             -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          440 -------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       440 -------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                                   .....++|..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                         01235788999999999999999999987   99999999999999999999999999986643221


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                      . .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....       ...+..    .+....   
T Consensus       270 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~----~~~~~~---  334 (375)
T cd05104         270 Y-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYK----MIKEGY---  334 (375)
T ss_pred             c-cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHH----HHHhCc---
Confidence            1 11112345667999999999999999999999999999998 8888743221       011111    111100   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                                   ....+...+.++.+++.+||+.||++||++.|+++.|++.+
T Consensus       335 -------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         335 -------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence                         00011223457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=345.11  Aligned_cols=257  Identities=31%  Similarity=0.492  Sum_probs=206.7

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEcC-----ce-EEEEEecc------ccHHHHHHHHHHHHhcCCCCeeEEEeee
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIRN-----QE-VAIKRMTA------TKTKEFMAEMKILCKVHHSNLVELIGYA  412 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~-vavK~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~  412 (639)
                      .++...++....++||+|+||.||+|++.-     .. ||||..+.      +..++|++|+++|++++|||||+++|++
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445556666667899999999999998752     23 89998874      2357899999999999999999999999


Q ss_pred             ecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       413 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                      ..+..+++|||+|.||+|.++|...    ...++...++.++.+.|.||+|||+++   ++||||..+|+|++.++.+||
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence            9999999999999999999999752    235999999999999999999999987   999999999999999999999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      +|||+++.-.   ........-.-+..|+|||.+..+.|++++|||||||++||+++ |..|+......           
T Consensus       304 SDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----------  369 (474)
T KOG0194|consen  304 SDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----------  369 (474)
T ss_pred             CccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----------
Confidence            9999987432   01111101134678999999999999999999999999999999 88888554321           


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +....+...                ..+...+...+..+..++.+||..||++||+|.++.+.|+.+
T Consensus       370 ~v~~kI~~~----------------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  370 EVKAKIVKN----------------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             HHHHHHHhc----------------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence            111111111                111123345677899999999999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.4e-39  Score=329.22  Aligned_cols=256  Identities=29%  Similarity=0.511  Sum_probs=204.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|+..+.||+|+||.||+|...+       ..+++|.++...    ..++.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467778899999999999998643       469999886432    346889999999999999999999999888999


Q ss_pred             EEEeeccCCChhhhccCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRG-----------QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF  488 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~  488 (639)
                      ++|||+++++|.+++.......           ...+++...+.++.|++.||+|||+++   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            9999999999999986532111           156889999999999999999999987   99999999999999999


Q ss_pred             CEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhh
Q 036507          489 RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       489 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~  567 (639)
                      .+||+|||++....... .........+++.|+|||.+.+..++.++|||||||++|||++ |..||.....        
T Consensus       162 ~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------  232 (283)
T cd05048         162 TVKISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------  232 (283)
T ss_pred             cEEECCCcceeeccccc-cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            99999999998653221 1122233456789999999988899999999999999999998 9988854321        


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..+..    .+...                .....+.+++.++.+|+.+||+.||++||+++||++.|+++
T Consensus       233 ~~~~~----~i~~~----------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 QEVIE----MIRSR----------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHH----HHHcC----------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11111    11111                00112345667899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-38  Score=329.80  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=200.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc------------------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR------------------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVEL  408 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l  408 (639)
                      .+|...++||+|+||.||++.+.                  +..||+|.+...    ...++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            56778889999999999999753                  236999998653    23568899999999999999999


Q ss_pred             EeeeecCCeEEEEEeeccCCChhhhccCCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 036507          409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQN--------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH  474 (639)
Q Consensus       409 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH  474 (639)
                      ++++.+.+..+++|||+++|+|.+++.....              .....++|.....++.|++.||.|||+++   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            9999999999999999999999998854221              11235788999999999999999999987   999


Q ss_pred             CCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc--CCc
Q 036507          475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS--GKE  552 (639)
Q Consensus       475 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt--G~~  552 (639)
                      |||||+|||+++++.+||+|||+++.+.... .........++..|+|||++.++.++.++||||||+++|||++  +..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGD-YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCc-eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999998653221 1111223455788999999988899999999999999999987  455


Q ss_pred             cccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          553 AIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       553 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                      |+.....        ................        . .    ....+..++..+.+++.+||+.||++|||++||.
T Consensus       241 p~~~~~~--------~~~~~~~~~~~~~~~~--------~-~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         241 PYGELTD--------EQVIENAGEFFRDQGR--------Q-V----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCcCCH--------HHHHHHHHHHhhhccc--------c-c----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            6643221        1111111111111100        0 0    0011234556799999999999999999999999


Q ss_pred             HHHhh
Q 036507          633 ISLSQ  637 (639)
Q Consensus       633 ~~L~~  637 (639)
                      +.|++
T Consensus       300 ~~l~~  304 (304)
T cd05096         300 AFLTE  304 (304)
T ss_pred             HHHhC
Confidence            99864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.3e-39  Score=326.43  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=201.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-----CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|+..+.||+|+||.||+|.+.     +..||+|.++...    ...+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356778889999999999999763     3579999987542    3468899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++...    ...+++...+.++.|++.||+|||+++   ++||||||+||+++.++.+|++|||.+..
T Consensus        84 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          84 VTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999998642    235899999999999999999999987   99999999999999999999999998764


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ....  .........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....        ..+    ...+.
T Consensus       157 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~----~~~~~  222 (266)
T cd05064         157 DKSE--AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDV----IKAVE  222 (266)
T ss_pred             cccc--chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHH----HHHHH
Confidence            3211  1111112345678999999999999999999999999999875 9999854321        011    11111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ..                .....+..++..+.+++.+||+.+|++||+++++++.|++++
T Consensus       223 ~~----------------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         223 DG----------------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             CC----------------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            10                000123445667999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.3e-39  Score=342.30  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=202.3

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKV-HHSNLVELIGYAATE  415 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l-~h~niv~l~~~~~~~  415 (639)
                      ...++|+..+.||+|+||.||++...       ...||+|.++...    .+.+.+|+++++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34457888999999999999998752       2479999986432    34578999999999 899999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCC--------------------------------------------------------
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQN--------------------------------------------------------  439 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  439 (639)
                      +..++||||+++|+|.++++....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            999999999999999998853210                                                        


Q ss_pred             ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          440 ---------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       440 ---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                               .....+++...++++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++.+..... ...
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~  270 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVV  270 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eee
Confidence                     11235788899999999999999999987   99999999999999999999999999986532211 111


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS  589 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  589 (639)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....       ...+..    .+....       
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~----~~~~~~-------  332 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYK----MVKRGY-------  332 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHH----HHHccc-------
Confidence            112335668999999998999999999999999999997 9999854221       011111    111100       


Q ss_pred             cccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       590 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                           .+.    .+...+.++.+++.+||+.||++||++.++++.|++++
T Consensus       333 -----~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         333 -----QMS----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -----Ccc----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                 000    11122456899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-39  Score=312.26  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHH-----HHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK-----EFMAEMKILCKVHHSNLVELIGYAAT--EDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv  421 (639)
                      +.|+..++|++|.||.||+|+++  ++.||+|+++.+..+     ..+||+.+|.+++|||||.+..+...  -+.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45777889999999999999875  678999999876543     36899999999999999999987654  4579999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      ||||+. +|...++.    -..++.......+..|+++|++|||.+-   |+|||||++|+|++..|.+||+|||+|+.+
T Consensus       156 Me~~Eh-DLksl~d~----m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMET----MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             HHHHHh-hHHHHHHh----ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            999976 99998874    2356888888999999999999999987   999999999999999999999999999987


Q ss_pred             CCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      +..   ....+..+-|.+|+|||.+.+ ..|+...|+||+|||+.||+++++.|.+...        .+....+-..++.
T Consensus       228 gsp---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--------~dQl~~If~llGt  296 (419)
T KOG0663|consen  228 GSP---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--------IDQLDKIFKLLGT  296 (419)
T ss_pred             cCC---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--------HHHHHHHHHHhCC
Confidence            543   345677889999999999887 5689999999999999999999988754432        2222333344443


Q ss_pred             CCCcccccccccc-----------cCCcccCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDY-----------IDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~-----------~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.+..+ ..+.+.           .--.++..++.. ....-.+|+...+..||.+|-|++|.|+
T Consensus       297 Pte~iw-pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  297 PSEAIW-PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CccccC-CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            322211 111110           001111111111 3466789999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-39  Score=336.29  Aligned_cols=241  Identities=27%  Similarity=0.437  Sum_probs=203.2

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCe
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVH-HSNLVELIGYAATEDE  417 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~  417 (639)
                      ...-++|...++||+|+||+|+++..+  ++.+|||.++++      +.+..+.|.+|+...+ ||.+++++..+...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345578999999999999999999886  478999998764      4567888999988776 9999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      +|+||||+.||++..+.+.      ..++......+|..++.||.|||+++   |||||||.+|||||.+|++||+|||+
T Consensus       444 l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             EEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccc
Confidence            9999999999996666542      45889999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ++.-   .........++|||.|||||++.+..|+..+|+|||||+|||||.|..||.+.+.        .++.+   .+
T Consensus       515 cKe~---m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------ee~Fd---sI  580 (694)
T KOG0694|consen  515 CKEG---MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------EEVFD---SI  580 (694)
T ss_pred             cccc---CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHH---HH
Confidence            9853   2233456679999999999999999999999999999999999999999954322        12221   12


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                      +.+.                  -.||..++.+...++.+++..+|++|-.+
T Consensus       581 ~~d~------------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VNDE------------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcCC------------------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2111                  12677788899999999999999999876

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.6e-39  Score=328.65  Aligned_cols=245  Identities=25%  Similarity=0.364  Sum_probs=197.1

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ..++|+....||+|+||.||+++.+  |..+|+|++++.      ..+....|-++|...++|.||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999764  689999999764      34668889999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||++||++.++|..     ...|+......++.+++.|++-||+.|   +|||||||+|+|||..|++||+||||+.-
T Consensus       219 iMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999964     456888888889999999999999988   99999999999999999999999999853


Q ss_pred             cCCC-------------------C--CCc------c-----------------eeeeeccccccCCccccccCCCCCcch
Q 036507          501 VGKT-------------------S--DGE------A-----------------TVTKVVGTFGYLAPEYLTDGLATAKSD  536 (639)
Q Consensus       501 ~~~~-------------------~--~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  536 (639)
                      +...                   .  +..      .                 .....+|||.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            3210                   0  000      0                 011248999999999999999999999


Q ss_pred             HHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHH
Q 036507          537 VYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQ  616 (639)
Q Consensus       537 Vws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~  616 (639)
                      +||+|||+||||.|.+||...+..    ...+.+..|-... . .|.                   ...+..+..+||.+
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~----~T~rkI~nwr~~l-~-fP~-------------------~~~~s~eA~DLI~r  425 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQ----ETYRKIVNWRETL-K-FPE-------------------EVDLSDEAKDLITR  425 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhhhc-c-CCC-------------------cCcccHHHHHHHHH
Confidence            999999999999999999765431    2223333332111 1 111                   12233578999999


Q ss_pred             hcccCCCCCCC
Q 036507          617 CVDEDPILRPD  627 (639)
Q Consensus       617 cl~~dP~~RPs  627 (639)
                      |+. ||++|-.
T Consensus       426 ll~-d~~~RLG  435 (550)
T KOG0605|consen  426 LLC-DPENRLG  435 (550)
T ss_pred             Hhc-CHHHhcC
Confidence            999 9999975

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=320.90  Aligned_cols=269  Identities=30%  Similarity=0.445  Sum_probs=204.2

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHh--cCCCCeeEEEeeeecCC----eEEEEEeeccCC
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAATED----ELFLIYEYAQKG  428 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~~----~~~lv~e~~~~g  428 (639)
                      ..++||+|.||.||+|.+.++.||||++...+...|.+|-+|.+.  ++|+||+++++.-....    +++||+||.++|
T Consensus       214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kG  293 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKG  293 (534)
T ss_pred             hHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCC
Confidence            356899999999999999999999999999999999999998765  57999999999876555    899999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH------TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      +|.++|..      ..++|....+|+..+++||+|||+.      .+++|+|||||+.|||+.+|+.+.|+|||+|..+.
T Consensus       294 sL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  294 SLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             cHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            99999974      4599999999999999999999974      35789999999999999999999999999999886


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCC------CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLA------TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ..... ......+||.+|||||++.+..-      -.+.||||+|.|||||++....++. .. ++..+      --+.+
T Consensus       368 p~~~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~-vp~Yq------lpfe~  438 (534)
T KOG3653|consen  368 PGKPQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GP-VPEYQ------LPFEA  438 (534)
T ss_pred             CCCCC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CC-CCccc------CchhH
Confidence            44332 23334799999999999987432      2368999999999999986544421 00 00000      00011


Q ss_pred             HhhcCCCc--ccccccccccCCcccCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          577 ALRNSPDS--MSMSSLKDYIDPNMMDLY-PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       577 ~~~~~~~~--~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .++..|..  +....+++...|.+.+.. ....+..+.+.+..||+.||+.|-|+.=|-+++.++
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            11222211  111122233333333221 124466799999999999999999999888887765

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-39  Score=335.44  Aligned_cols=240  Identities=26%  Similarity=0.364  Sum_probs=202.0

Q ss_pred             CCCCCceeecCceEEEEEEE--cCceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      |..++.||.|+-|.|-+|++  +|+.+|||++....      ...+.+|+-||+-+.|||++++++++.+..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            55577899999999999987  47899999986552      23477899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++|.|++++-.     ..++......+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|..-.  
T Consensus        94 v~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   94 VPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             cCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            999999999954     456888889999999999999999987   9999999999999999999999999997532  


Q ss_pred             CCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                        ........||+++|.+||++.+.+| ..++||||+|||||.||||+.||+..        +.+.|..   .+-+..  
T Consensus       164 --~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLl---KV~~G~--  228 (786)
T KOG0588|consen  164 --PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLL---KVQRGV--  228 (786)
T ss_pred             --CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHH---HHHcCc--
Confidence              2334566799999999999999988 57999999999999999999999632        1222222   221111  


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                      -+.|...+.++.+|+.+|+..||++|.|++||++
T Consensus       229 ----------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  229 ----------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ----------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                            0134566678999999999999999999999986

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=317.34  Aligned_cols=267  Identities=25%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecc-----ccHHHHHHHHHHHHhcCCCCeeEEEeeeec-----C
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIGYAAT-----E  415 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~-----~  415 (639)
                      .....|...+.||+|+||.|+.+..+  ++.||||++..     ...++..+|+++|+.++|+||+.+++++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34566666789999999999998775  68999999862     235778999999999999999999998765     3


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      ++.|+|+|+| ..+|...++.     +..++......+..|+++||+|+|+.+   |+||||||+|++++.++.+||+||
T Consensus        99 ~DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence            5789999999 6799999964     344888888999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccc-cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |+|+..... .....++.++.|.+|+|||++. ...|+...||||.|||+.||++|++.|-+.+.        .+....+
T Consensus       170 GLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--------v~Ql~lI  240 (359)
T KOG0660|consen  170 GLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--------VHQLQLI  240 (359)
T ss_pred             cceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--------HHHHHHH
Confidence            999987544 3445568889999999999875 57899999999999999999999988855442        2222223


Q ss_pred             HHHhhcCCCccc----ccccccccC-------CcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMS----MSSLKDYID-------PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~----~~~~~~~~d-------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...++.+++...    ......++.       ..+...++ ......++|+.+||..||.+|+|++|.++
T Consensus       241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            333333211100    000111111       11111222 34556899999999999999999999875

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-39  Score=325.38  Aligned_cols=245  Identities=35%  Similarity=0.601  Sum_probs=190.9

Q ss_pred             CCceeecCceEEEEEEEc------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          356 SSLLGHGTYGSVYYGNIR------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .+.||.|.||.||+|.+.      +..|+||.++..    ..+++.+|++++++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999998      468999999543    2567999999999999999999999999888899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.++++..   ....+++..+..|+.|+++||.|||+++   ++|+||+++||++++++.+||+|||++.......
T Consensus        84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            999999999763   2456899999999999999999999987   9999999999999999999999999998762211


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                       .............|+|||.+.+..++.++||||||+++|||++ |+.|+.....        ..+   .... ...   
T Consensus       158 -~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~---~~~~-~~~---  221 (259)
T PF07714_consen  158 -KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEI---IEKL-KQG---  221 (259)
T ss_dssp             -SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHH---HHHH-HTT---
T ss_pred             -cccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccc---cccc-ccc---
Confidence             1111222456778999999999999999999999999999999 6777743221        111   1111 111   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                                   .....+..++..+.+++..||+.||++||+++++++.|
T Consensus       222 -------------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 -------------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                         00112334566799999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=321.58  Aligned_cols=255  Identities=28%  Similarity=0.398  Sum_probs=199.2

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----------------HHHHHHHHHHHHhcCCCC
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----------------TKEFMAEMKILCKVHHSN  404 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----------------~~~~~~E~~il~~l~h~n  404 (639)
                      ++-...-++|+..+.||+|.||.|-+|...  ++.||||++.+.+                 .+...+|+.||++++|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            333445578999999999999999999875  5789999985432                 246889999999999999


Q ss_pred             eeEEEeeeecC--CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 036507          405 LVELIGYAATE--DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI  482 (639)
Q Consensus       405 iv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NI  482 (639)
                      ||+|+++..+.  +.+|||+|||..|.+...-.+     ...++..+.++++.++..||+|||.++   |+||||||+|+
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNL  241 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNL  241 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhhe
Confidence            99999998764  579999999999888765422     222899999999999999999999998   99999999999


Q ss_pred             EECCCCCEEEeccCCceecCCCC--CCcceeeeeccccccCCccccccCC----CCCcchHHHHHHHHHHHHcCCccccc
Q 036507          483 LLDSAFRAKISDFGLAKLVGKTS--DGEATVTKVVGTFGYLAPEYLTDGL----ATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       483 ll~~~~~~kl~Dfgla~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      ||+++|++||+|||.+.......  +........+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||..
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999999999999998663321  2222334478999999999987632    35789999999999999999999954


Q ss_pred             cccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          557 TEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       557 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...           .+....+..+                .+.-....+....+.+||.++|++||++|.+..+|..
T Consensus       322 ~~~-----------~~l~~KIvn~----------------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  322 DFE-----------LELFDKIVND----------------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             chH-----------HHHHHHHhcC----------------cccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            321           1112222211                1111111245567999999999999999999988753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.5e-38  Score=323.16  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=196.8

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      |+..+.||+|+||.||++...  ++.||+|.+....      ...+.+|++++++++|+||+++.+++.+.+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667789999999999999864  6899999876432      23467899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++|+|.+++...   ....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        82 ~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          82 MNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             cCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999887542   2335889999999999999999999987   999999999999999999999999999865321


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                          .......||..|+|||++.+..++.++|||||||++|||++|+.||......        .........+....  
T Consensus       156 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~--  221 (285)
T cd05631         156 ----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--------VKREEVDRRVKEDQ--  221 (285)
T ss_pred             ----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--------hhHHHHHHHhhccc--
Confidence                1223457899999999999999999999999999999999999999643321        00011111111100  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                                     ..++......+.+|+.+||+.||++||+     ++++++
T Consensus       222 ---------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 ---------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                           1122334557899999999999999997     788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-38  Score=319.23  Aligned_cols=254  Identities=27%  Similarity=0.472  Sum_probs=203.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-----CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|+..+.||+|+||.||+|.+.     ...||+|.++...    ..++.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            356888999999999999999874     2479999876432    3568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +|||+++++|.+++...    ...+++..++.++.|++.|++|||+++   |+|+||||+||++++++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          83 ITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence            99999999999998642    236899999999999999999999977   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      +.... .........++..|+|||.+.+..++.++||||||+++|||++ |..||.....        ..+....    .
T Consensus       156 ~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~----~  222 (266)
T cd05033         156 LEDSE-ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAV----E  222 (266)
T ss_pred             ccccc-cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHH----H
Confidence            64111 1111122345678999999998899999999999999999998 9888843221        1111111    1


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ...                ....+.+++..+.+++.+||+.+|++||+++|+++.|++++
T Consensus       223 ~~~----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         223 DGY----------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             cCC----------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            100                00012334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=334.13  Aligned_cols=261  Identities=26%  Similarity=0.454  Sum_probs=217.8

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      +|+++....+....++||-|.||.||.|.|+.  -.||||.++++  ..++|+.|..+|+.++|||+|+|+|+|..+-.+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            46777777777778899999999999999975  57999999876  478999999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      |+|.|||.+|+|.++|+...   ...++-...+.+|.||+.||+||..++   +|||||..+|.|+.++..+|++|||++
T Consensus       339 YIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             EEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence            99999999999999998743   445777788899999999999999877   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +.+..+.  ....-...-...|.|||.+....++.|+|||+|||+|||+.| |-.|+-+.           ++       
T Consensus       413 RlMtgDT--YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----------dl-------  472 (1157)
T KOG4278|consen  413 RLMTGDT--YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DL-------  472 (1157)
T ss_pred             hhhcCCc--eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----------cH-------
Confidence            9874321  111111233567999999999999999999999999999998 55555211           11       


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                                ..+.++++..++-+.|+.|+..+.+|++.||++.|.+||++.|+.+.++.++
T Consensus       473 ----------SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  473 ----------SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ----------HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                      1222333344445568899999999999999999999999999999998764

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.4e-38  Score=320.29  Aligned_cols=253  Identities=26%  Similarity=0.464  Sum_probs=202.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .+|+..+.||+|+||.||++...  ++.+|+|.+..+.  .+++.+|++++++++|+||+++++++..++..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            45667789999999999999875  5789999987543  4578899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++...   ....+++..++.++.|+++||+|||+++   ++||||||+||++++++.+||+|||++....... 
T Consensus        86 ~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-  158 (263)
T cd05052          86 YGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  158 (263)
T ss_pred             CCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce-
Confidence            99999998642   2345899999999999999999999987   9999999999999999999999999997653211 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                       ........++..|+|||.+.+..++.++||||||+++|||++ |..|+.....        ..+...    +...    
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~----~~~~----  221 (263)
T cd05052         159 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYEL----LEKG----  221 (263)
T ss_pred             -eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH----HHCC----
Confidence             111111234568999999999999999999999999999998 8888743211        111111    1110    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                                  .....+..++.++.+++.+||+.||++||++.+++++|+.++
T Consensus       222 ------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         222 ------------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                        001123344567999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-38  Score=338.67  Aligned_cols=261  Identities=27%  Similarity=0.477  Sum_probs=204.2

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKVH-HSNLVELIGYAATE  415 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~  415 (639)
                      ...++|...++||+|+||.||+|+..+       ..||||.++..    ..+.+.+|++++++++ ||||+++++++.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            446788889999999999999998632       36999998643    2356889999999996 99999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCC--------------------------------------------------------
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQN--------------------------------------------------------  439 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  439 (639)
                      +..++||||+++|+|.++++....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            999999999999999998864211                                                        


Q ss_pred             -----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 036507          440 -----------------------------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL  484 (639)
Q Consensus       440 -----------------------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll  484 (639)
                                                         .....+++..+..++.|+++||+|||+.+   |+||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                               01134788889999999999999999987   9999999999999


Q ss_pred             CCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccch
Q 036507          485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSK  563 (639)
Q Consensus       485 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~  563 (639)
                      ++++.+||+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....    
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~----  345 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV----  345 (400)
T ss_pred             eCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence            9999999999999986532211 111222456788999999998899999999999999999997 8888743211    


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                         ...+    ...+...            ..    ...+..++..+.+++.+||+.||++||++.+|.+.|++++
T Consensus       346 ---~~~~----~~~~~~~------------~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         346 ---DSTF----YNKIKSG------------YR----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ---hHHH----HHHHhcC------------CC----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence               0001    0111110            00    0112344567999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=324.82  Aligned_cols=244  Identities=26%  Similarity=0.442  Sum_probs=200.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ..|...++||+|+||.||+|...  ++.||+|++.-+    +.++..+|+.+|.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45666789999999999999876  578999998643    456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +.+|++.+.+....     .+.+....-|..++..|+.|||.++   .+|||||+.|||+.++|.+||+|||.+..+...
T Consensus        93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999996432     2355555567789999999999988   999999999999999999999999999877433


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .....++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.....+.               .+      
T Consensus       165 ~---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vl------  220 (467)
T KOG0201|consen  165 V---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VL------  220 (467)
T ss_pred             h---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EE------
Confidence            2   22256899999999999999899999999999999999999999996544310               00      


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         --+.+..-|.+.+    .+...+.+++..||+.||+.|||+.++++
T Consensus       221 ---flIpk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  221 ---FLIPKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ---EeccCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence               0111111223322    45567999999999999999999999986

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=318.22  Aligned_cols=265  Identities=27%  Similarity=0.426  Sum_probs=204.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHh--cCCCCeeEEEeeeecC----CeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAATE----DELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~----~~~~lv~e~  424 (639)
                      .+....+.||+|.||.||+|.++|+.||||++...+...+.+|.+|.+.  |+|+||+.+++.-..+    .+++||.+|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY  290 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY  290 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence            4556678899999999999999999999999999999999999999866  5999999999876543    268999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-----HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      .++|||.++|..      ..++-...++++..+|.||+|||-     +++|.|.|||||+.|||+..++.+.|+|+|+|-
T Consensus       291 He~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  291 HEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             ccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            999999999964      458888999999999999999994     578999999999999999999999999999997


Q ss_pred             ecCCC-CCCcceeeeeccccccCCccccccCCC------CCcchHHHHHHHHHHHHcC----------Cccccccccccc
Q 036507          500 LVGKT-SDGEATVTKVVGTFGYLAPEYLTDGLA------TAKSDVYAFGVVLFEIISG----------KEAIIRTEGMVS  562 (639)
Q Consensus       500 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DVws~Gvvl~elltG----------~~p~~~~~~~~~  562 (639)
                      ..... +.-....+..+||.+|||||++...-.      -..+||||||.|+||+...          +.||...-+..+
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            66443 223334456799999999999965321      1358999999999998752          234433222111


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...+       |...       .-...++..+...+   ...++...+.++++.||..+|.-|-|+-.+-+.|.++
T Consensus       445 s~ee-------MrkV-------VCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  445 SFEE-------MRKV-------VCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CHHH-------Hhcc-------eeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            1110       1000       01112222222222   2356788899999999999999999998888888765

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=325.29  Aligned_cols=240  Identities=25%  Similarity=0.352  Sum_probs=196.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.+...      ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36788899999999999999886  688999998643      2345788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            99999999999864     235888889999999999999999987   9999999999999999999999999997653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....           ............
T Consensus       153 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----------~~~~~~i~~~~~  215 (291)
T cd05612         153 DR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----------FGIYEKILAGKL  215 (291)
T ss_pred             CC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCc
Confidence            21      1235789999999999998899999999999999999999999854321           111111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                                        ..+......+.+++.+||+.||.+||+     ++|+++
T Consensus       216 ------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         216 ------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                              012223456889999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-37  Score=369.91  Aligned_cols=265  Identities=26%  Similarity=0.447  Sum_probs=208.4

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      ++++++.   +.|...+.||+|+||.||+|...  +..||||.+..... ....|++++++++||||++++++|.+.+..
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            3444443   35677889999999999999863  67899998865432 223568999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.++++.        ++|..+.+++.|+++||+|||++..++|+||||||+||+++.++..++. ||..
T Consensus       759 ~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence            999999999999999953        8999999999999999999997655679999999999999999888875 6655


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .....       .....+|+.|+|||++.+..++.++|||||||++|||++|+.|+....+      ....+..|.....
T Consensus       830 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~------~~~~~~~~~~~~~  896 (968)
T PLN00113        830 GLLCT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG------VHGSIVEWARYCY  896 (968)
T ss_pred             ccccc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC------CCCcHHHHHHHhc
Confidence            43211       1123678999999999999999999999999999999999999843222      1223334433222


Q ss_pred             hcCCCcccccccccccCCcccCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDL--YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..       .....++|+.+...  .+.++..++.+++.+||+.||++||+|+||+++|+++
T Consensus       897 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        897 SD-------CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             Cc-------cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            11       12344556655332  3445677889999999999999999999999999976

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-38  Score=316.74  Aligned_cols=254  Identities=25%  Similarity=0.421  Sum_probs=203.5

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..++|+..+.||+|+||.||++..++ +.||+|.++..  ..+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45678888999999999999998754 67999998654  3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++....   ...+++.....++.|++.|+.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999986522   346899999999999999999999987   9999999999999999999999999998764221


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .  ........+..|+|||++.+..++.++||||||+++|||++ |+.||.....        ..+..   ......   
T Consensus       158 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~---~~~~~~---  221 (261)
T cd05068         158 Y--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQ---QVDQGY---  221 (261)
T ss_pred             c--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH---HHHcCC---
Confidence            1  11111223457999999998899999999999999999999 8888843221        01111   111110   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                    ....+..++..+.+++.+|++.+|++||+++++++.|+++
T Consensus       222 --------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 --------------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --------------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                          0011233456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.8e-38  Score=319.73  Aligned_cols=263  Identities=26%  Similarity=0.435  Sum_probs=200.0

Q ss_pred             CCCCceeecCceEEEEEEE------cCceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEE
Q 036507          354 SDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATE--DELFLI  421 (639)
Q Consensus       354 ~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  421 (639)
                      ...+.||+|+||+||++..      .+..||+|.+...    ..+.+.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7788999999999988653      2467999998653    245688999999999999999999987653  458999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+||++++++.+||+|||++..+
T Consensus        87 ~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          87 MEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             ecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999999863      24899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ..............++..|+|||.+.+..++.++||||||+++|||++|+.|+........             ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-------------~~~~~~  224 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-------------EMIGPK  224 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-------------hhhccc
Confidence            4322111111223456679999999888899999999999999999999998754322100             000000


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ........+.+.++.......+..++.++.+++.+||+.||++|||++++++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         225 QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             ccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            000001111111222222223445667899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.7e-38  Score=321.82  Aligned_cols=256  Identities=28%  Similarity=0.476  Sum_probs=201.3

Q ss_pred             CCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      +|+..+.||+|+||.||+|....       ..+++|.+....    .+++.+|+++++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778899999999999998642       468888876432    3568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          421 IYEYAQKGSLKSHLHDPQN-------------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                      ++||+.+++|.+++.....                   .....+++...+.++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            9999999999998864221                   11245889999999999999999999887   9999999999


Q ss_pred             EEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccc
Q 036507          482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGM  560 (639)
Q Consensus       482 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~  560 (639)
                      |++++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDS-YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccc-hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence            9999999999999999976532211 111122345678999999988889999999999999999998 8888843221 


Q ss_pred             cchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       561 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                             ..+...    +...                .....+..+..++.+++.+||+.+|++||+++|+++.|++++
T Consensus       236 -------~~~~~~----~~~~----------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 -------ERLFNL----LKTG----------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             -------HHHHHH----HhCC----------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                   111111    1110                001112334557999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.7e-38  Score=316.19  Aligned_cols=249  Identities=26%  Similarity=0.456  Sum_probs=198.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++|+..+.||+|+||.||++.+.+ ..+|+|.+...  ..+++.+|++++++++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            456677889999999999998865 58999987654  346788999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.++++..    ...+++..+..++.|++.||+|||+++   ++|+||||+||++++++.+||+|||.++......  
T Consensus        84 ~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~--  154 (256)
T cd05114          84 GCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--  154 (256)
T ss_pred             CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc--
Confidence            9999998642    235889999999999999999999987   9999999999999999999999999987653211  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .....   .......    
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~---~i~~~~~----  219 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVE---MISRGFR----  219 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH---HHHCCCC----
Confidence            111122345668999999988889999999999999999999 8888853321        11111   1111100    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                            ...       +...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus       220 ------~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 ------LYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  001       1222356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.9e-38  Score=321.30  Aligned_cols=257  Identities=28%  Similarity=0.472  Sum_probs=200.8

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      ..++|+..+.||+|+||.||+|...+       ..+|+|.+...    ...++.+|+.++++++||||+++++++..++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46778999999999999999987642       46999988543    23468899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNR-----GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                      .++||||+++++|.+++......     ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            99999999999999998652211     1234688899999999999999999977   999999999999999999999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      +|||++........ ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....        ....
T Consensus       161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~  231 (277)
T cd05062         161 GDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVL  231 (277)
T ss_pred             CCCCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999875532111 111112345778999999998899999999999999999999 6777743221        0111


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      ..   ......                 ...+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus       232 ~~---~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         232 RF---VMEGGL-----------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HH---HHcCCc-----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11   111100                 00122345578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.5e-38  Score=327.57  Aligned_cols=237  Identities=29%  Similarity=0.383  Sum_probs=192.7

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      +.||+|+||.||++...  ++.||+|.++..      ....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999874  578999998643      2345778999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      +|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   .
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---~  149 (323)
T cd05571          81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---G  149 (323)
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC---C
Confidence            99999864     245889999999999999999999987   999999999999999999999999998753211   1


Q ss_pred             ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+   ........       
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~---~~~~~~~~-------  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKL---FELILMEE-------  211 (323)
T ss_pred             CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHH---HHHHHcCC-------
Confidence            223346799999999999999999999999999999999999999954321        111   11111110       


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                             .    ..+.....++.+++.+||+.||++||     ++.++++
T Consensus       212 -------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 -------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -------C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                   0    11233455689999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.7e-38  Score=317.67  Aligned_cols=253  Identities=27%  Similarity=0.471  Sum_probs=202.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|+..++||+|+||.||+|...+ ..||+|.+...  ..+.+.+|++++++++|+||+++++.+...+..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4678888999999999999998754 67999987643  34678899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.++++..   ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        85 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  157 (261)
T cd05072          85 KGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-  157 (261)
T ss_pred             CCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc-
Confidence            99999998642   2345888899999999999999999977   9999999999999999999999999998654321 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                       ........++..|+|||++.+..++.++||||||+++|||++ |+.||.....        ......+   ....    
T Consensus       158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~---~~~~----  221 (261)
T cd05072         158 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSAL---QRGY----  221 (261)
T ss_pred             -eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHH---HcCC----
Confidence             111122345678999999988889999999999999999998 8888843221        1111111   1100    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                               ...    .....+.++.+++.+||+.+|++||+++++.+.|+++
T Consensus       222 ---------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 ---------RMP----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---------CCC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                     000    1122345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.6e-38  Score=326.04  Aligned_cols=252  Identities=25%  Similarity=0.455  Sum_probs=198.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--Cc----eEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQ----EVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ..+|+..+.||+|+||.||+|.+.  +.    .||+|.++..    ..+++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356888999999999999999863  22    4899998643    245788999999999999999999998764 578


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +++||+++|+|.+++...    ...+++...+.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus        85 ~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          85 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence            999999999999998742    235788899999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+..... ........++..|++||.+.+..++.++||||||+++|||++ |+.|+.....        ..+    ...+
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~----~~~~  224 (316)
T cd05108         158 LLGADEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEI----SSIL  224 (316)
T ss_pred             cccCCCc-ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHH----HHHH
Confidence            7643211 111122334678999999999999999999999999999998 9988853221        011    1111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                ....+..+...+.+++.+||+.||++||++.+++..|.++
T Consensus       225 ~~~~----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         225 EKGE----------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             hCCC----------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1110                0001223445689999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-37  Score=316.38  Aligned_cols=255  Identities=27%  Similarity=0.500  Sum_probs=202.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--C---ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--N---QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ..+|+..+.||+|+||.||+|...  +   ..+++|.+...    ..+++.+|++++++++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346777889999999999999874  2   36999987643    24568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +|||+++++|.+++...    ...+++.....++.|++.|++|||+.+   ++|+||||+||++++++.+||+|||++..
T Consensus        84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          84 ITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence            99999999999998642    245899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ................+..|+|||++.+..++.++||||||+++|||++ |+.||.....        ..+...+    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i----~  224 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAI----N  224 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHH----h
Confidence            6432211111111223457999999988889999999999999999997 9999843221        1111111    1


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ..                .....+.+++.++.+++.+||+.+|++||++.+|++.|++++
T Consensus       225 ~~----------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         225 DG----------------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             cC----------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            10                000112334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6e-38  Score=328.94  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=200.8

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeec-C
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAAT-E  415 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~-~  415 (639)
                      ..++|+..+.||+|+||.||+|...       ++.||+|+++..    ..+.+.+|++++.++ +|+||+++++++.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4467888999999999999998643       257999988643    234577899999999 79999999998765 4


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCC-------------------------------------------------------
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNR-------------------------------------------------------  440 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  440 (639)
                      ..+++++||+++++|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5688999999999999988542110                                                       


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccc
Q 036507          441 -GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG  519 (639)
Q Consensus       441 -~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  519 (639)
                       ....++|..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++..+..... ........++..
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~~  240 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLK  240 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCcc
Confidence             0136899999999999999999999987   99999999999999999999999999986532211 111223455678


Q ss_pred             cCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcc
Q 036507          520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNM  598 (639)
Q Consensus       520 y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l  598 (639)
                      |+|||++.+..++.++|||||||++|||++ |..||......       ..+.    ..+....        .       
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-------~~~~----~~~~~~~--------~-------  294 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-------EEFC----RRLKEGT--------R-------  294 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-------HHHH----HHHhccC--------C-------
Confidence            999999999999999999999999999998 99888532210       0111    1111100        0       


Q ss_pred             cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          599 MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       599 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                       ...+.....++.+++.+||+.+|++||++.|+++.|++++
T Consensus       295 -~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         295 -MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0012233456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.3e-37  Score=323.97  Aligned_cols=195  Identities=26%  Similarity=0.413  Sum_probs=171.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .++|+..+.||+|+||.||++...  +..+|+|.+..+    ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468888999999999999999886  568999988643    23568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++..     ...+++.....++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            9999999999864     234788899999999999999999853  499999999999999999999999999876532


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      .     ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       157 ~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         157 S-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             c-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            1     12335789999999999999999999999999999999999999954

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-37  Score=317.66  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=197.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|...++||+|+||.||++...  +..||+|.++..    ....+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888899999999999999875  578999988643    234677999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++ ++|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus        85 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          85 LD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            96 5999888542    234788889999999999999999987   999999999999999999999999999764321


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                         ........+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.....        ......+...+...+.
T Consensus       157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~  225 (288)
T cd07871         157 ---TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--------KEELHLIFRLLGTPTE  225 (288)
T ss_pred             ---CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCCCh
Confidence               112233568999999998865 5689999999999999999999999854321        1111112222222111


Q ss_pred             ccc-----ccccccccCCcccCC----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMS-----MSSLKDYIDPNMMDL----YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~-----~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...     .........+.....    .......++.+++.+||+.||.+|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            100     011111111111100    01123456889999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.9e-38  Score=333.64  Aligned_cols=262  Identities=26%  Similarity=0.460  Sum_probs=204.4

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcC-CCCeeEEEeeeec
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVH-HSNLVELIGYAAT  414 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~-h~niv~l~~~~~~  414 (639)
                      ....++|...++||+|+||.||++.+.+       ..||+|+++...    .+.+.+|+++|.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            3445667778999999999999998643       579999987432    346889999999997 9999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCC-------------------------------------------------------
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQN-------------------------------------------------------  439 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  439 (639)
                      .+..++|+||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999865321                                                       


Q ss_pred             --------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          440 --------------------------------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       440 --------------------------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                                                            .....+++.....++.|++.||+|||+.+   ++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence                                                  01134778888999999999999999876   9999999999


Q ss_pred             EEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccc
Q 036507          482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGM  560 (639)
Q Consensus       482 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~  560 (639)
                      ||+++++.+||+|||+++.+...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... 
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-  347 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-  347 (401)
T ss_pred             EEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence            99999999999999999865322111 11122356788999999998889999999999999999998 8888743221 


Q ss_pred             cchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       561 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                            ...+    ...+...                .....+..+..++.+++.+||+.+|++||+++|++..|++++
T Consensus       348 ------~~~~----~~~~~~~----------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 ------NEQF----YNAIKRG----------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ------hHHH----HHHHHcC----------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                  0001    1111110                000112334567999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-37  Score=317.19  Aligned_cols=268  Identities=28%  Similarity=0.455  Sum_probs=199.0

Q ss_pred             CCCCCCCceeecCceEEEEEEE------cCceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAAT--EDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~  419 (639)
                      ++|+..+.||+|+||.||++..      .+..||+|.+....   .+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677788999999999999874      25689999986543   3568899999999999999999998754  34689


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +|+||+++++|.+++...    ...+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.
T Consensus        84 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            999999999999998642    235899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .+..............++..|+|||.+.+..++.++||||||+++|||++|..++.......             ...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------------~~~~~  223 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-------------MRMMG  223 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-------------hhhcc
Confidence            66432211111111234456999999998889999999999999999999877653221100             00000


Q ss_pred             cCCC-cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPD-SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .... ......+.+.+........+..++..+.+++.+||+.+|++|||++|++..|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000 0000000011111111112334556799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-38  Score=327.20  Aligned_cols=240  Identities=24%  Similarity=0.358  Sum_probs=195.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.+...      ..+.+.+|++++++++||||+++++++.+++..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56777889999999999999885  578999998643      2345789999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++....
T Consensus        98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999864     235788888889999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ............
T Consensus       170 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~i~~~~~  232 (329)
T PTZ00263        170 DR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----------FRIYEKILAGRL  232 (329)
T ss_pred             CC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----------HHHHHHHhcCCc
Confidence            21      1235799999999999999999999999999999999999999954321           011111111100


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                                        ..+......+.+++.+||+.||++||+     +++++.
T Consensus       233 ------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 ------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                              012223446889999999999999997     577653

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-37  Score=313.12  Aligned_cols=243  Identities=27%  Similarity=0.449  Sum_probs=192.4

Q ss_pred             ceeecCceEEEEEEEc----CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          358 LLGHGTYGSVYYGNIR----NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      .||+|+||.||+|.+.    +..+|+|+++...     .+++.+|+.++++++||||+++++++. .+..+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999653    4689999886432     356889999999999999999999885 45778999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      +|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+||++++++.+||+|||++..+.......
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999854     235889999999999999999999987   9999999999999999999999999998664322111


Q ss_pred             ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      .......++..|+|||.+....++.++||||||+++|||++ |+.||.....        ..+...    +...      
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~----i~~~------  214 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQM----IESG------  214 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH----HHCC------
Confidence            11122344678999999988889999999999999999998 9989854321        111111    1110      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                                .....+..++.++.+++.+||+.||++||++++|.+.|++
T Consensus       215 ----------~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         215 ----------ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                      0011233455678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-37  Score=320.11  Aligned_cols=256  Identities=24%  Similarity=0.439  Sum_probs=202.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .+|...+.||+|+||.||++...       ...+++|.+....   .+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45667789999999999999753       2458899886553   3568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC
Q 036507          421 IYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR  489 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~  489 (639)
                      ||||+++++|.+++.....           .....+++..++.++.|++.|++|||+++   |+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999864321           12235899999999999999999999987   999999999999999999


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhh
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  568 (639)
                      ++|+|||++....... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .
T Consensus       162 ~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~  232 (291)
T cd05094         162 VKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------T  232 (291)
T ss_pred             EEECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence            9999999997653221 1111223456788999999999999999999999999999999 9998854321        0


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .....    +....       .         ...+..++..+.+++.+||+.||++||++++|+++|+++
T Consensus       233 ~~~~~----~~~~~-------~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         233 EVIEC----ITQGR-------V---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHHHH----HhCCC-------C---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            11111    11100       0         001122345689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.3e-38  Score=318.80  Aligned_cols=255  Identities=26%  Similarity=0.448  Sum_probs=202.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|...+.||+|+||.||+|...       +..||+|.++..    ..+.+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45777889999999999999763       357999998653    2357889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          420 LIYEYAQKGSLKSHLHDPQ---------NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      ++|||+++++|.+++....         ......+++.....++.|++.|+.|||+++   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999996532         122345789999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||++........ ........++..|+|||++.+..+++++||||||+++|||++ |+.||.....        ..
T Consensus       162 kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~~  232 (280)
T cd05049         162 KIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------EE  232 (280)
T ss_pred             EECCcccceecccCcc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HH
Confidence            9999999976532211 111122345788999999999999999999999999999998 9998854321        11


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .....   .....                 ...+...+..+.+++.+||+.||++||+++||++.|++
T Consensus       233 ~~~~~---~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 VIECI---TQGRL-----------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHH---HcCCc-----------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            11111   11100                 01122345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-37  Score=318.47  Aligned_cols=255  Identities=29%  Similarity=0.497  Sum_probs=199.7

Q ss_pred             CCCCCCCceeecCceEEEEEEE------cCceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++|+..+.||+|+||.||+|..      .+..+++|.+...    ...++.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4566778999999999999975      2367999998642    23568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC
Q 036507          421 IYEYAQKGSLKSHLHDPQN------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF  488 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~  488 (639)
                      +|||+++++|.+++.....            .....+++...+.++.|++.||+|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853210            11235788999999999999999999987   99999999999999999


Q ss_pred             CEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhh
Q 036507          489 RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       489 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~  567 (639)
                      .+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||.....        
T Consensus       162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------  232 (283)
T cd05090         162 HVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------  232 (283)
T ss_pred             cEEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            999999999976532211 111223345678999999988889999999999999999998 8888743221        


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      ...    ........                ....+..++..+.+++.+||+.||++||++.++++.|..
T Consensus       233 ~~~----~~~~~~~~----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEV----IEMVRKRQ----------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH----HHHHHcCC----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            011    11111110                001223445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7e-38  Score=316.32  Aligned_cols=253  Identities=27%  Similarity=0.485  Sum_probs=204.5

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +..+|+..++||.|+||.||+|...+ ..+++|.+....   ..++.+|++++++++|+||+++++++...+..+++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            44567888999999999999998764 789999987543   45788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...   ....+++..++.++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++......
T Consensus        84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          84 MEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             cccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            9999999999752   2345899999999999999999999987   999999999999999999999999999765322


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   .......++..|++||.+....++.++||||||+++++|++ |+.||.....        .......   ....  
T Consensus       158 ~---~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~---~~~~--  221 (261)
T cd05148         158 V---YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQI---TAGY--  221 (261)
T ss_pred             c---ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHH---HhCC--
Confidence            1   11123345678999999988889999999999999999998 8888843221        1111111   1100  


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                     ....+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       222 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 ---------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                           0011234456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.6e-38  Score=321.79  Aligned_cols=262  Identities=28%  Similarity=0.471  Sum_probs=204.9

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhc-CCCCeeEEEeeee
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKV-HHSNLVELIGYAA  413 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l-~h~niv~l~~~~~  413 (639)
                      +....++|+..+.||+|+||.||++...+       ..+|+|.+....    ..++.+|++++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34455678888999999999999998642       579999886432    34578899999999 7999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI  482 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NI  482 (639)
                      .++..+++|||+++|+|.++++....           .....+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            99999999999999999999864210           22456899999999999999999999887   99999999999


Q ss_pred             EECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCcccccccccc
Q 036507          483 LLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMV  561 (639)
Q Consensus       483 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~  561 (639)
                      ++++++.+||+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..|+.....  
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  240 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  240 (293)
T ss_pred             EEcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence            999999999999999986533211 111122335678999999988899999999999999999998 8888743221  


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                            ..+.    ..+....                ....+..+...+.+++.+||+.||++|||++|+++.|++++
T Consensus       241 ------~~~~----~~~~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 ------EELF----KLLKEGY----------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ------HHHH----HHHHcCC----------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                  0011    1111110                00122344567999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-37  Score=314.87  Aligned_cols=254  Identities=26%  Similarity=0.493  Sum_probs=201.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-----CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .+|...+.||+|+||.||+|...     +..+|+|.++..    ..+.+.+|++++++++||||+++++++..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46777899999999999999763     236999988643    245688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++...    ...+++...+.++.|++.|+.|||+++   ++||||||+||+++.++.++|+|||++..+
T Consensus        84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999999642    245899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ..............++..|++||.+.+..++.++|+||||+++||+++ |+.||.....        ......+   ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~---~~~  225 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAI---EEG  225 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHH---hCC
Confidence            432211111122233568999999998889999999999999999887 9998854321        0111111   110


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .             ..    ..+..++..+.+++.+|++.+|++||+|.++++.|++++
T Consensus       226 ~-------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         226 Y-------------RL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             C-------------cC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            0             00    012234557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-37  Score=318.83  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=197.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|+||.||++...  ++.+|+|++...     ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888899999999999999886  478999988643     23567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++++.+..+...     ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9998777655432     235888889999999999999999987   99999999999999999999999999986532


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..  ........|++.|+|||++.+..++.++|||||||++|||++|+.||......     +  .+. .+.......+.
T Consensus       153 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-----~--~~~-~~~~~~~~~~~  222 (287)
T cd07848         153 GS--NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-----D--QLF-TIQKVLGPLPA  222 (287)
T ss_pred             cc--cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-----H--HHH-HHHHhhCCCCH
Confidence            21  11223457899999999999888999999999999999999999998543211     0  000 01111110000


Q ss_pred             cc-----cccccccccCCccc------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SM-----SMSSLKDYIDPNMM------DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~-----~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..     ..........+...      ..+....+..+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00     00000000001100      0111224557999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=323.32  Aligned_cols=234  Identities=25%  Similarity=0.362  Sum_probs=189.4

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ||+|+||.||++...  ++.||+|.+...      ....+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999875  578999988642      234577899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++..     ...+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....   ...
T Consensus        81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~  149 (312)
T cd05585          81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD---DDK  149 (312)
T ss_pred             HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC---CCc
Confidence            999864     235888999999999999999999987   999999999999999999999999998753221   112


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....           .......+....        
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----------~~~~~~~~~~~~--------  210 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------NEMYRKILQEPL--------  210 (312)
T ss_pred             cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----------HHHHHHHHcCCC--------
Confidence            3346799999999999999999999999999999999999999953221           111112221110        


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD---MKQVV  632 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl  632 (639)
                                ..+......+.+++.+||+.||++||+   +.|++
T Consensus       211 ----------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         211 ----------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             ----------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence                      112334456889999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.8e-37  Score=311.65  Aligned_cols=245  Identities=28%  Similarity=0.447  Sum_probs=192.7

Q ss_pred             CceeecCceEEEEEEE--cCceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          357 SLLGHGTYGSVYYGNI--RNQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      +.||+|+||.||++..  .++.+|+|.....    ....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999987  4678999987533    245688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++...    ...+++...+.++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||++........ ...
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~  152 (252)
T cd05084          81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-AST  152 (252)
T ss_pred             HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-ccc
Confidence            9998631    235889999999999999999999987   99999999999999999999999999875432110 000


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS  589 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  589 (639)
                      ......+..|+|||.+.++.++.++||||||+++|||++ |..|+.....     .   ..    ...+...        
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~---~~----~~~~~~~--------  212 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----Q---QT----REAIEQG--------  212 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----H---HH----HHHHHcC--------
Confidence            111123457999999998889999999999999999998 8887743221     0   00    0011000        


Q ss_pred             cccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       590 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                              .....+..++..+.+++.+||+.+|++|||++|++++|++
T Consensus       213 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         213 --------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             --------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence                    0001223345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=325.01  Aligned_cols=257  Identities=27%  Similarity=0.455  Sum_probs=214.2

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEcC------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeec
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAAT  414 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~  414 (639)
                      +.+...+.....++||.|.||.||+|.+.+      -.||||..+.+    +.+.|+.|.-+|+.++||||++++|+|. 
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-  461 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-  461 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-
Confidence            344555666678899999999999998753      25899988763    4677999999999999999999999996 


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                      +...|+|||+++.|.|..+|+.    +...++......++.||+.||+|||+..   ++||||..+|||+.....+||+|
T Consensus       462 e~P~WivmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  462 EQPMWIVMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             ccceeEEEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence            5678999999999999999974    3445888899999999999999999987   99999999999999999999999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      ||+++.+.+....  ..+...-+..|||||.+....++.++|||.|||.+||++. |..||.....              
T Consensus       535 FGLSR~~ed~~yY--kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN--------------  598 (974)
T KOG4257|consen  535 FGLSRYLEDDAYY--KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN--------------  598 (974)
T ss_pred             cchhhhccccchh--hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--------------
Confidence            9999988654322  2223345678999999999999999999999999999987 8999864332              


Q ss_pred             HHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                                    .+....++..-+...|..|+..+..|+.+||+.||.+||.+.|+...|++++
T Consensus       599 --------------sDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  599 --------------SDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             --------------cceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                          1222233333344568899999999999999999999999999999998763

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=328.88  Aligned_cols=242  Identities=26%  Similarity=0.411  Sum_probs=188.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +|+..++||+|+||.||++...  ++.||||.+....    .+.+.+|++++++++|+||+++++++...+.+++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3445678999999999999875  5789999985432    356889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|....         ...+.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.+....
T Consensus       155 ~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999986543         2456677889999999999999987   9999999999999999999999999998764321


Q ss_pred             CCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                         .......||..|+|||++..     ...+.++|||||||++|||++|+.||.....        ..+..........
T Consensus       223 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--------~~~~~~~~~~~~~  291 (353)
T PLN00034        223 ---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--------GDWASLMCAICMS  291 (353)
T ss_pred             ---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------ccHHHHHHHHhcc
Confidence               11233578999999998743     2345689999999999999999999852211        1111111111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..                 ...+..+..++.+++.+||+.||++||+++|+++
T Consensus       292 ~~-----------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        292 QP-----------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CC-----------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00                 0112334557899999999999999999999986

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3e-37  Score=311.27  Aligned_cols=245  Identities=27%  Similarity=0.438  Sum_probs=193.1

Q ss_pred             ceeecCceEEEEEEEc----CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          358 LLGHGTYGSVYYGNIR----NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      .||+|+||.||+|.+.    +..||+|.+....    .+++.+|++++++++|+||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999764    3469999886542    356889999999999999999999885 457899999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      |.+++...    ...+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++...........
T Consensus        81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99998642    345899999999999999999999987   99999999999999999999999999976533221111


Q ss_pred             eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                      ......++..|+|||.+....++.++||||||+++|||++ |..||.....        .....    .+...       
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~----~~~~~-------  214 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMS----FIEQG-------  214 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHH----HHHCC-------
Confidence            1122234578999999988889999999999999999996 9999854321        11111    11110       


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                               .....+..++.++.+++.+||+.||++||++.+|.+.|+.+
T Consensus       215 ---------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 ---------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                     00112334566799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-37  Score=326.06  Aligned_cols=264  Identities=22%  Similarity=0.343  Sum_probs=193.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----CeEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE-----DELF  419 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~  419 (639)
                      +|+..++||+|+||.||++...  +..||||.+...     ....+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4677889999999999999875  578999988632     234578999999999999999999987543     3579


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+. ++|.+++..     ...+++.....++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence            9999994 689988853     235889999999999999999999987   9999999999999999999999999997


Q ss_pred             ecCCCCCCcceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ................||+.|+|||++.+  ..++.++|||||||++|||++|+.||......        .....+...
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--------~~~~~~~~~  223 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--------HQLDLITDL  223 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--------HHHHHHHHH
Confidence            54322222222334679999999999865  67899999999999999999999998543210        111111111


Q ss_pred             hhcCCCcccc-----------cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMSM-----------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~-----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +...+.....           ..+.......+...+ ......+.+++.+||+.||++||+++|+++
T Consensus       224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            1111100000           000000000000001 123456889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-38  Score=312.39  Aligned_cols=242  Identities=25%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccccH------HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKT------KEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ..+|+..+.||+|.||.|-++..  .++.||||.++++..      -.+.+|++||+.|+||||+.++.+|.+.+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35677888999999999999975  478999999876543      2478999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||..+|.|.+++..     ...|+......++.||..|+.|+|.+.   ++|||||.+|||+|.|+++||+|||++..+
T Consensus       132 MEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  132 MEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence            999999999999964     456899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ..    ......++|++.|.+||++.+.+| .+.+|-|||||+||-|+.|.-||++.+        ...++..   +-+.
T Consensus       204 ~~----~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQ---Is~G  268 (668)
T KOG0611|consen  204 AD----KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQ---ISRG  268 (668)
T ss_pred             cc----ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHH---hhcc
Confidence            43    234566899999999999999888 589999999999999999999996543        2223222   2111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 .+.+|.        .+....-||++||..+|++|.|+.+|..
T Consensus       269 -----------aYrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  269 -----------AYREPE--------TPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             -----------cccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhh
Confidence                       122221        1234677999999999999999999865

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=325.67  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.++..      ....+.+|++++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36788899999999999999885  578999998643      2346788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            99999999999964     235788899999999999999999987   9999999999999999999999999997543


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .....   .... ..
T Consensus       153 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~---~i~~-~~  214 (333)
T cd05600         153 T------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWE---NLKY-WK  214 (333)
T ss_pred             c------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHH---HHHh-cc
Confidence            2      22345799999999999999999999999999999999999999954321        00111   1110 00


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      ..        .-.+... ........++.+++.+||+.+|++||+++|+++.
T Consensus       215 ~~--------~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 ET--------LQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cc--------ccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00        0000000 0012334568899999999999999999999853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-37  Score=311.29  Aligned_cols=248  Identities=31%  Similarity=0.498  Sum_probs=200.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEcCceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeEEEeeee-cCCeEEEEEeeccCC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAA-TEDELFLIYEYAQKG  428 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~g  428 (639)
                      ++|...+.||+|+||.||++...+..+++|.+.... .+.+.+|+.++++++|+|++++++++. .++..++++||++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   85 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence            467778899999999999999999999999987543 456889999999999999999999764 456789999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      +|.+++...   ....+++...+.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......   
T Consensus        86 ~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          86 SLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             cHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            999998642   2345889999999999999999999987   9999999999999999999999999987543211   


Q ss_pred             ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                         ....++..|+|||++.+..++.++||||||+++|||++ |+.|+....           +...........      
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----------~~~~~~~~~~~~------  216 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----------LKDVVPRVEKGY------  216 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHhcCC------
Confidence               12234568999999998889999999999999999997 888874321           111111111110      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                 ....+..++..+.+++.+||+.+|++|||++++++.|+++
T Consensus       217 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 -----------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                       0011223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-37  Score=317.68  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=202.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|...+.||+|+||.||++...       +..+|+|.+....   .+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356888899999999999999752       2458999886532   456889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          420 LIYEYAQKGSLKSHLHDPQN--------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                      ++|||+++++|.+++.....        .....+++..++.++.|++.||+|||+++   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            99999999999999864321        12235899999999999999999999987   99999999999999999999


Q ss_pred             EeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhH
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l  570 (639)
                      |+|||++....... .........++..|+|||.+.+..++.++||||||+++|||++ |..||.....        ...
T Consensus       161 l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~  231 (288)
T cd05093         161 IGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV  231 (288)
T ss_pred             eccCCccccccCCc-eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence            99999997653211 1111122345778999999998899999999999999999998 8888753321        011


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                         .........             +.    .+..++.++.+++.+||+.||.+|||++|+++.|+++
T Consensus       232 ---~~~i~~~~~-------------~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         232 ---IECITQGRV-------------LQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             ---HHHHHcCCc-------------CC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence               111111100             00    1122345689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=295.04  Aligned_cols=266  Identities=23%  Similarity=0.325  Sum_probs=206.2

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEecc---ccHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----C
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTA---TKTKEFMAEMKILCKVHHSNLVELIGYAATE-----D  416 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~  416 (639)
                      ....++|.+.++||+|+|+-||+++.  +++.||+|++.-   +..+..++|++..++++|||+++++++...+     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            34567899999999999999998874  567899998753   3456789999999999999999999887543     3


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..|++++|...|+|.+.+.... .....+++...+.|+.++++||++||+.. ++++||||||.|||+.+.+.++|.|||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence            4899999999999999987644 33457899999999999999999999986 579999999999999999999999999


Q ss_pred             CceecCCCCCCcce------eeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh
Q 036507          497 LAKLVGKTSDGEAT------VTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       497 la~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~  567 (639)
                      .++...-.-.....      ...-.-|..|+|||.+.   +...++++|||||||+||+|+.|..||+.-...      .
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------G  248 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------G  248 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc------C
Confidence            98754322111111      11124688999999885   456789999999999999999999999532210      0


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .+                   -...+..+.+.-......++.+.+++.+|++.||.+||++.+++..+++++
T Consensus       249 gS-------------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 GS-------------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             Ce-------------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            00                   001111111111111224667999999999999999999999999998764

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.6e-37  Score=315.67  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=196.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--Cc----eEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQ----EVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++|+..+.||+|+||.||+|.+.  +.    .+++|.+....    ..++..|+.++++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46777889999999999999873  33    47888875432    345777888999999999999999875 456789


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ++||+++|+|.++++..    ...+++.....++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.
T Consensus        86 i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence            99999999999999642    245899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      +.... .........++..|++||.+.++.++.++||||||+++|||++ |+.||.....        ....    ..+.
T Consensus       159 ~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~----~~~~  225 (279)
T cd05111         159 LYPDD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVP----DLLE  225 (279)
T ss_pred             ccCCC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH----HHHH
Confidence            54321 1122233457788999999998899999999999999999998 9988854321        1111    1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...         ...       .+..+...+.+++.+||..||++|||+.|+++.|..+
T Consensus       226 ~~~---------~~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         226 KGE---------RLA-------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             CCC---------cCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            110         000       1122345678899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.8e-37  Score=316.11  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=193.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc---CceEEEEEeccc-----cHHHHHHHHHHHHhc---CCCCeeEEEeeee-----c
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTAT-----KTKEFMAEMKILCKV---HHSNLVELIGYAA-----T  414 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~-----~~~~~~~E~~il~~l---~h~niv~l~~~~~-----~  414 (639)
                      ++|+..+.||+|+||.||++...   +..||+|.++..     ....+.+|+++++++   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999863   467999987532     234566788887766   6999999999875     2


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                      ...+++||||+. ++|.+++...   ....+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence            456899999995 6999988642   2345889999999999999999999987   99999999999999999999999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ||++......    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......        .....+
T Consensus       154 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--------~~~~~i  221 (290)
T cd07862         154 FGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--------DQLGKI  221 (290)
T ss_pred             ccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--------HHHHHH
Confidence            9999865322    2233457899999999998889999999999999999999999998643321        111111


Q ss_pred             HHHhhcCCCccccccc---ccccCCccc---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMSMSSL---KDYIDPNMM---DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~---~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ................   ...+.+...   .....+....+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1111111100000000   000110000   0011234556889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-37  Score=316.96  Aligned_cols=257  Identities=29%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      .+++|...+.||+|+||.||+|.+.+       ..|++|......    ..++.+|+.++++++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45678889999999999999998854       578999876432    3468899999999999999999999998889


Q ss_pred             EEEEEeeccCCChhhhccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC---CEEE
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQN--RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF---RAKI  492 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  492 (639)
                      .+++|||+++++|.++++....  .....++|..++.++.||+.||+|||+++   ++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999875332  12235899999999999999999999987   99999999999998754   5999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      +|||+++.+..... .........+..|+|||++.+..++.++|||||||++|||++ |+.||.....        ..+.
T Consensus       161 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~  231 (277)
T cd05036         161 ADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVM  231 (277)
T ss_pred             ccCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999986532111 111112233568999999998899999999999999999997 8888853221        1111


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .   ......                 ....+..++..+.+++.+||+.+|++||++.+|++.|.+
T Consensus       232 ~---~~~~~~-----------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         232 E---FVTGGG-----------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             H---HHHcCC-----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            1   111110                 001233345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-38  Score=291.56  Aligned_cols=244  Identities=26%  Similarity=0.404  Sum_probs=201.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC--ceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      -++|+..+.||+|.||.||.|+.+.  -.||+|++.+..      ..++.+|++|-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            4678889999999999999998764  479999986543      35688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +||..+|+|...|.+.+   ...++......+..|+|.|+.|+|..+   ++||||||+|+|++..+..||+|||.+..-
T Consensus       101 lEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999997533   344666777788899999999999876   999999999999999999999999998753


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .     .......+||..|.+||...+...+..+|+|++|++.||++.|.+||.....        ...   +..+.+. 
T Consensus       175 p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~et---YkrI~k~-  237 (281)
T KOG0580|consen  175 P-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SET---YKRIRKV-  237 (281)
T ss_pred             C-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHH---HHHHHHc-
Confidence            2     2233457999999999999999999999999999999999999999954221        111   1111111 


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +..       .|........++|.+|+..+|.+|.+..|++.
T Consensus       238 ----------~~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  238 ----------DLK-------FPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ----------ccc-------CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                      112       23444557899999999999999999999875

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=313.24  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=199.1

Q ss_pred             CCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe-----
Q 036507          353 FSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDE-----  417 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  417 (639)
                      |...+.||+|+||.||+|....     ..+|+|.++.+     ..+.+.+|+++++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998742     57999988643     23568899999999999999999998866554     


Q ss_pred             -EEEEEeeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          418 -LFLIYEYAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       418 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                       .++++||+++|+|.+++..... .....+++.....++.|++.||+|||+++   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             7999999999999999865321 22346899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |+++.+..... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....        ..+   .
T Consensus       158 g~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~---~  225 (273)
T cd05035         158 GLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEI---Y  225 (273)
T ss_pred             cceeecccccc-ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHH---H
Confidence            99986543221 111122345678999999988889999999999999999999 8888743221        111   1


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ........             +    ..+..+..++.+++.+||+.||++||++.|+++.|++++
T Consensus       226 ~~~~~~~~-------------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         226 DYLRHGNR-------------L----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             HHHHcCCC-------------C----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            11111100             0    012344567999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-37  Score=322.85  Aligned_cols=237  Identities=30%  Similarity=0.391  Sum_probs=191.7

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      +.||+|+||.||++...  +..||+|.+...      ....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999874  578999998643      2345678999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      +|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......   .
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---~  149 (323)
T cd05595          81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---G  149 (323)
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC---C
Confidence            99988854     235889999999999999999999987   999999999999999999999999998753211   1


Q ss_pred             ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ...   .........      
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~---~~~~~~~~~------  212 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERL---FELILMEEI------  212 (323)
T ss_pred             CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHH---HHHHhcCCC------
Confidence            222345799999999999999999999999999999999999999854321        011   111111100      


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                                  ..+.....++.+++.+||+.||++||     ++.++++
T Consensus       213 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                        01233455789999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.2e-37  Score=313.44  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=195.3

Q ss_pred             CCCCceeecCceEEEEEEEcC----ceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------CeE
Q 036507          354 SDSSLLGHGTYGSVYYGNIRN----QEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------DEL  418 (639)
Q Consensus       354 ~~~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~  418 (639)
                      ...+.||+|+||.||+|....    ..+|+|.++..     ..+.+.+|++++++++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999998753    25899987532     345688999999999999999999987432      246


Q ss_pred             EEEEeeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          419 FLIYEYAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      ++++||+++|+|.+++..... .....+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999988743221 22345899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ++.+..... ........+++.|++||.+.+..++.++||||||+++|||++ |+.||.....        ..+..    
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~----  225 (272)
T cd05075         159 SKKIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYD----  225 (272)
T ss_pred             ccccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH----
Confidence            986643211 111122346778999999999999999999999999999999 7888743211        11111    


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .+.....            .    ..+..++..+.+++.+||+.||++|||++|+++.|++++
T Consensus       226 ~~~~~~~------------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         226 YLRQGNR------------L----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             HHHcCCC------------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            1111100            0    012234456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.1e-37  Score=312.21  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=198.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-ceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++|...+.||+|+||.||++...+ ..+|+|.+....  .+++.+|+.++++++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            356667889999999999998765 469999887543  46789999999999999999999999988899999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++...    ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.++......  
T Consensus        84 ~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--  154 (256)
T cd05113          84 GCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--  154 (256)
T ss_pred             CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc--
Confidence            9999998642    225899999999999999999999987   9999999999999999999999999987653221  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........++..|++||.+.+..++.++||||||+++|||++ |+.||.....        .....   .......    
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~---~~~~~~~----  219 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVE---KVSQGLR----  219 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHH---HHhcCCC----
Confidence            111112345678999999988889999999999999999998 9888853221        01111   1111100    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                                   ...+......+.+++.+||+.||++||++.++++.|+
T Consensus       220 -------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 -------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                         0011223457899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-37  Score=329.47  Aligned_cols=269  Identities=21%  Similarity=0.310  Sum_probs=199.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ..+|+..+.||+|+||.||++...  ++.||+|...   ...+.+|++++++++||||+++++++...+..++++|++ .
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~  166 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K  166 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence            467999999999999999999875  5789999754   345678999999999999999999999999999999999 4


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|..++..     ...+++...+.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus       167 ~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~--  236 (391)
T PHA03212        167 TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN--  236 (391)
T ss_pred             CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc--
Confidence            788888754     235789999999999999999999987   9999999999999999999999999997532211  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+....+..........+ ..+.......+.....
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l-~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI-KLIIRRSGTHPNEFPI  315 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH-HHHHHHhcCChhhcCc
Confidence            122334679999999999999999999999999999999999998875443211111111111 1111212111111000


Q ss_pred             ---cccccc---------cCCcccCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          588 ---SSLKDY---------IDPNMMDL--YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       588 ---~~~~~~---------~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         ..+...         ..+.....  .....+.++.+++.+||+.||++|||++|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               000000         00000000  01134567899999999999999999999985

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-38  Score=313.40  Aligned_cols=264  Identities=24%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCC-----eEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATED-----ELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~lv~e~  424 (639)
                      .|...+++|+|+||.||+|...  ++.||||+.-.+.. --.+|+++|++++|||||++.-++....     ...+||||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            4556789999999999999875  47899998754432 2237999999999999999998876432     34589999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEeccCCceecCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGK  503 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~  503 (639)
                      |+. +|.+.++... .....++.....-+..||.+||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+..
T Consensus       104 mP~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             chH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            975 8988887521 22344666667778899999999999977   9999999999999987 8999999999998854


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ....    ..+.-|+.|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.++        .+....+..+++.+.
T Consensus       179 ~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--------~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  179 GEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--------VDQLVEIIKVLGTPT  246 (364)
T ss_pred             CCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--------HHHHHHHHHHhCCCC
Confidence            3322    34567899999999887 5689999999999999999999988855332        233344455555443


Q ss_pred             Cccccc---ccccccCCccc-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMS---SLKDYIDPNMM-----DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~---~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+....   ...+...|.+.     .........+..+++.++++.+|.+|.++.|++.
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            221111   00011112222     1233456778999999999999999999999875

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.8e-37  Score=322.84  Aligned_cols=237  Identities=28%  Similarity=0.387  Sum_probs=192.3

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      +.||+|+||.||++...  ++.||+|.+...      ....+.+|++++++++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999874  578999998643      2356788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      +|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~---~~  149 (328)
T cd05593          81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT---DA  149 (328)
T ss_pred             CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC---cc
Confidence            99988854     235889999999999999999999987   99999999999999999999999999875321   11


Q ss_pred             ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+   ........       
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~---~~~~~~~~-------  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKL---FELILMED-------  211 (328)
T ss_pred             cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHH---HHHhccCC-------
Confidence            223346799999999999998999999999999999999999999954221        011   11111110       


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                             ..    .+.....++.+++.+||+.||++||     ++.|+++
T Consensus       212 -------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 -------IK----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -------cc----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence                   01    1223445688999999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.9e-37  Score=315.99  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=195.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .++|...+.||+|+||.||++...  ++.||+|.+....    ...+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467888999999999999999885  6789999986432    3457789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+. ++|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++.....
T Consensus        84 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          84 YVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             CCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            995 6888777532    234788888999999999999999987   99999999999999999999999999875422


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .   ........+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......       ......+...+....
T Consensus       156 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~  225 (303)
T cd07869         156 P---SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-------QDQLERIFLVLGTPN  225 (303)
T ss_pred             C---CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHHhCCCC
Confidence            1   122234568999999998865 45788999999999999999999999643221       111111111111111


Q ss_pred             Ccccccccc--cccCCc-ccCCCC---------hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLK--DYIDPN-MMDLYP---------HDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~--~~~d~~-l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      . .......  ...++. +....+         ......+.+++.+||+.||++|||++|+++
T Consensus       226 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         226 E-DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             h-hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0 0000000  000000 000000         012346789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-37  Score=309.73  Aligned_cols=249  Identities=31%  Similarity=0.550  Sum_probs=203.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      .++|+..+.||+|+||.||++...++.||+|.+....  .+++.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            3567778899999999999999999999999987653  46788999999999999999999999988999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.+++...   ....+++.....++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||.++......  
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          85 GSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             CcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            9999998642   2236899999999999999999999987   9999999999999999999999999998653211  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                          .....+..|+|||.+....++.++||||||++++||++ |+.||.....        ..+.    ..+....    
T Consensus       157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~----~~~~~~~----  216 (256)
T cd05039         157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVV----PHVEKGY----  216 (256)
T ss_pred             ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHH----HHHhcCC----
Confidence                12334567999999988889999999999999999997 9988843221        1111    1111100    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  ....+...+..+.+++.+||+.+|++||+++|++.+|+++
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 ------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                        0011223356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-37  Score=316.75  Aligned_cols=265  Identities=24%  Similarity=0.420  Sum_probs=200.8

Q ss_pred             CCCCCCCceeecCceEEEEEEE------cCceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATE--DEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  418 (639)
                      +-|+..+.||+|+||.||++..      .+..||+|.++..    ..+.+.+|++++++++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467788999999999999874      2568999998643    235688999999999999999999998775  568


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      +++|||+++++|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence            9999999999999998532    235899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchh----hhhhhHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN----QERRSLASFM  574 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~----~~~~~l~~~~  574 (639)
                      ..+..............++..|+|||.+.+..++.++||||||+++|||++++.|...........    ......... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-  235 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-
Confidence            866432221111223456778999999988889999999999999999999876543211100000    000000000 


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ...+...                .....+..++..+.+++.+||+.+|++||+++++++.|++++
T Consensus       236 ~~~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         236 VRVLEEG----------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHHHcC----------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            0111100                000112335567999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-38  Score=325.78  Aligned_cols=247  Identities=24%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe-EEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDE-LFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~lv~  422 (639)
                      ++|...+.+|+|+||.+++.+++  +..+++|.++-.     ......+|+.++++++|||||.+.+.+..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56777899999999999977664  578999988643     24467899999999999999999999999888 89999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      +|++||+|.+.+...+   ...++......++.|++.|+.|||+..   |+|||||+.|||++.+..+||+|||+|+.+.
T Consensus        84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence            9999999999998643   456889999999999999999999776   9999999999999999999999999999875


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   .......||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+.           ...+..+.... 
T Consensus       158 ~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------~~Li~ki~~~~-  222 (426)
T KOG0589|consen  158 PED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------SELILKINRGL-  222 (426)
T ss_pred             Cch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------HHHHHHHhhcc-
Confidence            432   234557999999999999999999999999999999999999999965442           12222222211 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                                 +.     ..|.....++..++..|++.+|..||++.++|..
T Consensus       223 -----------~~-----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -----------YS-----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----------CC-----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                       11     1244456679999999999999999999999875

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-37  Score=310.79  Aligned_cols=249  Identities=27%  Similarity=0.450  Sum_probs=197.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      .+|+..+.||+|+||.||++.+.+ ..+|+|.+...  ...++.+|++++++++|+||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            346778899999999999998764 57999988653  345788999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.+++...    ...+++...+.++.|++.|++|||+.+   ++||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--  154 (256)
T cd05059          84 GCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--  154 (256)
T ss_pred             CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc--
Confidence            9999998642    235899999999999999999999987   9999999999999999999999999987653211  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .....   . +...     
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~---~-~~~~-----  217 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVE---S-VSAG-----  217 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHH---H-HHcC-----
Confidence            111111223457999999999899999999999999999999 7888853221        01111   1 1110     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                             ...    ..+..++.++.+++.+||+.+|++|||++|+++.|.
T Consensus       218 -------~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         218 -------YRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -------CcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                   000    112234567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-37  Score=324.94  Aligned_cols=240  Identities=27%  Similarity=0.372  Sum_probs=196.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC---ceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN---QEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|...+.||+|+||.||+|...+   ..||+|.+...      ..+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            567778899999999999998643   47999988542      245678899999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.+++..     ...+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..+
T Consensus       110 ~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999864     235888899999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ...   ........
T Consensus       182 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~---~~~i~~~~  244 (340)
T PTZ00426        182 DTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLI---YQKILEGI  244 (340)
T ss_pred             CCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHH---HHHHhcCC
Confidence            321      2345799999999999988899999999999999999999999964321        001   11111110


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                      .                  .++......+.+++.+|++.||++|+     +++|+++
T Consensus       245 ~------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        245 I------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             C------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            0                  01223345678999999999999995     8888764

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-37  Score=319.81  Aligned_cols=259  Identities=28%  Similarity=0.477  Sum_probs=202.7

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc---------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR---------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAAT  414 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~  414 (639)
                      ..++|...+.||+|+||.||++...         +..+|+|.+...    ...++.+|+++++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3466778899999999999999742         236999988643    235688999999999 79999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNR-----------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      ....+++|||+++|+|.+++......           ....+++..++.++.|+++||+|||+++   ++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            99999999999999999998753211           1245889999999999999999999987   999999999999


Q ss_pred             ECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccc
Q 036507          484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVS  562 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~  562 (639)
                      +++++.+||+|||+++.+...... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....   
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  245 (304)
T ss_pred             EcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence            999999999999999866432211 11122345678999999988889999999999999999998 6777643211   


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                              .+... .+....                ....+..++..+.+++.+||+.+|++||++.|+++.|++++
T Consensus       246 --------~~~~~-~~~~~~----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 --------EELFK-LLKEGH----------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             --------HHHHH-HHHcCC----------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                    11111 111110                00112345567999999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.1e-37  Score=316.89  Aligned_cols=254  Identities=27%  Similarity=0.430  Sum_probs=199.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      +|...+.||+|+||.||+|...       +..||+|.++...    .+.+.+|+.++.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3555778999999999999864       2579999987542    3457889999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC
Q 036507          421 IYEYAQKGSLKSHLHDPQ-----------NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR  489 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~  489 (639)
                      ++||+.+++|.+++....           ......+++..+..++.|++.||+|||+++   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999985211           011245888899999999999999999987   999999999999999999


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhh
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  568 (639)
                      +||+|||+++....... ........+++.|+|||.+.++.++.++||||||+++|||++ |..|+.....        .
T Consensus       163 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~  233 (283)
T cd05091         163 VKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------Q  233 (283)
T ss_pred             eEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence            99999999876532211 111223456788999999988889999999999999999998 7777743221        1


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .+   .... ....                ....+.+++..+.+++.+||+.+|++||++++++..|+.
T Consensus       234 ~~---~~~i-~~~~----------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 DV---IEMI-RNRQ----------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HH---HHHH-HcCC----------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11   1111 1110                011234566779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-37  Score=309.23  Aligned_cols=245  Identities=29%  Similarity=0.479  Sum_probs=194.1

Q ss_pred             CceeecCceEEEEEEEc--C---ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--N---QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++||+|+||.||+|...  +   ..+|+|.+....    .+++.+|++++++++|+||+++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999763  2   579999986543    356889999999999999999999875 5578999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++...     ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+......
T Consensus        80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999642     25899999999999999999999987   999999999999999999999999999866432221


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.        ..+....    ....    
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~----~~~~----  215 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAML----ESGE----  215 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHH----HcCC----
Confidence            111111233567999999998899999999999999999998 9999854321        1111111    1100    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  ....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       216 ------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 ------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                        0012233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.3e-37  Score=314.13  Aligned_cols=263  Identities=25%  Similarity=0.411  Sum_probs=202.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC------------------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN------------------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVE  407 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~------------------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~  407 (639)
                      ..+|+..+.||+|+||.||++...+                  ..||+|.+....    .+++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678889999999999999987643                  358999986542    456889999999999999999


Q ss_pred             EEeeeecCCeEEEEEeeccCCChhhhccCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       408 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                      +++++..++..++++||+++++|.+++......      ....+++...+.++.|++.||+|||+++   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            999999999999999999999999998754311      2236899999999999999999999987   9999999999


Q ss_pred             EEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc--CCcccccccc
Q 036507          482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS--GKEAIIRTEG  559 (639)
Q Consensus       482 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt--G~~p~~~~~~  559 (639)
                      |+++.++.++|+|||+++...... .........++..|+|||.+.+..++.++||||||+++|||++  |..|+.....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSD-YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCc-ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999987653221 1112223456788999999988889999999999999999998  5666643221


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                              ...........+..             +.......+..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus       240 --------~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 --------QQVIENAGHFFRDD-------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --------HHHHHHHHhccccc-------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                    11111111111100             0000001122344679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.4e-37  Score=320.47  Aligned_cols=258  Identities=29%  Similarity=0.493  Sum_probs=201.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC---------ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN---------QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATE  415 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  415 (639)
                      .++|...+.||+|+||.||++...+         ..+|+|.+...    ...++.+|+++++++ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3568888999999999999987532         46999998743    234678899999999 799999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNR-----------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL  484 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll  484 (639)
                      +..++||||+++|+|.+++......           ....+++..++.++.|++.||+|||+++   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            9999999999999999999753211           1245899999999999999999999987   9999999999999


Q ss_pred             CCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccch
Q 036507          485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSK  563 (639)
Q Consensus       485 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~  563 (639)
                      +.++.+||+|||++..+..... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence            9999999999999875532111 111111234568999999998889999999999999999998 7888743211    


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                             .+.. ..+....                ....+..+..++.+++.+||+.+|++||+|.|+++.|++++
T Consensus       249 -------~~~~-~~~~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 -------EELF-KLLKEGH----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             -------HHHH-HHHHcCC----------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                   0111 1111110                00122344567899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.9e-37  Score=310.61  Aligned_cols=256  Identities=22%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecc------ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTA------TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||+|..  .++.||||.+..      .....+.+|++++++++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688899999999999999987  468999997643      12346788999999999999999999999899999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++.... .....++......++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..+.
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            9999999998885422 12345788889999999999999999987   9999999999999999999999999988653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   .......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+.....         ....... .+....
T Consensus       158 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---------~~~~~~~-~~~~~~  224 (267)
T cd08228         158 SKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLFSLCQ-KIEQCD  224 (267)
T ss_pred             chh---HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---------cHHHHHH-HHhcCC
Confidence            221   112234688899999999888899999999999999999999999853221         0111111 111100


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  .+   ...+......+.+++.+||+.+|++||++++|++.|+++
T Consensus       225 ------------~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 ------------YP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ------------CC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                        00   011223456799999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.4e-37  Score=316.96  Aligned_cols=253  Identities=29%  Similarity=0.494  Sum_probs=197.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC----ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN----QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|+..+.||+|+||.||+|....    ..+++|.++..    ..+.+.+|+++++++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            567888899999999999998753    24788887642    235688999999999 799999999999998999999


Q ss_pred             EeeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          422 YEYAQKGSLKSHLHDPQNR-----------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      +||+++++|.++++.....           ....+++.....++.|++.||+|||+++   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            9999999999998653211           1235889999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||++.....    .........+..|+|||.+.+..++.++|||||||++|||++ |+.||.....        ..
T Consensus       159 kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~  226 (297)
T cd05089         159 KIADFGLSRGEEV----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AE  226 (297)
T ss_pred             EECCcCCCccccc----eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence            9999999863211    001111223457999999998889999999999999999997 9999854321        01


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +.   ......                 .....+..++..+.+++.+||+.+|.+||+++++++.|+++
T Consensus       227 ~~---~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         227 LY---EKLPQG-----------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             HH---HHHhcC-----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11   111110                 00011233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.8e-37  Score=319.77  Aligned_cols=195  Identities=26%  Similarity=0.418  Sum_probs=169.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .++|+..++||+|+||.||++...  +..+|+|.+...    ..+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478889999999999999999886  567899987543    23568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++..     ...+++.....++.|++.||.|||+..  +|+|+||||+|||+++++.+||+|||++..+..
T Consensus        84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          84 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999864     234788888999999999999999742  499999999999999999999999999875432


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      .     ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       157 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         157 S-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             h-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            1     12235689999999999988899999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.3e-37  Score=319.62  Aligned_cols=237  Identities=27%  Similarity=0.361  Sum_probs=190.2

Q ss_pred             CceeecCceEEEEEEE-----cCceEEEEEecccc-------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          357 SLLGHGTYGSVYYGNI-----RNQEVAIKRMTATK-------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +.||+|+||.||++..     .++.||+|.++...       ...+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999875     35789999986432       23467899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++..     ...+.+.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            999999999864     234777888889999999999999987   999999999999999999999999998754221


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.           ............  
T Consensus       154 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----------~~~~~~~~~~~~--  217 (323)
T cd05584         154 G---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----------KKTIDKILKGKL--  217 (323)
T ss_pred             C---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCC--
Confidence            1   122335799999999999988899999999999999999999999954321           011111111110  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                                      ..+......+.+++.+||+.||++||     ++++++.
T Consensus       218 ----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 ----------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                            01223345689999999999999999     7777764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4e-37  Score=337.35  Aligned_cols=248  Identities=22%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             CCCCCceeecCceEEEEEEEc---CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      |...+.||+|+||.||++...   +..||+|.+....   ...+.+|+++++.++||||+++++++..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            667889999999999999764   4578888764332   3456789999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.++++... ....++++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       149 gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        149 GGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999886421 22346888899999999999999999987   99999999999999999999999999987643211


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ...+...+....    
T Consensus       225 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----------~~~~~~~~~~~~----  288 (478)
T PTZ00267        225 -LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----------REIMQQVLYGKY----  288 (478)
T ss_pred             -cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCC----
Confidence             1123345799999999999999999999999999999999999999853221           111111111110    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                              +     ..+..+...+.+++.+||+.||++||++++++.
T Consensus       289 --------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 --------D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --------C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                    0     012233456899999999999999999999875

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.9e-37  Score=309.10  Aligned_cols=252  Identities=29%  Similarity=0.464  Sum_probs=199.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|...++||+|+||.||+|...+ ..||+|.+...  ..+++.+|++++++++|+||+++++++. .+..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            3568888999999999999998764 57999998753  2467899999999999999999999874 456899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.+++...   ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||.+..+.....
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999642   2345789999999999999999999987   99999999999999999999999999986643221


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                        .......++..|++||++.+..++.++||||||+++|||++ |+.||.....        ....   ........   
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~---~~~~~~~~---  221 (262)
T cd05071         158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVL---DQVERGYR---  221 (262)
T ss_pred             --ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHH---HHHhcCCC---
Confidence              11122346678999999988889999999999999999999 7777743221        0111   11111000   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                    ...+.+++..+.+++.+|++.||++||+++++++.|++.
T Consensus       222 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 --------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                          011234456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=307.90  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++|...+.||+|++|.||++...  ++.+|+|.+...        ..+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999764  588999987532        12457889999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ++||+++++|.+++..     ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.
T Consensus        82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            9999999999999864     234788888999999999999999987   99999999999999999999999999976


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...............++..|+|||.+.+..++.++||||||+++|||++|+.||...+..           .........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~~~~~~~~~  222 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----------AAIFKIATQ  222 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----------HHHHHHhcc
Confidence            533221111113356788999999999988999999999999999999999998543210           000111100


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      .                .....+......+.+++.+||+.+|++||++.|++..
T Consensus       223 ~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 P----------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             C----------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0                0011233445578999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.6e-37  Score=316.36  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=201.8

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKV-HHSNLVELIGYAATED  416 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  416 (639)
                      ..++|...+.||+|+||.||++...       +..+|+|.++...    .+.+.+|+++++++ +|+||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3456888899999999999998752       2479999886432    35688999999999 7999999999999999


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..+++|||+++|+|.++++...   ...+++.....++.|++.||+|||+++   |+|+||||+||+++.++.++|+|||
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            9999999999999999986422   234899999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ++..+..... ........++..|+|||.+.+..++.++|||||||++|||++ |..||......       ...    .
T Consensus       187 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~----~  254 (302)
T cd05055         187 LARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKF----Y  254 (302)
T ss_pred             ccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHH----H
Confidence            9986533211 111122345778999999999899999999999999999998 88887533210       001    1


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .......                ....+...+.++.+++.+||+.+|++||++.|+++.|++++
T Consensus       255 ~~~~~~~----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         255 KLIKEGY----------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             HHHHcCC----------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            1111100                00011223456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-37  Score=310.52  Aligned_cols=248  Identities=31%  Similarity=0.541  Sum_probs=193.3

Q ss_pred             CceeecCceEEEEEEEcC----ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIRN----QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||+|...+    ..+++|.++..    ..+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998753    24788887642    235688999999999 799999999999999999999999999


Q ss_pred             CChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          428 GSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       428 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      |+|.++++....           .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999875321           11235789999999999999999999977   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ++.....    .........+..|+|||++.+..++.++||||||+++|||++ |..||.....        ...   ..
T Consensus       158 l~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~---~~  222 (270)
T cd05047         158 LSRGQEV----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL---YE  222 (270)
T ss_pred             Cccccch----hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHH---HH
Confidence            9853211    001111233567999999988889999999999999999997 9988853221        011   11


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ......                 ....+..+...+.+++.+||+.+|.+|||+.|++..|++++
T Consensus       223 ~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 KLPQGY-----------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHhCCC-----------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            111000                 00012234456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.3e-37  Score=308.42  Aligned_cols=251  Identities=31%  Similarity=0.512  Sum_probs=199.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|+..++||+|+||.||++...+ ..+|+|.+...  ..+++.+|++++++++|+|++++++++. .+..+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            3567788899999999999998754 67999988653  3467899999999999999999999875 566899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.++++..   ....+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++..+.....
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999998752   2345889999999999999999999987   99999999999999999999999999986543211


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                        .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ......   .....    
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~---~~~~~----  220 (260)
T cd05070         158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQ---VERGY----  220 (260)
T ss_pred             --ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH---HHcCC----
Confidence              11112345668999999988889999999999999999999 8888843221        111111   11110    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                                   ....+.+.+..+.+++.+|++.+|++|||++++.+.|++
T Consensus       221 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 -------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                         001223445679999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.2e-37  Score=313.87  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=201.3

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATED  416 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~  416 (639)
                      ...++|+..+.||+|+||.||+|...       +..||+|.+....    ..++.+|+.++++++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678889999999999999998653       2479999876432    345788999999999999999999999899


Q ss_pred             eEEEEEeeccCCChhhhccCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQN-----RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                      ..+++|||+++|+|.+++.....     .....+.+.....++.|++.||.|||+++   |+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999964221     12345677888899999999999999987   99999999999999999999


Q ss_pred             EeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhH
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l  570 (639)
                      |+|||+++....... ........++..|+|||.+.++.++.++|||||||++|||++ |..||.....        ...
T Consensus       160 L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~  230 (288)
T cd05061         160 IGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQV  230 (288)
T ss_pred             ECcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence            999999875532211 111122345678999999998899999999999999999998 6777743221        011


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..   ......                . ...+..++..+.+++.+||+.||++|||+.++++.|.+.
T Consensus       231 ~~---~~~~~~----------------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         231 LK---FVMDGG----------------Y-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HH---HHHcCC----------------C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11   111110                0 001223456799999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-37  Score=338.32  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=200.2

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC----
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED----  416 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----  416 (639)
                      ...++|...+.||+|+||+||++..  .++.||||.+...     ....+.+|+.++..++|+|++++...+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457899999999999999999976  4689999998543     2345788999999999999999987764332    


Q ss_pred             ----eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          417 ----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       417 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                          .+++||||+++|+|.++++... .....+++.....++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                3689999999999999986532 22356889999999999999999999987   999999999999999999999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      +|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ..
T Consensus       185 ~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----------~~  252 (496)
T PTZ00283        185 GDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----------EE  252 (496)
T ss_pred             EecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----------HH
Confidence            99999986643211 1122346799999999999999999999999999999999999999853221           11


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+...+...            .+     ..+...+.++.+++.+||+.||++||++.+++.
T Consensus       253 ~~~~~~~~~------------~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        253 VMHKTLAGR------------YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HHHHHhcCC------------CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            111111111            00     122344567999999999999999999999975

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=311.79  Aligned_cols=247  Identities=28%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      +|+..++||+|+||.||++...  ++.||+|.+....      ...+.+|++++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999874  5789999886432      2346789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++...   ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999888642   2345899999999999999999999987   99999999999999999999999999986532


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..    ......|+..|+|||++.+..++.++||||||+++|||++|+.||......        .....+...+.... 
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~-  221 (285)
T cd05605         155 GE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--------VKREEVERRVKEDQ-  221 (285)
T ss_pred             CC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--------hHHHHHHHHhhhcc-
Confidence            11    123357899999999999889999999999999999999999999643220        11111111111110 


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                                      ..++...+..+.+++.+||+.||++||     ++++++.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                            112233455689999999999999999     7888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.5e-37  Score=320.86  Aligned_cols=247  Identities=26%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             CCCCCCceeecCceEEEEEEE-----cCceEEEEEeccc-------cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNI-----RNQEVAIKRMTAT-------KTKEFMAEMKILCKVH-HSNLVELIGYAATEDEL  418 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~-------~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~  418 (639)
                      +|+..+.||+|+||.||++..     .+..||+|.+...       ..+.+.+|++++.+++ |+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            467788999999999999875     3578999988642       1245778999999995 99999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            999999999999999854     235888899999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +.+....  ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.......       .........
T Consensus       153 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~~~~~~  223 (332)
T cd05614         153 KEFLSEE--KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-------TQSEVSRRI  223 (332)
T ss_pred             ccccccC--CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-------CHHHHHHHH
Confidence            7653221  1222346799999999998765 47889999999999999999999995432210       011111111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                      ...              ++.    .+......+.+++.+||+.||++||     +++++++
T Consensus       224 ~~~--------------~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         224 LKC--------------DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             hcC--------------CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            111              111    1223345688999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-36  Score=310.39  Aligned_cols=243  Identities=25%  Similarity=0.360  Sum_probs=191.6

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ||+|+||+||++...  ++.+|+|.+....      .+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999875  5789999986432      24567899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++.... .....+++.....++.|++.||+|||+++   |+||||||+||++++++.+||+|||++..+....   ..
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---~~  153 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SK  153 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC---cc
Confidence            98875422 22346899999999999999999999987   9999999999999999999999999997653321   12


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ............          
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~----------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------ENKELKQRILND----------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-------hHHHHHHhhccc----------
Confidence            234578999999999999999999999999999999999999985432210       000000011000          


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                            .  ...+...+..+.+++.+||+.||++||     ++++++.
T Consensus       217 ------~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 ------S--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ------C--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                  0  012233456789999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.6e-37  Score=317.75  Aligned_cols=253  Identities=30%  Similarity=0.526  Sum_probs=196.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--Cc--eEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQ--EVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|+..+.||+|+||.||+|.+.  +.  .+++|.+...    ...++.+|++++.++ +|+||+++++++..++..+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56777889999999999999864  33  4688876542    234678899999999 899999999999999999999


Q ss_pred             EeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          422 YEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      +||+++++|.++++....           .....+++..++.++.|++.|++|||+++   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999875321           11235889999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||++......    .......++..|+|||.+.+..++.++||||||+++|||+| |..||.....        ..
T Consensus       164 kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~  231 (303)
T cd05088         164 KIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE  231 (303)
T ss_pred             EeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HH
Confidence            99999998632110    01111234567999999988889999999999999999998 9988853321        01


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...   .. ...                .....+...+..+.+++.+||+.+|++||+++++++.|+++
T Consensus       232 ~~~---~~-~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         232 LYE---KL-PQG----------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHH---HH-hcC----------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111   11 000                00001222345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-37  Score=313.26  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=202.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .++|...+.||+|+||.||++...+       ..+|+|.+....    ..++.+|+.++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4577888999999999999998753       579999986432    34688999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNR-----GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                      +++|||+++|+|.+++......     ....++|...+.++.|++.||.|||+.+   ++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            9999999999999998653211     1235789999999999999999999877   9999999999999999999999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHH
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      |||+++.+..... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .....
T Consensus       162 dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~  232 (277)
T cd05032         162 DFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLK  232 (277)
T ss_pred             CcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHH
Confidence            9999876533211 111223456788999999988889999999999999999998 8888743221        11111


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .    .....                ....+..++..+.+++.+||+.+|++|||+.++++.|++
T Consensus       233 ~----~~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         233 F----VIDGG----------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             H----HhcCC----------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1    11100                001223345679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=300.72  Aligned_cols=266  Identities=23%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccccH-----HHHHHHHHHHHhcCCCC-eeEEEeeeecCC------e
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT-----KEFMAEMKILCKVHHSN-LVELIGYAATED------E  417 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-----~~~~~E~~il~~l~h~n-iv~l~~~~~~~~------~  417 (639)
                      .|...++||+|+||+||+|+..  |+.||+|+++-+..     ....+|+.+|++++|+| |+++++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            4555678999999999999874  67899999865432     34689999999999999 999999998877      7


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      +++||||+ .-+|..++....... ..++......++.||++||+|||+++   |+||||||.|||+++.|.+||+|||+
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            89999999 559999997643211 34666788899999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      |+.+..   .....+.-++|.+|+|||++.+. .|+...||||+|||+.||++++..|....+        .+....+-.
T Consensus       167 Ara~~i---p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--------~~ql~~If~  235 (323)
T KOG0594|consen  167 ARAFSI---PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--------IDQLFRIFR  235 (323)
T ss_pred             HHHhcC---CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--------HHHHHHHHH
Confidence            986542   23335667889999999999886 789999999999999999999887754332        112222233


Q ss_pred             HhhcCCCcccccccccccCCc--ccCCC-Ch-------hHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPN--MMDLY-PH-------DCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~--l~~~~-~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      .++.+. +..+.......+-.  ..... +.       .......+++.+|++.+|.+|.|++..+..
T Consensus       236 ~lGtP~-e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  236 LLGTPN-EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HcCCCC-ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            333322 22222222111111  11110 11       111368899999999999999999998864

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=327.66  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=199.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++...  ++.||+|+++..      ....+.+|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888899999999999999886  689999998643      2356788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++...     ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            999999999999642     45888999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCC--------------------------CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          503 KTSD--------------------------GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       503 ~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      ....                          .........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            3220                          01122345799999999999999999999999999999999999999964


Q ss_pred             cccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 036507          557 TEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-MKQVVI  633 (639)
Q Consensus       557 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  633 (639)
                      ...           ......... ...        ...-|.     ....+..+.+++.+|+. ||.+||+ ++|+++
T Consensus       233 ~~~-----------~~~~~~i~~-~~~--------~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         233 DTL-----------QETYNKIIN-WKE--------SLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCH-----------HHHHHHHhc-cCC--------cccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            331           001111111 000        000000     01135568899999998 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.5e-37  Score=310.85  Aligned_cols=253  Identities=26%  Similarity=0.487  Sum_probs=199.4

Q ss_pred             CCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .|...+.||+|+||.||+|....     ..||||.+...    ..++|..|++++++++||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            35667899999999999998752     35999998643    2457889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++...    ...+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++....
T Consensus        85 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          85 EFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             ecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999998642    245889999999999999999999987   9999999999999999999999999987654


Q ss_pred             CCCCCcceeeeec--cccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVV--GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .............  .+..|+|||.+.+..++.++||||||+++|||++ |..||.....        ......+    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i----~  225 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAI----E  225 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHH----H
Confidence            3221111111111  2457999999999999999999999999999886 9988854321        1111111    1


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ...                ....+.+++..+.+++.+||+.+|++||++++++..|++++
T Consensus       226 ~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         226 QDY----------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             cCC----------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            100                00012344567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-36  Score=305.76  Aligned_cols=256  Identities=21%  Similarity=0.385  Sum_probs=205.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||+|...  ++.+|+|.++..      ..+.+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999885  688999987531      2456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++.... .....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999999886432 22345889999999999999999999987   9999999999999999999999999987653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....         .+........... 
T Consensus       158 ~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~-  224 (267)
T cd08224         158 SKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSLCKKIEKCD-  224 (267)
T ss_pred             CCC---cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---------cHHHHHhhhhcCC-
Confidence            321   112234688899999999988899999999999999999999999853221         1111111110000 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                 . +   ..........+.+++.+||+.+|++||++.+++++|+++
T Consensus       225 -----------~-~---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         225 -----------Y-P---PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             -----------C-C---CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                       0 0   001123455789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.2e-37  Score=313.81  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=200.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .++|+..+.||+|+||.||++...       +..+|+|.+....    .+++.+|++++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888999999999999999863       4689999886532    35688999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQN-----------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                      ++++||+++|+|.+++.....                 .....+++..++.++.|++.||.|||+++   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999864211                 11235788999999999999999999987   9999999999


Q ss_pred             EEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccc
Q 036507          482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGM  560 (639)
Q Consensus       482 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~  560 (639)
                      |++++++.++|+|||++..+..... .........+..|+|||.+.+..++.++|||||||++|||++ |..||..... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-  238 (288)
T ss_pred             eEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            9999999999999999875532211 111112234667999999998899999999999999999997 8778743221 


Q ss_pred             cchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       561 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                                .+.... +....       .         ...+..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus       239 ----------~~~~~~-~~~~~-------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 ----------EEVIYY-VRDGN-------V---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----------HHHHHH-HhcCC-------C---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                      011111 11100       0         00122345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=326.33  Aligned_cols=245  Identities=27%  Similarity=0.452  Sum_probs=205.3

Q ss_pred             CCCceeecCceEEEEEEEcC-----ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          355 DSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..++||+|.||.|++|.|+.     -.||||.++.+.    ..+|++|+.+|.+|+|+|+++|+|+..+ ....||||++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            35689999999999999863     369999997653    5689999999999999999999999876 7788999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      +.|+|.+.|+.   .....|-......++.|||.||.||.++.   +|||||..+|+|+-....+||+|||+.+-++...
T Consensus       193 plGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  193 PLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             ccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999986   23456788888899999999999999987   9999999999999999999999999999887655


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      +.........-...|+|||.+....++.++|||+|||+||||+| |..||-+..+                         
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------------------------  321 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------------------------  321 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------------------------
Confidence            44333333445667999999999999999999999999999999 6788855433                         


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                         ..+.+.+|..-+...|..|++.+.+++..||..+|++||++..+.+.
T Consensus       322 ---~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  322 ---IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ---HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence               11222333333344588999999999999999999999999999744

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-36  Score=311.14  Aligned_cols=252  Identities=24%  Similarity=0.413  Sum_probs=197.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--Cc----eEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQ----EVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|+..++||+|+||.||+|.+.  +.    .||+|.+....    .+++.+|+.+++.++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            456788899999999999999863  33    48999886432    3567889999999999999999999875 4578


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +++||+++|+|.++++..    ...+++...+.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus        85 l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence            999999999999998642    245889999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+..... ........++..|++||.+.+..++.++||||||+++|||++ |..||.....        ..+....    
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~----  224 (279)
T cd05109         158 LLDIDET-EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLL----  224 (279)
T ss_pred             ecccccc-eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH----
Confidence            7642211 111112345678999999998899999999999999999998 8888743221        1111111    


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                ....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       225 ~~~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         225 EKGE----------------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             HCCC----------------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            1100                0001223445789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-36  Score=317.42  Aligned_cols=240  Identities=28%  Similarity=0.414  Sum_probs=190.1

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHH---HhcCCCCeeEEEeeeecCCeEEEE
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKIL---CKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il---~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      |+..+.||+|+||.||++...  ++.||||.++..      ..+.+.+|++++   ++++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556788999999999999875  578999998643      234466666655   566899999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|..+++.      ..+++.....++.|++.||+|||+++   |+||||||+||++++++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            999999999988753      35899999999999999999999987   999999999999999999999999998743


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...   ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.....        .   ..........
T Consensus       152 ~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~---~~~~~i~~~~  217 (324)
T cd05589         152 MGF---GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------E---EVFDSIVNDE  217 (324)
T ss_pred             CCC---CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------H---HHHHHHHhCC
Confidence            211   1222346799999999999999999999999999999999999999854321        0   1111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                      +                  ..+...+..+.+++.+||+.||++||+     +.++++
T Consensus       218 ~------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 V------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             C------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            0                  012334556889999999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-36  Score=311.11  Aligned_cols=256  Identities=23%  Similarity=0.405  Sum_probs=199.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|...++||+|+||.||++...       +..+++|.+....   .+++.+|++++++++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            356777889999999999998642       3578999876532   457889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC
Q 036507          420 LIYEYAQKGSLKSHLHDPQN----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR  489 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~  489 (639)
                      ++|||+++++|.+++.....          .....+++..++.++.|++.|++|||+.+   ++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999999865321          11235889999999999999999999987   999999999999999999


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhh
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  568 (639)
                      +||+|||++..+.... .........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....        .
T Consensus       161 ~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~  231 (280)
T cd05092         161 VKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------T  231 (280)
T ss_pred             EEECCCCceeEcCCCc-eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------H
Confidence            9999999997653211 1111122345678999999999999999999999999999998 8888843221        0


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      ..   ........+                 ...+..++..+.+++.+||+.||++||+++||++.|++
T Consensus       232 ~~---~~~~~~~~~-----------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         232 EA---IECITQGRE-----------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HH---HHHHHcCcc-----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11   111111100                 00122344568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.2e-37  Score=320.58  Aligned_cols=237  Identities=29%  Similarity=0.393  Sum_probs=190.9

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      +.||+|+||.||++...  +..||+|.+...      ....+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999874  578999998643      2345678999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      +|.+++..     ...+++.....++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---  149 (325)
T cd05594          81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---  149 (325)
T ss_pred             cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC---
Confidence            99998854     2358899999999999999999997 55   999999999999999999999999998753221   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+.   .......      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~---~~i~~~~------  212 (325)
T cd05594         150 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLF---ELILMEE------  212 (325)
T ss_pred             CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHH---HHHhcCC------
Confidence            1122345799999999999999999999999999999999999999954321        0111   1111110      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                              ..    .+.....++.+++.+||+.||++|+     ++.++++
T Consensus       213 --------~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         213 --------IR----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             --------CC----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                    00    1223345688999999999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.2e-37  Score=334.37  Aligned_cols=267  Identities=21%  Similarity=0.321  Sum_probs=193.1

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecC--------CeE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE--------DEL  418 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--------~~~  418 (639)
                      ..++|...++||+|+||.||+|...  ++.||||++.... ....+|+.+|++++||||+++++++...        ..+
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            4567999999999999999999874  5789999885432 2345799999999999999998876432        246


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCC
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGL  497 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl  497 (639)
                      ++||||++ ++|.+++.... .....+++.....++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+
T Consensus       143 ~lvmE~~~-~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        143 NVVMEFIP-QTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEecCC-ccHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence            78999996 47777664321 22356889999999999999999999987   99999999999999665 699999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ++.+....    ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||......        .....+..
T Consensus       218 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--------~~~~~i~~  285 (440)
T PTZ00036        218 AKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--------DQLVRIIQ  285 (440)
T ss_pred             chhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHH
Confidence            98653221    1223578999999998865 46899999999999999999999998543321        01111111


Q ss_pred             HhhcCCCcc--------cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSM--------SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~--------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+.......        ............+...++...+.++.+|+.+||+.||.+|||+.|++.
T Consensus       286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            111111000        000000111111222233345567999999999999999999999874

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-37  Score=291.75  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=199.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-------c----HHHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-------K----TKEFMAEMKILCKVH-HSNLVELIGYAATE  415 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-------~----~~~~~~E~~il~~l~-h~niv~l~~~~~~~  415 (639)
                      -.+|...+.||.|..++|-+..++  ++.+|+|++...       .    .+...+|+.||+++. ||+|+.+.+++...
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            356777889999999999887664  678999987421       1    244678999999986 99999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      ..+++|+|.|+.|.|.++|..     .-.++.....+|+.|+.+|++|||.++   |+||||||+|||+|++.++||+||
T Consensus        96 sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             chhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            999999999999999999964     345889999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCcccccc------CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      |+++.+..    .......+|||+|+|||.+..      ..|+..+|.|++||+||.|+.|.+||.....          
T Consensus       168 GFa~~l~~----GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----------  233 (411)
T KOG0599|consen  168 GFACQLEP----GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----------  233 (411)
T ss_pred             ceeeccCC----chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----------
Confidence            99998743    345667899999999998853      4678899999999999999999999943221          


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      + -...-++...         .++-.|.+     .+......+|+.+||+.||.+|.|++|+|.
T Consensus       234 m-lMLR~ImeGk---------yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  234 M-LMLRMIMEGK---------YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             H-HHHHHHHhcc---------cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1 1111112111         12222222     234556889999999999999999999875

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.6e-37  Score=311.50  Aligned_cols=258  Identities=24%  Similarity=0.437  Sum_probs=202.5

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeec-CCe
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAAT-EDE  417 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~  417 (639)
                      ..++|...+.||+|+||.||+|...+      ..|++|.+...    ..+.+.+|++++++++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35678888999999999999998754      67899987643    24568899999999999999999998766 467


Q ss_pred             EEEEEeeccCCChhhhccCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNR---GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                      .++++||+++++|.+++......   ....+++..+..++.|++.||+|||+++   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998653211   1256899999999999999999999887   99999999999999999999999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      ||+++.+.... .........++..|+|||.+.+..++.++||||||+++||+++ |+.||.....        ..+..+
T Consensus       161 ~g~~~~~~~~~-~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~  231 (280)
T cd05043         161 NALSRDLFPMD-YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAY  231 (280)
T ss_pred             CCCcccccCCc-eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHH
Confidence            99998653221 1111122345678999999998889999999999999999999 9999854321        111111


Q ss_pred             HHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                          +....            ...    .+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       232 ----~~~~~------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         232 ----LKDGY------------RLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             ----HHcCC------------CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                11100            000    1223445789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-36  Score=305.68  Aligned_cols=246  Identities=29%  Similarity=0.418  Sum_probs=199.4

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecc-----ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|++|.||++...  ++.+++|.+..     ...+++.+|++++++++|||++++++++.+.+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3666788999999999999874  57899998753     2356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.++++..   ....+++...+.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..+...
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999752   2346889999999999999999999877   999999999999999999999999998866432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .......|+..|+|||++.+..++.++|+||||+++|||++|+.||.....        ...   .........  
T Consensus       155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~---~~~~~~~~~--  218 (256)
T cd08529         155 T---NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GAL---ILKIIRGVF--  218 (256)
T ss_pred             c---chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHcCCC--
Confidence            1   122335688999999999998899999999999999999999999854321        011   111111100  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                                     ...+......+.+++.+||+.+|++||++.++++.
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 ---------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                           01122344579999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-36  Score=307.94  Aligned_cols=256  Identities=21%  Similarity=0.375  Sum_probs=203.9

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++..  .++.++||.+...      ...++.+|+++++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4577788999999999999986  4678999977532      2356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++.... .....+++...+.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..+.
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            9999999999886422 22346899999999999999999999987   9999999999999999999999999987653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   .......++..|+|||.+.+..++.++|+||||+++|||++|..||.....         ......... ..  
T Consensus       158 ~~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~-~~--  222 (267)
T cd08229         158 SKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSLCKKI-EQ--  222 (267)
T ss_pred             cCC---cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---------hHHHHhhhh-hc--
Confidence            221   112235688999999999888899999999999999999999999853221         011111000 00  


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                ...+..   .+......+.+++.+||+.||++||||.+|++.++++
T Consensus       223 ----------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         223 ----------CDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ----------CCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                      000111   1223556799999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-36  Score=311.42  Aligned_cols=263  Identities=24%  Similarity=0.383  Sum_probs=198.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC----------------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN----------------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELI  409 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~  409 (639)
                      ..+|+..+.||+|+||.||++...+                ..||+|.++..    ....+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578888999999999999986532                24899988653    234688999999999999999999


Q ss_pred             eeeecCCeEEEEEeeccCCChhhhccCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 036507          410 GYAATEDELFLIYEYAQKGSLKSHLHDPQN-------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI  482 (639)
Q Consensus       410 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NI  482 (639)
                      +++...+..++||||+++++|.+++.....       .....+++..++.++.|+++||+|||+++   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999999864221       11134788999999999999999999987   99999999999


Q ss_pred             EECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc--CCccccccccc
Q 036507          483 LLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS--GKEAIIRTEGM  560 (639)
Q Consensus       483 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt--G~~p~~~~~~~  560 (639)
                      ++++++.+||+|||++..+.... .........++..|+|||.+.++.++.++||||||++++||++  |..||..... 
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence            99999999999999997653221 1111222345678999999988889999999999999999998  5556643221 


Q ss_pred             cchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       561 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                             ...............        ....     ...+...+..+.+++.+||+.||++||+|++|++.|++
T Consensus       239 -------~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 -------EQVIENTGEFFRNQG--------RQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -------HHHHHHHHHhhhhcc--------cccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                   011111111111000        0000     00122234579999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-36  Score=306.11  Aligned_cols=250  Identities=30%  Similarity=0.488  Sum_probs=198.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-ceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++|...+.||+|+||.||++...+ ..+|+|.+....  .+.+.+|++++++++|+|++++++++. .+..+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            457778899999999999998765 579999876532  456889999999999999999999875 4568999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.++++..   ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++........ 
T Consensus        85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          85 GSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            9999999752   2345789999999999999999999887   99999999999999999999999999986532211 


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                       .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ......   ......    
T Consensus       158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~---~~~~~~----  221 (260)
T cd05069         158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQ---VERGYR----  221 (260)
T ss_pred             -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH---HHcCCC----
Confidence             11122345678999999998899999999999999999999 8888853221        011111   111100    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                               +    ..+.+.+..+.+++.+||+.||++||+++++++.|++
T Consensus       222 ---------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ---------M----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---------C----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                     0    1123345679999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-36  Score=307.29  Aligned_cols=251  Identities=28%  Similarity=0.495  Sum_probs=200.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-CceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|...++||+|+||.||++... ++.+|+|.+....  .+++.+|++++++++|+|++++++++. .+..+++|||++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            456788899999999999999875 4789999987543  467899999999999999999999874 567899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++...   ....+++...+.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++....... 
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  156 (260)
T cd05067          84 NGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE-  156 (260)
T ss_pred             CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence            99999998642   2346889999999999999999999887   9999999999999999999999999997654211 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                       ........++..|+|||.+....++.++||||||+++|||++ |+.||.....        ..+...    +....   
T Consensus       157 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~----~~~~~---  220 (260)
T cd05067         157 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQN----LERGY---  220 (260)
T ss_pred             -cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHH----HHcCC---
Confidence             111122345678999999998889999999999999999999 9999853321        111111    11100   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                                   ....+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus       221 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 -------------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                         001122334579999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-36  Score=314.42  Aligned_cols=199  Identities=27%  Similarity=0.448  Sum_probs=161.0

Q ss_pred             CCceeecCceEEEEEEEc----CceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEEEeeccCC
Q 036507          356 SSLLGHGTYGSVYYGNIR----NQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAAT--EDELFLIYEYAQKG  428 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  428 (639)
                      .++||+|+||.||+|...    +..+|+|.+.... ...+.+|++++++++||||+++++++..  +...+++|||+. +
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence            468999999999999864    3679999986543 4567899999999999999999998854  456899999995 5


Q ss_pred             ChhhhccCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----CCCCCEEEeccCCcee
Q 036507          429 SLKSHLHDPQN----RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFGLAKL  500 (639)
Q Consensus       429 sL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~~  500 (639)
                      +|.+++.....    .....+++.....++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            88877643211    12235888899999999999999999987   9999999999999    4567899999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTE  558 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~  558 (639)
                      +..............||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            6433222223345678999999999876 458999999999999999999999996433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-36  Score=314.90  Aligned_cols=236  Identities=26%  Similarity=0.432  Sum_probs=187.1

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.||+|.++..      ..+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875  467999988643      233456677777654 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---  149 (316)
T cd05592          81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG---  149 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---
Confidence            999998864     235788888999999999999999987   999999999999999999999999999754221   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.        ..+   ........      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~---~~~i~~~~------  212 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DEL---FDSILNDR------  212 (316)
T ss_pred             CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHcCC------
Confidence            1223346799999999999998999999999999999999999999954321        011   11111111      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK-QVV  632 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  632 (639)
                              +    ..+.....++.+++.+||+.||++||++. +++
T Consensus       213 --------~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         213 --------P----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                    0    11223445688999999999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=306.32  Aligned_cols=253  Identities=30%  Similarity=0.486  Sum_probs=203.0

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..++|...+.||+|+||.||++...+ ..+|||.+...  ..+++.+|++++++++|+||+++++++......+++|||+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            45678889999999999999998764 67999988753  3567899999999999999999999999889999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++...   ....+++..+..++.+++.|+.|||+++   ++|+||||+||++++++.+||+|||++..+....
T Consensus        84 ~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          84 SKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             CCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999752   2345899999999999999999999987   9999999999999999999999999998654211


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                        ........++..|+|||.+.+..++.++|+||||++++||++ |+.||.....        ....   ........  
T Consensus       158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~---~~~~~~~~--  222 (261)
T cd05034         158 --YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVL---EQVERGYR--  222 (261)
T ss_pred             --hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH---HHHHcCCC--
Confidence              111112234568999999998889999999999999999998 8988843221        1111   11111100  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                                     ...+.+.+.++.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ---------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                           00122235578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-36  Score=315.61  Aligned_cols=258  Identities=29%  Similarity=0.486  Sum_probs=200.5

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc---------CceEEEEEecccc----HHHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR---------NQEVAIKRMTATK----TKEFMAEMKILCKV-HHSNLVELIGYAAT  414 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~----~~~~~~E~~il~~l-~h~niv~l~~~~~~  414 (639)
                      ..++|...+.||+|+||.||++...         ...+|+|.++...    ..++.+|+++++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3456778899999999999998752         2468999876432    34678899999999 59999999999998


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      .+..+++|||+++|+|.+++.....           .....+++.....++.|++.||.|||+++   ++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            8999999999999999999865321           12345899999999999999999999987   999999999999


Q ss_pred             ECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccc
Q 036507          484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVS  562 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~  562 (639)
                      +++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....   
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---  242 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---  242 (314)
T ss_pred             EcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999765322111 11112234567999999998889999999999999999999 8888743221   


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                           ..+..    .+....                ....+..++.++.+++.+||+.||++||++.|+++.|+++
T Consensus       243 -----~~~~~----~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         243 -----EELFK----LLREGH----------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             -----HHHHH----HHHcCC----------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                 01111    111100                0011234455788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-36  Score=315.81  Aligned_cols=232  Identities=26%  Similarity=0.419  Sum_probs=187.1

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.||+|.+...      ..+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875  578999998643      234567888888876 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......   
T Consensus        81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~---  149 (320)
T cd05590          81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---  149 (320)
T ss_pred             chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---
Confidence            999998864     235888899999999999999999987   999999999999999999999999998753221   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+   .........     
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~---~~~i~~~~~-----  213 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDL---FEAILNDEV-----  213 (320)
T ss_pred             CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHH---HHHHhcCCC-----
Confidence            1223346799999999999999999999999999999999999999954321        111   111111110     


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                                   ..+.....++.+++.+||+.||++||++
T Consensus       214 -------------~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 -------------VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                         0122234568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=334.62  Aligned_cols=256  Identities=23%  Similarity=0.297  Sum_probs=202.0

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccc---cHHHHHHHHHHHHhcC-CCCeeEEEee-eec------
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT---KTKEFMAEMKILCKVH-HSNLVELIGY-AAT------  414 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~---~~~~~~~E~~il~~l~-h~niv~l~~~-~~~------  414 (639)
                      ....++++.+.|.+|||+.||.+...+  ..+|+|++-..   ..+.+.+|+++|++|. |+|||.+++. ...      
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            345667778899999999999998863  68999988543   3466889999999998 9999999993 221      


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                      .-+++|.||||.+|.|-+++...   ....|+...+++|+.|+++|+++||... ++|||||||-+||||+.+++.||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~R---lq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTR---LQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHH---HhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence            13678999999999999999753   2344999999999999999999999985 7899999999999999999999999


Q ss_pred             cCCceecCCCCCCccee------eeeccccccCCcccc---ccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhh
Q 036507          495 FGLAKLVGKTSDGEATV------TKVVGTFGYLAPEYL---TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~  565 (639)
                      ||.+.-...........      .....|+-|++||.+   .+...++|+|||+|||+||-|+....||+....      
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------  263 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------  263 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence            99986432211111000      113578999999987   467889999999999999999999999954321      


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                               ..+++..+.-.........+.+||..||+.||.+||++-+|+..+.++
T Consensus       264 -------------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  264 -------------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             -------------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                                     112222221111235567899999999999999999999999998776

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-36  Score=308.72  Aligned_cols=243  Identities=23%  Similarity=0.338  Sum_probs=190.9

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ||+|+||.||++...  ++.+|+|.+....      ...+..|++++++++||||+++.+++.++...+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875  6889999886432      23456799999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++..   .....+++.....++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++......    ..
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~~  150 (277)
T cd05607          81 KYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KT  150 (277)
T ss_pred             HHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC----ce
Confidence            988864   22345889999999999999999999987   999999999999999999999999998765321    12


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||......       ..............         
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~---------  214 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-------VAKEELKRRTLEDE---------  214 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-------hhHHHHHHHhhccc---------
Confidence            23457899999999999888999999999999999999999998532210       01111111111100         


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                         +..     .......++.+++.+||+.||++||+++|+++.+
T Consensus       215 ---~~~-----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         215 ---VKF-----EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ---ccc-----ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence               000     0112344689999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-36  Score=315.05  Aligned_cols=237  Identities=26%  Similarity=0.394  Sum_probs=190.2

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCC-CeeEEEeeeecCCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHS-NLVELIGYAATEDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~lv~  422 (639)
                      +|+..+.||+|+||.||+|...  ++.||+|.+...      ..+.+..|.+++..++|+ +|+++.+++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4677889999999999999876  468999998643      234577899999999765 5888999999899999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            99999999998854     235788899999999999999999987   9999999999999999999999999987432


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .   .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+   ........ 
T Consensus       153 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~---~~~i~~~~-  217 (324)
T cd05587         153 F---GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DEL---FQSIMEHN-  217 (324)
T ss_pred             C---CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHcCC-
Confidence            1   11223446799999999999999999999999999999999999999954321        111   11111111 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                                       ..++.....++.+++.+||+.||++|++.
T Consensus       218 -----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 -----------------VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                             01122344568899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-36  Score=324.86  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=191.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .|+..+.||+|+||+||++...  ++.||+|.+...      ..+.+.+|++++++++|+||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5777889999999999999875  578999998643      23457889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++..     ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            9999999999864     234788888899999999999999987   99999999999999999999999999764321


Q ss_pred             CCCC--------------------------------------------cceeeeeccccccCCccccccCCCCCcchHHH
Q 036507          504 TSDG--------------------------------------------EATVTKVVGTFGYLAPEYLTDGLATAKSDVYA  539 (639)
Q Consensus       504 ~~~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws  539 (639)
                      ....                                            ........||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            0000                                            00112357999999999999989999999999


Q ss_pred             HHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHH--h
Q 036507          540 FGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQ--C  617 (639)
Q Consensus       540 ~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--c  617 (639)
                      |||++|||++|+.||......     +      ......... .     .   ..-+     .......++.+++.+  |
T Consensus       234 lG~il~elltG~~Pf~~~~~~-----~------~~~~i~~~~-~-----~---~~~~-----~~~~~s~~~~dli~~ll~  288 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPT-----E------TQLKVINWE-N-----T---LHIP-----PQVKLSPEAVDLITKLCC  288 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHH-----H------HHHHHHccc-c-----c---cCCC-----CCCCCCHHHHHHHHHHcc
Confidence            999999999999999643320     0      000111000 0     0   0000     011234467788887  4


Q ss_pred             cccCCCCCCCHHHHHH
Q 036507          618 VDEDPILRPDMKQVVI  633 (639)
Q Consensus       618 l~~dP~~RPs~~evl~  633 (639)
                      +..++..||+++|++.
T Consensus       289 ~~~~~~~R~~~~~~l~  304 (381)
T cd05626         289 SAEERLGRNGADDIKA  304 (381)
T ss_pred             CcccccCCCCHHHHhc
Confidence            5566667999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.5e-36  Score=309.21  Aligned_cols=263  Identities=24%  Similarity=0.408  Sum_probs=200.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc------------------CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR------------------NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVE  407 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~------------------~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~  407 (639)
                      .++|+..+.||+|+||.||++...                  ...+|+|.+....    .+++.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            467888999999999999987542                  2358999986532    356889999999999999999


Q ss_pred             EEeeeecCCeEEEEEeeccCCChhhhccCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       408 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                      +++++...+..+++|||+++++|.+++......      ....+++.....++.|++.||+|||+++   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            999999999999999999999999998753211      1235788899999999999999999987   9999999999


Q ss_pred             EEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc--CCcccccccc
Q 036507          482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS--GKEAIIRTEG  559 (639)
Q Consensus       482 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt--G~~p~~~~~~  559 (639)
                      |+++.++.++|+|||++..+..... ........++..|++||...++.++.++|||||||++|||++  |..|+.....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999999976532211 111122344678999999888889999999999999999998  6677743221


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                              ...............        .....+     .+..++..+.+++.+||+.||++||++.||++.|++
T Consensus       240 --------~~~~~~~~~~~~~~~--------~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 --------EQVIENTGEFFRDQG--------RQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --------HHHHHHHHHHHhhcc--------ccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    001110101110000        000000     122345679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-36  Score=315.99  Aligned_cols=237  Identities=27%  Similarity=0.397  Sum_probs=189.9

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++||+|+||.||+|...  ++.||+|.+...      ..+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999876  468999998643      234567889998876 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|..++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......   
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~---  149 (321)
T cd05591          81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---  149 (321)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC---
Confidence            999988854     235888899999999999999999987   999999999999999999999999998754221   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+   .........     
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~---~~~i~~~~~-----  213 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDL---FESILHDDV-----  213 (321)
T ss_pred             CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHH---HHHHHcCCC-----
Confidence            1223345799999999999998999999999999999999999999954321        111   111111110     


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-------DMKQVVI  633 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~  633 (639)
                                   ..+.....++.+++.+||+.||++||       +++++++
T Consensus       214 -------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         214 -------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                         01222345688999999999999999       7777763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-37  Score=324.88  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=194.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||||++....      ...+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999875  5789999986432      345778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            99999999999864     235889999999999999999999987   9999999999999999999999999987653


Q ss_pred             CCCCCc-----------------------------------ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHH
Q 036507          503 KTSDGE-----------------------------------ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEI  547 (639)
Q Consensus       503 ~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~el  547 (639)
                      ......                                   ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  232 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence            211000                                   001124699999999999999999999999999999999


Q ss_pred             HcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 036507          548 ISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD  627 (639)
Q Consensus       548 ltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  627 (639)
                      ++|+.||.....           .......+... .        ....+.     .......+.+++.+|+. +|.+|++
T Consensus       233 ~~G~~Pf~~~~~-----------~~~~~~i~~~~-~--------~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         233 LVGYPPFCSDNP-----------QETYRKIINWK-E--------TLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             hcCCCCCCCCCH-----------HHHHHHHHcCC-C--------ccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            999999954321           00111111100 0        000000     01224467889999996 9999998


Q ss_pred             ---HHHHHH
Q 036507          628 ---MKQVVI  633 (639)
Q Consensus       628 ---~~evl~  633 (639)
                         ++|++.
T Consensus       287 ~~~~~~ll~  295 (364)
T cd05599         287 NNGVNEIKS  295 (364)
T ss_pred             CCCHHHHhc
Confidence               888865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.9e-36  Score=316.68  Aligned_cols=245  Identities=23%  Similarity=0.361  Sum_probs=191.0

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.||+|.++...      .+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875  5789999987532      24477899999998 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  149 (329)
T cd05588          81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP---  149 (329)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC---
Confidence            999988853     245899999999999999999999987   999999999999999999999999998742111   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ......+..+.+.....    
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~----  222 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP---DQNTEDYLFQVILEKQI----  222 (329)
T ss_pred             CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc---cccchHHHHHHHHcCCC----
Confidence            11233467999999999999999999999999999999999999999532211000   00111111111111100    


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC------HHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD------MKQVV  632 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl  632 (639)
                                   ..|.....++.+++.+||+.||++||+      +++++
T Consensus       223 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         223 -------------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             -------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence                         012234456899999999999999997      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-36  Score=317.31  Aligned_cols=241  Identities=25%  Similarity=0.381  Sum_probs=187.5

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.+|+|.++..      ..+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999875  578999998643      224467888888777 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|..++..     ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--  150 (329)
T cd05618          81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--  150 (329)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--
Confidence            999988853     245889999999999999999999987   9999999999999999999999999987532111  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ......+....+....     
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~~~~~~~~~~~i~~~~-----  221 (329)
T cd05618         151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILEKQ-----  221 (329)
T ss_pred             -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc---ccccHHHHHHHHhcCC-----
Confidence             1223467999999999999999999999999999999999999999532211000   0001111111111110     


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                                  ...|......+.+++.+||+.||++||++
T Consensus       222 ------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 ------------IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                        01233345578899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-36  Score=310.53  Aligned_cols=265  Identities=25%  Similarity=0.417  Sum_probs=202.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc------CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR------NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAAT--EDEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  418 (639)
                      +.|...+.||+|+||.||++.+.      +..+|||.+....    .+++.+|++++++++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45666789999999999999864      4689999986543    4578999999999999999999999877  5578


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      +++|||+++++|.+++...    ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence            9999999999999999742    235899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchh---hhhhhHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN---QERRSLASFML  575 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~---~~~~~l~~~~~  575 (639)
                      .................++..|++||.+.+..++.++||||||++++||++|+.|+..........   ...........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876422211111112345567999999988889999999999999999999998875432211000   00000001111


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..+..                ......+..++.++.+++.+||+.+|++||+|+||+++|+++
T Consensus       237 ~~~~~----------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKE----------------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHc----------------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111                111112234456799999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-36  Score=318.82  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=201.4

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC---------ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN---------QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAAT  414 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~  414 (639)
                      ...+|...+.||+|+||.||++...+         ..+|+|.++..    ..+++.+|+++++++ +||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            34568888999999999999997521         36899987643    245788999999999 79999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      .+..++++||+++|+|.+++.....           .....++|..++.++.|+++||.|||+++   ++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence            9999999999999999999864221           12345889999999999999999999987   999999999999


Q ss_pred             ECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccc
Q 036507          484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVS  562 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~  562 (639)
                      +++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....   
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  242 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---  242 (334)
T ss_pred             EcCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence            99999999999999986532211 111122334567999999999999999999999999999998 7777743211   


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                              ...........                 ....+..+..++.+++.+||+.+|++||++.|++..|+++
T Consensus       243 --------~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         243 --------EELFKLLKEGH-----------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             --------HHHHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                    11111111110                 0011233455789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.6e-36  Score=314.19  Aligned_cols=237  Identities=27%  Similarity=0.412  Sum_probs=190.9

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  +..||+|.+...      ....+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999885  468999998743      234567889999888 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++.....++.|++.||.|||+++   |+||||||+||++++++.+||+|||++......   
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---  149 (318)
T cd05570          81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG---  149 (318)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC---
Confidence            999998864     235899999999999999999999987   999999999999999999999999998743211   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........|++.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+   ........      
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~---~~~i~~~~------  212 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DEL---FQSILEDE------  212 (318)
T ss_pred             CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHH---HHHHHcCC------
Confidence            1122345789999999999999999999999999999999999999954321        111   11111110      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM-----KQVVI  633 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  633 (639)
                              .    ..+...+..+.+++.+||+.||++||++     .+++.
T Consensus       213 --------~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 --------V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --------C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                    0    0122344578999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-36  Score=319.92  Aligned_cols=261  Identities=28%  Similarity=0.451  Sum_probs=198.3

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEE-------cCceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNI-------RNQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATE  415 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~-------~~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  415 (639)
                      +..++|+..+.||+|+||.||+|..       .++.||||.++..    ....+.+|++++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3456788899999999999999974       2468999998653    234578899999999 689999999987654


Q ss_pred             -CeEEEEEeeccCCChhhhccCCCCC------------------------------------------------------
Q 036507          416 -DELFLIYEYAQKGSLKSHLHDPQNR------------------------------------------------------  440 (639)
Q Consensus       416 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  440 (639)
                       ...+++|||+++|+|.++++.....                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             4678999999999999998642110                                                      


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceee
Q 036507          441 --------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT  512 (639)
Q Consensus       441 --------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  512 (639)
                              ....+++.....++.|+++||+|||+++   |+||||||+||++++++.+||+|||++..+..... .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~  239 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKG  239 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcC
Confidence                    0134788889999999999999999987   99999999999999999999999999976532211 11111


Q ss_pred             eeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccc
Q 036507          513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLK  591 (639)
Q Consensus       513 ~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  591 (639)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..|+......       ..+    ...+....         
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~----~~~~~~~~---------  299 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEF----CRRLKEGT---------  299 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHH----HHHHhccC---------
Confidence            2345678999999988899999999999999999997 88887432210       001    11111110         


Q ss_pred             cccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          592 DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       592 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                         ...    .+.....++.+++..||+.||++||++.|+++.|++++
T Consensus       300 ---~~~----~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         300 ---RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             ---CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               000    01112346889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.2e-37  Score=325.34  Aligned_cols=252  Identities=20%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      .....++|+..++||+|+||.||++...  ++.||+|.+...      ..+.+.+|+++++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3445678888999999999999999875  578999998642      22346789999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++||||+++|+|.+++..      ..++......++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999999999864      23677778889999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccC----CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG----LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      +.......  ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....           ...
T Consensus       189 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~  255 (370)
T cd05596         189 CMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------VGT  255 (370)
T ss_pred             eeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----------HHH
Confidence            98653221  1122345799999999998653    478899999999999999999999954321           111


Q ss_pred             HHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 036507          574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL--RPDMKQVVI  633 (639)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  633 (639)
                      +..++.....         ...|   .  ....+.++.+++.+||+.+|++  ||+++|++.
T Consensus       256 ~~~i~~~~~~---------~~~~---~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         256 YSKIMDHKNS---------LTFP---D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHcCCCc---------CCCC---C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            1222211100         0000   0  1123457889999999999988  999999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-36  Score=305.00  Aligned_cols=246  Identities=29%  Similarity=0.525  Sum_probs=197.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      ++|+..+.||+|+||.||++...++.+|+|..+.. ..+.+.+|+.++++++|||++++++++.. +..+++|||+++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~   84 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGN   84 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCC
Confidence            45777889999999999999988999999998754 34578899999999999999999999865 45799999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      |.+++...   ....+++..++.++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++.......    
T Consensus        85 L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          85 LVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             HHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            99998652   2345789999999999999999999877   9999999999999999999999999987542211    


Q ss_pred             eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                        .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||.....        ..+..   ......       
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~---~~~~~~-------  214 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKE---CVEKGY-------  214 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHH---HHhCCC-------
Confidence              11234567999999988899999999999999999998 8888853321        01111   111100       


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                                ....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 ----------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                      001122345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4e-36  Score=312.41  Aligned_cols=236  Identities=28%  Similarity=0.437  Sum_probs=188.2

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.||+|.++..      ....+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999875  468999998653      234466788888764 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......   
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~---  149 (316)
T cd05619          81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG---  149 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC---
Confidence            999999864     235788889999999999999999987   999999999999999999999999998753211   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+...    +...      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~----i~~~------  211 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQS----IRMD------  211 (316)
T ss_pred             CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHH----HHhC------
Confidence            1223446799999999999999999999999999999999999999854321        111111    1110      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK-QVV  632 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  632 (639)
                             .+.    ++.....++.+++.+||+.||++||++. +++
T Consensus       212 -------~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         212 -------NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -------CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                   010    1122344688999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.5e-37  Score=318.85  Aligned_cols=234  Identities=26%  Similarity=0.360  Sum_probs=189.3

Q ss_pred             CceeecCceEEEEEEE-----cCceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          357 SLLGHGTYGSVYYGNI-----RNQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      +.||+|+||.||++..     .++.+|+|++....     ...+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999998865     35789999986532     2346789999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++......  
T Consensus        82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--  151 (318)
T cd05582          82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--  151 (318)
T ss_pred             CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence            9999999853     235889999999999999999999987   999999999999999999999999998764321  


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                       ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        .   ...........    
T Consensus       152 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~---~~~~~i~~~~~----  215 (318)
T cd05582         152 -EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------K---ETMTMILKAKL----  215 (318)
T ss_pred             -CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------H---HHHHHHHcCCC----
Confidence             1223346799999999999988899999999999999999999999854321        0   11111111110    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ  630 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  630 (639)
                                    ..+......+.+++.+||+.||++||++.+
T Consensus       216 --------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 --------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                          012233456889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-36  Score=320.78  Aligned_cols=198  Identities=26%  Similarity=0.399  Sum_probs=170.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||+||++...  ++.||+|++....      ...+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999875  5789999986532      245778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999864     245889999999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCCC--------------------------------cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcC
Q 036507          503 KTSDG--------------------------------EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG  550 (639)
Q Consensus       503 ~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG  550 (639)
                      .....                                .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            21100                                0011235799999999999999999999999999999999999


Q ss_pred             Cccccc
Q 036507          551 KEAIIR  556 (639)
Q Consensus       551 ~~p~~~  556 (639)
                      +.||..
T Consensus       233 ~~Pf~~  238 (363)
T cd05628         233 YPPFCS  238 (363)
T ss_pred             CCCCCC
Confidence            999954

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-35  Score=316.92  Aligned_cols=195  Identities=23%  Similarity=0.314  Sum_probs=166.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ..+|...+.||+|+||.||++.+.  ++.||||....   ..+.+|+++|++++|+||+++++++..++..+++||++ .
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~  243 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R  243 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence            457888999999999999999886  47899996433   34568999999999999999999999999999999999 5


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.+++...    ...++|..++.|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.... .
T Consensus       244 ~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-~  315 (461)
T PHA03211        244 SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-S  315 (461)
T ss_pred             CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc-c
Confidence            7888887532    236899999999999999999999987   9999999999999999999999999998653221 1


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++..
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence            1122345799999999999999999999999999999999998876643

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.2e-36  Score=314.35  Aligned_cols=237  Identities=26%  Similarity=0.374  Sum_probs=190.1

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +|...+.||+|+||.||++...  ++.+|+|.+....      .+.+..|.+++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677889999999999999876  4689999986432      23466788888777 4899999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999998854     235888999999999999999999987   9999999999999999999999999987542


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+.   ..+.... 
T Consensus       153 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~---~~i~~~~-  217 (323)
T cd05616         153 WD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELF---QSIMEHN-  217 (323)
T ss_pred             CC---CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHH---HHHHhCC-
Confidence            21   1223346799999999999999999999999999999999999999954321        1111   1111111 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                                       ..++.....++.+++.+|++.||++|++.
T Consensus       218 -----------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -----------------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----------------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                             01223345578999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-36  Score=301.24  Aligned_cols=249  Identities=25%  Similarity=0.320  Sum_probs=200.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC--ceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .+.|+..+.||+|.-|+||++++.+  ..+|+|++.++.      ......|-+||+.++||.++.|++.+..+...+++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3456667899999999999999986  689999997653      34567799999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      ||||+||+|..+++.   +..+.++......++..++.||+|||-.|   ||+|||||+||||.++|++-|+||.++...
T Consensus       156 meyCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EecCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999999986   44567899999999999999999999987   999999999999999999999999998543


Q ss_pred             CCC--------------------------------CCC---------------------cceeeeeccccccCCcccccc
Q 036507          502 GKT--------------------------------SDG---------------------EATVTKVVGTFGYLAPEYLTD  528 (639)
Q Consensus       502 ~~~--------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~  528 (639)
                      ...                                ...                     .......+||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            110                                000                     011123589999999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHH
Q 036507          529 GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLF  608 (639)
Q Consensus       529 ~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  608 (639)
                      ...+.++|+|+||++||||+.|..||.+.+.       +..+.    .++.+..              .+.+  ......
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-------~~Tl~----NIv~~~l--------------~Fp~--~~~vs~  362 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-------KETLR----NIVGQPL--------------KFPE--EPEVSS  362 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-------hhhHH----HHhcCCC--------------cCCC--CCcchh
Confidence            9999999999999999999999999965443       12222    2222211              1111  114456


Q ss_pred             HHHHHHHHhcccCCCCCCC----HHHH
Q 036507          609 KMAMLAKQCVDEDPILRPD----MKQV  631 (639)
Q Consensus       609 ~l~~li~~cl~~dP~~RPs----~~ev  631 (639)
                      .+.+||++.|.+||++|-.    +.||
T Consensus       363 ~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  363 AAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             HHHHHHHHHhccChhhhhccccchHHh
Confidence            7999999999999999987    5555

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4e-36  Score=312.48  Aligned_cols=236  Identities=25%  Similarity=0.424  Sum_probs=188.2

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.||+|.++..      ..+....|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999885  578999998643      234566788888764 899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....   .
T Consensus        81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~  149 (316)
T cd05620          81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---G  149 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc---C
Confidence            999998854     235788888999999999999999987   99999999999999999999999999874321   1


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+...   .....      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~---~~~~~------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFES---IRVDT------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHH---HHhCC------
Confidence            2233456799999999999999999999999999999999999999954321        111111   11110      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK-QVV  632 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  632 (639)
                              +.    .+.....++.+++.+||+.||++||++. +++
T Consensus       213 --------~~----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 --------PH----YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --------CC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                    11    1222345688999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.9e-36  Score=300.79  Aligned_cols=243  Identities=27%  Similarity=0.454  Sum_probs=192.7

Q ss_pred             CceeecCceEEEEEEEc-CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChh
Q 036507          357 SLLGHGTYGSVYYGNIR-NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLK  431 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  431 (639)
                      ++||+|+||.||+|... +..+|+|.++...    ...+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999875 4679999876532    345889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCccee
Q 036507          432 SHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV  511 (639)
Q Consensus       432 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  511 (639)
                      +++...    ...+++..++.++.|++.+|.|||+++   ++|+||||+||++++++.+||+|||++........  ...
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~  151 (250)
T cd05085          81 SFLRKK----KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--SSS  151 (250)
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc--ccC
Confidence            998642    235789999999999999999999987   99999999999999999999999999875432111  111


Q ss_pred             eeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          512 TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      ....++..|+|||++.+..++.++||||||+++||+++ |..||.....           .... ..+....        
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----------~~~~-~~~~~~~--------  211 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----------QQAR-EQVEKGY--------  211 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----------HHHH-HHHHcCC--------
Confidence            11234567999999998889999999999999999998 8888843221           0000 1111100        


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                              ....+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 --------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                    00112234567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=324.94  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=191.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...++||+|+||.||++...  ++.||||.+...      ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888899999999999999874  578999988543      2345788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            99999999999864     235788888889999999999999987   9999999999999999999999999996432


Q ss_pred             CCCCCc--------------------------------------------ceeeeeccccccCCccccccCCCCCcchHH
Q 036507          503 KTSDGE--------------------------------------------ATVTKVVGTFGYLAPEYLTDGLATAKSDVY  538 (639)
Q Consensus       503 ~~~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVw  538 (639)
                      ......                                            .......||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  232 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence            110000                                            000124699999999999999999999999


Q ss_pred             HHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhc
Q 036507          539 AFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCV  618 (639)
Q Consensus       539 s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl  618 (639)
                      ||||++|||++|+.||.....        ...   ...... ....        ..-|.     ......++.+++.+|+
T Consensus       233 SlGvil~elltG~~Pf~~~~~--------~~~---~~~i~~-~~~~--------~~~p~-----~~~~s~~~~dli~~lL  287 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENS--------HET---YRKIIN-WRET--------LYFPD-----DIHLSVEAEDLIRRLI  287 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCH--------HHH---HHHHHc-cCCc--------cCCCC-----CCCCCHHHHHHHHHHh
Confidence            999999999999999954321        011   111111 0000        00000     0123456889999999


Q ss_pred             ccCCCCC---CCHHHHHH
Q 036507          619 DEDPILR---PDMKQVVI  633 (639)
Q Consensus       619 ~~dP~~R---Ps~~evl~  633 (639)
                      . +|.+|   +++.|++.
T Consensus       288 ~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         288 T-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             c-CHhhcCCCCCHHHHhc
Confidence            7 66665   59998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.7e-36  Score=303.89  Aligned_cols=248  Identities=25%  Similarity=0.467  Sum_probs=189.0

Q ss_pred             CceeecCceEEEEEEEc-----CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeee-cCCeEEEEEeecc
Q 036507          357 SLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAA-TEDELFLIYEYAQ  426 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  426 (639)
                      +.||+|+||.||+|...     ...+|+|.+...    ..+.+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863     246999987532    2456888999999999999999999775 4556899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.+++...    ...+++...+.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.....
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999998642    233677888899999999999999987   99999999999999999999999999975432111


Q ss_pred             Cc-ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCc-cccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          507 GE-ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE-AIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       507 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .. .......++..|+|||.+.+..++.++||||||+++|||++|.. |+....        ...+...   ......  
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--------~~~~~~~---~~~~~~--  220 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--------SFDITVY---LLQGRR--  220 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHH---HhcCCC--
Confidence            00 11122345778999999988889999999999999999999654 442211        1111111   111100  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                                 +.    .+...+..+.+++.+||+.+|++||++.|++..|++++
T Consensus       221 -----------~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 -----------LL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -----------CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                       00    11223456899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-36  Score=306.74  Aligned_cols=249  Identities=29%  Similarity=0.510  Sum_probs=194.7

Q ss_pred             CceeecCceEEEEEEEcC--------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          357 SLLGHGTYGSVYYGNIRN--------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~--------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +.||+|+||.||+|+..+        ..+|+|.+...    ...++.+|++++++++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998643        46899987543    345788999999999999999999999998999999999


Q ss_pred             ccCCChhhhccCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-----CEEEeccCC
Q 036507          425 AQKGSLKSHLHDPQNR--GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-----RAKISDFGL  497 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgl  497 (639)
                      +++++|.+++......  ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999653211  2345789999999999999999999877   99999999999999887     899999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +..+..... ........++..|+|||.+.++.++.++||||||+++|||++ |+.||.....        ......   
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~---  225 (269)
T cd05044         158 ARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQH---  225 (269)
T ss_pred             ccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHH---
Confidence            875532211 111112345678999999999999999999999999999998 9988843221        011111   


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                       +...                .....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       226 -~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         226 -VTAG----------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -HhcC----------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             1100                0001123345678999999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-36  Score=316.06  Aligned_cols=233  Identities=28%  Similarity=0.380  Sum_probs=185.6

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMK-ILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.||+|.+....      ..++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999884  6789999986432      234455555 46789999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.....   .
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---~  149 (323)
T cd05575          81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---H  149 (323)
T ss_pred             CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc---C
Confidence            999998864     235788888999999999999999987   99999999999999999999999999875321   1


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.           .+.....+....     
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~~~-----  213 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----------AEMYDNILNKPL-----  213 (323)
T ss_pred             CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----------HHHHHHHHcCCC-----
Confidence            1223345799999999999999999999999999999999999999854321           111112221110     


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK  629 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  629 (639)
                               .    .+......+.+++.+||+.||++||++.
T Consensus       214 ---------~----~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 ---------R----LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ---------C----CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                     0    1122345689999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.6e-37  Score=320.51  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.++...      .+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888899999999999999874  5789999987532      345778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            999999999998642    245889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccc------cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLT------DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ...  ........||+.|+|||++.      ...++.++|||||||++|||++|+.||.....           ...+..
T Consensus       154 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----------~~~~~~  220 (330)
T cd05601         154 ANK--MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----------AKTYNN  220 (330)
T ss_pred             CCC--ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----------HHHHHH
Confidence            322  12223357899999999986      45678999999999999999999999954321           011111


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+...       .....  |     ........+.+++..|++ +|++||++++++.
T Consensus       221 i~~~~-------~~~~~--~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         221 IMNFQ-------RFLKF--P-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHcCC-------CccCC--C-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11110       00000  0     011234568899999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-36  Score=322.22  Aligned_cols=254  Identities=20%  Similarity=0.308  Sum_probs=197.4

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATE  415 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~  415 (639)
                      .++....++|+..+.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|+++++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            445556688999999999999999999885  578999988542      234577899999999999999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      +..++||||+++|+|.+++..      ..+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999863      23677888899999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccC----CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG----LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      |++..+....  ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....           .
T Consensus       187 G~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----------~  253 (370)
T cd05621         187 GTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----------V  253 (370)
T ss_pred             ccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----------H
Confidence            9998763221  1122346799999999998653    378899999999999999999999954321           1


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL--RPDMKQVVI  633 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  633 (639)
                      .....++.....         .   .+.  ........+.+++..|+..++.+  |++++|+++
T Consensus       254 ~~~~~i~~~~~~---------~---~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         254 GTYSKIMDHKNS---------L---NFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             HHHHHHHhCCcc---------c---CCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            111122111100         0   000  01123456788999999865544  889999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.6e-36  Score=303.03  Aligned_cols=247  Identities=28%  Similarity=0.449  Sum_probs=195.9

Q ss_pred             CceeecCceEEEEEEEcC-----ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIRN-----QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|++|.||+|.+..     ..+|+|.+....    .+++.+|++++++++||||+++++++.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998742     268999987643    3568899999999999999999999888 889999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.+++.....   ..++|.....++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            999999975321   46899999999999999999999987   999999999999999999999999999876432221


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..   ........   
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~---~~~~~~~~---  219 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILK---KIDKEGER---  219 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH---HHHhcCCc---
Confidence            111223457789999999998899999999999999999999 9999853321        01111   11111000   


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                                   ...+...+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus       220 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         220 -------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             -------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence                         00122345579999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.2e-36  Score=304.96  Aligned_cols=252  Identities=22%  Similarity=0.380  Sum_probs=189.8

Q ss_pred             CceeecCceEEEEEEEcC----ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          357 SLLGHGTYGSVYYGNIRN----QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      +.||+|+||.||+|...+    ..+|+|.++...    ...+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643    468999886432    246888999999999999999999999888999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      +|.++++..........++.....++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-~~  156 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED-YY  156 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc-ee
Confidence            9999997533233345678888899999999999999987   9999999999999999999999999987542211 11


Q ss_pred             ceeeeeccccccCCccccccC-------CCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDG-------LATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      .......++..|+|||++.+.       .++.++||||||+++|||++ |+.||.....     .   .....   ....
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~---~~~~~---~~~~  225 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----E---QVLTY---TVRE  225 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----H---HHHHH---Hhhc
Confidence            112234577889999998642       35789999999999999996 9989854321     0   01000   0000


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                              ......++.+..    .....+.+++..|| .+|++|||++||++.|+
T Consensus       226 --------~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 --------QQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             --------ccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                    001112222221    23345788999999 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7e-36  Score=305.06  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=193.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..++||+|+||.||++...  ++.+|+|.+..+    ..+++.+|++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999864  578999987543    235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|..+.         .+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++..+...
T Consensus        81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            9999997653         2677888899999999999999987   999999999999999999999999999765321


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                           ......|+..|+|||++.+..++.++||||||+++|||++|+.||.........    ..............   
T Consensus       149 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~---  216 (279)
T cd06619         149 -----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS----LMPLQLLQCIVDED---  216 (279)
T ss_pred             -----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc----cchHHHHHHHhccC---
Confidence                 123357899999999999989999999999999999999999998543221000    00001111110000   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                                .+.+   .......++.+++.+||+.||++||+++|+++.
T Consensus       217 ----------~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 ----------PPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ----------CCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                      0111   011223468899999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.4e-36  Score=302.56  Aligned_cols=252  Identities=25%  Similarity=0.468  Sum_probs=200.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-ceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|...++||+|+||.||++...+ ..+++|.+....  .+.+.+|++++++++|+||+++++++.. ...+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            4678888999999999999998754 679999876543  4578899999999999999999999877 77899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++...   ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+.... 
T Consensus        84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-  156 (260)
T cd05073          84 KGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  156 (260)
T ss_pred             CCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence            99999999652   2345788999999999999999999877   9999999999999999999999999997653221 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                       ........++..|+|||++....++.++|+||||+++||+++ |+.||.....        ..+...    +.....  
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~----~~~~~~--  221 (260)
T cd05073         157 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRA----LERGYR--  221 (260)
T ss_pred             -cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH----HhCCCC--
Confidence             111122345678999999998889999999999999999999 8888853221        111111    111100  


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                    ...+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       222 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         222 --------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             --------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                          001123345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=319.18  Aligned_cols=261  Identities=23%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcC-C-----CCeeEEEeeeecCCeEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVH-H-----SNLVELIGYAATEDELFLI  421 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~-h-----~niv~l~~~~~~~~~~~lv  421 (639)
                      +|.+.+.||+|+||.|.++.+.  ++.||||+++...  ..+...|+.||..|+ |     -|+|++++++..+++.|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            7888999999999999999875  5789999998654  355678999999997 3     5899999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC--CCEEEeccCCce
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA--FRAKISDFGLAK  499 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~  499 (639)
                      +|.+ .-+|.++++..   ....++....+.++.||++||.+||+.+   |||+||||+||||.+.  ..+||+|||+|+
T Consensus       267 fELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  267 FELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             ehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999 56999999863   3455999999999999999999999887   9999999999999754  469999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ....      ....+..++.|+|||++.+.+|+.+.||||||||+.||++|.+.|-+.+        +.+....+.+.++
T Consensus       340 ~~~q------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n--------e~DQl~~I~e~lG  405 (586)
T KOG0667|consen  340 FESQ------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN--------EYDQLARIIEVLG  405 (586)
T ss_pred             ccCC------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC--------HHHHHHHHHHHhC
Confidence            6532      2236788999999999999999999999999999999999976664322        2344444555555


Q ss_pred             cCCCcccc--cccccccC------------------------------------C-c---ccCCCChhHHHHHHHHHHHh
Q 036507          580 NSPDSMSM--SSLKDYID------------------------------------P-N---MMDLYPHDCLFKMAMLAKQC  617 (639)
Q Consensus       580 ~~~~~~~~--~~~~~~~d------------------------------------~-~---l~~~~~~~~~~~l~~li~~c  617 (639)
                      .+|..+..  .+.+.+++                                    | .   +...........+.+++.+|
T Consensus       406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~  485 (586)
T KOG0667|consen  406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC  485 (586)
T ss_pred             CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence            44332211  00111111                                    1 0   00011123456789999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 036507          618 VDEDPILRPDMKQVVI  633 (639)
Q Consensus       618 l~~dP~~RPs~~evl~  633 (639)
                      +.+||.+|+|..|.+.
T Consensus       486 L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  486 LEWDPAERITPAQALN  501 (586)
T ss_pred             hccCchhcCCHHHHhc
Confidence            9999999999999874

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.3e-36  Score=306.04  Aligned_cols=249  Identities=29%  Similarity=0.481  Sum_probs=195.1

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhc-CCCCeeEEEeeeecC------Ce
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKV-HHSNLVELIGYAATE------DE  417 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l-~h~niv~l~~~~~~~------~~  417 (639)
                      ++..|+..+.||+|+||.||+|...  ++.+|+|.+...  ...++.+|+.++.++ +|+||+++++++...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            4567888889999999999999875  578999988543  345688999999998 699999999998653      45


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .+++|||+.+++|.+++...   ....+++.....++.|++.|++|||+++   |+|+||||+||++++++.+||+|||+
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            89999999999999998752   2345889999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      +.......   .......|+..|+|||++.     +..++.++|||||||++|||++|+.||......       ...  
T Consensus       158 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~--  225 (272)
T cd06637         158 SAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RAL--  225 (272)
T ss_pred             ceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHH--
Confidence            97653211   1223457899999999986     346788999999999999999999998532210       000  


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       . ......             .+..   .+..++..+.+++.+||+.||.+|||++|+++
T Consensus       226 -~-~~~~~~-------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         226 -F-LIPRNP-------------APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -H-HHhcCC-------------CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             0 000000             0000   11233456899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.1e-36  Score=302.37  Aligned_cols=246  Identities=24%  Similarity=0.392  Sum_probs=197.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +|+..+.||+|+||.||++...  +..+|+|.++..    ..+.+.+|+.++++++|+||+++++.+..++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4667889999999999999875  578999987532    2456788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++...   ....++....+.++.|++.||.|||+++   |+|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999988642   2345788889999999999999999987   9999999999999999999999999997653321


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         .......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.           ............   
T Consensus       155 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~---  217 (255)
T cd08219         155 ---AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----------KNLILKVCQGSY---  217 (255)
T ss_pred             ---cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----------HHHHHHHhcCCC---
Confidence               122335688999999999988899999999999999999999999854221           011111111100   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                               .     ..+......+.+++.+||+.||++||++.|++..
T Consensus       218 ---------~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---------K-----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------C-----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                     0     0122334568899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4e-36  Score=338.60  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=200.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..++||+|+||.||+|...  ++.||+|++...      ..+++.+|++++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888899999999999999875  578999998643      1356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          423 EYAQKGSLKSHLHDPQN------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ||+++|+|.+++.....      .....+++...+.++.|+++||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211      11234677888999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCC---------------cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccccccc
Q 036507          497 LAKLVGKTSDG---------------EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV  561 (639)
Q Consensus       497 la~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~  561 (639)
                      +++........               ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~--  236 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG--  236 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence            99865211100               0011235799999999999999999999999999999999999999854221  


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhh
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-DMKQVVISLSQI  638 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i  638 (639)
                            ....  ....+.               ++.-.. ...+.+..+.+++.+|++.||++|| +++++++.|+..
T Consensus       237 ------~ki~--~~~~i~---------------~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        237 ------RKIS--YRDVIL---------------SPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             ------hhhh--hhhhcc---------------Chhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  0000  000000               000000 0123345688999999999999995 677788877654

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.1e-36  Score=301.80  Aligned_cols=249  Identities=24%  Similarity=0.441  Sum_probs=198.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-CceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      .+|+..+.||+|+||.||++.+. +..+|+|.+....  ..++.+|++++++++|||++++++++......++++||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            45666789999999999999875 6789999886542  46789999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.+++...    ...+++.....++.+++.+++|||+.+   ++|+||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  154 (256)
T cd05112          84 GCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--  154 (256)
T ss_pred             CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence            9999998642    235789999999999999999999987   9999999999999999999999999987653211  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........++.+|+|||.+.++.++.++||||||+++|||++ |+.||.....        ..+...    +...     
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~----~~~~-----  217 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVET----INAG-----  217 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHH----HhCC-----
Confidence            111112234678999999998889999999999999999998 8888853221        111111    1110     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                          .....       +...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       218 ----~~~~~-------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 ----FRLYK-------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCCCC-------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                00111       1123457999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-36  Score=323.70  Aligned_cols=248  Identities=23%  Similarity=0.296  Sum_probs=191.9

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      +|+..+.||+|+||.||++...  ++.||||.+...      ....+.+|+++|++++|+||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888899999999999999875  578999998643      23457889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++..     ...++......++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          82 YIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            9999999999864     234778888889999999999999987   99999999999999999999999999753311


Q ss_pred             CCC----------------------------------------CcceeeeeccccccCCccccccCCCCCcchHHHHHHH
Q 036507          504 TSD----------------------------------------GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVV  543 (639)
Q Consensus       504 ~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvv  543 (639)
                      ...                                        .........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            000                                        0001123579999999999999999999999999999


Q ss_pred             HHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCC
Q 036507          544 LFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI  623 (639)
Q Consensus       544 l~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~  623 (639)
                      +|||++|+.||......           ........ ...        ....+     ........+.+++.+|+ .+|.
T Consensus       234 lyell~G~~Pf~~~~~~-----------~~~~~i~~-~~~--------~~~~~-----~~~~~s~~~~~li~~l~-~~p~  287 (376)
T cd05598         234 LYEMLVGQPPFLADTPA-----------ETQLKVIN-WET--------TLHIP-----SQAKLSREASDLILRLC-CGAE  287 (376)
T ss_pred             eeehhhCCCCCCCCCHH-----------HHHHHHhc-cCc--------cccCC-----CCCCCCHHHHHHHHHHh-cCHh
Confidence            99999999999543320           00011110 000        00000     01123445777888876 5999


Q ss_pred             CCC---CHHHHHH
Q 036507          624 LRP---DMKQVVI  633 (639)
Q Consensus       624 ~RP---s~~evl~  633 (639)
                      +|+   ++.|++.
T Consensus       288 ~R~~~~t~~ell~  300 (376)
T cd05598         288 DRLGKNGADEIKA  300 (376)
T ss_pred             hcCCCCCHHHHhC
Confidence            999   8888874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-35  Score=308.97  Aligned_cols=198  Identities=28%  Similarity=0.459  Sum_probs=160.3

Q ss_pred             CCceeecCceEEEEEEEcC----ceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEEEeeccCC
Q 036507          356 SSLLGHGTYGSVYYGNIRN----QEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAAT--EDELFLIYEYAQKG  428 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g  428 (639)
                      ..+||+|+||.||++...+    ..||+|.+.... ...+.+|++++++++||||+++++++..  +...++++||+. +
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            4579999999999998643    579999886543 3567899999999999999999998853  457899999986 5


Q ss_pred             ChhhhccCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----CCCCCEEEeccCCcee
Q 036507          429 SLKSHLHDPQ----NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFGLAKL  500 (639)
Q Consensus       429 sL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~~  500 (639)
                      +|.+++....    ......+++.....++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            7777764211    112345889999999999999999999987   9999999999999    5667899999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCcccccc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRT  557 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~  557 (639)
                      +..............||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            6433222222344678999999999876 45789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-35  Score=314.70  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=193.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED------  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  416 (639)
                      .++|+..+.||+|+||.||++...  +..||+|.+...     ....+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            467888999999999999999874  578999998532     3456789999999999999999999886443      


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++||||+++ +|.+.++.       .+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence            47999999964 66666532       3778888899999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhh-----------
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ-----------  565 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~-----------  565 (639)
                      +++....    ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......           
T Consensus       169 ~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         169 LARTACT----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             Ccccccc----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            9975422    1122345789999999999999999999999999999999999999965432100000           


Q ss_pred             hhhhHHHHHHHHhhcCCCccccccccc----ccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKD----YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....+...........+.. ......+    +..+... .........+.+++.+||+.||++|||++|++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQY-PGISFEELFPDWIFPSES-ERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCC-CCcchhhhcccccccccc-ccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000011111111100 0000000    0001000 011123456899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-36  Score=300.70  Aligned_cols=248  Identities=32%  Similarity=0.549  Sum_probs=199.5

Q ss_pred             CceeecCceEEEEEEEc-----CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR-----NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...     +..+++|.+....    .+.+.+|++++++++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46999999999999886     5689999987543    46788999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          428 GSLKSHLHDPQNR----GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       428 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      ++|.+++......    ....+++..+..++.|++.||+|||+++   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999753110    1356899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ... ........++..|+|||.+....++.++||||||++++||++ |..||.....        ..+...    +... 
T Consensus       158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~----~~~~-  223 (262)
T cd00192         158 DDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEY----LRKG-  223 (262)
T ss_pred             ccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH----HHcC-
Confidence            221 122234567889999999988889999999999999999999 5888854321        111111    1110 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                                     .....+..++.++.+++.+||+.+|++|||++|++..|+
T Consensus       224 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ---------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                           000123334567999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-36  Score=322.85  Aligned_cols=197  Identities=27%  Similarity=0.395  Sum_probs=167.9

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .|+..++||+|+||.||++...  ++.+|+|.+....      ...+.+|++++++++|+||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5778899999999999999874  5789999986532      3467889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            9999999999864     234778888889999999999999987   99999999999999999999999999753321


Q ss_pred             CCC--------------------------------------------CcceeeeeccccccCCccccccCCCCCcchHHH
Q 036507          504 TSD--------------------------------------------GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYA  539 (639)
Q Consensus       504 ~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws  539 (639)
                      ...                                            .........||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            000                                            000012347999999999999999999999999


Q ss_pred             HHHHHHHHHcCCccccc
Q 036507          540 FGVVLFEIISGKEAIIR  556 (639)
Q Consensus       540 ~Gvvl~elltG~~p~~~  556 (639)
                      |||++|||++|+.||..
T Consensus       234 lGvil~elltG~~Pf~~  250 (382)
T cd05625         234 VGVILYEMLVGQPPFLA  250 (382)
T ss_pred             chHHHHHHHhCCCCCCC
Confidence            99999999999999954

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.9e-36  Score=312.26  Aligned_cols=240  Identities=25%  Similarity=0.364  Sum_probs=188.9

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|+.++.++ +||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875  478999998753      234577899999888 599999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|..++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---  149 (327)
T cd05617          81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---  149 (327)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC---
Confidence            999988853     235899999999999999999999987   999999999999999999999999998753211   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||........     ..........+...+.    
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~----  220 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-----MNTEDYLFQVILEKPI----  220 (327)
T ss_pred             CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-----cccHHHHHHHHHhCCC----
Confidence            1223346799999999999999999999999999999999999999954322100     0111111111111110    


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK  629 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  629 (639)
                                   ..+......+.+++.+||+.||++|+++.
T Consensus       221 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         221 -------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             -------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                         01233345688999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.3e-36  Score=306.97  Aligned_cols=246  Identities=29%  Similarity=0.410  Sum_probs=195.2

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      |+..+.||+|+||.||++...  ++.+|+|.+....      ...+.+|+.++++++|+|++++++.+.+.+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566788999999999999875  5789999875431      23467899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...   ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++......
T Consensus        82 ~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999988542   2345889999999999999999999987   999999999999999999999999998765321


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .    ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......    .....    ........  
T Consensus       156 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~----~~~~~----~~~~~~~~--  221 (285)
T cd05630         156 Q----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEV----ERLVKEVQ--  221 (285)
T ss_pred             c----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc----hHHHH----Hhhhhhhh--
Confidence            1    1223478999999999999999999999999999999999999996432110    00000    00100000  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                                     ..++......+.+++.+||+.||++|||     ++|+++
T Consensus       222 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 ---------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                           0112233456889999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.4e-36  Score=301.88  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=196.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .++|+..+.||+|+||.||+|...  ++.+|+|.+...   ....+.+|+.++++++||||+++++++..++..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            356888999999999999999874  578999988643   234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.++++.     ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+...
T Consensus        88 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          88 CGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             CCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            999999999864     235788999999999999999999987   999999999999999999999999999865321


Q ss_pred             CCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .   .......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+......     +  ..       ... 
T Consensus       160 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-----~--~~-------~~~-  221 (267)
T cd06646         160 I---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----R--AL-------FLM-  221 (267)
T ss_pred             c---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----h--hh-------eee-
Confidence            1   1122346889999999874   345788999999999999999999998533210     0  00       000 


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                          ..   .....+....  .......+.+++.+||+.||++||+++++++.|
T Consensus       222 ----~~---~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         222 ----SK---SNFQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----ec---CCCCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                00   0000111111  112345789999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-36  Score=319.91  Aligned_cols=267  Identities=21%  Similarity=0.282  Sum_probs=198.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc----CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR----NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..+|...+.||+|+||.||++...    +..|++|.+...  +...+|+++|++++||||+++++++...+..+++||++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            357888999999999999998764    357999987654  33568999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      . ++|.+++..     ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus       169 ~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        169 K-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             C-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            4 688888832     346899999999999999999999987   9999999999999999999999999997654322


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                       .........||+.|+|||++.+..++.++|||||||++|||++|+.||........    ...+ ..+...+...+...
T Consensus       240 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~l-~~i~~~~~~~~~~~  313 (392)
T PHA03207        240 -DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS----SSQL-RSIIRCMQVHPLEF  313 (392)
T ss_pred             -ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc----HHHH-HHHHHHhccCcccc
Confidence             12222346799999999999999999999999999999999999999965432110    0111 11111122111111


Q ss_pred             ccc---c-------cccccCCcccC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMS---S-------LKDYIDPNMMD---LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~---~-------~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...   .       ......+....   ........++.+++.+||..||++|||+.|++.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            000   0       00000010000   000122456889999999999999999999985

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-36  Score=304.49  Aligned_cols=252  Identities=25%  Similarity=0.440  Sum_probs=198.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--C----ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--N----QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~----~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ..+|+..+.||+|+||.||+|...  +    ..+|+|.+....    ..++.+|++++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            356777889999999999999864  2    258999876542    3568899999999999999999999987 7889


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +++||+++|+|.+++...    ...+++.....++.|++.||+|||+++   ++|+||||+||++++++.+||+|||+++
T Consensus        85 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence            999999999999998642    234899999999999999999999977   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+..... ........++..|++||.+....++.++|+||||+++||+++ |+.||.....        ..+...+   .
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~---~  225 (279)
T cd05057         158 LLDVDEK-EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLL---E  225 (279)
T ss_pred             cccCccc-ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHH---h
Confidence            6642211 111111234568999999988889999999999999999998 9999854321        1111111   1


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                 ...+..+...+.+++.+||..||++||++.++++.|+++
T Consensus       226 ~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         226 KGER-----------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CCCC-----------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1000                 011223445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.8e-36  Score=320.04  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=194.2

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC-----eEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED-----ELF  419 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~  419 (639)
                      +|+..+.||+|+||.||++...  ++.||||.+...     ..+.+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999864  688999988542     2356889999999999999999999988766     789


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +|+||+. ++|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence            9999995 688887753     245889999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ......  ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||......        .....+...+
T Consensus       152 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~  221 (372)
T cd07853         152 VEEPDE--SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--------QQLDLITDLL  221 (372)
T ss_pred             ecccCc--cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHHc
Confidence            653221  1222335688999999998774 5789999999999999999999999643321        0111111111


Q ss_pred             hcCCCcccc---cccc-----cccC-Cccc--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSM---SSLK-----DYID-PNMM--DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~---~~~~-----~~~d-~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +..+.....   ....     .... +...  .........++.+++.+||+.||++|||+.|++.
T Consensus       222 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         222 GTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            111000000   0000     0000 0000  0011223557899999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-35  Score=301.48  Aligned_cols=253  Identities=25%  Similarity=0.422  Sum_probs=197.7

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      |++.+++++.....||+|+||.||+|...  +..|++|.+...   ..+.+.+|++++++++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34567788888889999999999999875  467999987654   3456889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccC
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSL--SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFG  496 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  496 (639)
                      +++||+++++|.+++....    ..+  ++.....++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|||
T Consensus        82 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecch
Confidence            9999999999999987421    224  77888889999999999999887   999999999999976 6789999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCC--CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL--ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ++.......   .......++..|+|||++....  ++.++||||||+++|||++|+.|+......        ....+.
T Consensus       155 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~--------~~~~~~  223 (268)
T cd06624         155 TSKRLAGIN---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP--------QAAMFK  223 (268)
T ss_pred             hheecccCC---CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh--------hhhHhh
Confidence            987653211   1122346789999999986543  788999999999999999999998532210        000000


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......              .+    ..+.....++.+++.+||+.+|++|||+.|++.
T Consensus       224 ~~~~~~--------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         224 VGMFKI--------------HP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhhcc--------------CC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            000000              01    123334557899999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.6e-36  Score=304.13  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=198.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|...+.||+|+||.||+|...+     ..+++|.....    ..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3567778899999999999998643     36899987643    24568899999999999999999998865 56789


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +|||+++|+|.+++...    ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          84 VMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence            99999999999999642    235899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....  ....+...++..|+|||.+....++.++||||||++++||++ |..||.....        ......   ...
T Consensus       157 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~---~~~  223 (270)
T cd05056         157 LEDES--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGR---IEN  223 (270)
T ss_pred             ccccc--ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH---HHc
Confidence            53321  111122334568999999988889999999999999999986 9999854321        011111   100


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..             ..    ..+..++..+.+++.+|+..+|++|||+.++++.|+++
T Consensus       224 ~~-------------~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         224 GE-------------RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CC-------------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00             00    01234456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.1e-36  Score=302.77  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=187.0

Q ss_pred             ceeecCceEEEEEEEcC----ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          358 LLGHGTYGSVYYGNIRN----QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~~----~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      .||+|+||.||+|...+    ..+++|.+....    ...+.+|+++++.++|+||+++++.+...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997532    468889875432    3457889999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      |.+++...........++...+.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++....... ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED-YYI  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch-hee
Confidence            999997643333344567888899999999999999987   9999999999999999999999999986432211 111


Q ss_pred             eeeeeccccccCCcccccc-------CCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          510 TVTKVVGTFGYLAPEYLTD-------GLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||.....       ...    ........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~----~~~~~~~~  226 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-------EQV----LKQVVREQ  226 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHH----HHHHhhcc
Confidence            1122345678999998743       356789999999999999999 7777743221       001    11111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      .        ....++.+    +......+.+++..|| .||++||+++||++.|.
T Consensus       227 ~--------~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 D--------IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             C--------ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0        11112222    2234456778888998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.6e-36  Score=315.29  Aligned_cols=269  Identities=19%  Similarity=0.320  Sum_probs=194.7

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      ...+|...+.||+|+||.||+|...+  ..||+|......   ...|+.++++++|+||+++++++...+..++|+|++ 
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-  139 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-  139 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-
Confidence            44679999999999999999998864  689999754432   356999999999999999999999999999999999 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      .++|.+++..    ....+++..++.|+.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....   
T Consensus       140 ~~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  209 (357)
T PHA03209        140 SSDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---  209 (357)
T ss_pred             CCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence            5688888753    2346899999999999999999999987   99999999999999999999999999875321   


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchh---hhhhhHHHHHHHHhhcCCC
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN---QERRSLASFMLAALRNSPD  583 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~  583 (639)
                       ........||..|+|||++.+..++.++|||||||++|||+++..++..........   .....+...+ ..+...+.
T Consensus       210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~  287 (357)
T PHA03209        210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII-STLKVHPE  287 (357)
T ss_pred             -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH-HHhccChh
Confidence             112234578999999999999999999999999999999999765553322111000   0011111111 11111111


Q ss_pred             ccc----ccccccccCCccc--C-------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMS----MSSLKDYIDPNMM--D-------LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~----~~~~~~~~d~~l~--~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...    ......+++....  .       .........+.+++.+||+.||++|||++|++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            110    0000000100000  0       000122345677999999999999999999985

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-35  Score=308.18  Aligned_cols=264  Identities=23%  Similarity=0.348  Sum_probs=195.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|...+.||+|+||.||++...  ++.+|+|.++..    ....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999875  578999988643    234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++ +|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          86 LDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            964 888887542    234788889999999999999999987   999999999999999999999999998754321


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.        ......+...+...+.
T Consensus       158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~~  226 (309)
T cd07872         158 T---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV--------EDELHLIFRLLGTPTE  226 (309)
T ss_pred             c---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCH
Confidence            1   12223467899999998865 5678999999999999999999999854321        0111111111111111


Q ss_pred             ccc-----ccccccccCCcccC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMS-----MSSLKDYIDPNMMD----LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~-----~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...     .......-.+....    ........++.+++.+||+.||.+|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000     00000000000000    001123556889999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=305.94  Aligned_cols=241  Identities=23%  Similarity=0.382  Sum_probs=203.2

Q ss_pred             CCCCCceeecCceEEEEEEE--cCceEEEEEeccccH-----HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKT-----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      |...+.||+|.|..|-++++  .|..||||++.+.+.     ..+++|++-|+.++|||||+|+++......+|||+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            45567799999999998864  799999999976643     45789999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccCCceecCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~  504 (639)
                      .+|+|.+++...    ...+.+....+++.||.+|+.|+|+..   ++||||||+||.+.+ -|-+||.|||++..+.+ 
T Consensus       100 D~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-  171 (864)
T KOG4717|consen  100 DGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-  171 (864)
T ss_pred             CCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence            999999999643    345888889999999999999999865   999999999998755 58899999999987643 


Q ss_pred             CCCcceeeeeccccccCCccccccCCCC-CcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLAT-AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                         ....+..+|+..|-|||++.+..|+ +++||||||||||.|++|+.||..-++                        
T Consensus       172 ---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND------------------------  224 (864)
T KOG4717|consen  172 ---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND------------------------  224 (864)
T ss_pred             ---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc------------------------
Confidence               3356678999999999999998885 789999999999999999999964332                        


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         .+.+..++|-...  .|.....++++||..||..||++|.+.+|+..
T Consensus       225 ---SETLTmImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  225 ---SETLTMIMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---hhhhhhhhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence               1223334444433  36667788999999999999999999999864

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.5e-36  Score=312.83  Aligned_cols=238  Identities=26%  Similarity=0.355  Sum_probs=186.2

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMK-ILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.+|+|.+....      ..++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999875  4679999986432      223444444 56788999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+.......++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~---  149 (325)
T cd05602          81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH---  149 (325)
T ss_pred             CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC---
Confidence            999999864     234677778889999999999999987   999999999999999999999999998753221   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .   ...........     
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~---~~~~~i~~~~~-----  213 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------A---EMYDNILNKPL-----  213 (325)
T ss_pred             CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------H---HHHHHHHhCCc-----
Confidence            1123346799999999999999999999999999999999999999954321        0   11111111110     


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                           .        .+......+.+++.+|++.||.+||++.+.+..
T Consensus       214 -----~--------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         214 -----Q--------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             -----C--------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence                 0        112334568899999999999999998754443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.7e-36  Score=305.92  Aligned_cols=264  Identities=24%  Similarity=0.348  Sum_probs=194.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|++|.||+|...  +..||+|.+...     ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999874  578999987532     235678999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++ ++|.+++....  ....+++.....++.|+++||+|||+++   ++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            96 68988876422  2346899999999999999999999987   999999999999999999999999998765322


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                         ........+++.|+|||.+.+ ..++.++||||||++++||++|+.||......       ..+.... ..+.....
T Consensus       155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-------~~~~~~~-~~~~~~~~  223 (285)
T cd07861         155 ---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-------DQLFRIF-RILGTPTE  223 (285)
T ss_pred             ---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHH-HHhCCCCh
Confidence               112223457889999998865 45788999999999999999999998643221       0000000 00000000


Q ss_pred             cc-----cccccc----cccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SM-----SMSSLK----DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~-----~~~~~~----~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..     ......    ....... .........++.+++.+||+.||++|||+++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         224 DVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00     000000    0000000 0011224557889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-35  Score=302.75  Aligned_cols=246  Identities=27%  Similarity=0.381  Sum_probs=194.3

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      |+..+.||+|+||+||++...  ++.+|+|.+....      ...+.+|++++++++|+|++.+.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556788999999999999885  5789999886432      23467899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...   ....+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            9999999888642   2345899999999999999999999987   999999999999999999999999998765321


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                          .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.....       .... ..+........  
T Consensus       156 ----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-------~~~~-~~~~~~~~~~~--  221 (285)
T cd05632         156 ----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-------KVKR-EEVDRRVLETE--  221 (285)
T ss_pred             ----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-------HHHH-HHHHHhhhccc--
Confidence                112335789999999999988999999999999999999999999954321       0000 11111111100  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                                 +    .++......+.+++..||+.||++||+     +++++.
T Consensus       222 -----------~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 -----------E----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -----------c----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                       0    012233456889999999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=287.84  Aligned_cols=247  Identities=24%  Similarity=0.349  Sum_probs=195.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEec-----cccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +++|+..+.||+|.|+.||+...  .++.+|+|+++     ....+++.+|++|-+.|+||||+++.....+....|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35666677899999999998755  36677777654     345678899999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~  499 (639)
                      |+|.|++|..-+-.     +...++...-....||+++|.|+|.++   |+|||+||+|+++-+   ..-+||+|||+|.
T Consensus        90 e~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             ecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999765532     134667777788999999999999988   999999999999954   3458999999999


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .++    .........|||+|||||++...+|+..+|||+.||+||-|+.|.+||...+        ...+.+.   ++.
T Consensus       162 ~l~----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~---I~~  226 (355)
T KOG0033|consen  162 EVN----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQ---IKA  226 (355)
T ss_pred             EeC----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHH---Hhc
Confidence            875    2345567899999999999999999999999999999999999999995422        2223322   222


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+         +-.|.+     ....++..+|+.+||..||++|.|+.|.|.
T Consensus       227 g~yd---------~~~~~w-----~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  227 GAYD---------YPSPEW-----DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccC---------CCCccc-----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2111         000111     223456889999999999999999998763

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=297.93  Aligned_cols=245  Identities=29%  Similarity=0.470  Sum_probs=193.8

Q ss_pred             CceeecCceEEEEEEEc-CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChh
Q 036507          357 SLLGHGTYGSVYYGNIR-NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLK  431 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  431 (639)
                      ++||+|+||.||++... ++.|++|.+...    ..+.+.+|++++++++|+||+++++++...+..+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999876 688999987643    2456889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCccee
Q 036507          432 SHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV  511 (639)
Q Consensus       432 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  511 (639)
                      +++...    ...+++...+.++.+++.+++|||+++   ++||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~  152 (251)
T cd05041          81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSD  152 (251)
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-eecc
Confidence            998642    235788899999999999999999987   99999999999999999999999999875532110 0000


Q ss_pred             eeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          512 TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....+..|+|||.+.++.++.++|+||||+++|||++ |..||.....        .....    .+...         
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~----~~~~~---------  211 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRE----RIESG---------  211 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHH----HHhcC---------
Confidence            11233567999999988899999999999999999999 7777743221        01111    11110         


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                             .....+...+.++.+++.+||+.+|++||+++|+++.|+.
T Consensus       212 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         212 -------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             -------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence                   0001123445679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=308.66  Aligned_cols=246  Identities=28%  Similarity=0.400  Sum_probs=204.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVH-HSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~l  420 (639)
                      .+.|+..+.||+|.||.||++..+  ++.+|+|.+....      .+.+.+|+++|+++. ||||+.+.+.+.+...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            356777789999999999999875  5789999986542      357899999999999 9999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC----CCEEEeccC
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA----FRAKISDFG  496 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg  496 (639)
                      |||++.||.|.+.+...      .++......++.|++.+++|||+.+   |+||||||+|+|+...    +.+|++|||
T Consensus       114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            99999999999999753      2889999999999999999999987   9999999999999543    479999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ++.....    .......+||+.|+|||++....|+..+||||+||++|.|++|..||......           .....
T Consensus       185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-----------~~~~~  249 (382)
T KOG0032|consen  185 LAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-----------EIFLA  249 (382)
T ss_pred             CceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-----------HHHHH
Confidence            9998643    44667789999999999999999999999999999999999999999654320           01112


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.....              .+...+-.+....+.+++..|+..||.+|+++.++++
T Consensus       250 i~~~~~--------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  250 ILRGDF--------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHcCCC--------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            222211              1112222344567899999999999999999999986

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.2e-36  Score=313.71  Aligned_cols=237  Identities=27%  Similarity=0.369  Sum_probs=186.6

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMK-ILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||++...  ++.+|+|.+...      ...++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999874  678999998643      2234555555 46779999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|..++..     ...+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....   
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~---  149 (325)
T cd05604          81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ---  149 (325)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC---
Confidence            999988853     345889999999999999999999987   999999999999999999999999998743211   


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...+.           .......+....     
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----------~~~~~~~~~~~~-----  213 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----------AEMYDNILHKPL-----  213 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----------HHHHHHHHcCCc-----
Confidence            1223346799999999999999999999999999999999999999854321           111111111110     


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                           .+        +......+.+++.+|++.||.+||++++.+.
T Consensus       214 -----~~--------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         214 -----VL--------RPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             -----cC--------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence                 01        1123446889999999999999999864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-35  Score=322.90  Aligned_cols=268  Identities=22%  Similarity=0.274  Sum_probs=193.8

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCC------CCeeEEEeee
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHH------SNLVELIGYA  412 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h------~niv~l~~~~  412 (639)
                      .+++...+++|...++||+|+||+||++...  ++.||||+++..  ...+...|++++.+++|      .+++++++++
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            3455566789999999999999999999874  578999998642  23456678888877754      4588898888


Q ss_pred             ecC-CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEECCCC--
Q 036507          413 ATE-DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLDSAF--  488 (639)
Q Consensus       413 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~~~~--  488 (639)
                      ... ++.++|||++ +++|.+++..     ...+++.....|+.||+.||+|||++ +   |+||||||+|||++.++  
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~  271 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTV  271 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcc
Confidence            764 5788999988 7789888853     24588999999999999999999974 5   99999999999998765  


Q ss_pred             --------------CEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccc
Q 036507          489 --------------RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAI  554 (639)
Q Consensus       489 --------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~  554 (639)
                                    .+||+|||++....      ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        272 VDPVTNRALPPDPCRVRICDLGGCCDER------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             cccccccccCCCCceEEECCCCccccCc------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                          49999999876421      1223468999999999999999999999999999999999999999


Q ss_pred             cccccccchhhhhhhHHHHHHHHhhcCCCcccc--------------cccccccCCcc----cC---CCChhHHHHHHHH
Q 036507          555 IRTEGMVSKNQERRSLASFMLAALRNSPDSMSM--------------SSLKDYIDPNM----MD---LYPHDCLFKMAML  613 (639)
Q Consensus       555 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--------------~~~~~~~d~~l----~~---~~~~~~~~~l~~l  613 (639)
                      .....        ......+...++..+.....              ..+....++..    ..   .........+.+|
T Consensus       346 ~~~~~--------~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  417 (467)
T PTZ00284        346 DTHDN--------LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDL  417 (467)
T ss_pred             CCCCh--------HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHH
Confidence            64332        11111111111111100000              00000011100    00   0000113457899


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 036507          614 AKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       614 i~~cl~~dP~~RPs~~evl~  633 (639)
                      +.+||+.||++|||++|+++
T Consensus       418 i~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        418 IYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHhCCcChhhCCCHHHHhc
Confidence            99999999999999999985

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-35  Score=302.84  Aligned_cols=263  Identities=23%  Similarity=0.324  Sum_probs=191.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhc---CCCCeeEEEeeeec-----CC
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKV---HHSNLVELIGYAAT-----ED  416 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l---~h~niv~l~~~~~~-----~~  416 (639)
                      +|+..+.||+|+||.||++...  ++.||+|.++..     ....+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777889999999999999875  578999988642     123466788777665   69999999998754     34


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..+++|||+. ++|.+++...   ....+++.....++.|++.||.|||+++   |+||||||+||++++++.+||+|||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence            5799999996 5898888642   2345889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ++.......    ......||..|+|||++.+..++.++|||||||++|||++|++||......        .....+..
T Consensus       154 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--------~~~~~~~~  221 (288)
T cd07863         154 LARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--------DQLGKIFD  221 (288)
T ss_pred             ccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--------HHHHHHHH
Confidence            998653211    123356889999999999889999999999999999999999988543210        01111111


Q ss_pred             HhhcCCCcccccc---cccccCCcc---cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSMSS---LKDYIDPNM---MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~---~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+...........   ....+.+..   ......+....+.+++.+||+.||++|||+.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111110000000   000011100   00111234567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.8e-36  Score=300.80  Aligned_cols=248  Identities=29%  Similarity=0.492  Sum_probs=196.0

Q ss_pred             CCCCCceeecCceEEEEEEEcC--ceEEEEEeccccHH-----HHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATKTK-----EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      |+..+.||+|+||+||++...+  +.+|+|.+......     ...+|+.++++++||||+++++++.+.+..+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            3456789999999999999874  57999999765432     2345999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++.     ....+++..+..++.|+++||++||+.+   ++|+||||+||++++++.++|+|||.+....   
T Consensus        81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---  149 (260)
T PF00069_consen   81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS---  149 (260)
T ss_dssp             TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST---
T ss_pred             cccccccccc-----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc---
Confidence            9999999996     2345899999999999999999999987   9999999999999999999999999997641   


Q ss_pred             CCcceeeeeccccccCCccccc-cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      ..........++..|+|||.+. +..++.++||||+|+++++|++|+.|+.....     .+....   .........  
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~~~~~~---~~~~~~~~~--  219 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----DDQLEI---IEKILKRPL--  219 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----HHHHHH---HHHHHHTHH--
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----hhhhhh---hhhcccccc--
Confidence            2223444567899999999998 88899999999999999999999999864411     011111   111111000  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                            ..    ..  .........+.+++.+||+.||++||++.++++
T Consensus       220 ------~~----~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  220 ------PS----SS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ------HH----HT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ------cc----cc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00    00  000111267999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.7e-36  Score=311.18  Aligned_cols=233  Identities=26%  Similarity=0.359  Sum_probs=184.3

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMK-ILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++||+|+||.||++...  ++.||+|.+....      ..++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999885  5789999986432      233555554 57889999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|..++..     ...++......++.||++||+|||+++   |+||||||+||+++.++.+||+|||+++....   .
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---~  149 (321)
T cd05603          81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---P  149 (321)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC---C
Confidence            999988853     234778888889999999999999987   99999999999999999999999999874321   1


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.           ........... .    
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~i~~~~-~----  213 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----------SQMYDNILHKP-L----  213 (321)
T ss_pred             CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----------HHHHHHHhcCC-C----
Confidence            1223345799999999999998999999999999999999999999954321           11111111111 0    


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK  629 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  629 (639)
                                   ..+......+.+++.+||+.||.+||++.
T Consensus       214 -------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 -------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                         01223345688999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.4e-36  Score=308.31  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=196.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--Cc----eEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQ----EVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|+..+.||+|+||.||++...  +.    .+|+|.+....    ..++.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            456777889999999999999863  32    47889876542    23678999999999999999999998654 567


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +++||+++|+|.+++...    ...+++.....++.|++.||.|||+++   |+|+||||+||++++++.+||+|||+++
T Consensus        85 ~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence            999999999999998642    235788899999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+..... ........++..|++||.+.+..++.++||||||+++|||++ |+.||.....        ......    +
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~----~  224 (303)
T cd05110         158 LLEGDEK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDL----L  224 (303)
T ss_pred             cccCccc-ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH----H
Confidence            6542211 111222345778999999998999999999999999999997 8888843211        111111    1


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .....         .       ..+..+...+.+++.+||..+|++||+++++++.|+++
T Consensus       225 ~~~~~---------~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         225 EKGER---------L-------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             HCCCC---------C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11100         0       01122345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-35  Score=296.90  Aligned_cols=247  Identities=29%  Similarity=0.466  Sum_probs=200.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++|+..+.||+|+||.||++...  +..+++|.+.... .+++.+|++++++++|+||+++++++..+...++++||+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            57888899999999999999886  4789999987553 67789999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.+++...    ...+++.....++.|+++|+.|||+.+   ++|+||+|+||++++++.+||+|||++.......  
T Consensus        83 ~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--  153 (256)
T cd06612          83 GSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--  153 (256)
T ss_pred             CcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--
Confidence            9999998632    346899999999999999999999987   9999999999999999999999999988654321  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                       .......++..|+|||++.+..++.++||||||+++|||++|+.|+......       ..    ........      
T Consensus       154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-------~~----~~~~~~~~------  215 (256)
T cd06612         154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RA----IFMIPNKP------  215 (256)
T ss_pred             -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-------hh----hhhhccCC------
Confidence             1223345788999999999889999999999999999999999998543210       00    00000000      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                             .+.+.  .+......+.+++.+||+.||++|||++|+++
T Consensus       216 -------~~~~~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         216 -------PPTLS--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -------CCCCC--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                   00000  12233456899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.6e-35  Score=308.87  Aligned_cols=237  Identities=25%  Similarity=0.388  Sum_probs=189.4

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +|...+.||+|+||.||++...  ++.||+|.+...      ..+.+..|.+++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3666789999999999999875  578999998643      2345678889998886 577888999999899999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++...+.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999999854     235889999999999999999999987   9999999999999999999999999987532


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+   ....+....
T Consensus       153 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~---~~~i~~~~~  218 (323)
T cd05615         153 VD---GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DEL---FQSIMEHNV  218 (323)
T ss_pred             CC---CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHhCCC
Confidence            21   1122345699999999999999999999999999999999999999954321        111   111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                                        .++.....++.+++.+||+.+|.+|++.
T Consensus       219 ------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ------------------SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------------------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                              1122334568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-35  Score=299.20  Aligned_cols=236  Identities=23%  Similarity=0.360  Sum_probs=183.9

Q ss_pred             CceeecCceEEEEEEEcC--------------ceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          357 SLLGHGTYGSVYYGNIRN--------------QEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~--------------~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      +.||+|+||.||+|....              ..+++|.+....   ...+.+|+.++++++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997531              258889876443   346788999999999999999999999988999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC-------EEE
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR-------AKI  492 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl  492 (639)
                      ++|||+++|+|..++..    ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.       +++
T Consensus        81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence            99999999999988863    2245889999999999999999999987   999999999999987664       899


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccc-cCCCCCcchHHHHHHHHHHHH-cCCccccccccccchhhhhhhH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEII-SGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVws~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      +|||++......       ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+.....     .+   .
T Consensus       154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~---~  218 (262)
T cd05077         154 SDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----AE---K  218 (262)
T ss_pred             CCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----hH---H
Confidence            999998754211       1245788899999886 467899999999999999998 57777643211     00   0


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                          .......         ...         ......++.+++.+||+.||++||++.++++.|+
T Consensus       219 ----~~~~~~~---------~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ----ERFYEGQ---------CML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ----HHHHhcC---------ccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                0000000         000         0112346889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-35  Score=303.22  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=200.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|+||+||++...  ++.+|+|.+...    ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45667789999999999999876  678999987543    245788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++..     ...+++.....++.+++.+|.|||+..  +++|+||||+||++++++.++|+|||++......
T Consensus        85 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          85 MDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999998854     235889999999999999999999732  3999999999999999999999999998654221


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .     .....|+..|+|||++.+..++.++|||||||++|||++|+.||...............+...........+  
T Consensus       158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  230 (284)
T cd06620         158 I-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--  230 (284)
T ss_pred             c-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--
Confidence            1     123578999999999988889999999999999999999999996433211111111122222222222111  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                                 +.+   ...+.+..+.+++.+||+.||++||+++|++..
T Consensus       231 -----------~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 -----------PRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             -----------CCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                       001   112245578999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=302.31  Aligned_cols=235  Identities=23%  Similarity=0.415  Sum_probs=182.9

Q ss_pred             ceeecCceEEEEEEEc--------------------------CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEE
Q 036507          358 LLGHGTYGSVYYGNIR--------------------------NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVEL  408 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l  408 (639)
                      .||+|+||.||+|...                          ...|++|.+....   ..++.+|++++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999998742                          1248899886543   3468889999999999999999


Q ss_pred             EeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC
Q 036507          409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF  488 (639)
Q Consensus       409 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~  488 (639)
                      ++++.+....++||||+++|+|..++..    ....+++..++.++.|+++||+|||+++   |+||||||+|||++..+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence            9999999999999999999999999863    2345788899999999999999999987   99999999999997643


Q ss_pred             -------CEEEeccCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHH-cCCcccccccc
Q 036507          489 -------RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEII-SGKEAIIRTEG  559 (639)
Q Consensus       489 -------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~ell-tG~~p~~~~~~  559 (639)
                             .+|++|||++......       ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.....
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence                   3899999987643211       12356788999998865 56899999999999999995 68888854321


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                           .   .....    .....              .    .+......+.+++.+||+.+|++||+++++++.|+
T Consensus       228 -----~---~~~~~----~~~~~--------------~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 -----S---EKERF----YEKKH--------------R----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----H---HHHHH----HHhcc--------------C----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                 0   00010    11000              0    01111235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-35  Score=304.12  Aligned_cols=245  Identities=26%  Similarity=0.432  Sum_probs=197.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .+|+..+.||+|+||.||++...  ++.+++|.+...   ..+.+.+|++++++++|+|++++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888889999999999999864  578999988643   2456788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++..      ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654         100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            99999999853      24788899999999999999999987   9999999999999999999999999987543211


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         .......+++.|+|||.+.+..++.++|||||||++|||++|+.||.....       ...+.    .......   
T Consensus       171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~----~~~~~~~---  233 (296)
T cd06654         171 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALY----LIATNGT---  233 (296)
T ss_pred             ---cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHH----HHhcCCC---
Confidence               112234688999999999988899999999999999999999999853321       00110    0111000   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +.+  ..+......+.+++.+||+.||++||+++|++.
T Consensus       234 ----------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 ----------PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ----------CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                      000  012233456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-35  Score=315.14  Aligned_cols=258  Identities=19%  Similarity=0.304  Sum_probs=199.5

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeee
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYA  412 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~  412 (639)
                      ....++....++|+..+.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|+.+++.++||||+++++.+
T Consensus        33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (371)
T cd05622          33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF  112 (371)
T ss_pred             hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            345566677789999999999999999999885  578999998542      223467899999999999999999999


Q ss_pred             ecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       413 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                      .+++..++||||+++|+|.+++..      ..++......++.|++.||+|||+++   |+||||||+|||++.++.+||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999864      23677788889999999999999987   999999999999999999999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccC----CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG----LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      +|||++..+....  ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||...+.         
T Consensus       184 ~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------  252 (371)
T cd05622         184 ADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------  252 (371)
T ss_pred             EeCCceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---------
Confidence            9999998764221  1122346799999999998753    378899999999999999999999954321         


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL--RPDMKQVVIS  634 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  634 (639)
                        ......++.....       ....       ...+....+.+++..|+..++.+  ||+++|+++.
T Consensus       253 --~~~~~~i~~~~~~-------~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         253 --VGTYSKIMNHKNS-------LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             --HHHHHHHHcCCCc-------ccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence              1111122211100       0000       01234556889999999844433  7889888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2e-35  Score=300.83  Aligned_cols=255  Identities=25%  Similarity=0.467  Sum_probs=199.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|+..+.||+|+||.||++...       ...+++|.+....    .+++.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56788899999999999999863       3579999886432    357899999999999999999999999989999


Q ss_pred             EEEeeccCCChhhhccCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      +||||+++|+|.+++.......    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987532111    125899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |++......  .........++..|++||.+.+..++.++||||||++++||++ |..||.....        .....  
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~--  229 (275)
T cd05046         162 SLSKDVYNS--EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLN--  229 (275)
T ss_pred             ccccccCcc--cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHH--
Confidence            998644221  1112223456778999999988888999999999999999999 7777743211        01111  


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                       . .....               +....+..++..+.+++.+||+.+|++||++.|++..|.+
T Consensus       230 -~-~~~~~---------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         230 -R-LQAGK---------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -H-HHcCC---------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence             1 11000               0000122345579999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-35  Score=298.05  Aligned_cols=247  Identities=25%  Similarity=0.410  Sum_probs=191.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAAT--EDEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  418 (639)
                      .+|+..+.||+|+||.||++...  +..+++|.+...        ..+.+.+|++++++++||||+++++++..  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888899999999999999874  578999987532        13457889999999999999999998865  3568


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++++||+++++|.+++..     ...+++...+.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++
T Consensus        82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            899999999999999864     234788889999999999999999877   999999999999999999999999998


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ..+..............++..|+|||.+.+..++.++||||||+++|||++|+.||.....           ........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----------~~~~~~~~  222 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----------MAAIFKIA  222 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----------HHHHHHHh
Confidence            7653221111122335688999999999988899999999999999999999999853321           00111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...            ..+.    .+......+.+++ .||..+|++||+++|++.
T Consensus       223 ~~~------------~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         223 TQP------------TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             cCC------------CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            100            0111    1223344566676 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.5e-36  Score=303.71  Aligned_cols=241  Identities=25%  Similarity=0.439  Sum_probs=194.3

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      |+..+.||+|+||.||+|...  +..||+|.+...    ..+.+.+|++++++++||||+++++++..++..++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            445678999999999999874  568999987633    23568899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++..      ..+++.....++.|+++|+.|||+++   ++|+||+|+||++++++.++|+|||++..+.... 
T Consensus        86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          86 GGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            9999998853      34788999999999999999999987   9999999999999999999999999997653221 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                        .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......        ..   . ..+...     
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~---~-~~~~~~-----  216 (277)
T cd06642         156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RV---L-FLIPKN-----  216 (277)
T ss_pred             --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hH---H-hhhhcC-----
Confidence              1122346788999999999888999999999999999999999988532210        00   0 000000     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                             ..+.    .+...+..+.+++.+||+.+|++||+|.|++.
T Consensus       217 -------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 -------SPPT----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -------CCCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                   0111    12234567899999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.9e-35  Score=312.38  Aligned_cols=268  Identities=21%  Similarity=0.269  Sum_probs=193.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------C
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------D  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  416 (639)
                      .++|...+.||+|+||.||++...  ++.||||++...     ..+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467888999999999999999874  578999998642     245678999999999999999999987543      3


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++||||++ ++|.+.+..       .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence            5799999996 477776642       3778888999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhh-----------
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ-----------  565 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~-----------  565 (639)
                      +++.....    .......||..|+|||++.+..++.++|||||||++|||++|+.||...+.......           
T Consensus       172 ~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         172 LARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             CccccCCC----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            99765321    122345789999999999999999999999999999999999999954332100000           


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcc---cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNM---MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....+...........+... .....+.+...+   ...........+.+++.+|++.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYA-GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcC-CCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000000111111000 000000000000   00011122456889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3e-35  Score=303.84  Aligned_cols=264  Identities=24%  Similarity=0.353  Sum_probs=196.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.+...    ....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999875  578999988633    234677899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++ ++|.+++...    ...+++.....++.|+++||+|||+.+   |+|+||||+||++++++.+||+|||++......
T Consensus        86 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          86 LD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            96 6898888642    235788899999999999999999987   999999999999999999999999998754321


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.        ......+...+.....
T Consensus       158 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--------~~~~~~~~~~~~~~~~  226 (301)
T cd07873         158 T---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--------EEQLHFIFRILGTPTE  226 (301)
T ss_pred             C---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHcCCCCh
Confidence            1   12223457889999998865 4578899999999999999999999854321        1112222222222111


Q ss_pred             cccc-----cccccccCCcccC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSM-----SSLKDYIDPNMMD----LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~-----~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....     ......-.+....    .........+.+++.+|++.||.+|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1000     0000000011110    011234556889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.8e-35  Score=303.35  Aligned_cols=194  Identities=28%  Similarity=0.410  Sum_probs=167.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|+||.||++...  +..+|+|.+..+    ...++.+|++++++++||||+++++++..++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999875  567898987543    234588999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.++++..     ..+++.....++.|+++||.|||+..  +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999642     45788889999999999999999742  3999999999999999999999999998754221


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                           ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         154 -----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             -----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence                 12235788999999999888899999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=299.37  Aligned_cols=244  Identities=26%  Similarity=0.422  Sum_probs=197.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||.|+||.||++...  ++.+|+|.+....    ...+.+|++++++++|+|++++++++.++...++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999875  5789999886432    35678999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...      .+++.....++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            9999999998642      6899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .......++..|++||.+.+..++.++||||||+++|||++|+.||...+.        ...   ........   
T Consensus       152 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~---~~~~~~~~---  214 (274)
T cd06609         152 M---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRV---LFLIPKNN---  214 (274)
T ss_pred             c---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHH---HHHhhhcC---
Confidence            1   122335688899999999988899999999999999999999999854321        000   00010110   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                .+.+...   ..+..+.+++.+||..||++||+++++++
T Consensus       215 ----------~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 ----------PPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ----------CCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                      1111111   13446889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-35  Score=309.39  Aligned_cols=195  Identities=22%  Similarity=0.319  Sum_probs=160.5

Q ss_pred             CCceeec--CceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          356 SSLLGHG--TYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       356 ~~~lG~G--~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++||+|  +|++||++...  ++.||+|.+..+.     .+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            5679999  78899999875  5789999986432     2456789999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.+++...   ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.++++||+..........
T Consensus        83 ~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          83 YGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999998542   1234889999999999999999999987   99999999999999999999999986543321111


Q ss_pred             Ccc----eeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          507 GEA----TVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       507 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      ...    ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            100    0112356778999999876  4588999999999999999999999954

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.7e-35  Score=298.61  Aligned_cols=243  Identities=24%  Similarity=0.422  Sum_probs=197.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .|+..+.||.|+||.||+|...  +..+|+|.+...    ..+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4566788999999999999874  578999987643    2356889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++..      ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999999853      24788888899999999999999987   9999999999999999999999999997653221


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......        ..   .. ...      
T Consensus       156 ---~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~---~~-~~~------  214 (277)
T cd06640         156 ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RV---LF-LIP------  214 (277)
T ss_pred             ---cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hH---hh-hhh------
Confidence               1222346788999999998888999999999999999999999998532210        00   00 000      


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                                .......+..++..+.+++.+||+.+|++||++++++..
T Consensus       215 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 ----------KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ----------cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                      000112234566789999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-35  Score=312.27  Aligned_cols=270  Identities=20%  Similarity=0.269  Sum_probs=194.0

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------  415 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------  415 (639)
                      ..++|...+.||+|+||.||++...  ++.+|||.+...     ..+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468888999999999999999764  578999988642     235677899999999999999999987543      


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      ...+++|||+++ +|.+.+..       .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence            357999999964 67666632       3788888899999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh---------
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE---------  566 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~---------  566 (639)
                      |+++.....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........         
T Consensus       164 g~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         164 GLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             cccccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999764321    1223457899999999999989999999999999999999999999643311000000         


Q ss_pred             --hhhHHHHHHHHhhcCCCcccccccccccCCcc---cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          567 --RRSLASFMLAALRNSPDSMSMSSLKDYIDPNM---MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       567 --~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                        ...+...........+... .......+...+   ....+......+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYA-GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccc-cccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence              0000000111111111000 000000000000   001112234568999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.7e-35  Score=301.72  Aligned_cols=261  Identities=25%  Similarity=0.395  Sum_probs=201.3

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhc-CCCCeeEEEeeee--
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKV-HHSNLVELIGYAA--  413 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l-~h~niv~l~~~~~--  413 (639)
                      +.++.+..+.++|+..+.||+|+||.||++...  ++.+|+|.+...  ...++.+|+.+++++ +||||+++++++.  
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            445667778899999999999999999999874  578999987643  235678899999999 6999999999874  


Q ss_pred             ---cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          414 ---TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       414 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                         .++..+++|||+++++|.++++... .....+++.....++.|+++||.|||+++   ++||||||+||++++++.+
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence               3456899999999999999876422 12345788889999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~  565 (639)
                      ||+|||++..+....   .......|+..|+|||++..     ..++.++|||||||++|||++|+.|+......     
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----  235 (286)
T cd06638         164 KLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----  235 (286)
T ss_pred             EEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----
Confidence            999999988653211   12223468999999998753     45788999999999999999999998543210     


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                        ..+    .......             .+.+.  .+......+.+++.+||+.||++|||+.|+++.
T Consensus       236 --~~~----~~~~~~~-------------~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 --RAL----FKIPRNP-------------PPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             --HHH----hhccccC-------------CCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              000    0000000             00000  111233468999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.3e-36  Score=316.41  Aligned_cols=199  Identities=25%  Similarity=0.408  Sum_probs=170.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.++..      ....+.+|++++.+++|+||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36788899999999999999875  578999998643      2345778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            99999999999864     235888899999999999999999987   9999999999999999999999999987542


Q ss_pred             CCCCC--------------------------------cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcC
Q 036507          503 KTSDG--------------------------------EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG  550 (639)
Q Consensus       503 ~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG  550 (639)
                      .....                                .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG  232 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence            21100                                0011235799999999999999999999999999999999999


Q ss_pred             Ccccccc
Q 036507          551 KEAIIRT  557 (639)
Q Consensus       551 ~~p~~~~  557 (639)
                      +.||...
T Consensus       233 ~~Pf~~~  239 (360)
T cd05627         233 YPPFCSE  239 (360)
T ss_pred             CCCCCCC
Confidence            9999543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.7e-35  Score=296.80  Aligned_cols=235  Identities=28%  Similarity=0.462  Sum_probs=186.1

Q ss_pred             CceeecCceEEEEEEEcCc------------eEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          357 SLLGHGTYGSVYYGNIRNQ------------EVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~~------------~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +.||+|+||.||+|...+.            .+++|.+....  ...+.+|++++++++||||+++++++.. +..++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            4699999999999988643            37888776543  4678899999999999999999999987 7789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-------CEEEecc
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-------RAKISDF  495 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Df  495 (639)
                      ||+++|+|.+++....    ..+++..++.++.|++.||+|||+++   |+||||||+||+++.++       .+||+||
T Consensus        80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999987422    25889999999999999999999987   99999999999999887       7999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccC--CCCCcchHHHHHHHHHHHHcC-CccccccccccchhhhhhhHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG--LATAKSDVYAFGVVLFEIISG-KEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVws~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      |++.....       .....++..|+|||++.+.  .++.++||||||+++|||++| ..|+.....     .+   ...
T Consensus       153 g~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~~---~~~  217 (259)
T cd05037         153 GIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----SE---KER  217 (259)
T ss_pred             Cccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----hh---HHH
Confidence            99986532       1123567789999999876  789999999999999999994 666643221     00   000


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      +..   ...          .         .+......+.+++.+||+.+|.+||++.|+++.|+
T Consensus       218 ~~~---~~~----------~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 FYQ---DQH----------R---------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHh---cCC----------C---------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000   000          0         00111157899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.5e-35  Score=296.66  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=193.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAATE--DEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  418 (639)
                      .+|+..++||+|+||.||++...  +..||+|.+...        ..+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999874  578999987421        134678899999999999999999988663  467


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      +++|||+++++|.+++..     ...+++...++++.|++.||+|||+++   ++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence            899999999999999853     234788888899999999999999987   999999999999999999999999998


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .................++..|+|||.+.+..++.++||||||+++|||++|+.||.....          .. ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----------~~-~~~~~~  222 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----------MA-AIFKIA  222 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----------HH-HHHHHh
Confidence            7653221111122335688999999999888899999999999999999999999853221          00 011111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...            ..    ...+......+.+++.+|+. +|++||+++|+++
T Consensus       223 ~~~------------~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 TQP------------TN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             cCC------------CC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            110            00    11233445578889999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.8e-35  Score=297.76  Aligned_cols=245  Identities=23%  Similarity=0.386  Sum_probs=192.9

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      |+..+.||+|+||.||++...  +..+++|.+....   .+.+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            455678999999999999886  4678888876432   45688899999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|..++..    ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++......   
T Consensus        87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---  156 (282)
T cd06643          87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---  156 (282)
T ss_pred             CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc---
Confidence            999988763    2346899999999999999999999987   999999999999999999999999998754321   


Q ss_pred             cceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          508 EATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ........++..|+|||++.     +..++.++|||||||++|||++|+.||.....           ...........+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~~~~~~  225 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKSEP  225 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----------HHHHHHHhhcCC
Confidence            11223356889999999984     45577899999999999999999999843221           011111111111


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .             ..  ..+...+.++.+++.+||+.||++||++.++++
T Consensus       226 ~-------------~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         226 P-------------TL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             C-------------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0             00  012223456899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=321.91  Aligned_cols=246  Identities=26%  Similarity=0.422  Sum_probs=204.4

Q ss_pred             CCceeecCceEEEEEEEc------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          356 SSLLGHGTYGSVYYGNIR------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .++||+|+||+||+|.+-      +.+||+|++...    ..+++++|+-+|.+++|||+++++|+|.... +.||.+||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            678999999999999873      247999988653    3678999999999999999999999998655 88999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      +.|.|.++++.    .+..+-....+.|..|||+||.|||++.   ++||||..+|||+.+...+|+.|||+++.+....
T Consensus       780 P~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  780 PLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             ccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999985    3456888889999999999999999987   9999999999999999999999999999875433


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      . +.......-.+.|||-|.+....|+.++|||||||++||++| |..|+++...                         
T Consensus       853 ~-ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------------------------  906 (1177)
T KOG1025|consen  853 K-EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------------------------  906 (1177)
T ss_pred             c-cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------------------------
Confidence            2 222223344677999999999999999999999999999998 8888854332                         


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                         .++.+.++...+...|..|..++..++.+||..|++.||+++++...+.+.
T Consensus       907 ---~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  907 ---EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ---HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence               222233333333445788999999999999999999999999999887764

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-35  Score=297.02  Aligned_cols=246  Identities=24%  Similarity=0.440  Sum_probs=195.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------------TKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      +|...+.||+|+||.||+|...  ++.+|+|.+....            .+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3666789999999999999874  5789999875321            1457889999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++++||+++++|.+++..     ...+++.....++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence            9999999999999999964     235788888899999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCC---cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          498 AKLVGKTSDG---EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       498 a~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ++........   ........|+..|+|||.+.+..++.++|+||||+++|||++|+.||.....       ...    +
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~----~  221 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQA----I  221 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHH----H
Confidence            9866421111   1111224588899999999988899999999999999999999999854321       000    0


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....             ...+.    .+...+..+.+++.+||+.||++||++.|+++
T Consensus       222 ~~~~~-------------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 FKIGE-------------NASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHhc-------------cCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            01000             11111    12334567899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.5e-35  Score=296.58  Aligned_cols=248  Identities=24%  Similarity=0.423  Sum_probs=195.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc-CceEEEEEecccc---------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK---------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      +|...+.||+|+||.||+|... ++.+|+|.+....         ...+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4677889999999999999774 5779999875321         24578899999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +||+++++|.+++..     ...+++.....++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999999999854     234788888999999999999999987   999999999999999999999999998755


Q ss_pred             CCCCC---CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          502 GKTSD---GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       502 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .....   .........|+..|+|||.+.+..++.++||||||+++|||++|+.||...+..          ... ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------~~~-~~~~  221 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAM-FYIG  221 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----------HHH-HHhh
Confidence            32111   111123356899999999999888999999999999999999999998543210          000 0000


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...           ...+.+    +......+.+++.+||+.+|++||++.|++.
T Consensus       222 ~~~-----------~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         222 AHR-----------GLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hcc-----------CCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000           001111    2234456899999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-35  Score=294.80  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=198.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||.|+||.||.++..  ++.+++|.+...     ..+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4777899999999988877664  578999986532     245688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++....   ...+++.....++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999986421   345889999999999999999999987   999999999999999999999999999866332


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      ..   ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.....           .+..........  
T Consensus       155 ~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------~~~~~~~~~~~~--  218 (256)
T cd08221         155 YS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------LNLVVKIVQGNY--  218 (256)
T ss_pred             cc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHcCCC--
Confidence            21   22345689999999999888889999999999999999999998843221           111111111110  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                                .+     .+.....++.+++.+||+.+|++||+++|+++.+
T Consensus       219 ----------~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 ----------TP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----------CC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                      00     1123345688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-37  Score=313.41  Aligned_cols=241  Identities=29%  Similarity=0.498  Sum_probs=198.7

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +.|...+.||+|+||-||.++.  +++.||||++....      -.++..|+..|++++|||++.+.|++..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3466688899999999998876  45789999986532      256889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||| -|+-.+++.-    -.+++-...+..|+.+.+.||+|||+++   .||||||..|||+++.|.|||+|||.|.+..
T Consensus       106 EYC-lGSAsDlleV----hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  106 EYC-LGSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHH-hccHHHHHHH----HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence            999 6688887752    2457888889999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      +       ...++|||.|||||++.   .+.|+-|+||||||++..||.-.++|++..+.+.           ....+-.
T Consensus       178 P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-----------ALYHIAQ  239 (948)
T KOG0577|consen  178 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----------ALYHIAQ  239 (948)
T ss_pred             c-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-----------HHHHHHh
Confidence            3       23479999999999874   5889999999999999999999999997665421           0111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.             .|.+.   ..+....++.++..||++-|.+|||.++++.
T Consensus       240 Ne-------------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  240 NE-------------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             cC-------------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            11             12222   3455677999999999999999999999875

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.6e-35  Score=301.22  Aligned_cols=245  Identities=25%  Similarity=0.430  Sum_probs=197.6

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||+|+||.||++..  .++.||+|.+...   ..+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            6788899999999999999986  3688999988643   2456788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++..      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999999853      34788899999999999999999987   9999999999999999999999999987653221


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         .......+++.|++||.+.+..++.++|+|||||++|+|++|+.||...+..       ..+   . .....     
T Consensus       170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-------~~~---~-~~~~~-----  230 (297)
T cd06656         170 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RAL---Y-LIATN-----  230 (297)
T ss_pred             ---cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------hhe---e-eeccC-----
Confidence               1123346889999999999888999999999999999999999998543210       000   0 00000     


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                              -.+.+  ..+......+.+++.+||+.||++||+++++++
T Consensus       231 --------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         231 --------GTPEL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --------CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    00000  012334456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.4e-35  Score=294.41  Aligned_cols=245  Identities=24%  Similarity=0.419  Sum_probs=195.4

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT-EDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~e  423 (639)
                      +|+..+.||+|++|.||++...  ++.+|+|.+...     ..+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4777889999999999999874  578999988542     23467889999999999999999988764 446789999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++++|.+++...   ....+++.....++.+++.|++|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999998642   2345899999999999999999999987   99999999999999999999999999986633


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..   .......+++.|+|||++.+..++.++||||||++++||++|+.||...+.           ............ 
T Consensus       155 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----------~~~~~~~~~~~~-  219 (257)
T cd08223         155 QC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----------NSLVYRIIEGKL-  219 (257)
T ss_pred             cC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHhcCC-
Confidence            21   122345688999999999999999999999999999999999998853221           011111111100 


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                  +    ..+......+.+++.+||+.||++||++.++++
T Consensus       220 ------------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ------------P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ------------C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                        0    112334457999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=313.16  Aligned_cols=240  Identities=27%  Similarity=0.440  Sum_probs=195.5

Q ss_pred             ceeecCceEEEEEEEcC--ceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhh
Q 036507          358 LLGHGTYGSVYYGNIRN--QEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS  432 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  432 (639)
                      +||+|.||+||.|++..  ..+|||.+.+..   .+.++.|+.+-++|+|.|||+++|.+..++.+-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999998765  568999987654   3458899999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-CCCCEEEeccCCceecCCCCCCcc
Q 036507          433 HLHDPQNRGQTSL--SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       433 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      +|+.    .-.++  ++...-.+..||++||.|||++.   |+|||||-+|||++ -.|.+||+|||-++.+.   .-..
T Consensus       662 LLrs----kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA---ginP  731 (1226)
T KOG4279|consen  662 LLRS----KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA---GINP  731 (1226)
T ss_pred             HHHh----ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc---cCCc
Confidence            9974    22344  66677778899999999999987   99999999999996 56889999999998763   2233


Q ss_pred             eeeeeccccccCCccccccC--CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDG--LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                      ....+.||.-|||||++..+  .|..++|||||||++.||.||++||.......        -..+-..+++.       
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGmyKv-------  796 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGMYKV-------  796 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcceec-------
Confidence            34457899999999999865  57899999999999999999999996544310        00000011111       


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 ....|++...+...+|.+|+.+||.+||+++++++
T Consensus       797 -----------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  797 -----------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -----------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                       12247788889999999999999999999999875

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.4e-35  Score=294.15  Aligned_cols=247  Identities=32%  Similarity=0.542  Sum_probs=196.3

Q ss_pred             CCCCCceeecCceEEEEEEEcC------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          353 FSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      |+..+.||.|+||.||++...+      ..+|+|.+....    .+.+.+|++++.+++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456789999999999998864      779999986543    457889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++....   ...+++.....++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++....
T Consensus        81 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       81 EYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence            9999999999986422   122899999999999999999999987   9999999999999999999999999998664


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .....  ......++..|++||.+.+..++.++||||||++++||++ |+.|+.....        ..+...   .....
T Consensus       155 ~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~---~~~~~  221 (258)
T smart00219      155 DDDYY--KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEY---LKKGY  221 (258)
T ss_pred             ccccc--ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH---HhcCC
Confidence            32111  1112236789999999988889999999999999999998 7777743211        111111   11110


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                      .                 ...+...+.++.+++.+|+..||++|||+.|+++.|
T Consensus       222 ~-----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 R-----------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C-----------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0                 001222455799999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.2e-35  Score=295.07  Aligned_cols=245  Identities=23%  Similarity=0.406  Sum_probs=197.9

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|+||.+|++...  ++.+|+|.+...     ..+++.+|++++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4777899999999999998774  578999987532     245788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...   ....+++...+.++.|++.|+.|||+++   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            9999999988642   2235788999999999999999999987   999999999999999999999999999765322


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .......|+..|+|||++.+..++.++|+||||++++||++|+.|+.....           .+.....+....  
T Consensus       155 ~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------~~~~~~~~~~~~--  218 (256)
T cd08218         155 V---ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----------KNLVLKIIRGSY--  218 (256)
T ss_pred             h---hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----------HHHHHHHhcCCC--
Confidence            1   112234578899999999988899999999999999999999999853211           111111111110  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 +    ..+.....++.+++.+||+.+|++||+++||++
T Consensus       219 -----------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 -----------P----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -----------C----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                       0    012334557899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-34  Score=297.32  Aligned_cols=247  Identities=24%  Similarity=0.406  Sum_probs=195.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..++||+|+||.||++...  +..+++|.+....   .+++.+|++++++++|+|++++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888899999999999999875  4789999986543   456888999999999999999999999899999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|..++...    ...+++..+..++.|++.++.|||+++   ++||||||+||+++.++.+||+|||++...... 
T Consensus        92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-  163 (292)
T cd06644          92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-  163 (292)
T ss_pred             CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence            999998887532    235899999999999999999999987   999999999999999999999999998754221 


Q ss_pred             CCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                        ........++..|+|||++.     ...++.++|||||||++|||++|+.|+.....           ..........
T Consensus       164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~  230 (292)
T cd06644         164 --LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKS  230 (292)
T ss_pred             --ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----------HHHHHHHhcC
Confidence              11223456888999999985     34567899999999999999999999843221           0111111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+             +...  .+.....++.+++.+||+.||++||+++|+++
T Consensus       231 ~~-------------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 EP-------------PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC-------------ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            10             0000  12233456889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.8e-35  Score=297.00  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=197.0

Q ss_pred             CCCCCCceeecCceEEEEEEEcC---ceEEEEEeccc-------------cHHHHHHHHHHHHh-cCCCCeeEEEeeeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRN---QEVAIKRMTAT-------------KTKEFMAEMKILCK-VHHSNLVELIGYAAT  414 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~-------------~~~~~~~E~~il~~-l~h~niv~l~~~~~~  414 (639)
                      +|+..+.||+|+||.||++...+   +.+|+|.+...             ...++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999998854   67999987421             12456788888865 799999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                      .+..+++|||+++++|.+++.... .....+++..++.++.|++.+|.|||+..  +++|+||+|+||++++++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999998875321 12345888999999999999999999632  399999999999999999999999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ||++.......    ......|+..|++||.+.+..++.++||||||+++|||++|+.||.....        ...   .
T Consensus       158 fg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~---~  222 (269)
T cd08528         158 FGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSL---A  222 (269)
T ss_pred             ccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHH---H
Confidence            99998653321    33445788999999999988899999999999999999999999853321        001   1


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .......            ..+.    ........+.+++.+||+.||++||++.|+..+|++
T Consensus       223 ~~~~~~~------------~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         223 TKIVEAV------------YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HHHhhcc------------CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            1111100            0000    011234568999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-35  Score=333.60  Aligned_cols=253  Identities=24%  Similarity=0.408  Sum_probs=194.9

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT--EDEL  418 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  418 (639)
                      ...++|...+.||+|+||.||++...  +..+|+|.+...     ....+..|+.++++++||||+++++++..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568888999999999999999875  467899987532     34568899999999999999999998754  3568


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeeCCCCCCcEEECC--------
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK----THYVHRDIKSSNILLDS--------  486 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~----~~ivH~Dlkp~NIll~~--------  486 (639)
                      |+||||+++|+|.++|.... .....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            99999999999999986422 123468999999999999999999998541    34999999999999964        


Q ss_pred             ---------CCCEEEeccCCceecCCCCCCcceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCcccc
Q 036507          487 ---------AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAII  555 (639)
Q Consensus       487 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~  555 (639)
                               ...+||+|||++..+....    ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||.
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                     2348999999998653221    2234579999999999854  458899999999999999999999995


Q ss_pred             ccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          556 RTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       556 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....          ....+ ..+...+.              +   .....+.++.+|+..||+.+|.+||++.|++.
T Consensus       245 ~~~~----------~~qli-~~lk~~p~--------------l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANN----------FSQLI-SELKRGPD--------------L---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCc----------HHHHH-HHHhcCCC--------------C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3221          11111 11111110              0   00122456899999999999999999999984

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.3e-35  Score=298.01  Aligned_cols=254  Identities=28%  Similarity=0.474  Sum_probs=194.5

Q ss_pred             CCCCCceeecCceEEEEEEEc-----CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED------  416 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  416 (639)
                      |...+.||+|+||.||+|.+.     +..+|||.+..+     ..+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456778999999999999763     468999988643     2456889999999999999999999876532      


Q ss_pred             eEEEEEeeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      ..++++||+++|+|.+++..... .....+++...+.++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            24788999999999988753221 12235788899999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |+++...... .........++..|++||.+....++.++||||||+++|||++ |+.|+...+.        ..+... 
T Consensus       158 g~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~-  227 (273)
T cd05074         158 GLSKKIYSGD-YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNY-  227 (273)
T ss_pred             cccccccCCc-ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHH-
Confidence            9998653221 1111122345678999999998889999999999999999999 8888743221        111111 


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                        ......             ..    .+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       228 --~~~~~~-------------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 --LIKGNR-------------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --HHcCCc-------------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              111000             00    1123445799999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-35  Score=297.35  Aligned_cols=236  Identities=23%  Similarity=0.421  Sum_probs=185.1

Q ss_pred             CceeecCceEEEEEEEcC---------ceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          357 SLLGHGTYGSVYYGNIRN---------QEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +.||+|+||.||+|....         ..+++|.+....   .+++.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999997642         348888875432   35688899999999999999999999998999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC--------EEEeccC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR--------AKISDFG  496 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfg  496 (639)
                      +++|+|.++++..    ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++.        ++++|||
T Consensus        81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999742    235889999999999999999999987   999999999999987765        6999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCC-ccccccccccchhhhhhhHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGK-EAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ++.....       .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.....        ....   
T Consensus       154 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~---  215 (258)
T cd05078         154 ISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKL---  215 (258)
T ss_pred             cccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHH---
Confidence            8865421       122467889999999976 45789999999999999999995 44422111        0000   


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                       ......                  ...+.....++.+++.+||+.||++|||++++++.|+
T Consensus       216 -~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 -QFYEDR------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -HHHHcc------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             011110                  0012223356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.2e-35  Score=298.62  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=201.3

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKV-HHSNLVELIGYAATE  415 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  415 (639)
                      +..+++..++++|...+.||+|+||.||++...  ++.+|+|.+...  ...++.+|+.+++++ +|||++++++++...
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            455666677899999999999999999999874  578999988653  245677899999999 799999999988643


Q ss_pred             -----CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          416 -----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       416 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                           +..++|+||+++++|.++++... .....+++...+.++.|++.||+|||+.+   ++|+||||+||++++++.+
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence                 35899999999999999886422 12345889999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccC-----CCCCcchHHHHHHHHHHHHcCCccccccccccchhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-----LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~  565 (639)
                      ||+|||++........   ......|+..|+|||.+...     .++.++|||||||++|||++|+.|+.....      
T Consensus       168 kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------  238 (291)
T cd06639         168 KLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------  238 (291)
T ss_pred             EEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------
Confidence            9999999876532211   11234688899999988643     367899999999999999999999854321      


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       ...+    ....+..+.        ...+       +......+.+++.+||+.+|++||++.|+++
T Consensus       239 -~~~~----~~~~~~~~~--------~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         239 -VKTL----FKIPRNPPP--------TLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHH----HHHhcCCCC--------CCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             0111    111111110        0001       1223346899999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-35  Score=304.59  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=191.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.+...      ..+.+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888899999999999999875  578999998642      2345788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++...    ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            999999999998631    235788888999999999999999987   9999999999999999999999999987654


Q ss_pred             CCCCCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ....  .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.....           .+.....
T Consensus       154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----------~~~~~~i  220 (331)
T cd05597         154 ADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VETYGKI  220 (331)
T ss_pred             CCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----------HHHHHHH
Confidence            3221  12223469999999999863     4578899999999999999999999853221           1111111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCC--CCCCHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI--LRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~  633 (639)
                      +....       ... +.+.     ....+..+.+++.+|+..+++  .||++++++.
T Consensus       221 ~~~~~-------~~~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         221 MNHKE-------HFQ-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             HcCCC-------ccc-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            11100       000 0000     112345678888887765444  3789998875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-35  Score=303.21  Aligned_cols=277  Identities=23%  Similarity=0.346  Sum_probs=197.8

Q ss_pred             CCCCCCceeecCceEEEEEEEc----CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR----NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATE--DELF  419 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~  419 (639)
                      +|+..++||+|+||.||+|...    +..||+|.+...      ..+.+.+|++++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4677889999999999999874    578999998762      245678899999999999999999999887  7899


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC----CCCEEEecc
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS----AFRAKISDF  495 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  495 (639)
                      +||||+++ +|.+++..........++......++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 6777665433233346888999999999999999999987   999999999999999    899999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccch--hhhhhhHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK--NQERRSLAS  572 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~l~~  572 (639)
                      |++..+..............++..|+|||.+.+ ..++.++||||||++++||++|+.||.........  ......+. 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE-  235 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH-
Confidence            999866433221222234568899999998766 45789999999999999999999999654332100  00011111 


Q ss_pred             HHHHHhhcCCCccc-----cccccc----ccC-----CcccCCCCh--hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          573 FMLAALRNSPDSMS-----MSSLKD----YID-----PNMMDLYPH--DCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       573 ~~~~~~~~~~~~~~-----~~~~~~----~~d-----~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+...+........     ......    ...     ..+......  ....++.+++.+||+.||++|||+.|++.
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11122211110000     000000    000     000000001  33456899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.4e-35  Score=307.73  Aligned_cols=251  Identities=21%  Similarity=0.311  Sum_probs=193.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...++||+|+||.||++...  ++.+|+|.+...      ....+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46788899999999999999886  468999998642      1234778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            999999999999642    235888889999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCCCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ...  ........||+.|+|||++.     ...++.++|||||||++|||++|+.||.....           .......
T Consensus       154 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----------~~~~~~i  220 (332)
T cd05623         154 EDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VETYGKI  220 (332)
T ss_pred             cCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----------HHHHHHH
Confidence            221  22223357999999999986     35678999999999999999999999954321           1111122


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL--RPDMKQVVIS  634 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  634 (639)
                      .....         ..--|.    ....+...+.+++.+|+..++++  |++++|+++.
T Consensus       221 ~~~~~---------~~~~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         221 MNHKE---------RFQFPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             hCCCc---------cccCCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11110         000000    01233556888999988665544  6889988753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.4e-35  Score=298.33  Aligned_cols=255  Identities=28%  Similarity=0.461  Sum_probs=196.9

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhc-CCCCeeEEEeeeec---
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKV-HHSNLVELIGYAAT---  414 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l-~h~niv~l~~~~~~---  414 (639)
                      ..++..+...|+..+.||+|+||.||+|...  ++.+|+|.+...  ...++..|+.++.++ +|+||+++++++..   
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            3444456678888999999999999999884  578999987544  345678899999998 69999999998853   


Q ss_pred             ---CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          415 ---EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       415 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                         .+..+++|||+++|+|.+++....   ...+++.....++.|+++||.|||+++   |+|+||||+||++++++.++
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence               457899999999999999986422   234778888899999999999999987   99999999999999999999


Q ss_pred             EeccCCceecCCCCCCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE  566 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~  566 (639)
                      |+|||++.......   .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||......      
T Consensus       162 l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------  232 (282)
T cd06636         162 LVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------  232 (282)
T ss_pred             EeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------
Confidence            99999987543211   1122356889999999875     356788999999999999999999998533210      


Q ss_pred             hhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       567 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       ...    .......             .+..   .....+..+.+++.+||+.||.+||++.|++.
T Consensus       233 -~~~----~~~~~~~-------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         233 -RAL----FLIPRNP-------------PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -hhh----hhHhhCC-------------CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             000    0000000             0000   11234457999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.5e-35  Score=295.25  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=185.6

Q ss_pred             ceeecCceEEEEEEEcC----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          358 LLGHGTYGSVYYGNIRN----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      .||+|+||.||++...+    ..+++|.+...    ..+.+.+|+++++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            59999999999997532    34667776533    24578999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      |.++++.... ......+.....++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++...... ....
T Consensus        82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~-~~~~  156 (268)
T cd05086          82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIE  156 (268)
T ss_pred             HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcc-hhhh
Confidence            9999975321 1234667778889999999999999987   999999999999999999999999998642111 1111


Q ss_pred             eeeeeccccccCCcccccc-------CCCCCcchHHHHHHHHHHHHcC-CccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          510 TVTKVVGTFGYLAPEYLTD-------GLATAKSDVYAFGVVLFEIISG-KEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVws~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ......++..|+|||++..       ..++.++||||||+++|||+++ ..|+.....        .   +.+...+...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~---~~~~~~~~~~  225 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------R---EVLNHVIKDQ  225 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------H---HHHHHHHhhc
Confidence            1223567889999998753       2457899999999999999974 556633221        1   1111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                              .....++.+...    ....+.+++..|| .+|++||++++|++.|.
T Consensus       226 --------~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         226 --------QVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             --------ccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                    112233333322    2345788999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-34  Score=298.27  Aligned_cols=245  Identities=25%  Similarity=0.442  Sum_probs=197.6

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||.|+||.||++..  .++.|++|.+...   ..+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            5688889999999999999976  4678999988543   3456788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++..      ..+++..+..++.|++.|++|||+++   ++|+||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          99 AGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            99999998853      24789999999999999999999987   9999999999999999999999999987653221


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.       ...+    ........   
T Consensus       170 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~----~~~~~~~~---  232 (296)
T cd06655         170 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRAL----YLIATNGT---  232 (296)
T ss_pred             ---ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHH----HHHHhcCC---
Confidence               112234688899999999988899999999999999999999999854321       0000    01110000   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +.+  ..+......+.+++.+||..||++||++.+++.
T Consensus       233 ----------~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 ----------PEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ----------ccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      000  012234456889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=296.42  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=196.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .++|+..+.||.|+||.||++...  +..+|+|......   .+.+.+|++++++++|+||+++++++..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356788889999999999999875  5789999886443   35688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...    ...+++.....++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          84 CDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             cCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            9999999998642    245889999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                         ........++..|++||.+.     ...++.++||||||+++|||++|+.||.....           ...+.....
T Consensus       157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~  222 (280)
T cd06611         157 ---LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----------MRVLLKILK  222 (280)
T ss_pred             ---ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----------HHHHHHHhc
Confidence               11223456899999999875     34567899999999999999999999854321           011111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+             +.+  ..+......+.+++.+||+.+|.+||+++++++
T Consensus       223 ~~~-------------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         223 SEP-------------PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCC-------------CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            110             000  012233456889999999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4e-35  Score=307.05  Aligned_cols=250  Identities=21%  Similarity=0.289  Sum_probs=192.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||+++..  ++.||+|.+...      ....+.+|..++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999875  478999998642      2234778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+.
T Consensus        81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999642    235788888999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCCCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ...  ........||+.|+|||++.+     +.++.++|||||||++|||++|+.||...+.           .......
T Consensus       154 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----------~~~~~~i  220 (331)
T cd05624         154 QDG--TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VETYGKI  220 (331)
T ss_pred             CCC--ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----------HHHHHHH
Confidence            321  112233579999999999865     5678899999999999999999999953221           1111111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL--RPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  633 (639)
                      .....      .  -.+.+.     ..+...++.+++.+|+..++++  |+++++++.
T Consensus       221 ~~~~~------~--~~~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         221 MNHEE------R--FQFPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HcCCC------c--ccCCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            11100      0  000000     1123456888999999866554  467887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-34  Score=294.59  Aligned_cols=264  Identities=26%  Similarity=0.380  Sum_probs=196.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|++...     ..+.+.+|++++++++|+|++++++++...+..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46778889999999999999885  578999987533     23457899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++++.|..++..     ...+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            9999988887643     234899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......     +  .+.. .........
T Consensus       153 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-----~--~~~~-~~~~~~~~~  221 (286)
T cd07847         153 PGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-----D--QLYL-IRKTLGDLI  221 (286)
T ss_pred             Ccc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-----H--HHHH-HHHHhCCCC
Confidence            221   1223467889999999876 55789999999999999999999998543321     0  0100 001110000


Q ss_pred             Cc----cc-ccccccccCCcccCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DS----MS-MSSLKDYIDPNMMDLY-----PHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~----~~-~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..    .. ..-......+......     .......+.+++.+||+.||++||++.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00    00 0000000001100000     0123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.9e-35  Score=301.16  Aligned_cols=263  Identities=21%  Similarity=0.326  Sum_probs=193.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|+||.||++...  ++.+|+|.++...     ...+.+|++++++++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4677889999999999999884  6789999886431     24577899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++ ++|.+++...    ...+++...+.++.||++||.|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            96 5888877532    245899999999999999999999987   999999999999999999999999998765322


Q ss_pred             CCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   .......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.......       .........+...+ 
T Consensus       153 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~-  221 (284)
T cd07839         153 V---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-------DQLKRIFRLLGTPT-  221 (284)
T ss_pred             C---CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-------HHHHHHHHHhCCCC-
Confidence            1   122334678899999988764 46899999999999999999998875433210       00111111111100 


Q ss_pred             cccccccccccCC----ccc-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDP----NMM-----DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~----~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...........+.    ...     .........++.+++.+||+.||.+|||++|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000000000    000     0111234567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-35  Score=295.85  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=194.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|...+.||+|+||.||++...  ++.+|+|.++...   ...+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45666788999999999999874  5789999886543   345778999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++..     ...+++...+.++.|++.|+.|||+++   ++|+||||+||+++.++.+||+|||++..+....
T Consensus        89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          89 GGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999999854     235889999999999999999999987   9999999999999999999999999987653221


Q ss_pred             CCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          506 DGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                         .......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+......       ..+..    ..... 
T Consensus       161 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-------~~~~~----~~~~~-  225 (267)
T cd06645         161 ---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------RALFL----MTKSN-  225 (267)
T ss_pred             ---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-------hhHHh----hhccC-
Confidence               1223357899999999874   456788999999999999999999998543210       00000    00000 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                ...+....  ....+..+.+++.+||+.+|++||+++++++
T Consensus       226 ----------~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         226 ----------FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ----------CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                      00011110  0122346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1e-34  Score=292.11  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=195.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|+||.||++...  ++.+|+|.+...     ..+.+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777889999999999998764  578999987543     345688999999999999999999999989999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGK  503 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~  503 (639)
                      +++++|.+++...   ....+++..+..++.+++++++|||+++   ++|+||+|+||++++++ .+||+|||++.....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999652   2345889999999999999999999987   99999999999998654 589999999986643


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..    ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.           ............ 
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----------~~~~~~~~~~~~-  218 (256)
T cd08220         155 KS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PALVLKIMSGTF-  218 (256)
T ss_pred             Cc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----------HHHHHHHHhcCC-
Confidence            21    12234688999999999988889999999999999999999999843221           111111111110 


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                      ...+......+.+++.+||+.+|++|||++|+++
T Consensus       219 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 ----------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                            0012224456899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=295.36  Aligned_cols=245  Identities=27%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccccH------HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKT------KEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .+.|+.-++||+|+||.||-...  +|+.+|.|.+.+...      .-.++|-.||.+++.+.||.+--.+...+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            35678889999999999996654  578899998765433      2367899999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +..|.||+|.-+|.+   .+...++....+.+|.+|+.||++||+..   |++|||||+|||+|+.|+++|+|.|+|..+
T Consensus       264 LtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            999999999999975   34466899999999999999999999987   999999999999999999999999999987


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...    ......+||.+|||||++..+.|+...|+||+||+||||+.|+.||......+        -.+.+.......
T Consensus       338 ~~g----~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------k~eEvdrr~~~~  405 (591)
T KOG0986|consen  338 PEG----KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------KREEVDRRTLED  405 (591)
T ss_pred             CCC----CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------hHHHHHHHHhcc
Confidence            432    23445699999999999999999999999999999999999999995433211        111111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK  629 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  629 (639)
                                       ...++....++...+....|+.||++|-..+
T Consensus       406 -----------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 -----------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -----------------hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                             1235666677889999999999999997543

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=301.99  Aligned_cols=250  Identities=25%  Similarity=0.337  Sum_probs=197.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|++++++++|+||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36778889999999999999885  588999988643      2345788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+.+++|.+++...   ....+++.....++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            999999999998642   2346899999999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCCCc--------------------------ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          503 KTSDGE--------------------------ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       503 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      ......                          .......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            211100                          011124688999999999988899999999999999999999999854


Q ss_pred             cccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC----HHHHH
Q 036507          557 TEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD----MKQVV  632 (639)
Q Consensus       557 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl  632 (639)
                      .+.       ...    ..........              ...  ....+..+.+++.+||+.||++||+    ++|++
T Consensus       235 ~~~-------~~~----~~~~~~~~~~--------------~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll  287 (316)
T cd05574         235 SNR-------DET----FSNILKKEVT--------------FPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK  287 (316)
T ss_pred             Cch-------HHH----HHHHhcCCcc--------------CCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence            322       001    1111111100              000  1114567999999999999999999    66666


Q ss_pred             H
Q 036507          633 I  633 (639)
Q Consensus       633 ~  633 (639)
                      .
T Consensus       288 ~  288 (316)
T cd05574         288 Q  288 (316)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.2e-34  Score=293.62  Aligned_cols=242  Identities=24%  Similarity=0.434  Sum_probs=194.9

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      |+..+.||+|+||.||+|...  +..+|+|......    .+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            556788999999999999764  5789999875432    3568889999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++..      ..+++.....++.|++.++.|||+.+   ++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        86 ~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          86 GGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            9999999853      34789999999999999999999987   9999999999999999999999999987653211 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                        .......++..|++||.+.+..++.++|+|||||++|||++|..|+.....        .....   ......     
T Consensus       156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~---~~~~~~-----  217 (277)
T cd06641         156 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLF---LIPKNN-----  217 (277)
T ss_pred             --hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHH---HHhcCC-----
Confidence              112234678899999999888889999999999999999999999843221        00000   000000     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                              .+.    .+...+..+.+++.+||+.+|++||++.+++..
T Consensus       218 --------~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 --------PPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --------CCC----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                    011    122344568899999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-34  Score=291.39  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=200.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||.|+||.||++...  +..+++|.+...    ..+.+.+|+++++.++|+|++++++.+..++..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888899999999999999864  578999988643    346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.++++...  ....+++.....++.|++.||+|||+++   ++|+||+|+||++++++.++|+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            99999999986421  1245889999999999999999999987   999999999999999999999999998766443


Q ss_pred             CCCc-ceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          505 SDGE-ATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       505 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .... .......|+..|++||.+... .++.++|+||||+++|||++|+.||......           ..........+
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~  224 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----------KVLMLTLQNDP  224 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----------hhHHHHhcCCC
Confidence            2221 112334688999999998776 7899999999999999999999998543221           01111111111


Q ss_pred             CcccccccccccCCcccCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDL-YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .             .+... .....+..+.+++.+||+.||++||+++++++
T Consensus       225 ~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 P-------------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             C-------------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0             01000 01234567899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=310.00  Aligned_cols=236  Identities=25%  Similarity=0.323  Sum_probs=182.4

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhc---CCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKV---HHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ||+|+||.||++...  ++.||+|.+....      ...+..|..++.+.   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875  5789999986432      23355677777665   699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......   
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~---  149 (330)
T cd05586          81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD---  149 (330)
T ss_pred             ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---
Confidence            999998854     345888999999999999999999987   999999999999999999999999998753221   


Q ss_pred             cceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........||..|+|||.+.+. .++.++|||||||++|||++|+.||.....           ............    
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----------~~~~~~i~~~~~----  214 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----------QQMYRNIAFGKV----  214 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----------HHHHHHHHcCCC----
Confidence            1122346799999999998754 478999999999999999999999854321           011111111100    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD----MKQVVI  633 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~  633 (639)
                                .+.   .......+.+++.+||+.||++||+    +.++++
T Consensus       215 ----------~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         215 ----------RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----------CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                      000   0112446789999999999999985    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-34  Score=292.57  Aligned_cols=250  Identities=23%  Similarity=0.384  Sum_probs=196.2

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT--EDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~  422 (639)
                      +|+..+.||.|+||.||++...  +..+|+|.+...     ..+.+.+|++++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677889999999999999774  578999987532     24567889999999999999999997754  45689999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT--KTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||+++++|.+++.... .....+++...+.++.|++.||.|||..+  ..+++|+||||+||++++++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999999986532 22456899999999999999999999332  23499999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      .....   .......++..|+|||.+.+..++.++|+||||+++++|++|+.|+.....        ..+...    +..
T Consensus       160 ~~~~~---~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~----~~~  224 (265)
T cd08217         160 LGHDS---SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASK----IKE  224 (265)
T ss_pred             ccCCc---ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHH----Hhc
Confidence            64322   112335689999999999988899999999999999999999999854321        111111    111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..            .    ...+...+..+.+++.+|++.+|++||++++|++
T Consensus       225 ~~------------~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 GK------------F----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CC------------C----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00            0    0122334567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-34  Score=295.51  Aligned_cols=249  Identities=24%  Similarity=0.417  Sum_probs=196.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|+||.||++...  +..+|+|.+...    ....+.+|++++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35777889999999999999885  678999987542    235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++....  ....+++.....++.|++.||.|||+..  +|+|+||||+||+++.++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999886421  1346899999999999999999999742  3999999999999999999999999998755321


Q ss_pred             CCCcceeeeeccccccCCccccccC------CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDG------LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                           ......++..|+|||.+.+.      .++.++|+|||||++|||++|+.||.....        ...........
T Consensus       157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~  223 (286)
T cd06622         157 -----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--------ANIFAQLSAIV  223 (286)
T ss_pred             -----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--------hhHHHHHHHHh
Confidence                 12234678899999998554      347899999999999999999999853221        11111111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+             +    ..+.+...++.+++.+||+.+|++||++++++.
T Consensus       224 ~~~~-------------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DGDP-------------P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hcCC-------------C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1111             0    122335567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-34  Score=292.70  Aligned_cols=250  Identities=22%  Similarity=0.420  Sum_probs=196.9

Q ss_pred             CCCCCCceeecCceEEEEEEE--cCceEEEEEecccc---------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK---------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      +|+..+.||+|+||.||++..  +++.+|+|.+....         .+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999976  46789999886422         3568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCce
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAK  499 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~  499 (639)
                      |+||+++++|.+++..     ...+++.....++.|++.||.|||+++   ++|+||+|+||+++.++ .+||+|||++.
T Consensus        81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            9999999999999864     235788999999999999999999987   99999999999998776 59999999987


Q ss_pred             ecCCCCCCc-ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGE-ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+....... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||......        ..........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~  224 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--------NHLALIFKIA  224 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--------chHHHHHHHh
Confidence            664321111 1112346889999999998888999999999999999999999998532210        0011111110


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...            .    ....+......+.+++.+||+.+|++||++.|++.
T Consensus       225 ~~~------------~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SAT------------T----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ccC------------C----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000            0    01123345567899999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-34  Score=298.31  Aligned_cols=264  Identities=24%  Similarity=0.354  Sum_probs=195.8

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      +|...+.||+|+||.||+|...  ++.|++|.+....        ...+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4667789999999999999874  5799999986442        23467899999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+ +++|.+++....    ..+++..+..++.|+++||.|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            9999 999999996421    35899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....   .......++..|+|||.+.+ ..++.++|||||||+++||++|..+|......        .........+..
T Consensus       153 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--------~~~~~~~~~~~~  221 (298)
T cd07841         153 GSPN---RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--------DQLGKIFEALGT  221 (298)
T ss_pred             cCCC---ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--------HHHHHHHHHcCC
Confidence            4321   12223356788999998855 46789999999999999999997776433221        011111111111


Q ss_pred             CCCcc--cccccccccCCccc-----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          581 SPDSM--SMSSLKDYIDPNMM-----DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       581 ~~~~~--~~~~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      .....  ..............     ..........+.+++.+||+.||++|||++|++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            10000  00000011110000     01112345678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=291.27  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=198.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||.|+||.||++...  ++.+++|.+...   ..+.+.+|++++++++||||+++++++.+++..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888899999999999999874  578999988644   3567889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++...    ...+++.....++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++..+....
T Consensus        83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999998642    245888999999999999999999987   9999999999999999999999999987653211


Q ss_pred             CCcceeeeeccccccCCccccccC---CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDG---LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                         .......++..|+|||.+...   .++.++||||||+++|||++|+.|+......       .....    ..... 
T Consensus       156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~~~~----~~~~~-  220 (262)
T cd06613         156 ---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RALFL----ISKSN-  220 (262)
T ss_pred             ---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH----HHhcc-
Confidence               122335688899999998776   8899999999999999999999998543210       00000    00000 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                ...+.+.  .+...+.++.+++.+||+.+|.+||++++++.
T Consensus       221 ----------~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         221 ----------FPPPKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ----------CCCcccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                      0000110  12234567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-34  Score=296.03  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=190.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHH-HHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKI-LCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.++...    ..++..|+.+ ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788899999999999999875  6789999886432    3445667665 566789999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++ |+|.+++.... .....+++.....++.|++.||+|||++.  +++||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 68888775422 12356899999999999999999999861  399999999999999999999999999876532


Q ss_pred             CCCCcceeeeeccccccCCcccccc----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .    ...+...++..|+|||.+.+    ..++.++|+||||+++|||++|+.||......         . +.......
T Consensus       157 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~-~~~~~~~~  222 (283)
T cd06617         157 S----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------F-QQLKQVVE  222 (283)
T ss_pred             c----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------H-HHHHHHHh
Confidence            1    11233468889999998865    45688999999999999999999998532210         0 00111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...             +.+   .....+.++.+++.+||..+|++||+++++++
T Consensus       223 ~~~-------------~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EPS-------------PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCC-------------CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110             000   01123456899999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-34  Score=290.22  Aligned_cols=243  Identities=29%  Similarity=0.458  Sum_probs=195.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      +|+..+.||+|+||.||+|...  ++.|++|.+...        ..+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667789999999999999875  678999987532        235688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +||+++++|.+++..     ...+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence            999999999999864     235789999999999999999999987   999999999999999999999999998765


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCC-CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....    ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.....       ..    ........
T Consensus       153 ~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~----~~~~~~~~  217 (258)
T cd06632         153 VEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VA----AVFKIGRS  217 (258)
T ss_pred             cccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HH----HHHHHHhc
Confidence            3221    223456889999999987766 88999999999999999999999854321       00    00010000


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..                ....+......+.+++.+||+.+|++||++++++.
T Consensus       218 ~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 KE----------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cc----------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00                00112234456889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.8e-35  Score=305.78  Aligned_cols=260  Identities=22%  Similarity=0.333  Sum_probs=191.9

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------  415 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------  415 (639)
                      ..++|...+.||+|+||.||++...  ++.||||.+...     ..+.+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999874  578999998643     234577899999999999999999877532      


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      ...++++|++ +++|.+++..      ..+++.....++.|++.||.|||+++   |+||||||+||++++++.+||+||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence            3578999988 7899888753      34889999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |+++....      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..        .....+
T Consensus       163 g~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~  228 (343)
T cd07878         163 GLARQADD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--------DQLKRI  228 (343)
T ss_pred             ccceecCC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHH
Confidence            99986532      1234578999999999876 56889999999999999999999998543210        000111


Q ss_pred             HHHhhcCCCccc----cc-------ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMS----MS-------SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~----~~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .......+....    ..       .+.......+... .......+.+++.+|++.||++|||+.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111111000000    00       0000000000000 0112345789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-35  Score=307.15  Aligned_cols=239  Identities=24%  Similarity=0.399  Sum_probs=190.5

Q ss_pred             CCceeecCceEEEEEEEcC--ceEE---EEE--ec--cccHHHHHHHHHHHHhcCCCCeeEEEeeeecCC--eEEEEEee
Q 036507          356 SSLLGHGTYGSVYYGNIRN--QEVA---IKR--MT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATED--ELFLIYEY  424 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~--~~va---vK~--~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv~e~  424 (639)
                      ..+||+|+|-+||+|.+..  ..||   ||.  +.  ....+.|..|+.+|+.|+||||++++.++.+..  .+.+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            4579999999999998764  3444   221  11  223477999999999999999999999987754  47899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEeccCCceecCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGK  503 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~  503 (639)
                      |..|+|..++..     .+.++......|+.||++||.|||++. |+|+|||||-+||+|+.+ |.|||+|+|+|+....
T Consensus       125 ~TSGtLr~Y~kk-----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  125 FTSGTLREYRKK-----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ccCCcHHHHHHH-----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999965     345788899999999999999999996 789999999999999876 8999999999998743


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..     ...+.|||.|||||+.. ..|++.+||||||+.|+||+|+..||..-          .+-++.+.....+.. 
T Consensus       199 s~-----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC----------~n~AQIYKKV~SGiK-  261 (632)
T KOG0584|consen  199 SH-----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC----------TNPAQIYKKVTSGIK-  261 (632)
T ss_pred             cc-----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh----------CCHHHHHHHHHcCCC-
Confidence            32     23478999999999886 78999999999999999999999999533          233333444333221 


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         -..+.++-||            +++++|.+|+.. .++|||+.|+|.
T Consensus       262 ---P~sl~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  262 ---PAALSKVKDP------------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---HHHhhccCCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence               1233333333            578899999999 999999999985

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.2e-34  Score=289.01  Aligned_cols=249  Identities=28%  Similarity=0.464  Sum_probs=196.5

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|...+.||+|+||.||++...  ++.+++|.++..     ..+.+.+|++++++++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777889999999999999874  578999987643     345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++..     ...+++.....++.+++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            999999999864     234788888999999999999999987   999999999999999999999999999876433


Q ss_pred             CCCcce-eeeeccccccCCccccccCC---CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          505 SDGEAT-VTKVVGTFGYLAPEYLTDGL---ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       505 ~~~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...... .....++..|++||++.+..   .+.++||||||++++||++|+.||.....       ....   .......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~---~~~~~~~  222 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQI---MFHVGAG  222 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHH---HHHHhcC
Confidence            221111 22356788999999998766   78999999999999999999999854321       0000   0000000


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .             .+.+..  .......+.+++.+||+.+|++||+++|++.
T Consensus       223 ~-------------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 H-------------KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             C-------------CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0             011110  1123556889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.5e-35  Score=293.98  Aligned_cols=248  Identities=26%  Similarity=0.417  Sum_probs=197.8

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +|+..+.||+|+||.||++...  ++.+++|.+...    ..+++.+|++++++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5667789999999999999886  678999987644    2356889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++++|.+++....    ..++......++.|++.|++|||+ .+   ++|+||||+||++++++.++|+|||.+......
T Consensus        82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          82 DGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             CCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            9999999986421    568888889999999999999998 66   999999999999999999999999998755321


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      ..     ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......      .....+.+........  
T Consensus       155 ~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~--  221 (265)
T cd06605         155 LA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP------PDGIFELLQYIVNEPP--  221 (265)
T ss_pred             Hh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc------cccHHHHHHHHhcCCC--
Confidence            11     1156888999999999999999999999999999999999998543210      0111111111111110  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 +.+.   .......+.+++.+||..||++||++.|++.
T Consensus       222 -----------~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 -----------PRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -----------CCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                       1110   1114556899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=293.04  Aligned_cols=264  Identities=23%  Similarity=0.371  Sum_probs=193.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|++|.||++...  ++.||+|.+....    ...+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999874  5789999886432    24567899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +. ++|.+++...    ...+++.....++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        85 ~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          85 LD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             CC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            97 5999988642    235788999999999999999999987   999999999999999999999999998754221


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......       ..........+.....
T Consensus       157 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~  226 (291)
T cd07844         157 S---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-------EDQLHKIFRVLGTPTE  226 (291)
T ss_pred             C---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHhcCCCCh
Confidence            1   11122356889999998865 45789999999999999999999998543311       0111111111111100


Q ss_pred             ccccccc---cc-------cc-CCcccCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSL---KD-------YI-DPNMMDLY-PHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~---~~-------~~-d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      . .....   ..       .. ...+.... .......+.+++.+||+.+|++|||+.|++.
T Consensus       227 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         227 E-TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             h-hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0 00000   00       00 00000000 0111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.9e-34  Score=293.24  Aligned_cols=266  Identities=24%  Similarity=0.331  Sum_probs=193.4

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++++|...+.||+|+||.||+|...  ++.+|+|.+....    ...+.+|++++++++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578888999999999999999764  6789999986432    235778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+. ++|.+++...    ...+.+.....++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+++...
T Consensus        83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          83 EYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            9995 6777766431    234678888889999999999999987   9999999999999999999999999987543


Q ss_pred             CCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...   .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......      ...+. .....+...
T Consensus       155 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~------~~~~~-~~~~~~~~~  224 (291)
T cd07870         155 IPS---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV------FEQLE-KIWTVLGVP  224 (291)
T ss_pred             CCC---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH------HHHHH-HHHHHcCCC
Confidence            211   112234578899999998754 5788999999999999999999998643321      01111 111111110


Q ss_pred             CCccccc---ccccccCC--------cccCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMS---SLKDYIDP--------NMMDL-YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~---~~~~~~d~--------~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .. ....   .+.+....        .+... ........+.+++.+|++.||++|||++|++.
T Consensus       225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         225 TE-DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             Ch-hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00 0000   00000000        00000 00112456889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.9e-35  Score=297.90  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=194.1

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||.|+||.||++...  ++.||||.+....     .+.+.+|++++++++||||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4777889999999999999874  5789999886432     34688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +. ++|.+++...   ....+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+...
T Consensus        81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            95 6898888642   2345899999999999999999999987   999999999999999999999999998755321


Q ss_pred             CCCcceeeeeccccccCCccccccCC-CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.....       ...+.... ........
T Consensus       154 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-------~~~~~~~~-~~~~~~~~  222 (284)
T cd07860         154 V---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-------IDQLFRIF-RTLGTPDE  222 (284)
T ss_pred             c---cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHH-HHhCCCCh
Confidence            1   1122345688999999886644 58899999999999999999999854321       11111111 11111000


Q ss_pred             ccc---------ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMS---------MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~---------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...         ...........+.. ........+.+++.+||+.||++||+++|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         223 VVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000         00000011111100 01123456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.8e-34  Score=296.20  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=195.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.|++|.+....      .+.+.+|+++++.++||||+++++.+..++..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36778899999999999999876  4689999886532      345778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++..     ...+++.....++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            99999999999954     235889999999999999999999987   9999999999999999999999999986321


Q ss_pred             CCCC------------CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          503 KTSD------------GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       503 ~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      ....            .........++..|+|||.+.+..++.++|+||||+++|||++|+.||.....           
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----------  221 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----------  221 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------
Confidence            1000            00011124578899999999888899999999999999999999999853221           


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .+.........           ...+..    ....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus       222 ~~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         222 EELFGQVISDD-----------IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHHHhcc-----------cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            01111111110           000110    11234568999999999999999997666665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.2e-34  Score=292.66  Aligned_cols=263  Identities=22%  Similarity=0.327  Sum_probs=197.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|+||.||+|...  +..|++|.+....     .+.+.+|+.++++++||||+++++++..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999874  5789999986432     45788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      + +++|.+++...    ...+++..++.++.|++++|+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 99999998642    245899999999999999999999987   999999999999999999999999999866432


Q ss_pred             CCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .  ........++..|+|||.+.+. .++.++||||+|++++||++|+++|.....        ..........+.....
T Consensus       153 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--------~~~~~~~~~~~~~~~~  222 (286)
T cd07832         153 E--PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--------IEQLAIVFRTLGTPNE  222 (286)
T ss_pred             C--CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--------HHHHHHHHHHcCCCCh
Confidence            2  1123345689999999988654 468999999999999999999777643221        1111111111111100


Q ss_pred             cc-----cccccccccCC-----cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SM-----SMSSLKDYIDP-----NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~-----~~~~~~~~~d~-----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..     ..........+     .+.. ...+....+.+++.+||+.||++||++++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         223 ETWPGLTSLPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHHhhccCcchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00     00000000000     0000 11233478999999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-35  Score=284.50  Aligned_cols=278  Identities=25%  Similarity=0.357  Sum_probs=209.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC------ceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeec-CCeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAAT-EDEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~  418 (639)
                      ..|+....||+|.||.||++.-.+      ..+|+|.++.++     .....+|+.+++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            457778899999999999995432      369999987652     3457799999999999999999998877 7789


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC----CCEEEec
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA----FRAKISD  494 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D  494 (639)
                      +|++||.+. +|...++..+....+.++-.+...|+-||+.|+.|||++=   |+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 8888887655555578999999999999999999999976   9999999999999877    9999999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccch-hhhhhhHHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK-NQERRSLAS  572 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~l~~  572 (639)
                      ||+++.+...-..-.....++-|.+|+|||.+.+ ..|+++.|||+.|||..||++-.+.|...+..... +.-+.+...
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999988654333334456788999999999887 56899999999999999999998888654432221 122233344


Q ss_pred             HHHHHhhcCCCcccccccccccCC-cc----cCCCChh------------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDP-NM----MDLYPHD------------CLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~-~l----~~~~~~~------------~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+...++.+. ..++..+..+-+- .+    ...+-..            -.....+|+.++|+.||.+|.|+++.++
T Consensus       260 rIf~vLG~Pt-~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEVLGTPT-DKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHcCCCc-cccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            4445554432 2222333332222 00    0000000            1223788999999999999999999875

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-34  Score=295.74  Aligned_cols=264  Identities=27%  Similarity=0.387  Sum_probs=196.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..++||+|+||.||++...  ++.+|+|.+...     ..+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46777899999999999999885  578999987532     23567899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++++|.++...     ...+++...+.++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999887653     234899999999999999999999987   99999999999999999999999999876533


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..   .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......    .....+    ........
T Consensus       153 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~----~~~~~~----~~~~~~~~  221 (286)
T cd07846         153 PG---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI----DQLYHI----IKCLGNLI  221 (286)
T ss_pred             Cc---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH----HHHHHH----HHHhCCCc
Confidence            21   22233567899999999875 45688999999999999999999888532210    000001    11111000


Q ss_pred             Ccc----cc-cccccccCCcccC-----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSM----SM-SSLKDYIDPNMMD-----LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~----~~-~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...    .. ........+....     ......+..+.+++.+||+.+|++||+++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000    00 0000000010000     011234567999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-34  Score=295.35  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=190.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|...+.||+|+||.||++...  ++.+|+|.+...    ....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4445678999999999999875  578999988643    2456788999999996 99999999999988999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +. ++|.++...........+++.....++.+++.||+|||+..  +++||||||+||+++.++.+||+|||++..+...
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 45554432111122356899999999999999999999741  3999999999999999999999999998755321


Q ss_pred             CCCcceeeeeccccccCCccccccC---CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDG---LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .    ......|+..|+|||.+.+.   .++.++||||||+++|||++|+.||....          .....+.......
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----------~~~~~~~~~~~~~  227 (288)
T cd06616         162 I----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----------SVFDQLTQVVKGD  227 (288)
T ss_pred             C----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----------hHHHHHhhhcCCC
Confidence            1    11234688899999998776   68899999999999999999999984321          1111111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +             +.+....+...+.++.+++.+||+.||++|||+++|+.
T Consensus       228 ~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 P-------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             C-------------CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1             11111112234567999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.8e-34  Score=290.93  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=193.8

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-------------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-------------KTKEFMAEMKILCKVHHSNLVELIGYAATED  416 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-------------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  416 (639)
                      +|...+.||+|+||.||+|...  ++.+|+|.++..             ..+.+.+|++++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566789999999999999763  678999987421             1235778999999999999999999999999


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++|+||+++++|.+++...     ..+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence            999999999999999998642     45888889999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCC--CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL--ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ++....... .........++..|+|||.+....  ++.++|+||||+++|||++|..|+.....          ... .
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----------~~~-~  221 (272)
T cd06629         154 ISKKSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----------IAA-M  221 (272)
T ss_pred             ccccccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----------HHH-H
Confidence            987543211 111123356889999999987654  78999999999999999999999843221          000 0


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......        .....+.+.    .....+..+.+++.+||+.||++||+++++++
T Consensus       222 ~~~~~~--------~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         222 FKLGNK--------RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHhhcc--------ccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000000        000111111    11234567999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=292.19  Aligned_cols=253  Identities=29%  Similarity=0.456  Sum_probs=197.3

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhc-CCCCeeEEEeeeecCC------
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKV-HHSNLVELIGYAATED------  416 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l-~h~niv~l~~~~~~~~------  416 (639)
                      .++++|+..+.||+|+||.||++...  ++.+++|.+....  .+++.+|+++++++ +|+||+++++++....      
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            35688999999999999999999885  4689999886543  45688999999999 6999999999986544      


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..+++|||+++++|.+++.... .....+++.....++.|+++||.|||+++   ++|+||+|+||++++++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence            4899999999999999986422 11356889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      ++.......   .......|+..|+|||++..     ..++.++||||||++++||++|+.||.....       ...  
T Consensus       159 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~--  226 (275)
T cd06608         159 VSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRA--  226 (275)
T ss_pred             cceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHH--
Confidence            987653221   12233568899999998753     3467899999999999999999999853221       000  


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                        .........             +.+.  .+......+.+++.+||..||++|||++|+++
T Consensus       227 --~~~~~~~~~-------------~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         227 --LFKIPRNPP-------------PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --HHHhhccCC-------------CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              111111110             0110  12234557899999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.6e-35  Score=298.74  Aligned_cols=242  Identities=26%  Similarity=0.435  Sum_probs=192.5

Q ss_pred             CCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          355 DSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      ....||+|+||.||++...  +..||||.+...   ..+.+.+|+.++++++|+||+++++.+...+..+++|||+++++
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            3457999999999999874  678999987543   24568899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      |.+++..      ..+++.....++.|++.||+|||+++   |+||||||+||++++++.++|+|||++.......   .
T Consensus       106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---~  173 (292)
T cd06658         106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---P  173 (292)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc---c
Confidence            9998853      24788899999999999999999987   9999999999999999999999999987543211   1


Q ss_pred             eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS  589 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  589 (639)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....        ...   +.. +..         
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~---~~~-~~~---------  232 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQA---MRR-IRD---------  232 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHH-HHh---------
Confidence            12335689999999999888899999999999999999999999854221        000   011 110         


Q ss_pred             cccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       590 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                         .+.+.+..  .......+.+++.+||+.||++|||++|+++.
T Consensus       233 ---~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         233 ---NLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---cCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               01111111  11234468899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=295.14  Aligned_cols=264  Identities=25%  Similarity=0.381  Sum_probs=198.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|+||.||++...  ++.|++|.++..     ..+.+.+|++++++++|+||+++++++..++..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6778899999999999999885  578999987642     235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++++.+..+...     ...+++.....++.|++.||.|||+++   ++|+||+|+||++++++.+||+|||++......
T Consensus        82 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          82 VERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            998777666532     234788999999999999999999987   999999999999999999999999998866432


Q ss_pred             CCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..  .......++..|+|||++.+. .++.++||||||+++|||++|+.||......     +  .+. .....+...+.
T Consensus       154 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~--~~~-~~~~~~~~~~~  223 (288)
T cd07833         154 PA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----D--QLY-LIQKCLGPLPP  223 (288)
T ss_pred             cc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H--HHH-HHHHHhCCCCH
Confidence            21  122345688999999999887 8899999999999999999999888543210     0  010 01111111000


Q ss_pred             cc----------cccccccccCCc-ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SM----------SMSSLKDYIDPN-MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~----------~~~~~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..          .........++. ....++..++.++.+++.+||+.+|++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00          000000000110 011123334678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.6e-34  Score=293.50  Aligned_cols=249  Identities=27%  Similarity=0.446  Sum_probs=201.1

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .+++|+..+.||+|+||.||++...  +..+++|.+....  .+.+.+|++++++++|+|++++++++...+..++++||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4567888889999999999999886  6889999987654  56788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++....    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        97 ~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          97 MDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             cCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999997522    36899999999999999999999977   999999999999999999999999998755322


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      ..   ......++..|++||.+.+..++.++|+||||+++|+|++|+.|+......           ............ 
T Consensus       170 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~-  234 (286)
T cd06614         170 KS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----------RALFLITTKGIP-  234 (286)
T ss_pred             hh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCC-
Confidence            11   112345788999999998888999999999999999999999998532210           000111111000 


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                             .     ..  .+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       235 -------~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 -------P-----LK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -------C-----Cc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                   0     00  11224457899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-35  Score=300.30  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=194.2

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc-----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT-----KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFL  420 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~-----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~l  420 (639)
                      .....|++.++||+||.+.||++...+ +.+|+|++...     ...-|.+|+++|.+|+ |.+||++++|-..++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            445678889999999999999998764 66888776432     3456899999999997 9999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||- ..+|..+|..   .......| .++.+..|++.++.++|+++   |||.||||.|+|+-. |.+||+|||+|..
T Consensus       438 vmE~G-d~DL~kiL~k---~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~a  508 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKK---KKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANA  508 (677)
T ss_pred             Eeecc-cccHHHHHHh---ccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence            99987 5699999975   23334445 56788899999999999998   999999999999964 6899999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccC-----------CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDG-----------LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      +.... ........+||+-||+||.+...           ..+.++||||+|||||+|+.|+.||..          ...
T Consensus       509 I~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----------~~n  577 (677)
T KOG0596|consen  509 IQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----------IIN  577 (677)
T ss_pred             cCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH----------HHH
Confidence            75432 22233446899999999988532           245789999999999999999999943          222


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+..+                ..+.||...-++|.- ...++.++++.||+.||++||+..|+|+
T Consensus       578 ~~aKl----------------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 QIAKL----------------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHH----------------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            33322                233344222122211 1123899999999999999999999986

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.5e-34  Score=292.80  Aligned_cols=239  Identities=27%  Similarity=0.392  Sum_probs=194.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|++++++++||||+++++++.+++..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36778899999999999999875  578999988643      2356888999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++...     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            999999999998642     45889999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..      .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.....        ...   .........
T Consensus       153 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~---~~~~~~~~~  215 (290)
T cd05580         153 GR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQI---YEKILEGKV  215 (290)
T ss_pred             CC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHhcCCc
Confidence            22      2234688999999999888889999999999999999999999853321        000   111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVV  632 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl  632 (639)
                                        ..+......+.+++.+||+.||.+|+     +++|++
T Consensus       216 ------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 ------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                              01222345688999999999999999     667765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6e-34  Score=292.87  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=195.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATE--DELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  421 (639)
                      ++|+..+.||+|+||.||+|...  ++.+++|.++...     ...+.+|++++++++||||+++.+++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46777889999999999999886  5789999886432     23467899999999999999999998777  889999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +||+. ++|.+++...    ...+++...+.++.|++.||+|||+++   ++|+||||+||++++++.+||+|||++..+
T Consensus        85 ~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             ehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99996 5998888642    235899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....   .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||.......       .+ ......+..
T Consensus       157 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-------~~-~~~~~~~~~  225 (293)
T cd07843         157 GSPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-------QL-NKIFKLLGT  225 (293)
T ss_pred             cCCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HH-HHHHHHhCC
Confidence            4321   122334578899999988754 46889999999999999999999985433210       00 001111110


Q ss_pred             CCCc-------c---cccccccccCCcccCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDS-------M---SMSSLKDYIDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~-------~---~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....       .   ............+...++.. ....+.+++.+||+.||++|||+.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000       0   00000011111111122222 3567899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-34  Score=292.64  Aligned_cols=257  Identities=25%  Similarity=0.332  Sum_probs=196.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATE--DELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~  422 (639)
                      ++|+..+.||.|++|.||++...  ++.+|+|.+...    ...++.+|++++++++||||+++++++.+.  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35777889999999999999884  578999988643    245688999999999999999999988653  4689999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++.... .....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            9999999998875322 12345788889999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...     .....++..|++||.+.+..++.++||||||+++|||++|+.||.......   .....+..+   ......
T Consensus       157 ~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~---~~~~~~  225 (287)
T cd06621         157 NSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSY---IVNMPN  225 (287)
T ss_pred             ccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHH---HhcCCc
Confidence            211     123457889999999998899999999999999999999999986432100   001111111   111000


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .         .+.....  ........+.+++.+||+.+|++|||+.|+++
T Consensus       226 ~---------~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 P---------ELKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             h---------hhccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0         0000000  01123567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=6.5e-34  Score=294.76  Aligned_cols=241  Identities=31%  Similarity=0.515  Sum_probs=191.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +.|...+.||+|+||.||++...  ++.||+|.+...      ..+++.+|+++++.++|||++++.+++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999874  678999987532      2356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+. |+|.+++...    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....
T Consensus        95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9996 6777776421    235899999999999999999999987   9999999999999999999999999987543


Q ss_pred             CCCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ..       ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+...+..           ........
T Consensus       167 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----------~~~~~~~~  228 (307)
T cd06607         167 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQ  228 (307)
T ss_pred             CC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----------HHHHHHhc
Confidence            21       1246788999999874   456889999999999999999999998543210           00001111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+             +.+   .+......+.+++.+||+.||++||++.+++.
T Consensus       229 ~~~-------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         229 NDS-------------PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             CCC-------------CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            100             001   12234567999999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.4e-34  Score=286.65  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=201.4

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +|+..+.||+|++|.||++...  ++.+++|++....    .+++.+|++++.+++|+|++++++++...+..++++||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5777899999999999999886  6789999886542    467899999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++++|.+++...     ..+++.....++.|++++++|||+ .+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          82 DGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            999999999642     458899999999999999999999 77   999999999999999999999999999866432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      ..   ......++..|+|||.+....++.++|+||||+++|||++|+.|+.....        ....+..........  
T Consensus       154 ~~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~~~~~~~--  220 (264)
T cd06623         154 LD---QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--------PSFFELMQAICDGPP--  220 (264)
T ss_pred             CC---cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------cCHHHHHHHHhcCCC--
Confidence            21   11245688999999999988899999999999999999999999854431        011111111111110  


Q ss_pred             ccccccccccCCcccCCCChh-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                                 +.    .+.. .+..+.+++.+||+.+|++||++.|+++.
T Consensus       221 -----------~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 -----------PS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -----------CC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                       01    1122 45679999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-34  Score=289.64  Aligned_cols=243  Identities=26%  Similarity=0.463  Sum_probs=193.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVH---HSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .|+..+.||+|+||.||+|.+.  +..+|+|.++..    ..+++.+|++++++++   |||++++++++..+...+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4667889999999999999874  578999987532    3456888999999997   999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++..      ..+++...+.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..+.
T Consensus        82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999853      25889999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...   .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....           ....... .  
T Consensus       153 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----------~~~~~~~-~--  215 (277)
T cd06917         153 QNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----------FRAMMLI-P--  215 (277)
T ss_pred             CCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----------hhhhhcc-c--
Confidence            322   12233468899999998865 4468899999999999999999999853221           0000000 0  


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                ....+.+..   .....++.+++.+||+.||++||++.|++.
T Consensus       216 ----------~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         216 ----------KSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----------cCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                      000111111   113457899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.5e-34  Score=295.27  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=192.6

Q ss_pred             CCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          355 DSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      ....||+|+||.||++...  ++.||+|.+...   ..+.+.+|+.+++.++||||+++++++..++..++++||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999774  688999998542   34568899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      |.+++..      ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++..+....   .
T Consensus       105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---~  172 (297)
T cd06659         105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---P  172 (297)
T ss_pred             HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc---c
Confidence            9998743      34789999999999999999999987   9999999999999999999999999987543221   1


Q ss_pred             eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS  589 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  589 (639)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....           ..... .+...+.      
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~~-~~~~~~~------  234 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----------VQAMK-RLRDSPP------  234 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHH-HHhccCC------
Confidence            22335689999999999988899999999999999999999999853321           00011 1111100      


Q ss_pred             cccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       590 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                            +...  ........+.+++.+||+.+|++||+++++++
T Consensus       235 ------~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         235 ------PKLK--NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ------CCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                  0000  01122346889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-34  Score=289.62  Aligned_cols=245  Identities=24%  Similarity=0.408  Sum_probs=195.8

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|+||.||++..+  +..+|+|.+...     ..+.+.+|++++++++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999885  578999988543     345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC-EEEeccCCceecCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR-AKISDFGLAKLVGK  503 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~  503 (639)
                      +++++|.+++...   ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++. +||+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9999999998642   2235799999999999999999999987   999999999999998864 69999999876543


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..   .......|+..|+|||.+.+..++.++|+||||++++||++|+.|+.....           ...........  
T Consensus       155 ~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~--  218 (257)
T cd08225         155 SM---ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----------HQLVLKICQGY--  218 (257)
T ss_pred             Cc---ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHhccc--
Confidence            21   112234688999999999888899999999999999999999999843221           11111111111  


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +.+     .+......+.+++.+||+.+|++|||++|++.
T Consensus       219 ----------~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         219 ----------FAP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----------CCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                      000     01123446899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-34  Score=287.78  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=194.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAATE--DEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  418 (639)
                      .+|+..+.||+|+||.||++...  +..+|+|.+...        ....+.+|++++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999864  578999987421        234678899999999999999999988664  468


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++++||+++++|.+++..     ...+++.....++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence            899999999999999853     234788888999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      +................++..|+|||.+.+..++.++|+||||++++||++|+.||.....          . ..+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~-~~~~~~~  222 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----------M-AAIFKIA  222 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----------H-HHHHHHH
Confidence            8653221111222345689999999999988889999999999999999999999853221          0 0111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...                .....+......+.+++.+||+ +|.+||+..+++.
T Consensus       223 ~~~----------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQP----------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCC----------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            111                0111234455679999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.2e-33  Score=283.95  Aligned_cols=247  Identities=27%  Similarity=0.425  Sum_probs=200.6

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATE--DELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~  422 (639)
                      +|...+.||+|++|.||+|...  +..+++|.+....     .+.+.+|++++++++|+||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4667889999999999999886  6789999886544     56788999999999999999999999888  8899999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++...     ..+++..+..++.|++.+|+|||+.+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999998642     26899999999999999999999977   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..... .......++..|++||.+.+...+.++||||||+++++|++|+.||.....          .........    
T Consensus       153 ~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~----  217 (260)
T cd06606         153 DIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----------PMAALYKIG----  217 (260)
T ss_pred             ccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------hHHHHHhcc----
Confidence            33211 012335688899999999888899999999999999999999999854331          001111110    


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                  ........+......+.+++.+|++.||++||++.|++.
T Consensus       218 ------------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 ------------SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ------------ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                        000111123344667999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=293.24  Aligned_cols=261  Identities=24%  Similarity=0.379  Sum_probs=194.1

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      |+..+.||.|++|.||++...  +..||+|++...     ..+.+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            556788999999999999874  688999988643     2356888999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                       +++|.+++....   ...+++..++.++.|+++||+|||+++   ++|+||+|+||+++.++.++|+|||++..+....
T Consensus        81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 -DLDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             -CcCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence             468999886422   246899999999999999999999987   9999999999999999999999999987553211


Q ss_pred             CCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                         .......++..|+|||++.+. .++.++||||||+++|||++|+.||......       ..+.... ...... ..
T Consensus       154 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~-~~~~~~-~~  221 (283)
T cd07835         154 ---RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-------DQLFRIF-RTLGTP-DE  221 (283)
T ss_pred             ---cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH-HHhCCC-Ch
Confidence               112223568899999987664 5688999999999999999999998543321       1111111 101100 00


Q ss_pred             ccc----------cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSM----------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...          ........+... .........+.+++.+||+.||++||+++|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         222 DVWPGVTSLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HHhhhhhhchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000          000000001111 112233467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-34  Score=314.35  Aligned_cols=273  Identities=23%  Similarity=0.285  Sum_probs=186.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC---ceEEE------------------EEeccc--cHHHHHHHHHHHHhcCCCCee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN---QEVAI------------------KRMTAT--KTKEFMAEMKILCKVHHSNLV  406 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~---~~vav------------------K~~~~~--~~~~~~~E~~il~~l~h~niv  406 (639)
                      .++|+..+.||+|+||+||++....   ...+.                  |.+...  ....+.+|+++|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999886532   11111                  111111  234578999999999999999


Q ss_pred             EEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC
Q 036507          407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS  486 (639)
Q Consensus       407 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~  486 (639)
                      ++++++...+..++++|++ .++|.+++..................++.|++.||+|||+++   |+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence            9999999999999999998 457777765422221222345566789999999999999987   999999999999999


Q ss_pred             CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh
Q 036507          487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE  566 (639)
Q Consensus       487 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~  566 (639)
                      ++.+||+|||+++.+....  ........||..|+|||++.+..++.++|||||||++|||++|..++........    
T Consensus       303 ~~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~----  376 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP----  376 (501)
T ss_pred             CCCEEEEeCCCceecCccc--ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH----
Confidence            9999999999998764321  1122346799999999999999999999999999999999998754432211100    


Q ss_pred             hhhHHHHHHHHhhcCCCccc--ccccccccCCcccC----CC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          567 RRSLASFMLAALRNSPDSMS--MSSLKDYIDPNMMD----LY-----PHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       567 ~~~l~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~----~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+...+ ..+........  ...+.++++.....    ..     .......+.+++.+||+.||++|||+.|++.
T Consensus       377 ~~~~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        377 GKQLLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            01111111 00000000000  00011111100000    00     0112345778899999999999999999986

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.2e-34  Score=294.16  Aligned_cols=264  Identities=25%  Similarity=0.389  Sum_probs=192.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|++|.||+|...  ++.||+|.+...     ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46788899999999999999875  578999987542     23567889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~  502 (639)
                      |++ ++|.+++...   ....+++.....++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++....
T Consensus        82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            995 5888877532   2233577888899999999999999987   999999999999985 5679999999997543


Q ss_pred             CCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ..   ....+...++..|+|||++.+ ..++.++||||||+++|+|++|+.||......       ..+. .....+...
T Consensus       155 ~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-------~~~~-~~~~~~~~~  223 (294)
T PLN00009        155 IP---VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-------DELF-KIFRILGTP  223 (294)
T ss_pred             CC---ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHHHhCCC
Confidence            21   111223467889999998866 45789999999999999999999998543221       0111 111111111


Q ss_pred             CCcccc--cccccc-------cCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSM--SSLKDY-------IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~--~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......  ..+.+.       ....+. ........++.+++.+|++.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        224 NEETWPGVTSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ChhhccccccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110000  000000       000000 011223456899999999999999999999985

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.4e-34  Score=291.54  Aligned_cols=246  Identities=26%  Similarity=0.439  Sum_probs=196.9

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|...+.||+|+||.||++..  .++.+++|.+...   ..+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788889999999999999976  4578999987543   2456889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++..      ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.......
T Consensus        99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999999863      24788899999999999999999987   9999999999999999999999999987553321


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         .......+++.|++||.+....++.++||||||+++|||++|+.||......     +  .+    .......    
T Consensus       170 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~-----~--~~----~~~~~~~----  231 (293)
T cd06647         170 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----R--AL----YLIATNG----  231 (293)
T ss_pred             ---cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----h--he----eehhcCC----
Confidence               1223346888999999998888999999999999999999999999543210     0  00    0000000    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                               .+..  ..+......+.+++.+||+.+|++||++++++..
T Consensus       232 ---------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 ---------TPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---------CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0000  0122334568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=286.53  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      |...++||+|+||+||++.++  |+.+|||.+.-+ ..+++..|+.||++++.|++|+++|.+....++|+|||||-.|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            455788999999999999765  689999998754 57889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      ..+.++.    .+++|+...+..++...++||+|||...   -+|||||..|||++-+|.+||+|||.+-.+.+   .-.
T Consensus       115 iSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD---TMA  184 (502)
T KOG0574|consen  115 ISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD---TMA  184 (502)
T ss_pred             HHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh---hHH
Confidence            9999973    4567999999999999999999999876   89999999999999999999999999976643   233


Q ss_pred             eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS  589 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  589 (639)
                      ....+.||+.|||||++..-.|+.++||||||++..||..|++|+.....+              .+++ -.|       
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------------RAIF-MIP-------  242 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------------RAIF-MIP-------  242 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------------ceeE-ecc-------
Confidence            345578999999999999999999999999999999999999999654331              0000 000       


Q ss_pred             cccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       590 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                        ...-|.++  .|+....++.++++.||-+.|++|-|+-++++.
T Consensus       243 --T~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  243 --TKPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             --CCCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence              00112222  256677789999999999999999999988763

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=304.73  Aligned_cols=245  Identities=21%  Similarity=0.387  Sum_probs=197.8

Q ss_pred             CCCCCceeecCceEEEEEEEcCc--eEEEEEecc---ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          353 FSDSSLLGHGTYGSVYYGNIRNQ--EVAIKRMTA---TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~~~--~vavK~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.+...||.|+||.||++..+..  ..|-|.+..   ++.++++-|++||..++||+||+|++.|..++.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            34466799999999999987643  345666643   3567899999999999999999999999899999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |-....+-.    -...|...++.-++.|++.||.|||++.   |||||||..|||++-+|.++|+|||.+....   ..
T Consensus       114 GAVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~---~t  183 (1187)
T KOG0579|consen  114 GAVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK---ST  183 (1187)
T ss_pred             chHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch---hH
Confidence            999888754    2456899999999999999999999988   9999999999999999999999999886432   12


Q ss_pred             cceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          508 EATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ......+.|||+|||||++.     ..+|+.++||||||++|.||..+.+|....+.           ...+..+-+..|
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----------MRVllKiaKSeP  252 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKSEP  252 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----------HHHHHHHhhcCC
Confidence            22334578999999999875     46889999999999999999999988754332           222233323222


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .             .|.  -|......+.+++.+||..||..||++.++++
T Consensus       253 P-------------TLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 P-------------TLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             C-------------ccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            2             121  24556778999999999999999999999885

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.1e-34  Score=286.85  Aligned_cols=238  Identities=24%  Similarity=0.345  Sum_probs=192.0

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ||.|+||.||++...  ++.+++|.+...      ..+.+.+|++++++++||||+++++++.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999987  689999988542      235688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......    .
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~  148 (262)
T cd05572          81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----K  148 (262)
T ss_pred             HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----c
Confidence            9999642     34788899999999999999999977   9999999999999999999999999998664321    1


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....++..|++||.+.+..++.++|+||||+++|||++|..|+.....         .............         
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~---------  210 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---------DPMEIYNDILKGN---------  210 (262)
T ss_pred             cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---------CHHHHHHHHhccC---------
Confidence            2234688999999999888899999999999999999999999954331         0011111111100         


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                             .....+......+.+++.+||+.+|++||+     ++|+++
T Consensus       211 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 -------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                   011123333567999999999999999999     677764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.6e-34  Score=291.50  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=195.2

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +|+..+.||.|++|.||+|+..  +..||+|.++..    ..+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4777899999999999999985  678999988643    2456778999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++ +|.+++....  ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          81 DK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             Cc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            74 8888876422  1345899999999999999999999987   9999999999999999999999999987553211


Q ss_pred             CCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                         .......++..|++||.+.+ ..++.++||||||+++|||++|+.||...+..        ............. ..
T Consensus       155 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~-~~  222 (284)
T cd07836         155 ---NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--------DQLLKIFRIMGTP-TE  222 (284)
T ss_pred             ---cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHHHhCCC-Ch
Confidence               11223457889999998865 45688999999999999999999998643321        0111111111111 00


Q ss_pred             ccccccc----------cccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLK----------DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~----------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....+.          ...+... .......+..+.+++.+|++.||.+||+++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         223 STWPGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhHHHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000          0000000 0011233567889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-33  Score=289.67  Aligned_cols=268  Identities=22%  Similarity=0.343  Sum_probs=194.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCe-----
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVH-HSNLVELIGYAATEDE-----  417 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~-----  417 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.+....     ...+.+|++++++++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999875  5789999875432     356788999999995 6999999998877665     


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFG  496 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  496 (639)
                      .+++|||+++ +|.+++..........+++...+.++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 8988886533222456899999999999999999999987   999999999999998 8899999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ++..+....   .......+++.|+|||++.+ ..++.++||||||+++|||++|..||......       ..+.. +.
T Consensus       157 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-------~~~~~-~~  225 (295)
T cd07837         157 LGRAFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-------QQLLH-IF  225 (295)
T ss_pred             cceecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHH-HH
Confidence            987653211   11223356889999998865 45789999999999999999999988543221       11111 11


Q ss_pred             HHhhcCCCccc--cccccccc-----CCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMS--MSSLKDYI-----DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~--~~~~~~~~-----d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+........  ........     .+............++.+++.+||+.||++||+++|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            11111110000  00000000     000000011234567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=299.42  Aligned_cols=267  Identities=24%  Similarity=0.370  Sum_probs=194.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----CeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATE-----DEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  418 (639)
                      .++|...++||+|+||.||+|...  ++.||+|.+...    ....+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467888999999999999999874  678999988532    235578899999999999999999886543     357


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++++||+. ++|.+++..      ..+++.....++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence            99999996 588877753      35889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      .................|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.        ......+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--------~~~~~~~~~~  225 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--------LHQLNLILGV  225 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHH
Confidence            865432222222234578999999998654 5688999999999999999999999854321        1111111222


Q ss_pred             hhcCCCcccc----ccccccc-----CCccc-CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          578 LRNSPDSMSM----SSLKDYI-----DPNMM-DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       578 ~~~~~~~~~~----~~~~~~~-----d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      +...+.....    ......+     .+... .........++.+++.+||+.||++||++.|++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            2211110000    0000000     00000 00001224568999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2e-33  Score=287.88  Aligned_cols=244  Identities=25%  Similarity=0.420  Sum_probs=194.4

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .|...+.||+|++|.||++...  ++.+++|.+...   ..+.+.+|+.++++++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3445678999999999999864  578999987543   24557899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++..      ..+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++....... 
T Consensus       100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-  169 (285)
T cd06648         100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-  169 (285)
T ss_pred             CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-
Confidence            9999999864      34788899999999999999999987   9999999999999999999999999887543211 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                        .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.           ...........+    
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----------~~~~~~~~~~~~----  232 (285)
T cd06648         170 --PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LQAMKRIRDNLP----  232 (285)
T ss_pred             --cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----------HHHHHHHHhcCC----
Confidence              112234688999999999888899999999999999999999999854221           011111111110    


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                               +....  +...+..+.+++.+||+.+|++||++.++++
T Consensus       233 ---------~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         233 ---------PKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ---------CCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                     00100  1123457999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-35  Score=280.59  Aligned_cols=236  Identities=29%  Similarity=0.386  Sum_probs=196.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...++||+|.||.|-+.+.+  ++.+|+|+++++      +....+.|-++|+..+||.+..+.-.+...+.+++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            56777889999999999988764  688999998764      3344677999999999999999998999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+.||.|.-+|..     ...++....+.+-..|..||.|||+++   |+.||||.+|.|+|.+|++||+|||+++.- 
T Consensus       248 eyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~-  318 (516)
T KOG0690|consen  248 EYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE-  318 (516)
T ss_pred             EEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc-
Confidence            99999999999864     345777777778889999999999987   999999999999999999999999999743 


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                        -....++..++|||.|+|||++....|...+|+|.+||++|||++|+.||...+        +..+.+.+...--.  
T Consensus       319 --I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--------h~kLFeLIl~ed~k--  386 (516)
T KOG0690|consen  319 --IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--------HEKLFELILMEDLK--  386 (516)
T ss_pred             --ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc--------hhHHHHHHHhhhcc--
Confidence              233445677899999999999999999999999999999999999999996533        33444443221111  


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP  626 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  626 (639)
                                         +|.....+...|+...|.+||.+|.
T Consensus       387 -------------------FPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  387 -------------------FPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -------------------CCccCCHHHHHHHHHHhhcChHhhc
Confidence                               3444555688899999999999995

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-33  Score=281.61  Aligned_cols=245  Identities=29%  Similarity=0.491  Sum_probs=197.8

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .|+..+.||+|++|.||++...  +..+++|++....   .+++.+|++++++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667789999999999999886  6789999986543   4678899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++....    ..+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            999999986421    46899999999999999999999976   99999999999999999999999999876643221


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                          .....++..|++||.+.+..++.++||||||+++++|++|+.|+...+.       ...+    .........   
T Consensus       154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~----~~~~~~~~~---  215 (253)
T cd05122         154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKAL----FKIATNGPP---  215 (253)
T ss_pred             ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHH----HHHHhcCCC---
Confidence                2345688999999999888899999999999999999999999854321       0000    000000000   


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                           ...       .+......+.+++.+||+.||++|||+.|+++
T Consensus       216 -----~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 -----GLR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -----CcC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 000       01112456899999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=320.03  Aligned_cols=262  Identities=27%  Similarity=0.430  Sum_probs=208.0

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc---------CceEEEEEeccc----cHHHHHHHHHHHHhcC-CCCeeEEEe
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR---------NQEVAIKRMTAT----KTKEFMAEMKILCKVH-HSNLVELIG  410 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~  410 (639)
                      .++...++....+.||+|.||.|++|...         ...||||.++..    +.+.+..|+++|+.+- |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34455566666779999999999999754         236999998653    3567899999999985 999999999


Q ss_pred             eeecCCeEEEEEeeccCCChhhhccCCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 036507          411 YAATEDELFLIYEYAQKGSLKSHLHDPQ---------NRGQ--TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKS  479 (639)
Q Consensus       411 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp  479 (639)
                      .|..++..++|.||++.|+|.++++..+         ....  ..+.....+.++.|||.|++||++..   ++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999998765         1111  23899999999999999999999987   99999999


Q ss_pred             CcEEECCCCCEEEeccCCceecCCCCCCcceeeeec--cccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccc
Q 036507          480 SNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV--GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIR  556 (639)
Q Consensus       480 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~  556 (639)
                      +|||+.++..+||+|||+++.........  ...-.  -...|||||.+....|+.|+||||||++||||+| |..|+-.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~--~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYR--TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceE--ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999998654322211  11112  2446999999999999999999999999999999 6777732


Q ss_pred             cccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          557 TEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       557 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      ...       ...+.+                    .+.+..+...|..|..++.+++..||+.+|++||++.++.+.++
T Consensus       525 ~~~-------~~~l~~--------------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  525 IPP-------TEELLE--------------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             CCc-------HHHHHH--------------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            110       011111                    22222233457788889999999999999999999999999988


Q ss_pred             hh
Q 036507          637 QI  638 (639)
Q Consensus       637 ~i  638 (639)
                      ..
T Consensus       578 ~~  579 (609)
T KOG0200|consen  578 KH  579 (609)
T ss_pred             HH
Confidence            64

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-34  Score=290.34  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=195.3

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEEEe
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE--DELFLIYE  423 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~e  423 (639)
                      |+..+.||+|+||.||++...  ++.+|+|.+...     ....+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999886  478999998654     235688999999999999999999999887  78999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++ ++|.+++...    ...+++...+.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            997 4898888642    246899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...  ...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......        ..............
T Consensus       153 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--------~~~~~~~~~~~~~~  222 (287)
T cd07840         153 RNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--------EQLEKIFELCGSPT  222 (287)
T ss_pred             CCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCc
Confidence            321  12233467889999998765 45789999999999999999999998543321        11111111111110


Q ss_pred             Cccccccccc-----------ccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKD-----------YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~-----------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       ........+           .....+.......++..+.+++.+||+.+|++||+++++++
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         223 -DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             -hhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             000000000           00011111111123567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.8e-34  Score=289.31  Aligned_cols=260  Identities=25%  Similarity=0.284  Sum_probs=190.5

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecC--CeEEEEEe
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVH-HSNLVELIGYAATE--DELFLIYE  423 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~lv~e  423 (639)
                      |+..+.||+|+||.||++...  +..+|+|.++..    ......+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            455778999999999999874  578999987643    1234567899999986 99999999999887  88999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++ ++|.+++...    ...++|.....++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            996 5888877542    245899999999999999999999987   999999999999999 9999999999986532


Q ss_pred             CCCCcceeeeeccccccCCccccc-cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..    ......++..|+|||.+. +..++.++|||||||++|||++|+.||...+.        ..........+...+
T Consensus       152 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--------~~~~~~~~~~~~~~~  219 (282)
T cd07831         152 KP----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--------LDQIAKIHDVLGTPD  219 (282)
T ss_pred             CC----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--------HHHHHHHHHHcCCCC
Confidence            21    112346788999999764 45678899999999999999999999854332        111112222221111


Q ss_pred             Cccc----ccccccccCCccc----CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMS----MSSLKDYIDPNMM----DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~----~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....    .........+...    .......+..+.+++.+||+.+|++||+++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1000    0000000000000    0011234678999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-33  Score=283.33  Aligned_cols=247  Identities=25%  Similarity=0.420  Sum_probs=200.9

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|+||.||++...  +..+++|.+...     ..+++.+|++++++++|+|++++.+.+..++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677889999999999999886  688999998643     345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++..... ....+++.....++.+++.||.|||+++   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999875321 2356899999999999999999999987   999999999999999999999999999865432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .......|++.|+|||.+.+..++.++|+||+|+++++|++|+.|+.....           ............  
T Consensus       157 ~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~--  220 (258)
T cd08215         157 V---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----------LELALKILKGQY--  220 (258)
T ss_pred             c---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----------HHHHHHHhcCCC--
Confidence            2   122335788999999999888899999999999999999999999843321           111111111110  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                     ...+......+.+++.+||+.+|++||++.|+++
T Consensus       221 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 ---------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                           0112234557899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.1e-33  Score=292.26  Aligned_cols=242  Identities=30%  Similarity=0.510  Sum_probs=190.8

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .|...+.||+|+||.||++...  +..+|+|.+...      ..+++.+|++++++++|+|++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3666888999999999999874  578999988532      23468889999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+. |+|.+++..    ....+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            996 578777643    1345899999999999999999999987   99999999999999999999999999875432


Q ss_pred             CCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      .       ....|+..|+|||++.   .+.++.++|||||||++|||++|+.||.....       ...+    ......
T Consensus       178 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~----~~~~~~  239 (317)
T cd06635         178 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSAL----YHIAQN  239 (317)
T ss_pred             c-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHH----HHHHhc
Confidence            1       2246888999999873   45688999999999999999999999854321       0000    111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                      ..             +.   .........+.+++.+||+.+|.+||++.++++.+
T Consensus       240 ~~-------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         240 ES-------------PT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             cC-------------CC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            00             00   01123345689999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-33  Score=296.49  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=194.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------C
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------D  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  416 (639)
                      .++|+..+.||+|+||.||++...  ++.||+|.+...     ..+++.+|++++++++|+||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            477888999999999999999874  678999988532     235677899999999999999999987543      3


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++||||+. ++|.+.+..       .++......++.|++.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence            5799999995 588887742       2788888899999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ++.......    ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..        .....+..
T Consensus       164 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~  231 (353)
T cd07850         164 LARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI--------DQWNKIIE  231 (353)
T ss_pred             cceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHH
Confidence            998653221    123346789999999999999999999999999999999999998543311        00111111


Q ss_pred             HhhcCCC------------------ccccccccccc----CCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPD------------------SMSMSSLKDYI----DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~------------------~~~~~~~~~~~----d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+...+.                  ........+.+    .+......+......+.+++.+||+.||++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111000                  00000011111    111111112234567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.1e-34  Score=288.30  Aligned_cols=243  Identities=27%  Similarity=0.378  Sum_probs=197.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      +|+..+.||.|+||.||++...  +..+|+|.+...      ..+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777889999999999999885  688999988642      34678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++++|.+++...     ..+++.....++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999998642     46888999999999999999999987   99999999999999999999999999876533


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      ..    ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......         ............  
T Consensus       153 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~--  217 (258)
T cd05578         153 DT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---------IRDQIRAKQETA--  217 (258)
T ss_pred             Cc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---------HHHHHHHHhccc--
Confidence            21    223356888999999998888999999999999999999999998644321         011111111100  


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM--KQVV  632 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl  632 (639)
                                     ....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       218 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 ---------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                           011223344678999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.9e-33  Score=287.99  Aligned_cols=257  Identities=18%  Similarity=0.185  Sum_probs=181.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCc-----eEEEEEeccccH--------------HHHHHHHHHHHhcCCCCeeEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQ-----EVAIKRMTATKT--------------KEFMAEMKILCKVHHSNLVELIG  410 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~vavK~~~~~~~--------------~~~~~E~~il~~l~h~niv~l~~  410 (639)
                      .++|...++||+|+||.||+|...+.     .+++|.......              .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36788899999999999999987543     566665322110              01122334456678999999998


Q ss_pred             eeecCC----eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC
Q 036507          411 YAATED----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS  486 (639)
Q Consensus       411 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~  486 (639)
                      .+....    ..++++|++ ..++.+.+..     ....++.....++.|++.||+|||+++   |+||||||+|||++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            765443    336777776 3466666542     122467778899999999999999987   999999999999999


Q ss_pred             CCCEEEeccCCceecCCCCCC----cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccc
Q 036507          487 AFRAKISDFGLAKLVGKTSDG----EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS  562 (639)
Q Consensus       487 ~~~~kl~Dfgla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~  562 (639)
                      ++.++|+|||+++.+......    ........||+.|+|||.+.+..++.++|||||||+++||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999876432111    1112234699999999999999999999999999999999999999965421000


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                        .......++......                +..   ....++..+.+++..|+..+|++||+++++++.|+
T Consensus       242 --~~~~~~~~~~~~~~~----------------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 --LIHAAKCDFIKRLHE----------------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             --HHHHhHHHHHHHhhh----------------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence              000000111111100                000   11234567999999999999999999999998764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.4e-33  Score=291.32  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=189.0

Q ss_pred             ceeec--CceEEEEEEE--cCceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          358 LLGHG--TYGSVYYGNI--RNQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       358 ~lG~G--~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      .||+|  +||+||++.+  .++.||+|.+....     .+.+.+|+.+++.++||||+++++++..++..++++||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999987  46899999976432     356788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      +|.+++....   ...+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+..........
T Consensus        85 ~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          85 SANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999986522   235888999999999999999999887   9999999999999999999999998654322111111


Q ss_pred             ce----eeeeccccccCCccccccC--CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          509 AT----VTKVVGTFGYLAPEYLTDG--LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       509 ~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..    .....++..|++||++.+.  .++.++|||||||++|||++|+.||......       ..    ....+...+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-------~~----~~~~~~~~~  227 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-------QM----LLQKLKGPP  227 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-------HH----HHHHhcCCC
Confidence            00    0112346679999998763  4789999999999999999999998543210       00    001111000


Q ss_pred             Cc------------------------cccc-----ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DS------------------------MSMS-----SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~------------------------~~~~-----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..                        ....     ......++.+....+..+...+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         228 YSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00                        0000     000111122222223456778999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-33  Score=293.79  Aligned_cols=265  Identities=20%  Similarity=0.278  Sum_probs=192.4

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      .+.+|.|+++.||++...++.||||+++..     ..+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus         7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            445667777788888778899999997543     235688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC---
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG---  507 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~---  507 (639)
                      .+++....   ...+++.....++.|+++||+|||+++   |+||||||+||+++.++.+||+|||.+..+......   
T Consensus        87 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          87 EDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99987522   234788888899999999999999987   999999999999999999999999988755322111   


Q ss_pred             -cceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh----hc
Q 036507          508 -EATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL----RN  580 (639)
Q Consensus       508 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~----~~  580 (639)
                       ........++..|+|||++.+  ..++.++|||||||++|||++|+.||......       ..+.+......    ..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCcccccc
Confidence             111223457788999999876  35788999999999999999999999643321       11111100000    00


Q ss_pred             CCCccccccccc----ccCCc----ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKD----YIDPN----MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~----~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ............    ..++.    ...........++.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000000000000    01110    111122344567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.4e-34  Score=284.94  Aligned_cols=245  Identities=27%  Similarity=0.407  Sum_probs=197.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..++||+|+||.||++...  ++.+++|.+...     ...++.+|++++++++|+||+++.+++......++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677889999999999999774  578999987642     244678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++.... .....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999986522 22356899999999999999999999987   999999999999999999999999999765432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                           ......++..|++||.+.+..++.++|+||||+++|||++|+.||...+.        ..+..   ......   
T Consensus       157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~---~~~~~~---  217 (256)
T cd08530         157 -----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRY---KVQRGK---  217 (256)
T ss_pred             -----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH---HHhcCC---
Confidence                 11224678899999999998899999999999999999999999854321        01111   111100   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                    ....+.....++.+++.+|++.+|++||++.|+++
T Consensus       218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 --------------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --------------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                          00112244567999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.4e-33  Score=286.38  Aligned_cols=238  Identities=25%  Similarity=0.333  Sum_probs=182.9

Q ss_pred             ceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHH---hcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILC---KVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      +||+|+||.||++...  ++.+|+|.+....      ...+.+|..+++   ..+|||++.+.+++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999874  5789999875431      122344444333   3479999999999998999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++..     ...+++.....++.|++.||+|||+++   |+|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-  151 (279)
T cd05633          81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (279)
T ss_pred             CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence            9999998853     245899999999999999999999987   9999999999999999999999999987553211 


Q ss_pred             CcceeeeeccccccCCccccc-cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                          .....|+..|+|||.+. +..++.++|||||||+++||++|+.||......     ....+    ......     
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~----~~~~~~-----  213 (279)
T cd05633         152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEI----DRMTLT-----  213 (279)
T ss_pred             ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHHHH----HHHhhc-----
Confidence                12346899999999886 456789999999999999999999998543221     00000    000000     


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVIS  634 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  634 (639)
                              .+.    ..+...+.++.+++.+||+.||++||     +++|+++.
T Consensus       214 --------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 --------VNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --------CCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                    011    12233455789999999999999999     59888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=326.86  Aligned_cols=248  Identities=28%  Similarity=0.435  Sum_probs=198.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      -++....+||.|.||.||-+...  |...|+|.++..     ..+.+.+|+.++..|+|||+|+++|+-.+++..++.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            35666789999999999988753  567889876543     23567899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      ||++|+|.+.+...+     .+++.....+..|++.|+.|||+++   ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1315 yC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999997533     3455555667789999999999998   99999999999999999999999999987744


Q ss_pred             CC-CCcceeeeeccccccCCccccccCC---CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          504 TS-DGEATVTKVVGTFGYLAPEYLTDGL---ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       504 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .. ..........||+-|||||++.+..   -.-+.||||+|||++||+||+.||...+.         .+.-.+....+
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVAAG 1457 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHhcc
Confidence            32 1222334578999999999997643   35689999999999999999999976543         22222222222


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..|                  ..|+....+-.+++..||+.||++|.++.|+++
T Consensus      1458 h~P------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 HKP------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CCC------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            222                  235556777899999999999999999988875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=301.70  Aligned_cols=267  Identities=26%  Similarity=0.423  Sum_probs=203.8

Q ss_pred             CCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC------eEEEEEe
Q 036507          356 SSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATED------ELFLIYE  423 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------~~~lv~e  423 (639)
                      .+.||+|+||.||+|+.+  |+.||||.++..    ..+.+.+|+++|++++|+|||+++++-.+..      ...++||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            567999999999999864  789999998763    3567889999999999999999999865443      5689999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC--CCC--CEEEeccCCce
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD--SAF--RAKISDFGLAK  499 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfgla~  499 (639)
                      ||.+|||...|..+.+  ...|+....+.+..++..||.|||+++   |+||||||.||++-  ++|  ..||+|||.|+
T Consensus        98 yC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             ecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            9999999999987654  456999999999999999999999987   99999999999983  333  37999999999


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccc-cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+++    ....+..+||..|.+||... .+.|+..+|.|||||++||+.||..||....+       .+...+.+...+
T Consensus       173 el~d----~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~-------pk~~~~~~~~~~  241 (732)
T KOG4250|consen  173 ELDD----NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG-------PKNNKEIMWHII  241 (732)
T ss_pred             cCCC----CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC-------ccccchhhhhhh
Confidence            7743    33677899999999999998 58899999999999999999999999964433       122223344444


Q ss_pred             hcCCCcccccccccccCCc-ccCC------CChhHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPN-MMDL------YPHDCLFKMAMLAKQCVDEDPILRP--DMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~-l~~~------~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i  638 (639)
                      -+.+.........+.-+|- +...      ........+-..+..++..+|++|-  ...+....+..|
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            4444443322211111111 1111      1223344567778888999999998  766666666554

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.9e-33  Score=289.18  Aligned_cols=263  Identities=28%  Similarity=0.387  Sum_probs=193.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATE--DELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  420 (639)
                      .++|+..+.||+|+||.||++...  ++.||+|.+....     ...+.+|++++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367888999999999999999875  6789999886432     23466899999999999999999998654  56899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+. ++|.+++...    ...+++.....++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence            999996 5888887642    246899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....   ...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.        ......+...+.
T Consensus       158 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--------~~~~~~~~~~~~  226 (309)
T cd07845         158 YGLPA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--------IEQLDLIIQLLG  226 (309)
T ss_pred             cCCcc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcC
Confidence            64321   11222345788999999865 5578999999999999999999999854332        111111112111


Q ss_pred             cCCCccccccccc------c-cC----CcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKD------Y-ID----PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~------~-~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...... ......      . +.    ..+... .......+.+++.+||+.||++|||++|++.
T Consensus       227 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         227 TPNESI-WPGFSDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             CCChhh-chhhhcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            111100 000000      0 00    000000 0112456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.6e-33  Score=288.43  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=191.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCC-------
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATED-------  416 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~-------  416 (639)
                      ++|+..++||+|+||.||++...  ++.||||.+....     ...+.+|++++++++||||+++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            46888899999999999999875  5789999875332     234578999999999999999999886543       


Q ss_pred             -eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          417 -ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       417 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                       ..++||||+. ++|.+++...    ...+++.....++.|++.||+|||+++   ++|+||||+||+++.++.+||+||
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence             4599999995 5888877532    235899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCC-cceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHH
Q 036507          496 GLAKLVGKTSDG-EATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       496 gla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      |++..+...... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....        ......
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--------~~~~~~  235 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--------QHQLTL  235 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence            999765432211 1122334678899999988664 468899999999999999999988854322        111111


Q ss_pred             HHHHhhcCCCcccc-c-------------ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          574 MLAALRNSPDSMSM-S-------------SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       574 ~~~~~~~~~~~~~~-~-------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +....+..+..... .             .....+...+.   +......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            12222111110000 0             00000000000   0112345789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.3e-33  Score=285.02  Aligned_cols=240  Identities=27%  Similarity=0.380  Sum_probs=188.4

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ||+|+||+||++...  ++.+|+|.+....      ...+.+|++++++++|||++++.+.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999764  6789999885432      23467899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....    ...
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~----~~~  150 (277)
T cd05577          81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG----GKK  150 (277)
T ss_pred             HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc----CCc
Confidence            99986422   246899999999999999999999987   99999999999999999999999999876532    112


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....++..|++||.+.+..++.++||||||+++++|++|+.||........    ...    +.......         
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~----~~~~~~~~---------  213 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEE----LKRRTLEM---------  213 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHH----HHhccccc---------
Confidence            2234678899999999888899999999999999999999999854332100    000    00000000         


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                              ....+......+.+++.+||+.||++||     ++.+++.
T Consensus       214 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 --------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             --------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                    0012233455789999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-34  Score=296.35  Aligned_cols=243  Identities=25%  Similarity=0.367  Sum_probs=198.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ...|.....||+|.|+.|.++++.  +..||||.+.+..     ...+.+|+++|..++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456788899999999999999875  6899999987542     345889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+.+|.+++++...     ..........++.|+..|++|||+++   |+|||||++||||+.+.++||+|||++..+.
T Consensus       135 eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            999999999999652     22444667778899999999999998   9999999999999999999999999999874


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .    .......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+...-.        .+        +  
T Consensus       207 ~----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------~L--------r--  264 (596)
T KOG0586|consen  207 Y----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------EL--------R--  264 (596)
T ss_pred             c----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------cc--------c--
Confidence            3    334556899999999999998776 68999999999999999999999643210        00        0  


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                               ...+...++  .+.-...++.+++++++-.+|.+|++++++.+
T Consensus       265 ---------~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 ---------PRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ---------chheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                     000001111  12223445788999999999999999999864

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=278.39  Aligned_cols=243  Identities=31%  Similarity=0.525  Sum_probs=197.0

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|+..+.||+|++|.||++...  ++.+++|.+....     .+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677889999999999999875  5789999886543     35688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...     ..+++..+..++.|++.++.|||+.+   |+|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999998642     46899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      ..   ......++..|++||...+..++.++|||+||+++++|++|+.|+.....       ....    .......   
T Consensus       153 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~----~~~~~~~---  215 (254)
T cd06627         153 SK---DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAAL----FRIVQDD---  215 (254)
T ss_pred             cc---cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHH----HHHhccC---
Confidence            21   12334688899999999887889999999999999999999999853221       0001    0110000   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                .+.    .+......+.+++.+||..+|++||++.+++.
T Consensus       216 ----------~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 ----------HPP----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ----------CCC----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                      001    12233457889999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.1e-33  Score=285.93  Aligned_cols=249  Identities=23%  Similarity=0.419  Sum_probs=190.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|+..+.||+|+||.||++...  ++.||||.++..    ...++.+|+.++.+.. |+||+++++++.++...+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            356777889999999999999987  688999998643    2345667887777775 999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+. ++|.+++...    ...+++..+..++.|++.||+|||+..  +|+||||+|+||++++++.+||+|||++..+.
T Consensus        94 e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          94 ELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            9984 5777766431    236899999999999999999999741  39999999999999999999999999987653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCC----CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGL----ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ...    ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||.....      +    .+.....+
T Consensus       167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~----~~~~~~~~  232 (296)
T cd06618         167 DSK----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------E----FEVLTKIL  232 (296)
T ss_pred             CCC----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------H----HHHHHHHh
Confidence            221    112235788999999987543    78899999999999999999999843211      0    01111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      .....             .+.  ....+..++.+++.+||+.||++||++++++..
T Consensus       233 ~~~~~-------------~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         233 QEEPP-------------SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             cCCCC-------------CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11100             000  011234568999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=286.34  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=195.9

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      |+..+.||+|++|.||++...  ++.+++|.+....     ...+.+|++++++++|+||+++++++..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456778999999999999874  6789999876432     356788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++ +|.+++...    ...+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            65 888887642    246899999999999999999999987   9999999999999999999999999998764322


Q ss_pred             CCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                         .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..        .........+.... .
T Consensus       153 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--------~~~~~~~~~~~~~~-~  220 (283)
T cd05118         153 ---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--------DQLFKIFRTLGTPD-P  220 (283)
T ss_pred             ---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHcCCCc-h
Confidence               122234678899999998876 7899999999999999999999888543321        01111111111100 0


Q ss_pred             cccccccc-----------ccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKD-----------YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~-----------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ........           ..+... .....+...++.+++.+||+.||.+||++++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         221 EVWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HhcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00000000           000000 1112345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.7e-33  Score=283.45  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=191.2

Q ss_pred             CCCCCCceeecCceEEEEEEE-----cCceEEEEEecccc-------HHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNI-----RNQEVAIKRMTATK-------TKEFMAEMKILCKV-HHSNLVELIGYAATEDEL  418 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~~-------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  418 (639)
                      +|+..+.||+|+||.||++..     .+..||+|.+....       .+.+.+|+++++++ +|+||+++.+.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999876     45789999886431       35577899999999 599999999999988899


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++|+||+++++|.+++..     ...+++.....++.|+++||.|||+.+   ++||||+|+|||+++++.+||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence            999999999999999864     235788888889999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      .......  ........|+..|++||.+..  ..++.++||||||+++|+|++|+.|+.....       ..........
T Consensus       153 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~~~  223 (290)
T cd05613         153 KEFHEDE--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-------KNSQAEISRR  223 (290)
T ss_pred             eeccccc--ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-------cccHHHHHHH
Confidence            7653221  112223568899999999875  3467899999999999999999999853211       0111111111


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                      .....              +    .++......+.+++.+||+.||++||     ++++++.
T Consensus       224 ~~~~~--------------~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         224 ILKSE--------------P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hhccC--------------C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            11111              0    01233455688999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-32  Score=283.85  Aligned_cols=266  Identities=24%  Similarity=0.332  Sum_probs=194.7

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCC----
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATED----  416 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~----  416 (639)
                      ...++|+..+.||+|+||.||+|...  ++.||+|.++...     ...+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34577888999999999999999985  5789999986432     245778999999999999999999887654    


Q ss_pred             ------eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          417 ------ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       417 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                            .+++++||+++ +|...+...    ...+++.....++.|++.||+|||+.+   |+|+||||+||++++++.+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcE
Confidence                  78999999975 777766531    345899999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||++........  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....       ...
T Consensus       156 kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-------~~~  226 (302)
T cd07864         156 KLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-------LAQ  226 (302)
T ss_pred             EeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHH
Confidence            9999999986543221  11222356788999998765 4568899999999999999999999854321       011


Q ss_pred             HHHHHHHHhhcCCCcccccccc-----cccC------CcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLK-----DYID------PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~-----~~~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      + ..+.......... ....+.     ...+      ...... ....+..+.+++.+||+.||++||++++++.
T Consensus       227 ~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         227 L-ELISRLCGSPCPA-VWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             H-HHHHHHhCCCChh-hcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1 1111211111100 000000     0000      011111 1123567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5e-33  Score=292.04  Aligned_cols=266  Identities=26%  Similarity=0.389  Sum_probs=193.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecc-----ccHHHHHHHHHHHHhc-CCCCeeEEEeeeecC--CeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTA-----TKTKEFMAEMKILCKV-HHSNLVELIGYAATE--DELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~-----~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~--~~~~  419 (639)
                      .++|+..+.||+|+||.||+|...  ++.+|+|++..     .....+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            356778889999999999999874  57899998743     2234577899999999 999999999988643  4689


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||++ ++|.+++..      ..++|..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++.
T Consensus        86 lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          86 LVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            9999996 599988853      15788899999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCC--cceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          500 LVGKTSDG--EATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       500 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      .+......  ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.......        .......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--------~~~~~~~  227 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--------QLEKIIE  227 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHH
Confidence            65432211  122334578999999998765 557889999999999999999999985432110        0000000


Q ss_pred             HhhcCCCc--------cc---ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          577 ALRNSPDS--------MS---MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       577 ~~~~~~~~--------~~---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      .....+..        ..   .......-........ ...+.++.+++.+||+.||++|||+.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000000        00   0000000000001111 1245679999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.9e-33  Score=283.82  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=194.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc-----CceEEEEEeccc-------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT-------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDEL  418 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  418 (639)
                      +|+..+.||+|+||.||++...     +..+|||.++..       ..+.+.+|++++.++ +||||+++.+.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3666788999999999998753     467999988642       134577899999999 599999999999988999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++..     ...+++.....++.|++++|.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence            999999999999999853     235788899999999999999999977   999999999999999999999999998


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCC--CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL--ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ..+....  ........|+..|++||.+.+..  .+.++||||||+++|||++|..||......       .........
T Consensus       153 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~  223 (288)
T cd05583         153 KEFLAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-------NSQSEISRR  223 (288)
T ss_pred             ccccccc--ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-------chHHHHHHH
Confidence            7653321  11122346889999999987655  688999999999999999999998532211       001111111


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .....              +.    .+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus       224 ~~~~~--------------~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         224 ILKSK--------------PP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHccC--------------CC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11110              00    122234568899999999999999999888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.1e-33  Score=292.32  Aligned_cols=266  Identities=22%  Similarity=0.346  Sum_probs=195.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT----EDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~  419 (639)
                      ++|+..+.||+|+||.||++...  +..||+|++...     ..+.+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888899999999999999864  678999988643     23567789999999999999999987753    35689


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +|+||+. ++|.+++..     ...+++.....++.|++.||.|||+++   |+||||||+||++++++.+||+|||++.
T Consensus        85 lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          85 VVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            9999995 689988853     234899999999999999999999987   9999999999999999999999999997


Q ss_pred             ecCCCCCC-cceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          500 LVGKTSDG-EATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       500 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ........ ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..        .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--------~~~~~~~~~  227 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--------HQLKLILSV  227 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--------HHHHHHHHH
Confidence            65332211 112234578999999998765 56789999999999999999999999543221        011111111


Q ss_pred             hhcCCCcccc----cccccccC---Cccc---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMSM----SSLKDYID---PNMM---DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~----~~~~~~~d---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+..+.....    ..+...++   ..-.   .......+.++.+++.+||+.||++||++++++.
T Consensus       228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1111110000    00000000   0000   0001223567999999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-32  Score=278.12  Aligned_cols=243  Identities=21%  Similarity=0.292  Sum_probs=186.6

Q ss_pred             hhCCCCCCCce--eecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEe
Q 036507          349 ATEGFSDSSLL--GHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       349 a~~~f~~~~~l--G~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ..++|+..+.+  |+|+||.||++...  +..+|+|..........  |+.....+ +|||++++++.+...+..++|||
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            34566666666  99999999999864  57899998765432221  23222222 69999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  502 (639)
                      |+++++|.+++...     ..+++.....++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||++....
T Consensus        90 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         90 YIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            99999999998642     26899999999999999999999987   99999999999999998 99999999987653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..       ....++..|+|||++.+..++.++||||||+++|||++|+.||......      ......+.... ... 
T Consensus       162 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~-  226 (267)
T PHA03390        162 TP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------ELDLESLLKRQ-QKK-  226 (267)
T ss_pred             CC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc------hhhHHHHHHhh-ccc-
Confidence            21       1235789999999999989999999999999999999999999633221      01111111000 000 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-MKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~  633 (639)
                                       ...+......+.+++.+||+.+|.+||+ ++|+++
T Consensus       227 -----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 -----------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                             0011234557899999999999999995 688874

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=273.99  Aligned_cols=264  Identities=26%  Similarity=0.380  Sum_probs=209.8

Q ss_pred             chHHHHhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEe
Q 036507          342 TYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIG  410 (639)
Q Consensus       342 ~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~  410 (639)
                      ...|+.....+++...++-+|.||.||+|.+.+       +.|-+|.++...    ...++.|.-++..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            345677777889999999999999999997653       346667665432    345778888899999999999999


Q ss_pred             eeecC-CeEEEEEeeccCCChhhhccCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC
Q 036507          411 YAATE-DELFLIYEYAQKGSLKSHLHDPQ---NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS  486 (639)
Q Consensus       411 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~  486 (639)
                      ++.++ +..+++|.++.-|+|..||...+   ......+.-.+...++.|++.|++|||.++   ++|.||..+|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            88764 56789999999999999997322   233456777888899999999999999998   999999999999999


Q ss_pred             CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhh
Q 036507          487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       487 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~  565 (639)
                      ..++||+|=.+++++-+ .+.......-..+..||+||.+....|+..+|||||||+||||+| |+.|+..-+.      
T Consensus       432 ~LqVkltDsaLSRDLFP-~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------  504 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFP-GDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------  504 (563)
T ss_pred             heeEEeccchhccccCc-ccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------
Confidence            99999999999987633 233333333455678999999999999999999999999999998 8888854332      


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                        .    .+...+++                ..+-.-|.+|+.++..++.-||..+|++||++++++.-|.+
T Consensus       505 --f----Em~~ylkd----------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  505 --F----EMEHYLKD----------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             --H----HHHHHHhc----------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence              0    11112221                12222478899999999999999999999999999998875

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=281.92  Aligned_cols=261  Identities=27%  Similarity=0.392  Sum_probs=192.7

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      |...+.||+|+||.||+|...  ++.++||.+....    .....+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456788999999999999985  5789999876432    223457999999999 999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                       +|+|.+++....   ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence             889998886522   246899999999999999999999987   9999999999999999999999999998653221


Q ss_pred             CCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                          ......++..|+|||.+.+ ..++.++|+||||++++||++|+.||.......        ........+......
T Consensus       154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--------~~~~~~~~~~~~~~~  221 (283)
T cd07830         154 ----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--------QLYKICSVLGTPTKQ  221 (283)
T ss_pred             ----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--------HHHHHHHhcCCCChh
Confidence                1233567889999998754 557899999999999999999998885433210        000111111110000


Q ss_pred             c----------cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 M----------SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~----------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .          ....+.......+....+ .....+.+++.+||+.||++||+++|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         222 DWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0          000000000011111111 12467999999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=271.91  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=200.2

Q ss_pred             chHHHHhhhCCCCCCCceeecCceEEEEEE--EcCceEEEEEeccc---cHHHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 036507          342 TYDEILFATEGFSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTAT---KTKEFMAEMKILCKVH-HSNLVELIGYAATE  415 (639)
Q Consensus       342 ~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~--~~~~~vavK~~~~~---~~~~~~~E~~il~~l~-h~niv~l~~~~~~~  415 (639)
                      +++|+..-|     .+.||+|+|+.|--+.  .++.+||||++.+.   ......+|++++.+.+ |+||+.|++||.++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            456666665     5689999999998664  35789999998765   3567899999999997 99999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC---EEE
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKI  492 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl  492 (639)
                      ..+|||||.|.||+|..+++.     ...+++....++..+|+.||.|||.++   |.||||||+|||......   +||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ceEEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence            999999999999999999975     345888888999999999999999988   999999999999976654   799


Q ss_pred             eccCCceecCCCCC----CcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccch
Q 036507          493 SDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK  563 (639)
Q Consensus       493 ~Dfgla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~  563 (639)
                      |||.+..-+....+    ........+|+..|||||+..     ...|+.++|.||||||||-||+|.+||.+.-+....
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            99998765433222    222334568999999999874     346889999999999999999999999765432111


Q ss_pred             hhh-------hhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          564 NQE-------RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       564 ~~~-------~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      -..       +..|.+.+....            .++.|..+     .....+..+++...+-.|+.+|-++.+++.
T Consensus       301 WdrGe~Cr~CQ~~LFesIQEGk------------YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  301 WDRGEVCRVCQNKLFESIQEGK------------YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccCCCccHHHHHHHHHHHhccC------------CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            110       112222221111            11222222     234556788899999999999999988764

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=279.62  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=191.1

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhc---CCCCeeEEEeeeecCCe-----
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKV---HHSNLVELIGYAATEDE-----  417 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~-----  417 (639)
                      |+..+.||+|+||.||++...  ++.+|+|.++..     ....+.+|++++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456788999999999999985  578999998632     123466788877666   59999999999987766     


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .+++|||+. ++|.+++....   ...+++...+.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence            899999996 58988886422   235899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +..+....    ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.....       ...+.. +...
T Consensus       154 ~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-------~~~~~~-~~~~  221 (287)
T cd07838         154 ARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-------ADQLDK-IFDV  221 (287)
T ss_pred             ceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-------HHHHHH-HHHH
Confidence            97763321    11233578899999999998999999999999999999999988854221       011111 1111


Q ss_pred             hhcCCCcc-c------ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSM-S------MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~-~------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ........ .      ............ .....+....+.+++.+||+.||++||+++|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         222 IGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            11000000 0      000000000000 0011234567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-32  Score=285.29  Aligned_cols=239  Identities=29%  Similarity=0.505  Sum_probs=187.7

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      |...+.||+|+||.||+|...  +..+++|.+...      ...++.+|++++++++|||++++++++.+.+..+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999874  578999987532      224678899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +. |+|.+++..    ....+++..++.++.|++.++.|||+.+   ++|+||+|+||+++.++.+||+|||++..... 
T Consensus       103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633         103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence            95 677777653    2345899999999999999999999987   99999999999999999999999998864321 


Q ss_pred             CCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                            .....|+..|+|||++.   ...++.++||||||+++|||++|..|+...+..        ..   ........
T Consensus       174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~---~~~~~~~~  236 (313)
T cd06633         174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SA---LYHIAQND  236 (313)
T ss_pred             ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HH---HHHHHhcC
Confidence                  12346888999999974   466888999999999999999999998543220        00   00111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .             +..   ........+.+++.+||+.+|.+||++.+++.
T Consensus       237 ~-------------~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         237 S-------------PTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             C-------------CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0             000   01122345889999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-33  Score=279.30  Aligned_cols=239  Identities=25%  Similarity=0.317  Sum_probs=183.9

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHH-HhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKIL-CKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||+|...  ++.||+|.+....      ...+..|..++ ...+|+|++++++++..++..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999874  5789999986432      12234454443 455899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      ++|.+++..     ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....    
T Consensus        82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            999999864     235788888999999999999999987   99999999999999999999999999875432    


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                         .....++..|++||.+.+..++.++||||||+++|||++|..||...+.        ......   .......    
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~---~~~~~~~----  211 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDN---ILSRRIN----  211 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH---HHhcccC----
Confidence               1224678899999999888889999999999999999999999853221        111111   1110000    


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                            ..+.    ....++..+.+++.+||+.+|++||++.++.+.|
T Consensus       212 ------~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         212 ------WPEE----VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ------CCCc----ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence                  0000    1123455789999999999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-34  Score=267.06  Aligned_cols=242  Identities=24%  Similarity=0.402  Sum_probs=188.2

Q ss_pred             CCceeecCceEEEEEEEcC--ceEEEEEecccc----HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK----TKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      ...||+|..|.|++.+...  ..+|||.+....    .+.++..++++..-+ +|.||+.+|+|......++.||.|. .
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence            4569999999999998865  889999996543    345666777766655 8999999999999999999999983 3


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      -+..++.    +-..++++...-++...+..||.||.++.  +|+|||+||+|||+|+.|++||||||++-.+-++.   
T Consensus       176 C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---  246 (391)
T KOG0983|consen  176 CAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---  246 (391)
T ss_pred             HHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence            4444444    23456888888889999999999998754  69999999999999999999999999997764332   


Q ss_pred             ceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          509 ATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                       ..+...|-+.|||||.+.-   ..|+-.+||||||+.|+||.||+.||...+.          -.+.+..++.+.|.  
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----------dFe~ltkvln~ePP--  313 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----------DFEVLTKVLNEEPP--  313 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----------cHHHHHHHHhcCCC--
Confidence             2344578899999999864   4678899999999999999999999965432          12223333333332  


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 .|..  .......+++++..||++|+.+||...++++
T Consensus       314 -----------~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  314 -----------LLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -----------CCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                       1211  1224567999999999999999999999875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7e-33  Score=279.81  Aligned_cols=241  Identities=26%  Similarity=0.384  Sum_probs=190.6

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ||+|+||.||++...  ++.+++|.+....      .+.+.+|++++++++||||+++++.+..++..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986  6889999986432      34688899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC---
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG---  507 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~---  507 (639)
                      .+++...     ..+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++.........   
T Consensus        81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            9998642     25899999999999999999999987   999999999999999999999999998754322110   


Q ss_pred             --cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          508 --EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       508 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                        ........++..|++||.+.....+.++||||||++++||++|+.||.....        ...   ..........  
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~---~~~~~~~~~~--  219 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEI---FQNILNGKIE--  219 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHhcCCcC--
Confidence              1122335678899999999888889999999999999999999999853321        111   1111110000  


Q ss_pred             cccccccccCCcccCCCChh--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          586 SMSSLKDYIDPNMMDLYPHD--CLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                                      .+..  .+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       220 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 ----------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ----------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                            0111  2456899999999999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-33  Score=289.64  Aligned_cols=265  Identities=23%  Similarity=0.357  Sum_probs=198.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC-----eEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED-----ELF  419 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~  419 (639)
                      +|...+.||+|+||.||++...  ++.+|+|.+...     ..+.+.+|++++++++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777889999999999999875  578999987643     2456889999999999999999999987765     789


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ++|||++ ++|.+++..     ...+++...+.++.|++.||+|||+++   |+|+||||+||+++.++.++|+|||++.
T Consensus        81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            9999997 589888864     236899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ................++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......        ..........
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~  223 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--------DQLNLIVEVL  223 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--------HHHHHHHHhc
Confidence            764432111223445688999999999887 7899999999999999999999998554321        1111111111


Q ss_pred             hcCCCcc----cccccccccC---Cccc---CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSM----SMSSLKDYID---PNMM---DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~----~~~~~~~~~d---~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+...    ........+.   ....   ..........+.+++.+||+.+|++||++++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            1111000    0000000000   0000   0011224567899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1e-32  Score=285.99  Aligned_cols=242  Identities=29%  Similarity=0.487  Sum_probs=189.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +.|+..+.||+|+||.||+|...  +..+++|.+...      ...++.+|+++++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999874  578999987532      2346778999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+. |+|.+++...    ...+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        95 e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          95 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            9996 6887776431    235788999999999999999999987   9999999999999999999999999987653


Q ss_pred             CCCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ..       ....++..|+|||.+.   ...++.++|||||||++|||++|+.|+......           ........
T Consensus       167 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~~~~~~~~  228 (308)
T cd06634         167 PA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQ  228 (308)
T ss_pred             Cc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----------HHHHHHhh
Confidence            21       2346788999999874   356788999999999999999999998542210           00001111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      ..             .+..   ........+.+++.+||+.+|++||++++++..
T Consensus       229 ~~-------------~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         229 NE-------------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             cC-------------CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            00             0000   112345568999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.8e-32  Score=279.79  Aligned_cols=237  Identities=25%  Similarity=0.339  Sum_probs=183.1

Q ss_pred             ceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHH---HHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMK---ILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~---il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .||+|+||.||++...  ++.||+|.+....      ...+..|..   +++..+||||+.+.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999998764  5789999875432      112334433   4445679999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.+++..     ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..+.... 
T Consensus        81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-  151 (278)
T cd05606          81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (278)
T ss_pred             CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence            9999998853     245899999999999999999999987   9999999999999999999999999987553211 


Q ss_pred             CcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                          .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......     ...   .......      
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~---~~~~~~~------  213 (278)
T cd05606         152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHE---IDRMTLT------  213 (278)
T ss_pred             ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHH---HHHHhhc------
Confidence                1234689999999998754 68899999999999999999999986432210     000   0000000      


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                              .++.    .+.....++.+++.+|+..+|++||     ++.++++
T Consensus       214 --------~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 --------MAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --------cCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                    0111    1223356799999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-32  Score=282.43  Aligned_cols=240  Identities=24%  Similarity=0.413  Sum_probs=190.5

Q ss_pred             CCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          356 SSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ..+||+|+||.||++...  ++.+|+|.+...   ....+.+|+.++++++|+|++++++++...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999874  578999987532   235688899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++..      ..+++.....++.|++.+++|||+.+   ++|+||+|+||++++++.++|+|||++.......   ..
T Consensus       105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---~~  172 (292)
T cd06657         105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---PR  172 (292)
T ss_pred             HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc---cc
Confidence            998753      24788899999999999999999987   9999999999999999999999999987553211   11


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....|+..|++||.+.+..++.++|+||||+++|||++|+.||.....        ....    ..+...         
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~----~~~~~~---------  231 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAM----KMIRDN---------  231 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH----HHHHhh---------
Confidence            2335688999999999888889999999999999999999999853221        0000    011100         


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         +.+.+..  .......+.+++.+||+.||.+||++.+++.
T Consensus       232 ---~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         232 ---LPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ---CCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence               0001100  1122345888999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.9e-32  Score=287.34  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=193.6

Q ss_pred             CCCC-CCCceeecCceEEEEEEEc--CceEEEEEeccccH-----------------HHHHHHHHHHHhcCCCCeeEEEe
Q 036507          351 EGFS-DSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT-----------------KEFMAEMKILCKVHHSNLVELIG  410 (639)
Q Consensus       351 ~~f~-~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~-----------------~~~~~E~~il~~l~h~niv~l~~  410 (639)
                      ++|. ..+.||+|+||.||++...  ++.||||.+.....                 ..+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 3467999999999999864  57899998754321                 14678999999999999999999


Q ss_pred             eeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       411 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      ++..++..+++|||+. |+|.+++..     ...+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence            9999999999999996 689988853     234788899999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCC-----------CCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccc
Q 036507          491 KISDFGLAKLVGKTS-----------DGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTE  558 (639)
Q Consensus       491 kl~Dfgla~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~  558 (639)
                      ||+|||++.......           ..........++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999997654111           011112234568899999998764 46889999999999999999999985433


Q ss_pred             cccchhhhhhhHHHHHHHHhhcCCCccccc--c------cccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 036507          559 GMVSKNQERRSLASFMLAALRNSPDSMSMS--S------LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ  630 (639)
Q Consensus       559 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--~------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  630 (639)
                      .        ......+...++.........  .      ......+.+.. .......++.+++.+||+.+|++||+++|
T Consensus       239 ~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        239 E--------IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             H--------HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            2        111122222222221110000  0      00000111111 11223556889999999999999999999


Q ss_pred             HHH
Q 036507          631 VVI  633 (639)
Q Consensus       631 vl~  633 (639)
                      ++.
T Consensus       310 ~l~  312 (335)
T PTZ00024        310 ALK  312 (335)
T ss_pred             Hhc
Confidence            985

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.8e-33  Score=289.81  Aligned_cols=263  Identities=24%  Similarity=0.351  Sum_probs=194.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----CeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE-----DEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  418 (639)
                      .+|...+.||+|+||.||++...  +..||||.+...     ....+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            56888899999999999999875  578999987532     234677899999999999999999987643     357


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++++||+. ++|.+++..     ...+++.....++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        85 ~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          85 YIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            99999995 789888853     235889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      .......   .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+.        ..........
T Consensus       156 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~  224 (337)
T cd07858         156 RTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--------VHQLKLITEL  224 (337)
T ss_pred             cccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--------HHHHHHHHHH
Confidence            8653221   12233567889999998765 5688999999999999999999999854321        0111111111


Q ss_pred             hhcCCCcc----cccccccc-------cCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          578 LRNSPDSM----SMSSLKDY-------IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       578 ~~~~~~~~----~~~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      +...++..    ......+.       .++.+.. ...++..++.+++.+||+.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hCCCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            11111000    00000000       0111111 112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.7e-33  Score=281.40  Aligned_cols=246  Identities=27%  Similarity=0.437  Sum_probs=197.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|...+.||+|+||.||++...  +..+++|.+...      ..+.+.+|.+++++++ |+||+++++++.+.+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46778889999999999999874  688999988642      2356788999999999 99999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++..     ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            999999999999964     236899999999999999999999987   999999999999999999999999998865


Q ss_pred             CCCCCC-----------------cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchh
Q 036507          502 GKTSDG-----------------EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN  564 (639)
Q Consensus       502 ~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~  564 (639)
                      ......                 ........++..|++||.+....++.++|+||||++++++++|+.|+.....     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----  227 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----  227 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----
Confidence            432211                 0122234678999999999888899999999999999999999999854321     


Q ss_pred             hhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 036507          565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM----KQVVI  633 (639)
Q Consensus       565 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~  633 (639)
                        ...    .......                  ....+...+..+.+++.+||+.+|++||++    ++++.
T Consensus       228 --~~~----~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 --YLT----FQKILKL------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HHH----HHHHHhc------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              000    0111100                  001222335568999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-32  Score=284.03  Aligned_cols=267  Identities=24%  Similarity=0.339  Sum_probs=191.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecC-------
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATE-------  415 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~-------  415 (639)
                      .++|+..+.||+|+||.||++...  ++.+|+|.+....     ...+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888999999999999999875  5789999875322     24567899999999999999999876443       


Q ss_pred             -CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          416 -DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       416 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                       ..+++++||+. ++|...+..    ....+++.....++.|+++||.|||+++   |+|+||||+||++++++.+||+|
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence             34699999996 467777653    1345899999999999999999999987   99999999999999999999999


Q ss_pred             cCCceecCCCCCC--------cceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhh
Q 036507          495 FGLAKLVGKTSDG--------EATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       495 fgla~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~  565 (639)
                      ||++.........        ....+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......     
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----  233 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----  233 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence            9999765332211        111233467889999998765 45789999999999999999999998543321     


Q ss_pred             hhhhHHHHHHHHhhcCCCc-cc-cccccc--------ccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          566 ERRSLASFMLAALRNSPDS-MS-MSSLKD--------YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~-~~-~~~~~~--------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         .............+.. .. ...+..        ...+.+...+ ......+.+++.+||+.||++|||+.|++.
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         234 ---DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             ---HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence               1111111111111000 00 000000        0111111100 122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-33  Score=290.77  Aligned_cols=258  Identities=23%  Similarity=0.353  Sum_probs=188.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------C
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------D  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  416 (639)
                      .++|...+.||+|+||.||+|...  ++.||+|.+...     ....+.+|++++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368888999999999999999864  688999988642     234578999999999999999999988654      3


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++++||+. .+|..++.       ..+++.....++.|++.||+|||+++   ++||||||+||+++.++.+||+|||
T Consensus        94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence            4699999995 47766642       24788899999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      +++....      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..        .......
T Consensus       163 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--------~~~~~~~  228 (342)
T cd07879         163 LARHADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--------DQLTQIL  228 (342)
T ss_pred             CCcCCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence            9875422      1123467889999999876 46889999999999999999999999643210        0111111


Q ss_pred             HHhhcCCCccc-------c----cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMS-------M----SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~-------~----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+.......       .    ..........+.... ......+.+++.+||+.||++||+++|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11110000000       0    000000000110000 123456889999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.7e-33  Score=279.81  Aligned_cols=246  Identities=25%  Similarity=0.428  Sum_probs=191.2

Q ss_pred             CCCCCCceeecCceEEEEEEEcC--ceEEEEEecc--------ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTA--------TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      +|...+.||+|+||.||++....  ..+++|.++.        ....++.+|++++++++||||+++++++.+.+..+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778899999999999998753  3455555432        1234567899999999999999999999988899999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +||+++++|.+++.... .....+++...+.++.|+++|+.|||+.+   ++|+||+|+||++++ +.+||+|||++...
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence            99999999999886422 22346899999999999999999999987   999999999999975 56999999998765


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ....   .......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+....           ............
T Consensus       156 ~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~  221 (260)
T cd08222         156 MGSC---DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----------FLSVVLRIVEGP  221 (260)
T ss_pred             CCCc---ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHHHcCC
Confidence            3221   12223467889999999988888999999999999999999999884221           111111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                   .+.    .+...+.++.+++.+||+.+|++||++.|+++
T Consensus       222 -------------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 -------------TPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------------CCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                         111    12344567899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=266.27  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=196.5

Q ss_pred             hCCCCC-CCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEeeeec----CCeEEEE
Q 036507          350 TEGFSD-SSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAAT----EDELFLI  421 (639)
Q Consensus       350 ~~~f~~-~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~~~lv  421 (639)
                      +++|++ .++||-|-.|.|-....+  ++.+|+|++....  ...+|+++--+. .|||||.+++++.+    ...+.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            455654 467999999999887664  6789999886543  345788875555 49999999998754    4678999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCc
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLA  498 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla  498 (639)
                      ||+|+||.|+..+.+   .+...+.+.....|+.||+.|+.|||+.+   |.||||||+|+|...   |..+||+|||+|
T Consensus       138 mE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  138 MECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence            999999999999986   55667999999999999999999999987   999999999999964   456899999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      +.-..    .......+-||.|.|||++...+|+...|+||+||++|-|++|.+||....+..-....        ...+
T Consensus       212 K~t~~----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM--------k~rI  279 (400)
T KOG0604|consen  212 KETQE----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KRRI  279 (400)
T ss_pred             cccCC----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH--------HhHh
Confidence            86422    33455678899999999999999999999999999999999999999876652111111        1111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.        ...++-+|.+     ....+...++|+.+|..+|.+|.|+.|++.
T Consensus       280 ~~--------gqy~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  280 RT--------GQYEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hc--------cCccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            11        1112222322     245667889999999999999999999874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.4e-33  Score=309.17  Aligned_cols=250  Identities=31%  Similarity=0.472  Sum_probs=182.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeee-----------
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYA-----------  412 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~-----------  412 (639)
                      ..+|++.++||+||||.||+++.  .|..||||++.-.    ......+|+..|++|+|||||+++..+           
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            35678888999999999999975  5899999998644    234578999999999999999997210           


Q ss_pred             -------------------------------------------------e------------------c-----------
Q 036507          413 -------------------------------------------------A------------------T-----------  414 (639)
Q Consensus       413 -------------------------------------------------~------------------~-----------  414 (639)
                                                                       .                  +           
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                             0                  0           


Q ss_pred             ----------------------C--------CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036507          415 ----------------------E--------DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI  464 (639)
Q Consensus       415 ----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~L  464 (639)
                                            +        -.+|+-||||+...|.++++......    .-...++++.+|++||.|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHH
Confidence                                  0        12578899998888888876522111    2344567899999999999


Q ss_pred             HhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC---C------------CCCCcceeeeeccccccCCccccccC
Q 036507          465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG---K------------TSDGEATVTKVVGTFGYLAPEYLTDG  529 (639)
Q Consensus       465 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~---~------------~~~~~~~~~~~~gt~~y~aPE~~~~~  529 (639)
                      |+++   ||||||||.||++|+++.|||+|||+|+...   .            .+......+..+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9988   9999999999999999999999999998721   0            11222345668999999999999764


Q ss_pred             ---CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhH
Q 036507          530 ---LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDC  606 (639)
Q Consensus       530 ---~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  606 (639)
                         .|+.|+|+||+|+|++||+.   ||.. .      -++.    .....++...-  .. . .++.++         .
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-s------MERa----~iL~~LR~g~i--P~-~-~~f~~~---------~  843 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT-S------MERA----SILTNLRKGSI--PE-P-ADFFDP---------E  843 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCc-h------HHHH----HHHHhcccCCC--CC-C-cccccc---------c
Confidence               49999999999999999996   3421 1      1111    11222222110  00 0 112222         2


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          607 LFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       607 ~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...-..+|.++++.||++|||+.|+|.
T Consensus       844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  844 HPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            334578999999999999999999985

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=280.22  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=194.9

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      |+..+.||+|.||.||++...  ++.+++|.+...     ..+.+.+|++++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999885  578999988653     2356788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      + ++|.+++....    ..+++..+..++.|++.||+|||+++   |+|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            7 59999997421    35899999999999999999999987   9999999999999999999999999987653321


Q ss_pred             CCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                         .......++..|+|||.+... .++.++||||||+++|||++|+.||......        .....+...++.....
T Consensus       153 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~  221 (282)
T cd07829         153 ---RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--------DQLFKIFQILGTPTEE  221 (282)
T ss_pred             ---cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHHHhCCCcHH
Confidence               122234567789999998766 7899999999999999999999888543211        1111111111111000


Q ss_pred             c---------cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 M---------SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .         ................. ......+.+++.+||+.||++||++++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         222 SWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0         00001111111111111 112557999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.7e-32  Score=285.26  Aligned_cols=266  Identities=24%  Similarity=0.353  Sum_probs=195.0

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec-CC
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT-ED  416 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~  416 (639)
                      ++...+++|+..+.||.|+||.||++...  ++.+|+|.+...     ..+.+.+|++++++++||||+++.+++.. .+
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            33456788999999999999999999765  578999987432     24567899999999999999999998865 56


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++++||+ +++|.+++..      ..+++.....++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccc
Confidence            789999998 6689888753      24677888889999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ++......      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....        ........
T Consensus       154 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--------~~~~~~~~  219 (328)
T cd07856         154 LARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--------VNQFSIIT  219 (328)
T ss_pred             cccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            98754221      123467889999998766 5689999999999999999999998854321        01111111


Q ss_pred             HHhhcCCCcccc----ccccccc-CCcccCCCC-----hhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          576 AALRNSPDSMSM----SSLKDYI-DPNMMDLYP-----HDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       576 ~~~~~~~~~~~~----~~~~~~~-d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      ..+...+.....    .+..+.+ +-......+     ......+.+++.+||+.+|++||++++++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111111100000    0000000 000000001     1234679999999999999999999999753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-32  Score=288.33  Aligned_cols=267  Identities=22%  Similarity=0.314  Sum_probs=195.2

Q ss_pred             chHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeec
Q 036507          342 TYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAAT  414 (639)
Q Consensus       342 ~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~  414 (639)
                      ...++...+++|...+.||+|+||.||++...  ++.||+|++....     .+.+.+|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34566677899999999999999999999764  6789999886432     3457789999999999999999998754


Q ss_pred             C------CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC
Q 036507          415 E------DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF  488 (639)
Q Consensus       415 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~  488 (639)
                      .      ...+++++++ +++|.+++..      ..+++..+..++.|+++||+|||+++   |+||||||+||++++++
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~  157 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence            3      3467888887 7899888753      24889999999999999999999987   99999999999999999


Q ss_pred             CEEEeccCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh
Q 036507          489 RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       489 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~  567 (639)
                      .+||+|||++.....      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......       
T Consensus       158 ~~kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-------  224 (345)
T cd07877         158 ELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-------  224 (345)
T ss_pred             CEEEecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence            999999999875422      1223467889999998866 56788999999999999999999998432210       


Q ss_pred             hhHHHHHHHHhhcCCCccc-------c----cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          568 RSLASFMLAALRNSPDSMS-------M----SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~-------~----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       .............+....       .    ..+.......+.. ........+.+++.+|++.||.+||++.+++.
T Consensus       225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         225 -DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             -HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence             000001111110000000       0    0000000000000 00123446889999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.3e-32  Score=283.67  Aligned_cols=264  Identities=24%  Similarity=0.315  Sum_probs=189.4

Q ss_pred             CCCCCCceeecCceEEEEEEEc----CceEEEEEeccc-----cHHHHHHHHHHHHhc-CCCCeeEEEeeeec----CCe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR----NQEVAIKRMTAT-----KTKEFMAEMKILCKV-HHSNLVELIGYAAT----EDE  417 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~-----~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~  417 (639)
                      +|+..+.||+|+||.||++...    +..+|+|.+...     ..+.+.+|+++++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4667789999999999999875    458999987642     235678899999999 49999999987532    245


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++++||+. ++|.+++..     ...+++...+.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            788899885 689988853     345889999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCC-cceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          498 AKLVGKTSDG-EATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       498 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      +..+...... ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.        ........
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--------~~~~~~~~  223 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--------VDQLNQIL  223 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--------HHHHHHHH
Confidence            9865432211 111233578999999998765 5688999999999999999999998854321        01111111


Q ss_pred             HHhhcCCCccc-----------ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMS-----------MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~-----------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+...+....           .......-...+.. ........+.+++.+|++.||++|||++|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         224 QVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111110000           00000000000000 01112457899999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-33  Score=274.39  Aligned_cols=263  Identities=21%  Similarity=0.300  Sum_probs=203.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCC--C----CeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHH--S----NLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h--~----niv~l~~~~~~~~~~~  419 (639)
                      +++|.+..++|+|.||.|-...+.  +..||||+++.-  ..+..+-|+++|.++.+  |    .++.+.+++...++.+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            688999999999999999987664  468999998753  34556779999999942  2    3777888899999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC--------------
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD--------------  485 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~--------------  485 (639)
                      +|+|.+ |-|+.+++..   .+..+++......++.|++++++|||+..   ++|.||||+|||+.              
T Consensus       168 ivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            999998 7799999976   44567889999999999999999999987   99999999999983              


Q ss_pred             ------CCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccccc
Q 036507          486 ------SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG  559 (639)
Q Consensus       486 ------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~  559 (639)
                            .+..++++|||.|+....      ....++.|..|+|||++.+-.++.++||||+||||.||.+|...|...++
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHE------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             ceeccCCCcceEEEecCCcceecc------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                  134689999999986432      22557899999999999999999999999999999999999988854432


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcccccc---------------------cccccCCccc----CCCChhHHHHHHHHH
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSMSMSS---------------------LKDYIDPNMM----DLYPHDCLFKMAMLA  614 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~---------------------~~~~~d~~l~----~~~~~~~~~~l~~li  614 (639)
                             ...| ..|..+++..|..+....                     .+...++-..    ......+..++.+|+
T Consensus       315 -------~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  315 -------LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             -------HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence                   2222 334445554443332211                     1111111100    011234566799999


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 036507          615 KQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       615 ~~cl~~dP~~RPs~~evl~  633 (639)
                      .+||..||.+|+|+.|+++
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999885

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-32  Score=285.99  Aligned_cols=268  Identities=21%  Similarity=0.305  Sum_probs=192.2

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC----
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED----  416 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----  416 (639)
                      ...++|+..+.||+|+||.||++...  +..||||.+...     ..+.+.+|++++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34678999999999999999999764  578999988532     1345789999999999999999999886543    


Q ss_pred             --eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          417 --ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       417 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                        .+++||||+ +++|.+++..      ..+++...+.++.|+++||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence              468999999 7799888753      34889999999999999999999987   99999999999999999999999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh----hh
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER----RS  569 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~----~~  569 (639)
                      ||++......      .....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||.............    ..
T Consensus       162 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         162 FGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             cccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9998755321      123467889999998876 457889999999999999999999985432210000000    00


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+ ...+...........+.....+.+. .........+.+++.+|++.||++|||+.+++.
T Consensus       236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         236 SKEF-VQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CHHH-HHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000 0000000000000000000000000 011234456889999999999999999999884

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=4e-32  Score=285.76  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=188.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecC----------
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATE----------  415 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~----------  415 (639)
                      .+|...+.||.|+||.||+|...  ++.||+|.+...   ..+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999875  578999987543   345688999999999999999999766543          


Q ss_pred             ----CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCE
Q 036507          416 ----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRA  490 (639)
Q Consensus       416 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~  490 (639)
                          ...++++||++ ++|.+++..      ..+++.....++.|+++||.|||+.+   |+||||||+||+++. ++.+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~  154 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence                35789999996 589888753      24788999999999999999999987   999999999999974 5678


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||++..+..............++..|+|||.+.+ ..++.++|||||||++|||++|+.||........       
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-------  227 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-------  227 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence            99999999865332211111223467889999998654 5678899999999999999999999954332100       


Q ss_pred             HHHHHHHHhhcCCCccc--c--------cccc---cccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMS--M--------SSLK---DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~--~--------~~~~---~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                          ....+...+....  .        ....   ......+.. .......++.+++.+||+.||++||+++|++.
T Consensus       228 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         228 ----MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             ----HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                0001110000000  0        0000   000000000 01123456889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=2.7e-34  Score=269.81  Aligned_cols=252  Identities=22%  Similarity=0.349  Sum_probs=190.5

Q ss_pred             CCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHH-HhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKIL-CKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .+....||.|+||+|++-.++  ++..|||+++...    .++++.|.+.. +.-+.||||+++|.+..++..|++||+|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            334668999999999988775  6889999987543    35577787764 4446999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                       ..||..+....-......+++...-.|..-...||.||-+.-  .|+|||+||+|||++..|.+||||||.+-.+..+ 
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-  221 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-  221 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence             557766543211123445788888888888899999998754  6999999999999999999999999998765321 


Q ss_pred             CCcceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                         ...+.-.|-..|||||.+..  ..|+-+|||||||++|+|+.||+.|+...+          +..+.+.+.....|.
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----------svfeql~~Vv~gdpp  288 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----------SVFEQLCQVVIGDPP  288 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----------HHHHHHHHHHcCCCC
Confidence               22334578889999999864  358899999999999999999999985433          344444444444332


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....         .   .-..+....+.+++.-|+.+|-++||+..++.+
T Consensus       289 ~l~~---------~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  289 ILLF---------D---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             eecC---------c---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1110         0   001224556899999999999999999998864

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=6.9e-32  Score=270.47  Aligned_cols=232  Identities=29%  Similarity=0.422  Sum_probs=188.1

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      ||+|+||.||++...  ++.+++|.+....      ...+.+|++++++++|+||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999885  5789999876532      34688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcce
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT  510 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  510 (639)
                      .+++...     ..+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ..
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~  149 (250)
T cd05123          81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SR  149 (250)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC---Cc
Confidence            9998642     35889999999999999999999977   9999999999999999999999999998653321   12


Q ss_pred             eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       511 ~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      .....++..|++||...+...+.++|+||||+++|||++|+.||...+.        ...   ........         
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~---~~~~~~~~---------  209 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEI---YEKILKDP---------  209 (250)
T ss_pred             ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHH---HHHHhcCC---------
Confidence            2345688899999999888889999999999999999999999853321        111   11111100         


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ  630 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  630 (639)
                               ...+...+..+.+++.+||..||++||++.+
T Consensus       210 ---------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 ---------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                     0112223556899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=1.6e-31  Score=303.31  Aligned_cols=141  Identities=29%  Similarity=0.466  Sum_probs=127.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...++||+|+||.||++...  ++.||||+++...      ...+.+|++++..++|+||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56788899999999999999987  6899999986432      356888999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ||+.+++|.+++...     ..+++...+.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998642     34788888999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=4.3e-32  Score=285.62  Aligned_cols=259  Identities=22%  Similarity=0.359  Sum_probs=192.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe-----
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDE-----  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  417 (639)
                      .++|+..+.||+|+||.||++...  ++.||+|.+...     ..+.+.+|+.++++++|+|++++.+++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            567888999999999999999885  578999987542     23557789999999999999999987765554     


Q ss_pred             -EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          418 -LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       418 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                       .++|+||+ +++|.+++..      ..+++.....++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence             89999999 6799998853      35899999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ++......      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......        .......
T Consensus       164 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--------~~~~~i~  229 (343)
T cd07851         164 LARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--------DQLKRIM  229 (343)
T ss_pred             cccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHH
Confidence            99765321      233467889999998865 46788999999999999999999998543221        0001111


Q ss_pred             HHhhcCCCccc----ccccccc-------cCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMS----MSSLKDY-------IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~----~~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......++...    ......+       ..+.+.... .....++.+++.+||+.||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            11111110000    0000000       001111100 122567999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.5e-31  Score=266.28  Aligned_cols=219  Identities=22%  Similarity=0.236  Sum_probs=174.0

Q ss_pred             cCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCC
Q 036507          362 GTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQN  439 (639)
Q Consensus       362 G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  439 (639)
                      |.||.||++...  ++.+|+|.+....  .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++...  
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF--   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh--
Confidence            889999999874  5789999987643  2345555566667999999999999999999999999999999998642  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccc
Q 036507          440 RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG  519 (639)
Q Consensus       440 ~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  519 (639)
                         ..+++.....++.|+++||+|||+.+   ++||||||+||++++++.++++|||.+..+...      .....++..
T Consensus        80 ---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~~~  147 (237)
T cd05576          80 ---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVENM  147 (237)
T ss_pred             ---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcCcc
Confidence               34889999999999999999999987   999999999999999999999999988655322      122345678


Q ss_pred             cCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCccc
Q 036507          520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMM  599 (639)
Q Consensus       520 y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  599 (639)
                      |+|||...+..++.++||||+|+++|||++|+.|+......                 ..            ....    
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~------------~~~~----  194 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN------------THTT----  194 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc------------cccc----
Confidence            99999998888899999999999999999999776321100                 00            0000    


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 036507          600 DLYPHDCLFKMAMLAKQCVDEDPILRPDMK  629 (639)
Q Consensus       600 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  629 (639)
                      ...+......+.+++.+|++.||++||++.
T Consensus       195 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         195 LNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            011222345689999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=271.24  Aligned_cols=237  Identities=27%  Similarity=0.383  Sum_probs=193.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC--ceEEEEEecccc------HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK------TKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~------~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  421 (639)
                      .+|....+||+|+||.|.++..++  +.+|||+++++.      .+--+.|-++|.... -|.++.+...+..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467778899999999999998875  579999987642      233456777777664 67899999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+.||+|--+++..     ..+.+.....+|..||-||=|||+++   |+.||||.+|||+|.+|++||+|||+++. 
T Consensus       429 MEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE-  499 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-  499 (683)
T ss_pred             EEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc-
Confidence            9999999999998753     23556667788999999999999998   99999999999999999999999999974 


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                        .-....+....+|||.|+|||++..++|+..+|+|||||+||||+.|++||++.+.        ..+...   ++...
T Consensus       500 --ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~a---I~ehn  566 (683)
T KOG0696|consen  500 --NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQA---IMEHN  566 (683)
T ss_pred             --cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH---HHHcc
Confidence              23344566678999999999999999999999999999999999999999965432        223222   22111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD  627 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  627 (639)
                                        -.||.....+...+....+.+.|.+|..
T Consensus       567 ------------------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 ------------------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------------------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence                              1256677778899999999999999954

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-33  Score=303.34  Aligned_cols=259  Identities=25%  Similarity=0.357  Sum_probs=207.6

Q ss_pred             CCcccchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEE
Q 036507          337 KPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVEL  408 (639)
Q Consensus       337 ~~~~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l  408 (639)
                      ++..-...++....++|.+.++||+|+||.|..++++  ++.||+|++++.      +..-|..|-++|..-+.+-|+.+
T Consensus        61 kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~L  140 (1317)
T KOG0612|consen   61 KPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQL  140 (1317)
T ss_pred             HHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence            3445566778888899999999999999999999886  578999998763      33458889999999999999999


Q ss_pred             EeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC
Q 036507          409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF  488 (639)
Q Consensus       409 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~  488 (639)
                      .-.|.+..++|||||||+||+|-.++..     ...++......++..|..||.-||+.|   +|||||||+|||||..|
T Consensus       141 hyAFQD~~~LYlVMdY~pGGDlltLlSk-----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  141 HYAFQDERYLYLVMDYMPGGDLLTLLSK-----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             HHHhcCccceEEEEecccCchHHHHHhh-----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccC
Confidence            9999999999999999999999999964     225778888889999999999999987   99999999999999999


Q ss_pred             CEEEeccCCceecCCCCCCcceeeeeccccccCCccccc----c-CCCCCcchHHHHHHHHHHHHcCCccccccccccch
Q 036507          489 RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT----D-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK  563 (639)
Q Consensus       489 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~  563 (639)
                      ++||+|||.+-.+..  ++.......+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||..       
T Consensus       213 HikLADFGsClkm~~--dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-------  283 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDA--DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-------  283 (1317)
T ss_pred             cEeeccchhHHhcCC--CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-------
Confidence            999999999876643  4455556679999999999985    3 6789999999999999999999999953       


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 036507          564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD---MKQV  631 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev  631 (639)
                          .++++.+..++...       +...+.+       ..+.+.+..+||.+.+. +|+.|-.   .+++
T Consensus       284 ----dslveTY~KIm~hk-------~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedi  335 (1317)
T KOG0612|consen  284 ----DSLVETYGKIMNHK-------ESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDI  335 (1317)
T ss_pred             ----HHHHHHHHHHhchh-------hhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence                23444444444321       0011110       12355678888888776 6777766   5554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=285.63  Aligned_cols=238  Identities=25%  Similarity=0.355  Sum_probs=189.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      ++.|.....+|.|+|+.|-++.+.  ++..++|++... ..+..+|+.++.+. +||||+++.+.+.+..+.|+|||.+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            566777778999999999988764  578999998765 23344677776665 59999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE-CCCCCEEEeccCCceecCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL-DSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++-|.+.+...+      .....+..|+.+|+.|+.|||+++   ++||||||+|||+ ++.++++|+|||.++..... 
T Consensus       400 g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  400 GGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             ccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            998888775421      222667789999999999999987   9999999999999 68899999999999876443 


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                           ....+-|..|.|||++....|++++|+||||++||+||+|+.||......           ..+...+....   
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------~ei~~~i~~~~---  530 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------IEIHTRIQMPK---  530 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------HHHHHhhcCCc---
Confidence                 22345678999999999999999999999999999999999999654331           11112222111   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                      ..........+|+.+||+.||.+||+|.++..
T Consensus       531 ----------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 ----------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ----------------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                            11344557899999999999999999999864

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=278.23  Aligned_cols=239  Identities=25%  Similarity=0.371  Sum_probs=191.1

Q ss_pred             CCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          356 SSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      .+.||+|.||+||-|+++  |+.||||.+.+.     ....+.+|+.||++++||.||.+.-.|...+..++|||.+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            578999999999988774  789999988643     3467889999999999999999999999999999999999 66


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC---CCEEEeccCCceecCCCC
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~  505 (639)
                      +..+.+..   .....|+...-..+..||+.||.|||.++   |+|+||||+|||+.+.   ..+||||||+|+++++..
T Consensus       648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            77776654   33456888888888899999999999988   9999999999999654   579999999999986543


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                      -    ...++|||.|+|||++....|+..-|+||.|||+|--++|..||...++.....       +.+..++-..    
T Consensus       722 F----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-------QNAaFMyPp~----  786 (888)
T KOG4236|consen  722 F----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-------QNAAFMYPPN----  786 (888)
T ss_pred             h----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-------hccccccCCC----
Confidence            2    234789999999999999999999999999999999999999995544321111       1010011000    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                                      .-.+.....++||...|+..-.+|-|.+..+
T Consensus       787 ----------------PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  787 ----------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ----------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                            1123445688899999999999998887654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=237.43  Aligned_cols=263  Identities=23%  Similarity=0.385  Sum_probs=195.8

Q ss_pred             CCCCCCceeecCceEEEEEEEcC--ceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +|...++||+|.||+||+|+..+  +.||+|+++-++     .....+|+-+|+.++|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45557789999999999998754  679999886443     34678999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      + ..+|..+...    -...++......++.|+++|+.|+|+++   +.|||+||.|.|++.+|.+||+|||+++.++- 
T Consensus        83 c-dqdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi-  153 (292)
T KOG0662|consen   83 C-DQDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-  153 (292)
T ss_pred             h-hHHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC-
Confidence            9 4588887754    2345888888999999999999999998   99999999999999999999999999987642 


Q ss_pred             CCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                        .......-+-|.+|++|.++.+. .|+...|+||-||++.|+.....|.....+.    .+  .+.. +-..++ .+.
T Consensus       154 --pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv----dd--qlkr-if~~lg-~p~  223 (292)
T KOG0662|consen  154 --PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DD--QLKR-IFRLLG-TPT  223 (292)
T ss_pred             --ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH----HH--HHHH-HHHHhC-CCc
Confidence              12233345678999999999874 5789999999999999999754454333321    11  1111 111222 222


Q ss_pred             cccccccccccCCcccCCCCh---------hHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPH---------DCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +..+..+...-|-.....++.         .....=++++...+.-+|.+|.++++.++
T Consensus       224 ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  224 EDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            222333444444333322321         12223467888889999999999998775

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.7e-33  Score=259.37  Aligned_cols=266  Identities=22%  Similarity=0.325  Sum_probs=193.3

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec--------CC
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT--------ED  416 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~--------~~  416 (639)
                      .|....+||+|.||.||+++..  ++.||+|+.--+     -.....+|+++|..|+|+|++.+++.|..        +.
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3445678999999999999775  467888865322     23457899999999999999999998854        34


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      .+|+||++++. +|.-+|.+.    ...++...+.+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            58999999965 888887542    245888899999999999999999887   9999999999999999999999999


Q ss_pred             CceecCCCC-CCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          497 LAKLVGKTS-DGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       497 la~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      +++.+.... ......+..+-|.+|++||.+.+ ..|+++.|||.-|||+.||+|+.+.+.....        ......+
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--------qqql~~I  241 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--------QQQLHLI  241 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--------HHHHHHH
Confidence            998764332 22333566788999999998876 6789999999999999999999988755432        1112223


Q ss_pred             HHHhhcCC----Cccccccccccc--CCcccCCCC--hhH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSP----DSMSMSSLKDYI--DPNMMDLYP--HDC------LFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~----~~~~~~~~~~~~--d~~l~~~~~--~~~------~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....+...    .+++.-.+.+-+  .|-..+.+.  .+.      ..+..+|+..++..||.+|+.+++++.
T Consensus       242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            33332221    111111111111  110011000  011      235788999999999999999998863

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=281.28  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=207.0

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc--cHHHHHHHHHHHHhcC-CCCeeEEEeeeec---
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT--KTKEFMAEMKILCKVH-HSNLVELIGYAAT---  414 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~E~~il~~l~-h~niv~l~~~~~~---  414 (639)
                      ++.+...++-|++.+.||.|.+|.||+++.  .++..|+|++...  ..++...|.+||+.+. |||++.++|++..   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            344445567788899999999999998765  4678888887654  4567778899998884 9999999998753   


Q ss_pred             --CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          415 --EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       415 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                        ++++|||||||.+||..+++++..   ...+.|..+..|+..++.|+.|||.+.   ++|||||-.|||++.++.+||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence              578999999999999999998754   567999999999999999999999876   999999999999999999999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~  567 (639)
                      +|||.+..+....   .......|||.|||||++..     ..|+..+|+||||++..||--|.+|+.....+       
T Consensus       165 vDFGvSaQldsT~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------  234 (953)
T KOG0587|consen  165 VDFGVSAQLDSTV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------  234 (953)
T ss_pred             eeeeeeeeeeccc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence            9999998774332   22344689999999999964     34677899999999999999999999755431       


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                          ..+-.+.+++|             |.+  ..+..-.+++.++|..||.+|-++||++.++++
T Consensus       235 ----raLF~IpRNPP-------------PkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 ----RALFLIPRNPP-------------PKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----hhhccCCCCCC-------------ccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                11111222222             222  236677888999999999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7e-31  Score=290.83  Aligned_cols=264  Identities=17%  Similarity=0.202  Sum_probs=166.9

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc------CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEee------eecCC
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR------NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY------AATED  416 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~------~~~~~  416 (639)
                      ..++|+..++||+|+||.||+|.+.      +..||+|++......+...+. .+.+..+.++..++..      ...+.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhhchhhHHHHHHhhhcccccccCC
Confidence            5678999999999999999999875      468999988654322211111 1222222222222211      24567


Q ss_pred             eEEEEEeeccCCChhhhccCCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNR---------------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                      ..++|+||+.+++|.++++.....               ............++.|++.||+|||+++   |+||||||+|
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~N  285 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQN  285 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHH
Confidence            899999999999999998643210               0001122345578999999999999987   9999999999


Q ss_pred             EEECC-CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccC----------------------CCCCcchHH
Q 036507          482 ILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG----------------------LATAKSDVY  538 (639)
Q Consensus       482 Ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DVw  538 (639)
                      ||+++ ++.+||+|||+++.+....  ........+++.|+|||.+...                      .++.++|||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             EEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            99986 5789999999998653221  2223446789999999965322                      234567999


Q ss_pred             HHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCc----ccCCC--ChhHHHHHHH
Q 036507          539 AFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPN----MMDLY--PHDCLFKMAM  612 (639)
Q Consensus       539 s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~----l~~~~--~~~~~~~l~~  612 (639)
                      ||||+||||+++..+....            +..+.. .+.....  ........+.+.    +...+  .........+
T Consensus       364 SlGviL~el~~~~~~~~~~------------~~~~~~-~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d  428 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSN------------LIQFNR-QLKRNDY--DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE  428 (566)
T ss_pred             HHHHHHHHHHhCcCCCchH------------HHHHHH-HHHhcCC--cHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence            9999999999976554211            000000 0000000  000000011111    00000  0011224568


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 036507          613 LAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       613 li~~cl~~dP~~RPs~~evl~  633 (639)
                      |+.+||+.||++|||++|+++
T Consensus       429 Li~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        429 LLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHHHccCCcccCCCHHHHhC
Confidence            999999999999999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=287.39  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=191.2

Q ss_pred             CCCCCceeecCce-EEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          353 FSDSSLLGHGTYG-SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       353 f~~~~~lG~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      |...+.+|.|+.| .||+|...++.||||++-.+...-..+|+..|+.-+ |||||++++.-.++...|++.|.| ..+|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL  589 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL  589 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence            4556678999987 569999999999999998887777889999998885 999999999999999999999999 6699


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---C--CCEEEeccCCceecCCCC
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---A--FRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfgla~~~~~~~  505 (639)
                      .+++... ........-...+.+..|++.||+|||+.+   |+||||||.||||+.   +  .+++|+|||+++.+....
T Consensus       590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999763 111111111334567789999999999976   999999999999975   2  578999999999886544


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcC-CccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG-KEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      ..-.......||-+|+|||.+....-+.++||||+|||+|+.++| .+||...-.      .+       ..++..... 
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~------R~-------~NIl~~~~~-  731 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE------RQ-------ANILTGNYT-  731 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH------hh-------hhhhcCccc-
Confidence            333334567899999999999998888899999999999999996 899954321      00       011111110 


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                           +..     +  ....++  +..+||.+|++.||..||++.+|+.
T Consensus       732 -----L~~-----L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 -----LVH-----L--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -----eee-----e--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                 000     0  011222  6889999999999999999999973

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=275.04  Aligned_cols=238  Identities=22%  Similarity=0.338  Sum_probs=196.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEcCce--EEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~~~--vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++.....||-|+||.|=+...+++.  +|+|.+++..      .+....|-+||...+.|.||+++--|.+....||+|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            44555667999999999999887765  7888876543      355788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      |-|-||.|++.|++.     ..++......++..+.+|++|||+++   ||+|||||+|.+++.+|-+||.|||+|+.+.
T Consensus       500 EaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  500 EACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            999999999999763     34666777788899999999999988   9999999999999999999999999999875


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .    ......++|||.|.|||++.....+..+|.||||+++|||++|++||...+.+...           ..+++...
T Consensus       572 ~----g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-----------n~ILkGid  636 (732)
T KOG0614|consen  572 S----GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-----------NLILKGID  636 (732)
T ss_pred             c----CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-----------HHHHhhhh
Confidence            4    23456789999999999999999999999999999999999999999776653222           22222211


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD  627 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  627 (639)
                      .                -+.|........+++++.+..+|.+|..
T Consensus       637 ~----------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 K----------------IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             h----------------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            0                0134455667888999999999999965

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=4.7e-30  Score=254.89  Aligned_cols=234  Identities=29%  Similarity=0.418  Sum_probs=187.9

Q ss_pred             CceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhhhccC
Q 036507          363 TYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD  436 (639)
Q Consensus       363 ~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  436 (639)
                      +||.||++...  ++.+++|.+....    .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986  4889999986543    57889999999999999999999999998999999999999999999864


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeecc
Q 036507          437 PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG  516 (639)
Q Consensus       437 ~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  516 (639)
                      .     ..+++.....++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......    ......+
T Consensus        81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~  148 (244)
T smart00220       81 R-----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVG  148 (244)
T ss_pred             c-----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccC
Confidence            2     22888999999999999999999987   9999999999999999999999999998764321    2334568


Q ss_pred             ccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCC
Q 036507          517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDP  596 (639)
Q Consensus       517 t~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~  596 (639)
                      +..|++||.+....++.++|||+||+++++|++|..|+.....       ...+..    .+......           .
T Consensus       149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~----~~~~~~~~-----------~  206 (244)
T smart00220      149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFK----KIGKPKPP-----------F  206 (244)
T ss_pred             CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHH----HHhccCCC-----------C
Confidence            8899999999888889999999999999999999998854211       111111    11111000           0


Q ss_pred             cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          597 NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       597 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         .......+.++.+++.+|+..+|++||++.++++
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence               0000003457899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=237.02  Aligned_cols=203  Identities=24%  Similarity=0.363  Sum_probs=163.0

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  420 (639)
                      .+.+.......||+|++|.|-+-++  ++...|+|++...    ..+..++|+++..+. .+|.+|.++|........++
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            3344455567899999998865544  6789999988643    445677888876554 69999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +||.| ..||..+-.... .....+++...-+||..+.+||.|||++-  .++|||+||+|||++.+|++|+||||.+-.
T Consensus       123 cME~M-~tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             eHHHh-hhhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence            99999 568877754422 23456888888999999999999999975  799999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCcccccc----CCCCCcchHHHHHHHHHHHHcCCccccccc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTD----GLATAKSDVYAFGVVLFEIISGKEAIIRTE  558 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVws~Gvvl~elltG~~p~~~~~  558 (639)
                      +.++-    ..+.-.|-..|||||.+..    ..|+-|+||||||+.+.||.+++.|+....
T Consensus       199 L~dSi----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  199 LVDSI----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ehhhh----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            64321    1222457788999998864    468889999999999999999999996544

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=251.32  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=192.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHH-HHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKE-FMAEMKILCKV-HHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~-~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  420 (639)
                      -.+|...++||+|+|++|..+++.  .+.+|+|+++++-     .-+ ...|-.+..+- +||.+|-+..++..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            457888999999999999998875  4789999886542     112 34566665554 69999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      |.||+++|+|--+++.     +..++......+...|+-||.|||+++   |+.||||.+|||+|..|++||.|||+.+.
T Consensus       329 vieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence            9999999999988864     345888888888999999999999998   99999999999999999999999999874


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      --   ........++|||.|.|||++.+..|...+|+|++||+++||+.|+.||+-.....+....+..+.+.+.+---.
T Consensus       401 ~l---~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  401 GL---GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             CC---CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            32   223345668999999999999999999999999999999999999999975443222222223333332211111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD  627 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  627 (639)
                                           .|.....+...+++.-|++||.+|..
T Consensus       478 ---------------------iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 ---------------------IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ---------------------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                                 13333445677888999999998854

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1e-29  Score=274.61  Aligned_cols=263  Identities=19%  Similarity=0.244  Sum_probs=178.5

Q ss_pred             hhCCCCCCCceeecCceEEEEEEE------------------cCceEEEEEecccc---HHH--------------HHHH
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNI------------------RNQEVAIKRMTATK---TKE--------------FMAE  393 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~------------------~~~~vavK~~~~~~---~~~--------------~~~E  393 (639)
                      ..++|++.++||+|+||.||+|..                  .++.||||+++...   .++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                  23579999986432   122              3447


Q ss_pred             HHHHHhcCCCCe-----eEEEeeeec--------CCeEEEEEeeccCCChhhhccCCCC-------------------CC
Q 036507          394 MKILCKVHHSNL-----VELIGYAAT--------EDELFLIYEYAQKGSLKSHLHDPQN-------------------RG  441 (639)
Q Consensus       394 ~~il~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~  441 (639)
                      +.++.+++|.++     ++++++|..        ++..++||||+++++|.++++....                   ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888876654     667777643        3568999999999999999875211                   01


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccC
Q 036507          442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL  521 (639)
Q Consensus       442 ~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~  521 (639)
                      ...++|..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||++..+....  ........+|+.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--NFNPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC--ccCccccCCCccee
Confidence            234577888899999999999999987   9999999999999999999999999997653221  11112234578999


Q ss_pred             CccccccCC--------------------C--CCcchHHHHHHHHHHHHcCCc-cccccccccchhhh-hhhHHHHHHHH
Q 036507          522 APEYLTDGL--------------------A--TAKSDVYAFGVVLFEIISGKE-AIIRTEGMVSKNQE-RRSLASFMLAA  577 (639)
Q Consensus       522 aPE~~~~~~--------------------~--~~~~DVws~Gvvl~elltG~~-p~~~~~~~~~~~~~-~~~l~~~~~~~  577 (639)
                      |||.+....                    +  ..+.||||+||+++||++|.. |+............ ...+..|..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence            999875322                    1  134799999999999999875 55322110000000 001111100  


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDP---ILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~  633 (639)
                      ....           ..+-.    ..........+++.+++..+|   .+|+|++|+++
T Consensus       456 ~~~~-----------~~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 YKGQ-----------KYDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hccc-----------CCCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0000           00000    011234568889999999766   68999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-31  Score=261.01  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=188.5

Q ss_pred             CCCCCCceeecCceEEEEEEE--cCceEEEEEe--cccc--------HHHHHHHHHHHHhcCCCCeeEEEeeeec-CCeE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRM--TATK--------TKEFMAEMKILCKVHHSNLVELIGYAAT-EDEL  418 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~--~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~  418 (639)
                      +|-..++||+|+|+.||++.+  ..+.||||+-  +++.        .+...+|.+|-+.|+||.||++++++.- .+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            344567899999999999975  3578999974  2221        2346789999999999999999998864 5678


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEecc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDF  495 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df  495 (639)
                      +-|+||++|.+|.-+|..     .+.++......|+.||..||.||.+.. ++|||-||||.|||+-+   .|.+||.||
T Consensus       544 CTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            899999999999999964     345788899999999999999999875 78999999999999954   478999999


Q ss_pred             CCceecCCCCCC----cceeeeeccccccCCcccccc----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh
Q 036507          496 GLAKLVGKTSDG----EATVTKVVGTFGYLAPEYLTD----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       496 gla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~  567 (639)
                      |+++++...+..    ........||.+|++||.+.-    ...+.|+||||.|||+|.++.|+.||.....       .
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-------Q  690 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-------Q  690 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-------H
Confidence            999998665433    223345789999999997743    3568899999999999999999999965432       1


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                      .++.+. ..++..          .++--|     ...-...+...+|++||+.--++|....++.
T Consensus       691 QdILqe-NTIlkA----------tEVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  691 QDILQE-NTILKA----------TEVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHHhh-hchhcc----------eeccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            111110 011110          000000     0112234578899999999888888776653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=4.1e-30  Score=236.67  Aligned_cols=265  Identities=20%  Similarity=0.302  Sum_probs=197.3

Q ss_pred             hCCCCCCCceeecCceEEEEEE--EcCceEEEEEeccccHHHHHHHHHHHHhcC-CCCeeEEEeeeecCC--eEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATED--ELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~--~~~lv~e~  424 (639)
                      .++|++.+++|+|.++.||.|.  .+++.++||.++.-..+.+.+|+.||..|. ||||++++++..+..  ...|++||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            4678889999999999999997  457899999999988899999999999998 999999999987754  46799999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEeccCCceecCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGK  503 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~  503 (639)
                      +.+.+...+..        .++...+..++.+++.||.|+|+.|   |+|||+||.|+++|.. -.++|+|+|+|.++..
T Consensus       117 v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  117 VNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            99988877763        3677778889999999999999988   9999999999999975 4599999999998765


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh------hhhHHHHHHH
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE------RRSLASFMLA  576 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~------~~~l~~~~~~  576 (639)
                      ..+    ..-.+.+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||....+.....-.      ..++...+..
T Consensus       186 ~~e----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Cce----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            332    334567889999998865 66888999999999999999999999765432111000      0011111110


Q ss_pred             HhhcCCCccc-------ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMS-------MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~-------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .--..+....       ......++.+.-..    -...+..+++.+.|..|-.+|+|++|.+.
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0000000000       00111112211111    12356889999999999999999999763

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=243.98  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=186.6

Q ss_pred             CCceeecCceEEEEEEEc--CceEEEEEecc-----ccHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----CeEEEEEe
Q 036507          356 SSLLGHGTYGSVYYGNIR--NQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIGYAATE-----DELFLIYE  423 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~lv~e  423 (639)
                      .+-||.|+||.||..++.  ++.||+|++..     ...+.+.+|+++|..++|.|++..+++....     .++|++.|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            567999999999988774  68899998753     2467899999999999999999988876543     35788999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      +| ..+|...+-.     ...++-....-+..||++||+|||+.+   |.||||||.|.|+++|..+||||||+++....
T Consensus       138 Lm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  138 LM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            99 5589888854     344666667778899999999999987   99999999999999999999999999986532


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                        +....++.-+-|..|+|||++++ ..|+...||||.||++.||+..+-.|..-...     ++   .+.+...++.+.
T Consensus       209 --d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-----qQ---L~lItdLLGTPs  278 (449)
T KOG0664|consen  209 --RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-----EQ---LQMIIDLLGTPS  278 (449)
T ss_pred             --hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-----HH---HHHHHHHhCCCc
Confidence              23344566678999999999987 56899999999999999999776665432211     11   111122222110


Q ss_pred             Cc--------cccccccccc-CCcccCC----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          583 DS--------MSMSSLKDYI-DPNMMDL----YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       583 ~~--------~~~~~~~~~~-d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      .+        .....++.-. -|.+...    .+.+...+...+...++..||.+|.+..+.+.-
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            00        0000011100 1111111    122334456778889999999999998887653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-28  Score=248.50  Aligned_cols=271  Identities=21%  Similarity=0.349  Sum_probs=201.3

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcC-----C---CCeeEEEeeeec--
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVH-----H---SNLVELIGYAAT--  414 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~-----h---~niv~l~~~~~~--  414 (639)
                      ...+|...++||-|.|++||++.+.  .+.||+|+.+...  .+..+.||++|++++     |   ..||+|+++|..  
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            3468888999999999999999775  5789999987643  466789999999984     3   469999998864  


Q ss_pred             --CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-----
Q 036507          415 --EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-----  487 (639)
Q Consensus       415 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-----  487 (639)
                        +.+.+||+|++ |.+|..+|.....   +-++.....+|+.|++.||.|||..+  +|||.||||+|||+..+     
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~  229 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA  229 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence              56899999999 8899999976443   45888999999999999999999976  79999999999998200     


Q ss_pred             --------------------------------------------------------------------------------
Q 036507          488 --------------------------------------------------------------------------------  487 (639)
Q Consensus       488 --------------------------------------------------------------------------------  487 (639)
                                                                                                      
T Consensus       230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~  309 (590)
T KOG1290|consen  230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI  309 (590)
T ss_pred             hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 036507          488 --------------------------------------------------------------------------------  487 (639)
Q Consensus       488 --------------------------------------------------------------------------------  487 (639)
                                                                                                      
T Consensus       310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~  389 (590)
T KOG1290|consen  310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC  389 (590)
T ss_pred             CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence                                                                                            


Q ss_pred             -CCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh
Q 036507          488 -FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE  566 (639)
Q Consensus       488 -~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~  566 (639)
                       .++||+|||-|+..      ...++.-..|..|+|||++.+..|+..+||||++|+++||.||...|+...+.. ...+
T Consensus       390 di~vKIaDlGNACW~------~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~-Y~rD  462 (590)
T KOG1290|consen  390 DIRVKIADLGNACWV------HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGEN-YSRD  462 (590)
T ss_pred             ceeEEEeeccchhhh------hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCC-CCcc
Confidence             01344444444322      112233356888999999999999999999999999999999998887655422 3344


Q ss_pred             hhhHHHHHHHHhhcCCCcccc--cccccccCCc-----------------ccC--CCChhHHHHHHHHHHHhcccCCCCC
Q 036507          567 RRSLASFMLAALRNSPDSMSM--SSLKDYIDPN-----------------MMD--LYPHDCLFKMAMLAKQCVDEDPILR  625 (639)
Q Consensus       567 ~~~l~~~~~~~~~~~~~~~~~--~~~~~~~d~~-----------------l~~--~~~~~~~~~l~~li~~cl~~dP~~R  625 (639)
                      +..+.. +.+.++..|..+..  .--+++++..                 |.+  .++.+.+.++.+++.-||+.+|++|
T Consensus       463 EDHiA~-i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR  541 (590)
T KOG1290|consen  463 EDHIAL-IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR  541 (590)
T ss_pred             HHHHHH-HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence            444433 34445544432221  1111222211                 111  3567889999999999999999999


Q ss_pred             CCHHHHHH
Q 036507          626 PDMKQVVI  633 (639)
Q Consensus       626 Ps~~evl~  633 (639)
                      ||+.+.++
T Consensus       542 ~tA~~cl~  549 (590)
T KOG1290|consen  542 PTAAQCLK  549 (590)
T ss_pred             ccHHHHhc
Confidence            99999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1e-28  Score=255.92  Aligned_cols=199  Identities=26%  Similarity=0.382  Sum_probs=166.1

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      -|...+.||-|+||.|.++...  ...||+|.+++.+      ......|-+||..-+.+-||+|+-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            4777788999999999998754  4579999886543      3456789999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++||++-.+|..     ...+.+...+.++..+..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+.=
T Consensus       710 YIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             ccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            9999999999864     234677777778889999999999877   99999999999999999999999999853310


Q ss_pred             --------CCC-------------------------------CcceeeeeccccccCCccccccCCCCCcchHHHHHHHH
Q 036507          504 --------TSD-------------------------------GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVL  544 (639)
Q Consensus       504 --------~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl  544 (639)
                              .++                               ........+||+.|+|||++....++.-+|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                    000                               00011224899999999999999999999999999999


Q ss_pred             HHHHcCCccccccc
Q 036507          545 FEIISGKEAIIRTE  558 (639)
Q Consensus       545 ~elltG~~p~~~~~  558 (639)
                      |||+.|+.||....
T Consensus       862 ~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADT  875 (1034)
T ss_pred             HHHhhCCCCccCCC
Confidence            99999999995433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.8e-27  Score=229.10  Aligned_cols=207  Identities=38%  Similarity=0.657  Sum_probs=181.1

Q ss_pred             eeecCceEEEEEEEc--CceEEEEEeccccH----HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhh
Q 036507          359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS  432 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  432 (639)
                      ||+|.+|.||++...  ++.+++|.+.....    +.+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999987  78999999876643    678999999999999999999999998899999999999999999


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccCCceecCCCCCCccee
Q 036507          433 HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATV  511 (639)
Q Consensus       433 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~  511 (639)
                      ++....    ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........   ..
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~  150 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LL  150 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hh
Confidence            986421    35889999999999999999999987   999999999999999 89999999999986643221   12


Q ss_pred             eeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccccc
Q 036507          512 TKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL  590 (639)
Q Consensus       512 ~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  590 (639)
                      ....+...|++||..... ..+.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            334678899999999877 788999999999999999                                           


Q ss_pred             ccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       591 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                                       ..+.+++.+|++.+|++||+++++++.+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1377899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.5e-28  Score=249.83  Aligned_cols=283  Identities=21%  Similarity=0.265  Sum_probs=209.9

Q ss_pred             CCcccCCCCcccchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccH--HHHHHHHHHHHhcC----
Q 036507          330 TDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT--KEFMAEMKILCKVH----  401 (639)
Q Consensus       330 ~~~~~~~~~~~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~E~~il~~l~----  401 (639)
                      ....+.+....+.+.|+.  -.+|......|+|-|++|.+|...  +..||||++..++.  +.=+.|++||.+|+    
T Consensus       413 DNWdDaEGYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~  490 (752)
T KOG0670|consen  413 DNWDDAEGYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADP  490 (752)
T ss_pred             cCcccccceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCc
Confidence            334455555555555554  467888889999999999999875  57999999987653  45578999999995    


Q ss_pred             --CCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 036507          402 --HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKS  479 (639)
Q Consensus       402 --h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp  479 (639)
                        .-|.++|+-.|...+++|||||-+ .-+|.+.|....  ....|.......++.|+.-||..|-..+   |+|.||||
T Consensus       491 Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKP  564 (752)
T KOG0670|consen  491 EDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKP  564 (752)
T ss_pred             hhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCc
Confidence              357899999999999999999987 569999997643  2344777888899999999999999876   99999999


Q ss_pred             CcEEECCCC-CEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccc
Q 036507          480 SNILLDSAF-RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTE  558 (639)
Q Consensus       480 ~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~  558 (639)
                      +|||+++.- .+||||||.|...+.     ...+.+.-+..|.|||++.+-+|+...|+||.||+||||+||+-.|-+..
T Consensus       565 DNiLVNE~k~iLKLCDfGSA~~~~e-----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  565 DNILVNESKNILKLCDFGSASFASE-----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             cceEeccCcceeeeccCcccccccc-----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            999999864 579999999976532     23455677889999999999999999999999999999999998774432


Q ss_pred             cccchhhhhhhHHHHHHHHhhcCCCcccc----------------------------cccccccCC------cccC--CC
Q 036507          559 GMVSKNQERRSLASFMLAALRNSPDSMSM----------------------------SSLKDYIDP------NMMD--LY  602 (639)
Q Consensus       559 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----------------------------~~~~~~~d~------~l~~--~~  602 (639)
                      .        ..+...++..-+..|..+..                            ..+...+.|      .+..  .+
T Consensus       640 N--------N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~  711 (752)
T KOG0670|consen  640 N--------NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL  711 (752)
T ss_pred             c--------HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC
Confidence            1        11222222222222221110                            001111222      1111  02


Q ss_pred             C---hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          603 P---HDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       603 ~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +   .....++.+|+..|+..||++|.|..+.|.
T Consensus       712 ~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  712 PDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             CchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            2   234667999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=250.83  Aligned_cols=192  Identities=26%  Similarity=0.412  Sum_probs=164.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccccH-----------HHHHHHHHHHHhcC---CCCeeEEEeeeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATKT-----------KEFMAEMKILCKVH---HSNLVELIGYAAT  414 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~~-----------~~~~~E~~il~~l~---h~niv~l~~~~~~  414 (639)
                      .+|...+.+|.|+||.|+++.++.  ..|+||.+.+++.           ...-.|+.||+.++   |+||++++++|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458888999999999999998864  5789998866542           12456999999998   9999999999999


Q ss_pred             CCeEEEEEeec-cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          415 EDELFLIYEYA-QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       415 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                      .+.+||++|-. ++-+|++++.-     ...+++....-|+.|++.|+++||+++   |+|||||-+||.++.+|-+||+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence            99999999976 45689999853     345888888899999999999999998   9999999999999999999999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCcccc
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAII  555 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~  555 (639)
                      |||.+.....     .....++||..|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       713 dfgsaa~~ks-----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKS-----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcC-----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999976532     23445799999999999999877 577899999999999988777764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-28  Score=232.63  Aligned_cols=259  Identities=22%  Similarity=0.263  Sum_probs=189.4

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecc-----ccHHHHHHHHHHHHhcCCCCeeEEEeeeecC------Ce
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIGYAATE------DE  417 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~  417 (639)
                      .+|.....+|.|.- .|-.+.+  .+++||+|++..     ...+...+|...+..++|+|+++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46666778888887 5554433  478999998643     2356678999999999999999999988643      35


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .|+|||+| ..+|.+.++       ..++=.....|..|++.|++|||+.+   |+||||||+||++..++.+||.|||+
T Consensus        96 ~y~v~e~m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence            79999999 568888875       23556677789999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ++...    .....+.++.|..|.|||++-+..+.+.+||||.||++.||++|+-.|.+.+.        .+.+..+...
T Consensus       165 ar~e~----~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~--------idQ~~ki~~~  232 (369)
T KOG0665|consen  165 ARTED----TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH--------IDQWNKIIEQ  232 (369)
T ss_pred             hcccC----cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH--------HHHHHHHHHH
Confidence            97532    23466778999999999999988899999999999999999999987753321        1222222222


Q ss_pred             hhcCCCcc------------------cccccccc-cCCcccCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSM------------------SMSSLKDY-IDPNMMDL--YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~------------------~~~~~~~~-~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ++...+..                  ..-...+. -|-.+...  .+.-....+++++.+||-.||++|-|++++|+
T Consensus       233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            22211110                  00111111 11111111  11122345789999999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=8.6e-26  Score=221.95  Aligned_cols=195  Identities=33%  Similarity=0.518  Sum_probs=167.8

Q ss_pred             CCCCCceeecCceEEEEEEEcC--ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          353 FSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      |...+.||+|++|.||++...+  +.+++|.+...    ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556789999999999998864  88999998764    35678899999999999999999999998899999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++....    ..+++.....++.+++.++.+||+++   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999986422    11788999999999999999999986   99999999999999999999999999987643320


Q ss_pred             CcceeeeeccccccCCcccc-ccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          507 GEATVTKVVGTFGYLAPEYL-TDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                        .......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       154 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 --ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             --ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence              122345678899999998 667778899999999999999999999943

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.4e-26  Score=232.11  Aligned_cols=275  Identities=21%  Similarity=0.319  Sum_probs=198.9

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc-----CceEEEEEeccc-cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT-KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFL  420 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~l  420 (639)
                      .-.+.|...++||+|.|++||++.+.     ++.||+|.+... ......+|+++|..+. +.||+++.+++..++...+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            34567888999999999999998753     468999988654 4567889999999997 9999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEeccCCce
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAK  499 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~  499 (639)
                      |+||++.....++..+        ++......++..+..||+++|.++   |+||||||+|+|.+.. ++-.|+|||+|.
T Consensus       113 vlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence            9999999999999864        677888889999999999999988   9999999999999865 567899999996


Q ss_pred             ecCCCC-------------------------------CCc----------ceeeeeccccccCCcccccc-CCCCCcchH
Q 036507          500 LVGKTS-------------------------------DGE----------ATVTKVVGTFGYLAPEYLTD-GLATAKSDV  537 (639)
Q Consensus       500 ~~~~~~-------------------------------~~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV  537 (639)
                      ......                               ...          ...-...||++|+|||++.. ...++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            211000                               000          00112479999999999875 556889999


Q ss_pred             HHHHHHHHHHHcCCccccccccccchhhhhhhHHHH--HHH---Hhhc--CCC-cc---------cccccc-cccCC---
Q 036507          538 YAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF--MLA---ALRN--SPD-SM---------SMSSLK-DYIDP---  596 (639)
Q Consensus       538 ws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~--~~~---~~~~--~~~-~~---------~~~~~~-~~~d~---  596 (639)
                      ||.|||++-+++++.||....+......+...+..+  +.+   ..+.  ..+ ..         ....+. +.+.+   
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            999999999999999997765544433333222211  111   0011  000 00         000110 00000   


Q ss_pred             -cc-cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          597 -NM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       597 -~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       .+ ........+..+.+++.+|+..||.+|-|++|.|+
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence             00 11111222447899999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-27  Score=245.13  Aligned_cols=248  Identities=26%  Similarity=0.410  Sum_probs=196.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .++|+....+|+|.||.||+++..  ++..|+|.++-+   ...-..+|+-+++..+||||+.++|.+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            367788899999999999999874  678899988643   344566899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +.+|+|++.-+.     ..+++..++..+++...+|++|||+++   -+|||||-.||++++.+.+|++|||.+..+...
T Consensus        94 cgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             cCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            999999998864     456888888899999999999999988   899999999999999999999999998766422


Q ss_pred             CCCcceeeeeccccccCCcccc---ccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYL---TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                         -.....+.||+.|||||+.   ..+.|..++|||++|+...|+---++|......+         ..-++   +   
T Consensus       166 ---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---------r~l~L---m---  227 (829)
T KOG0576|consen  166 ---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---------RALFL---M---  227 (829)
T ss_pred             ---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---------HHHHH---h---
Confidence               2233457899999999976   4577899999999999999997777666433220         11111   1   


Q ss_pred             CCcccccccccccCCc-ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPN-MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                              .+..++|. +.+  ...-...+-++++.|+.++|++||+++.+++
T Consensus       228 --------TkS~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  228 --------TKSGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             --------hccCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                    11122221 221  2233456888999999999999999987664

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=8.6e-26  Score=262.60  Aligned_cols=197  Identities=19%  Similarity=0.258  Sum_probs=137.1

Q ss_pred             hcCC-CCeeEEEeee-------ecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036507          399 KVHH-SNLVELIGYA-------ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT  470 (639)
Q Consensus       399 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~  470 (639)
                      .++| .||++++++|       ...+.+++++||+ +++|.+++...    ...+++...+.++.||++||+|||+++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            3455 5777888876       2234577889988 66999999642    345899999999999999999999987  


Q ss_pred             CeeeCCCCCCcEEECCCC-------------------CEEEeccCCceecCCCCC-------------Ccceeeeecccc
Q 036507          471 HYVHRDIKSSNILLDSAF-------------------RAKISDFGLAKLVGKTSD-------------GEATVTKVVGTF  518 (639)
Q Consensus       471 ~ivH~Dlkp~NIll~~~~-------------------~~kl~Dfgla~~~~~~~~-------------~~~~~~~~~gt~  518 (639)
                       |+||||||+||||+..+                   .+|++|||+++.......             .........||+
T Consensus       101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence             99999999999996544                   455666666543211000             000011246889


Q ss_pred             ccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcc
Q 036507          519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNM  598 (639)
Q Consensus       519 ~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l  598 (639)
                      .|||||++.+..++.++|||||||+||||++|..|+....         ..+......                .+.+..
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~----------------~~~~~~  234 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHR----------------VLPPQI  234 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHh----------------hcChhh
Confidence            9999999999999999999999999999999987753211         000000000                000100


Q ss_pred             cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          599 MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       599 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .     ........++.+||+.||.+||+|.|+++
T Consensus       235 ~-----~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 L-----LNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             h-----hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            0     01223567889999999999999999975

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=212.30  Aligned_cols=246  Identities=22%  Similarity=0.370  Sum_probs=181.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccc--cHHHHHHHHHHHHhc-CCCCeeEEEee-eecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT--KTKEFMAEMKILCKV-HHSNLVELIGY-AATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~--~~~~~~~E~~il~~l-~h~niv~l~~~-~~~~~~~~lv~e~  424 (639)
                      +.|.+.+.||+|.||.+-++++++  ..+++|-+...  ..++|.+|...--.| .|.||+.-+++ |...+.+++++||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            567788899999999999999975  67999998765  467899998765555 48999988764 5556778899999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC--CCCCEEEeccCCceecC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD--SAFRAKISDFGLAKLVG  502 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~  502 (639)
                      ++.|+|.+-+..      ..+.+....+++.|++.|+.|||+++   ++|||||.+|||+-  +..++||||||..+..+
T Consensus       104 aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  104 APRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             CccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999988754      23667778889999999999999988   99999999999993  33579999999987543


Q ss_pred             CCCCCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      .      +.....-+..|.+||....     -...+.+|+|.||++++.++||+.||+...      ......++|+.-.
T Consensus       175 ~------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~------~~d~~Y~~~~~w~  242 (378)
T KOG1345|consen  175 T------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS------IMDKPYWEWEQWL  242 (378)
T ss_pred             c------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh------ccCchHHHHHHHh
Confidence            2      3333455677999997643     234678999999999999999999996321      1223444444322


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                      -+..+      .+.+.+.         .....+.++.++-+..+|++|=...++-
T Consensus       243 ~rk~~------~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  243 KRKNP------ALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             cccCc------cCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            22211      1111111         1234577888999999999994444443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=4.2e-24  Score=202.29  Aligned_cols=167  Identities=20%  Similarity=0.213  Sum_probs=124.2

Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.++++..    ...+++..+..|+.|+++||+|||+++         ||+|||++.++.+|+  ||++.......  
T Consensus         1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence            6888988642    345999999999999999999999864         999999999999999  99998653321  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                            ..||+.|||||++.+..++.++|||||||++|||++|+.||......      ...+.... ......      
T Consensus        64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~-~~~~~~------  124 (176)
T smart00750       64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILL-NGMPAD------  124 (176)
T ss_pred             ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHH-HHhccC------
Confidence                  25889999999999999999999999999999999999998543221      01111111 111000      


Q ss_pred             cccccccCCcccCCCChhHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          588 SSLKDYIDPNMMDLYPHDCLF--KMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                             ++.-. ..+.....  ++.+++.+||+.||++||++.|+++.+..+
T Consensus       125 -------~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      125 -------DPRDR-SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             -------Ccccc-ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                   00000 01112222  689999999999999999999999987643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6.3e-23  Score=212.96  Aligned_cols=163  Identities=18%  Similarity=0.204  Sum_probs=127.2

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc---CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAATED  416 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  416 (639)
                      ...++|...+.||+|+||+||+|.+.   +..+|||++...        ..+.+.+|+++|++++|+|++..+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34577889999999999999999763   466899986422        23458899999999999999853322   24


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCcEEECCCCCEEEecc
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI-KSSNILLDSAFRAKISDF  495 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Df  495 (639)
                      ..++||||+++++|... ..   .  .      ...++.+++++|.|||+++   |+|||| ||+|||++.++.+||+||
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~---~--~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP---H--G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc---c--c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence            57999999999999732 10   0  1      1356789999999999987   999999 999999999999999999


Q ss_pred             CCceecCCCCCCcc-----eeeeeccccccCCcccccc
Q 036507          496 GLAKLVGKTSDGEA-----TVTKVVGTFGYLAPEYLTD  528 (639)
Q Consensus       496 gla~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~  528 (639)
                      |+++.+...+....     ..+...+++.|++||.+..
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99997755432222     1245678999999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.7e-23  Score=196.19  Aligned_cols=242  Identities=21%  Similarity=0.366  Sum_probs=189.6

Q ss_pred             CceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChh
Q 036507          357 SLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLK  431 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  431 (639)
                      .+|.+...|..|+|++.+..+++|+++-.     ...+|..|.-.|+-+.||||+.++|.|.....+.++..||+.|+|.
T Consensus       196 tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly  275 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY  275 (448)
T ss_pred             hhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence            46888889999999999988888887543     3467888999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe--ccCCceecCCCCCCcc
Q 036507          432 SHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS--DFGLAKLVGKTSDGEA  509 (639)
Q Consensus       432 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfgla~~~~~~~~~~~  509 (639)
                      ..||+..   .-..+-.+..+++.++|+|++|||+.. +-|.---|.+..+++|++..++|+  |--++..    .    
T Consensus       276 nvlhe~t---~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq----e----  343 (448)
T KOG0195|consen  276 NVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----E----  343 (448)
T ss_pred             HHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee----c----
Confidence            9999733   345677788899999999999999976 335555789999999999887764  3222211    1    


Q ss_pred             eeeeeccccccCCccccccCCCC---CcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLAT---AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~---~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                        ....-.|.||+||.+...+.+   ..+|+|||.++||||.|...||.....+...          +            
T Consensus       344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------m------------  399 (448)
T KOG0195|consen  344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------M------------  399 (448)
T ss_pred             --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------h------------
Confidence              112346789999999876543   4799999999999999999999665432100          0            


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                           ++--+.++-..|......+.+|+.-|++.||.+||.++.++-.|++++
T Consensus       400 -----kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  400 -----KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                 011122333456667778999999999999999999999999999863

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=7.2e-21  Score=197.96  Aligned_cols=256  Identities=21%  Similarity=0.244  Sum_probs=190.0

Q ss_pred             CCCCCCceeecCceEEEEEEEcC---ceEEEEEeccccH---HHHHHHHHHHHhcCC----CCeeEEEeee-ecCCeEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRN---QEVAIKRMTATKT---KEFMAEMKILCKVHH----SNLVELIGYA-ATEDELFL  420 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~---~~vavK~~~~~~~---~~~~~E~~il~~l~h----~niv~l~~~~-~~~~~~~l  420 (639)
                      +|...++||+|+||.||.+....   ..+|+|.......   ..+..|..++..+.+    +++..++... ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            78889999999999999998765   3688887654321   257789999988873    5888898888 46778899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-----CCEEEecc
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-----FRAKISDF  495 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df  495 (639)
                      ||+.+ |.+|.++.....   ...++..+.+.|+.|++.+|++||+.+   ++||||||+|+++...     ..+.|.||
T Consensus        99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99988 889999875422   466899999999999999999999988   9999999999999765     45899999


Q ss_pred             CCceecC--CCCCC----cce-eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          496 GLAKLVG--KTSDG----EAT-VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       496 gla~~~~--~~~~~----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      |+++...  .....    ... .....||..|++++...+...+.+.|+||++.++.|++.|..||........    ..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~~  247 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----KS  247 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----HH
Confidence            9998332  11111    111 1235699999999999999999999999999999999999999854432111    00


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..    ......           .....     .....+.++.++...+-..+...+|....+...|.+.
T Consensus       248 ~~----~~~~~~-----------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  248 KF----EKDPRK-----------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HH----HHHhhh-----------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            01    000000           00000     1122344566677777778999999999888777653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=3.4e-20  Score=191.98  Aligned_cols=259  Identities=31%  Similarity=0.469  Sum_probs=193.0

Q ss_pred             CCCCCceeecCceEEEEEEEcCceEEEEEeccc------cHHHHHHHHHHHHhcCCC-CeeEEEeeeecCCeEEEEEeec
Q 036507          353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT------KTKEFMAEMKILCKVHHS-NLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      |...+.||.|+||.||++... ..+++|.+...      ....+.+|+.+++.+.|+ +++++..++......++++|++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            556778999999999999888 78888887543      245688999999999988 7999999997777789999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGKT  504 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~  504 (639)
                      .++++.+++......  ..+.......+..|++.+++|+|+.+   ++|||+||+||+++..+ .++++|||++..+...
T Consensus        81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999776542111  35788888999999999999999987   99999999999999998 7999999999865432


Q ss_pred             CCCc---ceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          505 SDGE---ATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       505 ~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ....   .......|+..|++||.+.+   ..+....|+|++|++++++++|..|+......        .........+
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--------~~~~~~~~~~  227 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--------SATSQTLKII  227 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--------ccHHHHHHHH
Confidence            2211   13456789999999999987   57889999999999999999999996433210        0001111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......        .................+.+++..|+..+|..|.++.+...
T Consensus       228 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         228 LELPTP--------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HhcCCc--------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            111100        00000000000223356889999999999999999887654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=4.2e-21  Score=186.59  Aligned_cols=201  Identities=20%  Similarity=0.282  Sum_probs=169.4

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecc-ccHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeecc
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTA-TKTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      -.|...++||+|+||..+.|+.  ++++||||.-.. .+.-++..|.+..+.|. .++|..++-|...+.+-.||+|++ 
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            4688899999999999999964  689999997643 34567788998888886 689999998888888889999998 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-----CCEEEeccCCceec
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-----FRAKISDFGLAKLV  501 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgla~~~  501 (639)
                      |-||.+++.-    ....++..+...+|.|++.-++|+|++.   +|.|||||+|+||...     ..+.++|||+|+.+
T Consensus       107 GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  107 GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8899998863    3456999999999999999999999987   9999999999999643     45899999999987


Q ss_pred             CCCCCCcc----eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccccc
Q 036507          502 GKTSDGEA----TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG  559 (639)
Q Consensus       502 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~  559 (639)
                      .+......    ......||.+||+-.-..+...+...|.=|+|-+++..|-|..||.+...
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            54332221    22346899999999999999999999999999999999999999987654

>PRK06347 autolysin; Reviewed

Probab=99.85  E-value=1.7e-21  Score=211.15  Aligned_cols=153  Identities=13%  Similarity=0.195  Sum_probs=118.0

Q ss_pred             eeEEEeCCCCCHHHHHHHhcCCcccceeccC-------CCceEeeeeeeeccCC----C----------CceeeceeEEE
Q 036507           43 FLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN-------EKNYIFIKKNCSCLST----T----------RNYVSNTTFTV  101 (639)
Q Consensus        43 ~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n-------~~~~l~ip~~~~~~~~----~----------~~~~~~~~y~v  101 (639)
                      ...|+|++||||+.||++||+++.+|+.+|+       .+|.|.||....-...    .          ........|+|
T Consensus       405 ~~~ytVk~GDTL~sIA~kygVSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtV  484 (592)
T PRK06347        405 AKVYTVVKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTV  484 (592)
T ss_pred             ceeEEecCCCCHHHHHHHhCCCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeeee
Confidence            4689999999999999999999999997776       4688999864211000    0          00112346999


Q ss_pred             EcCCceeehhHH---HhcCCcccccCCC-cccCCCCEEEEeeeecCCCC----------CCCceEEEEecCCCcHHHHHH
Q 036507          102 KSSGGYVYDVVV---NAYDGLAILDNST-RMARAGAVVSLRLFCGCSSG----------LWNYLMSYVMKDGDTVQSLAS  167 (639)
Q Consensus       102 ~~gd~t~~~ia~---~~~~~l~~~~~~~-~~l~~g~~l~ip~~~~~~~~----------~~~~~~~y~v~~Gdtl~~Ia~  167 (639)
                      ++|| |+|.||+   .+.+.|..||+.. +.|++||.|.||....-...          ......+|+|++|||||+||+
T Consensus       485 k~GD-TL~sIAkkygVSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL~sIA~  563 (592)
T PRK06347        485 AKGD-SLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSLWAISR  563 (592)
T ss_pred             cCCC-CHHHHHHHHCCCHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcHHHHHH
Confidence            9999 9999999   4677777888533 45999999999975321100          012356799999999999999


Q ss_pred             HhCCChHHHHHHcCCCCCCCccCCceEEec
Q 036507          168 RFGVSMDSIEQVNGIVNPNNVTAGDLFYIP  197 (639)
Q Consensus       168 ~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip  197 (639)
                      +||+++++|++||+|.. +.|++||+|.|+
T Consensus       564 KygvSv~~L~~~N~L~~-~~L~~GQ~L~I~  592 (592)
T PRK06347        564 QYKTTVDNIKAWNKLTS-NMIHVGQKLTIK  592 (592)
T ss_pred             HhCCCHHHHHHhcCCCc-ccCCCCCEEecC
Confidence            99999999999999975 779999999985

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-21  Score=214.65  Aligned_cols=248  Identities=21%  Similarity=0.247  Sum_probs=178.6

Q ss_pred             CCCCCCceeecCceEEEEEEEcCceEEEEEecccc----HHH---HHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK----TKE---FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++...+.||++.|=+|.++++.+..|+||++-...    ...   ...|++ ...++|||.+++.-+......-|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            45567789999999999999998889999875432    233   344555 5566899999998877666777888888


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      .. -+|.+.+..     +.-+.....+.|+.|++.||.-+|..+   |+|||||.+|||++..+-+.|+||..-+...-.
T Consensus       103 vk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  103 VK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             Hh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence            84 488888843     455778888899999999999999987   999999999999999999999999876643322


Q ss_pred             CCCcceeeee----ccccccCCccccccC----------C-CCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhh
Q 036507          505 SDGEATVTKV----VGTFGYLAPEYLTDG----------L-ATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       505 ~~~~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~  568 (639)
                      .+.....+.+    ..-..|.|||.+...          . .+++.||||+||++.||++ |+++|.- .          
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-S----------  242 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-S----------  242 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-H----------
Confidence            3333333333    233479999987541          1 5789999999999999998 5766632 1          


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                         +...  ++..........+.++-|            ..+++++..|++.||++|-|+++.|+.-..
T Consensus       243 ---QL~a--Yr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  243 ---QLLA--YRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             ---HHHh--HhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence               1110  011000000011111111            147889999999999999999999987543

>PRK06347 autolysin; Reviewed

Probab=99.84  E-value=1.1e-20  Score=205.05  Aligned_cols=157  Identities=13%  Similarity=0.168  Sum_probs=120.0

Q ss_pred             ceeEEEeCCCCCHHHHHHHhcCCcccceeccC-------CCceEeeeeeeeccCCC---------------CceeeceeE
Q 036507           42 TFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN-------EKNYIFIKKNCSCLSTT---------------RNYVSNTTF   99 (639)
Q Consensus        42 ~~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n-------~~~~l~ip~~~~~~~~~---------------~~~~~~~~y   99 (639)
                      ....|+|++||||+.||++||+++++|+.+|+       .||.|+||....-....               .......+|
T Consensus       329 ~~~~Y~V~sGDTL~~IA~rygvSv~eL~~~N~l~~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~~~y  408 (592)
T PRK06347        329 NAKIYTVVKGDSLWRIANNHKVTVANLKAWNNLKSDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNAKVY  408 (592)
T ss_pred             CceEEEeCCCCCHHHHHHHhCCCHHHHHHHhCCCccccccCcEEEEeccccccccccccccccccccccccccccCceeE
Confidence            46789999999999999999999999997776       57999999642110000               001123469


Q ss_pred             EEEcCCceeehhHHH---hcCCcccccCCC-cccCCCCEEEEeeeecC------CC----------CCCCceEEEEecCC
Q 036507          100 TVKSSGGYVYDVVVN---AYDGLAILDNST-RMARAGAVVSLRLFCGC------SS----------GLWNYLMSYVMKDG  159 (639)
Q Consensus       100 ~v~~gd~t~~~ia~~---~~~~l~~~~~~~-~~l~~g~~l~ip~~~~~------~~----------~~~~~~~~y~v~~G  159 (639)
                      +|++|| |+|.||+.   ....|..+|+.. +.|.+||.|.||....-      +.          .......+|+|++|
T Consensus       409 tVk~GD-TL~sIA~kygVSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtVk~G  487 (592)
T PRK06347        409 TVVKGD-SLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTVAKG  487 (592)
T ss_pred             EecCCC-CHHHHHHHhCCCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeeeecCC
Confidence            999999 99999983   566677777432 35999999999964210      00          00112457999999


Q ss_pred             CcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecCCC
Q 036507          160 DTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNS  200 (639)
Q Consensus       160 dtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~~  200 (639)
                      ||||+||++||+++++|++||++.. +.|++||+|.||...
T Consensus       488 DTL~sIAkkygVSv~~L~~~N~l~s-~~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        488 DSLWRIANNNKVTIANLKSWNNLKS-DFIYPGQKLKVSAGS  527 (592)
T ss_pred             CCHHHHHHHHCCCHHHHHHhcCCCc-ccccCCcEEEEecCc
Confidence            9999999999999999999999975 689999999999754

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=9.1e-21  Score=176.56  Aligned_cols=201  Identities=21%  Similarity=0.300  Sum_probs=166.1

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecccc-HHHHHHHHHHHHhcCC-CCeeEEEeeeecCCeEEEEEeecc
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK-TKEFMAEMKILCKVHH-SNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .+|...++||+|+||.+|.|..  .++.||||.-.... -..+..|..+...|++ ..|..+..+..++..-.+|||.+ 
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence            5788899999999999999976  47899999865443 3457789999999985 57888888888888889999998 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC---CCEEEeccCCceecCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGK  503 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~  503 (639)
                      |.+|.+++.-    ....++..+.+-++-|++.-++|+|.++   ++||||||+|+|..-+   ..+.|+|||+|+.+.+
T Consensus        94 GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   94 GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            8899998863    3456888899999999999999999988   9999999999999643   5689999999987754


Q ss_pred             CCCCcc----eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccccc
Q 036507          504 TSDGEA----TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG  559 (639)
Q Consensus       504 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~  559 (639)
                      ......    .-....||.+|.+-....+-..+...|+=|+|.+|..+.-|..||++...
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            332221    22346899999988877777778899999999999999999999977654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.4e-21  Score=214.29  Aligned_cols=251  Identities=22%  Similarity=0.271  Sum_probs=181.5

Q ss_pred             CCCCceeecCceEEEEEEEc--CceEEEEEe-----ccccH----HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          354 SDSSLLGHGTYGSVYYGNIR--NQEVAIKRM-----TATKT----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       354 ~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~-----~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ...+++|.|++|.|+.....  ....+.|..     ..+..    ..+..|..+-..++|+|++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45778999999977766543  122333322     11111    12556777788899999988887777666666669


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++ +|..++...     ..+....+-.++.|+..|++|||+.+   |.|||+|++|++++.++.+||+|||.+..+.
T Consensus       401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence            99999 999998642     34666777788999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCC-cceeeeeccccccCCccccccCCCCC-cchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          503 KTSDG-EATVTKVVGTFGYLAPEYLTDGLATA-KSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       503 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...+. .......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||..........          .. ...
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~~-~~~  540 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------KT-NNY  540 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------hh-hcc
Confidence            43322 13455689999999999999998875 6899999999999999999995433211100          00 000


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .       .-......  ......+.+.+.+.++.++|+.||.+|-+++++++
T Consensus       541 ~-------~~~~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  541 S-------DQRNIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             c-------cccccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0       00000000  01122455667889999999999999999999975

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=3.7e-20  Score=178.89  Aligned_cols=168  Identities=13%  Similarity=0.136  Sum_probs=131.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEecccc--H----HH------HHHHHHHHHhcCCCCeeEEEeeeecC--
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK--T----KE------FMAEMKILCKVHHSNLVELIGYAATE--  415 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~----~~------~~~E~~il~~l~h~niv~l~~~~~~~--  415 (639)
                      ..+|...++||.|+||.||+....+..+|||.+....  .    ..      +.+|++.+.+++|++|..+..++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            5789999999999999999987777899999986432  1    11      57899999999999999998875532  


Q ss_pred             ------CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC
Q 036507          416 ------DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR  489 (639)
Q Consensus       416 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~  489 (639)
                            +..+++|||++|.+|.++..         ++.    ....+++.++..||+.+   ++|||+||+||+++.++ 
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                  35789999999999988742         222    23558999999999988   99999999999999988 


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS  549 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt  549 (639)
                      ++|+|||...........               ..++....+..++|+|+||+.+..+..
T Consensus       173 i~liDfg~~~~~~e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccchhhH---------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999988654221110               113344556679999999999876653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=3e-19  Score=170.63  Aligned_cols=135  Identities=16%  Similarity=0.145  Sum_probs=103.9

Q ss_pred             CCceeecCceEEEEEEEc-CceEEEEEeccccH------------HH-----------------HHHHHHHHHhcCCCCe
Q 036507          356 SSLLGHGTYGSVYYGNIR-NQEVAIKRMTATKT------------KE-----------------FMAEMKILCKVHHSNL  405 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~------------~~-----------------~~~E~~il~~l~h~ni  405 (639)
                      .+.||+|+||.||+|... ++.||||.++....            ..                 ..+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            457999999999999874 78999999864311            11                 2349999999987776


Q ss_pred             eEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCcEEE
Q 036507          406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI-HEHTKTHYVHRDIKSSNILL  484 (639)
Q Consensus       406 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~~ivH~Dlkp~NIll  484 (639)
                      .....+..  ...++||||++++++......     ...+++.....++.|++.+|.|| |+.+   |+||||||+|||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli  151 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY  151 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence            43332222  223899999988777654321     23578888999999999999999 6776   9999999999999


Q ss_pred             CCCCCEEEeccCCceec
Q 036507          485 DSAFRAKISDFGLAKLV  501 (639)
Q Consensus       485 ~~~~~~kl~Dfgla~~~  501 (639)
                      + ++.++|+|||++...
T Consensus       152 ~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E-CCcEEEEEccccccC
Confidence            8 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2e-19  Score=202.56  Aligned_cols=198  Identities=22%  Similarity=0.284  Sum_probs=162.5

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccccHHHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEEE
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATKTKEFMAEMKILCKVH---HSNLVELIGYAATEDELFL  420 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~l  420 (639)
                      +++...+.|.+.+.||+|+||+||+|... ++.||+|.-+....-+|.-=.+++.||+   -+-|..+...+...+..++
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            34445567888899999999999999875 5789999987666555544455666666   2334444444455677899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-------CCCCEEEe
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-------SAFRAKIS  493 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~  493 (639)
                      |+||.+.|+|.+++.     ..+..+|...+.++.|++.-+++||..+   |||+||||+|.||.       +...++|+
T Consensus       772 v~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            999999999999996     3556899999999999999999999988   99999999999994       23458999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCC
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK  551 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~  551 (639)
                      |||.+.++....+. ..+...++|-.+-.+|.+.+.+++.+.|.|.|.-+++-||.|+
T Consensus       844 DfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            99999887654443 5677889999999999999999999999999999999999997

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=1.3e-18  Score=166.70  Aligned_cols=135  Identities=16%  Similarity=0.154  Sum_probs=106.4

Q ss_pred             CCceeecCceEEEEEEEc-CceEEEEEecccc-----------------------------HHHHHHHHHHHHhcCCCCe
Q 036507          356 SSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK-----------------------------TKEFMAEMKILCKVHHSNL  405 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~-----------------------------~~~~~~E~~il~~l~h~ni  405 (639)
                      .+.||+|+||.||+|... ++.||||.++...                             ...+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999999875 7899999986431                             0113578899999999987


Q ss_pred             eEEEeeeecCCeEEEEEeeccCCChhhh-ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEE
Q 036507          406 VELIGYAATEDELFLIYEYAQKGSLKSH-LHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       406 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIl  483 (639)
                      .....+...  ..++||||++++++... +..      ..++......++.|++.++.+||+ ++   |+||||||+||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl  150 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL  150 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence            544443332  24899999988755433 321      246677888999999999999999 77   999999999999


Q ss_pred             ECCCCCEEEeccCCceecC
Q 036507          484 LDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~~  502 (639)
                      ++ ++.++|+|||++..+.
T Consensus       151 l~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EE-CCCEEEEEcccceecC
Confidence            99 7899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.2e-18  Score=164.72  Aligned_cols=183  Identities=15%  Similarity=0.123  Sum_probs=137.0

Q ss_pred             CCCCceeecCceEEEEEEEcCceEEEEEeccccH--H-----HHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeec
Q 036507          354 SDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--K-----EFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       354 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--~-----~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .....|++|+||+||.+...+.+++.+.+.....  .     .+.+|+++|++|. |+++.+++++    +..+++|||+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            3466899999999998888788888777765422  2     4779999999996 5789999886    3469999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCcEEECCCCCEEEeccCCceecCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI-KSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      .|.+|.+.+..      .      ...++.|++.+|+++|+++   |+|||| ||+|||+++++.++|+|||++......
T Consensus        81 ~G~~L~~~~~~------~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         81 AGAAMYQRPPR------G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             cCccHHhhhhh------h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            99998754321      1      1246778999999999988   999999 799999999999999999999865432


Q ss_pred             CCC-----ccee-----eeeccccccCCccccccC-CCC-CcchHHHHHHHHHHHHcCCcccc
Q 036507          505 SDG-----EATV-----TKVVGTFGYLAPEYLTDG-LAT-AKSDVYAFGVVLFEIISGKEAII  555 (639)
Q Consensus       505 ~~~-----~~~~-----~~~~gt~~y~aPE~~~~~-~~~-~~~DVws~Gvvl~elltG~~p~~  555 (639)
                      ..-     ....     .....++.|+.|+...-- ..+ ...+.++-|.-+|.++|++.+..
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            210     0000     012357777777643321 222 46789999999999999987763

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.78  E-value=7.7e-19  Score=187.33  Aligned_cols=156  Identities=15%  Similarity=0.235  Sum_probs=115.2

Q ss_pred             eeEEEeCCCCCHHHHHHHhcCCcccceeccC----------CCceEeeeeeeec------cCC-----C------Cceee
Q 036507           43 FLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN----------EKNYIFIKKNCSC------LST-----T------RNYVS   95 (639)
Q Consensus        43 ~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n----------~~~~l~ip~~~~~------~~~-----~------~~~~~   95 (639)
                      +....+..+.+|..||+++|+++++|+..|.          ..+.|+||....-      ...     .      .....
T Consensus       263 ~~~V~v~~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~  342 (456)
T PRK10783        263 LARVDLGQQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLN  342 (456)
T ss_pred             eEEEecCCCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCC
Confidence            3444455567999999999999999995553          1266888864210      000     0      00012


Q ss_pred             ceeEEEEcCCceeehhHHH---hcCCcccccCC-CcccCCCCEEEEeeeecCCC-CCCCceEEEEecCCCcHHHHHHHhC
Q 036507           96 NTTFTVKSSGGYVYDVVVN---AYDGLAILDNS-TRMARAGAVVSLRLFCGCSS-GLWNYLMSYVMKDGDTVQSLASRFG  170 (639)
Q Consensus        96 ~~~y~v~~gd~t~~~ia~~---~~~~l~~~~~~-~~~l~~g~~l~ip~~~~~~~-~~~~~~~~y~v~~Gdtl~~Ia~~~~  170 (639)
                      ..+|+|++|| |+|.||+.   +...|..+|+. .+.|.+||.|.||..+.|.. ......++|+|++|||||+||++||
T Consensus       343 ~~~y~Vk~GD-TL~sIA~r~gvs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL~sIA~kyg  421 (456)
T PRK10783        343 SRSYKVRSGD-TLSGIASRLNVSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSLSSIAKRHG  421 (456)
T ss_pred             ceEEEECCCC-cHHHHHHHHCcCHHHHHHHcCCCcccCCCCCEEEecCCcccccccccccceeEEeCCCCCHHHHHHHhC
Confidence            3469999999 99999984   45566677733 24599999999998765532 2234467899999999999999999


Q ss_pred             CChHHHHHHcCCCCCCCccCCceEEecCCC
Q 036507          171 VSMDSIEQVNGIVNPNNVTAGDLFYIPLNS  200 (639)
Q Consensus       171 ~~~~~l~~~N~~~~~~~l~~g~~l~ip~~~  200 (639)
                      |++++|++||++... .|+|||+|.|++..
T Consensus       422 Vtv~~L~~~N~l~~~-~L~pGq~L~l~v~~  450 (456)
T PRK10783        422 VNIKDVMRWNSDTAK-NLQPGDKLTLFVKN  450 (456)
T ss_pred             CCHHHHHHhcCCCCC-cCCCCCEEEEecCC
Confidence            999999999998765 89999999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.4e-19  Score=190.81  Aligned_cols=220  Identities=27%  Similarity=0.347  Sum_probs=172.4

Q ss_pred             eeecCceEEEEE-----EEcCceEEEEEecccc-----HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          359 LGHGTYGSVYYG-----NIRNQEVAIKRMTATK-----TKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       359 lG~G~~g~Vy~~-----~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +|+|+||.|++.     ...+.-+|+|.+++..     ......|..++...+ ||.++++.-.+..+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            789999999854     3345678888765432     113456788888887 99999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|...+..     ...+.......+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-...  
T Consensus        82 g~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   82 GDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             chhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            999998854     334555566667778899999999988   9999999999999999999999999998653221  


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM  587 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  587 (639)
                           ..+||..|||||++.  .....+|.||||++++||+||..||..               +.+..+++..      
T Consensus       152 -----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------------~~~~~Il~~~------  203 (612)
T KOG0603|consen  152 -----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------------DTMKRILKAE------  203 (612)
T ss_pred             -----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------------HHHHHHhhhc------
Confidence                 128999999999998  556789999999999999999999843               1122222211      


Q ss_pred             cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                                  -..|......+.+++..++..+|.+|--.
T Consensus       204 ------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 ------------LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ------------cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                        11355666678888888888899888655

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.3e-18  Score=183.98  Aligned_cols=217  Identities=27%  Similarity=0.459  Sum_probs=161.4

Q ss_pred             HHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 036507          397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD  476 (639)
Q Consensus       397 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~D  476 (639)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..    ....++|.....+..+|++||+|||+..  --.|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence            4578899999999999999999999999999999999974    3456899999999999999999999854  239999


Q ss_pred             CCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCC-------CCCcchHHHHHHHHHHHHc
Q 036507          477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL-------ATAKSDVYAFGVVLFEIIS  549 (639)
Q Consensus       477 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DVws~Gvvl~ellt  549 (639)
                      +++.|.++|....+||+|||+........ .........-...|.|||.+....       .+.+.||||||++++|+++
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            99999999999999999999987653211 111111123445799999987631       4678999999999999999


Q ss_pred             CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 036507          550 GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK  629 (639)
Q Consensus       550 G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  629 (639)
                      -+.||.........    ..+...    ++..        -...+.|.+....  +...++..++..||..+|++||+++
T Consensus       154 r~~~~~~~~~~~~~----~eii~~----~~~~--------~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~  215 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDP----DEIILR----VKKG--------GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIE  215 (484)
T ss_pred             ccCccccccccCCh----HHHHHH----HHhc--------CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHH
Confidence            99999654331111    111111    1110        1122333332211  3344789999999999999999999


Q ss_pred             HHHHHHhhh
Q 036507          630 QVVISLSQI  638 (639)
Q Consensus       630 evl~~L~~i  638 (639)
                      ++-..++.+
T Consensus       216 ~i~~~~~~~  224 (484)
T KOG1023|consen  216 QIRSKLLTI  224 (484)
T ss_pred             HHHhhhhhh
Confidence            998877653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=5.7e-18  Score=168.65  Aligned_cols=226  Identities=18%  Similarity=0.260  Sum_probs=143.1

Q ss_pred             CCceeecCceEEEEEEEcC--ceEEEEEeccc------cHHHHHHHHHHHHhcC----------CCCeeEEEeee-----
Q 036507          356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT------KTKEFMAEMKILCKVH----------HSNLVELIGYA-----  412 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~------~~~~~~~E~~il~~l~----------h~niv~l~~~~-----  412 (639)
                      .+.||.|+++.||.+++.+  +.+|||.....      ..+++.+|.-....+.          |-.++-.++..     
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            6689999999999999964  89999987422      2345555554443322          21222222111     


Q ss_pred             ----e---cCC-----eEEEEEeeccCCChhhhccC---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 036507          413 ----A---TED-----ELFLIYEYAQKGSLKSHLHD---PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI  477 (639)
Q Consensus       413 ----~---~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dl  477 (639)
                          .   +.+     ..+++|+-+ .++|.+++..   .. .....+....++.+..|+.+.+++||+++   ++|+||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi  171 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-QTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI  171 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-cccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence                1   111     236677777 5688777532   11 11334666778888899999999999998   999999


Q ss_pred             CCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccC--------CCCCcchHHHHHHHHHHHHc
Q 036507          478 KSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG--------LATAKSDVYAFGVVLFEIIS  549 (639)
Q Consensus       478 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DVws~Gvvl~ellt  549 (639)
                      +|+|++++.+|.++|+||+.....+.      .......+..|.+||.....        .++.+.|.|++|+++|.|++
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGT------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTE------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCc------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999998765422      11113455789999977442        46889999999999999999


Q ss_pred             CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCC
Q 036507          550 GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR  625 (639)
Q Consensus       550 G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  625 (639)
                      |+.||..........                               ..+ ..+. +.++.+..||..+|+.+|.+|
T Consensus       246 ~~lPf~~~~~~~~~~-------------------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE-------------------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG-------------------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc-------------------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999996433210000                               011 1244 667789999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2e-17  Score=159.58  Aligned_cols=133  Identities=20%  Similarity=0.184  Sum_probs=102.1

Q ss_pred             CCCCceeecCceEEEEEEEcCceEEEEEeccc---cHHHHHHHHHHHHhc-----CCCCeeEEEeeeecCC---e-EEEE
Q 036507          354 SDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT---KTKEFMAEMKILCKV-----HHSNLVELIGYAATED---E-LFLI  421 (639)
Q Consensus       354 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l-----~h~niv~l~~~~~~~~---~-~~lv  421 (639)
                      ...+.||+|+||.||.... ....+||++...   ..+++.+|+++++++     +||||++++|++.++.   . +.+|
T Consensus         5 ~~~~~LG~G~~~~Vy~hp~-~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          5 SEQSPLGTGRHRKCYAHPE-DAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CCcceecCCCceEEEECCC-CcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            3467899999999996222 233478987644   456789999999999     5799999999998763   3 3378


Q ss_pred             Eee--ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCcEEECC----CCCEEEec
Q 036507          422 YEY--AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL-EYIHEHTKTHYVHRDIKSSNILLDS----AFRAKISD  494 (639)
Q Consensus       422 ~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D  494 (639)
                      +||  +.+|+|.+++...      .++..  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        84 ~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             ecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            999  5579999999642      14433  24567778777 9999988   999999999999974    34799999


Q ss_pred             cCCc
Q 036507          495 FGLA  498 (639)
Q Consensus       495 fgla  498 (639)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=2.6e-17  Score=160.62  Aligned_cols=131  Identities=19%  Similarity=0.378  Sum_probs=112.0

Q ss_pred             CceeecCceEEEEEEEcCceEEEEEecccc-----------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          357 SLLGHGTYGSVYYGNIRNQEVAIKRMTATK-----------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +.||+|++|.||+|...+..+++|......           ...+.+|++++..++|+++.....++...+..+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            579999999999999988999999764321           134778999999999999887777776777889999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +|++|.+++...        .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998531        12 67889999999999999987   99999999999999 78999999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=4.9e-17  Score=157.20  Aligned_cols=127  Identities=21%  Similarity=0.384  Sum_probs=105.1

Q ss_pred             ceeecCceEEEEEEEcCceEEEEEeccc-----------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          358 LLGHGTYGSVYYGNIRNQEVAIKRMTAT-----------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .||+|+||.||+|.+.+..+++|.....           ..+.+.+|++++..++|+++.....++...+..+++|||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            4899999999999998999999985421           12456789999999998876555555555667799999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +++|.+++....      .      .++.+++++|.+||+.+   ++|+|++|+||+++ ++.++++|||++..
T Consensus        81 g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        81 GKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998875311      0      67889999999999987   99999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.69  E-value=3.2e-17  Score=181.20  Aligned_cols=209  Identities=26%  Similarity=0.372  Sum_probs=143.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      .+|...++|..|+||.||..+++  .+++|+|+ +++..  +.+-  |+.....|.+|                     |
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--ilRn--ilt~a~npfvv---------------------g  136 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--ILRN--ILTFAGNPFVV---------------------G  136 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcc-cccch--hhhc--cccccCCccee---------------------c
Confidence            56778899999999999999877  57889843 33221  1111  22233333333                     5


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC--
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD--  506 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~--  506 (639)
                      +-.+.+...     .+++.        +++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++.......  
T Consensus       137 Dc~tllk~~-----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  137 DCATLLKNI-----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             hhhhhcccC-----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence            666666431     22322        2267899999987   99999999999999999999999999875322110  


Q ss_pred             ----------CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          507 ----------GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       507 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                                .+.....++||+.|+|||++.-+.|...+|+|++|+|+||.+-|+.||+....        ..|...+..
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp--------eelfg~vis  272 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFGQVIS  272 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH--------HHHHhhhhh
Confidence                      11112346899999999999999999999999999999999999999976432        122222222


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD  627 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  627 (639)
                      ....+++.                  .+....++++++.+.|+.+|..|--
T Consensus       273 d~i~wpE~------------------dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  273 DDIEWPEE------------------DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhcccccc------------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            22222111                  1122346889999999999999953

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1.5e-16  Score=176.84  Aligned_cols=134  Identities=22%  Similarity=0.332  Sum_probs=112.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----------KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      ...|...++||+|+||.||++.+.+..+++|+....           ..+.+.+|++++.+++|++++....++...+..
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            345566889999999999999988776666543211           124578999999999999999888877777788


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++++|.+++.             ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|+|||++
T Consensus       412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            99999999999998874             24678899999999999987   9999999999999 6789999999999


Q ss_pred             ee
Q 036507          499 KL  500 (639)
Q Consensus       499 ~~  500 (639)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            75

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=3.1e-16  Score=154.97  Aligned_cols=138  Identities=15%  Similarity=0.127  Sum_probs=106.8

Q ss_pred             CCCCCCceeecCceEEEEEE-E--cCceEEEEEecccc---------------------------HHHHHHHHHHHHhcC
Q 036507          352 GFSDSSLLGHGTYGSVYYGN-I--RNQEVAIKRMTATK---------------------------TKEFMAEMKILCKVH  401 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~-~--~~~~vavK~~~~~~---------------------------~~~~~~E~~il~~l~  401 (639)
                      .|...+.||+|+||.||+|. .  +++.||+|.++...                           ...+.+|++++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 2  57899999876421                           012467999999997


Q ss_pred             CC--CeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 036507          402 HS--NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKS  479 (639)
Q Consensus       402 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp  479 (639)
                      +.  .+.+++++    ...++||||+++++|......     ...+.......++.|++.++++||+++  +++||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            53  34455543    234899999999888766422     123445556789999999999999864  499999999


Q ss_pred             CcEEECCCCCEEEeccCCceec
Q 036507          480 SNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       480 ~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      +||+++ ++.++|+|||.+...
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhcc
Confidence            999999 889999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=2e-17  Score=171.57  Aligned_cols=177  Identities=29%  Similarity=0.446  Sum_probs=132.8

Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      ..+|+.|+++...+|.+||.+.+  .....+|...+.++.|++.+++|   ++   .+|+|+||.||+...+..+||.||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence            35789999999999999997543  33457888899999999999999   55   999999999999999999999999


Q ss_pred             CCceecCCCC---CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHH
Q 036507          496 GLAKLVGKTS---DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       496 gla~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      |+........   ......+...||..||+||.+.+..|+.|+||||||++|+||+. =...+...          ..+ 
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~-  469 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATL-  469 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhh-
Confidence            9987654322   11234566799999999999999999999999999999999998 22222110          000 


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV  631 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  631 (639)
                          ..++           ...+.|....++|.     -..++.+++...|.+||++.++
T Consensus       470 ----~d~r-----------~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 ----TDIR-----------DGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ----hhhh-----------cCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence                0011           11233333344443     3678999999999999955443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=6.6e-16  Score=153.84  Aligned_cols=194  Identities=22%  Similarity=0.279  Sum_probs=132.6

Q ss_pred             CCCCeeEEEeeeec---------------------------CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHH
Q 036507          401 HHSNLVELIGYAAT---------------------------EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI  453 (639)
Q Consensus       401 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  453 (639)
                      +|||||+++++|.+                           ...+|+||.-+ ..+|++++..      ...+.....-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~------~~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT------RHRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc------CCCchHHHHHH
Confidence            59999999986532                           23478888877 4589988854      23555566678


Q ss_pred             HHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC--CC--CCEEEeccCCceecCCCCC---CcceeeeeccccccCCcccc
Q 036507          454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLD--SA--FRAKISDFGLAKLVGKTSD---GEATVTKVVGTFGYLAPEYL  526 (639)
Q Consensus       454 ~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~--~~--~~~kl~Dfgla~~~~~~~~---~~~~~~~~~gt~~y~aPE~~  526 (639)
                      ..|+++|+.|||.++   |.|||+|++|||+.  ++  ..+.++|||.+---...+-   .....-...|...-||||+.
T Consensus       347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            889999999999998   99999999999993  33  3478999997642211000   00011123566778999987


Q ss_pred             ccCC--C----CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccC
Q 036507          527 TDGL--A----TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMD  600 (639)
Q Consensus       527 ~~~~--~----~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  600 (639)
                      ...+  .    -.|+|.|+.|.+.||++....||.....+..+.                       ....+---|.   
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-----------------------r~Yqe~qLPa---  477 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-----------------------RTYQESQLPA---  477 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-----------------------hhhhhhhCCC---
Confidence            5422  1    258999999999999999999996522111000                       0001111112   


Q ss_pred             CCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 036507          601 LYPHDCLFKMAMLAKQCVDEDPILRPDMKQV  631 (639)
Q Consensus       601 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  631 (639)
                       .|..++..+++++...++.||++|+|.+-.
T Consensus       478 -lp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  478 -LPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             -CcccCChHHHHHHHHHhcCCccccCCccHH
Confidence             345666779999999999999999987533

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=1.2e-15  Score=147.39  Aligned_cols=139  Identities=17%  Similarity=0.108  Sum_probs=107.7

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEecccc-------------------------HHHHHHHHHHHH
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK-------------------------TKEFMAEMKILC  398 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~-------------------------~~~~~~E~~il~  398 (639)
                      ++......|...+.||+|+||.||++... ++.+|||++....                         ...+.+|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            44444444777899999999999999874 7899999864321                         112567888999


Q ss_pred             hcCCCC--eeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 036507          399 KVHHSN--LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD  476 (639)
Q Consensus       399 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~D  476 (639)
                      .+.|++  +...++.    ...+++|||+++++|......           .....++.+++.++.++|+.+   ++|+|
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~D  150 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGD  150 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence            998774  4444432    345899999999999776421           123467889999999999977   99999


Q ss_pred             CCCCcEEECCCCCEEEeccCCceec
Q 036507          477 IKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       477 lkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+||++++++.++|+|||++...
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=6.5e-15  Score=134.87  Aligned_cols=134  Identities=20%  Similarity=0.231  Sum_probs=114.4

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEecccc-HHHHHHHHHHHHhcCC--CCeeEEEeeeecCCeEEEEEeeccCCChh
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-TKEFMAEMKILCKVHH--SNLVELIGYAATEDELFLIYEYAQKGSLK  431 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~  431 (639)
                      +.+.||+|.++.||++...+..+++|...... ..++.+|+.++..++|  .++.+++++....+..++++||++++.+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            35679999999999999988899999986654 3578899999999986  58999999888888899999999887775


Q ss_pred             hhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          432 SHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       432 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      .+            +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            43            4456677889999999999986445699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=99.61  E-value=1.4e-14  Score=151.22  Aligned_cols=50  Identities=24%  Similarity=0.415  Sum_probs=45.5

Q ss_pred             ceEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecCCC
Q 036507          150 YLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNS  200 (639)
Q Consensus       150 ~~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~~  200 (639)
                      ...+|+|++|||||.||++||+++++|++||++.+ +.|++||+|.||...
T Consensus       198 ~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s-~~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        198 NATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSS-SSIYVGQKLAIKQTA  247 (481)
T ss_pred             CCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCc-cccCCCCEEEecCCC
Confidence            35679999999999999999999999999999976 679999999999654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=2.5e-14  Score=141.69  Aligned_cols=132  Identities=17%  Similarity=0.238  Sum_probs=104.1

Q ss_pred             CCcee-ecCceEEEEEEEcCceEEEEEeccc----------------cHHHHHHHHHHHHhcCCCCe--eEEEeeeecCC
Q 036507          356 SSLLG-HGTYGSVYYGNIRNQEVAIKRMTAT----------------KTKEFMAEMKILCKVHHSNL--VELIGYAATED  416 (639)
Q Consensus       356 ~~~lG-~G~~g~Vy~~~~~~~~vavK~~~~~----------------~~~~~~~E~~il~~l~h~ni--v~l~~~~~~~~  416 (639)
                      ...|| .|+.|+||.....+..++||.....                ....+.+|++++.+|+|+++  +..+++...+.
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            45688 8999999999998999999977431                12346789999999998775  67777644322


Q ss_pred             e----EEEEEeeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          417 E----LFLIYEYAQK-GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       417 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                      .    .++|+|++++ .+|.+++..      ..++..    .+.+++.+|.+||+.+   |+|+||||+|||++.++.++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence            2    3599999997 689888753      123332    3568999999999988   99999999999999999999


Q ss_pred             EeccCCcee
Q 036507          492 ISDFGLAKL  500 (639)
Q Consensus       492 l~Dfgla~~  500 (639)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1.5e-15  Score=168.24  Aligned_cols=251  Identities=25%  Similarity=0.320  Sum_probs=181.2

Q ss_pred             CCCCCCceeecCceEEEEEEEc---CceEEEEEecccc-----HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTATK-----TKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~-----~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .|...+.||+|+|+.|-.....   ...+|+|.+....     .+....|..+-..+. |+|++.+++...+.+..++..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4455666999999999866543   3456777654331     223344677777776 999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCcee
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-EHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKL  500 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~  500 (639)
                      ||..++++.+.+..   ......+......++.|+..++.|+| ..+   +.|+|+||+|.+++..+ ..+++|||+|..
T Consensus       101 ~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  101 SYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             Cccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999998832   11112333344567889999999999 766   99999999999999999 999999999998


Q ss_pred             cCCCCCCcceeeeecc-ccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          501 VGKTSDGEATVTKVVG-TFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      +.............+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......      .....|+.   
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~------~~~~~~~~---  245 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD------GRYSSWKS---  245 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc------ccceeecc---
Confidence            7663445556666788 9999999999884 55788999999999999999999986543311      00111100   


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                                 ....    ..............++..+++..+|..|.+.+++-
T Consensus       246 -----------~~~~----~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  246 -----------NKGR----FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -----------cccc----cccCccccCChhhhhcccccccCCchhcccccccc
Confidence                       0000    00111222334567788889989999999887763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.52  E-value=8.4e-14  Score=133.07  Aligned_cols=131  Identities=21%  Similarity=0.228  Sum_probs=94.4

Q ss_pred             CCceeecCceEEEEEEEc-CceEEEEEeccccH-----HH----------------------HHHHHHHHHhcCCCC--e
Q 036507          356 SSLLGHGTYGSVYYGNIR-NQEVAIKRMTATKT-----KE----------------------FMAEMKILCKVHHSN--L  405 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~-----~~----------------------~~~E~~il~~l~h~n--i  405 (639)
                      .+.||+|+||.||++... ++.||||.++....     ..                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999887 78999998764311     11                      134566666665432  4


Q ss_pred             eEEEeeeecCCeEEEEEeeccCCChhhh-ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEE
Q 036507          406 VELIGYAATEDELFLIYEYAQKGSLKSH-LHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       406 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIl  483 (639)
                      .+.++.    ...+++|||++++.+... +....      .. .....++.+++.++.++|+ .+   |+|+||||+||+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil  147 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL  147 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence            444443    235899999998654322 11100      01 4466789999999999998 66   999999999999


Q ss_pred             ECCCCCEEEeccCCceec
Q 036507          484 LDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~  501 (639)
                      ++ ++.++|+|||.+...
T Consensus       148 i~-~~~~~liDfg~a~~~  164 (187)
T cd05119         148 VD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EE-CCcEEEEECcccccc
Confidence            99 899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=3.1e-12  Score=137.68  Aligned_cols=137  Identities=19%  Similarity=0.179  Sum_probs=95.9

Q ss_pred             CCceeecCceEEEEEEEc-CceEEEEEeccccHHH-------------------------------------------HH
Q 036507          356 SSLLGHGTYGSVYYGNIR-NQEVAIKRMTATKTKE-------------------------------------------FM  391 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~-------------------------------------------~~  391 (639)
                      .+.||.|++|.||+|++. |+.||||+.+....+.                                           +.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999985 7899999876432221                                           33


Q ss_pred             HHHHHHHhcC----CCCeeEEEeeee-cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 036507          392 AEMKILCKVH----HSNLVELIGYAA-TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR-GLEYIH  465 (639)
Q Consensus       392 ~E~~il~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-al~~LH  465 (639)
                      +|.+.+.+++    |.+-+.+-.++. ..+..++||||++|++|.++.....    ...+   +..++..+++ .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHH
Confidence            4444444442    222233323332 2345799999999999988764211    1122   3456666666 467889


Q ss_pred             hcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       466 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ..+   ++|+|+||.||++++++.++++|||++..+.
T Consensus       275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            877   9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=7.1e-13  Score=129.59  Aligned_cols=153  Identities=25%  Similarity=0.334  Sum_probs=115.0

Q ss_pred             HHHhcCCCCeeEEEeeeecC-----CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036507          396 ILCKVHHSNLVELIGYAATE-----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT  470 (639)
Q Consensus       396 il~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~  470 (639)
                      -|-++.|.|||++..|+.+.     .+..++.|||+.|+|..+|+..+ .....+......+|+-||..||.|||+.. |
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            34556799999999987653     35788999999999999998644 33456777788899999999999999976 7


Q ss_pred             CeeeCCCCCCcEEECCCCCEEEeccCCceecCCC--CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHH
Q 036507          471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT--SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII  548 (639)
Q Consensus       471 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ell  548 (639)
                      +|+|+++..+-|++..++.+|+.--.... ....  .........-.+-++|.+||+=.....+.++|||+||...+||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            79999999999999999988874221111 0000  00011111235678999999866666677899999999999998


Q ss_pred             cCC
Q 036507          549 SGK  551 (639)
Q Consensus       549 tG~  551 (639)
                      .|.
T Consensus       277 ilE  279 (458)
T KOG1266|consen  277 ILE  279 (458)
T ss_pred             Hhe
Confidence            875

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.32  E-value=8.2e-12  Score=117.21  Aligned_cols=128  Identities=18%  Similarity=0.136  Sum_probs=97.3

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEecccc--HHHHHHHHHHHHhcCCCCee-EEEeeeecCCeEEEEEeeccCCChhh
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTATK--TKEFMAEMKILCKVHHSNLV-ELIGYAATEDELFLIYEYAQKGSLKS  432 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~  432 (639)
                      .+.|+.|.++.||+.+..++.+++|......  ...+.+|++++..+.+.+++ +++.+.  .+..++||||+++.++..
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            3568899999999999989999999876543  24467899999998765544 444443  334589999999988764


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          433 HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT--KTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       433 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ..          .   ....++.+++++|..||+..  ...++|+|++|+||+++ ++.++++|||.+.
T Consensus        81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            31          0   01235678999999999876  23469999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.29  E-value=2.3e-12  Score=91.53  Aligned_cols=43  Identities=37%  Similarity=0.721  Sum_probs=36.0

Q ss_pred             EEecCCCcHHHHHHHhCCChHHHHHHc-CCCCCCCccCCceEEec
Q 036507          154 YVMKDGDTVQSLASRFGVSMDSIEQVN-GIVNPNNVTAGDLFYIP  197 (639)
Q Consensus       154 y~v~~Gdtl~~Ia~~~~~~~~~l~~~N-~~~~~~~l~~g~~l~ip  197 (639)
                      |+|++|||+|+||++||++.++|++|| ++..+. |.+||+|.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~-l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDN-LQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCccc-CCCCCEEEeC
Confidence            899999999999999999999999999 775544 9999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=7.5e-12  Score=132.91  Aligned_cols=244  Identities=27%  Similarity=0.296  Sum_probs=171.3

Q ss_pred             CCCCCCceee--cCceEEEEEEE----cCceEEEEEeccc-----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEE
Q 036507          352 GFSDSSLLGH--GTYGSVYYGNI----RNQEVAIKRMTAT-----KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELF  419 (639)
Q Consensus       352 ~f~~~~~lG~--G~~g~Vy~~~~----~~~~vavK~~~~~-----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~  419 (639)
                      .|.....+|.  |.+|.||.+..    ....+|+|+-+..     ....-.+|....+.++ |+|.++....+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4555778999  99999998876    2467888873321     2233346777777775 999999888888899999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEec
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----GLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISD  494 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D  494 (639)
                      +-.|++ +.+|.++.+...+.    ++....+.+..+...    |+.++|+..   ++|-|+||.||+...+ ...+++|
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~----~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNF----LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeccc-cchhHHhhhccccc----CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            999988 57998888764332    333334444555555    999999987   9999999999999999 8899999


Q ss_pred             cCCceecCCCCCCcce--eeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHH
Q 036507          495 FGLAKLVGKTSDGEAT--VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       495 fgla~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      ||+...++........  .....|...|++||... +.++...|+|++|.+.+|-.+|-+.......             
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------------  332 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-------------  332 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-------------
Confidence            9999988654422221  12236788899999874 4678899999999999999998765532210             


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                               ..+   ..++....   ..++-.....++...+..+++.+|-.|++.+.+.
T Consensus       333 ---------~~W---~~~r~~~i---p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  333 ---------SSW---SQLRQGYI---PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             ---------CCc---cccccccC---chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence                     000   00111111   1111112233455688999999999999988765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.13  E-value=1.1e-09  Score=117.55  Aligned_cols=160  Identities=15%  Similarity=0.228  Sum_probs=116.1

Q ss_pred             CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHH
Q 036507          374 NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR  450 (639)
Q Consensus       374 ~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~  450 (639)
                      +.+|.|...+..   ......+-++.|+.++||||++++.....++..|+|.|-+.  .|...+..        +.....
T Consensus        37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~~~v  106 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGKEEV  106 (690)
T ss_pred             CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHHHHH
Confidence            345555544332   23446677888999999999999999999999999999873  67766653        223344


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCC
Q 036507          451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL  530 (639)
Q Consensus       451 ~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  530 (639)
                      .-.+.||+.||.|||+.+  +++|++|..+.|++++.|..||++|.++........   ......--..|..|+.+....
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc
Confidence            456789999999999765  699999999999999999999999998764422211   111112223456666543322


Q ss_pred             CCCcchHHHHHHHHHHHHcC
Q 036507          531 ATAKSDVYAFGVVLFEIISG  550 (639)
Q Consensus       531 ~~~~~DVws~Gvvl~elltG  550 (639)
                        -..|.|.||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              245999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.12  E-value=5.4e-11  Score=129.66  Aligned_cols=141  Identities=15%  Similarity=0.183  Sum_probs=90.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHH----------------------------------------
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK----------------------------------------  388 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----------------------------------------  388 (639)
                      ..|+. +.||+|++|.||+|++.  |+.||||+++....+                                        
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 68999999999999985  689999998643110                                        


Q ss_pred             ---HHHHHHHHHHhcC----CCCeeEEEeeeec-CCeEEEEEeeccCCChhhhc--cCCCCCCCCCCCHHHHHHHHHHHH
Q 036507          389 ---EFMAEMKILCKVH----HSNLVELIGYAAT-EDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAA  458 (639)
Q Consensus       389 ---~~~~E~~il~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia  458 (639)
                         ++.+|+.-+.+++    +.+.+.+-.++.+ ....+|||||++|+++.+.-  .... .....+.......++.|  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHH--
Confidence               1334444444442    3333443333332 35678999999999998742  2100 00111222222222223  


Q ss_pred             HHHHHHHhcCCCCeeeCCCCCCcEEECCCC----CEEEeccCCceecCC
Q 036507          459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAF----RAKISDFGLAKLVGK  503 (639)
Q Consensus       459 ~al~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~  503 (639)
                           ++..+   ++|+|+||.||+++.++    .++++|||++..++.
T Consensus       276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 34455   99999999999999888    999999999987643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=5.3e-10  Score=102.32  Aligned_cols=128  Identities=23%  Similarity=0.385  Sum_probs=101.3

Q ss_pred             CceeecCceEEEEEEEcCceEEEEEeccc-----------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          357 SLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..+++|+-+.+|.+.+.+..+++|.-...           ..+...+|..++.+++--.|....-+..+.+...++|||.
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            35789999999999888877777753211           1244678999999997666555555666778889999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +|..|.+.+...            +..++..+-.-+.-||..+   |+|+||.++||++..+. +.++|||++.+
T Consensus        82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888642            2456677788889999987   99999999999998765 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.08  E-value=1.1e-09  Score=99.76  Aligned_cols=140  Identities=19%  Similarity=0.207  Sum_probs=103.8

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEeccc-----------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ...+|-+|+-+.|+++.+.++...||.-...           ..+...+|+++|.+++--.|.-..-++.+...-.++||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            4678999999999999999999888853211           13457889999999875555554445555566678899


Q ss_pred             eccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC---EEEeccCCce
Q 036507          424 YAQK-GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAK  499 (639)
Q Consensus       424 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~  499 (639)
                      |+++ .++.+++...-.   ..........++..|-+.+.-||...   |+|+||.++||++..++.   +.++|||++.
T Consensus        91 ~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             eccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence            9966 477777754221   11222223577888999999999987   999999999999976543   5899999986


Q ss_pred             e
Q 036507          500 L  500 (639)
Q Consensus       500 ~  500 (639)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=2.7e-09  Score=101.28  Aligned_cols=131  Identities=18%  Similarity=0.167  Sum_probs=93.4

Q ss_pred             CceeecCceEEEEEEEc--------CceEEEEEeccc-------------------------cHHHH----HHHHHHHHh
Q 036507          357 SLLGHGTYGSVYYGNIR--------NQEVAIKRMTAT-------------------------KTKEF----MAEMKILCK  399 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--------~~~vavK~~~~~-------------------------~~~~~----~~E~~il~~  399 (639)
                      ..||.|--+.||.|...        +..+|||+.+..                         ..+.+    .+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999754        268999965311                         01112    379999999


Q ss_pred             cCC--CCeeEEEeeeecCCeEEEEEeeccCCChhh-hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeC
Q 036507          400 VHH--SNLVELIGYAATEDELFLIYEYAQKGSLKS-HLHDPQNRGQTSLSWIMRVQIALDAARGLEYI-HEHTKTHYVHR  475 (639)
Q Consensus       400 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~~ivH~  475 (639)
                      +..  -++..++.+    ..-++||||+.++.+.. .+.+      ..++......+..+++.+|..| |..+   ++|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            863  456666654    45689999997654422 2221      1233344566778999999999 7766   9999


Q ss_pred             CCCCCcEEECCCCCEEEeccCCceec
Q 036507          476 DIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       476 Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      ||++.||+++ ++.+.|+|||.+...
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeC
Confidence            9999999997 468999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.05  E-value=2.1e-09  Score=105.45  Aligned_cols=137  Identities=18%  Similarity=0.246  Sum_probs=106.9

Q ss_pred             CceeecCceEEEEEEEcC-ceEEEEEecccc----HHHHHHHHHHHHhcCC--CCeeEEEeeeecC---CeEEEEEeecc
Q 036507          357 SLLGHGTYGSVYYGNIRN-QEVAIKRMTATK----TKEFMAEMKILCKVHH--SNLVELIGYAATE---DELFLIYEYAQ  426 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~----~~~~~~E~~il~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  426 (639)
                      +.|+.|..+.+|+....+ +.+++|......    ..++.+|.++++.+++  .++.+++.+....   +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999998876 789999876532    4568899999999975  4457777776654   25689999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT--------------------------------------  468 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--------------------------------------  468 (639)
                      +.++.+.+..      ..++...+..++.++++.|..||+..                                      
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888776531      23566677778888888888888521                                      


Q ss_pred             ---------------CCCeeeCCCCCCcEEECC--CCCEEEeccCCce
Q 036507          469 ---------------KTHYVHRDIKSSNILLDS--AFRAKISDFGLAK  499 (639)
Q Consensus       469 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~  499 (639)
                                     ...++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                           245899999999999998  5668999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.01  E-value=2.1e-10  Score=122.86  Aligned_cols=96  Identities=19%  Similarity=0.207  Sum_probs=77.0

Q ss_pred             eeEEEeCCCCCHHHHHHHhcCCcccceeccC-------CCceEeeeeeeeccCCCCceeeceeEEEEcCCceeehhHH--
Q 036507           43 FLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN-------EKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVYDVVV--  113 (639)
Q Consensus        43 ~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n-------~~~~l~ip~~~~~~~~~~~~~~~~~y~v~~gd~t~~~ia~--  113 (639)
                      ...|+|++||||+.||++||+++.+|..+|+       .||.|.||.++.+.... ......+|+|++|| |+|.||+  
T Consensus       343 ~~~y~Vk~GDTL~sIA~r~gvs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~~-~~~~~~~Y~Vr~GD-TL~sIA~ky  420 (456)
T PRK10783        343 SRSYKVRSGDTLSGIASRLNVSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRLA-NNSDSITYRVRKGD-SLSSIAKRH  420 (456)
T ss_pred             ceEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCcccCCCCCEEEecCCccccccc-ccccceeEEeCCCC-CHHHHHHHh
Confidence            4679999999999999999999999997776       56899999877664211 12234569999999 9999999  


Q ss_pred             -HhcCCcccccCCC-cccCCCCEEEEeee
Q 036507          114 -NAYDGLAILDNST-RMARAGAVVSLRLF  140 (639)
Q Consensus       114 -~~~~~l~~~~~~~-~~l~~g~~l~ip~~  140 (639)
                       .+.+.|..||+.. +.|++||+|.|++.
T Consensus       421 gVtv~~L~~~N~l~~~~L~pGq~L~l~v~  449 (456)
T PRK10783        421 GVNIKDVMRWNSDTAKNLQPGDKLTLFVK  449 (456)
T ss_pred             CCCHHHHHHhcCCCCCcCCCCCEEEEecC
Confidence             5777788888532 26999999999874

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.99  E-value=8.4e-10  Score=92.53  Aligned_cols=51  Identities=25%  Similarity=0.496  Sum_probs=43.3

Q ss_pred             ceEEEEecCCCcHHHHHHHhCCC--------hHHHHHHcCCCCCCCccCCceEEecCCCC
Q 036507          150 YLMSYVMKDGDTVQSLASRFGVS--------MDSIEQVNGIVNPNNVTAGDLFYIPLNSV  201 (639)
Q Consensus       150 ~~~~y~v~~Gdtl~~Ia~~~~~~--------~~~l~~~N~~~~~~~l~~g~~l~ip~~~~  201 (639)
                      ...+|+|++|||||+||++|+.+        ++.|++.|++.+ +.|+|||+|.||+...
T Consensus        35 ~~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~-~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         35 QYVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPS-GHIKAGDKLVIPVLKS   93 (103)
T ss_pred             CcEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCC-CcCCCCCEEEEecCCC
Confidence            35679999999999999999876        577788899976 5799999999997643

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.95  E-value=1.1e-09  Score=77.68  Aligned_cols=42  Identities=36%  Similarity=0.630  Sum_probs=38.8

Q ss_pred             ecCCCcHHHHHHHhCCChHHHHHHcC-CCCCCCccCCceEEec
Q 036507          156 MKDGDTVQSLASRFGVSMDSIEQVNG-IVNPNNVTAGDLFYIP  197 (639)
Q Consensus       156 v~~Gdtl~~Ia~~~~~~~~~l~~~N~-~~~~~~l~~g~~l~ip  197 (639)
                      |++|||||+||++||++.++|.++|+ +.+++.+.+||+|.||
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            68999999999999999999999997 5567789999999998

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.95  E-value=3.5e-08  Score=100.38  Aligned_cols=266  Identities=16%  Similarity=0.189  Sum_probs=159.4

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEee------eecCCe-EEEEEeeccC
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGY------AATEDE-LFLIYEYAQK  427 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~------~~~~~~-~~lv~e~~~~  427 (639)
                      .+-||+|+-+.+|---.-...|| |+....-...-...++.|... .||-+-.-+.+      ..+++. .-+.|..+++
T Consensus        16 gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g   94 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVSG   94 (637)
T ss_pred             CccccCCccceeeecchhhchhh-eeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCCC
Confidence            56799999999994322223344 665443221112233344433 35533221111      112222 5667777655


Q ss_pred             C-ChhhhccC-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          428 G-SLKSHLHD-PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       428 g-sL~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      . ....++.- .+.......+|...++++..++.+.+-||+.+   .+-+|++++|+|+.+++.+.|.|=+.-...    
T Consensus        95 ~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~----  167 (637)
T COG4248          95 KEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN----  167 (637)
T ss_pred             ccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec----
Confidence            3 23333321 22234456799999999999999999999998   889999999999999999999997655432    


Q ss_pred             CCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcC-Cccccccccccchhh-hhhhHHHHHHHHh
Q 036507          506 DGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISG-KEAIIRTEGMVSKNQ-ERRSLASFMLAAL  578 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG-~~p~~~~~~~~~~~~-~~~~l~~~~~~~~  578 (639)
                      .........+|...|.+||.-.     +..-+...|-|.+||++++|+.| ++||.+......... .+..+..   ..+
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~---g~f  244 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH---GRF  244 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc---cee
Confidence            2333445568999999999754     34456789999999999999986 999965332111100 0000000   000


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED--PILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~i  638 (639)
                      ...      .+...-..|.-....-.-.+..+..+..+|+...  +.-||+++-++..|..+
T Consensus       245 ~ya------~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         245 AYA------SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eec------hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            000      0000011111111111234556788889999653  56899999999888653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.93  E-value=5.7e-10  Score=118.72  Aligned_cols=244  Identities=20%  Similarity=0.231  Sum_probs=169.3

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEc---CceEEEEEecccc---HHH--HHHHHHHHHhcC-CCCeeEEEeeeecCC
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTATK---TKE--FMAEMKILCKVH-HSNLVELIGYAATED  416 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~---~~~--~~~E~~il~~l~-h~niv~l~~~~~~~~  416 (639)
                      ......+|.....||.|.|+.|+....+   +..|++|.+...-   ..+  -..|+-+...+. |.+++..+..+..-.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3445668889999999999999976644   4678888765432   111  245666666664 888888777766667


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEecc
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDF  495 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  495 (639)
                      ..|+--||++++++...+.     ....++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.||
T Consensus       340 ~~~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cccCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence            7789999999998877652     1234566667788899999999999877   9999999999999886 78899999


Q ss_pred             CCceecCCCCCCcceeeeeccccccC--CccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYL--APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      |.+..+....      ....+..+++  +++......+..+.|+++||.-+.|.++|.........              
T Consensus       412 ~~~t~~~~~~------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------------  471 (524)
T KOG0601|consen  412 GCWTRLAFSS------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------------  471 (524)
T ss_pred             ccccccceec------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------------
Confidence            9886432111      1112233344  55566667788999999999999999998743311110              


Q ss_pred             HHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                                   ...+..-.-+.    .+.. ...+..+...+...|+..||++.++....
T Consensus       472 -------------~~~i~~~~~p~----~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  472 -------------SLTIRSGDTPN----LPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             -------------ceeeecccccC----CCch-HHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                         00111111111    1122 25677788899999999999998876543

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.87  E-value=2.5e-09  Score=94.72  Aligned_cols=47  Identities=26%  Similarity=0.681  Sum_probs=44.2

Q ss_pred             eEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecC
Q 036507          151 LMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPL  198 (639)
Q Consensus       151 ~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~  198 (639)
                      ..+|+|++||||+.||++|++++.+|+++|++.++ .+++||.|.+|.
T Consensus        66 ~~~~~V~~gdtL~~Ia~~~~~tv~~l~~~n~l~~~-~i~~gq~l~~~~  112 (124)
T COG1388          66 VVTYTVKKGDTLSKIARKYGVTVAELKQLNNLSSD-KIKVGQKLKLPV  112 (124)
T ss_pred             CceEEEecCCCHHHHHHHhCCCHHHHHHHhccCCC-ceecCcEEEEec
Confidence            45799999999999999999999999999999875 999999999996

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=3.3e-08  Score=99.16  Aligned_cols=138  Identities=14%  Similarity=0.122  Sum_probs=99.4

Q ss_pred             CceeecCceEEEEEEEcCceEEEEEecccc----HH----------HHHHHHHHHHhcCCC--CeeEEEeeeec-----C
Q 036507          357 SLLGHGTYGSVYYGNIRNQEVAIKRMTATK----TK----------EFMAEMKILCKVHHS--NLVELIGYAAT-----E  415 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~----~~----------~~~~E~~il~~l~h~--niv~l~~~~~~-----~  415 (639)
                      +.+-.-....|++....|+.+.||......    .+          .+.+|.+.+.+|...  ....++++...     .
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444445577888888999999764332    11          367899998888533  23344445432     2


Q ss_pred             CeEEEEEeeccCC-ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-------C
Q 036507          416 DELFLIYEYAQKG-SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-------A  487 (639)
Q Consensus       416 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-------~  487 (639)
                      ..-++|+|++++. +|.+++....   ....+...+..++.++++.+.-||+.+   |+|+|++++|||++.       +
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence            3568999999875 8988875311   123455667788999999999999988   999999999999975       4


Q ss_pred             CCEEEeccCCcee
Q 036507          488 FRAKISDFGLAKL  500 (639)
Q Consensus       488 ~~~kl~Dfgla~~  500 (639)
                      ..+.|+||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6799999998853

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.86  E-value=2.5e-09  Score=107.47  Aligned_cols=47  Identities=26%  Similarity=0.383  Sum_probs=45.1

Q ss_pred             EEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecCC
Q 036507          153 SYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLN  199 (639)
Q Consensus       153 ~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~  199 (639)
                      +|+||+|||||.||++||+++.+|.+||+|.+|+.|++||+|.||..
T Consensus        62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             ceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence            49999999999999999999999999999999999999999999864

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.85  E-value=5.7e-09  Score=74.10  Aligned_cols=45  Identities=38%  Similarity=0.846  Sum_probs=42.6

Q ss_pred             EEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEec
Q 036507          153 SYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIP  197 (639)
Q Consensus       153 ~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip  197 (639)
                      +|+|++|||+++||++||++..+|.++|+..+...+.+|+.|.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence            599999999999999999999999999999777889999999987

This domain may have a general peptidoglycan binding function.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.84  E-value=9.8e-10  Score=122.79  Aligned_cols=246  Identities=23%  Similarity=0.283  Sum_probs=158.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC--ceEEEEEec------cccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMT------ATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|.+.+-+.+|+++.++.+.-.+  ...+.|...      ....+....+-.++-.-+||-++...--+.-....+|+
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            3556666678889999988665432  222333221      11122222232233223456666555444557788999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      ++|+.+++|...++....     .+..........+..+.+|||+..   +.|+|++|.|.+...+++.++.|||.....
T Consensus       883 ~~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hHHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            999999999999986432     222222334456678899999876   899999999999999999999999843221


Q ss_pred             CCC---------------------C-------CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcc
Q 036507          502 GKT---------------------S-------DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEA  553 (639)
Q Consensus       502 ~~~---------------------~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p  553 (639)
                      +..                     .       +.........||+.|.+||.+.+......+|+|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                     0       000112235789999999999999999999999999999999999999


Q ss_pred             ccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH
Q 036507          554 IIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK  629 (639)
Q Consensus       554 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  629 (639)
                      |......        ..   +..++...              ..+. ..+.....+..+++...+..+|.+|-.|.
T Consensus      1035 ~na~tpq--------~~---f~ni~~~~--------------~~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQ--------QI---FENILNRD--------------IPWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchh--------hh---hhccccCC--------------CCCC-CCccccChhhhhhhhhhhccCchhccCcc
Confidence            8543320        00   00111110              0000 12334455677888889999999997665

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.83  E-value=1e-07  Score=99.61  Aligned_cols=166  Identities=18%  Similarity=0.263  Sum_probs=124.9

Q ss_pred             eEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEEEEeeccC-CChhhhc
Q 036507          365 GSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAAT----EDELFLIYEYAQK-GSLKSHL  434 (639)
Q Consensus       365 g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~l  434 (639)
                      .+.|++..+  |..|++|+++...   ......-+++++++.|+|+|++.+++..    +..+++||+|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            577888664  6789999995432   2233456889999999999999988762    4578999999986 6776654


Q ss_pred             cCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          435 HDPQN----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       435 ~~~~~----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      .....          .....+++...+.++.|+..||.++|+.|   +.-+-|.+.+|+++.+.+++|+..|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            33211          12344677888999999999999999988   888999999999999999999999988765322


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEA  553 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p  553 (639)
                      .               .  |-+.+   -.+-|.=.||.+++.|.||...
T Consensus       447 ~---------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 P---------------T--EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             C---------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            1               0  11222   1367899999999999999754

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.77  E-value=1.1e-08  Score=101.47  Aligned_cols=48  Identities=27%  Similarity=0.596  Sum_probs=44.8

Q ss_pred             CceEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEec
Q 036507          149 NYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIP  197 (639)
Q Consensus       149 ~~~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip  197 (639)
                      ....+|+|++|||||+||+|||+++++|++||++. ++.|++||+|+||
T Consensus       291 ~~~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~-~~~L~~GQ~L~IP  338 (338)
T TIGR02907       291 TKLRMCIVQEGDTIETIAERYEISVSQLIRHNQLE-DFEVNEGQILYIP  338 (338)
T ss_pred             cccEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence            45678999999999999999999999999999997 6899999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=1.7e-08  Score=109.00  Aligned_cols=151  Identities=23%  Similarity=0.377  Sum_probs=103.5

Q ss_pred             HHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCccee------eeeccccccCCccccccC
Q 036507          456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV------TKVVGTFGYLAPEYLTDG  529 (639)
Q Consensus       456 ~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~  529 (639)
                      +++.|+.|+|...  ++||++|.|++|.++.++..||+.|+++.............      --......|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4458999999864  79999999999999999999999999876443211100000      011334579999999998


Q ss_pred             CCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHH
Q 036507          530 LATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLF  608 (639)
Q Consensus       530 ~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  608 (639)
                      ..+.++|+||+||++|.+.. |+..+........                         .......+..-...++.+.+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-------------------------~~~~~~~~~~~~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-------------------------YSFSRNLLNAGAFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcch-------------------------hhhhhcccccccccccccCcH
Confidence            88999999999999999995 4444432221100                         001111111111223456677


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          609 KMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       609 ~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ++++-+.+++..++..||++.++..
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhc
Confidence            8999999999999999998877653

>PRK09902 hypothetical protein; Provisional

Probab=98.58  E-value=1.3e-06  Score=83.14  Aligned_cols=150  Identities=12%  Similarity=0.139  Sum_probs=108.2

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEec---------cccHHHHHHHHHHHHhcCC--CCeeEEEee
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMT---------ATKTKEFMAEMKILCKVHH--SNLVELIGY  411 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~---------~~~~~~~~~E~~il~~l~h--~niv~l~~~  411 (639)
                      ++.+........+.---|+||-+.|++-...+..+-+|+..         ..-...|.+|...|.+|..  -++.+++ +
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f   88 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-F   88 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-e
Confidence            34444433344334445778999999998888889999764         1234568999999999863  2344444 3


Q ss_pred             ee-c--C--CeEEEEEeeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC
Q 036507          412 AA-T--E--DELFLIYEYAQK-GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD  485 (639)
Q Consensus       412 ~~-~--~--~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~  485 (639)
                      +. .  .  -.-+||+|-+.+ -+|.+++.+   ....+.+...+..+..++++.+.-||+.+   +.|+|+.+.||+++
T Consensus        89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~---~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~  162 (216)
T PRK09902         89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQ---HAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVK  162 (216)
T ss_pred             eeeeccCCceEEEEEEEeCCCCccHHHHHhc---CCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeec
Confidence            22 1  1  235789997753 688888754   22234567778889999999999999988   99999999999998


Q ss_pred             CCCC--EEEeccCCce
Q 036507          486 SAFR--AKISDFGLAK  499 (639)
Q Consensus       486 ~~~~--~kl~Dfgla~  499 (639)
                      .++.  ++++||.-++
T Consensus       163 ~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        163 TEGKAEAGFLDLEKSR  178 (216)
T ss_pred             CCCCeeEEEEEhhccc
Confidence            6667  9999998665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.57  E-value=8.9e-07  Score=83.79  Aligned_cols=120  Identities=23%  Similarity=0.226  Sum_probs=77.3

Q ss_pred             EEEEEEc-CceEEEEEeccc---------------c--------------HHHHHHHHHHHHhcCCC--CeeEEEeeeec
Q 036507          367 VYYGNIR-NQEVAIKRMTAT---------------K--------------TKEFMAEMKILCKVHHS--NLVELIGYAAT  414 (639)
Q Consensus       367 Vy~~~~~-~~~vavK~~~~~---------------~--------------~~~~~~E~~il~~l~h~--niv~l~~~~~~  414 (639)
                      ||.|... +..+|||..+..               .              .....+|.+.|.++..-  ++.+++.+.  
T Consensus         2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--   79 (188)
T PF01163_consen    2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN--   79 (188)
T ss_dssp             EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred             EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence            8888874 678999975321               0              12356899999999865  456666553  


Q ss_pred             CCeEEEEEeecc--CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          415 EDELFLIYEYAQ--KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY-IHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       415 ~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                        .-++||||++  +..+..+....       ++......++.+++..+.. +|..+   |+|+||.+.||+++++ .+.
T Consensus        80 --~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 --RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred             --CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence              3479999998  65565544321       1122234566777776666 46665   9999999999999988 999


Q ss_pred             EeccCCceec
Q 036507          492 ISDFGLAKLV  501 (639)
Q Consensus       492 l~Dfgla~~~  501 (639)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>smart00257 LysM Lysin motif

Probab=98.52  E-value=1.7e-07  Score=65.54  Aligned_cols=44  Identities=36%  Similarity=0.776  Sum_probs=40.0

Q ss_pred             EEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEe
Q 036507          153 SYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYI  196 (639)
Q Consensus       153 ~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~i  196 (639)
                      +|+|++|||+|+||++|+++..++.++|+..+...+.+|+.+.|
T Consensus         1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEeC
Confidence            38999999999999999999999999999766688999998864

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.49  E-value=6.4e-07  Score=86.83  Aligned_cols=105  Identities=22%  Similarity=0.245  Sum_probs=80.9

Q ss_pred             HHHHHHHHHHHhcCC--CCeeEEEeeeecC----CeEEEEEeeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHH
Q 036507          388 KEFMAEMKILCKVHH--SNLVELIGYAATE----DELFLIYEYAQK-GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG  460 (639)
Q Consensus       388 ~~~~~E~~il~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~a  460 (639)
                      ....+|.+.+.+|..  -...+.+++....    ...++|+|++++ .+|.+++....     ..+......++.++++.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARL  130 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHH
Confidence            346788888877753  3345556655442    245899999987 48999886421     14555677899999999


Q ss_pred             HHHHHhcCCCCeeeCCCCCCcEEECCCC---CEEEeccCCcee
Q 036507          461 LEYIHEHTKTHYVHRDIKSSNILLDSAF---RAKISDFGLAKL  500 (639)
Q Consensus       461 l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~  500 (639)
                      +.-||+.+   |+|+|+++.|||++.+.   .+.++||+.++.
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999988   99999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=98.45  E-value=2e-07  Score=98.18  Aligned_cols=47  Identities=21%  Similarity=0.418  Sum_probs=43.2

Q ss_pred             EEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecCC
Q 036507          152 MSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLN  199 (639)
Q Consensus       152 ~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~  199 (639)
                      .+|+|++|||||+||++||+++++|+++|++. ++.|++||.|.||..
T Consensus        28 ~tytVq~GDTLw~IA~~ygvtv~~I~~~N~l~-~~~I~~Gq~L~Ip~~   74 (481)
T PRK13914         28 STVVVEAGDTLWGIAQSKGTTVDAIKKANNLT-TDKIVPGQKLQVNEV   74 (481)
T ss_pred             ceEEECCCCCHHHHHHHHCCCHHHHHHHhCCC-cccccCCCEEEeCCC
Confidence            35999999999999999999999999999995 478999999999954

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=98.39  E-value=3.8e-07  Score=82.69  Aligned_cols=46  Identities=26%  Similarity=0.509  Sum_probs=41.5

Q ss_pred             EEEEecCCCcHHHHHHHhC---CChHHHHHHcC--CCCCCCccCCceEEec
Q 036507          152 MSYVMKDGDTVQSLASRFG---VSMDSIEQVNG--IVNPNNVTAGDLFYIP  197 (639)
Q Consensus       152 ~~y~v~~Gdtl~~Ia~~~~---~~~~~l~~~N~--~~~~~~l~~g~~l~ip  197 (639)
                      .+|+|++|||||+||++|.   .....|.++|+  +.+++.|+|||+|.||
T Consensus        96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            4699999999999999984   35789999998  8888999999999998

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.39  E-value=1.7e-06  Score=84.38  Aligned_cols=131  Identities=17%  Similarity=0.125  Sum_probs=92.2

Q ss_pred             CCCCceeecCceEEEEEEEc-CceEEEEEeccc-------------------------cHHHHHHHHHHHHhcCCC--Ce
Q 036507          354 SDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT-------------------------KTKEFMAEMKILCKVHHS--NL  405 (639)
Q Consensus       354 ~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~-------------------------~~~~~~~E~~il~~l~h~--ni  405 (639)
                      .....||-|.-+.||.|... +.++|||.=+..                         ......+|.++|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            44678999999999999886 789999942110                         012356899999999744  56


Q ss_pred             eEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC
Q 036507          406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD  485 (639)
Q Consensus       406 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~  485 (639)
                      .+.+++    +.-.+||||+++-.|...--          +....-.++..|++-+.-+-..+   |+|+|+++-||+++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            666654    44579999998866654421          11112234445555555544544   99999999999999


Q ss_pred             CCCCEEEeccCCceec
Q 036507          486 SAFRAKISDFGLAKLV  501 (639)
Q Consensus       486 ~~~~~kl~Dfgla~~~  501 (639)
                      ++|.+.++||--+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.37  E-value=5.2e-06  Score=81.57  Aligned_cols=138  Identities=17%  Similarity=0.183  Sum_probs=85.7

Q ss_pred             CceeecCceEEEEEEEcCceEEEEEecccc-HHHHHHHHHHHHhcCCCC--eeEEEeeeecCCeEEEEEeeccCCC-hhh
Q 036507          357 SLLGHGTYGSVYYGNIRNQEVAIKRMTATK-TKEFMAEMKILCKVHHSN--LVELIGYAATEDELFLIYEYAQKGS-LKS  432 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L~~  432 (639)
                      ..||+|..+.||+.  .+..+++|...... .....+|.++++.+..-+  +.+.+++....+...++||+++|.+ +..
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~   84 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSR   84 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhh
Confidence            56899999999984  35577888876543 456788999999986433  4667777777777889999998863 211


Q ss_pred             h---------------------ccCCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhc-CCCCeeeCCCCC
Q 036507          433 H---------------------LHDPQNRGQTSLSWIMRVQIAL----------DAAR-GLEYIHEH-TKTHYVHRDIKS  479 (639)
Q Consensus       433 ~---------------------l~~~~~~~~~~l~~~~~~~i~~----------~ia~-al~~LH~~-~~~~ivH~Dlkp  479 (639)
                      .                     +|..... ...+.... ..+-.          .+.+ ...+|... ..+.++|+|+.|
T Consensus        85 ~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        85 IISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            1                     2211000 01111000 00000          0011 12222211 134589999999


Q ss_pred             CcEEECCCCCEEEeccCCce
Q 036507          480 SNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       480 ~NIll~~~~~~kl~Dfgla~  499 (639)
                      .||++++++ +.++||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.33  E-value=7.5e-07  Score=74.80  Aligned_cols=47  Identities=15%  Similarity=0.046  Sum_probs=37.1

Q ss_pred             CcceeEEEeCCCCCHHHHHHHhcCC--------cccceeccC-------CCceEeeeeeeec
Q 036507           40 CATFLAYEMQPNQTLSVIQSMFDVL--------PKDVTVEGN-------EKNYIFIKKNCSC   86 (639)
Q Consensus        40 c~~~~~y~v~~g~~l~~ia~~~~~~--------~~~i~~~~n-------~~~~l~ip~~~~~   86 (639)
                      +..+..|+|++|||||.||++|+++        +..|+..|+       .||.|.||+..+-
T Consensus        33 ~~~~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~~~~~   94 (103)
T PRK14125         33 KNQYVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPVLKSK   94 (103)
T ss_pred             CCCcEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEecCCCC
Confidence            4568999999999999999999876        355554454       6799999986643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=3e-06  Score=92.17  Aligned_cols=136  Identities=16%  Similarity=0.182  Sum_probs=88.6

Q ss_pred             CceeecCceEEEEEEEc-CceEEEEEeccccHH-------------------------------------------HHHH
Q 036507          357 SLLGHGTYGSVYYGNIR-NQEVAIKRMTATKTK-------------------------------------------EFMA  392 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-------------------------------------------~~~~  392 (639)
                      +-|+.++-|.||+|++. |+.||||+.+.+-.+                                           ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            56999999999999998 799999987533211                                           1334


Q ss_pred             HHHHHHhcC-----CCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 036507          393 EMKILCKVH-----HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG-LEYIHE  466 (639)
Q Consensus       393 E~~il~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~a-l~~LH~  466 (639)
                      |..-+.+++     .+++.-..-|....+...|+|||++|-.+.+...-..    ...+.   ..++..++++ +..+-.
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~---k~ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDR---KELAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCH---HHHHHHHHHHHHHHHHh
Confidence            554444442     3333322222333466789999999988888742111    12332   2233333332 222223


Q ss_pred             cCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       467 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      .+   ++|.|.+|.||+++.++++.+.|||+...+.
T Consensus       284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            34   9999999999999999999999999987664

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.25  E-value=1.5e-05  Score=76.18  Aligned_cols=134  Identities=13%  Similarity=0.162  Sum_probs=91.6

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccccH------------HHHHHHHHHHHhcCCC---CeeEEEee--
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT------------KEFMAEMKILCKVHHS---NLVELIGY--  411 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~------------~~~~~E~~il~~l~h~---niv~l~~~--  411 (639)
                      ...+|...+++-......|.+-..+++.+++|..+....            ....+++..+.+++..   ....++..  
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            346777777888888888888888999999998765421            1123444444444322   22222211  


Q ss_pred             ---eecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC
Q 036507          412 ---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF  488 (639)
Q Consensus       412 ---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~  488 (639)
                         +......+|+|||++|..|.++..         ++.    .++..+.+++.-||+.|   +.|+|.+|.|++++++ 
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-  171 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-  171 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence               222345679999999988877642         221    24456778899999988   9999999999999865 


Q ss_pred             CEEEeccCCce
Q 036507          489 RAKISDFGLAK  499 (639)
Q Consensus       489 ~~kl~Dfgla~  499 (639)
                      .++++||+..+
T Consensus       172 ~i~iID~~~k~  182 (229)
T PF06176_consen  172 GIRIIDTQGKR  182 (229)
T ss_pred             cEEEEECcccc
Confidence            49999998665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=98.23  E-value=5.5e-07  Score=63.63  Aligned_cols=36  Identities=22%  Similarity=0.335  Sum_probs=28.2

Q ss_pred             EEeCCCCCHHHHHHHhcCCcccceecc-C-------CCceEeee
Q 036507           46 YEMQPNQTLSVIQSMFDVLPKDVTVEG-N-------EKNYIFIK   81 (639)
Q Consensus        46 y~v~~g~~l~~ia~~~~~~~~~i~~~~-n-------~~~~l~ip   81 (639)
                      |+|++|||++.||++|+++..+|..+| +       .||.|.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence            899999999999999999999999777 4       56778776

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.23  E-value=2.2e-06  Score=87.63  Aligned_cols=93  Identities=20%  Similarity=0.193  Sum_probs=73.8

Q ss_pred             eEEEEcCCceeehhHHH---hcCCcccccCC-CcccCCCCEEEEeeeecCCCCCCCceEEEEecCCCcHHHHHHHhCCCh
Q 036507           98 TFTVKSSGGYVYDVVVN---AYDGLAILDNS-TRMARAGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSM  173 (639)
Q Consensus        98 ~y~v~~gd~t~~~ia~~---~~~~l~~~~~~-~~~l~~g~~l~ip~~~~~~~~~~~~~~~y~v~~Gdtl~~Ia~~~~~~~  173 (639)
                      .|.|++|| +.+.|++.   +-..+...+.- .+.|.+||.+.||..          ...|.|++|||+++||++|||+.
T Consensus         3 i~~~~pg~-~~~~i~~~~~~~~~~i~~~~~~~~d~~~~~q~~~v~~~----------~~~y~~~~~d~~~Sia~~~~vt~   71 (423)
T COG3858           3 IHLVGPGD-SRLIIAVYFPYTNNRIVNGNDYTNDDLVDGQTFVVPPS----------GHFYDVGPGDTLTSIARTVGVTQ   71 (423)
T ss_pred             EEEccCCc-eeeeehhhccccccccccccccccccccCceeEEECCc----------ceEEEecCCcchhhhhhhhcCCH
Confidence            38899999 88888872   33333333311 156999999999952          24599999999999999999999


Q ss_pred             HHHHHHcCCCCCCCccCCceEEecCCCC
Q 036507          174 DSIEQVNGIVNPNNVTAGDLFYIPLNSV  201 (639)
Q Consensus       174 ~~l~~~N~~~~~~~l~~g~~l~ip~~~~  201 (639)
                      +.+...|....+..+.+|=.+.+|-...
T Consensus        72 ~~~~~m~~~~~~~~l~~~~~l~~P~~~~   99 (423)
T COG3858          72 DSAAIMNFVICPGYLQYGLNLYIPSARK   99 (423)
T ss_pred             HHHHhhcccccccceeeeeEEeccCCCC
Confidence            9999999988888999999999996543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=4.6e-05  Score=72.39  Aligned_cols=104  Identities=21%  Similarity=0.235  Sum_probs=81.7

Q ss_pred             HHHHHHHhcCC-CCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 036507          392 AEMKILCKVHH-SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT  470 (639)
Q Consensus       392 ~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~  470 (639)
                      .|.-+|+.+++ +++.+++|+|-    .+++.||...+++......  ....-..+|..|.+||.++++.+++|++....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            57888888886 69999999993    2678999987766422000  00112368999999999999999999986555


Q ss_pred             CeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       471 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      .+...|++++|+-+++++++|++|.+.+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6889999999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.17  E-value=1.9e-05  Score=78.76  Aligned_cols=140  Identities=17%  Similarity=0.146  Sum_probs=87.0

Q ss_pred             eeecCc-eEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeeccCCChhhhc--
Q 036507          359 LGHGTY-GSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSLKSHL--  434 (639)
Q Consensus       359 lG~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--  434 (639)
                      |-.|.. ..||+....+..+.||........+..+|+++++.+. +--+.+++++....+..++|||+++|.+|.+..  
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~   85 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEE   85 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcc
Confidence            444444 7899987777788999876654455678999988885 444667777776666789999999988776432  


Q ss_pred             -----------------cCCCCCCCCCCC-H-HHHHHHHH--------------------HHHHHHHHHHh----cCCCC
Q 036507          435 -----------------HDPQNRGQTSLS-W-IMRVQIAL--------------------DAARGLEYIHE----HTKTH  471 (639)
Q Consensus       435 -----------------~~~~~~~~~~l~-~-~~~~~i~~--------------------~ia~al~~LH~----~~~~~  471 (639)
                                       |..... ..+.. + ..+.....                    .+...+..|-.    ...+.
T Consensus        86 ~~~~~~~~~l~~~l~~lH~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  164 (244)
T cd05150          86 LEPERLVDALAEALRRLHALPVA-DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLV  164 (244)
T ss_pred             cCHHHHHHHHHHHHHHHhcCCcc-cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceE
Confidence                             111100 00111 0 00000000                    01111222211    12356


Q ss_pred             eeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          472 YVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       472 ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ++|+|+.|.|||++++..+.|+||+.+.
T Consensus       165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         165 VTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EECCCCCCccEEEeCCcEEEEEEccccc
Confidence            9999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.16  E-value=2.8e-05  Score=76.52  Aligned_cols=143  Identities=18%  Similarity=0.202  Sum_probs=86.2

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCC--CeeEEEeeeec---CCeEEEEEeeccCCC
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHS--NLVELIGYAAT---EDELFLIYEYAQKGS  429 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~gs  429 (639)
                      .+.|+.|..+.||+....++.+++|..... ....+.+|..+++.+...  .+.+++.+...   ....+++|+++++..
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~   81 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP   81 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence            356899999999999998899999998765 456678899998888533  34566654422   334789999999887


Q ss_pred             hhh----------------h---ccCCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHhc-
Q 036507          430 LKS----------------H---LHDPQNRGQTSLSWIM---------RVQI------------ALDAAR-GLEYIHEH-  467 (639)
Q Consensus       430 L~~----------------~---l~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-al~~LH~~-  467 (639)
                      +..                .   +|... .......+..         ....            ...+.+ .++.+++. 
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (239)
T PF01636_consen   82 LDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL  160 (239)
T ss_dssp             HHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence            777                1   11111 0111111111         0000            111222 33333321 


Q ss_pred             ---CCCCeeeCCCCCCcEEEC-CCCCEEEeccCCce
Q 036507          468 ---TKTHYVHRDIKSSNILLD-SAFRAKISDFGLAK  499 (639)
Q Consensus       468 ---~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~  499 (639)
                         ....++|+|+.++||+++ +++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               345699999999999999 66667899999875

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=0.00014  Score=68.93  Aligned_cols=122  Identities=22%  Similarity=0.340  Sum_probs=88.9

Q ss_pred             CCCCCCCceeecCc-eEEEEEEEcCceEEEEEecc------------------------ccHHHHHHHHHHHHhcC---C
Q 036507          351 EGFSDSSLLGHGTY-GSVYYGNIRNQEVAIKRMTA------------------------TKTKEFMAEMKILCKVH---H  402 (639)
Q Consensus       351 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~vavK~~~~------------------------~~~~~~~~E~~il~~l~---h  402 (639)
                      .+++..+.||.|.- |.||+++..+..+|+|.+..                        .....|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            67888999999999 99999999999999998321                        01124778888887775   4


Q ss_pred             CCe--eEEEeeeecC------------------CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 036507          403 SNL--VELIGYAATE------------------DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE  462 (639)
Q Consensus       403 ~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~  462 (639)
                      .++  ++++||..-.                  -.+.+|.||++...              .+.    ..-+.+|.+-|.
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHHH
Confidence            566  8999987321                  12457777765432              111    123456777888


Q ss_pred             HHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       463 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      .+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            899877   999999999985     3489999864

>PRK10593 hypothetical protein; Provisional

Probab=97.97  E-value=0.00013  Score=74.91  Aligned_cols=76  Identities=9%  Similarity=-0.004  Sum_probs=58.8

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCC---CCeeEEEeeeec---CCeEEEEEeeccC
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHH---SNLVELIGYAAT---EDELFLIYEYAQK  427 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h---~niv~l~~~~~~---~~~~~lv~e~~~~  427 (639)
                      ..+.||.|..+.||+-...+..+.+|..+.. ....+..|.+.|+.|..   ..+.++++++..   .+..++|||++++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            3567999999999998776667788875542 34578899999998853   467788887754   3668999999988


Q ss_pred             CCh
Q 036507          428 GSL  430 (639)
Q Consensus       428 gsL  430 (639)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.94  E-value=1.3e-06  Score=93.74  Aligned_cols=183  Identities=20%  Similarity=0.178  Sum_probs=130.6

Q ss_pred             CCceeecCceEEEEEEEcC-ceEEEEEeccccHHHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEEEEEeeccCC-Chhh
Q 036507          356 SSLLGHGTYGSVYYGNIRN-QEVAIKRMTATKTKEFMAEMKILCKVHHSN-LVELIGYAATEDELFLIYEYAQKG-SLKS  432 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~~  432 (639)
                      .+-+++|+++++||.+... +....+.+...  .+..-++++|.+++||| .+..++-+..++..++.++++..+ +-..
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            4457899999999887653 33335544433  34456899999999999 666666666677788999999776 2222


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceee
Q 036507          433 HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT  512 (639)
Q Consensus       433 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  512 (639)
                      ...    .....+.......+...-.+++++||+..   -+|+|    ||+..+ +..|..||+....+....    ..+
T Consensus       325 ~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~  388 (829)
T KOG0576|consen  325 EMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPR  388 (829)
T ss_pred             cCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc----ccc
Confidence            211    11222334444555666778899999853   48888    777766 678999999987664322    344


Q ss_pred             eeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccc
Q 036507          513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR  556 (639)
Q Consensus       513 ~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~  556 (639)
                      ...+|+.+++||+.....+..+.|+|++|+-..++--|-+|-..
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            56899999999999999999999999999887788777766543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.88  E-value=0.00017  Score=84.61  Aligned_cols=145  Identities=19%  Similarity=0.314  Sum_probs=91.0

Q ss_pred             CCceeecCceEEEEEEEcC----ceEEEEEeccc----cHHHHHHHHHHHHhcC-CCCe--eEEEeeeecC---CeEEEE
Q 036507          356 SSLLGHGTYGSVYYGNIRN----QEVAIKRMTAT----KTKEFMAEMKILCKVH-HSNL--VELIGYAATE---DELFLI  421 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~-h~ni--v~l~~~~~~~---~~~~lv  421 (639)
                      .+.++.|.+..+|+....+    ..+++|+....    ....+.+|.++|+.+. |.++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            5678999999999887654    46788876432    2356889999999996 6654  7888887664   467899


Q ss_pred             EeeccCCChhhh-----------------------ccCCCCC--C----CCCCCHHH--HHHHH---------------H
Q 036507          422 YEYAQKGSLKSH-----------------------LHDPQNR--G----QTSLSWIM--RVQIA---------------L  455 (639)
Q Consensus       422 ~e~~~~gsL~~~-----------------------l~~~~~~--~----~~~l~~~~--~~~i~---------------~  455 (639)
                      |||+++..+.+.                       ||.....  +    ..+..+..  ...+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999987643221                       2221100  0    01111111  11111               1


Q ss_pred             HHHHHHHHHHhcCC--------CCeeeCCCCCCcEEECCC-CC-EEEeccCCcee
Q 036507          456 DAARGLEYIHEHTK--------THYVHRDIKSSNILLDSA-FR-AKISDFGLAKL  500 (639)
Q Consensus       456 ~ia~al~~LH~~~~--------~~ivH~Dlkp~NIll~~~-~~-~kl~Dfgla~~  500 (639)
                      .+.+.+.+|..+.+        +.++|+|+++.||+++.+ .. .-|.||.++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            23334566754322        359999999999999853 34 57999998864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.85  E-value=0.0001  Score=67.51  Aligned_cols=126  Identities=22%  Similarity=0.208  Sum_probs=87.9

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeE-EEeeeecCCeEEEEEeeccCCChhhh
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVE-LIGYAATEDELFLIYEYAQKGSLKSH  433 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gsL~~~  433 (639)
                      .+.|++|.+|.||++.+.+..+|+|.-+.+. ...+..|.++|..+.-.++.+ ++.|.    .-++.|||..|-.|.++
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~  102 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKL  102 (201)
T ss_pred             hhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhh
Confidence            5679999999999999999999999876654 567889999999998665543 44332    22445999988888777


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC-CCcEEECCCCCEEEeccCCcee
Q 036507          434 LHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIK-SSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       434 l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfgla~~  500 (639)
                      -..        .+-    +-...+++.---|...   +|-|+.|. |...++.++..+.|+||..|+.
T Consensus       103 ~~~--------~~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         103 EIG--------GDR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhc--------ccH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            542        111    1223445552233333   48898887 4444444555999999999874

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.80  E-value=0.00024  Score=68.94  Aligned_cols=146  Identities=18%  Similarity=0.198  Sum_probs=91.6

Q ss_pred             hHHHHhhhCCCCCCC---ceeecCceEEEEEEEc-CceEEEEEeccccH----------------------HH-----HH
Q 036507          343 YDEILFATEGFSDSS---LLGHGTYGSVYYGNIR-NQEVAIKRMTATKT----------------------KE-----FM  391 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~---~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~----------------------~~-----~~  391 (639)
                      .+.+.....+..+..   .|+.|.-+.||+|... +..+|||+.+....                      .+     ..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            333433334443333   4667777899998764 67899998753210                      00     23


Q ss_pred             HHHHHHHhcC--CCCeeEEEeeeecCCeEEEEEeeccCCCh-hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 036507          392 AEMKILCKVH--HSNLVELIGYAATEDELFLIYEYAQKGSL-KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT  468 (639)
Q Consensus       392 ~E~~il~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~  468 (639)
                      .|..-|.++.  +-.+.+.+++..    -.|||||+....+ .=.|.+      -.+.......+..++++.+.-|-...
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            5777777764  344455555432    3799999954311 111111      11222234456677888888877633


Q ss_pred             CCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       469 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                        +++|+||..-|||+. ++.+.++|||-|...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              599999999999999 889999999988654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.74  E-value=0.00029  Score=69.77  Aligned_cols=72  Identities=10%  Similarity=0.167  Sum_probs=46.0

Q ss_pred             CceeecCce-EEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCC---CeeEEEeeeecC---CeEEEEEeeccCC
Q 036507          357 SLLGHGTYG-SVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHS---NLVELIGYAATE---DELFLIYEYAQKG  428 (639)
Q Consensus       357 ~~lG~G~~g-~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~~g  428 (639)
                      +.|+.|+.. .||+.   +..+++|..+.. ...++.+|.+++..+...   .+.++++.....   ...+++||+++|.
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~   79 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGE   79 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCC
Confidence            456766665 58864   346778876553 245788999999887531   344444443332   2347899999987


Q ss_pred             Chh
Q 036507          429 SLK  431 (639)
Q Consensus       429 sL~  431 (639)
                      ++.
T Consensus        80 ~l~   82 (235)
T cd05155          80 TAT   82 (235)
T ss_pred             CCC
Confidence            764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.67  E-value=0.0003  Score=72.25  Aligned_cols=144  Identities=15%  Similarity=0.171  Sum_probs=89.8

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcCCCC--eeEEEee------eecCCeEEEEEeeccC
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSN--LVELIGY------AATEDELFLIYEYAQK  427 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~~~  427 (639)
                      .+.|..|....+|+....+..+++|........+...|++++..+.+.+  +.+++..      ....+..+++++|++|
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G   98 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG   98 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence            4567788878999988777889999887644566778888888885432  4444432      1223456899999998


Q ss_pred             CChhh--------------hccCCC----C--CCCCCCCHHHHHH----------HHHHHHHHHHHHHh----cCCCCee
Q 036507          428 GSLKS--------------HLHDPQ----N--RGQTSLSWIMRVQ----------IALDAARGLEYIHE----HTKTHYV  473 (639)
Q Consensus       428 gsL~~--------------~l~~~~----~--~~~~~l~~~~~~~----------i~~~ia~al~~LH~----~~~~~iv  473 (639)
                      ..+..              .+|...    .  .......|.....          ....+...+.++.+    ..+..++
T Consensus        99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~  178 (296)
T cd05153          99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI  178 (296)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence            76532              011100    0  0011223332210          11123334455443    1234599


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCce
Q 036507          474 HRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       474 H~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      |+|+.|.||+++++..+.|+||+.+.
T Consensus       179 HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         179 HADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             ccCcCcccEEEeCCceEEEeehhhhc
Confidence            99999999999998777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.60  E-value=0.00045  Score=69.36  Aligned_cols=135  Identities=16%  Similarity=0.132  Sum_probs=79.2

Q ss_pred             eeecCceEEEEEEEcCceEEEEEeccccH---HHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEeeccCCChhhh-
Q 036507          359 LGHGTYGSVYYGNIRNQEVAIKRMTATKT---KEFMAEMKILCKVHHSNL-VELIGYAATEDELFLIYEYAQKGSLKSH-  433 (639)
Q Consensus       359 lG~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~-  433 (639)
                      +..|-...+|+....++.+++|.......   -+..+|.++++.+...++ .+++....    -++|+||++|..+... 
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~   79 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ   79 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence            55677789998887778899987543321   135679999998864333 33443332    3689999998766421 


Q ss_pred             ----------------ccCCCCCCCCCCCHHHHH-HHHHH---------HHHHHHHHHhc-----CCCCeeeCCCCCCcE
Q 036507          434 ----------------LHDPQNRGQTSLSWIMRV-QIALD---------AARGLEYIHEH-----TKTHYVHRDIKSSNI  482 (639)
Q Consensus       434 ----------------l~~~~~~~~~~l~~~~~~-~i~~~---------ia~al~~LH~~-----~~~~ivH~Dlkp~NI  482 (639)
                                      +|.... ...+++...+. .+..+         +..-++.+-..     .+..++|+|+.|.||
T Consensus        80 ~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        80 FVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             ccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                            222111 11122222111 11111         11112222111     124599999999999


Q ss_pred             EECCCCCEEEeccCCce
Q 036507          483 LLDSAFRAKISDFGLAK  499 (639)
Q Consensus       483 ll~~~~~~kl~Dfgla~  499 (639)
                      ++++++ +.++||..+.
T Consensus       159 l~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEeCCC-CEEEeccccC
Confidence            999876 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.56  E-value=0.0013  Score=62.89  Aligned_cols=126  Identities=21%  Similarity=0.284  Sum_probs=87.7

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEecccc-------------------HHHHHHHHHHHHhcC------CCCeeEEE
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-------------------TKEFMAEMKILCKVH------HSNLVELI  409 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~il~~l~------h~niv~l~  409 (639)
                      ....||+|+.=.||.--. +....||+.....                   .++..+|+.-..++.      +.+|.+++
T Consensus         5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            356799999999995422 3456778776555                   567778887776665      88999999


Q ss_pred             eeeecCCeEEEEEeeccC------CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          410 GYAATEDELFLIYEYAQK------GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       410 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      |+..+.....+|+|.+.+      -+|.+++.+      ..++. ..   ...+-+-.+||-++.   |+.+|++|+||+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv  150 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIV  150 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence            999999889999998754      256666643      12443 22   223334455666655   999999999999


Q ss_pred             ECCCC----CEEEec
Q 036507          484 LDSAF----RAKISD  494 (639)
Q Consensus       484 l~~~~----~~kl~D  494 (639)
                      +....    .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            95432    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=97.56  E-value=9.3e-05  Score=74.86  Aligned_cols=41  Identities=15%  Similarity=0.081  Sum_probs=35.2

Q ss_pred             eeEEEeCCCCCHHHHHHHhcCCcccceeccC--------CCceEeeeee
Q 036507           43 FLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN--------EKNYIFIKKN   83 (639)
Q Consensus        43 ~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n--------~~~~l~ip~~   83 (639)
                      --+|+|++||||+.||.+||+++.+|..+||        .||.|.||.+
T Consensus        60 ~~~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         60 GSTYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             CCceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence            3479999999999999999999999998888        4577777643

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.54  E-value=0.00059  Score=74.29  Aligned_cols=137  Identities=18%  Similarity=0.180  Sum_probs=83.6

Q ss_pred             CCceeecCceEEEEEEEcC-ceEEEEEeccccH----------------------------------H------HHHHHH
Q 036507          356 SSLLGHGTYGSVYYGNIRN-QEVAIKRMTATKT----------------------------------K------EFMAEM  394 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~~~----------------------------------~------~~~~E~  394 (639)
                      .+-||.-+.|.||+|++.+ +.||||+.+..-.                                  +      +|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            3568999999999999875 6799997643211                                  0      133444


Q ss_pred             HHHHh----cCCCCe---eEEEeeeec-CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HH
Q 036507          395 KILCK----VHHSNL---VELIGYAAT-EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY-IH  465 (639)
Q Consensus       395 ~il~~----l~h~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~-LH  465 (639)
                      +-..+    +.|-+.   |.+=.++.+ .....|+||||+|..+.+.-.-    ....++-.   .++..+.++... |-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i----~~~gi~~~---~i~~~l~~~~~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI----DKRGISPH---DILNKLVEAYLEQIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH----HHcCCCHH---HHHHHHHHHHHHHHH
Confidence            33322    345551   112222222 3567999999999877665321    11123333   333333333222 11


Q ss_pred             hcCCCCeeeCCCCCCcEEECC----CCCEEEeccCCceecC
Q 036507          466 EHTKTHYVHRDIKSSNILLDS----AFRAKISDFGLAKLVG  502 (639)
Q Consensus       466 ~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~  502 (639)
                      ..   +++|+|=+|.||+++.    ++.+.+-|||+...+.
T Consensus       319 ~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 KT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             hc---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            22   4999999999999983    6789999999987653

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.50  E-value=0.001  Score=65.81  Aligned_cols=139  Identities=16%  Similarity=0.211  Sum_probs=79.6

Q ss_pred             CceeecCceEEEEEEEc---CceEEEEEeccccH--HHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEeeccCCCh
Q 036507          357 SLLGHGTYGSVYYGNIR---NQEVAIKRMTATKT--KEFMAEMKILCKVHHSNL-VELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~~--~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      +.|..|-...+|+....   ++.+++|.......  .+..+|+.++..+...++ .++++...  +  .++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence            45777888899988765   46788897654321  233478889988864333 34444332  1  479999988765


Q ss_pred             hhh-----------------ccCCCCCCC------CCCC-HHHHHHHHH----------------------HHHHHHHHH
Q 036507          431 KSH-----------------LHDPQNRGQ------TSLS-WIMRVQIAL----------------------DAARGLEYI  464 (639)
Q Consensus       431 ~~~-----------------l~~~~~~~~------~~l~-~~~~~~i~~----------------------~ia~al~~L  464 (639)
                      ...                 +|.......      .... |.....+..                      .+...+..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            321                 122111110      1111 211111111                      111111111


Q ss_pred             ----Hhc-CCCCeeeCCCCCCcEEECC-CCCEEEeccCCce
Q 036507          465 ----HEH-TKTHYVHRDIKSSNILLDS-AFRAKISDFGLAK  499 (639)
Q Consensus       465 ----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~  499 (639)
                          ... ....++|+|+.+.|||+++ +..+.++||..+.
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence                111 2346999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK05231 homoserine kinase; Provisional

Probab=97.45  E-value=0.0038  Score=64.92  Aligned_cols=144  Identities=11%  Similarity=0.167  Sum_probs=81.3

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcCCCC--eeEEEe------eeecCCeEEEEEeeccC
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSN--LVELIG------YAATEDELFLIYEYAQK  427 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~------~~~~~~~~~lv~e~~~~  427 (639)
                      .+.|+.|....+|+....+..+++|+......++...|++++..|...+  +.+.+.      +....+..++++||++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~G  106 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLEG  106 (319)
T ss_pred             cchhccccccceEEEEeCCCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecCC
Confidence            3457777778999988777789999876333455556667776664222  233332      11224567899999988


Q ss_pred             CChhh--------------hccCCCC----C--CCCCCCHH-HHHH-H-----------H-HHHHHHHHHHHhc----CC
Q 036507          428 GSLKS--------------HLHDPQN----R--GQTSLSWI-MRVQ-I-----------A-LDAARGLEYIHEH----TK  469 (639)
Q Consensus       428 gsL~~--------------~l~~~~~----~--~~~~l~~~-~~~~-i-----------~-~~ia~al~~LH~~----~~  469 (639)
                      ..+..              .+|....    .  ....+.|. .... +           . ..+...++.+.+.    -+
T Consensus       107 ~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~lp  186 (319)
T PRK05231        107 KWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPALP  186 (319)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccCC
Confidence            65421              0121100    0  01112232 1111 0           0 1111122233211    24


Q ss_pred             CCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          470 THYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       470 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      .+++|+|+++.||+++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            569999999999999976556899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.41  E-value=0.0023  Score=66.13  Aligned_cols=144  Identities=14%  Similarity=0.179  Sum_probs=85.7

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCCC--eeEEEee------eecCCeEEEEEeecc
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHSN--LVELIGY------AATEDELFLIYEYAQ  426 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~~  426 (639)
                      .+.++.|....+|+....++.+++|..... ..++...|.+++..|...+  +.+++..      ....+..++++||++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~  106 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ  106 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence            455777777899998777778889987543 2455667788887774322  3444432      122456789999998


Q ss_pred             CCChhh--------------hccCCCCC--C-----CCCCCHHHHHH------------HHHHHHHHHHHHHh----cCC
Q 036507          427 KGSLKS--------------HLHDPQNR--G-----QTSLSWIMRVQ------------IALDAARGLEYIHE----HTK  469 (639)
Q Consensus       427 ~gsL~~--------------~l~~~~~~--~-----~~~l~~~~~~~------------i~~~ia~al~~LH~----~~~  469 (639)
                      |..+..              .+|.....  .     ...-.|.....            ....+.+.++++..    ..+
T Consensus       107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~  186 (307)
T TIGR00938       107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLP  186 (307)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            855421              12211000  0     00112221110            01123334555532    223


Q ss_pred             CCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          470 THYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       470 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      .+++|+|+++.||++++++...|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            569999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.31  E-value=0.00067  Score=78.24  Aligned_cols=195  Identities=19%  Similarity=0.197  Sum_probs=130.9

Q ss_pred             HHHHHHHHHhcCCCCeeEEEeeeecCCeEE----EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 036507          390 FMAEMKILCKVHHSNLVELIGYAATEDELF----LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH  465 (639)
Q Consensus       390 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH  465 (639)
                      ..-|.+.+..+.|+|++.++.|...+...-    +..|++..-++...+..     -..++....+.+..++.+|+.|+|
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHHHH
Confidence            344666788889999999999876554332    34567777777777754     334777788888999999999999


Q ss_pred             hcCCCCeeeCCCCCC---cEEECCCCCEEEe--ccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCc--chHH
Q 036507          466 EHTKTHYVHRDIKSS---NILLDSAFRAKIS--DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK--SDVY  538 (639)
Q Consensus       466 ~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DVw  538 (639)
                      +..   ..|.-+..+   +.-.+.++.+.++  ||+.+..+......    ....-+..+.++|......++.+  .|+|
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHH
Confidence            874   555444444   4445666677777  99988765432211    11234556778887776665544  7999


Q ss_pred             HHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhc
Q 036507          539 AFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCV  618 (639)
Q Consensus       539 s~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl  618 (639)
                      .+|..+..+..|..+-.....                              ...++        +..+.....+...+|+
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~------------------------------~~~~l--------~~~~~~~~~d~~~~~~  418 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAV------------------------------PVSLL--------DVLSTSELLDALPKCL  418 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccc------------------------------hhhhh--------ccccchhhhhhhhhhc
Confidence            999999999998754321110                              00011        1111114677888999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 036507          619 DEDPILRPDMKQVVIS  634 (639)
Q Consensus       619 ~~dP~~RPs~~evl~~  634 (639)
                      ..++++|++..+++..
T Consensus       419 ~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  419 DEDSEERLSALELLTH  434 (1351)
T ss_pred             chhhhhccchhhhhhc
Confidence            9999999999998864

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=97.26  E-value=0.00013  Score=51.19  Aligned_cols=26  Identities=19%  Similarity=0.158  Sum_probs=23.2

Q ss_pred             eCCCCCHHHHHHHhcCCcccceeccC
Q 036507           48 MQPNQTLSVIQSMFDVLPKDVTVEGN   73 (639)
Q Consensus        48 v~~g~~l~~ia~~~~~~~~~i~~~~n   73 (639)
                      |++||||+.||++|+++..+|..+|+
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~   26 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANP   26 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhh
Confidence            68999999999999999999986654

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=97.20  E-value=0.00025  Score=49.62  Aligned_cols=29  Identities=17%  Similarity=0.314  Sum_probs=26.2

Q ss_pred             EEEeCCCCCHHHHHHHhcCCcccceeccC
Q 036507           45 AYEMQPNQTLSVIQSMFDVLPKDVTVEGN   73 (639)
Q Consensus        45 ~y~v~~g~~l~~ia~~~~~~~~~i~~~~n   73 (639)
                      .|+|++|||++.||+.|+++..+|...|+
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~   30 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNG   30 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcC
Confidence            68999999999999999999999985555

This domain may have a general peptidoglycan binding function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.19  E-value=0.0043  Score=65.82  Aligned_cols=71  Identities=14%  Similarity=0.114  Sum_probs=51.5

Q ss_pred             CCceeecCceEEEEEEEcCc--eEEEEEec-------c---ccHHHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEEE
Q 036507          356 SSLLGHGTYGSVYYGNIRNQ--EVAIKRMT-------A---TKTKEFMAEMKILCKVH---HSNLVELIGYAATEDELFL  420 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~--~vavK~~~-------~---~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~l  420 (639)
                      .+.||.|.+..||+....+.  .++||.-.       .   -..+.+..|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            34689999999999988764  89999743       1   12345677888888763   3456777766  3456789


Q ss_pred             EEeeccCC
Q 036507          421 IYEYAQKG  428 (639)
Q Consensus       421 v~e~~~~g  428 (639)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99998764

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=97.14  E-value=0.00026  Score=70.81  Aligned_cols=40  Identities=13%  Similarity=0.263  Sum_probs=34.0

Q ss_pred             ceeEEEeCCCCCHHHHHHHhcCCcccceeccC-------CCceEeee
Q 036507           42 TFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN-------EKNYIFIK   81 (639)
Q Consensus        42 ~~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n-------~~~~l~ip   81 (639)
                      ...+|+|++||||+.||++||+++.+|+.+|+       .||.|+||
T Consensus       292 ~~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~~~~L~~GQ~L~IP  338 (338)
T TIGR02907       292 KLRMCIVQEGDTIETIAERYEISVSQLIRHNQLEDFEVNEGQILYIP  338 (338)
T ss_pred             ccEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCCccccCCCCEEEeC
Confidence            46789999999999999999999999997775       45666665

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.12  E-value=0.005  Score=63.03  Aligned_cols=142  Identities=16%  Similarity=0.239  Sum_probs=81.7

Q ss_pred             ceeecCceEEEEEEEcCceEEEEEecc-----ccHHHHHHHHHHHHhcCC--CCeeEEEeeeecCC--eEEEEEeeccCC
Q 036507          358 LLGHGTYGSVYYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHH--SNLVELIGYAATED--ELFLIYEYAQKG  428 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~g  428 (639)
                      .+..|..-.+|+....++++++. ...     ....+..+|.++++.+.-  .-+...+++|.++.  ..|.||+|++|.
T Consensus        32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe  110 (321)
T COG3173          32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE  110 (321)
T ss_pred             eccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence            33333334455555557788888 331     223445678888888753  23445667776655  679999999885


Q ss_pred             ChhhhccCCCC---------------------------------CCCCCCCHHHHHHHHH--------HHHHHHHHHHhc
Q 036507          429 SLKSHLHDPQN---------------------------------RGQTSLSWIMRVQIAL--------DAARGLEYIHEH  467 (639)
Q Consensus       429 sL~~~l~~~~~---------------------------------~~~~~l~~~~~~~i~~--------~ia~al~~LH~~  467 (639)
                      .+.+.+.....                                 ...+...|......+.        ....-..||+++
T Consensus       111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            44333221000                                 0011111222221010        112224445443


Q ss_pred             C-----CCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          468 T-----KTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       468 ~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      .     ++.++|+|+++.|++++.+..+-+.||+++..
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            2     34699999999999999998899999999874

>PF04225 OapA: Opacity-associated protein A LysM-like domain; InterPro: IPR007340 This entry includes the Haemophilus influenzae opacity-associated protein

Probab=97.10  E-value=0.00035  Score=56.75  Aligned_cols=48  Identities=25%  Similarity=0.453  Sum_probs=27.4

Q ss_pred             EEEEecCCCcHHHHHHHhCCChHHHHHH---cC-CCCCCCccCCceEEecCC
Q 036507          152 MSYVMKDGDTVQSLASRFGVSMDSIEQV---NG-IVNPNNVTAGDLFYIPLN  199 (639)
Q Consensus       152 ~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~---N~-~~~~~~l~~g~~l~ip~~  199 (639)
                      .+|+|++||||+.|-+++|++.++|.+.   +. ...-..|+|||+|.+-+.
T Consensus         3 ~~~~V~~GDtLs~iF~~~gls~~dl~~v~~~~~~~k~L~~L~pGq~l~f~~d   54 (85)
T PF04225_consen    3 QEYTVKSGDTLSTIFRRAGLSASDLYAVLEADGEAKPLTRLKPGQTLEFQLD   54 (85)
T ss_dssp             -EEE--TT--HHHHHHHTT--HHHHHHHHHHGGGT--GGG--TT-EEEEEE-
T ss_pred             cEEEECCCCcHHHHHHHcCCCHHHHHHHHhccCccchHhhCCCCCEEEEEEC
Confidence            4699999999999999999998776654   31 123356999999888664

This protein is required for efficient nasopharyngeal mucosal colonization, and its expression is associated with a distinctive transparent colony phenotype. OapA is thought to be a secreted protein, and its expression exhibits high-frequency phase variation [].; PDB: 2GU1_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	639
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-43
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-43
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-42
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-40
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-26
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-25
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-25
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-25
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-24
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-24
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-24
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-24
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-24
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-24
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-23
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-23
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-23
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-22
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-22
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-22
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-22
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-22
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-22
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-22
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-22
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-22
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-22
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-22
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-22
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-22
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-22
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-21
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-21
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-20
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-20
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-20
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-20
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-20
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-20
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-20
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-20
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-20
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-20
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-20
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-20
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-19
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-19
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-17
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-17
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-17
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-17
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-17
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-16
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-16
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-16
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-16
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-16
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-16
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-16
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-16
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-16
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-16
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-16
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-15
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-14
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-14
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-14
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-08
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-05

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  172 bits (437), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 116/311 (37%), Positives = 169/311 (54%), Gaps = 34/311 (10%)
Query: 341 FTYDEILFATEGFSDSSL------LGHGTYGSVYYGNIRNQEVAIKRMTA-------TKT 387
           F++ E+   T  F +  +      +G G +G VY G + N  VA+K++ A          
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           ++F  E+K++ K  H NLVEL+G+++  D+L L+Y Y   GSL   L      G   LSW
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSW 132
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
            MR +IA  AA G+ ++HE+   H++HRDIKS+NILLD AF AKISDFGLA+   K +  
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ- 188
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
               +++VGT  Y+APE L  G  T KSD+Y+FGVVL EII+G  A       V +++E 
Sbjct: 189 TVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA-------VDEHREP 240
Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
           + L                  +++DYID  M D      +  M  +A QC+ E    RPD
Sbjct: 241 QLLLDIKEEI------EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 628 MKQVVISLSQI 638
           +K+V   L ++
Sbjct: 294 IKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  172 bits (435), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 115/304 (37%), Positives = 165/304 (54%), Gaps = 34/304 (11%)
Query: 341 FTYDEILFATEGFSDSSL------LGHGTYGSVYYGNIRNQEVAIKRMTA-------TKT 387
           F++ E+   T  F +  +      +G G +G VY G + N  VA+K++ A          
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           ++F  E+K++ K  H NLVEL+G+++  D+L L+Y Y   GSL   L      G   LSW
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSW 132
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
            MR +IA  AA G+ ++HE+   H++HRDIKS+NILLD AF AKISDFGLA+   K +  
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ- 188
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
                ++VGT  Y+APE L  G  T KSD+Y+FGVVL EII+G  A       V +++E 
Sbjct: 189 TVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA-------VDEHREP 240
Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
           + L                  +++DYID  M D      +  M  +A QC+ E    RPD
Sbjct: 241 QLLLDIKEEI------EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 628 MKQV 631
           +K+V
Sbjct: 294 IKKV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  172 bits (435), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 116/311 (37%), Positives = 168/311 (54%), Gaps = 34/311 (10%)
Query: 341 FTYDEILFATEGFSDSSL------LGHGTYGSVYYGNIRNQEVAIKRMTA-------TKT 387
           F++ E+   T  F +  +      +G G +G VY G + N  VA+K++ A          
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           ++F  E+K++ K  H NLVEL+G+++  D+L L+Y Y   GSL   L      G   LSW
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSW 126
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
            MR +IA  AA G+ ++HE+   H++HRDIKS+NILLD AF AKISDFGLA+   K +  
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ- 182
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
                ++VGT  Y+APE L  G  T KSD+Y+FGVVL EII+G  A       V +++E 
Sbjct: 183 XVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA-------VDEHREP 234
Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
           + L                  +++DYID  M D      +  M  +A QC+ E    RPD
Sbjct: 235 QLLLDIKEEI------EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPD 287
Query: 628 MKQVVISLSQI 638
           +K+V   L ++
Sbjct: 288 IKKVQQLLQEM 298

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  170 bits (430), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/310 (33%), Positives = 162/310 (52%), Gaps = 36/310 (11%)
Query: 341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE-VAIKRMTATKTK----EFMAEMK 395
           F+  E+  A++ FS+ ++LG G +G VY G + +   VA+KR+   + +    +F  E++
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           ++    H NL+ L G+  T  E  L+Y Y   GS+ S L + +   Q  L W  R +IAL
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIAL 146
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
            +ARGL Y+H+H     +HRD+K++NILLD  F A + DFGLAKL+            V 
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--XHVXXAVR 204
Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
           GT G++APEYL+ G ++ K+DV+ +GV+L E+I+G+ A                   F L
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA-------------------FDL 245
Query: 576 AALRNSPDSMSM---------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
           A L N  D M +           L+  +D ++   Y  + + ++  +A  C    P+ RP
Sbjct: 246 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 305
Query: 627 DMKQVVISLS 636
            M +VV  L 
Sbjct: 306 KMSEVVRMLE 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  169 bits (429), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 112/296 (37%), Positives = 161/296 (54%), Gaps = 23/296 (7%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATKTK---EFMAEMKILCKVHHSN 404
           AT  F    L+GHG +G VY G +R+  +VA+KR T   ++   EF  E++ L    H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           LV LIG+    +E+ LIY+Y + G+LK HL+   +    S+SW  R++I + AARGL Y+
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV-GTFGYLAP 523
           H       +HRD+KS NILLD  F  KI+DFG++K    T  G+  +  VV GT GY+ P
Sbjct: 156 HTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGYIDP 210
Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
           EY   G  T KSDVY+FGVVLFE++  + AI+            +SL   M+     + +
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV------------QSLPREMVNLAEWAVE 258
Query: 584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           S +   L+  +DPN+ D    + L K    A +C+      RP M  V+  L   L
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  169 bits (429), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 112/295 (37%), Positives = 160/295 (54%), Gaps = 21/295 (7%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATKTK---EFMAEMKILCKVHHSN 404
           AT  F    L+GHG +G VY G +R+  +VA+KR T   ++   EF  E++ L    H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           LV LIG+    +E+ LIY+Y + G+LK HL+   +    S+SW  R++I + AARGL Y+
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRD+KS NILLD  F  KI+DFG++K  G   D       V GT GY+ PE
Sbjct: 156 HTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLXXVVKGTLGYIDPE 211
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
           Y   G  T KSDVY+FGVVLFE++  + AI++     S  +E  +LA + + +  N    
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-----SLPREMVNLAEWAVESHNN---- 262
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                L+  +DPN+ D    + L K    A +C+      RP M  V+  L   L
Sbjct: 263 ---GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  168 bits (426), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 102/310 (32%), Positives = 161/310 (51%), Gaps = 36/310 (11%)
Query: 341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE-VAIKRMTATKTK----EFMAEMK 395
           F+  E+  A++ F + ++LG G +G VY G + +   VA+KR+   +T+    +F  E++
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           ++    H NL+ L G+  T  E  L+Y Y   GS+ S L + +   Q  L W  R +IAL
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRIAL 138
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
            +ARGL Y+H+H     +HRD+K++NILLD  F A + DFGLAKL+            V 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--XHVXXAVR 196
Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
           G  G++APEYL+ G ++ K+DV+ +GV+L E+I+G+ A                   F L
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA-------------------FDL 237
Query: 576 AALRNSPDSMSM---------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
           A L N  D M +           L+  +D ++   Y  + + ++  +A  C    P+ RP
Sbjct: 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297
Query: 627 DMKQVVISLS 636
            M +VV  L 
Sbjct: 298 KMSEVVRMLE 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  162 bits (409), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 112/304 (36%), Positives = 160/304 (52%), Gaps = 34/304 (11%)
Query: 341 FTYDEILFATEGFSDSSL------LGHGTYGSVYYGNIRNQEVAIKRMTA-------TKT 387
           F++ E+   T  F +  +       G G +G VY G + N  VA+K++ A          
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           ++F  E+K+  K  H NLVEL+G+++  D+L L+Y Y   GSL   L      G   LSW
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD--GTPPLSW 123
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
             R +IA  AA G+ ++HE+   H++HRDIKS+NILLD AF AKISDFGLA+   K +  
Sbjct: 124 HXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ- 179
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
               +++VGT  Y APE L  G  T KSD+Y+FGVVL EII+G  A       V +++E 
Sbjct: 180 XVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPA-------VDEHREP 231
Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
           + L                  +++DYID    D      +     +A QC+ E    RPD
Sbjct: 232 QLLLDIKEEI------EDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPD 284
Query: 628 MKQV 631
           +K+V
Sbjct: 285 IKKV 288

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 107/196 (54%), Gaps = 11/196 (5%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+V+       +VA+K +      A +  EF+ E+ I+ ++ H N+V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
               L ++ EY  +GSL   LH    R Q  L    R+ +A D A+G+ Y+H       V
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA 533
           HR++KS N+L+D  +  K+ DFGL++L   T     +     GT  ++APE L D  +  
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 534 KSDVYAFGVVLFEIIS 549
           KSDVY+FGV+L+E+ +
Sbjct: 219 KSDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 11/196 (5%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+V+       +VA+K +      A +  EF+ E+ I+ ++ H N+V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
               L ++ EY  +GSL   LH    R Q  L    R+ +A D A+G+ Y+H       V
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA 533
           HRD+KS N+L+D  +  K+ DFGL++L    +          GT  ++APE L D  +  
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL---KASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 534 KSDVYAFGVVLFEIIS 549
           KSDVY+FGV+L+E+ +
Sbjct: 219 KSDVYSFGVILWELAT 234

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 145/305 (47%), Gaps = 60/305 (19%)
Query: 358 LLGHGTYGSVYYGNIRNQ----EVAIKRMTATKTKE----FMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+      + AIKRM    +K+    F  E+++LCK+ HH N++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH-------DPQ----NRGQTSLSWIMRVQIALDA 457
           +G       L+L  EYA  G+L   L        DP     N   ++LS    +  A D 
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           ARG++Y+   ++  ++HRD+ + NIL+   + AKI+DFGL++        E  V K +G 
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 202
Query: 518 F--GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
               ++A E L   + T  SDV+++GV+L+EI+S                          
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------------------------- 236
Query: 576 AALRNSPD-SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
             L  +P   M+ + L + +        P +C  ++  L +QC  E P  RP   Q+++S
Sbjct: 237 --LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
Query: 635 LSQIL 639
           L+++L
Sbjct: 295 LNRML 299

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 145/305 (47%), Gaps = 60/305 (19%)
Query: 358 LLGHGTYGSVYYGNIRNQ----EVAIKRMTATKTKE----FMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+      + AIKRM    +K+    F  E+++LCK+ HH N++ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH-------DPQ----NRGQTSLSWIMRVQIALDA 457
           +G       L+L  EYA  G+L   L        DP     N   ++LS    +  A D 
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           ARG++Y+   ++  ++HRD+ + NIL+   + AKI+DFGL++        E  V K +G 
Sbjct: 142 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 192
Query: 518 F--GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
               ++A E L   + T  SDV+++GV+L+EI+S                          
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------------------------- 226
Query: 576 AALRNSPD-SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
             L  +P   M+ + L + +        P +C  ++  L +QC  E P  RP   Q+++S
Sbjct: 227 --LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 284
Query: 635 LSQIL 639
           L+++L
Sbjct: 285 LNRML 289

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 109/193 (56%), Gaps = 14/193 (7%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G V  G+ R  +VA+K +    T + F+AE  ++ ++ HSNLV+L+G    E  
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 79
Query: 418 -LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD 476
            L+++ EY  KGSL  +L   ++RG++ L     ++ +LD    +EY+      ++VHRD
Sbjct: 80  GLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSD 536
           + + N+L+     AK+SDFGL K    T D      K      + APE L +   + KSD
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFSTKSD 187
Query: 537 VYAFGVVLFEIIS 549
           V++FG++L+EI S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 109/193 (56%), Gaps = 14/193 (7%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G V  G+ R  +VA+K +    T + F+AE  ++ ++ HSNLV+L+G    E  
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88
Query: 418 -LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD 476
            L+++ EY  KGSL  +L   ++RG++ L     ++ +LD    +EY+      ++VHRD
Sbjct: 89  GLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSD 536
           + + N+L+     AK+SDFGL K    T D      K      + APE L +   + KSD
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSD 196
Query: 537 VYAFGVVLFEIIS 549
           V++FG++L+EI S
Sbjct: 197 VWSFGILLWEIYS 209

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 145/305 (47%), Gaps = 60/305 (19%)
Query: 358 LLGHGTYGSVYYGNIRNQ----EVAIKRMTATKTKE----FMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+      + AIKRM    +K+    F  E+++LCK+ HH N++ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH-------DPQ----NRGQTSLSWIMRVQIALDA 457
           +G       L+L  EYA  G+L   L        DP     N   ++LS    +  A D 
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           ARG++Y+   ++  ++HR++ + NIL+   + AKI+DFGL++        E  V K +G 
Sbjct: 149 ARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 199
Query: 518 F--GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
               ++A E L   + T  SDV+++GV+L+EI+S                          
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-------------------------- 233
Query: 576 AALRNSPD-SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
             L  +P   M+ + L + +        P +C  ++  L +QC  E P  RP   Q+++S
Sbjct: 234 --LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 291
Query: 635 LSQIL 639
           L+++L
Sbjct: 292 LNRML 296

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 109/193 (56%), Gaps = 14/193 (7%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G V  G+ R  +VA+K +    T + F+AE  ++ ++ HSNLV+L+G    E  
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 418 -LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD 476
            L+++ EY  KGSL  +L   ++RG++ L     ++ +LD    +EY+      ++VHRD
Sbjct: 74  GLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSD 536
           + + N+L+     AK+SDFGL K    T D      K      + APE L +   + KSD
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSD 181
Query: 537 VYAFGVVLFEIIS 549
           V++FG++L+EI S
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/193 (34%), Positives = 109/193 (56%), Gaps = 14/193 (7%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G V  G+ R  +VA+K +    T + F+AE  ++ ++ HSNLV+L+G    E  
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260
Query: 418 -LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD 476
            L+++ EY  KGSL  +L   ++RG++ L     ++ +LD    +EY+      ++VHRD
Sbjct: 261 GLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSD 536
           + + N+L+     AK+SDFGL K    T D      K      + APE L +   + KSD
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSD 368
Query: 537 VYAFGVVLFEIIS 549
           V++FG++L+EI S
Sbjct: 369 VWSFGILLWEIYS 381

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 142/288 (49%), Gaps = 41/288 (14%)
Query: 356 SSLLGHGTYGSVYYGNIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIG 410
           S+ +G G++G+VY G     +VA+K +     T  + + F  E+ +L K  H N++  +G
Sbjct: 41  STRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           Y  T+D L ++ ++ +  SL  HLH  + + Q        + IA   A+G++Y+H     
Sbjct: 100 YM-TKDNLAIVTQWCEGSSLYKHLHVQETKFQM----FQLIDIARQTAQGMDYLHA---K 151
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT--- 527
           + +HRD+KS+NI L      KI DFGLA +  + S G   V +  G+  ++APE +    
Sbjct: 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-GSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   + +SDVY++G+VL+E+++G+        +   +   R    FM+            
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTGE--------LPYSHINNRDQIIFMVG----------- 251
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              + Y  P++  LY  +C   M  L   CV +    RP   Q++ S+
Sbjct: 252 ---RGYASPDLSKLYK-NCPKAMKRLVADCVKKVKEERPLFPQILSSI 295

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 139/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 21  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 78
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 241
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 242 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 272

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 139/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 16  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 236
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 237 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 139/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 21  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 78
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 241
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 242 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 272

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 139/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 18  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 75
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 76  TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 128
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 238
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 239 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 269

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 139/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 44  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 101
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 264
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 265 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 139/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 43  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 100
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 101 TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 153
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 263
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 264 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 294

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 138/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 16  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T  +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 74  TAPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 236
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 237 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 138/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 16  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA    + S G     ++ G+  ++APE +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 236
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 237 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 138/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 44  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 101
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA    + S G     ++ G+  ++APE +       
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 264
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 265 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/195 (35%), Positives = 111/195 (56%), Gaps = 14/195 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG+G +G V+ G    N +VAIK +   T + E F+ E +I+ K+ H  LV+L     +E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYA-VVSE 75
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L D + R   +L     V +A   A G+ YI    + +Y+HR
Sbjct: 76  EPIYIVTEYMNKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++S+NIL+ +    KI+DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L E+++
Sbjct: 187 SDVWSFGILLTELVT 201

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 138/285 (48%), Gaps = 41/285 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 36  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 93
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH  +    T    I  + IA   A+G++Y+H  +    +
Sbjct: 94  TKPQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---II 146
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA    + S G     ++ G+  ++APE +       
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R    FM+     SPD   + S 
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIFMVGRGYLSPDLSKVRS- 256
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                         +C   M  L  +C+ +    RP   Q++ S+
Sbjct: 257 --------------NCPKAMKRLMAECLKKKRDERPLFPQILASI 287

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 146/321 (45%), Gaps = 37/321 (11%)
Query: 329 GTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV---YYGNIRN---QEVAIKRM 382
           G   F+   P  F    + F  +       LG G +GSV    Y  +++   + VA+K++
Sbjct: 1   GAMAFEDRDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 53
Query: 383 ---TATKTKEFMAEMKILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDP 437
              T    ++F  E++IL  + H N+V+  G  Y+A    L LI EY   GSL+ +L   
Sbjct: 54  QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 113
Query: 438 QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL 497
           + R    +  I  +Q      +G+EY+       Y+HRD+ + NIL+++  R KI DFGL
Sbjct: 114 KER----IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGL 166
Query: 498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRT 557
            K++ +  +             + APE LT+   +  SDV++FGVVL+E+ +  E     
Sbjct: 167 TKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE----- 221
Query: 558 EGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQC 617
                  + +   A FM     +    M +  L + +  N     P  C  ++ M+  +C
Sbjct: 222 -------KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTEC 274
Query: 618 VDEDPILRPDMKQVVISLSQI 638
            + +   RP  + + + + QI
Sbjct: 275 WNNNVNQRPSFRDLALRVDQI 295

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 149/323 (46%), Gaps = 38/323 (11%)
Query: 327 ALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV---YYGNIRN---QEVAIK 380
           A+G+  F+   P  F    + F  +       LG G +GSV    Y  +++   + VA+K
Sbjct: 25  AMGS-AFEDRDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 381 RM---TATKTKEFMAEMKILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLH 435
           ++   T    ++F  E++IL  + H N+V+  G  Y+A    L LI EY   GSL+ +L 
Sbjct: 77  KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 436 DPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF 495
             + R    +  I  +Q      +G+EY+       Y+HRD+ + NIL+++  R KI DF
Sbjct: 137 KHKER----IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDF 189
Query: 496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAII 555
           GL K++ +  +             + APE LT+   +  SDV++FGVVL+E+ +  E   
Sbjct: 190 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--- 246
Query: 556 RTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                    + +   A FM     +    M +  L + +  N     P  C  ++ M+  
Sbjct: 247 ---------KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT 297
Query: 616 QCVDEDPILRPDMKQVVISLSQI 638
           +C + +   RP  + + + + QI
Sbjct: 298 ECWNNNVNQRPSFRDLALRVDQI 320

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 139/288 (48%), Gaps = 41/288 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 20  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 77
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH      +T       + IA   ARG++Y+H  +    +
Sbjct: 78  TKPQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA +  + S G     ++ G+  ++APE +       
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R     M+     SPD   + S 
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIEMVGRGSLSPDLSKVRS- 240
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
                         +C  +M  L  +C+ +    RP   +++  + ++
Sbjct: 241 --------------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 145/317 (45%), Gaps = 37/317 (11%)
Query: 333 FDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV---YYGNIRN---QEVAIKRM---T 383
           F+   P  F    + F  +       LG G +GSV    Y  +++   + VA+K++   T
Sbjct: 6   FEDRDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 58
Query: 384 ATKTKEFMAEMKILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRG 441
               ++F  E++IL  + H N+V+  G  Y+A    L LI EY   GSL+ +L   + R 
Sbjct: 59  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER- 117
Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV 501
              +  I  +Q      +G+EY+       Y+HRD+ + NIL+++  R KI DFGL K++
Sbjct: 118 ---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 171
Query: 502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV 561
            +  +             + APE LT+   +  SDV++FGVVL+E+ +  E         
Sbjct: 172 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--------- 222
Query: 562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED 621
              + +   A FM     +    M +  L + +  N     P  C  ++ M+  +C + +
Sbjct: 223 ---KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 279
Query: 622 PILRPDMKQVVISLSQI 638
              RP  + + + + QI
Sbjct: 280 VNQRPSFRDLALRVDQI 296

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 144/315 (45%), Gaps = 37/315 (11%)
Query: 335 MEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV---YYGNIRN---QEVAIKRM---TAT 385
           M  P  F    + F  +       LG G +GSV    Y  +++   + VA+K++   T  
Sbjct: 1   MRDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 53
Query: 386 KTKEFMAEMKILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT 443
             ++F  E++IL  + H N+V+  G  Y+A    L LI EY   GSL+ +L   + R   
Sbjct: 54  HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--- 110
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
            +  I  +Q      +G+EY+       Y+HRD+ + NIL+++  R KI DFGL K++ +
Sbjct: 111 -IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
             +             + APE LT+   +  SDV++FGVVL+E+ +  E           
Sbjct: 167 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE----------- 215
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            + +   A FM     +    M +  L + +  N     P  C  ++ M+  +C + +  
Sbjct: 216 -KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVN 274
Query: 624 LRPDMKQVVISLSQI 638
            RP  + + + + QI
Sbjct: 275 QRPSFRDLALRVDQI 289

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 133
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 241
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 242 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 138/290 (47%), Gaps = 46/290 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRNQEVAIKRM-TATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
             ++G G +G V     R ++VAIK++ + ++ K F+ E++ L +V+H N+V+L  Y A 
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL--YGAC 71
Query: 415 EDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
            + + L+ EYA+ GSL + LH     P      ++SW       L  ++G+ Y+H     
Sbjct: 72  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 125
Query: 471 HYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +HRD+K  N+LL +     KI DFG A       D +  +T   G+  ++APE     
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGS 179
Query: 530 LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS 589
             + K DV+++G++L+E+I+ ++      G                      P    M +
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDEIGG----------------------PAFRIMWA 217
Query: 590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           + +   P ++   P      +  L  +C  +DP  RP M+++V  ++ ++
Sbjct: 218 VHNGTRPPLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 145/317 (45%), Gaps = 37/317 (11%)
Query: 333 FDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV---YYGNIRN---QEVAIKRM---T 383
           F+   P  F    + F  +       LG G +GSV    Y  +++   + VA+K++   T
Sbjct: 3   FEDRDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 55
Query: 384 ATKTKEFMAEMKILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRG 441
               ++F  E++IL  + H N+V+  G  Y+A    L LI EY   GSL+ +L   + R 
Sbjct: 56  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER- 114
Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV 501
              +  I  +Q      +G+EY+       Y+HRD+ + NIL+++  R KI DFGL K++
Sbjct: 115 ---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 168
Query: 502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV 561
            +  +             + APE LT+   +  SDV++FGVVL+E+ +  E         
Sbjct: 169 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--------- 219
Query: 562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED 621
              + +   A FM     +    M +  L + +  N     P  C  ++ M+  +C + +
Sbjct: 220 ---KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 276
Query: 622 PILRPDMKQVVISLSQI 638
              RP  + + + + QI
Sbjct: 277 VNQRPSFRDLALRVDQI 293

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 145/317 (45%), Gaps = 37/317 (11%)
Query: 333 FDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV---YYGNIRN---QEVAIKRM---T 383
           F+   P  F    + F  +       LG G +GSV    Y  +++   + VA+K++   T
Sbjct: 4   FEDRDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 56
Query: 384 ATKTKEFMAEMKILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRG 441
               ++F  E++IL  + H N+V+  G  Y+A    L LI EY   GSL+ +L   + R 
Sbjct: 57  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER- 115
Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV 501
              +  I  +Q      +G+EY+       Y+HRD+ + NIL+++  R KI DFGL K++
Sbjct: 116 ---IDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 169
Query: 502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV 561
            +  +             + APE LT+   +  SDV++FGVVL+E+ +  E         
Sbjct: 170 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--------- 220
Query: 562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED 621
              + +   A FM     +    M +  L + +  N     P  C  ++ M+  +C + +
Sbjct: 221 ---KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 277
Query: 622 PILRPDMKQVVISLSQI 638
              RP  + + + + QI
Sbjct: 278 VNQRPSFRDLALRVDQI 294

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 138/290 (47%), Gaps = 46/290 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRNQEVAIKRM-TATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
             ++G G +G V     R ++VAIK++ + ++ K F+ E++ L +V+H N+V+L  Y A 
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL--YGAC 70
Query: 415 EDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
            + + L+ EYA+ GSL + LH     P      ++SW       L  ++G+ Y+H     
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPK 124
Query: 471 HYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +HRD+K  N+LL +     KI DFG A       D +  +T   G+  ++APE     
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 530 LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS 589
             + K DV+++G++L+E+I+ ++      G                      P    M +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGG----------------------PAFRIMWA 216
Query: 590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           + +   P ++   P      +  L  +C  +DP  RP M+++V  ++ ++
Sbjct: 217 VHNGTRPPLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 148
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 256
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 257 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 130
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 238
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 148
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 256
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 257 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 128
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 236
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 237 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K++H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 225
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K++H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 211
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 129
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 237
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 238 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 210
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 202
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 210
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 225
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 225
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 211
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 138/288 (47%), Gaps = 41/288 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 32  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T+ +L ++ ++ +  SL  HLH      +T       + IA   ARG++Y+H  +    +
Sbjct: 90  TKPQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA    + S G     ++ G+  ++APE +       
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R     M+     SPD   + S 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIEMVGRGSLSPDLSKVRS- 252
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
                         +C  +M  L  +C+ +    RP   +++  + ++
Sbjct: 253 --------------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 227
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 141/294 (47%), Gaps = 36/294 (12%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 130
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPE 524
               Y+HRD+ + NIL+++  R KI DFGL K++    D E    K  G    F Y APE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEFFKVKEPGESPIFWY-APE 187
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            LT+   +  SDV++FGVVL+E+ +  E            + +   A FM     +    
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQ 235
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           M +  L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 217
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV----K 211
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 138/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI E+   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 133
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 241
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 242 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLV---GKTSDGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ +   G    G   +  V     
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV----K 228
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLV---GKTSDGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ +   G    G   +  V     
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV----K 251
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 137/291 (47%), Gaps = 30/291 (10%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L     R    +  I  +Q      +G+EY+   
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER----IDHIKLLQYTSQICKGMEYL--- 133
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               Y+HRD+ + NIL+++  R KI DFGL K++ +  +             + APE LT
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
           +   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQMIV 241
Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 242 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 359 LGHGTYGSVYYGNIRNQ-------EVAIKRMTATKTKE----FMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +++    F+ E  I+ K +H N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L +  P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 466 EHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTS---DGEATVTKVVGTFG 519
           E+   H++HRDI + N LL        AKI DFG+A+ + + S    G   +  V     
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----K 237
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           ++ PE   +G+ T+K+D ++FGV+L+EI S
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 137/288 (47%), Gaps = 41/288 (14%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G     +VA+K +  T     + + F  E+ +L K  H N++  +GY+ 
Sbjct: 32  IGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T  +L ++ ++ +  SL  HLH      +T       + IA   ARG++Y+H  +    +
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGL 530
           HRD+KS+NI L      KI DFGLA    + S G     ++ G+  ++APE +       
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            + +SDVYAFG+VL+E+++G+        +   N   R     M+     SPD   + S 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ--------LPYSNINNRDQIIEMVGRGSLSPDLSKVRS- 252
Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
                         +C  +M  L  +C+ +    RP   +++  + ++
Sbjct: 253 --------------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 36/294 (12%)
Query: 359 LGHGTYGSV---YYGNIRN---QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV    Y  +++   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   + R    +  I  +Q      +G+EY+   
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYL--- 131
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPE 524
               Y+HR++ + NIL+++  R KI DFGL K++    D E    K  G    F Y APE
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVL--PQDKEYYKVKEPGESPIFWY-APE 188
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            LT+   +  SDV++FGVVL+E+ +  E            + +   A FM     +    
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQ 236
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           M +  L + +  N     P  C  ++ M+  +C + +   RP  + + + + QI
Sbjct: 237 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 290

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 16/225 (7%)
Query: 329 GTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIK--RMTAT 385
           G+     +KP  +  DE     E       LG G +G V+ G      +VA+K  +  + 
Sbjct: 1   GSQTQKPQKP--WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM 58
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL 445
               F+AE  ++ ++ H  LV L     T++ +++I EY + GSL   L  P       L
Sbjct: 59  SPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKL 114
Query: 446 SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS 505
           +    + +A   A G+ +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    
Sbjct: 115 TINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---E 168
Query: 506 DGEATVTKVVG-TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           D E T  +       + APE +  G  T KSDV++FG++L EI++
Sbjct: 169 DNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K  +  +     F+AE  ++ ++
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 71
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 72  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 127
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 128 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIK 181
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 74
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 75  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 130
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 131 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIK 184
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 185 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 67
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 68  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 123
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 124 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIK 177
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 178 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 105/195 (53%), Gaps = 13/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G   N  +VA+K +       + F+ E  ++  + H  LV L      E
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I EY  KGSL   L   +  G+  L  +  +  +   A G+ YI    + +Y+HR
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKL--IDFSAQIAEGMAYIE---RKNYIHR 134
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++N+L+  +   KI+DFGLA+++    D E T  +       + APE +  G  T K
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L+EI++
Sbjct: 192 SDVWSFGILLYEIVT 206

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K  +  +     F+AE  ++ ++
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 66  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 121
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIK 175
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 66
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 67  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 122
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 123 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIK 176
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 177 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 66  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 121
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIK 175
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 71
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 72  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 127
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 128 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIK 181
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 182 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K  +  +     F+AE  ++ ++
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 75
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 76  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 131
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 132 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIK 185
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 186 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 70
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 71  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 126
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 127 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIK 180
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 181 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 139/309 (44%), Gaps = 47/309 (15%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK---- 388
           VF  DE   + E  +    LG G++G VY GN R+         VA+K +  + +     
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQT 443
           EF+ E  ++      ++V L+G  +      ++ E    G LKS+L    P+   N G+ 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             +    +Q+A + A G+ Y++      +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    ++APE L DG+ T  SD+++FGVVL+EI S              
Sbjct: 183 T-DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 227
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                 LA      L N         LK  +D   +D  P +C  ++  L + C   +P 
Sbjct: 228 ------LAEQPYQGLSNE------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPK 274
Query: 624 LRPDMKQVV 632
           +RP   ++V
Sbjct: 275 MRPTFLEIV 283

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 139/309 (44%), Gaps = 47/309 (15%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK---- 388
           VF  DE   + E  +    LG G++G VY GN R+         VA+K +  + +     
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQT 443
           EF+ E  ++      ++V L+G  +      ++ E    G LKS+L    P+   N G+ 
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             +    +Q+A + A G+ Y++      +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    ++APE L DG+ T  SD+++FGVVL+EI S              
Sbjct: 180 T-DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 224
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                 LA      L N         LK  +D   +D  P +C  ++  L + C   +P 
Sbjct: 225 ------LAEQPYQGLSNE------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPK 271
Query: 624 LRPDMKQVV 632
           +RP   ++V
Sbjct: 272 MRPTFLEIV 280

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 66  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 121
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIK 175
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 132/309 (42%), Gaps = 55/309 (17%)
Query: 345 EILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRM-------TATKTKEFMAEMKIL 397
           EI FA    +   ++G G +G VY       EVA+K          +   +    E K+ 
Sbjct: 3   EIDFAE--LTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 398 CKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA 457
             + H N++ L G    E  L L+ E+A+ G L   L   +      ++W      A+  
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQI 114
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR--------AKISDFGLAKLVGKTSDGEA 509
           ARG+ Y+H+      +HRD+KSSNIL+              KI+DFGLA+   +T+   A
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS 569
                 G + ++APE +   + +  SDV+++GV+L+E+++G+      +G+         
Sbjct: 175 A-----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY----- 224
Query: 570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK 629
                          ++M+ L   I        P  C    A L + C + DP  RP   
Sbjct: 225 --------------GVAMNKLALPI--------PSTCPEPFAKLMEDCWNPDPHSRPSFT 262
Query: 630 QVVISLSQI 638
            ++  L+ I
Sbjct: 263 NILDQLTTI 271

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R QT       +++  D    +EY+       ++HR
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L++     K+SDFGL++ V    D E +         +  PE L     ++KS
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 536 DVYAFGVVLFEIIS 549
           D++AFGV+++EI S
Sbjct: 203 DIWAFGVLMWEIYS 216

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKV 400
           DE     E       LG G +G V+ G      +VA+K +   +     F+AE  ++ ++
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 60
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H  LV L     T++ +++I EY + GSL   L  P       L+    + +A   A G
Sbjct: 61  QHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEG 116
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFG 519
           + +I E    +Y+HRD++++NIL+      KI+DFGLA+L+    D E T  +       
Sbjct: 117 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIK 170
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           + APE +  G  T KSDV++FG++L EI++
Sbjct: 171 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 103/195 (52%), Gaps = 14/195 (7%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G  G V+ G      +VA+K  +  +     F+AE  ++ ++ H  LV L     T+
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQ 79
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I EY + GSL   L  P       L+    + +A   A G+ +I E    +Y+HR
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      KI+DFGLA+L+    D E T  +       + APE +  G  T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L EI++
Sbjct: 191 SDVWSFGILLTEIVT 205

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/309 (26%), Positives = 139/309 (44%), Gaps = 47/309 (15%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK---- 388
           V+  DE   + E  +    LG G++G VY GN R+         VA+K +  + +     
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQT 443
           EF+ E  ++      ++V L+G  +      ++ E    G LKS+L    P+   N G+ 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             +    +Q+A + A G+ Y++      +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    ++APE L DG+ T  SD+++FGVVL+EI S              
Sbjct: 183 T-DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 227
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                 LA      L N         LK  +D   +D  P +C  ++  L + C   +P 
Sbjct: 228 ------LAEQPYQGLSNE------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPN 274
Query: 624 LRPDMKQVV 632
           +RP   ++V
Sbjct: 275 MRPTFLEIV 283

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R QT       +++  D    +EY+       ++HR
Sbjct: 76  RPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAMEYLE---SKQFLHR 128
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L++     K+SDFGL++ V    D E T +  VG+     +  PE L     +
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS--VGSKFPVRWSPPEVLMYSKFS 183
Query: 533 AKSDVYAFGVVLFEIIS 549
           +KSD++AFGV+++EI S
Sbjct: 184 SKSDIWAFGVLMWEIYS 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R QT       +++  D    +EY+       ++HR
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L++     K+SDFGL++ V    D E T +  VG+     +  PE L     +
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS--VGSKFPVRWSPPEVLMYSKFS 179
Query: 533 AKSDVYAFGVVLFEIIS 549
           +KSD++AFGV+++EI S
Sbjct: 180 SKSDIWAFGVLMWEIYS 196

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R QT       +++  D    +EY+       ++HR
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L++     K+SDFGL++ V    D E T +  VG+     +  PE L     +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS--VGSKFPVRWSPPEVLMYSKFS 199
Query: 533 AKSDVYAFGVVLFEIIS 549
           +KSD++AFGV+++EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 254 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 288
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 289 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 338
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 339 TFKQLVEDLDRIV 351

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R QT       +++  D    +EY+       ++HR
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L++     K+SDFGL++ V    D E T +  VG+     +  PE L     +
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS--VGSKFPVRWSPPEVLMYSKFS 184
Query: 533 AKSDVYAFGVVLFEIIS 549
           +KSD++AFGV+++EI S
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 14/195 (7%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G      +VA+K +   +     F+AE  ++ ++ H  LV L     T+
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQ 75
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I EY + GSL   L  P       L+    + +A   A G+ +I E    +Y+HR
Sbjct: 76  EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 129
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           +++++NIL+      KI+DFGLA+L+    D E T  +       + APE +  G  T K
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L EI++
Sbjct: 187 SDVWSFGILLTEIVT 201

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 13/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G   N  +VA+K +       + F+ E  ++  + H  LV L      E
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I E+  KGSL   L   +  G+  L  +  +  +   A G+ YI    + +Y+HR
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEG-GKVLLPKL--IDFSAQIAEGMAYIE---RKNYIHR 133
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++N+L+  +   KI+DFGLA+++    D E T  +       + APE +  G  T K
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 535 SDVYAFGVVLFEIIS 549
           S+V++FG++L+EI++
Sbjct: 191 SNVWSFGILLYEIVT 205

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 198 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 232
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 233 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 283 TFKQLVEDLDRIV 295

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 202 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 236
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 237 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 286
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 287 TFKQLVEDLDRIV 299

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 144/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 185 T-DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 240
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 241 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 276
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 277 MRPSFLEIISSIKE 290

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R QT       +++  D    +EY+       ++HR
Sbjct: 83  RPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAMEYLE---SKQFLHR 135
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L++     K+SDFGL++ V    D E T +  VG+     +  PE L     +
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS--VGSKFPVRWSPPEVLMYSKFS 190
Query: 533 AKSDVYAFGVVLFEIIS 549
           +KSD++AFGV+++EI S
Sbjct: 191 SKSDIWAFGVLMWEIYS 207

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 205 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 239
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 240 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 289
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 290 TFKQLVEDLDRIV 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 213 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 247
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 248 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 298 TFKQLVEDLDRIV 310

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 139/309 (44%), Gaps = 47/309 (15%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK---- 388
           VF  DE   + E  +    LG G++G VY GN R+         VA+K +  + +     
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQT 443
           EF+ E  ++      ++V L+G  +      ++ E    G LKS+L    P+   N G+ 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             +    +Q+A + A G+ Y++      +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    ++APE L DG+ T  SD+++FGVVL+EI S              
Sbjct: 183 T-DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 227
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                 LA      L N         LK  +D   +D  P +C  ++  L + C   +P 
Sbjct: 228 ------LAEQPYQGLSNE------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPK 274
Query: 624 LRPDMKQVV 632
           +RP   ++V
Sbjct: 275 MRPTFLEIV 283

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 206 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 240
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 241 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 290
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 291 TFKQLVEDLDRIV 303

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 77
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++++ EY  KGSL   L     +G+T   L     V +A   A G+ Y+    + +YV
Sbjct: 78  EPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 187 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 216

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 213 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 247
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 248 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 298 TFKQLVEDLDRIV 310

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 18/197 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R QT       +++  D    +EY+       ++HR
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLAT 532
           D+ + N L++     K+SDFGL++ V    D E T ++  G+     +  PE L     +
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSR--GSKFPVRWSPPEVLMYSKFS 184
Query: 533 AKSDVYAFGVVLFEIIS 549
           +KSD++AFGV+++EI S
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 140/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 213 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 247
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 248 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 298 TFKQLVEDLDRIV 310

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 139/313 (44%), Gaps = 70/313 (22%)
Query: 359 LGHGTYGSVYYGNI---------RNQEVAIKRMTATKTK----EFMAEMKILCKV-HHSN 404
           LG G +G V              R  +VA+K + +  T+    + ++EM+++  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLH-----------DPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L            +P +  +  LS    V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV------GKTSDG 507
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +       KT++G
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
              V        ++APE L D + T +SDV++FGV+L+EI +                  
Sbjct: 213 RLPVK-------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------ 247
Query: 568 RSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                     L  SP   + +  L   +        P +C  ++ M+ + C    P  RP
Sbjct: 248 ----------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 297
Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 298 TFKQLVEDLDRIV 310

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 141/296 (47%), Gaps = 49/296 (16%)
Query: 357 SLLGHGTYGSVYYGNI-----RNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
            ++G G +G V  G++     R   VAIK +    T  + ++F++E  I+ +  H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G       + +I E+ + GSL S L   QN GQ ++  I  V +    A G++Y+ + 
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTV--IQLVGMLRGIAAGMKYLAD- 153
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVG---TFGYLAP 523
              +YVHRD+ + NIL++S    K+SDFGL++ L   TSD   T T  +G      + AP
Sbjct: 154 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD--PTYTSALGGKIPIRWTAP 209
Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
           E +     T+ SDV+++G+V++E++S  E               R         + N+ +
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGE---------------RPYWDMTNQDVINAIE 254
Query: 584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                  +DY  P      P DC   +  L   C  +D   RP   Q+V +L +++
Sbjct: 255 -------QDYRLPP-----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 357 SLLGHGTYGSVYY------GNIRNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVE 407
           S LG G +GSV        G+     VA+K++  +   + ++F  E++IL  +H   +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 408 LIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
             G  Y     EL L+ EY   G L+  L   + R   S   +   QI     +G+EY+ 
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC----KGMEYL- 127
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                  VHRD+ + NIL++S    KI+DFGLAKL+    D             + APE 
Sbjct: 128 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 526 LTDGLATAKSDVYAFGVVLFEIIS 549
           L+D + + +SDV++FGVVL+E+ +
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 144/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           VF  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 182 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 237
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 238 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 273
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 274 MRPSFLEIISSIKE 287

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 333
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++++ EY  KGSL   L     +G+T   L     V +A   A G+ Y+    + +YV
Sbjct: 334 EPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 443 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 472

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 47/294 (15%)
Query: 358 LLGHGTYGSVYYGNIR---NQE--VAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++    +E  VAIK +    T  + +EF++E  I+ +  H N++ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + ++ E+ + G+L S L    N GQ ++  I  V +    A G+ Y+ E +
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTV--IQLVGMLRGIASGMRYLAEMS 136
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG---TFGYLAPEY 525
              YVHRD+ + NIL++S    K+SDFGL++ + + S  + T T  +G      + APE 
Sbjct: 137 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS-DPTYTSSLGGKIPIRWTAPEA 192
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
           +     T+ SD +++G+V++E++S  E                          R   D M
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGE--------------------------RPYWD-M 225
Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           S   + + I+ +     P DC   +  L   C  +D   RP   QVV +L +++
Sbjct: 226 SNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 279

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 45/293 (15%)
Query: 358 LLGHGTYGSVYYGNIR---NQE--VAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++    +E  VAIK +    T  + +EF++E  I+ +  H N++ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + ++ E+ + G+L S L    N GQ ++  I  V +    A G+ Y+ E +
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTV--IQLVGMLRGIASGMRYLAEMS 138
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG--YLAPEYL 526
              YVHRD+ + NIL++S    K+SDFGL++ + + S      + + G     + APE +
Sbjct: 139 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
                T+ SD +++G+V++E++S  E                          R   D MS
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGE--------------------------RPYWD-MS 228
Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
              + + I+ +     P DC   +  L   C  +D   RP   QVV +L +++
Sbjct: 229 NQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           SDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNRE 223

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           SDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNRE 223

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 140/312 (44%), Gaps = 53/312 (16%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK---- 388
           VF  DE   + E  +    LG G++G VY GN R+         VA+K +  + +     
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQT 443
           EF+ E  ++      ++V L+G  +      ++ E    G LKS+L    P+   N G+ 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             +    +Q+A + A G+ Y++      +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 504 TS---DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
           T+    G   +  V     ++APE L DG+ T  SD+++FGVVL+EI S           
Sbjct: 183 TAYYRKGGKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------- 227
Query: 561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDE 620
                    LA      L N         LK  +D   +D  P +C  ++  L + C   
Sbjct: 228 ---------LAEQPYQGLSNE------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQF 271
Query: 621 DPILRPDMKQVV 632
           +P +RP   ++V
Sbjct: 272 NPKMRPTFLEIV 283

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++++ EY  KGSL   L     +G+T   L     V ++   A G+ Y+    + +YV
Sbjct: 82  EPIYIVTEYMNKGSLLDFL-----KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI---EDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 191 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 220

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++++ EY  KGSL   L     +G+T   L     V +A   A G+ Y+    + +YV
Sbjct: 251 EPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 360 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 389

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 74
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + + ++ EY  KGSL   L     +G+T   L     V +A   A G+ Y+    + +YV
Sbjct: 75  EPIXIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 184 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 213

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++++ EY  KGSL   L     +G+T   L     V +A   A G+ Y+    + +YV
Sbjct: 251 EPIYIVTEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 360 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 389

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 73
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           SDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 185 SDVWSFGILLTELTT--KGRVPYPGMVNRE 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++++ EY  KGSL   L     +G+T   L     V ++   A G+ Y+    + +YV
Sbjct: 82  EPIYIVTEYMNKGSLLDFL-----KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 191 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 220

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 75
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 76  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           SDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 187 SDVWSFGILLTELTT--KGRVPYPGMVNRE 214

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           SDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNRE 223

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 137/294 (46%), Gaps = 48/294 (16%)
Query: 358 LLGHGTYGSVYYGNIRNQE------VAIKRMTATKTK----EFMAEMKILCKVHHSNLVE 407
           ++G G +G VY G ++         VAIK + A  T+    +F+ E  I+ +  H N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G  +    + +I EY + G+L   L +         S +  V +    A G++Y+   
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYL--- 163
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG--YLAPEY 525
              +YVHRD+ + NIL++S    K+SDFGL++++    D EAT T   G     + APE 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEA 221
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
           ++    T+ SDV++FG+V++E+++  E   R    +S ++  +++            D  
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGE---RPYWELSNHEVMKAIN-----------DGF 267
Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
            + +             P DC   +  L  QC  ++   RP    +V  L +++
Sbjct: 268 RLPT-------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 144/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 184 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 239
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 240 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 275
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 276 MRPSFLEIISSIKE 289

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 132
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + ++++ EY  KGSL   L     +G+T   L     V +A   A G+ Y+    + +YV
Sbjct: 251 EPIYIVGEYMSKGSLLDFL-----KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLAT 532
           HRD++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            KSDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 360 IKSDVWSFGILLTELTT--KGRVPYPGMVNRE 389

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 41/272 (15%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVCEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYI 594
           SDV++FG++L E+ +  +  +   GMV++    +    + +      P+S+         
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESL--------- 244
Query: 595 DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                    HD       L  QC  +DP  RP
Sbjct: 245 ---------HD-------LMCQCWRKDPEERP 260

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 144/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 191 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 246
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 247 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 282
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 283 MRPSFLEIISSIKE 296

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           SDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNRE 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 140/310 (45%), Gaps = 47/310 (15%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK----EFMA 392
           DE   A E  + S  LG G++G VY G  +          VAIK +    +     EF+ 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL---SW 447
           E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L   S 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
              +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +T D 
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET-DX 178
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
                K +    +++PE L DG+ T  SDV++FGVVL+EI                    
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA------------------- 219
Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
            +LA      L N         L+  ++  ++D  P +C   +  L + C   +P +RP 
Sbjct: 220 -TLAEQPYQGLSNE------QVLRFVMEGGLLD-KPDNCPDMLLELMRMCWQYNPKMRPS 271
Query: 628 MKQVVISLSQ 637
             +++ S+ +
Sbjct: 272 FLEIISSIKE 281

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 144/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 184 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 239
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 240 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 275
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 276 MRPSFLEIISSIKE 289

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 144/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 185 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 240
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 241 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 276
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 277 MRPSFLEIISSIKE 290

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 106/195 (54%), Gaps = 14/195 (7%)
Query: 359 LGHGTYGSVYYGNI-RNQEVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+     ++ +VA+K M   +   + F+AE  ++  + H  LV+L     T+
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 81
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I E+  KGSL   L   +   Q     I     +   A G+ +I +    +Y+HR
Sbjct: 82  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI---DFSAQIAEGMAFIEQR---NYIHR 135
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+ ++   KI+DFGLA+++    D E T  +       + APE +  G  T K
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L EI++
Sbjct: 193 SDVWSFGILLMEIVT 207

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 144/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 213 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 268
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 269 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 304
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 305 MRPSFLEIISSIKE 318

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 134
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 193 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 224
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 139
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 198 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 229
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 134
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 193 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 224
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++        VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + ++ EY + GSL S L  HD Q       + I  V +    A G++Y+ +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSD 165
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPE 524
                YVHRD+ + NIL++S    K+SDFGLA+++    D EA  T   G     + +PE
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLARVL--EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+VL+E++S  E                                
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---------------------------E 253
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MS   +   +D       P DC   +  L   C  +D   RP  +Q+V  L +++
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 137/304 (45%), Gaps = 45/304 (14%)
Query: 337 KPVVF----TYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTK 388
           KP ++     YD+        +    LG G YG VY G  +     VA+K +     + +
Sbjct: 202 KPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 261
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           EF+ E  ++ ++ H NLV+L+G    E   ++I E+   G+L  +L +  NR + S   +
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSA--V 318
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
           + + +A   +  +EY+    K +++HR++ + N L+      K++DFGL++L+  T D  
Sbjct: 319 VLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTY 373
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
                      + APE L     + KSDV+AFGV+L+EI         T GM        
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA--------TYGM-------- 417
Query: 569 SLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
                       SP   + +S + + ++ +     P  C  K+  L + C   +P  RP 
Sbjct: 418 ------------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 465
Query: 628 MKQV 631
             ++
Sbjct: 466 FAEI 469

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           ++G G  G V YG +R     +  VAIK + A  T    ++F++E  I+ +  H N++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G         ++ EY + GSL + L  HD    GQ ++  ++ +   + A  G+ Y+  
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGA--GMRYL-- 167
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
            +   YVHRD+ + N+L+DS    K+SDFGL++++    D   T T       + APE +
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKE 552
                ++ SDV++FGVV++E+++  E
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGE 252

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 134
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 193 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 224
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   +++ EY   G+L  +L +      T+   ++ + +A   +  +EY+    K +++H
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTA---VVLLYMATQISSAMEYLE---KKNFIH 153
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 212 SDVWAFGVLLWEIAT 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 134
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 193 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 224
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYY------GNIRNQEVAIKRMTAT---KTKEFMAEM 394
           D  +F        S LG G +GSV        G+     VA+K++  +   + ++F  E+
Sbjct: 4   DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 63
Query: 395 KILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           +IL  +H   +V+  G  Y      L L+ EY   G L+  L   + R   S   +   Q
Sbjct: 64  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 123
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           I     +G+EY+        VHRD+ + NIL++S    KI+DFGLAKL+    D      
Sbjct: 124 IC----KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 176
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                  + APE L+D + + +SDV++FGVVL+E+ +
Sbjct: 177 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 20/203 (9%)
Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G +     R   VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + ++ EY + GSL + L   +N GQ ++  I  V +    + G++Y+   +
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLK--KNDGQFTV--IQLVGMLRGISAGMKYL---S 141
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG--YLAPEYL 526
              YVHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + APE +
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAI 199
Query: 527 TDGLATAKSDVYAFGVVLFEIIS 549
                T+ SDV+++G+V++E++S
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRE-CNRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 139
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 135
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 193
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYY------GNIRNQEVAIKRMTAT---KTKEFMAEM 394
           D  +F        S LG G +GSV        G+     VA+K++  +   + ++F  E+
Sbjct: 3   DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 62
Query: 395 KILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           +IL  +H   +V+  G  Y      L L+ EY   G L+  L   + R   S   +   Q
Sbjct: 63  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           I     +G+EY+        VHRD+ + NIL++S    KI+DFGLAKL+    D      
Sbjct: 123 IC----KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 175
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                  + APE L+D + + +SDV++FGVVL+E+ +
Sbjct: 176 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 18/198 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 79  EPPFYIITEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 132
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLTDGLA 531
           RD+ + N L+      K++DFGL++L+  T D   T T   G      + APE L     
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM--TGD---TFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 532 TAKSDVYAFGVVLFEIIS 549
           + KSDV+AFGV+L+EI +
Sbjct: 188 SIKSDVWAFGVLLWEIAT 205

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYY------GNIRNQEVAIKRMTAT---KTKEFMAEM 394
           D  +F        S LG G +GSV        G+     VA+K++  +   + ++F  E+
Sbjct: 16  DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75
Query: 395 KILCKVHHSNLVELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           +IL  +H   +V+  G  Y      L L+ EY   G L+  L   + R   S   +   Q
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           I     +G+EY+        VHRD+ + NIL++S    KI+DFGLAKL+    D      
Sbjct: 136 IC----KGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                  + APE L+D + + +SDV++FGVVL+E+ +
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 139/309 (44%), Gaps = 47/309 (15%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK---- 388
           V+  DE   + E  +    LG G++G VY GN R+         VA+K +  + +     
Sbjct: 7   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 66
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQT 443
           EF+ E  ++      ++V L+G  +      ++ E    G LKS+L    P+   N G+ 
Sbjct: 67  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             +    +Q+A + A G+ Y++      +VHR++ + N ++   F  KI DFG+ + + +
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 183
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    ++APE L DG+ T  SD+++FGVVL+EI S              
Sbjct: 184 T-DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 228
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                 LA      L N         LK  +D   +D  P +C  ++  L + C   +P 
Sbjct: 229 ------LAEQPYQGLSNE------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPN 275
Query: 624 LRPDMKQVV 632
           +RP   ++V
Sbjct: 276 MRPTFLEIV 284

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D+ ++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           SDV++FG++L E+ +  +  +   GMV++ 
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNRE 223

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRE-CNRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 139
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 41/272 (15%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KG L   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVMEYMSKGCLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYI 594
           SDV++FG++L E+ +  +  +   GMV++    +    + +      P+S+         
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESL--------- 244
Query: 595 DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                    HD       L  QC  +DP  RP
Sbjct: 245 ---------HD-------LMCQCWRKDPEERP 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 82  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 135
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 106/195 (54%), Gaps = 14/195 (7%)
Query: 359 LGHGTYGSVYYGNI-RNQEVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+     ++ +VA+K M   +   + F+AE  ++  + H  LV+L     T+
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 254
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I E+  KGSL   L   +   Q     I     +   A G+ +I +    +Y+HR
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI---DFSAQIAEGMAFIEQR---NYIHR 308
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+ ++   KI+DFGLA+++    D E T  +       + APE +  G  T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 535 SDVYAFGVVLFEIIS 549
           SDV++FG++L EI++
Sbjct: 366 SDVWSFGILLMEIVT 380

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 139/309 (44%), Gaps = 47/309 (15%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK---- 388
           V+  DE   + E  +    LG G++G VY GN R+         VA+K +  + +     
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQT 443
           EF+ E  ++      ++V L+G  +      ++ E    G LKS+L    P+   N G+ 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             +    +Q+A + A G+ Y++      +VHR++ + N ++   F  KI DFG+ + + +
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    ++APE L DG+ T  SD+++FGVVL+EI S              
Sbjct: 183 T-DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------- 227
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                 LA      L N         LK  +D   +D  P +C  ++  L + C   +P 
Sbjct: 228 ------LAEQPYQGLSNE------QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPN 274
Query: 624 LRPDMKQVV 632
           +RP   ++V
Sbjct: 275 MRPTFLEIV 283

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 41/272 (15%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMT-ATKTKE-FMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +   T + E F+ E +++ K+ H  LV+L     +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KG L   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 85  EPIYIVTEYMSKGCLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGLA+L+    D E T  +       + APE    G  T K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYI 594
           SDV++FG++L E+ +  +  +   GMV++    +    + +      P+S+         
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESL--------- 244
Query: 595 DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                    HD       L  QC  +DP  RP
Sbjct: 245 ---------HD-------LMCQCWRKDPEERP 260

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           ++G G  G V YG +R     +  VAIK + A  T    ++F++E  I+ +  H N++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G         ++ EY + GSL + L  HD    GQ ++  ++ +   + A  G+ Y+  
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGA--GMRYL-- 167
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
            +   YVHRD+ + N+L+DS    K+SDFGL++++    D   T T       + APE +
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKE 552
                ++ SDV++FGVV++E+++  E
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGE 252

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRE-CNRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 139
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G +G VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + S   ++ + +A   +  +EY+    K +++H
Sbjct: 79  EPPFYIITEFMTYGNLLDYLREC-NRQEVSA--VVLLYMATQISSAMEYLE---KKNFIH 132
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 142/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-----PQNRGQT 443
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L         N    
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 191 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 246
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 247 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 282
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 283 MRPSFLEIISSIKE 296

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 136
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 135/309 (43%), Gaps = 55/309 (17%)
Query: 348 FATE----GFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEM 394
           FA E      S   ++G G +G V  G ++        VAIK +    T  + ++F+ E 
Sbjct: 26  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQ 452
            I+ +  H N++ L G       + ++ EY + GSL S L  HD Q       + I  V 
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVG 139
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +    A G++Y+ +     YVHRD+ + NIL++S    K+SDFGL++++    D EA  T
Sbjct: 140 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYT 194
Query: 513 KVVGT--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL 570
              G     + +PE +     T+ SDV+++G+VL+E++S  E                  
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-------------- 240
Query: 571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
                         MS   +   +D       P DC   +  L   C  +D   RP  +Q
Sbjct: 241 -------------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 287
Query: 631 VVISLSQIL 639
           +V  L +++
Sbjct: 288 IVSILDKLI 296

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/314 (26%), Positives = 142/314 (45%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-----PQNRGQT 443
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L         N    
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S 
Sbjct: 181 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSN 236
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            Q  R +   M   L + PD+                    D LF+   L + C   +P 
Sbjct: 237 EQVLRFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPK 272
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 273 MRPSFLEIISSIKE 286

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 137/304 (45%), Gaps = 45/304 (14%)
Query: 337 KPVVF----TYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTK 388
           KP V+     YD+        +    LG G YG VY G  +     VA+K +     + +
Sbjct: 241 KPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 300
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           EF+ E  ++ ++ H NLV+L+G    E   ++I E+   G+L  +L +  NR + +   +
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNA--V 357
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
           + + +A   +  +EY+    K +++HR++ + N L+      K++DFGL++L+  T D  
Sbjct: 358 VLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTY 412
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
                      + APE L     + KSDV+AFGV+L+EI         T GM        
Sbjct: 413 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA--------TYGM-------- 456
Query: 569 SLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
                       SP   + +S + + ++ +     P  C  K+  L + C   +P  RP 
Sbjct: 457 ------------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 504
Query: 628 MKQV 631
             ++
Sbjct: 505 FAEI 508

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRE-CNRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 138
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 142/310 (45%), Gaps = 47/310 (15%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK----EFMA 392
           DE   A E  + S  LG G++G VY G  +          VAIK +    +     EF+ 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL---SW 447
           E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L   S 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
              +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +T D 
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DY 180
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
                K +    +++PE L DG+ T  SDV++FGVVL+EI +  E   +    +S  Q  
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVL 237
Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
           R +   M   L + PD+                    D LF+   L + C   +P +RP 
Sbjct: 238 RFV---MEGGLLDKPDNCP------------------DMLFE---LMRMCWQYNPKMRPS 273
Query: 628 MKQVVISLSQ 637
             +++ S+ +
Sbjct: 274 FLEIISSIKE 283

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 140/295 (47%), Gaps = 49/295 (16%)
Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G++     R   VAIK +    T  + ++F++E  I+ +  H N++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + +I E+ + GSL S L   QN GQ ++  I  V +    A G++Y+ +  
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTV--IQLVGMLRGIAAGMKYLAD-- 127
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVG---TFGYLAPE 524
             +YVHR + + NIL++S    K+SDFGL++ L   TSD   T T  +G      + APE
Sbjct: 128 -MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSD--PTYTSALGGKIPIRWTAPE 184
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+V++E++S  E               R         + N+ + 
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGE---------------RPYWDMTNQDVINAIE- 228
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                 +DY  P      P DC   +  L   C  +D   RP   Q+V +L +++
Sbjct: 229 ------QDYRLPP-----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 134
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 193 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 224
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 134
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 193 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 224
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 86  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 139
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 198 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 229
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 230 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 132/290 (45%), Gaps = 47/290 (16%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRMTATKTK----EFMAEMKILCKVHHSNLVE 407
           LG G++G VY GN R+         VA+K +  + +     EF+ E  ++      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHD--PQ---NRGQTSLSWIMRVQIALDAARGLE 462
           L+G  +      ++ E    G LKS+L    P+   N G+   +    +Q+A + A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y++      +VHRD+ + N ++   F  KI DFG+ + + +T D      K +    ++A
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRWMA 199
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           PE L DG+ T  SD+++FGVVL+EI S                    LA      L N  
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITS--------------------LAEQPYQGLSNE- 238
Query: 583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
                  LK  +D   +D  P +C  ++  L + C   +P +RP   ++V
Sbjct: 239 -----QVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++        VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + ++ EY + GSL S L  HD Q       + I  V +    A G++Y+ +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSD 165
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPE 524
                YVHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + +PE
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+VL+E++S  E                                
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---------------------------E 253
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MS   +   +D       P DC   +  L   C  +D   RP  +Q+V  L +++
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 130/295 (44%), Gaps = 51/295 (17%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++        VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + ++ EY + GSL S L  HD Q       + I  V +    A G++Y+ +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSD 165
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPE 524
                YVHRD+ + NIL++S    K+SDFGL +++    D EA  T   G     + +PE
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+VL+E++S  E                                
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---------------------------E 253
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MS   +   +D       P DC   +  L   C  +D   RP  +Q+V  L +++
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 135/309 (43%), Gaps = 55/309 (17%)
Query: 348 FATE----GFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEM 394
           FA E      S   ++G G +G V  G ++        VAIK +    T  + ++F+ E 
Sbjct: 9   FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQ 452
            I+ +  H N++ L G       + ++ EY + GSL S L  HD Q       + I  V 
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVG 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +    A G++Y+ +     YVHRD+ + NIL++S    K+SDFGL++++    D EA  T
Sbjct: 123 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYT 177
Query: 513 KVVGT--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL 570
              G     + +PE +     T+ SDV+++G+VL+E++S  E                  
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-------------- 223
Query: 571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
                         MS   +   +D       P DC   +  L   C  +D   RP  +Q
Sbjct: 224 -------------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 270
Query: 631 VVISLSQIL 639
           +V  L +++
Sbjct: 271 IVSILDKLI 279

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 135/309 (43%), Gaps = 55/309 (17%)
Query: 348 FATE----GFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEM 394
           FA E      S   ++G G +G V  G ++        VAIK +    T  + ++F+ E 
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQ 452
            I+ +  H N++ L G       + ++ EY + GSL S L  HD Q       + I  V 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVG 151
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +    A G++Y+ +     YVHRD+ + NIL++S    K+SDFGL++++    D EA  T
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYT 206
Query: 513 KVVGT--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL 570
              G     + +PE +     T+ SDV+++G+VL+E++S  E                  
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-------------- 252
Query: 571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
                         MS   +   +D       P DC   +  L   C  +D   RP  +Q
Sbjct: 253 -------------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 631 VVISLSQIL 639
           +V  L +++
Sbjct: 300 IVSILDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++        VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + ++ EY + GSL S L  HD Q       + I  V +    A G++Y+ +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSD 165
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPE 524
                YVHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + +PE
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+VL+E++S  E                                
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---------------------------E 253
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MS   +   +D       P DC   +  L   C  +D   RP  +Q+V  L +++
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++        VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + ++ EY + GSL S L  HD Q       + I  V +    A G++Y+ +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSD 165
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPE 524
                YVHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + +PE
Sbjct: 166 ---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+VL+E++S  E                                
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---------------------------E 253
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MS   +   +D       P DC   +  L   C  +D   RP  +Q+V  L +++
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRMTA--TKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK +       + F+ E +++ K+ H  LV+L     +E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 251
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L     +    L     V +A   A G+ Y+    + +YVHR
Sbjct: 252 EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG-TFGYLAPEYLTDGLATAK 534
           D++++NIL+      K++DFGL +L+    D E T  +       + APE    G  T K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYI 594
           SDV++FG++L E+ +  +  +   GMV++    +    + +      P+S+         
Sbjct: 363 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESL--------- 411
Query: 595 DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                    HD       L  QC  +DP  RP
Sbjct: 412 ---------HD-------LMCQCWRKDPEERP 427

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 135/309 (43%), Gaps = 55/309 (17%)
Query: 348 FATE----GFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEM 394
           FA E      S   ++G G +G V  G ++        VAIK +    T  + ++F+ E 
Sbjct: 36  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQ 452
            I+ +  H N++ L G       + ++ EY + GSL S L  HD Q       + I  V 
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVG 149
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +    A G++Y+ +     YVHRD+ + NIL++S    K+SDFGL++++    D EA  T
Sbjct: 150 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYT 204
Query: 513 KVVGT--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL 570
              G     + +PE +     T+ SDV+++G+VL+E++S  E                  
Sbjct: 205 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-------------- 250
Query: 571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
                         MS   +   +D       P DC   +  L   C  +D   RP  +Q
Sbjct: 251 -------------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 297
Query: 631 VVISLSQIL 639
           +V  L +++
Sbjct: 298 IVSILDKLI 306

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 141/314 (44%), Gaps = 47/314 (14%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTK---- 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSL- 445
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L    P+      L 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 446 --SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N  +   F  KI DFG+ + + +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI                
Sbjct: 178 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------------- 221
Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                +LA      L N         L+  ++  ++D  P +C   +  L + C   +P 
Sbjct: 222 -----TLAEQPYQGLSNE------QVLRFVMEGGLLD-KPDNCPDMLLELMRMCWQYNPK 269
Query: 624 LRPDMKQVVISLSQ 637
           +RP   +++ S+ +
Sbjct: 270 MRPSFLEIISSIKE 283

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 136
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 94  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 147
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 205
Query: 535 SDVYAFGVVLFEIIS 549
           SDV+AFGV+L+EI +
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L +  NR + +   ++ + +A   +  +EY+    K +++H
Sbjct: 83  EPPFYIITEFMTYGNLLDYLREC-NRQEVNA--VVLLYMATQISSAMEYLE---KKNFIH 136
Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD+ + N L+      K++DFGL++L+  T D             + APE L     + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDY 593
           SDV+AFGV+L+EI         T GM                    SP   + +S + + 
Sbjct: 195 SDVWAFGVLLWEIA--------TYGM--------------------SPYPGIDLSQVYEL 226
Query: 594 IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++ +     P  C  K+  L + C   +P  RP   ++
Sbjct: 227 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++        VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + ++ EY + GSL S L  HD Q       + I  V +    A G++Y+ +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSD 165
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPE 524
                +VHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + +PE
Sbjct: 166 ---MGFVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+VL+E++S  E                                
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---------------------------E 253
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MS   +   +D       P DC   +  L   C  +D   RP  +Q+V  L +++
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQEV-AIKRMTAT------KTKEFMAEMKILCKVHHSN 404
           FSD   +GHG++G+VY+  ++RN EV AIK+M+ +      K ++ + E++ L K+ H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 405 LVELIGYAATEDELFLIYEYAQKGS---LKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
            ++  G    E   +L+ EY    +   L+ H        +  L  +    +   A +GL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--------KKPLQEVEIAAVTHGALQGL 167
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H H     +HRD+K+ NILL      K+ DFG A ++       A     VGT  ++
Sbjct: 168 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANXFVGTPYWM 217
Query: 522 APEY---LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
           APE    + +G    K DV++ G+   E+   K  +     M
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 120/241 (49%), Gaps = 25/241 (10%)
Query: 314 TGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR 373
           T ++ NPP    K L  D    +   VF   E             LG G+YGSVY    +
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLE------------KLGEGSYGSVYKAIHK 51
Query: 374 N--QEVAIKRM-TATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL 430
              Q VAIK++   +  +E + E+ I+ +    ++V+  G      +L+++ EY   GS+
Sbjct: 52  ETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA 490
            S +   +N+  T       +Q  L   +GLEY+H   K   +HRDIK+ NILL++   A
Sbjct: 112 -SDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFMRK---IHRDIKAGNILLNTEGHA 164
Query: 491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           K++DFG+A   G+ +D  A    V+GT  ++APE + +      +D+++ G+   E+  G
Sbjct: 165 KLADFGVA---GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
Query: 551 K 551
           K
Sbjct: 222 K 222

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQEV-AIKRMTAT------KTKEFMAEMKILCKVHHSN 404
           FSD   +GHG++G+VY+  ++RN EV AIK+M+ +      K ++ + E++ L K+ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 405 LVELIGYAATEDELFLIYEYAQKGS---LKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
            ++  G    E   +L+ EY    +   L+ H        +  L  +    +   A +GL
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--------KKPLQEVEIAAVTHGALQGL 128
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H H     +HRD+K+ NILL      K+ DFG A ++       A     VGT  ++
Sbjct: 129 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANXFVGTPYWM 178
Query: 522 APEY---LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
           APE    + +G    K DV++ G+   E+   K  +     M
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 110/203 (54%), Gaps = 20/203 (9%)
Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G +     R   VAIK + A  T    ++F++E  I+ +  H N++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + +I EY + GSL + L   +N G+ ++  I  V +      G++Y+ + +
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTV--IQLVGMLRGIGSGMKYLSDMS 130
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPEYL 526
              YVHRD+ + NIL++S    K+SDFG+++++    D EA  T   G     + APE +
Sbjct: 131 ---YVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 527 TDGLATAKSDVYAFGVVLFEIIS 549
                T+ SDV+++G+V++E++S
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMS 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 22/194 (11%)
Query: 359 LGHGTYGSVYYGNI-RNQEVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+     ++ +VA+K M   +   + F+AE  ++  + H  LV+L     T+
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 248
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I E+  KGSL   L   +   Q     I     +   A G+ +I +    +Y+HR
Sbjct: 249 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI---DFSAQIAEGMAFIEQR---NYIHR 302
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D++++NIL+ ++   KI+DFGLA++  K                + APE +  G  T KS
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFP------------IKWTAPEAINFGSFTIKS 350
Query: 536 DVYAFGVVLFEIIS 549
           DV++FG++L EI++
Sbjct: 351 DVWSFGILLMEIVT 364

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 110/203 (54%), Gaps = 20/203 (9%)
Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G +     R   VAIK + A  T    ++F++E  I+ +  H N++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + +I EY + GSL + L   +N G+ ++  I  V +      G++Y+ + +
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTV--IQLVGMLRGIGSGMKYLSDMS 136
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPEYL 526
              YVHRD+ + NIL++S    K+SDFG+++++    D EA  T   G     + APE +
Sbjct: 137 ---YVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 527 TDGLATAKSDVYAFGVVLFEIIS 549
                T+ SDV+++G+V++E++S
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 134/309 (43%), Gaps = 55/309 (17%)
Query: 348 FATE----GFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEM 394
           FA E      S   ++G G +G V  G ++        VAIK +    T  + ++F+ E 
Sbjct: 9   FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQ 452
            I+ +  H N++ L G       + ++ E  + GSL S L  HD Q       + I  V 
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ------FTVIQLVG 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +    A G++Y+ +     YVHRD+ + NIL++S    K+SDFGL++++    D EA  T
Sbjct: 123 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYT 177
Query: 513 KVVGT--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL 570
              G     + +PE +     T+ SDV+++G+VL+E++S  E                  
Sbjct: 178 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-------------- 223
Query: 571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
                         MS   +   +D       P DC   +  L   C  +D   RP  +Q
Sbjct: 224 -------------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 270
Query: 631 VVISLSQIL 639
           +V  L +++
Sbjct: 271 IVSILDKLI 279

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTKE----FMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+E     ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 134/309 (43%), Gaps = 55/309 (17%)
Query: 348 FATE----GFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEM 394
           FA E      S   ++G G +G V  G ++        VAIK +    T  + ++F+ E 
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQ 452
            I+ +  H N++ L G       + ++ E  + GSL S L  HD Q       + I  V 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ------FTVIQLVG 151
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           +    A G++Y+ +     YVHRD+ + NIL++S    K+SDFGL++++    D EA  T
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYT 206
Query: 513 KVVGT--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL 570
              G     + +PE +     T+ SDV+++G+VL+E++S  E                  
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-------------- 252
Query: 571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
                         MS   +   +D       P DC   +  L   C  +D   RP  +Q
Sbjct: 253 -------------EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 631 VVISLSQIL 639
           +V  L +++
Sbjct: 300 IVSILDKLI 308

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 109/203 (53%), Gaps = 20/203 (9%)
Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G +     R+  VAIK +    T  + ++F+ E  I+ +  H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + ++ E+ + G+L + L   ++ GQ ++  I  V +    A G+ Y+ +  
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLR--KHDGQFTV--IQLVGMLRGIAAGMRYLAD-- 163
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYL 526
              YVHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + APE +
Sbjct: 164 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVI--EDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 527 TDGLATAKSDVYAFGVVLFEIIS 549
                T+ SDV+++G+V++E++S
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 255 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 300
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 301 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 339
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 21  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 80
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 81  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 198 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 243
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 244 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 282
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 283 DCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 19  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 78
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 196 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 241
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 242 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 280
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 281 DCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDXXKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDXXKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 24  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 83
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 201 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 246
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 247 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 285
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 286 DCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 33/218 (15%)
Query: 357 SLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LCKVHHSNLVELI--GYA 412
            L+G G YG+VY G++  + VA+K  +    + F+ E  I  +  + H N+   I     
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDER 78
Query: 413 ATED---ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH---- 465
            T D   E  L+ EY   GSL  +L         +  W+   ++A    RGL Y+H    
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 466 --EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA------KLVGKTSDGEATVTKVVGT 517
             +H K    HRD+ S N+L+ +     ISDFGL+      +LV    +  A +++ VGT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE-VGT 191
Query: 518 FGYLAPEYLTDGL-------ATAKSDVYAFGVVLFEII 548
             Y+APE L   +       A  + D+YA G++ +EI 
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 362 GTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LCKVHHSNLVELIGY----AATE 415
           G +G V+   + N+ VA+K       + +  E ++  L  + H N+++ IG      + +
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT------- 468
            +L+LI  + +KGSL   L          +SW     IA   ARGL Y+HE         
Sbjct: 95  VDLWLITAFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLA-KLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
           K    HRDIKS N+LL +   A I+DFGLA K     S G+      VGT  Y+APE L 
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ--VGTRRYMAPEVLE 206
Query: 528 DGL-----ATAKSDVYAFGVVLFEIIS 549
             +     A  + D+YA G+VL+E+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      +I+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 109/203 (53%), Gaps = 20/203 (9%)
Query: 358 LLGHGTYGSVYYGNI-----RNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G +     R   VAIK + A  T    ++F++E  I+ +  H N++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G       + +I EY + GSL + L   +N G+ ++  I  V +      G++Y+ + +
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTV--IQLVGMLRGIGSGMKYLSDMS 151
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPEYL 526
               VHRD+ + NIL++S    K+SDFG+++++    D EA  T   G     + APE +
Sbjct: 152 A---VHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 527 TDGLATAKSDVYAFGVVLFEIIS 549
                T+ SDV+++G+V++E++S
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 126/258 (48%), Gaps = 45/258 (17%)
Query: 325 PKALGTDVFD-MEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV-------YYGNIRNQE 376
           P +L  D F  +E P      +  F  +       LG G +G V         G      
Sbjct: 2   PLSLSVDAFKILEDP------KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 377 VAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS 432
           VA+K +    + ++ ++ ++E  +L +V+H ++++L G  + +  L LI EYA+ GSL+ 
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 433 HLHDPQNRG-------------------QTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
            L + +  G                   + +L+    +  A   ++G++Y+ E +    V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LV 172
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTDGLA 531
           HRD+ + NIL+    + KISDFGL++ V    + ++ V +  G     ++A E L D + 
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDV---YEEDSXVKRSQGRIPVKWMAIESLFDHIY 229
Query: 532 TAKSDVYAFGVVLFEIIS 549
           T +SDV++FGV+L+EI++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKI 396
           D+ +   E       +G G +G V+ G +R  N  VA+K    T     K K F+ E +I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARI 165
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           L +  H N+V LIG    +  ++++ E  Q G   + L     R +        +Q+  D
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK----TLLQMVGD 221
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
           AA G+EY+        +HRD+ + N L+      KISDFG+++   + +DG    +  + 
Sbjct: 222 AAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLR 275
Query: 517 T--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                + APE L  G  +++SDV++FG++L+E  S
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE-VAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G   N++ VAIK  R  A   ++F+ E +++ K+ H  LV+L G    +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L++E+ + G L  +L     RG  +   ++   + LD   G+ Y+ E +    +HR
Sbjct: 75  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLL--GMCLDVCEGMAYLEEAS---VIHR 127
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+      K+SDFG+ + V       +T TK      + +PE  +    ++KS
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKS 185
Query: 536 DVYAFGVVLFEIIS 549
           DV++FGV+++E+ S
Sbjct: 186 DVWSFGVLMWEVFS 199

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 125/258 (48%), Gaps = 45/258 (17%)
Query: 325 PKALGTDVFD-MEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV-------YYGNIRNQE 376
           P +L  D F  +E P      +  F  +       LG G +G V         G      
Sbjct: 2   PLSLSVDAFKILEDP------KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 377 VAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS 432
           VA+K +    + ++ ++ ++E  +L +V+H ++++L G  + +  L LI EYA+ GSL+ 
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 433 HLHDPQNRG-------------------QTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
            L + +  G                   + +L+    +  A   ++G++Y+ E      V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTDGLA 531
           HRD+ + NIL+    + KISDFGL++ V    + ++ V +  G     ++A E L D + 
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDV---YEEDSXVKRSQGRIPVKWMAIESLFDHIY 229
Query: 532 TAKSDVYAFGVVLFEIIS 549
           T +SDV++FGV+L+EI++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE-VAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G   N++ VAIK  R  A   ++F+ E +++ K+ H  LV+L G    +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L++E+ + G L  +L     RG  +   ++   + LD   G+ Y+ E      +HR
Sbjct: 75  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLL--GMCLDVCEGMAYLEEAC---VIHR 127
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+      K+SDFG+ + V       +T TK      + +PE  +    ++KS
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKS 185
Query: 536 DVYAFGVVLFEIIS 549
           DV++FGV+++E+ S
Sbjct: 186 DVWSFGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE-VAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G   N++ VAIK  R  A   ++F+ E +++ K+ H  LV+L G    +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L++E+ + G L  +L     RG  +   ++   + LD   G+ Y+ E      +HR
Sbjct: 73  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLL--GMCLDVCEGMAYLEEAC---VIHR 125
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+      K+SDFG+ + V       +T TK      + +PE  +    ++KS
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKS 183
Query: 536 DVYAFGVVLFEIIS 549
           DV++FGV+++E+ S
Sbjct: 184 DVWSFGVLMWEVFS 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE-VAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G   N++ VAIK  R  A   ++F+ E +++ K+ H  LV+L G    +
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L++E+ + G L  +L     RG  +   ++   + LD   G+ Y+ E      +HR
Sbjct: 78  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLL--GMCLDVCEGMAYLEEAC---VIHR 130
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+      K+SDFG+ + V       +T TK      + +PE  +    ++KS
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKS 188
Query: 536 DVYAFGVVLFEIIS 549
           DV++FGV+++E+ S
Sbjct: 189 DVWSFGVLMWEVFS 202

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 118/257 (45%), Gaps = 27/257 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTK----------EFMA--EMKILCKV 400
           F    +LG G +G V    +R    A  +M A K            E MA  E +IL KV
Sbjct: 186 FRQYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           +   +V L     T+D L L+      G LK H++   + GQ        V  A +   G
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGQAGFPEARAVFYAAEICCG 298
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           LE +H   +   V+RD+K  NILLD     +ISD GLA  V    +G+ T+   VGT GY
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQ-TIKGRVGTVGY 351
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA-ALR 579
           +APE + +   T   D +A G +L+E+I+G+    + +  + + +  R +       + R
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER 411
Query: 580 NSPDSMSMSSLKDYIDP 596
            SP + S+ S     DP
Sbjct: 412 FSPQARSLCSQLLCKDP 428

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKI 396
           D+ +   E       +G G +G V+ G +R  N  VA+K    T     K K F+ E +I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARI 165
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           L +  H N+V LIG    +  ++++ E  Q G   + L     R +        +Q+  D
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK----TLLQMVGD 221
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
           AA G+EY+        +HRD+ + N L+      KISDFG+++   + +DG    +  + 
Sbjct: 222 AAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLR 275
Query: 517 T--FGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                + APE L  G  +++SDV++FG++L+E  S
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 358 LLGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           ++G G +G V  G ++        VAIK +    T  + ++F+ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + ++ E  + GSL S L  HD Q       + I  V +    A G++Y+ +
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ------FTVIQLVGMLRGIASGMKYLSD 165
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT--FGYLAPE 524
                 VHRD+ + NIL++S    K+SDFGL++++    D EA  T   G     + +PE
Sbjct: 166 MGA---VHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPE 220
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +     T+ SDV+++G+VL+E++S  E                                
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW---------------------------E 253
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           MS   +   +D       P DC   +  L   C  +D   RP  +Q+V  L +++
Sbjct: 254 MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 140/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I EYA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                  T++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDYYKNTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 125/258 (48%), Gaps = 45/258 (17%)
Query: 325 PKALGTDVFD-MEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV-------YYGNIRNQE 376
           P +L  D F  +E P      +  F  +       LG G +G V         G      
Sbjct: 2   PLSLSVDAFKILEDP------KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 377 VAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS 432
           VA+K +    + ++ ++ ++E  +L +V+H ++++L G  + +  L LI EYA+ GSL+ 
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 433 HLHDPQNRG-------------------QTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
            L + +  G                   + +L+    +  A   ++G++Y+ E      V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTDGLA 531
           HRD+ + NIL+    + KISDFGL++ V    + ++ V +  G     ++A E L D + 
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDV---YEEDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 532 TAKSDVYAFGVVLFEIIS 549
           T +SDV++FGV+L+EI++
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 362 GTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGY----AATE 415
           G +G V+   + N  VA+K       + + +E +I     + H NL++ I      +  E
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLE 85
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT------- 468
            EL+LI  +  KGSL  +L     +G   ++W     +A   +RGL Y+HE         
Sbjct: 86  VELWLITAFHDKGSLTDYL-----KGNI-ITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 469 -KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
            K    HRD KS N+LL S   A ++DFGLA +  +           VGT  Y+APE L 
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-VRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 528 DGL-----ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
             +     A  + D+YA G+VL+E++S  +A    +G V +         +ML       
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKA---ADGPVDE---------YMLPFEEEIG 246
Query: 583 DSMSMSSLKDYI-----DPNMMDLY-PHDCLFKMAMLAKQCVDEDPILR 625
              S+  L++ +      P + D +  H  L ++ +  ++C D D   R
Sbjct: 247 QHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEAR 295

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 137/301 (45%), Gaps = 37/301 (12%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGYAATE- 415
           +G G YG V+ G+ + + VA+K  ++   K +  E ++   V   H N++  I    T  
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 104
Query: 416 ---DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
               +L+LI  Y + GSL  +L        T+L  +  ++I L  A GL ++H       
Sbjct: 105 HSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+    +  I+D GLA +  ++++  +      VGT  Y+APE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 527 TDGLAT------AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            + +         + D++AFG+VL+E+            MVS          F    + N
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV---------ARRMVSNGIVEDYKPPFY-DVVPN 268
Query: 581 SPDSMSMSSL--KDYIDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
            P    M  +   D   PN+ + +  D  L  +A L K+C  ++P  R    ++  +L++
Sbjct: 269 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 328
Query: 638 I 638
           I
Sbjct: 329 I 329

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 137/301 (45%), Gaps = 37/301 (12%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGYAATE- 415
           +G G YG V+ G+ + + VA+K  ++   K +  E ++   V   H N++  I    T  
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75
Query: 416 ---DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
               +L+LI  Y + GSL  +L        T+L  +  ++I L  A GL ++H       
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+    +  I+D GLA +  ++++  +      VGT  Y+APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 527 TDGLAT------AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            + +         + D++AFG+VL+E+            MVS          F    + N
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV---------ARRMVSNGIVEDYKPPF-YDVVPN 239
Query: 581 SPDSMSMSSL--KDYIDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
            P    M  +   D   PN+ + +  D  L  +A L K+C  ++P  R    ++  +L++
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 638 I 638
           I
Sbjct: 300 I 300

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 48/300 (16%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQE-----VAIKRM----TATKTKEFMAEMKILCK 399
           A E    + +LG G +G VY G   N +     VA+K      T    ++FM+E  I+  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H ++V+LIG    E+  ++I E    G L  +L     R + SL  +  V  +L   +
Sbjct: 66  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICK 120
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            + Y+      + VHRDI   NIL+ S    K+ DFGL++ +      +A+VT++     
Sbjct: 121 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIK 175
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL 578
           +++PE +     T  SDV+ F V ++EI+S GK+     E                    
Sbjct: 176 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------------------- 215
Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             + D + +    D +        P  C   +  L  +C D DP  RP   ++V SLS +
Sbjct: 216 --NKDVIGVLEKGDRLPK------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 48/300 (16%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQE-----VAIKRM----TATKTKEFMAEMKILCK 399
           A E    + +LG G +G VY G   N +     VA+K      T    ++FM+E  I+  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H ++V+LIG    E+  ++I E    G L  +L     R + SL  +  V  +L   +
Sbjct: 82  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICK 136
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            + Y+      + VHRDI   NIL+ S    K+ DFGL++ +      +A+VT++     
Sbjct: 137 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIK 191
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL 578
           +++PE +     T  SDV+ F V ++EI+S GK+     E                    
Sbjct: 192 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------------------- 231
Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             + D + +    D +        P  C   +  L  +C D DP  RP   ++V SLS +
Sbjct: 232 --NKDVIGVLEKGDRLPK------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 118/257 (45%), Gaps = 27/257 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTK----------EFMA--EMKILCKV 400
           F    +LG G +G V    +R    A  +M A K            E MA  E +IL KV
Sbjct: 186 FRQYRVLGKGGFGEVCACQVR----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           +   +V L     T+D L L+      G LK H++   + GQ        V  A +   G
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY---HMGQAGFPEARAVFYAAEICCG 298
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           LE +H   +   V+RD+K  NILLD     +ISD GLA  V    +G+ T+   VGT GY
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQ-TIKGRVGTVGY 351
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA-ALR 579
           +APE + +   T   D +A G +L+E+I+G+    + +  + + +  R +       + R
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER 411
Query: 580 NSPDSMSMSSLKDYIDP 596
            SP + S+ S     DP
Sbjct: 412 FSPQARSLCSQLLCKDP 428

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 36/218 (16%)
Query: 359 LGHGTYGSVYYGNI-------RNQEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHL---------HDPQNRGQTSLSWIMRVQIAL 455
            L+G A T+    L +I E+ + G+L ++L         + P++  +  L+    +  + 
Sbjct: 97  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEATV 511
             A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A +
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 512 TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                   ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 213 P-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 140/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I  YA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 139/319 (43%), Gaps = 47/319 (14%)
Query: 334 DMEKPVVFTYDEILFATEGFSDSS--LLGHGTYGSVYYGNIRNQ-----EVAIK---RMT 383
           D++  ++    ++L   E     S  ++G G +G VY+G   +Q     + AIK   R+T
Sbjct: 2   DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT 61
Query: 384 ATKTKE-FMAEMKILCKVHHSNLVELIGYAATEDEL-FLIYEYAQKGSLKSHLHDPQNRG 441
             +  E F+ E  ++  ++H N++ LIG     + L  ++  Y   G L   +  PQ R 
Sbjct: 62  EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RN 120
Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-L 500
            T    I      L  ARG+EY+ E     +VHRD+ + N +LD +F  K++DFGLA+ +
Sbjct: 121 PTVKDLI---SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174
Query: 501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
           + +                + A E L     T KSDV++FGV+L+E++        T G 
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL--------TRGA 226
Query: 561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDE 620
                      +  LA  R  P                    P  C   +  + +QC + 
Sbjct: 227 PPYRHIDPFDLTHFLAQGRRLPQ-------------------PEYCPDSLYQVMQQCWEA 267
Query: 621 DPILRPDMKQVVISLSQIL 639
           DP +RP  + +V  + QI+
Sbjct: 268 DPAVRPTFRVLVGEVEQIV 286

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 137/301 (45%), Gaps = 37/301 (12%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGYAATE- 415
           +G G YG V+ G+ + + VA+K  ++   K +  E ++   V   H N++  I    T  
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR 75
Query: 416 ---DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
               +L+LI  Y + GSL  +L        T+L  +  ++I L  A GL ++H       
Sbjct: 76  HSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+    +  I+D GLA +  ++++  +      VGT  Y+APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 527 TDGLAT------AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            + +         + D++AFG+VL+E+            MVS          F    + N
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV---------ARRMVSNGIVEDYKPPF-YDVVPN 239
Query: 581 SPDSMSMSSL--KDYIDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
            P    M  +   D   PN+ + +  D  L  +A L K+C  ++P  R    ++  +L++
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 638 I 638
           I
Sbjct: 300 I 300

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 48/300 (16%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQE-----VAIKRM----TATKTKEFMAEMKILCK 399
           A E    + +LG G +G VY G   N +     VA+K      T    ++FM+E  I+  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H ++V+LIG    E+  ++I E    G L  +L     R + SL  +  V  +L   +
Sbjct: 70  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICK 124
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            + Y+      + VHRDI   NIL+ S    K+ DFGL++ +      +A+VT++     
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIK 179
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL 578
           +++PE +     T  SDV+ F V ++EI+S GK+     E                    
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------------------- 219
Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             + D + +    D +        P  C   +  L  +C D DP  RP   ++V SLS +
Sbjct: 220 --NKDVIGVLEKGDRLPK------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 359 LGHGTYGSVYYGNIRNQE-------VAIKRM---TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N         VA+K +   T    K+F  E ++L  + H ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDP-----------QNRGQTSLSWIMRVQIAL 455
            G     D L +++EY + G L   L  H P           Q +G+  LS ++   IA 
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML--HIAS 140
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
             A G+ Y+      H+VHRD+ + N L+ +    KI DFG+++ V  T D        +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-DYYRVGGHTM 196
Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
               ++ PE +     T +SDV++FGV+L+EI + GK+
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/324 (24%), Positives = 140/324 (43%), Gaps = 70/324 (21%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNI------RNQE---VAIKRMTATKTK----EFMAEM 394
           F  +  +    LG G +G V           + +E   VA+K +    T+    + ++EM
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 395 KILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQ 442
           +++  +  H N++ L+G    +  L++I  YA KG+L+ +L           +D     +
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +++   V      ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 503 ------KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                 KT++G   V        ++APE L D + T +SDV++FGV+++EI +       
Sbjct: 209 NIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------- 254
Query: 557 TEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK 615
                                L  SP   + +  L   +        P +C  ++ M+ +
Sbjct: 255 ---------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 616 QCVDEDPILRPDMKQVVISLSQIL 639
            C    P  RP  KQ+V  L +IL
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 331 DVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYY------GNIRNQEVAIKRMTA 384
           D+   +KP     D   F          LG G +G V        G+   ++VA+K +  
Sbjct: 2   DIVSEKKPAT-EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 385 TKTKEFMAEMK----ILCKVHHSNLVELIGYAATEDE---LFLIYEYAQKGSLKSHLHDP 437
                 +A++K    IL  ++H N+V+  G   TED    + LI E+   GSLK +L  P
Sbjct: 61  ESGGNHIADLKKEIEILRNLYHENIVKYKG-ICTEDGGNGIKLIMEFLPSGSLKEYL--P 117
Query: 438 QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL 497
           +N+ + +L    +++ A+   +G++Y+       YVHRD+ + N+L++S  + KI DFGL
Sbjct: 118 KNKNKINLK--QQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGL 172
Query: 498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            K +    +             + APE L        SDV++FGV L E+++
Sbjct: 173 TKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 359 LGHGTYGSVYY------GNIRNQEVAIKRMTATKTKEFMAEMK----ILCKVHHSNLVEL 408
           LG G +G V        G+   ++VA+K +        +A++K    IL  ++H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 409 IGYAATEDE---LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            G   TED    + LI E+   GSLK +L  P+N+ + +L    +++ A+   +G++Y+ 
Sbjct: 77  KG-ICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLK--QQLKYAVQICKGMDYL- 130
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                 YVHRD+ + N+L++S  + KI DFGL K +    +             + APE 
Sbjct: 131 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 526 LTDGLATAKSDVYAFGVVLFEIIS 549
           L        SDV++FGV L E+++
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 41/303 (13%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGY----A 412
           +G G YG V+ G  R ++VA+K    T+   +  E +I   V   H N++  I       
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT---- 468
            +  +L+LI +Y + GSL  +L        T+L     +++A  +  GL ++H       
Sbjct: 105 GSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 469 -KTHYVHRDIKSSNILLDSAFRAKISDFGLA-KLVGKTSDGEATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA K +  T++ +      VGT  Y+ PE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 527 TDGL------ATAKSDVYAFGVVLFEI----ISGKEAIIRTEGMVSKNQERRSLASFMLA 576
            + L      +   +D+Y+FG++L+E+    +SG        G+V + Q    L    L 
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSG--------GIVEEYQ----LPYHDLV 266
Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHD-CLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
               S + M        + P+  + +  D CL +M  L  +C   +P  R    +V  +L
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 636 SQI 638
           +++
Sbjct: 327 AKM 329

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGY----A 412
           +G G +G V+ G  R +EVA+K  ++ + + +  E +I   V   H N++  I       
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 109
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
            T  +L+L+ +Y + GSL  +L    NR   ++  +  +++AL  A GL ++H       
Sbjct: 110 GTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 163
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA      +D  +      VGT  Y+APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 527 TDGL------ATAKSDVYAFGVVLFEI 547
            D +      +  ++D+YA G+V +EI
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 134/303 (44%), Gaps = 65/303 (21%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT----------ATKTKEFMAEMKILCKVHHSNLV 406
           +G G +G V+ G +   +  VAIK +             K +EF  E+ I+  ++H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
           +L  Y    +   ++ E+   G L   L D  +     + W +++++ LD A G+EY+  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQN 140
Query: 467 HTKTHYVHRDIKSSNILLDSAFR-----AKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
                 VHRD++S NI L S        AK++DFGL++          +V+ ++G F ++
Sbjct: 141 QNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWM 193
Query: 522 APEYL--TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           APE +   +   T K+D Y+F ++L+ I++G+                            
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF------------------------- 228
Query: 580 NSPDSMSMSSLKDYI----DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              D  S   +K +I    +  +    P DC  ++  + + C   DP  RP    +V  L
Sbjct: 229 ---DEYSYGKIK-FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 636 SQI 638
           S++
Sbjct: 285 SEL 287

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 33/299 (11%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGY----A 412
           +G G +G V+ G  R +EVA+K  ++ + + +  E +I   V   H N++  I       
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 96
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
            T  +L+L+ +Y + GSL  +L    NR   ++  +  +++AL  A GL ++H       
Sbjct: 97  GTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 150
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA      +D  +      VGT  Y+APE L
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 527 TDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            D +      +  ++D+YA G+V +EI             +    E   L  + L     
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEIAR--------RCSIGGIHEDYQLPYYDLVPSDP 262
Query: 581 SPDSMSMSSLKDYIDPNMMDLYPH-DCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           S + M     +  + PN+ + +   + L  MA + ++C   +   R    ++  +LSQ+
Sbjct: 263 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 321

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 33/299 (11%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGY----A 412
           +G G +G V+ G  R +EVA+K  ++ + + +  E +I   V   H N++  I       
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 71
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
            T  +L+L+ +Y + GSL  +L    NR   ++  +  +++AL  A GL ++H       
Sbjct: 72  GTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 125
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA      +D  +      VGT  Y+APE L
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 527 TDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            D +      +  ++D+YA G+V +EI             +    E   L  + L     
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEIAR--------RCSIGGIHEDYQLPYYDLVPSDP 237
Query: 581 SPDSMSMSSLKDYIDPNMMDLYPH-DCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           S + M     +  + PN+ + +   + L  MA + ++C   +   R    ++  +LSQ+
Sbjct: 238 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 296

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 33/299 (11%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGY----A 412
           +G G +G V+ G  R +EVA+K  ++ + + +  E +I   V   H N++  I       
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 76
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
            T  +L+L+ +Y + GSL  +L    NR   ++  +  +++AL  A GL ++H       
Sbjct: 77  GTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 130
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA      +D  +      VGT  Y+APE L
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 527 TDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            D +      +  ++D+YA G+V +EI             +    E   L  + L     
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEIAR--------RCSIGGIHEDYQLPYYDLVPSDP 242
Query: 581 SPDSMSMSSLKDYIDPNMMDLYPH-DCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           S + M     +  + PN+ + +   + L  MA + ++C   +   R    ++  +LSQ+
Sbjct: 243 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 301

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGY----A 412
           +G G +G V+ G  R +EVA+K  ++ + + +  E +I   V   H N++  I       
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 70
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
            T  +L+L+ +Y + GSL  +L    NR   ++  +  +++AL  A GL ++H       
Sbjct: 71  GTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 124
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA      +D  +      VGT  Y+APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 527 TDGL------ATAKSDVYAFGVVLFEI 547
            D +      +  ++D+YA G+V +EI
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 43/250 (17%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V     ++  ++VA+K+M   K +       E+ I+   HH N+V++     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   R L Y+H       
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLHNQG---V 162
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL S  R K+SDFG    V K       +   VGT  ++APE ++     
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL---VGTPYWMAPEVISRLPYG 219
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E+I G+                            N P   +M  ++D
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYF------------------------NEPPLQAMRRIRD 255
Query: 593 YIDPNMMDLY 602
            + P + DL+
Sbjct: 256 SLPPRVKDLH 265

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 33/299 (11%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGY----A 412
           +G G +G V+ G  R +EVA+K  ++ + + +  E +I   V   H N++  I       
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
            T  +L+L+ +Y + GSL  +L    NR   ++  +  +++AL  A GL ++H       
Sbjct: 74  GTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 127
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA      +D  +      VGT  Y+APE L
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 527 TDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            D +      +  ++D+YA G+V +EI             +    E   L  + L     
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEIAR--------RCSIGGIHEDYQLPYYDLVPSDP 239
Query: 581 SPDSMSMSSLKDYIDPNMMDLYPH-DCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           S + M     +  + PN+ + +   + L  MA + ++C   +   R    ++  +LSQ+
Sbjct: 240 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 298

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE-VAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G   N++ VAIK  R  A   ++F+ E +++ K+ H  LV+L G    +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L+ E+ + G L  +L     RG  +   ++   + LD   G+ Y+ E      +HR
Sbjct: 76  APICLVTEFMEHGCLSDYLR--TQRGLFAAETLL--GMCLDVCEGMAYLEEAC---VIHR 128
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+      K+SDFG+ + V       +T TK      + +PE  +    ++KS
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKS 186
Query: 536 DVYAFGVVLFEIIS 549
           DV++FGV+++E+ S
Sbjct: 187 DVWSFGVLMWEVFS 200

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGYAATE- 415
           +G G YG V+ G    + VA+K  ++   + +  E +I   V   H N++  I    T  
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSR 75
Query: 416 ---DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-----EH 467
               +L+LI  Y + GSL   L       + +L   + +++A+ AA GL ++H       
Sbjct: 76  NSSTQLWLITHYHEHGSLYDFLQ------RQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYL 526
            K    HRD KS N+L+ S  +  I+D GLA +  + SD  +      VGT  Y+APE L
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 527 TDGLAT------AKSDVYAFGVVLFEI 547
            + + T        +D++AFG+VL+EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYGNIRNQ-EVAIK----RMTATKTKEFMAEMKILCKVH 401
           +F         +LG G +G       R   EV +     R      + F+ E+K++  + 
Sbjct: 6   IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+++ IG    +  L  I EY + G+L+  +        +   W  RV  A D A G+
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGM 121
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV---GKTSDGEATVTK----- 513
            Y+H     + +HRD+ S N L+       ++DFGLA+L+       +G  ++ K     
Sbjct: 122 AYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 514 ---VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
              VVG   ++APE +       K DV++FG+VL EII
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 85  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 132 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 407 EL--IGYAATEDELFLIYEYAQ-KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
            +  I  A T +++  +Y      G+    L   Q+     + + +  QI     RGL+Y
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL-YQIL----RGLKY 159
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           IH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V T  Y AP
Sbjct: 160 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 524 EYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           E + +     KS D+++ G +L E++S +
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 85  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 132 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQE-VAIKRMTATKTKE--FMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G   N++ VAIK +      E  F+ E +++ K+ H  LV+L G    +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L++E+ + G L  +L     RG  +   ++   + LD   G+ Y+ E      +HR
Sbjct: 95  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLL--GMCLDVCEGMAYLEEAC---VIHR 147
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+      K+SDFG+ + V       +T TK      + +PE  +    ++KS
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKS 205
Query: 536 DVYAFGVVLFEIIS 549
           DV++FGV+++E+ S
Sbjct: 206 DVWSFGVLMWEVFS 219

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 34/216 (15%)
Query: 359 LGHGTYGSVYYGNI-------RNQEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHDPQNRG-------QTSLSWIMRVQIALDA 457
            L+G A T+    L +I E+ + G+L ++L   +N         +  L+    +  +   
Sbjct: 95  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEATVTK 513
           A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A +  
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP- 209
Query: 514 VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                 ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 210 ----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRM--TATKTKEFMAEMKILCKV-HHSNLVE 407
           F    L+G+GTYG VY G      Q  AIK M  T  + +E   E+ +L K  HH N+  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 408 LIGY------AATEDELFLIYEYAQKGSLKSHLHDPQNRGQT-SLSWIMRVQIALDAARG 460
             G          +D+L+L+ E+   GS+   + +   +G T    WI    I  +  RG
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWI--AYICREILRG 141
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L ++H+H     +HRDIK  N+LL      K+ DFG++  + +T     T    +GT  +
Sbjct: 142 LSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYW 195
Query: 521 LAPEYLT-----DGLATAKSDVYAFGVVLFEIISG 550
           +APE +      D     KSD+++ G+   E+  G
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 85  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 132 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 87  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 134 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 85  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 132 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 89  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 136 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 37/219 (16%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 407 ELIGYAATED--ELFLIYEYAQKGSLKSHLHD----------PQNRGQTSLSWIMRVQIA 454
            L+G A T+    L +I E+ + G+L ++L            P++  +  L+    +  +
Sbjct: 96  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEAT 510
              A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A 
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 212 LP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 105 GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 151
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 152 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA----TKTKEFMAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++     T  +  + E+KIL +  H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 89  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 136 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSN 404
           E +     +G GTYG VY   + + + VA+KR+      E      + E+ +L ++HH N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V LI    +E  L L++E+ +K  LK  L + +   Q S   I   Q+     RG+ + 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL----RGVAHC 135
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H+H     +HRD+K  N+L++S    K++DFGLA+  G       + T  V T  Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVVTLWYRAPD 189
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGK 551
            L      + S D+++ G +  E+I+GK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSN 404
           E +     +G GTYG VY   + + + VA+KR+      E      + E+ +L ++HH N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V LI    +E  L L++E+ +K  LK  L + +   Q S   I   Q+     RG+ + 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL----RGVAHC 135
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H+H     +HRD+K  N+L++S    K++DFGLA+  G       + T  V T  Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVVTLWYRAPD 189
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGK 551
            L      + S D+++ G +  E+I+GK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 93  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 139
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 140 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 85  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 132 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 83  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 130 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 90  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 137 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 83  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 130 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 91  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 137
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 138 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 82  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 128
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 129 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 89  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKCQHLSNDHICYFLY 135
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 136 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 89  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 136 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 407 ELIGYAATED--ELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 95  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 211 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 34/216 (15%)
Query: 359 LGHGTYGSVYYGNI-------RNQEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHDPQNRG-------QTSLSWIMRVQIALDA 457
            L+G A T+    L +I E+ + G+L ++L   +N         +  L+    +  +   
Sbjct: 95  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEATVTK 513
           A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A +  
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP- 209
Query: 514 VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
                 ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 210 ----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 133/303 (43%), Gaps = 65/303 (21%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT----------ATKTKEFMAEMKILCKVHHSNLV 406
           +G G +G V+ G +   +  VAIK +             K +EF  E+ I+  ++H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
           +L  Y    +   ++ E+   G L   L D  +     + W +++++ LD A G+EY+  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQN 140
Query: 467 HTKTHYVHRDIKSSNILLDSAFR-----AKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
                 VHRD++S NI L S        AK++DFG ++          +V+ ++G F ++
Sbjct: 141 QNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVSGLLGNFQWM 193
Query: 522 APEYL--TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           APE +   +   T K+D Y+F ++L+ I++G+                            
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF------------------------- 228
Query: 580 NSPDSMSMSSLKDYI----DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              D  S   +K +I    +  +    P DC  ++  + + C   DP  RP    +V  L
Sbjct: 229 ---DEYSYGKIK-FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 636 SQI 638
           S++
Sbjct: 285 SEL 287

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 86  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 202 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 407 ELIGYAATED--ELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 95  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 211 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 407 ELIGYAATED--ELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 95  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 211 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAI++++  + + +    + E+KIL +  H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 89  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 136 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 97  NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 156 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 213 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 10  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA +G +   L    +   Q + ++I  +      A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL------A 123
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 175
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 132 NLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 191 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 248 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 86  NLLG-ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 202 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 87  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 134 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +N +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +  V   S   A    + GT 
Sbjct: 119 NALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA---LCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 133/303 (43%), Gaps = 65/303 (21%)
Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRMT----------ATKTKEFMAEMKILCKVHHSNLV 406
           +G G +G V+ G +   +  VAIK +             K +EF  E+ I+  ++H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
           +L  Y    +   ++ E+   G L   L D  +     + W +++++ LD A G+EY+  
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYMQN 140
Query: 467 HTKTHYVHRDIKSSNILLDSAFR-----AKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
                 VHRD++S NI L S        AK++DF L++          +V+ ++G F ++
Sbjct: 141 QNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLLGNFQWM 193
Query: 522 APEYL--TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           APE +   +   T K+D Y+F ++L+ I++G+                            
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF------------------------- 228
Query: 580 NSPDSMSMSSLKDYI----DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
              D  S   +K +I    +  +    P DC  ++  + + C   DP  RP    +V  L
Sbjct: 229 ---DEYSYGKIK-FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 636 SQI 638
           S++
Sbjct: 285 SEL 287

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 99/194 (51%), Gaps = 12/194 (6%)
Query: 359 LGHGTYGSVYYGNIRNQ-EVAIKRMT--ATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V  G  + Q +VA+K +   +    EF  E + + K+ H  LV+  G  + E
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             ++++ EY   G L ++L   ++ G+  L     +++  D   G+ ++  H    ++HR
Sbjct: 76  YPIYIVTEYISNGCLLNYL---RSHGK-GLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+D     K+SDFG+ + V       +  TK      + APE       ++KS
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF--PVKWSAPEVFHYFKYSSKS 186
Query: 536 DVYAFGVVLFEIIS 549
           DV+AFG++++E+ S
Sbjct: 187 DVWAFGILMWEVFS 200

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 87  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V
Sbjct: 134 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 134/302 (44%), Gaps = 53/302 (17%)
Query: 357 SLLGHGTYGSVYYGNIRNQE-----VAIKRM-----TATKTKEFMAEMKILCKVHHSNLV 406
            +LG G +GSV  GN++ ++     VA+K M     +  + +EF++E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 407 ELIGYAATED-----ELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARG 460
            L+G           +  +I  + + G L ++L +     G   +     ++  +D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF-- 518
           +EY+   +  +++HRD+ + N +L       ++DFGL+K   K   G+      +     
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYRQGRIAKMPV 213
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS-KNQERRSLASFMLAA 577
            ++A E L D + T+KSDV+AFGV ++EI         T GM      +   +  ++L  
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIA--------TRGMTPYPGVQNHEMYDYLLHG 265
Query: 578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
            R          LK           P DCL ++  +   C   DP+ RP    + + L +
Sbjct: 266 HR----------LKQ----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
Query: 638 IL 639
           +L
Sbjct: 306 LL 307

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 134/296 (45%), Gaps = 48/296 (16%)
Query: 356 SSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTK----EFMAEMKILCKVHHSNLVELI 409
             ++G G    V   Y   + ++VAIKR+   K +    E + E++ + + HH N+V   
Sbjct: 15  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 74
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQ--------TSLSWIMRVQIALDAARGL 461
                +DEL+L+ +    GS+   +     +G+        ++++ I+R     +   GL
Sbjct: 75  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR-----EVLEGL 129
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV----VGT 517
           EY+H   K   +HRD+K+ NILL      +I+DFG++  +   + G+ T  KV    VGT
Sbjct: 130 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA--TGGDITRNKVRKTFVGT 184
Query: 518 FGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
             ++APE +        K+D+++FG+   E+ +G     +   M             ++ 
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----------KVLML 233
Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
            L+N P S+         D  M+  Y      KM  L   C+ +DP  RP   +++
Sbjct: 234 TLQNDPPSLETG----VQDKEMLKKY-GKSFRKMISL---CLQKDPEKRPTAAELL 281

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK------RMTATKTKEFMAEMKILCKVHHSNLVELIG 410
           LG G   +VY     I N +VAIK      R      K F  E+    ++ H N+V +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 411 YAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
               +D  +L+ EY +  +L  ++  H P       LS    +        G+++ H+  
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGIKHAHD-- 129
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               VHRDIK  NIL+DS    KI DFG+AK + +TS  +     V+GT  Y +PE    
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT--NHVLGTVQYFSPEQ-AK 185
Query: 529 GLATAK-SDVYAFGVVLFEIISGK 551
           G AT + +D+Y+ G+VL+E++ G+
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T++ GT 
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTELCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 38/291 (13%)
Query: 356 SSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTK----EFMAEMKILCKVHHSNLVELI 409
             ++G G    V   Y   + ++VAIKR+   K +    E + E++ + + HH N+V   
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGLEYIHE 466
                +DEL+L+ +    GS+   +     +G+     +    IA    +   GLEY+H 
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH- 138
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV----VGTFGYLA 522
             K   +HRD+K+ NILL      +I+DFG++  +   + G+ T  KV    VGT  ++A
Sbjct: 139 --KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA--TGGDITRNKVRKTFVGTPCWMA 194
Query: 523 PEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           PE +        K+D+++FG+   E+ +G     +   M             ++  L+N 
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----------KVLMLTLQND 243
Query: 582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
           P S+         D  M+  Y      KM  L   C+ +DP  RP   +++
Sbjct: 244 PPSLETG----VQDKEMLKKY-GKSFRKMISL---CLQKDPEKRPTAAELL 286

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 86  NLLG-ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 202 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 89  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    + + V
Sbjct: 136 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++  + + +    + E+KIL +  H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ---------IAL 455
            +  I  A T +++  +Y               Q+  +T L  +++ Q            
Sbjct: 90  GINDIIRAPTIEQMKDVYIV-------------QDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
              RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    + + V
Sbjct: 137 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 516 GTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            T  Y APE + +     KS D+++ G +L E++S +
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 38/220 (17%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 407 ELIGYAATE--DELFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
            L+G A T+    L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 86  NLLG-ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 202 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV I +     T   + E ++L    
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 68
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL    +R +       R   A +    L
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSAL 123
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       V+RDIK  N++LD     KI+DFGL K     SDG AT+    GT  YL
Sbjct: 124 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKXFCGTPEYL 177
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L D       D +  GVV++E++ G+        +   NQ+   L   +L      
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFELILMEEIRF 229
Query: 582 PDSMS 586
           P ++S
Sbjct: 230 PRTLS 234

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 31  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 90
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 144
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 145 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 196
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIK----RMTATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G VY G  N   + VAIK         + ++   E+ +L +     
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +    G      +L++I EY   GS    L  P    +T ++ I+R     +  +GL+Y+
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILR-----EILKGLDYL 132
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++APE
Sbjct: 133 HSERK---IHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNXFVGTPFWMAPE 186
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +       K+D+++ G+   E+  G+            N +   +    L   +NSP +
Sbjct: 187 VIKQSAYDFKADIWSLGITAIELAKGEPP----------NSDLHPMRVLFLIP-KNSPPT 235
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
           +     K + +                   + C+++DP  RP  K+++
Sbjct: 236 LEGQHSKPFKE-----------------FVEACLNKDPRFRPTAKELL 266

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV I +     T   + E ++L    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL    +R +       R   A +    L
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSAL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       V+RDIK  N++LD     KI+DFGL K     SDG AT+    GT  YL
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKXFCGTPEYL 172
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L D       D +  GVV++E++ G+        +   NQ+   L   +L      
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFELILMEEIRF 224
Query: 582 PDSMS 586
           P ++S
Sbjct: 225 PRTLS 229

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV I +     T   + E ++L    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL    +R +       R   A +    L
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSAL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       V+RDIK  N++LD     KI+DFGL K     SDG AT+    GT  YL
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKTFCGTPEYL 172
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L D       D +  GVV++E++ G+        +   NQ+   L   +L      
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFELILMEEIRF 224
Query: 582 PDSMS 586
           P ++S
Sbjct: 225 PRTLS 229

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV I +     T   + E ++L    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL    +R +       R   A +    L
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSAL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       V+RDIK  N++LD     KI+DFGL K     SDG AT+    GT  YL
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKTFCGTPEYL 172
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L D       D +  GVV++E++ G+        +   NQ+   L   +L      
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFELILMEEIRF 224
Query: 582 PDSMS 586
           P ++S
Sbjct: 225 PRTLS 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV I +     T   + E ++L    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL    +R +       R   A +    L
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSAL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       V+RDIK  N++LD     KI+DFGL K     SDG AT+    GT  YL
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKXFCGTPEYL 172
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L D       D +  GVV++E++ G+        +   NQ+   L   +L      
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFELILMEEIRF 224
Query: 582 PDSMS 586
           P ++S
Sbjct: 225 PRTLS 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    + ++  +A+K +   + +      +   E++I   
Sbjct: 2   WALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 61
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 115
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 116 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 167
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 168 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV I +     T   + E ++L    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL    +R +       R   A +    L
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSAL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       V+RDIK  N++LD     KI+DFGL K     SDG AT+    GT  YL
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKXFCGTPEYL 172
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L D       D +  GVV++E++ G+        +   NQ+   L   +L      
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFELILMEEIRF 224
Query: 582 PDSMS 586
           P ++S
Sbjct: 225 PRTLS 229

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 132/288 (45%), Gaps = 46/288 (15%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIK----RMTATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G V+ G  N   + VAIK         + ++   E+ +L +     
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           + +  G    + +L++I EY   GS    L +P    +T ++ I+R     +  +GL+Y+
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGPLDETQIATILR-----EILKGLDYL 140
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++APE
Sbjct: 141 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPE 194
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            +      +K+D+++ G+   E+  G+            + E   +    L   +N+P +
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPP----------HSELHPMKVLFLIP-KNNPPT 243
Query: 585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
           +      +Y  P             +    + C++++P  RP  K+++
Sbjct: 244 LE----GNYSKP-------------LKEFVEACLNKEPSFRPTAKELL 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 6   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 119
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTL 171
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 121
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 173
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIK----RMTATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G V+ G  N   + VAIK         + ++   E+ +L +     
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           + +  G    + +L++I EY   GS    L +P    +T ++ I+R     +  +GL+Y+
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILR-----EILKGLDYL 135
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++APE
Sbjct: 136 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNXFVGTPFWMAPE 189
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            +      +K+D+++ G+   E+  G+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV I +     T   + E ++L    
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 66
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL    +R +       R   A +    L
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGA-EIVSAL 121
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       V+RDIK  N++LD     KI+DFGL K     SDG AT+    GT  YL
Sbjct: 122 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKTFCGTPEYL 175
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L D       D +  GVV++E++ G+        +   NQ+   L   +L      
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--------LPFYNQDHERLFELILMEEIRF 227
Query: 582 PDSMS 586
           P ++S
Sbjct: 228 PRTLS 232

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 22  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 81
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 135
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 136 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 187
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 131/273 (47%), Gaps = 36/273 (13%)
Query: 307 SGDYIQTTGEVSNPPITIPKALGTDVFD---------MEKPVVFTYDEILFATEGFSDSS 357
           S  Y      +++P    P  + T VF+          +K +    D +L A        
Sbjct: 289 SDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA------DI 342
Query: 358 LLGHGTYGSVYYGNIRNQ----EVAIKRMT----ATKTKEFMAEMKILCKVHHSNLVELI 409
            LG G +GSV  G  R +    +VAIK +        T+E M E +I+ ++ +  +V LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G    E  L L+ E A  G L   L     R +  +S +   ++    + G++Y+ E   
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNV--AELLHQVSMGMKYLEE--- 454
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLT 527
            ++VHR++ + N+LL +   AKISDFGL+K +G  +D      +  G +   + APE + 
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG--ADDSYYTARSAGKWPLKWYAPECIN 512
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG 559
               +++SDV+++GV ++E +S G++   + +G
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 10  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 123
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 175
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 10  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 123
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTL 175
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTXLCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIK----RMTATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G V+ G  N   + VAIK         + ++   E+ +L +     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           + +  G    + +L++I EY   GS    L +P    +T ++ I+R     +  +GL+Y+
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILR-----EILKGLDYL 120
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++APE
Sbjct: 121 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNXFVGTPFWMAPE 174
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            +      +K+D+++ G+   E+  G+
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 56/293 (19%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIK----RMTATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G V+ G  N   Q VAIK         + ++   E+ +L +   S 
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLH-DPQNRGQ--TSLSWIMRVQIALDAARGL 461
           + +  G      +L++I EY   GS    L   P +  Q  T L  I++         GL
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK---------GL 133
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y+H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++
Sbjct: 134 DYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIKRNTFVGTPFWM 187
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE +      +K+D+++ G+   E+  G+            N +   +    L    N 
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPP----------NSDMHPMRVLFLIPKNNP 237
Query: 582 PDSMS--MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
           P  +     S K++ID                     C+++DP  RP  K+++
Sbjct: 238 PTLVGDFTKSFKEFID--------------------ACLNKDPSFRPTAKELL 270

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 4   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 63
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 117
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 118 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 169
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 116/258 (44%), Gaps = 34/258 (13%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT------------KEFMAEMKILCKV 400
           F D  +LG G +G V+   ++    A  ++ A K             +  M E KIL KV
Sbjct: 187 FLDFRVLGRGGFGEVFACQMK----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH--DPQNRG-QTSLSWIMRVQIALDA 457
           H   +V L     T+ +L L+      G ++ H++  D  N G Q   +     QI    
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV--- 299
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
             GLE++H+    + ++RD+K  N+LLD     +ISD GLA    +   G+       GT
Sbjct: 300 -SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGT 352
Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
            G++APE L         D +A GV L+E+I+ +    R  G   +N+E   L   +L  
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKE---LKQRVLEQ 408
Query: 578 LRNSPDSMSMSSLKDYID 595
               PD  S +S KD+ +
Sbjct: 409 AVTYPDKFSPAS-KDFCE 425

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 9   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 68
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 122
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 123 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 174
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           ++    +G G YG V   Y ++R   VAIK+++  + + +    + E++IL +  H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 407 EL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
            +  I  A+T + +  +Y    +  +++ L+      Q S   I          RGL+YI
Sbjct: 105 GIRDILRASTLEAMRDVY--IVQDLMETDLYKLLKSQQLSNDHI--CYFLYQILRGLKYI 160
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H     + +HRD+K SN+L+++    KI DFGLA++     D    +T+ V T  Y APE
Sbjct: 161 H---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGK 551
            + +     KS D+++ G +L E++S +
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 359 LGHGTYGSVYYGNI-------RNQEVAIK----RMTATKTKEFMAEMKILCKVHHSNLVE 407
           LG   +G VY G++       + Q VAIK    +      +EF  E  +  ++ H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQIALD 456
           L+G    +  L +I+ Y   G L   L            D     +++L     V +   
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+EY+  H   H VH+D+ + N+L+      KISD GL + V   +D    +   + 
Sbjct: 154 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYYKLLGNSLL 209
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              ++APE +  G  +  SD++++GVVL+E+ S
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 10  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA +G +   L    +   Q + ++I  +      A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL------A 123
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +    + GT 
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLXGTL 175
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIK----RMTATKTKEFMAEMKILCKVHHSN 404
           E F+    +G G++G V+ G  N   + VAIK         + ++   E+ +L +     
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           + +  G    + +L++I EY   GS    L +P    +T ++ I+R     +  +GL+Y+
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILR-----EILKGLDYL 120
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H   K   +HRDIK++N+LL      K++DFG+A   G+ +D +      VGT  ++APE
Sbjct: 121 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPE 174
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            +      +K+D+++ G+   E+  G+
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 359 LGHGTYGSVYYGNI-------RNQEVAIK----RMTATKTKEFMAEMKILCKVHHSNLVE 407
           LG   +G VY G++       + Q VAIK    +      +EF  E  +  ++ H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQIALD 456
           L+G    +  L +I+ Y   G L   L            D     +++L     V +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+EY+  H   H VH+D+ + N+L+      KISD GL + V   +D    +   + 
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYYKLLGNSLL 192
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              ++APE +  G  +  SD++++GVVL+E+ S
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 359 LGHGTYGSVYYGNIRN----QE---VAIKRM---TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N    Q+   VA+K +   +    K+F  E ++L  + H ++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDP------QNRGQTSLSWIMRVQIALDAARG 460
            G     D L +++EY + G L   L  H P      +    T L+    + IA   A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           + Y+      H+VHRD+ + N L+      KI DFG+++ V  T D        +    +
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST-DYYRVGGHTMLPIRW 196
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
           + PE +     T +SDV++ GVVL+EI + GK+
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 345 EILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKI 396
           +I    E F    +LG G++G V+    +  NQ  AIK +           +  M E ++
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 397 LCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           L     H  L  +     T++ LF + EY   G L  H+    ++   S +     +I L
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIIL 130
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
               GL+++H       V+RD+K  NILLD     KI+DFG+ K   +   G+A   +  
Sbjct: 131 ----GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFC 180
Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           GT  Y+APE L         D ++FGV+L+E++ G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 113/254 (44%), Gaps = 26/254 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR--------NQEVAIKRMTATKTKEFMAEMKILCKVHHSN 404
           F D  +LG G +G V+   ++         +    +       +  M E KIL KVH   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLH--DPQNRG-QTSLSWIMRVQIALDAARGL 461
           +V L     T+ +L L+      G ++ H++  D  N G Q   +     QI      GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H+    + ++RD+K  N+LLD     +ISD GLA    +   G+       GT G++
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFM 356
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L         D +A GV L+E+I+ +    R  G   +N+E   L   +L      
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKE---LKQRVLEQAVTY 412
Query: 582 PDSMSMSSLKDYID 595
           PD  S +S KD+ +
Sbjct: 413 PDKFSPAS-KDFCE 425

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 106/208 (50%), Gaps = 24/208 (11%)
Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVELI 409
           +LG G    V+   ++R +++VA+K + A   ++      F  E +    ++H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV- 77
Query: 410 GYAATEDEL------FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
            YA  E E       +++ EY    +L+  +H      +  ++    +++  DA + L +
Sbjct: 78  -YATGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNF 131
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H++     +HRD+K +NI++ +    K+ DFG+A+ +  + +       V+GT  YL+P
Sbjct: 132 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E        A+SDVY+ G VL+E+++G+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 121
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +  V   S   A    + GT 
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA---LCGTL 173
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 121
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 173
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 113/254 (44%), Gaps = 26/254 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR--------NQEVAIKRMTATKTKEFMAEMKILCKVHHSN 404
           F D  +LG G +G V+   ++         +    +       +  M E KIL KVH   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLH--DPQNRG-QTSLSWIMRVQIALDAARGL 461
           +V L     T+ +L L+      G ++ H++  D  N G Q   +     QI      GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H+    + ++RD+K  N+LLD     +ISD GLA    +   G+       GT G++
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFM 356
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L         D +A GV L+E+I+ +    R  G   +N+E   L   +L      
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKE---LKQRVLEQAVTY 412
Query: 582 PDSMSMSSLKDYID 595
           PD  S +S KD+ +
Sbjct: 413 PDKFSPAS-KDFCE 425

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 113/254 (44%), Gaps = 26/254 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR--------NQEVAIKRMTATKTKEFMAEMKILCKVHHSN 404
           F D  +LG G +G V+   ++         +    +       +  M E KIL KVH   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLH--DPQNRG-QTSLSWIMRVQIALDAARGL 461
           +V L     T+ +L L+      G ++ H++  D  N G Q   +     QI      GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H+    + ++RD+K  N+LLD     +ISD GLA    +   G+       GT G++
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFM 356
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L         D +A GV L+E+I+ +    R  G   +N+E   L   +L      
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKE---LKQRVLEQAVTY 412
Query: 582 PDSMSMSSLKDYID 595
           PD  S +S KD+ +
Sbjct: 413 PDKFSPAS-KDFCE 425

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +  V   S   A    + GT 
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA---LCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 127/289 (43%), Gaps = 34/289 (11%)
Query: 316 EVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ 375
           E +N P+   K +  +  +  KP      ++    E F    ++G G +G V    ++N 
Sbjct: 40  ECNNSPLRREKNI-LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA 98
Query: 376 EVAI--------KRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDE-LFLIYEYAQ 426
           +           + +   +T  F  E  +L     S  +  + YA  +D  L+L+ +Y  
Sbjct: 99  DKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLHYAFQDDNNLYLVMDYYV 157
Query: 427 KGSLKSHLHDPQNRGQTSLS--WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
            G L + L   ++R    ++  ++  + IA+D+   L         HYVHRDIK  NIL+
Sbjct: 158 GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---------HYVHRDIKPDNILM 208
Query: 485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYA 539
           D     +++DFG    +    DG    +  VGT  Y++PE L       G    + D ++
Sbjct: 209 DMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 540 FGVVLFEIISGK-----EAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
            GV ++E++ G+     E+++ T G +  ++ER    + +     N+ D
Sbjct: 267 LGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 6   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 119
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +  V   S    T   + GT 
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT---LCGTL 171
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMTATKTK------EFMAEMKILCKVHHSNLVELIG 410
           LG GT+G V  G   +   +VA+K +   K +      +   E++ L    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
             +T  ++F++ EY   G L  ++     R     S  +  QI      G++Y H H   
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQIL----SGVDYCHRHM-- 136
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD+   AKI+DFGL+ ++   SDGE  +    G+  Y APE ++  L
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGE-FLRXSCGSPNYAAPEVISGRL 191
Query: 531 -ATAKSDVYAFGVVLFEIISG 550
            A  + D+++ GV+L+ ++ G
Sbjct: 192 YAGPEVDIWSSGVILYALLCG 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTK--EFMAEMKILCKVHHS----- 403
           F + ++LG G +G V      + ++  AIK++  T+ K    ++E+ +L  ++H      
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 404 --------NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
                   N V+ +     +  LF+  EY + G+L   +H      Q    W +  QI L
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI-L 126
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD--------- 506
           +A   L YIH       +HRD+K  NI +D +   KI DFGLAK V ++ D         
Sbjct: 127 EA---LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 507 --GEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEII 548
                 +T  +GT  Y+A E L   G    K D+Y+ G++ FE+I
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 6   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 65
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 119
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----CHAPSSRRTTLSGTL 171
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 40/268 (14%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQ--EVAIKRM------TATKTKEFMAEMKILCKVHH 402
           E F   +LLG G++  VY     +   EVAIK +       A   +    E+KI C++ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-----PQNRGQTSLSWIMRVQIALDA 457
            +++EL  Y    + ++L+ E    G +  +L +      +N  +  +  I+        
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII-------- 122
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
             G+ Y+H H     +HRD+  SN+LL      KI+DFGLA  +    +   T   + GT
Sbjct: 123 -TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGT 175
Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK-----EAIIRT-EGMVSKNQERRSLA 571
             Y++PE  T      +SDV++ G + + ++ G+     + +  T   +V  + E  S  
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235
Query: 572 SFMLAAL------RNSPDSMSMSSLKDY 593
           S     L      RN  D +S+SS+ D+
Sbjct: 236 SIEAKDLIHQLLRRNPADRLSLSSVLDH 263

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 147
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +++       +VHRD+ + N +LD  F  K++DFGLA+ ++ K  D     T       +
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 31  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 90
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 144
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +     +   +     + GT 
Sbjct: 145 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTL 196
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 117/236 (49%), Gaps = 42/236 (17%)
Query: 348 FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMT----ATKTKEFMAEMKI 396
           F  E      +LG G +G V     YG  +     +VA+K +     +++ +  M+E+K+
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 397 LCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL-------------HDPQNRGQ 442
           + ++  H N+V L+G       ++LI+EY   G L ++L             ++ Q R +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 443 TS-----LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL 497
                  L++   +  A   A+G+E++   +    VHRD+ + N+L+      KI DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGL 218
Query: 498 AKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           A+ +   S+    G A +        ++APE L +G+ T KSDV+++G++L+EI S
Sbjct: 219 ARDIMSDSNYVVRGNARLP-----VKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 15/182 (8%)
Query: 375 QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL 434
           +E+ I RM++ + +E   E+ +L  + H N+V+          L+++ +Y + G L   +
Sbjct: 55  KEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 435 HDPQN---RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK 491
           +  +    +    L W   VQI L     L+++H+      +HRDIKS NI L      +
Sbjct: 115 NAQKGVLFQEDQILDWF--VQICL----ALKHVHDRK---ILHRDIKSQNIFLTKDGTVQ 165
Query: 492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           + DFG+A+++  T +        +GT  YL+PE   +     KSD++A G VL+E+ + K
Sbjct: 166 LGDFGIARVLNSTVE---LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
Query: 552 EA 553
            A
Sbjct: 223 HA 224

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 358 LLGHGTYGSVYYG-NIRN-QEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVELI 409
           +LG G    V+   ++R+ ++VA+K + A   ++      F  E +    ++H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 410 GYAATEDEL----FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
                E       +++ EY    +L+  +H      +  ++    +++  DA + L + H
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSH 133
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           ++     +HRD+K +NIL+ +    K+ DFG+A+ +  + +       V+GT  YL+PE 
Sbjct: 134 QNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
                  A+SDVY+ G VL+E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 359 LGHGTYGSVYYGNIRNQ----EVAIKRMT----ATKTKEFMAEMKILCKVHHSNLVELIG 410
           LG G +GSV  G  R +    +VAIK +        T+E M E +I+ ++ +  +V LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
               E  L L+ E A  G L   L     R +  +S +   ++    + G++Y+ E    
Sbjct: 78  VCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNV--AELLHQVSMGMKYLEE---K 129
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLTD 528
           ++VHRD+ + N+LL +   AKISDFGL+K +G  +D      +  G +   + APE +  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALG--ADDSYYTARSAGKWPLKWYAPECINF 187
Query: 529 GLATAKSDVYAFGVVLFEIIS 549
              +++SDV+++GV ++E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 7   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 66
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 120
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI++FG +          +  T + GT 
Sbjct: 121 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTL 172
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 10  WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 69
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 123
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +  T + GT 
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTL 175
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +       K D+++ GV+ +E + GK
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 10  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 120
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 121 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 176
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 414 TEDELFLIYEYAQKGSLKSHLHDP-QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + LE++H +     
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLHSN---QV 137
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG      + +  ++  +++VGT  ++APE +T     
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSEMVGTPYWMAPEVVTRKAYG 194
Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E+I G+
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 345 EILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKI 396
           +I    E F    +LG G++G V+    +  NQ  AIK +           +  M E ++
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 397 LCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           L     H  L  +     T++ LF + EY   G L  H+        +  ++      A 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY-----AA 125
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
           +   GL+++H       V+RD+K  NILLD     KI+DFG+ K   +   G+A      
Sbjct: 126 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNXFC 179
Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           GT  Y+APE L         D ++FGV+L+E++ G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 7   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 66
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 120
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +    + GT 
Sbjct: 121 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTL 172
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 138/301 (45%), Gaps = 38/301 (12%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKTKEFMAEMKILCKVH 401
           ++  F     LG+GTY +VY G  +        +EV +     T +   + E+ ++ ++ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKELK 61
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT----SLSWIMRVQIALDA 457
           H N+V L     TE++L L++E+     LK ++ D +  G T     L+ +   Q  L  
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLVKYFQWQL-- 117
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
            +GL + HE+     +HRD+K  N+L++   + K+ DFGLA+  G   +   T +  V T
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---TFSSEVVT 171
Query: 518 FGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
             Y AP+ L      + S D+++ G +L E+I+GK     T      N E +    F + 
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT------NDEEQLKLIFDIM 225
Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI--------LRPDM 628
              N     S++ L  Y +PN+    P D    +    K+ +D + +        L PDM
Sbjct: 226 GTPNESLWPSVTKLPKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284
Query: 629 K 629
           +
Sbjct: 285 R 285

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 121
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI++FG +          +  T + GT 
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTL 173
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 32  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFY-----TAEIV 142
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTA 198
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A+  SD++A G +++++++G
Sbjct: 199 QYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 9   EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 119
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 120 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 175
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 414 TEDELFLIYEYAQKGSLKSHLHDP-QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + LE++H +     
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLHSN---QV 137
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG    +       +T   +VGT  ++APE +T     
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYG 194
Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E+I G+
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--------LIGFGLQVAKGM 205
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +++       +VHRD+ + N +LD  F  K++DFGLA+ +  K  D     T       +
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 7   EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 117
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 118 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 173
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 144
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +++       +VHRD+ + N +LD  F  K++DFGLA+ +  K  D     T       +
Sbjct: 145 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 5   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 64
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +    + GT 
Sbjct: 119 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTL 170
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I  +      A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------A 121
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +     +   +     + GT 
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTL 173
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 358 LLGHGTYGSVYYG-NIRN-QEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVELI 409
           +LG G    V+   ++R+ ++VA+K + A   ++      F  E +    ++H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 410 GYAATEDEL----FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
                E       +++ EY    +L+  +H      +  ++    +++  DA + L + H
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSH 133
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           ++     +HRD+K +NI++ +    K+ DFG+A+ +  + +       V+GT  YL+PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
                  A+SDVY+ G VL+E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 358 LLGHGTYGSVYYG-NIRN-QEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVELI 409
           +LG G    V+   ++R+ ++VA+K + A   ++      F  E +    ++H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 410 GYAATEDEL----FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
                E       +++ EY    +L+  +H      +  ++    +++  DA + L + H
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSH 133
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           ++     +HRD+K +NI++ +    K+ DFG+A+ +  + +       V+GT  YL+PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
                  A+SDVY+ G VL+E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 8   EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 118
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 174
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +A E F     LG G +G+VY    +  +  +A+K +   + +      +   E++I   
Sbjct: 8   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 67
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT------ELA 121
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL SA   KI+DFG +          +    + GT 
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTL 173
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            YL PE +   +   K D+++ GV+ +E + GK
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 146
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +++       +VHRD+ + N +LD  F  K++DFGLA+ +  K  D     T       +
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 151
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +++       +VHRD+ + N +LD  F  K++DFGLA+ +  K  D     T       +
Sbjct: 152 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 147
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +++       +VHRD+ + N +LD  F  K++DFGLA+ +  K  D     T       +
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 146
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +++       +VHRD+ + N +LD  F  K++DFGLA+ +  K  D     T       +
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 32  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 142
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 198
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 414 TEDELFLIYEYAQKGSLKSHLHDP-QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + LE++H +     
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLHSN---QV 137
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG      + +  ++  + +VGT  ++APE +T     
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 194
Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E+I G+
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 414 TEDELFLIYEYAQKGSLKSHLHDP-QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + LE++H +     
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLHSN---QV 138
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG      + +  ++  + +VGT  ++APE +T     
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 195
Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E+I G+
Sbjct: 196 PKVDIWSLGIMAIEMIEGE 214

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 33  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 143
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 144 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 199
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVELI 409
           +LG G    V+   ++R +++VA+K + A   ++      F  E +    ++H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 410 GYAATEDEL----FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
                E       +++ EY    +L+  +H      +  ++    +++  DA + L + H
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSH 133
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           ++     +HRD+K +NI++ +    K+ DFG+A+ +  + +       V+GT  YL+PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
                  A+SDVY+ G VL+E+++G+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 33  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 88
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 143
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 144 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTA 199
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 37  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 92
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 93  RLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 147
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 148 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 203
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 407 ELIGYA-ATEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--------LIGFGLQVAKGM 145
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 30  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 140
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 196
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 30  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 140
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 196
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 32  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 142
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 198
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 14  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 69
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 124
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 125 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 180
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 35  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 90
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 145
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 146 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 201
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 30  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 140
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANAFVGTA 196
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 32  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 142
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 198
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 29  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 139
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 140 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 195
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG------NIRNQEVAIKRMTATKTK----EFMAEMK 395
           IL  TE      +LG G +G+VY G            VAIK +  T       EFM E  
Sbjct: 34  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           I+  + H +LV L+G   +   + L+ +    G L  ++H+ ++    Q  L+W +++  
Sbjct: 93  IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 149
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV-GKTSDGEATVT 512
               A+G+ Y+ E      VHRD+ + N+L+ S    KI+DFGLA+L+ G   +  A   
Sbjct: 150 ----AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           K+     ++A E +     T +SDV+++GV ++E+++
Sbjct: 203 KM--PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 32  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 142
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 198
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 29  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 84
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 139
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 140 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTA 195
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 359 LGHGTYGSVYYGNIRN----------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N             A+K  + +  ++F  E ++L  + H ++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNR----------GQTSLSWIMRVQIALD 456
            G       L +++EY + G L   L  H P  +          G   L  ++ V  A  
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV--ASQ 166
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+ Y+      H+VHRD+ + N L+      KI DFG+++ +  ++D      + + 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTML 222
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
              ++ PE +     T +SDV++FGVVL+EI + GK+
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 359 LGHGTYGSVYYGNIRN----------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N             A+K  + +  ++F  E ++L  + H ++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNR----------GQTSLSWIMRVQIALD 456
            G       L +++EY + G L   L  H P  +          G   L  ++ V  A  
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV--ASQ 143
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+ Y+      H+VHRD+ + N L+      KI DFG+++ +  ++D      + + 
Sbjct: 144 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTML 199
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
              ++ PE +     T +SDV++FGVVL+EI + GK+
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +V    +  +E+A  R  A K  E               E  ++ 
Sbjct: 32  EDFKFGKILGEGSFSTV----VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 87
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 142
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 143 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 198
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 359 LGHGTYGSVYYGNIRN----------QEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N             A+K  + +  ++F  E ++L  + H ++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQNR----------GQTSLSWIMRVQIALD 456
            G       L +++EY + G L   L  H P  +          G   L  ++ V  A  
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV--ASQ 137
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+ Y+      H+VHRD+ + N L+      KI DFG+++ +  ++D      + + 
Sbjct: 138 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTML 193
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE 552
              ++ PE +     T +SDV++FGVVL+EI + GK+
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV + +     T   + E ++L    
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSR 68
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL   +   +    +        +    L
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSAL 123
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y+H  ++ + V+RD+K  N++LD     KI+DFGL K      DG AT+    GT  YL
Sbjct: 124 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG-ATMKXFCGTPEYL 178
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L D       D +  GVV++E++ G+
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVELI 409
           +LG G    V+   ++R +++VA+K + A   ++      F  E +    ++H  +V + 
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 410 GYAATEDEL----FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
                E       +++ EY    +L+  +H      +  ++    +++  DA + L + H
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSH 150
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           ++     +HRD+K +NI++ +    K+ DFG+A+ +  + +       V+GT  YL+PE 
Sbjct: 151 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
                  A+SDVY+ G VL+E+++G+
Sbjct: 208 ARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG------NIRNQEVAIKRMTATKTK----EFMAEMK 395
           IL  TE      +LG G +G+VY G            VAIK +  T       EFM E  
Sbjct: 11  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           I+  + H +LV L+G   +   + L+ +    G L  ++H+ ++    Q  L+W +++  
Sbjct: 70  IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 126
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV-GKTSDGEATVT 512
               A+G+ Y+ E      VHRD+ + N+L+ S    KI+DFGLA+L+ G   +  A   
Sbjct: 127 ----AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           K+     ++A E +     T +SDV+++GV ++E+++
Sbjct: 180 KM--PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +  E F     LG G +G+VY    R  +  +A+K +  T+ +      +   E++I   
Sbjct: 9   WTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT------ELA 122
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL S    KI+DFG +          +  T + GT 
Sbjct: 123 NALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS-----VHAPSSRRTTLCGTL 174
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            YL PE +   +   K D+++ GV+ +E + G
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV + +     T   + E ++L    
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSR 66
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL   +   +    +        +    L
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSAL 121
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y+H  ++ + V+RD+K  N++LD     KI+DFGL K      DG AT+    GT  YL
Sbjct: 122 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG-ATMKXFCGTPEYL 176
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L D       D +  GVV++E++ G+
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 31/245 (12%)
Query: 353 FSDSSLLGHGTYGSVYY-----GNIRNQEVAIKRMTATKTK-----EFMAEMKILCKVHH 402
           F    +LG G++G V+      G+   Q  A+K +     K         E  IL +V+H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-WIMRVQIALDAARGL 461
             +V+L     TE +L+LI ++ + G L + L       +  +  ++  + +ALD    L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
             I+         RD+K  NILLD     K++DFGL+K   ++ D E       GT  Y+
Sbjct: 146 GIIY---------RDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 193
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE +     T  +D ++FGV++FE+++G         +  + ++R+   + +L A    
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGT--------LPFQGKDRKETMTMILKAKLGM 245
Query: 582 PDSMS 586
           P  +S
Sbjct: 246 PQFLS 250

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV + +     T   + E ++L    
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSR 67
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL   +   +    +        +    L
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSAL 122
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y+H  ++ + V+RD+K  N++LD     KI+DFGL K      DG AT+    GT  YL
Sbjct: 123 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG-ATMKXFCGTPEYL 177
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L D       D +  GVV++E++ G+
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV + +     T   + E ++L    
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSR 209
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL   +   +    +        +    L
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSAL 264
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y+H  ++ + V+RD+K  N++LD     KI+DFGL K      DG AT+    GT  YL
Sbjct: 265 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG-ATMKTFCGTPEYL 319
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L D       D +  GVV++E++ G+
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 31/245 (12%)
Query: 353 FSDSSLLGHGTYGSVYY-----GNIRNQEVAIKRMTATKTK-----EFMAEMKILCKVHH 402
           F    +LG G++G V+      G+   Q  A+K +     K         E  IL +V+H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-WIMRVQIALDAARGL 461
             +V+L     TE +L+LI ++ + G L + L       +  +  ++  + +ALD    L
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
             I+         RD+K  NILLD     K++DFGL+K   ++ D E       GT  Y+
Sbjct: 147 GIIY---------RDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 194
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE +     T  +D ++FGV++FE+++G         +  + ++R+   + +L A    
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGT--------LPFQGKDRKETMTMILKAKLGM 246
Query: 582 PDSMS 586
           P  +S
Sbjct: 247 PQFLS 251

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 353 FSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVH 401
           F    LLG GT+G V          YY   I  +EV + +     T   + E ++L    
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSR 206
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H  L  L     T D L  + EYA  G L  HL   +   +    +        +    L
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY-----GAEIVSAL 261
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y+H  ++ + V+RD+K  N++LD     KI+DFGL K      DG AT+    GT  YL
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG-ATMKTFCGTPEYL 316
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L D       D +  GVV++E++ G+
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 114/245 (46%), Gaps = 31/245 (12%)
Query: 353 FSDSSLLGHGTYGSVYY-----GNIRNQEVAIKRMTATKTK-----EFMAEMKILCKVHH 402
           F    +LG G++G V+      G+   Q  A+K +     K         E  IL +V+H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-WIMRVQIALDAARGL 461
             +V+L     TE +L+LI ++ + G L + L       +  +  ++  + +ALD    L
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
             I+         RD+K  NILLD     K++DFGL+K   ++ D E       GT  Y+
Sbjct: 146 GIIY---------RDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 193
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE +     T  +D ++FGV++FE+++G         +  + ++R+   + +L A    
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGT--------LPFQGKDRKETMTMILKAKLGM 245
Query: 582 PDSMS 586
           P  +S
Sbjct: 246 PQFLS 250

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 140/314 (44%), Gaps = 48/314 (15%)
Query: 344 DEILFATEGFSDSSLLGHGTYG--SVYYGNIRN----QEVAIKRMTA----TKTKEFMAE 393
           D  +F          LG G +G  S+Y  +  N    + VA+K + A         +  E
Sbjct: 7   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQE 66
Query: 394 MKILCKVHHSNLVELIGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV 451
           + IL  ++H ++++  G    + E  L L+ EY   GSL+ +L  P++    S+     +
Sbjct: 67  IDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRH----SIGLAQLL 120
Query: 452 QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK-------T 504
             A     G+ Y+H     HY+HR++ + N+LLD+    KI DFGLAK V +        
Sbjct: 121 LFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 177
Query: 505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            DG++ V      F Y APE L +      SDV++FGV L+E+++  ++   ++   +K 
Sbjct: 178 EDGDSPV------FWY-APECLKEYKFYYASDVWSFGVTLYELLTHCDS---SQSPPTKF 227
Query: 565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL 624
            E   +A   +  LR          L + ++       P  C  ++  L K C + +   
Sbjct: 228 LELIGIAQGQMTVLR----------LTELLERGERLPRPDKCPCEVYHLMKNCWETEASF 277
Query: 625 RPDMKQVVISLSQI 638
           RP  + ++  L  +
Sbjct: 278 RPTFENLIPILKTV 291

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 140/314 (44%), Gaps = 48/314 (15%)
Query: 344 DEILFATEGFSDSSLLGHGTYG--SVYYGNIRN----QEVAIKRMTA----TKTKEFMAE 393
           D  +F          LG G +G  S+Y  +  N    + VA+K + A         +  E
Sbjct: 7   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQE 66
Query: 394 MKILCKVHHSNLVELIGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV 451
           + IL  ++H ++++  G    + E  L L+ EY   GSL+ +L  P++    S+     +
Sbjct: 67  IDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRH----SIGLAQLL 120
Query: 452 QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK-------T 504
             A     G+ Y+H     HY+HR++ + N+LLD+    KI DFGLAK V +        
Sbjct: 121 LFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 177
Query: 505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
            DG++ V      F Y APE L +      SDV++FGV L+E+++  ++   ++   +K 
Sbjct: 178 EDGDSPV------FWY-APECLKEYKFYYASDVWSFGVTLYELLTHCDS---SQSPPTKF 227
Query: 565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL 624
            E   +A   +  LR          L + ++       P  C  ++  L K C + +   
Sbjct: 228 LELIGIAQGQMTVLR----------LTELLERGERLPRPDKCPCEVYHLMKNCWETEASF 277
Query: 625 RPDMKQVVISLSQI 638
           RP  + ++  L  +
Sbjct: 278 RPTFENLIPILKTV 291

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 34/292 (11%)
Query: 359 LGHGTYG--SVYYGNIRN----QEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVEL 408
           LG G +G  S+Y  +  N    + VA+K + A    +    +  E+ IL  ++H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 409 IGYA--ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G    A    L L+ EY   GSL+ +L  P++    S+     +  A     G+ Y+H 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRH----SIGLAQLLLFAQQICEGMAYLH- 151
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
               HY+HRD+ + N+LLD+    KI DFGLAK V +  +             + APE L
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
            +      SDV++FGV L+E+++  ++   ++   +K  E   +A   +  LR       
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDS---SQSPPTKFLELIGIAQGQMTVLR------- 259
Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
              L + ++       P  C  ++  L K C + +   RP  + ++  L  +
Sbjct: 260 ---LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V    +R+  + VA+K+M   K +       E+ I+    H N+VE+     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   + L  +H       
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 146
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL    R K+SDFG    V K          +VGT  ++APE ++     
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYG 203
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E++ G+        + +    R +L   +    + SP      SLK 
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP------SLKG 257
Query: 593 YID 595
           ++D
Sbjct: 258 FLD 260

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 164
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 165 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTK------EFMAEMKILCKVHHSNLVELIG 410
           LG GT+G V  G   +   +VA+K +   K +      +   E++ L    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
             +T  + F++ EY   G L  ++      G+       R+   + +A  ++Y H H   
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSA--VDYCHRHM-- 131
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD+   AKI+DFGL+ ++   SDGE   T   G+  Y APE ++  L
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTS-CGSPNYAAPEVISGRL 186
Query: 531 -ATAKSDVYAFGVVLFEIISG 550
            A  + D+++ GV+L+ ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V    +R+  + VA+K+M   K +       E+ I+    H N+VE+     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   + L  +H       
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 148
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL    R K+SDFG    V K          +VGT  ++APE ++     
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYG 205
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E++ G+        + +    R +L   +    + SP      SLK 
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP------SLKG 259
Query: 593 YID 595
           ++D
Sbjct: 260 FLD 262

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 36/240 (15%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P    Y+E   F          LG G +G V     +G  +     +VA+K + +T    
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL---------- 434
           + +  M+E+KI+  +  H N+V L+G       + +I EY   G L + L          
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEY 151
Query: 435 -HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
            ++P +  +  LS    +  +   A+G+ ++      + +HRD+ + N+LL +   AKI 
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIG 208
Query: 494 DFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           DFGLA+ +   S+    G A +        ++APE + D + T +SDV+++G++L+EI S
Sbjct: 209 DFGLARDIMNDSNYIVKGNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 407 ELIGYA-ATEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 138
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 139 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 414 TEDELFLIYEYAQKGSLKSHLHDP-QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ EY   GSL   + +   + GQ +        +  +  + LE++H +     
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEFLHSN---QV 138
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HR+IKS NILL      K++DFG    +       +T   +VGT  ++APE +T     
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYG 195
Query: 533 AKSDVYAFGVVLFEIISGK 551
            K D+++ G++  E+I G+
Sbjct: 196 PKVDIWSLGIMAIEMIEGE 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V    +R+  + VA+K+M   K +       E+ I+    H N+VE+     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   + L  +H       
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 137
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL    R K+SDFG    V K          +VGT  ++APE ++     
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYG 194
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E++ G+        + +    R +L   +    + SP      SLK 
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP------SLKG 248
Query: 593 YID 595
           ++D
Sbjct: 249 FLD 251

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 165
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 166 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE------------FMAEMKILC 398
           E F    +LG G++ +     +  +E+A  R  A K  E               E  ++ 
Sbjct: 30  EDFKFGKILGEGSFST----TVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H   V+L      +++L+    YA+ G L  ++    +  +T   +        +  
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIV 140
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LEY+H       +HRD+K  NILL+     +I+DFG AK++   S  +A     VGT 
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANXFVGTA 196
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            Y++PE LT+  A   SD++A G +++++++G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCK 399
           L   E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           ++H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQ 118
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           GL + H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLW 172
Query: 520 YLAPEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           Y APE L      +   D+++ G +  E+++ +
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 146
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V    +R+  + VA+K+M   K +       E+ I+    H N+VE+     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   + L  +H       
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 141
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL    R K+SDFG    V K          +VGT  ++APE ++     
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYG 198
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E++ G+        + +    R +L   +    + SP      SLK 
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP------SLKG 252
Query: 593 YID 595
           ++D
Sbjct: 253 FLD 255

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 143
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 144 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK+ +        T +   +         +GL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ-DLKTFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 171
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 145
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTK--EFMAEMKILCKVHHS----- 403
           F + ++LG G +G V      + ++  AIK++  T+ K    ++E+ +L  ++H      
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 404 --------NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
                   N V+ +     +  LF+  EY +  +L   +H      Q    W +  QI L
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI-L 126
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD--------- 506
           +A   L YIH       +HRD+K  NI +D +   KI DFGLAK V ++ D         
Sbjct: 127 EA---LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 507 --GEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEII 548
                 +T  +GT  Y+A E L   G    K D+Y+ G++ FE+I
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 172
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 179
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--------LIGFGLQVAKGM 146
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 407 ELIGYA-ATEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 144
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 145 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V    +R+  + VA+K+M   K +       E+ I+    H N+VE+     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   + L  +H       
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 191
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL    R K+SDFG    V K          +VGT  ++APE ++     
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYG 248
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E++ G+        + +    R +L   +    + SP      SLK 
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP------SLKG 302
Query: 593 YID 595
           ++D
Sbjct: 303 FLD 305

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 330 TDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE 389
            +  +  KP      E+    E F    ++G G +G V    ++N E  I  M      E
Sbjct: 53  AEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTE-RIYAMKILNKWE 111
Query: 390 FMAEMKILCKVHHSNL--------VELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNR 440
            +   +  C     ++        +  + YA   E+ L+L+ +Y   G L + L   +++
Sbjct: 112 MLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK 171
Query: 441 GQTSLS--WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA 498
               ++  +I  + +A+D+      IH+    HYVHRDIK  N+LLD     +++DFG  
Sbjct: 172 LPEDMARFYIGEMVLAIDS------IHQ---LHYVHRDIKPDNVLLDVNGHIRLADFG-- 220
Query: 499 KLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGLAT--AKSDVYAFGVVLFEIISGK-- 551
             +    DG    +  VGT  Y++PE L    DG+     + D ++ GV ++E++ G+  
Sbjct: 221 SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280
Query: 552 ---EAIIRTEGMVSKNQERRSLAS 572
              E+++ T G +  ++ER    S
Sbjct: 281 FYAESLVETYGKIMNHEERFQFPS 304

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           +  E F     LG G +G+VY    R  +  +A+K +  T+ +      +   E++I   
Sbjct: 9   WTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSH 68
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAA 458
           + H N++ L GY      ++LI EYA  G++   L    +   Q + ++I       + A
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT------ELA 122
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             L Y H       +HRDIK  N+LL S    KI+DFG +  V   S    T   + GT 
Sbjct: 123 NALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT---LCGTL 174
Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            YL PE +   +   K D+++ GV+ +E + G
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 171
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 172
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y 
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYR 171
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 171
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V    +R+  + VA+K+M   K +       E+ I+    H N+VE+     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 414 TEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             DEL+++ E+ + G+L   + H   N  Q +        + L   + L  +H       
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQG---V 268
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS +ILL    R K+SDFG    V K          +VGT  ++APE ++     
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYG 325
Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            + D+++ G+++ E++ G+        + +    R +L   +    + SP      SLK 
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSP------SLKG 379
Query: 593 YID 595
           ++D
Sbjct: 380 FLD 382

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 358 LLGHGTYGSVYYGNIRNQEV-----AIKRMTATKTKE---FMAEMKILCK-VHHSNLVEL 408
           ++G G++G V     + +EV      +++    K KE    M+E  +L K V H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                T D+L+ + +Y   G L  HL     R +  L    R   A + A  L Y+H   
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAA-EIASALGYLHS-- 157
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
             + V+RD+K  NILLDS     ++DFGL K   +  +  +T +   GT  YLAPE L  
Sbjct: 158 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 529 GLATAKSDVYAFGVVLFEIISG 550
                  D +  G VL+E++ G
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 330 TDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE 389
            +  +  KP      E+    E F    ++G G +G V    ++N E  I  M      E
Sbjct: 69  AEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTE-RIYAMKILNKWE 127
Query: 390 FMAEMKILCKVHHSNL--------VELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNR 440
            +   +  C     ++        +  + YA   E+ L+L+ +Y   G L + L   +++
Sbjct: 128 MLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK 187
Query: 441 GQTSLS--WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA 498
               ++  +I  + +A+D+      IH+    HYVHRDIK  N+LLD     +++DFG  
Sbjct: 188 LPEDMARFYIGEMVLAIDS------IHQ---LHYVHRDIKPDNVLLDVNGHIRLADFG-- 236
Query: 499 KLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGLAT--AKSDVYAFGVVLFEIISGK-- 551
             +    DG    +  VGT  Y++PE L    DG+     + D ++ GV ++E++ G+  
Sbjct: 237 SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296
Query: 552 ---EAIIRTEGMVSKNQERRSLAS 572
              E+++ T G +  ++ER    S
Sbjct: 297 FYAESLVETYGKIMNHEERFQFPS 320

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 172
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 356 SSLLGHGTYGSVYYGNIRNQE-----VAIKRMTAT----KTKEFMAEMKILCKVHHSNLV 406
           + ++G G +G VY+G + + +      A+K +       +  +F+ E  I+    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 407 ELIGYAA-TEDELFLIYEYAQKGSLKSHL----HDPQNRGQTSLSWIMRVQIALDAARGL 461
            L+G    +E    ++  Y + G L++ +    H+P  +          +   L  A+G+
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL--------IGFGLQVAKGM 141
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGY 520
           +Y+       +VHRD+ + N +LD  F  K++DFGLA+ +  K        T       +
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +A E L     T KSDV++FGV+L+E+++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 38/234 (16%)
Query: 332 VFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATK--- 386
           VFD  + V F + EIL A         +G G++G V     N   +  A+K M   K   
Sbjct: 5   VFDENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE 55
Query: 387 ---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQN---R 440
               +    E++I+  + H  LV L      E+++F++ +    G L+ HL   QN   +
Sbjct: 56  RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ--QNVHFK 113
Query: 441 GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL 500
            +T   +I  + +ALD  +             +HRD+K  NILLD      I+DF +A +
Sbjct: 114 EETVKLFICELVMALDYLQN---------QRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164
Query: 501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS---DVYAFGVVLFEIISGK 551
           + +    E  +T + GT  Y+APE  +       S   D ++ GV  +E++ G+
Sbjct: 165 LPR----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 179
Query: 524 EYLT-DGLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 172
Query: 524 EYLT-DGLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----TKEFMAEMKILCKVHHS 403
           E +     +G G+YG V+    R+  Q VAIK+   ++      K  + E+++L ++ H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           NLV L+     +  L L++EY     L        +R Q  +   +   I     + + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHE-----LDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H+H     +HRD+K  NIL+      K+ DFG A+L+   SD        V T  Y +P
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD---YYDDEVATRWYRSP 171
Query: 524 EYLT-DGLATAKSDVYAFGVVLFEIISG 550
           E L  D       DV+A G V  E++SG
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL---QVR-KFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPESINFR 187
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTK------EFMAEMKILCKVHHSNLVELIG 410
           LG GT+G V  G   +   +VA+K +   K +      +   E++ L    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
             +T  + F++ EY   G L  ++      G+       R+   + +A  ++Y H H   
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSA--VDYCHRHM-- 131
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD+   AKI+DFGL+ ++   SDGE  +    G+  Y APE ++  L
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGE-FLRDSCGSPNYAAPEVISGRL 186
Query: 531 -ATAKSDVYAFGVVLFEIISG 550
            A  + D+++ GV+L+ ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 139/320 (43%), Gaps = 62/320 (19%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQE-----VAIKRMTA-----TKTKEFMAE 393
           +++L   + F+   +LG G +GSV    ++ ++     VA+K + A     +  +EF+ E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 394 MKILCKVHHSNLVELIGYAATEDEL------FLIYEYAQKGSLKSHL------HDPQNRG 441
              + +  H ++ +L+G +             +I  + + G L + L       +P N  
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA-KL 500
             +L     V+  +D A G+EY+   +  +++HRD+ + N +L       ++DFGL+ K+
Sbjct: 136 LQTL-----VRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187
Query: 501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
                  +   +K+     +LA E L D L T  SDV+AFGV ++EI+        T G 
Sbjct: 188 YSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIM--------TRGQ 237
Query: 561 VS-KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVD 619
                 E   + ++++   R          LK           P +C+ ++  L  QC  
Sbjct: 238 TPYAGIENAEIYNYLIGGNR----------LKQ----------PPECMEEVYDLMYQCWS 277
Query: 620 EDPILRPDMKQVVISLSQIL 639
            DP  RP    + + L  IL
Sbjct: 278 ADPKQRPSFTCLRMELENIL 297

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK+ +        T +   +         +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 173
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKR----MTATKTKEFMAEMKILCKVHHSNLVEL---- 408
           LG G +G V  +      ++VAIK+    ++    + +  E++I+ K++H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 409 --IGYAATEDELFLIYEYAQKGSLKSHLHDPQN-----RG--QTSLSWIMRVQIALDAAR 459
             +   A  D   L  EY + G L+ +L+  +N      G  +T LS         D + 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---------DISS 133
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVG 516
            L Y+HE+     +HRD+K  NI+L    +    KI D G AK +    D     T+ VG
Sbjct: 134 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQGELCTEFVG 186
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           T  YLAPE L     T   D ++FG + FE I+G
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKR----MTATKTKEFMAEMKILCKVHHSNLVEL---- 408
           LG G +G V  +      ++VAIK+    ++    + +  E++I+ K++H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 409 --IGYAATEDELFLIYEYAQKGSLKSHLHDPQN-----RG--QTSLSWIMRVQIALDAAR 459
             +   A  D   L  EY + G L+ +L+  +N      G  +T LS         D + 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---------DISS 132
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVG 516
            L Y+HE+     +HRD+K  NI+L    +    KI D G AK +    D     T+ VG
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL----DQGELCTEFVG 185
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           T  YLAPE L     T   D ++FG + FE I+G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 40/226 (17%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIG- 410
           F +  L+G G +G V+    R + +  + R      ++   E+K L K+ H N+V   G 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 411 ------YAATEDE----------------------LFLIYEYAQKGSLKSHLHDPQNRGQ 442
                    T D+                      LF+  E+  KG+L+  +   + RG+
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGE 131
Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             L  ++ +++     +G++YIH       +HRD+K SNI L    + KI DFGL  +  
Sbjct: 132 -KLDKVLALELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQVKIGDFGL--VTS 185
Query: 503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
             +DG+ T +K  GT  Y++PE ++      + D+YA G++L E++
Sbjct: 186 LKNDGKRTRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCK 399
           L + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           ++H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQ 118
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           GL + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLW 172
Query: 520 YLAPEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           Y APE L      +   D+++ G +  E+++ +
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 139/307 (45%), Gaps = 55/307 (17%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
           KV     ++A E +   + T +SDV+++GV ++E+++                       
Sbjct: 180 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT----------------------- 214
Query: 573 FMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                  + P D +  S +   ++       P  C   + M+ ++C   D   RP  +++
Sbjct: 215 -----FGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269
Query: 632 VISLSQI 638
           +I  S++
Sbjct: 270 IIEFSKM 276

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCK 399
           L + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           ++H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQ 117
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           GL + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLW 171
Query: 520 YLAPEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           Y APE L      +   D+++ G +  E+++ +
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 170
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 172
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 170
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 119 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 172
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 118
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 172
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 173
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           F  + F     LG G +G+VY    +     VA+K +  ++ +      +   E++I   
Sbjct: 20  FTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAH 79
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           +HH N++ L  Y      ++LI EYA +G L   L       +   + IM      + A 
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIME-----ELAD 134
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            L Y H       +HRDIK  N+LL      KI+DFG +  V   S    T   + GT  
Sbjct: 135 ALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT---MCGTLD 186
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           YL PE +   +   K D++  GV+ +E++ G
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYRAP 171
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 38/252 (15%)
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +  E++IL  ++H ++V+  G    + E  + L+ EY   GSL+ +L     R    L+ 
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQ 113
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK---- 503
           ++    A     G+ Y+H     HY+HR + + N+LLD+    KI DFGLAK V +    
Sbjct: 114 LLL--FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 168
Query: 504 ---TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
                DG++ V      F Y APE L +      SDV++FGV L+E+++           
Sbjct: 169 YRVREDGDSPV------FWY-APECLKECKFYYASDVWSFGVTLYELLT----------Y 211
Query: 561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDE 620
              NQ   +  + ++    ++   M++  L + ++       P  C  ++  L K C + 
Sbjct: 212 CDSNQSPHTKFTELIG---HTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWET 268
Query: 621 DPILRPDMKQVV 632
           +   RP  + +V
Sbjct: 269 EASFRPTFQNLV 280

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 38/252 (15%)
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +  E++IL  ++H ++V+  G    + E  + L+ EY   GSL+ +L     R    L+ 
Sbjct: 57  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQ 112
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK---- 503
           ++    A     G+ Y+H     HY+HR + + N+LLD+    KI DFGLAK V +    
Sbjct: 113 LLL--FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 167
Query: 504 ---TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
                DG++ V      F Y APE L +      SDV++FGV L+E+++           
Sbjct: 168 YRVREDGDSPV------FWY-APECLKECKFYYASDVWSFGVTLYELLT----------Y 210
Query: 561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDE 620
              NQ   +  + ++    ++   M++  L + ++       P  C  ++  L K C + 
Sbjct: 211 CDSNQSPHTKFTELIG---HTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWET 267
Query: 621 DPILRPDMKQVV 632
           +   RP  + +V
Sbjct: 268 EASFRPTFQNLV 279

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 170
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 139/307 (45%), Gaps = 55/307 (17%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 73  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
           KV     ++A E +   + T +SDV+++GV ++E+++                       
Sbjct: 183 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT----------------------- 217
Query: 573 FMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                  + P D +  S +   ++       P  C   + M+ ++C   D   RP  +++
Sbjct: 218 -----FGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 272
Query: 632 VISLSQI 638
           +I  S++
Sbjct: 273 IIEFSKM 279

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 117 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 170
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 171
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYRAP 171
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 171
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 74  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 131 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 184 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQE----VAIKRMTATKTKEF-----MAEMKILCK 399
           + E + +  L+G G+YG V     RN++    VAIK+   +   +      M E+K+L +
Sbjct: 23  SMEKYENLGLVGEGSYGMVM--KCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H NLV L+     +   +L++E+     L     D        L + +  +       
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTIL-----DDLELFPNGLDYQVVQKYLFQIIN 135
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV---GKTSDGEATVTKVVG 516
           G+ + H H     +HRDIK  NIL+  +   K+ DFG A+ +   G+  D E      V 
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE------VA 186
Query: 517 TFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  Y APE L   +   K+ DV+A G ++ E+  G+
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL---QVR-KYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 187
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 116
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 170
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
           +G G +G V+               VA+K +    +A    +F  E  ++ +  + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLH-------------DPQNRGQTS------LSWI 448
           L+G  A    + L++EY   G L   L              D   R + S      LS  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
            ++ IA   A G+ Y+ E     +VHRD+ + N L+      KI+DFGL++ +      +
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           A     +    ++ PE +     T +SDV+A+GVVL+EI S
Sbjct: 232 ADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y AP
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYRAP 173
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 114
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 115 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 169 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+ ++      E      + E+ +L +++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 172
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 351 EGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY     +  + VA+ ++      E      + E+ +L +++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAP 171
Query: 524 EYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           E L      +   D+++ G +  E+++ +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 117/247 (47%), Gaps = 29/247 (11%)
Query: 353 FSDSSLLGHGTYGSVYY---------GNIRNQEVAIKRMTATKTK-EFMAEMKILCKVHH 402
           F    +LG G++G V+          G++   +V  K     + +     E  IL  V+H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             +V+L     TE +L+LI ++ + G L + L       +  + + +  ++AL    GL+
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-AELAL----GLD 144
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           ++H       ++RD+K  NILLD     K++DFGL+K   +  D E       GT  Y+A
Sbjct: 145 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMA 198
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           PE +     +  +D +++GV++FE+++G         +  + ++R+   + +L A    P
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTG--------SLPFQGKDRKETMTLILKAKLGMP 250
Query: 583 DSMSMSS 589
             +S  +
Sbjct: 251 QFLSTEA 257

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 106 G-VITENPVWIIMELCTLGELRSFL---QVR-KYSLDLASLILYAYQLSTALAYLESK-- 158
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 159 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 215
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 216 RFTSASDVWMFGVCMWEIL 234

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 71  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 128 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 181 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 180 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL---QVR-KYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 187
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 83  G-VITENPVWIIMELCTLGELRSFL---QVR-KYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 192
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 193 RFTSASDVWMFGVCMWEIL 211

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 139/307 (45%), Gaps = 55/307 (17%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 80  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 136
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 137 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
           KV     ++A E +   + T +SDV+++GV ++E+++                       
Sbjct: 190 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT----------------------- 224
Query: 573 FMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                  + P D +  S +   ++       P  C   + M+ ++C   D   RP  +++
Sbjct: 225 -----FGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 279
Query: 632 VISLSQI 638
           +I  S++
Sbjct: 280 IIEFSKM 286

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 42/211 (19%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVAIK     ++  T  ++   E++I+  ++H N+V+L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 412 AATEDELFLIYEYAQKGS----LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
             TE  L+LI EYA  G     L +H    +   ++    I+           ++Y H+ 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV---------SAVQYCHQ- 129
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF----GYLAP 523
                VHRD+K+ N+LLD+    KI+DFG +         E TV   + TF     Y AP
Sbjct: 130 --KRIVHRDLKAENLLLDADMNIKIADFGFS--------NEFTVGGKLDTFCGSPPYAAP 179
Query: 524 EYLT----DGLATAKSDVYAFGVVLFEIISG 550
           E       DG    + DV++ GV+L+ ++SG
Sbjct: 180 ELFQGKKYDG---PEVDVWSLGVILYTLVSG 207

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 73  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 183 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G+ G V     ++  ++VA+K M   K +       E+ I+    H N+VE+     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
             +EL+++ E+ Q G+L   +       Q  L+      +     + L Y+H       +
Sbjct: 113 VGEELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA 533
           HRDIKS +ILL    R K+SDFG    + K          +VGT  ++APE ++  L   
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX---LVGTPYWMAPEVISRSLYAT 220
Query: 534 KSDVYAFGVVLFEIISGK 551
           + D+++ G+++ E++ G+
Sbjct: 221 EVDIWSLGIMVIEMVDGE 238

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 182 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 71  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 128 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 181 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+  +  LK  +        T +   +         +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 119
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 173
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 70/328 (21%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQE---VAIKRMTA----T 385
           P    YD    F     S    LG G +G V     YG I++     VA+K +      T
Sbjct: 32  PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR---G 441
           + +  M+E+K+L  + +H N+V L+G         +I EY   G L + L   ++     
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 442 QTSLSWIMRV-----------QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA 490
           +TS + IM               +   A+G+ ++      + +HRD+ + NILL      
Sbjct: 152 KTSPA-IMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRIT 207
Query: 491 KISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
           KI DFGLA+ +   S+    G A +        ++APE + + + T +SDV+++G+ L+E
Sbjct: 208 KICDFGLARHIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWE 262
Query: 547 IISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSM-SSLKDYIDPNMMDLYPH 604
           + S                            L +SP   M + S     I      L P 
Sbjct: 263 LFS----------------------------LGSSPYPGMPVDSKFYKMIKEGFRMLSPE 294
Query: 605 DCLFKMAMLAKQCVDEDPILRPDMKQVV 632
               +M  + K C D DP+ RP  KQ+V
Sbjct: 295 HAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 75  G-VITENPVWIIMELCTLGELRSFL---QVR-KYSLDLASLILYAYQLSTALAYLE---S 126
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 184
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 185 RFTSASDVWMFGVCMWEIL 203

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 130
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 131 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 185 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 130
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 131 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 185 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 73  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 183 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 180 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 81  G-VITENPVWIIMELCTLGELRSFL---QVR-KYSLDLASLILYAYQLSTALAYLE---S 132
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 190
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 191 RFTSASDVWMFGVCMWEIL 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 80  G-VITENPVWIIMELCTLGELRSFL---QVR-KYSLDLASLILYAYQLSTALAYLE---S 131
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 189
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 190 RFTSASDVWMFGVCMWEIL 208

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 73  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 183 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 180 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 182 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 36  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 95  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 151
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 152 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 205 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 187 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-------FMA---EMKI 396
           +F         +LG G +G+V+ G    +  +IK     K  E       F A    M  
Sbjct: 27  IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 86
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMRVQ 452
           +  + H+++V L+G       L L+ +Y   GSL  H+   Q+RG    Q  L+W +++ 
Sbjct: 87  IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVR--QHRGALGPQLLLNWGVQI- 142
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
                A+G+ Y+ EH     VHR++ + N+LL S  + +++DFG+A L+    D +   +
Sbjct: 143 -----AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL-PPDDKQLLYS 193
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +      ++A E +  G  T +SDV+++GV ++E+++
Sbjct: 194 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCK 399
           L + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAA 458
           ++H N+V+L+    TE++L+L++E+     L   L D  +    T +   +         
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           +GL + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T 
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTL 170
Query: 519 GYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
            Y APE L      +   D+++ G +  E+++ +
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 113/238 (47%), Gaps = 34/238 (14%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P    Y+E   F          LG G +G V     +G  +     +VA+K + +T    
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH--------D 436
           + +  M+E+KI+  +  H N+V L+G       + +I EY   G L + L         D
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 437 PQNR-GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF 495
           P      ++LS    +  +   A+G+ ++      + +HRD+ + N+LL +   AKI DF
Sbjct: 152 PAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 496 GLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           GLA+ +   S+    G A +        ++APE + D + T +SDV+++G++L+EI S
Sbjct: 209 GLARDIMNDSNYIVKGNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 70/328 (21%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQE---VAIKRMTA----T 385
           P    YD    F     S    LG G +G V     YG I++     VA+K +      T
Sbjct: 25  PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 84
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR---G 441
           + +  M+E+K+L  + +H N+V L+G         +I EY   G L + L   ++     
Sbjct: 85  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 144
Query: 442 QTSLSWIMRV-----------QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA 490
           +TS + IM               +   A+G+ ++      + +HRD+ + NILL      
Sbjct: 145 KTSPA-IMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRIT 200
Query: 491 KISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
           KI DFGLA+ +   S+    G A +        ++APE + + + T +SDV+++G+ L+E
Sbjct: 201 KICDFGLARDIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWE 255
Query: 547 IISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSM-SSLKDYIDPNMMDLYPH 604
           + S                            L +SP   M + S     I      L P 
Sbjct: 256 LFS----------------------------LGSSPYPGMPVDSKFYKMIKEGFRMLSPE 287
Query: 605 DCLFKMAMLAKQCVDEDPILRPDMKQVV 632
               +M  + K C D DP+ RP  KQ+V
Sbjct: 288 HAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 114
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 115 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 169 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 128
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 129 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 183 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 70/328 (21%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQE---VAIKRMTA----T 385
           P    YD    F     S    LG G +G V     YG I++     VA+K +      T
Sbjct: 32  PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR---G 441
           + +  M+E+K+L  + +H N+V L+G         +I EY   G L + L   ++     
Sbjct: 92  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 442 QTSLSWIMRV-----------QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA 490
           +TS + IM               +   A+G+ ++      + +HRD+ + NILL      
Sbjct: 152 KTSPA-IMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRIT 207
Query: 491 KISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
           KI DFGLA+ +   S+    G A +        ++APE + + + T +SDV+++G+ L+E
Sbjct: 208 KICDFGLARDIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWE 262
Query: 547 IISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSM-SSLKDYIDPNMMDLYPH 604
           + S                            L +SP   M + S     I      L P 
Sbjct: 263 LFS----------------------------LGSSPYPGMPVDSKFYKMIKEGFRMLSPE 294
Query: 605 DCLFKMAMLAKQCVDEDPILRPDMKQVV 632
               +M  + K C D DP+ RP  KQ+V
Sbjct: 295 HAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 76  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 132
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 133 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 186 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL---QVR-KFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ +    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 131 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 187
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 64  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 120
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 121 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 174 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/327 (25%), Positives = 135/327 (41%), Gaps = 68/327 (20%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQE---VAIKRMTA----T 385
           P    YD    F     S    LG G +G V     YG I++     VA+K +      T
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR---G 441
           + +  M+E+K+L  + +H N+V L+G         +I EY   G L + L   ++     
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 442 QTSLSWIMRV----------QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK 491
           +TS + +               +   A+G+ ++      + +HRD+ + NILL      K
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 185
Query: 492 ISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEI 547
           I DFGLA+ +   S+    G A +        ++APE + + + T +SDV+++G+ L+E+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 548 ISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSM-SSLKDYIDPNMMDLYPHD 605
            S                            L +SP   M + S     I      L P  
Sbjct: 241 FS----------------------------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEH 272
Query: 606 CLFKMAMLAKQCVDEDPILRPDMKQVV 632
              +M  + K C D DP+ RP  KQ+V
Sbjct: 273 APAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P    Y+E   F          LG G +G V     +G  +     +VA+K + +T    
Sbjct: 24  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH-----DPQN 439
           + +  M+E+KI+  +  H N+V L+G       + +I EY   G L + L      D   
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 143
Query: 440 RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK 499
                L     +  +   A+G+ ++      + +HRD+ + N+LL +   AKI DFGLA+
Sbjct: 144 EDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 200
Query: 500 LVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +   S+    G A +        ++APE + D + T +SDV+++G++L+EI S
Sbjct: 201 DIMNDSNYIVKGNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCK 399
           L + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           ++H N+V+L+    TE++L+L++E+     LK  +        T +   +         +
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM---DASALTGIPLPLIKSYLFQLLQ 117
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           GL + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLW 171
Query: 520 YLAPEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           Y APE L      +   D+++ G +  E+++ +
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 70/328 (21%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQE---VAIKRMTA----T 385
           P    YD    F     S    LG G +G V     YG I++     VA+K +      T
Sbjct: 27  PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 86
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR---G 441
           + +  M+E+K+L  + +H N+V L+G         +I EY   G L + L   ++     
Sbjct: 87  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 146
Query: 442 QTSLSWIMRV-----------QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA 490
           +TS + IM               +   A+G+ ++      + +HRD+ + NILL      
Sbjct: 147 KTSPA-IMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRIT 202
Query: 491 KISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
           KI DFGLA+ +   S+    G A +        ++APE + + + T +SDV+++G+ L+E
Sbjct: 203 KICDFGLARDIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWE 257
Query: 547 IISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSM-SSLKDYIDPNMMDLYPH 604
           + S                            L +SP   M + S     I      L P 
Sbjct: 258 LFS----------------------------LGSSPYPGMPVDSKFYKMIKEGFRMLSPE 289
Query: 605 DCLFKMAMLAKQCVDEDPILRPDMKQVV 632
               +M  + K C D DP+ RP  KQ+V
Sbjct: 290 HAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKE-------FMA---EMKI 396
           +F         +LG G +G+V+ G    +  +IK     K  E       F A    M  
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMRVQ 452
           +  + H+++V L+G       L L+ +Y   GSL  H+   Q+RG    Q  L+W +++ 
Sbjct: 69  IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVR--QHRGALGPQLLLNWGVQI- 124
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
                A+G+ Y+ EH     VHR++ + N+LL S  + +++DFG+A L+    D +   +
Sbjct: 125 -----AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL-PPDDKQLLYS 175
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           +      ++A E +  G  T +SDV+++GV ++E+++
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 110
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 111 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 347 LFATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCK 399
           L + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAA 458
           ++H N+V+L+    TE++L+L++E+     L   L D  +    T +   +         
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           +GL + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T 
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTL 169
Query: 519 GYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
            Y APE L      +   D+++ G +  E+++ +
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 42/211 (19%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA+K     ++  T  ++   E++I+  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 412 AATEDELFLIYEYAQKGS----LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
             TE  L+L+ EYA  G     L +H    +   +     I+           ++Y H+ 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV---------SAVQYCHQ- 132
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF----GYLAP 523
              + VHRD+K+ N+LLD     KI+DFG +         E TV   + TF     Y AP
Sbjct: 133 --KYIVHRDLKAENLLLDGDMNIKIADFGFS--------NEFTVGNKLDTFCGSPPYAAP 182
Query: 524 EYLT----DGLATAKSDVYAFGVVLFEIISG 550
           E       DG    + DV++ GV+L+ ++SG
Sbjct: 183 ELFQGKKYDG---PEVDVWSLGVILYTLVSG 210

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 36/225 (16%)
Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTK--EFMAEMKILCKVHHS----- 403
           F + ++LG G +G V      + ++  AIK++  T+ K    ++E+ +L  ++H      
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 404 --------NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
                   N V+       +  LF+  EY +  +L   +H      Q    W +  QI L
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI-L 126
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD--------- 506
           +A   L YIH       +HR++K  NI +D +   KI DFGLAK V ++ D         
Sbjct: 127 EA---LSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 507 --GEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEII 548
                 +T  +GT  Y+A E L   G    K D Y+ G++ FE I
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 120
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 121 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 108
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 109 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 163 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIG 410
           F +  L+G G +G V+    R   +   IKR+     K    E+K L K+ H N+V   G
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-EREVKALAKLDHVNIVHYNG 71
Query: 411 YAATEDE----------------LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA 454
                D                 LF+  E+  KG+L+  +   + RG+  L  ++ +++ 
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGE-KLDKVLALELF 128
Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
               +G++YIH       ++RD+K SNI L    + KI DFGL  +    +DG+   +K 
Sbjct: 129 EQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRXRSK- 182
Query: 515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
            GT  Y++PE ++      + D+YA G++L E++
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 125
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 126 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 348 FATEGFSDSSLLGHGTYGSV----------YYG-NIRNQEVAIKRMTATKTKEFMAEMKI 396
           ++ + F     LG G++G V          YY   +  +E+ ++      T +   E  +
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ERLM 59
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           L  V H  ++ + G      ++F+I +Y + G L S L   Q R    ++     ++ L 
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCL- 117
Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
               LEY+H       ++RD+K  NILLD     KI+DFG AK V   +        + G
Sbjct: 118 ---ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YXLCG 165
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           T  Y+APE ++        D ++FG++++E+++G
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVH 401
           + E F     +G GTYG VY     +  + VA+K++      E      + E+ +L +++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N+V+L+    TE++L+L++E+     LK  +        T +   +         +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFM---DASALTGIPLPLIKSYLFQLLQGL 117
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            + H H     +HRD+K  N+L+++    K++DFGLA+  G       T    V T  Y 
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV---RTYXHEVVTLWYR 171
Query: 522 APEYLTD-GLATAKSDVYAFGVVLFEIISGK 551
           APE L      +   D+++ G +  E+++ +
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 38/209 (18%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVAIK     ++  T  ++   E++I+  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 412 AATEDELFLIYEYAQKGS----LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
             TE  L+LI EYA  G     L +H    +   ++    I+           ++Y H+ 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV---------SAVQYCHQ- 132
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK--LVGKTSDGEATVTKVVGTFGYLAPEY 525
                VHRD+K+ N+LLD+    KI+DFG +    VG   D         G   Y APE 
Sbjct: 133 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA------FCGAPPYAAPEL 184
Query: 526 LT----DGLATAKSDVYAFGVVLFEIISG 550
                 DG    + DV++ GV+L+ ++SG
Sbjct: 185 FQGKKYDG---PEVDVWSLGVILYTLVSG 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 355 DSSLLGHGTYGSVYYG-NIRNQ-EVAIKRMTATKTK---EFMAEMKILCKVHHSNLVELI 409
           D  +LG GTYG VY G ++ NQ  +AIK +    ++       E+ +   + H N+V+ +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHD---PQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
           G  +    + +  E    GSL + L     P    + ++ +  + QI      GL+Y+H+
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QI----LEGLKYLHD 140
Query: 467 HTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           +     VHRDIK  N+L+++ +   KISDFG +K +   +    T T   GT  Y+APE 
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPEI 194
Query: 526 LTDGLA--TAKSDVYAFGVVLFEIISGK 551
           +  G       +D+++ G  + E+ +GK
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 111/233 (47%), Gaps = 24/233 (10%)
Query: 329 GTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYY--GNIRNQEVAIKRMTATK 386
           G +    + P +F        ++ +    +LG G++G V      I  QE A+K ++  +
Sbjct: 10  GRENLYFQGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 69
Query: 387 TKE------FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR 440
            K+       + E+++L ++ H N+++L  +   +   +L+ E    G L   +   +  
Sbjct: 70  VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 129
Query: 441 GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGL 497
            +   + I+R  ++     G+ Y+H   K   VHRD+K  N+LL+S  +    +I DFGL
Sbjct: 130 SEVDAARIIRQVLS-----GITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 181
Query: 498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           +       +    +   +GT  Y+APE L  G    K DV++ GV+L+ ++SG
Sbjct: 182 STHF----EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 358 LLGHGTYGSVYY--GNIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIG 410
           +LG G++G V      I  QE A+K +     K       + E+++L K+ H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
                   +++ E    G L   +   +   +   + I++   +     G+ Y+H+H   
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS-----GITYMHKH--- 140
Query: 471 HYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
           + VHRD+K  NILL+S  +    KI DFGL+    + +     +   +GT  Y+APE L 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLR 196
Query: 528 DGLATAKSDVYAFGVVLFEIISG 550
            G    K DV++ GV+L+ ++SG
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSG 218

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P    Y+E   F          LG G +G V     +G  +     +VA+K + +T    
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH-----DPQN 439
           + +  M+E+KI+  +  H N+V L+G       + +I EY   G L + L      D   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK 151
Query: 440 RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK 499
                L     +  +   A+G+ ++      + +HRD+ + N+LL +   AKI DFGLA+
Sbjct: 152 EDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 208
Query: 500 LVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +   S+    G A +        ++APE + D + T +SDV+++G++L+EI S
Sbjct: 209 DIMNDSNYIVKGNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 24/224 (10%)
Query: 338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYY--GNIRNQEVAIKRMTATKTKE------ 389
           P +F        ++ +    +LG G++G V      I  QE A+K ++  + K+      
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
            + E+++L ++ H N+++L  +   +   +L+ E    G L   +   +   +   + I+
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSD 506
           R  ++     G+ Y+H   K   VHRD+K  N+LL+S  +    +I DFGL+       +
Sbjct: 133 RQVLS-----GITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----E 180
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
               +   +GT  Y+APE L  G    K DV++ GV+L+ ++SG
Sbjct: 181 ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 128/288 (44%), Gaps = 37/288 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 122
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 123 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 175
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
                + +SD+++ G+ L E+  G+  I   +   +K   R  +A F             
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD---AKEDSRPPMAIF------------- 219
Query: 587 MSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPDMKQVVI 633
              L DYI        P      +      +C+ ++P  R D+KQ+++
Sbjct: 220 --ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 265

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG---------NIRNQEVAIKRMTATKT-KEFMAEMK 395
           IL  TE F    +LG G +G+VY G          I    + ++  T+ K  KE + E  
Sbjct: 45  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 104 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 160
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 161 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 214 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 67  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 123
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 124 ----AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 177 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 125
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 126 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 112/238 (47%), Gaps = 34/238 (14%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P    Y+E   F          LG G +G V     +G  +     +VA+K + +T    
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS 444
           + +  M+E+KI+  +  H N+V L+G       + +I EY   G L + L       +T 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 445 LSWIMR---------VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF 495
            ++ +          +  +   A+G+ ++      + +HRD+ + N+LL +   AKI DF
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 496 GLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           GLA+ +   S+    G A +        ++APE + D + T +SDV+++G++L+EI S
Sbjct: 209 GLARDIMNDSNYIVKGNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 472
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 473 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 354 SDSSLLGHGTYGSVYYG-NIRNQ-EVAIKRMTATKTK---EFMAEMKILCKVHHSNLVEL 408
            D  +LG GTYG VY G ++ NQ  +AIK +    ++       E+ +   + H N+V+ 
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHD---PQNRGQTSLSWIMRVQIALDAARGLEYIH 465
           +G  +    + +  E    GSL + L     P    + ++ +  + QI      GL+Y+H
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QI----LEGLKYLH 125
Query: 466 EHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           ++     VHRDIK  N+L+++ +   KISDFG +K +   +    T T   GT  Y+APE
Sbjct: 126 DN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPE 179
Query: 525 YLTDGLA--TAKSDVYAFGVVLFEIISGK 551
            +  G       +D+++ G  + E+ +GK
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 9/161 (5%)
Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           E +AE  ++ ++ +  +V +IG    E  + L+ E A+ G L  +L   QNR     + I
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNII 473
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
              ++    + G++Y+ E   +++VHRD+ + N+LL +   AKISDFGL+K +    +  
Sbjct: 474 ---ELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              T       + APE +     ++KSDV++FGV+++E  S
Sbjct: 528 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 350 TEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHS 403
            E +     LG G YG V      +  + VA+K +   +     +    E+ I   ++H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAAR 459
           N+V+  G+    +  +L  EY   G L   +      P+   Q     +M          
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------- 116
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           G+ Y+H    TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  
Sbjct: 117 GVVYLHGIGITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 172
Query: 520 YLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           Y+APE L      A+  DV++ G+VL  +++G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 24/224 (10%)
Query: 338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYY--GNIRNQEVAIKRMTATKTKE------ 389
           P +F        ++ +    +LG G++G V      I  QE A+K ++  + K+      
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 96
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
            + E+++L ++ H N+++L  +   +   +L+ E    G L   +   +   +   + I+
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 156
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSD 506
           R  ++     G+ Y+H   K   VHRD+K  N+LL+S  +    +I DFGL+       +
Sbjct: 157 RQVLS-----GITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----E 204
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
               +   +GT  Y+APE L  G    K DV++ GV+L+ ++SG
Sbjct: 205 ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 350 TEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHS 403
            E +     LG G YG V      +  + VA+K +   +     +    E+ I   ++H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAAR 459
           N+V+  G+    +  +L  EY   G L   +      P+   Q     +M          
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--------- 115
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           G+ Y+H    TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  
Sbjct: 116 GVVYLHGIGITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLP 171
Query: 520 YLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           Y+APE L      A+  DV++ G+VL  +++G+
Sbjct: 172 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 24/224 (10%)
Query: 338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYY--GNIRNQEVAIKRMTATKTKE------ 389
           P +F        ++ +    +LG G++G V      I  QE A+K ++  + K+      
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 95
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
            + E+++L ++ H N+++L  +   +   +L+ E    G L   +   +   +   + I+
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 155
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSD 506
           R  ++     G+ Y+H   K   VHRD+K  N+LL+S  +    +I DFGL+       +
Sbjct: 156 RQVLS-----GITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----E 203
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
               +   +GT  Y+APE L  G    K DV++ GV+L+ ++SG
Sbjct: 204 ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 359 LGHGTYGSVYYGNI-----RNQEVAIKRMTA------TKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G       +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G   T   + ++ E A  GSL   L   +++G   L  + R   A+  A G+ Y+   
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRY--AVQVAEGMGYLE-- 128
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG-----MVSKNQER--------RSLASF 573
               +  SD + FGV L+E+ + G+E  I   G      + K  ER        + + + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 574 MLAALRNSP-DSMSMSSLKDYI 594
           M+    + P D  +  +L+D++
Sbjct: 248 MVQCWAHKPEDRPTFVALRDFL 269

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 138/307 (44%), Gaps = 55/307 (17%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFG AKL+G +  +  A   
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
           KV     ++A E +   + T +SDV+++GV ++E+++                       
Sbjct: 182 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT----------------------- 216
Query: 573 FMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                  + P D +  S +   ++       P  C   + M+ ++C   D   RP  +++
Sbjct: 217 -----FGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 271
Query: 632 VISLSQI 638
           +I  S++
Sbjct: 272 IIEFSKM 278

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 125
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 126 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFL---QVR-KFSLDLASLILYAYQLSTALAYLE---S 509
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ S    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 567
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 138/307 (44%), Gaps = 55/307 (17%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFG AKL+G +  +  A   
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
           KV     ++A E +   + T +SDV+++GV ++E+++                       
Sbjct: 182 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT----------------------- 216
Query: 573 FMLAALRNSP-DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                  + P D +  S +   ++       P  C   + M+ ++C   D   RP  +++
Sbjct: 217 -----FGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 271
Query: 632 VISLSQI 638
           +I  S++
Sbjct: 272 IIEFSKM 278

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 123
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 124 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 351 EGFSDSSLLGHGTYGSVYY--GNIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E ++   +LG G++G V      I  QE A+K +     K       + E+++L K+ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+++L          +++ E    G L   +   +   +   + I++   +     G+ Y
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS-----GITY 136
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           +H+H   + VHRD+K  NILL+S  +    KI DFGL+    + +     +   +GT  Y
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYY 189
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           +APE L  G    K DV++ GV+L+ ++SG
Sbjct: 190 IAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 125
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 126 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 125
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 126 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 125
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 126 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 351 EGFSDSSLLGHGTYGSVYY--GNIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E ++   +LG G++G V      I  QE A+K +     K       + E+++L K+ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+++L          +++ E    G L   +   +   +   + I++   +     G+ Y
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS-----GITY 136
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           +H+H   + VHRD+K  NILL+S  +    KI DFGL+    + +     +   +GT  Y
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYY 189
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           +APE L  G    K DV++ GV+L+ ++SG
Sbjct: 190 IAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 359 LGHGTYGSVYYGNI-----RNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G       +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G   T   + ++ E A  GSL   L   +++G   L  + R   A+  A G+ Y+   
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRY--AVQVAEGMGYLE-- 138
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG-----MVSKNQER--------RSLASF 573
               +  SD + FGV L+E+ + G+E  I   G      + K  ER        + + + 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 257
Query: 574 MLAALRNSP-DSMSMSSLKDYI 594
           M+    + P D  +  +L+D++
Sbjct: 258 MVQCWAHKPEDRPTFVALRDFL 279

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 125
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 126 ITH---RDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 359 LGHGTYGSVYYGNI-----RNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G       +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G   T   + ++ E A  GSL   L   +++G   L  + R   A+  A G+ Y+   
Sbjct: 80  LYGVVLTP-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRY--AVQVAEGMGYLE-- 132
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 133 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG-----MVSKNQER--------RSLASF 573
               +  SD + FGV L+E+ + G+E  I   G      + K  ER        + + + 
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 251
Query: 574 MLAALRNSP-DSMSMSSLKDYI 594
           M+    + P D  +  +L+D++
Sbjct: 252 MVQCWAHKPEDRPTFVALRDFL 273

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 74  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFG AKL+G +  +  A   
Sbjct: 131 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 184 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 19/199 (9%)
Query: 359 LGHGTYGSVYYGNIRNQE-----VAIK---RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK     T+   +E F+ E   + +  H ++V+LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L   Q R + SL     +  A   +  L Y+     
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFL---QVR-KFSLDLASLILYAYQLSTALAYLE---S 509
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             +VHRDI + N+L+ +    K+ DFGL++ +  ++  +A+  K+     ++APE +   
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 567
Query: 530 LATAKSDVYAFGVVLFEII 548
             T+ SDV+ FGV ++EI+
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +L  G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 187 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 33/302 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 122
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 123 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 175
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAI-------------IRTEGMVSKNQERRSLASF 573
                + +SD+++ G+ L E+  G+  I              + EG  ++   R      
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 574 MLAAL-RNSPDSMSMSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPDMKQV 631
            L++   +S   M++  L DYI        P      +      +C+ ++P  R D+KQ+
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 632 VI 633
           ++
Sbjct: 296 MV 297

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 359 LGHGTYGSVYYGNI-----RNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G       +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G   T   + ++ E A  GSL   L   +++G   L  + R   A+  A G+ Y+   
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRY--AVQVAEGMGYLE-- 128
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG-----MVSKNQER--------RSLASF 573
               +  SD + FGV L+E+ + G+E  I   G      + K  ER        + + + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 574 MLAALRNSP-DSMSMSSLKDYI 594
           M+    + P D  +  +L+D++
Sbjct: 248 MVQCWAHKPEDRPTFVALRDFL 269

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 72  VMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFG AKL+G +  +  A   
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 182 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 359 LGHGTYGSVYYG-NIRN--QEVAIKRMTATKTKEFM--------AEMKILCKVHHSNLVE 407
           +G G YG V+   +++N  + VA+KR+     +E M        A ++ L    H N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 408 L-----IGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAARGL 461
           L     +     E +L L++E+  +  L ++L   P+    T     M  Q+     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL----RGL 133
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H H     VHRD+K  NIL+ S+ + K++DFGLA++       +  +T VV T  Y 
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS----FQMALTSVVVTLWYR 186
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L         D+++ G +  E+   K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 33/302 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 122
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 123 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 175
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAI-------------IRTEGMVSKNQERRSLASF 573
                + +SD+++ G+ L E+  G+  I              + EG  ++   R      
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 574 MLAAL-RNSPDSMSMSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPDMKQV 631
            L++   +S   M++  L DYI        P      +      +C+ ++P  R D+KQ+
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 632 VI 633
           ++
Sbjct: 296 MV 297

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G YG V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 32/220 (14%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-------NIRNQEVAIKRM----TATKTKEFMAEM 394
           IL  TE      +LG G +G+VY G       N++   VAIK +    +    KE + E 
Sbjct: 13  ILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVK-IPVAIKVLRENTSPKANKEILDEA 70
Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMR 450
            ++  V    +  L+G   T   + L+ +    G L  H+   +NRG    Q  L+W M+
Sbjct: 71  YVMAGVGSPYVSRLLGICLTS-TVQLVTQLMPYGCLLDHVR--ENRGRLGSQDLLNWCMQ 127
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEA 509
           +      A+G+ Y+ +      VHRD+ + N+L+ S    KI+DFGLA+L+    ++  A
Sbjct: 128 I------AKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
              KV     ++A E +     T +SDV+++GV ++E+++
Sbjct: 179 DGGKV--PIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 33/302 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 122
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 123 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 175
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAI-------------IRTEGMVSKNQERRSLASF 573
                + +SD+++ G+ L E+  G+  I              + EG  ++   R      
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 574 MLAAL-RNSPDSMSMSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPDMKQV 631
            L++   +S   M++  L DYI        P      +      +C+ ++P  R D+KQ+
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 632 VI 633
           ++
Sbjct: 296 MV 297

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 135/302 (44%), Gaps = 33/302 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 122
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 123 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 175
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAI-------------IRTEGMVSKNQERRSLASF 573
                + +SD+++ G+ L E+  G+  I              + EG  ++   R      
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 574 MLAAL-RNSPDSMSMSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPDMKQV 631
            L++   +S   M++  L DYI        P      +      +C+ ++P  R D+KQ+
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 632 VI 633
           ++
Sbjct: 296 MV 297

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 359 LGHGTYGSVYYGNIRNQ---------EVAIKRMTATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G+YG      IR +         E+    MT  + +  ++E+ +L ++ H N+V   
Sbjct: 14  IGTGSYGRC--QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 410 GYA--ATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
                 T   L+++ EY + G L S +    + R      +++RV   L  A  L+  H 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHR 129
Query: 467 HTKTHY--VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
            +   +  +HRD+K +N+ LD     K+ DFGLA+++    D      + VGT  Y++PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED---FAKEFVGTPYYMSPE 186
Query: 525 YLTDGLATAKSDVYAFGVVLFEI 547
            +       KSD+++ G +L+E+
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFG AKL+G +  +  A   
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 180 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 137/303 (45%), Gaps = 35/303 (11%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 184
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 185 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 237
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAI-------------IRTEGMVSKNQERRSLASF 573
                + +SD+++ G+ L E+  G+  I              + EG  ++   R      
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 297
Query: 574 MLAAL-RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAM--LAKQCVDEDPILRPDMKQ 630
            L++   +S   M++  L DYI        P   +F +       +C+ ++P  R D+KQ
Sbjct: 298 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLP-SAVFSLEFQDFVNKCLIKNPAERADLKQ 356
Query: 631 VVI 633
           +++
Sbjct: 357 LMV 359

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +LG G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFG AKL+G +  +  A   
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 187 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 351 EGFSDSSLLGHGTYGSVYY---------GNIRNQEVAIKRM---TATKTKEFMAEMKILC 398
           E F    +LG G YG V+          G I   +V  K M    A  T    AE  IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMRVQIA 454
           +V H  +V+LI    T  +L+LI EY   G L   L   +  G     T+  ++  + +A
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
           L         H H K   ++RD+K  NI+L+     K++DFGL K      DG  T T  
Sbjct: 134 LG--------HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHT-F 181
Query: 515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            GT  Y+APE L         D ++ G +++++++G
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +L  G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 70  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 180 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 26/217 (11%)
Query: 346 ILFATEGFSDSSLLGHGTYGSVYYG-NIRNQE-----VAIKRM----TATKTKEFMAEMK 395
           IL  TE F    +L  G +G+VY G  I   E     VAIK +    +    KE + E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR--GQTSLSWIMRVQI 453
           ++  V + ++  L+G   T   + LI +    G L  ++ + ++    Q  L+W +++  
Sbjct: 77  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG-KTSDGEATVT 512
               A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G +  +  A   
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           KV     ++A E +   + T +SDV+++GV ++E+++
Sbjct: 187 KV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 359 LGHGTYGSVYYGNI-----RNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G       +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G   T   + ++ E A  GSL   L   +++G   L  + R   A+  A G+ Y+   
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRY--AVQVAEGMGYLE-- 138
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG-----MVSKNQER--------RSLASF 573
               +  SD + FGV L+E+ + G+E  I   G      + K  ER        + + + 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 257
Query: 574 MLAALRNSP-DSMSMSSLKDYI 594
           M+    + P D  +  +L+D++
Sbjct: 258 MVQCWAHKPEDRPTFVALRDFL 279

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 25/255 (9%)
Query: 351 EGFSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSN 404
           E +     +G GTYG VY   N   +  A+K++   K  E      + E+ IL ++ HSN
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V+L     T+  L L++E+     L   L    +  +  L  +      L    G+ Y 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H+      +HRD+K  N+L++     KI+DFGLA+  G         T  V T  Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEVVTLWYRAPD 170
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
            L      + + D+++ G +  E+++G        G+   +Q  R    F +    NS +
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF---PGVSEADQLMR---IFRILGTPNSKN 224
Query: 584 SMSMSSLKDYIDPNM 598
             +++ L  Y DPN 
Sbjct: 225 WPNVTELPKY-DPNF 238

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 359 LGHGTYGSVYYGNI-----RNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G       +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G   T   + ++ E A  GSL   L   +++G   L  + R   A+  A G+ Y+   
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRY--AVQVAEGMGYLE-- 128
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG-----MVSKNQER--------RSLASF 573
               +  SD + FGV L+E+ + G+E  I   G      + K  ER        + + + 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 574 MLAALRNSP-DSMSMSSLKDYI 594
           M+    + P D  +  +L+D++
Sbjct: 248 MVQCWAHKPEDRPTFVALRDFL 269

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 359 LGHGTYGSVYYG-NIRN--QEVAIKRMTATKTKEFM--------AEMKILCKVHHSNLVE 407
           +G G YG V+   +++N  + VA+KR+     +E M        A ++ L    H N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 408 L-----IGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAARGL 461
           L     +     E +L L++E+  +  L ++L   P+    T     M  Q+     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL----RGL 133
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H H     VHRD+K  NIL+ S+ + K++DFGLA++       +  +T VV T  Y 
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS----FQMALTSVVVTLWYR 186
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L         D+++ G +  E+   K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 25/255 (9%)
Query: 351 EGFSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSN 404
           E +     +G GTYG VY   N   +  A+K++   K  E      + E+ IL ++ HSN
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V+L     T+  L L++E+     L   L    +  +  L  +      L    G+ Y 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H+      +HRD+K  N+L++     KI+DFGLA+  G         T  V T  Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEVVTLWYRAPD 170
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
            L      + + D+++ G +  E+++G        G+   +Q  R    F +    NS +
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGAPLF---PGVSEADQLMR---IFRILGTPNSKN 224
Query: 584 SMSMSSLKDYIDPNM 598
             +++ L  Y DPN 
Sbjct: 225 WPNVTELPKY-DPNF 238

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 359 LGHGTYGSVYYG-NIRN--QEVAIKRMTATKTKEFM--------AEMKILCKVHHSNLVE 407
           +G G YG V+   +++N  + VA+KR+     +E M        A ++ L    H N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 408 L-----IGYAATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAARGL 461
           L     +     E +L L++E+  +  L ++L   P+    T     M  Q+     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL----RGL 133
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H H     VHRD+K  NIL+ S+ + K++DFGLA++       +  +T VV T  Y 
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS----FQMALTSVVVTLWYR 186
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L         D+++ G +  E+   K
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           GF+    +       V+ G I  + + +K     + ++   E+ I   + H ++V   G+
Sbjct: 29  GFAKCFEISDADTKEVFAGKIVPKSLLLK---PHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               D +F++ E  ++ SL      +  L +P+ R      + +R QI L    G +Y+H
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIVL----GCQYLH 134
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
              +   +HRD+K  N+ L+     KI DFGLA  V    DGE   T + GT  Y+APE 
Sbjct: 135 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKT-LCGTPNYIAPEV 188
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           L+    + + DV++ G +++ ++ GK
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           GF+    +       V+ G I  + + +K     + ++   E+ I   + H ++V   G+
Sbjct: 33  GFAKCFEISDADTKEVFAGKIVPKSLLLK---PHQREKMSMEISIHRSLAHQHVVGFHGF 89
Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               D +F++ E  ++ SL      +  L +P+ R      + +R QI L    G +Y+H
Sbjct: 90  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIVL----GCQYLH 138
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
              +   +HRD+K  N+ L+     KI DFGLA  V    DGE   T + GT  Y+APE 
Sbjct: 139 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKT-LCGTPNYIAPEV 192
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           L+    + + DV++ G +++ ++ GK
Sbjct: 193 LSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           GF+    +       V+ G I  + + +K     + ++   E+ I   + H ++V   G+
Sbjct: 29  GFAKCFEISDADTKEVFAGKIVPKSLLLK---PHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               D +F++ E  ++ SL      +  L +P+ R      + +R QI L    G +Y+H
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIVL----GCQYLH 134
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
              +   +HRD+K  N+ L+     KI DFGLA  V    DGE   T + GT  Y+APE 
Sbjct: 135 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKT-LCGTPNYIAPEV 188
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           L+    + + DV++ G +++ ++ GK
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 34/262 (12%)
Query: 359 LGHGTYGSVYYGNI-----RNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G       +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G   T   + ++ E A  GSL   L   +++G   L  + R   A+  A G+ Y+   
Sbjct: 80  LYGVVLTP-PMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRY--AVQVAEGMGYLE-- 132
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 133 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG-----MVSKNQER--------RSLASF 573
               +  SD + FGV L+E+ + G+E  I   G      + K  ER        + + + 
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 251
Query: 574 MLAALRNSP-DSMSMSSLKDYI 594
           M+    + P D  +  +L+D++
Sbjct: 252 MVQCWAHKPEDRPTFVALRDFL 273

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 43/247 (17%)
Query: 338 PVVFTYDEIL-FATEGFSDSSLLGHGTYGSVY----YGNIRNQ---EVAIKRMTAT---- 385
           P    Y+E   F          LG G +G V     +G  +     +VA+K + +T    
Sbjct: 17  PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 76
Query: 386 KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL---------- 434
           + +  M+E+KI+  +  H N+V L+G       + +I EY   G L + L          
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGP 136
Query: 435 -----HDPQNRGQTS---LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS 486
                 DP+   +     L     +  +   A+G+ ++      + +HRD+ + N+LL +
Sbjct: 137 SLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTN 193
Query: 487 AFRAKISDFGLAKLVGKTSD----GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGV 542
              AKI DFGLA+ +   S+    G A +        ++APE + D + T +SDV+++G+
Sbjct: 194 GHVAKIGDFGLARDIMNDSNYIVKGNARL-----PVKWMAPESIFDCVYTVQSDVWSYGI 248
Query: 543 VLFEIIS 549
           +L+EI S
Sbjct: 249 LLWEIFS 255

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 25/255 (9%)
Query: 351 EGFSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSN 404
           E +     +G GTYG VY   N   +  A+K++   K  E      + E+ IL ++ HSN
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +V+L     T+  L L++E+     L   L    +  +  L  +      L    G+ Y 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H+      +HRD+K  N+L++     KI+DFGLA+  G         T  + T  Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWYRAPD 170
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
            L      + + D+++ G +  E+++G        G+   +Q  R    F +    NS +
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF---PGVSEADQLMR---IFRILGTPNSKN 224
Query: 584 SMSMSSLKDYIDPNM 598
             +++ L  Y DPN 
Sbjct: 225 WPNVTELPKY-DPNF 238

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 42/211 (19%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA+K     ++ ++  ++   E++I+  ++H N+V+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----GLEYIHEH 467
             TE  L+L+ EYA  G +  +L         +  W M+ + A    R     ++Y H+ 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYL--------VAHGW-MKEKEARAKFRQIVSAVQYCHQ- 124
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF----GYLAP 523
                VHRD+K+ N+LLD+    KI+DFG +         E T    + TF     Y AP
Sbjct: 125 --KFIVHRDLKAENLLLDADMNIKIADFGFS--------NEFTFGNKLDTFCGSPPYAAP 174
Query: 524 EYLT----DGLATAKSDVYAFGVVLFEIISG 550
           E       DG    + DV++ GV+L+ ++SG
Sbjct: 175 ELFQGKKYDG---PEVDVWSLGVILYTLVSG 202

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYA 412
           LG GTY +VY G   + +  VA+K +     +      + E+ +L  + H+N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
            TE  L L++EY  K  LK +L D  N        +   Q+     RGL Y H   +   
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL----RGLAYCH---RQKV 121
Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAK---LVGKTSDGEATVTKVVGTFGYLAPEYL--- 526
           +HRD+K  N+L++     K++DFGLA+   +  KT D E      V T  Y  P+ L   
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE------VVTLWYRPPDILLGS 175
Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
           TD   + + D++  G + +E+ +G+
Sbjct: 176 TD--YSTQIDMWGVGCIFYEMATGR 198

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 351 EGFSDSSLLGHGTYGSVYY---------GNIRNQEVAIKRM---TATKTKEFMAEMKILC 398
           E F    +LG G YG V+          G I   +V  K M    A  T    AE  IL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIMRVQIA 454
           +V H  +V+LI    T  +L+LI EY   G L   L   +  G     T+  ++  + +A
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMA 133
Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
           L         H H K   ++RD+K  NI+L+     K++DFGL     K S  + TVT  
Sbjct: 134 LG--------HLHQKG-IIYRDLKPENIMLNHQGHVKLTDFGLC----KESIHDGTVTHX 180
Query: 515 V-GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             GT  Y+APE L         D ++ G +++++++G
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 34/207 (16%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA+K     ++ ++  ++   E++I+  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             TE  L+L+ EYA  G +  +L       +       R  ++      ++Y H+     
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQ---KF 133
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF----GYLAPEYLT 527
            VHRD+K+ N+LLD+    KI+DFG +         E T    + TF     Y APE   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS--------NEFTFGNKLDTFCGSPPYAAPELFQ 185
Query: 528 ----DGLATAKSDVYAFGVVLFEIISG 550
               DG    + DV++ GV+L+ ++SG
Sbjct: 186 GKKYDG---PEVDVWSLGVILYTLVSG 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 141
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 142 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 194
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
                + +SD+++ G+ L E+  G+  I    G                        SM+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSG------------------------SMA 230
Query: 587 MSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPDMKQVVI 633
           +  L DYI        P      +      +C+ ++P  R D+KQ+++
Sbjct: 231 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 278

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 34/207 (16%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA+K     ++ ++  ++   E++I+  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             TE  L+L+ EYA  G +  +L       +       R  ++      ++Y H+     
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQ---KF 133
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF----GYLAPEYLT 527
            VHRD+K+ N+LLD+    KI+DFG +         E T    + TF     Y APE   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS--------NEFTFGNKLDTFCGSPPYAAPELFQ 185
Query: 528 ----DGLATAKSDVYAFGVVLFEIISG 550
               DG    + DV++ GV+L+ ++SG
Sbjct: 186 GKKYDG---PEVDVWSLGVILYTLVSG 209

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           F  + F     LG G +G+VY    +  +  +A+K +  ++ +      +   E++I   
Sbjct: 12  FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 71
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H N++ +  Y      ++L+ E+A +G L   L       +   +  M      + A 
Sbjct: 72  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-----ELAD 126
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            L Y HE      +HRDIK  N+L+      KI+DFG +               + GT  
Sbjct: 127 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLD 178
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           YL PE +       K D++  GV+ +E + G
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 359 LGHGTYGSVYYGNIRNQ--EVAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYA 412
           LG G +G V+    R+   E  IK +   +++    +  AE+++L  + H N++++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
                ++++ E  + G L   +   Q RG+ +LS     ++       L Y H     H 
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 473 VHRDIKSSNILL-DSAFRA--KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
           VH+D+K  NIL  D++  +  KI DFGLA+L    SD  +  T   GT  Y+APE     
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHS--TNAAGTALYMAPEVFKRD 201
Query: 530 LATAKSDVYAFGVVLFEIISG 550
           + T K D+++ GVV++ +++G
Sbjct: 202 V-TFKCDIWSAGVVMYFLLTG 221

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 359 LGHGTYGSVYYGNIRNQ---------EVAIKRMTATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G+YG      IR +         E+    MT  + +  ++E+ +L ++ H N+V   
Sbjct: 14  IGTGSYGRC--QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 410 GYA--ATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
                 T   L+++ EY + G L S +    + R      +++RV   L  A  L+  H 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHR 129
Query: 467 HTKTHY--VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
            +   +  +HRD+K +N+ LD     K+ DFGLA+++   +    T    VGT  Y++PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT---FVGTPYYMSPE 186
Query: 525 YLTDGLATAKSDVYAFGVVLFEI 547
            +       KSD+++ G +L+E+
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 98
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 157 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 209
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 210 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 87
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 146 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 198
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 199 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 359 LGHGTYGSVYYGNIRNQEV-AIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G VY    +   V A  ++  TK++E    +M E+ IL    H N+V+L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 414 TEDELFLIYEYAQKGSLKS---HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
            E+ L+++ E+   G++ +    L  P    Q  +      +  LDA   L Y+H++   
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV----CKQTLDA---LNYLHDN--- 154
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---- 526
             +HRD+K+ NIL       K++DFG++    K +         +GT  ++APE +    
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 527 -TDGLATAKSDVYAFGVVLFEI 547
             D     K+DV++ G+ L E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEM 233

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 80
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 139 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 191
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 192 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 221

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V     R   + + R      +      + + E+++L + +   +V
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L + +   +  L      ++++   RGL Y+ E
Sbjct: 78  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE 132
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y+APE L
Sbjct: 133 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMAPERL 185
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAI 554
                + +SD+++ G+ L E+  G+  I
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 359 LGHGTYGSVYYGNIRNQEV-AIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G VY    +   V A  ++  TK++E    +M E+ IL    H N+V+L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 414 TEDELFLIYEYAQKGSLKS---HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
            E+ L+++ E+   G++ +    L  P    Q  +      +  LDA   L Y+H++   
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV----CKQTLDA---LNYLHDNK-- 155
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---- 526
             +HRD+K+ NIL       K++DFG++    K +         +GT  ++APE +    
Sbjct: 156 -IIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 527 -TDGLATAKSDVYAFGVVLFEI 547
             D     K+DV++ G+ L E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEM 233

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 190
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 191 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 22/210 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 172 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 224
Query: 523 PEYLTDGLA-TAKSDVYAFGVVLFEIISGK 551
           PE +      T+  DV++ G VL E++ G+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 359 LGHGTYGSVYYGNIRNQEV-AIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G VY    +   V A  ++  TK++E    +M E+ IL    H N+V+L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 414 TEDELFLIYEYAQKGSLKS---HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
            E+ L+++ E+   G++ +    L  P    Q  +      +  LDA   L Y+H++   
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV----CKQTLDA---LNYLHDNK-- 155
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL---- 526
             +HRD+K+ NIL       K++DFG++    K +         +GT  ++APE +    
Sbjct: 156 -IIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 527 -TDGLATAKSDVYAFGVVLFEI 547
             D     K+DV++ G+ L E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEM 233

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 91
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 202
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 203 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 190
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 191 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 91
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 202
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 203 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 232

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 19/170 (11%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYA--ATEDELFLIYEYAQKGS-LKSHLHDPQNRGQTS 444
           ++   E+ IL K+ H N+V+L+       ED L++++E   +G  ++     P +  Q  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 445 LSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT 504
             +        D  +G+EY+H       +HRDIK SN+L+      KI+DFG++    K 
Sbjct: 141 FYF-------QDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KG 189
Query: 505 SDGEATVTKVVGTFGYLAPEYL--TDGLATAKS-DVYAFGVVLFEIISGK 551
           SD  A ++  VGT  ++APE L  T  + + K+ DV+A GV L+  + G+
Sbjct: 190 SD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTK------EFMAEMKILCK 399
           F  + F     LG G +G+VY    +  +  +A+K +  ++ +      +   E++I   
Sbjct: 11  FTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H N++ +  Y      ++L+ E+A +G L   L       +   +  M      + A 
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-----ELAD 125
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            L Y HE      +HRDIK  N+L+      KI+DFG +               + GT  
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-----VHAPSLRRRXMCGTLD 177
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           YL PE +       K D++  GV+ +E + G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 133/302 (44%), Gaps = 33/302 (10%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 149
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A     VGT  Y++PE L
Sbjct: 150 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMA--NSFVGTRSYMSPERL 202
Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAI-------------IRTEGMVSKNQERRSLASF 573
                + +SD+++ G+ L E+  G+  I              + EG  ++   R      
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 574 MLAAL-RNSPDSMSMSSLKDYIDPNMMDLYPHDCL-FKMAMLAKQCVDEDPILRPDMKQV 631
            L     +S   M++  L DYI        P      +      +C+ ++P  R D+KQ+
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 632 VI 633
           ++
Sbjct: 323 MV 324

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 83
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 142 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 194
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 195 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 224

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           +H  LV L     TE  LF + EY   G L  H+   Q +     +     +I+L     
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL----A 133
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L Y+HE      ++RD+K  N+LLDS    K++D+G+ K   +  D   T +   GT  Y
Sbjct: 134 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNY 187
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEA--IIRTEGMVSKNQERRSLASFMLAAL 578
           +APE L         D +A GV++FE+++G+    I+ +     +N E       +   +
Sbjct: 188 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 247
Query: 579 RNSPDSMSM---SSLKDYIDPN 597
           R  P SMS+   S LK +++ +
Sbjct: 248 R-IPRSMSVKAASVLKSFLNKD 268

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 92
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 151 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 203
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 204 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 358 LLGHGTYGSVYYGNIRN--QEVAIKRMTATKTKEF--------MAEMKILCKVHHSNLVE 407
            LG G + +VY    +N  Q VAIK++      E         + E+K+L ++ H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L+     +  + L++++ +   L+  + D  N    + S I    +     +GLEY+H+H
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLM--TLQGLEYLHQH 131
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                +HRD+K +N+LLD     K++DFGLAK  G  S   A   +VV T  Y APE L 
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYXHQVV-TRWYRAPELLF 185
Query: 528 DG-LATAKSDVYAFGVVLFEII 548
              +     D++A G +L E++
Sbjct: 186 GARMYGVGVDMWAVGCILAELL 207

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 115
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 174 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 226
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 227 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 256

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 34/207 (16%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA++     ++ ++  ++   E++I+  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             TE  L+L+ EYA  G +  +L       +       R  ++      ++Y H+     
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQ---KF 133
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF----GYLAPEYLT 527
            VHRD+K+ N+LLD+    KI+DFG +         E T    + TF     Y APE   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFS--------NEFTFGNKLDTFCGSPPYAAPELFQ 185
Query: 528 ----DGLATAKSDVYAFGVVLFEIISG 550
               DG    + DV++ GV+L+ ++SG
Sbjct: 186 GKKYDG---PEVDVWSLGVILYTLVSG 209

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 107
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 166 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 218
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 219 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 172 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 224
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 225 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 254

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           GF+    +       V+ G I  + + +K     + ++   E+ I   + H ++V   G+
Sbjct: 53  GFAKCFEISDADTKEVFAGKIVPKSLLLK---PHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               D +F++ E  ++ SL      +  L +P+ R      + +R QI L    G +Y+H
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIVL----GCQYLH 158
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
              +   +HRD+K  N+ L+     KI DFGLA  V    DGE     + GT  Y+APE 
Sbjct: 159 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-LCGTPNYIAPEV 212
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           L+    + + DV++ G +++ ++ GK
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           GF+    +       V+ G I  + + +K     + ++   E+ I   + H ++V   G+
Sbjct: 51  GFAKCFEISDADTKEVFAGKIVPKSLLLK---PHQREKMSMEISIHRSLAHQHVVGFHGF 107
Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               D +F++ E  ++ SL      +  L +P+ R      + +R QI L    G +Y+H
Sbjct: 108 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIVL----GCQYLH 156
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
              +   +HRD+K  N+ L+     KI DFGLA  V    DGE     + GT  Y+APE 
Sbjct: 157 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-LCGTPNYIAPEV 210
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           L+    + + DV++ G +++ ++ GK
Sbjct: 211 LSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 190
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 191 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 22/196 (11%)
Query: 359 LGHGTYGSVY--YGNIRNQEVAIK----RMTATKTKEFMAEMKI--LCKVHHSNLVELIG 410
           LG G++G V   Y     Q+VA+K    ++ A    +   E +I  L  + H ++++L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              ++DE+ ++ EYA        +   +   Q +  +  ++  A+      EY H H   
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV------EYCHRHK-- 133
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD     KI+DFGL+ ++   +DG    T   G+  Y APE ++  L
Sbjct: 134 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTS-CGSPNYAAPEVISGKL 188
Query: 531 -ATAKSDVYAFGVVLF 545
            A  + DV++ GV+L+
Sbjct: 189 YAGPEVDVWSCGVILY 204

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 359 LGHGTYGSVYYGNIRNQ---------EVAIKRMTATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G+YG      IR +         E+    MT  + +  ++E+ +L ++ H N+V   
Sbjct: 14  IGTGSYGRC--QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 410 GYA--ATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
                 T   L+++ EY + G L S +    + R      +++RV   L  A  L+  H 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHR 129
Query: 467 HTKTHY--VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
            +   +  +HRD+K +N+ LD     K+ DFGLA+++   +   +     VGT  Y++PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAFVGTPYYMSPE 186
Query: 525 YLTDGLATAKSDVYAFGVVLFEI 547
            +       KSD+++ G +L+E+
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYY--GNIRNQEVAIKRMTATKTKE------ 389
           P  F        ++ +    +LG G++G V      I  QE A+K ++  + K+      
Sbjct: 13  PGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
            + E+++L ++ H N+ +L  +   +   +L+ E    G L   +   +   +   + I+
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSD 506
           R  ++     G+ Y H   K   VHRD+K  N+LL+S  +    +I DFGL+       +
Sbjct: 133 RQVLS-----GITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF----E 180
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                   +GT  Y+APE L  G    K DV++ GV+L+ ++SG
Sbjct: 181 ASKKXKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 22/196 (11%)
Query: 359 LGHGTYGSVY--YGNIRNQEVAIK----RMTATKTKEFMAEMKI--LCKVHHSNLVELIG 410
           LG G++G V   Y     Q+VA+K    ++ A    +   E +I  L  + H ++++L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              ++DE+ ++ EYA        +   +   Q +  +  ++  A+      EY H H   
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV------EYCHRHK-- 127
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD     KI+DFGL+ ++   +DG    T   G+  Y APE ++  L
Sbjct: 128 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTS-CGSPNYAAPEVISGKL 182
Query: 531 -ATAKSDVYAFGVVLF 545
            A  + DV++ GV+L+
Sbjct: 183 YAGPEVDVWSCGVILY 198

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 117
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 176 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 228
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 229 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 258

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 23/223 (10%)
Query: 338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYY--GNIRNQEVAIK--RMTATKTK---EF 390
           P +F   +    +E +     LG G YG V      + + E AIK  R T+  T    + 
Sbjct: 24  PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL 83
Query: 391 MAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR 450
           + E+ +L  + H N+++L  +   +   +L+ E  + G L   +       +   + I++
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDG 507
             ++     G+ Y+H+H   + VHRD+K  N+LL+S  +    KI DFGL+ +     + 
Sbjct: 144 QVLS-----GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF----EN 191
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           +  + + +GT  Y+APE L       K DV++ GV+LF +++G
Sbjct: 192 QKKMKERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAG 233

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 22/196 (11%)
Query: 359 LGHGTYGSVY--YGNIRNQEVAIK----RMTATKTKEFMAEMKI--LCKVHHSNLVELIG 410
           LG G++G V   Y     Q+VA+K    ++ A    +   E +I  L  + H ++++L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              ++DE+ ++ EYA        +   +   Q +  +  ++  A+      EY H H   
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV------EYCHRHK-- 123
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD     KI+DFGL+ ++   +DG    T   G+  Y APE ++  L
Sbjct: 124 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTS-CGSPNYAAPEVISGKL 178
Query: 531 -ATAKSDVYAFGVVLF 545
            A  + DV++ GV+L+
Sbjct: 179 YAGPEVDVWSCGVILY 194

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 24/211 (11%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL-- 408
           ++D+ ++G+G++G VY   +    + VAIK++   K  +   E++I+ K+ H N+V L  
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-NRELQIMRKLDHCNIVRLRY 80
Query: 409 IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
             Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L YI
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           H        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y AP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRAP 191
Query: 524 EYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           E +   TD   T+  DV++ G VL E++ G+
Sbjct: 192 ELIFGATD--YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 84
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 143 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 195
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 196 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 225

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL-- 408
           ++D+ ++G+G++G VY   +    + VAIK++   K  +   E++I+ K+ H N+V L  
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-NRELQIMRKLDHCNIVRLRY 80
Query: 409 IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
             Y++ E  DE++L  + +Y      +   H   +R + +L  I          R L YI
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           H        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y AP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRAP 191
Query: 524 EYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           E +   TD   T+  DV++ G VL E++ G+
Sbjct: 192 ELIFGATD--YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 24/211 (11%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL-- 408
           ++D+ ++G+G++G VY   +    + VAIK++   K  +   E++I+ K+ H N+V L  
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-NRELQIMRKLDHCNIVRLRY 80
Query: 409 IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
             Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L YI
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           H        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y AP
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRAP 191
Query: 524 EYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           E +   TD   T+  DV++ G VL E++ G+
Sbjct: 192 ELIFGATD--YTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           +H  LV L     TE  LF + EY   G L  H+   Q +     +     +I+L     
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL----A 165
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L Y+HE      ++RD+K  N+LLDS    K++D+G+ K   +  D   T +   GT  Y
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNY 219
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +APE L         D +A GV++FE+++G+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGYA 412
           LG G  G V      +  + VA+K +   +     +    E+ I   ++H N+V+  G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 413 ATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
              +  +L  EY   G L   +      P+   Q     +M          G+ Y+H   
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------GVVYLHGIG 124
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            TH   RDIK  N+LLD     KISDFGLA  V + ++ E  + K+ GT  Y+APE L  
Sbjct: 125 ITH---RDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 529 GLATAKS-DVYAFGVVLFEIISGK 551
               A+  DV++ G+VL  +++G+
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 22/196 (11%)
Query: 359 LGHGTYGSVY--YGNIRNQEVAIK----RMTATKTKEFMAEMKI--LCKVHHSNLVELIG 410
           LG G++G V   Y     Q+VA+K    ++ A    +   E +I  L  + H ++++L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              ++DE+ ++ EYA        +   +   Q +  +  ++  A+      EY H H   
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAV------EYCHRHK-- 132
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD     KI+DFGL+ ++   +DG    T   G+  Y APE ++  L
Sbjct: 133 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTS-CGSPNYAAPEVISGKL 187
Query: 531 -ATAKSDVYAFGVVLF 545
            A  + DV++ GV+L+
Sbjct: 188 YAGPEVDVWSCGVILY 203

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 158
Query: 409 -IGYAATE--DELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E  DE++L  + +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRY-YRA 269
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 270 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 299

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           +H  LV L     TE  LF + EY   G L  H+   Q +     +     +I+L     
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL----A 122
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L Y+HE      ++RD+K  N+LLDS    K++D+G+ K   +  D   T +   GT  Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNY 176
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +APE L         D +A GV++FE+++G+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           +H  LV L     TE  LF + EY   G L  H+   Q +     +     +I+L     
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL----A 118
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L Y+HE      ++RD+K  N+LLDS    K++D+G+ K   +  D   T +   GT  Y
Sbjct: 119 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNY 172
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +APE L         D +A GV++FE+++G+
Sbjct: 173 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA+K     ++ ++  ++   E++I+  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             TE  L+L+ EYA  G +  +L       +       R  ++      ++Y H+     
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQ---KF 133
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAK--LVGKTSDGEATVTKVVGTFGYLAPEYLT-- 527
            VHRD+K+ N+LLD+    KI+DFG +     G   D         G   Y APE     
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA------FCGAPPYAAPELFQGK 187
Query: 528 --DGLATAKSDVYAFGVVLFEIISG 550
             DG    + DV++ GV+L+ ++SG
Sbjct: 188 KYDG---PEVDVWSLGVILYTLVSG 209

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFM-AEMKILCKVHHSNLVEL- 408
           ++D+ ++G+G++G VY   +    + VAIK++   + K F   E++I+ K+ H N+V L 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 409 -IGYAATEDE----LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
              Y++ E +    L L+ +Y  +   +   H   +R + +L  I          R L Y
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           IH        HRDIK  N+LLD      K+ DFG AK + +   GE  V+ +   + Y A
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRY-YRA 190
Query: 523 PEYL---TDGLATAKSDVYAFGVVLFEIISGK 551
           PE +   TD   T+  DV++ G VL E++ G+
Sbjct: 191 PELIFGATD--YTSSIDVWSAGCVLAELLLGQ 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           GF+    +       V+ G I  + + +K     + ++   E+ I   + H ++V   G+
Sbjct: 27  GFAKCFEISDADTKEVFAGKIVPKSLLLK---PHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               D +F++ E  ++ SL      +  L +P+ R      + +R QI L    G +Y+H
Sbjct: 84  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIVL----GCQYLH 132
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
              +   +HRD+K  N+ L+     KI DFGLA  V    DGE     + GT  Y+APE 
Sbjct: 133 ---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-LCGTPNYIAPEV 186
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           L+    + + DV++ G +++ ++ GK
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 30/205 (14%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA++     ++ ++  ++   E++I+  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             TE  L+L+ EYA  G +  +L       +       R  ++      ++Y H+     
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQYCHQ---KF 133
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAK--LVGKTSDGEATVTKVVGTFGYLAPEYLT-- 527
            VHRD+K+ N+LLD+    KI+DFG +     G   D      +  G+  Y APE     
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------EFCGSPPYAAPELFQGK 187
Query: 528 --DGLATAKSDVYAFGVVLFEIISG 550
             DG    + DV++ GV+L+ ++SG
Sbjct: 188 KYDG---PEVDVWSLGVILYTLVSG 209

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 352 GFSDSSLLGHGTYGSVYYGN-IRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIG 410
            +++  ++G+G++G V+    + + EVAIK++   K  +   E++I+  V H N+V+L  
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-NRELQIMRIVKHPNVVDLKA 99
Query: 411 Y----AATEDELFL--IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +       +DE+FL  + EY  +   ++  H  + +    +  I      L   R L YI
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL--LRSLAYI 157
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           H        HRDIK  N+LLD      K+ DFG AK++     GE  V+ +   + Y AP
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVSXICSRY-YRAP 210
Query: 524 EYLTDGLA-TAKSDVYAFGVVLFEIISGK 551
           E +      T   D+++ G V+ E++ G+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRN-----------QEVAIKRMTATKTKEFMAEMKI 396
              + F    +LG G++G V    ++            ++V ++      T   M E +I
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT---MTEKRI 76
Query: 397 LCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           L    +H  L +L     T D LF + E+   G L  H+   +   +    +      A 
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-----AA 131
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
           +    L ++H+      ++RD+K  N+LLD     K++DFG+ K      +G  T T   
Sbjct: 132 EIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTAT-FC 185
Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           GT  Y+APE L + L     D +A GV+L+E++ G
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 358 LLGHGTYGSVYYGNIRNQE--VAIKRMTATKTKE------FMAEMKILCKVHHSN-LVEL 408
           +LG G++G V   + +  E   AIK +      +       M E ++L  +     L +L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                T D L+ + EY   G L  H+   Q  G+        V  A + + GL ++H   
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGK--FKEPQAVFYAAEISIGLFFLH--- 137
Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
           K   ++RD+K  N++LDS    KI+DFG+ K      DG  T  +  GT  Y+APE +  
Sbjct: 138 KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDG-VTTREFCGTPDYIAPEIIAY 194
Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
                  D +A+GV+L+E+++G+
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLV 406
           F   S LG G  G V+  + +   + + R      +      + + E+++L + +   +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G   ++ E+ +  E+   GSL   L   +  G+     + +V IA+   +GL Y+ E
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLRE 125
Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             K   +HRD+K SNIL++S    K+ DFG++   G+  D  A   + VGT  Y++PE L
Sbjct: 126 KHKI--MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDEMA--NEFVGTRSYMSPERL 178
Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
                + +SD+++ G+ L E+  G+
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 54/295 (18%)
Query: 352 GFSDSSLLGHGTYGSVYYGN--IRNQEVAIKR------MTATKTKEFMAEMKILCKVHHS 403
            F     +G G +  VY     +    VA+K+      M A    + + E+ +L +++H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLK---SHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           N+++       ++EL ++ E A  G L     H    +        W   VQ+       
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SA 148
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           LE++H       +HRDIK +N+ + +    K+ D GL +     S        +VGT  Y
Sbjct: 149 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYY 202
Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           ++PE + +     KSD+++ G +L+E                            +AAL+ 
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYE----------------------------MAALQ- 233
Query: 581 SP---DSMSMSSLKDYIDPNMMDLYPHDCLF-KMAMLAKQCVDEDPILRPDMKQV 631
           SP   D M++ SL   I+       P D    ++  L   C++ DP  RPD+  V
Sbjct: 234 SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 326 KALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIK----- 380
           KA  T +F  E  + F   EI           L+G G +G VY+G     EVAI+     
Sbjct: 17  KASQTSIFLQEWDIPFEQLEI---------GELIGKGRFGQVYHGRWHG-EVAIRLIDIE 66
Query: 381 RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR 440
           R    + K F  E+    +  H N+V  +G   +   L +I    +  +L S + D    
Sbjct: 67  RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---- 122
Query: 441 GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL 500
            +  L      QIA +  +G+ Y+H       +H+D+KS N+  D+  +  I+DFGL  +
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSI 178
Query: 501 VGKTSDG--EATVTKVVGTFGYLAPEYL--------TDGLATAK-SDVYAFGVVLFEI 547
            G    G  E  +    G   +LAPE +         D L  +K SDV+A G + +E+
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 38/268 (14%)
Query: 351 EGFSDSSLLGHGTYGSVYY---------GNIRNQEVAIKRMT----ATKTKEFMAEMKIL 397
           E F    +LG G YG V+          G +   +V +K+ T    A  T+    E ++L
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV-LKKATIVQKAKTTEHTRTERQVL 112
Query: 398 CKVHHSNLVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL- 455
             +  S  +  + YA  TE +L LI +Y   G L +HL   +   +        VQI + 
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE------VQIYVG 166
Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
           +    LE++H   K   ++RDIK  NILLDS     ++DFGL+K     +D         
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--VADETERAYDFC 221
Query: 516 GTFGYLAPEYLTDGLATAKS--DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF 573
           GT  Y+AP+ +  G +      D ++ GV+++E+++G           + + E+ S A  
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-------TVDGEKNSQAEI 274
Query: 574 MLAALRNSPD-SMSMSSL-KDYIDPNMM 599
               L++ P     MS+L KD I   +M
Sbjct: 275 SRRILKSEPPYPQEMSALAKDLIQRLLM 302

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 372 IRNQEVAIKRMTATKTKEFMA----EMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQ 426
           ++  EV  +R++  + +E       E  IL +V  H +++ LI    +   +FL+++  +
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS 486
           KG L  +L +     +     IMR  +       + ++H     + VHRD+K  NILLD 
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLE-----AVSFLH---ANNIVHRDLKPENILLDD 235
Query: 487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA------KSDVYAF 540
             + ++SDFG +        GE  + ++ GT GYLAPE L   +         + D++A 
Sbjct: 236 NMQIRLSDFGFS---CHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 541 GVVLFEIISG 550
           GV+LF +++G
Sbjct: 292 GVILFTLLAG 301

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 353 FSDSSLLGHGTYGSVY------YGNIRNQEVAIKRMTATKTKEFMA--EMKILCKVHHSN 404
           FS   ++G G +G VY       G +   +   K+    K  E +A  E  +L  V   +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 405 --LVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +  + YA  T D+L  I +    G L  HL       +  + +      A +   GL
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY-----AAEIILGL 305
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H       V+RD+K +NILLD     +ISD GLA    K     +     VGT GY+
Sbjct: 306 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 357
Query: 522 APEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           APE L  G+A  + +D ++ G +LF+++ G     +      K +++  +    L     
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-----HKTKDKHEIDRMTLTMAVE 412
Query: 581 SPDSMS 586
            PDS S
Sbjct: 413 LPDSFS 418

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 30/246 (12%)
Query: 353 FSDSSLLGHGTYGSVY------YGNIRNQEVAIKRMTATKTKEFMA--EMKILCKVHHSN 404
           FS   ++G G +G VY       G +   +   K+    K  E +A  E  +L  V   +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 405 --LVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +  + YA  T D+L  I +    G L  HL       +  + +      A +   GL
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY-----AAEIILGL 305
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H       V+RD+K +NILLD     +ISD GLA    K     +     VGT GY+
Sbjct: 306 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 357
Query: 522 APEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           APE L  G+A  + +D ++ G +LF+++ G     +      K +++  +    L     
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-----HKTKDKHEIDRMTLTMAVE 412
Query: 581 SPDSMS 586
            PDS S
Sbjct: 413 LPDSFS 418

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGN--------------IRNQEVAIKRMTATKTKEFMAE 393
            AT  +   + +G G YG+VY                 + N       +  +  +E +A 
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE-VAL 64
Query: 394 MKILCKVHHSNLVELIGYAAT-----EDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLS 446
           ++ L    H N+V L+   AT     E ++ L++E+  +  L+++L    P      ++ 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 447 WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
            +MR  +     RGL+++H +     VHRD+K  NIL+ S    K++DFGLA++      
Sbjct: 124 DLMRQFL-----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--- 172
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            +  +T VV T  Y APE L         D+++ G +  E+   K
Sbjct: 173 -QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 38/209 (18%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVA+K     ++ ++  ++   E++I   ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 412 AATEDELFLIYEYAQKGS----LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
             TE  L+L+ EYA  G     L +H    +   +     I+           ++Y H+ 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS---------AVQYCHQ- 131
Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK--LVGKTSDGEATVTKVVGTFGYLAPEY 525
                VHRD+K+ N+LLD+    KI+DFG +     G   D         G   Y APE 
Sbjct: 132 --KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA------FCGAPPYAAPEL 183
Query: 526 LT----DGLATAKSDVYAFGVVLFEIISG 550
                 DG    + DV++ GV+L+ ++SG
Sbjct: 184 FQGKKYDG---PEVDVWSLGVILYTLVSG 209

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 23/236 (9%)
Query: 345 EILFATEGFSDSSLLGHGTYGSVYYGNIRNQEV----AIKRMTATK-TKEFMAEMKILCK 399
           E LF  EG      +G GTYG VY    ++ +     A+K++  T  +     E+ +L +
Sbjct: 19  EDLFEYEGCK----VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRE 74
Query: 400 VHHSNLVEL--IGYAATEDELFLIYEYAQKG---SLKSHLHDPQNRGQTSLSWIMRVQIA 454
           + H N++ L  +  +  + +++L+++YA+      +K H     N+    L   M   + 
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFGLAKLVGKTSDGEAT 510
                G+ Y+H +     +HRD+K +NIL+        R KI+D G A+L        A 
Sbjct: 135 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 511 VTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGKEAI-IRTEGMVSKN 564
           +  VV TF Y APE L       K+ D++A G +  E+++ +     R E + + N
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMTATKTKEFMAEMKI------LCKVHHSNLVELIG 410
           LG G++G V         Q+VA+K ++    K+    M++      L  + H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              T  ++ ++ EYA  G L  ++ + +   +       +  I       +EY H H   
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYCHRHK-- 128
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             VHRD+K  N+LLD     KI+DFGL+ ++   +DG    T   G+  Y APE +   L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTS-CGSPNYAAPEVINGKL 183
Query: 531 -ATAKSDVYAFGVVLFEIISGK 551
            A  + DV++ G+VL+ ++ G+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 37/287 (12%)
Query: 353 FSDSSLLGHGTYGSVY------YGNIRNQEVAIKRMTATKTKEFMA--EMKILCKVHHSN 404
           FS   ++G G +G VY       G +   +   K+    K  E +A  E  +L  V   +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 405 --LVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +  + YA  T D+L  I +    G L  HL       +  + +      A +   GL
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY-----AAEIILGL 305
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H       V+RD+K +NILLD     +ISD GLA    K     +     VGT GY+
Sbjct: 306 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 357
Query: 522 APEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           APE L  G+A  + +D ++ G +LF+++ G     +      K +++  +    L     
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-----HKTKDKHEIDRMTLTMAVE 412
Query: 581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK--QCVDEDPILR 625
            PDS S   L+  ++     L   D   ++  L +  Q V E P  R
Sbjct: 413 LPDSFS-PELRSLLE----GLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 37/287 (12%)
Query: 353 FSDSSLLGHGTYGSVY------YGNIRNQEVAIKRMTATKTKEFMA--EMKILCKVHHSN 404
           FS   ++G G +G VY       G +   +   K+    K  E +A  E  +L  V   +
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 405 --LVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +  + YA  T D+L  I +    G L  HL       +  + +      A +   GL
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY-----AAEIILGL 304
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H       V+RD+K +NILLD     +ISD GLA    K     +     VGT GY+
Sbjct: 305 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 356
Query: 522 APEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           APE L  G+A  + +D ++ G +LF+++ G     +      K +++  +    L     
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-----HKTKDKHEIDRMTLTMAVE 411
Query: 581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAK--QCVDEDPILR 625
            PDS S   L+  ++     L   D   ++  L +  Q V E P  R
Sbjct: 412 LPDSFS-PELRSLLE----GLLQRDVNRRLGCLGRGAQEVKESPFFR 453

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
            F +  L+ H +   VY   + ++   IKR   + +  F  E  I+   +   +V+L  Y
Sbjct: 81  AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLF-Y 136
Query: 412 AATEDE-LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           A  +D  L+++ EY   G L + + +     + +  +   V +ALDA   + +IH     
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH----- 191
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT--- 527
               RD+K  N+LLD +   K++DFG    + K  +G       VGT  Y++PE L    
Sbjct: 192 ----RDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 528 -DGLATAKSDVYAFGVVLFEIISG 550
            DG    + D ++ GV L+E++ G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
            F +  L+ H +   VY   + ++   IKR   + +  F  E  I+   +   +V+L  Y
Sbjct: 86  AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLF-Y 141
Query: 412 AATEDE-LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           A  +D  L+++ EY   G L + + +     + +  +   V +ALDA   + +IH     
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH----- 196
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT--- 527
               RD+K  N+LLD +   K++DFG    + K  +G       VGT  Y++PE L    
Sbjct: 197 ----RDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 528 -DGLATAKSDVYAFGVVLFEIISG 550
            DG    + D ++ GV L+E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTKEFM--------AEMKIL 397
            AT  +   + +G G YG+VY     +    VA+K +     +E +        A ++ L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 398 CKVHHSNLVELIGYAAT-----EDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMR 450
               H N+V L+   AT     E ++ L++E+  +  L+++L    P      ++  +MR
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT 510
             +     RGL+++H +     VHRD+K  NIL+ S    K++DFGLA++       +  
Sbjct: 120 QFL-----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY----QMA 167
Query: 511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +  VV T  Y APE L         D+++ G +  E+   K
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
            F +  L+ H +   VY   + ++   IKR   + +  F  E  I+   +   +V+L  Y
Sbjct: 86  AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLF-Y 141
Query: 412 AATEDE-LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           A  +D  L+++ EY   G L + + +     + +  +   V +ALDA   + +IH     
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH----- 196
Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT--- 527
               RD+K  N+LLD +   K++DFG    + K  +G       VGT  Y++PE L    
Sbjct: 197 ----RDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 528 -DGLATAKSDVYAFGVVLFEIISG 550
            DG    + D ++ GV L+E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 348 FATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTAT----KTKEFMAEMKILCKVH 401
           F  E   D   +G G YGSV         Q +A+KR+ +T    + K+ + ++ ++ +  
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 402 HSN-LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
               +V+  G    E + ++  E       K + +            I+  +I L   + 
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-KITLATVKA 137
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L ++ E+ K   +HRDIK SNILLD +   K+ DFG++   G+  D  A  T+  G   Y
Sbjct: 138 LNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAK-TRDAGCRPY 191
Query: 521 LAPEYLTDGLAT----AKSDVYAFGVVLFEIISGK 551
           +APE +    +      +SDV++ G+ L+E+ +G+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G+G YG V     R   Q+VAIK++       T  K  + E+KIL    H N++     
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNII----- 117
Query: 412 AATEDELFLIYEYAQKGS-------LKSHLHDPQNRGQT-SLSWIMRVQIALDAARGLEY 463
            A +D L     Y +  S       ++S LH   +  Q  +L  +      L   RGL+Y
Sbjct: 118 -AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL--LRGLKY 174
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGYLA 522
           +H       +HRD+K SN+L++     KI DFG+A+ L    ++ +  +T+ V T  Y A
Sbjct: 175 MH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 523 PEY-LTDGLATAKSDVYAFGVVLFEIISGKE 552
           PE  L+    T   D+++ G +  E+++ ++
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATK----------------TKEFMAEMKILCKV 400
           LG G YG V     +N   E AIK +  ++                 +E   E+ +L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H N+++L      +   +L+ E+ + G L   + +     +   + IM+  ++     G
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS-----G 158
Query: 461 LEYIHEHTKTHYVHRDIKSSNILLD---SAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           + Y+H+H   + VHRDIK  NILL+   S    KI DFGL+    K    +  +   +GT
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK----DYKLRDRLGT 211
Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             Y+APE L       K DV++ GV+++ ++ G
Sbjct: 212 AYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 351 EGFSDS----SLLGHGTYGSVYY--GNIRNQEVAIKRM------TATKTKEFMAEMKILC 398
           +G SD       LG G YG V      +   E AIK +      T + +   + E+ +L 
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ H N+++L  +   +   +L+ E  + G L   +   Q   +   + IM+  ++    
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---- 132
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLA---KLVGKTSDGEATVT 512
            G  Y+H+H   + VHRD+K  N+LL+S  R    KI DFGL+   ++ GK  +      
Sbjct: 133 -GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER----- 183
Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             +GT  Y+APE L       K DV++ GV+L+ ++ G
Sbjct: 184 --LGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 218

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTKEFM--------AEMKIL 397
            AT  +   + +G G YG+VY     +    VA+K +     +E +        A ++ L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 398 CKVHHSNLVELIGYAAT-----EDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMR 450
               H N+V L+   AT     E ++ L++E+  +  L+++L    P      ++  +MR
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT 510
             +     RGL+++H +     VHRD+K  NIL+ S    K++DFGLA++       +  
Sbjct: 120 QFL-----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY----QMA 167
Query: 511 VTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +  VV T  Y APE L         D+++ G +  E+   K
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 88/185 (47%), Gaps = 21/185 (11%)
Query: 374 NQEVAIK----RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS 429
           NQ  A+K    RM A   KE  A +K LC+  H N+V+L      +   FL+ E    G 
Sbjct: 36  NQAFAVKIISKRMEANTQKEITA-LK-LCE-GHPNIVKLHEVFHDQLHTFLVMELLNGGE 92
Query: 430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DS 486
           L   +   ++  +T  S+IMR  ++      + ++H+      VHRD+K  N+L    + 
Sbjct: 93  LFERIKKKKHFSETEASYIMRKLVS-----AVSHMHD---VGVVHRDLKPENLLFTDEND 144
Query: 487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFE 546
               KI DFG A+L  K  D +   T    T  Y APE L         D+++ GV+L+ 
Sbjct: 145 NLEIKIIDFGFARL--KPPDNQPLKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVILYT 201
Query: 547 IISGK 551
           ++SG+
Sbjct: 202 MLSGQ 206

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     K++DFGLAK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 107/264 (40%), Gaps = 35/264 (13%)
Query: 330 TDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTY-----------GSVYYGNIRNQEVA 378
            D     +P+V    E+    + F    ++G G +           G VY   I N+   
Sbjct: 40  ADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM 99
Query: 379 IKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQ 438
           +KR   +  +E   E  +L       + +L      E+ L+L+ EY   G L + L    
Sbjct: 100 LKRGEVSCFRE---ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG 156
Query: 439 NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA 498
            R    ++     +I +     ++ +H   +  YVHRDIK  NILLD     +++DFG  
Sbjct: 157 ERIPAEMARFYLAEIVM----AIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG-- 207
Query: 499 KLVGKTSDGEATVTKVVGTFGYLAPEYLT-------DGLATAKSDVYAFGVVLFEIISGK 551
             +   +DG       VGT  YL+PE L         G    + D +A GV  +E+  G+
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 552 -----EAIIRTEGMVSKNQERRSL 570
                ++   T G +   +E  SL
Sbjct: 268 TPFYADSTAETYGKIVHYKEHLSL 291

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 19/167 (11%)
Query: 391 MAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
           + E+ IL KV  H N+++L     T    FL+++  +KG L  +L +     +     IM
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 117
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA 509
           R   AL     LE I    K + VHRD+K  NILLD     K++DFG +    +   GE 
Sbjct: 118 R---AL-----LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEK 166
Query: 510 TVTKVVGTFGYLAPEYLTDGLAT------AKSDVYAFGVVLFEIISG 550
            + +V GT  YLAPE +   +         + D+++ GV+++ +++G
Sbjct: 167 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTKEFM--------AEMKILC 398
           AT  +   + +G G YG+VY     +    VA+K +     +E +        A ++ L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 399 KVHHSNLVELIGYAAT-----EDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRV 451
              H N+V L+   AT     E ++ L++E+  +  L+++L    P      ++  +MR 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 452 QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
            +     RGL+++H +     VHRD+K  NIL+ S    K++DFGLA++       +  +
Sbjct: 121 FL-----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY----QMAL 168
Query: 512 TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
             VV T  Y APE L         D+++ G +  E+   K
Sbjct: 169 FPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 359 LGHGTYGSVYY--GNIRNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVELIG 410
           LG G YG V      +   E AIK +      T + +   + E+ +L ++ H N+++L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           +   +   +L+ E  + G L   +   Q   +   + IM+  ++     G  Y+H+H   
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS-----GTTYLHKH--- 123
Query: 471 HYVHRDIKSSNILLDSAFR---AKISDFGLA---KLVGKTSDGEATVTKVVGTFGYLAPE 524
           + VHRD+K  N+LL+S  R    KI DFGL+   ++ GK       + + +GT  Y+APE
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-------MKERLGTAYYIAPE 176
Query: 525 YLTDGLATAKSDVYAFGVVLFEIISG 550
            L       K DV++ GV+L+ ++ G
Sbjct: 177 VLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G+G YG V     R   Q+VAIK++       T  K  + E+KIL    H N++     
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNII----- 116
Query: 412 AATEDELFLIYEYAQKGS-------LKSHLHDPQNRGQT-SLSWIMRVQIALDAARGLEY 463
            A +D L     Y +  S       ++S LH   +  Q  +L  +      L   RGL+Y
Sbjct: 117 -AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL--LRGLKY 173
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGYLA 522
           +H       +HRD+K SN+L++     KI DFG+A+ L    ++ +  +T+ V T  Y A
Sbjct: 174 MH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 523 PEY-LTDGLATAKSDVYAFGVVLFEIISGKE 552
           PE  L+    T   D+++ G +  E+++ ++
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     K++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 356 SSLLGHGTY----GSVYYGNIRNQEVAIKRMTATKTK-EFMAEMKILCKVH-HSNLVELI 409
           S LLG G Y    G+V   N +   V I    A  ++     E++ L +   + N++ELI
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
            +   +   +L++E  Q GS+ +H+   ++  +   S ++R     D A  L+++  HTK
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVR-----DVAAALDFL--HTK 130
Query: 470 THYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEAT------VTKVVGTFGY 520
               HRD+K  NIL +S  +    KI DF L    G   +   T      +T   G+  Y
Sbjct: 131 G-IAHRDLKPENILCESPEKVSPVKICDFDLGS--GMKLNNSCTPITTPELTTPCGSAEY 187
Query: 521 LAPEYL---TDG--LATAKSDVYAFGVVLFEIISG 550
           +APE +   TD       + D+++ GVVL+ ++SG
Sbjct: 188 MAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 391 MAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
           + E+ IL KV  H N+++L     T    FL+++  +KG L  +L +     +     IM
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA 509
           R   AL     LE I    K + VHRD+K  NILLD     K++DFG +  +    D   
Sbjct: 131 R---AL-----LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGE 178
Query: 510 TVTKVVGTFGYLAPEYLTDGLAT------AKSDVYAFGVVLFEIISG 550
            + +V GT  YLAPE +   +         + D+++ GV+++ +++G
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     K++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     K++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE----FMAEMKILCKVHHSN-LVELIGY 411
           +G GT G V+    R     +A+K+M  +  KE     + ++ ++ K H    +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             T  ++F+  E    G+    L   + R Q  +   +  ++ +   + L Y+ E  K  
Sbjct: 93  FITNTDVFIAMELM--GTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRD+K SNILLD   + K+ DFG++   G+  D +A   +  G   Y+APE +     
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAK-DRSAGCAAYMAPERIDPPDP 201
Query: 532 TA-----KSDVYAFGVVLFEIISGK 551
           T      ++DV++ G+ L E+ +G+
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 391 MAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM 449
           + E+ IL KV  H N+++L     T    FL+++  +KG L  +L +     +     IM
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA 509
           R   AL     LE I    K + VHRD+K  NILLD     K++DFG +  +    D   
Sbjct: 131 R---AL-----LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGE 178
Query: 510 TVTKVVGTFGYLAPEYLTDGLAT------AKSDVYAFGVVLFEIISG 550
            +  V GT  YLAPE +   +         + D+++ GV+++ +++G
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     +++DFGLAK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 18/178 (10%)
Query: 374 NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKS- 432
           N +++IK    +K  +F  E++I+  + +   +   G     DE+++IYEY +  S+   
Sbjct: 78  NDKISIK----SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133
Query: 433 -HLHDPQNRGQTSLSWIMRVQIALDAA-RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA 490
                  ++  T    I  ++  + +      YIH   + +  HRD+K SNIL+D   R 
Sbjct: 134 DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRV 191
Query: 491 KISDFGLAK-LVGKTSDGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLF 545
           K+SDFG ++ +V K   G        GT+ ++ PE+ ++      AK D+++ G+ L+
Sbjct: 192 KLSDFGESEYMVDKKIKGSR------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 16/187 (8%)
Query: 366 SVYYGNIRNQEVAIKRMTATKTKEFMA-EMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
            V+ G +  + + +K       KE M+ E+ I   + + ++V   G+   +D ++++ E 
Sbjct: 68  EVFAGKVVPKSMLLK----PHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEI 123
Query: 425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
            ++ SL       +   +    + MR  I     +G++Y+H +     +HRD+K  N+ L
Sbjct: 124 CRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN---RVIHRDLKLGNLFL 175
Query: 485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVL 544
           +     KI DFGLA  +    DGE   T + GT  Y+APE L     + + D+++ G +L
Sbjct: 176 NDDMDVKIGDFGLATKI--EFDGERKKT-LCGTPNYIAPEVLCKKGHSFEVDIWSLGCIL 232
Query: 545 FEIISGK 551
           + ++ GK
Sbjct: 233 YTLLVGK 239

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 34/189 (17%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIG- 410
           +G GT+G V+    R   Q+VA+K++     KE      + E+KIL  + H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 411 -------YAATEDELFLIYEYAQK---GSLKSHLHDPQNRGQTSLSWIMRV-QIALDAAR 459
                  Y   +  ++L++++ +    G L + L       + +LS I RV Q+ L+   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN--- 136
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL--VGKTSDGEATVTKVVGT 517
           GL YIH   +   +HRD+K++N+L+      K++DFGLA+   + K S       +VV T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 518 FGYLAPEYL 526
             Y  PE L
Sbjct: 193 LWYRPPELL 201

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 34/189 (17%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIG- 410
           +G GT+G V+    R   Q+VA+K++     KE      + E+KIL  + H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 411 -------YAATEDELFLIYEYAQK---GSLKSHLHDPQNRGQTSLSWIMRV-QIALDAAR 459
                  Y   +  ++L++++ +    G L + L       + +LS I RV Q+ L+   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN--- 136
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL--VGKTSDGEATVTKVVGT 517
           GL YIH   +   +HRD+K++N+L+      K++DFGLA+   + K S       +VV T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 518 FGYLAPEYL 526
             Y  PE L
Sbjct: 193 LWYRPPELL 201

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 34/189 (17%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIG- 410
           +G GT+G V+    R   Q+VA+K++     KE      + E+KIL  + H N+V LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 411 -------YAATEDELFLIYEYAQK---GSLKSHLHDPQNRGQTSLSWIMRV-QIALDAAR 459
                  Y   +  ++L++++ +    G L + L       + +LS I RV Q+ L+   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN--- 135
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL--VGKTSDGEATVTKVVGT 517
           GL YIH   +   +HRD+K++N+L+      K++DFGLA+   + K S       +VV T
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 191
Query: 518 FGYLAPEYL 526
             Y  PE L
Sbjct: 192 LWYRPPELL 200

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 34/189 (17%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIG- 410
           +G GT+G V+    R   Q+VA+K++     KE      + E+KIL  + H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 411 -------YAATEDELFLIYEYAQK---GSLKSHLHDPQNRGQTSLSWIMRV-QIALDAAR 459
                  Y   +  ++L++++ +    G L + L       + +LS I RV Q+ L+   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLN--- 136
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL--VGKTSDGEATVTKVVGT 517
           GL YIH   +   +HRD+K++N+L+      K++DFGLA+   + K S       +VV T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 518 FGYLAPEYL 526
             Y  PE L
Sbjct: 193 LWYRPPELL 201

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 47/223 (21%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           F   SLLG G YG V     +   + VAIK++       F    + E+KIL    H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 407 ELIGYAATE-----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD----- 456
            +      +     +E+++I E  Q                T L  ++  Q+  D     
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQ----------------TDLHRVISTQMLSDDHIQY 116
Query: 457 ----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS--DGEAT 510
                 R ++ +H    ++ +HRD+K SN+L++S    K+ DFGLA+++ +++  + E T
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 511 -----VTKVVGTFGYLAPE-YLTDGLATAKSDVYAFGVVLFEI 547
                +T+ V T  Y APE  LT    +   DV++ G +L E+
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     K++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 103/201 (51%), Gaps = 24/201 (11%)
Query: 359 LGHGTYGSVYYGNIRNQE---VAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGY 411
           LG G +G VY    +N+E   +A  ++  TK++E    ++ E++IL    H  +V+L+G 
Sbjct: 19  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              + +L+++ E+   G++ + + +  +RG T        QI +   + LE ++      
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE------PQIQVVCRQMLEALNFLHSKR 129
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY-----L 526
            +HRD+K+ N+L+      +++DFG++    KT     +    +GT  ++APE      +
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETM 186
Query: 527 TDGLATAKSDVYAFGVVLFEI 547
            D     K+D+++ G+ L E+
Sbjct: 187 KDTPYDYKADIWSLGITLIEM 207

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +I   V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRIQQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     K++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     K++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 103/201 (51%), Gaps = 24/201 (11%)
Query: 359 LGHGTYGSVYYGNIRNQE---VAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGY 411
           LG G +G VY    +N+E   +A  ++  TK++E    ++ E++IL    H  +V+L+G 
Sbjct: 27  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              + +L+++ E+   G++ + + +  +RG T        QI +   + LE ++      
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE------PQIQVVCRQMLEALNFLHSKR 137
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY-----L 526
            +HRD+K+ N+L+      +++DFG++    KT     +    +GT  ++APE      +
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETM 194
Query: 527 TDGLATAKSDVYAFGVVLFEI 547
            D     K+D+++ G+ L E+
Sbjct: 195 KDTPYDYKADIWSLGITLIEM 215

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 47/223 (21%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           F   SLLG G YG V     +   + VAIK++       F    + E+KIL    H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 407 ELIGYAATE-----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD----- 456
            +      +     +E+++I E  Q                T L  ++  Q+  D     
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQ----------------TDLHRVISTQMLSDDHIQY 116
Query: 457 ----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS--DGEAT 510
                 R ++ +H    ++ +HRD+K SN+L++S    K+ DFGLA+++ +++  + E T
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 511 -----VTKVVGTFGYLAPE-YLTDGLATAKSDVYAFGVVLFEI 547
                +T+ V T  Y APE  LT    +   DV++ G +L E+
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     K++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 43  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 99
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 148
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV-GKTSDGEATVTKVVGTFGYL 521
           Y+H       ++RD+K  N+L+D     +++DFG AK V G+T         + GT  YL
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYL 198
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D +A GV+++E+ +G
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLAGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 43  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 99
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 148
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 199
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 71  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 127
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 176
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGATWTLCGTPEYLA 227
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 45/271 (16%)
Query: 312 QTTGEVSNPPITIPKAL-------GTDVFDMEKPVVFTYDEILFATEGFSDSSL--LGHG 362
           Q+ G+  NP + IPK          T   D++     +     F  +      +  LG G
Sbjct: 3   QSKGKKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRG 62
Query: 363 TYGSVYYGNIRN----QEVAIKRMTAT----KTKEFMAEMKILCK-VHHSNLVELIGYAA 413
            YG V    +R+    Q +A+KR+ AT    + K  + ++ I  + V     V   G   
Sbjct: 63  AYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 120
Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
            E ++++  E     SL        ++GQT    I+  +IA+   + LE  H H+K   +
Sbjct: 121 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILG-KIAVSIVKALE--HLHSKLSVI 176
Query: 474 HRDIKSSNILLDSAFRAKISDFG----LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
           HRD+K SN+L+++  + K+ DFG    L   V KT D         G   Y+APE +   
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA--------GCKPYMAPERINPE 228
Query: 530 LA----TAKSDVYAFGVVLFEIISGKEAIIR 556
           L     + KSD+++ G+ + E+     AI+R
Sbjct: 229 LNQKGYSVKSDIWSLGITMIEL-----AILR 254

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 37  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 93
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 142
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 193
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK 399
           +F + E L  T  FS+  L      G ++       +   K+    K      E+ +L K
Sbjct: 23  IFEFKETL-GTGAFSEVVLAEEKATGKLF-----AVKCIPKKALKGKESSIENEIAVLRK 76
Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H N+V L     + + L+L+ +    G L   + +     +   S ++R    LDA  
Sbjct: 77  IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ--VLDA-- 132
Query: 460 GLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            + Y+H   +   VHRD+K  N+L    D   +  ISDFGL+K+ GK       ++   G
Sbjct: 133 -VYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD----VMSTACG 184
Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           T GY+APE L     +   D ++ GV+ + ++ G
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 71  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 127
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 176
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 227
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLXGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 71  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 127
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 176
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 227
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 353 FSDSSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTK----EFMAEMKILCKVHHSNLV 406
           F     LG G +G V+     + +   AIKR+     +    + M E+K L K+ H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 407 ------------ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR---V 451
                       E +  ++ +  L++  +  +K +LK  ++     G+ ++    R   +
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-----GRCTIEERERSVCL 121
Query: 452 QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
            I L  A  +E++H       +HRD+K SNI        K+ DFGL   + +  + +  +
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 512 TKV---------VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
           T +         VGT  Y++PE +     + K D+++ G++LFE++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   L +L
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLTKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     K++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   L +L
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLTKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     K++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   L +L
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLTKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EYA  G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     K++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
            F +  L+ H     VY   + ++   IKR   + +  F  E  I+   +   +V+L   
Sbjct: 87  AFGEVQLVRHKASQKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFCA 143
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              +  L+++ EY   G L + + +     + +  +   V +ALDA   +  IH      
Sbjct: 144 FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH------ 197
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---- 527
              RD+K  N+LLD     K++DFG    + +T  G       VGT  Y++PE L     
Sbjct: 198 ---RDVKPDNMLLDKHGHLKLADFGTCMKMDET--GMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 528 DGLATAKSDVYAFGVVLFEIISG 550
           DG    + D ++ GV LFE++ G
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 45  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 101
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 150
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 201
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 90/186 (48%), Gaps = 14/186 (7%)
Query: 366 SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA 425
            V+ G +  + + +K     + ++   E+ I   + + ++V   G+   +D ++++ E  
Sbjct: 52  EVFAGKVVPKSMLLK---PHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC 108
Query: 426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD 485
           ++ SL       +   +    + MR  I     +G++Y+H +     +HRD+K  N+ L+
Sbjct: 109 RRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN---RVIHRDLKLGNLFLN 160
Query: 486 SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLF 545
                KI DFGLA  +    DGE     + GT  Y+APE L     + + D+++ G +L+
Sbjct: 161 DDMDVKIGDFGLATKI--EFDGERK-KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILY 217
Query: 546 EIISGK 551
            ++ GK
Sbjct: 218 TLLVGK 223

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 358 LLGHGTYGSV-----------YYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSN-L 405
           +LG G++G V           Y   I  ++V I+      T   M E ++L        L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFL 404
Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            +L     T D L+ + EY   G L  H+   Q  G+        V  A + A GL ++ 
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR--FKEPHAVFYAAEIAIGLFFLQ 459
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                  ++RD+K  N++LDS    KI+DFG+ K      DG  T     GT  Y+APE 
Sbjct: 460 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDG-VTTKXFCGTPDYIAPEI 513
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           +         D +AFGV+L+E+++G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 16/187 (8%)
Query: 366 SVYYGNIRNQEVAIKRMTATKTKEFMA-EMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
            V+ G +  + + +K       KE M+ E+ I   + + ++V   G+   +D ++++ E 
Sbjct: 68  EVFAGKVVPKSMLLK----PHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEI 123
Query: 425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
            ++ SL       +   +    + MR  I     +G++Y+H +     +HRD+K  N+ L
Sbjct: 124 CRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN---RVIHRDLKLGNLFL 175
Query: 485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVL 544
           +     KI DFGLA  +    DGE     + GT  Y+APE L     + + D+++ G +L
Sbjct: 176 NDDMDVKIGDFGLATKI--EFDGERK-KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCIL 232
Query: 545 FEIISGK 551
           + ++ GK
Sbjct: 233 YTLLVGK 239

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 26/231 (11%)
Query: 332 VFDMEK-----PVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMT 383
           VFD+ K     PV   +D +L   + +     LG G +G V+    R   N   A   MT
Sbjct: 136 VFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 384 ATKTKE--FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG 441
             ++ +     E++ +  + H  LV L      ++E+ +IYE+   G L   + D  N+ 
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK- 251
Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--AFRAKISDFGLAK 499
              +S    V+      +GL ++HE+   +YVH D+K  NI+  +  +   K+ DFGL  
Sbjct: 252 ---MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            +    D + +V    GT  + APE          +D+++ GV+ + ++SG
Sbjct: 306 HL----DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 16/187 (8%)
Query: 366 SVYYGNIRNQEVAIKRMTATKTKEFMA-EMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
            V+ G +  + + +K       KE M+ E+ I   + + ++V   G+   +D ++++ E 
Sbjct: 68  EVFAGKVVPKSMLLK----PHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEI 123
Query: 425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
            ++ SL       +   +    + MR  I     +G++Y+H +     +HRD+K  N+ L
Sbjct: 124 CRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN---RVIHRDLKLGNLFL 175
Query: 485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVL 544
           +     KI DFGLA  +    DGE     + GT  Y+APE L     + + D+++ G +L
Sbjct: 176 NDDMDVKIGDFGLATKI--EFDGERK-KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCIL 232
Query: 545 FEIISGK 551
           + ++ GK
Sbjct: 233 YTLLVGK 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+++D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 36  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 92
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 141
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWTLCGTPEYLA 192
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 107
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 156
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWTLCGTPEYLA 207
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV-GKTSDGEATVTKVVGTFGYL 521
           Y+H       ++RD+K  N+L+D     +++DFG AK V G+T         + GT  YL
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYL 205
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D +A GV+++E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 358 LLGHGTYGSV-----------YYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSN-L 405
           +LG G++G V           Y   I  ++V I+      T   M E ++L        L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFL 83
Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            +L     T D L+ + EY   G L  H+   Q  G+        V  A + A GL ++ 
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGR--FKEPHAVFYAAEIAIGLFFLQ 138
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                  ++RD+K  N++LDS    KI+DFG+ K      DG  T     GT  Y+APE 
Sbjct: 139 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDG-VTTKXFCGTPDYIAPEI 192
Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
           +         D +AFGV+L+E+++G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 26/231 (11%)
Query: 332 VFDMEK-----PVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMT 383
           VFD+ K     PV   +D +L   + +     LG G +G V+    R   N   A   MT
Sbjct: 30  VFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 86
Query: 384 ATKTKE--FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG 441
             ++ +     E++ +  + H  LV L      ++E+ +IYE+   G L   + D  N+ 
Sbjct: 87  PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK- 145
Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--AFRAKISDFGLAK 499
              +S    V+      +GL ++HE+    YVH D+K  NI+  +  +   K+ DFGL  
Sbjct: 146 ---MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 199
Query: 500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            +    D + +V    GT  + APE          +D+++ GV+ + ++SG
Sbjct: 200 HL----DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 358 LLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +LG G +  V    + R Q++   +  A K  E        E+ +L K+ H N+V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             +   L+LI +    G L   + +     +   S ++  Q+ LDA +   Y+H+     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQV-LDAVK---YLHD---LG 136
Query: 472 YVHRDIKSSNIL---LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            VHRD+K  N+L   LD   +  ISDFGL+K+     D  + ++   GT GY+APE L  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 529 GLATAKSDVYAFGVVLFEIISG 550
              +   D ++ GV+ + ++ G
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCG 214

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 47/223 (21%)
Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEF----MAEMKILCKVHHSNLV 406
           F   SLLG G YG V     +   + VAIK++       F    + E+KIL    H N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 407 ELIGYAATE-----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD----- 456
            +      +     +E+++I E  Q                T L  ++  Q+  D     
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQ----------------TDLHRVISTQMLSDDHIQY 116
Query: 457 ----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS--DGEAT 510
                 R ++ +H    ++ +HRD+K SN+L++S    K+ DFGLA+++ +++  + E T
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 511 -----VTKVVGTFGYLAPE-YLTDGLATAKSDVYAFGVVLFEI 547
                + + V T  Y APE  LT    +   DV++ G +L E+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           LG GTYG VY     + N+ VAIKR+     +E      + E+ +L ++ H N++EL   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
                 L LI+EYA+    K    +P    +   S++ ++        G+ + H      
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHSR---R 152
Query: 472 YVHRDIKSSNILLDSAFRA-----KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
            +HRD+K  N+LL  +  +     KI DFGLA+  G         T  + T  Y  PE L
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHEIITLWYRPPEIL 209
Query: 527 TDGLATAKS-DVYAFGVVLFEII 548
                 + S D+++   +  E++
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEML 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRMTAT----KTKEFM-AEMKILCKVHHSNLVELIG 410
           +LG G +  V      I +QE A+K +       +++ F   EM   C+  H N++ELI 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-GHRNVLELIE 78
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           +   ED  +L++E  + GS+ SH+H  ++  +   S +++     D A  L+++H     
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DVASALDFLH---NK 130
Query: 471 HYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVV----GTFGYLAP 523
              HRD+K  NIL +   +    KI DFGL   +    D     T  +    G+  Y+AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 524 EYL-----TDGLATAKSDVYAFGVVLFEIISG 550
           E +        +   + D+++ GV+L+ ++SG
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 12/103 (11%)
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD---- 506
           +  +   ARG+E++   +    +HRD+ + NILL      KI DFGLA+ + K  D    
Sbjct: 202 ISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
           G+  +        ++APE + D + + KSDV+++GV+L+EI S
Sbjct: 259 GDTRLP-----LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----TKE------FMAEMKILCKVHH 402
           S  LG G  G V     R   ++VAIK ++  K      +E         E++IL K++H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             ++++  +   ED  +++ E  + G L   +     R + +   +   Q+ L     ++
Sbjct: 75  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLL----AVQ 128
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G+TS     +  + GT  
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPT 181
Query: 520 YLAPEYL----TDGLATAKSDVYAFGVVLFEIISG 550
           YLAPE L    T G   A  D ++ GV+LF  +SG
Sbjct: 182 YLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSG 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ +   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----TKE------FMAEMKILCKVHH 402
           S  LG G  G V     R   ++VAIK ++  K      +E         E++IL K++H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             ++++  +   ED  +++ E  + G L   +     R + +   +   Q+ L     ++
Sbjct: 75  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLL----AVQ 128
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G+TS     +  + GT  
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPT 181
Query: 520 YLAPEYL----TDGLATAKSDVYAFGVVLFEIISG 550
           YLAPE L    T G   A  D ++ GV+LF  +SG
Sbjct: 182 YLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----TKE------FMAEMKILCKVHH 402
           S  LG G  G V     R   ++VAIK ++  K      +E         E++IL K++H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             ++++  +   ED  +++ E  + G L   +     R + +   +   Q+ L     ++
Sbjct: 75  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLL----AVQ 128
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G+TS     +  + GT  
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPT 181
Query: 520 YLAPEYL----TDGLATAKSDVYAFGVVLFEIISG 550
           YLAPE L    T G   A  D ++ GV+LF  +SG
Sbjct: 182 YLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----TKE------FMAEMKILCKVHH 402
           S  LG G  G V     R   ++VAIK ++  K      +E         E++IL K++H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             ++++  +   ED  +++ E  + G L   +     R + +   +   Q+ L     ++
Sbjct: 74  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLL----AVQ 127
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G+TS     +  + GT  
Sbjct: 128 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPT 180
Query: 520 YLAPEYL----TDGLATAKSDVYAFGVVLFEIISG 550
           YLAPE L    T G   A  D ++ GV+LF  +SG
Sbjct: 181 YLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSG 214

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ +   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----TKE------FMAEMKILCKVHH 402
           S  LG G  G V     R   ++VAIK ++  K      +E         E++IL K++H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             ++++  +   ED  +++ E  + G L   +     R + +   +   Q+ L     ++
Sbjct: 81  PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLL----AVQ 134
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G+TS     +  + GT  
Sbjct: 135 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPT 187
Query: 520 YLAPEYL----TDGLATAKSDVYAFGVVLFEIISG 550
           YLAPE L    T G   A  D ++ GV+LF  +SG
Sbjct: 188 YLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSG 221

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ +   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRNQE--VAIKRMTATKTKEFM-AEMKILCKVHHSNLVELI 409
           F   S LG G    VY    +  +   A+K +  T  K+ +  E+ +L ++ H N+++L 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----GLEYIH 465
               T  E+ L+ E    G L   + +     +           A DA +     + Y+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERD---------AADAVKQILEAVAYLH 165
Query: 466 EHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           E+     VHRD+K  N+L  +       KI+DFGL+K+V    + +  +  V GT GY A
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV----EHQVLMKTVCGTPGYCA 218
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG 559
           PE L       + D+++ G++ + ++ G E      G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 45/225 (20%)
Query: 359 LGHGTYGSVYYGNIRN--QEVAIKRM-----TATKTKEFMAEMKILCKVH-HSNLVELIG 410
           LG G YG V+    R   + VA+K++      +T  +    E+ IL ++  H N+V L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 411 Y--AATEDELFLIYEYAQ---KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
              A  + +++L+++Y +      +++++ +P          + +  +     + ++Y+H
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEP----------VHKQYVVYQLIKVIKYLH 126
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL------------------VGKTSDG 507
                  +HRD+K SNILL++    K++DFGL++                        D 
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           +  +T  V T  Y APE L       K  D+++ G +L EI+ GK
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 353 FSDSSLLGHGTYGS-VYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIG 410
           F    +LGHG  G+ VY G   N++VA+KR+          E+++L +   H N+   I 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV---IR 82
Query: 411 YAATEDELFLIYEYAQ--KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           Y  TE +    Y   +    +L+ ++ + ++     L  I  +Q       GL ++H   
Sbjct: 83  YFCTEKDRQFQYIAIELCAATLQEYV-EQKDFAHLGLEPITLLQ---QTTSGLAHLH--- 135
Query: 469 KTHYVHRDIKSSNILLD-----SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
             + VHRD+K  NIL+         +A ISDFGL K +       +  + V GT G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 524 EYLTDGLA---TAKSDVYAFGVVLFEIIS 549
           E L++      T   D+++ G V + +IS
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRMT--ATKTKE--FMAEMKILCKVHHSNLVELIGY 411
           +LG G +  V    + R Q+ VAIK +   A + KE     E+ +L K+ H N+V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             +   L+LI +    G L   + +     +   S ++  Q+ LDA +   Y+H+     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQV-LDAVK---YLHD---LG 136
Query: 472 YVHRDIKSSNIL---LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            VHRD+K  N+L   LD   +  ISDFGL+K+     D  + ++   GT GY+APE L  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 529 GLATAKSDVYAFGVVLFEIISG 550
              +   D ++ GV+ + ++ G
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCG 214

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 12/100 (12%)
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 261 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRMT--ATKTKE--FMAEMKILCKVHHSNLVELIGY 411
           +LG G +  V    + R Q+ VAIK +   A + KE     E+ +L K+ H N+V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             +   L+LI +    G L   + +     +   S ++  Q+ LDA +   Y+H+     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQV-LDAVK---YLHD---LG 136
Query: 472 YVHRDIKSSNIL---LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            VHRD+K  N+L   LD   +  ISDFGL+K+     D  + ++   GT GY+APE L  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 529 GLATAKSDVYAFGVVLFEIISG 550
              +   D ++ GV+ + ++ G
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCG 214

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 354 SDSSLLGHGTYGSVYYGNIRNQEVA---------IKRMTATKTKEFMAEMKILCKVHHSN 404
           S + +LG G +G V+    + +E A         IK       +E   E+ ++ ++ H+N
Sbjct: 92  SKTEILGGGRFGQVH----KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           L++L     +++++ L+ EY   G L   + D ++   T L  I+ ++       G+ ++
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMK---QICEGIRHM 203
Query: 465 HEHTKTHYVHRDIKSSNILL--DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           H+    + +H D+K  NIL     A + KI DFGLA+        +       GT  +LA
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTPEFLA 256
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +     +  +D+++ GV+ + ++SG
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRMT--ATKTKE--FMAEMKILCKVHHSNLVELIGY 411
           +LG G +  V    + R Q+ VAIK +   A + KE     E+ +L K+ H N+V L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             +   L+LI +    G L   + +     +   S ++  Q+ LDA +   Y+H+     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI-FQV-LDAVK---YLHD---LG 136
Query: 472 YVHRDIKSSNIL---LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            VHRD+K  N+L   LD   +  ISDFGL+K+     D  + ++   GT GY+APE L  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 529 GLATAKSDVYAFGVVLFEIISG 550
              +   D ++ GV+ + ++ G
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCG 214

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 12/100 (12%)
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 263 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 12/100 (12%)
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 256 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 12/100 (12%)
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----GEA 509
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D    G+A
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS 549
            +        ++APE + D + T +SDV++FGV+L+EI S
Sbjct: 254 RLP-----LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----------TKEFMAEMKILCKVHH 402
           S  LG G  G V     R   ++VAI+ ++  K                 E++IL K++H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             ++++  +   ED  +++ E  + G L   +     R + +   +   Q+ L     ++
Sbjct: 200 PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLL----AVQ 253
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G+TS     +  + GT  
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPT 306
Query: 520 YLAPEYL----TDGLATAKSDVYAFGVVLFEIISG 550
           YLAPE L    T G   A  D ++ GV+LF  +SG
Sbjct: 307 YLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSG 340

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT  YLA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEYLA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           P  +         D +A GV+++E+ +G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 359 LGHGTYGSVYYGNIRN----QEVAIKRMTAT----KTKEFMAEMKILCK-VHHSNLVELI 409
           LG G YG V    +R+    Q +A+KR+ AT    + K  + ++ I  + V     V   
Sbjct: 15  LGRGAYGVV--EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G    E ++++  E     SL        ++GQT    I+  +IA+   + LE  H H+K
Sbjct: 73  GALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILG-KIAVSIVKALE--HLHSK 128
Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
              +HRD+K SN+L+++  + K+ DFG++   G   D  A      G   Y+APE +   
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDID-AGCKPYMAPERINPE 184
Query: 530 LA----TAKSDVYAFGVVLFEIISGKEAIIR 556
           L     + KSD+++ G+ + E+     AI+R
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL-----AILR 210

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 23  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 82
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 129
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 130 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 186
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 187 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK-----------TKEFMAEMKILCKVHH 402
           S  LG G  G V     R   ++VAI+ ++  K                 E++IL K++H
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             ++++  +   ED  +++ E  + G L   +     R + +   +   Q+ L     ++
Sbjct: 214 PCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLL----AVQ 267
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G+TS     +  + GT  
Sbjct: 268 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPT 320
Query: 520 YLAPEYL----TDGLATAKSDVYAFGVVLFEIISG 550
           YLAPE L    T G   A  D ++ GV+LF  +SG
Sbjct: 321 YLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSG 354

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 24  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 130
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 187
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 188 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 128
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDE--M 179
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 180 TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 9   ERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 115
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKIL 172
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 173 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 124
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDE--M 175
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLH--DPQNRGQTSLSWIMRVQIAL-DA 457
           N++ L+     A + +E   +Y       L +HL   D  N  + +      VQ  +   
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMGADLNNIVKCAKLTDDHVQFLIYQI 130
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
            RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +T  V T
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDE--MTGYVAT 181
Query: 518 FGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
             Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 47/248 (18%)
Query: 329 GTDVFDM--EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKR 381
           G+ + +M  E+P  +  +    I    E + + S +G G YGSV   +       VA+K+
Sbjct: 18  GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 77
Query: 382 MTA-----TKTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSH 433
           ++         K    E+++L  + H N++ L+     A + +E   +Y       L +H
Sbjct: 78  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTH 130
Query: 434 LHDPQNRGQTSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILL 484
           L          L+ I++ Q   D           RGL+YIH       +HRD+K SN+ +
Sbjct: 131 LMG------ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 181
Query: 485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVV 543
           +     KI DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G +
Sbjct: 182 NEDCELKILDFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 235
Query: 544 LFEIISGK 551
           + E+++G+
Sbjct: 236 MAELLTGR 243

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 10  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 69
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHL------MG 116
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 173
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 174 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 47/248 (18%)
Query: 329 GTDVFDM--EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKR 381
           G+ + +M  E+P  +  +    I    E + + S +G G YGSV   +       VA+K+
Sbjct: 1   GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 60
Query: 382 MTA-----TKTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSH 433
           ++         K    E+++L  + H N++ L+     A + +E   +Y       L +H
Sbjct: 61  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTH 113
Query: 434 LHDPQNRGQTSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILL 484
           L          L+ I++ Q   D           RGL+YIH       +HRD+K SN+ +
Sbjct: 114 LMG------ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 164
Query: 485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVV 543
           +     KI DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G +
Sbjct: 165 NEDCELKILDFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 544 LFEIISGK 551
           + E+++G+
Sbjct: 219 MAELLTGR 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 133
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 134 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDE--M 184
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 15  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 121
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 122 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKIL 178
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 179 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 359 LGHGTYGSV---YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIG 410
           +G G YGSV   Y   +R Q+VA+K+++         +    E+++L  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 411 Y----AATED--ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
                 + ED  E++L+      G+  +++   Q      + +++         RGL+YI
Sbjct: 95  VFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLV-----YQLLRGLKYI 147
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRD+K SN+ ++     +I DFGLA+        +  +T  V T  Y APE
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR------QADEEMTGYVATRWYRAPE 198
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGK 551
            + + +   ++ D+++ G ++ E++ GK
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKXQKLTDDHVQ 128
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA----RHTDDE--M 179
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVEL 408
            T  F    L+ H   G+ Y   I +++  +K      T   + E +IL  V+   LV+L
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKL 106
Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH------DPQNRGQTSLSWIMRVQIALDAARGLE 462
                    L+++ EY   G + SHL       +P  R           QI L      E
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-------FYAAQIVLT----FE 155
Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       ++RD+K  N+L+D     +++DFG AK V      +     + GT   LA
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLCGTPEALA 206
Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE +         D +A GV+++E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 47/248 (18%)
Query: 329 GTDVFDM--EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKR 381
           G+ + +M  E+P  +  +    I    E + + S +G G YGSV   +       VA+K+
Sbjct: 1   GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 60
Query: 382 MTA-----TKTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSH 433
           ++         K    E+++L  + H N++ L+     A + +E   +Y       L +H
Sbjct: 61  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTH 113
Query: 434 LHDPQNRGQTSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILL 484
           L          L+ I++ Q   D           RGL+YIH       +HRD+K SN+ +
Sbjct: 114 LMG------ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 164
Query: 485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVV 543
           +     KI DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G +
Sbjct: 165 NEDSELKILDFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 218
Query: 544 LFEIISGK 551
           + E+++G+
Sbjct: 219 MAELLTGR 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 11  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 117
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 174
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA+    T+D    +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 175 DFGLAR---HTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 19/193 (9%)
Query: 361 HGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL 420
           H T G  +   I N     K+++A   ++   E +I  K+ H N+V L      E   +L
Sbjct: 50  HKTTGLEFAAKIIN----TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105
Query: 421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSS 480
           +++    G L   +   +   +   S    +Q  L++   + Y H +     VHR++K  
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADASHC--IQQILES---IAYCHSNG---IVHRNLKPE 157
Query: 481 NILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDV 537
           N+LL S  +    K++DFGLA  V   +D EA      GT GYL+PE L     +   D+
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEV---NDSEAW-HGFAGTPGYLSPEVLKKDPYSKPVDI 213
Query: 538 YAFGVVLFEIISG 550
           +A GV+L+ ++ G
Sbjct: 214 WACGVILYILLVG 226

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 11  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 117
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 174
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA+    T+D    +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 175 DFGLAR---HTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 6   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 112
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 169
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 170 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 11  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 117
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 174
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA+    T+D    +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 175 DFGLAR---HTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 24  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 83
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 130
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 187
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 188 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 16  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 122
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 179
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 180 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 16  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 122
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 179
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 180 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 16  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSII 75
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 122
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 179
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 180 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 23  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 82
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 129
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 130 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 186
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 187 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 128
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDE--M 179
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 11  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 117
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 174
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 175 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 9   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 115
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 172
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 173 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 6   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 112
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 169
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 170 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 3   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 62
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 109
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 110 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 166
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 167 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 359 LGHGTYGSV---YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIG 410
           +G G YGSV   Y   +R Q+VA+K+++         +    E+++L  + H N++ L+ 
Sbjct: 28  VGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 86
Query: 411 Y----AATED--ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
                 + ED  E++L+      G+  +++   Q      + +++         RGL+YI
Sbjct: 87  VFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLV-----YQLLRGLKYI 139
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRD+K SN+ ++     +I DFGLA+        +  +T  V T  Y APE
Sbjct: 140 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR------QADEEMTGYVATRWYRAPE 190
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGK 551
            + + +   ++ D+++ G ++ E++ GK
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 6   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 112
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKIL 169
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 170 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 15  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 121
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 122 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 178
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 179 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 1   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 107
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 108 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 164
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 165 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 124
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDE--M 175
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 126
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 127 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDE--M 177
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 1   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 107
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 108 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 164
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 165 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + + +G G YGSV   +       VA+K+++       
Sbjct: 14  ERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 120
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 121 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 177
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 178 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 19/193 (9%)
Query: 361 HGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL 420
           H T G  +   I N     K+++A   ++   E +I  K+ H N+V L      E   +L
Sbjct: 27  HKTTGLEFAAKIIN----TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82
Query: 421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSS 480
           +++    G L   +   +   +   S  ++ QI       + Y H +     VHR++K  
Sbjct: 83  VFDLVTGGELFEDIVAREFYSEADASHCIQ-QIL----ESIAYCHSNG---IVHRNLKPE 134
Query: 481 NILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDV 537
           N+LL S  +    K++DFGLA  V   +D EA      GT GYL+PE L     +   D+
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEV---NDSEAW-HGFAGTPGYLSPEVLKKDPYSKPVDI 190
Query: 538 YAFGVVLFEIISG 550
           +A GV+L+ ++ G
Sbjct: 191 WACGVILYILLVG 203

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRMTAT----KTKEFM-AEMKILCKVHHSNLVELIG 410
           +LG G +  V      I +QE A+K +       +++ F   EM   C+  H N++ELI 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ-GHRNVLELIE 78
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           +   ED  +L++E  + GS+ SH+H  ++  +   S +++     D A  L+++H     
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DVASALDFLH---NK 130
Query: 471 HYVHRDIKSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVV----GTFGYLAP 523
              HRD+K  NIL +   +    KI DF L   +    D     T  +    G+  Y+AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 524 EYL-----TDGLATAKSDVYAFGVVLFEIISG 550
           E +        +   + D+++ GV+L+ ++SG
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 9   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 115
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 172
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 173 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 6   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 112
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 169
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 170 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 19/193 (9%)
Query: 361 HGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL 420
           H T G  +   I N     K+++A   ++   E +I  K+ H N+V L      E   +L
Sbjct: 27  HKTTGLEFAAKIIN----TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82
Query: 421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSS 480
           +++    G L   +   +   +   S    +Q  L++   + Y H +     VHR++K  
Sbjct: 83  VFDLVTGGELFEDIVAREFYSEADASHC--IQQILES---IAYCHSNG---IVHRNLKPE 134
Query: 481 NILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDV 537
           N+LL S  +    K++DFGLA  V   +D EA      GT GYL+PE L     +   D+
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEV---NDSEAW-HGFAGTPGYLSPEVLKKDPYSKPVDI 190
Query: 538 YAFGVVLFEIISG 550
           +A GV+L+ ++ G
Sbjct: 191 WACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 19/193 (9%)
Query: 361 HGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL 420
           H T G  +   I N     K+++A   ++   E +I  K+ H N+V L      E   +L
Sbjct: 26  HKTTGLEFAAKIIN----TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 81
Query: 421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSS 480
           +++    G L   +   +   +   S  ++ QI       + Y H +     VHR++K  
Sbjct: 82  VFDLVTGGELFEDIVAREFYSEADASHCIQ-QIL----ESIAYCHSNG---IVHRNLKPE 133
Query: 481 NILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDV 537
           N+LL S  +    K++DFGLA  V   +D EA      GT GYL+PE L     +   D+
Sbjct: 134 NLLLASKAKGAAVKLADFGLAIEV---NDSEAW-HGFAGTPGYLSPEVLKKDPYSKPVDI 189
Query: 538 YAFGVVLFEIISG 550
           +A GV+L+ ++ G
Sbjct: 190 WACGVILYILLVG 202

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D       +LS +  +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD------ANLSQV--IQMELDHERMSYLLYQMLVGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ GV++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D       +LS +  +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD------ANLSQV--IQMELDHERMSYLLYQMLVGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ GV++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 24  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 130
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 187
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA+       G       V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 188 DFGLARHTDDEMXG------XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 10  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHL------MG 116
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 173
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 174 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 359 LGHGTYGSV---YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIG 410
           +G G YGSV   Y   +R Q+VA+K+++         +    E+++L  + H N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLR-QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 411 Y----AATED--ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
                 + ED  E++L+      G+  +++   Q      + +++         RGL+YI
Sbjct: 95  VFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLV-----YQLLRGLKYI 147
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRD+K SN+ ++     +I DFGLA+        +  +T  V T  Y APE
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR------QADEEMTGYVATRWYRAPE 198
Query: 525 YLTDGLATAKS-DVYAFGVVLFEIISGK 551
            + + +   ++ D+++ G ++ E++ GK
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 59/245 (24%)
Query: 359 LGHGTYGSVYYGNIRNQEVAI---KRMTATKTKEF--------MAEMKILCKVHHSNLVE 407
           +G G+YG V    I NQ  AI   K M   K ++           E++++ K+HH N+  
Sbjct: 34  IGQGSYGVVRVA-IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 408 LIGYAATEDELF--LIYEYAQKGSLKSHLH----DPQNRG-------------------- 441
           L  Y   EDE +  L+ E    G L   L+    D   +                     
Sbjct: 93  L--YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 442 -------QTSLSWIMRVQIALDAAR----GLEYIHEHTKTHYVHRDIKSSNILL--DSAF 488
                  + SL ++ R ++  +  R     L Y+H        HRDIK  N L   + +F
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSF 207
Query: 489 RAKISDFGLAKLVGKTSDGE-ATVTKVVGTFGYLAPEYL--TDGLATAKSDVYAFGVVLF 545
             K+ DFGL+K   K ++GE   +T   GT  ++APE L  T+     K D ++ GV+L 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 546 EIISG 550
            ++ G
Sbjct: 268 LLLMG 272

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +   V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +   V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DFGLA----RHTDDE--MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 24/243 (9%)
Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G GTYG+V+    R  ++ VA+KR+      E      + E+ +L ++ H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             ++ +L L++E+  +  LK +     +     L   +         +GL + H     +
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-L 530
            +HRD+K  N+L++     K++DFGLA+  G         +  V T  Y  P+ L    L
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKL 178
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            +   D+++ G +  E+ +    +    G    +Q +R    F L          SM+ L
Sbjct: 179 YSTSIDMWSAGCIFAELANAARPLF--PGNDVDDQLKR---IFRLLGTPTEEQWPSMTKL 233
Query: 591 KDY 593
            DY
Sbjct: 234 PDY 236

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELIGY 411
           +G G YGSV         ++VAIK+++     E  A     E+ +L  + H N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA--------RGLEY 463
                 L   Y++        +L  P    QT L  IM ++ + +          +GL+Y
Sbjct: 110 FTPASSLRNFYDF--------YLVMP--FMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKY 159
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           IH       VHRD+K  N+ ++     KI DFGLA+        +A +T  V T  Y AP
Sbjct: 160 IHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAP 210
Query: 524 EYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           E +   +   ++ D+++ G ++ E+++GK
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 124
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DFGLA    + +D E  +
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDE--M 175
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
              V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 176 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELIGY 411
           +G G YGSV         ++VAIK+++     E  A     E+ +L  + H N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIM-------RVQ-IALDAARGLEY 463
                 L   Y++        +L  P    QT L  IM       ++Q +     +GL+Y
Sbjct: 92  FTPASSLRNFYDF--------YLVMP--FMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           IH       VHRD+K  N+ ++     KI DFGLA+        +A +T  V T  Y AP
Sbjct: 142 IHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAP 192
Query: 524 EYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           E +   +   ++ D+++ G ++ E+++GK
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 353 FSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNL 405
           + D   +G G YG+V          +VAIK++      E  A     E+++L  + H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 406 VELIGYAATEDEL------FLIYEY--AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA 457
           + L+     ++ L      +L+  +     G L  H    +  G+  + +++   +    
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLGEDRIQFLVYQML---- 138
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
            +GL YIH       +HRD+K  N+ ++     KI DFGLA+        ++ +   V T
Sbjct: 139 -KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------QADSEMXGXVVT 188
Query: 518 FGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGK 551
             Y APE + + +  T   D+++ G ++ E+I+GK
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 110/239 (46%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           D+GLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DYGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK--------TKEFMAE 393
           D++LF  + +    ++G G +  V     R   Q+ A+K +   K        T++   E
Sbjct: 18  DDVLF-EDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 394 MKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIM 449
             I   + H ++VEL+   +++  L++++E+     L   +    + G    +   S  M
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTSD 506
           R QI L+A R   Y H++   + +HRD+K  N+LL   +++   K+ DFG+A  +G++  
Sbjct: 137 R-QI-LEALR---YCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG- 187
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                   VGT  ++APE +         DV+  GV+LF ++SG
Sbjct: 188 --LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLH--DPQNR 440
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL   D  N 
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMGADLNNI 116
Query: 441 GQTSLSWIMRVQIAL-DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK 499
            ++       VQ  +    RGL+YIH       +HRD+K SN+ ++     KI DFGL  
Sbjct: 117 VKSQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLC- 172
Query: 500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
              + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 173 ---RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E +   S +G G YGSV   Y      ++A+K+++       
Sbjct: 33  ERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSII 92
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 93  HAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVY-------LVTHLMG------ 139
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 140 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 196
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA    + +D E  +T  V T  Y APE + + +    + D+++ G ++ E+++G+
Sbjct: 197 DFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKTK-----------EFMAEMKILCKVHHSNLV 406
           LLG G+YG V    + + E   +R      K               E+++L ++ H N++
Sbjct: 12  LLGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 407 ELIG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +L+   Y   + +++++ EY   G  +     P+ R     +     Q+      GLEY+
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----DGLEYL 125
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       VH+DIK  N+LL +    KIS  G+A+ +   +  + T     G+  +  PE
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA-ADDTCRTSQGSPAFQPPE 181
Query: 525 YLTDGLAT---AKSDVYAFGVVLFEIISG 550
            + +GL T    K D+++ GV L+ I +G
Sbjct: 182 -IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 27  ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 133
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 134 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 190
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           DFGLA+       G       V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 191 DFGLARHTDDEMXG------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 379 IKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQ 438
           IK+  A +      E+ +L K+ H N+V L     +    +L+ +    G L   + +  
Sbjct: 42  IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG 101
Query: 439 NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDF 495
              +   S +  +Q  L A +   Y+HE+     VHRD+K  N+L    +   +  I+DF
Sbjct: 102 VYTEKDASLV--IQQVLSAVK---YLHENG---IVHRDLKPENLLYLTPEENSKIMITDF 153
Query: 496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           GL+K+     +    ++   GT GY+APE L     +   D ++ GV+ + ++ G
Sbjct: 154 GLSKM-----EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 20/190 (10%)
Query: 365 GSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
           G  Y   I N     K+++A   ++   E +I   + H N+V L    + E   +LI++ 
Sbjct: 47  GQEYAAKIIN----TKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 102
Query: 425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
              G L   +   +   +   S    +Q  L+A      +H H +   VHRD+K  N+LL
Sbjct: 103 VTGGELFEDIVAREYYSEADASHC--IQQILEAV-----LHCH-QMGVVHRDLKPENLLL 154
Query: 485 DSAFRA---KISDFGLAKLVGKTSDGEATVT-KVVGTFGYLAPEYLTDGLATAKSDVYAF 540
            S  +    K++DFGLA  V    +GE        GT GYL+PE L         D++A 
Sbjct: 155 ASKLKGAAVKLADFGLAIEV----EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 210
Query: 541 GVVLFEIISG 550
           GV+L+ ++ G
Sbjct: 211 GVILYILLVG 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D       +LS +  +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD------ANLSQV--IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 358 LLGHGTYGSVYYGNIRNQE--VAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIG 410
           L+G G+YG VY    +N E  VAIK++          K  + E+ IL ++    ++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 411 YAATED-----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               +D     EL+++ E A    LK     P    +  +  I+      +   G  +IH
Sbjct: 93  LIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTIL-----YNLLLGENFIH 146
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG------------------ 507
           E   +  +HRD+K +N LL+     K+ DFGLA+ +    D                   
Sbjct: 147 E---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 508 -EATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIIS 549
            +  +T  V T  Y APE +       KS D+++ G +  E+++
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 18/189 (9%)
Query: 365 GSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
           G  Y   I N     K+++A   ++   E +I   + HSN+V L    + E   +L+++ 
Sbjct: 29  GHEYAAKIIN----TKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDL 84
Query: 425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
              G L   +   +   +   S    +Q  L+A      +H H +   VHRD+K  N+LL
Sbjct: 85  VTGGELFEDIVAREYYSEADASHC--IQQILEAV-----LHCH-QMGVVHRDLKPENLLL 136
Query: 485 DSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFG 541
            S  +    K++DFGLA  +    D +A      GT GYL+PE L         D++A G
Sbjct: 137 ASKCKGAAVKLADFGLA--IEVQGDQQAWFG-FAGTPGYLSPEVLRKEAYGKPVDIWACG 193
Query: 542 VVLFEIISG 550
           V+L+ ++ G
Sbjct: 194 VILYILLVG 202

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 377 VAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD 436
           +  K+++A   ++   E +I   + H N+V L    + E   +L+++    G L   +  
Sbjct: 64  INTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA 123
Query: 437 PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA---KIS 493
            +   +   S  +  QI       + +IH+H     VHRD+K  N+LL S  +    K++
Sbjct: 124 REYYSEADASHCIH-QIL----ESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLA 175
Query: 494 DFGLAKLVGKTSDGEATVT-KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           DFGLA  V     GE        GT GYL+PE L         D++A GV+L+ ++ G
Sbjct: 176 DFGLAIEV----QGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D       +LS +  +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD------ANLSQV--IQMELDHERMSYLLYQMLVGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLXQV-------IQMELD 124
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 125 HERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS-- 179
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 180 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  + ++ VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   L   L D  N  Q        +Q+ LD  R          G+
Sbjct: 92  FTPQKTL----EEFQDVYLVMELMD-ANLXQV-------IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 44/234 (18%)
Query: 351 EGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           + +    L+G G+YG VY  Y    N+ VAIK++          K  + E+ IL ++   
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 404 NLVELIGYAATED-----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
            ++ L      ED     EL+++ E A    LK     P    +  +  I+      +  
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEQHVKTIL-----YNLL 141
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD------------ 506
            G ++IHE   +  +HRD+K +N LL+     KI DFGLA+ +    D            
Sbjct: 142 LGEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 507 ----------GEATVTKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIIS 549
                      +  +T  V T  Y APE  L     T   D+++ G +  E+++
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 115/260 (44%), Gaps = 42/260 (16%)
Query: 353 FSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLV- 406
           + D   LG G  G V+    N  ++ VAIK++  T     K  + E+KI+ ++ H N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 407 --ELIGYAATE-----------DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
             E++G + ++           + ++++ EY +          P       L        
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-------F 125
Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVT 512
                RGL+YIH     + +HRD+K +N+ +++     KI DFGLA+++      +  ++
Sbjct: 126 MYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 513 KVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGKE-----------AIIRTEGM 560
           + + T  Y +P  L       K+ D++A G +  E+++GK             +I     
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 561 VSKNQERRSLASFMLAALRN 580
           V   ++R+ L S +   +RN
Sbjct: 243 VVHEEDRQELLSVIPVYIRN 262

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 42/221 (19%)
Query: 351 EGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----TKTKEFMAEMKILCKVHHS 403
           E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 404 NLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD---- 456
           N++ L+     A + +E   +Y       L +HL          L+ I++ Q   D    
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ADLNNIVKCQKLTDDHVQ 128
Query: 457 -----AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV 511
                  RGL+YIH       +HRD+K SN+ ++     KI DF LA    + +D E  +
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLA----RHTDDE--M 179
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D       +LS +  +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD------ANLSQV--IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D       +LS +  +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD------ANLSQV--IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 24/243 (9%)
Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G GTYG+V+    R  ++ VA+KR+      E      + E+ +L ++ H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             ++ +L L++E+  +  LK +     +     L   +         +GL + H     +
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-L 530
            +HRD+K  N+L++     K+++FGLA+  G         +  V T  Y  P+ L    L
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKL 178
Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
            +   D+++ G +  E+ +    +    G    +Q +R    F L          SM+ L
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKR---IFRLLGTPTEEQWPSMTKL 233
Query: 591 KDY 593
            DY
Sbjct: 234 PDY 236

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  + ++ VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   L   L D  N  Q        +Q+ LD  R          G+
Sbjct: 92  FTPQKTL----EEFQDVYLVMELMDA-NLCQV-------IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
            FGLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 GFGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           D GLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DAGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           D GLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DRGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLXQV-------IQMELD 117
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 118 HERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS-- 172
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D  N  Q        +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 73/136 (53%), Gaps = 13/136 (9%)
Query: 417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD 476
           E+ LI EYA  G + S L  P+     S + ++R  +      G+ Y+H++   + VH D
Sbjct: 103 EIILILEYAAGGEIFS-LCLPELAEMVSENDVIR--LIKQILEGVYYLHQN---NIVHLD 156
Query: 477 IKSSNILLDSAF---RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA 533
           +K  NILL S +     KI DFG+++ +G   +    + +++GT  YLAPE L     T 
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNYDPITT 212
Query: 534 KSDVYAFGVVLFEIIS 549
            +D++  G++ + +++
Sbjct: 213 ATDMWNIGIIAYMLLT 228

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLXQV-------IQMELD 124
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 125 HERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS-- 179
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 180 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  + ++ VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   L   L D  N  Q        +Q+ LD  R          G+
Sbjct: 130 FTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 177
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 178 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYR 230
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G ++ E++  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 359 LGHGTYGSVYYGN--IRNQEVAIKRMTAT----KTKEFMAEMKILCK-VHHSNLVELIGY 411
           LG G YG V         Q  A+KR+ AT    + K  + ++ I  + V     V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              E ++++  E     SL        ++GQT    I+  +IA+   + LE  H H+K  
Sbjct: 102 LFREGDVWICXELXDT-SLDKFYKQVIDKGQTIPEDILG-KIAVSIVKALE--HLHSKLS 157
Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRD+K SN+L+++  + K  DFG++   G   D  A      G   Y APE +   L 
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGIS---GYLVDDVAKDID-AGCKPYXAPERINPELN 213
Query: 532 ----TAKSDVYAFGVVLFEIISGKEAIIR 556
               + KSD+++ G+   E+     AI+R
Sbjct: 214 QKGYSVKSDIWSLGITXIEL-----AILR 237

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 118
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 119 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 173
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 174 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 117
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 172
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D  N  Q        +Q+ LD  R          G+
Sbjct: 93  FTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 140
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 141 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYR 193
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  I  + VAIK+++      T  K    E+ +
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   +   L D  N  Q        +Q+ LD
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELD 124
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 125 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
               +T  V T  Y APE +         D+++ G ++ E+I G
Sbjct: 180 --FMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 125
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 126 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 180
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 336 EKPVVFTYD---EILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMTA-----T 385
           E+P  +  +    I    E + + S +G G YGSV   +       VA+K+++       
Sbjct: 4   ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 386 KTKEFMAEMKILCKVHHSNLVELIGY---AATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
             K    E+++L  + H N++ L+     A + +E   +Y       L +HL        
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMG------ 110
Query: 443 TSLSWIMRVQIALD---------AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
             L+ I++ Q   D           RGL+YIH       +HRD+K SN+ ++     KI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
           D GLA    + +D E  +T  V T  Y APE + + +   ++ D+++ G ++ E+++G+
Sbjct: 168 DGGLA----RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 124
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 125 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 180 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 118
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 119 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 173
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 174 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 55  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 162
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 163 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 217
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 218 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 16  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 75
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 123
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 124 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 178
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 179 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 91/228 (39%), Gaps = 25/228 (10%)
Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIRNQE----VAIKRMTATKTKEFMAEMKILCKVHHS 403
           F  + F   S LGHG+YG V+   +R++E     A+KR  +     F        K+   
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVF--KVRSKEDGRLYAVKRSMSP----FRGPKDRARKLAEV 107
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA------LDA 457
              E +G       L   +E      L++ L  P  + Q   +W   +  A       D 
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQ-QHCEAWGASLPEAQVWGYLRDT 166
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
              L ++H       VH D+K +NI L    R K+ DFGL   +G    GE       G 
Sbjct: 167 LLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGD 219
Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ 565
             Y+APE L     TA +DV++ G+ + E+    E     EG     Q
Sbjct: 220 PRYMAPELLQGSYGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQ 266

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 17  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 124
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 125 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 180 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D  N  Q        +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y 
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  + ++ VAIK+++      T  K    E+ +
Sbjct: 18  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   L   L D  N  Q        +Q+ LD
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IQMELD 125
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 126 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 180
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 337 KPVVFTY-DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ--EVAIKRMTATKTKEFMAE 393
           KPV + Y +E+ +AT        LG G++G V+    +    + A+K++   + + F AE
Sbjct: 82  KPVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKV---RLEVFRAE 134
Query: 394 MKILCK-VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWI 448
             + C  +    +V L G       + +  E  + GSL   + +    P++R    L   
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG-- 192
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDG 507
                   A  GLEY+H       +H D+K+ N+LL S    A + DFG A  +     G
Sbjct: 193 -------QALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 508 EATVTK--VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           ++ +T   + GT  ++APE +      AK DV++   ++  +++G
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 359 LGHGTYG--SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILC--KVHHSNLVELIGYAAT 414
           +G G +G   +    +  + VA+K +      +   + +I+    + H N+V       T
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
              L +I EYA  G L   + +     +    +  +  ++     G+ Y H        H
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYCH---SMQICH 139
Query: 475 RDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           RD+K  N LLD   A R KI DFG +K     S  ++T    VGT  Y+APE L      
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLRQEYD 195
Query: 533 AK-SDVYAFGVVLFEIISG 550
            K +DV++ GV L+ ++ G
Sbjct: 196 GKIADVWSCGVTLYVMLVG 214

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 393 EMKILCKVHHSNLVELIGYAATED--ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR 450
           E+ I+ ++HH  L+ L  + A ED  E+ LI E+   G L     D        +S    
Sbjct: 98  EISIMNQLHHPKLINL--HDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEV 151
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGE 508
           +     A  GL+++HEH+    VH DIK  NI+ ++  A   KI DFGLA  +    D  
Sbjct: 152 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEI 206
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             VT     F   APE +        +D++A GV+ + ++SG
Sbjct: 207 VKVTTATAEFA--APEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 16/178 (8%)
Query: 377 VAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD 436
           +  K+++A   ++   E +I   + H N+V L    + E   +LI++    G L   +  
Sbjct: 44  INTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA 103
Query: 437 PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA---KIS 493
            +   +   S    +Q  L+A      +H H +   VHR++K  N+LL S  +    K++
Sbjct: 104 REYYSEADASHC--IQQILEAV-----LHCH-QMGVVHRNLKPENLLLASKLKGAAVKLA 155
Query: 494 DFGLAKLVGKTSDGEATVT-KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           DFGLA  V    +GE        GT GYL+PE L         D++A GV+L+ ++ G
Sbjct: 156 DFGLAIEV----EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 358 LLGHGTYGSVYY-GNIRNQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATE 415
           +LG+G+ G+V + G+ + + VA+KRM        + E+K+L +   H N++       T+
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR---VQIALDAARGLEYIHEHTKTHY 472
             L++  E          L + +N    +L        + +    A G+ ++H       
Sbjct: 82  RFLYIALELCNLNL--QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKI 136
Query: 473 VHRDIKSSNILLDSA-------------FRAKISDFGL-AKLVGKTSDGEATVTKVVGTF 518
           +HRD+K  NIL+ ++              R  ISDFGL  KL    S     +    GT 
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 519 GYLAPEYL--TDGLATAKS-----DVYAFGVVLFEIIS 549
           G+ APE L  ++ L T +      D+++ G V + I+S
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 47/78 (60%), Gaps = 4/78 (5%)
Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT-VTKVVGTFGYLAPEYLTDGLAT 532
           HRD+K  NIL+ +   A + DFG+A     T+D + T +   VGT  Y APE  ++  AT
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYXAPERFSESHAT 213
Query: 533 AKSDVYAFGVVLFEIISG 550
            ++D+YA   VL+E ++G
Sbjct: 214 YRADIYALTCVLYECLTG 231

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 27/203 (13%)
Query: 359 LGHGTYG--SVYYGNIRNQEVAIK------RMTATKTKEFMAEMKILCKVHHSNLVELIG 410
           +G G +G   +      N+ VA+K      ++ A   +E +    +     H N+V    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL----RHPNIVRFKE 82
Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              T   L ++ EYA  G L   + +     +    +  +  I+     G+ Y H     
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AM 134
Query: 471 HYVHRDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
              HRD+K  N LLD   A R KI DFG +K     S  ++T    VGT  Y+APE L  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 190
Query: 529 GLATAK-SDVYAFGVVLFEIISG 550
                K +DV++ GV L+ ++ G
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 19/199 (9%)
Query: 359 LGHGTYG--SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAAT 414
           +G G +G   +      N+ VA+K +   +  +   + +I+    + H N+V       T
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
              L ++ EYA  G L   + +     +    +  +  I+     G+ Y H        H
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVCH 137
Query: 475 RDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           RD+K  N LLD   A R KI DFG +K     S  ++T    VGT  Y+APE L      
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKKEYD 193
Query: 533 AK-SDVYAFGVVLFEIISG 550
            K +DV++ GV L+ ++ G
Sbjct: 194 GKVADVWSCGVTLYVMLVG 212

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D  N  Q        +Q+ LD  R          G+
Sbjct: 94  FTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 141
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +      +   V T  Y 
Sbjct: 142 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMVPFVVTRYYR 194
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E+I G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 337 KPVVFTY-DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQ--EVAIKRMTATKTKEFMAE 393
           KPV + Y +E+ +AT        LG G++G V+    +    + A+K++   + + F AE
Sbjct: 63  KPVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKV---RLEVFRAE 115
Query: 394 MKILCK-VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWI 448
             + C  +    +V L G       + +  E  + GSL   + +    P++R    L   
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG-- 173
Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDG 507
                   A  GLEY+H       +H D+K+ N+LL S    A + DFG A  +     G
Sbjct: 174 -------QALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 508 EATVTK--VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           +  +T   + GT  ++APE +      AK DV++   ++  +++G
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 359 LGHGTYG--SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAAT 414
           +G G +G   +      N+ VA+K +   +  +   + +I+    + H N+V       T
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
              L ++ EYA  G L   + +     +    +  +  I+     G+ Y H        H
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYAH---AMQVAH 138
Query: 475 RDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           RD+K  N LLD   A R KI+DFG +    K S   +     VGT  Y+APE L      
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYS----KASVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 533 AK-SDVYAFGVVLFEIISG 550
            K +DV++ GV L+ ++ G
Sbjct: 195 GKVADVWSCGVTLYVMLVG 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 337 KPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIK-RMTATKTKEFMAEMK 395
           KPV + Y E        +    LG G++G V+   +++++   +  +   + + F  E  
Sbjct: 61  KPVDYEYRE---EVHWMTHQPRLGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVEEL 115
Query: 396 ILCK-VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMR 450
           + C  +    +V L G       + +  E  + GSL   +      P++R    L     
Sbjct: 116 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG---- 171
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEA 509
                 A  GLEY+H       +H D+K+ N+LL S   RA + DFG A  +     G++
Sbjct: 172 -----QALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 223
Query: 510 TVTK--VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            +T   + GT  ++APE +      AK D+++   ++  +++G
Sbjct: 224 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 365 GSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
           G  Y   I N     K+++A   ++   E +I   + H N+V L    + E   +L+++ 
Sbjct: 29  GQEYAAKIIN----TKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDL 84
Query: 425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
              G L   +   +   +   S  ++ QI       LE ++       VHRD+K  N+LL
Sbjct: 85  VTGGELFEDIVAREYYSEADASHCIQ-QI-------LESVNHCHLNGIVHRDLKPENLLL 136
Query: 485 DSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFG 541
            S  +    K++DFGLA  +    D +A      GT GYL+PE L         D++A G
Sbjct: 137 ASKSKGAAVKLADFGLA--IEVQGDQQAWFG-FAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 542 VVLFEIISG 550
           V+L+ ++ G
Sbjct: 194 VILYILLVG 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 18/189 (9%)
Query: 365 GSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
           G  Y   I N     K+++A   ++   E +I   + H N+V L    + E   +L+++ 
Sbjct: 29  GQEYAAKIIN----TKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDL 84
Query: 425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
              G L   +   +   +   S  ++ QI       LE ++       VHRD+K  N+LL
Sbjct: 85  VTGGELFEDIVAREYYSEADASHCIQ-QI-------LESVNHCHLNGIVHRDLKPENLLL 136
Query: 485 DSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFG 541
            S  +    K++DFGLA  +    D +A      GT GYL+PE L         D++A G
Sbjct: 137 ASKSKGAAVKLADFGLA--IEVQGDQQAWFG-FAGTPGYLSPEVLRKDPYGKPVDMWACG 193
Query: 542 VVLFEIISG 550
           V+L+ ++ G
Sbjct: 194 VILYILLVG 202

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT 510
           + I +  A  +E++H       +HRD+K SNI        K+ DFGL   + +  + +  
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 511 VTKV---------VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEII 548
           +T +         VGT  Y++PE +     + K D+++ G++LFE++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D  N  Q        +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +   E  V     T  Y 
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV----TRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 44/271 (16%)
Query: 335 MEKPVVFTYDEILFATEG-----FSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKT 387
           +E+P      E L A EG     +S  S LG G +G V+      +N+EV +K +   K 
Sbjct: 3   LEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV 62
Query: 388 KE-----------FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD 436
            E              E+ IL +V H+N+++++     +    L+ E    G       D
Sbjct: 63  LEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID 122
Query: 437 PQNRGQTSL-SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF 495
              R    L S+I R  ++      L+ I        +HRDIK  NI++   F  K+ DF
Sbjct: 123 RHPRLDEPLASYIFRQLVSAVGYLRLKDI--------IHRDIKDENIVIAEDFTIKLIDF 174
Query: 496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGK--- 551
           G A  + +   G+   T   GT  Y APE L  +     + ++++ GV L+ ++  +   
Sbjct: 175 GSAAYLER---GKLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
Query: 552 -------EAIIRTEGMVSKNQERRSLASFML 575
                  EA I    +VSK  E  SL S +L
Sbjct: 231 CELEETVEAAIHPPYLVSK--ELMSLVSGLL 259

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 358 LLGHGTYGSV-YYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATE 415
           +LG+G+ G+V + G+ + + VA+KRM        + E+K+L +   H N++       T+
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 99
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR---VQIALDAARGLEYIHEHTKTHY 472
             L++  E          L + +N    +L        + +    A G+ ++H       
Sbjct: 100 RFLYIALELCNLNL--QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKI 154
Query: 473 VHRDIKSSNILLDSA-------------FRAKISDFGL-AKLVGKTSDGEATVTKVVGTF 518
           +HRD+K  NIL+ ++              R  ISDFGL  KL          +    GT 
Sbjct: 155 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTS 214
Query: 519 GYLAPEYL---TDGLATAKSDVYAFGVVLFEIIS 549
           G+ APE L   T    T   D+++ G V + I+S
Sbjct: 215 GWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  I  + VAIK+++      T  K    E+ +
Sbjct: 22  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 81
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   +   L D  N  Q        +Q+ LD
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELD 129
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 130 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 184
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 185 --FMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKI 396
           D      + + +   +G G  G V   Y  I  + VAIK+++      T  K    E+ +
Sbjct: 11  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 397 LCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
           +  V+H N++ L+     +  L    E  Q   +   L D  N  Q        +Q+ LD
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELD 118
Query: 457 AAR----------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
             R          G++++H       +HRD+K SNI++ S    KI DFGLA+  G +  
Sbjct: 119 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 173
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
               +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 174 --FMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 358 LLGHGTYGSV-YYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATE 415
           +LG+G+ G+V + G+ + + VA+KRM        + E+K+L +   H N++       T+
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 99
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR---VQIALDAARGLEYIHEHTKTHY 472
             L++  E          L + +N    +L        + +    A G+ ++H       
Sbjct: 100 RFLYIALELCNLNL--QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKI 154
Query: 473 VHRDIKSSNILLDSA-------------FRAKISDFGL-AKLVGKTSDGEATVTKVVGTF 518
           +HRD+K  NIL+ ++              R  ISDFGL  KL          +    GT 
Sbjct: 155 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTS 214
Query: 519 GYLAPEYL---TDGLATAKSDVYAFGVVLFEIIS 549
           G+ APE L   T    T   D+++ G V + I+S
Sbjct: 215 GWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 46/229 (20%)
Query: 358 LLGHGTYGSV--YYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIG 410
           L+G G+YG V   Y  +  + VAIK++          K  + E+ IL +++H ++V+++ 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 411 YAATED-----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
               +D     EL+++ E A     K        R    L+ +    +  +   G++Y+H
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLF------RTPVYLTELHIKTLLYNLLVGVKYVH 173
Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA---------------- 509
                  +HRD+K +N L++     K+ DFGLA+ V    +G +                
Sbjct: 174 ---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 510 --------TVTKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIIS 549
                    +T  V T  Y APE  L     T   DV++ G +  E+++
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 358 LLGHGTYGSVYY-GNIRNQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATE 415
           +LG+G+ G+V + G+ + + VA+KRM        + E+K+L +   H N++       T+
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR---VQIALDAARGLEYIHEHTKTHY 472
             L++  E          L + +N    +L        + +    A G+ ++H       
Sbjct: 82  RFLYIALELCNLNL--QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKI 136
Query: 473 VHRDIKSSNILLDSA-------------FRAKISDFGL-AKLVGKTSDGEATVTKVVGTF 518
           +HRD+K  NIL+ ++              R  ISDFGL  KL          +    GT 
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTS 196
Query: 519 GYLAPEYL--TDGLATAKS-----DVYAFGVVLFEIIS 549
           G+ APE L  ++ L T +      D+++ G V + I+S
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   +  +    VA+K+++      T  K    E+ +L  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   L   L D  N  Q        + + LD  R          G+
Sbjct: 92  FTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IHMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA    +T+     +T  V T  Y 
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTACTNFMMTPYVVTRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +      A  D+++ G ++ E++ G
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   +   L D  N  Q        +Q+ LD  R          G+
Sbjct: 92  FTPQKSL----EEFQDVYIVMELMD-ANLCQV-------IQMELDHERMSYLLYQMLCGI 139
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA+  G +   E  V     T  Y 
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV----TRYYR 192
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 337 KPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIK-RMTATKTKEFMAEMK 395
           KPV + Y E        +    +G G++G V+   +++++   +  +   + + F  E  
Sbjct: 47  KPVDYEYRE---EVHWMTHQPRVGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVEEL 101
Query: 396 ILCK-VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMR 450
           + C  +    +V L G       + +  E  + GSL   +      P++R    L     
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG---- 157
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEA 509
                 A  GLEY+H       +H D+K+ N+LL S   RA + DFG A  +     G++
Sbjct: 158 -----QALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209
Query: 510 TVTK--VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            +T   + GT  ++APE +      AK D+++   ++  +++G
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 353 FSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVE 407
           F    + G GT+G+V  G  ++    VAIK++      + +E    M+ L  +HH N+V+
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQ 83
Query: 408 LIGYAATEDE-------LFLIYEYAQKGSLKSHLH---DPQNRGQTSLSWIMRVQIALDA 457
           L  Y  T  E       L ++ EY     +   LH       R Q +   I+        
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            R +  +H  +  +  HRDIK  N+L++ A    K+ DFG AK   K S  E  V  +  
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK---KLSPSEPNVAYICS 194
Query: 517 TFGYLAPEYL-TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE 566
            + Y APE +  +   T   D+++ G +  E++ G E I R +    +  E
Sbjct: 195 RY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSAGQLHE 243

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 337 KPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIK-RMTATKTKEFMAEMK 395
           KPV + Y E        +    +G G++G V+   +++++   +  +   + + F  E  
Sbjct: 63  KPVDYEYRE---EVHWMTHQPRVGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRVEEL 117
Query: 396 ILCK-VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMR 450
           + C  +    +V L G       + +  E  + GSL   +      P++R    L     
Sbjct: 118 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG---- 173
Query: 451 VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEA 509
                 A  GLEY+H       +H D+K+ N+LL S   RA + DFG A  +     G++
Sbjct: 174 -----QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 225
Query: 510 TVTK--VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            +T   + GT  ++APE +      AK D+++   ++  +++G
Sbjct: 226 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 359 LGHGTYG--SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAAT 414
           +G G +G   +      N+ VA+K +   +  +   + +I+    + H N+V       T
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
              L ++ EYA  G L   + +     +    +  +  I+     G+ Y H        H
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVCH 138
Query: 475 RDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           RD+K  N LLD   A R KI  FG +K     S  ++T    VGT  Y+APE L      
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKKEYD 194
Query: 533 AK-SDVYAFGVVLFEIISG 550
            K +DV++ GV L+ ++ G
Sbjct: 195 GKVADVWSCGVTLYVMLVG 213

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 28/194 (14%)
Query: 378 AIKRMTATKTK---EFMAEMKILCKVHHSNLVELIGYAATE----DELFLIYEYAQKGSL 430
           A+KR+   + +   E   E  +    +H N++ L+ Y   E     E +L+  + ++G+L
Sbjct: 58  ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117
Query: 431 KSHLHDPQNRG----QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS 486
            + +   +++G    +  + W++     L   RGLE IH      Y HRD+K +NILL  
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLL-----LGICRGLEAIH---AKGYAHRDLKPTNILLGD 169
Query: 487 AFRAKISDFGLAKLVGKTSDGEATVTKVVG------TFGYLAPEYL---TDGLATAKSDV 537
             +  + D G         +G      +        T  Y APE     +  +   ++DV
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229
Query: 538 YAFGVVLFEIISGK 551
           ++ G VL+ ++ G+
Sbjct: 230 WSLGCVLYAMMFGE 243

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI 477
           L +I E  + G L S +   Q RG  + +     +I  D    ++++H H   +  HRD+
Sbjct: 101 LLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 154
Query: 478 KSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           K  N+L  S  +    K++DFG AK   + +      T       Y+APE L        
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVAPEVLGPEKYDKS 209
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGM-VSKNQERR 568
            D+++ GV+++ ++ G        G  +S   +RR
Sbjct: 210 CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK--------TKEFMAE 393
           D++LF  + +    ++G G +  V     R   Q+ A+K +   K        T++   E
Sbjct: 20  DDVLF-EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 78
Query: 394 MKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIM 449
             I   + H ++VEL+   +++  L++++E+     L   +    + G    +   S  M
Sbjct: 79  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 138
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTSD 506
           R QI L+A R   Y H+    + +HRD+K   +LL   +++   K+  FG+A  +G++  
Sbjct: 139 R-QI-LEALR---YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG- 189
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                   VGT  ++APE +         DV+  GV+LF ++SG
Sbjct: 190 --LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK--------TKEFMAE 393
           D++LF  + +    ++G G +  V     R   Q+ A+K +   K        T++   E
Sbjct: 18  DDVLF-EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 394 MKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG----QTSLSWIM 449
             I   + H ++VEL+   +++  L++++E+     L   +    + G    +   S  M
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 450 RVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVGKTSD 506
           R QI L+A R   Y H+    + +HRD+K   +LL   +++   K+  FG+A  +G++  
Sbjct: 137 R-QI-LEALR---YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG- 187
Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                   VGT  ++APE +         DV+  GV+LF ++SG
Sbjct: 188 --LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI 477
           L +I E  + G L S +   Q RG  + +     +I  D    ++++H H   +  HRD+
Sbjct: 82  LLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 135
Query: 478 KSSNILLDSAFR---AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           K  N+L  S  +    K++DFG AK   + +      T       Y+APE L        
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVAPEVLGPEKYDKS 190
Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGM-VSKNQERR 568
            D+++ GV+++ ++ G        G  +S   +RR
Sbjct: 191 CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 225

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 359 LGHGTYG--SVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAAT 414
           +G G +G   +      N+ VA+K +   +  +   + +I+    + H N+V       T
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
              L ++ EYA  G L   + +     +    +  +  I+     G+ Y H        H
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-----GVSYCH---AMQVCH 138
Query: 475 RDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           RD+K  N LLD   A R KI  FG +    K+S   +     VGT  Y+APE L      
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYS----KSSVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 533 AK-SDVYAFGVVLFEIISG 550
            K +DV++ GV L+ ++ G
Sbjct: 195 GKVADVWSCGVTLYVMLVG 213

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 30  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 138
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 139 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 185
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 243
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 244 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 280

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 31  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 139
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 140 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 186
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 244
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 245 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 281

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 63/279 (22%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 31  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 139
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 140 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 186
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSK- 563
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR +    + 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246
Query: 564 -NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL 601
            + E + L  + L ALR S D  +   ++++  P M D+
Sbjct: 247 VSXECQHLIRWCL-ALRPS-DRPTFEEIQNH--PWMQDV 281

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 36/209 (17%)
Query: 359 LGHGTYGSV--YYGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G  G V   +  +    VA+K+++      T  K    E+ +L  V+H N++ L+  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR----------GL 461
              +  L    E  Q   L   L D  N  Q        + + LD  R          G+
Sbjct: 90  FTPQKTL----EEFQDVYLVMELMD-ANLCQV-------IHMELDHERMSYLLYQMLCGI 137
Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       +HRD+K SNI++ S    KI DFGLA    +T+     +T  V T  Y 
Sbjct: 138 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTASTNFMMTPYVVTRYYR 190
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D+++ G ++ E++ G
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 50  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 158
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 159 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 205
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 263
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 264 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 300

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 63/279 (22%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 30  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 138
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 139 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 185
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSK- 563
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR +    + 
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245
Query: 564 -NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL 601
            + E + L  + L ALR S D  +   ++++  P M D+
Sbjct: 246 VSXECQHLIRWCL-ALRPS-DRPTFEEIQNH--PWMQDV 280

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 15  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 123
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 124 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 170
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 171 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 228
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 229 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 265

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 63/279 (22%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 11  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 119
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 120 --LEAVR-----HCHNXG-VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 166
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSK- 563
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR +    + 
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 226
Query: 564 -NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL 601
            + E + L  + L ALR S D  +   ++++  P M D+
Sbjct: 227 VSXECQHLIRWCL-ALRPS-DRPTFEEIQNH--PWMQDV 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 16  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 124
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 125 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 171
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 229
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 230 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 266

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 15  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 123
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 124 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 170
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 171 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 228
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 229 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 265

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 358 LLGHGTYGSVYYGNI--RNQEVAIKRMTATKTKEFMAEMKILCKVH----HSNLVELIGY 411
           +L  G +  VY        +E A+KR+ + + ++  A ++ +C +     H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 412 AATEDEL-------FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           A+   E        FL+     KG L   L   ++RG  S   +++  I     R ++++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCRAVQHM 152
Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD----------GEATVTKV 514
           H   K   +HRD+K  N+LL +    K+ DFG A  +    D           E  +T+ 
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 515 VGTFGYLAPEYL---TDGLATAKSDVYAFGVVLF 545
             T  Y  PE +   ++     K D++A G +L+
Sbjct: 212 T-TPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 14  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 72
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 123 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 169
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 170 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 227
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 228 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 11  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 119
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 120 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 166
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 224
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 225 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 261

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 16  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 124
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 125 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 171
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 229
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 230 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 266

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 43  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 151
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 152 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 198
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 256
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 257 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 293

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 63/279 (22%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 38  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 96
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 146
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 147 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 193
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSK- 563
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR +    + 
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 253
Query: 564 -NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL 601
            + E + L  + L ALR S D  +   ++++  P M D+
Sbjct: 254 VSXECQHLIRWCL-ALRPS-DRPTFEEIQNH--PWMQDV 288

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 16  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 124
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 125 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 171
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 172 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 229
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 230 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 266

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 119/280 (42%), Gaps = 65/280 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 58  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 116
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 166
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 167 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 213
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSKN 564
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR  G V   
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--GQVFFR 271
Query: 565 QERRSLASFMLA---ALRNSPDSMSMSSLKDYIDPNMMDL 601
           Q   S    ++    ALR S D  +   ++++  P M D+
Sbjct: 272 QRVSSECQHLIRWCLALRPS-DRPTFEEIQNH--PWMQDV 308

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 380 KRMTATKT----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH 435
           +R+++++     +E   E+ IL ++ H N++ L      + ++ LI E    G L   L 
Sbjct: 41  RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 100
Query: 436 DPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAK 491
           + ++  +   +  ++ QI LD   G+ Y+H     H+   D+K  NI LLD      R K
Sbjct: 101 EKESLTEDEATQFLK-QI-LD---GVHYLHSKRIAHF---DLKPENIMLLDKNVPNPRIK 152
Query: 492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           + DFG+A  +   ++       + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 153 LIDFGIAHKIEAGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 63/279 (22%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 63  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 121
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 122 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 171
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 172 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 218
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSK- 563
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR +    + 
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 278
Query: 564 -NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL 601
            + E + L  + L ALR S D  +   ++++  P M D+
Sbjct: 279 VSXECQHLIRWCL-ALRPS-DRPTFEEIQNH--PWMQDV 313

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 57/234 (24%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 31  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 139
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 140 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 186
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTE 558
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR +
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 240

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 63/279 (22%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 58  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 116
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 166
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 167 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 213
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG------KEAIIRTEGMVSK- 563
           T   GT  Y  PE++       +S  V++ G++L++++ G       E IIR +    + 
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 564 -NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL 601
            + E + L  + L ALR S D  +   ++++  P M D+
Sbjct: 274 VSXECQHLIRWCL-ALRPS-DRPTFEEIQNH--PWMQDV 308

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 380 KRMTATKT----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLH 435
           +R+++++     +E   E+ IL ++ H N++ L      + ++ LI E    G L   L 
Sbjct: 48  RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 107
Query: 436 DPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAK 491
           + ++  +   +  ++ QI LD   G+ Y+H     H+   D+K  NI LLD      R K
Sbjct: 108 EKESLTEDEATQFLK-QI-LD---GVHYLHSKRIAHF---DLKPENIMLLDKNVPNPRIK 159
Query: 492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           + DFG+A  +   ++       + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 160 LIDFGIAHKIEAGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 16/167 (9%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +E   E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   + 
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 133
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGK 503
            ++ QI LD   G+ Y+H     H+   D+K  NI LLD      R K+ DFG+A  +  
Sbjct: 134 FLK-QI-LD---GVHYLHSKRIAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 185
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            ++       + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 186 GNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 347 LFATEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHS 403
           L  ++G+     +G G+Y           N E A+K +  +K ++   E++IL +   H 
Sbjct: 23  LVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-RDPSEEIEILLRYGQHP 81
Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N++ L         ++L+ E  + G L   +   +   +   S+++         + +EY
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT-----IGKTVEY 136
Query: 464 IHEHTKTHYVHRDIKSSNIL-LDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           +H       VHRD+K SNIL +D +      +I DFG AK + +  +G   +     T  
Sbjct: 137 LHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENG--LLMTPCYTAN 190
Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
           ++APE L         D+++ G++L+ +++G
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 44  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 152
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 153 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 199
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 44  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 152
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 153 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 199
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLK----SHLHDPQNRGQTSL 445
              E+ +    +H N+V        ++EL+++  +   GS K    +H  D  N  + ++
Sbjct: 57  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN--ELAI 114
Query: 446 SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS 505
           ++I++        + L+YIH      YVHR +K+S+IL+    +  +S  GL   +   S
Sbjct: 115 AYILQ-----GVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIS 164
Query: 506 DGEATVTKVVGTFG--------YLAPEYLTDGLA--TAKSDVYAFGVVLFEIISG 550
            G+    +VV  F         +L+PE L   L    AKSD+Y+ G+   E+ +G
Sbjct: 165 HGQRQ--RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 217

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 343 YDEILFATEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMAEMKILCKV 400
           Y + +  ++G+     +G G+Y           N E A+K +  +K ++   E++IL + 
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-RDPSEEIEILLRY 77
Query: 401 -HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
             H N++ L         ++L+ E  + G L   +   +   +   S+++         +
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT-----IGK 132
Query: 460 GLEYIHEHTKTHYVHRDIKSSNIL-LDSAFRA---KISDFGLAKLVGKTSDGEATVTKVV 515
            +EY+H       VHRD+K SNIL +D +      +I DFG AK + +  +G   +    
Sbjct: 133 TVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENG--LLMTPC 186
Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            T  ++APE L         D+++ G++L+ +++G
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 390 FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLK----SHLHDPQNRGQTSL 445
              E+ +    +H N+V        ++EL+++  +   GS K    +H  D  N  + ++
Sbjct: 73  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN--ELAI 130
Query: 446 SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS 505
           ++I++        + L+YIH      YVHR +K+S+IL+    +  +S  GL   +   S
Sbjct: 131 AYILQ-----GVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIS 180
Query: 506 DGEATVTKVVGTFG--------YLAPEYLTDGLA--TAKSDVYAFGVVLFEIISG 550
            G+    +VV  F         +L+PE L   L    AKSD+Y+ G+   E+ +G
Sbjct: 181 HGQRQ--RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 11  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 119
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 120 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 166
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 44  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 152
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 153 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 199
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 43  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 151
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 152 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 198
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 43  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 151
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 152 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 198
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 44  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 152
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 153 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 199
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 51/220 (23%)
Query: 358 LLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMA---------EMKILCKVH--HS 403
           LLG G +GSVY G IR   N  VAIK +   +  ++           E+ +L KV    S
Sbjct: 43  LLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 404 NLVELIGYAATEDELFLIYE-----------YAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
            ++ L+ +    D   LI E             ++G+L+  L         S  W +   
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-------ARSFFWQV--- 151
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATV 511
             L+A R     H H     +HRDIK  NIL+D +    K+ DFG   L+  T       
Sbjct: 152 --LEAVR-----HCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VY 198
Query: 512 TKVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISG 550
           T   GT  Y  PE++       +S  V++ G++L++++ G
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 121
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 122 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 170
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 121
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 122 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 170
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +E   E+ IL +V H N++ L        ++ LI E    G L   L   ++  +   + 
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGK 503
            ++ QI LD   G+ Y+H     H+   D+K  NI LLD        K+ DFGLA  +  
Sbjct: 120 FIK-QI-LD---GVNYLHTKKIAHF---DLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             DG      + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 170 -EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 37/266 (13%)
Query: 356 SSLLGHGTYGSVYYGN--IRNQEVAIKRMTATKTKEFMA---------EMKILCKVH--- 401
             LLG G +G+V+ G+      +VAIK +   +   +           E+ +L KV    
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 402 -HSNLVELIGYAATEDELFLIYEYAQKGS-LKSHLHDPQNRGQ-TSLSWIMRVQIALDAA 458
            H  ++ L+ +  T++   L+ E       L  ++ +    G+  S  +  +V  A+   
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ-- 153
Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
                 H H++   VHRDIK  NIL+D     AK+ DFG   L+      +   T   GT
Sbjct: 154 ------HCHSRG-VVHRDIKDENILIDLRRGCAKLIDFGSGALL-----HDEPYTDFDGT 201
Query: 518 FGYLAPEYLTDGLATA-KSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
             Y  PE+++     A  + V++ G++L++++ G     R + ++       +  S    
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCC 261
Query: 577 ALRN---SPDSMSMSSLKD-YIDPNM 598
           AL     +P   S  SL++  +DP M
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E+ IL ++ H N++ L      + ++ LI E    G L   L + ++  +   +  ++ Q
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLK-Q 122
Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGKTSDGE 508
           I      G+ Y+H     H+   D+K  NI LLD      R KI DFGLA  +    D  
Sbjct: 123 IL----NGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFG 171
Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
                + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +E   E+ IL +V H N++ L        ++ LI E    G L   L   ++  +   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGK 503
            ++ QI LD   G+ Y+H     H+   D+K  NI LLD        K+ DFGLA    +
Sbjct: 120 FIK-QI-LD---GVNYLHTKKIAHF---DLKPENIMLLDKNIPIPHIKLIDFGLAH---E 168
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             DG      + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNL 405
           T+G+     +G G+Y SV    I    N E A+K +  +K ++   E++IL +   H N+
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNI 78
Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
           + L         ++++ E  + G L   +   +   +   S ++         + +EY+H
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH 133
Query: 466 EHTKTHYVHRDIKSSNIL-LDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
                  VHRD+K SNIL +D +      +I DFG AK + +  +G   +     T  ++
Sbjct: 134 AQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENG--LLMTPCYTANFV 187
Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE L      A  D+++ GV+L+ +++G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +E   E+ IL +V H N++ L        ++ LI E    G L   L   ++  +   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGK 503
            ++ QI LD   G+ Y+H     H+   D+K  NI LLD        K+ DFGLA    +
Sbjct: 120 FIK-QI-LD---GVNYLHTKKIAHF---DLKPENIMLLDKNIPIPHIKLIDFGLAH---E 168
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             DG      + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +E   E+ IL +V H N++ L        ++ LI E    G L   L   ++  +   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGK 503
            ++ QI LD   G+ Y+H     H+   D+K  NI LLD        K+ DFGLA    +
Sbjct: 120 FIK-QI-LD---GVNYLHTKKIAHF---DLKPENIMLLDKNIPIPHIKLIDFGLAH---E 168
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             DG      + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +E   E+ IL +V H N++ L        ++ LI E    G L   L   ++  +   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGK 503
            ++ QI LD   G+ Y+H     H+   D+K  NI LLD        K+ DFGLA    +
Sbjct: 120 FIK-QI-LD---GVNYLHTKKIAHF---DLKPENIMLLDKNIPIPHIKLIDFGLAH---E 168
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             DG      + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 16/167 (9%)
Query: 388 KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW 447
           +E   E+ IL +V H N++ L        ++ LI E    G L   L   ++  +   + 
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI-LLDSAF---RAKISDFGLAKLVGK 503
            ++ QI LD   G+ Y+H     H+   D+K  NI LLD        K+ DFGLA    +
Sbjct: 120 FIK-QI-LD---GVNYLHTKKIAHF---DLKPENIMLLDKNIPIPHIKLIDFGLAH---E 168
Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             DG      + GT  ++APE +       ++D+++ GV+ + ++SG
Sbjct: 169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 121/297 (40%), Gaps = 63/297 (21%)
Query: 359 LGHGTYGSVYYGNIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIG--Y 411
           L     G ++ G  +  ++ +K +     +  K+++F  E   L    H N++ ++G   
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQN----RGQTSLSWIMRVQIALDAARGLEYIHEH 467
           +       LI  +   GSL + LH+  N    + Q        V+ ALD ARG+ ++H  
Sbjct: 78  SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA-------VKFALDMARGMAFLH-- 128
Query: 468 TKTHYVHRD-IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
           T    + R  + S ++++D    A+IS   +       S G            ++APE L
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVK--FSFQSPGRMYAP------AWVAPEAL 180
Query: 527 T---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
               +      +D+++F V+L+E+++ +                        A L N   
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP---------------------FADLSNMEI 219
Query: 584 SM--SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
            M  ++  L+  I P    + PH     ++ L K C++EDP  RP    +V  L ++
Sbjct: 220 GMKVALEGLRPTIPPG---ISPH-----VSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 359 LGHGTYGSVYYG-NIR-NQEVAIK-RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G++G +Y G NI+ N+EVAIK     TK  + + E KI   +     +  + +   E
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
            +    Y       L   L D  N     LS    + +A      +E++H  +   ++HR
Sbjct: 75  GD----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 476 DIKSSNILLDSAFRAK---ISDFGLAKLVGKTSDGEATVTK----VVGTFGYLAPEYLTD 528
           DIK  N L+    RA    I DFGLAK    TS  +    +    + GT  Y +      
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG 187
Query: 529 GLATAKSDVYAFGVVLFEIISG 550
              + + D+ + G VL   + G
Sbjct: 188 IEQSRRDDLESLGYVLMYFLRG 209
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	639
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-113
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-113
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-109
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-88
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-78
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-70
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-70
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-65
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-63
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-63
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-62
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-61
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-61
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-48
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-43
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-43
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-42
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-41
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-41
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-40
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-40
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-39
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-39
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-38
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-38
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-38
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-36
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-34
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-26
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-20
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	8e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-09
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-06
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	5e-04
1y7m_A	164	Hypothetical protein BSU14040; surface mutagenesis	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  341 bits (877), Expect = e-113
 Identities = 116/327 (35%), Positives = 170/327 (51%), Gaps = 23/327 (7%)

Query: 318 SNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QE 376
           S    +I  AL +      +       ++  AT  F    L+GHG +G VY G +R+  +
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65

Query: 377 VAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSH 433
           VA+KR T       +EF  E++ L    H +LV LIG+    +E+ LIY+Y + G+LK H
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125

Query: 434 LHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS 493
           L+   +    S+SW  R++I + AARGL Y+H       +HRD+KS NILLD  F  KI+
Sbjct: 126 LYGS-DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181

Query: 494 DFGLAKLVGKTSDGEATV-TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE 552
           DFG++K    T   +  + T V GT GY+ PEY   G  T KSDVY+FGVVLFE++  + 
Sbjct: 182 DFGISKKG--TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Query: 553 AIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAM 612
           AI++     S  +E  +LA + + +  N         L+  +DPN+ D    + L K   
Sbjct: 240 AIVQ-----SLPREMVNLAEWAVESHNN-------GQLEQIVDPNLADKIRPESLRKFGD 287

Query: 613 LAKQCVDEDPILRPDMKQVVISLSQIL 639
            A +C+      RP M  V+  L   L
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYAL 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  340 bits (874), Expect = e-113
 Identities = 115/313 (36%), Positives = 168/313 (53%), Gaps = 34/313 (10%)

Query: 340 VFTYDEILFATEGFSD------SSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT------ 387
            F++ E+   T  F +       + +G G +G VY G + N  VA+K++ A         
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEEL 73

Query: 388 -KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS 446
            ++F  E+K++ K  H NLVEL+G+++  D+L L+Y Y   GSL   L      G   LS
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLS 131

Query: 447 WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD 506
           W MR +IA  AA G+ ++HE+   H++HRDIKS+NILLD AF AKISDFGLA+   +   
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA-SEKFA 187

Query: 507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE 566
                +++VGT  Y+APE L  G  T KSD+Y+FGVVL EII+G  A       V +++E
Sbjct: 188 QTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA-------VDEHRE 239

Query: 567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
            + L                  +++DYID  M D      +  M  +A QC+ E    RP
Sbjct: 240 PQLLLDIKEEIEDEE------KTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292

Query: 627 DMKQVVISLSQIL 639
           D+K+V   L ++ 
Sbjct: 293 DIKKVQQLLQEMT 305

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  329 bits (847), Expect = e-109
 Identities = 102/304 (33%), Positives = 165/304 (54%), Gaps = 20/304 (6%)

Query: 338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTATKT----KEFMA 392
              F+  E+  A++ FS+ ++LG G +G VY G + +   VA+KR+   +T     +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ 452
           E++++    H NL+ L G+  T  E  L+Y Y   GS+ S L + +   Q  L W  R +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQR 135

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV- 511
           IAL +ARGL Y+H+H     +HRD+K++NILLD  F A + DFGLAKL+      +  V 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVT 192

Query: 512 TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA 571
           T V GT G++APEYL+ G ++ K+DV+ +GV+L E+I+G+ A    +     N +   L 
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF---DLARLANDDDVMLL 249

Query: 572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
            ++   L+          L+  +D ++   Y  + + ++  +A  C    P+ RP M +V
Sbjct: 250 DWVKGLLKE-------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 632 VISL 635
           V  L
Sbjct: 303 VRML 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  276 bits (709), Expect = 2e-88
 Identities = 83/317 (26%), Positives = 131/317 (41%), Gaps = 33/317 (10%)

Query: 341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LC 398
              + + F +       +   G +G V+   + N+ VA+K       + +  E ++  L 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 399 KVHHSNLVELIGY----AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA 454
            + H N+++ IG      + + +L+LI  + +KGSL   L          +SW     IA
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHIA 127

Query: 455 LDAARGLEYIHEHT-------KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
              ARGL Y+HE         K    HRDIKS N+LL +   A I+DFGLA         
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 508 EATVTKVVGTFGYLAPEYLTDGL-----ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS 562
             T    VGT  Y+APE L   +     A  + D+YA G+VL+E+ S   A    +G V 
Sbjct: 188 GDT-HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA---DGPVD 243

Query: 563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLY-PHDCLFKMAMLAKQCVDED 621
           +      L          S + M    +     P + D +  H  +  +    ++C D D
Sbjct: 244 EYM----LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299

Query: 622 PILRPDMKQVVISLSQI 638
              R     V   ++Q+
Sbjct: 300 AEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  250 bits (639), Expect = 7e-78
 Identities = 71/326 (21%), Positives = 127/326 (38%), Gaps = 38/326 (11%)

Query: 341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LC 398
               E     +      L+G G YG+VY G++  + VA+K  +    + F+ E  I  + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62

Query: 399 KVHHSNLVELIGY-----AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
            + H N+   I       A    E  L+ EY   GSL  +L         +  W+   ++
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRL 116

Query: 454 ALDAARGLEYIHE------HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS-- 505
           A    RGL Y+H       H K    HRD+ S N+L+ +     ISDFGL+  +      
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 506 ---DGEATVTKVVGTFGYLAPEYLTDGL-------ATAKSDVYAFGVVLFEIISGKEAII 555
              + +      VGT  Y+APE L   +       A  + D+YA G++ +EI      + 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 556 RTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHD--CLFKMAML 613
             E +         +A         + + M +   ++   P   + +  +   +  +   
Sbjct: 237 PGESV-----PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 614 AKQCVDEDPILRPDMKQVVISLSQIL 639
            + C D+D   R   +     +++++
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELM 317

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  229 bits (587), Expect = 2e-70
 Identities = 75/294 (25%), Positives = 134/294 (45%), Gaps = 54/294 (18%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+V+       +VA+K +      A +  EF+ E+ I+ ++ H N+V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
               L ++ EY  +GSL   LH    R Q  L    R+ +A D A+G+ Y+H       V
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNR-NPPIV 161

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATA 533
           HR++KS N+L+D  +  K+ DFGL++L   T     +     GT  ++APE L D  +  
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL---SSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 534 KSDVYAFGVVLFEIISGKE--------AIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
           KSDVY+FGV+L+E+ + ++         ++     V    +R                  
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKCKR------------------ 257

Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                        +++ P +   ++A + + C   +P  RP    ++  L  ++
Sbjct: 258 -------------LEI-PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  227 bits (582), Expect = 9e-70
 Identities = 70/290 (24%), Positives = 128/290 (44%), Gaps = 52/290 (17%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G V     R ++VAIK++ +    K F+ E++ L +V+H N+V+L G  A  + 
Sbjct: 16  VGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG--ACLNP 73

Query: 418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI 477
           + L+ EYA+ GSL + LH  +       +    +   L  ++G+ Y+H       +HRD+
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131

Query: 478 KSSNILLDSAFR-AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSD 536
           K  N+LL +     KI DFG A  +      +  +T   G+  ++APE       + K D
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDI------QTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 537 VYAFGVVLFEIISGKE-------AIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS 589
           V+++G++L+E+I+ ++          R    V     R  L                   
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPL------------------- 225

Query: 590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                          +    +  L  +C  +DP  RP M+++V  ++ ++
Sbjct: 226 -------------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  218 bits (558), Expect = 2e-66
 Identities = 74/298 (24%), Positives = 134/298 (44%), Gaps = 59/298 (19%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKR-----MTATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G+VY G   + +VA+K       T  + + F  E+ +L K  H N++  +G  +
Sbjct: 32  IGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YS 89

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           T  +L ++ ++ +  SL  HLH  + +          + IA   ARG++Y+H       +
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHAK---SII 142

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA-- 531
           HRD+KS+NI L      KI DFGLA    + S G     ++ G+  ++APE +    +  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 532 -TAKSDVYAFGVVLFEIISGK---------EAIIRTEGMVSKNQERRSLASFMLAALRNS 581
            + +SDVYAFG+VL+E+++G+         + II    MV +      L+          
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---EMVGRGSLSPDLSKV-------- 250

Query: 582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                                  +C  +M  L  +C+ +    RP   +++  + ++ 
Sbjct: 251 ---------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  218 bits (557), Expect = 2e-66
 Identities = 79/338 (23%), Positives = 141/338 (41%), Gaps = 78/338 (23%)

Query: 327 ALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRM-- 382
           A+G   F   +      +EI +  +       +G G +G V+ G        VAIK +  
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 383 --------TATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHL 434
                      K +EF  E+ I+  ++H N+V+L G     +   ++ E+   G L   L
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRL 112

Query: 435 HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-----FR 489
            D  +     + W +++++ LD A G+EY+        VHRD++S NI L S        
Sbjct: 113 LDKAH----PIKWSVKLRLMLDIALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVC 167

Query: 490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT--DGLATAKSDVYAFGVVLFEI 547
           AK++DFGL++    +       + ++G F ++APE +   +   T K+D Y+F ++L+ I
Sbjct: 168 AKVADFGLSQQSVHSV------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221

Query: 548 ISGKE-------AIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMD 600
           ++G+          I+   M+ +   R                            P +  
Sbjct: 222 LTGEGPFDEYSYGKIKFINMIREEGLR----------------------------PTI-- 251

Query: 601 LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             P DC  ++  + + C   DP  RP    +V  LS++
Sbjct: 252 --PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  215 bits (549), Expect = 2e-65
 Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 69/303 (22%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRM-------TATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G +G VY       EVA+K          +   +    E K+   + H N++ L G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              E  L L+ E+A+ G L   L   +      +   + V  A+  ARG+ Y+H+     
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 472 YVHRDIKSSNILLDSAFR--------AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            +HRD+KSSNIL+              KI+DFGLA+   +T     T     G + ++AP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-----TKMSAAGAYAWMAP 183

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGKE--------AIIRTEGMVSKNQERRSLASFML 575
           E +   + +  SDV+++GV+L+E+++G+         A+      V+ N+          
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA---YGVAMNKLA-------- 232

Query: 576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                                  + + P  C    A L + C + DP  RP    ++  L
Sbjct: 233 -----------------------LPI-PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

Query: 636 SQI 638
           + I
Sbjct: 269 TTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  214 bits (546), Expect = 4e-64
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 33/301 (10%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LCKVHHSNLVELIGY---- 411
            +G G YG V+ G  R ++VA+K    T+   +  E +I     + H N++  I      
Sbjct: 44  QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE----- 466
             +  +L+LI +Y + GSL  +L         +L     +++A  +  GL ++H      
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLA-KLVGKTSDGEATVTKVVGTFGYLAPEY 525
             K    HRD+KS NIL+       I+D GLA K +  T++ +      VGT  Y+ PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 526 LTDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           L + L      +   +D+Y+FG++L+E+                  E   L    L    
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCV--------SGGIVEEYQLPYHDLVPSD 269

Query: 580 NSPDSMSMSSLKDYIDPNMMDLY-PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
            S + M        + P+  + +   +CL +M  L  +C   +P  R    +V  +L+++
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 639 L 639
            
Sbjct: 330 S 330

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  211 bits (539), Expect = 2e-63
 Identities = 62/305 (20%), Positives = 115/305 (37%), Gaps = 68/305 (22%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           +G G +G VY+G   + EVAI+ +        + K F  E+    +  H N+V  +G   
Sbjct: 41  IGKGRFGQVYHG-RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           +   L +I    +  +L S + D +      L      QIA +  +G+ Y+H       +
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEIVKGMGYLHAK---GIL 152

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKT--SDGEATVTKVVGTFGYLAPEYLTDGLA 531
           H+D+KS N+  D+  +  I+DFGL  + G       E  +    G   +LAPE +     
Sbjct: 153 HKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 532 ---------TAKSDVYAFGVVLFEIISGK--------EAIIRTEGMVSKNQERRSLASFM 574
                    +  SDV+A G + +E+ + +        EAII     +     + +L+   
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII---WQMGTG-MKPNLS--- 264

Query: 575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
                                             +++ +   C   +   RP   +++  
Sbjct: 265 ----------------------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

Query: 635 LSQIL 639
           L ++ 
Sbjct: 297 LEKLP 301

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  205 bits (523), Expect = 3e-61
 Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 33/300 (11%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LCKVHHSNLVELIGY---- 411
            +G G YG V+ G+ + + VA+K  ++   K +  E ++     + H N++  I      
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE----- 466
             +  +L+LI  Y + GSL  +L         +L  +  ++I L  A GL ++H      
Sbjct: 75  RHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD-GEATVTKVVGTFGYLAPE- 524
             K    HRD+KS NIL+    +  I+D GLA +  ++++  +      VGT  Y+APE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 525 -----YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
                 +    +  + D++AFG+VL+E+              +   E      + +    
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV--------SNGIVEDYKPPFYDVVPND 240

Query: 580 NSPDSMSMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
            S + M      D   PN+    +    L  +A L K+C  ++P  R    ++  +L++I
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  206 bits (526), Expect = 3e-61
 Identities = 75/301 (24%), Positives = 133/301 (44%), Gaps = 33/301 (10%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LCKVHHSNLVELIG----Y 411
            +G G +G V+ G  R +EVA+K  ++ + + +  E +I     + H N++  I      
Sbjct: 49  SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT--- 468
             T  +L+L+ +Y + GSL  +L+      + +++    +++AL  A GL ++H      
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 469 --KTHYVHRDIKSSNILLDSAFRAKISDFGLAK-LVGKTSDGEATVTKVVGTFGYLAPEY 525
             K    HRD+KS NIL+       I+D GLA      T   +      VGT  Y+APE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 526 LTDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           L D +      +  ++D+YA G+V +EI             +    E   L  + L    
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCS--------IGGIHEDYQLPYYDLVPSD 274

Query: 580 NSPDSMSMSSLKDYIDPNMMD-LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
            S + M     +  + PN+ +     + L  MA + ++C   +   R    ++  +LSQ+
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

Query: 639 L 639
            
Sbjct: 335 S 335

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  205 bits (523), Expect = 4e-61
 Identities = 69/298 (23%), Positives = 117/298 (39%), Gaps = 51/298 (17%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G           + + +K +        + F+ E+K++  + H N+++ IG   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
            +  L  I EY + G+L+  +    ++      W  RV  A D A G+ Y+H     + +
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLHSM---NII 130

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-----------TKVVGTFGYLA 522
           HRD+ S N L+       ++DFGLA+L+         +             VVG   ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           PE +       K DV++FG+VL EII    A       + +  +      F L       
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA---DPDYLPRTMD------FGLNVRGF-- 239

Query: 583 DSMSMSSLKDYIDPNMMDLY-PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                           +D Y P +C      +  +C D DP  RP   ++   L  + 
Sbjct: 240 ----------------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  204 bits (520), Expect = 4e-61
 Identities = 58/315 (18%), Positives = 115/315 (36%), Gaps = 74/315 (23%)

Query: 343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRM-----TATKTKEFMAEMKIL 397
           + ++ F T+       L     G ++ G  +  ++ +K +     +  K+++F  E   L
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61

Query: 398 CKVHHSNLVELIGYAATE---DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA 454
               H N++ ++G A          LI  +   GSL + LH+  N     +     V+ A
Sbjct: 62  RIFSHPNVLPVLG-ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFA 117

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
           LD ARG+ ++H           + S ++++D    A+IS   +                 
Sbjct: 118 LDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKF--------SFQSPGR 168

Query: 515 VGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKE--------AIIRTEGMVSK 563
           +    ++APE L           +D+++F V+L+E+++ +          I      V+ 
Sbjct: 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---MKVAL 225

Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
              R ++                                P      ++ L K C++EDP 
Sbjct: 226 EGLRPTI--------------------------------PPGISPHVSKLMKICMNEDPA 253

Query: 624 LRPDMKQVVISLSQI 638
            RP    +V  L ++
Sbjct: 254 KRPKFDMIVPILEKM 268

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  173 bits (440), Expect = 1e-48
 Identities = 73/291 (25%), Positives = 119/291 (40%), Gaps = 49/291 (16%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           +G G +G V+ G     N  VA+K            +F+ E +IL +  H N+V LIG  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             +  ++++ E  Q G   + L   +  G   L     +Q+  DAA G+EY+        
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL---RTEGA-RLRVKTLLQMVGDAAAGMEYLESK---CC 234

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGL 530
           +HRD+ + N L+      KISDFG+++     +DG    +  +        APE L  G 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGGLRQVPVKWTAPEALNYGR 291

Query: 531 ATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQE-RRSLASFMLAALRNSPDSMSMS 588
            +++SDV++FG++L+E  S G         +   NQ+ R  +                  
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPY---PNL--SNQQTREFVE----------------- 329

Query: 589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
             K       +   P  C   +  L +QC   +P  RP    +   L  I 
Sbjct: 330 --KGGR----LPC-PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  168 bits (427), Expect = 6e-46
 Identities = 80/288 (27%), Positives = 133/288 (46%), Gaps = 51/288 (17%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRM-TATKTKEFMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G V  G+ R  +VA+K +      + F+AE  ++ ++ HSNLV+L+G    E++
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG-VIVEEK 259

Query: 418 --LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             L+++ EY  KGSL  +L   ++RG++ L     ++ +LD    +EY+  +   ++VHR
Sbjct: 260 GGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 313

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLATA 533
           D+ + N+L+     AK+SDFGL K    T D         G       APE L +   + 
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKWTAPEALREKKFST 365

Query: 534 KSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSMSMSSLKD 592
           KSDV++FG++L+EI         + G V                    P   + +  +  
Sbjct: 366 KSDVWSFGILLWEIY--------SFGRV--------------------PYPRIPLKDVVP 397

Query: 593 YIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
            ++    MD  P  C   +  + K C   D   RP   Q+   L  I 
Sbjct: 398 RVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  165 bits (419), Expect = 1e-44
 Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 43/287 (14%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIKRM--TATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K +     + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L   +   +  +S ++ + +A   +  +EY+ +    +++H
Sbjct: 288 EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLAT 532
           R++ + N L+      K++DFGL++L+     G+         F     APE L     +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            KSDV+AFGV+L+EI +    +    G+     +   L                    KD
Sbjct: 398 IKSDVWAFGVLLWEIAT--YGMSPYPGI--DLSQVYELLE------------------KD 435

Query: 593 YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           Y     M+  P  C  K+  L + C   +P  RP   ++  +   + 
Sbjct: 436 YR----MER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  159 bits (404), Expect = 5e-44
 Identities = 65/295 (22%), Positives = 126/295 (42%), Gaps = 54/295 (18%)

Query: 359 LGHGTYGSVYYGNIRNQ------EVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G+VY G    +       VAIK +    +    KE + E  ++  V + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +G       + LI +    G L  ++   +++      ++  +   +  A+G+ Y+ +  
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYL--LNWCVQIAKGMNYLEDR- 136

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYL 526
               VHRD+ + N+L+ +    KI+DFGLAKL+G     E       G     ++A E +
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---AEEKEYHAEGGKVPIKWMALESI 191

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSM 585
              + T +SDV+++GV ++E++        T G                      P D +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELM--------TFGS--------------------KPYDGI 223

Query: 586 SMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
             S +   ++    +   P  C   + M+ ++C   D   RP  ++++I  S++ 
Sbjct: 224 PASEISSILEKGERLPQ-PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  157 bits (399), Expect = 1e-43
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 36/295 (12%)

Query: 359 LGHGTYGSVYYG------NIRNQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV         +   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   +++ +     +  +Q      +G+EY+   
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKL--LQYTSQICKGMEYLGTK 133

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEY 525
               Y+HRD+ + NIL+++  R KI DFGL K++    D E    K  G     + APE 
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLP--QDKEFFKVKEPGESPIFWYAPES 188

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
           LT+   +  SDV++FGVVL+E+ +  E            + +   A FM     +    M
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIE------------KSKSPPAEFMRMIGNDKQGQM 236

Query: 586 SMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
            +  L + +  N  +   P  C  ++ M+  +C + +   RP  + + + + QI 
Sbjct: 237 IVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  161 bits (410), Expect = 1e-43
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK  +      + F+ E +++ K+ H  LV+L     +E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L   +      L     V +A   A G+ Y+      +YVHR
Sbjct: 251 EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D++++NIL+      K++DFGLA+L+           K      + APE    G  T KS
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKS 362

Query: 536 DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYID 595
           DV++FG++L E+ +  +  +   GM   N+E       +L  +            + Y  
Sbjct: 363 DVWSFGILLTELTT--KGRVPYPGM--VNRE-------VLDQVE-----------RGYR- 399

Query: 596 PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
              M   P +C   +  L  QC  ++P  RP  + +   L    
Sbjct: 400 ---MPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  156 bits (398), Expect = 1e-43
 Identities = 68/199 (34%), Positives = 112/199 (56%), Gaps = 26/199 (13%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKT-KEFMAEMKILCKVHHSNLVELIGYAATEDE 417
           +G G +G V  G+ R  +VA+K +    T + F+AE  ++ ++ HSNLV+L+G    E++
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG-VIVEEK 87

Query: 418 --LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             L+++ EY  KGSL  +L   ++RG++ L     ++ +LD    +EY+  +   ++VHR
Sbjct: 88  GGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 141

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL-----APEYLTDGL 530
           D+ + N+L+     AK+SDFGL K    T D            G L     APE L +  
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------GKLPVKWTAPEALREKK 190

Query: 531 ATAKSDVYAFGVVLFEIIS 549
            + KSDV++FG++L+EI S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  158 bits (401), Expect = 1e-43
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 43/298 (14%)

Query: 359 LGHGTYGSVYYG------NIRNQEVAIKRMTATKT---KEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV         +     VA+K++  +     ++F  E++IL  +H   +V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y      L L+ EY   G L+  L   ++R +   S +  +  +    +G+EY+   
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRL--LLYSSQICKGMEYLGSR 146

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL-----A 522
                VHRD+ + NIL++S    KI+DFGLAKL+    D    V       G       A
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVR----EPGQSPIFWYA 198

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           PE L+D + + +SDV++FGVVL+E+         T    S      S ++  L  +    
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELF--------TYCDKS-----CSPSAEFLRMMGCER 245

Query: 583 DSMSMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           D  ++S L + ++    +   P  C  ++  L K C    P  RP    +   L  + 
Sbjct: 246 DVPALSRLLELLEEGQRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (400), Expect = 2e-43
 Identities = 80/296 (27%), Positives = 140/296 (47%), Gaps = 38/296 (12%)

Query: 359 LGHGTYGSVYYG------NIRNQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +GSV         +   + VA+K++   T    ++F  E++IL  + H N+V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 410 G--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G  Y+A    L LI EY   GSL+ +L   +++ +     +  +Q      +G+EY+   
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKL--LQYTSQICKGMEYLGTK 164

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEY 525
               Y+HRD+ + NIL+++  R KI DFGL K++    D E    K  G     + APE 
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLP--QDKEYYKVKEPGESPIFWYAPES 219

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DS 584
           LT+   +  SDV++FGVVL+E+ +  E             + +S  +  +  + N     
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIE-------------KSKSPPAEFMRMIGNDKQGQ 266

Query: 585 MSMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           M +  L + +  N  +   P  C  ++ M+  +C + +   RP  + + + + QI 
Sbjct: 267 MIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  161 bits (409), Expect = 6e-43
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G       VAIK  +      + F+ E +++ K+ H  LV+L     +E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 333

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + ++++ EY  KGSL   L   +      L     V +A   A G+ Y+      +YVHR
Sbjct: 334 EPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D++++NIL+      K++DFGLA+L+           K      + APE    G  T KS
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKS 445

Query: 536 DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYID 595
           DV++FG++L E+ +  +  +   GM   N+E       +L  +            + Y  
Sbjct: 446 DVWSFGILLTELTT--KGRVPYPGM--VNRE-------VLDQVE-----------RGYR- 482

Query: 596 PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
              M   P +C   +  L  QC  ++P  RP  + +   L    
Sbjct: 483 ---MPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  154 bits (392), Expect = 1e-42
 Identities = 70/296 (23%), Positives = 131/296 (44%), Gaps = 38/296 (12%)

Query: 359 LGHGTYGSVYYG------NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V         +   ++VA+K +          +   E++IL  ++H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 409 IG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G       + + LI E+   GSLK +L  P+N+ + +L     ++ A+   +G++Y+  
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQ--LKYAVQICKGMDYLGS 144

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPE 524
                YVHRD+ + N+L++S  + KI DFGL K +   +D E    K        + APE
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--TDKEYYTVKDDRDSPVFWYAPE 199

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS 584
            L        SDV++FGV L E+             ++      S  +  L  +  +   
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHEL-------------LTYCDSDSSPMALFLKMIGPTHGQ 246

Query: 585 MSMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           M+++ L + +     +   P +C  ++  L ++C +  P  R   + ++     +L
Sbjct: 247 MTVTRLVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  153 bits (390), Expect = 2e-42
 Identities = 63/196 (32%), Positives = 104/196 (53%), Gaps = 16/196 (8%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+ G      +VA+K  +  +     F+AE  ++ ++ H  LV L     T+
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQ 79

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I EY + GSL   L   +      L+    + +A   A G+ +I E    +Y+HR
Sbjct: 80  EPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLATA 533
           D++++NIL+      KI+DFGLA+L+    D E T  +    F     APE +  G  T 
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI---EDNEYT-AREGAKFPIKWTAPEAINYGTFTI 189

Query: 534 KSDVYAFGVVLFEIIS 549
           KSDV++FG++L EI++
Sbjct: 190 KSDVWSFGILLTEIVT 205

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  151 bits (384), Expect = 8e-42
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 16/196 (8%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G   N+ +VAIK  R  A   ++F+ E +++ K+ H  LV+L G    +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L+ E+ + G L  +L     RG  +   +  + + LD   G+ Y+ E      +HR
Sbjct: 76  APICLVTEFMEHGCLSDYLRT--QRGLFAAETL--LGMCLDVCEGMAYLEEA---CVIHR 128

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLATA 533
           D+ + N L+      K+SDFG+ + V      +   +     F     +PE  +    ++
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 534 KSDVYAFGVVLFEIIS 549
           KSDV++FGV+++E+ S
Sbjct: 185 KSDVWSFGVLMWEVFS 200

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  153 bits (388), Expect = 9e-42
 Identities = 85/309 (27%), Positives = 141/309 (45%), Gaps = 68/309 (22%)

Query: 358 LLGHGTYGSVYYGNIRNQE----VAIKRM----TATKTKEFMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+        AIKRM    +    ++F  E+++LCK+ HH N++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQIALDA 457
           +G       L+L  EYA  G+L   L               N   ++LS    +  A D 
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           ARG++Y+ +     ++HRD+ + NIL+   + AKI+DFGL++        E     V  T
Sbjct: 152 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQE---VYVKKT 199

Query: 518 FGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
            G L     A E L   + T  SDV+++GV+L+EI+S                       
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------------------- 236

Query: 573 FMLAALRNSP-DSMSMSSLKDYIDP-NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ 630
                L  +P   M+ + L + +     ++  P +C  ++  L +QC  E P  RP   Q
Sbjct: 237 -----LGGTPYCGMTCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQ 290

Query: 631 VVISLSQIL 639
           +++SL+++L
Sbjct: 291 ILVSLNRML 299

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  152 bits (385), Expect = 1e-41
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 51/291 (17%)

Query: 359 LGHGTYGSVYYGNIRNQE--VAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
           LG G YG VY G  +     VA+K  +    + +EF+ E  ++ ++ H NLV+L+G    
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E   ++I E+   G+L  +L   +   +  +S ++ + +A   +  +EY+ +    +++H
Sbjct: 81  EPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLAT 532
           RD+ + N L+      K++DFGL++L+     G+         F     APE L     +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMV----SKNQERRSLASFMLAALRNSPDSMSMS 588
            KSDV+AFGV+L+EI         T GM         +       +   L          
Sbjct: 191 IKSDVWAFGVLLWEIA--------TYGMSPYPGIDLSQ-------VYELLE--------- 226

Query: 589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
             KDY     M+  P  C  K+  L + C   +P  RP   ++  +   + 
Sbjct: 227 --KDYR----MER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  152 bits (386), Expect = 1e-41
 Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 46/299 (15%)

Query: 359 LGHGTYGSVYYGNIRN------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V             + VA+K +           +  E+ IL  ++H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 409 IG--YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            G    A    L L+ EY   GSL+ +L         S+     +  A     G+ Y+H 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA 152

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL----- 521
               HY+HRD+ + N+LLD+    KI DFGLAK V +  +        V   G       
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-----RVREDGDSPVFWY 204

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS 581
           APE L +      SDV++FGV L+E+             ++     +S  +  L  +  +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYEL-------------LTHCDSSQSPPTKFLELIGIA 251

Query: 582 PDSMSMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
              M++  L + ++    +   P  C  ++  L K C + +   RP  + ++  L  + 
Sbjct: 252 QGQMTVLRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  153 bits (389), Expect = 1e-41
 Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 70/313 (22%)

Query: 359 LGHGTYGSVYYGNIRN---------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSN 404
           LG G +G V                  VA+K +    T     + ++EM+++  +  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           +D     +  +++   V  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
               ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +            
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID------YY 259

Query: 514 VVGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
              T G L     APE L D + T +SDV++FGV+++EI +                   
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------------------- 300

Query: 569 SLASFMLAALRNSP-DSMSMSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                    L  SP   + +  L   + + + MD  P +C  ++ M+ + C    P  RP
Sbjct: 301 ---------LGGSPYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAVPSQRP 350

Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +IL
Sbjct: 351 TFKQLVEDLDRIL 363

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  155 bits (393), Expect = 3e-41
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 16/196 (8%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V+        +VA+K  +  +   + F+AE  ++  + H  LV+L     T+
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 254

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
           + +++I E+  KGSL   L   ++   +       +  +   A G+ +I +    +Y+HR
Sbjct: 255 EPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLATA 533
           D++++NIL+ ++   KI+DFGLA+++    +      +    F     APE +  G  T 
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 534 KSDVYAFGVVLFEIIS 549
           KSDV++FG++L EI++
Sbjct: 365 KSDVWSFGILLMEIVT 380

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  151 bits (383), Expect = 4e-41
 Identities = 65/295 (22%), Positives = 125/295 (42%), Gaps = 54/295 (18%)

Query: 359 LGHGTYGSVYYGNIRNQ------EVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G+VY G    +       VAIK +    +    KE + E  ++  V + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +G       + LI +    G L  ++   +++      ++  +   +  A+G+ Y+ +  
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYL--LNWCVQIAKGMNYLEDR- 136

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYL 526
               VHRD+ + N+L+ +    KI+DFGLAKL+G     E       G     ++A E +
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---AEEKEYHAEGGKVPIKWMALESI 191

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSM 585
              + T +SDV+++GV ++E++        T G                      P D +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELM--------TFGS--------------------KPYDGI 223

Query: 586 SMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
             S +   ++    +   P  C   + M+  +C   D   RP  ++++I  S++ 
Sbjct: 224 PASEISSILEKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  150 bits (382), Expect = 5e-41
 Identities = 63/295 (21%), Positives = 124/295 (42%), Gaps = 54/295 (18%)

Query: 359 LGHGTYGSVYYGNIRNQ------EVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G+V+ G    +       V IK +         +     M  +  + H+++V L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +G       L L+ +Y   GSL  H+   Q+RG      +  +   +  A+G+ Y+ EH 
Sbjct: 81  LG-LCPGSSLQLVTQYLPLGSLLDHVR--QHRGALGPQLL--LNWGVQIAKGMYYLEEH- 134

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYL 526
               VHR++ + N+LL S  + +++DFG+A L+      +  +          ++A E +
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLP---PDDKQLLYSEAKTPIKWMALESI 189

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DSM 585
             G  T +SDV+++GV ++E++        T G                      P   +
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELM--------TFGA--------------------EPYAGL 221

Query: 586 SMSSLKDYIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
            ++ + D ++    +   P  C   + M+  +C   D  +RP  K++    +++ 
Sbjct: 222 RLAEVPDLLEKGERLAQ-PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  149 bits (379), Expect = 5e-41
 Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 16/196 (8%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R Q +VAIK  +  +    EF+ E K++  + H  LV+L G    +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L +   R +     +  +++  D    +EY+       ++HR
Sbjct: 92  RPIFIITEYMANGCLLNYLRE--MRHRFQTQQL--LEMCKDVCEAMEYLESK---QFLHR 144

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLATA 533
           D+ + N L++     K+SDFGL++ V      +   + V   F      PE L     ++
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 534 KSDVYAFGVVLFEIIS 549
           KSD++AFGV+++EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  150 bits (381), Expect = 9e-41
 Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 70/313 (22%)

Query: 359 LGHGTYGSVYYGNIRN---------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSN 404
           LG G +G V                  VA+K +    T     + ++EM+++  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           +D     +  +++   V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
               ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +            
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID------YY 213

Query: 514 VVGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
              T G L     APE L D + T +SDV++FGV+++EI +                   
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT------------------- 254

Query: 569 SLASFMLAALRNSP-DSMSMSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                    L  SP   + +  L   + + + MD  P +C  ++ M+ + C    P  RP
Sbjct: 255 ---------LGGSPYPGIPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRP 304

Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +IL
Sbjct: 305 TFKQLVEDLDRIL 317

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  148 bits (376), Expect = 1e-40
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 16/196 (8%)

Query: 359 LGHGTYGSVYYGNIRNQ-EVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V  G  + Q +VA+K  +  +    EF  E + + K+ H  LV+  G  + E
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             ++++ EY   G L ++L    +      S +  +++  D   G+ ++  H    ++HR
Sbjct: 76  YPIYIVTEYISNGCLLNYLR--SHGKGLEPSQL--LEMCYDVCEGMAFLESH---QFIHR 128

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYLTDGLATA 533
           D+ + N L+D     K+SDFG+ + V      +  V+ V   F     APE       ++
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184

Query: 534 KSDVYAFGVVLFEIIS 549
           KSDV+AFG++++E+ S
Sbjct: 185 KSDVWAFGILMWEVFS 200

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  148 bits (377), Expect = 1e-40
 Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 69/303 (22%)

Query: 359 LGHGTYGSVYYG-----NIRNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G     + +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G       + ++ E A  GSL   L   +++G   L  +   + A+  A G+ Y+   
Sbjct: 86  LYG-VVLTPPMKMVTELAPLGSLLDRLR--KHQGHFLLGTL--SRYAVQVAEGMGYLESK 140

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEY 525
               ++HRD+ + N+LL +    KI DFGL + + +  D    V +      +   APE 
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFAWCAPES 195

Query: 526 LTDGLATAKSDVYAFGVVLFEIIS----------GKEAIIRTEGMVSKNQERRSLASFML 575
           L     +  SD + FGV L+E+ +          G + +      + K  ER        
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGER-------- 243

Query: 576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
                      +               P DC   +  +  QC    P  RP    +   L
Sbjct: 244 -----------LPR-------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

Query: 636 SQI 638
            + 
Sbjct: 280 LEA 282

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  149 bits (379), Expect = 1e-40
 Identities = 75/304 (24%), Positives = 130/304 (42%), Gaps = 61/304 (20%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIK--RMTATKT--KEFMAEMKILCKVHHSNLVE 407
           LG G++G VY G  +          VAIK     A+     EF+ E  ++ + +  ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL-----HDPQNRGQTSLSWIMRVQIALDAARGLE 462
           L+G  +      +I E   +G LKS+L         N      S    +Q+A + A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL- 521
           Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +T           G  G L 
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------YYRKGGKGLLP 203

Query: 522 ----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
               +PE L DG+ T  SDV++FGVVL+EI +                            
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------------------- 235

Query: 578 LRNSP-DSMSMSSLKDYIDP-NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
           L   P   +S   +  ++    ++D  P +C   +  L + C   +P +RP   +++ S+
Sbjct: 236 LAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

Query: 636 SQIL 639
            + +
Sbjct: 295 KEEM 298

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  148 bits (377), Expect = 2e-40
 Identities = 63/290 (21%), Positives = 118/290 (40%), Gaps = 56/290 (19%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIK------RMTATKTKEFMAEMKILCKVHHSNLVELI 409
            +G G +  VY     +    VA+K       M A    + + E+ +L +++H N+++  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT---SLSWIMRVQIALDAARGLEYIHE 466
                ++EL ++ E A  G L   +   + + +       W   VQ+       LE++H 
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHS 154

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 +HRDIK +N+ + +    K+ D GL +     +    +   +VGT  Y++PE +
Sbjct: 155 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS---LVGTPYYMSPERI 208

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
            +     KSD+++ G +L+E+ + +                     F         D M+
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP-------------------F-------YGDKMN 242

Query: 587 MSSL-----KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           + SL     +    P   D Y  +    +  L   C++ DP  RPD+  V
Sbjct: 243 LYSLCKKIEQCDYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDVTYV 288

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  148 bits (375), Expect = 2e-40
 Identities = 61/296 (20%), Positives = 120/296 (40%), Gaps = 53/296 (17%)

Query: 359 LGHGTYGSVYYGNIRN-----QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G +G VY+G + +        A+K +       +  +F+ E  I+    H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 410 GYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G      E    ++  Y + G L++ + +  +      +    +   L  A+G++Y+   
Sbjct: 93  G-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLASK 147

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEY 525
               +VHRD+ + N +LD  F  K++DFGLA+ +    +  +   K        ++A E 
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVKWMALES 203

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DS 584
           L     T KSDV++FGV+L+E+++                                P   
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT----------------------------RGAPPYPD 235

Query: 585 MSMSSLKDYIDP-NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           ++   +  Y+     +   P  C   +  +  +C      +RP   ++V  +S I 
Sbjct: 236 VNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  147 bits (374), Expect = 5e-40
 Identities = 76/315 (24%), Positives = 126/315 (40%), Gaps = 74/315 (23%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 407 ELIGYAATEDE-LFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQIA 454
            L+G        L +I E+ + G+L ++L             P++  +  L+    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
              A+G+E++        +HRD+ + NILL      KI DFGLA+ + K          V
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYV 205

Query: 515 VGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM-----VSKN 564
                 L     APE + D + T +SDV++FGV+L+EI         + G      V  +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF--------SLGASPYPGVKID 257

Query: 565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL 624
           +E           L+                   M   P     +M      C   +P  
Sbjct: 258 EE-------FCRRLKEG---------------TRMR-APDYTTPEMYQTMLDCWHGEPSQ 294

Query: 625 RPDMKQVVISLSQIL 639
           RP   ++V  L  +L
Sbjct: 295 RPTFSELVEHLGNLL 309

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (378), Expect = 5e-40
 Identities = 60/296 (20%), Positives = 121/296 (40%), Gaps = 53/296 (17%)

Query: 359 LGHGTYGSVYYGNIRN-----QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G +G VY+G + +        A+K +       +  +F+ E  I+    H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 410 GYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G      E    ++  Y + G L++ + +  +      +    +   L  A+G++++   
Sbjct: 157 G-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLASK 211

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEY 525
               +VHRD+ + N +LD  F  K++DFGLA+ +    + ++   K        ++A E 
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVKWMALES 267

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP-DS 584
           L     T KSDV++FGV+L+E+++                                P   
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT----------------------------RGAPPYPD 299

Query: 585 MSMSSLKDYIDP-NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           ++   +  Y+     +   P  C   +  +  +C      +RP   ++V  +S I 
Sbjct: 300 VNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  147 bits (374), Expect = 6e-40
 Identities = 74/318 (23%), Positives = 138/318 (43%), Gaps = 75/318 (23%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G +G V      +         VA+K +    + ++ ++ ++E  +L +V+H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL-------------------HDPQNRGQTSLSWI 448
           L G  + +  L LI EYA+ GSL+  L                       +  + +L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
             +  A   ++G++Y+ E      VHRD+ + NIL+    + KISDFGL++ V +     
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED--- 204

Query: 509 ATVTKVVGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
              + V  + G +     A E L D + T +SDV++FGV+L+EI++              
Sbjct: 205 ---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------------- 247

Query: 564 NQERRSLASFMLAALRNSP-DSMSMSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDED 621
                         L  +P   +    L + +   + M+  P +C  +M  L  QC  ++
Sbjct: 248 --------------LGGNPYPGIPPERLFNLLKTGHRMER-PDNCSEEMYRLMLQCWKQE 292

Query: 622 PILRPDMKQVVISLSQIL 639
           P  RP    +   L +++
Sbjct: 293 PDKRPVFADISKDLEKMM 310

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (374), Expect = 1e-39
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G++G           ++  IK     RM++ + +E   E+ +L  + H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS----WIMRVQIALDAARGLEYIHE 466
                  L+++ +Y + G L   +     +              VQI L     L+++H+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICL----ALKHVHD 143

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 +HRDIKS NI L      ++ DFG+A+++  T +        +GT  YL+PE  
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA---CIGTPYYLSPEIC 197

Query: 527 TDGLATAKSDVYAFGVVLFEIISGK 551
            +     KSD++A G VL+E+ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  147 bits (372), Expect = 1e-39
 Identities = 67/306 (21%), Positives = 122/306 (39%), Gaps = 64/306 (20%)

Query: 359 LGHGTYGSVYYGNIRN-----QEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +GSV    ++       +VA+K      + ++  +EF+ E   + +  H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 409 IG------YAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARG 460
           +G               +I  + + G L + L           +L     V+  +D A G
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF-NLPLQTLVRFMVDIACG 149

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           +EY+      +++HRD+ + N +L       ++DFGL++ +       +      G    
Sbjct: 150 MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI------YSGDYYRQGCASK 200

Query: 521 L-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
           L     A E L D L T  SDV+AFGV ++EI++                          
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-------------------------- 234

Query: 576 AALRNSP-DSMSMSSLKDYIDP-NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI 633
                +P   +  + + +Y+   N +   P +C+ ++  L  QC   DP  RP    + +
Sbjct: 235 --RGQTPYAGIENAEIYNYLIGGNRLKQ-PPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291

Query: 634 SLSQIL 639
            L  IL
Sbjct: 292 ELENIL 297

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  145 bits (368), Expect = 2e-39
 Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 54/294 (18%)

Query: 359 LGHGTYGSVYYGNIRNQE-----VAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK      + +  ++F+ E   + +  H ++V+LI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L     +    L+ +  +  A   +  L Y+     
Sbjct: 83  G-VITENPVWIIMELCTLGELRSFLQ--VRKYSLDLASL--ILYAYQLSTALAYLESK-- 135

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYL 526
             +VHRDI + N+L+ S    K+ DFGL++ +      ++T  K         ++APE +
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESI 189

Query: 527 TDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
                T+ SDV+ FGV ++EI+  G +     +G+  KN +       ++  +       
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPF---QGV--KNND-------VIGRIE------ 231

Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                     P      P +C   +  L  +C   DP  RP   ++   LS IL
Sbjct: 232 -----NGERLPM-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  148 bits (375), Expect = 2e-39
 Identities = 82/313 (26%), Positives = 136/313 (43%), Gaps = 70/313 (22%)

Query: 359 LGHGTYGSVYYGNIRN---------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSN 404
           LG G +G V                 +VA+K +    T     + ++EM+++  +  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQI 453
           ++ L+G    +  L++I EYA KG+L+ +L           ++P +  +  LS    V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
           A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +            
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID------YY 247

Query: 514 VVGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
              T G L     APE L D + T +SDV++FGV+L+EI +                   
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------------- 288

Query: 569 SLASFMLAALRNSP-DSMSMSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP 626
                    L  SP   + +  L   + + + MD  P +C  ++ M+ + C    P  RP
Sbjct: 289 ---------LGGSPYPGVPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRP 338

Query: 627 DMKQVVISLSQIL 639
             KQ+V  L +I+
Sbjct: 339 TFKQLVEDLDRIV 351

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  146 bits (371), Expect = 2e-39
 Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 61/304 (20%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K +    +     +F+ E  I+ K +H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L    P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 466 EHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL- 521
           E+   H++HRDI + N LL        AKI DFG+A+ + + S          G    L 
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS------YYRKGGCAMLP 208

Query: 522 ----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
                PE   +G+ T+K+D ++FGV+L+EI S                            
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------------------- 240

Query: 578 LRNSP-DSMSMSSLKDYIDP-NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
           L   P  S S   + +++     MD  P +C   +  +  QC    P  RP+   ++  +
Sbjct: 241 LGYMPYPSKSNQEVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

Query: 636 SQIL 639
               
Sbjct: 300 EYCT 303

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  145 bits (368), Expect = 2e-39
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 51/293 (17%)

Query: 359 LGHGTYGSVYYGNIRNQ----EVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +G+V  G  + +     VA+K             E +AE  ++ ++ +  +V +I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G     +   L+ E A+ G L  +L   ++    ++     +++    + G++Y+ E   
Sbjct: 85  G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEES-- 136

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLT 527
            ++VHRD+ + N+LL +   AKISDFGL+K +   +D      +  G +   + APE + 
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALR--ADENYYKAQTHGKWPVKWYAPECIN 193

Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
               ++KSDV++FGV+++E  S G++      GM  K  E       + A L        
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPY---RGM--KGSE-------VTAMLE------- 234

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
               K           P  C  +M  L   C   D   RP    V + L    
Sbjct: 235 ----KGERMGC-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  145 bits (369), Expect = 2e-39
 Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 36/222 (16%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIK--RMTATKTKEFMAEMKILCKVHHSNLVELIG--- 410
           +LG G +G V        ++  AIK  R T  K    ++E+ +L  ++H  +V       
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 411 ----------YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
                         +  LF+  EY + G+L   +H      Q    W +  QI       
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE----A 128

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV--------- 511
           L YIH       +HRD+K  NI +D +   KI DFGLAK V ++ D              
Sbjct: 129 LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 512 --TKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISG 550
             T  +GT  Y+A E L   G    K D+Y+ G++ FE+I  
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (369), Expect = 3e-39
 Identities = 72/308 (23%), Positives = 127/308 (41%), Gaps = 69/308 (22%)

Query: 359 LGHGTYGSVYYGNIRN-----QEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +GSV  GN++       +VA+K       +  + +EF++E   +    H N++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 409 IGYAATEDE------LFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARG 460
           +G    E          +I  + + G L ++L     +   +  +     ++  +D A G
Sbjct: 102 LG-VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK-HIPLQTLLKFMVDIALG 159

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           +EY+      +++HRD+ + N +L       ++DFGL+K +              G    
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD------YYRQGRIAK 210

Query: 521 L-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV----SKNQERRSLA 571
           +     A E L D + T+KSDV+AFGV ++EI         T GM      +N E     
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA--------TRGMTPYPGVQNHE----- 257

Query: 572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
             M   L +                + +   P DCL ++  +   C   DP+ RP    +
Sbjct: 258 --MYDYLLHG---------------HRLKQ-PEDCLDELYEIMYSCWRTDPLDRPTFSVL 299

Query: 632 VISLSQIL 639
            + L ++L
Sbjct: 300 RLQLEKLL 307

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (367), Expect = 3e-39
 Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 51/293 (17%)

Query: 359 LGHGTYGSVYYGNIRNQ----EVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIG 410
           LG G +GSV  G  R +    +VAIK +        T+E M E +I+ ++ +  +V LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
                + L L+ E A  G L   L     R +  +      ++    + G++Y+ E    
Sbjct: 78  -VCQAEALMLVMEMAGGGPLHKFLV--GKREE--IPVSNVAELLHQVSMGMKYLEEK--- 129

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLT 527
           ++VHRD+ + N+LL +   AKISDFGL+K +G     ++  T          + APE + 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALG---ADDSYYTARSAGKWPLKWYAPECIN 186

Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
               +++SDV+++GV ++E +S G++     + M  K  E       ++A +        
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPY---KKM--KGPE-------VMAFIE------- 227

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
               +           P +C  ++  L   C       RPD   V   +    
Sbjct: 228 ----QGKRMEC-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  151 bits (384), Expect = 5e-39
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)

Query: 359 LGHGTYGSVYYGNIRNQE-----VAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G +G V+ G   + E     VAIK      + +  ++F+ E   + +  H ++V+LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G   TE+ +++I E    G L+S L     +    L+ +  +  A   +  L Y+     
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQ--VRKFSLDLASL--ILYAYQLSTALAYLESK-- 510

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLT 527
             +VHRDI + N+L+ S    K+ DFGL++ +    +         G     ++APE + 
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWMAPESIN 565

Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
               T+ SDV+ FGV ++EI+  G +     +G+  KN +       ++  +        
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPF---QGV--KNND-------VIGRIE------- 606

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                    P      P +C   +  L  +C   DP  RP   ++   LS IL
Sbjct: 607 ----NGERLPM-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  145 bits (368), Expect = 6e-39
 Identities = 69/310 (22%), Positives = 121/310 (39%), Gaps = 67/310 (21%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V               +VA+K +     A + +  M+E+KI+  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHL---------HDPQNRGQTSLSWIMRVQIALDA 457
            L+G       + +I EY   G L + L                 ++ S    +  +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           A+G+ ++      + +HRD+ + N+LL +   AKI DFGLA+ +   S+       +V  
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN------YIVKG 224

Query: 518 FGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
              L     APE + D + T +SDV+++G++L+EI S                       
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----------------------- 261

Query: 573 FMLAALRNSP--DSMSMSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK 629
                L  +P    +  S     + D   M   P      +  + + C   +P  RP  +
Sbjct: 262 -----LGLNPYPGILVNSKFYKLVKDGYQMA-QPAFAPKNIYSIMQACWALEPTHRPTFQ 315

Query: 630 QVVISLSQIL 639
           Q+   L +  
Sbjct: 316 QICSFLQEQA 325

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  143 bits (364), Expect = 8e-39
 Identities = 73/301 (24%), Positives = 123/301 (40%), Gaps = 63/301 (20%)

Query: 359 LGHGTYGSVYYGNIR-----NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G +G VY+G          + AIK +       + + F+ E  ++  ++H N++ LI
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 410 GYAATEDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           G      E    ++  Y   G L   +  PQ     + +    +   L  ARG+EY+ E 
Sbjct: 89  G-IMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLAEQ 143

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL-----A 522
               +VHRD+ + N +LD +F  K++DFGLA+ +    D E    +       L     A
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQ-QHRHARLPVKWTA 196

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV----SKNQERRSLASFMLAAL 578
            E L     T KSDV++FGV+L+E++        T G          +       +   L
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELL--------TRGAPPYRHIDPFD-------LTHFL 241

Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
                               +   P  C   +  + +QC + DP +RP  + +V  + QI
Sbjct: 242 AQG---------------RRLP-QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

Query: 639 L 639
           +
Sbjct: 286 V 286

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  143 bits (363), Expect = 9e-39
 Identities = 46/212 (21%), Positives = 90/212 (42%), Gaps = 35/212 (16%)

Query: 359 LGHGTYGSVYYG---------NIRNQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLV 406
           LG GT+  ++ G          +   EV +K +       ++ F     ++ K+ H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
              G     DE  L+ E+ + GSL ++L    N+   ++ W   +++A   A  + ++ E
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWK--LEVAKQLAAAMHFLEE 131

Query: 467 HTKTHYVHRDIKSSNILLDSAFR--------AKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           +     +H ++ + NILL              K+SD G++  V      +  +       
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182

Query: 519 GYLAPEYLTDGLA-TAKSDVYAFGVVLFEIIS 549
            ++ PE + +       +D ++FG  L+EI S
Sbjct: 183 -WVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (366), Expect = 1e-38
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 21/203 (10%)

Query: 359 LGHGTYGSVYYG------NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVEL 408
           +G G +G VY G        +   VAIK +    T  +  +F+ E  I+ +  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
            G  +    + +I EY + G+L   L   +  G+   S +  V +    A G++Y+    
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR--EKDGE--FSVLQLVGMLRGIAAGMKYLANM- 166

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY--LAPEYL 526
             +YVHRD+ + NIL++S    K+SDFGL++++    D EAT T   G       APE +
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEAI 222

Query: 527 TDGLATAKSDVYAFGVVLFEIIS 549
           +    T+ SDV++FG+V++E+++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  146 bits (369), Expect = 1e-38
 Identities = 79/304 (25%), Positives = 128/304 (42%), Gaps = 61/304 (20%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIK--RMTATKT--KEFMAEMKILCKVHHSNLVE 407
           LGHG +G VY G +          +VA+K      ++    +F+ E  I+ K +H N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
            IG +      F++ E    G LKS L    P+    +SL+ +  + +A D A G +Y+ 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 466 EHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL- 521
           E+   H++HRDI + N LL        AKI DFG+A+ + +            G    L 
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG------YYRKGGCAMLP 249

Query: 522 ----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
                PE   +G+ T+K+D ++FGV+L+EI S                            
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS---------------------------- 281

Query: 578 LRNSP-DSMSMSSLKDYIDP-NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
           L   P  S S   + +++     MD  P +C   +  +  QC    P  RP+   ++  +
Sbjct: 282 LGYMPYPSKSNQEVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

Query: 636 SQIL 639
               
Sbjct: 341 EYCT 344

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  144 bits (366), Expect = 1e-38
 Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 20/202 (9%)

Query: 359 LGHGTYGSVYYG-----NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G  G V YG       R+  VAIK +    T  + ++F++E  I+ +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G         ++ EY + GSL + L    + GQ   + +  V +      G+ Y+ +   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQ--FTIMQLVGMLRGVGAGMRYLSDL-- 170

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL--APEYLT 527
             YVHRD+ + N+L+DS    K+SDFGL++++    D +A  T   G       APE + 
Sbjct: 171 -GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 528 DGLATAKSDVYAFGVVLFEIIS 549
               ++ SDV++FGVV++E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  144 bits (365), Expect = 2e-38
 Identities = 69/318 (21%), Positives = 118/318 (37%), Gaps = 75/318 (23%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
           +G G +G V+               VA+K +    +A    +F  E  ++ +  + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL-------------------HDPQNRGQTSLSWI 448
           L+G  A    + L++EY   G L   L                       + G   LS  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
            ++ IA   A G+ Y+ E     +VHRD+ + N L+      KI+DFGL++ +       
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD--- 228

Query: 509 ATVTKVVGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
                       +      PE +     T +SDV+A+GVVL+EI S              
Sbjct: 229 ---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS-------------- 271

Query: 564 NQERRSLASFMLAALRNSP-DSMSMSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDED 621
                             P   M+   +  Y+ D N++   P +C  ++  L + C  + 
Sbjct: 272 --------------YGLQPYYGMAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKL 316

Query: 622 PILRPDMKQVVISLSQIL 639
           P  RP    +   L ++ 
Sbjct: 317 PADRPSFCSIHRILQRMC 334

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  142 bits (360), Expect = 2e-38
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 23/202 (11%)

Query: 359 LGHGTYGSVYYGNIRNQE-----VAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           LG G +G VY G   N +     VA+K      T    ++FM+E  I+  + H ++V+LI
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G    E+  ++I E    G L  +L   +N+    +  +  V  +L   + + Y+     
Sbjct: 80  G-IIEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTL--VLYSLQICKAMAYLESI-- 132

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF--GYLAPEYLT 527
            + VHRDI   NIL+ S    K+ DFGL++ +    + E      V      +++PE + 
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYI----EDEDYYKASVTRLPIKWMSPESIN 187

Query: 528 DGLATAKSDVYAFGVVLFEIIS 549
               T  SDV+ F V ++EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  144 bits (365), Expect = 3e-38
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 20/202 (9%)

Query: 359 LGHGTYGSVYYG-----NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELI 409
           +G G +G V  G     + +   VAIK +    T  + ++F+ E  I+ +  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G       + ++ EY + GSL S L   ++  Q   + I  V +    A G++Y+ +   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQ--FTVIQLVGMLRGIASGMKYLSDM-- 166

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL--APEYLT 527
             YVHRD+ + NIL++S    K+SDFGL +++    D EA  T   G       +PE + 
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 528 DGLATAKSDVYAFGVVLFEIIS 549
               T+ SDV+++G+VL+E++S
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  143 bits (363), Expect = 3e-38
 Identities = 68/321 (21%), Positives = 124/321 (38%), Gaps = 80/321 (24%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V               +VA+K +     +++ +  M+E+K++ ++  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHL------------------HDPQNRGQTSLSWI 448
            L+G       ++LI+EY   G L ++L                     +      L++ 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE 508
             +  A   A+G+E++        VHRD+ + N+L+      KI DFGLA+ +   S+  
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 509 ATVTKVVGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM--- 560
                       L     APE L +G+ T KSDV+++G++L+EI         + G+   
Sbjct: 230 VR------GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF--------SLGVNPY 275

Query: 561 --VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCV 618
             +  +             ++N                  MD  P     ++ ++ + C 
Sbjct: 276 PGIPVDAN-------FYKLIQNG---------------FKMD-QPFYATEEIYIIMQSCW 312

Query: 619 DEDPILRPDMKQVVISLSQIL 639
             D   RP    +   L   L
Sbjct: 313 AFDSRKRPSFPNLTSFLGCQL 333

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  142 bits (361), Expect = 4e-38
 Identities = 67/316 (21%), Positives = 119/316 (37%), Gaps = 75/316 (23%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V                VA+K +      T+ +  M+E+K+L  + +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHL-------------HDPQNRGQTSLSWIMRVQI 453
            L+G         +I EY   G L + L                    + +L     +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
           +   A+G+ ++      + +HRD+ + NILL      KI DFGLA+ +   S+       
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK--- 204

Query: 514 VVGTFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM-----VSK 563
                  L     APE + + + T +SDV+++G+ L+E+         + G      +  
Sbjct: 205 ---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF--------SLGSSPYPGMPV 253

Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
           + +           ++                   M   P     +M  + K C D DP+
Sbjct: 254 DSK-------FYKMIKEG---------------FRML-SPEHAPAEMYDIMKTCWDADPL 290

Query: 624 LRPDMKQVVISLSQIL 639
            RP  KQ+V  + + +
Sbjct: 291 KRPTFKQIVQLIEKQI 306

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  142 bits (359), Expect = 8e-38
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 34/216 (15%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N         VA+K +   + +  ++F  E ++L  + H ++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL--HDPQ--------NRGQTSLSWIMRVQIALDAA 458
            G       L +++EY + G L   L  H P         +     L     + +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
            G+ Y+      H+VHRD+ + N L+      KI DFG+++ +       +T    VG  
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI------YSTDYYRVGGR 219

Query: 519 GYL-----APEYLTDGLATAKSDVYAFGVVLFEIIS 549
             L      PE +     T +SDV++FGVVL+EI +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  140 bits (356), Expect = 1e-37
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVEL 408
           LG G +G V+     N         VA+K +   T    K+F  E ++L  + H ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQIALDA 457
            G     D L +++EY + G L   L                + +  L     + IA   
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           A G+ Y+      H+VHRD+ + N L+ +    KI DFG+++ V      +      VG 
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYY---RVGG 193

Query: 518 FGYL-----APEYLTDGLATAKSDVYAFGVVLFEIIS 549
              L      PE +     T +SDV++FGV+L+EI +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (354), Expect = 2e-37
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 36/218 (16%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVE 407
           LG   +G VY G++         Q VAIK +         +EF  E  +  ++ H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHL-----------HDPQNRGQTSLSWIMRVQIALD 456
           L+G    +  L +I+ Y   G L   L            D     +++L     V +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            A G+EY+  H   H VH+D+ + N+L+      KISD GL + V       A     + 
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREV------YAADYYKLL 187

Query: 517 TFGYL-----APEYLTDGLATAKSDVYAFGVVLFEIIS 549
               L     APE +  G  +  SD++++GVVL+E+ S
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  139 bits (353), Expect = 2e-37
 Identities = 61/295 (20%), Positives = 109/295 (36%), Gaps = 68/295 (23%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY---- 411
           L+G G +G V+    R   +   IKR+     ++   E+K L K+ H N+V   G     
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76

Query: 412 ------------AATEDELFLIYEYAQKGSLKSHLHDPQNRG---QTSLSWIMRVQIALD 456
                        +    LF+  E+  KG+L+  +   +        +L      QI   
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF--EQITK- 133

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
              G++YIH       ++RD+K SNI L    + KI DFGL   +          T+  G
Sbjct: 134 ---GVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK----RTRSKG 183

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA 576
           T  Y++PE ++      + D+YA G++L E++   +    T    +  ++          
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI-------- 235

Query: 577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                 D       K  +                    ++ + + P  RP+  ++
Sbjct: 236 ----ISDIFD-KKEKTLL--------------------QKLLSKKPEDRPNTSEI 265

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  139 bits (353), Expect = 4e-37
 Identities = 66/291 (22%), Positives = 98/291 (33%), Gaps = 69/291 (23%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKR-----MTATKTKEFMAEMKILCKV-HHSNLVELI 409
            LGHG+YG V+    +   +  A+KR              +AE+    KV  H   V L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT---SLSWIMRVQIALDAARGLEYIHE 466
                   L+L  E     SL+ H    +  G +   +  W       L     L ++H 
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHC---EAWGASLPEAQVWGYLRDTLL----ALAHLHS 175

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 VH D+K +NI L    R K+ DFGL   +G    GE       G   Y+APE L
Sbjct: 176 QGL---VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV----QEGDPRYMAPELL 228

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS----- 581
                   +DV++ G+ + E+    E     EG                  LR       
Sbjct: 229 QGS-YGTAADVFSLGLTILEVACNMELPHGGEGW---------------QQLRQGYLPPE 272

Query: 582 -PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
               +S S L+  +                       ++ DP LR   + +
Sbjct: 273 FTAGLS-SELRSVL--------------------VMMLEPDPKLRATAEAL 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (349), Expect = 6e-37
 Identities = 57/292 (19%), Positives = 111/292 (38%), Gaps = 57/292 (19%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G+YG       +   + +  K      MT  + +  ++E+ +L ++ H N+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 411 --YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT---SLSWIMRVQIALDAARGLEYIH 465
                T   L+++ EY + G L S +       Q         +  Q+ L     L+  H
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL----ALKECH 128

Query: 466 EHTKTHY--VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
             +   +  +HRD+K +N+ LD     K+ DFGLA+++   +    T    VGT  Y++P
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT---FVGTPYYMSP 185

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD 583
           E +       KSD+++ G +L+E+ +                       F          
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP-------------------F---------T 217

Query: 584 SMSMSSLKDYID----PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           + S   L   I       +   Y  +       +  + ++     RP ++++
Sbjct: 218 AFSQKELAGKIREGKFRRIPYRYSDEL----NEIITRMLNLKDYHRPSVEEI 265

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (366), Expect = 6e-37
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 51/293 (17%)

Query: 359 LGHGTYGSVYYGNIRNQ----EVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIG 410
           LG G +GSV  G  R +    +VAIK +        T+E M E +I+ ++ +  +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
                + L L+ E A  G L   L     R +  +      ++    + G++Y+ E    
Sbjct: 404 -VCQAEALMLVMEMAGGGPLHKFLV--GKREE--IPVSNVAELLHQVSMGMKYLEEK--- 455

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT---FGYLAPEYLT 527
           ++VHR++ + N+LL +   AKISDFGL+K +G     ++  T          + APE + 
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALG---ADDSYYTARSAGKWPLKWYAPECIN 512

Query: 528 DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
               +++SDV+++GV ++E +S G++     + M  K  E       ++A +        
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPY---KKM--KGPE-------VMAFIE------- 553

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
               +           P +C  ++  L   C       RPD   V   +    
Sbjct: 554 ----QGKRMEC-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  139 bits (353), Expect = 4e-36
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 353 FSDSSLLGHGTYGSVYY-GNIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIG 410
           F    +LGHG  G++ Y G   N++VA+KR+          E+++L +   H N++    
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFC 85

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQ-NRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
                   ++  E     +L+ ++              +++ Q       GL ++H    
Sbjct: 86  TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ-QTT----SGLAHLHSL-- 137

Query: 470 THYVHRDIKSSNILL-----DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
            + VHRD+K  NIL+         +A ISDFGL K +       +  + V GT G++APE
Sbjct: 138 -NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 525 YLTDGL---ATAKSDVYAFGVVLFEIISG 550
            L++      T   D+++ G V + +IS 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  139 bits (351), Expect = 8e-36
 Identities = 66/303 (21%), Positives = 116/303 (38%), Gaps = 60/303 (19%)

Query: 358 LLGHGTYGSVYY-GNIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAATE 415
           +LG+G+ G+V + G+ + + VA+KRM        + E+K+L +   H N++       T+
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR--VQIALDAARGLEYIHEHTKTHYV 473
             L++  E     +L+  +       +          + +    A G+ ++H       +
Sbjct: 82  RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KII 137

Query: 474 HRDIKSSNILLDSA-------------FRAKISDFGLAK-LVGKTSDGEATVTKVVGTFG 519
           HRD+K  NIL+ ++              R  ISDFGL K L    S     +    GT G
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197

Query: 520 YLAPEYLTDGLA-------TAKSDVYAFGVVLFEIISGKE----AIIRTEGMVSKNQERR 568
           + APE L +          T   D+++ G V + I+S  +         E  + +     
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGI--- 254

Query: 569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM 628
               F L  ++   D   ++   D I                     Q +D DP+ RP  
Sbjct: 255 ----FSLDEMKCLHDRSLIAEATDLI--------------------SQMIDHDPLKRPTA 290

Query: 629 KQV 631
            +V
Sbjct: 291 MKV 293

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  135 bits (341), Expect = 1e-35
 Identities = 56/304 (18%), Positives = 113/304 (37%), Gaps = 68/304 (22%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKR----MTATKTKEFMAEMKILCKVHHSNLVELIGY 411
            LG G +G V+    +  +   AIKR          ++ M E+K L K+ H  +V     
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 412 AATEDE------------LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR--VQIALDA 457
              ++             L++  +  +K +LK  ++      +   S  +   +QIA   
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE-- 129

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV------ 511
              +E++H       +HRD+K SNI        K+ DFGL   + +  + +  +      
Sbjct: 130 --AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 512 ---TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
              T  VGT  Y++PE +     + K D+++ G++LFE                      
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE---------------------- 222

Query: 569 SLASFMLAALRNSPDSMS-MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
                +L       + +  ++ +++   P +             ++ +  +   P+ RP+
Sbjct: 223 -----LLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPC----EYVMVQDMLSPSPMERPE 273

Query: 628 MKQV 631
              +
Sbjct: 274 AINI 277

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (337), Expect = 6e-35
 Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 34/215 (15%)

Query: 358 LLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNL--VELI 409
            +G G    V+   N + Q  AIK +   +        +  E+  L K+   +   + L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYIHEH 467
            Y  T+  ++++ E      L S L   + +              +       +  IH+H
Sbjct: 95  DYEITDQYIYMVMECGN-IDLNSWL---KKKKSIDPWERKSYWKNML----EAVHTIHQH 146

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                VH D+K +N L+      K+ DFG+A  +   +      +  VGT  Y+ PE + 
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIK 201

Query: 528 DGLA-----------TAKSDVYAFGVVLFEIISGK 551
           D  +           + KSDV++ G +L+ +  GK
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  133 bits (337), Expect = 1e-34
 Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 34/215 (15%)

Query: 358 LLGHGTYGSVYYG-NIRNQEVAIKR-----MTATKTKEFMAEMKILCKV--HHSNLVELI 409
            +G G    V+   N + Q  AIK              +  E+  L K+  H   ++ L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYIHEH 467
            Y  T+  ++++ E      L S L   + +              +       +  IH+H
Sbjct: 76  DYEITDQYIYMVMECGN-IDLNSWL---KKKKSIDPWERKSYWKNMLE----AVHTIHQH 127

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                VH D+K +N L+      K+ DFG+A  +   +      +  VGT  Y+ PE + 
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIK 182

Query: 528 DGLA-----------TAKSDVYAFGVVLFEIISGK 551
           D  +           + KSDV++ G +L+ +  GK
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  131 bits (332), Expect = 2e-34
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIK-----RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
            LG G +   +   +    +  A K      +     +E    E+ I   + H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 410 GYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           G+    D +F++ E  ++ SL      +  L +P+ R      + +R QI      G +Y
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIV----LGCQY 130

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H +     +HRD+K  N+ L+     KI DFGLA  V    DGE     + GT  Y+AP
Sbjct: 131 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-LCGTPNYIAP 184

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E L+    + + DV++ G +++ ++ GK
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  132 bits (335), Expect = 2e-34
 Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIK---RMTATKTKEFMA-----------------EMKILC 398
           L  G +  +      N+  A+K   +    K ++F                   E++I+ 
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
            + +   +   G     DE+++IYEY +  S+             + +  + +Q+     
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIKCII 157

Query: 459 R----GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
           +       YIH     +  HRD+K SNIL+D   R K+SDFG ++ +    D    +   
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDK--KIKGS 210

Query: 515 VGTFGYLAPEYLT--DGLATAKSDVYAFGVVLFEIISGK 551
            GT+ ++ PE+ +       AK D+++ G+ L+ +    
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  132 bits (335), Expect = 2e-34
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIK-----RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
            LG G +   +   +    +  A K      +     +E    E+ I   + H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 410 GYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           G+    D +F++ E  ++ SL      +  L +P+ R      + +R QI      G +Y
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR------YYLR-QIV----LGCQY 156

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H +     +HRD+K  N+ L+     KI DFGLA  V    DGE     + GT  Y+AP
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-LCGTPNYIAP 210

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E L+    + + DV++ G +++ ++ GK
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  132 bits (333), Expect = 2e-34
 Identities = 62/305 (20%), Positives = 115/305 (37%), Gaps = 60/305 (19%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYA 412
            LG G +  V    G       A+KR+   + ++      E  +    +H N++ L+ Y 
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 413 ATED----ELFLIYEYAQKGSLKSHLHDPQNRGQT-SLSWIMRVQIALDAARGLEYIHEH 467
             E     E +L+  + ++G+L + +   +++G   +   I+   + L   RGLE IH  
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW--LLLGICRGLEAIHAK 153

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV------VGTFGYL 521
               Y HRD+K +NILL    +  + D G         +G      +        T  Y 
Sbjct: 154 ---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 522 APEYLTDG----LATAKSDVYAFGVVLFEIISGK---EAIIRTEGMVSKNQERRSLASFM 574
           APE L       +   ++DV++ G VL+ ++ G+   + + +    V+   + +      
Sbjct: 211 APE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ------ 263

Query: 575 LAALRNSPDSMSMSS-LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI 633
                + P S   SS L   +                       +  DP  RP +  ++ 
Sbjct: 264 ----LSIPQSPRHSSALWQLL--------------------NSMMTVDPHQRPHIPLLLS 299

Query: 634 SLSQI 638
            L  +
Sbjct: 300 QLEAL 304

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (330), Expect = 3e-34
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 358 LLGHGTYGSVYYG-NIRN-QEVAIK-----RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
            LG G +G+VY     ++   +A+K     ++     +     E++I   + H N++ L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           GY      ++LI EYA  G++   L    ++     +     ++A      L Y H    
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELAN----ALSYCHSK-- 128

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
              +HRDIK  N+LL SA   KI+DFG +               + GT  YL PE +   
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTD-LCGTLDYLPPEMIEGR 182

Query: 530 LATAKSDVYAFGVVLFEIISGK 551
           +   K D+++ GV+ +E + GK
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK 204

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (336), Expect = 3e-34
 Identities = 46/215 (21%), Positives = 83/215 (38%), Gaps = 34/215 (15%)

Query: 358 LLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNL--VELI 409
            +G G    V+   N + Q  AIK +   +        +  E+  L K+   +   + L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYIHEH 467
            Y  T+  ++++ E      L S L   + +              +       +  IH+H
Sbjct: 123 DYEITDQYIYMVMECGN-IDLNSWL---KKKKSIDPWERKSYWKNMLE----AVHTIHQH 174

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                VH D+K +N L+      K+ DFG+A  +   +      +  VG   Y+ PE + 
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEAIK 229

Query: 528 DGLA-----------TAKSDVYAFGVVLFEIISGK 551
           D  +           + KSDV++ G +L+ +  GK
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  130 bits (329), Expect = 4e-34
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIK-----RMTATKTKE-FMAEMKILCKVHHSNLVELI 409
           LLG G++  VY   +I    EVAIK      M      +    E+KI C++ H +++EL 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
            Y    + ++L+ E    G +  +L +       + +     QI      G+ Y+H H  
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSH-- 131

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
              +HRD+  SN+LL      KI+DFGLA  +      E   T + GT  Y++PE  T  
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYT-LCGTPNYISPEIATRS 187

Query: 530 LATAKSDVYAFGVVLFEIISGK 551
               +SDV++ G + + ++ G+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR 209

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  131 bits (330), Expect = 6e-34
 Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 35/217 (16%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGY 411
           +LG G   +V+ G  +      AIK              M E ++L K++H N+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 412 --AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHE 466
               T     LI E+   GSL + L +P N           ++R  +      G+ ++ E
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR-DV----VGGMNHLRE 130

Query: 467 HTKTHYVHRDIKSSNILL----DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           +     VHR+IK  NI+     D     K++DFG A+ +    D E  V+ + GT  YL 
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVS-LYGTEEYLH 183

Query: 523 PEYLTDGLA--------TAKSDVYAFGVVLFEIISGK 551
           P+     +          A  D+++ GV  +   +G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (328), Expect = 7e-34
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G++ +VY G       EVA   +     T ++ + F  E ++L  + H N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 411 Y----AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
                   +  + L+ E    G+LK++L   +      L    R QI     +GL+++H 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLHT 147

Query: 467 HTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
                 +HRD+K  NI +       KI D GLA L   +         V+GT  ++APE 
Sbjct: 148 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEM 201

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
             +       DVYAFG+ + E+ + +
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSE 226

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (325), Expect = 2e-33
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVEL 408
            L+G G  G VY     +R + VA+K M+ T + +         E +   ++   ++V +
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
             +   + +L++         L + L       Q  L+    V I       L+  H   
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK---VVGTFGYLAPEY 525
                HRD+K  NIL+ +   A + DFG+A         +  +T+    VGT  Y+APE 
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-----DEKLTQLGNTVGTLYYMAPER 206

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
            ++  AT ++D+YA   VL+E ++G 
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGS 232

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  130 bits (329), Expect = 3e-33
 Identities = 63/305 (20%), Positives = 108/305 (35%), Gaps = 35/305 (11%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVELIGY 411
           +LG G   +V+ G         AIK              M E ++L K++H N+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 412 --AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHE 466
               T     LI E+   GSL + L +P N           ++R  +      G+ ++ E
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR-DVVG----GMNHLRE 130

Query: 467 HTKTHYVHRDIKSSNILL----DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           +     VHR+IK  NI+     D     K++DFG A+ +    D E  V+ + GT  YL 
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVS-LYGTEEYLH 183

Query: 523 PEYLTDGLA--------TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM 574
           P+     +          A  D+++ GV  +   +G       EG     +    + +  
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
            +   +         +    D  +           +  +    ++ D        Q    
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 635 LSQIL 639
            S IL
Sbjct: 304 TSDIL 308

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (337), Expect = 5e-33
 Identities = 46/207 (22%), Positives = 78/207 (37%), Gaps = 31/207 (14%)

Query: 357 SLLGHGTYGSVYYG---NIRNQEVAIKRMTATKTKEFMA----EMKILCKVHHSNLVELI 409
             + HG  G +Y     N+  + V +K +  +   E  A    E + L +V H ++V++ 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 410 GYAATEDE-----LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
            +    D       +++ EY    SLK             L     +   L+    L Y+
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       V+ D+K  NI+L    + K+ D G    +            + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------LYGTPGFQAPE 247

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            +  G  T  +D+Y  G  L  +    
Sbjct: 248 IVRTG-PTVATDIYTVGRTLAALTLDL 273

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  127 bits (321), Expect = 6e-33
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 25/204 (12%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELI 409
            LG G +G+VY    +     +A+K +  ++        +   E++I   + H N++ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARGLEYIHEH 467
            Y      ++L+ E+A +G L   L   Q  G+     S     ++A      L Y HE 
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELAD----ALHYCHER 133

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
                +HRDIK  N+L+      KI+DFG +             T + GT  YL PE + 
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWSVHA----PSLRRRT-MCGTLDYLPPEMIE 185

Query: 528 DGLATAKSDVYAFGVVLFEIISGK 551
                 K D++  GV+ +E + G 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (320), Expect = 9e-33
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVEL 408
             LG G   +VY     I N +VAIK +     ++      F  E+    ++ H N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           I     +D  +L+ EY +  +L  ++          LS    +        G+++ H+  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDM- 130

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK---VVGTFGYLAPEY 525
               VHRDIK  NIL+DS    KI DFG+AK +      E ++T+   V+GT  Y +PE 
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-----ETSLTQTNHVLGTVQYFSPEQ 183

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGK 551
                    +D+Y+ G+VL+E++ G+
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  126 bits (318), Expect = 1e-32
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)

Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRM---TATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           +LG GTYG VY G ++ NQ  +AIK +    +  ++    E+ +   + H N+V+ +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYIHEHTKT 470
           +    + +  E    GSL + L       + +   I     QI L    GL+Y+H++   
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI-L---EGLKYLHDNQI- 143

Query: 471 HYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
             VHRDIK  N+L+++     KISDFG +K +   +    T     GT  Y+APE +  G
Sbjct: 144 --VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET---FTGTLQYMAPEIIDKG 198

Query: 530 L--ATAKSDVYAFGVVLFEIISGK 551
                  +D+++ G  + E+ +GK
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGK 222

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (320), Expect = 2e-32
 Identities = 47/315 (14%), Positives = 98/315 (31%), Gaps = 51/315 (16%)

Query: 305 CKSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTY 364
               +  +   ++          LG+ +  +                      LLG G +
Sbjct: 39  SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHH--------------------LLGEGAF 78

Query: 365 GSVYYG-------NIRNQEVAIKRMTATKTKEF---MAEMKILCKVHHSNLVELIGYAAT 414
             VY             Q+  +K        EF      M+ L        ++       
Sbjct: 79  AQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           ++   L+ E    G+L + ++  +N  +  +   + +  A+     +E +H+      +H
Sbjct: 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIH 195

Query: 475 RDIKSSNILLDSAFRA-----------KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            DIK  N +L + F              + D G +  +     G    T    T G+   
Sbjct: 196 GDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT-IFTAKCETSGFQCV 254

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE------RRSLASFMLAA 577
           E L++     + D +     ++ ++ G    ++ EG   K +          + +     
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHV 314

Query: 578 LRNSPDSMSMSSLKD 592
           + N PD   + SL  
Sbjct: 315 MLNIPDCHHLPSLDL 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  125 bits (316), Expect = 6e-32
 Identities = 47/261 (18%), Positives = 98/261 (37%), Gaps = 48/261 (18%)

Query: 382 MTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG 441
            + +       +++ +      N V  +  ++ +  L++  +  +K +LK  ++   +  
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159

Query: 442 QTSLSWIMR--VQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK 499
                  +   +QIA      +E++H       +HRD+K SNI        K+ DFGL  
Sbjct: 160 DREHGVCLHIFIQIAE----AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVT 212

Query: 500 LVGKTSDGEATV---------TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            + +  + +  +         T  VGT  Y++PE +     + K D+++ G++LFE++  
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

Query: 551 KEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKM 610
                    M     ER  +    +  +RN                     YP     + 
Sbjct: 273 FST-----QM-----ERVRI----ITDVRNL-----------KFPLLFTQKYP-----QE 302

Query: 611 AMLAKQCVDEDPILRPDMKQV 631
            M+ +  +   P  RP+   +
Sbjct: 303 HMMVQDMLSPSPTERPEATDI 323

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  124 bits (313), Expect = 1e-31
 Identities = 53/210 (25%), Positives = 104/210 (49%), Gaps = 26/210 (12%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE------FMAEMKILCKVHHSNLVEL 408
            +LG G    V+       +++VA+K + A   ++      F  E +    ++H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 409 IGYAATEDEL----FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
                 E       +++ EY    +L+  +H     G   ++    +++  DA + L + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGP--MTPKRAIEVIADACQALNFS 132

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK---VVGTFGYL 521
           H++     +HRD+K +NI++ +    K+ DFG+A+ +   +D   +VT+   V+GT  YL
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVTQTAAVIGTAQYL 186

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +PE        A+SDVY+ G VL+E+++G+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  129 bits (326), Expect = 1e-31
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE----FMAEMKILCKVHHSNLVELI--- 409
           LG G +G V         ++VAIK+     + +    +  E++I+ K++H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 410 ---GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYI 464
                 A  D   L  EY + G L+ +L+  +N        I  +   I+      L Y+
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS----ALRYL 137

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           HE+     +HRD+K  NI+L    +    KI D G AK +     GE      VGT  YL
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTE-FVGTLQYL 190

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L     T   D ++FG + FE I+G 
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGF 220

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (310), Expect = 4e-31
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 19/201 (9%)

Query: 358 LLGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
            +G G++G V+   + +     A+K++     +  + E+     +    +V L G     
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--VEELVACAGLSSPRIVPLYGAVREG 122

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV--QIALDAARGLEYIHEHTKTHYV 473
             + +  E  + GSL   +   +  G       +    Q  L    GLEY+H       +
Sbjct: 123 PWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQA-L---EGLEYLHTRRI---L 172

Query: 474 HRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTK--VVGTFGYLAPEYLTDGL 530
           H D+K+ N+LL S   RA + DFG A  +     G++ +T   + GT  ++APE +    
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 531 ATAKSDVYAFGVVLFEIISGK 551
             AK D+++   ++  +++G 
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (310), Expect = 9e-31
 Identities = 54/307 (17%), Positives = 108/307 (35%), Gaps = 48/307 (15%)

Query: 360 GHGTYGSVYYG--NIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           G     +V         + V ++R+     +         E+ +    +H N+V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 413 ATEDELFLIYEYAQKGS----LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
             ++EL+++  +   GS    + +H  D  N     +++I++        + L+YIH   
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA--IAYILQ-----GVLKALDYIHHM- 147

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT----KVVGTFGYLAPE 524
              YVHR +K+S+IL+    +  +S       +      +  V       V    +L+PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 525 YLTDGLA--TAKSDVYAFGV-------------------VLFEIISGKEAIIRTEGMVSK 563
            L   L    AKSD+Y+ G+                   +L E ++G    +     +  
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265

Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
            +   S +  +  +  +   + S     +   P+          F      +QC+  +P 
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH--FVEQCLQRNPD 323

Query: 624 LRPDMKQ 630
            RP    
Sbjct: 324 ARPSAST 330

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  120 bits (302), Expect = 3e-30
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 33/210 (15%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM---TATKTKEF---MAEMKILCKVHHSNLVELI 409
           +LG G++ +V        ++E AIK +      K  +      E  ++ ++ H   V+L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GL 461
                +++L+    YA+ G L  ++   +  G                 R         L
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI---RKIGS----------FDETCTRFYTAEIVSAL 143

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       +HRD+K  NILL+     +I+DFG AK++   S      +  VGT  Y+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYV 199

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +PE LT+  A   SD++A G +++++++G 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (301), Expect = 3e-30
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 350 TEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHS 403
            E F+    +G G++G V+ G  N   + VAIK +       + ++   E+ +L +    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
            + +  G    + +L++I EY   GS    L +P    +T ++ I+R     +  +GL+Y
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILR-----EILKGLDY 134

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H   K   +HRDIK++N+LL      K++DFG+A  +  T     T    VGT  ++AP
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAP 188

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E +      +K+D+++ G+   E+  G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (300), Expect = 9e-30
 Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 75/314 (23%)

Query: 358 LLGHGTYGSVY--YGNIRNQEVAIKRMTAT---KTKEFMAEMKILCKV-HHSNLVELIGY 411
           +L  G +  VY        +E A+KR+ +    K +  + E+  + K+  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 412 AA-------TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           A+       T    FL+     KG L   L   ++RG  S   +++  I     R ++++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCRAVQHM 152

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV---------V 515
           H   K   +HRD+K  N+LL +    K+ DFG A  +    D   +  +           
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 516 GTFGYLAPE---YLTDGLATAKSDVYAFGVVLFEII--------SGKEAIIRTEGMVSKN 564
            T  Y  PE     ++     K D++A G +L+ +           K  I+         
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-------- 263

Query: 565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL 624
                   + +      P   +  +                       L +  +  +P  
Sbjct: 264 ------GKYSI------PPHDTQYT-------------------VFHSLIRAMLQVNPEE 292

Query: 625 RPDMKQVVISLSQI 638
           R  + +VV  L +I
Sbjct: 293 RLSIAEVVHQLQEI 306

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (300), Expect = 1e-29
 Identities = 62/305 (20%), Positives = 122/305 (40%), Gaps = 35/305 (11%)

Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVH 401
              + F   S LG G  G V+  + +     +A K +          + + E+++L + +
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +V   G   ++ E+ +  E+   GSL   L       +  L      ++++   +GL
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGL 144

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK-VVGTFGY 520
            Y+ E  K   +HRD+K SNIL++S    K+ DFG++   G+  D   ++    VGT  Y
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLID---SMANSFVGTRSY 196

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           ++PE L     + +SD+++ G+ L E+  G+  I   +    +      +          
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 581 SPDSMSMSSLKDYIDPNMMDLY------PHDCLFKMAMLA---------KQCVDEDPILR 625
                   +         M ++       ++   K+              +C+ ++P  R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316

Query: 626 PDMKQ 630
            D+KQ
Sbjct: 317 ADLKQ 321

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (295), Expect = 2e-29
 Identities = 56/310 (18%), Positives = 95/310 (30%), Gaps = 86/310 (27%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKR-----MTATKTKEFMAEMKILCKV-HHSNLVELI 409
            +G G +GSV+    R      AIKR       +   +  + E+     +  HS++V   
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQT---SLSWIMRVQIALDAARGLEYIHE 466
              A +D + +  EY   GSL   + +          +    + +Q+      GL YIH 
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR----GLRYIHS 133

Query: 467 HTKTHYVHRDIKSSNILLD-------------------SAFRAKISDFGLAKLVGKTSDG 507
            +    VH DIK SNI +                    +    KI D G    +      
Sbjct: 134 MSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 189

Query: 508 EATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE 566
                   G   +LA E L +      K+D++A  + +      +           +N +
Sbjct: 190 ------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--------PRNGD 235

Query: 567 RRSLASFMLAALRNS-----PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED 621
                      +R       P  +S     + +                    K  +  D
Sbjct: 236 -------QWHEIRQGRLPRIPQVLS-QEFTELL--------------------KVMIHPD 267

Query: 622 PILRPDMKQV 631
           P  RP    +
Sbjct: 268 PERRPSAMAL 277

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (299), Expect = 2e-29
 Identities = 24/232 (10%), Positives = 51/232 (21%), Gaps = 48/232 (20%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIK------RMTATKTKEFMAEMKILCKVHHSNLVELI 409
            L  G    V+        ++ A+K        + ++ +          ++   +  E  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 410 GYA--------------------------ATEDELFLIYEYAQKGSLKS--HLHDPQNRG 441
                                               L+   A    L+      D     
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV 501
           +     +    +     R    +        VH      N+ +    R  + D      V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLA--TAKSDVYAFGVVLFEIISGK 551
           G                 Y   E+L    A  T   + +  G+ ++ +    
Sbjct: 245 GTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  117 bits (295), Expect = 2e-29
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 23/210 (10%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM---TATKTKEFMAEMKILCKVHHSN 404
            + ++    +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGL 461
           +V  +      DEL+++ EY   GSL   +       +T +      QIA    +  + L
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMD---EGQIAAVCRECLQAL 129

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H +     +HRDIKS NILL      K++DFG    +       +T   +VGT  ++
Sbjct: 130 EFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWM 183

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +T      K D+++ G++  E+I G+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  116 bits (292), Expect = 8e-29
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM---TATKTKEFMAEMKILCKVHHSN 404
                    +G G+ G V     +   ++VA+K M      + +    E+ I+    H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGL 461
           +VE+       +EL+++ E+ Q G+L   +       Q  L+     QIA       + L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLN---EEQIATVCEAVLQAL 154

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H       +HRDIKS +ILL    R K+SDFG    + K      +   +VGT  ++
Sbjct: 155 AYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWM 208

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE ++  L   + D+++ G+++ E++ G+
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (291), Expect = 9e-29
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM-TATKTKEFMAEMKILCKVHHSNLV 406
            E F     LG G+YGSVY    +   Q VAIK++   +  +E + E+ I+ +    ++V
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVV 87

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGLEY 463
           +  G      +L+++ EY   GS+   +             +   +IA       +GLEY
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-------LTEDEIATILQSTLKGLEY 140

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H   K   +HRDIK+ NILL++   AK++DFG+A  +  T     T   V+GT  ++AP
Sbjct: 141 LHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAP 194

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E + +      +D+++ G+   E+  GK
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGK 222

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  114 bits (287), Expect = 3e-28
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           +G G    V       + ++VAIKR+      T   E + E++ + + HH N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGLEYIHEHTK 469
             +DEL+L+ +    GS+   +     +G+     +    IA    +   GLEY+H++  
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK--VVGTFGYLAPEYLT 527
              +HRD+K+ NILL      +I+DFG++  +    D      +   VGT  ++APE + 
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199

Query: 528 DGLA-TAKSDVYAFGVVLFEIISGK 551
                  K+D+++FG+   E+ +G 
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGA 224

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  112 bits (283), Expect = 6e-28
 Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 38/211 (18%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKEFMA----EMKILCKVHHSNLVELIGY 411
            LG G YG V    N    + VA+K +   +  +       E+ I   ++H N+V+  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GLEY 463
               +  +L  EY   G L   +                + +    A+        G+ Y
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H        HRDIK  N+LLD     KISDFGLA +    +        + GT  Y+AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176

Query: 524 EYLT----DGLATAKSDVYAFGVVLFEIISG 550
           E L             DV++ G+VL  +++G
Sbjct: 177 ELLKRREFHA---EPVDVWSCGIVLTAMLAG 204

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (287), Expect = 8e-28
 Identities = 33/242 (13%), Positives = 66/242 (27%), Gaps = 59/242 (24%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-------------------------- 389
           +LG     +      +   +   +     T+                             
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 390 -----FMAEMKILCKVHHSNLVELIGYAATED--ELFLIYEYAQKGSLKSHLHDPQNRG- 441
                F+    ++       ++ +            F +Y   Q  +L++      +   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 198

Query: 442 -QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL 500
              SL    R+Q+ L   R L  +H +     VH  ++  +I+LD      ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 501 VGKTSDGEATVTKVVGTFGYLAPEYLTD-----------GLATAKSDVYAFGVVLFEIIS 549
            G              + G+  PE                L T   D +A G+V++ I  
Sbjct: 256 DGARVV-------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 550 GK 551
             
Sbjct: 309 AD 310

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  112 bits (282), Expect = 1e-27
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 21/207 (10%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKEFMA-------EMKILCKVHHSNLVEL 408
           LLG G+YG V    +       A+K +   K +           E+++L ++ H N+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 409 --IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
             + Y   + +++++ EY   G  +     P+ R     +     Q+      GLEY+H 
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----GLEYLHS 127

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 VH+DIK  N+LL +    KIS  G+A+ +   +  +   T   G+  +  PE  
Sbjct: 128 Q---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIA 183

Query: 527 --TDGLATAKSDVYAFGVVLFEIISGK 551
              D  +  K D+++ GV L+ I +G 
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  114 bits (287), Expect = 1e-27
 Identities = 31/236 (13%), Positives = 64/236 (27%), Gaps = 48/236 (20%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-------------------------- 389
           +LG     +      +   +   +     T+                             
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 390 -----FMAEMKILCKVHHSNLVELIGYAATED--ELFLIYEYAQKGSLKSHLHDPQNRGQ 442
                F+    ++       ++ +            F +Y   Q  +L++      +   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSS 203

Query: 443 T--SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL 500
           T  SL    R+Q+ L   R L  +H +     VH  ++  +I+LD      ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 501 VGKTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGK 551
            G ++                A   L        L T   D +  G+ ++ I    
Sbjct: 261 DGASAVSPIGR--GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  112 bits (281), Expect = 3e-27
 Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 38/211 (18%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKEFMA----EMKILCKVHHSNLVELIGY 411
            LG G YG V    N    + VA+K +   +  +       E+ I   ++H N+V+  G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GLEY 463
               +  +L  EY   G L   +                + +    A+        G+ Y
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +H        HRDIK  N+LLD     KISDFGLA +    +        + GT  Y+AP
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176

Query: 524 EYLT----DGLATAKSDVYAFGVVLFEIISG 550
           E L             DV++ G+VL  +++G
Sbjct: 177 ELLKRREFHA---EPVDVWSCGIVLTAMLAG 204

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  111 bits (279), Expect = 4e-27
 Identities = 44/215 (20%), Positives = 95/215 (44%), Gaps = 26/215 (12%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM---TATKTKEFMAEMKILCKVHHSN 404
            E +     LG G +G VY    +      A K +   +  + ++++ E++IL    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL---DAARGL 461
           +V+L+G    + +L+++ E+   G++ + + +           +   QI +        L
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-------LTEPQIQVVCRQMLEAL 130

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            ++H       +HRD+K+ N+L+      +++DFG++    K           +GT  ++
Sbjct: 131 NFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWM 184

Query: 522 APE-----YLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE      + D     K+D+++ G+ L E+   +
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  111 bits (279), Expect = 4e-27
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 43/217 (19%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKEFMA---------EMKILCKVH----H 402
           LLG G +G+V+ G  +    +VAIK +   +   +           E+ +L KV     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 403 SNLVELIGYAATEDELFLIYEYAQKG-------SLKSHLHDPQNRGQTSLSWIMRVQIAL 455
             ++ L+ +  T++   L+ E            + K  L +  +R           Q+  
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC------FFG-QVV- 149

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKV 514
                +++ H       VHRDIK  NIL+D     AK+ DFG   L     D   T    
Sbjct: 150 ---AAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDF-- 198

Query: 515 VGTFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISG 550
            GT  Y  PE+++        + V++ G++L++++ G
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  110 bits (278), Expect = 4e-27
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 58/235 (24%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIK---RMTATKTKEFMA-------------------- 392
            +G G+YG V        N   A+K   +    +   F                      
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 393 ------EMKILCKVHHSNLVEL--IGYAATEDELFLIYEYAQKGSL-----KSHLHDPQN 439
                 E+ IL K+ H N+V+L  +     ED L++++E   +G +        L + Q 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 440 RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK 499
           R         +  +      G+EY+H       +HRDIK SN+L+      KI+DFG++ 
Sbjct: 140 RF------YFQ-DLIK----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT---AKSDVYAFGVVLFEIISGK 551
                   +A ++  VGT  ++APE L++          DV+A GV L+  + G+
Sbjct: 186 EF---KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (278), Expect = 7e-27
 Identities = 52/243 (21%), Positives = 83/243 (34%), Gaps = 53/243 (21%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK--------RMTATKTKEFMAEMKILCKVHHSNLVEL 408
           +G G+YG V            AIK        ++     +    E++++ K+HH N+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL------------- 455
                 E  + L+ E    G L   L+   +      +  +                   
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 456 ---------------DAAR-------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRA--K 491
                            +         L Y+H        HRDIK  N L  +      K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 492 ISDFGLAKLVGKTSDGEATV-TKVVGTFGYLAPEYLTDGLA--TAKSDVYAFGVVLFEII 548
           + DFGL+K   K ++GE    T   GT  ++APE L         K D ++ GV+L  ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 549 SGK 551
            G 
Sbjct: 271 MGA 273

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 1e-26
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 25/218 (11%)

Query: 350 TEGFSDSSLLGHGTYGSVYYG-NIR-NQEVAIKRM--TATKTKEFMAEMKILCKV-HHSN 404
              F    L+G+GTYG VY G +++  Q  AIK M  T  + +E   E+ +L K  HH N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 405 LVELIG------YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           +    G          +D+L+L+ E+   GS+ + L            WI    I  +  
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIA--YICREIL 139

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           RGL ++H+H     +HRDIK  N+LL      K+ DFG++  + +T     T    +GT 
Sbjct: 140 RGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTP 193

Query: 519 GYLAPE-----YLTDGLATAKSDVYAFGVVLFEIISGK 551
            ++APE        D     KSD+++ G+   E+  G 
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  112 bits (282), Expect = 2e-26
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           LG G YG V     +  + E AIK      ++ +   + + E+ +L  + H N+++L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              +   +L+ E  + G L   +       +   + I++ Q+      G+ Y+H+H   +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLHKH---N 156

Query: 472 YVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
            VHRD+K  N+LL+S       KI DFGL+ +          + + +GT  Y+APE L  
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGTAYYIAPEVL-R 211

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
                K DV++ GV+LF +++G 
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGY 234

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  109 bits (275), Expect = 2e-26
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 38/210 (18%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELIGY 411
           +G G +  V      +  +EVAIK +  T+           E++I+  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
             TE  L+LI EYA  G +         + + + R         R QI       ++Y H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR------SKFR-QIV----SAVQYCH 131

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           +      VHRD+K+ N+LLD+    KI+DFG +      + G        G   Y APE 
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF---TVGGKLDA-FCGAPPYAAPEL 184

Query: 526 LT----DGLATAKSDVYAFGVVLFEIISGK 551
                 DG    + DV++ GV+L+ ++SG 
Sbjct: 185 FQGKKYDG---PEVDVWSLGVILYTLVSGS 211

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (273), Expect = 3e-26
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 45/216 (20%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFMA-----------EMKILCKVHHSNL 405
           LG G +G V+      +N+EV +K +   K  E              E+ IL +V H+N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 406 VELIGYAATEDELFLIYEYAQKG-------SLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++++     +    L+ E    G            L +P          I R Q+     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY------IFR-QLV---- 140

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             + Y+        +HRDIK  NI++   F  K+ DFG A  +     G+   T   GT 
Sbjct: 141 SAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTI 193

Query: 519 GYLAPEYLT----DGLATAKSDVYAFGVVLFEIISG 550
            Y APE L      G    + ++++ GV L+ ++  
Sbjct: 194 EYCAPEVLMGNPYRG---PELEMWSLGVTLYTLVFE 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (272), Expect = 3e-26
 Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 41/216 (18%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFMA---------EMKILCKVHHS--N 404
           LLG G +GSVY G     N  VAIK +   +  ++           E+ +L KV      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 405 LVELIGYAATEDELFLIYEYAQ-KGSL------KSHLHDPQNRGQTSLSWIMRVQIALDA 457
           ++ L+ +    D   LI E  +    L      +  L +   R           Q+    
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS------FFW-QVL--- 159

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
              + + H       +HRDIK  NIL+D      K+ DFG   L     D   T     G
Sbjct: 160 -EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDF--DG 210

Query: 517 TFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISGK 551
           T  Y  PE++         + V++ G++L++++ G 
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  108 bits (271), Expect = 4e-26
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 37/209 (17%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           +LG G +  V+    R   +  A+K +    A +      E+ +L K+ H N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 413 ATEDELFLIYEYAQKGSL------KSHL--HDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
            +    +L+ +    G L      +      D         S +++ Q+ L A   ++Y+
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDA--------SLVIQ-QV-LSA---VKYL 122

Query: 465 HEHTKTHYVHRDIKSSNILLDSAF---RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           HE+     VHRD+K  N+L  +     +  I+DFGL+K+          ++   GT GY+
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-----QNGIMSTACGTPGYV 174

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE L     +   D ++ GV+ + ++ G
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  110 bits (276), Expect = 4e-26
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 53/252 (21%)

Query: 333 FDMEKPVVFTY-----DEILFATEGFSD----SSLLGHGTYGSVYYGNIR--NQEVAIK- 380
             + +  VF +     D+     +   D    S  LG G  G V     R   ++VAI+ 
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167

Query: 381 ----------RMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL 430
                        A        E++IL K++H  ++++  +   ED  +++ E  + G L
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL 226

Query: 431 ------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL 484
                    L +   +           Q+ L     ++Y+HE+     +HRD+K  N+LL
Sbjct: 227 FDKVVGNKRLKEATCKL------YFY-QMLL----AVQYLHEN---GIIHRDLKPENVLL 272

Query: 485 DSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA---TAKSDVY 538
            S       KI+DFG +K++G   +     T + GT  YLAPE L            D +
Sbjct: 273 SSQEEDCLIKITDFGHSKILG---ETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCW 328

Query: 539 AFGVVLFEIISG 550
           + GV+LF  +SG
Sbjct: 329 SLGVILFICLSG 340

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (270), Expect = 9e-26
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 350 TEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRM------TATKTKEFMAEMKILCKVH 401
            + FSD   +GHG++G+VY+      ++ VAIK+M      +  K ++ + E++ L K+ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           H N ++  G    E   +L+ EY    +        +   +  ++ +        A +GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH-----GALQGL 167

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK---VVGTF 518
            Y+H H     +HRD+K+ NILL      K+ DFG A          + +      VGT 
Sbjct: 168 AYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSA----------SIMAPANSFVGTP 214

Query: 519 GYLAPE---YLTDGLATAKSDVYAFGVVLFEIISGK 551
            ++APE    + +G    K DV++ G+   E+   K
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (275), Expect = 1e-25
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 29/205 (14%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           LG G++G V     R   QE A+K           T   + E+++L K+ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHEHT 468
                  +++ E    G L     +   R + S    + I++ Q+      G+ Y+H+H 
Sbjct: 90  LEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIK-QV----FSGITYMHKH- 140

Query: 469 KTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
             + VHRD+K  NILL+S       KI DFGL+    + +     +   +GT  Y+APE 
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEV 194

Query: 526 LTDGLATAKSDVYAFGVVLFEIISG 550
           L  G    K DV++ GV+L+ ++SG
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSG 218

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  106 bits (266), Expect = 1e-25
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 29/205 (14%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           LG G++G V     R   QE A+K           T   + E+++L K+ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHEHT 468
                  +++ E    G L     +   R + S    + I++ Q+      G+ Y+H+H 
Sbjct: 90  LEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAARIIK-QV----FSGITYMHKH- 140

Query: 469 KTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
             + VHRD+K  NILL+S       KI DFGL+    + +     +   +GT  Y+APE 
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEV 194

Query: 526 LTDGLATAKSDVYAFGVVLFEIISG 550
           L  G    K DV++ GV+L+ ++SG
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSG 218

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  109 bits (275), Expect = 1e-25
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKR------MTATKTKEFMAEMKILCKVHHSNLVELIG 410
           LG G++G V     +   QE A+K          T  +  + E+++L ++ H N+++L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
           +   +   +L+ E    G L   +   +   +   + I+R Q+      G+ Y+H++   
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMHKN--- 145

Query: 471 HYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
             VHRD+K  N+LL+S       +I DFGL+     +      +   +GT  Y+APE L 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVL- 200

Query: 528 DGLATAKSDVYAFGVVLFEIISG 550
            G    K DV++ GV+L+ ++SG
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSG 223

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  105 bits (264), Expect = 2e-25
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)

Query: 350 TEGFSD----SSLLGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILC 398
           +  FSD       LG G +  V     +    E A K     +++A   ++   E +I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 399 KVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIAL 455
           K+ H N+V L      E   +L+++    G L     D   R   S    S  ++ QI  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ-QI-- 114

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVT 512
                + Y H +     VHR++K  N+LL S  +    K++DFGLA  V    D EA   
Sbjct: 115 --LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAW-H 165

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
              GT GYL+PE L     +   D++A GV+L+ ++ G
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  109 bits (274), Expect = 2e-25
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV 400
           F D  +LG G +G V+      Q  A  ++ A K   K+           M E KIL KV
Sbjct: 187 FLDFRVLGRGGFGEVFAC----QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 401 HHSNLVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV---QIALD 456
           H   +V L  YA  T+ +L L+      G ++ H+++                  QI   
Sbjct: 243 HSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS- 300

Query: 457 AARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG 516
              GLE++H+    + ++RD+K  N+LLD     +ISD GLA  +     G+       G
Sbjct: 301 ---GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL---KAGQTKTKGYAG 351

Query: 517 TFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           T G++APE L         D +A GV L+E+I+ +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (264), Expect = 3e-25
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 19/204 (9%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHS-NLVELIGY 411
           LG G YG V         Q +A+KR+ AT    + K  + ++ I  +       V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
              E ++++  E       K +              + +  IA+   + LE++H   K  
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHS--KLS 130

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRD+K SN+L+++  + K+ DFG++   G   D  A      G   Y+APE +   L 
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDI-DAGCKPYMAPERINPELN 186

Query: 532 ----TAKSDVYAFGVVLFEIISGK 551
               + KSD+++ G+ + E+   +
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILR 210

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  109 bits (274), Expect = 3e-25
 Identities = 66/219 (30%), Positives = 94/219 (42%), Gaps = 42/219 (19%)

Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV 400
           F    +LG G +G V       Q  A  +M A K   K+           + E +IL KV
Sbjct: 186 FRQYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR- 459
           +   +V L     T+D L L+      G LK H+    + GQ               A  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI---YHMGQAGFP--------EARAVF 290

Query: 460 -------GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
                  GLE +H       V+RD+K  NILLD     +ISD GLA       +G+    
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKG 344

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           + VGT GY+APE + +   T   D +A G +L+E+I+G+
Sbjct: 345 R-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  105 bits (265), Expect = 3e-25
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 44/217 (20%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK-----------RMTATKTKEFMAEMKILCKVHHSNL 405
           LG G  G V     R   ++VAIK              A        E++IL K++H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 406 VELIGYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           +++  +   ED  +++ E  + G L         L +   +           Q+ L    
Sbjct: 78  IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL------YFY-QMLL---- 125

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVG 516
            ++Y+HE+     +HRD+K  N+LL S       KI+DFG +K++G   +     T + G
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRT-LCG 178

Query: 517 TFGYLAPEYLTDGLA---TAKSDVYAFGVVLFEIISG 550
           T  YLAPE L            D ++ GV+LF  +SG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (264), Expect = 4e-25
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 20/216 (9%)

Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCK-V 400
           F  E   D   +G G YGSV     +   Q +A+KR+ +T    + K+ + ++ ++ +  
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
               +V+  G    E + ++  E     S         +     +   +  +I L   + 
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL-AKLVGKTSDGEATVTKVVGTFG 519
           L ++ E+ K   +HRDIK SNILLD +   K+ DFG+  +LV   +      T+  G   
Sbjct: 138 LNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-----TRDAGCRP 190

Query: 520 YLAPEYLTDGLA----TAKSDVYAFGVVLFEIISGK 551
           Y+APE +    +      +SDV++ G+ L+E+ +G+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  108 bits (272), Expect = 7e-25
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 43/220 (19%)

Query: 353 FSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV 400
           FS   ++G G +G VY      ++    +M A K   K+           + E  +L  V
Sbjct: 191 FSVHRIIGRGGFGEVYGC----RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246

Query: 401 HHSN---LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----Q 452
              +   +V +     T D+L  I +    G L  HL      G  S +    +     +
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEA---DMRFYAAE 300

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
           I L    GLE++H       V+RD+K +NILLD     +ISD GLA         +    
Sbjct: 301 IIL----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHA 349

Query: 513 KVVGTFGYLAPEYLTDGLATAKS-DVYAFGVVLFEIISGK 551
             VGT GY+APE L  G+A   S D ++ G +LF+++ G 
Sbjct: 350 -SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 8e-25
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 21/202 (10%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE---FMA--EMKILCKVHHSNLVELIGY 411
           +G G+YG V+    R   Q VAIK+   ++       +A  E+++L ++ H NLV L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 412 AATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              +  L L++EY    ++   L    +   +  +  I   Q      + + + H+H   
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW-QTL----QAVNFCHKH--- 121

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
           + +HRD+K  NIL+      K+ DFG A+L+   SD        V T  Y +PE L    
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD---YYDDEVATRWYRSPELLVGDT 178

Query: 531 ATAKS-DVYAFGVVLFEIISGK 551
                 DV+A G V  E++SG 
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGV 200

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (260), Expect = 1e-24
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 49/233 (21%)

Query: 349 ATEGFSD----SSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK------------EF 390
           +T GF +      +LG G    V     +   +E A+K +  T                 
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 391 MAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQT 443
           + E+ IL KV  H N+++L     T    FL+++  +KG L      K  L + + R   
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK-- 128

Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
               IMR  +       +  +H+    + VHRD+K  NILLD     K++DFG +  +  
Sbjct: 129 ----IMR-ALL----EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD- 175

Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKS------DVYAFGVVLFEIISG 550
              GE     V GT  YLAPE +   +           D+++ GV+++ +++G
Sbjct: 176 --PGEKLRE-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (268), Expect = 1e-24
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 34/213 (15%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK----------------RMTATKTKEFMAEMKILCKV 400
           LG G YG V     +  + E AIK                +      +E   E+ +L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
            H N+++L      +   +L+ E+ + G L   + +     +   + IM+ QI      G
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI----LSG 158

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           + Y+H+H   + VHRDIK  NILL++       KI DFGL+    K       +   +GT
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY----KLRDRLGT 211

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             Y+APE L       K DV++ GV+++ ++ G
Sbjct: 212 AYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (263), Expect = 1e-24
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 44/218 (20%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTK-----------EFMAEMKILCKVH-HSN 404
           +G G    V     R    E A+K M  T  +               E  IL +V  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 405 LVELIGYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAA 458
           ++ LI    +   +FL+++  +KG L      K  L + + R       IMR  +     
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS------IMR-SLL---- 210

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             + ++H +   + VHRD+K  NILLD   + ++SDFG +  +     GE     + GT 
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRE-LCGTP 263

Query: 519 GYLAPEYLTDGLATA------KSDVYAFGVVLFEIISG 550
           GYLAPE L   +         + D++A GV+LF +++G
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  103 bits (258), Expect = 2e-24
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK----RMTATKTKEFMAEMKILCKVHHSNLVELIGYA 412
           LG G +G V+    R    E  IK      +    ++  AE+++L  + H N++++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIHEH 467
                ++++ E  + G L   +   Q RG+ +LS      +M+ Q+       L Y H  
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMK-QM----MNALAYFHSQ 143

Query: 468 TKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
              H VH+D+K  NIL          KI DFGLA+L           T   GT  Y+APE
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTALYMAPE 196

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISG 550
                + T K D+++ GVV++ +++G
Sbjct: 197 VFKRDV-TFKCDIWSAGVVMYFLLTG 221

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (263), Expect = 2e-24
 Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 42/237 (17%)

Query: 359 LGHGTYGSVYYGNIR----NQEVAIKR-------MTATKTKEFMAEMKILCKVHHSNLVE 407
           +G GTYG VY    +    +++ A+K+       M+A        E+ +L ++ H N++ 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKHPNVIS 82

Query: 408 LIG--YAATEDELFLIYEYAQ---KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
           L     +  + +++L+++YA+      +K H     N+    L   M   +      G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRA----KISDFGLAKLVGKTSDGEATVTKVVGTF 518
           Y+H +     +HRD+K +NIL+          KI+D G A+L        A +  VV TF
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 519 GYLAPEYLTDGLA----TAKSDVYAFGVVLFEIIS------GKEAIIRTEGMVSKNQ 565
            Y APE L   L     T   D++A G +  E+++       ++  I+T      +Q
Sbjct: 200 WYRAPELL---LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  102 bits (256), Expect = 2e-24
 Identities = 45/206 (21%), Positives = 85/206 (41%), Gaps = 33/206 (16%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAA 413
           +G G++G V     +      A K++     ++   F  E++I+  + H N++ L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 414 TEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
              +++L+ E    G L      K    +           IM+  +       + Y H+ 
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMK-DV----LSAVAYCHKL 125

Query: 468 TKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
              +  HRD+K  N L  +       K+ DFGLA            +   VGT  Y++P+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSPQ 178

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISG 550
            L +GL   + D ++ GV+++ ++ G
Sbjct: 179 VL-EGLYGPECDEWSAGVMMYVLLCG 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (261), Expect = 2e-24
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 34/208 (16%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           LG G +  V     +    E A K     +++A   ++   E +I  K+ H N+V L   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 412 AATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
              E   +L+++    G L      +    +            ++ QI       + Y H
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH------CIQ-QI----LESIAYCH 145

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
            +     VHR++K  N+LL S  +    K++DFGLA  V    D EA      GT GYL+
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAW-HGFAGTPGYLS 198

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE L     +   D++A GV+L+ ++ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  104 bits (261), Expect = 3e-24
 Identities = 58/259 (22%), Positives = 97/259 (37%), Gaps = 44/259 (16%)

Query: 314 TGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSD----SSLLGHGTYGSVYY 369
            G         PK    D F  +    +    +        D       LG G +G V+ 
Sbjct: 10  HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR 69

Query: 370 GNIR--NQEVAIKRMTATKTKE---FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY 424
              +   +    K +      +      E+ I+ ++HH  L+ L      + E+ LI E+
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129

Query: 425 AQKGSL------KSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIHEHTKTHYV 473
              G L      + +           +S       MR Q       GL+++HEH     V
Sbjct: 130 LSGGELFDRIAAEDY----------KMSEAEVINYMR-QAC----EGLKHMHEH---SIV 171

Query: 474 HRDIKSSNILLDSAFRA--KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
           H DIK  NI+ ++   +  KI DFGLA  +    + +  V     T  + APE +     
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAPEIVDREPV 227

Query: 532 TAKSDVYAFGVVLFEIISG 550
              +D++A GV+ + ++SG
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 4e-24
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 27/205 (13%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVELIGY 411
           LG G +  V         QE A       +++A   ++   E +I   + H N+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHEHT 468
            + E   +LI++    G L     D   R   S    S  ++ QI L+A   + + H+  
Sbjct: 79  ISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQ-QI-LEA---VLHCHQM- 129

Query: 469 KTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
               VHR++K  N+LL S  +    K++DFGLA  V      +       GT GYL+PE 
Sbjct: 130 --GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV---EGEQQAWFGFAGTPGYLSPEV 184

Query: 526 LTDGLATAKSDVYAFGVVLFEIISG 550
           L         D++A GV+L+ ++ G
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVG 209

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  102 bits (255), Expect = 5e-24
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 23/205 (11%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHS-NLVELIGY 411
           +G GT G V+    R     +A+K+M  +    + K  + ++ ++ K H    +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             T  ++F+  E     + K          +  L      ++ +   + L Y+ E  K  
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE--KHG 145

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRD+K SNILLD   + K+ DFG++   G+  D +A   +  G   Y+APE +     
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAK-DRSAGCAAYMAPERIDPPDP 201

Query: 532 -----TAKSDVYAFGVVLFEIISGK 551
                  ++DV++ G+ L E+ +G+
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQ 226

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  102 bits (257), Expect = 9e-24
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 353 FSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELI-- 409
           +++  ++G+G++G V+    + + EVAIK++   K  +   E++I+  V H N+V+L   
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-ELQIMRIVKHPNVVDLKAF 100

Query: 410 ----GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV---QIALDAARGLE 462
               G    E  L L+ EY  + ++           QT    ++++   Q+     R L 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLA 155

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           YIH        HRDIK  N+LLD      K+ DFG AK       GE  V+ +  +  Y 
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNVSYIC-SRYYR 208

Query: 522 APE-YLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE        T   D+++ G V+ E++ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  103 bits (259), Expect = 9e-24
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 23/248 (9%)

Query: 316 EVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-N 374
           E +N P+   K +   + +  KP      ++    E F    ++G G +G V    ++  
Sbjct: 40  ECNNSPLRREKNILEYL-EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA 98

Query: 375 QEV-AIKRM---TATKTKE---FMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK 427
            +V A+K +      K  E   F  E  +L       +  L      ++ L+L+ +Y   
Sbjct: 99  DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158

Query: 428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA 487
           G L + L   ++R    ++     ++ +     ++ +H+    HYVHRDIK  NIL+D  
Sbjct: 159 GDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSVHQL---HYVHRDIKPDNILMDMN 211

Query: 488 FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS-----DVYAFGV 542
              +++DFG    + +  DG    +  VGT  Y++PE L              D ++ GV
Sbjct: 212 GHIRLADFGSCLKLME--DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269

Query: 543 VLFEIISG 550
            ++E++ G
Sbjct: 270 CMYEMLYG 277

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (255), Expect = 1e-23
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 30/205 (14%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-FMAEMKILCKVHHSNLVELIGYAAT 414
            LG G    VY    +   +  A+K +  T  K+    E+ +L ++ H N+++L     T
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119

Query: 415 EDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
             E+ L+ E    G L      K +  +            ++ QI       + Y+HE+ 
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAAD------AVK-QI----LEAVAYLHEN- 167

Query: 469 KTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
               VHRD+K  N+L  +       KI+DFGL+K+V         +  V GT GY APE 
Sbjct: 168 --GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPEI 221

Query: 526 LTDGLATAKSDVYAFGVVLFEIISG 550
           L       + D+++ G++ + ++ G
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCG 246

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  100 bits (251), Expect = 1e-23
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 43/214 (20%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATK-TKEFMA-----EMKILCKVHHSNLVELI 409
            LG GT+G V  G   +   +VA+K +   K     +      E++ L    H ++++L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GL 461
              +T  + F++ EY   G L  ++      G        RV+     AR         +
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYI---CKHG--------RVEE--MEARRLFQQILSAV 124

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y H H     VHRD+K  N+LLD+   AKI+DFGL+ +    SDGE   T   G+  Y 
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRT-SCGSPNYA 177

Query: 522 APEYLT----DGLATAKSDVYAFGVVLFEIISGK 551
           APE ++     G    + D+++ GV+L+ ++ G 
Sbjct: 178 APEVISGRLYAG---PEVDIWSCGVILYALLCGT 208

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  102 bits (256), Expect = 1e-23
 Identities = 52/238 (21%), Positives = 103/238 (43%), Gaps = 46/238 (19%)

Query: 337 KPVVFTYDEILFATEGFSD------SSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK 388
            P  F +  +       +       + +LG G +G V+         ++A K +     K
Sbjct: 69  PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128

Query: 389 ---EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL------KSHLHDPQN 439
              E   E+ ++ ++ H+NL++L     +++++ L+ EY   G L      +S+      
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY------ 182

Query: 440 RGQTSLS-----WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA--KI 492
               +L+       M+ QI  +   G+ ++H+    + +H D+K  NIL  +      KI
Sbjct: 183 ----NLTELDTILFMK-QI-CE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKI 230

Query: 493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            DFGLA+           +    GT  +LAPE +     +  +D+++ GV+ + ++SG
Sbjct: 231 IDFGLARRY----KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  100 bits (252), Expect = 1e-23
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 28/205 (13%)

Query: 359 LGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE---FMA--EMKILCKVHHSNLVELIGYA 412
           +G GTYG VY   + + + VA+KR+      E     A  E+ +L ++HH N+V LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL--SWIMRVQIALDAARGLEYIHEHTKT 470
            +E  L L++E+ +K  LK  L + +   Q S    ++   Q+     RG+ + H+H   
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY--QLL----RGVAHCHQH--- 138

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             +HRD+K  N+L++S    K++DFGLA+  G       + T  V T  Y AP+ L   +
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR---SYTHEVVTLWYRAPDVL---M 192

Query: 531 -ATAKS---DVYAFGVVLFEIISGK 551
            +   S   D+++ G +  E+I+GK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  102 bits (256), Expect = 1e-23
 Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 42/217 (19%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVELI 409
           ++G G +  V    ++   Q  A+K M         +   F  E  +L       + +L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 410 GYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------G 460
            +A   E+ L+L+ EY   G L + L      G+         +I  + AR         
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLL---SKFGE---------RIPAEMARFYLAEIVMA 174

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           ++ +H      YVHRDIK  NILLD     +++DFG    +   +DG       VGT  Y
Sbjct: 175 IDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLR--ADGTVRSLVAVGTPDY 229

Query: 521 LAPEYLTDGLATAKSDVY-------AFGVVLFEIISG 550
           L+PE L        +  Y       A GV  +E+  G
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  101 bits (253), Expect = 2e-23
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 21/202 (10%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKE---FMA--EMKILCKVHHSNLVELIGY 411
           +G G+YG V    N      VAIK+   +   +    +A  E+K+L ++ H NLV L+  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 412 AATEDELFLIYEYAQKGSLKSHLHD-PQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
              +   +L++E+    ++   L   P       +   +  QI      G+ + H H   
Sbjct: 93  CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLF-QII----NGIGFCHSH--- 143

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
           + +HRDIK  NIL+  +   K+ DFG A+ +    +        V T  Y APE L   +
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPELLVGDV 200

Query: 531 ATAKS-DVYAFGVVLFEIISGK 551
              K+ DV+A G ++ E+  G+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE 222

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (252), Expect = 2e-23
 Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 39/213 (18%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTK---------EFMAEMKILCKVHHSNLVE 407
           LG G +  V     +    E A K +   +++         E   E+ IL +V H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 408 LIGYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           L        ++ LI E    G L      K  L + +       +  ++ QI      G+
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------ATSFIK-QI----LDGV 128

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDS----AFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
            Y+H        H D+K  NI+L          K+ DFGLA  +            + GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGT 181

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             ++APE +       ++D+++ GV+ + ++SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  102 bits (255), Expect = 2e-23
 Identities = 62/247 (25%), Positives = 105/247 (42%), Gaps = 36/247 (14%)

Query: 318 SNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQ 375
                 +   + T     ++P   +Y +            ++G+G++G VY   +    +
Sbjct: 31  DKDGSKVTTVVATPGQGPDRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGE 80

Query: 376 EVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGY------AATEDELFLIYEYAQKGS 429
            VAIK++   K  +   E++I+ K+ H N+V L  +         E  L L+ +Y  + +
Sbjct: 81  LVAIKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-T 138

Query: 430 LKSHLHDPQNRGQTSLSWIMRV---QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS 486
           +           QT     +++   Q+     R L YIH        HRDIK  N+LLD 
Sbjct: 139 VYRVARHYSRAKQTLPVIYVKLYMYQLF----RSLAYIHSF---GICHRDIKPQNLLLDP 191

Query: 487 A-FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVL 544
                K+ DFG AK   +   GE  V+ +  +  Y APE        T+  DV++ G VL
Sbjct: 192 DTAVLKLCDFGSAK---QLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVL 247

Query: 545 FEIISGK 551
            E++ G+
Sbjct: 248 AELLLGQ 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  100 bits (252), Expect = 3e-23
 Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 39/213 (18%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTK---------EFMAEMKILCKVHHSNLVE 407
           LG G +  V     +    E A K +   +++         E   E+ IL +V H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 408 LIGYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           L        ++ LI E    G L      K  L + +       +  ++ QI      G+
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE------ATSFIK-QI----LDGV 128

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDS----AFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
            Y+H        H D+K  NI+L          K+ DFGLA  +            + GT
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGT 181

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             ++APE +       ++D+++ GV+ + ++SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (250), Expect = 4e-23
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 34/212 (16%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATK--------TKEFMAEMKILCKVHHSNLVEL 408
           +G G +  V     R   Q+ A+K +   K        T++   E  I   + H ++VEL
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL-------SWIMRVQIALDAARGL 461
           +   +++  L++++E+     L     +   R            S  MR QI L+A   L
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMR-QI-LEA---L 143

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTF 518
            Y H++   + +HRD+K   +LL S   +   K+  FG+A  +G++          VGT 
Sbjct: 144 RYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVGTP 197

Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
            ++APE +         DV+  GV+LF ++SG
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  100 bits (250), Expect = 5e-23
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 28/219 (12%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM---TATKTKEFMAEMKILCKVHHSN 404
            + F    + G GT+G+V  G  +     VAIK++      + +E    M+ L  +HH N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80

Query: 405 LVEL--IGYAATEDE-----LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV---QIA 454
           +V+L    Y   E +     L ++ EY    +L     +   R       +++V   Q+ 
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTK 513
               R +  +H  +  +  HRDIK  N+L++ A    K+ DFG AK +      E  V  
Sbjct: 140 ----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---SEPNVAY 191

Query: 514 VVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISGK 551
           +   + Y APE    +   T   D+++ G +  E++ G+
Sbjct: 192 ICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 31/208 (14%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIK-----RMTATKTKEFMAEMKILCKV-HHSNLVELIG 410
           LG G +  V     +   QE A K     R       E + E+ +L        ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIH 465
                 E+ LI EYA  G + S            +S      +++ QI      G+ Y+H
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIK-QI----LEGVYYLH 148

Query: 466 EHTKTHYVHRDIKSSNILLDSAF---RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           ++   + VH D+K  NILL S +     KI DFG+++ +G        + +++GT  YLA
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HAC-ELREIMGTPEYLA 201

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE L     T  +D++  G++ + +++ 
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 25/202 (12%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCK-VHHSNLVELIGYAATE 415
           +G G+Y        +  N E A+K +     ++   E++IL +   H N++ L       
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDG 88

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHEHTKTHY 472
             ++++ E  + G L   L     +   S    S ++   I     + +EY+H       
Sbjct: 89  KYVYVVTELMKGGEL---LDKILRQKFFSEREASAVLF-TIT----KTVEYLHAQ---GV 137

Query: 473 VHRDIKSSNILL----DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
           VHRD+K SNIL      +    +I DFG AK +         +     T  ++APE L  
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLER 194

Query: 529 GLATAKSDVYAFGVVLFEIISG 550
               A  D+++ GV+L+ +++G
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTG 216

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (250), Expect = 7e-23
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 41/214 (19%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKVHHSNL 405
            +G G++G V       Q+   K+M A K   K+             E++I+  + H  L
Sbjct: 22  AIGKGSFGKVCIV----QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----QIALDAARG 460
           V L      E+++F++ +    G L+ HL   Q            V     ++ +     
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEE---TVKLFICELVM----A 127

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L+Y+        +HRD+K  NILLD      I+DF +A ++          T + GT  Y
Sbjct: 128 LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITT-MAGTKPY 180

Query: 521 LAPEYLTDGLATAKS---DVYAFGVVLFEIISGK 551
           +APE  +       S   D ++ GV  +E++ G+
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 99.4 bits (248), Expect = 8e-23
 Identities = 60/211 (28%), Positives = 84/211 (39%), Gaps = 41/211 (19%)

Query: 358 LLGHGTYGSVYYG-NIR-NQEVAIKRMTATK-TKEFMA-EMKILCKVHHSNLVELIGYAA 413
            +G G +G      +    + VA+K +       E +  E+     + H N+V       
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GLEYIH 465
           T   L +I EYA  G L   +    N G        R     D AR        G+ Y H
Sbjct: 87  TPTHLAIIMEYASGGELYERI---CNAG--------RFSE--DEARFFFQQLLSGVSYCH 133

Query: 466 EHTKTHYVHRDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
                   HRD+K  N LLD   A R KI DFG +K    +       +  VGT  Y+AP
Sbjct: 134 SM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKS-TVGTPAYIAP 186

Query: 524 EYLT----DGLATAKSDVYAFGVVLFEIISG 550
           E L     DG     +DV++ GV L+ ++ G
Sbjct: 187 EVLLRQEYDG---KIADVWSCGVTLYVMLVG 214

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 99.2 bits (248), Expect = 9e-23
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 26/185 (14%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKE---FMA--EMKILCKVHHSNLVELIG- 410
           +G GT+G V+   + +  + VA+K++     KE     A  E+KIL  + H N+V LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 411 -------YAATEDELFLIYEYAQKGSLKSHLHDPQNR-GQTSLSWIMRVQIALDAARGLE 462
                  Y   +  ++L++++ +   L   L +   +   + +  +M+  +      GL 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ-MLL----NGLY 138

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-TKVVGTFGYL 521
           YIH +     +HRD+K++N+L+      K++DFGLA+      + +    T  V T  Y 
Sbjct: 139 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 522 APEYL 526
            PE L
Sbjct: 196 PPELL 200

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 23/201 (11%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAATE 415
           LG G++        +  NQ  A+K ++         E+  L     H N+V+L      +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHEHTKTHY 472
              FL+ E    G L       + +   S    S+IMR ++       + ++H+      
Sbjct: 79  LHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMR-KLV----SAVSHMHDV---GV 127

Query: 473 VHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
           VHRD+K  N+L          KI DFG A+L          +     T  Y APE L   
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLK---PPDNQPLKTPCFTLHYAAPELLNQN 184

Query: 530 LATAKSDVYAFGVVLFEIISG 550
                 D+++ GV+L+ ++SG
Sbjct: 185 GYDESCDLWSLGVILYTMLSG 205

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 21/176 (11%)

Query: 359 LGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE---FMA--EMKILCKVHHSNLVELIGYA 412
           +G GTYG VY   N   +  A+K++   K  E        E+ IL ++ HSN+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL--SWIMRVQIALDAARGLEYIHEHTKT 470
            T+  L L++E+  +  LK  L   +   ++    S+++  Q+      G+ Y H+    
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLL--QLL----NGIAYCHDR--- 119

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
             +HRD+K  N+L++     KI+DFGLA+  G         T  + T  Y AP+ L
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVL 172

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 22/177 (12%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKE---FMA--EMKILCKVHHSNLVELIGY 411
           +G GTYG+V+   N    E VA+KR+      E     A  E+ +L ++ H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL--SWIMRVQIALDAARGLEYIHEHTK 469
             ++ +L L++E+  +  LK +           +  S++   Q+     +GL + H    
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLF--QLL----KGLGFCHSR-- 120

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
            + +HRD+K  N+L++     K+++FGLA+  G         +  V T  Y  P+ L
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVL 173

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (252), Expect = 2e-22
 Identities = 58/263 (22%), Positives = 106/263 (40%), Gaps = 38/263 (14%)

Query: 306 KSGDYIQTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSD----SSLLGH 361
           + G  +   G++     T+       VFD+ K   +    +    +   D       LG 
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQ--YYPQPVEIKHDHVLDHYDIHEELGT 167

Query: 362 GTYGSVYYGNIR--NQEVAIKRMTATKTKEFMA---EMKILCKVHHSNLVELIGYAATED 416
           G +G V+    R      A K +      +      E++ +  + H  LV L      ++
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 417 ELFLIYEYAQKGSL-------KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           E+ +IYE+   G L        + + + +          MR Q+     +GL ++HE+  
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVE------YMR-QV----CKGLCHMHEN-- 274

Query: 470 THYVHRDIKSSNILLDSAFRA--KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
            +YVH D+K  NI+  +      K+ DFGL   +    D + +V    GT  + APE   
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEVAE 329

Query: 528 DGLATAKSDVYAFGVVLFEIISG 550
                  +D+++ GV+ + ++SG
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 98.4 bits (246), Expect = 2e-22
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIK--RMTATKTKE----FMA--EMKILCKVHHSNLVEL 408
           LG G + +VY   +    + VAIK  ++      +      A  E+K+L ++ H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL--SWIMRVQIALDAARGLEYIHE 466
           +     +  + L++++ +   L+  + D       S   ++++         +GLEY+H+
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYML--MTL----QGLEYLHQ 130

Query: 467 HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
           H     +HRD+K +N+LLD     K++DFGLAK  G         T  V T  Y APE L
Sbjct: 131 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG---SPNRAYTHQVVTRWYRAPELL 184

Query: 527 TDGL-ATAKS---DVYAFGVVLFEIISGK 551
                A       D++A G +L E++   
Sbjct: 185 ---FGARMYGVGVDMWAVGCILAELLLRV 210

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 39/213 (18%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTK---------EFMAEMKILCKVHHSNLVE 407
           LG G +  V     +   +E A K +   +           E   E+ IL ++ H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 408 LIGYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           L      + ++ LI E    G L      K  L + +          ++ QI      G+
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLK-QI----LDGV 121

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRA----KISDFGLAKLVGKTSDGEATVTKVVGT 517
            Y+H        H D+K  NI+L          K+ DFG+A  +    +       + GT
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI----EAGNEFKNIFGT 174

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             ++APE +       ++D+++ GV+ + ++SG
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 26/181 (14%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKR----------MTATKTKEFMAEMKILCKVHHSNLV 406
           LG+GTY +VY G N      VA+K            TA      + E+ ++ ++ H N+V
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHENIV 66

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQ-IALDAARGLEYIH 465
            L     TE++L L++E+     LK ++             +  V+       +GL + H
Sbjct: 67  RLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           E+     +HRD+K  N+L++   + K+ DFGLA+  G   +   T +  V T  Y AP+ 
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---TFSSEVVTLWYRAPDV 179

Query: 526 L 526
           L
Sbjct: 180 L 180

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 39/213 (18%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTK---------EFMAEMKILCKVHHSNLVE 407
           LG G +  V     +    + A K +   +TK         +   E+ IL ++ H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 408 LIGYAATEDELFLIYEYAQKGSL------KSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
           L      + ++ LI E    G L      K  L + +       +  ++ QI      G+
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE------ATEFLK-QI----LNGV 127

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRA----KISDFGLAKLVGKTSDGEATVTKVVGT 517
            Y+H        H D+K  NI+L          KI DFGLA  +    D       + GT
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFGT 180

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             ++APE +       ++D+++ GV+ + ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 40/203 (19%), Positives = 82/203 (40%), Gaps = 27/203 (13%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE--FMAEMKILCKVHHSNLVELIGYAAT 414
           LG G +G V+        +    K +    T +     E+ IL    H N++ L     +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIHEHTK 469
            +EL +I+E+     +   ++         L+       +  Q+       L+++H H  
Sbjct: 73  MEELVMIFEFISGLDIFERINT---SA-FELNEREIVSYVH-QVC----EALQFLHSH-- 121

Query: 470 THYVHRDIKSSNILLDSAFRA--KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
            +  H DI+  NI+  +   +  KI +FG A+ +            +     Y APE   
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPEVHQ 176

Query: 528 DGLATAKSDVYAFGVVLFEIISG 550
             + +  +D+++ G +++ ++SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 99.9 bits (249), Expect = 2e-22
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 37/211 (17%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATK-TKEFMA-----EMKILCKVHHSNLVELI 409
            LG GT+G V  G   +   +VA+K +   K     +      E++ L    H ++++L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GL 461
              +T  ++F++ EY   G L  ++      G        R+      +R        G+
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI---CKNG--------RLDE--KESRRLFQQILSGV 129

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +Y H H     VHRD+K  N+LLD+   AKI+DFGL+ ++   SDGE   T   G+  Y 
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRT-SCGSPNYA 182

Query: 522 APEYLTDGL-ATAKSDVYAFGVVLFEIISGK 551
           APE ++  L A  + D+++ GV+L+ ++ G 
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 40/211 (18%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKR----------MTATKTKEFMAEMKILCKVHHSNLV 406
           LG GTY +VY G  +  +  VA+K            TA      + E+ +L  + H+N+V
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDLKHANIV 63

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL--SWIMRVQIALDAARGLEYI 464
            L     TE  L L++EY  K  LK +L D  N         ++   Q+     RGL Y 
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLF--QLL----RGLAYC 116

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRD+K  N+L++     K++DFGLA+          T    V T  Y  P+
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS---IPTKTYDNEVVTLWYRPPD 170

Query: 525 YLTDGL-ATAKS---DVYAFGVVLFEIISGK 551
            L   L +T  S   D++  G + +E+ +G+
Sbjct: 171 IL---LGSTDYSTQIDMWGVGCIFYEMATGR 198

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 33/210 (15%)

Query: 358 LLGHGTYGSVY-----YGNIRNQEVAIK-----RMTATKTKEFMAEMKILCKVHHSNLVE 407
           +LG G++G V+      G+   Q  A+K      +          E  IL +V+H  +V+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 408 LIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----QIALDAARGL 461
           L  YA  TE +L+LI ++ + G L + L         +      V     ++AL     L
Sbjct: 91  LH-YAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEE---DVKFYLAELAL----AL 139

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +++H       ++RD+K  NILLD     K++DFGL+K        +   +   GT  Y+
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYS-FCGTVEYM 193

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +     T  +D ++FGV++FE+++G 
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 24/180 (13%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKE---FMA--EMKILCKVHHSNLVELIGY 411
           LG GTYG VY   +    E VAIKR+     +E     A  E+ +L ++ H N++EL   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
                 L LI+EYA+   LK ++    +     +   +  Q+      G+ + H      
Sbjct: 102 IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLY-QL----INGVNFCHSR---R 152

Query: 472 YVHRDIKSSNILLDSAFRA-----KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
            +HRD+K  N+LL  +  +     KI DFGLA+  G         T  + T  Y  PE L
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHEIITLWYRPPEIL 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 33/208 (15%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGY--- 411
           +LG G  G V     R   Q+ A+K +    + +   E+    +     ++V ++     
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHIVCILDVYEN 93

Query: 412 -AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIH 465
               +  L +I E  + G L S +   Q RG  + +      IMR  I       ++++H
Sbjct: 94  MHHGKRCLLIIMECMEGGELFSRI---QERGDQAFTEREAAEIMR-DIG----TAIQFLH 145

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
            H   +  HRD+K  N+L  S  +    K++DFG AK        +  +     T  Y+A
Sbjct: 146 SH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-----QNALQTPCYTPYYVA 197

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISG 550
           PE L         D+++ GV+++ ++ G
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE---FMAEMKILCKV-HHSNLVELIGY 411
           +LG G +  V        +QE A+K +             E+++L +   H N++ELI +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS---LSWIMRVQIALDAARGLEYIHEHT 468
              ED  +L++E  + GS+ SH+H    R   +    S +++  +A      L+++H   
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHK---RRHFNELEASVVVQ-DVA----SALDFLHNK- 130

Query: 469 KTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTK----VVGTFGYL 521
                HRD+K  NIL +   +    KI DF L   +    D     T       G+  Y+
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 522 APEYLTDGLATAKS-----DVYAFGVVLFEIISG 550
           APE +      A       D+++ GV+L+ ++SG
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 97.5 bits (243), Expect = 8e-22
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 39/213 (18%)

Query: 358 LLGHGTYGSVYY-GNIRNQEV-AIKRM------TATKTKEFMAEMKILCKVHHSNLVELI 409
           ++G G +G V    +   ++V A+K +        + +  F  E  I+   +   +V+L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GL 461
                +  L+++ EY   G L + +                  +    AR         L
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFYTAEVVLAL 181

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           + IH      ++HRD+K  N+LLD +   K++DFG    + K  +G       VGT  Y+
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--EGMVRCDTAVGTPDYI 236

Query: 522 APEYLT----DGLATAKSDVYAFGVVLFEIISG 550
           +PE L     DG    + D ++ GV L+E++ G
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEF---MAEMKILCKVHHSN 404
           F     LG G++G V     +      A+K +      K K+    + E +IL  V+   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR---VQIALDAARGL 461
           LV+L         L+++ EY   G + SHL   +  G+ S     R    QI L      
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH-ARFYAAQIVL----TF 154

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY+H       ++RD+K  N+L+D     +++DFG AK V        T T + GT   L
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWT-LCGTPEAL 205

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISG 550
           APE +         D +A GV+++E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 51/254 (20%), Positives = 95/254 (37%), Gaps = 32/254 (12%)

Query: 312 QTTGEVSNPPITIPKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGN 371
             T  + +PP   P                   +     +    S +LG G  G V    
Sbjct: 23  PPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIF 82

Query: 372 IR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGY----AATEDELFLIYEY 424
            +   ++ A+K +      +   E+++  +     ++V ++       A    L ++ E 
Sbjct: 83  NKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140

Query: 425 AQKGSLKSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKS 479
              G L       Q+RG  + +      IM+  I       ++Y+H     +  HRD+K 
Sbjct: 141 LDGGEL---FSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHSI---NIAHRDVKP 189

Query: 480 SNILLDSAFRA---KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSD 536
            N+L  S       K++DFG AK          ++T    T  Y+APE L         D
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKET----TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245

Query: 537 VYAFGVVLFEIISG 550
           +++ GV+++ ++ G
Sbjct: 246 MWSLGVIMYILLCG 259

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM---TATKTKEF---MAEMKILCKVHHSNLVELI 409
            LG G++G V+    R   +  A+K +      + K+      E  +L  V H  ++ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----QIALDAARGLEYI 464
           G      ++F+I +Y + G L S L   +   +              ++ L     LEY+
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNP---VAKFYAAEVCL----ALEYL 122

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       ++RD+K  NILLD     KI+DFG AK V        T T + GT  Y+APE
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYT-LCGTPDYIAPE 173

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISG 550
            ++        D ++FG++++E+++G
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAG 199

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 94.5 bits (236), Expect = 2e-21
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 35/212 (16%)

Query: 358 LLGHGTYGSVY-----YGNIRNQEVAIK----RMTATKTKEF---MAEMKILCKVHHSNL 405
           +LG G YG V+      G    +  A+K     M     K+     AE  IL +V H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 406 VELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----QIALDAAR 459
           V+LI YA  T  +L+LI EY   G L   L   +  G               +I++    
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGELFMQL---EREGIFMED---TACFYLAEISM---- 132

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            L ++H+      ++RD+K  NI+L+     K++DFGL K      DG  T T   GT  
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHT-FCGTIE 186

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           Y+APE L         D ++ G +++++++G 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 44/214 (20%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEF-MA-----EMKILCKVHHSNLVELI 409
            LG G++G V         Q+VA+K ++    K+  M      E+  L  + H ++++L 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR--------GL 461
               T  ++ ++ EYA  G L  ++     +         R+    D  R         +
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYI---VEKK--------RMTE--DEGRRFFQQIICAI 121

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           EY H H     VHRD+K  N+LLD     KI+DFGL+ ++   +DG    T   G+  Y 
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKT-SCGSPNYA 174

Query: 522 APEYLT----DGLATAKSDVYAFGVVLFEIISGK 551
           APE +      G    + DV++ G+VL+ ++ G+
Sbjct: 175 APEVINGKLYAG---PEVDVWSCGIVLYVMLVGR 205

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 69/209 (33%), Positives = 89/209 (42%), Gaps = 33/209 (15%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKVHHSNL 405
           LLG GT+G V       +E A  R  A K   KE           + E ++L    H  L
Sbjct: 12  LLGKGTFGKVILV----REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 406 VELIGYAA--TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLE 462
             L    A  T D L  + EYA  G L  HL         +     R +    +    LE
Sbjct: 68  TAL--KYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEE---RARFYGAEIVSALE 119

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       V+RDIK  N++LD     KI+DFGL K     SDG    T   GT  YLA
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKT-FCGTPEYLA 173

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           PE L D       D +  GVV++E++ G+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 21/203 (10%), Positives = 56/203 (27%), Gaps = 48/203 (23%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVEL 408
              G       +       +++VA+  +           +E ++    L ++    +  +
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           +    T     ++ E+ + GSL+              S +  ++     A   +  H   
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA- 148

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
                      S + +                   + DG+     V+     +       
Sbjct: 149 --GVALSIDHPSRVRV-------------------SIDGDV----VLAYPATMPD----- 178

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
             A  + D+   G  L+ ++  +
Sbjct: 179 --ANPQDDIRGIGASLYALLVNR 199

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 95.2 bits (237), Expect = 6e-21
 Identities = 66/211 (31%), Positives = 92/211 (43%), Gaps = 34/211 (16%)

Query: 357 SLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKVHHSN 404
            LLG GT+G V       +E A  R  A K   KE           + E ++L    H  
Sbjct: 154 KLLGKGTFGKVILV----KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHD----PQNRGQTSLSWIMRVQIALDAARG 460
           L  L     T D L  + EYA  G L  HL       ++R +   +     +I       
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-----EIVS----A 260

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L+Y+H   + + V+RD+K  N++LD     KI+DFGL K      DG    T   GT  Y
Sbjct: 261 LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKT-FCGTPEY 315

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           LAPE L D       D +  GVV++E++ G+
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 92.7 bits (230), Expect = 2e-20
 Identities = 74/362 (20%), Positives = 123/362 (33%), Gaps = 118/362 (32%)

Query: 359 LGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNLV 406
           LG G +G V   +          + VA+K +    T ++ +  M+E+KIL  + HH N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 407 ELIGYAATEDE-LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD--------- 456
            L+G        L +I E+ + G+L ++L   +N      +   R +   D         
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 457 -------------------AARGLEYIHEHTKTHYVHRDIKSSNILL------------- 484
                                + L  + E      +++D  +   L+             
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 485 --------DSAFR---------AKISDFGLAKLVGKTSDGEATVTKVVGTFGYL-----A 522
                   D A R          KI DFGLA+ + K          V      L     A
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMA 263

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM-----VSKNQERRSLASFMLAA 577
           PE + D + T +SDV++FGV+L+EI         + G      V  ++E           
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIF--------SLGASPYPGVKIDEE-------FCRR 308

Query: 578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
           L+   +   M +             P     +M      C   +P  RP   ++V  L  
Sbjct: 309 LK---EGTRMRA-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352

Query: 638 IL 639
           +L
Sbjct: 353 LL 354

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 359 LGHGTYGSVYYG-NIRNQE-VAIKRMTATKTKEFMA--------EMKIL---CKVHHSNL 405
           +G G YG+VY   +  +   VA+K +                  E+ +L       H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 406 VELI-----GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAA 458
           V L+          E ++ L++E+  +  L+++L      G  +  +  +MR Q      
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR-QFL---- 130

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
           RGL+++H +     VHRD+K  NIL+ S    K++DFGLA++       +  +T VV T 
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSY----QMALTPVVVTL 183

Query: 519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
            Y APE L         D+++ G +  E+   K
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 39/216 (18%)

Query: 358 LLGHGTYGSVY----YGNIRNQEV-AI----KRMTATKTKEF---MAEMKILCKV-HHSN 404
           +LG G YG V+           ++ A+    K     K K       E ++L  +     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 405 LVELIGYA-ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----QIALDAA 458
           LV L  YA  TE +L LI +Y   G L +HL     R + +      V     +I L   
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHL---SQRERFTEH---EVQIYVGEIVL--- 170

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTF 518
             LE++H+      ++RDIK  NILLDS     ++DFGL+K      + E       GT 
Sbjct: 171 -ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYD-FCGTI 224

Query: 519 GYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGK 551
            Y+AP+ +     G   A  D ++ GV+++E+++G 
Sbjct: 225 EYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.3 bits (225), Expect = 6e-20
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 37/214 (17%)

Query: 359 LGHGTYGSVYYG-NIR--NQEVAIKRMTATKTKE---FMA--EMKIL---CKVHHSNLVE 407
           +G G YG V+   +++   + VA+KR+     +E        E+ +L       H N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78

Query: 408 LI-----GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTS--LSWIMRVQIALDAARG 460
           L           E +L L++E+  +  L ++L      G  +  +  +M  Q+     RG
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF-QLL----RG 132

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L+++H H     VHRD+K  NIL+ S+ + K++DFGLA++       +  +T VV T  Y
Sbjct: 133 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF----QMALTSVVVTLWY 185

Query: 521 LAPEYLTDGLATAKS---DVYAFGVVLFEIISGK 551
            APE L   L ++ +   D+++ G +  E+   K
Sbjct: 186 RAPEVL---LQSSYATPVDLWSVGCIFAEMFRRK 216

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score = 87.5 bits (216), Expect = 8e-20
 Identities = 36/208 (17%), Positives = 71/208 (34%), Gaps = 34/208 (16%)

Query: 33  CTDTTRLCATFLA-YEMQPNQTLSVIQSMFDVLPKDVTVEGNEK---------------- 75
           C  +   C   LA Y ++   TLSVI    +           +                 
Sbjct: 1   CRTS---CPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQM 57

Query: 76  -NYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGY-----VYDVVVNAYDGLAILDN-STRM 128
            + + +   C C         N +++V+    Y          +   + L   +      
Sbjct: 58  GSRVLVPFPCECQPGDF-LGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATN 116

Query: 129 ARAGAVVSLRLFCGCS----SGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVN 184
               A +++ + C C     S  +   ++Y ++  D++ S+A   GVS D +++ N  VN
Sbjct: 117 IPLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVN 176

Query: 185 PNNVTAGDLFYIPLNSVPGEPYPVENDT 212
            N  +   + Y+P     G   P ++  
Sbjct: 177 FN--SGNGIVYVPGRDPNGAFPPFKSSK 202

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 40/220 (18%)

Query: 353 FSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTA----TKTKEFMAEMKILCKVHHSNLV 406
           +++ S +G G YG V   Y N+    VAIK+++     T  +  + E+KIL +  H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 407 EL--IGYAATED---ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA---- 457
            +  I  A T +   +++++ +  +                T L  +++ Q   +     
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLME----------------TDLYKLLKTQHLSNDHICY 132

Query: 458 -----ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
                 RGL+YIH     + +HRD+K SN+LL++    KI DFGLA++     D    +T
Sbjct: 133 FLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 513 KVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISGK 551
           + V T  Y APE  L     T   D+++ G +L E++S +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 43/228 (18%)

Query: 350 TEGFSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKEFMA--------------EM 394
              ++    +  G+YG+V  G +     VAIKR+  T +                   E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 395 KILCKVHHSNLVELI-----GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS--- 446
           ++L   HH N++ L             +L+L+ E  +     + L    +  +  +S   
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIVISPQH 135

Query: 447 --WIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT 504
             + M   I      GL  +HE      VHRD+   NILL       I DF LA    + 
Sbjct: 136 IQYFM-YHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLA----RE 183

Query: 505 SDGEATVTKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISGK 551
              +A  T  V    Y APE  +     T   D+++ G V+ E+ + K
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 32/208 (15%)

Query: 359 LGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVEL--IGYAA 413
           LG G Y  V+       N++V +K +   K K+   E+KIL  +    N++ L  I    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIHEHT 468
                 L++E+      K            +L+     + M  +I     + L+Y H   
Sbjct: 104 VSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMY-EI----LKALDYCHSM- 149

Query: 469 KTHYVHRDIKSSNILLDSAFRA-KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               +HRD+K  N+++D   R  ++ D+GLA    +           V +  +  PE L 
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPELLV 203

Query: 528 DGLATAKS-DVYAFGVVLFEIISGKEAI 554
           D      S D+++ G +L  +I  KE  
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 53/229 (23%), Positives = 102/229 (44%), Gaps = 49/229 (21%)

Query: 353 FSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMT---ATKTKEFMAEMKILCKVHHSNLVE 407
           + D   LG G  G V+    N  ++ VAIK++        K  + E+KI+ ++ H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 408 LI--------------GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
           +               G     + ++++ EY +                T L+ ++    
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----------------TDLANVLEQGP 116

Query: 454 ALDA---------ARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGK 503
            L+           RGL+YIH     + +HRD+K +N+ +++     KI DFGLA+++  
Sbjct: 117 LLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 504 TSDGEATVTKVVGTFGYLAPE-YLTDGLATAKSDVYAFGVVLFEIISGK 551
               +  +++ + T  Y +P   L+    T   D++A G +  E+++GK
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 32/214 (14%)

Query: 353 FSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHHSNL 405
           + +   +G G  G V   Y  I  + VAIK+++      T  K    E+ ++  V+H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 406 VELI------GYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIALDA 457
           + L+             +++++ E        ++L            +S+++  Q+    
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQMELDHERMSYLL-YQM---- 136

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
             G++++H       +HRD+K SNI++ S    KI DFGLA    +T+     +T  V T
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVT 189

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
             Y APE +         D+++ G ++ E+I G 
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 35/218 (16%)

Query: 350 TEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHH 402
            + +   + +G G YGSV         ++VAIK+++         K    E+ +L  + H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 403 SNLVELI------GYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQTSLSWIMRVQIA 454
            N++ L+             + +L+  + Q     + L         +  + +++  Q+ 
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEKIQYLV-YQML 136

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
               +GL+YIH       VHRD+K  N+ ++     KI DFGLA+        +A +T  
Sbjct: 137 ----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA------DAEMTGY 183

Query: 515 VGTFGYLAPE-YLTDGLATAKSDVYAFGVVLFEIISGK 551
           V T  Y APE  L+        D+++ G ++ E+++GK
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 42/213 (19%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV-HHSN 404
           +LG G++G V+      +     +  A K   K+           M E ++L     H  
Sbjct: 24  MLGKGSFGKVFLA----EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79

Query: 405 LVELIGYAA--TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----QIALDA 457
           L  +  +    T++ LF + EY   G L  H+   Q+  +  LS   R      +I L  
Sbjct: 80  LTHM--FCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLS---RATFYAAEIIL-- 129

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
             GL+++H       V+RD+K  NILLD     KI+DFG+ K          T T   GT
Sbjct: 130 --GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNT-FCGT 181

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISG 550
             Y+APE L         D ++FGV+L+E++ G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 66/210 (31%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 358 LLGHGTYGSVYYGNIRNQEV--AIKRM---TATKTKEF---MAEMKILCK-VHHSNLVEL 408
           ++G G++G V     + +EV  A+K +      K KE    M+E  +L K V H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 409 IGYAA--TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRV-----QIALDAARGL 461
             + +  T D+L+ + +Y   G L  HL   Q           R      +IA      L
Sbjct: 105 --HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEP---RARFYAAEIAS----AL 152

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            Y+H     + V+RD+K  NILLDS     ++DFGL K          T T   GT  YL
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTST-FCGTPEYL 206

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L         D +  G VL+E++ G 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 90.1 bits (223), Expect = 6e-19
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 357 SLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV-HHS 403
            +LG G++G V     +        + A K   K+           M E ++L       
Sbjct: 347 MVLGKGSFGKVMLSERKGT----DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLE 462
            L +L     T D L+ + EY   G L  H+   Q  G+            A + A GL 
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEP---HAVFYAAEIAIGLF 456

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           ++        ++RD+K  N++LDS    KI+DFG+ K      DG  T T   GT  Y+A
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKT-FCGTPDYIA 510

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           PE +         D +AFGV+L+E+++G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 87.3 bits (217), Expect = 8e-19
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV-HHSN 404
           ++G G+Y  V    ++       R+ A K   KE             E  +  +  +H  
Sbjct: 16  VIGRGSYAKVLLVRLKKT----DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLEY 463
           LV L     TE  LF + EY   G L  H+   Q + +         +  + + +  L Y
Sbjct: 72  LVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEE---HARFYSAEISLALNY 125

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +HE      ++RD+K  N+LLDS    K++D+G+ K       G+ T T   GT  Y+AP
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTST-FCGTPNYIAP 179

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E L         D +A GV++FE+++G+
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGR 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 30/208 (14%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV-HHSN 404
           +LG G++G V     +        + A K   K+           M E ++L        
Sbjct: 27  VLGKGSFGKVMLSERKGT----DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLEY 463
           L +L     T D L+ + EY   G L  H+   Q  G+            A + A GL +
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEP---HAVFYAAEIAIGLFF 136

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +        ++RD+K  N++LDS    KI+DFG+ K      DG  T T   GT  Y+AP
Sbjct: 137 LQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKT-FCGTPDYIAP 190

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E +         D +AFGV+L+E+++G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV-HHSN 404
           +LG G++G V       +      + A K   K+           M E +IL    +H  
Sbjct: 30  VLGKGSFGKVMLA----RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85

Query: 405 LVELIGYAA--TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGL 461
           L +L  +    T D LF + E+   G L  H+   Q   +   +   R +  A +    L
Sbjct: 86  LTQL--FCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEA---RARFYAAEIISAL 137

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
            ++H+      ++RD+K  N+LLD     K++DFG+ K      +G  T T   GT  Y+
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTAT-FCGTPDYI 191

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE L + L     D +A GV+L+E++ G 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEF----------MAEMKILCKV-HHSN 404
           ++G G+Y  V    ++       R+ A +   KE             E  +  +  +H  
Sbjct: 59  VIGRGSYAKVLLVRLKKT----DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI-ALDAARGLEY 463
           LV L     TE  LF + EY   G L  H+   Q + +         +  + + +  L Y
Sbjct: 115 LVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEE---HARFYSAEISLALNY 168

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           +HE      ++RD+K  N+LLDS    K++D+G+ K       G+ T T   GT  Y+AP
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTST-FCGTPNYIAP 222

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK 551
           E L         D +A GV++FE+++G+
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 50/229 (21%), Positives = 99/229 (43%), Gaps = 33/229 (14%)

Query: 339 VVFTYDEILFA-TEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMA--- 392
                 +  F   + + +   +G G  G V   Y  + ++ VAIK+++     +  A   
Sbjct: 49  YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 108

Query: 393 --EMKILCKVHHSNLVELI------GYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQ 442
             E+ ++  V+H N++ L+             +++L+ E        ++L          
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQMELDH 163

Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
             +S+++  Q+      G++++H       +HRD+K SNI++ S    KI DFGLA    
Sbjct: 164 ERMSYLL-YQML----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA---- 211

Query: 503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           +T+     +T  V T  Y APE +         D+++ G ++ E++  K
Sbjct: 212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 53/245 (21%)

Query: 335 MEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTA----TKTK 388
           M K +V+           F   SLLG G YG V         + VAIK++          
Sbjct: 1   MPKRIVYNISS------DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL 54

Query: 389 EFMAEMKILCKVHHSNLVEL--IGYAATED---ELFLIYEYAQKGSLKSHLHDPQNRGQT 443
             + E+KIL    H N++ +  I    + +   E+++I E  Q                T
Sbjct: 55  RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----------------T 98

Query: 444 SLSWIMRVQIALDA---------ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD 494
            L  ++  Q+  D           R ++ +H    ++ +HRD+K SN+L++S    K+ D
Sbjct: 99  DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCD 155

Query: 495 FGLAKLVGKTSDGEATV-------TKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFE 546
           FGLA+++ +++   +          + V T  Y APE  LT    +   DV++ G +L E
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

Query: 547 IISGK 551
           +   +
Sbjct: 216 LFLRR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 48/225 (21%)

Query: 350 TEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHH 402
              + D   +G G YG+V          +VAIK++      E  A     E+++L  + H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 403 SNLVELI------GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
            N++ L+             + +L+  +                  T L  +M+ +   +
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMG----------------TDLGKLMKHEKLGE 127

Query: 457 A---------ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
                      +GL YIH       +HRD+K  N+ ++     KI DFGLA+        
Sbjct: 128 DRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA------ 178

Query: 508 EATVTKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISGK 551
           ++ +T  V T  Y APE  L     T   D+++ G ++ E+I+GK
Sbjct: 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 41/177 (23%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNLVELI-- 409
           +G G+YG V   Y  +  + VAIK++               E+ IL +++H ++V+++  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120

Query: 410 ---GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA-------- 458
                    DEL+++ E A                 +    + R  + L           
Sbjct: 121 VIPKDVEKFDELYVVLEIAD----------------SDFKKLFRTPVYLTELHIKTLLYN 164

Query: 459 --RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
              G++Y+H       +HRD+K +N L++     K+ DFGLA+ V    +G + +  
Sbjct: 165 LLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 53/246 (21%), Positives = 90/246 (36%), Gaps = 56/246 (22%)

Query: 350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVE 407
           ++ +S    LG G++G V         +  A+K++      +   E+ I+  + H N+++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-ELDIMKVLDHVNIIK 64

Query: 408 L--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQ--------------------TSL 445
           L    Y   ++E            L    +   N  +                     +L
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124

Query: 446 SWIMRV------------------QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA 487
             +++                   Q+     R + +IH        HRDIK  N+L++S 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSK 177

Query: 488 -FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE-YLTDGLATAKSDVYAFGVVLF 545
               K+ DFG AK   K    E +V  +   F Y APE  L     T   D+++ G V  
Sbjct: 178 DNTLKLCDFGSAK---KLIPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 546 EIISGK 551
           E+I GK
Sbjct: 234 ELILGK 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 48/225 (21%)

Query: 350 TEGFSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMT-----ATKTKEFMAEMKILCKVHH 402
            E + + S +G G YGSV   +       VA+K+++         K    E+++L  + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 403 SNLVELI------GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALD 456
            N++ L+            ++++L+                       L+ I++ Q   D
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMG----------------ADLNNIVKCQKLTD 131

Query: 457 A---------ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
                      RGL+YIH       +HRD+K SN+ ++     KI DFGLA+        
Sbjct: 132 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT------ 182

Query: 508 EATVTKVVGTFGYLAPE-YLTDGLATAKSDVYAFGVVLFEIISGK 551
              +T  V T  Y APE  L         D+++ G ++ E+++G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 56/279 (20%), Positives = 94/279 (33%), Gaps = 67/279 (24%)

Query: 359 LGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVHHSNLVEL--I 409
           +G G+YG VY  Y     + VAIK++               E+ IL ++    ++ L  +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93

Query: 410 GYAATED---ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA-------- 458
                     EL+++ E A                 + L  + +  I L           
Sbjct: 94  IIPDDLLKFDELYIVLEIAD----------------SDLKKLFKTPIFLTEEHIKTILYN 137

Query: 459 --RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV----- 511
              G  +IHE   +  +HRD+K +N LL+     K+ DFGLA+ +    D          
Sbjct: 138 LLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 512 --------------TKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISGKEAIIR 556
                         T  V T  Y APE  L     T   D+++ G +  E+++       
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML----- 249

Query: 557 TEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYID 595
            +  ++    R  L         +   +      K   D
Sbjct: 250 -QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 35/166 (21%), Positives = 65/166 (39%), Gaps = 28/166 (16%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGY---- 411
           LG G  G V     +   ++ A+K +      +   E+++  +     ++V ++      
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENL 83

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLS-----WIMRVQIALDAARGLEYIHE 466
            A    L ++ E    G L       Q+RG  + +      IM+  I       ++Y+H 
Sbjct: 84  YAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMK-SIG----EAIQYLHS 135

Query: 467 HTKTHYVHRDIKSSNILLDSAFRA---KISDFGLAKLVGKTSDGEA 509
               +  HRD+K  N+L  S       K++DFG AK        ++
Sbjct: 136 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKS 178

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 57/237 (24%)

Query: 353 FSDSSLLGHGTYGSVY--YGNIRNQEVAIKRMTATKTKEFMA-----EMKILCKVH-HSN 404
           +     LG G YG V+        + VA+K++         A     E+ IL ++  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 405 LVEL--IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA----- 457
           +V L  +  A  + +++L+++Y +                T L  ++R  I         
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYME----------------TDLHAVIRANILEPVHKQYV 114

Query: 458 ----ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-- 511
                + ++Y+H       +HRD+K SNILL++    K++DFGL++           +  
Sbjct: 115 VYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 512 ----------------TKVVGTFGYLAPEY-LTDGLATAKSDVYAFGVVLFEIISGK 551
                           T  V T  Y APE  L     T   D+++ G +L EI+ GK
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 30/168 (17%), Positives = 60/168 (35%), Gaps = 35/168 (20%)

Query: 359 LGHGTYGSVYYG----------NIRNQEVAIK--------------RMTATKTKEFMAEM 394
                 G +Y              + Q+ ++K                 A K  +     
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 395 KILCKVHHSNLVELIGYAATEDEL-FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
           K L       +   +G+   +D+  FL+     + SL     D   +   S   ++  Q+
Sbjct: 110 K-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SL-QSALDVSPKHVLSERSVL--QV 164

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI--SDFGLAK 499
           A      LE++HE+    YVH ++ + NI +D   ++++  + +G A 
Sbjct: 165 ACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 35/151 (23%), Positives = 64/151 (42%), Gaps = 19/151 (12%)

Query: 359 LGHGTYGSVYYG-NIR-NQEVAIKRMTATKTKE--FMAEMKILCKVHHSNLV-ELIGYAA 413
           +G G +G +  G N+  N+ VAIK +   K++      E +   ++   + + ++  +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
                 ++ E     SL   L D  +R   + S    + IA+     +EY+H     + +
Sbjct: 76  CGKYNAMVLELLGP-SL-EDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSK---NLI 127

Query: 474 HRDIKSSNILLDSAFRAK-----ISDFGLAK 499
           +RD+K  N L+            I DF LAK
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.6 bits (151), Expect = 1e-10
 Identities = 35/222 (15%), Positives = 59/222 (26%), Gaps = 61/222 (27%)

Query: 336 EKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRM-----------TA 384
           + PV F++      TE       +G G +G V+     +  VAIK +             
Sbjct: 8   KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 385 TKTKEFMAEMKILCKVH---------HSNLVELIG------------------------- 410
              +E + E+ I  ++              + L                           
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 411 -----YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
                    +D+LF++ E+   G     +           S      I       L    
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL------SSLATAKSILHQLTASLAVAE 178

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
                 + HRD+   N+LL      K+      K     S G
Sbjct: 179 A--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG 218

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77

 Score = 56.0 bits (135), Expect = 2e-10
 Identities = 17/70 (24%), Positives = 35/70 (50%), Gaps = 3/70 (4%)

Query: 143 CSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVP 202
             S +    + + ++ GDT+  LA ++GV+M+ I++ N +   +++      YIP   + 
Sbjct: 7   GCSPVRERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIP---IL 63

Query: 203 GEPYPVENDT 212
            EP  + N  
Sbjct: 64  TEPRDLFNSG 73

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 34/150 (22%), Positives = 56/150 (37%), Gaps = 17/150 (11%)

Query: 359 LGHGTYGSVYYG-NIRN-QEVAIKRMTA-TKTKEFMAEMKILCKVHHSNLV-ELIGYAAT 414
           +G G++G ++ G N+ N Q+VAIK     +   +   E +    +     +  +  +   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
                L+ +     SL   L D   R     S       A      ++ IHE      V+
Sbjct: 78  GLHNVLVIDLLGP-SL-EDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVY 129

Query: 475 RDIKSSNILLDSAFRAK-----ISDFGLAK 499
           RDIK  N L+            + DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 48/246 (19%), Positives = 102/246 (41%), Gaps = 44/246 (17%)

Query: 357 SLLGHGTYGSVY--YGNIRNQEVAIKRMTATK--TKEFMAEMKILCKVH----------- 401
             LG G + +V+     + N  VA+K +   K  T+    E+K+L +V+           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 402 HSNLVELIGY----AATEDELFLIYEYAQKGSLKSHLHD--PQNRGQT-SLSWIMRVQIA 454
            +++++L+ +          + +++E      L  +L     +   +   L ++ +  I+
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQ--IS 137

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA------KISDFGLAKLVGKTSDGE 508
                GL+Y+H   +   +H DIK  N+L++           KI+D G A         +
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------CWYD 189

Query: 509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR 568
              T  + T  Y +PE L        +D+++   ++FE+I+G   +   +   S  ++  
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDD 248

Query: 569 SLASFM 574
            +A  +
Sbjct: 249 HIAQII 254

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 42/148 (28%), Positives = 64/148 (43%), Gaps = 15/148 (10%)

Query: 359 LGHGTYGSVYYG-NIRN-QEVAIKRMTA-TKTKEFMAEMKILCKVHHSNLV-ELIGYAAT 414
           +G G++G +Y G +I   +EVAIK     TK  +   E KI   +     +  +    A 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
            D   ++ E     SL   L +  +R     S    + +A      +EYIH     +++H
Sbjct: 77  GDYNVMVMELLGP-SL-EDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIH 128

Query: 475 RDIKSSNILL---DSAFRAKISDFGLAK 499
           RD+K  N L+          I DFGLAK
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 35/169 (20%)

Query: 358 LLGHGTYGSVYYGNIR-------NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G +G +Y  ++        +    +K +  +       E+K   +      ++   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVK-VEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 411 YAATEDEL-------FLIYEYAQKG-----------SLKSHLHDPQNRGQTSLSWIMRVQ 452
                  L         +++   K             L   +++   +     S    +Q
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL-QKIYEANAK---RFSRKTVLQ 156

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI--SDFGLAK 499
           ++L     LEYIHEH    YVH DIK+SN+LL+     ++   D+GLA 
Sbjct: 157 LSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 13/60 (21%), Positives = 25/60 (41%)

Query: 153 SYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPYPVENDT 212
           +  ++ GDT++ +  RF      I + N I N + +  G +  +P     G       D+
Sbjct: 64  TVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDS 123

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 15/148 (10%)

Query: 359 LGHGTYGSVYYG-NIRN-QEVAIKRMTA-TKTKEFMAEMKILCKVHHSNLV-ELIGYAAT 414
           +G G++G +Y G NI+  +EVAIK     TK  + + E KI   +     +  +  +   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
            D   L+ +     SL   L +  +R    LS    + +A      +E++H      ++H
Sbjct: 75  GDYNVLVMDLLGP-SL-EDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLH 126

Query: 475 RDIKSSNILLDSAFRAK---ISDFGLAK 499
           RDIK  N L+    RA    I DFGLAK
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 19/50 (38%), Positives = 30/50 (60%), Gaps = 5/50 (10%)

Query: 452 QIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI--SDFGLAK 499
           Q+ +     LEYIHE+    YVH DIK++N+LL      ++  +D+GL+ 
Sbjct: 155 QLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 46/210 (21%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 357 SLLGHGTYGSVY--YGNIRNQEVAIKRMTATKT--KEFMAEMKILCKV------HHSNLV 406
            ++G G++G V   Y +  +Q VA+K +   K   ++   E++IL  +      +  N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHD--PQNRGQ-TSLSWIMRVQIALDAARGLEY 463
            ++      + + + +E      L  +L++   +N+ Q  SL  + +   A    + L+ 
Sbjct: 163 HMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDA 215

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRA--KISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           +H++     +H D+K  NILL    R+  K+ DFG +    +       V   + +  Y 
Sbjct: 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ------RVYTYIQSRFYR 266

Query: 522 APEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           APE +         D+++ G +L E+++G 
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 2e-07
 Identities = 29/236 (12%), Positives = 79/236 (33%), Gaps = 53/236 (22%)

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHL-HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           +    + + +  + +      L   +  +  +R   S +  +R+       R L     +
Sbjct: 189 LKNCNSPETVLEMLQ-----KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVG--TFGYLAPEY 525
                V  +++++     +AF     +    K++  T      VT  +   T  +++ ++
Sbjct: 244 ENCLLVLLNVQNAKAW--NAF-----NLS-CKILLTTRF--KQVTDFLSAATTTHISLDH 293

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK--NQERRSLASFMLAALRNSPD 583
            +  L   +                       + ++ K  +   + L       L  +P 
Sbjct: 294 HSMTLTPDEV----------------------KSLLLKYLDCRPQDLPR---EVLTTNPR 328

Query: 584 SMSM--SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-DMKQVVISLS 636
            +S+   S++D       D + H    K+  + +  ++    L P + +++   LS
Sbjct: 329 RLSIIAESIRD--GLATWDNWKHVNCDKLTTIIESSLNV---LEPAEYRKMFDRLS 379

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 357 SLLGHGTYGSVY--YGNIRNQEVAIK--RMTATKTKEFMAEMKILCKV------HHSNLV 406
           SL+G G++G V   Y  +  + VAIK  +       +   E+++L  +          +V
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 407 ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE 466
            L  +    + L L++E     +L   L +   RG  SL+   +   A      L ++  
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRG-VSLNLTRK--FAQQMCTALLFLAT 175

Query: 467 HTKTHYVHRDIKSSNILLDSAFRA--KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
             +   +H D+K  NILL +  R+  KI DFG +  +G+       + + + +  Y +PE
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ------RIYQYIQSRFYRSPE 228

Query: 525 YLTDGLA-TAKSDVYAFGVVLFEIISGK 551
            L  G+      D+++ G +L E+ +G+
Sbjct: 229 VLL-GMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 50/267 (18%), Positives = 91/267 (34%), Gaps = 91/267 (34%)

Query: 357 SLLGHGTYGSVY--YGNIRNQEVAIKRMTATK--TKEFMAEMKILCKVHHSN-------- 404
             LG G + +V+  +     + VA+K + + +  T+  + E+++L  V +S+        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 405 LVELIGYAATEDELF-----------LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
           +V+L+         F           +++E      L   +     +G   L      +I
Sbjct: 103 VVQLLDD-------FKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQG---LPLPCVKKI 151

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILL----------------------------- 484
                +GL+Y+H  TK   +H DIK  NILL                             
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 485 --------------------DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
                                   + KI+D G A  V K        T+ + T  Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF------TEDIQTRQYRSLE 263

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK 551
            L        +D+++   + FE+ +G 
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGD 290

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 Length = 48

 Score = 37.1 bits (87), Expect = 5e-04
 Identities = 9/33 (27%), Positives = 20/33 (60%)

Query: 152 MSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVN 184
           ++Y ++ GD++ S+A R GV++  + + N    
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTA 35

>1y7m_A Hypothetical protein BSU14040; surface mutagenesis, cysteine proteases, cell WALL catabolism, structural genomics, PSI; 2.05A {Bacillus subtilis subsp} SCOP: b.160.1.1 d.7.1.1 Length = 164

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 17/55 (30%), Positives = 29/55 (52%), Gaps = 1/55 (1%)

Query: 151 LMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEP 205
           +++Y +K GDT+ S+A+ F +S  ++ Q N  +    +TAG    IP    P   
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQA-GLTAGQSIVIPGLPDPYTI 54

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	639
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.48
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	99.31
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.19
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.01
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	98.97
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.87
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.44
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	98.4
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.35
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.18
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	98.12
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	98.12
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.11
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.98
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.72
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.5
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.42
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.11
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.98
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.97
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.92
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.84
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	96.75
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.55
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.43
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	96.4
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	95.33
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.28
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.04
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.71
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.29
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.0
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	91.29
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.55
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	85.81
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.67
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	84.03

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.8e-54  Score=444.07  Aligned_cols=256  Identities=23%  Similarity=0.416  Sum_probs=203.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++|...++||+|+||+||+|++.       +..||||.++...   .++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45666788999999999999874       4679999997543   4679999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          421 IYEYAQKGSLKSHLHDPQN----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      |||||++|+|.++++....          ....+++|..++.|+.||+.||+|||+++   |+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999976432          12356999999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||+++.+.... .....+...||+.|||||++.+..++.++|||||||+||||+| |+.||.....        ..
T Consensus       198 Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~  268 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TE  268 (329)
T ss_dssp             EECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HH
T ss_pred             EEcccccceeccCCC-cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------HH
Confidence            999999998764322 2223345689999999999999999999999999999999999 8999964332        11


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +   +..+.....                 ...|..++.++.+|+.+||+.||++||||+||++.|+.+
T Consensus       269 ~---~~~i~~g~~-----------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          269 A---IDCITQGRE-----------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             H---HHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             H---HHHHHcCCC-----------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1   111111110                 112445667899999999999999999999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.7e-54  Score=440.06  Aligned_cols=256  Identities=25%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++|...+.||+|+||+||+|++.       +..||||+++...   .++|.+|+++|++++|||||+++|+|.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45667789999999999999874       4679999997543   4679999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          421 IYEYAQKGSLKSHLHDPQ--------NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                      |||||++|+|.++|+...        ......++|..++.|+.||+.||+|||+++   |+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997532        123457999999999999999999999987   999999999999999999999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      +|||+|+...... .........||+.|||||++.+..|+.++|||||||+||||+| |+.||.....        ..+ 
T Consensus       170 ~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~-  239 (299)
T 4asz_A          170 GDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV-  239 (299)
T ss_dssp             CCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH-
T ss_pred             CCcccceecCCCC-ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH-
Confidence            9999998664321 1222233579999999999999999999999999999999999 8999964322        111 


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                        +..+.....                 ...|..++.++.+|+.+||+.||++||||+||++.|+++
T Consensus       240 --~~~i~~~~~-----------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          240 --IECITQGRV-----------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             --HHHHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHcCCC-----------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              111111110                 112455667899999999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-53  Score=438.59  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=208.4

Q ss_pred             CCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++..++||+|+||+||+|.+.       ++.||||.++..    ..++|.+|+++|++++|||||+++|+|.+++.++||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            334678999999999999873       467999998643    357899999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          422 YEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      ||||++|+|.++|+....           .....++|..++.|+.|||.||+|||+++   |+||||||+||||++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence            999999999999965321           11346899999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||+++.+.... .....+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.....        ..
T Consensus       185 Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------~~  255 (308)
T 4gt4_A          185 KISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD  255 (308)
T ss_dssp             EECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------HH
T ss_pred             EECCcccceeccCCC-ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence            999999998764322 2223345689999999999999999999999999999999999 8999854322        11


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +..    .+....                ....|.+++..+.+|+.+||+.||++||||+||++.|+.+
T Consensus       256 ~~~----~i~~~~----------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 VVE----MIRNRQ----------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHH----HHHTTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHH----HHHcCC----------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111    111110                0113456777899999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-53  Score=434.06  Aligned_cols=258  Identities=29%  Similarity=0.536  Sum_probs=203.4

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ...++|...++||+|+||+||+|++.+ .||||.++..     ..++|.+|+++|++++|||||+++|++.+ +.++|||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            445677778899999999999998765 6899998632     34679999999999999999999999864 5789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      |||++|+|.++|+..    ...++|..++.|+.|||.||+|||+++   |+||||||+||||++++.+||+|||+|+...
T Consensus       111 Ey~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             ECCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EcCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            999999999999742    345999999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ... .....+..+||+.|||||++.+   +.|+.++|||||||+||||+||+.||......       .    .+...+.
T Consensus       184 ~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~----~~~~~~~  251 (307)
T 3omv_A          184 RWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------D----QIIFMVG  251 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------H----HHHHHHH
T ss_pred             cCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------H----HHHHHHh
Confidence            322 2233455789999999999864   46899999999999999999999999643320       0    1111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..           ...|.+. ..+.+++..+.+|+.+||+.||++||||+||++.|+.+
T Consensus       252 ~~-----------~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          252 RG-----------YASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             TT-----------CCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             cC-----------CCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11           1112221 13445677899999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.9e-52  Score=432.48  Aligned_cols=268  Identities=26%  Similarity=0.419  Sum_probs=216.9

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhcCC-CCeeEE
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKVHH-SNLVEL  408 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l~h-~niv~l  408 (639)
                      +..+++++..++|+..+.||+|+||+||+|.+.+       +.||||.++..    ..++|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4456777888899999999999999999998753       47999998753    24568999999999975 899999


Q ss_pred             EeeeecC-CeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 036507          409 IGYAATE-DELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD  476 (639)
Q Consensus       409 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~D  476 (639)
                      +|+|... +.+++|||||++|+|.++|+....           .....++|..++.++.|||+||+|||+++   |+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9998764 568999999999999999975321           12356899999999999999999999987   99999


Q ss_pred             CCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCcccc
Q 036507          477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAII  555 (639)
Q Consensus       477 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~  555 (639)
                      |||+|||+++++.+||+|||+|+.+.... .....+...||+.|||||++.+..|+.++|||||||+||||+| |+.||.
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCC-CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998764332 2223345689999999999999999999999999999999998 899995


Q ss_pred             ccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          556 RTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       556 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                      .....       ..+    ...+....                ....|..++.++.+++.+||+.||++||||+||++.|
T Consensus       290 ~~~~~-------~~~----~~~i~~g~----------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L  342 (353)
T 4ase_A          290 GVKID-------EEF----CRRLKEGT----------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  342 (353)
T ss_dssp             TCCCS-------HHH----HHHHHHTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCHH-------HHH----HHHHHcCC----------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            43220       011    11111110                0112445566799999999999999999999999999


Q ss_pred             hhhC
Q 036507          636 SQIL  639 (639)
Q Consensus       636 ~~il  639 (639)
                      ++++
T Consensus       343 ~~ll  346 (353)
T 4ase_A          343 GNLL  346 (353)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.5e-51  Score=421.49  Aligned_cols=269  Identities=26%  Similarity=0.403  Sum_probs=203.0

Q ss_pred             CCCCCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHH--HHhcCCCCeeEEEeeeecCC----eEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKI--LCKVHHSNLVELIGYAATED----ELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~i--l~~l~h~niv~l~~~~~~~~----~~~lv~e~~  425 (639)
                      +|...++||+|+||+||+|+++++.||||+++....+++.+|.++  +.+++|||||++++++.+++    .++||||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~   83 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence            455678899999999999999999999999987776666555554  56889999999999997653    589999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT-----KTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ++|+|.++++.      ..++|..+.+++.|++.||+|||++.     .++|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           84 EHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             TTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999974      34899999999999999999999872     34699999999999999999999999999987


Q ss_pred             cCCCCCCc-ceeeeeccccccCCccccccC------CCCCcchHHHHHHHHHHHHcCCcccccccccc-chhh---hhhh
Q 036507          501 VGKTSDGE-ATVTKVVGTFGYLAPEYLTDG------LATAKSDVYAFGVVLFEIISGKEAIIRTEGMV-SKNQ---ERRS  569 (639)
Q Consensus       501 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~-~~~~---~~~~  569 (639)
                      ........ ......+||+.|||||++.+.      .++.++|||||||+||||+||+.|+....... +...   ....
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            64332211 122346899999999998764      46789999999999999999988775432210 0000   0001


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDL-YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .... ...+           ....++|.+... .+.++...+.+|+.+||+.||++||||.||++.|+++
T Consensus       238 ~~~~-~~~~-----------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          238 VEEM-RKVV-----------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             HHHH-HHHH-----------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH-HHHH-----------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1111 1111           111223332221 1245677899999999999999999999999999876

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-51  Score=425.53  Aligned_cols=246  Identities=22%  Similarity=0.380  Sum_probs=199.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|+||+||++++.  ++.||||+++..     ..+.+.+|+++|++++|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            67888999999999999999885  689999998643     24568999999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++..   .....+++...+.|+.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.+..
T Consensus       104 y~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          104 YCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             CCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             CCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            9999999999964   22345788899999999999999999987   99999999999999999999999999987632


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   ....+..+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.           .+.+..++.....
T Consensus       178 ~---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------~~~~~~i~~~~~~  243 (350)
T 4b9d_A          178 T---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----------KNLVLKIISGSFP  243 (350)
T ss_dssp             H---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHTCCC
T ss_pred             C---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHcCCCC
Confidence            1   1223456899999999999999999999999999999999999999954321           1222233322211


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                   .    .+...+.++.+|+.+||+.||++|||++|+++
T Consensus       244 -------------~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 -------------P----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -------------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------------C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                         0    12234557899999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-50  Score=418.85  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=204.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +.|+..++||+|+||+||+|.+.  ++.||||+++..   ..+.+.+|+++|++++|||||++++++.+++.+||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888899999999999999985  689999998643   3456889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.+++..      ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+....
T Consensus       154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            99999999863      34899999999999999999999988   9999999999999999999999999999764322


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         ...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.           .+.+..+....+.  
T Consensus       225 ---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~~~~~--  288 (346)
T 4fih_A          225 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAMKMIRDNLPP--  288 (346)
T ss_dssp             ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSSCC--
T ss_pred             ---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHcCCCC--
Confidence               234457899999999999999999999999999999999999999954321           1111122222111  


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 .+.  .+...+.++.+|+.+||+.||++|||++|+++
T Consensus       289 -----------~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 -----------RLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -----------CCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----------CCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                       110  12344567899999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.7e-51  Score=420.62  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=204.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKG  428 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  428 (639)
                      +.|...++||+|+||.||+|++.  ++.||||+++.+..  ..+|+++|++++|||||++++++.+++.+||||||+++|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            45677788999999999999986  68999999976532  247999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecCCCCCC
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~  507 (639)
                      +|.++++.     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++ ++||+|||+|+.+......
T Consensus       136 ~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          136 SLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             BHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999964     245899999999999999999999987   99999999999999987 6999999999987543222


Q ss_pred             cc--eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          508 EA--TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       508 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                      ..  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......        .+   +..+....+.  
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~---~~~i~~~~~~--  274 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--------PL---CLKIASEPPP--  274 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--------CC---HHHHHHSCCG--
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HH---HHHHHcCCCC--
Confidence            21  223468999999999999999999999999999999999999999643321        01   1111122110  


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  + ...+.+++..+.+++.+||+.||++|||+.|+++.|.+.
T Consensus       275 ------------~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          275 ------------I-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ------------G-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------c-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                        0 112345566799999999999999999999999988764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-50  Score=413.62  Aligned_cols=244  Identities=25%  Similarity=0.413  Sum_probs=204.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||+||+++..  ++.||||.++..      ..+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46888999999999999999985  678999998643      3467899999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+.
T Consensus       112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            99999999999964     245899999999999999999999988   9999999999999999999999999999875


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ... ........+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.           .+.+..+.....
T Consensus       184 ~~~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~~~~  251 (311)
T 4aw0_A          184 PES-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------GLIFAKIIKLEY  251 (311)
T ss_dssp             TTT-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTCC
T ss_pred             CCC-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCC
Confidence            332 22234557899999999999999999999999999999999999999954321           112222222211


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                      .                  +|.....++.+|+.+||+.||++|||++|++
T Consensus       252 ~------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 D------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            0                  1223345689999999999999999999863

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.4e-50  Score=406.42  Aligned_cols=241  Identities=22%  Similarity=0.369  Sum_probs=192.6

Q ss_pred             CCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEEEEe
Q 036507          355 DSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT----EDELFLIYE  423 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~e  423 (639)
                      ..++||+|+||+||+|.+.  +..||+|.+...     ..+.|.+|+++|++++|||||++++++.+    ++.+|||||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            3557999999999999986  578999998643     24568999999999999999999998864    356899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~  502 (639)
                      ||++|+|.++++.     ...+++.....|+.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus       110 y~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          110 LMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             CCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999964     346899999999999999999999975 46999999999999984 7899999999998542


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .     ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.....          .......+.....
T Consensus       184 ~-----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----------~~~~~~~i~~~~~  247 (290)
T 3fpq_A          184 A-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQIYRRVTSGVK  247 (290)
T ss_dssp             T-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHHHHHHHTTTCC
T ss_pred             C-----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----------HHHHHHHHHcCCC
Confidence            1     23345789999999998865 699999999999999999999999954322          1111111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .            +.    .+...+.++.+|+.+||+.||++|||++|+++
T Consensus       248 ~------------~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 P------------AS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             C------------GG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C------------CC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0            01    11223346899999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=420.04  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=204.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +.|+..++||+|+||.||+|.+.  ++.||||++...   ..+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56888999999999999999985  689999998643   3456889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.+++..      ..+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+....
T Consensus       231 ~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          231 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            99999999863      24899999999999999999999988   9999999999999999999999999999764322


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                         ...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||.....           .+.+..+....+.  
T Consensus       302 ---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~~~~~--  365 (423)
T 4fie_A          302 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAMKMIRDNLPP--  365 (423)
T ss_dssp             ---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCC--
T ss_pred             ---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHcCCCC--
Confidence               234457899999999999999999999999999999999999999954321           1111122222111  


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 .+.  .+.....++.+|+.+||+.||++|||++|+++
T Consensus       366 -----------~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 -----------RLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -----------CCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----------CCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                       111  12234557899999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.9e-49  Score=397.53  Aligned_cols=241  Identities=23%  Similarity=0.367  Sum_probs=188.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||+||++...  ++.||||.++..      ..+.+.+|+++|++++||||+++++++.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57888999999999999999875  689999998643      2456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+ +|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||+++++++||+|||+|+...
T Consensus        93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            999 7899999864     245899999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ..    ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+.           ......+....
T Consensus       164 ~~----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----------~~~~~~i~~~~  228 (275)
T 3hyh_A          164 DG----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----------PVLFKNISNGV  228 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTC
T ss_pred             CC----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHcCC
Confidence            22    23345789999999999998776 5799999999999999999999954221           11122222221


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.                  .+...+.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 YT------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CC------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            10                  12234456899999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8e-50  Score=407.12  Aligned_cols=243  Identities=26%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-----CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++|+..+.||+|+||+||+++..     ++.||||.++..     ....+.+|+++|++++|||||++++++.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56888999999999999999862     468999998643     23468899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.
T Consensus       104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            9999999999999964     345899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....   .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.           .+.+..+...
T Consensus       176 ~~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------~~~~~~i~~~  241 (304)
T 3ubd_A          176 SIDH---EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----------KETMTMILKA  241 (304)
T ss_dssp             --------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHC
T ss_pred             ccCC---CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----------HHHHHHHHcC
Confidence            5322   2233457899999999999999999999999999999999999999964321           1122222222


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM-----KQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~  633 (639)
                      .+.                  .|...+.++.+|+.+||+.||++|||+     +|+++
T Consensus       242 ~~~------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          242 KLG------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCC------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCC------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            111                  133345678999999999999999984     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-47  Score=390.52  Aligned_cols=247  Identities=23%  Similarity=0.388  Sum_probs=183.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC---------
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATED---------  416 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~---------  416 (639)
                      +|+..+.||+|+||+||+|+..  ++.||||+++..    ..+.+.+|+++|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            4777899999999999999885  689999998643    2356889999999999999999999886543         


Q ss_pred             ---eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          417 ---ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       417 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                         .+|+||||+++|+|.+++....  ......+...+.++.||++||+|||+++   |+||||||+|||++.++.+||+
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence               3799999999999999997532  2234567778899999999999999987   9999999999999999999999


Q ss_pred             ccCCceecCCCCCCc---------ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchh
Q 036507          494 DFGLAKLVGKTSDGE---------ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN  564 (639)
Q Consensus       494 Dfgla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~  564 (639)
                      |||+|+.+.......         ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||....      
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------  231 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------  231 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence            999998765432211         12234689999999999999999999999999999999997   553211      


Q ss_pred             hhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       565 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                          .....+... ....            -|.    ........+.+|+.+||+.||++|||+.|+++
T Consensus       232 ----~~~~~~~~~-~~~~------------~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 ----ERVRTLTDV-RNLK------------FPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----HHHHHHHHH-HTTC------------CCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHHHH-hcCC------------CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                011111111 1110            000    01223345678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=392.64  Aligned_cols=266  Identities=21%  Similarity=0.338  Sum_probs=200.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec------CCe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT------EDE  417 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~  417 (639)
                      ++|+..+.||+|+||+||+|.+.  ++.||||+++..     ..+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            56888999999999999999985  689999998643     23568899999999999999999998753      367


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      +|||||||+ |+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence            899999995 789999964     346999999999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCC-CCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          498 AKLVGKTS-DGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       498 a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      |+.+.... ......+..+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.        ......+.
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--------~~~l~~I~  276 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--------VHQLQLIM  276 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--------HHHHHHHH
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--------HHHHHHHH
Confidence            98764322 122234557999999999998774 569999999999999999999999964332        22223333


Q ss_pred             HHhhcCCCccccc----ccccc---cCCcccC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSMS----SLKDY---IDPNMMD---LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~~----~~~~~---~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......+......    .....   +.+....   ........++.+|+.+||+.||++|||++|+++
T Consensus       277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            3333322111100    00000   0000000   001123456899999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-45  Score=385.09  Aligned_cols=202  Identities=27%  Similarity=0.407  Sum_probs=170.8

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEc-----CceEEEEEeccc-cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT-KTKEFMAEMKILCKV-HHSNLVELIGYAATEDEL  418 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  418 (639)
                      +..-.++|+..++||+|+||+||+|+.+     ++.||||.+... ....+.+|+++|+++ +||||+++++++.+.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            3344578999999999999999999863     468999988654 456788999999998 599999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEeccCC
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGL  497 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl  497 (639)
                      |+||||+++|+|.+++.        .+++.....++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||+
T Consensus        96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            99999999999999984        2788999999999999999999988   9999999999999877 7999999999


Q ss_pred             ceecCCCCC-------------------------CcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCC
Q 036507          498 AKLVGKTSD-------------------------GEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGK  551 (639)
Q Consensus       498 a~~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~  551 (639)
                      |+.......                         .....+..+||+.|||||++.+. .|+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            986543211                         01123346899999999999775 5899999999999999999999


Q ss_pred             ccccccc
Q 036507          552 EAIIRTE  558 (639)
Q Consensus       552 ~p~~~~~  558 (639)
                      .||....
T Consensus       245 ~Pf~~~~  251 (361)
T 4f9c_A          245 YPFYKAS  251 (361)
T ss_dssp             SSSSCCS
T ss_pred             CCCCCCC
Confidence            9996543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.9e-44  Score=372.19  Aligned_cols=282  Identities=38%  Similarity=0.637  Sum_probs=231.4

Q ss_pred             ccchHHHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 036507          340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATE  415 (639)
Q Consensus       340 ~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~  415 (639)
                      .+++.++...+++|+..+.||+|+||.||+|.+. ++.||||.+...   ..+.+.+|++++++++||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            3455666778899999999999999999999875 578999988643   346789999999999999999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      +..++||||+++|+|.+++.... .....++|..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred             CeEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence            99999999999999999997532 22346899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      |+++....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +......+..
T Consensus       184 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~-----~~~~~~~~~~  257 (321)
T 2qkw_B          184 GISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-----EMVNLAEWAV  257 (321)
T ss_dssp             TTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS-----SCCCHHHHTH
T ss_pred             ccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH-----HHHHHHHHhh
Confidence            99986543221 22233456899999999999999999999999999999999999999654321     1112222222


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....       ...+...+++.+....+.+++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       258 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          258 ESHN-------NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HHHT-------TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccc-------cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2211       1234556677776677888999999999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.3e-44  Score=370.81  Aligned_cols=289  Identities=35%  Similarity=0.627  Sum_probs=237.0

Q ss_pred             CCCcccchHHHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccccH----HHHHHHHHHHHhcCCCCeeEEEe
Q 036507          336 EKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIG  410 (639)
Q Consensus       336 ~~~~~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~----~~~~~E~~il~~l~h~niv~l~~  410 (639)
                      .....|++.++....++|...+.||+|+||.||++... ++.||||++.....    ..+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34467899999999999999999999999999999874 67899999875432    36889999999999999999999


Q ss_pred             eeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       411 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      ++.+.+..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++..++|+||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            9999999999999999999999997643 234569999999999999999999999833349999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      ||+|||++.......  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......   ......+
T Consensus       174 kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~  248 (326)
T 3uim_A          174 VVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA---NDDDVML  248 (326)
T ss_dssp             EECCCSSCEECCSSS--SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT---TTSCSBH
T ss_pred             EeccCccccccCccc--ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc---cccchhH
Confidence            999999998764322  22334456999999999999999999999999999999999999999532211   0111222


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      ..+.....       .........+..+....+.+....+.+++.+||+.||++|||++||++.|++
T Consensus       249 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          249 LDWVKGLL-------KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHHHTTTT-------SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHh-------hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            23322211       1234556667777777888899999999999999999999999999999985

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.6e-44  Score=395.47  Aligned_cols=247  Identities=22%  Similarity=0.319  Sum_probs=204.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.+....   .+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57888999999999999999985  6799999986543   456889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC--CCEEEeccCCceecCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA--FRAKISDFGLAKLVGK  503 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~  503 (639)
                      ++|+|.+++...    ...+++.....++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.+..
T Consensus       237 ~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          237 SGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             CCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999998642    345899999999999999999999988   9999999999999854  8999999999998743


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                          .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....           .+.+..+......
T Consensus       310 ----~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----------~~~~~~i~~~~~~  374 (573)
T 3uto_A          310 ----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------DETLRNVKSCDWN  374 (573)
T ss_dssp             ----TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHHTTCCC
T ss_pred             ----CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHhCCCC
Confidence                2344567899999999999999999999999999999999999999964332           1111222221110


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +.    .........++.+|+.+||+.||++|||++|+++
T Consensus       375 ----------~~----~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 ----------MD----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----------CC----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----------CC----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      00    1111233456889999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.6e-44  Score=393.99  Aligned_cols=243  Identities=25%  Similarity=0.317  Sum_probs=196.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHH---HHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMA---EMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~---E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|+..++||+|+||+||+++..  ++.||||+++...      .....+   ++++++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57888999999999999999985  6799999986432      222333   456677789999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||++||+|.++|..     ...+++.....++.||+.||+|||+++   |+||||||+||||+.+|++||+|||+|+
T Consensus       269 lVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999964     245899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+...     .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......        .........+
T Consensus       341 ~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--------~~~~i~~~i~  407 (689)
T 3v5w_A          341 DFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DKHEIDRMTL  407 (689)
T ss_dssp             ECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--------CHHHHHHHHH
T ss_pred             ecCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhhc
Confidence            76432     2234689999999999964 57999999999999999999999999643321        1111111222


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVV  632 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl  632 (639)
                      ....                  .+|.....++.+|+.+||+.||++|++     ++|++
T Consensus       408 ~~~~------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          408 TMAV------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HCCC------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             CCCC------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            2111                  123344567899999999999999998     57765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.1e-42  Score=353.09  Aligned_cols=279  Identities=40%  Similarity=0.653  Sum_probs=226.9

Q ss_pred             cccchHHHHhhhCCCCCC------CceeecCceEEEEEEEcCceEEEEEeccc-------cHHHHHHHHHHHHhcCCCCe
Q 036507          339 VVFTYDEILFATEGFSDS------SLLGHGTYGSVYYGNIRNQEVAIKRMTAT-------KTKEFMAEMKILCKVHHSNL  405 (639)
Q Consensus       339 ~~~~~~e~~~a~~~f~~~------~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~h~ni  405 (639)
                      ..|+++++..++++|...      +.||+|+||.||+|..+++.||||.+...       ..+.+.+|++++++++||||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   92 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL   92 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence            568999999999999887      89999999999999999999999998532       24678899999999999999


Q ss_pred             eEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC
Q 036507          406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD  485 (639)
Q Consensus       406 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~  485 (639)
                      +++++++.+.+..+++|||+++++|.+++....  ....+++..+..++.|++.||+|||+++   |+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             EEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999986422  2346899999999999999999999987   99999999999999


Q ss_pred             CCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhh
Q 036507          486 SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       486 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~  565 (639)
                      +++.+||+|||++....... .........||+.|+|||.+.+ .++.++||||||+++|||++|+.||........   
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---  242 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFA-QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL---  242 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCS-SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB---
T ss_pred             CCCcEEEeeccccccccccc-ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH---
Confidence            99999999999998764322 1222334579999999998865 578999999999999999999999965432110   


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                          +..+. ..+...     ...+.+.+++.+. ..+......+.+++.+||+.||++|||++++++.|+++
T Consensus       243 ----~~~~~-~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          243 ----LLDIK-EEIEDE-----EKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             ----TTHHH-HHHHTT-----SCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----HHHHH-HHhhhh-----hhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                11111 111111     1123344444443 24667788999999999999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=365.78  Aligned_cols=254  Identities=28%  Similarity=0.494  Sum_probs=206.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-----CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|...+.||+|+||.||+|.+.     +..||||.++..    ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            456778899999999999999984     346999998753    24568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       128 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999642    245899999999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      +..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..   ....
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~---~~~~  269 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVIS---SVEE  269 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHH---HHHT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHH---HHHc
Confidence            7544333333444567889999999999999999999999999999999 9999854322        11111   1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..                 ....+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       270 ~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          270 GY-----------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             TC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            10                 0112334556799999999999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.9e-43  Score=363.64  Aligned_cols=263  Identities=27%  Similarity=0.467  Sum_probs=203.6

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      .+++....++|+..+.||+|+||+||+++..++.||||.+...     ..+++.+|++++++++||||+++++++.+.+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            3444455678888999999999999999999999999998643     23568899999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++||||+++|+|.+++....  ....+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++.+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            999999999999999997521  1234899999999999999999999875 3499999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ++.....   ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ...   ....
T Consensus       186 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~---~~~~  251 (309)
T 3p86_A          186 SRLKAST---FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQV---VAAV  251 (309)
T ss_dssp             -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHH---HHHH
T ss_pred             Ccccccc---ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHHH
Confidence            9754321   1223346799999999999999999999999999999999999999954322        011   1111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .....                ....+..++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       252 ~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          252 GFKCK----------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             HHSCC----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCC----------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            10100                0112334456799999999999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.2e-43  Score=371.19  Aligned_cols=254  Identities=27%  Similarity=0.500  Sum_probs=195.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-----CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|...+.||+|+||.||+|+..     +..||||.++..    ..+++.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            467889999999999999999875     457999998643    34578999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.++++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       124 v~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999742    345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..    .+.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~----~i~  264 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIK----AVD  264 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHH----HHH
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH----HHH
Confidence            6433222222223356788999999999999999999999999999998 9999854321        11111    111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..                .....+.+++..+.+++.+||+.||++||+++|+++.|+++
T Consensus       265 ~~----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          265 EG----------------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             TT----------------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC----------------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            10                01112334566799999999999999999999999999876

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.6e-43  Score=368.86  Aligned_cols=258  Identities=28%  Similarity=0.483  Sum_probs=208.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc---------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR---------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATE  415 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  415 (639)
                      .++|...+.||+|+||.||++.+.         +..||||.++..    ..+++.+|+++++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467778899999999999999863         246999998653    245688999999999 899999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL  484 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll  484 (639)
                      +..++||||+++|+|.+++.....           .....+++..++.++.||+.||+|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999975321           12345899999999999999999999987   9999999999999


Q ss_pred             CCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccch
Q 036507          485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSK  563 (639)
Q Consensus       485 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~  563 (639)
                      +.++.+||+|||+++.+..... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....    
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~----  311 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  311 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCT-TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred             CCCCCEEEccccCCcccCcccc-eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence            9999999999999987643221 112233467889999999999999999999999999999999 9999854321    


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                          ..+...    +...                .....+..++.++.+++.+||+.||++||+++|+++.|++++
T Consensus       312 ----~~~~~~----~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          312 ----EELFKL----LKEG----------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ----GGHHHH----HHTT----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHH----HhcC----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                111111    1111                001123445667999999999999999999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=357.77  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=205.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .++|...++||+|+||.||++.+.  +..||+|.+...   ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            356777889999999999999986  678999988543   346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        89 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           89 IKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             cCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999642    345899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCc-----------ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHH
Q 036507          505 SDGE-----------ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       505 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      ....           .......||+.|+|||.+.+..++.++||||||+++|||++|..|+..........  .....  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--~~~~~--  237 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--GLNVR--  237 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--SBCHH--
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--hhhhh--
Confidence            2111           01114579999999999999999999999999999999999998875432210000  00000  


Q ss_pred             HHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                        ...+    ...+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       238 ------------------~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          238 ------------------GFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ------------------HHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------cccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                              0000    011233344689999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.9e-42  Score=353.24  Aligned_cols=262  Identities=27%  Similarity=0.430  Sum_probs=205.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHh--cCCCCeeEEEeeeec----CCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAAT----EDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~----~~~~~lv~e  423 (639)
                      .++|+..+.||+|+||.||+|+.+++.||||++.......+.+|.+++..  ++||||+++++++..    ....++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            46788899999999999999999999999999988877888888888877  789999999998654    356899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH--------EHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      |+++|+|.++++.      ..+++..+..++.|++.||+|||        +++   |+||||||+|||++.++.+||+||
T Consensus        87 ~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           87 YHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             CCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             hccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999953      35899999999999999999999        665   999999999999999999999999


Q ss_pred             CCceecCCCCCCc-ceeeeeccccccCCccccccC------CCCCcchHHHHHHHHHHHHcC----------Cccccccc
Q 036507          496 GLAKLVGKTSDGE-ATVTKVVGTFGYLAPEYLTDG------LATAKSDVYAFGVVLFEIISG----------KEAIIRTE  558 (639)
Q Consensus       496 gla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DVws~Gvvl~elltG----------~~p~~~~~  558 (639)
                      |+++......... .......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998664322211 112234799999999999876      455799999999999999999          66764332


Q ss_pred             cccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCccc-CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          559 GMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMM-DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       559 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      .....      .. .+.......           ...+.+. ...+..++..+.+++.+||+.||++|||++|+++.|++
T Consensus       238 ~~~~~------~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          238 PNDPS------FE-DMRKVVCVD-----------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CSSCC------HH-HHHHHHTTS-----------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcc------hh-hhhHHHhcc-----------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            21110      11 111111110           0011111 11234577889999999999999999999999999997


Q ss_pred             h
Q 036507          638 I  638 (639)
Q Consensus       638 i  638 (639)
                      |
T Consensus       300 i  300 (301)
T 3q4u_A          300 I  300 (301)
T ss_dssp             H
T ss_pred             c
Confidence            6

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.7e-42  Score=360.05  Aligned_cols=273  Identities=29%  Similarity=0.390  Sum_probs=208.5

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccccH--HHHHHHHHHHHhcCCCCeeEEEeeeecCC----eEEE
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEFMAEMKILCKVHHSNLVELIGYAATED----ELFL  420 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~l  420 (639)
                      ....++|+..++||+|+||.||+|+..++.||||++.....  ....+|+.++++++||||+++++++....    .+++
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            34557788899999999999999999999999999976543  34566888899999999999999988743    4799


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT-------KTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                      ||||+++|+|.+++..      ..+++..+..++.|++.||+|||+..       .++|+||||||+|||++.++.+||+
T Consensus       100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999964      24899999999999999999999870       0139999999999999999999999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh--
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE--  566 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~--  566 (639)
                      |||+++.+..... ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||............  
T Consensus       174 DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          174 DFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             cCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            9999987643322 222333579999999999976     34567899999999999999999998654321110000  


Q ss_pred             ---hhhHHHHHHHHhhcCCCcccccccccccCCcccCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          567 ---RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL-YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       567 ---~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                         .............            ....+.+... ....++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVH------------KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             HCSSCCHHHHHHHHTT------------SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhc------------ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               0011111111111            1111211111 1235667799999999999999999999999999976

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-42  Score=356.37  Aligned_cols=266  Identities=27%  Similarity=0.456  Sum_probs=202.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEE------cCceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATE--DEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  418 (639)
                      .++|+..+.||+|+||.||++++      .++.||||++....   .+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            45677889999999999999985      35789999987543   35688999999999999999999998653  458


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             EEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            9999999999999999642    235899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccch----hhhhhhHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK----NQERRSLASFM  574 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~----~~~~~~l~~~~  574 (639)
                      .................++..|+|||.+.+..++.++||||||+++|||++|..|+.........    ...........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            87644332222233456788899999999999999999999999999999999887533210000    00000011111


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...+..                ......+..++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       242 ~~~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          242 IELLKN----------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHT----------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhc----------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111                111122445567899999999999999999999999999886

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.6e-41  Score=345.88  Aligned_cols=246  Identities=25%  Similarity=0.409  Sum_probs=203.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .++|+..+.||+|+||.||++...  ++.||||.+...   ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            467999999999999999999864  678999998543   356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++|+|.+++..      ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        99 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999864      24889999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ...    .......... 
T Consensus       170 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~----~~~~~~~~~~-  234 (297)
T 3fxz_A          170 Q---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRA----LYLIATNGTP-  234 (297)
T ss_dssp             T---CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHH----HHHHHHHCSC-
T ss_pred             c---cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHH----HHHHHhCCCC-
Confidence            2   223446799999999999999999999999999999999999999954322       000    1111111100 


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                  .  ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       235 ------------~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ------------E--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------------C--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------------C--CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                        0  0113344567899999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4e-42  Score=373.62  Aligned_cols=253  Identities=30%  Similarity=0.479  Sum_probs=208.3

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC-eEEEEEe
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYAATED-ELFLIYE  423 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~e  423 (639)
                      +....++|...+.||+|+||.||+|.+.++.||||.++.. ..+.+.+|+++|++++||||+++++++...+ ..++|||
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3445677888899999999999999999999999999765 4577999999999999999999999987655 7999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++...   ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       268 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             ecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            99999999999752   2344789999999999999999999987   99999999999999999999999999986432


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......        .....    +... 
T Consensus       342 ~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~----i~~~-  402 (450)
T 1k9a_A          342 T------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPR----VEKG-  402 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------THHHH----HHTT-
T ss_pred             c------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH----HHcC-
Confidence            1      122357889999999999999999999999999999998 99998543320        11111    1110 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                     .....+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       403 ---------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          403 ---------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                           01112445667899999999999999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.1e-43  Score=370.54  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=206.1

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ....++|...+.||+|+||.||+|.+.  ++.||||.++...    .+++.+|+++|++++||||+++++++...+..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            344567788899999999999999985  6789999987542    2457899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.++++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       190 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            99999999999999632    235899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ..... .........++..|+|||.+.++.++.++||||||+++|||++ |+.||.....        ....    ..+.
T Consensus       263 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~----~~~~  329 (377)
T 3cbl_A          263 EADGV-YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTR----EFVE  329 (377)
T ss_dssp             CTTSE-EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHH----HHHH
T ss_pred             cCCCc-eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH----HHHH
Confidence            43211 0000111245778999999998999999999999999999998 9998854321        0111    1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...                ....+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       330 ~~~----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          330 KGG----------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             TTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC----------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            110                0112344566799999999999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.2e-42  Score=345.41  Aligned_cols=254  Identities=25%  Similarity=0.431  Sum_probs=208.0

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ...++|+..+.||+|+||.||++...+ ..||+|.+...  ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            345678889999999999999998876 47999998754  457789999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           85 ISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             cCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999642    235899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .  ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        .   ........... 
T Consensus       158 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~---~~~~~~~~~~~-  223 (268)
T 3sxs_A          158 Q--YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------S---EVVLKVSQGHR-  223 (268)
T ss_dssp             C--EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------H---HHHHHHHTTCC-
T ss_pred             h--hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------H---HHHHHHHcCCC-
Confidence            1  222233456778999999999899999999999999999999 9999854322        0   11111111110 


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                               .       ..+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       224 ---------~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          224 ---------L-------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             ---------C-------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---------C-------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                     0       01222345689999999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-42  Score=379.74  Aligned_cols=258  Identities=25%  Similarity=0.447  Sum_probs=211.7

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++...++|...+.||+|+||.||+|.+.  +..||||.++..  ..+++.+|+++|++++||||+++++++...+..++|
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            3445567888899999999999999987  578999998754  467899999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.+++...   ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       295 ~E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          295 TEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999742   2345899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...  .........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+...    +..
T Consensus       369 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--------~~~~~~----~~~  434 (495)
T 1opk_A          369 TGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYEL----LEK  434 (495)
T ss_dssp             TTC--CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHH----HHT
T ss_pred             cCC--ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHH----HHc
Confidence            321  1111223456788999999999999999999999999999999 8888854322        111111    111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .                .....+..++..+.+|+.+||+.||++|||++|+++.|++++
T Consensus       435 ~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 D----------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             T----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             C----------------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1                111124455677999999999999999999999999998863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-42  Score=347.81  Aligned_cols=253  Identities=24%  Similarity=0.411  Sum_probs=206.6

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..++|+..+.||+|+||.||++... ++.||+|.+...  ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            3466778899999999999999984 578999998754  3577999999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           88 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             TTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999642    345899999999999999999999987   9999999999999999999999999998653211


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                        ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ...   ........   
T Consensus       161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~---~~~~~~~~---  224 (269)
T 4hcu_A          161 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEV---VEDISTGF---  224 (269)
T ss_dssp             --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH---HHHHHTTC---
T ss_pred             --cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHH---HHHHhcCc---
Confidence              111223456778999999999999999999999999999999 8999854321        111   11111110   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                .    ...+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       225 ----------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          225 ----------R----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ----------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------c----CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                      0    011223345689999999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-42  Score=352.25  Aligned_cols=269  Identities=23%  Similarity=0.414  Sum_probs=206.5

Q ss_pred             CCCCCCCceeecCceEEEEEEE------cCceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATE--DEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  418 (639)
                      ++|+..+.||+|+||.||++.+      .++.||+|.+...    ..+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4577788999999999999985      3578999998643    346788999999999999999999999876  668


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence            9999999999999999532    245899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .................||..|+|||.+.+..++.++||||||+++|||++|+.|+......             .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~~~~~  240 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL-------------FLKMI  240 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-------------HHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH-------------Hhhcc
Confidence            87754332222333457888999999999999999999999999999999999886432110             00000


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ...........+...+........+..++..+.+++.+||+.||++|||++|+++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0000000000011111111111233445667999999999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.4e-42  Score=345.04  Aligned_cols=251  Identities=29%  Similarity=0.505  Sum_probs=197.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|+..+.||+|+||.||++.+.++.+|||.++..       ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            467888899999999999999999999999998643       2356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC--------CCCEEEec
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--------AFRAKISD  494 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D  494 (639)
                      ||+++++|.+++..      ..+++.....++.|++.||+|||+++..+|+||||||+||+++.        ++.+||+|
T Consensus        86 e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           86 EFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             ECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            99999999999853      35899999999999999999999987555999999999999986        67899999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ||++.......     .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......           ...
T Consensus       160 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~~~  223 (271)
T 3dtc_A          160 FGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----------AVA  223 (271)
T ss_dssp             CCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----------HHH
T ss_pred             CCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHH
Confidence            99998653221     22357899999999999999999999999999999999999999543320           001


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .......                .....+..++..+.+++.+||+.||++|||++|+++.|++|
T Consensus       224 ~~~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 YGVAMNK----------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHTSC----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HhhhcCC----------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1111110                01112334456799999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-42  Score=359.43  Aligned_cols=264  Identities=24%  Similarity=0.417  Sum_probs=211.8

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeee
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYA  412 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~  412 (639)
                      .++....++|...+.||+|+||.||++...+       +.||||.++...    .+.+.+|++++++++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3445567889999999999999999999864       689999987542    45688999999999999999999999


Q ss_pred             ecCCeEEEEEeeccCCChhhhccCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 036507          413 ATEDELFLIYEYAQKGSLKSHLHDPQNR-------------------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV  473 (639)
Q Consensus       413 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iv  473 (639)
                      .+.+..++||||+++|+|.+++......                   ....+++..++.++.|+++||+|||+++   |+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            9999999999999999999998653211                   1256899999999999999999999987   99


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCc
Q 036507          474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKE  552 (639)
Q Consensus       474 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~  552 (639)
                      ||||||+|||++.++.+||+|||+++.+.... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999998654321 1122234568899999999999999999999999999999999 999


Q ss_pred             cccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          553 AIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       553 p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                      ||.....        ..+   .........                 ...+..++..+.+++.+||+.||++|||+.|++
T Consensus       276 p~~~~~~--------~~~---~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~  327 (343)
T 1luf_A          276 PYYGMAH--------EEV---IYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIH  327 (343)
T ss_dssp             TTTTSCH--------HHH---HHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cCCCCCh--------HHH---HHHHhCCCc-----------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            9854321        111   111111110                 012334456799999999999999999999999


Q ss_pred             HHHhhhC
Q 036507          633 ISLSQIL  639 (639)
Q Consensus       633 ~~L~~il  639 (639)
                      +.|+++.
T Consensus       328 ~~L~~~~  334 (343)
T 1luf_A          328 RILQRMC  334 (343)
T ss_dssp             HHHHHTT
T ss_pred             HHHHHHH
Confidence            9999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.4e-42  Score=361.52  Aligned_cols=268  Identities=27%  Similarity=0.427  Sum_probs=212.9

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhc-CCCCeeEE
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKV-HHSNLVEL  408 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l-~h~niv~l  408 (639)
                      +...++....++|...+.||+|+||.||++.+.       ++.||||.++...    .+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            455667778899999999999999999999853       2679999997532    35689999999999 79999999


Q ss_pred             EeeeecCC-eEEEEEeeccCCChhhhccCCCCCC----------------------------------------------
Q 036507          409 IGYAATED-ELFLIYEYAQKGSLKSHLHDPQNRG----------------------------------------------  441 (639)
Q Consensus       409 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------  441 (639)
                      ++++.+.+ ..++||||+++|+|.++++......                                              
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988755 4899999999999999997643210                                              


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          442 ---------------QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       442 ---------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                                     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+.... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-  247 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-  247 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc-
Confidence                           122889999999999999999999987   9999999999999999999999999998664322 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                      .........||+.|+|||++.+..++.++||||||+++|||++ |+.||......       ..+    ...+....   
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~----~~~~~~~~---  313 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEF----CRRLKEGT---  313 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHH----HHHHHHTC---
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHH----HHHHHcCC---
Confidence            2223345678999999999999999999999999999999998 99998543321       011    11111110   


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                               .    ...+..+..++.+++.+||+.||++|||++|+++.|++++
T Consensus       314 ---------~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          314 ---------R----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             ---------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------C----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence                     0    0112334457899999999999999999999999999863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-41  Score=352.78  Aligned_cols=243  Identities=26%  Similarity=0.386  Sum_probs=201.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|...+.||+|+||.||+|.+  .++.||||++...     ..+.+.+|++++++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46788899999999999999997  4689999998643     2456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        94 e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           94 EYASGGEVFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CCCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             ECCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999864     235889999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCC-CcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLAT-AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ..    .......||+.|+|||++.+..+. .++|||||||++|||++|+.||...+.           ...........
T Consensus       166 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~~  230 (328)
T 3fe3_A          166 VG----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----------KELRERVLRGK  230 (328)
T ss_dssp             SS----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCC
T ss_pred             CC----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCC
Confidence            32    123446899999999999887775 799999999999999999999954321           11111222211


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .                  ..|...+..+.+++.+||+.||++|||++|+++
T Consensus       231 ~------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 Y------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             C------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             C------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1                  012234456889999999999999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-40  Score=345.84  Aligned_cols=256  Identities=24%  Similarity=0.389  Sum_probs=209.0

Q ss_pred             ccchHHHHhhhCC----------CCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCC
Q 036507          340 VFTYDEILFATEG----------FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSN  404 (639)
Q Consensus       340 ~~~~~e~~~a~~~----------f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~n  404 (639)
                      .++++++..+++.          |...+.||+|+||.||+|...  ++.||||.+...   ..+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4777888777654          556678999999999999885  689999998643   3567889999999999999


Q ss_pred             eeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 036507          405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL  484 (639)
Q Consensus       405 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll  484 (639)
                      |+++++++...+..++||||+++++|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||+
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  174 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL  174 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence            99999999999999999999999999999863      34899999999999999999999987   9999999999999


Q ss_pred             CCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchh
Q 036507          485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN  564 (639)
Q Consensus       485 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~  564 (639)
                      +.++.+||+|||++.......   .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----  246 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----  246 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred             CCCCcEEEeeeeeeeecccCc---cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            999999999999998764322   122346799999999999999999999999999999999999999954321     


Q ss_pred             hhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       565 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                            ...........+             +.+.  .+...+..+.+++.+||+.||++|||++|+++
T Consensus       247 ------~~~~~~~~~~~~-------------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 ------VQAMKRLRDSPP-------------PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ------HHHHHHHHHSSC-------------CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------HHHHHHHhcCCC-------------CCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  011111111111             1110  12234456899999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.1e-42  Score=353.53  Aligned_cols=262  Identities=27%  Similarity=0.458  Sum_probs=210.1

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeee
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAA  413 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~  413 (639)
                      ++....++|...+.||+|+||.||++...       +..||||.+...    ..+.+.+|++++++++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            33445678888999999999999999873       267999998653    2356889999999999999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQNR-------------------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH  474 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH  474 (639)
                      +.+..++||||+++|+|.+++......                   ....+++..++.++.|+++||+|||+++   |+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence            999999999999999999999753221                   1245899999999999999999999987   999


Q ss_pred             CCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCcc
Q 036507          475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEA  553 (639)
Q Consensus       475 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p  553 (639)
                      |||||+||++++++.+||+|||++....... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEED-SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTS-CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccc-cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764322 1112233467889999999999999999999999999999999 9999


Q ss_pred             ccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          554 IIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       554 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      |.....        ..+...    +....                ....+..++..+.+++.+||+.||++||+++|+++
T Consensus       253 ~~~~~~--------~~~~~~----~~~~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPP--------ERLFNL----LKTGH----------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCG--------GGHHHH----HHTTC----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCH--------HHHHHH----hhcCC----------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            854332        111111    11110                01122344567999999999999999999999999


Q ss_pred             HHhhh
Q 036507          634 SLSQI  638 (639)
Q Consensus       634 ~L~~i  638 (639)
                      .|+++
T Consensus       305 ~l~~~  309 (314)
T 2ivs_A          305 DLEKM  309 (314)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-41  Score=345.90  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=203.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|+..+.||+|+||.||++...  +..||+|.+...      ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367888999999999999999875  578999987432      245688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..+
T Consensus        90 ~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EeCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            999999999999864     235899999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ....  ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....           .......+...
T Consensus       162 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~  228 (294)
T 4eqm_A          162 SETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----------VSIAIKHIQDS  228 (294)
T ss_dssp             ---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----------HHHHHHHHSSC
T ss_pred             cccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhhcc
Confidence            3321  1223346799999999999999999999999999999999999999954322           11111112111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhC
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-DMKQVVISLSQIL  639 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~il  639 (639)
                      .             +......+.+.+..+.+++.+||+.||++|| +++++.+.|++++
T Consensus       229 ~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          229 V-------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             C-------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             C-------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            1             1111112234456799999999999999998 9999999998763

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=361.74  Aligned_cols=259  Identities=29%  Similarity=0.481  Sum_probs=209.1

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC---------ceEEEEEecccc----HHHHHHHHHHHHhc-CCCCeeEEEeeee
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN---------QEVAIKRMTATK----TKEFMAEMKILCKV-HHSNLVELIGYAA  413 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~~----~~~~~~E~~il~~l-~h~niv~l~~~~~  413 (639)
                      ...++|...+.||+|+||.||++...+         ..||||+++...    .+++.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            345678888999999999999998632         469999986542    35688999999999 8999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNI  482 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NI  482 (639)
                      ..+..++||||+++|+|.+++.....           .....+++..++.++.|++.||+|||+++   |+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            99999999999999999999975321           11346899999999999999999999987   99999999999


Q ss_pred             EECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCcccccccccc
Q 036507          483 LLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMV  561 (639)
Q Consensus       483 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~  561 (639)
                      |++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....  
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--  299 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  299 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEcCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999999999987643221 122333567889999999999999999999999999999999 9999854321  


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                            ..+.    ..+....                ....+..++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       300 ------~~~~----~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          300 ------EELF----KLLKEGH----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             ------HHHH----HHHHTTC----------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHH----HHHHcCC----------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  1111    1111110                0111233456799999999999999999999999999886

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=343.37  Aligned_cols=270  Identities=22%  Similarity=0.313  Sum_probs=211.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC--eEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATED--ELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv~  422 (639)
                      ++|...++||+|+||.||++...  ++.||||+++..    ..+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56778899999999999999986  678999998753    3467889999999999999999999987655  789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----CCCCCEEEeccCCc
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFGLA  498 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla  498 (639)
                      ||+++++|.+++....  ....+++..+..++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             ECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             eCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999997532  1234899999999999999999999987   9999999999999    88888999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccc--------cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLT--------DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      +.+....    ......||+.|+|||++.        +..++.++|||||||++|||++|+.||......       ...
T Consensus       164 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~  232 (319)
T 4euu_A          164 RELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-------RRN  232 (319)
T ss_dssp             EECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-------GGC
T ss_pred             eecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------chh
Confidence            8764322    223457999999999986        577899999999999999999999999643321       111


Q ss_pred             HHHHHHHhhcCCCcccccccccccC------Cc--ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYID------PN--MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d------~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      ...+...+...+..... ......+      +.  .....+......+.+++.+||+.||++|||++|+++..++
T Consensus       233 ~~~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          233 KEVMYKIITGKPSGAIS-GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHHHHHHHCCTTCCE-EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccch-hhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            22233333333322111 1111100      11  1123456788899999999999999999999999998765

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-41  Score=353.87  Aligned_cols=252  Identities=25%  Similarity=0.455  Sum_probs=199.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--Cc----eEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQ----EVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|+..++||+|+||.||+|.+.  ++    .||+|.+...    ..+++.+|++++++++||||+++++++.+. ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            356777899999999999999874  22    4688887542    346789999999999999999999999865 478


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +++||+++|+|.+++...    ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence            999999999999999742    345899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+.... .........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..    .+
T Consensus       166 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~----~~  232 (327)
T 3poz_A          166 LLGAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISS----IL  232 (327)
T ss_dssp             HHTTTC-C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHH----HH
T ss_pred             EccCCc-ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--------HHHHH----HH
Confidence            764332 2222334567889999999999999999999999999999999 9999864332        11111    11


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...                .....+..+...+.+++.+||+.||++||+++|+++.|+++
T Consensus       233 ~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          233 EKG----------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HTT----------------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HcC----------------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111                00112334556799999999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.9e-42  Score=348.41  Aligned_cols=258  Identities=26%  Similarity=0.450  Sum_probs=212.3

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++....++|...+.||+|+||.||++.+.  +..||+|.+...  ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            44456678888999999999999999987  578999998754  34678999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++++|.+++..   .....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        87 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEECCTTEEHHHHHHH---CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEcCCCCcHHHHHHh---cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999964   23356899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ....  .........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....        ......    +.
T Consensus       161 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~~~~~----~~  226 (288)
T 3kfa_A          161 MTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYEL----LE  226 (288)
T ss_dssp             SCSS--SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHHH----HH
T ss_pred             ccCC--ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH----Hh
Confidence            5422  2223334567889999999999999999999999999999999 8888854332        111111    11


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..                .....+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       227 ~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          227 KD----------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             TT----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc----------------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            11                01112334456799999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.7e-42  Score=374.43  Aligned_cols=258  Identities=25%  Similarity=0.449  Sum_probs=208.7

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      +++...++|...+.||+|+||.||+|.+. +..||||.++..  ..+++.+|+++|++++||||+++++++. .+..++|
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            34455677888899999999999999986 578999999754  4678999999999999999999999986 6678999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.++++..   ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       261 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             ECCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            9999999999999742   1235788899999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....  ........+|..|+|||.+....++.++||||||+++|||++ |+.||.....        ..+...   ....
T Consensus       335 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~---i~~~  401 (454)
T 1qcf_A          335 EDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRA---LERG  401 (454)
T ss_dssp             CCHH--HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHH---HHHT
T ss_pred             CCCc--eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHH---HHcC
Confidence            3211  111122346788999999999999999999999999999999 9999854321        111111   1111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .                 ....+..++..+.+++.+||+.||++|||+++|++.|++++
T Consensus       402 ~-----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          402 Y-----------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             C-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             C-----------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            0                 00123445667999999999999999999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.4e-42  Score=354.76  Aligned_cols=264  Identities=26%  Similarity=0.456  Sum_probs=196.0

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeee
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA  413 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~  413 (639)
                      +++....++|+..+.||+|+||.||++....     ..||||.++..     ..+++.+|++++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            4455567889999999999999999998753     27999998643     3467899999999999999999999998


Q ss_pred             cCCeE------EEEEeeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC
Q 036507          414 TEDEL------FLIYEYAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS  486 (639)
Q Consensus       414 ~~~~~------~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~  486 (639)
                      ..+..      +++|||+++|+|.+++..... .....+++..+..++.|++.||+|||+++   |+||||||+|||+++
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence            76655      999999999999999864221 12235899999999999999999999987   999999999999999


Q ss_pred             CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhh
Q 036507          487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       487 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~  565 (639)
                      ++.+||+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....      
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------  245 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGD-YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------  245 (323)
T ss_dssp             TSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------
T ss_pred             CCCEEEeeccccccccccc-cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh------
Confidence            9999999999998664322 1122233567889999999999999999999999999999999 8998854332      


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                        ..+..   .......                 ...+..++..+.+++.+||+.||++|||+.|+++.|++++
T Consensus       246 --~~~~~---~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          246 --AEIYN---YLIGGNR-----------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             --GGHHH---HHHTTCC-----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHH---HHhcCCC-----------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              11111   1111110                 0112334567999999999999999999999999999863

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.2e-42  Score=347.84  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=204.5

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ...++|+..+.||+|+||.||++.+.+ ..||+|.+...  ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            345678888999999999999998875 57999999754  457799999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus       101 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          101 MANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             cCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999742    235899999999999999999999987   999999999999999999999999999865321


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .  ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ...   ........  
T Consensus       174 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~---~~~~~~~~--  238 (283)
T 3gen_A          174 E--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SET---AEHIAQGL--  238 (283)
T ss_dssp             H--HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH---HHHHHTTC--
T ss_pred             c--cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHH---HHHHhccc--
Confidence            1  111222356788999999998899999999999999999998 9999854332        011   11111110  


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                     ....+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       239 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          239 ---------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                           0111223345789999999999999999999999999886

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-40  Score=347.21  Aligned_cols=243  Identities=29%  Similarity=0.387  Sum_probs=201.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.++..      ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56788899999999999999885  678999998643      3456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999864     245889999999999999999999987   9999999999999999999999999998542


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+   ...+.....
T Consensus       157 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~---~~~i~~~~~  222 (337)
T 1o6l_A          157 SD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERL---FELILMEEI  222 (337)
T ss_dssp             CT---TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHCCC
T ss_pred             cC---CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHH---HHHHHcCCC
Confidence            21   2233456899999999999999999999999999999999999999954321        111   111121110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                                        .++.....++.+++.+||+.||++||     +++|+++
T Consensus       223 ------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                              02233455789999999999999999     8998864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-41  Score=351.79  Aligned_cols=254  Identities=27%  Similarity=0.498  Sum_probs=198.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|...+.||+|+||.||+|....      ..||||.++..    ...++.+|++++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4567778899999999999998753      25999998653    2356889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+++|+|.+++..    ....+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus       123 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence            99999999999999964    2345899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ................+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+   .. .+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~---~~-~~  263 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEV---MK-AI  263 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH---HH-HH
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHH---HH-HH
Confidence            76433222222233456889999999999999999999999999999999 9999854321        111   11 11


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                ....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       264 ~~~~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          264 NDGF----------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             HTTC----------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HCCC----------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1110                0011234456799999999999999999999999999876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.1e-41  Score=339.91  Aligned_cols=250  Identities=21%  Similarity=0.351  Sum_probs=203.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC--CeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE--DELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~  422 (639)
                      .++|...+.||+|+||.||+|.+.++.+|||.+...     ..+.+.+|++++++++||||+++++++.+.  +..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            356777889999999999999999999999998643     245689999999999999999999999876  7889999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++...   ....+++..+..++.|++.||+|||+++ +.|+||||||+||+++.++.++|+|||++....
T Consensus        89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999752   2336899999999999999999999864 459999999999999999999999999876432


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCC---cchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATA---KSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .        ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.....           .........
T Consensus       165 ~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~  225 (271)
T 3kmu_A          165 S--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----------MEIGMKVAL  225 (271)
T ss_dssp             C--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------HHHHHHHHH
T ss_pred             c--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------HHHHHHHHh
Confidence            1        1246899999999998765554   79999999999999999999954321           011111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..            ..+    ..+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       226 ~~------------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          226 EG------------LRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             SC------------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC------------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            11            011    12334456799999999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=354.24  Aligned_cols=263  Identities=26%  Similarity=0.430  Sum_probs=209.7

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeee
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAA  413 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~  413 (639)
                      +....++|...+.||+|+||.||++...       +..||||.+...    ..+.+.+|++++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3455678888999999999999999872       357999998643    245688999999999 8999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQNR------------------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR  475 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~  475 (639)
                      ..+..++||||+++|+|.+++......                  ....+++..++.++.|++.||+|||+++   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999999753211                  1134899999999999999999999987   9999


Q ss_pred             CCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccc
Q 036507          476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAI  554 (639)
Q Consensus       476 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~  554 (639)
                      ||||+|||++.++.+||+|||++..+.... .........||+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCc-cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999998764322 2223334567889999999999999999999999999999998 99998


Q ss_pred             cccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          555 IRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       555 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      ......       ..+    ...+...                .....+..++..+.+++.+||+.||++|||+.|+++.
T Consensus       276 ~~~~~~-------~~~----~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          276 PGIPVD-------ANF----YKLIQNG----------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTCCCS-------HHH----HHHHHTT----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCcH-------HHH----HHHHhcC----------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            543320       011    1111111                0011223345679999999999999999999999999


Q ss_pred             HhhhC
Q 036507          635 LSQIL  639 (639)
Q Consensus       635 L~~il  639 (639)
                      |+.++
T Consensus       329 l~~~~  333 (344)
T 1rjb_A          329 LGCQL  333 (344)
T ss_dssp             HHHHC
T ss_pred             HHHHH
Confidence            98864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=346.14  Aligned_cols=265  Identities=27%  Similarity=0.419  Sum_probs=204.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhc--CCCCeeEEEeeeecC----CeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV--HHSNLVELIGYAATE----DELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l--~h~niv~l~~~~~~~----~~~~lv~e  423 (639)
                      .++|+..+.||+|+||.||+|+..++.||||.+.......+.+|.+++..+  +||||+++++++...    ...++|||
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            467889999999999999999999999999999877777777788877665  899999999998876    68999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT-----KTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      |+++|+|.++++.      ..+++..++.++.|++.||+|||++.     +++|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          116 YHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            9999999999964      24899999999999999999999871     124999999999999999999999999999


Q ss_pred             eecCCCCCCc-ceeeeeccccccCCccccccCCCCCc------chHHHHHHHHHHHHcCC----------cccccccccc
Q 036507          499 KLVGKTSDGE-ATVTKVVGTFGYLAPEYLTDGLATAK------SDVYAFGVVLFEIISGK----------EAIIRTEGMV  561 (639)
Q Consensus       499 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~------~DVws~Gvvl~elltG~----------~p~~~~~~~~  561 (639)
                      ..+....... .......||+.|+|||.+.+...+.+      +|||||||++|||++|.          .||.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            8764322211 11224579999999999988776665      99999999999999994          4443221110


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccC-CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMD-LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .      .. .........           ....+.+.. ..+.+++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       270 ~------~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          270 P------SY-EDMREIVCI-----------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             C------CH-HHHHHHHTT-----------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------ch-hhhHHHHhh-----------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            0      00 001111110           011111111 11246788899999999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=362.31  Aligned_cols=257  Identities=27%  Similarity=0.442  Sum_probs=204.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .++|...+.||+|+||.||+|.+.       +..||||.++..    ...++.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            356778899999999999999853       357999998643    345688999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC---CEEEe
Q 036507          419 FLIYEYAQKGSLKSHLHDPQN--RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF---RAKIS  493 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  493 (639)
                      ++||||+++|+|.+++.....  .....+++..++.++.|++.||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999975322  22345899999999999999999999987   99999999999999554   59999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHH
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      |||+++.+..... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....        ..+. 
T Consensus       227 DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~-  296 (367)
T 3l9p_A          227 DFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL-  296 (367)
T ss_dssp             CCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH-
T ss_pred             CCccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH-
Confidence            9999975532211 112233568999999999999999999999999999999998 9999854321        1111 


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                        .......                 ....+..++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       297 --~~i~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          297 --EFVTSGG-----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             --HHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              1111111                 0112334456799999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.2e-41  Score=348.95  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|+||.||++...  ++.||||.+....    .+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57888999999999999999885  6789999986432    35588999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        87 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           87 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999964     345899999999999999999999987   999999999999999999999999999866432


Q ss_pred             CCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      . .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......      .....+    ....  
T Consensus       159 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~----~~~~--  225 (323)
T 3tki_A          159 N-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDW----KEKK--  225 (323)
T ss_dssp             T-EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------HHHHHH----HTTC--
T ss_pred             C-cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHH----hccc--
Confidence            2 1222345689999999999987765 778999999999999999999996433210      111111    0000  


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                              ....      ........+.+|+.+||+.||++|||++|+++
T Consensus       226 --------~~~~------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          226 --------TYLN------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             --------TTST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------ccCC------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                    0000      11233456889999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7e-41  Score=347.22  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=204.0

Q ss_pred             CCCCCceeecCceEEEEEEE------cCceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEE
Q 036507          353 FSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAAT--EDELFL  420 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~l  420 (639)
                      |+..+.||+|+||.||++.+      .++.||||+++...    .+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            46788999999999998875      35789999987542    4568899999999999999999999987  467899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus       113 v~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999964      23899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchh----hhhhhHHHHHHH
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN----QERRSLASFMLA  576 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~----~~~~~l~~~~~~  576 (639)
                      ...............+|..|+|||.+.+..++.++||||||+++|||++|+.||..........    ....... ....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  262 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-RLTE  262 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH-HHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH-HHHH
Confidence            7543322222334568889999999999899999999999999999999999985432110000    0000000 0111


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .                ++.......+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       263 ~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          263 L----------------LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             H----------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----------------HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1                111111222345566799999999999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.5e-41  Score=349.19  Aligned_cols=262  Identities=26%  Similarity=0.423  Sum_probs=209.5

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeee
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAA  413 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~  413 (639)
                      +....++|...+.||+|+||.||++...       +..||||.++..    ..+.+.+|+++++++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            3445578888999999999999999862       368999998754    246688999999999 8999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQN-------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSS  480 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~  480 (639)
                      ..+..++||||+++|+|.+++.....             .....+++..++.++.|++.||+|||+++   |+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            99999999999999999999875321             11235899999999999999999999987   999999999


Q ss_pred             cEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCcccccccc
Q 036507          481 NILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEG  559 (639)
Q Consensus       481 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~  559 (639)
                      ||+++.++.+||+|||++....... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             eEEEcCCCCEEEccccccccccccc-cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999999998764332 1222234567889999999999999999999999999999999 9999854332


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .       ..+..    .+....            .    ...+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       254 ~-------~~~~~----~~~~~~------------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          254 D-------SKFYK----MIKEGF------------R----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             S-------HHHHH----HHHHTC------------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             h-------hHHHH----HhccCC------------C----CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            1       01111    111110            0    011233455799999999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.5e-41  Score=350.81  Aligned_cols=269  Identities=27%  Similarity=0.399  Sum_probs=208.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEE------cCceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeee--cCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAA--TEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~  418 (639)
                      .++|+..+.||+|+||.||++.+      .+..||||.+....   .+.+.+|++++++++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35677789999999999999985      35789999987543   355889999999999999999999886  45668


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       102 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence            9999999999999999642    235899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .................||..|+|||.+.+..++.++||||||+++|||++|+.||........             ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-------------~~~  241 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-------------RMM  241 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-------------HHC
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-------------hhc
Confidence            8765433222223345688889999999999999999999999999999999999854321000             000


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...........+.+.+........+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             C----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             ccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            000000000011111111112223445567799999999999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-41  Score=344.98  Aligned_cols=253  Identities=27%  Similarity=0.428  Sum_probs=203.4

Q ss_pred             hCCCCCCC-ceeecCceEEEEEEEc----CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSS-LLGHGTYGSVYYGNIR----NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~-~lG~G~~g~Vy~~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|...+ .||+|+||.||+|.+.    +..||||.++..    ..+.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            34555555 8999999999999863    567999998753    345688999999999999999999999 4567899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++++|.+++..    ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        87 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence            9999999999999963    2345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..    .+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~----~i~  227 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMA----FIE  227 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHH----HHH
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHH----HHh
Confidence            6433221122223456889999999998889999999999999999998 9999854332        11111    111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...                ....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       228 ~~~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          228 QGK----------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             TTC----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC----------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            110                0112334556799999999999999999999999999876

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-40  Score=351.56  Aligned_cols=247  Identities=21%  Similarity=0.297  Sum_probs=202.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---------KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .++|...+.||+|+||.||++...  ++.||+|.++..         ..+.+.+|+++|++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            356888899999999999999986  678999998643         246789999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC----CEEEec
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF----RAKISD  494 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D  494 (639)
                      ++||||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++    .+||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            999999999999999964     345899999999999999999999987   99999999999998877    799999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      ||++..+...    .......||+.|+|||++.+..++.++|||||||++|||++|..||.....        ..+   .
T Consensus       163 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~---~  227 (361)
T 2yab_A          163 FGLAHEIEDG----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QET---L  227 (361)
T ss_dssp             CSSCEECCTT----CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHH---H
T ss_pred             cCCceEcCCC----CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHH---H
Confidence            9999876432    123446799999999999999999999999999999999999999954321        111   1


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+......          +++..    .......+.+++.+||+.||++|||++|+++
T Consensus       228 ~~i~~~~~~----------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          228 ANITAVSYD----------FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHTTCCC----------CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCC----------CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111100          01111    1123456899999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.6e-40  Score=341.77  Aligned_cols=265  Identities=25%  Similarity=0.338  Sum_probs=200.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .++|+..++||+|+||+||++... ++.||+|++....     .+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            367888899999999999999984 5789999986432     3568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |++ ++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A          100 FME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             CCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            997 5888887642    345899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....        ......+...+....
T Consensus       172 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~  240 (311)
T 3niz_A          172 P---VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD--------DDQLPKIFSILGTPN  240 (311)
T ss_dssp             C---CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST--------TTHHHHHHHHHCCCC
T ss_pred             C---cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHHCCCC
Confidence            2   222344578999999999876 5689999999999999999999999965432        112222333333222


Q ss_pred             Ccccc--cccc-------cccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSM--SSLK-------DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~--~~~~-------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....  ..+.       ..++.............++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11100  0000       000100000011223457899999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-40  Score=343.97  Aligned_cols=248  Identities=17%  Similarity=0.268  Sum_probs=203.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .++|...+.||+|+||.||++...  +..+|+|.+...  ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            367888899999999999999885  578999998654  3456889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC--CCCEEEeccCCceecCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--AFRAKISDFGLAKLVGK  503 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~  503 (639)
                      ++|+|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||++.  ++.+||+|||++..+..
T Consensus        84 ~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           84 SGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999642    245899999999999999999999987   999999999999987  78999999999987643


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                          ........||+.|+|||++.+..++.++||||||+++|||++|+.||.....        .   ............
T Consensus       157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~---~~~~~i~~~~~~  221 (321)
T 1tki_A          157 ----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------Q---QIIENIMNAEYT  221 (321)
T ss_dssp             ----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------H---HHHHHHHHTCCC
T ss_pred             ----CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------H---HHHHHHHcCCCC
Confidence                2234556899999999999998899999999999999999999999954321        1   111122221110


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +++..    ....+.++.+++.+||+.||++|||+.|+++
T Consensus       222 ----------~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          222 ----------FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----------CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----------CChhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                      00000    1123456899999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-41  Score=344.90  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=193.7

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      ...++|+..+.||+|+||.||+|....     ..||+|.+...    ..+.+.+|+.++++++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            345678888999999999999998742     46999998653    2456889999999999999999999984 5678


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred             EEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccc
Confidence            9999999999999999642    235899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +......  ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ......   .
T Consensus       164 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~~~~---i  230 (281)
T 1mp8_A          164 RYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGR---I  230 (281)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHH---H
T ss_pred             cccCccc--ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHHHHH---H
Confidence            8764321  112233467789999999998999999999999999999997 8989854332        111111   1


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .....                 ...+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       231 ~~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          231 ENGER-----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             HTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCC-----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11100                 012234456799999999999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=349.50  Aligned_cols=273  Identities=25%  Similarity=0.396  Sum_probs=202.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHH--hcCCCCeeEEEeeee-----cCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILC--KVHHSNLVELIGYAA-----TEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~--~l~h~niv~l~~~~~-----~~~~~~lv~  422 (639)
                      .++|+..+.||+|+||.||+|+..++.||||++.......+..|.+++.  .++||||+++++.+.     ....+++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            4678888999999999999999999999999998777777777766654  589999999997543     234678999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT------KTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ||+++|+|.+++..      ...++.....++.|++.||+|||++.      .++|+||||||+|||++.++.+||+|||
T Consensus        92 e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           92 EYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             CCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            99999999999964      23588899999999999999999981      1139999999999999999999999999


Q ss_pred             CceecCCCCC-----CcceeeeeccccccCCcccccc-------CCCCCcchHHHHHHHHHHHHcCCccccccccccchh
Q 036507          497 LAKLVGKTSD-----GEATVTKVVGTFGYLAPEYLTD-------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN  564 (639)
Q Consensus       497 la~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~  564 (639)
                      +++.+.....     .........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+..........
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987643221     1122234579999999999976       456678999999999999999988875433211110


Q ss_pred             hhh------hhHHHHHHHHhhcCCCcccccccccccCCcccCC--CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          565 QER------RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL--YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       565 ~~~------~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      ...      .............           ....+.+...  ....++..+.+++.+||+.||++|||++|+++.|+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSR-----------EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTT-----------SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhcc-----------cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            000      0000001111110           0111111111  12346778999999999999999999999999999


Q ss_pred             hhC
Q 036507          637 QIL  639 (639)
Q Consensus       637 ~il  639 (639)
                      +++
T Consensus       315 ~ll  317 (336)
T 3g2f_A          315 ELM  317 (336)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-41  Score=368.85  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=203.3

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      +...++|...+.||+|+||.||+|.+.+ ..||||.++..  ..+++.+|+++|++++||||+++++++.+ +..++|||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            3455677888999999999999999976 57999998754  35789999999999999999999999876 67899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++|+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       259 ~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             hhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999999999631   2245889999999999999999999987   99999999999999999999999999986642


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..  ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ...   ........ 
T Consensus       333 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~---~~~i~~~~-  398 (452)
T 1fmk_A          333 NE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REV---LDQVERGY-  398 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH---HHHHHTTC-
T ss_pred             Cc--eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHH---HHHHHcCC-
Confidence            21  112223457789999999999999999999999999999999 8999854321        011   11111110 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                                      ....+..++..+.+++.+||+.||++|||++++++.|++++
T Consensus       399 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          399 ----------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                            01123455667999999999999999999999999999863

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-41  Score=377.01  Aligned_cols=245  Identities=27%  Similarity=0.438  Sum_probs=195.9

Q ss_pred             ceeecCceEEEEEEEc----CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          358 LLGHGTYGSVYYGNIR----NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      .||+|+||.||+|.+.    +..||||.++..    ..+++.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874    346999998753    45789999999999999999999999976 56999999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      |.+++...    ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.+........
T Consensus       422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            99999642    346899999999999999999999987   99999999999999999999999999987643222111


Q ss_pred             eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....        ..+..    .+...       
T Consensus       495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~----~i~~~-------  555 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMA----FIEQG-------  555 (613)
T ss_dssp             -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHH----HHHTT-------
T ss_pred             eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHH----HHHcC-------
Confidence            2223456789999999999999999999999999999998 9999964332        11111    11111       


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                               .....+..++.++.+++.+||+.||++||+++++++.|+.+
T Consensus       556 ---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          556 ---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     01112445667899999999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=353.58  Aligned_cols=257  Identities=16%  Similarity=0.210  Sum_probs=211.7

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEE-------EcCceEEEEEeccccHHHHHHHHHHHHhcC---CCCeeEEEeeeec
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGN-------IRNQEVAIKRMTATKTKEFMAEMKILCKVH---HSNLVELIGYAAT  414 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~  414 (639)
                      ++....++|...++||+|+||.||+|.       ..++.||||.+......++.+|++++.+++   |+||+++++++..
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            334556788889999999999999994       246789999999888888999999999997   9999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC--------
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--------  486 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~--------  486 (639)
                      .+..++||||+++|+|.+++..........+++..++.++.|++.||+|||+++   |+||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence            999999999999999999997533334567999999999999999999999987   999999999999998        


Q ss_pred             ---CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccch
Q 036507          487 ---AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK  563 (639)
Q Consensus       487 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~  563 (639)
                         ++.+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             ccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence               8999999999998764322 2334556789999999999999999999999999999999999999985432200  


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhh
Q 036507          564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR-PDMKQVVISLSQI  638 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i  638 (639)
                                              ..    ++..+...   .....+.+++..|++.+|.+| |+++++.+.|+++
T Consensus       293 ------------------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 ------------------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ------------------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ------------------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                                    00    11111111   124467889999999999998 6888888888765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.6e-40  Score=338.95  Aligned_cols=251  Identities=28%  Similarity=0.519  Sum_probs=200.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----------TKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      .++|+..+.||+|+||.||++.+.  ++.||+|.+....          .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367777889999999999999984  6789999985321          167889999999999999999999986654 


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC-----EEE
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR-----AKI  492 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl  492 (639)
                       ++||||+++|+|.+++...    ...+++..+..++.|++.||+|||+++ ++|+||||||+|||++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence             6999999999999988642    346899999999999999999999875 34999999999999988776     999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCcccc--ccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL--TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      +|||+++....      ......||+.|+|||.+  ....++.++||||||+++|||++|+.||......      ....
T Consensus       171 ~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~  238 (287)
T 4f0f_A          171 ADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKF  238 (287)
T ss_dssp             CCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------HHHH
T ss_pred             CCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------HHHH
Confidence            99999974322      23446799999999998  4556789999999999999999999999543321      0011


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                         ........            ..    ...+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       239 ---~~~~~~~~------------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          239 ---INMIREEG------------LR----PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---HHHHHHSC------------CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---HHHHhccC------------CC----CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence               11111111            01    112344556799999999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-41  Score=345.19  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=201.9

Q ss_pred             hhhCCCCCCC-ceeecCceEEEEEEEc----CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          348 FATEGFSDSS-LLGHGTYGSVYYGNIR----NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       348 ~a~~~f~~~~-~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      ...++|...+ .||+|+||.||++.+.    +..||||.++...     .+++.+|++++++++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            3445676676 8999999999999653    3679999986432     46788999999999999999999999 5677


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++||||+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        92 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             cEEEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence            8999999999999999964     235889999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +.................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+    ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~----~~  231 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEV----TA  231 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH----HH
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHH----HH
Confidence            9876443222222233456789999999998889999999999999999999 9999854322        111    11


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .+....            .    ...+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       232 ~~~~~~------------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          232 MLEKGE------------R----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             HHHTTC------------C----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCC------------C----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111110            0    012334456799999999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=344.86  Aligned_cols=252  Identities=27%  Similarity=0.494  Sum_probs=197.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEcCceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGS  429 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  429 (639)
                      ++|+..+.||+|+||.||++...++.||||.+.... .+.+.+|++++++++||||+++++++.  +..++||||+++|+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~   85 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS   85 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence            467778899999999999999999999999997543 567899999999999999999999886  45799999999999


Q ss_pred             hhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC-EEEeccCCceecCCCCCCc
Q 036507          430 LKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR-AKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       430 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~~  508 (639)
                      |.+++....  ....+++...+.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.....     
T Consensus        86 L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----  158 (307)
T 2eva_A           86 LYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----  158 (307)
T ss_dssp             HHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             HHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----
Confidence            999997532  2234788899999999999999999943234999999999999998887 79999999975532     


Q ss_pred             ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......         ............       
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~~~~~~~~~-------  221 (307)
T 2eva_A          159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---------AFRIMWAVHNGT-------  221 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---------HHHHHHHHHTTC-------
T ss_pred             -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---------HHHHHHHHhcCC-------
Confidence             122346899999999999999999999999999999999999999543221         001111111111       


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                            .+.    .+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       222 ------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          222 ------RPP----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             ------CCC----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCC----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                  011    1223445689999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.2e-41  Score=350.89  Aligned_cols=252  Identities=24%  Similarity=0.428  Sum_probs=198.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC--c----eEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN--Q----EVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~----~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|+..+.||+|+||.||+|.+..  .    .||+|.+...    ....+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            3567778999999999999998753  3    3888887533    2345678999999999999999999986 56789


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence            999999999999999742    345888899999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+.... .........||..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+...    +
T Consensus       164 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~----~  230 (325)
T 3kex_A          164 LLPPDD-KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--------AEVPDL----L  230 (325)
T ss_dssp             GSCCCT-TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--------THHHHH----H
T ss_pred             ccCccc-ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--------HHHHHH----H
Confidence            764332 2223345678889999999999999999999999999999999 9999964332        111111    1


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                ....+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       231 ~~~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          231 EKGE----------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             HTTC----------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             HcCC----------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1110                0001222333578899999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5e-41  Score=341.29  Aligned_cols=257  Identities=28%  Similarity=0.498  Sum_probs=207.0

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      +.....++|...+.||+|+||.||++...+ ..||+|.+...  ..+.+.+|++++++++||||+++++++. .+..++|
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            344556788889999999999999999875 58999998754  4577899999999999999999999986 4568999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+||++++++.+||+|||++...
T Consensus        86 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            9999999999999642   1235899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....  ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+   ... +..
T Consensus       160 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~---~~~-~~~  225 (279)
T 1qpc_A          160 EDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEV---IQN-LER  225 (279)
T ss_dssp             SSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH---HHH-HHT
T ss_pred             cCcc--cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHH---HHH-Hhc
Confidence            4321  111223456788999999998899999999999999999999 8988854321        011   111 111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..            .    ...+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       226 ~~------------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          226 GY------------R----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             TC------------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc------------C----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            10            0    011233456799999999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=340.30  Aligned_cols=245  Identities=26%  Similarity=0.413  Sum_probs=194.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----------------------------HHHHHHHHHHHH
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----------------------------TKEFMAEMKILC  398 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----------------------------~~~~~~E~~il~  398 (639)
                      .++|...+.||+|+||.||++...  ++.||||.+....                             .+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357888899999999999999875  5789999986432                             245789999999


Q ss_pred             hcCCCCeeEEEeeeec--CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 036507          399 KVHHSNLVELIGYAAT--EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD  476 (639)
Q Consensus       399 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~D  476 (639)
                      +++||||+++++++.+  .+..++||||+++++|.+++.      ...+++.....++.|++.||+|||+++   |+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence            9999999999999886  568999999999999988754      245899999999999999999999987   99999


Q ss_pred             CCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCC---CCCcchHHHHHHHHHHHHcCCcc
Q 036507          477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL---ATAKSDVYAFGVVLFEIISGKEA  553 (639)
Q Consensus       477 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DVws~Gvvl~elltG~~p  553 (639)
                      |||+|||++.++.+||+|||++..+...   ........||+.|+|||.+.+..   ++.++||||||+++|||++|+.|
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGS---DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSS---SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccc---cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999999999999999999876432   22334568999999999997655   37789999999999999999999


Q ss_pred             ccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          554 IIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       554 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      |.....           .............         .  +     .....+..+.+++.+||+.||++|||++|+++
T Consensus       240 f~~~~~-----------~~~~~~~~~~~~~---------~--~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERI-----------MCLHSKIKSQALE---------F--P-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSH-----------HHHHHHHHHCCCC---------C--C-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccH-----------HHHHHHHhcccCC---------C--C-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            954221           1111111111100         0  0     01223456899999999999999999999874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=349.62  Aligned_cols=244  Identities=25%  Similarity=0.403  Sum_probs=196.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|+..+.||+|+||.||+++..  ++.||||.++..      ..+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            467888999999999999999885  578999998653      345578899999998 69999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999864     245899999999999999999999987   99999999999999999999999999985


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...   ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..   ....+...
T Consensus       174 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~---~~~~i~~~  239 (353)
T 3txo_A          174 GIC---NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DD---LFEAILND  239 (353)
T ss_dssp             SCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH---HHHHHHHC
T ss_pred             ccc---CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HH---HHHHHHcC
Confidence            322   22234456899999999999999999999999999999999999999954321        11   11222221


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM------KQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~  633 (639)
                      ..                  .++......+.+++.+||+.||++||++      +|+++
T Consensus       240 ~~------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          240 EV------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CC------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CC------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            11                  1223344568999999999999999998      66653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=345.62  Aligned_cols=246  Identities=21%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|...+.||+|+||.||++...  +..||+|.+...         ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45777889999999999999986  678999988643         2467899999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC----CEEEecc
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF----RAKISDF  495 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  495 (639)
                      +||||+++|+|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        91 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999964     345899999999999999999999987   99999999999999887    8999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      |++..+....    ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....        ...   ..
T Consensus       163 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~---~~  227 (326)
T 2y0a_A          163 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QET---LA  227 (326)
T ss_dssp             TTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHH---HH
T ss_pred             CCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHH---HH
Confidence            9998764322    23345799999999999999999999999999999999999999954321        011   11


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ........          +.+.    .....+..+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~----------~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          228 NVSAVNYE----------FEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHTCCC----------CCHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCC----------cCcc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111100          0000    11223456889999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-40  Score=346.57  Aligned_cols=241  Identities=23%  Similarity=0.376  Sum_probs=198.5

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||+|.+  .++.||||.+....      .+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788889999999999999998  46789999986432      346889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+ +|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++....
T Consensus        89 E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           89 EYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             CCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             ECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            999 7899998854     235899999999999999999999988   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ..    .......||+.|+|||.+.+..+ ++++|||||||++|||++|+.||......                     
T Consensus       160 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---------------------  214 (336)
T 3h4j_B          160 DG----NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP---------------------  214 (336)
T ss_dssp             TS----BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST---------------------
T ss_pred             CC----cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH---------------------
Confidence            32    22334579999999999988776 78999999999999999999999543210                     


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                             .+...+... ....+...+..+.+++.+||+.||.+|||++|+++
T Consensus       215 -------~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          215 -------NLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -------TCBCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -------HHHHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   000000000 01123344567899999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.2e-40  Score=345.33  Aligned_cols=259  Identities=17%  Similarity=0.222  Sum_probs=205.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc-cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT-KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .++|...+.||+|+||.||+|..  .++.||||.+... ..+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            36788899999999999999996  4688999998644 344688999999999 8999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC-----EEEeccCCcee
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR-----AKISDFGLAKL  500 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~  500 (639)
                       +++|.+++...    ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           88 -GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             -CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence             99999998742    346899999999999999999999987   999999999999999887     99999999987


Q ss_pred             cCCCCCCcc----eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          501 VGKTSDGEA----TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       501 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +........    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +.......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~  234 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQKIGD  234 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHHHHh
Confidence            643322111    123568999999999999999999999999999999999999999654321     00111111111


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .....+.            +.+    ...++ ++.+++..||+.||.+||+++++++.|+++
T Consensus       235 ~~~~~~~------------~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          235 TKRATPI------------EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHHHSCH------------HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hhccCCH------------HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            1000000            000    11234 799999999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.9e-41  Score=360.02  Aligned_cols=261  Identities=20%  Similarity=0.307  Sum_probs=208.5

Q ss_pred             ccchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEee
Q 036507          340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGY  411 (639)
Q Consensus       340 ~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~  411 (639)
                      .+.+.++....++|+..++||+|+||+||+++..  ++.||+|+++...      .+.+.+|.+++.+++||||++++++
T Consensus        63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3456677778899999999999999999999986  4789999986532      2237899999999999999999999


Q ss_pred             eecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       412 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                      +.+.+.+++||||+++|+|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEE
Confidence            99999999999999999999999742    345899999999999999999999987   99999999999999999999


Q ss_pred             EeccCCceecCCCCCCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE  566 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~  566 (639)
                      |+|||+++.....  ........+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+.       
T Consensus       216 L~DFGla~~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-------  286 (437)
T 4aw2_A          216 LADFGSCLKLMED--GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------  286 (437)
T ss_dssp             ECCCTTCEECCTT--SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred             EcchhhhhhcccC--CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-------
Confidence            9999999876432  222334468999999999987     56789999999999999999999999964321       


Q ss_pred             hhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 036507          567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL--RPDMKQVVI  633 (639)
Q Consensus       567 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  633 (639)
                       ...   ...++...         ....-|..    ......++.+|+.+||..+|++  ||+++|+++
T Consensus       287 -~~~---~~~i~~~~---------~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          287 -VET---YGKIMNHK---------ERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             -HHH---HHHHHTHH---------HHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             -hHH---HHhhhhcc---------ccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence             111   11111100         00000110    1123456899999999988888  999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.6e-40  Score=336.01  Aligned_cols=264  Identities=25%  Similarity=0.353  Sum_probs=198.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|+||.||++... ++.||+|.+....     .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46778899999999999999885 6789999985432     36688999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++ +|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             cCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            975 999888642    245889999999999999999999987   999999999999999999999999999865321


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                         ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....        ......+...+.....
T Consensus       154 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~  222 (288)
T 1ob3_A          154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--------ADQLMRIFRILGTPNS  222 (288)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCCCT
T ss_pred             ---ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHHCCCCh
Confidence               122334578999999999876 4589999999999999999999999954321        1111122222222111


Q ss_pred             ccc-ccccccccCCccc-------CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMS-MSSLKDYIDPNMM-------DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~-~~~~~~~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ... ........++.+.       .......+.++.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100 0000011111111       1112234567899999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-41  Score=338.95  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=205.9

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..++|...+.||+|+||.||++... ++.||+|.+...  ..+++.+|++++++++||||+++++++.+.+..+++|||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3467778899999999999999985 568999998754  4577899999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++++|.+++...    ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++...... 
T Consensus        86 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-  157 (267)
T 3t9t_A           86 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-  157 (267)
T ss_dssp             TTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred             CCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence            999999999642    245889999999999999999999987   999999999999999999999999999765321 


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                       .........++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        ...   .........  
T Consensus       158 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~---~~~i~~~~~--  223 (267)
T 3t9t_A          158 -QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEV---VEDISTGFR--  223 (267)
T ss_dssp             -HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH---HHHHHTTCC--
T ss_pred             -cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHH---HHHHhcCCc--
Confidence             1111123456788999999998899999999999999999999 8988854321        111   111111100  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                     ...+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       224 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          224 ---------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                           011223345789999999999999999999999999886

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-40  Score=339.63  Aligned_cols=259  Identities=28%  Similarity=0.555  Sum_probs=194.7

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ...++|+..++||+|+||.||++...+ .+|+|.++..     ..+.+.+|++++++++||||+++++++ ..+..++||
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            345678889999999999999998665 5999998643     245688999999999999999999976 456789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++....
T Consensus        99 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           99 QWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             ECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence            99999999999964    2345899999999999999999999987   9999999999999999999999999997654


Q ss_pred             CCCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ... .........||+.|+|||.+.   +..++.++||||||+++|||++|+.||.....       ...+..    .+.
T Consensus       172 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~----~~~  239 (289)
T 3og7_A          172 RWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIE----MVG  239 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHH----HHH
T ss_pred             ccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHH----Hhc
Confidence            321 122334467999999999986   56788899999999999999999999964332       011111    111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ...           ..+.+. .....++..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       240 ~~~-----------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          240 RGS-----------LSPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HTS-----------CCCCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ccc-----------cCcchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            110           011111 122345567999999999999999999999999999873

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.5e-40  Score=350.83  Aligned_cols=248  Identities=25%  Similarity=0.364  Sum_probs=197.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKV-HHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|+..++||+|+||.||+++..  ++.||+|+++...      .+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            356888899999999999999886  5789999987542      23477899999887 89999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       131 V~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999999864     245899999999999999999999987   99999999999999999999999999985


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ............+...
T Consensus       203 ~~~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~--~~~~~~~~~~~~i~~~  277 (396)
T 4dc2_A          203 GLRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--PDQNTEDYLFQVILEK  277 (396)
T ss_dssp             CCCT---TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------CCHHHHHHHHHHC
T ss_pred             cccC---CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccc--cchhhHHHHHHHHhcc
Confidence            3221   2234457899999999999999999999999999999999999999954321100  0000111111111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                      ..                  ..|.....++.+|+.+||+.||++||++
T Consensus       278 ~~------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 QI------------------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CC------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cc------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            10                  1233445678999999999999999996

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.4e-40  Score=335.62  Aligned_cols=264  Identities=20%  Similarity=0.323  Sum_probs=201.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..++||+|+||+||++...  ++.||||.+...     ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46788899999999999999985  578999998643     23678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++ +|.+.+..    ....+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            9975 56555542    2345899999999999999999999987   99999999999999999999999999987642


Q ss_pred             CCCCcceeeeeccccccCCccccccCC-CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .   ........||+.|+|||.+.+.. ++.++|||||||++|||++|..|+.....       .......+........
T Consensus       154 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-------~~~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          154 P---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-------VDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             C---CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-------HHHHHHHHHHHHCCCC
T ss_pred             c---cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-------HHHHHHHHHHHhCCCC
Confidence            2   22234457899999999997765 79999999999999999999888744332       1112222223332222


Q ss_pred             CcccccccccccCC---------cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDP---------NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~---------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .. ......+..+.         .............+.+++.+||+.||++|||++|+++
T Consensus       224 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          224 EE-QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TT-TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hh-hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            11 11111111100         0011122345667899999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.5e-41  Score=348.36  Aligned_cols=267  Identities=27%  Similarity=0.453  Sum_probs=211.8

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEE
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELI  409 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~  409 (639)
                      +..+++....++|...+.||+|+||.||+|...       +..||||.+...    ....+.+|++++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344555667788999999999999999999765       467999998653    234688999999999999999999


Q ss_pred             eeeecCCeEEEEEeeccCCChhhhccCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 036507          410 GYAATEDELFLIYEYAQKGSLKSHLHDPQ-----NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL  484 (639)
Q Consensus       410 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll  484 (639)
                      +++.+.+..++||||+++|+|.+++....     ......+++..++.++.|++.||+|||+++   |+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            99999999999999999999999986421     111245789999999999999999999987   9999999999999


Q ss_pred             CCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccch
Q 036507          485 DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSK  563 (639)
Q Consensus       485 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~  563 (639)
                      +.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....    
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  246 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----  246 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----
T ss_pred             cCCCeEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----
Confidence            9999999999999986533211 111223467889999999999999999999999999999999 8888854321    


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                          ..+   .........                 ...+..++..+.+++.+||+.||++|||+.|+++.|++++
T Consensus       247 ----~~~---~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          247 ----EQV---LRFVMEGGL-----------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             ----HHH---HHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ----HHH---HHHHHcCCc-----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                111   111111110                 0112344567999999999999999999999999998763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.8e-41  Score=342.11  Aligned_cols=250  Identities=30%  Similarity=0.502  Sum_probs=198.4

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeeeecC-CeEEEEEeecc
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYAATE-DELFLIYEYAQ  426 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~-~~~~lv~e~~~  426 (639)
                      ..++|+..+.||+|+||.||++...++.||||.++.. ..+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            3467888899999999999999999999999998765 456789999999999999999999987554 47899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......  
T Consensus        99 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           99 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             TEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            99999998642   1234788899999999999999999987   999999999999999999999999998754321  


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                          .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..    .+...    
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~----~~~~~----  230 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVP----RVEKG----  230 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHH----HHTTT----
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH----HHhcC----
Confidence                122367889999999999999999999999999999998 9999854321        11111    11110    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  .....+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       231 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          231 ------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                        00112334456799999999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-40  Score=339.18  Aligned_cols=260  Identities=17%  Similarity=0.178  Sum_probs=207.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc-cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT-KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .++|...+.||+|+||.||++..  .++.||||.+... ..+.+.+|++++.++ +|+|++++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            35788899999999999999996  4689999988644 345678999999999 7999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC-----EEEeccCCcee
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR-----AKISDFGLAKL  500 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~  500 (639)
                       +++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.     +||+|||++..
T Consensus        89 -~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           89 -GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             -CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence             99999999742    235899999999999999999999987   999999999999987776     99999999987


Q ss_pred             cCCCCCCc----ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          501 VGKTSDGE----ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       501 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ........    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........     ......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~  235 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIGE  235 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-----HHHHHHHHh
Confidence            65432211    123446799999999999999999999999999999999999999965432110     111111111


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .....+.            +.    ....++..+.+++.+||+.||++||++++|++.|+++
T Consensus       236 ~~~~~~~------------~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          236 KKQSTPL------------RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHSCH------------HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hccCccH------------HH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            1110000            00    0113345799999999999999999999999999876

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=344.80  Aligned_cols=240  Identities=27%  Similarity=0.362  Sum_probs=189.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..++||+|+||+||+|...  ++.||||++...     .......|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            56888999999999999999986  678999987542     223455666666555 8999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+ +++|.+++...    ...++|..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       137 e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             ECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            999 77999988642    345999999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...    ......||+.|+|||++.+ .++.++|||||||++|||++|..++.....          +     ..+... 
T Consensus       209 ~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~-----~~~~~~-  267 (311)
T 3p1a_A          209 TAG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------W-----QQLRQG-  267 (311)
T ss_dssp             ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------H-----HHHTTT-
T ss_pred             cCC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------H-----HHHhcc-
Confidence            321    2334569999999999876 789999999999999999999766632211          0     011110 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                ...+.+    +...+.++.+++.+||+.||++|||++|+++
T Consensus       268 ----------~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          268 ----------YLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----------CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----------CCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                      001111    1233457999999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-40  Score=348.19  Aligned_cols=258  Identities=27%  Similarity=0.464  Sum_probs=206.7

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc---------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR---------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAAT  414 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~  414 (639)
                      ..++|...+.||+|+||.||++...         +..||||.++..    ..+.+.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4567888899999999999999864         357999998754    245688999999999 89999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNR-----------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      .+..++||||+++|+|.+++......           ....+++..++.++.|++.||+|||+++   |+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            99999999999999999999763321           1235899999999999999999999987   999999999999


Q ss_pred             ECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccc
Q 036507          484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVS  562 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~  562 (639)
                      ++.++.+||+|||++....... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....   
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---  265 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  265 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTS-SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             EcCCCCEEEccccccccccccc-cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence            9999999999999998764321 1112233467889999999998899999999999999999999 9999854321   


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                           ..+..   .......                 ...+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       266 -----~~~~~---~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          266 -----EELFK---LLKEGHR-----------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             -----HHHHH---HHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHH---HHhcCCC-----------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 11111   1111110                 011234456799999999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.8e-40  Score=344.95  Aligned_cols=263  Identities=26%  Similarity=0.413  Sum_probs=207.6

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHh--cCCCCeeEEEeeeecCC----eEEEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCK--VHHSNLVELIGYAATED----ELFLIY  422 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~~----~~~lv~  422 (639)
                      ..++|...+.||+|+||.||+++.+++.||||.+.......+.+|.+++..  ++||||+++++++...+    ..++||
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            346788999999999999999999999999999988878888999999988  78999999999998775    789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH--------EHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                      ||+++|+|.+++..      ..+++..++.++.|++.||+|||        +++   |+||||||+|||++.++.+||+|
T Consensus       120 e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          120 DYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECC
T ss_pred             eecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEE
Confidence            99999999999963      24899999999999999999999        655   99999999999999999999999


Q ss_pred             cCCceecCCCCCCc-ceeeeeccccccCCccccccC------CCCCcchHHHHHHHHHHHHcC----------Ccccccc
Q 036507          495 FGLAKLVGKTSDGE-ATVTKVVGTFGYLAPEYLTDG------LATAKSDVYAFGVVLFEIISG----------KEAIIRT  557 (639)
Q Consensus       495 fgla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DVws~Gvvl~elltG----------~~p~~~~  557 (639)
                      ||++.......... .......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99998764322111 012345799999999998765      234689999999999999999          5566432


Q ss_pred             ccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCC-CChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          558 EGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDL-YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       558 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      ....      .....+......            ....+.+... ...++...+.+++.+||+.||++|||++|+++.|+
T Consensus       271 ~~~~------~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          271 VPSD------PSVEEMRKVVCE------------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             SCSS------CCHHHHHHHHTT------------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CcCc------ccHHHHHHHHHH------------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            2110      011111111111            1111111111 13467788999999999999999999999999999


Q ss_pred             hh
Q 036507          637 QI  638 (639)
Q Consensus       637 ~i  638 (639)
                      ++
T Consensus       333 ~i  334 (342)
T 1b6c_B          333 QL  334 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.1e-40  Score=347.23  Aligned_cols=244  Identities=23%  Similarity=0.387  Sum_probs=199.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.+...      ..+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56778899999999999999886  478999998643      3467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+.+|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999964     345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ..    .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||......        ...........
T Consensus       167 ~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--------~~~~~~~~~~~  234 (384)
T 4fr4_A          167 RE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--------SSKEIVHTFET  234 (384)
T ss_dssp             TT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--------CHHHHHHHHHH
T ss_pred             CC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--------cHHHHHHHHhh
Confidence            32    23345689999999999864   45899999999999999999999999643321        01111111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-MKQVV  632 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl  632 (639)
                      ..                  ..++......+.+++.+||+.||++||+ +++++
T Consensus       235 ~~------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          235 TV------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             CC------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             cc------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            11                  0123344567999999999999999998 66665

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-40  Score=349.60  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=200.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++|+..+.||+|+||.||++...  ++.||||.+...        ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46788899999999999999885  678999998532        35678999999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC---EEEeccCC
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGL  497 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl  497 (639)
                      ||||+++++|.+++.... .....+++.....++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       104 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999988875321 12335889999999999999999999987   999999999999987655   99999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +......   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....         .+   ....
T Consensus       180 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~---~~~i  244 (351)
T 3c0i_A          180 AIQLGES---GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RL---FEGI  244 (351)
T ss_dssp             CEECCTT---SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HH---HHHH
T ss_pred             eeEecCC---CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HH---HHHH
Confidence            9876432   2223446799999999999999999999999999999999999999954211         11   1111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......          .++..    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~----------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKYK----------MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCCC----------CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCC----------CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111110          00000    0123456899999999999999999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-40  Score=338.91  Aligned_cols=240  Identities=25%  Similarity=0.363  Sum_probs=200.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.++..      ..+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56778899999999999999885  678999998653      3456788999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           86 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999964     235889999999999999999999987   9999999999999999999999999998753


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.           ......++....
T Consensus       158 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~~~  220 (318)
T 1fot_A          158 DV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------MKTYEKILNAEL  220 (318)
T ss_dssp             SC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHCCC
T ss_pred             Cc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCC
Confidence            21      2345799999999999999999999999999999999999999954321           111112222110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                                        .++.....++.+++.+||+.||++||     +++|+++
T Consensus       221 ------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                              01223345789999999999999999     8888863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=345.91  Aligned_cols=252  Identities=25%  Similarity=0.463  Sum_probs=196.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--Cc----eEEEEEecc----ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQ----EVAIKRMTA----TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~----~vavK~~~~----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .++|+..++||+|+||.||+|.+.  ++    .||+|.+..    ...+.+.+|++++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467888999999999999999874  33    368887743    24577899999999999999999999998654 78


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +++||+.+|+|.+++...    ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            999999999999998642    345899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+.... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..    .+
T Consensus       166 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~----~~  232 (327)
T 3lzb_A          166 LLGAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISS----IL  232 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHH----HH
T ss_pred             EccCcc-ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHH----HH
Confidence            764322 1222333467889999999999999999999999999999999 9999954332        11111    11


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                ....+..++..+.+++.+||+.||++||+++|+++.|+++
T Consensus       233 ~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          233 EKGE----------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HTTC----------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCC----------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1110                0112333455799999999999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.6e-40  Score=347.85  Aligned_cols=275  Identities=23%  Similarity=0.312  Sum_probs=210.0

Q ss_pred             CcccchHHHHhhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc--cHHHHHHHHHHHHhcC-----CCCeeEE
Q 036507          338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT--KTKEFMAEMKILCKVH-----HSNLVEL  408 (639)
Q Consensus       338 ~~~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~E~~il~~l~-----h~niv~l  408 (639)
                      ...+++.+.....++|...++||+|+||.||++..  .++.||||.++..  ....+..|++++++++     ||||+++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            34566666677788999999999999999999998  4678999998743  3456788999999996     9999999


Q ss_pred             EeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC--
Q 036507          409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--  486 (639)
Q Consensus       409 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~--  486 (639)
                      ++++...+..++||||+ +++|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.  
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            99999999999999999 99999999752   2345899999999999999999999987   999999999999976  


Q ss_pred             -----------------------CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHH
Q 036507          487 -----------------------AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVV  543 (639)
Q Consensus       487 -----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvv  543 (639)
                                             ++.+||+|||++......      .....||+.|+|||++.+..++.++|||||||+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                   789999999999865322      124578999999999999999999999999999


Q ss_pred             HHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc----ccccccC-CcccCCCC---------------
Q 036507          544 LFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS----SLKDYID-PNMMDLYP---------------  603 (639)
Q Consensus       544 l~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~~d-~~l~~~~~---------------  603 (639)
                      +|||++|+.||.....        ......+.......+......    .....++ ..+....+               
T Consensus       249 l~ell~g~~pf~~~~~--------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  320 (360)
T 3llt_A          249 LAELYTGSLLFRTHEH--------MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC  320 (360)
T ss_dssp             HHHHHHSSCSCCCSSH--------HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred             HHHHHHCCCCCCCCcH--------HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence            9999999999964332        111122222222221110000    0000000 00000000               


Q ss_pred             -----hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          604 -----HDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       604 -----~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                           ......+.+|+.+||+.||++|||++|+++
T Consensus       321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 011256889999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=350.62  Aligned_cols=272  Identities=22%  Similarity=0.307  Sum_probs=212.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC--eEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATED--ELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv~  422 (639)
                      ++|...++||+|+||.||+|.+.  ++.||||.+...    ..+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56778899999999999999986  678999998753    3467889999999999999999999987655  789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----CCCCCEEEeccCCc
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFGLA  498 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla  498 (639)
                      ||+++|+|.+++....  ....+++..++.++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        89 e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             CCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             ecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999997532  1233899999999999999999999987   9999999999999    77888999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCcccccc--------CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTD--------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      +.....    .......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.......       ..
T Consensus       164 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-------~~  232 (396)
T 4eut_A          164 RELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-------RN  232 (396)
T ss_dssp             EECCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-------TC
T ss_pred             eEccCC----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-------ch
Confidence            876432    22334579999999999865        567789999999999999999999996433211       11


Q ss_pred             HHHHHHHhhcCCCcccccccccccC------C--cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYID------P--NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d------~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .+.+...+...+..... ......+      +  ......+......+.+++.+||+.||++||+++|+++.|++++
T Consensus       233 ~~~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          233 KEVMYKIITGKPSGAIS-GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             HHHHHHHHHSCCTTCCE-EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccch-hheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            22233344443322111 1111000      0  1112244678889999999999999999999999999998763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.3e-40  Score=345.44  Aligned_cols=245  Identities=27%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDEL  418 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  418 (639)
                      ...++|...+.||+|+||.||+++..  ++.||||.++..      ..+.+.+|.+++.++ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578888999999999999999985  578999998653      345678899999887 899999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        94 ~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999964     235889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      +.....   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+   ...+.
T Consensus       166 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~---~~~i~  231 (345)
T 1xjd_A          166 KENMLG---DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EEL---FHSIR  231 (345)
T ss_dssp             BCCCCT---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHH
T ss_pred             hhcccC---CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHH---HHHHH
Confidence            854221   1223456899999999999999999999999999999999999999954321        111   11111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK-QVV  632 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  632 (639)
                      ...+              .    ++.....++.+++.+||+.||++||++. |++
T Consensus       232 ~~~~--------------~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          232 MDNP--------------F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HCCC--------------C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             hCCC--------------C----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1111              0    1223445789999999999999999997 554

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8e-41  Score=348.88  Aligned_cols=263  Identities=24%  Similarity=0.392  Sum_probs=209.0

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeee
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYA  412 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~  412 (639)
                      ++....++|...+.||+|+||.||++...+       ..||+|.+...    ..+.+.+|+++++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            344566889999999999999999998753       37999998654    345688999999999 899999999999


Q ss_pred             ecCCeEEEEEeeccCCChhhhccCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          413 ATEDELFLIYEYAQKGSLKSHLHDPQN---------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       413 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      .+.+..++||||+++|+|.+++.....         .....+++..++.++.|++.||+|||+++   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            999999999999999999999864210         01345799999999999999999999987   999999999999


Q ss_pred             ECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccc
Q 036507          484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVS  562 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~  562 (639)
                      ++.++.+||+|||++....... .........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......  
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--  273 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--  273 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCT-TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--
T ss_pred             ECCCCeEEECcccccccccccc-ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--
Confidence            9999999999999998664322 1222334567889999999999999999999999999999999 88888543220  


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                           ..+.    ..+....            .    ...+..++..+.+++.+||+.||.+|||++|+++.|+++
T Consensus       274 -----~~~~----~~~~~~~------------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          274 -----SKFY----KLVKDGY------------Q----MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -----HHHH----HHHHHTC------------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHH----HHHhcCC------------C----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                 0111    1111110            0    001223345789999999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=344.40  Aligned_cols=266  Identities=27%  Similarity=0.459  Sum_probs=205.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEE------cCceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCC--eE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI------RNQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATED--EL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~  418 (639)
                      .++|+..+.||+|+||.||++.+      .++.||||.+....   .+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45677788999999999999985      35789999986543   457889999999999999999999987654  68


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++++|.+++...    ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       120 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence            9999999999999999642    245899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccch----hhhhhhHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK----NQERRSLASFM  574 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~----~~~~~~l~~~~  574 (639)
                      .................++..|+|||.+.+..++.++||||||+++|||++|+.|+.........    ...........
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654322111122345778899999999888999999999999999999999888532110000    00000011111


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...+..                ......+..++.++.+++.+||+.||++|||++|+++.|+++
T Consensus       273 ~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          273 IELLKN----------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHT----------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhc----------------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111                111112344566799999999999999999999999999876

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.4e-40  Score=353.58  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=199.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|+..+.||+|+||.||++...  ++.+|+|.+....     .+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            356888899999999999999874  6789999986432     356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC---CCCCEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD---SAFRAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~  499 (639)
                      ||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++   .++.+||+|||++.
T Consensus        90 E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           90 DLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             CCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999864     245899999999999999999999987   99999999999998   46789999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+..   ....
T Consensus       162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~---~i~~  227 (444)
T 3soa_A          162 EVEGE---QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQ---QIKA  227 (444)
T ss_dssp             CCCTT---CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHH---HHHH
T ss_pred             EecCC---CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHH---HHHh
Confidence            66432   2233456899999999999999999999999999999999999999954321        11111   1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...         ....+.     ....+.++.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~---------~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          228 GAY---------DFPSPE-----WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TCC---------CCCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC---------CCCccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111         000111     1223456899999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.6e-40  Score=342.11  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=180.9

Q ss_pred             CCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeeccCCChhh
Q 036507          356 SSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSLKS  432 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  432 (639)
                      .+.||+|+||.||++...  ++.||||.+.......+.+|++++.++. ||||+++++++.+++..++||||+++|+|.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            478999999999999986  5789999998877788899999999997 9999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC---CEEEeccCCceecCCCCCCcc
Q 036507          433 HLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF---RAKISDFGLAKLVGKTSDGEA  509 (639)
Q Consensus       433 ~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~  509 (639)
                      ++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++.....   ..
T Consensus        96 ~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~  164 (325)
T 3kn6_A           96 RIKK-----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD---NQ  164 (325)
T ss_dssp             HHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC---CC
Confidence            9964     245899999999999999999999987   99999999999997765   8999999999865432   22


Q ss_pred             eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccc
Q 036507          510 TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS  589 (639)
Q Consensus       510 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  589 (639)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........    .....+..........       
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~~~i~~~~~-------  233 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----CTSAVEIMKKIKKGDF-------  233 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------CCCHHHHHHHHTTTCC-------
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----cccHHHHHHHHHcCCC-------
Confidence            33446789999999999999999999999999999999999999965332100    0111111111111110       


Q ss_pred             cccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       590 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                             .+........+.++.+++.+||+.||++|||++|+++
T Consensus       234 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 -------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             -------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             -------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                   0000001234557899999999999999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-40  Score=349.17  Aligned_cols=264  Identities=18%  Similarity=0.211  Sum_probs=201.3

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccccH--------------HHHHHHHHHHHhcCCCCeeE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTATKT--------------KEFMAEMKILCKVHHSNLVE  407 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~~~--------------~~~~~E~~il~~l~h~niv~  407 (639)
                      ..++|...+.||+|+||.||+|.+..       +.||||.+.....              ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35678889999999999999998853       5799999865431              12344566677788999999


Q ss_pred             EEeeeecC----CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          408 LIGYAATE----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       408 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      +++++...    ...++||||+ +++|.+++..    ....+++..++.++.|++.||+|||+++   |+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil  184 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL  184 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence            99998764    4589999999 9999999964    2346999999999999999999999987   999999999999


Q ss_pred             EC--CCCCEEEeccCCceecCCCCCCc----ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccc
Q 036507          484 LD--SAFRAKISDFGLAKLVGKTSDGE----ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRT  557 (639)
Q Consensus       484 l~--~~~~~kl~Dfgla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~  557 (639)
                      ++  .++.+||+|||+++.+.......    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  88999999999998764332111    1113356999999999999999999999999999999999999999643


Q ss_pred             ccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 036507          558 EGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ  637 (639)
Q Consensus       558 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  637 (639)
                      ...       .............        .+...+++.+.   ...++.++.+++..||+.||++||+++++++.|++
T Consensus       265 ~~~-------~~~~~~~~~~~~~--------~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          265 LKD-------PKYVRDSKIRYRE--------NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             TTC-------HHHHHHHHHHHHH--------CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccC-------HHHHHHHHHHhhh--------hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            221       1111111111111        11122222111   12335579999999999999999999999999987


Q ss_pred             h
Q 036507          638 I  638 (639)
Q Consensus       638 i  638 (639)
                      +
T Consensus       327 ~  327 (364)
T 3op5_A          327 G  327 (364)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.2e-40  Score=345.23  Aligned_cols=247  Identities=23%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|...+.||+|+||.||++...  +..||+|.+...     ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356888999999999999999885  678999998643     2356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC---CEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF---RAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~  499 (639)
                      ||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++   .+||+|||++.
T Consensus       108 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          108 DLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             CCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999864     245899999999999999999999987   99999999999998654   59999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+..   .+..
T Consensus       180 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~---~i~~  244 (362)
T 2bdw_A          180 EVNDS----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYA---QIKA  244 (362)
T ss_dssp             CCTTC----CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH---HHHH
T ss_pred             EecCC----cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHH---HHHh
Confidence            66432    123346899999999999999999999999999999999999999954321        11111   1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....         ...+.     ....+.++.+++.+||+.||++||++.|+++
T Consensus       245 ~~~~---------~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          245 GAYD---------YPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             TCCC---------CCTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCC---------CCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100         00011     1223456899999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-40  Score=347.69  Aligned_cols=247  Identities=23%  Similarity=0.303  Sum_probs=201.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|...+.||+|+||.||++...  ++.+|+|.+...   ....+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            57888999999999999999885  578999998654   3456889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC--CCCEEEeccCCceecCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--AFRAKISDFGLAKLVGK  503 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~  503 (639)
                      ++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.  ++.+||+|||+++.+..
T Consensus       131 ~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          131 SGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999998642    235899999999999999999999987   999999999999974  47799999999987643


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .   ............
T Consensus       204 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~---~~~~~i~~~~~~  268 (387)
T 1kob_A          204 D----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------L---ETLQNVKRCDWE  268 (387)
T ss_dssp             T----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------H---HHHHHHHHCCCC
T ss_pred             C----cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------H---HHHHHHHhCCCC
Confidence            2    223445799999999999999999999999999999999999999964321        0   111111111100


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +++    ......+.++.+++.+||+.||++|||++|+++
T Consensus       269 ----------~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          269 ----------FDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ----------CCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ----------CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                      011    112234557899999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-39  Score=337.50  Aligned_cols=268  Identities=24%  Similarity=0.386  Sum_probs=191.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .++|+..+.||+|+||.||+|...  ++.||+|.++..    ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467888999999999999999875  678999998643    23678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      |++ |+|.+++..... .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 699998864221 22345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....        ......+...+...
T Consensus       160 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          160 IPV---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND--------EEQLKLIFDIMGTP  228 (317)
T ss_dssp             SCC---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCSC
T ss_pred             CCc---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCC
Confidence            321   12334578999999999876 4689999999999999999999999964332        11222222333322


Q ss_pred             CCcccccccccc--cCCcc------------cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDY--IDPNM------------MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~--~d~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.... ......  .++..            ....+.....++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          229 NESLW-PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CTTTC-GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ChhHh-hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            21111 010000  00000            00111233457999999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.8e-40  Score=350.77  Aligned_cols=203  Identities=20%  Similarity=0.303  Sum_probs=173.1

Q ss_pred             hCCCCCCCceeec--CceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHG--TYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G--~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|+..++||+|  +||.||++...  ++.||||+++...     .+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3568888999999  99999999986  6789999986432     3567889999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999998642   2345899999999999999999999987   99999999999999999999999999865


Q ss_pred             cCCCCCC----cceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccc
Q 036507          501 VGKTSDG----EATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTE  558 (639)
Q Consensus       501 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~  558 (639)
                      .......    ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            4321110    111122478999999999987  678999999999999999999999996543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-40  Score=343.13  Aligned_cols=268  Identities=27%  Similarity=0.433  Sum_probs=211.8

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEE
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVEL  408 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l  408 (639)
                      +...++....++|...+.||+|+||.||++.+.       ++.||||.++..    ..+.+.+|++++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            445566677789999999999999999999853       368999998753    235688999999999 69999999


Q ss_pred             EeeeecCC-eEEEEEeeccCCChhhhccCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 036507          409 IGYAATED-ELFLIYEYAQKGSLKSHLHDPQNR-----------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRD  476 (639)
Q Consensus       409 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~D  476 (639)
                      ++++...+ ..++||||+++|+|.+++......           ....+++..+..++.|++.||+|||+++   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987654 589999999999999999753321           0223889999999999999999999987   99999


Q ss_pred             CCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCcccc
Q 036507          477 IKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAII  555 (639)
Q Consensus       477 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~  555 (639)
                      |||+||+++.++.+||+|||+++.+.... .........||+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceEEECCCCCEEECCCccccccccCc-cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999998664322 2223334578899999999999999999999999999999998 999985


Q ss_pred             ccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 036507          556 RTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL  635 (639)
Q Consensus       556 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  635 (639)
                      .....       ..+.    ..+....            ..    ..+......+.+++.+||+.||++|||+.|+++.|
T Consensus       253 ~~~~~-------~~~~----~~~~~~~------------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          253 GVKID-------EEFC----RRLKEGT------------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             TCCCS-------HHHH----HHHHHTC------------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccchh-------HHHH----HHhccCc------------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            43220       0111    1111110            00    01223345689999999999999999999999999


Q ss_pred             hhhC
Q 036507          636 SQIL  639 (639)
Q Consensus       636 ~~il  639 (639)
                      ++++
T Consensus       306 ~~~~  309 (316)
T 2xir_A          306 GNLL  309 (316)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8863

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-39  Score=341.50  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=196.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|+..+.||+|+||.||+++..  ++.||+|.++..      ..+.+.+|.+++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46777899999999999999986  578999998643      234578899999988 899999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             ECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999999864     235899999999999999999999987   999999999999999999999999999854


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  .................
T Consensus       161 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~i~~~~  235 (345)
T 3a8x_A          161 LRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--PDQNTEDYLFQVILEKQ  235 (345)
T ss_dssp             CCT---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHHHHHHHCC
T ss_pred             cCC---CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccc--cccccHHHHHHHHHcCC
Confidence            221   1233456899999999999999999999999999999999999999954221100  00000111111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                      .                  ..+......+.+++.+||+.||++||++
T Consensus       236 ~------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 I------------------RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             C------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             C------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            0                  1233345578999999999999999996

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.8e-41  Score=373.54  Aligned_cols=257  Identities=27%  Similarity=0.459  Sum_probs=207.3

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++...++|...++||+|+||.||+|.+.+ ..||||.++..  ..++|.+|+++|++++||||+++++++.+ +..++||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            33455677888999999999999999976 57999999754  35789999999999999999999999876 6789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.++++..   ....+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       341 e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             CCCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             ehhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            999999999999641   1245889999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...  ........++..|+|||.+.+..++.++||||||++||||++ |+.||.....        ..+   ... +...
T Consensus       415 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~---~~~-i~~~  480 (535)
T 2h8h_A          415 DNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REV---LDQ-VERG  480 (535)
T ss_dssp             CHH--HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHH---HHH-HHTT
T ss_pred             CCc--eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHH---HHH-HHcC
Confidence            210  111122356788999999999999999999999999999999 8999854321        011   111 1111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                                      .....+..++..+.+|+.+||+.||++|||+++|++.|++++
T Consensus       481 ----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          481 ----------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ----------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                            001123445667999999999999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-40  Score=337.68  Aligned_cols=252  Identities=29%  Similarity=0.458  Sum_probs=200.1

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ..++|...+.||+|+||.||+|...+     ..||+|.+...    ..+.+.+|++++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34677788999999999999998753     25999998754    34678899999999999999999999864 4568


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus        89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence            999999999999999642    245889999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ......  ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ........   
T Consensus       162 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--------~~~~~~~~---  228 (281)
T 3cc6_A          162 YIEDED--YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--------KDVIGVLE---  228 (281)
T ss_dssp             CC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--------GGHHHHHH---
T ss_pred             cccccc--ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--------HHHHHHHh---
Confidence            654321  112233467889999999998999999999999999999998 9999854322        11111111   


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                 ...+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       229 ~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          229 KGDR-----------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             HTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCC-----------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            1100                 001223445689999999999999999999999999876

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-40  Score=342.71  Aligned_cols=264  Identities=25%  Similarity=0.452  Sum_probs=199.4

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeee
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYA  412 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~  412 (639)
                      .+++....++|...+.||+|+||.||+|....     ..||+|.++..     ..+.+.+|++++++++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34555667788889999999999999997743     37999998643     235688999999999999999999998


Q ss_pred             ecCC-----eEEEEEeeccCCChhhhccCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC
Q 036507          413 ATED-----ELFLIYEYAQKGSLKSHLHDPQN-RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS  486 (639)
Q Consensus       413 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~  486 (639)
                      .+.+     ..++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+++   |+||||||+||+++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence            7754     35999999999999999853221 23456899999999999999999999987   999999999999999


Q ss_pred             CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhh
Q 036507          487 AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       487 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~  565 (639)
                      ++.+||+|||++..+.... .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....      
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  255 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------  255 (313)
T ss_dssp             TSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------
T ss_pred             CCcEEEeecCcceeccccc-ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH------
Confidence            9999999999998654321 1122233567889999999999999999999999999999999 8888854322      


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                        ..+...   ......                 ...+..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       256 --~~~~~~---~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          256 --HEMYDY---LLHGHR-----------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             --GGHHHH---HHTTCC-----------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHH---HHcCCC-----------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              111111   111100                 012234456799999999999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-40  Score=354.32  Aligned_cols=256  Identities=20%  Similarity=0.324  Sum_probs=205.4

Q ss_pred             chHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeee
Q 036507          342 TYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAA  413 (639)
Q Consensus       342 ~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~  413 (639)
                      ...++....++|...++||+|+||.||+++..  ++.||+|+++...      .+.+.+|+++++.++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            44566677889999999999999999999986  5789999986532      234789999999999999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                      +.+.+++||||+++|+|.+++..      ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence            99999999999999999999863      24788899999999999999999987   9999999999999999999999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCccccccCC----CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL----ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      |||+++.+...  ........+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+.        ..
T Consensus       211 DFG~a~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~  280 (410)
T 3v8s_A          211 DFGTCMKMNKE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VG  280 (410)
T ss_dssp             CCTTCEECCTT--SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HH
T ss_pred             ccceeEeeccC--CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hh
Confidence            99999876432  122234568999999999997655    78999999999999999999999964321        11


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL--RPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~  633 (639)
                      .   ...++...         ....-|.     ......++.+|+.+||+.+|++  ||+++|+++
T Consensus       281 ~---~~~i~~~~---------~~~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          281 T---YSKIMNHK---------NSLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             H---HHHHHTHH---------HHCCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             H---HHHHHhcc---------ccccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            1   11111100         0000000     1123456899999999999998  999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-40  Score=337.32  Aligned_cols=266  Identities=23%  Similarity=0.334  Sum_probs=199.8

Q ss_pred             hhCCCCCCCceeecCceEEEEEEE--cCceEEEEEecccc--------HHHHHHHHHHHHhcC---CCCeeEEEeeeecC
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK--------TKEFMAEMKILCKVH---HSNLVELIGYAATE  415 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~--------~~~~~~E~~il~~l~---h~niv~l~~~~~~~  415 (639)
                      ..++|+..+.||+|+||+||++..  .++.||||.+....        ...+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999986  46789999986322        346778888877765   99999999998765


Q ss_pred             C-----eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          416 D-----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       416 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      .     ..+++|||+. ++|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence            4     5799999996 6999999752   2344899999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      ||+|||+++.....    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....        ...
T Consensus       160 kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~  227 (308)
T 3g33_A          160 KLADFGLARIYSYQ----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--------ADQ  227 (308)
T ss_dssp             EECSCSCTTTSTTC----CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH--------HHH
T ss_pred             EEeeCccccccCCC----cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHH
Confidence            99999999865322    223446899999999999999999999999999999999999999954332        122


Q ss_pred             HHHHHHHhhcCCCccccccc---ccccCCc---ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          571 ASFMLAALRNSPDSMSMSSL---KDYIDPN---MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~---~~~~d~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+...+...+........   ...+.+.   .......+....+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            22233333322211110000   0000000   000011234567899999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-40  Score=373.48  Aligned_cols=245  Identities=27%  Similarity=0.430  Sum_probs=195.6

Q ss_pred             CceeecCceEEEEEEEc----CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIR----NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      +.||+|+||.||+|.+.    ++.||||+++...     .+++.+|+++|++++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999763    3679999987532     467999999999999999999999996 4568999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+......
T Consensus       454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999964     245899999999999999999999987   999999999999999999999999999876543322


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....        ..+    ...+...     
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~----~~~i~~~-----  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEV----TAMLEKG-----  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH----HHHHHTT-----
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH----HHHHHcC-----
Confidence            223344567889999999999999999999999999999998 9999954332        111    1111111     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                 .....+..++.++.+++..||+.||++||++++|++.|+++
T Consensus       589 -----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 -----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                       01112345567899999999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-39  Score=341.89  Aligned_cols=240  Identities=23%  Similarity=0.324  Sum_probs=200.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.+...      ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56778899999999999999985  678999998643      3456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       121 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999964     235889999999999999999999987   9999999999999999999999999998763


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ......+.....
T Consensus       193 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~i~~~~~  255 (350)
T 1rdq_E          193 GR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------IQIYEKIVSGKV  255 (350)
T ss_dssp             SC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCC
T ss_pred             CC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----------HHHHHHHHcCCC
Confidence            21      2345799999999999999999999999999999999999999954321           111112222110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                                        ..+...+..+.+++.+||+.||++||+     ++|+++
T Consensus       256 ------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                              012334557899999999999999998     788764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.1e-40  Score=336.23  Aligned_cols=247  Identities=23%  Similarity=0.413  Sum_probs=198.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC---------ceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN---------QEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      .++|...+.||+|+||.||++....         ..||+|.+...   ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3567778899999999999997753         46999998643   35678999999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC--------
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR--------  489 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------  489 (639)
                      .++||||+++|+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.        
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999742    234899999999999999999999987   999999999999998887        


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      +||+|||++.....       .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.....       ..
T Consensus       160 ~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~~  225 (289)
T 4fvq_A          160 IKLSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------SQ  225 (289)
T ss_dssp             EEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HH
T ss_pred             eeeccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-------hH
Confidence            99999999865421       123468999999999987 7789999999999999999996655432221       00


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ..    .........                  .+...+.++.+++.+||+.||++|||++|+++.|++++
T Consensus       226 ~~----~~~~~~~~~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          226 RK----LQFYEDRHQ------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HH----HHHHHTTCC------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             HH----HHHhhccCC------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            00    011111100                  01111234788999999999999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=342.17  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=188.0

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ..++|+..+.||+|+||.||++...  ++.||||.++.. ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            3467888999999999999999986  468999998765 3456788999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCceecC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLAKLVG  502 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~  502 (639)
                      ++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       131 ~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          131 TGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999864     245899999999999999999999987   999999999999975   8899999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..    .......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ..+   .........
T Consensus       203 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~---~~~i~~~~~  268 (349)
T 2w4o_A          203 HQ----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFM---FRRILNCEY  268 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHH---HHHHHTTCC
T ss_pred             cc----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHH---HHHHHhCCC
Confidence            21    2233467999999999999999999999999999999999999998543320       001   111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                               ....+     ...+.+..+.+++.+||+.||++|||+.|+++
T Consensus       269 ---------~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 ---------YFISP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ---------CCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------ccCCc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     00111     11234557899999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.7e-40  Score=338.21  Aligned_cols=253  Identities=24%  Similarity=0.436  Sum_probs=197.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeee-cCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAA-TEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~l  420 (639)
                      .+|...+.||+|+||.||+|...+     ..+|+|.+...    ..+.+.+|++++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            456678899999999999998642     25899988643    2456889999999999999999999864 4567899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      +|||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus       105 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            9999999999999964    2345789999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCC-CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCC-ccccccccccchhhhhhhHHHHHHHHh
Q 036507          501 VGKTSD-GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK-EAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       501 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ...... .........+|+.|+|||.+.+..++.++||||||+++|||++|. +|+.....        ......   ..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~~~~---~~  246 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITVY---LL  246 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTHHHH---HH
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHH---Hh
Confidence            643221 111233456788999999999999999999999999999999954 44432221        111111   11


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....                 ...+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       247 ~~~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          247 QGRR-----------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             TTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCC-----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1100                 011233445799999999999999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.3e-40  Score=340.87  Aligned_cols=248  Identities=23%  Similarity=0.395  Sum_probs=194.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC--------
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATED--------  416 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--------  416 (639)
                      ++|+..+.||+|+||.||++...  ++.||||+++..    ..+.+.+|++++++++||||+++++++.+.+        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46778899999999999999985  678999998632    3467899999999999999999999885543        


Q ss_pred             -------------------------------------------------eEEEEEeeccCCChhhhccCCCCCCCCCCCH
Q 036507          417 -------------------------------------------------ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSW  447 (639)
Q Consensus       417 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~  447 (639)
                                                                       ..++||||+++|+|.+++....  ......+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~  163 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREH  163 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchhh
Confidence                                                             3799999999999999997633  2345677


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCc---------ceeeeecccc
Q 036507          448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGE---------ATVTKVVGTF  518 (639)
Q Consensus       448 ~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~---------~~~~~~~gt~  518 (639)
                      ..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.........         .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            788999999999999999987   9999999999999999999999999998775432111         1223457999


Q ss_pred             ccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcc
Q 036507          519 GYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNM  598 (639)
Q Consensus       519 ~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l  598 (639)
                      .|+|||.+.+..++.++||||||+++|||++|..|+....          .   .... .....            .+. 
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~---~~~~-~~~~~------------~~~-  293 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------R---IITD-VRNLK------------FPL-  293 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------H---HHHH-HHTTC------------CCH-
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------H---HHHH-hhccC------------CCc-
Confidence            9999999999999999999999999999999986652111          0   1111 11110            000 


Q ss_pred             cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          599 MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       599 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         ........+.+++.+||+.||++|||++|+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence               01233456789999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=351.91  Aligned_cols=251  Identities=24%  Similarity=0.457  Sum_probs=189.5

Q ss_pred             CCCCCceeecCceEEEEEEEc--C---ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEEEE
Q 036507          353 FSDSSLLGHGTYGSVYYGNIR--N---QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAAT-EDELFLIY  422 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~--~---~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~  422 (639)
                      |...+.||+|+||.||+|...  +   ..||+|.++..    ..+++.+|++++++++||||+++++++.. ++..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            455678999999999999864  2   35899988642    34678999999999999999999998754 56789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++...    ...+++..+..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       171 e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             ECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             ECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999742    345789999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCC-cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          503 KTSDG-EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       503 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ..... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......        .....   ....
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--------~~~~~---~~~~  312 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------DITVY---LLQG  312 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--------CHHHH---HHTT
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--------HHHHH---HHcC
Confidence            32211 112233567889999999999999999999999999999999 56666432210        11111   1111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .                 ....+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       313 ~-----------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          313 R-----------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             C-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0                 0011334456799999999999999999999999999876

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-39  Score=340.72  Aligned_cols=243  Identities=25%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|...+.||+|+||.||++...+  +.||||.++..      ..+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4678889999999999999999864  68999998653      345678899999988 79999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        99 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999964     235899999999999999999999987   99999999999999999999999999985


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ..+   ...++..
T Consensus       171 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~---~~~i~~~  236 (353)
T 2i0e_A          171 NIWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DEL---FQSIMEH  236 (353)
T ss_dssp             CCCT---TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHC
T ss_pred             cccC---CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHH---HHHHHhC
Confidence            4221   2233456899999999999999999999999999999999999999954321        111   1222221


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVV  632 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl  632 (639)
                      ..                  .++...+.++.+++.+||+.||++||+     ++|++
T Consensus       237 ~~------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~  275 (353)
T 2i0e_A          237 NV------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  275 (353)
T ss_dssp             CC------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred             CC------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            11                  022334557899999999999999996     46665

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-39  Score=339.17  Aligned_cols=244  Identities=25%  Similarity=0.334  Sum_probs=191.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEE-----cCceEEEEEeccc-------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI-----RNQEVAIKRMTAT-------KTKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      .++|+..+.||+|+||.||++..     .++.||+|.++..       ....+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35678889999999999999987     3578999998653       23457789999999999999999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++||||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence            9999999999999999864     235788899999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ++.....   ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ...   ...+
T Consensus       168 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~---~~~i  233 (327)
T 3a62_A          168 CKESIHD---GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKT---IDKI  233 (327)
T ss_dssp             C-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHH---HHHH
T ss_pred             ccccccC---CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHH---HHHH
Confidence            9754221   1123345799999999999999999999999999999999999999954321        111   1112


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                      .....                  ..+......+.+++.+||+.||++||     +++|+++
T Consensus       234 ~~~~~------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          234 LKCKL------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHTCC------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HhCCC------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            21110                  01223445789999999999999999     6777764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-39  Score=347.10  Aligned_cols=249  Identities=20%  Similarity=0.344  Sum_probs=188.1

Q ss_pred             CCCCC-CceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHh-cCCCCeeEEEeeeec----CCeEEEEEe
Q 036507          352 GFSDS-SLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCK-VHHSNLVELIGYAAT----EDELFLIYE  423 (639)
Q Consensus       352 ~f~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~-l~h~niv~l~~~~~~----~~~~~lv~e  423 (639)
                      +|... ++||+|+||+||++...  ++.||||++...  ..+.+|++++.+ .+||||+++++++..    .+.+++|||
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E  139 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME  139 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence            34444 68999999999999885  578999998643  456789998744 579999999998865    567899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCcee
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLAKL  500 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~  500 (639)
                      |+++|+|.+++...   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+++.
T Consensus       140 ~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          140 CLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             CCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            99999999999752   2346899999999999999999999987   999999999999998   78999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...    .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........    .....+   ...
T Consensus       214 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~i---~~~  282 (400)
T 1nxk_A          214 TTS----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRI---RMG  282 (400)
T ss_dssp             CC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC----SHHHHH---HHT
T ss_pred             cCC----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH----HHHHHH---HcC
Confidence            532    122345689999999999999999999999999999999999999996543311100    011111   000


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..         ....+.     ......++.+|+.+||+.||++|||++|+++
T Consensus       283 ~~---------~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          283 QY---------EFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CC---------CCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc---------cCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00         000010     1234557899999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-40  Score=335.72  Aligned_cols=252  Identities=27%  Similarity=0.459  Sum_probs=199.0

Q ss_pred             CCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE-EEEE
Q 036507          353 FSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL-FLIY  422 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-~lv~  422 (639)
                      |...++||+|+||.||+|.+.+     ..+|+|.+...    ..+.+.+|++++++++||||+++++++.+.+.. +++|
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            4456889999999999998632     26999998643    245688999999999999999999999876655 9999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+.+|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.+.
T Consensus       103 e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          103 PYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             CCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             ecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999974    2345899999999999999999999987   9999999999999999999999999997653


Q ss_pred             CCCC-CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSD-GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .... .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.....       ...+....    ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~----~~~  244 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-------PFDLTHFL----AQG  244 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------GGGHHHHH----HTT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-------HHHHHHHh----hcC
Confidence            2211 11122335688999999999999999999999999999999997666533221       11111111    111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .                ....+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       245 ~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          245 R----------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             C----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0                0011233455799999999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.7e-40  Score=341.68  Aligned_cols=253  Identities=31%  Similarity=0.535  Sum_probs=201.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--Cc--eEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQ--EVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|...+.||+|+||.||++...  +.  .+|+|.+...    ..+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56777889999999999999874  34  3599988643    234688999999999 899999999999999999999


Q ss_pred             EeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          422 YEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      |||+++|+|.+++.....           .....+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            999999999999975320           12346899999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||+++.....    .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..
T Consensus       182 kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~  249 (327)
T 1fvr_A          182 KIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE  249 (327)
T ss_dssp             EECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred             EEcccCcCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HH
Confidence            99999999743221    11223467889999999998889999999999999999998 9999854321        01


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +   . ..+...            .    ....+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus       250 ~---~-~~~~~~------------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          250 L---Y-EKLPQG------------Y----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             H---H-HHGGGT------------C----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---H-HHhhcC------------C----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1   1 111110            0    0112334456799999999999999999999999999876

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.9e-40  Score=345.75  Aligned_cols=249  Identities=23%  Similarity=0.273  Sum_probs=191.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .++|...+.||+|+||.||++...  ++.||||.+...  ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            467888999999999999999985  678999998654  3467889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC--EEEeccCCceecCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR--AKISDFGLAKLVGK  503 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~  503 (639)
                      ++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||+++....
T Consensus        99 ~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           99 SGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            99999999854     235899999999999999999999987   999999999999987765  99999999974322


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCc-chHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAK-SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                          ........||+.|+|||++.+..++.+ +|||||||++|||++|+.||......       ...............
T Consensus       171 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~~~~~~~~~~~  239 (361)
T 3uc3_A          171 ----HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------RDYRKTIQRILSVKY  239 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-------CCHHHHHHHHHTTCC
T ss_pred             ----cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHHhcCCC
Confidence                122334579999999999988877655 89999999999999999999653321       111111222221110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .                ..........+.+|+.+||+.||++|||++|+++
T Consensus       240 ~----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 S----------------IPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             C----------------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             C----------------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            0                0001123456899999999999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=329.20  Aligned_cols=244  Identities=25%  Similarity=0.424  Sum_probs=180.3

Q ss_pred             CCCCCCCceeecCceEEEEEEE--cCceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++..  .++.||||.+....      .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688889999999999999987  46789999986432      366889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++....
T Consensus        91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             ECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999742    346899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        .       +    
T Consensus       164 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~-------~----  221 (278)
T 3cok_A          164 MPH---EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--------T-------L----  221 (278)
T ss_dssp             -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------
T ss_pred             CCC---CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------H-------H----
Confidence            322   12233578999999999999899999999999999999999999985432100        0       0    


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                              ........  ..+...+.++.+++.+||+.||++|||++|+++
T Consensus       222 --------~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 --------NKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----------CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --------HHHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                    00000000  112334557899999999999999999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=352.24  Aligned_cols=260  Identities=22%  Similarity=0.285  Sum_probs=206.0

Q ss_pred             ccchHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEee
Q 036507          340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGY  411 (639)
Q Consensus       340 ~~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~  411 (639)
                      .+.+.+.....++|+..+.||+|+||.||+++..  ++.||||+++...      .+.+.+|.+++.+++||||++++++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            4556677778899999999999999999999985  6899999986532      2347889999999999999999999


Q ss_pred             eecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       412 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                      +.+.+..|+||||+++|+|.+++...    ...+++.....++.||+.||+|||+++   |+||||||+|||++.++++|
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEE
Confidence            99999999999999999999999642    235899999999999999999999987   99999999999999999999


Q ss_pred             EeccCCceecCCCCCCcceeeeeccccccCCccccc-------cCCCCCcchHHHHHHHHHHHHcCCccccccccccchh
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-------DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN  564 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~  564 (639)
                      |+|||+++.+....  .......+||+.|+|||++.       ...++.++|||||||++|||++|+.||...+.     
T Consensus       203 L~DFGla~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----  275 (412)
T 2vd5_A          203 LADFGSCLKLRADG--TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----  275 (412)
T ss_dssp             ECCCTTCEECCTTS--CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----
T ss_pred             EeechhheeccCCC--ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----
Confidence            99999998764321  22223468999999999987       45789999999999999999999999954322     


Q ss_pred             hhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 036507          565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILR---PDMKQVVI  633 (639)
Q Consensus       565 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~  633 (639)
                         ...   ...++...         ....-|..    +...+.++.+++.+||+ +|++|   |+++|+++
T Consensus       276 ---~~~---~~~i~~~~---------~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          276 ---AET---YGKIVHYK---------EHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ---HHH---HHHHHTHH---------HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ---HHH---HHHHHhcc---------cCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence               111   11111100         00000111    12334578999999999 99998   68998864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.6e-40  Score=334.71  Aligned_cols=244  Identities=26%  Similarity=0.452  Sum_probs=200.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeec--------------
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAAT--------------  414 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--------------  414 (639)
                      .+|+..+.||+|+||.||++...  ++.||+|.+.... +.+.+|++++++++||||+++++++..              
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            46778899999999999999986  6899999987543 456789999999999999999998754              


Q ss_pred             --CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          415 --EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       415 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                        ....++||||+++++|.+++...   ....+++..+..++.|++.||.|||+++   |+|+||||+||++++++.+||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEE
Confidence              44589999999999999999642   2346899999999999999999999987   999999999999999999999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      +|||++.......    ......||+.|+|||.+.+..++.++||||||+++|||++|..|+....          ..  
T Consensus       164 ~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------~~--  227 (284)
T 2a19_B          164 GDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------KF--  227 (284)
T ss_dssp             CCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------HH--
T ss_pred             Ccchhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------HH--
Confidence            9999998764322    2234578999999999999999999999999999999999998874211          01  


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                       . ..+...               .    .+...+..+.+++.+||+.||++|||+.|+++.|..+
T Consensus       228 -~-~~~~~~---------------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          228 -F-TDLRDG---------------I----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             -H-HHHHTT---------------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -H-HHhhcc---------------c----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             1 111110               0    1112234588999999999999999999999999865

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=341.18  Aligned_cols=262  Identities=17%  Similarity=0.195  Sum_probs=197.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-----CceEEEEEecccc--------------HHHHHHHHHHHHhcCCCCeeEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-----NQEVAIKRMTATK--------------TKEFMAEMKILCKVHHSNLVELIG  410 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~vavK~~~~~~--------------~~~~~~E~~il~~l~h~niv~l~~  410 (639)
                      .++|...+.||+|+||.||+|...     +..+|||......              ...+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367888899999999999999984     4679999886432              123667888999999999999999


Q ss_pred             eeec----CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC
Q 036507          411 YAAT----EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS  486 (639)
Q Consensus       411 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~  486 (639)
                      ++..    ....++||||+ +++|.+++...     ..+++..++.++.|++.||+|||+++   |+||||||+|||++.
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence            9887    67899999999 99999999642     26899999999999999999999987   999999999999988


Q ss_pred             CC--CEEEeccCCceecCCCCCC----cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccc
Q 036507          487 AF--RAKISDFGLAKLVGKTSDG----EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM  560 (639)
Q Consensus       487 ~~--~~kl~Dfgla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~  560 (639)
                      ++  .+||+|||+++.+......    ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            87  9999999999876432211    11123457999999999999999999999999999999999999999542211


Q ss_pred             cchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       561 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                            ...............+.     .+....       ....++.++.+++.+||+.||++||++++|++.|+++
T Consensus       267 ------~~~~~~~~~~~~~~~~~-----~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          267 ------PVAVQTAKTNLLDELPQ-----SVLKWA-------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             ------HHHHHHHHHHHHHTTTH-----HHHHHS-------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             ------cHHHHHHHHhhcccccH-----HHHhhc-------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence                  11111111111111110     000000       0113455799999999999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.9e-40  Score=341.40  Aligned_cols=251  Identities=22%  Similarity=0.408  Sum_probs=190.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCe----
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDE----  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~----  417 (639)
                      .++|+..+.||+|+||.||++...  ++.||||.++...      ...+.+|++++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            367888999999999999999974  5789999986531      3468899999999999999999999876543    


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++||||+++++|.++++.     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             cEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            4999999999999999964     235899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +..+..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....           .......
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~  231 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQH  231 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHH
Confidence            98765433322333446799999999999999999999999999999999999999954321           1111122


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .......           +   .......+.++.+++.+||+.||++||++.+++.
T Consensus       232 ~~~~~~~-----------~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          232 VREDPIP-----------P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHCCCCC-----------H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             hcCCCCC-----------c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            2221100           0   0001223456899999999999999997666553

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=345.83  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=192.4

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc-----cHHHHHHHHHHHHhcCC--CCeeEEEeeeecCCeEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT-----KTKEFMAEMKILCKVHH--SNLVELIGYAATEDELFL  420 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~l  420 (639)
                      ..++|+..+.||+|+||.||++... ++.||||.+...     ..+.+.+|+++|.+++|  +||+++++++.+++..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            4567888999999999999999875 467999998643     23568899999999986  999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      |||+ .+++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++ ++.+||+|||+++.
T Consensus        87 v~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence            9995 58899999964     345889999999999999999999987   99999999999997 57899999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCcccccc-----------CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTD-----------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      +.... .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....          
T Consensus       157 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------  225 (343)
T 3dbq_A          157 MQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------  225 (343)
T ss_dssp             C-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------
T ss_pred             cCccc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----------
Confidence            64322 1122334679999999999865           6788999999999999999999999954221          


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ........+                ++......+......+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          226 QISKLHAII----------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHHHHHHH----------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHh----------------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            001111111                111111223333457899999999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=343.66  Aligned_cols=242  Identities=21%  Similarity=0.348  Sum_probs=192.2

Q ss_pred             CCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          356 SSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      .+.||+|+||.||++...  +..||+|.++..   ..+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999875  678999998764   346788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE--CCCCCEEEeccCCceecCCCCCCc
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL--DSAFRAKISDFGLAKLVGKTSDGE  508 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~  508 (639)
                      .+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+  +.++.+||+|||+++.+....   
T Consensus       174 ~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---  243 (373)
T 2x4f_A          174 FDRIID----ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---  243 (373)
T ss_dssp             HHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred             HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence            998863    2345899999999999999999999987   9999999999999  667899999999998764322   


Q ss_pred             ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccccc
Q 036507          509 ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS  588 (639)
Q Consensus       509 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  588 (639)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ......++.....     
T Consensus       244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~i~~~~~~-----  306 (373)
T 2x4f_A          244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----------AETLNNILACRWD-----  306 (373)
T ss_dssp             -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCC-----
T ss_pred             -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhccCC-----
Confidence             22345799999999999999999999999999999999999999954332           0111122221110     


Q ss_pred             ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                           +.+.    .......++.+++.+||+.||++|||++|+++
T Consensus       307 -----~~~~----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 -----LEDE----EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -----SCSG----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CChh----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0000    01223457899999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-39  Score=333.29  Aligned_cols=260  Identities=20%  Similarity=0.231  Sum_probs=200.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeee-ecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYA-ATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~-~~~~~~~lv~e~~  425 (639)
                      .++|+..+.||+|+||.||++...  ++.||||.+... ...++.+|++++++++|++++..+.++ ...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            467899999999999999999964  678999986543 234578899999999988777666655 5677889999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---CCCCCEEEeccCCceecC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  502 (639)
                       +++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++....
T Consensus        88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           88 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             -CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             -CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence             99999998632    245899999999999999999999987   9999999999999   788999999999998765


Q ss_pred             CCCCCc----ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          503 KTSDGE----ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       503 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ......    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........    ..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~  235 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----QKYERISEKKM  235 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS----SHHHHHHHHHH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh----hhhhhhhcccc
Confidence            432211    1223467999999999999999999999999999999999999999654331111    11111111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ... .            +.    .....+..+.+++.+||+.||++|||++++++.|+++
T Consensus       236 ~~~-~------------~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          236 STP-I------------EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HSC-H------------HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             cch-h------------hh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            110 0            00    0112345799999999999999999999999999876

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-39  Score=356.88  Aligned_cols=250  Identities=30%  Similarity=0.419  Sum_probs=204.2

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ..++|...+.||+|+||.||++...  ++.||+|.+...      ....+.+|+++|++++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            4467888999999999999999985  689999998643      23567899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++...   ....+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       262 VmEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence            99999999999999752   2345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      +...    .......||+.|+|||++.+..++.++|||||||++|||++|+.||........    ...+.    ..+..
T Consensus       336 ~~~~----~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~----~~i~~  403 (576)
T 2acx_A          336 VPEG----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVE----RLVKE  403 (576)
T ss_dssp             CCTT----CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHH----HHHHH
T ss_pred             cccC----ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHH----HHhhc
Confidence            6432    223446899999999999999999999999999999999999999965432110    01111    11111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                      .+.                 .++.....++.+|+.+||+.||++||     +++|+++
T Consensus       404 ~~~-----------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          404 VPE-----------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccc-----------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            110                 12233455789999999999999999     6788764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-39  Score=351.32  Aligned_cols=242  Identities=25%  Similarity=0.408  Sum_probs=200.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||+|.+.  ++.||||+++..      ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56778889999999999999985  689999998653      2356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999964     345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ..    ......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....        ..+   ...+....
T Consensus       168 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~---~~~i~~~~  232 (476)
T 2y94_A          168 DG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTL---FKKICDGI  232 (476)
T ss_dssp             TT----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHH---HHHHHTTC
T ss_pred             cc----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHH---HHHHhcCC
Confidence            32    22344689999999999988765 6899999999999999999999954321        111   11111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .                  ..+......+.+++.+||+.||++|||++|+++
T Consensus       233 ~------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 F------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             C------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            0                  012233456899999999999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=342.42  Aligned_cols=238  Identities=23%  Similarity=0.370  Sum_probs=198.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----------HHHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----------TKEFMAEMKILCKVHHSNLVELIGYAATED  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~  416 (639)
                      .++|...+.||+|+||.||++...  ++.||||.++...           .+.+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            467888999999999999999874  5789999986532           234678999999999999999999999999


Q ss_pred             eEEEEEeeccCC-ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          417 ELFLIYEYAQKG-SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       417 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      ..++||||+.+| +|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            999999999777 99999864     235899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |++......    .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......              
T Consensus       175 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------  236 (335)
T 3dls_A          175 GSAAYLERG----KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------  236 (335)
T ss_dssp             TTCEECCTT----CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------
T ss_pred             ccceECCCC----CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------
Confidence            999876432    12334679999999999988776 78999999999999999999998532210              


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                         .            ....      ..+...+.++.+++.+||+.||++|||++|+++.
T Consensus       237 ---~------------~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ---V------------EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---T------------TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---H------------hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0            0000      0122234568999999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=332.42  Aligned_cols=264  Identities=27%  Similarity=0.376  Sum_probs=195.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|++....     .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            56888899999999999999986  6789999885432     3557899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++++|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999998864     245899999999999999999999987   99999999999999999999999999987642


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..   .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......        .....+...+....
T Consensus       155 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  223 (311)
T 4agu_A          155 PS---DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--------DQLYLIRKTLGDLI  223 (311)
T ss_dssp             --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSCC
T ss_pred             cc---cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhcccc
Confidence            21   22334578999999999876 67899999999999999999999999654321        11111111111110


Q ss_pred             Ccc-------cccccccccCCcccC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSM-------SMSSLKDYIDPNMMD---LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~-------~~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...       .........++....   ......+..+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000       000000000110000   000234556899999999999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.5e-39  Score=327.75  Aligned_cols=243  Identities=27%  Similarity=0.433  Sum_probs=197.4

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC--ceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      +.++|+..+.||+|+||.||++....  ..||+|.+...      ....+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34678888999999999999998864  57999998543      24568899999999999999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        87 v~e~~~~~~l~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence            9999999999999864     235889999999999999999999987   99999999999999999999999999864


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ...   .......
T Consensus       159 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~---~~~~~~~  222 (279)
T 3fdn_A          159 APS-----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QET---YKRISRV  222 (279)
T ss_dssp             C-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH---HHHHHHT
T ss_pred             CCc-----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHH---HHHHHhC
Confidence            422     122345789999999999999999999999999999999999999854321        111   1111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .              .    ..+......+.+++.+||+.||++|||++|+++
T Consensus       223 ~--------------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          223 E--------------F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             C--------------C----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             C--------------C----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1              0    012233456889999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-39  Score=335.78  Aligned_cols=256  Identities=21%  Similarity=0.372  Sum_probs=193.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++...  +..||||.+...      ..+++.+|++++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            56888899999999999999874  688999998632      2456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++.... .....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus       112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999986421 12345889999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....         ..............
T Consensus       188 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~  255 (310)
T 2wqm_A          188 SKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSLCKKIEQCDY  255 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---------CHHHHHHHHHTTCS
T ss_pred             CCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---------hHHHHHHHhhcccC
Confidence            321   122345789999999999999999999999999999999999999854321         11111111111100


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                   +   .......+.++.+++.+||+.||++|||++++++.|+++
T Consensus       256 -------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          256 -------------P---PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             -------------C---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------C---CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                         0   001123445799999999999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-39  Score=331.25  Aligned_cols=260  Identities=20%  Similarity=0.235  Sum_probs=202.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeee-ecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYA-ATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~-~~~~~~~lv~e~~  425 (639)
                      .++|...+.||+|+||.||++..  .++.||||.+... ..+++.+|++++++++|++++..+.++ ...+..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            46788899999999999999996  4689999988644 345688999999999988866666554 5567789999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---CCCCCEEEeccCCceecC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  502 (639)
                       +++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++....
T Consensus        88 -~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           88 -GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             -CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence             99999999632    245899999999999999999999987   9999999999999   488999999999998765


Q ss_pred             CCCCCc----ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          503 KTSDGE----ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       503 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ......    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........    ..+........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~  235 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----QKYERISEKKM  235 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS----SHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh----hhhhhhccccc
Confidence            432211    1123467999999999999999999999999999999999999999654321110    11111111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....             +.    ....++.++.+++.+||+.||++|||++++++.|+++
T Consensus       236 ~~~~-------------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          236 STPI-------------EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HSCH-------------HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             CCch-------------HH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            1100             00    0122345699999999999999999999999999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-39  Score=347.26  Aligned_cols=265  Identities=23%  Similarity=0.394  Sum_probs=189.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCC--eEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVH-HSNLVELIGYAATED--ELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~--~~~  419 (639)
                      .++|+..+.||+|+||.||++.+.  ++.||||++...     ..+.+.+|+.++.++. ||||+++++++...+  ..+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            468888999999999999999875  678999988532     3456789999999998 999999999987543  789


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||++ ++|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        88 lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            9999996 699998863      35889999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCC------------------CCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccc
Q 036507          500 LVGKTS------------------DGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGM  560 (639)
Q Consensus       500 ~~~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~  560 (639)
                      .+....                  ......+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-  236 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-  236 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence            763211                  11222345689999999999876 6789999999999999999999999965332 


Q ss_pred             cchhhhhhhHHHHHHHHhhcCCCcccccccc------------ccc---CCcccC------------CCChhHHHHHHHH
Q 036507          561 VSKNQERRSLASFMLAALRNSPDSMSMSSLK------------DYI---DPNMMD------------LYPHDCLFKMAML  613 (639)
Q Consensus       561 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~------------~~~---d~~l~~------------~~~~~~~~~l~~l  613 (639)
                             ......+...+..+.. .....+.            ...   ......            ..+..+..++.+|
T Consensus       237 -------~~~~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  308 (388)
T 3oz6_A          237 -------MNQLERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL  308 (388)
T ss_dssp             -------HHHHHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred             -------HHHHHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence                   1111112222221110 0000000            000   000000            0111345678999


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 036507          614 AKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       614 i~~cl~~dP~~RPs~~evl~  633 (639)
                      +.+||+.||++|||++|+++
T Consensus       309 l~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          309 LDKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             HHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhhccCcccCCCHHHHhC
Confidence            99999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-39  Score=354.27  Aligned_cols=244  Identities=29%  Similarity=0.384  Sum_probs=192.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|+..++||+|+||.||++...  ++.||||.+...      ....+.+|++++++++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            356888899999999999999875  578999998643      234577899999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      |||+++|+|.+++..     ...+++.....++.|++.||+|||+ ++   |+||||||+|||++.++.+||+|||+++.
T Consensus       227 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             ECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999864     2458999999999999999999998 66   99999999999999999999999999975


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...   .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+   ...+...
T Consensus       299 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~---~~~i~~~  364 (446)
T 4ejn_A          299 GIK---DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKL---FELILME  364 (446)
T ss_dssp             TCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHC
T ss_pred             ccC---CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHH---HHHHHhC
Confidence            322   22234457899999999999999999999999999999999999999954321        111   1111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                      ..                  ..+.....++.+++.+||+.||++||     +++|+++
T Consensus       365 ~~------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          365 EI------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            10                  01233445789999999999999999     9999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-39  Score=339.91  Aligned_cols=259  Identities=24%  Similarity=0.283  Sum_probs=198.8

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--------KTKEFMAEMKILCKVHHSNLVELIGYAATED  416 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  416 (639)
                      ....++|...+.||+|+||.||++...  +..||+|.+...        ..+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            344577888999999999999999885  468999998543        3467889999999999999999999999999


Q ss_pred             eEEEEEeeccCCChhhhccCCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNR-----------------------------------GQTSLSWIMRVQIALDAARGL  461 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~al  461 (639)
                      ..++||||+++|+|.+++......                                   ....+++.....++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998521100                                   012345677888999999999


Q ss_pred             HHHHhcCCCCeeeCCCCCCcEEECCCC--CEEEeccCCceecCCCCCC-cceeeeeccccccCCcccccc--CCCCCcch
Q 036507          462 EYIHEHTKTHYVHRDIKSSNILLDSAF--RAKISDFGLAKLVGKTSDG-EATVTKVVGTFGYLAPEYLTD--GLATAKSD  536 (639)
Q Consensus       462 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  536 (639)
                      +|||+++   |+||||||+|||++.++  .+||+|||++..+...... ........||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999987   99999999999998776  8999999999876432221 122345679999999999875  67899999


Q ss_pred             HHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHH
Q 036507          537 VYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQ  616 (639)
Q Consensus       537 Vws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~  616 (639)
                      |||||+++|||++|+.||.....           .+.....+.....         ...+.     .......+.+++.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~---------~~~~~-----~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVND-----------ADTISQVLNKKLC---------FENPN-----YNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCC---------TTSGG-----GGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcccc---------cCCcc-----cccCCHHHHHHHHH
Confidence            99999999999999999954332           1111122221110         00011     11234578999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 036507          617 CVDEDPILRPDMKQVVI  633 (639)
Q Consensus       617 cl~~dP~~RPs~~evl~  633 (639)
                      ||+.||++||++.|+++
T Consensus       314 ~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HSCSCTTTSCCHHHHHH
T ss_pred             HcCCChhHCCCHHHHhc
Confidence            99999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.8e-39  Score=331.41  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=196.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      -++|...+.||+|+||.||++...  ++.||+|.+....      .+.+.+|++++++++||||+++++++..++..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367888999999999999999875  6789999986432      35688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus       113 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EECCCCEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999864     235899999999999999999999987   999999999999999999999999999765


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ....  ........|++.|+|||.+.+..++.++||||||+++|||++|+.||.....        .    .+...+...
T Consensus       185 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~----~~~~~~~~~  250 (309)
T 2h34_A          185 TDEK--LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------S----VMGAHINQA  250 (309)
T ss_dssp             --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------H----HHHHHHHSC
T ss_pred             cccc--cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------H----HHHHHhccC
Confidence            3321  1223345799999999999999999999999999999999999999854221        0    111112211


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhC
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-DMKQVVISLSQIL  639 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~il  639 (639)
                      ...              ....+...+..+.+++.+||+.||++|| +++++++.|++++
T Consensus       251 ~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          251 IPR--------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             CCC--------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             CCC--------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            100              0011233445689999999999999999 9999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.9e-39  Score=335.49  Aligned_cols=246  Identities=21%  Similarity=0.287  Sum_probs=201.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.+...         ..+++.+|++++++++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46778899999999999999985  678999998643         2567899999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC----CEEEecc
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF----RAKISDF  495 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  495 (639)
                      +||||+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++    .+||+||
T Consensus        92 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999964     245899999999999999999999987   99999999999999888    7999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      |++.......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ..   ...
T Consensus       164 g~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~---~~~  228 (321)
T 2a2a_A          164 GLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QE---TLA  228 (321)
T ss_dssp             TTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HH---HHH
T ss_pred             ccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HH---HHH
Confidence            9998764322    22345799999999999999999999999999999999999999954321        01   111


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .......          .+++..    ....+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~i~~~~~----------~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          229 NITSVSY----------DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHTTCC----------CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHhccc----------ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111110          001111    1123456899999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.8e-39  Score=351.01  Aligned_cols=261  Identities=20%  Similarity=0.265  Sum_probs=193.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------C
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------D  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  416 (639)
                      .++|+..+.||+|+||.||++...  ++.||||++...     ..+.+.+|+++|++++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999875  678999998642     346688999999999999999999998654      4


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++||||+++ +|.+.+..       .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence            57999999965 56666632       3889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +++....    ....+...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        ......+..
T Consensus       210 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~--------~~~~~~i~~  277 (464)
T 3ttj_A          210 LARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--------IDQWNKVIE  277 (464)
T ss_dssp             CC---------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred             eeeecCC----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHH
Confidence            9986532    2234457899999999999999999999999999999999999999965332        111122222


Q ss_pred             HhhcCCCcc------------------cccccccccCCcccCC---CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSM------------------SMSSLKDYIDPNMMDL---YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~------------------~~~~~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .++......                  ........+...+...   .......++.+|+.+||+.||++|||++|+++
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            222111000                  0000001110000000   01122567999999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.6e-40  Score=340.74  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=200.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-------CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .++|...+.||+|+||.||+|.+.       +..||||.+...    ...++.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            467888999999999999999842       457999998543    345688999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEe
Q 036507          419 FLIYEYAQKGSLKSHLHDPQN--RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKIS  493 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  493 (639)
                      ++||||+++++|.+++.....  .....+++..++.++.|++.||.|||+++   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975322  12245899999999999999999999987   999999999999984   4569999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHH
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLAS  572 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~  572 (639)
                      |||++....... .........||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        ..+..
T Consensus       186 Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~  256 (327)
T 2yfx_A          186 DFGMARDIYRAS-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE  256 (327)
T ss_dssp             CCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred             cccccccccccc-ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHH
Confidence            999997553221 1112233567899999999999999999999999999999998 8888854321        11111


Q ss_pred             HHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                         .......                 ...+..++..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       257 ---~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          257 ---FVTSGGR-----------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ---HHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHhcCCC-----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               1111100                 011233455789999999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.6e-39  Score=351.69  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=201.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|...+.||+|+||.||++...  ++.||+|++...      ..+.+.+|++++++++||||+++++++.+.+.+++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888899999999999999985  688999998643      235688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.+++.... .....+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       264 mE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             ECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999987532 12346899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .........+...
T Consensus       340 ~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-------~~~~~~~~i~~~~  409 (543)
T 3c4z_A          340 KAGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------ENKELKQRVLEQA  409 (543)
T ss_dssp             CTTC---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-------CHHHHHHHHHHCC
T ss_pred             cCCC---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-------hHHHHHHHHhhcc
Confidence            4322   12334589999999999999999999999999999999999999996533210       1111111222111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                      .                  .++...+..+.+++.+||+.||++||++
T Consensus       410 ~------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 V------------------TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             C------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             c------------------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            0                  1233445678999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=342.29  Aligned_cols=261  Identities=15%  Similarity=0.193  Sum_probs=203.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc----------CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeE-------------
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR----------NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVE-------------  407 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~-------------  407 (639)
                      ++|...+.||+|+||.||++...          ++.||||.+...  +.+.+|++++++++||||++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            67888999999999999999875          568999998755  45789999999999999987             


Q ss_pred             --EEeeeec-CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 036507          408 --LIGYAAT-EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL  484 (639)
Q Consensus       408 --l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll  484 (639)
                        +++++.. .+..++||||+ +++|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||+
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~  192 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV  192 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred             cchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence              5666665 67889999999 99999999742   1356999999999999999999999987   9999999999999


Q ss_pred             CCCC--CEEEeccCCceecCCCCCC----cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccc
Q 036507          485 DSAF--RAKISDFGLAKLVGKTSDG----EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTE  558 (639)
Q Consensus       485 ~~~~--~~kl~Dfgla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~  558 (639)
                      +.++  .+||+|||+++.+......    ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  8999999999876432211    111233579999999999999999999999999999999999999996543


Q ss_pred             cccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          559 GMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       559 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..      ...+............         ...++...   ....+..+.+++.+||+.||++|||++++++.|+++
T Consensus       273 ~~------~~~~~~~~~~~~~~~~---------~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          273 PN------TEDIMKQKQKFVDKPG---------PFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TC------HHHHHHHHHHHHHSCC---------CEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cC------HHHHHHHHHhccCChh---------hhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            11      1111111111111111         11111100   112345799999999999999999999999999876

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-39  Score=343.70  Aligned_cols=245  Identities=27%  Similarity=0.347  Sum_probs=191.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHH-HHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKI-LCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|+..+.||+|+||.||+++..  +..||||.++...      ...+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            356788899999999999999986  4689999986532      2345667776 577899999999999999999999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus       117 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            9999999999999864     235788889999999999999999987   99999999999999999999999999985


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ....   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.           .+....++..
T Consensus       189 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~~  254 (373)
T 2r5t_A          189 NIEH---NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----------AEMYDNILNK  254 (373)
T ss_dssp             GBCC---CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----------HHHHHHHHHS
T ss_pred             cccC---CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHhc
Confidence            4221   1233456899999999999999999999999999999999999999954321           1111222221


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS  634 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  634 (639)
                      ..                  .++......+.+++.+||+.||++||++.+.++.
T Consensus       255 ~~------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          255 PL------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             CC------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             cc------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence            10                  0122334568999999999999999998644433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-39  Score=339.12  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=197.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|+..+.||+|+||.||++...  ++.||||.+..... ...+|++++.++ +||||+++++++.+++..++||||++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   99 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK   99 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence            356888899999999999999986  57899999865432 345788999888 79999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC----CCEEEeccCCceecC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA----FRAKISDFGLAKLVG  502 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~~  502 (639)
                      +|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||+.++    +.+||+|||+++...
T Consensus       100 gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A          100 GGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             SCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999864     245899999999999999999999987   9999999999998543    359999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......        ...+....+.....
T Consensus       172 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~~~~i~~~~~  240 (342)
T 2qr7_A          172 AEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--------TPEEILARIGSGKF  240 (342)
T ss_dssp             CTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--------CHHHHHHHHHHCCC
T ss_pred             CCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--------CHHHHHHHHccCCc
Confidence            322   2233467899999999998888999999999999999999999999643210        11111111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                    .+........+.++.+++.+||+.||++||++.|+++
T Consensus       241 --------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 --------------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --------------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                          0011112334557899999999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.4e-39  Score=326.07  Aligned_cols=247  Identities=23%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|+..+.||+|+||.||++...  +..||+|.+...     ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467888999999999999999886  578999998643     2356789999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC---EEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~  499 (639)
                      ||+++++|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.   +||+|||++.
T Consensus        85 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             CCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999988864     245899999999999999999999987   999999999999987655   9999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        .....   ....
T Consensus       157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~---~~~~  221 (284)
T 3kk8_A          157 EVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYA---QIKA  221 (284)
T ss_dssp             ECCSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH---HHHH
T ss_pred             EcccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHH---HHHh
Confidence            764322    22346799999999999999999999999999999999999999954321        11111   1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...         ....+.     ....+.++.+++.+||+.||++|||++|+++
T Consensus       222 ~~~---------~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          222 GAY---------DYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TCC---------CCCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccc---------cCCchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            110         000111     1233456899999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=337.75  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=195.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHH----HHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK----EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.+......    .+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46788899999999999999985  578999998654322    345799999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      ++ |+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            96 6998888642    345899999999999999999999987   999999999999999999999999999865322


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                         ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....        ......+...+...+.
T Consensus       154 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~  222 (324)
T 3mtl_A          154 ---TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--------EEQLHFIFRILGTPTE  222 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCCCT
T ss_pred             ---ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCCCh
Confidence               223344578999999999876 5689999999999999999999999954332        1222333333333222


Q ss_pred             cccccc-----cccccCCcccC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSS-----LKDYIDPNMMD----LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~-----~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......     ......+....    .........+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            111000     00000000000    011233557899999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6e-39  Score=325.17  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=199.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|+||.||++...  ++.||||.+...    ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            46777889999999999999885  678999998643    246788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++..     ...+++.....++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||++..+...
T Consensus        87 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           87 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999864     345899999999999999999999987   999999999999999999999999999865332


Q ss_pred             CCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      . .........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......      ..+..+    ..... 
T Consensus       159 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~----~~~~~-  226 (276)
T 2yex_A          159 N-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDW----KEKKT-  226 (276)
T ss_dssp             T-EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS------HHHHHH----HTTCT-
T ss_pred             c-chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHh----hhccc-
Confidence            1 1122334678999999999987665 779999999999999999999996533210      011111    11100 


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                               ...      .....+..+.+++.+||+.||++|||++|+++
T Consensus       227 ---------~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 ---------YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---------TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------ccC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                     000      11233456889999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2e-39  Score=340.33  Aligned_cols=241  Identities=28%  Similarity=0.483  Sum_probs=195.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +.|...+.||+|+||.||+|...  ++.||||.+...      ..+++.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45778899999999999999874  678999998532      2356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+. |+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++....
T Consensus       134 e~~~-g~l~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          134 EYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             ECCS-EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            9996 688887753    1345899999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ..       ....||+.|+|||++.   ...++.++|||||||++|||++|+.||.....           .........
T Consensus       206 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----------~~~~~~~~~  267 (348)
T 1u5q_A          206 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQ  267 (348)
T ss_dssp             SB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHH
T ss_pred             CC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHh
Confidence            21       2357999999999984   56789999999999999999999999854321           011111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...             +.+   .+...+..+.+++.+||+.||++|||++++++
T Consensus       268 ~~~-------------~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          268 NES-------------PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             SCC-------------CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCC-------------CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            111             000   11223456889999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.7e-39  Score=334.36  Aligned_cols=265  Identities=18%  Similarity=0.259  Sum_probs=202.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcC-CCCeeEEEeeeec--CCeEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAAT--EDELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~--~~~~~lv~e~  424 (639)
                      .++|+..+.||+|+||.||++...  ++.||||.++....+.+.+|++++++++ ||||+++++++.+  ....++||||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            367888999999999999999874  6799999999888889999999999997 9999999999987  6678999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGK  503 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~  503 (639)
                      +++++|.+++..        +++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       115 ~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          115 VNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             cCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999999842        788899999999999999999987   99999999999999776 899999999987643


Q ss_pred             CCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh------hhhHHHHHHH
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE------RRSLASFMLA  576 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~------~~~l~~~~~~  576 (639)
                      ..    ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............      ...+..++..
T Consensus       184 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            22    2234578999999999877 67899999999999999999999999543321100000      0001111100


Q ss_pred             HhhcCCCc-------ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDS-------MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~-------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....+..       .......+..    ....+.....++.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFV----HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGC----CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhc----cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000       0000011111    11122334667999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.2e-40  Score=334.65  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=194.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .++|+..+.||+|+||.||++.+..     ..||||.++..      ..+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3567788999999999999998632     25899987642      3467889999999999999999999997654 8


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++|+||+++++|.+++...    ...+++..+..++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||++
T Consensus        96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence            8999999999999998642    245889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      .................+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .   ......
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~---~~~~~~  237 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------S---QILHKI  237 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H---HHHHHH
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------H---HHHHHH
Confidence            876543322222334567889999999998889999999999999999999 9999854321        0   111111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ......                ...+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       238 ~~~~~~----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          238 DKEGER----------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             HTSCCC----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HccCCC----------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence            111100                011234456799999999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1e-38  Score=347.91  Aligned_cols=273  Identities=22%  Similarity=0.351  Sum_probs=186.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec-----CCeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT-----EDEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~-----~~~~  418 (639)
                      ++|+..++||+|+||.||++.+.  ++.||||++...     ..+.+.+|+++|++++||||+++++++..     ...+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67888999999999999999875  578999998542     34668899999999999999999999844     3578


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      |+||||+ +++|.+++..     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence            9999998 6799999864     345899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCC------------------------cceeeeeccccccCCcccc-ccCCCCCcchHHHHHHHHHHHHc----
Q 036507          499 KLVGKTSDG------------------------EATVTKVVGTFGYLAPEYL-TDGLATAKSDVYAFGVVLFEIIS----  549 (639)
Q Consensus       499 ~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVws~Gvvl~ellt----  549 (639)
                      +........                        ....+..+||++|+|||++ .+..++.++|||||||++|||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            876432211                        1134456889999999976 56679999999999999999999    


Q ss_pred             -------CCccccccccccc------------hhhhhhhHHHHHHHHhhcCCCcccc----cccccc-------cCCccc
Q 036507          550 -------GKEAIIRTEGMVS------------KNQERRSLASFMLAALRNSPDSMSM----SSLKDY-------IDPNMM  599 (639)
Q Consensus       550 -------G~~p~~~~~~~~~------------~~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~-------~d~~l~  599 (639)
                             |+++|........            ...........+...++..+.....    .....+       ....+.
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   4444422210000            0001112222233333322211000    000000       000111


Q ss_pred             CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          600 DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       600 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .. ......++.+|+.+||+.||++|||++|+++
T Consensus       364 ~~-~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          364 ER-FPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             GG-STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH-CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11 1233567899999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.2e-39  Score=345.41  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=191.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc-----cHHHHHHHHHHHHhcC--CCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT-----KTKEFMAEMKILCKVH--HSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|...+.||+|+||.||++... ++.||||.+...     ..+.+.+|+++|.+++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            345888999999999999999875 578999998543     2466889999999997  59999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      || +.+++|.+++..     ...+++..+..++.||+.||+|||+++   |+||||||+|||++ ++.+||+|||+++.+
T Consensus       135 ~E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EE-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             Ee-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            99 568899999964     235888899999999999999999987   99999999999996 579999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCcccccc-----------CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTD-----------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      .... .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....          .
T Consensus       205 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------~  273 (390)
T 2zmd_A          205 QPDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------Q  273 (390)
T ss_dssp             ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------H
T ss_pred             cCCC-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----------H
Confidence            4321 1112334679999999999865           4688999999999999999999999954221          0


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+...+..                ......+......+.+++.+||+.||++|||+.|+++
T Consensus       274 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          274 ISKLHAIIDP----------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHHHHHCT----------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhCc----------------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1111111111                1111122223456899999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-38  Score=326.55  Aligned_cols=243  Identities=22%  Similarity=0.364  Sum_probs=200.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56777899999999999999986  578999988543      2456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++....
T Consensus        95 e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           95 ELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             ECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999998853     235899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....           .+..........
T Consensus       167 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~  232 (294)
T 2rku_A          167 YDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRIKKNEY  232 (294)
T ss_dssp             STTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTTCC
T ss_pred             cCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhhccC
Confidence            3221   22345789999999999998899999999999999999999999854321           011111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                        ..+......+.+++.+||+.||++|||++|+++
T Consensus       233 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 ------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                              012233456889999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.9e-38  Score=321.86  Aligned_cols=245  Identities=20%  Similarity=0.314  Sum_probs=198.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC--ceEEEEEecc---ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN--QEVAIKRMTA---TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||+|+||.||++...+  ..+|+|.+..   ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            467888999999999999999864  5799999864   34577899999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---CCCCCEEEeccCCceecC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  502 (639)
                      ++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||++   +.++.+||+|||++..+.
T Consensus        89 ~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           89 TGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999998864     245899999999999999999999987   9999999999999   788999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ...    ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||.....        .   ...........
T Consensus       161 ~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~---~~~~~~~~~~~  224 (277)
T 3f3z_A          161 PGK----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------S---EVMLKIREGTF  224 (277)
T ss_dssp             TTS----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------H---HHHHHHHHCCC
T ss_pred             Ccc----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------H---HHHHHHHhCCC
Confidence            321    23345799999999998654 89999999999999999999999954321        0   11111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      . .          +..   .....+..+.+++.+||+.||++|||+.|+++
T Consensus       225 ~-~----------~~~---~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 T-F----------PEK---DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             C-C----------CHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C-C----------Cch---hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 0          000   00123457899999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=335.92  Aligned_cols=261  Identities=22%  Similarity=0.303  Sum_probs=200.4

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeee----cCCeE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAA----TEDEL  418 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~----~~~~~  418 (639)
                      ...++|+..+.||+|+||.||++..  .++.||||.+...   ..+.+.+|++++++++||||+++++++.    .....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            3456788899999999999999987  4688999988543   3466889999999999999999999986    34578


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            99999999999999986422 12356899999999999999999999987   999999999999999999999999998


Q ss_pred             eecCCCCCCcc------eeeeeccccccCCccccccCC---CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          499 KLVGKTSDGEA------TVTKVVGTFGYLAPEYLTDGL---ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       499 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~---~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      ...........      ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||......      ...
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~  255 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------GDS  255 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT------TSC
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc------cch
Confidence            76532111100      012245799999999987543   689999999999999999999998532110      001


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +...    ....                .....+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       256 ~~~~----~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          256 VALA----VQNQ----------------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             HHHH----HHCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hhHH----hhcc----------------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            1110    0100                00001123345799999999999999999999999999876

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.9e-39  Score=336.73  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=192.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|+..++||+|+||.||++...  ++.||||+++...     .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            357888999999999999999875  6789999986432     345779999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE-----CCCCCEEEeccCC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL-----DSAFRAKISDFGL  497 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~Dfgl  497 (639)
                      ||++ |+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||+     ++++.+||+|||+
T Consensus       113 e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          113 EYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             ECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             ecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9997 599999864     234899999999999999999999987   9999999999999     4555699999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +..+...   ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....        ......+..
T Consensus       184 a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~  252 (329)
T 3gbz_A          184 ARAFGIP---IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--------IDQLFKIFE  252 (329)
T ss_dssp             HHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred             ccccCCc---ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--------HHHHHHHHH
Confidence            9866422   2223445789999999999874 589999999999999999999999954322        111111222


Q ss_pred             HhhcCCCccc--ccccc-------cccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMS--MSSLK-------DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~--~~~~~-------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+...+....  .....       ......+....+.....++.+|+.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            2222211110  00000       000111111111224567899999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=338.81  Aligned_cols=257  Identities=21%  Similarity=0.310  Sum_probs=184.8

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEecccc---HHHHHHHHHHHHhcC-CCCeeEEEeeee-------
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK---TKEFMAEMKILCKVH-HSNLVELIGYAA-------  413 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~E~~il~~l~-h~niv~l~~~~~-------  413 (639)
                      .....+|+..++||+|+||.||++.+  .++.||||.+....   .+.+.+|+.++.++. ||||+++++++.       
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34456788899999999999999998  46899999885433   456889999999996 999999999983       


Q ss_pred             -cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          414 -TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       414 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                       ....++++|||+. |+|.+++....  ....+++..+..++.|++.||+|||+++ ++|+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence             3455899999995 79998885421  2345899999999999999999999874 35999999999999999999999


Q ss_pred             eccCCceecCCCCCCc---------ceeeeeccccccCCcccc---ccCCCCCcchHHHHHHHHHHHHcCCccccccccc
Q 036507          493 SDFGLAKLVGKTSDGE---------ATVTKVVGTFGYLAPEYL---TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM  560 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~  560 (639)
                      +|||++..........         .......||+.|+|||++   .+..++.++||||||+++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998764322111         011134689999999998   5677889999999999999999999998532210


Q ss_pred             cchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       561 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                 .    .+...            ..    ...+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       260 -----------~----~~~~~------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          260 -----------R----IVNGK------------YS----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ---------------------------------CC----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------H----hhcCc------------cc----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                       0    00000            00    000111223478899999999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.2e-39  Score=333.79  Aligned_cols=244  Identities=22%  Similarity=0.367  Sum_probs=201.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|...+.||+|+||.||++...  ++.+|+|.+...      ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            356778899999999999999986  468999998643      345688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       120 ~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          120 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             ECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            999999999998853     245899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      .....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....           .+.........
T Consensus       192 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~  257 (335)
T 2owb_A          192 EYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRIKKNE  257 (335)
T ss_dssp             CSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTC
T ss_pred             ccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----------HHHHHHHhcCC
Confidence            43221   22345799999999999999999999999999999999999999854321           01111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .              .    .+......+.+++.+||+.||++|||++|+++
T Consensus       258 ~--------------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 Y--------------S----IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             C--------------C----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C--------------C----CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0              0    12233456889999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.9e-39  Score=329.64  Aligned_cols=243  Identities=25%  Similarity=0.459  Sum_probs=200.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +.|...+.||+|+||.||+|...  ++.||||.+...    ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56778899999999999999875  578999998643    357789999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++..      ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||++......
T Consensus       102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999863      35899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .   .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ...   ........+  
T Consensus       173 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~---~~~~~~~~~--  236 (303)
T 3a7i_A          173 Q---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKV---LFLIPKNNP--  236 (303)
T ss_dssp             B---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHH---HHHHHHSCC--
T ss_pred             c---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHH---HHHhhcCCC--
Confidence            1   122345789999999999999999999999999999999999999854321        011   111111111  


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 +.+    +...+..+.+++.+||+.||++|||++|+++
T Consensus       237 -----------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          237 -----------PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             -----------CCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----------CCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                       111    1223456899999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=340.40  Aligned_cols=250  Identities=26%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEE-----cCceEEEEEeccc-------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI-----RNQEVAIKRMTAT-------KTKEFMAEMKILCKV-HHSNLVELIGYAATED  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~-------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  416 (639)
                      .++|...+.||+|+||.||+++.     .++.||||+++..       ..+.+.+|++++.++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35788889999999999999988     4678999998642       235577899999999 6999999999999999


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++||||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eEEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence            99999999999999999964     235889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      +++.+....  ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......       ......
T Consensus       205 ~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~~~  275 (355)
T 1vzo_A          205 LSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-------SQAEIS  275 (355)
T ss_dssp             EEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-------CHHHHH
T ss_pred             CCeecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-------hHHHHH
Confidence            998653221  222334679999999999985  447899999999999999999999996432211       111111


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVIS  634 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  634 (639)
                      .......+                  .++.+....+.+++.+||+.||++||     +++|+++.
T Consensus       276 ~~~~~~~~------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          276 RRILKSEP------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHhccCC------------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            12221111                  12333455689999999999999999     99998753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.6e-39  Score=327.39  Aligned_cols=246  Identities=22%  Similarity=0.322  Sum_probs=197.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.++..         ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45777899999999999999986  679999988643         2567899999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC----CEEEecc
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF----RAKISDF  495 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  495 (639)
                      +||||+++++|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++    .+||+||
T Consensus        85 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999863     245899999999999999999999987   99999999999998877    8999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      |++.......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ...   ..
T Consensus       157 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~---~~  221 (283)
T 3bhy_A          157 GIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QET---LT  221 (283)
T ss_dssp             TTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH---HH
T ss_pred             ccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHH---HH
Confidence            9998764321    22345789999999999999999999999999999999999999854321        011   11


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .......          ...+..    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~~~~----------~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          222 NISAVNY----------DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHTTCC----------CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhHhccc----------CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            1111100          000001    1123456899999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-38  Score=333.59  Aligned_cols=266  Identities=18%  Similarity=0.273  Sum_probs=203.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEeccccH--------------------HHHHHHHHHHHhcCCCCeeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--------------------KEFMAEMKILCKVHHSNLVELI  409 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~il~~l~h~niv~l~  409 (639)
                      .++|...+.||+|+||.||++...++.||||.+.....                    +.+.+|++++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            46788899999999999999999889999999864321                    7899999999999999999999


Q ss_pred             eeeecCCeEEEEEeeccCCChhhhccCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEEC
Q 036507          410 GYAATEDELFLIYEYAQKGSLKSHLHDP---QNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNILLD  485 (639)
Q Consensus       410 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIll~  485 (639)
                      +++.+.+..++||||+++|+|.+++...   .......+++..+..++.|++.||.|||+ ++   |+||||||+||+++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEc
Confidence            9999999999999999999999993210   11224679999999999999999999998 76   99999999999999


Q ss_pred             CCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccC-CCCC-cchHHHHHHHHHHHHcCCccccccccccch
Q 036507          486 SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATA-KSDVYAFGVVLFEIISGKEAIIRTEGMVSK  563 (639)
Q Consensus       486 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DVws~Gvvl~elltG~~p~~~~~~~~~~  563 (639)
                      .++.+||+|||++......     ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......   
T Consensus       187 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---  258 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---  258 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred             CCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence            9999999999999875322     33446799999999999877 6666 999999999999999999999643321   


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcc-cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          564 NQERRSLASFMLAALRNSPDSM-SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                          ..+   ............ ..........+..........+..+.+++.+||+.||++|||++|+++
T Consensus       259 ----~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 ----VEL---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ----HHH---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHH---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                111   111111111000 000000000000001111344567999999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9e-39  Score=325.98  Aligned_cols=248  Identities=26%  Similarity=0.363  Sum_probs=193.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|...++||+|+||.||++...  +..+|+|.+...    ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            45777889999999999999885  578999998653    347789999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---CCCCCEEEeccCCceec
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLV  501 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~  501 (639)
                      +++|+|.+++.... .....+++..+..++.|++.||+|||+++   |+||||||+||++   +.++.+||+|||++..+
T Consensus       102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999885421 11245899999999999999999999987   9999999999999   55678999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...    .......||+.|+|||.+. +.++.++||||||+++|||++|+.||.....           ...........
T Consensus       178 ~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----------~~~~~~~~~~~  241 (285)
T 3is5_A          178 KSD----EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----------EEVQQKATYKE  241 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCC
T ss_pred             CCc----ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----------HHHHhhhccCC
Confidence            332    2233467999999999885 5688999999999999999999999954321           01111111111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.              ... ........+.+++.+||+.||++|||++|+++
T Consensus       242 ~~--------------~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 PN--------------YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC--------------CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc--------------ccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10              000 00112346889999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=332.85  Aligned_cols=266  Identities=25%  Similarity=0.355  Sum_probs=196.5

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--------TKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      ..++|...+.||+|+||.||++...  ++.||||.+....        .+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3478999999999999999999875  6789999986422        23578999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++ +|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        88 ~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             EEEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            999999975 888888642    345788889999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +.+...   ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||.....        ......+...
T Consensus       160 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--------~~~~~~i~~~  228 (346)
T 1ua2_A          160 KSFGSP---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--------LDQLTRIFET  228 (346)
T ss_dssp             STTTSC---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHH
T ss_pred             eeccCC---cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHH
Confidence            866432   222344678999999999875 4578999999999999999999988854321        1111122222


Q ss_pred             hhcCCCccc--ccccccccCCcccCCC-----ChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMS--MSSLKDYIDPNMMDLY-----PHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~--~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .........  .....+.+........     .......+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            222211100  0011111110000000     1234567999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.9e-39  Score=344.91  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=188.9

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----------HHHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----------TKEFMAEMKILCKVHHSNLVELIGYAATE  415 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----------~~~~~~E~~il~~l~h~niv~l~~~~~~~  415 (639)
                      ..++|...+.||+|+||.||+|...  ++.||||.+....           ...+.+|+++|++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3578999999999999999999885  4789999986432           124789999999999999999999975 4


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC---CEEE
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF---RAKI  492 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  492 (639)
                      +..++||||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++   .+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             CceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence            568999999999999999864     345899999999999999999999987   99999999999997544   5999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      +|||+++....    ........||+.|+|||++.+   ..++.++|||||||++|||++|+.||......       ..
T Consensus       284 ~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~  352 (419)
T 3i6u_A          284 TDFGHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VS  352 (419)
T ss_dssp             CCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-------CC
T ss_pred             eecccceecCC----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-------HH
Confidence            99999987642    223345689999999999853   66788999999999999999999999643221       01


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +...    +......         ..+..    ....+..+.+++.+||+.||++|||++|+++
T Consensus       353 ~~~~----i~~~~~~---------~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 LKDQ----ITSGKYN---------FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHH----HHTTCCC---------CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHH----HhcCCCC---------CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111    1110000         00000    1123456899999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-39  Score=346.46  Aligned_cols=269  Identities=21%  Similarity=0.265  Sum_probs=197.0

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeec----------
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAAT----------  414 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----------  414 (639)
                      ....++|...+.||+|+||.||++...  ++.||||++..+. ....+|++++++++||||+++++++..          
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            345678999999999999999999874  6899999886542 223479999999999999999998843          


Q ss_pred             ----------------------------CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 036507          415 ----------------------------EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE  466 (639)
Q Consensus       415 ----------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~  466 (639)
                                                  ....++||||++ |+|.+.+.... .....+++..+..++.|++.||+|||+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             ----------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                        234889999997 58777765311 123468999999999999999999999


Q ss_pred             cCCCCeeeCCCCCCcEEEC-CCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHH
Q 036507          467 HTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVL  544 (639)
Q Consensus       467 ~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl  544 (639)
                      ++   |+||||||+|||++ .++.+||+|||+++.+....    ......||+.|+|||.+.+. .++.++|||||||++
T Consensus       160 ~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          160 LG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             Cc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            87   99999999999998 68899999999998764322    22345789999999998764 489999999999999


Q ss_pred             HHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc--------ccccccccccCCcccCCCChhHHHHHHHHHHH
Q 036507          545 FEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS--------MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQ  616 (639)
Q Consensus       545 ~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~  616 (639)
                      |||++|+.||.....        ......+...+......        .............+....+...+..+.+|+.+
T Consensus       233 ~ell~g~~pf~~~~~--------~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  304 (383)
T 3eb0_A          233 GELILGKPLFSGETS--------IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ  304 (383)
T ss_dssp             HHHHHSSCSSCCSSH--------HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred             HHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence            999999999965332        11111122222211100        00001111111112222344456679999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 036507          617 CVDEDPILRPDMKQVVI  633 (639)
Q Consensus       617 cl~~dP~~RPs~~evl~  633 (639)
                      ||+.||++|||+.|+++
T Consensus       305 ~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HCCSSGGGSCCHHHHHT
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999974

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-38  Score=347.20  Aligned_cols=260  Identities=21%  Similarity=0.278  Sum_probs=203.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-cHHHHHHHHHHHHhcCC-CCeeEEEeeeecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-KTKEFMAEMKILCKVHH-SNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .++|...++||+|+||.||++.+.  ++.||||++... ...++.+|+++++.++| +++..+..++...+..++||||+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            367889999999999999999975  689999987643 33468899999999987 56666666777788899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---CCCCCEEEeccCCceecC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  502 (639)
                       +++|.+++...    ...+++..++.|+.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        86 -g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           86 -GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             -CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             -CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence             99999999632    345899999999999999999999987   9999999999999   688999999999998775


Q ss_pred             CCCCCc----ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          503 KTSDGE----ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       503 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ......    .......||+.|+|||.+.+..++.++|||||||+||||++|+.||........    ...+.......+
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~i~~~~~  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYEKISEKKV  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH----HHHHHHHHHHHH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH----HHHHHHHhhccc
Confidence            433211    112256899999999999999999999999999999999999999965433110    011111111111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...        +.     .+    ...++.++.+++..||+.||++||++++|++.|+++
T Consensus       234 ~~~--------~~-----~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          234 ATS--------IE-----AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HSC--------HH-----HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccc--------HH-----HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            100        00     00    112345799999999999999999999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2e-38  Score=342.33  Aligned_cols=195  Identities=21%  Similarity=0.329  Sum_probs=169.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhc------CCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKV------HHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l------~h~niv~l~~~~~~~~~~~  419 (639)
                      ..+|+..++||+|+||.||+|...  ++.||||+++...  ..++.+|++++..+      +|+||+++++++...+..+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            356888999999999999999885  5789999997653  35677899988887      5779999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC--EEEeccCC
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR--AKISDFGL  497 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgl  497 (639)
                      +||||+. ++|.+++...   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.  +||+|||+
T Consensus       176 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999995 6999988652   2345899999999999999999999987   999999999999999987  99999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccc
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRT  557 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~  557 (639)
                      +.....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       249 a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYEHQ------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEETTC------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecCC------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            976532      123357899999999999999999999999999999999999998543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-38  Score=322.28  Aligned_cols=241  Identities=23%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++...  +..||+|.+...      ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56777889999999999999986  468999998543      2456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++....
T Consensus        94 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           94 EFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999864     235889999999999999999999987   9999999999999999999999999997653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..     ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....        .   .......... 
T Consensus       166 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~---~~~~~~~~~~-  228 (284)
T 2vgo_A          166 SL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------T---ETHRRIVNVD-  228 (284)
T ss_dssp             SS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------H---HHHHHHHTTC-
T ss_pred             cc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------h---HHHHHHhccc-
Confidence            21     12335789999999999999999999999999999999999999854321        0   0111111111 


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                   ..    .+...+..+.+++.+||+.||++||+++|+++
T Consensus       229 -------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 -------------LK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -------------CC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------------cC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                         00    12233456899999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.1e-39  Score=330.72  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             CCCCC-CCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSD-SSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~-~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      +.|.. .+.||+|+||.||++...  ++.||||.+...   ..+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45665 368999999999999864  678999998643   356789999999985 79999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC---EEEeccCCcee
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDFGLAKL  500 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~  500 (639)
                      |+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||++..
T Consensus        92 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           92 KMRGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             CCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             cCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999964     235889999999999999999999987   999999999999998776   99999999976


Q ss_pred             cCCCCCC----cceeeeeccccccCCcccccc-----CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh---h
Q 036507          501 VGKTSDG----EATVTKVVGTFGYLAPEYLTD-----GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER---R  568 (639)
Q Consensus       501 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~---~  568 (639)
                      .......    ........||+.|+|||.+.+     ..++.++|||||||++|||++|+.||.............   .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            5322111    112233569999999999875     568899999999999999999999996543211000000   0


Q ss_pred             h-HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          569 S-LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       569 ~-l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      . ..............         ..+ ..    ....+..+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~i~~~~~~---------~~~-~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYE---------FPD-KD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHCCCC---------CCH-HH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHhccCcc---------cCc-hh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0 00111111111100         000 00    0123456899999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1e-39  Score=331.50  Aligned_cols=254  Identities=20%  Similarity=0.342  Sum_probs=198.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeee--cCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAA--TEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~~lv  421 (639)
                      ++|+..+.||+|+||.||++...  ++.||+|.+...     ..+.+.+|++++++++||||+++++++.  ..+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            56778899999999999999885  578999998642     3456889999999999999999999874  35689999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT--KTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      |||+++++|.+++.... .....+++..++.++.|++.||+|||+++  ..+|+||||||+||+++.++.+||+|||++.
T Consensus        86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999986422 12345899999999999999999999975  1239999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....   ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ..+...   ...
T Consensus       165 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~---i~~  230 (279)
T 2w5a_A          165 ILNHD---TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGK---IRE  230 (279)
T ss_dssp             HC------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH---HHH
T ss_pred             eeccc---cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHH---Hhh
Confidence            65321   1122335789999999999998999999999999999999999999854321        111111   111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      ...             +    ..+...+.++.+++.+||+.||++|||++|+++.+.
T Consensus       231 ~~~-------------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          231 GKF-------------R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             TCC-------------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ccc-------------c----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            110             0    112334557999999999999999999999997653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.4e-39  Score=334.95  Aligned_cols=264  Identities=25%  Similarity=0.376  Sum_probs=196.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|+||.||++...  ++.||||.+....     .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            56788899999999999999986  6789999885432     3457799999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..+..
T Consensus       105 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          105 FVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             CCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999888653     235899999999999999999999987   99999999999999999999999999986533


Q ss_pred             CCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .   ........||+.|+|||.+.+. .++.++||||||+++|||++|+.||......       ..+ ..+........
T Consensus       177 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~-~~~~~~~~~~~  245 (331)
T 4aaa_A          177 P---GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-------DQL-YHIMMCLGNLI  245 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHH-HHHHHHHCSCC
T ss_pred             C---ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-------HHH-HHHHHHhCCCC
Confidence            2   1223345789999999998775 7899999999999999999999998543321       111 11111111100


Q ss_pred             Cccc-----ccccccccCCcccCC-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMS-----MSSLKDYIDPNMMDL-----YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~-----~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....     .........+.+...     .....+..+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000     000001111111111     11234567999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.1e-38  Score=342.55  Aligned_cols=275  Identities=23%  Similarity=0.337  Sum_probs=196.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----Ce
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE-----DE  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  417 (639)
                      .++|...+.||+|+||.||++...  ++.||||++...     ..+.+.+|+++|++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            367888999999999999999885  578999998642     246788999999999999999999998766     57


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .|+||||+. |+|.+++..     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence            899999995 699999964     345899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCC-------------------cceeeeeccccccCCcccc-ccCCCCCcchHHHHHHHHHHHHcCCcccccc
Q 036507          498 AKLVGKTSDG-------------------EATVTKVVGTFGYLAPEYL-TDGLATAKSDVYAFGVVLFEIISGKEAIIRT  557 (639)
Q Consensus       498 a~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVws~Gvvl~elltG~~p~~~~  557 (639)
                      ++........                   ....+..+||++|+|||++ ....++.++|||||||++|||++|..|+...
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            9876432211                   0123567899999999985 5667999999999999999999865554321


Q ss_pred             c----------cccc----------hhhhhhhHHHHHHHHhhcCCCccc----cccccccc---CCcccC---CCChhHH
Q 036507          558 E----------GMVS----------KNQERRSLASFMLAALRNSPDSMS----MSSLKDYI---DPNMMD---LYPHDCL  607 (639)
Q Consensus       558 ~----------~~~~----------~~~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~---d~~l~~---~~~~~~~  607 (639)
                      .          ...+          ...........+...++.++....    .......+   ......   .......
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence            1          0000          000111222223333333221100    00000000   000000   0002245


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          608 FKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       608 ~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+.+|+.+||+.||++|||++|+++
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            67899999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-38  Score=331.02  Aligned_cols=248  Identities=22%  Similarity=0.313  Sum_probs=196.5

Q ss_pred             CCCCCC-CceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDS-SLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|... +.||+|+||.||++...  ++.||+|.+...     ...++.+|+.++.++. ||||+++++++.+.+..++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            345544 78999999999999886  689999988643     3567899999999995 69999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCc
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLA  498 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla  498 (639)
                      |||+++|+|.+++..   .....+++..+..++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus       108 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            999999999999864   22356899999999999999999999987   999999999999998   789999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ...   .....
T Consensus       182 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~---~~~i~  246 (327)
T 3lm5_A          182 RKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QET---YLNIS  246 (327)
T ss_dssp             EEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHH
T ss_pred             cccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHH---HHHHH
Confidence            8764321    23346799999999999999999999999999999999999999954322        011   11111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....              .............+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~--------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          247 QVNV--------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HTCC--------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hccc--------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            1110              0001112234557899999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=334.26  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=197.0

Q ss_pred             chHHHHhhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc--cHHHHHHHHHHHHhc-CCCCeeEEEeeeec--
Q 036507          342 TYDEILFATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT--KTKEFMAEMKILCKV-HHSNLVELIGYAAT--  414 (639)
Q Consensus       342 ~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~E~~il~~l-~h~niv~l~~~~~~--  414 (639)
                      ++.++....++|+..+.||+|+||.||+|..  .++.||||.+...  ..+.+.+|+++++++ +||||+++++++..  
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3445555678899999999999999999998  4688999998643  456788999999999 79999999999876  


Q ss_pred             ----CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          415 ----EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       415 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                          .+..++||||+++|+|.+++...   ....+++.....++.|++.||.|||+++   |+|+||||+||+++.++.+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                46789999999999999999742   2346889999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ  565 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~  565 (639)
                      ||+|||++.......   .......||+.|+|||.+.     +..++.++||||||+++|||++|+.||.....      
T Consensus       169 kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------  239 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------  239 (326)
T ss_dssp             EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred             EEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------
Confidence            999999998653221   1223457899999999987     56789999999999999999999999854321      


Q ss_pred             hhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          566 ERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       566 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       .    ............             .+   .+...+..+.+++.+||+.||++||+++|+++
T Consensus       240 -~----~~~~~~~~~~~~-------------~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          240 -M----RALFLIPRNPAP-------------RL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -H----HHHHHHHHSCCC-------------CC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -H----HHHHHhhcCccc-------------cC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             0    011111111110             00   11223457899999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8e-38  Score=320.13  Aligned_cols=249  Identities=24%  Similarity=0.426  Sum_probs=196.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|....+||+|+||.||+|...  +..||||.+...   ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            44556678999999999999984  578999998653   2467889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-CCCEEEeccCCceecCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~  504 (639)
                      ++++|.+++...  .....+++..+..++.|++.||+|||+++   |+|+||||+||+++. ++.+||+|||++......
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          102 PGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             SEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999999998642  12345678889999999999999999987   999999999999987 899999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccCC--CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGL--ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                         ........||+.|+|||.+.+..  ++.++||||||+++|||++|+.||......      ....   .......  
T Consensus       177 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~---~~~~~~~--  242 (295)
T 2clq_A          177 ---NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAM---FKVGMFK--  242 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHH---HHHHHHC--
T ss_pred             ---CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHH---Hhhcccc--
Confidence               11223457899999999987654  789999999999999999999999543220      0000   0000111  


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 ..+.    .+...+.++.+++.+||+.||++||+++|+++
T Consensus       243 -----------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 -----------VHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -----------CCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -----------cccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                       0111    22334557899999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-38  Score=320.17  Aligned_cols=243  Identities=24%  Similarity=0.405  Sum_probs=192.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|...+.||+|+||.||++...  ++.||||.+...      ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467888899999999999999985  689999998643      245688999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++++|.+++..     ...+++.....++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||++...
T Consensus        90 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           90 MEYVSGGELFDYICK-----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence            999999999999864     235889999999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      ...    .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.....        ..+   .......
T Consensus       162 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~---~~~~~~~  226 (276)
T 2h6d_A          162 SDG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTL---FKKIRGG  226 (276)
T ss_dssp             CC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHC
T ss_pred             CCC----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHH---HHHhhcC
Confidence            322    12234578999999999988765 6899999999999999999999854221        111   1111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..                  ..+......+.+++.+||+.||++|||++|+++
T Consensus       227 ~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          227 VF------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CC------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            10                  012233456899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.7e-39  Score=326.50  Aligned_cols=242  Identities=25%  Similarity=0.343  Sum_probs=194.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  421 (639)
                      .++|+..+.||+|+||.||++...  ++.||+|.+...     ...++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            356788899999999999999985  689999998642     345688999999999 899999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---------------
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---------------  486 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---------------  486 (639)
                      |||+++++|.+++.... .....+++..+..++.|++.||+|||+++   |+||||||+||+++.               
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           90 NEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999996421 11245899999999999999999999987   999999999999984               


Q ss_pred             ----CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCcccccccccc
Q 036507          487 ----AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMV  561 (639)
Q Consensus       487 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~  561 (639)
                          ...+||+|||++.......       ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++.....  
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                4479999999998764321       23589999999999765 566899999999999999999876532110  


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                              .    .......             .+.    .+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 --------~----~~~~~~~-------------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 --------W----HEIRQGR-------------LPR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --------H----HHHHTTC-------------CCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------H----HHHHcCC-------------CCC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                    0    0111110             011    12334557999999999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=325.59  Aligned_cols=248  Identities=28%  Similarity=0.418  Sum_probs=198.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|+..+.||+|+||.||++...  ++.||+|.+... ..+++.+|++++++++||||+++++++...+..++||||++
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            467888999999999999999886  678999998754 35778999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +++|.+++..    ....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++....... 
T Consensus       108 ~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          108 AGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             TEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            9999999852    1345899999999999999999999987   9999999999999999999999999998764321 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       .    ..........+.   
T Consensus       180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~----~~~~~~~~~~~~---  243 (314)
T 3com_A          180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------M----RAIFMIPTNPPP---  243 (314)
T ss_dssp             --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------H----HHHHHHHHSCCC---
T ss_pred             --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------H----HHHHHHhcCCCc---
Confidence              122345789999999999999999999999999999999999999854321       0    001111111110   


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                .+  ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       244 ----------~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 ----------TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----------CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----------cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                      00  012334557899999999999999999999975

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.5e-38  Score=330.67  Aligned_cols=267  Identities=21%  Similarity=0.297  Sum_probs=199.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec--------C
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT--------E  415 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~--------~  415 (639)
                      ++|+..+.||+|+||.||++...  ++.||||++...     ....+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            56888899999999999999984  678999988543     23568899999999999999999999876        3


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      +..++||||+++ +|.+.+...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence            468999999964 777777542    245899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCC-CcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHH
Q 036507          496 GLAKLVGKTSD-GEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       496 gla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      |+++.+..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....        ......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~  240 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--------QHQLAL  240 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH
Confidence            99987643221 1222344678999999998876 5579999999999999999999999864332        122223


Q ss_pred             HHHHhhcCCCcccc----cccccccCCcccCCCC-hh------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          574 MLAALRNSPDSMSM----SSLKDYIDPNMMDLYP-HD------CLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       574 ~~~~~~~~~~~~~~----~~~~~~~d~~l~~~~~-~~------~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.......+.....    ....+.+......... .+      ....+.+|+.+||+.||++|||++|+++
T Consensus       241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            33333332221110    0000000000000000 00      1345889999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-38  Score=322.59  Aligned_cols=244  Identities=22%  Similarity=0.356  Sum_probs=192.6

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEE
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT----EDELFL  420 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~l  420 (639)
                      .|...+.||+|+||.||+|...  +..||+|.+...     ..+.+.+|++++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3566778999999999999885  467999988643     24568899999999999999999998764    456899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-CCCCEEEeccCCce
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAK  499 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~  499 (639)
                      ||||+++++|.+++..     ...+++..+..++.|++.||.|||+++ .+|+||||||+||+++ +++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999999964     245889999999999999999999875 3599999999999998 78999999999997


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ....     .......||+.|+|||.+. +.++.++||||||+++|||++|+.||.....          ..........
T Consensus       181 ~~~~-----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------~~~~~~~~~~  244 (290)
T 1t4h_A          181 LKRA-----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQIYRRVTS  244 (290)
T ss_dssp             GCCT-----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHHHHHHHTT
T ss_pred             cccc-----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc----------HHHHHHHHhc
Confidence            5422     1233457999999999886 4589999999999999999999999954322          1111111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...            ...    .+.....++.+++.+||+.||++|||++|+++
T Consensus       245 ~~~------------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          245 GVK------------PAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TCC------------CGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCC------------ccc----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            100            000    11222346899999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=335.48  Aligned_cols=259  Identities=21%  Similarity=0.322  Sum_probs=193.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED------  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  416 (639)
                      .++|...+.||+|+||.||+|...  ++.||||++...     ..+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467888999999999999999875  678999998532     2456889999999999999999999987653      


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      .+++||||+ +++|.+++..      ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence            469999999 8899999863      34889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      +++....      ..+...+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...+.        ......+.
T Consensus       174 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~  239 (367)
T 1cm8_A          174 LARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--------LDQLKEIM  239 (367)
T ss_dssp             TCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred             ccccccc------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            9987532      1234578999999999877 6789999999999999999999999964332        11112222


Q ss_pred             HHhhcCCCcccc-----------cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSM-----------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~-----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......+.....           ..+.......+.. ........+.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          240 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            222221110000           0000001111111 12234567999999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.1e-39  Score=337.99  Aligned_cols=195  Identities=26%  Similarity=0.420  Sum_probs=171.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .++|+..+.||+|+||.||++...  +..||+|.+...    ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357888999999999999999986  678999998643    24568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      |+++++|.+++..     ...+++.....++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||++....
T Consensus       112 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999964     23588999999999999999999985 6   9999999999999999999999999987542


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccc
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRT  557 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~  557 (639)
                      ..     ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       184 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          184 DS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             HH-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             cc-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            21     223457999999999999999999999999999999999999999643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.3e-39  Score=339.41  Aligned_cols=249  Identities=12%  Similarity=0.020  Sum_probs=176.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhc--CCCCeeEEE-------eeee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKV--HHSNLVELI-------GYAA  413 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l--~h~niv~l~-------~~~~  413 (639)
                      .+|...+.||+|+||.||++.+.  ++.||||++....      .+.+.+|+++++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            44777889999999999999975  5789999987632      34567775544444  699988855       3332


Q ss_pred             cC-----------------CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 036507          414 TE-----------------DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMR------VQIALDAARGLEYIHEHTKT  470 (639)
Q Consensus       414 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~al~~LH~~~~~  470 (639)
                      ..                 ...++||||++ |+|.+++....    ..+.+..+      ..++.|++.||+|||+++  
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            22                 34899999998 89999997421    22344445      778899999999999987  


Q ss_pred             CeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHH
Q 036507          471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEII  548 (639)
Q Consensus       471 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~ell  548 (639)
                       |+||||||+|||++.++.+||+|||+++....      ......+|+.|+|||++.+  ..++.++|||||||++|||+
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell  287 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW  287 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence             99999999999999999999999999986532      1224567799999999987  77999999999999999999


Q ss_pred             cCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          549 SGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       549 tG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                      +|+.||.........                    ..............+.......++..+.+++.+||+.||++|||+
T Consensus       288 tg~~Pf~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          288 CLFLPFGLVTPGIKG--------------------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             HSSCSTTBCCTTCTT--------------------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             hCCCCCCCcCccccc--------------------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            999999654321000                    000000000111111111123456679999999999999999999


Q ss_pred             HHHHH
Q 036507          629 KQVVI  633 (639)
Q Consensus       629 ~evl~  633 (639)
                      .|+++
T Consensus       348 ~e~l~  352 (371)
T 3q60_A          348 LEAME  352 (371)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.4e-38  Score=332.51  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=199.9

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----------HHHHHHHHHHHHhc-CCCCeeEEEeeee
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----------TKEFMAEMKILCKV-HHSNLVELIGYAA  413 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----------~~~~~~E~~il~~l-~h~niv~l~~~~~  413 (639)
                      ...++|...+.||+|+||.||++.+.  ++.||||++....           .+.+.+|++++.++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            34467888999999999999999985  6899999885432           34578899999999 7999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                      ..+..++||||+++++|.+++..     ...+++..+..++.|++.||.|||+++   |+|+||||+|||++.++.+||+
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999863     245899999999999999999999987   9999999999999999999999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCcccccc------CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~  567 (639)
                      |||++..+....    ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....        
T Consensus       243 DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------  310 (365)
T 2y7j_A          243 DFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--------  310 (365)
T ss_dssp             CCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred             ecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------
Confidence            999998764321    2344689999999999863      3578899999999999999999999954321        


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...   ..........         ...+.+     ...+..+.+++.+||+.||++|||++|+++
T Consensus       311 ~~~---~~~i~~~~~~---------~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          311 ILM---LRMIMEGQYQ---------FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH---HHHHHHTCCC---------CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHH---HHHHHhCCCC---------CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111   1111111100         000000     122446899999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.6e-40  Score=347.29  Aligned_cols=240  Identities=17%  Similarity=0.174  Sum_probs=186.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHH---HHHHhcCCCCeeEEE-------ee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEM---KILCKVHHSNLVELI-------GY  411 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~---~il~~l~h~niv~l~-------~~  411 (639)
                      .++|...+.||+|+||.||+|...  ++.||||.+...      ..+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            456778899999999999999864  689999998632      246788999   455666899999988       55


Q ss_pred             eecCC-----------------eEEEEEeeccCCChhhhccCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036507          412 AATED-----------------ELFLIYEYAQKGSLKSHLHDPQN--RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY  472 (639)
Q Consensus       412 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i  472 (639)
                      +.+.+                 ..+++|||+ +|+|.+++.....  .....+++..++.|+.|++.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 6899999974211  11234567888899999999999999987   9


Q ss_pred             eeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccC-----------CCCCcchHHHHH
Q 036507          473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-----------LATAKSDVYAFG  541 (639)
Q Consensus       473 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DVws~G  541 (639)
                      +||||||+|||++.++.+||+|||+++...      .......| +.|+|||++.+.           .++.++||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            999999999999999999999999998532      13345577 999999999887           899999999999


Q ss_pred             HHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccC
Q 036507          542 VVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED  621 (639)
Q Consensus       542 vvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d  621 (639)
                      |++|||++|+.||.......                           .......      ....++..+.+++.+||+.|
T Consensus       301 ~il~elltg~~Pf~~~~~~~---------------------------~~~~~~~------~~~~~~~~~~~li~~~L~~d  347 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALG---------------------------GSEWIFR------SCKNIPQPVRALLEGFLRYP  347 (377)
T ss_dssp             HHHHHHHHSSCCC------C---------------------------CSGGGGS------SCCCCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHCCCCCccccccc---------------------------chhhhhh------hccCCCHHHHHHHHHHcCCC
Confidence            99999999999985322100                           0000000      01223456899999999999


Q ss_pred             CCCCCCHHHHHH
Q 036507          622 PILRPDMKQVVI  633 (639)
Q Consensus       622 P~~RPs~~evl~  633 (639)
                      |++|||+.|+++
T Consensus       348 p~~Rpt~~e~l~  359 (377)
T 3byv_A          348 KEDRLLPLQAME  359 (377)
T ss_dssp             GGGCCCHHHHHT
T ss_pred             chhCCCHHHHhh
Confidence            999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.6e-39  Score=328.49  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=184.0

Q ss_pred             hhCCCCCCCceeecCceEEEEEEE--cCceEEEEEecccc----H-HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTATK----T-KEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~~----~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ..++|+..+.||+|+||.||++..  .++.||+|.+....    . +.+.++...++.++||||+++++++.+++..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            346788899999999999999998  46889999986532    1 2234455558888999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      |||++ |+|.+++.... .....+++..+..++.|++.||+|||++ +   |+||||||+||+++.++.+||+|||++..
T Consensus        85 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             Eehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99996 58877765311 1235689999999999999999999997 7   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCcccc----ccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYL----TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ....    .......||+.|+|||.+    .+..++.++||||||+++|||++|+.||......      .    .....
T Consensus       160 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~----~~~~~  225 (290)
T 3fme_A          160 LVDD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------F----QQLKQ  225 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------H----HHHHH
T ss_pred             cccc----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------H----HHHHH
Confidence            5332    122334799999999996    5667889999999999999999999999542210      0    11111


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .......                ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          226 VVEEPSP----------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHSCCC----------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HhccCCC----------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111110                0011233456899999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.1e-39  Score=342.75  Aligned_cols=276  Identities=24%  Similarity=0.359  Sum_probs=184.8

Q ss_pred             CCC-CCceeecCceEEEEEEEc----CceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeEEEeeee--cCCeEEEEEee
Q 036507          353 FSD-SSLLGHGTYGSVYYGNIR----NQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAA--TEDELFLIYEY  424 (639)
Q Consensus       353 f~~-~~~lG~G~~g~Vy~~~~~----~~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~~lv~e~  424 (639)
                      |.. .++||+|+||.||++...    +..||||.+.... ...+.+|+++|++++||||+++++++.  .....++||||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~  101 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY  101 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEEC
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeC
Confidence            443 558999999999999975    4689999997543 457889999999999999999999984  46789999999


Q ss_pred             ccCCChhhhccCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----CCCCCEEEeccC
Q 036507          425 AQKGSLKSHLHDPQ----NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL----DSAFRAKISDFG  496 (639)
Q Consensus       425 ~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg  496 (639)
                      +. |+|.+++....    ......+++..+..++.||+.||+|||+++   |+||||||+|||+    +.++.+||+|||
T Consensus       102 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A          102 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             CS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             CC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            96 58877765211    112235899999999999999999999987   9999999999999    778899999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccc-hhhhhhhHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS-KNQERRSLASFM  574 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~l~~~~  574 (639)
                      +++.+..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99876433222233445789999999999887 4589999999999999999999999965432110 001111222233


Q ss_pred             HHHhhcCCCcccccccccccC---------Cc-ccC--------CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYID---------PN-MMD--------LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d---------~~-l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+...+.. ....+....+         .. ...        .........+.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          258 FNVMGFPADK-DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHCCCCTT-TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhCCCChh-hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            3333332221 1111111100         00 000        000111346889999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=320.23  Aligned_cols=246  Identities=23%  Similarity=0.335  Sum_probs=194.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-------cHHHHHHHHHHHHhcCCCCeeEEEeeee--cCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-------KTKEFMAEMKILCKVHHSNLVELIGYAA--TEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-------~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~~  419 (639)
                      ++|...+.||+|+||.||++...  +..+|+|.++..       ..+.+.+|++++++++||||+++++++.  +.+..+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            67999999999999999999874  578999998643       2456889999999999999999999984  456789


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||++++ |.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus        85 lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            999999776 77776542   2346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCC--CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGL--ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ...... .........||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.....           .......
T Consensus       158 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~i  225 (305)
T 2wtk_C          158 ALHPFA-ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----------YKLFENI  225 (305)
T ss_dssp             ECCTTC-SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHH
T ss_pred             ccCccc-cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----------HHHHHHH
Confidence            764322 222334567999999999987643  37799999999999999999999854321           1111111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....                  ..+.++...+.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          226 GKGSY------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHCCC------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hcCCC------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11110                  012234557899999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.1e-39  Score=347.78  Aligned_cols=264  Identities=24%  Similarity=0.352  Sum_probs=191.2

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecC------CeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATE------DELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~~lv~e  423 (639)
                      +|+..+.||+|+||.||++.+.  ++.||||++.... ....+|+++|++++||||+++++++...      ..+++|||
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            5677889999999999999985  6889999986542 2234799999999999999999988532      23679999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~  502 (639)
                      |+++ +|.+.+.... .....+++..+..++.||++||+|||+++   |+||||||+|||++.+ +.+||+|||+++.+.
T Consensus       134 ~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          134 YVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             CCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             cccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            9975 6665553211 12356899999999999999999999987   9999999999999965 568999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...    ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......       ..+. .+...+...
T Consensus       209 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-------~~l~-~i~~~lg~p  276 (420)
T 1j1b_A          209 RGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-------DQLV-EIIKVLGTP  276 (420)
T ss_dssp             TTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH-HHHHHHCSC
T ss_pred             cCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHHHhCCC
Confidence            322    22345789999999998764 7899999999999999999999999653321       1111 111222111


Q ss_pred             CCcccc---cccccccCCc-----ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSM---SSLKDYIDPN-----MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~---~~~~~~~d~~-----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......   ....++..+.     +...++...+.++.+|+.+||+.||++||++.|+++
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            100000   0000111111     111122344567999999999999999999999974

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=335.44  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      .+.....++|...+.||+|+||.||+|...+ .+|+|.++..     ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            3444556889999999999999999998876 5899988643     234577899999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      +++|||+++++|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+||+++ ++.+||+|||++
T Consensus       105 ~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             EEEeecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence            9999999999999999642    345889999999999999999999987   99999999999998 679999999998


Q ss_pred             eecCCCCC--CcceeeeeccccccCCcccccc---------CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhh
Q 036507          499 KLVGKTSD--GEATVTKVVGTFGYLAPEYLTD---------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER  567 (639)
Q Consensus       499 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~  567 (639)
                      ........  .........||+.|+|||.+.+         ..++.++||||||+++|||++|+.||.....        
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------  248 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------  248 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence            76532111  1122233568999999999864         4578899999999999999999999854321        


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      .   ..........             .+...   +..++..+.+++.+||+.||++|||++++++.|+++
T Consensus       249 ~---~~~~~~~~~~-------------~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          249 E---AIIWQMGTGM-------------KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             H---HHHHHHHTTC-------------CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             H---HHHHHhccCC-------------CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            0   1111111111             01110   111233588999999999999999999999999876

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.2e-38  Score=357.50  Aligned_cols=244  Identities=24%  Similarity=0.371  Sum_probs=201.6

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELF  419 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  419 (639)
                      ..++|...+.||+|+||.||++...  ++.||||+++..      ..+.+..|.+++..+ +||||+.+++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4567888999999999999999986  467999998643      245678899999988 6999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       419 lV~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEeCcCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999999964     235899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....   ........||+.|+|||++.+..++.++|||||||+||||++|+.||...+.           .+....++.
T Consensus       491 ~~~~~---~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i~~  556 (674)
T 3pfq_A          491 ENIWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------DELFQSIME  556 (674)
T ss_dssp             ECCCT---TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHS
T ss_pred             ccccC---CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHh
Confidence            64322   2234457899999999999999999999999999999999999999954321           111222222


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCH-----HHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDM-----KQVV  632 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl  632 (639)
                      ...                  .++.....++.+|+.+||+.||++||++     +|++
T Consensus       557 ~~~------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          557 HNV------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             SCC------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             CCC------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence            111                  1233445679999999999999999998     6665

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-38  Score=333.70  Aligned_cols=273  Identities=23%  Similarity=0.267  Sum_probs=198.2

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEecccc--------------HHHHHHHHHHHHhcCCCCe
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK--------------TKEFMAEMKILCKVHHSNL  405 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~--------------~~~~~~E~~il~~l~h~ni  405 (639)
                      ....++....++|...+.||+|+||.||++... +..||||++....              .+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            455677888899999999999999999999765 5789999885321              2678999999999999999


Q ss_pred             eEEEeeeec-----CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 036507          406 VELIGYAAT-----EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSS  480 (639)
Q Consensus       406 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~  480 (639)
                      +++++++..     ....++||||++ |+|.+++..    ....+++..+..++.|++.||.|||+++   |+||||||+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~  163 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPG  163 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChH
Confidence            999999843     346899999997 688888864    2346899999999999999999999987   999999999


Q ss_pred             cEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCcccccccc
Q 036507          481 NILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEG  559 (639)
Q Consensus       481 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~  559 (639)
                      |||++.++.+||+|||++......    .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HEEEcCCCCEEEEecCcccccccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999754321    22344678999999999876 6789999999999999999999999964331


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcc----cccccccccCCcccC-------CCChhHHHHHHHHHHHhcccCCCCCCCH
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSM----SMSSLKDYIDPNMMD-------LYPHDCLFKMAMLAKQCVDEDPILRPDM  628 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~  628 (639)
                              ......+...........    ......+.+...+..       .........+.+++.+||+.||++|||+
T Consensus       240 --------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  311 (362)
T 3pg1_A          240 --------YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST  311 (362)
T ss_dssp             --------HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             --------HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence                    111111111111110000    000000111110000       0112335568999999999999999999


Q ss_pred             HHHHH
Q 036507          629 KQVVI  633 (639)
Q Consensus       629 ~evl~  633 (639)
                      +|+++
T Consensus       312 ~ell~  316 (362)
T 3pg1_A          312 EQALR  316 (362)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            99985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-38  Score=334.25  Aligned_cols=266  Identities=24%  Similarity=0.349  Sum_probs=199.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----CeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATE-----DEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  418 (639)
                      .++|+..+.||+|+||.||++...  +..||||.+...    ..+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            467888999999999999999875  578999998643    235688999999999999999999998654     368


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+. |+|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       106 ~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence            99999996 699998863      34899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      .................||+.|+|||++.+ ..++.++|||||||++|||++|+.||......        .....+...
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~  247 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--------DQLNHILGI  247 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--------GHHHHHHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHHH
Confidence            876543322222345689999999998654 55899999999999999999999999654321        111222222


Q ss_pred             hhcCCCccccc-------c-cccccCCccc--CCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMSMS-------S-LKDYIDPNMM--DLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~-------~-~~~~~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +...+......       . ......+...  .........++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            22211100000       0 0000000000  0011223456899999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-38  Score=323.33  Aligned_cols=245  Identities=21%  Similarity=0.353  Sum_probs=198.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.+...   ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            56778899999999999999985  688999998654   2356889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---CCCCCEEEeccCCceecC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  502 (639)
                      ++++|.+++..     ...+++.....++.|++.||.|||+++   |+||||||+||++   ++++.+||+|||++....
T Consensus        89 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           89 SGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999854     235889999999999999999999987   9999999999999   788999999999987542


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ..+.   ........
T Consensus       161 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~---~~i~~~~~  224 (304)
T 2jam_A          161 NG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLF---EKIKEGYY  224 (304)
T ss_dssp             CB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH---HHHHHCCC
T ss_pred             CC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHH---HHHHcCCC
Confidence            21     22335789999999999999999999999999999999999999854321        1111   11111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .          +.    .......+..+.+++.+||+.||++|||++|+++
T Consensus       225 ~----------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 E----------FE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             C----------CC----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             C----------CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0          00    0112234557999999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8e-39  Score=362.29  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecC
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATE  415 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~  415 (639)
                      +.....++|...+.||+|+||.||+|.+..     ..||||.+....    .+.+.+|+.++++++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            334455778889999999999999998742     469999986432    366889999999999999999999985 5


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      +..++||||+++|+|.+++...    ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence            6789999999999999999642    235899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |+++......  ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....        .....  
T Consensus       536 G~a~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~--  603 (656)
T 2j0j_A          536 GLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIG--  603 (656)
T ss_dssp             CCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHH--
T ss_pred             CCCeecCCCc--ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHH--
Confidence            9998764321  122233567889999999999999999999999999999997 8989854321        11111  


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                       .......                 ...+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       604 -~i~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          604 -RIENGER-----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -HHHHTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHcCCC-----------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             1111110                 012334556799999999999999999999999999886

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-39  Score=328.77  Aligned_cols=264  Identities=24%  Similarity=0.427  Sum_probs=187.0

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEE--cCceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ...++|...+.||+|+||.||++..  .++.||||.+...    ..+++.+|++++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3457888899999999999999976  4688999988643    245678999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          422 YEYAQKGSLKSHLHDP---QNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      |||+++++|.+++...   .......+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999998631   1112356899999999999999999999987   999999999999999999999999998


Q ss_pred             eecCCCCC--CcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          499 KLVGKTSD--GEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       499 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ........  .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......       ..    ..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~----~~  237 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------KV----LM  237 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------GH----HH
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-------hH----HH
Confidence            76543221  1112234579999999999876 56899999999999999999999999653321       01    11


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......+....    ....++..    ....+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          238 LTLQNDPPSLE----TGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHTSSCCCTT----C-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhccCCCccc----cccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11222111110    01111111    1223456899999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.5e-38  Score=325.19  Aligned_cols=267  Identities=23%  Similarity=0.332  Sum_probs=201.1

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc---CceEEEEEecccc-----HHHHHHHHHHHHhc---CCCCeeEEEeeee---
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTATK-----TKEFMAEMKILCKV---HHSNLVELIGYAA---  413 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~-----~~~~~~E~~il~~l---~h~niv~l~~~~~---  413 (639)
                      ...++|+..+.||+|+||.||++...   ++.||+|.+....     ...+.+|+++++++   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34578999999999999999999883   5789999886432     23566788887776   8999999999987   


Q ss_pred             --cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEE
Q 036507          414 --TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAK  491 (639)
Q Consensus       414 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  491 (639)
                        .....++||||++ |+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEE
Confidence              5567899999997 6999998652   2345899999999999999999999987   99999999999999999999


Q ss_pred             EeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHH
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      |+|||++......    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ....
T Consensus       161 l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~  228 (326)
T 1blx_A          161 LADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------VDQL  228 (326)
T ss_dssp             ECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH
T ss_pred             EecCcccccccCC----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHH
Confidence            9999999865321    123346789999999999999999999999999999999999999964332        1112


Q ss_pred             HHHHHHhhcCCCcccccc---ccccc---CCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          572 SFMLAALRNSPDSMSMSS---LKDYI---DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~---~~~~~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+...+...+.......   ....+   ..........+.+..+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            222222222111000000   00000   000011122345667899999999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.4e-38  Score=343.27  Aligned_cols=245  Identities=26%  Similarity=0.403  Sum_probs=197.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecc-----ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTA-----TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~-----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|...++||+|+||+||++...  ++.||||.+..     .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            56888899999999999999985  67899999853     245678999999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC---CCCCEEEeccCCcee
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD---SAFRAKISDFGLAKL  500 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~  500 (639)
                      |+++|+|.+++..     ...+++.....++.|++.||.|||+++   |+||||||+|||++   .++.+||+|||+++.
T Consensus       102 ~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          102 LYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999998854     245899999999999999999999987   99999999999995   456799999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      +...    .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....        ..+   .......
T Consensus       174 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~---~~~i~~~  237 (486)
T 3mwu_A          174 FQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDI---LKRVETG  237 (486)
T ss_dssp             BCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHT
T ss_pred             CCCC----CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHhC
Confidence            5322    22344679999999999875 589999999999999999999999954321        111   1111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...         .-.+.     ....+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~---------~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          238 KYA---------FDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CCC---------SCSGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCC---------CCCcc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            100         00011     1233456899999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-37  Score=332.89  Aligned_cols=269  Identities=19%  Similarity=0.261  Sum_probs=202.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcC--------CCCeeEEEeeee----
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVH--------HSNLVELIGYAA----  413 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~--------h~niv~l~~~~~----  413 (639)
                      .++|...++||+|+||.||++...  ++.||||.++...  .+.+.+|++++++++        |+||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            367888999999999999999875  5789999997543  466889999999985        788999999987    


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEECCCC----
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLDSAF----  488 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~~~~----  488 (639)
                      +....++||||+ +++|.+++..   .....+++..+..++.||+.||+|||++ +   |+||||||+|||++.++    
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence            566899999999 6677666643   2234589999999999999999999997 6   99999999999999775    


Q ss_pred             ---------------------------------------------CEEEeccCCceecCCCCCCcceeeeeccccccCCc
Q 036507          489 ---------------------------------------------RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP  523 (639)
Q Consensus       489 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aP  523 (639)
                                                                   .+||+|||++......      .....||+.|+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aP  262 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCC
Confidence                                                         7999999999876432      2335789999999


Q ss_pred             cccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc------------ccccc
Q 036507          524 EYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS------------MSSLK  591 (639)
Q Consensus       524 E~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------------~~~~~  591 (639)
                      |++.+..++.++|||||||++|||++|+.||.........  ........+...+...+....            .....
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT--RDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC--HHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC--chHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            9999999999999999999999999999999654331111  111122223333332221100            00000


Q ss_pred             cccCCc---------ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          592 DYIDPN---------MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       592 ~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+..         -....+......+.+|+.+||+.||++|||++|+++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000         001235667788999999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-37  Score=342.89  Aligned_cols=246  Identities=25%  Similarity=0.375  Sum_probs=196.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----------------cHHHHHHHHHHHHhcCCCCeeEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----------------KTKEFMAEMKILCKVHHSNLVELIGY  411 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----------------~~~~~~~E~~il~~l~h~niv~l~~~  411 (639)
                      .++|...++||+|+||+||++...  +..||+|.+...                ..+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467888999999999999999985  478999998642                23568899999999999999999999


Q ss_pred             eecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC---
Q 036507          412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF---  488 (639)
Q Consensus       412 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~---  488 (639)
                      +.+.+..++||||+++|+|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++   
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999998854     245899999999999999999999987   99999999999998776   


Q ss_pred             CEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          489 RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       489 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      .+||+|||++..+...    .......||+.|+|||++. +.++.++|||||||++|+|++|+.||.....        .
T Consensus       187 ~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~  253 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--------Q  253 (504)
T ss_dssp             SEEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred             cEEEEECCCCEEcCCC----CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence            6999999999876432    2234467999999999987 4689999999999999999999999964322        1


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+   ...+......          ++...    ....+.++.+++.+||+.||++|||++|+++
T Consensus       254 ~~---~~~i~~~~~~----------~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          254 DI---IKKVEKGKYY----------FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HH---HHHHHHCCCC----------CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH---HHHHHcCCCC----------CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11   1111111100          00000    0123456899999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.3e-38  Score=331.65  Aligned_cols=260  Identities=21%  Similarity=0.285  Sum_probs=189.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED------  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  416 (639)
                      .++|...+.||+|+||.||++...  ++.||||++...     ..+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367888999999999999999875  678999998642     2456889999999999999999999987654      


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++||||++ ++|.+++..       .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence            7899999996 578888752       3788999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +++.....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..        .....+..
T Consensus       173 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~  240 (371)
T 2xrw_A          173 LARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--------DQWNKVIE  240 (371)
T ss_dssp             C--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHC
T ss_pred             cccccccc----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHH
Confidence            99865321    2234468999999999999999999999999999999999999999653321        01111110


Q ss_pred             -------------------HhhcCCCcccccccccccCCcccC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 -------------------ALRNSPDSMSMSSLKDYIDPNMMD---LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 -------------------~~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                         .....+. .........+......   ..+......+.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          241 QLGTPCPEFMKKLQPTVRTYVENRPK-YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHSSCC-CCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhCCCCHHHHHHhhhHHHHHHhhCcc-ccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                               1111110 0000001111000000   011233677999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2e-37  Score=323.26  Aligned_cols=263  Identities=19%  Similarity=0.276  Sum_probs=201.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEE---cCceEEEEEecccc--HHHHHHHHHHHHhcCCC------CeeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNI---RNQEVAIKRMTATK--TKEFMAEMKILCKVHHS------NLVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~---~~~~vavK~~~~~~--~~~~~~E~~il~~l~h~------niv~l~~~~~~~~~~  418 (639)
                      .++|+..+.||+|+||.||++..   .++.||||.++...  .+.+.+|++++++++|+      +++++++++...+..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            35788899999999999999987   35789999987543  46688999999998765      499999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC------------
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS------------  486 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~------------  486 (639)
                      ++||||+ +++|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.            
T Consensus        93 ~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999 89999998652   2346889999999999999999999987   999999999999987            


Q ss_pred             -------CCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccccc
Q 036507          487 -------AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG  559 (639)
Q Consensus       487 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~  559 (639)
                             ++.+||+|||++......      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                   668999999999865321      2235789999999999999999999999999999999999999954332


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcccccc----------------------cccccCCcc-cCCCChhHHHHHHHHHHH
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSMSMSS----------------------LKDYIDPNM-MDLYPHDCLFKMAMLAKQ  616 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----------------------~~~~~d~~l-~~~~~~~~~~~l~~li~~  616 (639)
                              ......+.......+.......                      ......+.. ....+......+.+++.+
T Consensus       240 --------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          240 --------KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             --------HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             --------HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence                    1111222222222211100000                      000000000 011234567789999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 036507          617 CVDEDPILRPDMKQVVI  633 (639)
Q Consensus       617 cl~~dP~~RPs~~evl~  633 (639)
                      ||+.||++|||++|+++
T Consensus       312 ~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          312 MLEYDPAKRITLREALK  328 (339)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HhCcCcccccCHHHHhc
Confidence            99999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.3e-38  Score=345.49  Aligned_cols=245  Identities=23%  Similarity=0.400  Sum_probs=199.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecc------ccHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTA------TKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|...+.||+|+||.||++...  ++.||||.+..      ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56788899999999999999885  67899999853      23567899999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---CCCCCEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL---DSAFRAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~  499 (639)
                      ||+.+|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++.
T Consensus       106 e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          106 EVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             CCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999864     245899999999999999999999987   9999999999999   567899999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .+...    .......||+.|+|||++.+ .++.++|||||||++|||++|+.||.....        ..+   ...+..
T Consensus       178 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~---~~~i~~  241 (484)
T 3nyv_A          178 HFEAS----KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDI---LKKVEK  241 (484)
T ss_dssp             HBCCC----CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHH
T ss_pred             Ecccc----cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHH---HHHHHc
Confidence            66432    12334579999999999876 689999999999999999999999954322        111   111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....         .-.+.     ....+..+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~---------~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 GKYT---------FELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCC---------CCSGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC---------CCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1100         00011     1234557899999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-38  Score=327.45  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=192.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc-----------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK-----------TKEFMAEMKILCKVHHSNLVELIGYAATEDE  417 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~-----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  417 (639)
                      ++|...+.||+|+||.||++...  ++.||||.+....           ...+.+|++++++++||||+++++++..++ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            56888899999999999999885  5789999986432           234789999999999999999999987654 


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC---EEEec
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISD  494 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  494 (639)
                      .++||||+++++|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++.   +||+|
T Consensus        89 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            8999999999999999864     345899999999999999999999987   999999999999987665   99999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHH
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      ||++.....    ........||+.|+|||++.   ...++.++||||||+++|||++|+.||......       ..+.
T Consensus       161 fg~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~  229 (322)
T 2ycf_A          161 FGHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLK  229 (322)
T ss_dssp             CTTCEECCC----CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-------SCHH
T ss_pred             Cccceeccc----ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-------HHHH
Confidence            999987632    12223457899999999974   567889999999999999999999999543321       1111


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+.   .....          ..+..    ....+..+.+++.+||+.||++||+++|+++
T Consensus       230 ~~~~---~~~~~----------~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          230 DQIT---SGKYN----------FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHH---HTCCC----------CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHH---hCccc----------cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1111   11000          00111    1123456899999999999999999999984

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.2e-38  Score=320.63  Aligned_cols=247  Identities=24%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------------HHHHHHHHHHHHhcC-CCCeeEEEeeeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------------TKEFMAEMKILCKVH-HSNLVELIGYAAT  414 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------------~~~~~~E~~il~~l~-h~niv~l~~~~~~  414 (639)
                      .++|...+.||+|+||.||++...  ++.||||.+....            .+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            367888899999999999999985  5789999985321            345789999999996 9999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEec
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD  494 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  494 (639)
                      .+..++||||+++++|.+++..     ...+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.+||+|
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999964     245899999999999999999999987   99999999999999999999999


Q ss_pred             cCCceecCCCCCCcceeeeeccccccCCccccc------cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          495 FGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT------DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       495 fgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      ||++..+....    ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.....        .
T Consensus       168 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~  235 (298)
T 1phk_A          168 FGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------M  235 (298)
T ss_dssp             CTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred             ccchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------H
Confidence            99998764321    233457899999999885      45678999999999999999999999854321        1


Q ss_pred             hHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..   ..........         ...+     .....+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~---~~~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          236 LM---LRMIMSGNYQ---------FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HH---HHHHHHTCCC---------CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HH---HHHHhcCCcc---------cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11   1111111100         0001     11234557999999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.3e-38  Score=343.95  Aligned_cols=245  Identities=26%  Similarity=0.408  Sum_probs=194.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|...+.||+|+||.||++...  +..+|+|.+...     ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888899999999999999985  578999998643     34678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC---CCEEEeccCCcee
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKL  500 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~  500 (639)
                      |+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++..   +.+||+|||++..
T Consensus       117 ~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          117 CYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999998854     245889999999999999999999987   9999999999999764   4599999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      +...    .......||+.|+|||++. ..++.++|||||||++|||++|+.||.....        ..+   .......
T Consensus       189 ~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~---~~~i~~~  252 (494)
T 3lij_A          189 FENQ----KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEI---LRKVEKG  252 (494)
T ss_dssp             CBTT----BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHT
T ss_pred             CCCC----ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHhC
Confidence            6432    2234467999999999986 5689999999999999999999999954322        111   1111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...         ...+.+     ...+..+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~---------~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          253 KYT---------FDSPEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCC---------CCSGGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC---------CCchhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            100         001111     123456899999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.4e-38  Score=324.16  Aligned_cols=248  Identities=22%  Similarity=0.389  Sum_probs=195.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .++|+..+.||+|+||.||++...  +..+|+|.+...   ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467888899999999999999986  578999988643   357789999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++++|.+++...    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           98 CPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999988631    245899999999999999999999987   999999999999999999999999987533111


Q ss_pred             CCCcceeeeeccccccCCcccc-----ccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          505 SDGEATVTKVVGTFGYLAPEYL-----TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                         ........||+.|+|||.+     .+..++.++||||||+++|||++|+.||.....           .........
T Consensus       171 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~  236 (302)
T 2j7t_A          171 ---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAK  236 (302)
T ss_dssp             ---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHH
T ss_pred             ---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHHHHHHhc
Confidence               1112235789999999998     367789999999999999999999999854321           111111222


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+..               ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          237 SDPPT---------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SCCCC---------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCCcc---------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11110               0112334567899999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.7e-38  Score=326.48  Aligned_cols=254  Identities=23%  Similarity=0.369  Sum_probs=177.3

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHH-HHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMK-ILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ..++|...+.||+|+||.||++...  ++.||||.+....    ..++.+|+. +++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3467888999999999999999986  6889999986532    334556666 67788999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      |||+++ +|.+++..........+++..+..++.|++.||.|||++ +   |+||||||+||+++.++.+||+|||++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999974 887776531112245689999999999999999999998 7   99999999999999999999999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCcccc----ccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYL----TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ....    .......||+.|+|||.+    .+..++.++||||||+++|||++|+.||.......          .    
T Consensus       176 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------~----  237 (327)
T 3aln_A          176 LVDS----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----------D----  237 (327)
T ss_dssp             ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------
T ss_pred             cccc----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----------H----
Confidence            5322    122334799999999998    45678999999999999999999999985422100          0    


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+..         ......+.+...........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 QLTQ---------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             --CC---------CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHH---------HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000         00001111111112334567999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.8e-39  Score=341.38  Aligned_cols=265  Identities=22%  Similarity=0.320  Sum_probs=191.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeecCC------eEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAATED------ELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------~~~lv~e  423 (639)
                      .+|...++||+|+||.||++... +..+|+|++.... ....+|++++++++||||+++++++...+      ..++|||
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            46788899999999999999985 4569999875432 12237999999999999999999985433      3789999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-CCCCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~  502 (639)
                      |++++.+....+..  .....+++.....++.|++.||+|||+++   |+||||||+|||++ .++.+||+|||+++.+.
T Consensus       119 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          119 YVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             CCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            99765444332211  12346889999999999999999999987   99999999999999 78999999999998763


Q ss_pred             CCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...    ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....        ......+...+...
T Consensus       194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          194 AGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--------IDQLVEIIKVLGTP  261 (394)
T ss_dssp             TTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCCC
T ss_pred             CCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCC
Confidence            322    22345789999999998764 589999999999999999999999965332        11111122222211


Q ss_pred             CCccc--------ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMS--------MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~--------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....        ...........+....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            10000        00000001111111122335567999999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.8e-38  Score=332.98  Aligned_cols=259  Identities=23%  Similarity=0.342  Sum_probs=181.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC------C
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE------D  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  416 (639)
                      .++|...+.||+|+||.||+|...  ++.||||++...     ..+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478888999999999999999874  678999998542     245688999999999999999999998654      5


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ..++++|++ +++|.+++..      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred             eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence            679999999 7899998853      35899999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      +++....      ..+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.        ......+.
T Consensus       178 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~  243 (367)
T 2fst_X          178 LARHTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--------IDQLKLIL  243 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH
T ss_pred             ccccccc------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            9986432      2344689999999999877 6789999999999999999999999964332        11222222


Q ss_pred             HHhhcCCCccc----cccccccc-------CCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMS----MSSLKDYI-------DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~----~~~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..+...+....    ......++       ...+.. ........+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            22222111000    00000000       000000 01123456899999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-37  Score=327.05  Aligned_cols=265  Identities=23%  Similarity=0.348  Sum_probs=197.4

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecC-----CeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATE-----DEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  418 (639)
                      .++|...+.||+|+||.||++...  ++.||||.+....    ...+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            367888899999999999999986  6789999986432    35678999999999999999999987654     678


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+. ++|.+++..      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence            99999996 699998863      35899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcc-------eeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          499 KLVGKTSDGEA-------TVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       499 ~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      ..+........       ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....        ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~  231 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--------RHQ  231 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--------HHH
Confidence            87643221111       1223578999999998754 7789999999999999999999999964332        111


Q ss_pred             HHHHHHHhhcCCCccccc-----ccccc-------cCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          571 ASFMLAALRNSPDSMSMS-----SLKDY-------IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~-----~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...+..............     ...+.       ....+.. .....+.++.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            112222222211100000     00000       0000000 11234567899999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-37  Score=327.82  Aligned_cols=273  Identities=21%  Similarity=0.262  Sum_probs=188.3

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe--
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDE--  417 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~--  417 (639)
                      .+.....++|...+.||+|+||.||++...  +..||||++...  ......+|++.+..++||||+++++++...+.  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            345566789999999999999999999986  678999988543  23456788888999999999999999865333  


Q ss_pred             -----EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeCCCCCCcEEECC-CCC
Q 036507          418 -----LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH--EHTKTHYVHRDIKSSNILLDS-AFR  489 (639)
Q Consensus       418 -----~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~  489 (639)
                           .++||||+++ +|...+.... .....+++.....++.|++.||.|||  +++   |+||||||+|||++. ++.
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                 7899999976 5544432211 22446888999999999999999999  766   999999999999997 899


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      +||+|||++..+....    ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....        .
T Consensus       171 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--------~  238 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS--------A  238 (360)
T ss_dssp             EEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred             EEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh--------H
Confidence            9999999998764322    22345789999999998664 489999999999999999999999965332        1


Q ss_pred             hHHHHHHHHhhcCCCccc--------ccccccccC---CcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          569 SLASFMLAALRNSPDSMS--------MSSLKDYID---PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~--------~~~~~~~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....+...+...+....        .........   .......+.....++.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111112222211110000        000000000   00001122335678999999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.9e-38  Score=325.67  Aligned_cols=256  Identities=23%  Similarity=0.346  Sum_probs=194.7

Q ss_pred             cchHHHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc-----cHHHHHHHHHHHHhcC--CCCeeEEEeee
Q 036507          341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT-----KTKEFMAEMKILCKVH--HSNLVELIGYA  412 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~E~~il~~l~--h~niv~l~~~~  412 (639)
                      +.+..+....++|...+.||+|+||.||++... ++.||||.+...     ..+.+.+|++++.+++  |+||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            344445556678999999999999999999875 578999998543     2466889999999997  59999999999


Q ss_pred             ecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       413 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                      .+.+..+++|| +.+++|.+++..     ...+++..+..++.|++.||.|||+++   |+||||||+|||+++ +.+||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence            99999999999 558899999964     235889999999999999999999987   999999999999975 89999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCcccccc-----------CCCCCcchHHHHHHHHHHHHcCCcccccccccc
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-----------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV  561 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~  561 (639)
                      +|||++..+..... ........||+.|+|||.+.+           ..++.++||||||+++|||++|+.||...... 
T Consensus       168 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  245 (313)
T 3cek_A          168 IDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-  245 (313)
T ss_dssp             CCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-
T ss_pred             eeccccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-
Confidence            99999986643221 112234579999999999875           46788999999999999999999998543210 


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                               .......+.                +......+......+.+++.+||+.||++||+++|+++
T Consensus       246 ---------~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 ---------ISKLHAIID----------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ---------HHHHHHHHC----------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHHHHHHHh----------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                     011111111                11111122233457899999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=322.91  Aligned_cols=263  Identities=23%  Similarity=0.353  Sum_probs=189.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeee-----------
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAA-----------  413 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~-----------  413 (639)
                      .++|...+.||+|+||.||++...  ++.||+|.+....   .+++.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367888999999999999999986  6789999886443   456889999999999999999999873           


Q ss_pred             ---cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-CCCC
Q 036507          414 ---TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFR  489 (639)
Q Consensus       414 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-~~~~  489 (639)
                         +.+..++||||++ |+|.+++..      ..+++.....++.|++.||+|||+++   |+||||||+||+++ +++.
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence               3467899999997 699999853      35889999999999999999999987   99999999999997 5679


Q ss_pred             EEEeccCCceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh
Q 036507          490 AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR  568 (639)
Q Consensus       490 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~  568 (639)
                      +||+|||++.................+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......        
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------  231 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--------  231 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--------
Confidence            999999999876432222222334567999999998865 67899999999999999999999999643321        


Q ss_pred             hHHHHHHHHhhcCCCccc--cccccc---------ccCCcc-cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          569 SLASFMLAALRNSPDSMS--MSSLKD---------YIDPNM-MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       569 ~l~~~~~~~~~~~~~~~~--~~~~~~---------~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..   ........+....  ...+..         ...+.. ........+.++.+++.+||+.||++|||++|+++
T Consensus       232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          232 EQ---MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HH---HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HH---HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            01   1111111110000  000000         000000 00011234567999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-37  Score=336.95  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=185.9

Q ss_pred             CCCCCceeecCceEEEEE-EEcCceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeeccCCCh
Q 036507          353 FSDSSLLGHGTYGSVYYG-NIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~-~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      |...+.||+|+||+||.+ ...++.||||++..+..+.+.+|++++.++ +||||+++++++.+++..++||||+. |+|
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            344678999999999654 456789999999877777888999999986 89999999999999999999999995 699


Q ss_pred             hhhccCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-------------CCEEEecc
Q 036507          431 KSHLHDPQNRGQ--TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-------------FRAKISDF  495 (639)
Q Consensus       431 ~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl~Df  495 (639)
                      .+++........  ....+...+.++.||+.||+|||+++   |+||||||+|||++.+             +.+||+||
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            999976332111  11133345679999999999999987   9999999999999654             48999999


Q ss_pred             CCceecCCCCCC-cceeeeeccccccCCcccccc-------CCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhh
Q 036507          496 GLAKLVGKTSDG-EATVTKVVGTFGYLAPEYLTD-------GLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQE  566 (639)
Q Consensus       496 gla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~  566 (639)
                      |+++.+...... ........||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.....      .
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~  246 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------R  246 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT------H
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh------h
Confidence            999876432211 112334689999999999875       678999999999999999999 8999853221      0


Q ss_pred             hhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       567 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .       ...+.....           .+......+.....++.+++.+||+.||++|||+.|+++
T Consensus       247 ~-------~~i~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E-------SNIIRGIFS-----------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H-------HHHHHTCCC-----------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-------HHHhcCCCC-----------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            0       011111100           001111123456778999999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.8e-37  Score=315.88  Aligned_cols=249  Identities=27%  Similarity=0.439  Sum_probs=188.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeec------------
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAAT------------  414 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~------------  414 (639)
                      ++|+..+.||+|+||.||++...  ++.||||.+...  ..+.+.+|++++++++||||+++++++.+            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            56788899999999999999974  678999998653  34668899999999999999999998754            


Q ss_pred             -CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          415 -EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       415 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                       .+..++||||+++|+|.+++...    ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence             45689999999999999999642    245788889999999999999999987   9999999999999999999999


Q ss_pred             ccCCceecCCCCC-----------CcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCcccccccccc
Q 036507          494 DFGLAKLVGKTSD-----------GEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMV  561 (639)
Q Consensus       494 Dfgla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~  561 (639)
                      |||++........           .........||+.|+|||.+.+. .++.++||||||+++|||++   |+...    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----  231 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----  231 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence            9999986542211           01123345789999999999764 68999999999999999998   33211    


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                         .+....   ... +...             ...+....+...+..+.+++.+||+.||++|||++|+++
T Consensus       232 ---~~~~~~---~~~-~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 ---MERVNI---LKK-LRSV-------------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---HHHHHH---HHH-HHST-------------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---hhHHHH---HHh-cccc-------------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               011111   111 1111             011111233444567899999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=339.87  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=187.0

Q ss_pred             hhhCCCCCCCceeecCceEE-EEEEEcCceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEEEeec
Q 036507          348 FATEGFSDSSLLGHGTYGSV-YYGNIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~V-y~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ....+|...++||+|+||+| |++...++.||||++.......+.+|+++|+++ +||||+++++++.+.+..++||||+
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            34556888899999999985 566667899999999766555567899999999 7999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-----CCCEEEeccCCcee
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-----AFRAKISDFGLAKL  500 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~  500 (639)
                      . |+|.+++.....    .+.+.....++.||+.||+|||+++   |+||||||+|||++.     ...+||+|||+++.
T Consensus       101 ~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          101 A-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             S-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             C-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            5 699999975321    2333345688999999999999987   999999999999953     34688999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccc---cCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHH
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLT---DGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +..............||+.|+|||++.   ...++.++|||||||++|||++ |+.||.....      .   .   ...
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------~---~---~~~  240 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------R---Q---ANI  240 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------H---H---HHH
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------H---H---HHH
Confidence            643322223344568999999999997   4567889999999999999999 8888843221      0   0   001


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .......        ...      .........+.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~--------~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          241 LLGACSL--------DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HTTCCCC--------TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccCCc--------ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111000        000      012344566889999999999999999999984

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-37  Score=323.57  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=171.5

Q ss_pred             hCCCCCC-CceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEEEE
Q 036507          350 TEGFSDS-SLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAAT----EDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~  422 (639)
                      .++|... ++||+|+||.||++...  ++.||||++..... ...+....++.++||||+++++++..    +...++||
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  105 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM  105 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence            3566664 46999999999999986  68999999865422 22233344677789999999999876    45589999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~  499 (639)
                      ||+++|+|.+++...   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.   ++.+||+|||++.
T Consensus       106 e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          106 ECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             ECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             eccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            999999999999752   2346999999999999999999999987   999999999999986   4559999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....     ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......        ........+.
T Consensus       180 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~  246 (336)
T 3fhr_A          180 ETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA--------ISPGMKRRIR  246 (336)
T ss_dssp             EC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh--------hhhhHHHhhh
Confidence            65321     2234578999999999988889999999999999999999999995433210        0000000000


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..             ............+..+.+++.+||+.||++|||++|+++
T Consensus       247 ~~-------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          247 LG-------------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cc-------------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00             000000111234567899999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.2e-37  Score=325.39  Aligned_cols=199  Identities=24%  Similarity=0.324  Sum_probs=169.1

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcC-CC-----CeeEEEeeeecCCe
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVH-HS-----NLVELIGYAATEDE  417 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~-h~-----niv~l~~~~~~~~~  417 (639)
                      ...++|...+.||+|+||.||+|...  ++.||||+++...  ..++.+|++++..++ |+     +|+++++++...+.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            34578999999999999999999885  5789999997543  456778999998885 44     49999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC--CCCCEEEecc
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD--SAFRAKISDF  495 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Df  495 (639)
                      .++||||+. ++|.+++...   ....+++..+..++.|++.||.|||++. .+|+||||||+|||++  .++.+||+||
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             eEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            999999995 5999998752   2345899999999999999999999632 3599999999999994  4788999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccc
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRT  557 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~  557 (639)
                      |+++.....      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       206 G~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          206 GSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999876421      23457899999999999999999999999999999999999999643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-37  Score=328.97  Aligned_cols=258  Identities=23%  Similarity=0.310  Sum_probs=194.0

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE----
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL----  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~----  418 (639)
                      .++|...+.||+|+||.||++...  ++.||||.+...     ..+.+.+|++++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468888999999999999999875  678999998643     245688999999999999999999999876654    


Q ss_pred             --EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          419 --FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       419 --~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                        ++||||+. ++|.+++.       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence              99999996 68888874       23899999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      +++....      ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.        ......+.
T Consensus       190 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~  255 (371)
T 4exu_A          190 LARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQIL  255 (371)
T ss_dssp             CC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH
T ss_pred             ccccccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHH
Confidence            9986532      2234578999999999877 7889999999999999999999999964332        11111111


Q ss_pred             HHhhcCCCccc----cc-------ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMS----MS-------SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~----~~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......+....    ..       .+.......+. .........+.+|+.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            21111110000    00       00000000000 011234567999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-37  Score=322.93  Aligned_cols=263  Identities=21%  Similarity=0.291  Sum_probs=199.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--C-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCC------eeEEEeeeecCCeE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--N-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSN------LVELIGYAATEDEL  418 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~~  418 (639)
                      .++|...+.||+|+||.||++...  + ..||+|.++..  ..+.+.+|++++++++|++      ++.+.+++...+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            367888999999999999999875  3 58999999753  3456888999999997665      99999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE--------------
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILL--------------  484 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll--------------  484 (639)
                      ++||||+ +++|.+++..   .....+++..+..++.|++.||+|||+++   |+||||||+|||+              
T Consensus        98 ~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            9999999 6677777754   22346899999999999999999999987   9999999999999              


Q ss_pred             -----CCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccccc
Q 036507          485 -----DSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG  559 (639)
Q Consensus       485 -----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~  559 (639)
                           +.++.+||+|||+++.....      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                 56789999999999865322      2335799999999999999999999999999999999999999964332


Q ss_pred             ccchhhhhhhHHHHHHHHhhcCCCcccccc----------------------cccccCCcc-cCCCChhHHHHHHHHHHH
Q 036507          560 MVSKNQERRSLASFMLAALRNSPDSMSMSS----------------------LKDYIDPNM-MDLYPHDCLFKMAMLAKQ  616 (639)
Q Consensus       560 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~----------------------~~~~~d~~l-~~~~~~~~~~~l~~li~~  616 (639)
                              ......+.......+.......                      ..+...+.. ...........+.+|+.+
T Consensus       245 --------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  316 (355)
T 2eu9_A          245 --------REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR  316 (355)
T ss_dssp             --------HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             --------HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence                    1112222222222221100000                      000000000 001123446689999999


Q ss_pred             hcccCCCCCCCHHHHHH
Q 036507          617 CVDEDPILRPDMKQVVI  633 (639)
Q Consensus       617 cl~~dP~~RPs~~evl~  633 (639)
                      ||+.||++|||++|+++
T Consensus       317 ~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          317 MLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HTCSSTTTSCCHHHHTT
T ss_pred             HhcCChhhCcCHHHHhc
Confidence            99999999999999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.9e-37  Score=324.65  Aligned_cols=269  Identities=21%  Similarity=0.321  Sum_probs=200.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcC-----------CCCeeEEEeeeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVH-----------HSNLVELIGYAAT  414 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~-----------h~niv~l~~~~~~  414 (639)
                      .++|...+.||+|+||.||++...  ++.||||.+....  .+.+.+|++++++++           |+||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            367888999999999999999874  6789999997543  456788999999886           8999999999876


Q ss_pred             CC----eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEEC----
Q 036507          415 ED----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLD----  485 (639)
Q Consensus       415 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~----  485 (639)
                      .+    ..+++|||+ +++|.+++...   ....+++..+..++.||+.||+|||++ +   |+||||||+|||++    
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            54    789999999 89999998652   234589999999999999999999997 7   99999999999994    


Q ss_pred             --CCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccch
Q 036507          486 --SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK  563 (639)
Q Consensus       486 --~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~  563 (639)
                        ..+.+||+|||++......      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence              4458999999999876432      23357899999999999999999999999999999999999999654321100


Q ss_pred             hhhhhhHHHHHHHHhhcCCCcccc------------cccccccCCc---------ccCCCChhHHHHHHHHHHHhcccCC
Q 036507          564 NQERRSLASFMLAALRNSPDSMSM------------SSLKDYIDPN---------MMDLYPHDCLFKMAMLAKQCVDEDP  622 (639)
Q Consensus       564 ~~~~~~l~~~~~~~~~~~~~~~~~------------~~~~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP  622 (639)
                       . .......+...+...+.....            ..........         -....+.....++.+|+.+||+.||
T Consensus       245 -~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          245 -K-DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             -C-HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             -C-hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence             0 111112222223322211000            0000000000         0112456778899999999999999


Q ss_pred             CCCCCHHHHHH
Q 036507          623 ILRPDMKQVVI  633 (639)
Q Consensus       623 ~~RPs~~evl~  633 (639)
                      ++|||++|+++
T Consensus       323 ~~Rpt~~ell~  333 (373)
T 1q8y_A          323 RKRADAGGLVN  333 (373)
T ss_dssp             TTCBCHHHHHT
T ss_pred             cccCCHHHHhh
Confidence            99999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=320.19  Aligned_cols=258  Identities=22%  Similarity=0.307  Sum_probs=193.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe-----
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDE-----  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  417 (639)
                      .++|...+.||+|+||.||+|...  ++.||||.+...     ..+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888899999999999999875  679999998643     24568899999999999999999999877654     


Q ss_pred             -EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          418 -LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       418 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                       .++||||+. ++|.+++..       .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence             499999996 688888742       3889999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ++.....      ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.        ......+.
T Consensus       172 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~i~  237 (353)
T 3coi_A          172 LARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQIL  237 (353)
T ss_dssp             CTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--------HHHHHHHH
T ss_pred             cccCCCC------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            9975432      1234578999999999877 6789999999999999999999999965332        11111111


Q ss_pred             HHhhcCCCccc----c-------cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMS----M-------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~----~-------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......+....    .       ..+.....+.+.. ........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            21111110000    0       0000000111111 12344667999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.1e-37  Score=314.83  Aligned_cols=245  Identities=26%  Similarity=0.402  Sum_probs=196.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|...+.||+|+||.||++...  ++.||+|.+...     ..+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            57888999999999999999985  678999998542     35678999999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC---CCEEEeccCCcee
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA---FRAKISDFGLAKL  500 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~  500 (639)
                      |+++++|.+++..     ...+++..+..++.|++.||+|||+++   |+|+||||+||+++.+   +.+||+|||++..
T Consensus       102 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          102 LYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             ccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999988853     235899999999999999999999987   9999999999999764   4699999999986


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                      .....    ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....        ..+   .......
T Consensus       174 ~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~---~~~~~~~  237 (287)
T 2wei_A          174 FQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDI---LKRVETG  237 (287)
T ss_dssp             BCCCS----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHC
T ss_pred             ecCCC----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHH---HHHHHcC
Confidence            53321    2233468999999999875 489999999999999999999999854321        111   1111111


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...          .+...    ....+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~----------~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 KYA----------FDLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCC----------CCSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC----------CCchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            100          00000    1123456899999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=318.40  Aligned_cols=237  Identities=24%  Similarity=0.411  Sum_probs=188.4

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---------HHHHHHHHHHHHhc----CCCCeeEEEeeee
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---------TKEFMAEMKILCKV----HHSNLVELIGYAA  413 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---------~~~~~~E~~il~~l----~h~niv~l~~~~~  413 (639)
                      -.++|...+.||+|+||.||++...  ++.||||.+....         ...+.+|++++.++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3578999999999999999999874  5789999986542         12356799999998    8999999999999


Q ss_pred             cCCeEEEEEee-ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-CCCCEE
Q 036507          414 TEDELFLIYEY-AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAK  491 (639)
Q Consensus       414 ~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  491 (639)
                      ..+..++|+|+ +.+++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+||+++ +++.+|
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            99999999999 789999999964     235899999999999999999999987   99999999999999 889999


Q ss_pred             EeccCCceecCCCCCCcceeeeeccccccCCccccccCCCC-CcchHHHHHHHHHHHHcCCccccccccccchhhhhhhH
Q 036507          492 ISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT-AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSL  570 (639)
Q Consensus       492 l~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l  570 (639)
                      |+|||++......     ......||..|+|||++.+..+. .++||||||+++|||++|+.||.....           
T Consensus       181 l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------  244 (312)
T 2iwi_A          181 LIDFGSGALLHDE-----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------  244 (312)
T ss_dssp             ECCCSSCEECCSS-----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred             EEEcchhhhcccC-----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence            9999999876432     22345799999999998876664 589999999999999999999843210           


Q ss_pred             HHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          571 ASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                            ......                  ..+......+.+++.+||+.||++|||++|+++
T Consensus       245 ------~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ------ILEAEL------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ------HHHTCC------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------Hhhhcc------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  011100                  012233456899999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=313.13  Aligned_cols=247  Identities=21%  Similarity=0.338  Sum_probs=176.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----H-HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----T-KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      .++|+..+.||+|+||.||++...  ++.||||.+....    . +.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            456777889999999999999985  6899999986532    1 22344555688889999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      ||+ ++.+..+...    ....+++..+..++.|++.||.|||++ +   |+|+||||+||+++.++.+||+|||++...
T Consensus       104 e~~-~~~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             CCC-SEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             ecc-CCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999 5555554432    134589999999999999999999985 6   999999999999999999999999999765


Q ss_pred             CCCCCCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      ...    .......||+.|+|||.+.     ...++.++||||||+++|||++|+.||.....          .......
T Consensus       176 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~  241 (318)
T 2dyl_A          176 VDD----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----------DFEVLTK  241 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHHH
T ss_pred             cCC----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----------cHHHHHH
Confidence            332    1223457999999999984     56688999999999999999999999854221          1111222


Q ss_pred             HhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....+..             +..  ....+..+.+++.+||+.||.+||+++|+++
T Consensus       242 ~~~~~~~~-------------~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          242 VLQEEPPL-------------LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHSCCCC-------------CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HhccCCCC-------------CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            22222110             000  1123456899999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-37  Score=322.09  Aligned_cols=238  Identities=25%  Similarity=0.391  Sum_probs=195.7

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---------HHHHHHHHHHHHhcC--CCCeeEEEeeeec
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---------TKEFMAEMKILCKVH--HSNLVELIGYAAT  414 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---------~~~~~~E~~il~~l~--h~niv~l~~~~~~  414 (639)
                      ...++|...+.||+|+||.||+|...  ++.||||.+....         .+.+.+|++++++++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34577888999999999999999874  6789999986542         134668999999996  5999999999999


Q ss_pred             CCeEEEEEeeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-CCCCEEE
Q 036507          415 EDELFLIYEYAQK-GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKI  492 (639)
Q Consensus       415 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl  492 (639)
                      .+..++++|++.+ ++|.+++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++ +++.+||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             CCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence            9999999999976 899999864     245889999999999999999999987   99999999999999 7889999


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLA  571 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~  571 (639)
                      +|||++......     ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....            
T Consensus       192 ~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------  254 (320)
T 3a99_A          192 IDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------  254 (320)
T ss_dssp             CCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred             eeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------
Confidence            999999876432     2234579999999999987665 6789999999999999999999843210            


Q ss_pred             HHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                           ......          .        .+...+.++.+++.+||+.||++|||++|+++
T Consensus       255 -----~~~~~~----------~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 -----IIRGQV----------F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -----HHHCCC----------C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----hhcccc----------c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 011100          0        11223456899999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-36  Score=336.41  Aligned_cols=261  Identities=25%  Similarity=0.301  Sum_probs=194.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeec------CCeE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAAT------EDEL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~~  418 (639)
                      ++|+..+.||+|+||.||++...  ++.||||.++..    ..+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67899999999999999999874  678999988643    24568899999999999999999998765      6678


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCC---EEEecc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFR---AKISDF  495 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df  495 (639)
                      ++||||+++|+|.+++....  ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.   +||+||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            99999999999999997532  2335888889999999999999999987   999999999999997765   999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      |++.......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......          ..|..
T Consensus       169 G~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----------~~~~~  234 (676)
T 3qa8_A          169 GYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----------VQWHG  234 (676)
T ss_dssp             CCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----------HHSST
T ss_pred             cccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----------hhhhh
Confidence            9998764322    223468999999999999999999999999999999999999999543210          00000


Q ss_pred             HHhhcC-CCcccccccccc--cCC--cccCCCChhHHHHHHHHHHHhcccCCCCCCCHHH
Q 036507          576 AALRNS-PDSMSMSSLKDY--IDP--NMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQ  630 (639)
Q Consensus       576 ~~~~~~-~~~~~~~~~~~~--~d~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  630 (639)
                      ...... ............  +..  ..........+..+.+++.+||+.||++|||++|
T Consensus       235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            000000 000000000000  000  1112244567889999999999999999999987

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-35  Score=303.00  Aligned_cols=223  Identities=11%  Similarity=0.098  Sum_probs=178.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++...  ++.||||.+....      .+.+.+|++++.+++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888899999999999999986  6899999986542      267899999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++...       ........++.|++.||+|||+++   |+||||||+|||++.++.+||++++      
T Consensus       111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999998531       244467889999999999999987   9999999999999999999998543      


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                                       |++|       ++.++||||||+++|||++|+.||.........                   
T Consensus       175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------------------  211 (286)
T 3uqc_A          175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------------------  211 (286)
T ss_dssp             -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------------------
T ss_pred             -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------------------
Confidence                             3332       678999999999999999999999653321000                   


Q ss_pred             CcccccccccccCCcc--cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          583 DSMSMSSLKDYIDPNM--MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                           ......+....  ......+++.++.+++.+||+.||++| |+.|+++.|+++
T Consensus       212 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          212 -----APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             -----EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             -----HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence                 00000000000  001123345679999999999999999 999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-35  Score=339.36  Aligned_cols=234  Identities=23%  Similarity=0.337  Sum_probs=188.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc---CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCe-----E
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDE-----L  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----~  418 (639)
                      ++|...+.||+|+||.||++.+.   ++.||||.+...    ..+.+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67888999999999999999874   578999988643    23467899999999999999999999987655     7


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      |+||||+++++|.+++..       .+++..++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||++
T Consensus       160 ~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence            999999999999987742       5899999999999999999999987   9999999999999986 9999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      +.....       ....||+.|+|||++.+.. +.++|||||||++|||++|..|+......                  
T Consensus       229 ~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------  282 (681)
T 2pzi_A          229 SRINSF-------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------  282 (681)
T ss_dssp             EETTCC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------
T ss_pred             hhcccC-------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------
Confidence            876432       3357999999999987654 88999999999999999998887432110                  


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-DMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i  638 (639)
                       ..+                ...........+.+++.+||+.||++|| +++++.+.|..+
T Consensus       283 -~~~----------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          283 -GLP----------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -SCC----------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -ccc----------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             000                0000112335688999999999999999 566676666543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.5e-35  Score=299.08  Aligned_cols=227  Identities=19%  Similarity=0.311  Sum_probs=175.3

Q ss_pred             CCCCCC-CceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHH-HhcCCCCeeEEEeeeec----CCeEEEEE
Q 036507          351 EGFSDS-SLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKIL-CKVHHSNLVELIGYAAT----EDELFLIY  422 (639)
Q Consensus       351 ~~f~~~-~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il-~~l~h~niv~l~~~~~~----~~~~~lv~  422 (639)
                      ++|... +.||+|+||.||++...  ++.||+|.+...  ..+.+|++++ +.++||||+++++++..    ....++||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~   94 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   94 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence            345444 67999999999999884  578999998653  4567899988 66689999999999876    67789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~  499 (639)
                      ||+++|+|.+++..   .....+++..+..++.|++.||+|||+++   |+||||||+||+++.   ++.+||+|||++.
T Consensus        95 e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           95 ECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             CCCCSCBHHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             eecCCCcHHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            99999999999975   22346899999999999999999999987   999999999999998   7889999999987


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ...                         +..++.++|||||||++|||++|+.||.......               ...
T Consensus       169 ~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---------------~~~  208 (299)
T 3m2w_A          169 ETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---------------ISP  208 (299)
T ss_dssp             ECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------------C
T ss_pred             ccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh---------------hhH
Confidence            542                         2346779999999999999999999995433200               000


Q ss_pred             cCCCcccccccccccCCcc--cCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNM--MDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..        .........  ........+.++.+++.+||+.||++|||++|+++
T Consensus       209 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 GM--------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CS--------CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH--------HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00        000000000  00000234567999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1e-35  Score=319.59  Aligned_cols=241  Identities=16%  Similarity=0.133  Sum_probs=178.4

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCC-CCee-------------
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHH-SNLV-------------  406 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h-~niv-------------  406 (639)
                      .+.+|...++||+|+||.||+|.+.  ++.||||+++..      ..+.+.+|+.+++.++| .|..             
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3445667789999999999999986  789999998722      24668899999999987 2211             


Q ss_pred             --------EEEeeeec-----CCeEEEEEeeccCCChhhhccCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 036507          407 --------ELIGYAAT-----EDELFLIYEYAQKGSLKSHLHDPQ--NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH  471 (639)
Q Consensus       407 --------~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~  471 (639)
                              .++.++..     ....+++|+++ +++|.+++....  ......+++..++.++.|+++||+|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                    11111111     12457777766 789998884110  122456889999999999999999999987   


Q ss_pred             eeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCcccc----------ccCCCCCcchHHHHH
Q 036507          472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL----------TDGLATAKSDVYAFG  541 (639)
Q Consensus       472 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DVws~G  541 (639)
                      |+||||||+|||++.++.+||+|||+++....      ......| +.|+|||++          .+..++.++||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence            99999999999999999999999999986532      1344577 999999999          556688899999999


Q ss_pred             HHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccC
Q 036507          542 VVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDED  621 (639)
Q Consensus       542 vvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d  621 (639)
                      |++|||++|+.||.......                           .....+.    .  ....+..+.+|+.+||+.|
T Consensus       305 vil~elltg~~Pf~~~~~~~---------------------------~~~~~~~----~--~~~~~~~~~~li~~~l~~d  351 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDDAALG---------------------------GSEWIFR----S--CKNIPQPVRALLEGFLRYP  351 (413)
T ss_dssp             HHHHHHHHSSCCCCTTGGGS---------------------------CSGGGGS----S--CCCCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHHCCCCCCCcchhh---------------------------hHHHHHh----h--cccCCHHHHHHHHHHccCC
Confidence            99999999999995432100                           0000111    0  0122356999999999999


Q ss_pred             CCCCCCHHHHHH
Q 036507          622 PILRPDMKQVVI  633 (639)
Q Consensus       622 P~~RPs~~evl~  633 (639)
                      |++||++.|+++
T Consensus       352 P~~Rpt~~~~l~  363 (413)
T 3dzo_A          352 KEDRLLPLQAME  363 (413)
T ss_dssp             GGGSCCHHHHTT
T ss_pred             hhhCcCHHHHHh
Confidence            999999887753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.9e-35  Score=307.39  Aligned_cols=239  Identities=17%  Similarity=0.187  Sum_probs=183.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEecccc-----------HHHHHHHHHHHHhcC---------CCCeeEEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-----------TKEFMAEMKILCKVH---------HSNLVELI  409 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~---------h~niv~l~  409 (639)
                      .++|+..+.||+|+||.||+|+.+++.||||++....           .+.+.+|++++++++         ||||+++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            3567778999999999999999999999999986442           277889999999886         77777777


Q ss_pred             eeee------------------------------cCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHH
Q 036507          410 GYAA------------------------------TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR  459 (639)
Q Consensus       410 ~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  459 (639)
                      +++.                              ..+..++||||+++|++.+.+..      ..+++.....++.||+.
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHH
Confidence            6532                              26789999999999987777642      34789999999999999


Q ss_pred             HHHHHH-hcCCCCeeeCCCCCCcEEECCCC--------------------CEEEeccCCceecCCCCCCcceeeeecccc
Q 036507          460 GLEYIH-EHTKTHYVHRDIKSSNILLDSAF--------------------RAKISDFGLAKLVGKTSDGEATVTKVVGTF  518 (639)
Q Consensus       460 al~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  518 (639)
                      ||+||| +++   |+||||||+|||++.++                    .+||+|||+++.....        ...||+
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~  241 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCC
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEee
Confidence            999999 887   99999999999999887                    8999999999876321        347999


Q ss_pred             ccCCccccccCCCCCcchHHHHHHH-HHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCc
Q 036507          519 GYLAPEYLTDGLATAKSDVYAFGVV-LFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPN  597 (639)
Q Consensus       519 ~y~aPE~~~~~~~~~~~DVws~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~  597 (639)
                      .|+|||++.+.. +.++|||||+++ .+++++|..||....          .+.......+....           ....
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----------~~~~~~~~~~~~~~-----------~~~~  299 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----------WLHYLTDKMLKQMT-----------FKTK  299 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----------HHHHHHHHHHHTCC-----------CSSC
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----------hhhHHHHhhhhhhc-----------cCcc
Confidence            999999998766 889999998777 778999998883210          00001111111100           0000


Q ss_pred             ccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          598 MMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       598 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                      .....+...+.++.+|+.+||+.|     |++|++
T Consensus       300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            011123457788999999999976     999988

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=100.00  E-value=1.4e-33  Score=269.52  Aligned_cols=166  Identities=20%  Similarity=0.336  Sum_probs=137.9

Q ss_pred             CccCc-ceeEEEeCCCCCHHHHHHHhcCCc--------ccceecc-C--------CCceEeeeeeeeccCCCCceeecee
Q 036507           37 TRLCA-TFLAYEMQPNQTLSVIQSMFDVLP--------KDVTVEG-N--------EKNYIFIKKNCSCLSTTRNYVSNTT   98 (639)
Q Consensus        37 ~~~c~-~~~~y~v~~g~~l~~ia~~~~~~~--------~~i~~~~-n--------~~~~l~ip~~~~~~~~~~~~~~~~~   98 (639)
                      .++|+ |++.|+|++||||+.||++||+++        ++|+.+| +        .||.|+||++|+|..+ .......+
T Consensus         2 ~~~C~~a~~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~-~~~~~~~~   80 (212)
T 4eby_A            2 RTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPG-DFLGHNFS   80 (212)
T ss_dssp             CCCCSCEEEEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETT-TEEEEEEE
T ss_pred             CCCCccceEEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCC-ccccCceE
Confidence            57899 999999999999999999999999        8998788 4        4799999999999754 24556678


Q ss_pred             EEEEcCCceeehhHHHhcCCcc------cccC-CCcccCCCCEEEEeeeecCCCCC----CCceEEEEecCCCcHHHHHH
Q 036507           99 FTVKSSGGYVYDVVVNAYDGLA------ILDN-STRMARAGAVVSLRLFCGCSSGL----WNYLMSYVMKDGDTVQSLAS  167 (639)
Q Consensus        99 y~v~~gd~t~~~ia~~~~~~l~------~~~~-~~~~l~~g~~l~ip~~~~~~~~~----~~~~~~y~v~~Gdtl~~Ia~  167 (639)
                      |+|++|| |||.||+..|.+|+      .+|+ +++.|++||+|.||..|+|++..    .+..++|+|++|||||+||+
T Consensus        81 Y~V~~GD-TL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~~~~Y~V~~GDTL~~IA~  159 (212)
T 4eby_A           81 YSVRQED-TYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIAR  159 (212)
T ss_dssp             EECCTTC-CHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCTTTCSSCCCEEEEECCTTCCHHHHHH
T ss_pred             EEecCCC-cHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCcccccCCCCeEEEEECCCCcHHHHHH
Confidence            9999999 99999976776554      3443 23459999999999999997643    34568999999999999999


Q ss_pred             HhCCChHHHHHHcCCCCCCCccCCceEEecCCCCCCCCC
Q 036507          168 RFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNSVPGEPY  206 (639)
Q Consensus       168 ~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~~~~~~~~  206 (639)
                      +||+++++|++||++.+ ..+.+|+ |+||.....+..+
T Consensus       160 ~fgvsv~~L~~~N~~~~-~~~~~g~-l~IP~~~~~~~~~  196 (212)
T 4eby_A          160 SSGVSADILQRYNPGVN-FNSGNGI-VYVPGRDPNGAFP  196 (212)
T ss_dssp             HHTSCHHHHHHHSTTCC-TTSCSSE-EEEECCCTTSCCC
T ss_pred             HHCcCHHHHHHhcCCCc-cCCCCCE-EEecCCCCCCccC
Confidence            99999999999999876 4555555 9999877655443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=7.2e-29  Score=275.78  Aligned_cols=182  Identities=15%  Similarity=0.119  Sum_probs=128.8

Q ss_pred             ceeecCceEEEEEE--EcCceEEEEEeccc-------------cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 036507          358 LLGHGTYGSVYYGN--IRNQEVAIKRMTAT-------------KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       358 ~lG~G~~g~Vy~~~--~~~~~vavK~~~~~-------------~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ..+.|++|.+..++  ..++.+++|.+...             ..++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35566666665443  35788999998532             235699999999999 699999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||++|++|.++|...     .+++..   +|+.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus       321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            9999999999999752     345543   58899999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAI  554 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~  554 (639)
                      ....   ...+..+||++|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       390 ~~~~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          390 PQDC---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             C------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCCC---ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            4322   23345789999999999976 4567899999999999887776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=8.9e-27  Score=257.54  Aligned_cols=183  Identities=18%  Similarity=0.216  Sum_probs=143.8

Q ss_pred             CCCCceeecCceEEEEEEEcCceEEEEEecccc-----------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          354 SDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-----------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       354 ~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ...++||+|+||.||++...+..+++|......           .+.+.+|++++++++||||+++..++...+..++||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            446789999999999998888999999864321           234789999999999999996666666677889999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++++|.+++..             +..++.|+++||+|||+++   |+||||||+|||+++  .+||+|||+++...
T Consensus       419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            99999999999863             4578999999999999987   999999999999999  99999999999764


Q ss_pred             CCCCCcc----eeeeeccccccCCcccccc--CCCCCcchHHHHHHHHHHHHcCCccc
Q 036507          503 KTSDGEA----TVTKVVGTFGYLAPEYLTD--GLATAKSDVYAFGVVLFEIISGKEAI  554 (639)
Q Consensus       503 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DVws~Gvvl~elltG~~p~  554 (639)
                      .......    ......||+.|||||++..  ..|+..+|+|+...-.++-+.++.++
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            3211000    1234689999999999987  66788899999999888888776554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=9.2e-22  Score=199.42  Aligned_cols=148  Identities=16%  Similarity=0.070  Sum_probs=117.5

Q ss_pred             HHHHhhhCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc---------------------cHHHHHHHHHHHHhcC
Q 036507          344 DEILFATEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT---------------------KTKEFMAEMKILCKVH  401 (639)
Q Consensus       344 ~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~---------------------~~~~~~~E~~il~~l~  401 (639)
                      ..+......|...+.||+|+||.||++... ++.||||.++..                     ....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344445556667799999999999999984 678999998632                     2345889999999999


Q ss_pred             CCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       402 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                      |   +++.+++. .+..++||||+++++|.+ +..         .  ....++.|++.||.|||+++   |+||||||+|
T Consensus       163 ~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~--~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N  223 (282)
T 1zar_A          163 G---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------E--NPDEVLDMILEEVAKFYHRG---IVHGDLSQYN  223 (282)
T ss_dssp             T---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             C---CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------h--hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence            4   55555443 356699999999999998 421         1  13368999999999999987   9999999999


Q ss_pred             EEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccc
Q 036507          482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT  527 (639)
Q Consensus       482 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  527 (639)
                      ||++ ++.+||+|||+++..                ..++|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~~----------------~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV----------------GEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET----------------TSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeEC----------------CCCCHHHHHH
Confidence            9999 999999999999743                3578899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=1.9e-18  Score=172.75  Aligned_cols=132  Identities=17%  Similarity=0.206  Sum_probs=102.4

Q ss_pred             CCCCCceeecCceEEEEEEE--cCce--EEEEEecccc---------------------------HHHHHHHHHHHHhcC
Q 036507          353 FSDSSLLGHGTYGSVYYGNI--RNQE--VAIKRMTATK---------------------------TKEFMAEMKILCKVH  401 (639)
Q Consensus       353 f~~~~~lG~G~~g~Vy~~~~--~~~~--vavK~~~~~~---------------------------~~~~~~E~~il~~l~  401 (639)
                      |...+.||+|+||.||+|..  .++.  ||||.++...                           ...+.+|+++|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678899999999999988  6778  9999864321                           125788999999998


Q ss_pred             CCCe--eEEEeeeecCCeEEEEEeeccC-C----ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCee
Q 036507          402 HSNL--VELIGYAATEDELFLIYEYAQK-G----SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH-EHTKTHYV  473 (639)
Q Consensus       402 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~~iv  473 (639)
                      |+++  ..++.+    +..++||||+.+ |    +|.++...        .++.....++.|++.+|.||| +.+   |+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            8754  344432    356899999942 4    56655421        123345678999999999999 877   99


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          474 HRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       474 H~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      ||||||+|||+++  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999999754

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.73  E-value=2.1e-18  Score=164.50  Aligned_cols=104  Identities=18%  Similarity=0.317  Sum_probs=85.5

Q ss_pred             eceeEEEEcCCceeehhHHH---hc--------CCccccc-CC--CcccCCCCEEEEeeeecCCCCC-CCceEEEEecCC
Q 036507           95 SNTTFTVKSSGGYVYDVVVN---AY--------DGLAILD-NS--TRMARAGAVVSLRLFCGCSSGL-WNYLMSYVMKDG  159 (639)
Q Consensus        95 ~~~~y~v~~gd~t~~~ia~~---~~--------~~l~~~~-~~--~~~l~~g~~l~ip~~~~~~~~~-~~~~~~y~v~~G  159 (639)
                      +..+|+|++|| |||.||+.   +.        +.|..+| +.  ++.|++||.|.||..|.|..+. .....+|+|++|
T Consensus         8 a~~~Y~V~~GD-TL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y~V~~G   86 (212)
T 4eby_A            8 ALASYYLENGT-TLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQE   86 (212)
T ss_dssp             EEEEEECCTTC-CHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEEEECCTT
T ss_pred             ceEEEEeCCCC-CHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceEEEecCC
Confidence            34569999999 99999994   32        4555666 43  4569999999999999887542 234578999999


Q ss_pred             CcHHHHH-HHhC--CChHHHHHHcCCCCCCCccCCceEEecCCC
Q 036507          160 DTVQSLA-SRFG--VSMDSIEQVNGIVNPNNVTAGDLFYIPLNS  200 (639)
Q Consensus       160 dtl~~Ia-~~~~--~~~~~l~~~N~~~~~~~l~~g~~l~ip~~~  200 (639)
                      ||||+|| ++|+  +++++|++||++ +++.|++||+|.||...
T Consensus        87 DTL~~IA~~~y~~lvt~~~L~~~N~~-~~~~l~~Gq~L~IP~~~  129 (212)
T 4eby_A           87 DTYERVAISNYANLTTMESLQARNPF-PATNIPLSATLNVLVNC  129 (212)
T ss_dssp             CCHHHHHHTTTTTSSCHHHHHHHCCS-CTTCCCTTCEEEEEEEC
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHhcCC-CcccCCCCCEEEEcCCC
Confidence            9999999 7999  999999999995 56899999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=2.2e-15  Score=156.78  Aligned_cols=132  Identities=14%  Similarity=0.123  Sum_probs=96.6

Q ss_pred             CCCCCCceeecCceEEEEEEEc-CceEEEEEecccc-----------------HHH--------HHHHHHHHHhcCCCCe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK-----------------TKE--------FMAEMKILCKVHHSNL  405 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~-----------------~~~--------~~~E~~il~~l~h~ni  405 (639)
                      -|+..+.||+|+||.||+|... ++.||||+++...                 ...        ..+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4788899999999999999875 6789999864210                 111        1346666777654443


Q ss_pred             e--EEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          406 V--ELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       406 v--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      .  ..+.+    ...+|||||+++++|..+...         .  ....++.|++.+|.|||+.+   |+||||||.|||
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL  237 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------P--DPASLYADLIALILRLAKHG---LIHGDFNEFNIL  237 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhccc---------H--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence            2  22222    123799999999998776531         1  12457889999999999987   999999999999


Q ss_pred             ECCCC----------CEEEeccCCceec
Q 036507          484 LDSAF----------RAKISDFGLAKLV  501 (639)
Q Consensus       484 l~~~~----------~~kl~Dfgla~~~  501 (639)
                      +++++          .+.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98876          3899999987643

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.48  E-value=2.2e-14  Score=114.31  Aligned_cols=62  Identities=23%  Similarity=0.435  Sum_probs=55.6

Q ss_pred             CCCEEEEeeeecCCCCCCCceEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecCCC
Q 036507          131 AGAVVSLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLNS  200 (639)
Q Consensus       131 ~g~~l~ip~~~~~~~~~~~~~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~~  200 (639)
                      .||.|.+|..        ....+|+|++|||||+||++||+++++|+++|++.+++.|++||+|.||...
T Consensus         3 ~Gq~l~ip~~--------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVR--------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCC--------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEeeccCC--------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            6889998853        2467899999999999999999999999999999888999999999999754

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=99.31  E-value=1.6e-12  Score=93.24  Aligned_cols=45  Identities=27%  Similarity=0.579  Sum_probs=42.7

Q ss_pred             EEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecC
Q 036507          152 MSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPL  198 (639)
Q Consensus       152 ~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~  198 (639)
                      .+|+|++|||||+||++||+++++|+++|+  +++.|++||+|.||+
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~--~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS--DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCS--CGGGCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC--CCCcCCcCCEEEEec
Confidence            469999999999999999999999999999  678999999999996

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=9.3e-12  Score=124.23  Aligned_cols=140  Identities=14%  Similarity=0.101  Sum_probs=111.8

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEecc---ccHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeec
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTA---TKTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      -.+|+....++.|+.+.||+....++.+++|....   .....+.+|+++++.+. +.++.++++++.+.+..|+||||+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            35677777788888899999987788999999865   33456889999999985 677888999988888999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH--------------------------------------  467 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~--------------------------------------  467 (639)
                      +|.+|.+.+...          .....++.++++++..||+.                                      
T Consensus        93 ~G~~l~~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           93 DGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             SSEEHHHHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             CCeehhhccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999998764210          11236778999999999981                                      


Q ss_pred             ------------------CCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          468 ------------------TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       468 ------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                                        ....++|+|+++.||+++++..+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              01349999999999999876566799999775

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.19  E-value=1.7e-11  Score=111.99  Aligned_cols=49  Identities=22%  Similarity=0.488  Sum_probs=46.4

Q ss_pred             eEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecCC
Q 036507          151 LMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLN  199 (639)
Q Consensus       151 ~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~  199 (639)
                      ..+|+||+|||||.||++||+++.+|++||++.+|+.|+|||+|.||..
T Consensus        62 ~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~  110 (167)
T 2l9y_A           62 TATVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTK  110 (167)
T ss_dssp             CEEEEECTTCCHHHHHHHTTCCHHHHHHHHTCCGGGCCCTTEEEEESCC
T ss_pred             CceEEECCCCcHHHHHHHcCCCHHHHHHHcCCCCcccccCCCEEEEcCC
Confidence            3569999999999999999999999999999999999999999999964

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.08  E-value=2.4e-10  Score=113.46  Aligned_cols=127  Identities=13%  Similarity=0.084  Sum_probs=96.0

Q ss_pred             eecCceEEEEEEEc-CceEEEEEeccccHHHHHHHHHHHHhcCCCC--eeEEEeeeecCCeEEEEEeeccCCChhhhccC
Q 036507          360 GHGTYGSVYYGNIR-NQEVAIKRMTATKTKEFMAEMKILCKVHHSN--LVELIGYAATEDELFLIYEYAQKGSLKSHLHD  436 (639)
Q Consensus       360 G~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  436 (639)
                      +.|..+.||+.... +..+++|.........+.+|+++++.+.+.+  +.+++++...++..++||||++|.+|.  ...
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~  106 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH  106 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc
Confidence            45566999998765 4679999976654456778999999986544  556888888778899999999998884  211


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 036507          437 PQNRGQTSLSWIMRVQIALDAARGLEYIHEHT------------------------------------------------  468 (639)
Q Consensus       437 ~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------------------------------------------------  468 (639)
                              .+   ...++.++++.|..||+..                                                
T Consensus       107 --------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          107 --------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             --------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             --------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence                    11   1256677888888888642                                                


Q ss_pred             -------CCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          469 -------KTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       469 -------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                             +..++|+|++|.||+++++..+.|+||+.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   1239999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=7.7e-10  Score=115.66  Aligned_cols=139  Identities=16%  Similarity=0.209  Sum_probs=108.1

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEec--ccc----HHHHHHHHHHHHhcC--CCCeeEEEeeeecC---CeEEEEEe
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMT--ATK----TKEFMAEMKILCKVH--HSNLVELIGYAATE---DELFLIYE  423 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~--~~~----~~~~~~E~~il~~l~--h~niv~l~~~~~~~---~~~~lv~e  423 (639)
                      ..+.|+.|.++.||+....+..+++|+..  ...    ...+.+|.++++.+.  +.++.+++.++.+.   +..|+|||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            35678999999999998888899999876  332    346788999999997  45678888888766   45899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT-----------------------------------  468 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----------------------------------  468 (639)
                      |++|..+.+...       ..++...+..++.++++.|..||+..                                   
T Consensus       122 ~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          122 FVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             CCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             ecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999888754221       23677788889999999999999731                                   


Q ss_pred             --------------------CCCeeeCCCCCCcEEECCCCC--EEEeccCCcee
Q 036507          469 --------------------KTHYVHRDIKSSNILLDSAFR--AKISDFGLAKL  500 (639)
Q Consensus       469 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~  500 (639)
                                          ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                256999999999999997753  68999999864

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.01  E-value=3.8e-12  Score=116.35  Aligned_cols=87  Identities=15%  Similarity=0.111  Sum_probs=65.8

Q ss_pred             eceeEEEEcCCceeehhHHH---hcCCcccccCCC--cccCCCCEEEEeeeecCCC--C--CCCceEEEEecCCCcHHHH
Q 036507           95 SNTTFTVKSSGGYVYDVVVN---AYDGLAILDNST--RMARAGAVVSLRLFCGCSS--G--LWNYLMSYVMKDGDTVQSL  165 (639)
Q Consensus        95 ~~~~y~v~~gd~t~~~ia~~---~~~~l~~~~~~~--~~l~~g~~l~ip~~~~~~~--~--~~~~~~~y~v~~Gdtl~~I  165 (639)
                      +..+|+||+|| |||.||+.   .+..|..+|+..  +.|++||+|.||....-+.  .  .......|+|++||||++|
T Consensus        61 ~~~~y~V~~GD-TL~~IA~~~~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL~aI  139 (167)
T 2l9y_A           61 GTATVTVQQGD-TLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVLEAE  139 (167)
T ss_dssp             SCEEEEECTTC-CHHHHHHHTTCCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEEEEE
T ss_pred             CCceEEECCCC-cHHHHHHHcCCCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccccccccccceEEEeCCcCChHHH
Confidence            44569999999 99999994   566666777443  4599999999997533211  1  1122367999999999999


Q ss_pred             HHHhCCChHHHHHHcCC
Q 036507          166 ASRFGVSMDSIEQVNGI  182 (639)
Q Consensus       166 a~~~~~~~~~l~~~N~~  182 (639)
                      |++||.+++..+.+|..
T Consensus       140 A~r~G~~v~s~i~Ln~~  156 (167)
T 2l9y_A          140 LRYSGGWNRSRIYLDEH  156 (167)
T ss_dssp             EEETTEEEEEEECGGGT
T ss_pred             HHHcCCceEEEEEcccc
Confidence            99999988887777764

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=98.97  E-value=6.3e-10  Score=115.56  Aligned_cols=129  Identities=12%  Similarity=0.076  Sum_probs=83.1

Q ss_pred             ceeEEEeCCCCCHHHHHHHhcCCcccceeccC------------CCceEeeeeeeeccCCCCceeeceeEEEEcCCceee
Q 036507           42 TFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN------------EKNYIFIKKNCSCLSTTRNYVSNTTFTVKSSGGYVY  109 (639)
Q Consensus        42 ~~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n------------~~~~l~ip~~~~~~~~~~~~~~~~~y~v~~gd~t~~  109 (639)
                      ....|+|++||||+.||++||+++++|..+|+            .||.|.||....   +   ......|.+...+ ++ 
T Consensus         6 ~~~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~---~---~l~~l~~~~~~~~-~~-   77 (361)
T 2gu1_A            6 KRIHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDM---G---QLSRLIYHMSIVE-KA-   77 (361)
T ss_dssp             -CEEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTT---S---CEEEEEEEEETTE-EE-
T ss_pred             CceEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECCC---C---cceEEEEEcCccc-eE-
Confidence            35689999999999999999999999986654            568888886421   1   1111223333222 11 


Q ss_pred             hhHHHhcCCcccccCCCcccCCCC-EE-EEeeeecCCCCCCCceEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCC--
Q 036507          110 DVVVNAYDGLAILDNSTRMARAGA-VV-SLRLFCGCSSGLWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNP--  185 (639)
Q Consensus       110 ~ia~~~~~~l~~~~~~~~~l~~g~-~l-~ip~~~~~~~~~~~~~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~--  185 (639)
                      .+...          .     .|+ .. .++.      .......+|+|+.|||||.||++||++.++|++||++...  
T Consensus        78 ~~~~~----------~-----~g~f~~~~~~~------~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~i  136 (361)
T 2gu1_A           78 IYTRE----------N-----DGSFSYDFQEI------SGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKI  136 (361)
T ss_dssp             EEEEC----------T-----TSCEEEEEEEC------CCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTC
T ss_pred             EEEec----------C-----CCcceeeeccc------CceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccc
Confidence            00000          0     000 00 0110      0001234699999999999999999999999999998543  


Q ss_pred             ---CCccCCceEEecCC
Q 036507          186 ---NNVTAGDLFYIPLN  199 (639)
Q Consensus       186 ---~~l~~g~~l~ip~~  199 (639)
                         ..|++||+|.|+..
T Consensus       137 df~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A          137 DFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             CTTTCCCC-CEEEEEEE
T ss_pred             cccccCCCCCEEEEEEE
Confidence               45999999999853

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.87  E-value=1.9e-09  Score=109.91  Aligned_cols=182  Identities=20%  Similarity=0.246  Sum_probs=120.2

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcC-CCC--eeEEEeeeecCC---eEEEEEeeccCC
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVH-HSN--LVELIGYAATED---ELFLIYEYAQKG  428 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~g  428 (639)
                      .+.++.|....||+..   ..+++|..... ....+.+|.++|+.+. +..  +.+++......+   ..|+|||+++|.
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~  101 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV  101 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence            4568999999999763   67899986654 3466889999998884 322  445555543333   347899999998


Q ss_pred             ChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 036507          429 SLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-----------------------------------------  467 (639)
Q Consensus       429 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-----------------------------------------  467 (639)
                      +|.+...       ..++...+..++.++++.+..||+.                                         
T Consensus       102 ~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          102 PLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             ECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            8865321       1255666677777888888888751                                         


Q ss_pred             --------------CCCCeeeCCCCCCcEEECC--CCCEEEeccCCceecCCCCCCcceeeeecccccc---CCcccccc
Q 036507          468 --------------TKTHYVHRDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY---LAPEYLTD  528 (639)
Q Consensus       468 --------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  528 (639)
                                    ..+.++|+|+++.||++++  +..+.|+||+.+..-....+    .   .....+   ..|+....
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D----l---~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND----F---ISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH----H---HTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH----H---HHHHhhccccCHHHHHH
Confidence                          1245899999999999998  45678999999865321100    0   000001   12221110


Q ss_pred             -----CCC---------CCcchHHHHHHHHHHHHcCCccc
Q 036507          529 -----GLA---------TAKSDVYAFGVVLFEIISGKEAI  554 (639)
Q Consensus       529 -----~~~---------~~~~DVws~Gvvl~elltG~~p~  554 (639)
                           +..         ....+.|+++.++|.+.+|..++
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                 111         11368999999999999999776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.44  E-value=9.3e-07  Score=88.06  Aligned_cols=133  Identities=17%  Similarity=0.119  Sum_probs=96.3

Q ss_pred             ceeecCce-EEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEeeccCCChhhh
Q 036507          358 LLGHGTYG-SVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSLKSH  433 (639)
Q Consensus       358 ~lG~G~~g-~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  433 (639)
                      .+..|..+ .||+....  +..+.+|.-......++.+|..+|+.+. +-.+.++++++.+.+..++|||++++.++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            45555555 68976654  4579999987777778889999999885 44467788888888899999999999887665


Q ss_pred             ccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 036507          434 LHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH----------------------------------------------  467 (639)
Q Consensus       434 l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~----------------------------------------------  467 (639)
                      ....         ......++.++++.|.-||+.                                              
T Consensus       111 ~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          111 LEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            4210         111233455666666666641                                              


Q ss_pred             ---------CCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          468 ---------TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       468 ---------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                               ..+.++|+|+++.|||+++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     01238999999999999987777899999875

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=98.40  E-value=1.8e-07  Score=85.36  Aligned_cols=47  Identities=34%  Similarity=0.573  Sum_probs=42.9

Q ss_pred             eEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecC
Q 036507          151 LMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPL  198 (639)
Q Consensus       151 ~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~  198 (639)
                      +++|+||+||||++||++|+++.++|+++|+..++. |.+||++.||.
T Consensus         2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~~-l~~g~~i~ip~   48 (165)
T 4a1k_A            2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAG-LTAGQSIVIPG   48 (165)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGGC-CCTTCEEEETT
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCCc-cCCCccccCcc
Confidence            478999999999999999999999999999987654 78999999984

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.35  E-value=4.6e-06  Score=84.81  Aligned_cols=135  Identities=18%  Similarity=0.190  Sum_probs=92.4

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCC---CeeEEEeeee-cCCeEEEEEeeccCCCh
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHS---NLVELIGYAA-TEDELFLIYEYAQKGSL  430 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gsL  430 (639)
                      .+.++.|....||+.   ++.+++|.-... ....+.+|.++|+.+.+.   .+.+++.++. ..+..+++|||++|.+|
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence            456888998899987   678899986443 345688999999999752   3556666663 44567899999999888


Q ss_pred             hhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 036507          431 KSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-------------------------------------------  467 (639)
Q Consensus       431 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-------------------------------------------  467 (639)
                      .+....       .++...+..++.++++.|..||+.                                           
T Consensus       101 ~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          101 GEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             HHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             chhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            653211       123333344444444444444431                                           


Q ss_pred             --------------CCCCeeeCCCCCCcEEECC---CCC-EEEeccCCcee
Q 036507          468 --------------TKTHYVHRDIKSSNILLDS---AFR-AKISDFGLAKL  500 (639)
Q Consensus       468 --------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfgla~~  500 (639)
                                    ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2345799999999999997   455 48999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.18  E-value=3.2e-06  Score=87.84  Aligned_cols=76  Identities=13%  Similarity=0.123  Sum_probs=55.6

Q ss_pred             Cce-eecCceEEEEEEEc--------CceEEEEEecccc------HHHHHHHHHHHHhcC-C--CCeeEEEeeeecC---
Q 036507          357 SLL-GHGTYGSVYYGNIR--------NQEVAIKRMTATK------TKEFMAEMKILCKVH-H--SNLVELIGYAATE---  415 (639)
Q Consensus       357 ~~l-G~G~~g~Vy~~~~~--------~~~vavK~~~~~~------~~~~~~E~~il~~l~-h--~niv~l~~~~~~~---  415 (639)
                      +.| +.|....+|+....        ++.+++|.-....      ...+.+|.++++.+. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999988765        6788999865432      245778999988885 2  3567788777654   


Q ss_pred             CeEEEEEeeccCCChhh
Q 036507          416 DELFLIYEYAQKGSLKS  432 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~  432 (639)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877654

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=98.12  E-value=1e-06  Score=91.27  Aligned_cols=49  Identities=16%  Similarity=0.393  Sum_probs=44.3

Q ss_pred             eEEEEecCCCcHHHHHHHhCCChHHHHHHcCCCC----CCCccCCceEEecCC
Q 036507          151 LMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVN----PNNVTAGDLFYIPLN  199 (639)
Q Consensus       151 ~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~----~~~l~~g~~l~ip~~  199 (639)
                      ..+|+|++|||||+||++||+++++|.++|++..    .+.|++||+|.||..
T Consensus         7 ~~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~   59 (361)
T 2gu1_A            7 RIHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMD   59 (361)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEEC
T ss_pred             ceEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEEC
Confidence            4679999999999999999999999999999742    478999999999964

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.12  E-value=9.6e-07  Score=69.69  Aligned_cols=43  Identities=16%  Similarity=0.240  Sum_probs=38.0

Q ss_pred             ceeEEEeCCCCCHHHHHHHhcCCcccceeccC--------CCceEeeeeee
Q 036507           42 TFLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN--------EKNYIFIKKNC   84 (639)
Q Consensus        42 ~~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n--------~~~~l~ip~~~   84 (639)
                      .+..|+|++||||+.||++|++++++|+.+|+        .+|.|.||...
T Consensus        14 ~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A           14 RRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             EEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            57889999999999999999999999997776        46889999754

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.11  E-value=1.1e-06  Score=62.34  Aligned_cols=39  Identities=21%  Similarity=0.213  Sum_probs=33.3

Q ss_pred             eEEEeCCCCCHHHHHHHhcCCcccceeccC------CCceEeeee
Q 036507           44 LAYEMQPNQTLSVIQSMFDVLPKDVTVEGN------EKNYIFIKK   82 (639)
Q Consensus        44 ~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n------~~~~l~ip~   82 (639)
                      .+|+|++||||+.||++|++++.+|...|+      .||.|.||+
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCGGGCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHHHHHCcCHHHHHHhCCCCCcCCcCCEEEEec
Confidence            479999999999999999999999986664      457777775

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.04  E-value=1.9e-05  Score=81.18  Aligned_cols=142  Identities=15%  Similarity=0.243  Sum_probs=82.7

Q ss_pred             CceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcCC--CCeeEEEe------eeecCCeEEEEEeeccCC
Q 036507          357 SLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHH--SNLVELIG------YAATEDELFLIYEYAQKG  428 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~h--~niv~l~~------~~~~~~~~~lv~e~~~~g  428 (639)
                      +.|+.|..+.||+....++.+++|..... ..+...|.+++..|..  -.+.+++.      +....+..+++|||++|.
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~  116 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP-EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGR  116 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC-HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCB
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCc
Confidence            34666778899999888778999998763 3444456666665531  12333332      112356789999999986


Q ss_pred             Chh--------------hhccCCC--C--C-C----CCCCCHHHHH-------------------------------HHH
Q 036507          429 SLK--------------SHLHDPQ--N--R-G----QTSLSWIMRV-------------------------------QIA  454 (639)
Q Consensus       429 sL~--------------~~l~~~~--~--~-~----~~~l~~~~~~-------------------------------~i~  454 (639)
                      ++.              ..+|...  .  . .    .....|....                               .+.
T Consensus       117 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (346)
T 2q83_A          117 PFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFI  196 (346)
T ss_dssp             CCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHH
Confidence            542              1112100  0  0 0    0112332210                               011


Q ss_pred             HHHHHHHHHHHh----------cCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          455 LDAARGLEYIHE----------HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       455 ~~ia~al~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ..+..++++|++          ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            123345666763          124569999999999999888899999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.98  E-value=3.8e-05  Score=77.94  Aligned_cols=141  Identities=19%  Similarity=0.190  Sum_probs=95.9

Q ss_pred             CCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcC---CCCeeEEEeeeecCCeEEEEEeeccCCChh
Q 036507          355 DSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVH---HSNLVELIGYAATEDELFLIYEYAQKGSLK  431 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  431 (639)
                      ..+.|+.|....+|+....++.+++|.........+..|.+.|+.|.   ...+.+++.++...+..++||||+++..+.
T Consensus        40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~  119 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK  119 (312)
T ss_dssp             EEEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred             eeEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence            35678999999999988777899999887666677889999998884   356788888888788899999999987652


Q ss_pred             h-----------hccCCCC---CC--------------CCCCCHHHHH---HHHH----------------HHHHH-HHH
Q 036507          432 S-----------HLHDPQN---RG--------------QTSLSWIMRV---QIAL----------------DAARG-LEY  463 (639)
Q Consensus       432 ~-----------~l~~~~~---~~--------------~~~l~~~~~~---~i~~----------------~ia~a-l~~  463 (639)
                      .           .||....   .+              ...-+|....   ++..                .+.+. ...
T Consensus       120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~  199 (312)
T 3jr1_A          120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT  199 (312)
T ss_dssp             TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence            1           1222111   00              0112455321   1111                11111 123


Q ss_pred             HHh-cCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          464 IHE-HTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       464 LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      |.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            422 2356799999999999999887 8899984

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.72  E-value=8.7e-05  Score=78.19  Aligned_cols=71  Identities=11%  Similarity=0.064  Sum_probs=48.2

Q ss_pred             CCceeecCceEEEEEEE--cCceEEEEEeccc----------cHHHHHHHHHHHHhcCC--C-CeeEEEeeeecCCeEEE
Q 036507          356 SSLLGHGTYGSVYYGNI--RNQEVAIKRMTAT----------KTKEFMAEMKILCKVHH--S-NLVELIGYAATEDELFL  420 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~--~~~~vavK~~~~~----------~~~~~~~E~~il~~l~h--~-niv~l~~~~~~~~~~~l  420 (639)
                      .+.||.|.++.||++..  .++.++||.....          ..+.+..|.++|+.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            45789999999999954  4578999975421          12346789999988742  3 34455544  3445689


Q ss_pred             EEeeccCC
Q 036507          421 IYEYAQKG  428 (639)
Q Consensus       421 v~e~~~~g  428 (639)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.50  E-value=0.00058  Score=69.44  Aligned_cols=158  Identities=10%  Similarity=0.120  Sum_probs=88.4

Q ss_pred             chHHHHhhhCCCCC-----CCceeecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCCC--eeEEEee--
Q 036507          342 TYDEILFATEGFSD-----SSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHSN--LVELIGY--  411 (639)
Q Consensus       342 ~~~e~~~a~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~n--iv~l~~~--  411 (639)
                      +.+++...-.+|..     .+.|+.|....+|+....+..+++|..... ..+++..|.+++..+...+  +.+++..  
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~   87 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD   87 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence            34444444444543     234667888899999887778999988762 3345667888887774222  2233321  


Q ss_pred             ----eecCCeEEEEEeeccCCChhh--------------hccCC----CCCC---CCCCCHHHHHH------------HH
Q 036507          412 ----AATEDELFLIYEYAQKGSLKS--------------HLHDP----QNRG---QTSLSWIMRVQ------------IA  454 (639)
Q Consensus       412 ----~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~~---~~~l~~~~~~~------------i~  454 (639)
                          ....+..+++++|++|..+..              .+|..    ....   .....|.....            +.
T Consensus        88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~  167 (322)
T 2ppq_A           88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  167 (322)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence                112356789999998865421              01210    0000   01112332111            01


Q ss_pred             HHHHHHHHHHHhc----CCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          455 LDAARGLEYIHEH----TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       455 ~~ia~al~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ..+.+.++++++.    .+..++|+|+++.|||++++..+.|+||+.+.
T Consensus       168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            1234455565532    23469999999999999987656899999875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.42  E-value=0.0004  Score=73.70  Aligned_cols=78  Identities=8%  Similarity=0.092  Sum_probs=47.7

Q ss_pred             CCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeec--cccccCCccccccC---CCCCcchHHHHHHH
Q 036507          469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV--GTFGYLAPEYLTDG---LATAKSDVYAFGVV  543 (639)
Q Consensus       469 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DVws~Gvv  543 (639)
                      ...++|+|+++.|||++.++ ++++||+.+..-....+    .....  -...|.+|+.....   ......++......
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D----la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD----IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ  305 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH----HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH----HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence            45699999999999999876 99999998874321100    00001  11235566544311   11123455678888


Q ss_pred             HHHHHcCC
Q 036507          544 LFEIISGK  551 (639)
Q Consensus       544 l~elltG~  551 (639)
                      +|+.++++
T Consensus       306 ~~~~y~~~  313 (420)
T 2pyw_A          306 TWNLFNKR  313 (420)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88887764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.25  E-value=0.00055  Score=70.05  Aligned_cols=142  Identities=13%  Similarity=0.090  Sum_probs=73.3

Q ss_pred             CceeecCceE-EEEEEEc-CceEEEEEeccccHHHHHHHHHHHHhcCC--CCeeEEEeeeecCCeEEEEEeeccCCChhh
Q 036507          357 SLLGHGTYGS-VYYGNIR-NQEVAIKRMTATKTKEFMAEMKILCKVHH--SNLVELIGYAATEDELFLIYEYAQKGSLKS  432 (639)
Q Consensus       357 ~~lG~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  432 (639)
                      +.|+.|.... +|+.... ++.+++|........++..|+++++.+..  -.+.+++.+....+  +++||++.+..+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~  101 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTE  101 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHH
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHH
Confidence            3465555444 6676654 66788887544322344567777776642  23456666643333  78999987666644


Q ss_pred             hccC---------------------CCCCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHH---hcC
Q 036507          433 HLHD---------------------PQNRGQTSLSWIMRV-------Q-------------IALDAARGLEYIH---EHT  468 (639)
Q Consensus       433 ~l~~---------------------~~~~~~~~l~~~~~~-------~-------------i~~~ia~al~~LH---~~~  468 (639)
                      ++..                     ........++.....       .             ....+...++.+.   ...
T Consensus       102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~  181 (333)
T 3csv_A          102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG  181 (333)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred             HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence            3321                     100001111111000       0             0001112222221   112


Q ss_pred             CCCeeeCCCCCCcEEECCC----CCEEEeccCCcee
Q 036507          469 KTHYVHRDIKSSNILLDSA----FRAKISDFGLAKL  500 (639)
Q Consensus       469 ~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~  500 (639)
                      ...++|+|+.+.|||++.+    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3569999999999999875    6799999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.11  E-value=0.0019  Score=68.53  Aligned_cols=71  Identities=18%  Similarity=0.225  Sum_probs=49.7

Q ss_pred             CCceeecCceEEEEEEEc---------CceEEEEEeccccH-HHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEee
Q 036507          356 SSLLGHGTYGSVYYGNIR---------NQEVAIKRMTATKT-KEFMAEMKILCKVHHSNL-VELIGYAATEDELFLIYEY  424 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~~-~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~  424 (639)
                      .+.|+.|....+|+....         +..+.+|+...... +.+.+|..+++.+...++ .++++.+.+    .+|+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            346788888999998875         36789998744223 567789999888853333 566666543    289999


Q ss_pred             ccCCCh
Q 036507          425 AQKGSL  430 (639)
Q Consensus       425 ~~~gsL  430 (639)
                      ++|.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986444

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.10  E-value=0.0019  Score=64.99  Aligned_cols=138  Identities=12%  Similarity=0.074  Sum_probs=76.1

Q ss_pred             CCceeecCceEEEEEEEcCceEEEEEeccccH--HHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEeec-cCCChh
Q 036507          356 SSLLGHGTYGSVYYGNIRNQEVAIKRMTATKT--KEFMAEMKILCKVHHSNL-VELIGYAATEDELFLIYEYA-QKGSLK  431 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL~  431 (639)
                      .+.|+.|....+|+.    +.+++|+-.....  .+..+|..+++.+...++ .++++++  .+.-++++||+ ++.+|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEECC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccCC
Confidence            567999999999988    6788888754321  123468888777752222 3555543  33347899999 665443


Q ss_pred             h------------------hccCCCCCCCCCCCHHHH-HHHHH--------------HHHHHHH----HHHh-cCCCCee
Q 036507          432 S------------------HLHDPQNRGQTSLSWIMR-VQIAL--------------DAARGLE----YIHE-HTKTHYV  473 (639)
Q Consensus       432 ~------------------~l~~~~~~~~~~l~~~~~-~~i~~--------------~ia~al~----~LH~-~~~~~iv  473 (639)
                      .                  .+|............... ..+..              .+.+.+.    .+.. ..+..++
T Consensus        97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~  176 (301)
T 3dxq_A           97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC  176 (301)
T ss_dssp             HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred             HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence            1                  122211100111111111 11100              0111111    1111 1234599


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          474 HRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       474 H~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      |+|+.+.||+ ..++.+.++||..+..
T Consensus       177 HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          177 HCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ccCCCcCCEE-ECCCCEEEEecccccC
Confidence            9999999999 5667889999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.98  E-value=0.0028  Score=65.93  Aligned_cols=141  Identities=16%  Similarity=0.158  Sum_probs=82.5

Q ss_pred             CCceeecCceEEEEEEEc---------CceEEEEEeccc--cHHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEEEEe
Q 036507          356 SSLLGHGTYGSVYYGNIR---------NQEVAIKRMTAT--KTKEFMAEMKILCKVH-HSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~--~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      .+.|..|-...+|+....         ++.+.+|+-...  ......+|.++++.|. +.-..++++++.+    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            345777777889988763         367889885332  3566778999998875 2223556666643    28999


Q ss_pred             eccCCChhhh-----------------ccCCCCCCCCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 036507          424 YAQKGSLKSH-----------------LHDPQNRGQTSLS--WIMRVQIALDAA-------------------RGLEYIH  465 (639)
Q Consensus       424 ~~~~gsL~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~al~~LH  465 (639)
                      |++|..|..-                 ||...........  |....++..++.                   +.+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9988655321                 2221111112222  344444443332                   1233332


Q ss_pred             ----hc-CCCCeeeCCCCCCcEEECCC----CCEEEeccCCcee
Q 036507          466 ----EH-TKTHYVHRDIKSSNILLDSA----FRAKISDFGLAKL  500 (639)
Q Consensus       466 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~  500 (639)
                          .. .+..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 23459999999999999876    7899999998863

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.97  E-value=0.002  Score=64.33  Aligned_cols=75  Identities=16%  Similarity=0.170  Sum_probs=52.7

Q ss_pred             CCCCCCceeecCceEEEEEEEc-CceEEEEEecccc---HHHHHHHHHHHHhcCC---CCeeEEEeeeecCCeEEEEEee
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK---TKEFMAEMKILCKVHH---SNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~E~~il~~l~h---~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      .....+.+|.|..+.||+.+.. ++.+.+|+-....   ...|.+|.+.|+.|..   -.+.+++++.    .-+++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            3444677999999999999986 5789999865432   2457789999988852   2344555542    23789999


Q ss_pred             ccCCCh
Q 036507          425 AQKGSL  430 (639)
Q Consensus       425 ~~~gsL  430 (639)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            887643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.92  E-value=0.003  Score=67.51  Aligned_cols=71  Identities=14%  Similarity=0.107  Sum_probs=47.4

Q ss_pred             CCceeecCceEEEEEEEcC--ceEEEEEecccc--HHHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEeeccCCCh
Q 036507          356 SSLLGHGTYGSVYYGNIRN--QEVAIKRMTATK--TKEFMAEMKILCKVHHSNL-VELIGYAATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~--~~vavK~~~~~~--~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  430 (639)
                      .+.|+.|-...+|+....+  ..+++|+.....  .-+..+|..++..|...++ .++++.+.  +  .+|+||++|.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            3468888889999998876  788898764321  1122578999998875444 46777663  2  259999987554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.84  E-value=0.0071  Score=61.40  Aligned_cols=141  Identities=11%  Similarity=0.148  Sum_probs=79.9

Q ss_pred             CceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCC--CeeEEEee-----eecCCeEEEEEeecc
Q 036507          357 SLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHS--NLVELIGY-----AATEDELFLIYEYAQ  426 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~  426 (639)
                      ..++ |....||+....+ +.+++|..+..  ....+..|..++..+...  .+.+++..     ....+..+++|||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            3466 7778999877654 47999998633  356677888888877522  23344432     112455688999998


Q ss_pred             CCChhh--------------hccC----CCCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc--
Q 036507          427 KGSLKS--------------HLHD----PQNRGQTSLSWIMR----VQI---------------ALDAARGLEYIHEH--  467 (639)
Q Consensus       427 ~gsL~~--------------~l~~----~~~~~~~~l~~~~~----~~i---------------~~~ia~al~~LH~~--  467 (639)
                      |..+..              .+|.    .........++...    ..+               ...+...++.+.+.  
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            754421              0111    00001112222211    000               00111223333221  


Q ss_pred             --CCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          468 --TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       468 --~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                        .+..++|+|+++.||+++ + .+.++||+.+..
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              234589999999999999 4 899999987753

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=96.75  E-value=0.00055  Score=62.20  Aligned_cols=39  Identities=21%  Similarity=0.335  Sum_probs=33.1

Q ss_pred             eeEEEeCCCCCHHHHHHHhcCCcccceeccC-------CCceEeee
Q 036507           43 FLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN-------EKNYIFIK   81 (639)
Q Consensus        43 ~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n-------~~~~l~ip   81 (639)
                      ..+|+||+||||..||++|+++..+|+++|.       .++.+.||
T Consensus         2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~~l~~g~~i~ip   47 (165)
T 4a1k_A            2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIP   47 (165)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGGCCCTTCEEEET
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCCccCCCccccCc
Confidence            5789999999999999999999999995554       34667776

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.55  E-value=0.0048  Score=63.97  Aligned_cols=70  Identities=10%  Similarity=0.082  Sum_probs=42.6

Q ss_pred             CceeecCceEEEEEEEcC----------ceEEEEEeccccH--HHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEEEEEe
Q 036507          357 SLLGHGTYGSVYYGNIRN----------QEVAIKRMTATKT--KEFMAEMKILCKVHHSN-LVELIGYAATEDELFLIYE  423 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~----------~~vavK~~~~~~~--~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv~e  423 (639)
                      +.|+.|....+|+....+          +.+++|+......  .+...|.++++.+...+ ..++++..  .  -+++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            457778888999988754          6788887654321  12357888888775333 33565543  2  268999


Q ss_pred             eccCCCh
Q 036507          424 YAQKGSL  430 (639)
Q Consensus       424 ~~~~gsL  430 (639)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.43  E-value=0.015  Score=59.50  Aligned_cols=67  Identities=12%  Similarity=0.117  Sum_probs=43.2

Q ss_pred             ecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHHHhcCC---CCeeEEEee------eecCCeEEEEEeeccCCCh
Q 036507          361 HGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKILCKVHH---SNLVELIGY------AATEDELFLIYEYAQKGSL  430 (639)
Q Consensus       361 ~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~h---~niv~l~~~------~~~~~~~~lv~e~~~~gsL  430 (639)
                      .|....||+....+..+++|+......   .+|++++..|..   |++.+++..      ....+..+++|||++|..+
T Consensus        33 ~g~~N~vy~v~~~~g~~vLK~~~~~~~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           33 ADTNAFAYQADSESKSYFIKLKYGYHD---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             SCSSCEEEEEECSSCEEEEEEEECSSC---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             CccccceEEEEeCCCCEEEEEecCccc---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            333678999887666999998765432   356666666531   224444432      2235678999999998766

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=96.40  E-value=0.0048  Score=63.44  Aligned_cols=53  Identities=15%  Similarity=0.282  Sum_probs=44.9

Q ss_pred             CCCceEEEEecCCCcHHHHHHHhCCChHHHHHHcCCC----CCCCccCCceEEecCC
Q 036507          147 LWNYLMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIV----NPNNVTAGDLFYIPLN  199 (639)
Q Consensus       147 ~~~~~~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~----~~~~l~~g~~l~ip~~  199 (639)
                      ...+..+|+|++||||.+|-+++|++.+++.+++...    +...|+|||+|.+.+.
T Consensus        10 ~~~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~   66 (371)
T 3slu_A           10 QTAYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVG   66 (371)
T ss_dssp             CCCEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEEC
T ss_pred             CCCceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEEC
Confidence            3457888999999999999999999999999988653    5678999999999764

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=95.33  E-value=0.025  Score=58.06  Aligned_cols=106  Identities=14%  Similarity=0.082  Sum_probs=67.1

Q ss_pred             ceeeceeEEEEcCCceeehhHHHh------cCCccccc---CCCcccCCCCEEEEeeeecCC--------CC-CCCceE-
Q 036507           92 NYVSNTTFTVKSSGGYVYDVVVNA------YDGLAILD---NSTRMARAGAVVSLRLFCGCS--------SG-LWNYLM-  152 (639)
Q Consensus        92 ~~~~~~~y~v~~gd~t~~~ia~~~------~~~l~~~~---~~~~~l~~g~~l~ip~~~~~~--------~~-~~~~~~-  152 (639)
                      ....+..|+|++|| ||..|-+..      ...+....   .....|++||+|.+.....-.        +. .....+ 
T Consensus        10 ~~~~W~~~~V~~GD-TL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~   88 (371)
T 3slu_A           10 QTAYWVQEAVQPGD-SLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVA   88 (371)
T ss_dssp             CCCEEEEEECCTTC-CHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEE
T ss_pred             CCCceEEEEECCCC-cHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEE
Confidence            34456779999999 999888732      11111111   233469999999997632100        00 000000 


Q ss_pred             ------EEEe----------------cCCCcHHHHHHHhCCChHHHHHHcCCCCC----CCccCCceEEecC
Q 036507          153 ------SYVM----------------KDGDTVQSLASRFGVSMDSIEQVNGIVNP----NNVTAGDLFYIPL  198 (639)
Q Consensus       153 ------~y~v----------------~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~----~~l~~g~~l~ip~  198 (639)
                            .|++                .-.++|+..|.+.|++.+.+++++.+-..    ..|++|+.+.|..
T Consensus        89 i~~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~  160 (371)
T 3slu_A           89 LEKKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLIY  160 (371)
T ss_dssp             EEEETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEE
T ss_pred             EEecCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccCcCHHHcCCCCEEEEEE
Confidence                  1222                23899999999999999999998876322    3489999998875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.28  E-value=0.088  Score=49.45  Aligned_cols=102  Identities=10%  Similarity=0.042  Sum_probs=64.9

Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      -+|.+.|..    ...+++..+.+.++.|.+.+|.-+-.+..+  ..+=+-|..|++..+|.+.+.+ +.+.        
T Consensus        33 vSL~eIL~~----~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           33 LSLEEILRL----YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             ccHHHHHHH----cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence            378888863    346799999999999999988776221111  1223346899999999988764 2111        


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE  552 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~  552 (639)
                             .....+.+||... ...+.+.-|||+|+++|.-+--..
T Consensus        98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence                   0122466888763 345678899999999999887443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.71  E-value=0.022  Score=38.44  Aligned_cols=17  Identities=29%  Similarity=0.354  Sum_probs=10.3

Q ss_pred             eeehhhhHHHHHHHHHH
Q 036507          240 WIIGGLVVGLGLIILSI  256 (639)
Q Consensus       240 ~ii~~i~~~~~~~~l~~  256 (639)
                      .|++|+++|++++++++
T Consensus        12 ~IA~gVVgGv~~~~ii~   28 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVA   28 (44)
T ss_dssp             SSTHHHHHHHHHHHHHH
T ss_pred             eEEeehhHHHHHHHHHH
Confidence            36667777666555444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.29  E-value=0.25  Score=51.92  Aligned_cols=140  Identities=12%  Similarity=0.165  Sum_probs=83.2

Q ss_pred             CCceeecCceEEEEEEEc---------CceEEEEEecccc--HHHHHHHHHHHHhcCCCC-eeEEEeeeecCCeEEEEEe
Q 036507          356 SSLLGHGTYGSVYYGNIR---------NQEVAIKRMTATK--TKEFMAEMKILCKVHHSN-LVELIGYAATEDELFLIYE  423 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~---------~~~vavK~~~~~~--~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv~e  423 (639)
                      .+.+..|-...+|+....         +..+++|+.....  .-+..+|.++++.+...+ ..++++.+.    -++|+|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            345777888899998876         5789998864422  123357888888875222 344555432    278999


Q ss_pred             eccCCChhh-h----------------ccCCCC-----C---CCCCCCHHHHHHHHHHH-------------------HH
Q 036507          424 YAQKGSLKS-H----------------LHDPQN-----R---GQTSLSWIMRVQIALDA-------------------AR  459 (639)
Q Consensus       424 ~~~~gsL~~-~----------------l~~~~~-----~---~~~~l~~~~~~~i~~~i-------------------a~  459 (639)
                      |++|..|.. -                +|....     .   ...+.-|....++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            999866421 0                111100     0   11222244433333222                   22


Q ss_pred             HHHHHHh---------------------cCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          460 GLEYIHE---------------------HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       460 al~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      .+.+|.+                     ..+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2333321                     11345999999999999 7888999999998863

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.00  E-value=0.026  Score=38.05  Aligned_cols=17  Identities=24%  Similarity=0.444  Sum_probs=10.2

Q ss_pred             eeehhhhHHHHHHHHHH
Q 036507          240 WIIGGLVVGLGLIILSI  256 (639)
Q Consensus       240 ~ii~~i~~~~~~~~l~~  256 (639)
                      .|++|+++|++++++++
T Consensus        11 aIA~gVVgGv~~v~ii~   27 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVG   27 (44)
T ss_dssp             HHHHHHHHHHHHHHHHH
T ss_pred             eEEEeehHHHHHHHHHH
Confidence            46667777666555443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=91.29  E-value=0.087  Score=35.40  Aligned_cols=9  Identities=11%  Similarity=0.246  Sum_probs=4.0

Q ss_pred             HHHHhhccc
Q 036507          257 AVCIWLRSS  265 (639)
Q Consensus       257 ~~~~~~~~~  265 (639)
                      .+++|+|+|
T Consensus        30 ~~~~~~RRR   38 (44)
T 2jwa_A           30 VFGILIKRR   38 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHhheehh
Confidence            344455443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.55  E-value=0.86  Score=42.63  Aligned_cols=124  Identities=10%  Similarity=0.109  Sum_probs=83.2

Q ss_pred             HHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036507          393 EMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY  472 (639)
Q Consensus       393 E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i  472 (639)
                      |+.+|.. .||+.+.. .+-..++.+.+.|+.-+.+.=...+        ..++...+++++.+|+....+++.     -
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--------k~~~~~eKlr~l~ni~~l~~~~~~-----r  100 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--------KSFTKNEKLRYLLNIKNLEEVNRT-----R  100 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--------GGSCHHHHHHHHHHGGGGGGGGGS-----S
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--------HhcCHHHHHHHHHHHHHHHHHhcC-----c
Confidence            3444433 58888866 4666677777777654422222223        237788899999999988866664     5


Q ss_pred             eeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCc
Q 036507          473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE  552 (639)
Q Consensus       473 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~  552 (639)
                      +|--|.|+|++++.++.+++.=.|+-..                    ++|.     ..++..=.-.+=+++..+++++.
T Consensus       101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~--------------------l~P~-----~~~ee~fL~qyKAliiall~~K~  155 (215)
T 4ann_A          101 YTFVLAPDELFFTRDGLPIAKTRGLQNV--------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQ  155 (215)
T ss_dssp             EECCCSGGGEEECTTSCEEESCCEETTT--------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTC
T ss_pred             eEEEEecceEEEcCCCCEEEEEccCccC--------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCC
Confidence            7888999999999999999987765432                    2232     12222334567889999999988


Q ss_pred             cccc
Q 036507          553 AIIR  556 (639)
Q Consensus       553 p~~~  556 (639)
                      .|..
T Consensus       156 ~Fe~  159 (215)
T 4ann_A          156 SFDA  159 (215)
T ss_dssp             CHHH
T ss_pred             CHHH
Confidence            8843

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=85.81  E-value=0.33  Score=32.32  Aligned_cols=15  Identities=40%  Similarity=0.718  Sum_probs=9.3

Q ss_pred             ceeehhhhHHHHHHH
Q 036507          239 GWIIGGLVVGLGLII  253 (639)
Q Consensus       239 ~~ii~~i~~~~~~~~  253 (639)
                      +++++++++|+++++
T Consensus        13 ~~I~~~vv~Gv~ll~   27 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLL   27 (41)
T ss_dssp             THHHHHHHHHHHHHH
T ss_pred             EEEEeehhHHHHHHH
Confidence            446666676666655

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.67  E-value=1.6  Score=40.90  Aligned_cols=115  Identities=10%  Similarity=0.131  Sum_probs=78.4

Q ss_pred             CCCCeeEEEeeeecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeCCCCC
Q 036507          401 HHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE-YIHEHTKTHYVHRDIKS  479 (639)
Q Consensus       401 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~-~LH~~~~~~ivH~Dlkp  479 (639)
                      .||++  -..+-.+++.+.+.|+.-+++.=..-++        .++...+++++.+|+.... +++.     -+|--|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence            57887  4445567788888777654433333333        2677888888888887766 5654     67888999


Q ss_pred             CcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccc
Q 036507          480 SNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAII  555 (639)
Q Consensus       480 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~  555 (639)
                      +|+++|.++.+++.=.|+-..                    ++|.-+     ++.-=.-.+=+++..++.++..|+
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~~--------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKES--------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGEEECTTCCEEESCCEETTT--------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             ceEEEeCCCcEEEEEcCCccc--------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999987775432                    333221     222224467788888999887774

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=84.03  E-value=0.73  Score=30.03  Aligned_cols=15  Identities=27%  Similarity=0.073  Sum_probs=8.4

Q ss_pred             eeehhhhHHHHHHHH
Q 036507          240 WIIGGLVVGLGLIIL  254 (639)
Q Consensus       240 ~ii~~i~~~~~~~~l  254 (639)
                      ..|+|+++|+++.++
T Consensus        11 GaIAGiVvG~v~gv~   25 (38)
T 2k1k_A           11 GEIVAVIFGLLLGAA   25 (38)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             CceeeeehHHHHHHH
Confidence            355677766654433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	639
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-15
d1e0ga_	48	d.7.1.1 (A:) Membrane-bound lytic murein transclyc	3e-06
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	6e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 3e-66
 Identities = 75/290 (25%), Positives = 139/290 (47%), Gaps = 41/290 (14%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGYA 412
            +G G++G+VY G   + +VA+K +     T  + + F  E+ +L K  H N++  +GY+
Sbjct: 15  RIGSGSFGTVYKG-KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
            T  +L ++ ++ +  SL  HLH  + +       I  + IA   A+G++Y+H       
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAK---SI 125

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT---DG 529
           +HRD+KS+NI L      KI DFGLA +  +   G     ++ G+  ++APE +      
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSR-WSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 530 LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS 589
             + +SDVYAFG+VL+E+++G+        +                   N+ D +    
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY---SNI-------------------NNRDQIIFMV 222

Query: 590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
            + Y+ P++  +   +C   M  L  +C+ +    RP   Q++ S+  + 
Sbjct: 223 GRGYLSPDLSKV-RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 1e-61
 Identities = 74/300 (24%), Positives = 135/300 (45%), Gaps = 33/300 (11%)

Query: 359 LGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFM--AEMKILCKVHHSNLVELIGYAATED 416
           +G G +G V+ G  R +EVA+K  ++ + + +   AE+     + H N++  I     ++
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 70

Query: 417 ----ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH----- 467
               +L+L+ +Y + GSL  +L+      + +++    +++AL  A GL ++H       
Sbjct: 71  GTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATV-TKVVGTFGYLAPEYL 526
            K    HRD+KS NIL+       I+D GLA      +D         VGT  Y+APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 527 TDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            D +      +  ++D+YA G+V +EI             +    E   L  + L     
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRC--------SIGGIHEDYQLPYYDLVPSDP 236

Query: 581 SPDSMSMSSLKDYIDPNMMDLY-PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           S + M     +  + PN+ + +   + L  MA + ++C   +   R    ++  +LSQ+ 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-60
 Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 39/285 (13%)

Query: 358 LLGHGTYGSVYYGNIR-NQEVAIKRM--TATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
            LG G +G V+ G    + +VA+K +   +     F+AE  ++ ++ H  LV L     T
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           ++ +++I EY + GSL   L  P       L+    + +A   A G+ +I E    +Y+H
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER---NYIH 132

Query: 475 RDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAK 534
           RD++++NIL+      KI+DFGLA+L+    +             + APE +  G  T K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 535 SDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYI 594
           SDV++FG++L EI++                             R     M+   +   +
Sbjct: 191 SDVWSFGILLTEIVTHG---------------------------RIPYPGMTNPEVIQNL 223

Query: 595 DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           +     + P +C  ++  L + C  E P  RP    +   L    
Sbjct: 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-60
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 41/283 (14%)

Query: 358 LLGHGTYGSVYYGNIRNQEVAIKRMTATKT-KEFMAEMKILCKVHHSNLVELIGYAATED 416
            +G G +G V  G+ R  +VA+K +    T + F+AE  ++ ++ HSNLV+L+G    E 
Sbjct: 14  TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73

Query: 417 E-LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             L+++ EY  KGSL  +L    +RG++ L     ++ +LD    +EY+  +   ++VHR
Sbjct: 74  GGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 127

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N+L+     AK+SDFGL K    T               + APE L +   + KS
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 181

Query: 536 DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYID 595
           DV++FG++L+EI S                             R     + +  +   ++
Sbjct: 182 DVWSFGILLWEIYSFG---------------------------RVPYPRIPLKDVVPRVE 214

Query: 596 PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
                  P  C   +  + K C   D  +RP   Q+   L  I
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  201 bits (511), Expect = 4e-60
 Identities = 74/319 (23%), Positives = 137/319 (42%), Gaps = 54/319 (16%)

Query: 341 FTYDEILFATEGFSDS---------SLLGHGTYGSVYYG-----NIRNQEVAIKRMTATK 386
           FT+++   A   F+            ++G G +G V  G       R   VAIK + +  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 387 T----KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQ 442
           T    ++F++E  I+ +  H N++ L G       + +I E+ + GSL S L     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 443 TSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG 502
              + I  V +    A G++Y+ +    +YVHRD+ + NIL++S    K+SDFGL++ + 
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 503 KTSDGEATVTKV--VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGM 560
             +      + +       + APE +     T+ SDV+++G+V++E++S  E        
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER------- 232

Query: 561 VSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDE 620
                                   M+   + + I+ +     P DC   +  L   C  +
Sbjct: 233 --------------------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQK 272

Query: 621 DPILRPDMKQVVISLSQIL 639
           D   RP   Q+V +L +++
Sbjct: 273 DRNHRPKFGQIVNTLDKMI 291

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-59
 Identities = 67/304 (22%), Positives = 128/304 (42%), Gaps = 33/304 (10%)

Query: 349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT----KEFMAEMKILCKVHH 402
             + F   S LG G  G V+  + +     +A K +          + + E+++L + + 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
             +V   G   ++ E+ +  E+   GSL   L          +   +  ++++   +GL 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLT 118

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+ E  K   +HRD+K SNIL++S    K+ DFG++  +  +          VGT  Y++
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMS 171

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGK-------------EAIIRTEGMVSKNQER-R 568
           PE L     + +SD+++ G+ L E+  G+                 + EG  ++   R R
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 569 SLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAM-LAKQCVDEDPILRPD 627
           +    + +   +S   M++  L DYI        P             +C+ ++P  R D
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 628 MKQV 631
           +KQ+
Sbjct: 292 LKQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-58
 Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 39/283 (13%)

Query: 359 LGHGTYGSVYYGNIR-NQEVAIKRM--TATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           LG G +G V YG  R   +VAIK +   +    EF+ E K++  + H  LV+L G    +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             +F+I EY   G L ++L + ++R          +++  D    +EY+       ++HR
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESK---QFLHR 124

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L++     K+SDFGL++ V    D   +         +  PE L     ++KS
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 536 DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYID 595
           D++AFGV+++EI S                             +   +  + S   ++I 
Sbjct: 183 DIWAFGVLMWEIYSLG---------------------------KMPYERFTNSETAEHIA 215

Query: 596 PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
             +    PH    K+  +   C  E    RP  K ++ ++  +
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-57
 Identities = 72/306 (23%), Positives = 130/306 (42%), Gaps = 46/306 (15%)

Query: 344 DEILFATEGFSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTATKT----KEFMAE 393
            EI       +   ++G G +G VY G ++         VAIK + A  T     +F+ E
Sbjct: 2   TEI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59

Query: 394 MKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
             I+ +  H N++ L G  +    + +I EY + G+L   L +         S +  V +
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGM 115

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
               A G++Y+      +YVHRD+ + NIL++S    K+SDFGL++++    +   T + 
Sbjct: 116 LRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 514 VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF 573
                 + APE ++    T+ SDV++FG+V++E+++  E                     
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP------------------- 213

Query: 574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI 633
                      +S   +   I+       P DC   +  L  QC  ++   RP    +V 
Sbjct: 214 --------YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265

Query: 634 SLSQIL 639
            L +++
Sbjct: 266 ILDKLI 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (488), Expect = 5e-57
 Identities = 70/306 (22%), Positives = 133/306 (43%), Gaps = 39/306 (12%)

Query: 338 PVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM--TATKTKEFMAE 393
           P    YD+        +    LG G YG VY G  +  +  VA+K +     + +EF+ E
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63

Query: 394 MKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQI 453
             ++ ++ H NLV+L+G    E   ++I E+   G+L  +L +     +  +S ++ + +
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYM 120

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
           A   +  +EY+ +    +++HRD+ + N L+      K++DFGL++L+  T D       
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAG 175

Query: 514 VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF 573
                 + APE L     + KSDV+AFGV+L+EI +                        
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG---------------------- 213

Query: 574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI 633
                 +    + +S + + ++ +     P  C  K+  L + C   +P  RP   ++  
Sbjct: 214 -----MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

Query: 634 SLSQIL 639
           +   + 
Sbjct: 269 AFETMF 274

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-56
 Identities = 63/284 (22%), Positives = 121/284 (42%), Gaps = 39/284 (13%)

Query: 359 LGHGTYGSVYYG-NIRNQEVAIKRM--TATKTKEFMAEMKILCKVHHSNLVELIGYAATE 415
           +G G +G V+ G  +   +VAIK +   A   ++F+ E +++ K+ H  LV+L G    +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72

Query: 416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHR 475
             + L++E+ + G L  +L   +       +    + + LD   G+ Y+ E      +HR
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEEA---CVIHR 125

Query: 476 DIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKS 535
           D+ + N L+      K+SDFG+ + V    D   + T       + +PE  +    ++KS
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 536 DVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYID 595
           DV++FGV+++E+ S                             +   ++ S S + + I 
Sbjct: 184 DVWSFGVLMWEVFSEG---------------------------KIPYENRSNSEVVEDIS 216

Query: 596 PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
                  P      +  +   C  E P  RP   +++  L++I 
Sbjct: 217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-56
 Identities = 68/304 (22%), Positives = 121/304 (39%), Gaps = 44/304 (14%)

Query: 345 EILFATEGFSDSSL-LGHGTYGSVYYGNIR----NQEVAIKRM----TATKTKEFMAEMK 395
           ++    +    + + LG G +GSV  G  R      +VAIK +        T+E M E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 396 ILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           I+ ++ +  +V LIG     + L L+ E A  G L   L   +      +      ++  
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLH 116

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
             + G++Y+ E    ++VHRD+ + N+LL +   AKISDFGL+K +G         +   
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 516 GTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML 575
               + APE +     +++SDV+++GV ++E                            L
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWE---------------------------AL 206

Query: 576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISL 635
           +  +     M    +  +I+       P +C  ++  L   C       RPD   V   +
Sbjct: 207 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

Query: 636 SQIL 639
               
Sbjct: 267 RACY 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  189 bits (481), Expect = 7e-56
 Identities = 66/327 (20%), Positives = 118/327 (36%), Gaps = 61/327 (18%)

Query: 343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKT----KEFM 391
              + +          +G G +G V+               VA+K +    +     +F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 392 AEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR----------- 440
            E  ++ +  + N+V+L+G  A    + L++EY   G L   L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 441 --------GQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI 492
                   G   LS   ++ IA   A G+ Y+ E     +VHRD+ + N L+      KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181

Query: 493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE 552
           +DFGL++ +  ++D             ++ PE +     T +SDV+A+GVVL+EI S   
Sbjct: 182 ADFGLSRNI-YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG- 239

Query: 553 AIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAM 612
                                           M+   +  Y+    +   P +C  ++  
Sbjct: 240 --------------------------LQPYYGMAHEEVIYYVRDGNILACPENCPLELYN 273

Query: 613 LAKQCVDEDPILRPDMKQVVISLSQIL 639
           L + C  + P  RP    +   L ++ 
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQRMC 300

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 8e-56
 Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 45/289 (15%)

Query: 359 LGHGTYGSVYYGNIRN----QEVAIKRMTATKT-----KEFMAEMKILCKVHHSNLVELI 409
           LG G +G+V  G  +     + VA+K +           E +AE  ++ ++ +  +V +I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G     +   L+ E A+ G L  +L          +     +++    + G++Y+ E   
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEES-- 126

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
            ++VHRD+ + N+LL +   AKISDFGL+K +    +     T       + APE +   
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 530 LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSS 589
             ++KSDV++FGV+++E  S  +                                M  S 
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPY---------------------------RGMKGSE 218

Query: 590 LKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           +   ++       P  C  +M  L   C   D   RP    V + L   
Sbjct: 219 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 2e-55
 Identities = 72/302 (23%), Positives = 119/302 (39%), Gaps = 39/302 (12%)

Query: 341 FTYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRM--TATKTKEFMAEMKIL 397
              D      E       LG G +G V+ G       VAIK +       + F+ E +++
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM 66

Query: 398 CKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDA 457
            K+ H  LV+L     +E+ ++++ EY  KGSL   L     +          V +A   
Sbjct: 67  KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQI 122

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           A G+ Y+      +YVHRD++++NIL+      K++DFGLA+L+    +           
Sbjct: 123 ASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 177

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
             + APE    G  T KSDV++FG++L E+ +                            
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG-------------------------- 211

Query: 578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
            R     M    + D ++       P +C   +  L  QC  ++P  RP  + +   L  
Sbjct: 212 -RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270

Query: 638 IL 639
             
Sbjct: 271 YF 272

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 3e-55
 Identities = 79/302 (26%), Positives = 136/302 (45%), Gaps = 54/302 (17%)

Query: 358 LLGHGTYGSVYYGNIRN----QEVAIKRMTATKT----KEFMAEMKILCKV-HHSNLVEL 408
           ++G G +G V    I+      + AIKRM    +    ++F  E+++LCK+ HH N++ L
Sbjct: 17  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLH-----------DPQNRGQTSLSWIMRVQIALDA 457
           +G       L+L  EYA  G+L   L               N   ++LS    +  A D 
Sbjct: 77  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136

Query: 458 ARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGT 517
           ARG++Y+ +     ++HRD+ + NIL+   + AKI+DFGL++      +     T     
Sbjct: 137 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ----EVYVKKTMGRLP 189

Query: 518 FGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA 577
             ++A E L   + T  SDV+++GV+L+EI+S                            
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-------------------------- 223

Query: 578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQ 637
                  M+ + L + +        P +C  ++  L +QC  E P  RP   Q+++SL++
Sbjct: 224 -GTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282

Query: 638 IL 639
           +L
Sbjct: 283 ML 284

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-54
 Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 55/307 (17%)

Query: 358 LLGHGTYGSVYYGNIR-------NQEVAIKRM----TATKTKEFMAEMKILCKV-HHSNL 405
            LG G +G V                VA+K +      T+ +  M+E+K+L  + +H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR-------------GQTSLSWIMRVQ 452
           V L+G         +I EY   G L + L   ++               + +L     + 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
            +   A+G+ ++      + +HRD+ + NILL      KI DFGLA+ + K         
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI-KNDSNYVVKG 205

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
                  ++APE + + + T +SDV+++G+ L+E+ S   +                   
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------------- 246

Query: 573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
                    P     S     I      L P     +M  + K C D DP+ RP  KQ+V
Sbjct: 247 -------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

Query: 633 ISLSQIL 639
             + + +
Sbjct: 300 QLIEKQI 306

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (472), Expect = 2e-54
 Identities = 69/310 (22%), Positives = 122/310 (39%), Gaps = 56/310 (18%)

Query: 334 DMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM------TAT 385
           D +   +F  D+     + FSD   +GHG++G+VY+      ++ VAIK+M      +  
Sbjct: 1   DPDVAELFFKDDP---EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57

Query: 386 KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSL 445
           K ++ + E++ L K+ H N ++  G    E   +L+ EY    +            +  L
Sbjct: 58  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-----KKPL 112

Query: 446 SWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS 505
             +    +   A +GL Y+H H   + +HRD+K+ NILL      K+ DFG A ++    
Sbjct: 113 QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168

Query: 506 DGEATVTKVVGTFGYLAPEYL---TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVS 562
                    VGT  ++APE +    +G    K DV++ G+   E+   K  +        
Sbjct: 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-------- 214

Query: 563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDP 622
                               +  +MS+L          L               C+ + P
Sbjct: 215 -------------------FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255

Query: 623 ILRPDMKQVV 632
             RP  + ++
Sbjct: 256 QDRPTSEVLL 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 3e-53
 Identities = 65/326 (19%), Positives = 131/326 (40%), Gaps = 50/326 (15%)

Query: 325 PKALGTDVFDMEKPVVFTYDEILFATEGFSDSSLLGHGTYGSVYYG-----NIRNQEVAI 379
             AL  ++    + VV     ++     F++  ++G G +G VY+G     + +    A+
Sbjct: 6   LSALNPELVQAVQHVVIGPSSLIVH---FNE--VIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 380 KRM----TATKTKEFMAEMKILCKVHHSNLVELIGYAA-TEDELFLIYEYAQKGSLKSHL 434
           K +       +  +F+ E  I+    H N++ L+G    +E    ++  Y + G L++ +
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 435 HDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISD 494
            +  +      +    +   L  A+G++++       +VHRD+ + N +LD  F  K++D
Sbjct: 121 RNETHN----PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 173

Query: 495 FGLAKLVGKTSDGEATV-TKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEA 553
           FGLA+ +           T       ++A E L     T KSDV++FGV+L+E+++    
Sbjct: 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG-- 231

Query: 554 IIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAML 613
                                          ++   +  Y+      L P  C   +  +
Sbjct: 232 -------------------------APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266

Query: 614 AKQCVDEDPILRPDMKQVVISLSQIL 639
             +C      +RP   ++V  +S I 
Sbjct: 267 MLKCWHPKAEMRPSFSELVSRISAIF 292

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-52
 Identities = 64/308 (20%), Positives = 120/308 (38%), Gaps = 60/308 (19%)

Query: 358 LLGHGTYGSVYYGNIRN-------QEVAIKRM----TATKTKEFMAEMKILCKV-HHSNL 405
           +LG G +G V               +VA+K +     +++ +  M+E+K++ ++  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 406 VELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNR------------------GQTSLSW 447
           V L+G       ++LI+EY   G L ++L   + +                      L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 448 IMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG 507
              +  A   A+G+E++        VHRD+ + N+L+      KI DFGLA+ +  +   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI-MSDSN 219

Query: 508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQER 567
                       ++APE L +G+ T KSDV+++G++L+EI S                  
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--------------- 264

Query: 568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD 627
                         P     ++    I        P     ++ ++ + C   D   RP 
Sbjct: 265 -----------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313

Query: 628 MKQVVISL 635
              +   L
Sbjct: 314 FPNLTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-52
 Identities = 67/305 (21%), Positives = 124/305 (40%), Gaps = 47/305 (15%)

Query: 345 EILFATEGFSDSSLLGHGTYGSVYY------GNIRNQEVAIKRMTATKT----KEFMAEM 394
            IL  TE F    +LG G +G+VY       G      VAIK +    +    KE + E 
Sbjct: 4   RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 395 KILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIA 454
            ++  V + ++  L+G       + LI +    G L     D     + ++     +   
Sbjct: 63  YVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWC 117

Query: 455 LDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKV 514
           +  A+G+ Y+ +      VHRD+ + N+L+ +    KI+DFGLAKL+G   + E      
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-EEKEYHAEGG 173

Query: 515 VGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM 574
                ++A E +   + T +SDV+++GV ++E+++                         
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------------------- 214

Query: 575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVIS 634
                   D +  S +   ++       P  C   + M+  +C   D   RP  ++++I 
Sbjct: 215 --------DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

Query: 635 LSQIL 639
            S++ 
Sbjct: 267 FSKMA 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 4e-52
 Identities = 53/286 (18%), Positives = 111/286 (38%), Gaps = 43/286 (15%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G+YG       +   + +  K +     T  + +  ++E+ +L ++ H N+V    
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 411 Y--AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                T   L+++ EY + G L S +       Q  L     +++       L+  H  +
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECHRRS 129

Query: 469 KTH--YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                 +HRD+K +N+ LD     K+ DFGLA+++   +   +     VGT  Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKAFVGTPYYMSPEQM 186

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
                  KSD+++ G +L+E+ +                                  + S
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPF----------------------------TAFS 218

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
              L   I        P+    ++  +  + ++     RP +++++
Sbjct: 219 QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-51
 Identities = 64/281 (22%), Positives = 102/281 (36%), Gaps = 42/281 (14%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKT----KEFMAEMKILCKVHHSNLVELIGY 411
            LG G YG V     R   + VA+K +   +     +    E+ I   ++H N+V+  G+
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
               +  +L  EY   G L   +          +      +       G+ Y+H      
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGI---G 123

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-L 530
             HRDIK  N+LLD     KISDFGLA +    +  E  + K+ GT  Y+APE L     
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREF 182

Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
                DV++ G+VL  +++G+                          L     S S    
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE--------------------------LPWDQPSDSCQEY 216

Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
            D+ +                 L  + + E+P  R  +  +
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-51
 Identities = 56/283 (19%), Positives = 116/283 (40%), Gaps = 46/283 (16%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELIGYAA 413
           LG G +G VY    +  +   A K +   +  + +++M E+ IL    H N+V+L+    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
            E+ L+++ E+   G++ + + + +      L+      +       L Y+H++     +
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLHDN---KII 132

Query: 474 HRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL-----TD 528
           HRD+K+ NIL       K++DFG++    +T          +GT  ++APE +      D
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---RRDSFIGTPYWMAPEVVMCETSKD 189

Query: 529 GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS 588
                K+DV++ G+ L E+   +                 +    +L   ++ P ++   
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIE-----------PPHHELNPMRVLLKIAKSEPPTL--- 235

Query: 589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           +       N  D              K+C++++   R    Q+
Sbjct: 236 AQPSRWSSNFKD------------FLKKCLEKNVDARWTTSQL 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-51
 Identities = 68/293 (23%), Positives = 110/293 (37%), Gaps = 50/293 (17%)

Query: 348 FATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCK 399
           +A E F     LG G +G+VY    +     +A+K +       A    +   E++I   
Sbjct: 3   WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSH 62

Query: 400 VHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAAR 459
           + H N++ L GY      ++LI EYA  G++   L                     + A 
Sbjct: 63  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELAN 117

Query: 460 GLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
            L Y H       +HRDIK  N+LL SA   KI+DFG +     +       T + GT  
Sbjct: 118 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTTLCGTLD 169

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           YL PE +   +   K D+++ GV+ +E + GK              E  +         R
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-----------EANTYQETYKRISR 218

Query: 580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
                       D++     D            L  + +  +P  RP +++V+
Sbjct: 219 VEFT------FPDFVTEGARD------------LISRLLKHNPSQRPMLREVL 253

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-50
 Identities = 53/287 (18%), Positives = 109/287 (37%), Gaps = 52/287 (18%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +G G++ +VY G       EVA   +     T ++ + F  E ++L  + H N+V     
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 412 AAT----EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
             +    +  + L+ E    G+LK++L   +      +   +         +GL+++H  
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR 131

Query: 468 TKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL 526
                +HRD+K  NI +       KI D GLA L   +         V+GT  ++APE  
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMY 185

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
            +       DVYAFG+ + E+ + +                               +  +
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSE---------------------------YPYSECQN 217

Query: 587 MSSLKDYI-DPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
            + +   +        +    + ++  + + C+ ++   R  +K ++
Sbjct: 218 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-50
 Identities = 76/316 (24%), Positives = 137/316 (43%), Gaps = 47/316 (14%)

Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATKT----K 388
           V+  DE   A E  + S  LG G++G VY G  +          VAIK +    +     
Sbjct: 9   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 68

Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQ-----NRGQT 443
           EF+ E  ++ + +  ++V L+G  +      +I E   +G LKS+L   +     N    
Sbjct: 69  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128

Query: 444 SLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK 503
             S    +Q+A + A G+ Y++ +    +VHRD+ + N ++   F  KI DFG+ + + +
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 185

Query: 504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSK 563
           T D      K +    +++PE L DG+ T  SDV++FGVVL+EI +              
Sbjct: 186 T-DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA------------ 232

Query: 564 NQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPI 623
                                +S   +  ++    +   P +C   +  L + C   +P 
Sbjct: 233 ---------------EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPK 277

Query: 624 LRPDMKQVVISLSQIL 639
           +RP   +++ S+ + +
Sbjct: 278 MRPSFLEIISSIKEEM 293

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 3e-49
 Identities = 66/292 (22%), Positives = 106/292 (36%), Gaps = 47/292 (16%)

Query: 359 LGHGTYGSVYYG-----NIRNQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVE 407
           LG G++G V  G     + +   VA+K +            +F+ E+  +  + H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L G       + ++ E A  GSL   L   Q             + A+  A G+ Y+   
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLESK 130

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
               ++HRD+ + N+LL +    KI DFGL + + +  D           F + APE L 
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
               +  SD + FGV L+E                           M    +     ++ 
Sbjct: 188 TRTFSHASDTWMFGVTLWE---------------------------MFTYGQEPWIGLNG 220

Query: 588 SSLKDYIDPNMMDL-YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI 638
           S +   ID     L  P DC   +  +  QC    P  RP    +   L + 
Sbjct: 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 4e-49
 Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 46/291 (15%)

Query: 358 LLGHGTYGSVYYGNIRNQE-----VAIKRMTATKT----KEFMAEMKILCKVHHSNLVEL 408
            +G G +G V+ G   + E     VAIK      +    ++F+ E   + +  H ++V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
           IG   TE+ +++I E    G L+S L   +     SL     +  A   +  L Y+    
Sbjct: 74  IGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK- 127

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
              +VHRDI + N+L+ S    K+ DFGL++ +          +K      ++APE +  
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINF 183

Query: 529 GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMS 588
              T+ SDV+ FGV ++EI+                                    +  +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHG---------------------------VKPFQGVKNN 216

Query: 589 SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
            +   I+       P +C   +  L  +C   DP  RP   ++   LS IL
Sbjct: 217 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 7e-49
 Identities = 76/307 (24%), Positives = 132/307 (42%), Gaps = 56/307 (18%)

Query: 358 LLGHGTYGSVYYG---------NIRNQEVAIKRMTATKT----KEFMAEMKILCKV-HHS 403
            LG G +G V              R  +VA+K + +  T     + ++EM+++  +  H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLH-----------DPQNRGQTSLSWIMRVQ 452
           N++ L+G    +  L++I EYA KG+L+ +L            +P +  +  LS    V 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 453 IALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVT 512
            A   ARG+EY+        +HRD+ + N+L+      KI+DFGLA+ +      + T  
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 513 KVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLAS 572
                  ++APE L D + T +SDV++FGV+L+EI +   +                   
Sbjct: 197 GR-LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP------------------ 237

Query: 573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV 632
                       + +  L   +        P +C  ++ M+ + C    P  RP  KQ+V
Sbjct: 238 ---------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

Query: 633 ISLSQIL 639
             L +I+
Sbjct: 289 EDLDRIV 295

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-47
 Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 43/279 (15%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELIGYA 412
            +G G  G+VY        QEVAI++M      K +  + E+ ++ +  + N+V  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
              DEL+++ EY   GSL   + +                +  +  + LE++H +     
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHSN---QV 137

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRDIKS NILL      K++DFG    +          + +VGT  ++APE +T     
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYG 194

Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
            K D+++ G++  E+I G+                  L +  L A   +P+        +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPY----------LNENPLRALYLIATNGTPE----LQNPE 240

Query: 593 YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
            +     D               +C+D D   R   K++
Sbjct: 241 KLSAIFRD------------FLNRCLDMDVEKRGSAKEL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 3e-47
 Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 54/306 (17%)

Query: 358 LLGHGTYGSVYYGNIR-------NQEVAIKRM----TATKTKEFMAEMKILCK-VHHSNL 405
            LG G +G V   +          + VA+K +    T ++ +  M+E+KIL    HH N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 406 VELIGYAATEDE-LFLIYEYAQKGSLKSHLHD-----------PQNRGQTSLSWIMRVQI 453
           V L+G        L +I E+ + G+L ++L             P++  +  L+    +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 454 ALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTK 513
           +   A+G+E++        +HRD+ + NILL      KI DFGLA+ + K  D       
Sbjct: 140 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GD 195

Query: 514 VVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF 573
                 ++APE + D + T +SDV++FGV+L+EI S                        
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--------------------- 234

Query: 574 MLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI 633
                   P           +        P     +M      C   +P  RP   ++V 
Sbjct: 235 -----SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

Query: 634 SLSQIL 639
            L  +L
Sbjct: 290 HLGNLL 295

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 67/312 (21%), Positives = 117/312 (37%), Gaps = 51/312 (16%)

Query: 332 VFDMEK-----PVVFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMT- 383
           VFD+ K     PV   +D +L   + +     LG G +G V+    R      A K +  
Sbjct: 5   VFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61

Query: 384 --ATKTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRG 441
              +  +    E++ +  + H  LV L      ++E+ +IYE+   G L   + D  N+ 
Sbjct: 62  PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK- 120

Query: 442 QTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF--RAKISDFGLAK 499
              +S    V+      +GL ++HE+   +YVH D+K  NI+  +      K+ DFGL  
Sbjct: 121 ---MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174

Query: 500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEG 559
            +    D + +V    GT  + APE          +D+++ GV+ + ++SG         
Sbjct: 175 HL----DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL-------- 222

Query: 560 MVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVD 619
                            +     +           D NM D              ++ + 
Sbjct: 223 -----------------SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 265

Query: 620 EDPILRPDMKQV 631
            DP  R  + Q 
Sbjct: 266 ADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-44
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCKVHH 402
           E F    +LG G++ +V        ++E AIK +         K      E  ++ ++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 403 SNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLE 462
              V+L      +++L+    YA+ G L  ++         S           +    LE
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALE 122

Query: 463 YIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLA 522
           Y+H       +HRD+K  NILL+     +I+DFG AK++   S         VGT  Y++
Sbjct: 123 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQYVS 178

Query: 523 PEYLTDGLATAKSDVYAFGVVLFEIISGK 551
           PE LT+  A   SD++A G +++++++G 
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 60/281 (21%), Positives = 104/281 (37%), Gaps = 43/281 (15%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRM---TATKTKEFMAEMKILCKVHHSNLVELIGYA 412
            LG G +G V+        +    K +             E+ I+ ++HH  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
             + E+ LI E+   G L   +     +    +S    +     A  GL+++HEH     
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMHEH---SI 148

Query: 473 VHRDIKSSNILLDSAF--RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
           VH DIK  NI+ ++      KI DFGLA  +         V     T  + APE +    
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREP 204

Query: 531 ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSL 590
               +D++A GV+ + ++SG       + + +    +R    F      ++  S+S    
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----DEDAFSSVS-PEA 259

Query: 591 KDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           KD+I                    K  + ++P  R  +   
Sbjct: 260 KDFI--------------------KNLLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 56/295 (18%), Positives = 121/295 (41%), Gaps = 46/295 (15%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVELI 409
           +LG G    V+       +++VA+K +        +    F  E +    ++H  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 410 GYAATEDE----LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIH 465
                E       +++ EY    +L+  +H         ++    +++  DA + L + H
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFSH 128

Query: 466 EHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEY 525
           ++     +HRD+K +NI++ +    K+ DFG+A+ +  + +       V+GT  YL+PE 
Sbjct: 129 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
                  A+SDVY+ G VL+E+++G+                 S  S     +R  P  +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPF-----------TGDSPVSVAYQHVREDP--I 232

Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-DMKQVVISLSQIL 639
             S+  + +  ++              +  + + ++P  R     ++   L ++ 
Sbjct: 233 PPSARHEGLSADLDA------------VVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 5e-41
 Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 42/300 (14%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIG 410
           ++D+ ++G+G++G VY   +    + VAIK++   K +    E++I+ K+ H N+V L  
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRY 80

Query: 411 YAATEDE------LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           +  +  E      L L+ +Y  +   +   H   +R + +L  I          R L YI
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 465 HEHTKTHYVHRDIKSSNILLDS-AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           H        HRDIK  N+LLD      K+ DFG AK +     GE  V+ +   +     
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSYICSRYYRAPE 192

Query: 524 EYLTDGLATAKSDVYAFGVVLFEIISGK------------EAIIRTEGMVSKNQERRSLA 571
                   T+  DV++ G VL E++ G+              II+  G  ++ Q R    
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 572 SFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           ++                 +    P  +             L  + ++  P  R    + 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIA------------LCSRLLEYTPTARLTPLEA 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 8e-41
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 14/291 (4%)

Query: 350 TEGFSDSSLLGHGTYGSVYYG--NIRNQEVAIKRMTATKT----KEFMAEMKILCKVHHS 403
              +++ S +G G YG V     N+    VAIK+++  +     +  + E+KIL +  H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N++ +           +   Y     + + L+         LS            RGL+Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           IH     + +HRD+K SN+LL++    KI DFGLA++     D    +T+ V T  Y AP
Sbjct: 125 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 524 EYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           E + +    T   D+++ G +L E++S +        +   N     L S     L    
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 583 DSMSMSSLKDYIDPNMMDL--YPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           +  + + L      N +       +   K   L  + +  +P  R +++Q 
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (370), Expect = 2e-40
 Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 58/302 (19%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT------------KEFMAEMKI 396
           E +    +LG G    V     +   +E A+K +  T              +  + E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 397 LCKVH-HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIAL 455
           L KV  H N+++L     T    FL+++  +KG L  +L +     + +LS     +I  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMR 117

Query: 456 DAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVV 515
                +  +H+    + VHRD+K  NILLD     K++DFG +  +    D    + +V 
Sbjct: 118 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVC 170

Query: 516 GTFGYLAPEYLTDGLA------TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS 569
           GT  YLAPE +   +         + D+++ GV+++ +++G       + M+        
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------- 222

Query: 570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK 629
               ML  + +           D     + D            L  + +   P  R   +
Sbjct: 223 ----MLRMIMSGNYQFGSPEWDD-YSDTVKD------------LVSRFLVVQPQKRYTAE 265

Query: 630 QV 631
           + 
Sbjct: 266 EA 267

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 33/290 (11%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKT--------KEFMAEMKILCKVHHSNLVE 407
            LG G + +VY    +  NQ VAIK++             +  + E+K+L ++ H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 408 LIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH 467
           L+     +  + L++++ +                  L+        L   +GLEY+H+H
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 468 TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYL- 526
                +HRD+K +N+LLD     K++DFGLAK  G  +      T  V T  Y APE L 
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYTHQVVTRWYRAPELLF 173

Query: 527 TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS 586
              +     D++A G +L E++     +     +    +   +L +              
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP------TEEQWPD 227

Query: 587 MSSLKDYIDPNMMDLYPHDCLFKMAM-----LAKQCVDEDPILRPDMKQV 631
           M SL DY+        P   +F  A      L +     +P  R    Q 
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-40
 Identities = 46/280 (16%), Positives = 99/280 (35%), Gaps = 42/280 (15%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKE--FMAEMKILCKVHHSNLVELIGYAA 413
            LG G +G V+        +    K +    T +     E+ IL    H N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 414 TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYV 473
           + +EL +I+E+     +   ++         L+    V         L+++H H   +  
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQFLHSH---NIG 124

Query: 474 HRDIKSSNILLDS--AFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
           H DI+  NI+  +  +   KI +FG A+ +            +     Y APE     + 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVV 180

Query: 532 TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLK 591
           +  +D+++ G +++ ++SG    +                  ++  + N+  +    + K
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQ------------IIENIMNAEYTFDEEAFK 228

Query: 592 DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           + I    MD               + + ++   R    + 
Sbjct: 229 E-ISIEAMD------------FVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 56/280 (20%), Positives = 100/280 (35%), Gaps = 40/280 (14%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM----TATKTKEFMAEMKILCKVHHSNLVELIGY 411
           +LG G +  V     +   + VAIK +       K      E+ +L K+ H N+V L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             +   L+LI +    G L   + +     +   +     ++       ++Y+H+    H
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
              +        LD   +  ISDFGL+K+    S     ++   GT GY+APE L     
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPY 186

Query: 532 TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLK 591
           +   D ++ GV+ + ++ G              Q  ++   F              S   
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-------------DSPYW 233

Query: 592 DYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           D I  +  D              +  +++DP  R   +Q 
Sbjct: 234 DDISDSAKD------------FIRHLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (372), Expect = 8e-40
 Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 40/297 (13%)

Query: 353 FSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTK---------EFMAEMKILCKVH 401
           FS   ++G G +G VY        +  A+K +   + K              + ++    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 402 HSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGL 461
              +V +     T D+L  I +    G L  HL       +  + +        +   GL
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-----EIILGL 120

Query: 462 EYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYL 521
           E++H       V+RD+K +NILLD     +ISD GLA    K           VGT GY+
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVGTHGYM 172

Query: 522 APEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
           APE L  G+A  + +D ++ G +LF+++ G            K +++  +    L     
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-----RQHKTKDKHEIDRMTLTMAVE 227

Query: 581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQC--------VDEDPILRPDMK 629
            PDS S   L+  ++  ++    +  L  +   A++         +D   +      
Sbjct: 228 LPDSFS-PELRSLLE-GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 20/203 (9%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCKV-HHSNLVEL 408
           +LG G++G V+    +  NQ  AIK +           +  M E ++L     H  L  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 409 IGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT 468
                T++ LF + EY   G L  H+                   A +   GL+++H   
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSK- 122

Query: 469 KTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD 528
               V+RD+K  NILLD     KI+DFG+ K   +   G+A      GT  Y+APE L  
Sbjct: 123 --GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 529 GLATAKSDVYAFGVVLFEIISGK 551
                  D ++FGV+L+E++ G+
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 5e-39
 Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 31/292 (10%)

Query: 357 SLLGHGTYGSVYYGNIR---NQEVAIKRMTATKTKE--------FMAEMKILCKVHHSNL 405
           + +G G YG V+         + VA+KR+     +E         +A ++ L    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 406 VELIGYAAT-----EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
           V L           E +L L++E+  +         P+      +       +     RG
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMFQLLRG 128

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGY 520
           L+++H H     VHRD+K  NIL+ S+ + K++DFGLA++          +T VV T  Y
Sbjct: 129 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWY 181

Query: 521 LAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN 580
            APE L         D+++ G +  E+   K       G    +Q  + L    L    +
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF---RGSSDVDQLGKILDVIGLPGEED 238

Query: 581 SPDSMSMSSLKDY-IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
            P  +++     +      ++ +  D       L  +C+  +P  R      
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 6e-39
 Identities = 51/284 (17%), Positives = 102/284 (35%), Gaps = 43/284 (15%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGY--- 411
           +LG G  G V     +   ++ A+K +      +   E+++  +     ++V ++     
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYEN 76

Query: 412 -AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
             A    L ++ E    G L S + D   RG  + +     +I       ++Y+H     
Sbjct: 77  LYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSI--- 130

Query: 471 HYVHRDIKSSNILLDSAF---RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLT 527
           +  HRD+K  N+L  S       K++DFG AK     +    ++T    T  Y+APE L 
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLG 186

Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
                   D+++ GV+++ ++ G        G+      +  +              +S 
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS- 245

Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
             +K  I                    +  +  +P  R  + + 
Sbjct: 246 EEVKMLI--------------------RNLLKTEPTQRMTITEF 269

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-38
 Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 18/289 (6%)

Query: 351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHS 403
           E F     +G GTYG VY    +   + VA+K++      E      + E+ +L +++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 404 NLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
           N+V+L+    TE++L+L++E+  +   K           T +   +         +GL +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAF 117

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
            H H     +HRD+K  N+L+++    K++DFGLA+  G       T T  V T  Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAP 171

Query: 524 E-YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           E  L     +   D+++ G +  E+++ +        +    +  R+L +          
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query: 583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                                         L  Q +  DP  R   K  
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  140 bits (353), Expect = 4e-38
 Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 16/279 (5%)

Query: 359 LGHGTYGSVYYG-NIRNQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGYA 412
           +G GTYG VY   N   +  A+K++   K  E      + E+ IL ++ HSN+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
            T+  L L++E+  +   K             L  +      L    G+ Y H+      
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDR---RV 121

Query: 473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLAT 532
           +HRD+K  N+L++     KI+DFGLA+  G          ++V  +       +     +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 533 AKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKD 592
              D+++ G +  E+++G              +  R L +       N  +         
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 593 YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
             +P   + +          L  + +  DP  R   KQ 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (352), Expect = 9e-38
 Identities = 53/292 (18%), Positives = 90/292 (30%), Gaps = 38/292 (13%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRM-TATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
            +G G++G +Y G      +EVAIK     TK  +   E KI   +     +  I +   
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E +  ++       SL+   +    +     S    + +A      +EYIH     +++H
Sbjct: 74  EGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK---NFIH 126

Query: 475 RDIKSSNIL---LDSAFRAKISDFGLAKLVGKTSDGEATV----TKVVGTFGYLAPEYLT 527
           RD+K  N L           I DFGLAK        +         + GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 528 DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSM 587
               + + D+ + G VL     G       +    + +  R     M   +         
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP- 245

Query: 588 SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
           S    Y+                      C       +PD   +      + 
Sbjct: 246 SEFATYL--------------------NFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  138 bits (347), Expect = 4e-37
 Identities = 45/294 (15%), Positives = 87/294 (29%), Gaps = 40/294 (13%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMT-ATKTKEFMAEMKILCKVHHSNLVELIGYAAT 414
            +G G++G ++ G   + NQ+VAIK     +   +   E +    +     +  + Y   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71

Query: 415 EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVH 474
           E    ++       SL+  L     +     S       A      ++ IHE      V+
Sbjct: 72  EGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEK---SLVY 124

Query: 475 RDIKSSNILLDSAFR-----AKISDFGLAKLVGKTSDGEATV----TKVVGTFGYLAPEY 525
           RDIK  N L+            + DFG+ K        +         + GT  Y++   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 526 LTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM 585
                 + + D+ A G V    + G                           L+ + +  
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGS---------------------LPWQGLKAATNKQ 223

Query: 586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
               + +      +         +         +      PD   +    S++L
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 7e-37
 Identities = 56/293 (19%), Positives = 111/293 (37%), Gaps = 28/293 (9%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIG- 410
           +G GT+G V+    R   Q+VA+K++     KE      + E+KIL  + H N+V LI  
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 411 -------YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEY 463
                  Y   +  ++L++++ +        +       + +  +M+  +       L  
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ-ML-------LNG 129

Query: 464 IHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEAT-VTKVVGTFGYLA 522
           ++   +   +HRD+K++N+L+      K++DFGLA+      + +    T  V T  Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 523 PEYL-TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF---MLAAL 578
           PE L  +       D++  G ++ E+ +    +             +   S    +   +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
            N      +  +K         L  +        L  + +  DP  R D    
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-36
 Identities = 55/307 (17%), Positives = 108/307 (35%), Gaps = 55/307 (17%)

Query: 340 VFTYDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT---------K 388
           VF  + +    + +     LG G +  V     +    + A K +   +T         +
Sbjct: 2   VFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 389 EFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWI 448
           +   E+ IL ++ H N++ L      + ++ LI E    G L   L + +     SL+  
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEE 113

Query: 449 MRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS----AFRAKISDFGLAKLVGKT 504
              +       G+ Y+H        H D+K  NI+L        R KI DFGLA  +   
Sbjct: 114 EATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170

Query: 505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKN 564
           +        + GT  ++APE +       ++D+++ GV+ + ++SG    +         
Sbjct: 171 N----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--------- 217

Query: 565 QERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPIL 624
                                   +    ++    D Y  +         ++ + +DP  
Sbjct: 218 ----------------GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261

Query: 625 RPDMKQV 631
           R  ++  
Sbjct: 262 RMTIQDS 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 22/202 (10%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVELI 409
            LG G++G V+    R   +  A+K +         + +    E  +L  V H  ++ + 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
           G      ++F+I +Y + G L S L   Q          +    A +    LEY+H    
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLHSK-- 123

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
              ++RD+K  NILLD     KI+DFG AK V            + GT  Y+APE ++  
Sbjct: 124 -DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVSTK 176

Query: 530 LATAKSDVYAFGVVLFEIISGK 551
                 D ++FG++++E+++G 
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGY 198

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 60/289 (20%), Positives = 98/289 (33%), Gaps = 62/289 (21%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRMTATK---------TKEFMAEMKILCKVH--HSN 404
           LLG G +GSVY G     N  VAIK +   +               E+ +L KV    S 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           ++ L+ +    D   LI E  +           +      L   +           + + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHC 126

Query: 465 HEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAP 523
           H       +HRDIK  NIL+D +    K+ DFG   L+  T       T   GT  Y  P
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPP 178

Query: 524 EYL-TDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP 582
           E++         + V++ G++L++++ G       E ++      R   S          
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS---------- 228

Query: 583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                S  +  I                    + C+   P  RP  +++
Sbjct: 229 -----SECQHLI--------------------RWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 59/202 (29%), Positives = 84/202 (41%), Gaps = 19/202 (9%)

Query: 358 LLGHGTYGSVYYGNIR--NQEVAIKRM------TATKTKEFMAEMKILCKVHHSNLVELI 409
           LLG GT+G V     +   +  A+K +         +    + E ++L    H  L  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
               T D L  + EYA  G L  HL   +       +         +    LEY+H    
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSR-- 124

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
              V+RDIK  N++LD     KI+DFGL K          T+    GT  YLAPE L D 
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDN 180

Query: 530 LATAKSDVYAFGVVLFEIISGK 551
                 D +  GVV++E++ G+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 52/290 (17%), Positives = 107/290 (36%), Gaps = 32/290 (11%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G YG+V          +VAIK++     +    K    E+++L  + H N++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 411 YAATED------ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
               ++      + +L+  +   G+    L          L       +     +GL YI
Sbjct: 85  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYI 137

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRD+K  N+ ++     KI DFGLA+              VV  +      
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEV 189

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF---MLAALRNS 581
            L     T   D+++ G ++ E+I+GK     ++ +    +  +   +     +  L++ 
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
                M  L +    +   +  +     + +L ++ +  D   R    + 
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLL-EKMLVLDAEQRVTAGEA 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 53/293 (18%), Positives = 111/293 (37%), Gaps = 42/293 (14%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKTKE-----FMAEMKILCKVHHSNLVELIGY 411
           +G GTYG+V+    R  ++ VA+KR+      E      + E+ +L ++ H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 412 AATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTH 471
             ++ +L L++E+  +   K       +         +         +GL + H     +
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSR---N 121

Query: 472 YVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA 531
            +HRD+K  N+L++     K+++FGLA+  G          +VV  +           L 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 532 TAKSDVYAFGVVLFEIISGK-------------EAIIRTEGMVSKNQERRSLASFMLAAL 578
           +   D+++ G +  E+ +               + I R  G  ++ Q             
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
              P + S+ ++   ++    D            L +  +  +P+ R   ++ 
Sbjct: 240 PMYPATTSLVNVVPKLNATGRD------------LLQNLLKCNPVQRISAEEA 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (314), Expect = 3e-32
 Identities = 49/294 (16%), Positives = 96/294 (32%), Gaps = 39/294 (13%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAAT 414
            LG G Y  V+       N++V +K +   K K+   E+KIL  +    N++ L      
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD 101

Query: 415 EDE--LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY 472
                  L++E+      K            +L+         +  + L+Y H       
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM---GI 150

Query: 473 VHRDIKSSNILLDSAFR-AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE-YLTDGL 530
           +HRD+K  N+++D   R  ++ D+GLA+               V +  +  PE  +   +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQM 206

Query: 531 ATAKSDVYAFGVVLFEIISGK-------------EAIIRTEGMVSKNQERRSLASFMLAA 577
                D+++ G +L  +I  K               I +  G              +   
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
             +     S    + ++      L   + L        + +  D   R   ++ 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEAL----DFLDKLLRYDHQSRLTAREA 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 22/201 (10%)

Query: 359 LGHGTYGSVYYGNIR--NQEVAIKRMTATKT------KEFMAEMKILCKVHHSNLVELIG 410
           LG G++G V     +      A+K +   K       +  + E +IL  V+   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 411 YAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKT 470
                  L+++ EY   G + SHL           S       A       EY+H     
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSL--- 160

Query: 471 HYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGL 530
             ++RD+K  N+L+D     +++DFG AK        +     + GT   LAPE +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 531 ATAKSDVYAFGVVLFEIISGK 551
                D +A GV+++E+ +G 
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY 235

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 8e-28
 Identities = 59/301 (19%), Positives = 111/301 (36%), Gaps = 43/301 (14%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELIG 410
            +G G  G V      + ++ VAIK++       T  K    E+ ++  V+H N++ L+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 411 YAATED------ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
               +       +++L+ E       +    +                +      G++++
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKHL 135

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H       +HRD+K SNI++ S    KI DFGLA+  G +      +T  V T  Y APE
Sbjct: 136 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPE 188

Query: 525 YLTDGLATAKSDVYAFGVVLFEIISGK------------EAIIRTEGMVSKNQERRSLAS 572
            +         D+++ G ++ E++  K              +I   G     +  + L  
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP-EFMKKLQP 247

Query: 573 FMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAM--LAKQCVDEDPILRPDMKQ 630
            +   + N P    ++  K + D        H+ L       L  + +  DP  R  +  
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 631 V 631
            
Sbjct: 308 A 308

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-27
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 25/209 (11%)

Query: 358 LLGHGTYGSVY-----YGNIRNQEVAIKRM-------TATKTKEFMAEMKILCKV-HHSN 404
           +LG G YG V+      G+   +  A+K +        A  T+    E ++L  +     
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 405 LVELIGYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYI 464
           LV L     TE +L LI +Y   G L +HL   +       +         +    LE++
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHL 145

Query: 465 HEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPE 524
           H+      ++RDIK  NILLDS     ++DFGL+K         A      GT  Y+AP+
Sbjct: 146 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC--GTIEYMAPD 200

Query: 525 YLTDGLA--TAKSDVYAFGVVLFEIISGK 551
            +  G +      D ++ GV+++E+++G 
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 4e-27
 Identities = 55/296 (18%), Positives = 106/296 (35%), Gaps = 42/296 (14%)

Query: 357 SLLGHGTYGSVYYG--NIRNQEVAIKRM-----TATKTKEFMAEMKILCKVHHSNLVELI 409
           S +G G YGSV           VA+K++     +    K    E+++L  + H N++ L+
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 410 GYAATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK 469
                   L    +      L     +   + Q  L+      +     RGL+YIH    
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSA-- 140

Query: 470 THYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG 529
              +HRD+K SN+ ++     KI DFGLA+              V   +       L   
Sbjct: 141 -DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWM 194

Query: 530 LATAKSDVYAFGVVLFEIISGK------------EAIIRTEGMVSKNQERRSLASFMLAA 577
                 D+++ G ++ E+++G+            + I+R  G       ++  +      
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 578 LRNSPD--SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV 631
           +++      M+ +++    +P  +D            L ++ +  D   R    Q 
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVD------------LLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (254), Expect = 3e-24
 Identities = 55/300 (18%), Positives = 114/300 (38%), Gaps = 25/300 (8%)

Query: 358 LLGHGTYGSVYYG--NIRNQEVAIKRMTATK--TKEFMAEMKILCKVHHSNLVELIGYAA 413
            LG G + +V+     + N  VA+K +   K  T+    E+K+L +V+ ++  +     A
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 414 -------------TEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARG 460
                          + + ++  +   G     L          L ++ +  I+     G
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLLLG 137

Query: 461 LEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDFGLAKLVGKTSDGEATVTKVVGTFG 519
           L+Y+H       +H DIK  N+L++       +    +A L G     +   T  + T  
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADL-GNACWYDEHYTNSIQTRE 194

Query: 520 YLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR 579
           Y +PE L        +D+++   ++FE+I+G   +   +   S  ++   +A  ++  L 
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDDHIAQ-IIELLG 252

Query: 580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL 639
             P  +  +        N   L  +    K   L     ++    + + K++   LS +L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.1 bits (176), Expect = 3e-15
 Identities = 22/161 (13%), Positives = 42/161 (26%), Gaps = 34/161 (21%)

Query: 357 SLLGHGTYGSVYYG-NIRNQEVAIKRMTATKT-------------KEFMAEMKILCKVHH 402
            L+G G   +V+   + +  E  +K      T               F        +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 403 SNLVELIGYAATE----DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAA 458
             L +L G A  +    +   ++ E      L                     ++     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113

Query: 459 RGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK 499
             +   +       VH D+   N+L+       I DF  + 
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

 Score = 42.3 bits (100), Expect = 3e-06
 Identities = 12/47 (25%), Positives = 26/47 (55%), Gaps = 2/47 (4%)

Query: 152 MSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPL 198
           ++Y ++ GD++ S+A R GV++  + + N      N+  GD   + +
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSD--TANLQPGDKLTLFV 47

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 41.4 bits (97), Expect = 6e-06
 Identities = 16/47 (34%), Positives = 27/47 (57%), Gaps = 1/47 (2%)

Query: 151 LMSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIP 197
           +++Y +K GDT+ S+A+ F +S  ++ Q N  +     TAG    IP
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGL-TAGQSIVIP 46

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	639
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.56
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.53
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	98.82
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	98.75
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.41
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.87
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.87
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.58
d1ijwc_	47	HIN recombinase (DNA-binding domain) {Synthetic}	81.11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=411.67  Aligned_cols=260  Identities=28%  Similarity=0.542  Sum_probs=204.3

Q ss_pred             HHhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          346 ILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       346 ~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      ++...++|+..+.||+|+||+||+|++++ .||||.++..     ..+.|.+|+++|++++||||+++++++. .+.+++
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence            34556789999999999999999998655 6999998532     3567899999999999999999999975 456899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.++++..    ...+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|+.
T Consensus        81 v~Ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             EEECCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEecCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceee
Confidence            99999999999999742    245899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      ..... .....+...||+.|||||++.+   ..++.++|||||||+||||+||+.||......       ..+    ...
T Consensus       154 ~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~----~~~  221 (276)
T d1uwha_         154 KSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQI----IFM  221 (276)
T ss_dssp             -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHH----HHH
T ss_pred             ccccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHH----HHH
Confidence            64322 2233455789999999999864   45789999999999999999999999643320       011    111


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +...           ...|.+. ..+.+++.++.+|+.+||+.||++||||+|+++.|+.+
T Consensus       222 ~~~~-----------~~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         222 VGRG-----------YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             HHHT-----------SCCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcC-----------CCCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1111           1111111 12345567899999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-51  Score=418.69  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=214.8

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      +++++...++|+..+.||+|+||+||+|.+.  ++.||||+++.+  ..+++.+|+++|++++|||||++++++.+++..
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3445556677888899999999999999985  578999998754  467899999999999999999999999999999


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++..   .....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++
T Consensus        89 ~iv~E~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             EEEEECCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             EEEeecccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence            999999999999999864   23456899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      +.....  .........|++.|+|||++.+..++.++|||||||++|||++|..|+.....       ...+.    ..+
T Consensus       163 ~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~----~~i  229 (287)
T d1opja_         163 RLMTGD--TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVY----ELL  229 (287)
T ss_dssp             TTCCSS--SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHH----HHH
T ss_pred             eecCCC--CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHH----HHH
Confidence            876432  22233445689999999999999999999999999999999998777643221       11111    111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ...                .....+..++.++.+|+.+||+.||++||||+||++.|+.++
T Consensus       230 ~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         230 EKD----------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             HTT----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hcC----------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111                111123445667999999999999999999999999998763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-51  Score=418.81  Aligned_cols=254  Identities=26%  Similarity=0.480  Sum_probs=196.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|+..++||+|+||+||+|.+..     ..||||.+...    ..++|.+|+++|++++|||||+++|++.+++.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345567899999999999998752     25899987543    345799999999999999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.+++..    ....++|..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       106 ~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence            999999999998864    2345899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCcc--eeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          502 GKTSDGEA--TVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       502 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ........  ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.....        ..+..   .+.
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~---~i~  247 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVIN---AIE  247 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHH---HHH
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHH---HHH
Confidence            54322111  1223468999999999999999999999999999999998 8999854321        11111   111


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      ...                 ....+.+++.++.+|+.+||+.||++||||+||++.|++++
T Consensus       248 ~~~-----------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         248 QDY-----------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             TTC-----------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cCC-----------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            110                 01124456678999999999999999999999999999863

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-51  Score=407.64  Aligned_cols=253  Identities=23%  Similarity=0.400  Sum_probs=197.9

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|+..+.||+|+||+||+|.+. ++.||||+++..  ..++|.+|++++++++||||++++|++.+.+..++||||++
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            356777889999999999999986 467999998754  45789999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.+++..    ....++|..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+.... 
T Consensus        84 ~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-  155 (263)
T d1sm2a_          84 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  155 (263)
T ss_dssp             TCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-
Confidence            9999999864    2356899999999999999999999987   9999999999999999999999999998764322 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                       ........||+.|+|||++.+..++.++|||||||++|||+|+..|+.....       ...+...+   ....     
T Consensus       156 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i---~~~~-----  219 (263)
T d1sm2a_         156 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDI---STGF-----  219 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHH---HHTC-----
T ss_pred             -ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHH---HhcC-----
Confidence             2223346789999999999999999999999999999999996545432211       11111111   1111     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  ....|..++.++.+++.+||+.||++||||+||++.|++|
T Consensus       220 ------------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         220 ------------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                        0112334456799999999999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=410.32  Aligned_cols=258  Identities=28%  Similarity=0.482  Sum_probs=208.0

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEE
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      +++...++|+..+.||+|+||.||+|.+++ ..||||+++..  ..++|.+|+++|++++|||||+++|++. ++..++|
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv   85 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEE
Confidence            334455678888999999999999999975 67999999754  4577999999999999999999999885 4567999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.+++...   ....++|..++.|+.||++||+|||+++   |+||||||+|||+++++.+||+|||+|+.+
T Consensus        86 ~Ey~~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          86 TEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence            9999999999988642   2345899999999999999999999987   999999999999999999999999999977


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ....  ........||+.|||||++.++.++.++|||||||++|||+||..|+.....       ...+   ... +...
T Consensus       160 ~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~---~~~-i~~~  226 (272)
T d1qpca_         160 EDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEV---IQN-LERG  226 (272)
T ss_dssp             SSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHH---HHH-HHTT
T ss_pred             cCCc--cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHH---HHH-HHhc
Confidence            4321  2223345789999999999999999999999999999999997666533221       0111   111 1111


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  ..    ...+..++.++.+|+.+||+.||++||||+||++.|+++
T Consensus       227 ------------~~----~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         227 ------------YR----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ------------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CC----CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                        00    112334556799999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=409.43  Aligned_cols=255  Identities=27%  Similarity=0.480  Sum_probs=199.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      .+.|+..++||+|+||.||+|.+.+      ..||||.++..    ..++|.+|++++++++|||||+++|++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            3457778899999999999998753      36999998643    2356889999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+.+|+|.+++..    ....++|..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          86 IITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence            99999999999988753    2356999999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .+..............||+.|||||++.++.++.++|||||||++|||++|..|+.....       ...+.    ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~----~~i~  227 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVM----KAIN  227 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHH----HHHH
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHH----HHHh
Confidence            765433333334446789999999999999999999999999999999997666533211       01111    1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..                .....+.+++.++.+|+.+||+.||++||||+||++.|+++
T Consensus       228 ~~----------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         228 DG----------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             TT----------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cc----------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence            11                11123445567799999999999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=407.94  Aligned_cols=253  Identities=27%  Similarity=0.430  Sum_probs=204.3

Q ss_pred             hCCCCCCC-ceeecCceEEEEEEEc----CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          350 TEGFSDSS-LLGHGTYGSVYYGNIR----NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       350 ~~~f~~~~-~lG~G~~g~Vy~~~~~----~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .++|...+ +||+|+||+||+|.+.    +..||||.++..    ..++|.+|+++|++++|||||+++|++.+ +.+++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            34455555 4999999999999764    246999998643    34679999999999999999999999864 56899


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ||||+++|+|.+++..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        86 vmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence            9999999999999854    2346899999999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      +..............||+.|+|||++.++.++.++|||||||++|||+| |+.||.....        ..+.    ..+.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~----~~i~  226 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVM----AFIE  226 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHH----HHHH
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHH----HHHH
Confidence            7543332233334578999999999999999999999999999999998 8999964332        1111    1111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ...                ....|..++.++.+|+.+||+.||++||||.+|++.|+.+
T Consensus       227 ~~~----------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         227 QGK----------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             TTC----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC----------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            110                0112445667899999999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=396.63  Aligned_cols=252  Identities=27%  Similarity=0.429  Sum_probs=210.1

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|+..++||+|+||+||+|++++ ..||||.++..  ..++|.+|++++++++||||++++|++.+.+.+++||||++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            3678889999999999999999975 58999998753  45789999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|.+++...    ...+++..+++++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++.+.... 
T Consensus        83 ~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-  154 (258)
T d1k2pa_          83 NGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  154 (258)
T ss_dssp             TEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred             CCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence            99999997642    345889999999999999999999987   9999999999999999999999999998764322 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                       ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....        ..+   ...+ ...    
T Consensus       155 -~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~---~~~i-~~~----  217 (258)
T d1k2pa_         155 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SET---AEHI-AQG----  217 (258)
T ss_dssp             -CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHH---HHHH-HTT----
T ss_pred             -ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHH---HHHH-HhC----
Confidence             223334679999999999999999999999999999999998 8988854322        111   1111 111    


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  .....|..++.++.+|+.+||+.||++|||++|+++.|.+|
T Consensus       218 ------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 ------------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ------------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                        00112344556799999999999999999999999999765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=400.89  Aligned_cols=248  Identities=25%  Similarity=0.335  Sum_probs=200.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..+.||+|+||+||+|.+.  ++.||||+++...    .+.+.+|+++|++++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46788899999999999999985  6789999986432    34588999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        85 ~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          85 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            999999999964     346899999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      . .....+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......      ...    .. ......
T Consensus       157 ~-~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~----~~-~~~~~~  224 (271)
T d1nvra_         157 N-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEY----SD-WKEKKT  224 (271)
T ss_dssp             T-EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHH----HH-HHTTCT
T ss_pred             C-ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHH----HH-HhcCCC
Confidence            2 2223445789999999999988776 578999999999999999999996433210      000    01 111100


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                     ........+.++.+|+.+||+.||++|||++|+++
T Consensus       225 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 ---------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                           00011233456889999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-50  Score=402.24  Aligned_cols=245  Identities=27%  Similarity=0.431  Sum_probs=198.0

Q ss_pred             CceeecCceEEEEEEEcC----ceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeeccC
Q 036507          357 SLLGHGTYGSVYYGNIRN----QEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQK  427 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~~----~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  427 (639)
                      ++||+|+||+||+|.+.+    +.||||.++..     ..+++.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998743    57999998643     24579999999999999999999999864 567899999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.++++.     ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+......
T Consensus        92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999864     345899999999999999999999987   999999999999999999999999999977543333


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                      ........||+.|||||.+.+..++.++|||||||++|||+| |+.||.....        ..+.    ..+...     
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~----~~i~~~-----  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVT----AMLEKG-----  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHH----HHHHTT-----
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHH----HHHHcC-----
Confidence            333344679999999999999999999999999999999998 8999854321        1111    111111     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                 .....|..++.++.+|+.+||+.||++||||++|++.|+..
T Consensus       227 -----------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         227 -----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                       00112345567899999999999999999999999988763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=393.35  Aligned_cols=241  Identities=27%  Similarity=0.431  Sum_probs=202.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||+||++...  ++.||+|.+...      ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            35777889999999999999985  578999998642      2456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999864     245899999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .     .......||+.|||||++.+..++.++|||||||++|||++|+.||...+.           .+....+....+
T Consensus       158 ~-----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~i~~~~~  221 (263)
T d2j4za1         158 S-----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------QETYKRISRVEF  221 (263)
T ss_dssp             C-----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTTCC
T ss_pred             C-----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCC
Confidence            2     123456899999999999999999999999999999999999999954321           111111111111


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                        ..|...+.++.+|+.+||+.||++|||++|+++
T Consensus       222 ------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                              022334567899999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=396.16  Aligned_cols=245  Identities=25%  Similarity=0.415  Sum_probs=204.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||+|+||+||+|...  ++.||||+++..   ..+.+.+|+++|++++||||+++++++.+++.+|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999875  689999998643   4567899999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.+++..      ..+++.....++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.+... 
T Consensus       100 ~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-  169 (293)
T d1yhwa1         100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-  169 (293)
T ss_dssp             TTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred             CCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc-
Confidence            99999998753      34899999999999999999999987   999999999999999999999999999876432 


Q ss_pred             CCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCcc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSM  585 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  585 (639)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ...+.........  
T Consensus       170 --~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~~~~~~~~--  234 (293)
T d1yhwa1         170 --QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNGTP--  234 (293)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHCSC--
T ss_pred             --cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----------HHHHHHHHhCCCC--
Confidence              2233456899999999999999999999999999999999999999954321           0111111111110  


Q ss_pred             cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          586 SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                 .+  ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       235 -----------~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 -----------EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----------CC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----------CC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       00  113344567999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=407.86  Aligned_cols=259  Identities=26%  Similarity=0.436  Sum_probs=208.1

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecC
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATE  415 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  415 (639)
                      +..++|+..++||+|+||+||+|++.+       ..||+|.+...    ....+.+|+.+|.++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            455678889999999999999998753       26999988543    235688999999998 899999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQN------------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI  477 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dl  477 (639)
                      +..++||||+++|+|.++++....                  .....+++..++.++.||++||+|||+++   |+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            999999999999999999975331                  11245899999999999999999999987   999999


Q ss_pred             CCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccc
Q 036507          478 KSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIR  556 (639)
Q Consensus       478 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~  556 (639)
                      ||+|||++.++.+||+|||+|+...... .........||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             chhccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998764322 2223345678999999999999999999999999999999998 8999854


Q ss_pred             cccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          557 TEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       557 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      ....       ..+    ...+...                .....|..++.++.+|+.+||+.||++||||+||++.|.
T Consensus       270 ~~~~-------~~~----~~~~~~~----------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVD-------ANF----YKLIQNG----------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCS-------HHH----HHHHHTT----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHH-------HHH----HHHHhcC----------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3220       111    1112211                011124455678999999999999999999999999996


Q ss_pred             h
Q 036507          637 Q  637 (639)
Q Consensus       637 ~  637 (639)
                      .
T Consensus       323 ~  323 (325)
T d1rjba_         323 C  323 (325)
T ss_dssp             H
T ss_pred             C
Confidence            4

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-50  Score=400.09  Aligned_cols=251  Identities=20%  Similarity=0.343  Sum_probs=191.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec--CCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT--EDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv  421 (639)
                      ++|+..+.||+|+||+||+++..  ++.||||.+...     ..+.+.+|+++|++++||||+++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56888899999999999999885  678999998543     23568899999999999999999998865  4568999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTK--THYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      |||+++|+|.+++.... .....+++..++.++.|++.||+|||+++.  .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999986421 123468999999999999999999998652  359999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .+...   ........||+.|||||++.+..++.++|||||||++|||++|+.||...+.        ..+   ...+..
T Consensus       163 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~---~~~i~~  228 (269)
T d2java1         163 ILNHD---TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KEL---AGKIRE  228 (269)
T ss_dssp             HC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHH---HHHHHH
T ss_pred             ecccC---CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHH---HHHHHc
Confidence            76432   2233457899999999999999999999999999999999999999954321        111   111111


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....                 ..+..++.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~-----------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         229 GKFR-----------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             TCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC-----------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1110                 112334557999999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=395.34  Aligned_cols=249  Identities=30%  Similarity=0.504  Sum_probs=198.5

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcCceEEEEEecccc-HHHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEEEEeeccC
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK-TKEFMAEMKILCKVHHSNLVELIGYAAT-EDELFLIYEYAQK  427 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~  427 (639)
                      .++|+..+.||+|+||.||+|.+++..||||.++.+. .+++.+|++++++++||||++++|++.+ .+.+++||||+++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            3456667889999999999999999999999997654 5679999999999999999999999865 4568999999999


Q ss_pred             CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCCC
Q 036507          428 GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDG  507 (639)
Q Consensus       428 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  507 (639)
                      |+|.+++..   .....++|..+++|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....    
T Consensus        86 g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          86 GSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             EEHHHHHHH---HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCHHHHHHh---cCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----
Confidence            999999964   22345899999999999999999999987   99999999999999999999999999986532    


Q ss_pred             cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          508 EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       508 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                        ......+|..|+|||++.++.+++++||||||+++|||+| |+.|+.....        ..+...+    ..      
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~i----~~------  215 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRV----EK------  215 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHH----TT------
T ss_pred             --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHH----Hc------
Confidence              2233468899999999999999999999999999999998 6777644322        1111111    11      


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                ......+..++.++.+|+.+||+.||++||||.|+++.|+++
T Consensus       216 ----------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         216 ----------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                      011123444556799999999999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-49  Score=402.35  Aligned_cols=265  Identities=24%  Similarity=0.403  Sum_probs=212.3

Q ss_pred             hHHHHhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEee
Q 036507          343 YDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGY  411 (639)
Q Consensus       343 ~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~  411 (639)
                      +.+++...++|+..+.||+|+||+||+|++.+       +.||||+++..    ..+++.+|+++|++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            34566678889999999999999999998753       57999998653    24568999999999999999999999


Q ss_pred             eecCCeEEEEEeeccCCChhhhccCCC-------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036507          412 AATEDELFLIYEYAQKGSLKSHLHDPQ-------------------NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHY  472 (639)
Q Consensus       412 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i  472 (639)
                      +...+..+++|||+++|+|.++++...                   ......+++..++.|+.|++.||+|||+++   |
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence            999999999999999999999986421                   122345899999999999999999999987   9


Q ss_pred             eeCCCCCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCC-
Q 036507          473 VHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK-  551 (639)
Q Consensus       473 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~-  551 (639)
                      +||||||+|||++.++.+||+|||+++.+.... .....+...||+.|+|||.+.+..++.++|||||||++|||++|. 
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            999999999999999999999999998664322 222334567899999999999999999999999999999999996 


Q ss_pred             ccccccccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHH
Q 036507          552 EAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQV  631 (639)
Q Consensus       552 ~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  631 (639)
                      +||.....        ..+   ...+.....                 ...+.+++.++.+|+.+||+.||++||||.||
T Consensus       241 ~p~~~~~~--------~e~---~~~v~~~~~-----------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev  292 (301)
T d1lufa_         241 QPYYGMAH--------EEV---IYYVRDGNI-----------------LACPENCPLELYNLMRLCWSKLPADRPSFCSI  292 (301)
T ss_dssp             CTTTTSCH--------HHH---HHHHHTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCH--------HHH---HHHHHcCCC-----------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            45543221        111   111111110                 11234455679999999999999999999999


Q ss_pred             HHHHhhhC
Q 036507          632 VISLSQIL  639 (639)
Q Consensus       632 l~~L~~il  639 (639)
                      +++|++|.
T Consensus       293 ~~~L~~i~  300 (301)
T d1lufa_         293 HRILQRMC  300 (301)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHhc
Confidence            99999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=398.45  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=200.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEcC-ceEEEEEeccc--cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIRN-QEVAIKRMTAT--KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      .++|+..+.||+|+||.||+|.+++ ..||||+++..  ..++|.+|+.++++++|||||++++++. .+..++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            4568888999999999999999875 57999998754  3577999999999999999999999985 456899999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTSD  506 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  506 (639)
                      +|+|..++...   ....++|..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        95 ~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-  167 (285)
T d1fmka3          95 KGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  167 (285)
T ss_dssp             TCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence            99999988642   2345899999999999999999999987   9999999999999999999999999998764322 


Q ss_pred             CcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCccc
Q 036507          507 GEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDSMS  586 (639)
Q Consensus       507 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  586 (639)
                       ........||+.|+|||++..+.++.++|||||||++|||++|..|+.....       ...+...   +....     
T Consensus       168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~---i~~~~-----  231 (285)
T d1fmka3         168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQ---VERGY-----  231 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHH---HHTTC-----
T ss_pred             -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHH---HHhcC-----
Confidence             2233446799999999999999999999999999999999997766643221       0111111   11110     


Q ss_pred             ccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          587 MSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                  ....+..++.++.+++.+||+.||++||||++|+++|++.
T Consensus       232 ------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         232 ------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             ------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence                        0112345566799999999999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=396.09  Aligned_cols=247  Identities=23%  Similarity=0.391  Sum_probs=201.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      +.|+..+.||+|+||+||+|.+.  +..||||+++..   ..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45777889999999999999985  578999998643   3467889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.+++...    ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        92 ~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-  163 (288)
T d2jfla1          92 AGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-  163 (288)
T ss_dssp             TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred             CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence            999999987531    345899999999999999999999987   999999999999999999999999999765321 


Q ss_pred             CCcceeeeeccccccCCccccc-----cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLT-----DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRN  580 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~  580 (639)
                        ........||+.|||||++.     +..|+.++|||||||++|||++|+.||......        .   .+......
T Consensus       164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------~---~~~~i~~~  230 (288)
T d2jfla1         164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------R---VLLKIAKS  230 (288)
T ss_dssp             --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------G---HHHHHHHS
T ss_pred             --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--------H---HHHHHHcC
Confidence              11233468999999999984     466889999999999999999999999643321        1   11222222


Q ss_pred             CCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          581 SPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+..             +  ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~-------------~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 EPPT-------------L--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCCC-------------C--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC-------------C--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2110             0  113345567999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=393.81  Aligned_cols=244  Identities=25%  Similarity=0.400  Sum_probs=200.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||+||+|...  ++.||||.++..      ..+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46888899999999999999885  678999998642      3456899999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence            99999999998864     345899999999999999999999987   9999999999999999999999999999774


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .... ........||+.|||||++.+..++.++|||||||++|||++|+.||...+.           ......+....+
T Consensus       160 ~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------~~~~~~i~~~~~  227 (288)
T d1uu3a_         160 PESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------YLIFQKIIKLEY  227 (288)
T ss_dssp             -----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHTTCC
T ss_pred             cCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----------HHHHHHHHcCCC
Confidence            3222 2233456899999999999999999999999999999999999999954321           111122222211


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVV  632 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  632 (639)
                                        ..+.....++.+|+.+||+.||++|||++|++
T Consensus       228 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 ------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence                              01233445689999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=404.33  Aligned_cols=197  Identities=25%  Similarity=0.420  Sum_probs=173.9

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ..++|+..++||+|+||+||+|...  ++.||+|.++..    ..+.+.+|+++|++++|||||++++++.+++++++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4578888999999999999999985  678999998643    2457889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEH-TKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      ||+++|+|.+++..     ...+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             ECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999964     23589999999999999999999974 6   999999999999999999999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccc
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTE  558 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~  558 (639)
                      ...     ..+..+||+.|||||++.+..|+.++||||+||++|||++|+.||...+
T Consensus       156 ~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         156 IDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CCC-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            322     2234689999999999999999999999999999999999999996543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=385.07  Aligned_cols=241  Identities=22%  Similarity=0.369  Sum_probs=191.5

Q ss_pred             CCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec----CCeEEEEEe
Q 036507          355 DSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT----EDELFLIYE  423 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~e  423 (639)
                      ..++||+|+||+||+|.+.  +..||+|.+...     ..+.+.+|+++|++++||||+++++++.+    +..+++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            3457999999999999986  568999988543     24568899999999999999999999864    356899999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC-CCCCEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD-SAFRAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~  502 (639)
                      |+++|+|.+++..     ...+++.....++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++...
T Consensus        93 ~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          93 LMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             CCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999964     245899999999999999999999875 4599999999999996 57899999999998542


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .     .......||+.|||||++.+ .++.++|||||||++|||++|+.||.....          .............
T Consensus       167 ~-----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----------~~~~~~~i~~~~~  230 (270)
T d1t4ha_         167 A-----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQIYRRVTSGVK  230 (270)
T ss_dssp             T-----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHHHHHHHTTTCC
T ss_pred             C-----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----------HHHHHHHHHcCCC
Confidence            2     12345689999999999865 599999999999999999999999954322          1111111111110


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .            +.    .+.....++.+|+.+||+.||++|||++|+++
T Consensus       231 ~------------~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 P------------AS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             C------------GG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C------------cc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0            01    11223446889999999999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=391.99  Aligned_cols=254  Identities=27%  Similarity=0.417  Sum_probs=195.5

Q ss_pred             hhhCCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeE
Q 036507          348 FATEGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDEL  418 (639)
Q Consensus       348 ~a~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  418 (639)
                      ...++|+..+.||+|+||.||+|.+..     ..||||.++..    ..+.+.+|+++|++++||||+++++++. ++..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            345678888999999999999998752     35889988642    2456899999999999999999999985 5678


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      ++||||+++|+|.+++..    ....+++..++.++.||++||+|||+++   |+||||||+||++++++.+||+|||++
T Consensus        83 ~iv~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             EEEEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred             EEEEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhh
Confidence            999999999999998753    2346899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHH
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      +.+...  .....+...||+.|+|||.+.+..++.++|||||||++|||++ |..||.....        ..+...   +
T Consensus       156 ~~~~~~--~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~---i  222 (273)
T d1mp8a_         156 RYMEDS--TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGR---I  222 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHH---H
T ss_pred             eeccCC--cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHHHH---H
Confidence            876432  2223344678999999999999999999999999999999998 8888854332        111111   1


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                      .....                 ...+..++.++.+|+.+||+.||++|||++||++.|++++
T Consensus       223 ~~~~~-----------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         223 ENGER-----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HTTCC-----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCC-----------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11110                 0123445667999999999999999999999999998763

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=394.85  Aligned_cols=251  Identities=25%  Similarity=0.448  Sum_probs=200.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC------ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN------QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFL  420 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  420 (639)
                      .+|+..++||+|+||+||+|.+..      ..||+|.++..    ..+++.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            458888999999999999998753      25899988643    356799999999999999999999999864 5678


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ++||+.+|+|.+++..    ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence            8899999999998764    3456899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          501 VGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      +.... .........||+.|+|||++.++.++.++|||||||++|||+| |+.||.....        ..+...+..   
T Consensus       161 ~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~~i~~---  228 (317)
T d1xkka_         161 LGAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEK---  228 (317)
T ss_dssp             TTTTC-C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHHHHHH---
T ss_pred             ccccc-ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHc---
Confidence            64322 2223344578999999999999999999999999999999999 7888754322        111111111   


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..                 ....+..++..+.+|+.+||+.||++|||++|+++.|+++
T Consensus       229 ~~-----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         229 GE-----------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             TC-----------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            10                 0112445667799999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-47  Score=390.02  Aligned_cols=246  Identities=23%  Similarity=0.371  Sum_probs=188.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      +.|+..+.||+|+||+||+|...  ++.||||.+....    .+.+.+|+++|++++||||+++++++.+++.+|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56888899999999999999985  6789999986432    34577899999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC---CCCCEEEeccCCceec
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD---SAFRAKISDFGLAKLV  501 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~  501 (639)
                      +++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        89 ~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          89 VSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             cCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999964     345899999999999999999999987   99999999999994   5789999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...    ......+||+.|||||++.+..++.++|||||||++|||++|+.||.....           .+....+....
T Consensus       161 ~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------~~~~~~i~~~~  225 (307)
T d1a06a_         161 DPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----------AKLFEQILKAE  225 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHTTC
T ss_pred             cCC----CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----------HHHHHHHhccC
Confidence            322    223456899999999999999999999999999999999999999954321           11112222211


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..              .......+.+.++.+|+.+||+.||++|||++|+++
T Consensus       226 ~~--------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         226 YE--------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CC--------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC--------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            10              001112334567899999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-47  Score=392.58  Aligned_cols=241  Identities=27%  Similarity=0.445  Sum_probs=197.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      +.|+..+.||+|+||+||+|...  ++.||||.++..      ..+++.+|+++|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            34788899999999999999875  578999998643      2356889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|..++..     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence            99999999876643     346899999999999999999999987   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCcccccc---CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD---GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ..       ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.....           .+.+.....
T Consensus       167 ~~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----------~~~~~~i~~  228 (309)
T d1u5ra_         167 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQ  228 (309)
T ss_dssp             SB-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHH
T ss_pred             CC-------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHh
Confidence            21       23579999999999864   5689999999999999999999999954321           111122222


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....             .+   .+...+..+.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~-------------~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         229 NESP-------------AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SCCC-------------CC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC-------------CC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            2111             01   11233457899999999999999999999975

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=388.53  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=196.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC-----ceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|+..+.||+|+||.||+|++..     ..||||.++..      ..++|.+|+++|++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            567778899999999999998742     36899987542      24678999999999999999999999965 5678


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+++|+|.+++..    ....+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        87 lv~e~~~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK----HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEECCTTCBHHHHHHH----HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeeeecCcchhhhhhc----ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence            99999999999988763    2345999999999999999999999987   9999999999999999999999999999


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+..............|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+.           .+....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----------~~~~~~i~  228 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------SQILHKID  228 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHH
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----------HHHHHHHH
Confidence            87554433333445678899999999999999999999999999999998 8999854322           11112222


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      +..                .....+..++..+.+|+.+||+.||++||||+||++.|++.
T Consensus       229 ~~~----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 KEG----------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TSC----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hCC----------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            211                00112334456799999999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-46  Score=391.42  Aligned_cols=247  Identities=22%  Similarity=0.317  Sum_probs=203.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||+|+||.||+|...  ++.||||++....   .+.+.+|+++|++++||||+++++++.+++.+++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47888999999999999999885  6799999986543   456889999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC--CCCEEEeccCCceecCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS--AFRAKISDFGLAKLVGK  503 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~  503 (639)
                      ++|+|.+++...    ...+++.....++.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+++.+..
T Consensus       106 ~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         106 SGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999998642    345999999999999999999999987   999999999999964  57899999999987643


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .    .......||+.|||||++.+..++.++|||||||++|||++|+.||...+.           .+.+..+......
T Consensus       179 ~----~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~i~~~~~~  243 (350)
T d1koaa2         179 K----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------DETLRNVKSCDWN  243 (350)
T ss_dssp             T----SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTCCC
T ss_pred             c----cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCC
Confidence            2    234457899999999999999999999999999999999999999954321           1111222221110


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                +.+.    .....+.++.+|+.+||+.||++|||++|+++
T Consensus       244 ----------~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         244 ----------MDDS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ----------SCCG----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----------CCcc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      0000    11233456899999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-48  Score=392.55  Aligned_cols=267  Identities=27%  Similarity=0.416  Sum_probs=200.9

Q ss_pred             chHHHHhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEE
Q 036507          342 TYDEILFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELI  409 (639)
Q Consensus       342 ~~~e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~  409 (639)
                      ..++++...++|+..++||+|+||.||+|.+.+       +.||||.++..    ..+.+.+|..++.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            345555666789999999999999999998742       47999998643    245677888888777 689999999


Q ss_pred             eeeecC-CeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 036507          410 GYAATE-DELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDI  477 (639)
Q Consensus       410 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dl  477 (639)
                      +++... +.+++||||+++|+|.++++....           .....+++..+..++.||+.||+|||+++   |+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            987664 568999999999999999864321           12345899999999999999999999987   999999


Q ss_pred             CCCcEEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCC-ccccc
Q 036507          478 KSSNILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK-EAIIR  556 (639)
Q Consensus       478 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~-~p~~~  556 (639)
                      ||+|||+++++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||++|. .||..
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceeECCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987643322 22334467999999999999999999999999999999999975 45643


Q ss_pred             cccccchhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 036507          557 TEGMVSKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLS  636 (639)
Q Consensus       557 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  636 (639)
                      ....       ..    +...+....            .+    ..+..++.++.+++.+||+.||++|||++|+++.|+
T Consensus       240 ~~~~-------~~----~~~~~~~~~------------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         240 VKID-------EE----FCRRLKEGT------------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             CCCS-------HH----HHHHHHHTC------------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHH-------HH----HHHHHhcCC------------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2210       01    111111110            11    123344567999999999999999999999999999


Q ss_pred             hhC
Q 036507          637 QIL  639 (639)
Q Consensus       637 ~il  639 (639)
                      +++
T Consensus       293 ~il  295 (299)
T d1ywna1         293 NLL  295 (299)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-46  Score=389.04  Aligned_cols=247  Identities=22%  Similarity=0.297  Sum_probs=203.7

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      ++|+..+.||+|+||.||+|...  ++.||||.++...   .+.+.+|+++|++++||||+++++++.+++.+|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46888899999999999999975  6889999986543   346789999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEC--CCCCEEEeccCCceecCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLD--SAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~  503 (639)
                      ++|+|.+++..    ....+++.....|+.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+|+.+..
T Consensus       109 ~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         109 SGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999988753    2345899999999999999999999987   99999999999998  678999999999997743


Q ss_pred             CCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                          ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....           ...+..+......
T Consensus       182 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i~~~~~~  246 (352)
T d1koba_         182 ----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------LETLQNVKRCDWE  246 (352)
T ss_dssp             ----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHHHCCCC
T ss_pred             ----CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCC
Confidence                2234557899999999999999999999999999999999999999954322           1111222222110


Q ss_pred             cccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                                    .........+.++.+|+.+||+.||++|||++|+++
T Consensus       247 --------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         247 --------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                          111122334557899999999999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=387.39  Aligned_cols=269  Identities=27%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             CCCCCCceeecCceEEEEEEEcCceEEEEEeccccHHHHHHHHHHH--HhcCCCCeeEEEeeeecCC----eEEEEEeec
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATKTKEFMAEMKIL--CKVHHSNLVELIGYAATED----ELFLIYEYA  425 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~E~~il--~~l~h~niv~l~~~~~~~~----~~~lv~e~~  425 (639)
                      .|...+.||+|+||.||+|+++++.||||.++....+++.+|.+++  .+++||||+++++++.+.+    .+++||||+
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~   83 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence            3555678999999999999999999999999877777766666655  5789999999999997643    689999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCcEEECCCCCEEEeccCCcee
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT-----KTHYVHRDIKSSNILLDSAFRAKISDFGLAKL  500 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  500 (639)
                      ++|+|.++++.      ..++|..+++++.|++.||+|||+..     .++|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          84 EHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             TTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999974      34899999999999999999999742     24599999999999999999999999999987


Q ss_pred             cCCCCCCc-ceeeeeccccccCCccccccCC------CCCcchHHHHHHHHHHHHcCCccccccccccchhhh----hhh
Q 036507          501 VGKTSDGE-ATVTKVVGTFGYLAPEYLTDGL------ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE----RRS  569 (639)
Q Consensus       501 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~------~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~----~~~  569 (639)
                      ........ .......||+.|+|||++.+..      ++.++|||||||+||||+||..|+............    ...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            74433211 1233468999999999987542      567899999999999999999887543321100000    001


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCC-ChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLY-PHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ... .....           ....++|.+.... +.++...+.+|+.+||+.||++||||.||++.|+++
T Consensus       238 ~~~-~~~~~-----------~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         238 VEE-MRKVV-----------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             HHH-HHHHH-----------TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH-HHHHH-----------hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            111 11111           1111223222211 335667899999999999999999999999999886

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=389.65  Aligned_cols=254  Identities=31%  Similarity=0.529  Sum_probs=202.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEcC--c--eEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIRN--Q--EVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~~--~--~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|+..++||+|+||.||+|.+.+  .  .||||.++..    ..+++.+|+++|+++ +||||+++++++.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            456667899999999999998853  2  5788887543    345689999999999 799999999999999999999


Q ss_pred             EeeccCCChhhhccCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCE
Q 036507          422 YEYAQKGSLKSHLHDPQ-----------NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRA  490 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  490 (639)
                      |||+++|+|.++++...           ......++|..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            99999999999997531           123457999999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCc-cccccccccchhhhhhh
Q 036507          491 KISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKE-AIIRTEGMVSKNQERRS  569 (639)
Q Consensus       491 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~  569 (639)
                      ||+|||+++......    ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...+.          
T Consensus       167 kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----------  232 (309)
T d1fvra_         167 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------  232 (309)
T ss_dssp             EECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------
T ss_pred             EEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH----------
Confidence            999999998653221    1223568999999999999999999999999999999999765 4532211          


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                       .+.... +...            ..    ...+..++.++.+|+.+||+.||++||||+||++.|++++
T Consensus       233 -~~~~~~-i~~~------------~~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         233 -AELYEK-LPQG------------YR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             -HHHHHH-GGGT------------CC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHH-HHhc------------CC----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             111111 1110            01    1123445668999999999999999999999999998863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=388.98  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=203.7

Q ss_pred             hhCCCCCCCceeecCceEEEEEEEcC---------ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 036507          349 ATEGFSDSSLLGHGTYGSVYYGNIRN---------QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAAT  414 (639)
Q Consensus       349 a~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~  414 (639)
                      ..++|+..+.||+|+||.||+|+..+         ..||||+++.+    ...++.+|...+.++ +||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34567778899999999999998642         36999998654    246688899999888 79999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQN-----------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNIL  483 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIl  483 (639)
                      ++..++||||+++|+|.+++.....           .....+++..++.++.||+.||+|||+++   |+||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence            9999999999999999999975331           12356899999999999999999999987   999999999999


Q ss_pred             ECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHc-CCccccccccccc
Q 036507          484 LDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIIS-GKEAIIRTEGMVS  562 (639)
Q Consensus       484 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~ellt-G~~p~~~~~~~~~  562 (639)
                      ++.++.+||+|||+++....... ........||+.|+|||.+.++.|+.++||||||+++|||++ |..||.....   
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---  243 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  243 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             ecCCCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence            99999999999999987754322 223344678999999999999999999999999999999998 6777743221   


Q ss_pred             hhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          563 KNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       563 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                           ..+.    ..+....            .+    ..+..++.++.+|+.+||+.||++|||++||++.|++|+
T Consensus       244 -----~~~~----~~i~~~~------------~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 -----EELF----KLLKEGH------------RM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             -----HHHH----HHHHTTC------------CC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHH----HHHHcCC------------CC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                 1111    1111110            01    123344567999999999999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=389.70  Aligned_cols=263  Identities=25%  Similarity=0.420  Sum_probs=209.3

Q ss_pred             HhhhCCCCCCCceeecCceEEEEEEEcC-------ceEEEEEeccc----cHHHHHHHHHHHHhc-CCCCeeEEEeeeec
Q 036507          347 LFATEGFSDSSLLGHGTYGSVYYGNIRN-------QEVAIKRMTAT----KTKEFMAEMKILCKV-HHSNLVELIGYAAT  414 (639)
Q Consensus       347 ~~a~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~vavK~~~~~----~~~~~~~E~~il~~l-~h~niv~l~~~~~~  414 (639)
                      +...++|+..++||+|+||.||+|++.+       +.||||+++..    ...++.+|+.+++++ +|||||++++++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            3455778888999999999999998732       57999998653    345688999999999 69999999999999


Q ss_pred             CCeEEEEEeeccCCChhhhccCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 036507          415 EDELFLIYEYAQKGSLKSHLHDPQN-------------RGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSN  481 (639)
Q Consensus       415 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~N  481 (639)
                      .+..+++|||+++|+|.++++....             .....+++..+..++.||++||+|||+++   ++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence            9999999999999999999865321             12346899999999999999999999987   9999999999


Q ss_pred             EEECCCCCEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCcccccccccc
Q 036507          482 ILLDSAFRAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMV  561 (639)
Q Consensus       482 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~  561 (639)
                      |+++.++.+|++|||+++...... .....+...||+.|+|||.+.++.++.++|||||||++|||+|++.|+.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             ccccccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998765332 2334445789999999999999999999999999999999999554543222110


Q ss_pred             chhhhhhhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          562 SKNQERRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       562 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                            ..+.    ..+...                .....+..++.++.+|+.+||+.||++||||+|++++|++++
T Consensus       255 ------~~~~----~~i~~~----------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         255 ------SKFY----KMIKEG----------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             ------HHHH----HHHHHT----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHH----HHHhcC----------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence                  0111    111111                111123344567999999999999999999999999998753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-47  Score=383.67  Aligned_cols=246  Identities=21%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc---------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT---------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~---------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|+..+.||+|+||+||+|...  ++.||||.++..         ..+.+.+|+++|++++||||+++++++.+.+.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57888999999999999999985  679999998532         2467899999999999999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC----CEEEecc
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF----RAKISDF  495 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  495 (639)
                      +||||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||++.++    .+||+||
T Consensus        90 iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          90 LILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            99999999999999964     245899999999999999999999987   99999999999998776    5999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      |++..+....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.        .   +.+.
T Consensus       162 G~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~---~~~~  226 (293)
T d1jksa_         162 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------Q---ETLA  226 (293)
T ss_dssp             TTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H---HHHH
T ss_pred             hhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------H---HHHH
Confidence            9998764322    23446799999999999999999999999999999999999999964321        1   1111


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .+......              .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       227 ~i~~~~~~--------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         227 NVSAVNYE--------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHTTCCC--------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCC--------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111110              000011233456889999999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.6e-46  Score=379.20  Aligned_cols=255  Identities=22%  Similarity=0.396  Sum_probs=199.1

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC----eE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATED----EL  418 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~  418 (639)
                      ++|+..+.||+|+||.||+|.+.  ++.||||.++..      ..+.+.+|++++++++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            56888999999999999999975  689999998643      2346889999999999999999999987643    47


Q ss_pred             EEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCc
Q 036507          419 FLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLA  498 (639)
Q Consensus       419 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  498 (639)
                      |+||||+++|+|.+++..     ...+++...+.++.||+.||+|||+++   |+||||||+|||++.++..+++|||.+
T Consensus        87 ~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            999999999999998854     345899999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          499 KLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       499 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .................||+.|+|||++.+..+++++|||||||++|||+||+.||.....           .+.....+
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~~~  227 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHV  227 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHH
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----------HHHHHHHH
Confidence            8765444444445567899999999999999999999999999999999999999954321           11122233


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhh
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-DMKQVVISLSQI  638 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i  638 (639)
                      ...+..              ......+.+.++.+++.+||+.||++|| |++++++.|.++
T Consensus       228 ~~~~~~--------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         228 REDPIP--------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HCCCCC--------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             hcCCCC--------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            322110              0011223445789999999999999999 899999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=384.49  Aligned_cols=243  Identities=29%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||+++..  ++.||||+++..      ..+.+.+|+++|++++||||+++++++.+++.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            46888899999999999999975  689999998643      3466889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus        85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999864     345888889999999999999999988   9999999999999999999999999998653


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..   .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.        ..+   ........+
T Consensus       157 ~~---~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~---~~~i~~~~~  222 (337)
T d1o6la_         157 SD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERL---FELILMEEI  222 (337)
T ss_dssp             CT---TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHCCC
T ss_pred             cC---CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHH---HHHHhcCCC
Confidence            22   2234457899999999999999999999999999999999999999964332        111   112222211


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                                        ..|...+.++.+|+.+||+.||++||+     ++|+++
T Consensus       223 ------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                              023334557899999999999999995     777764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=383.70  Aligned_cols=249  Identities=24%  Similarity=0.444  Sum_probs=199.0

Q ss_pred             CCceeecCceEEEEEEEcC-----ceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeec-CCeEEEEEeec
Q 036507          356 SSLLGHGTYGSVYYGNIRN-----QEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAAT-EDELFLIYEYA  425 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~e~~  425 (639)
                      .++||+|+||+||+|.+.+     ..||||+++..    ..++|.+|+++|++++||||++++|++.. ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4579999999999998743     25899998642    34679999999999999999999999865 56899999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      ++|+|.++++.    ....+++..+++++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            99999999874    2345788899999999999999999987   9999999999999999999999999998764432


Q ss_pred             CC-cceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DG-EATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                      .. ........||+.|+|||.+....++.++||||||+++|||++|+.|+.....       ...+   ........   
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~---~~~i~~g~---  251 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDI---TVYLLQGR---  251 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------C---HHHHHTTC---
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHH---HHHHHcCC---
Confidence            21 1222335789999999999999999999999999999999998887743221       0111   11111111   


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                                .+    ..|..++.++.+|+.+||+.||++||||+||++.|+++
T Consensus       252 ----------~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         252 ----------RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ----------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CC----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                      00    11334456799999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=387.90  Aligned_cols=263  Identities=27%  Similarity=0.443  Sum_probs=210.2

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEc-------CceEEEEEecccc----HHHHHHHHHHHHhcCCCCeeEEEeeee
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIR-------NQEVAIKRMTATK----TKEFMAEMKILCKVHHSNLVELIGYAA  413 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~  413 (639)
                      +++...++|...+.||+|+||+||+|.+.       +..||||+++...    ...+.+|++++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            44555677888899999999999999874       3579999997532    245889999999999999999999999


Q ss_pred             cCCeEEEEEeeccCCChhhhccCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC
Q 036507          414 TEDELFLIYEYAQKGSLKSHLHDPQ-----NRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF  488 (639)
Q Consensus       414 ~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~  488 (639)
                      .++..++||||+++|+|.++++...     ......+++..+.+++.|+++||.|||+++   |+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence            9999999999999999999886421     122345799999999999999999999987   99999999999999999


Q ss_pred             CEEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCC-ccccccccccchhhhh
Q 036507          489 RAKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGK-EAIIRTEGMVSKNQER  567 (639)
Q Consensus       489 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~-~p~~~~~~~~~~~~~~  567 (639)
                      ++||+|||+++.+.... .........||+.|+|||.+.+..++.++||||||+++|||+||+ .|+.....        
T Consensus       171 ~~Kl~DFGla~~~~~~~-~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------  241 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------  241 (308)
T ss_dssp             CEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------
T ss_pred             eEEEeecccceeccCCc-ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------
Confidence            99999999998764322 222233457899999999999999999999999999999999985 55532211        


Q ss_pred             hhHHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 036507          568 RSLASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQIL  639 (639)
Q Consensus       568 ~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il  639 (639)
                         .+....+....                 ....+..++..+.+++.+||+.||++||||+||+++|++.+
T Consensus       242 ---~~~~~~i~~~~-----------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         242 ---EQVLRFVMEGG-----------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             ---HHHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ---HHHHHHHHhCC-----------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence               11111111111                 01123345567999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.4e-46  Score=380.24  Aligned_cols=240  Identities=25%  Similarity=0.363  Sum_probs=200.9

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||+||+++..  ++.||||+++..      ..+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            45778899999999999999975  688999998643      3467889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+++|+|..++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence            99999999998864     345788888899999999999999987   9999999999999999999999999998764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..      ....+||+.|||||++.+..++.++|||||||++|||++|+.||...+.           .+....++....
T Consensus       156 ~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~i~~~~~  218 (316)
T d1fota_         156 DV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------MKTYEKILNAEL  218 (316)
T ss_dssp             SC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHCCC
T ss_pred             cc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----------HHHHHHHHcCCC
Confidence            32      2346899999999999999999999999999999999999999954321           111222222211


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                                        ..+...+.++.+++.+||+.||++|+     |++|+++
T Consensus       219 ------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                              01233445689999999999999996     8998874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.8e-45  Score=367.79  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=201.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------------HHHHHHHHHHHHhcC-CCCeeEEEeeeecC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------------TKEFMAEMKILCKVH-HSNLVELIGYAATE  415 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------------~~~~~~E~~il~~l~-h~niv~l~~~~~~~  415 (639)
                      ++|+..+.||+|+||+||+++..  ++.||||++....            .+.+.+|++++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67888999999999999999884  5899999985421            235789999999997 99999999999999


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      +..|+||||+++|+|.+++..     ...+++.....++.||++||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence            999999999999999999964     345899999999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCcccccc------CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhh
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD------GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRS  569 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  569 (639)
                      |+++.+....    ..+...||+.|+|||++.+      ..++.++||||+||++|||++|+.||.....          
T Consensus       155 G~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----------  220 (277)
T d1phka_         155 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----------  220 (277)
T ss_dssp             TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred             hheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----------
Confidence            9999774322    2344689999999999853      4568899999999999999999999964331          


Q ss_pred             HHHHHHHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          570 LASFMLAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       570 l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                       ......++.....              .........+.++.+++.+||+.||++|||++|+++
T Consensus       221 -~~~~~~i~~~~~~--------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         221 -MLMLRMIMSGNYQ--------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -HHHHHHHHHTCCC--------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHHHHHHhCCCC--------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             1111122222110              011112344567999999999999999999999976

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-45  Score=380.48  Aligned_cols=240  Identities=23%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  422 (639)
                      ++|+..+.||+|+||.||++.+.  ++.||||++...      ..+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46888899999999999999985  689999998643      3456889999999999999999999999999999999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecC
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVG  502 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  502 (639)
                      ||+.+|+|.+++..     ...+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       121 e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999999864     235899999999999999999999987   9999999999999999999999999999764


Q ss_pred             CCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..      .....||+.|||||++.+..++.++|||||||++|||++|+.||...+.           ......+....+
T Consensus       193 ~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~i~~~~~  255 (350)
T d1rdqe_         193 GR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------IQIYEKIVSGKV  255 (350)
T ss_dssp             SC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCC
T ss_pred             cc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----------HHHHHHHhcCCC
Confidence            21      2346899999999999999999999999999999999999999954321           111222222211


Q ss_pred             CcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 036507          583 DSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRP-----DMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  633 (639)
                      .                  .+...+.++.+++.+||+.||++|+     |++|+++
T Consensus       256 ~------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 R------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1                  1233445789999999999999994     8999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=375.45  Aligned_cols=247  Identities=17%  Similarity=0.266  Sum_probs=202.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccH--HHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeecc
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKT--KEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      ++|+..+.||+|+||+||+|.+.  ++.||||.++....  ..+.+|+++|++++||||+++++++.+++.+|+||||++
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            67888999999999999999885  57899999976543  457899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC--CCEEEeccCCceecCCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA--FRAKISDFGLAKLVGKT  504 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~  504 (639)
                      +|+|.+++...    ...+++.....++.||+.||+|||+++   |+||||||+|||++.+  ..+||+|||+++.... 
T Consensus        85 gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-  156 (321)
T d1tkia_          85 GLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-  156 (321)
T ss_dssp             CCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred             CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence            99999999642    235899999999999999999999987   9999999999999854  5899999999987632 


Q ss_pred             CCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                         ........+|+.|+|||.+.+..++.++|||||||++|||++|+.||.....           .+.+..++..... 
T Consensus       157 ---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----------~~~~~~i~~~~~~-  221 (321)
T d1tkia_         157 ---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------QQIIENIMNAEYT-  221 (321)
T ss_dssp             ---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCC-
T ss_pred             ---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCC-
Confidence               2234456899999999999999999999999999999999999999954321           1112222222110 


Q ss_pred             ccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                               ++..    .....+.++.+|+.+||+.||++|||++|+++
T Consensus       222 ---------~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         222 ---------FDEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---------CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------CChh----hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     0000    01123456899999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-45  Score=378.31  Aligned_cols=250  Identities=20%  Similarity=0.331  Sum_probs=195.6

Q ss_pred             CCCCCCC-ceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhc-CCCCeeEEEeeeec----CCeEEEEE
Q 036507          351 EGFSDSS-LLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKV-HHSNLVELIGYAAT----EDELFLIY  422 (639)
Q Consensus       351 ~~f~~~~-~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~~~lv~  422 (639)
                      ++|...+ .||+|+||+||+|.+.  ++.||||+++..  +.+.+|++++.++ +||||+++++++.+    +..+|+||
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm   88 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   88 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence            4676654 6999999999999875  579999998653  4567899987655 79999999998865    46789999


Q ss_pred             eeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCce
Q 036507          423 EYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLAK  499 (639)
Q Consensus       423 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~  499 (639)
                      ||+++|+|.+++..   .+...+++.....|+.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+++
T Consensus        89 Ey~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          89 ECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             ECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             ECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence            99999999999975   23356999999999999999999999987   999999999999985   4679999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      ......    ......||+.|||||++.+..|+.++|||||||++|||+||+.||.......        ....+   ..
T Consensus       163 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--------~~~~~---~~  227 (335)
T d2ozaa1         163 ETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------ISPGM---KT  227 (335)
T ss_dssp             ECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred             eccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--------HHHHH---HH
Confidence            764322    2345689999999999999999999999999999999999999996543210        00000   00


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ..          ...+..+........+.++.+|+.+||+.||++|||++|++.
T Consensus       228 ~i----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 RI----------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CC----------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH----------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00          000000111111244567999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=376.33  Aligned_cols=242  Identities=27%  Similarity=0.419  Sum_probs=199.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc------cHHHHHHHHHHHH-hcCCCCeeEEEeeeecCCeEEEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT------KTKEFMAEMKILC-KVHHSNLVELIGYAATEDELFLI  421 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~lv  421 (639)
                      ++|+..+.||+|+||+||+|+..  ++.||||+++..      ..+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            56888899999999999999985  688999998632      3456777888765 68999999999999999999999


Q ss_pred             EeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceec
Q 036507          422 YEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLV  501 (639)
Q Consensus       422 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  501 (639)
                      |||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++..
T Consensus        82 mEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence            999999999999964     235788899999999999999999987   999999999999999999999999999865


Q ss_pred             CCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          502 GKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...   ....+...||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..+   ...+....
T Consensus       154 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~---~~~i~~~~  219 (320)
T d1xjda_         154 MLG---DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EEL---FHSIRMDN  219 (320)
T ss_dssp             CCT---TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH---HHHHHHCC
T ss_pred             ccc---cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHH---HHHHHcCC
Confidence            332   2234456899999999999999999999999999999999999999964321        111   11122221


Q ss_pred             CCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 036507          582 PDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMK-QVV  632 (639)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl  632 (639)
                      +.                  .|..++.++.+|+.+||+.||++||++. |++
T Consensus       220 ~~------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 PF------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             CC------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CC------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            11                  2233455789999999999999999995 664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-45  Score=371.52  Aligned_cols=258  Identities=24%  Similarity=0.307  Sum_probs=194.2

Q ss_pred             CCceeecCceEEEEEEEc--CceEEEEEecccc--------HHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEeec
Q 036507          356 SSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--------TKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEYA  425 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~~  425 (639)
                      .++||+|+||+||+|.+.  ++.||||+++...        .+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            568999999999999875  6789999986432        235789999999999999999999999999999999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKTS  505 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  505 (639)
                      .++++..+...     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            88877776643     345778888999999999999999987   9999999999999999999999999998654322


Q ss_pred             CCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCCc
Q 036507          506 DGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPDS  584 (639)
Q Consensus       506 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  584 (639)
                         ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....        .+....+...+......
T Consensus       155 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--------~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         155 ---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--------LDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             ---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCCCCTT
T ss_pred             ---ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--------HHHHHHHHHhcCCCChh
Confidence               22334679999999998865 4679999999999999999999999854332        11222223333222211


Q ss_pred             ccccccccccCC-cccC--C-----CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          585 MSMSSLKDYIDP-NMMD--L-----YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       585 ~~~~~~~~~~d~-~l~~--~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .. ......... ....  .     .......++.+|+.+||+.||++|||++|+++
T Consensus       224 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         224 QW-PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TS-SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hc-cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            11 000000000 0000  0     01123457899999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-44  Score=378.63  Aligned_cols=244  Identities=24%  Similarity=0.303  Sum_probs=195.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc------HHHHHH---HHHHHHhcCCCCeeEEEeeeecCCeEE
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK------TKEFMA---EMKILCKVHHSNLVELIGYAATEDELF  419 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~------~~~~~~---E~~il~~l~h~niv~l~~~~~~~~~~~  419 (639)
                      ++|+..++||+|+||.||+|...  ++.||||.+....      ...+.+   |+++++.++||||+++++++.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            56888899999999999999985  6889999986432      223344   466777888999999999999999999


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      +||||+++|+|.+++..     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence            99999999999999964     345788899999999999999999987   9999999999999999999999999999


Q ss_pred             ecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      .+...     ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......        ...... ...
T Consensus       156 ~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~-~~~  221 (364)
T d1omwa3         156 DFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DKHEID-RMT  221 (364)
T ss_dssp             ECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--------CHHHHH-HHS
T ss_pred             ecCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH-Hhc
Confidence            76432     2234589999999999864 56899999999999999999999999653321        111111 110


Q ss_pred             hcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          579 RNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                      ...             .+    ..+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       222 ~~~-------------~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 LTM-------------AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSC-------------CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ccC-------------CC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            000             00    112334557899999999999999999     577764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-44  Score=363.43  Aligned_cols=264  Identities=25%  Similarity=0.396  Sum_probs=198.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..+.||+|+||+||+|.+.  ++.||||+++..     ..+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57888999999999999999985  688999998543     24568899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      |+.++ +.+++..   .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~~-~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQD-LKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSEE-HHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ecCCc-hhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence            99654 4444432   22345999999999999999999999987   99999999999999999999999999986643


Q ss_pred             CCCCcceeeeeccccccCCccccccCC-CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      .   ........||+.|+|||.+.... ++.++|||||||++|||++|+.||...+.        ......+....... 
T Consensus       155 ~---~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--------~~~~~~i~~~~~~~-  222 (298)
T d1gz8a_         155 P---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--------IDQLFRIFRTLGTP-  222 (298)
T ss_dssp             C---SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCC-
T ss_pred             C---cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--------HHHHHHHHHhcCCC-
Confidence            2   22334468999999999877655 57899999999999999999999954321        11111112222221 


Q ss_pred             CcccccccccccC--CcccCC-------CChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYID--PNMMDL-------YPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d--~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ............+  +.....       .......++.+|+.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111111111100  000000       01123457899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=362.13  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=197.7

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc---CceEEEEEecccc-----HHHHHHHHHHHHhc---CCCCeeEEEeeeec----
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR---NQEVAIKRMTATK-----TKEFMAEMKILCKV---HHSNLVELIGYAAT----  414 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~vavK~~~~~~-----~~~~~~E~~il~~l---~h~niv~l~~~~~~----  414 (639)
                      .++|+..++||+|+||+||+|.+.   ++.||||+++...     ...+.+|+++|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468899999999999999999874   3569999985432     23466788887766   79999999998853    


Q ss_pred             -CCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEe
Q 036507          415 -EDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKIS  493 (639)
Q Consensus       415 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  493 (639)
                       ....+++|||+.++++......    ....+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence             3568999999988777655432    2345889999999999999999999987   9999999999999999999999


Q ss_pred             ccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHH
Q 036507          494 DFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       494 Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      |||+++....    ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.        ......
T Consensus       159 dfg~~~~~~~----~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--------~~~~~~  226 (305)
T d1blxa_         159 DFGLARIYSF----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------VDQLGK  226 (305)
T ss_dssp             SCCSCCCCCG----GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH
T ss_pred             chhhhhhhcc----cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence            9999875432    2234457899999999999999999999999999999999999999964332        111222


Q ss_pred             HHHHhhcCCCcccc-------cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          574 MLAALRNSPDSMSM-------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       574 ~~~~~~~~~~~~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +...+.........       ....... +.............+.+|+.+||+.||++|||++|+++
T Consensus       227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         227 ILDVIGLPGEEDWPRDVALPRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCC-CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhCCCchhcccccccchhhhhcccc-ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            22222222111000       0000000 00111123344567899999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.7e-44  Score=364.65  Aligned_cols=264  Identities=23%  Similarity=0.339  Sum_probs=198.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc-CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEee
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR-NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYEY  424 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e~  424 (639)
                      ++|+..++||+|+||+||+|++. ++.||||+++..     ..+.+.+|+++|++++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57888999999999999999886 578999998643     246789999999999999999999999999999999999


Q ss_pred             ccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCCC
Q 036507          425 AQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGKT  504 (639)
Q Consensus       425 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  504 (639)
                      +.++.+..+...     ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            987777766643     356999999999999999999999987   999999999999999999999999999876432


Q ss_pred             CCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCCC
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSPD  583 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  583 (639)
                      .   .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.....        ......+...+.....
T Consensus       154 ~---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~~~  222 (286)
T d1ob3a_         154 V---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--------ADQLMRIFRILGTPNS  222 (286)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCCCT
T ss_pred             c---cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--------HHHHHHHHHhhCCCCh
Confidence            2   22334578999999999875 4568999999999999999999999954321        1111112222222111


Q ss_pred             ccc--ccccccc------cCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          584 SMS--MSSLKDY------IDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       584 ~~~--~~~~~~~------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...  .......      .++.............+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110  0000000      0111111122334567899999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=360.93  Aligned_cols=235  Identities=25%  Similarity=0.399  Sum_probs=192.6

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc---------HHHHHHHHHHHHhcC--CCCeeEEEeeeecCCe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK---------TKEFMAEMKILCKVH--HSNLVELIGYAATEDE  417 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~---------~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~  417 (639)
                      ++|+..++||+|+||+||+|...  ++.||||.++...         ...+.+|+++|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            56888899999999999999985  6789999986432         123668999999997  8999999999999999


Q ss_pred             EEEEEeeccC-CChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCC-CCEEEecc
Q 036507          418 LFLIYEYAQK-GSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSA-FRAKISDF  495 (639)
Q Consensus       418 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  495 (639)
                      .++||||+.+ +++.+++..     ...+++.....++.|+++||+|||+++   |+||||||+|||++.+ +.+||+||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence            9999999976 577777753     345899999999999999999999987   9999999999999854 78999999


Q ss_pred             CCceecCCCCCCcceeeeeccccccCCccccccCCC-CCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHH
Q 036507          496 GLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLA-TAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFM  574 (639)
Q Consensus       496 gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~  574 (639)
                      |+++.....     ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+.               
T Consensus       156 G~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------------  215 (273)
T d1xwsa_         156 GSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------------  215 (273)
T ss_dssp             TTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------------
T ss_pred             ccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------------
Confidence            999865322     2345689999999999987665 5779999999999999999999953211               


Q ss_pred             HHHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          575 LAALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                        ......          .        .+...+.++.+++.+||+.||++|||++|+++
T Consensus       216 --i~~~~~----------~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 --IIRGQV----------F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --HHHCCC----------C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --Hhhccc----------C--------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              111110          0        11223456899999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=368.15  Aligned_cols=264  Identities=24%  Similarity=0.334  Sum_probs=191.9

Q ss_pred             CCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcCCCCeeEEEeeeec------CCeEEEEEe
Q 036507          352 GFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVHHSNLVELIGYAAT------EDELFLIYE  423 (639)
Q Consensus       352 ~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~~~lv~e  423 (639)
                      +|...++||+|+||+||+|++.  ++.||||++..+. ....+|+++|++++||||+++++++..      ...+++|||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            4556788999999999999985  6789999986543 223479999999999999999998853      235789999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVG  502 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  502 (639)
                      |++++.+..+.+..  .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+.
T Consensus       100 y~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_         100 YVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             CCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             ccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            99766444433211  22456899999999999999999999987   99999999999999775 89999999998764


Q ss_pred             CCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcC
Q 036507          503 KTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNS  581 (639)
Q Consensus       503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~  581 (639)
                      ...    ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......        .....+...+...
T Consensus       175 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--------~~l~~i~~~~g~~  242 (350)
T d1q5ka_         175 RGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--------DQLVEIIKVLGTP  242 (350)
T ss_dssp             TTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--------HHHHHHHHHHCCC
T ss_pred             CCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--------HHHHHHHHHhCCC
Confidence            322    2234589999999998765 57899999999999999999999999543321        1111111111111


Q ss_pred             CCcc--------cccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          582 PDSM--------SMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       582 ~~~~--------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ....        ............+..........++.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1000        000111111111111122344567899999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-42  Score=352.43  Aligned_cols=267  Identities=20%  Similarity=0.266  Sum_probs=194.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec--------C
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT--------E  415 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~--------~  415 (639)
                      ++|+..++||+|+||+||+|.+.  ++.||||++...     ..+++.+|+++|++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67888999999999999999985  678999987533     34668899999999999999999998755        3


Q ss_pred             CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEecc
Q 036507          416 DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDF  495 (639)
Q Consensus       416 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  495 (639)
                      +.++++|||+.++.+..+...     ...++......++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence            468999999988777655532     345788888999999999999999987   999999999999999999999999


Q ss_pred             CCceecCCCCCC-cceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHH
Q 036507          496 GLAKLVGKTSDG-EATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASF  573 (639)
Q Consensus       496 gla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~  573 (639)
                      |+++.+...... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....        ......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--------~~~~~~  233 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--------QHQLAL  233 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--------HHHHHH
Confidence            999876532211 1122335799999999998764 689999999999999999999999954322        122222


Q ss_pred             HHHHhhcCCCccccc----ccccccCCcccCCCC-------hhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          574 MLAALRNSPDSMSMS----SLKDYIDPNMMDLYP-------HDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       574 ~~~~~~~~~~~~~~~----~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      +.......+......    .....+........+       ......+.+|+.+||+.||++|||++|+++
T Consensus       234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            333333322211100    001111000000000       111345788999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.9e-42  Score=352.60  Aligned_cols=267  Identities=19%  Similarity=0.250  Sum_probs=199.0

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccccHHHHHHHHHHHHhcC-CCCeeEEEeeeec--CCeEEEEEeec
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATKTKEFMAEMKILCKVH-HSNLVELIGYAAT--EDELFLIYEYA  425 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~--~~~~~lv~e~~  425 (639)
                      ++|+..++||+|+||+||+|+..  ++.||||+++....+++.+|+++|++++ ||||+++++++..  ....++||||+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            57888999999999999999985  6889999999888888999999999996 9999999999874  45689999999


Q ss_pred             cCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCC-CEEEeccCCceecCCC
Q 036507          426 QKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAF-RAKISDFGLAKLVGKT  504 (639)
Q Consensus       426 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~  504 (639)
                      ++++|..+.+        .+++.....++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.....
T Consensus       115 ~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         115 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             CSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             CCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999987653        3889999999999999999999988   99999999999998655 5999999999876432


Q ss_pred             CCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhh------hHHHHHHHH
Q 036507          505 SDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERR------SLASFMLAA  577 (639)
Q Consensus       505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~------~l~~~~~~~  577 (639)
                      .    ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..............      ....+. ..
T Consensus       184 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~-~~  258 (328)
T d3bqca1         184 Q----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI-DK  258 (328)
T ss_dssp             C----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH-HH
T ss_pred             C----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh-hh
Confidence            2    23446789999999998765 479999999999999999999999965433111000000      000000 00


Q ss_pred             hhcCCCccccccccc----ccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          578 LRNSPDSMSMSSLKD----YIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...............    ................++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000000000000    00000111122334567899999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-42  Score=349.71  Aligned_cols=259  Identities=19%  Similarity=0.223  Sum_probs=196.3

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-cHHHHHHHHHHHHhcCCCCee-EEEeeeecCCeEEEEEeecc
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLV-ELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  426 (639)
                      ++|+..+.||+|+||.||+|.+.  ++.||||.+... ..+++.+|++++++++|+|++ .+..+..+.+..++||||+ 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            46888999999999999999975  679999987654 335688999999999877655 5555667778899999999 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC---CCCEEEeccCCceecCC
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS---AFRAKISDFGLAKLVGK  503 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~~~  503 (639)
                      +++|.+.+..    ....+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+|+.+..
T Consensus        86 ~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          86 GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            5677666542    2346899999999999999999999987   999999999999864   45799999999998754


Q ss_pred             CCCCc----ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhh
Q 036507          504 TSDGE----ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALR  579 (639)
Q Consensus       504 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~  579 (639)
                      .....    .......||+.|||||.+.+..++.++|||||||++|||++|+.||.........    ..........+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~----~~~~~~~~~~~~  234 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----QKYERISEKKMS  234 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH----HHHHHhhcccCC
Confidence            32211    1234468999999999999999999999999999999999999999654321100    001011001000


Q ss_pred             cCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          580 NSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ..             .+.+    ...++.++.+++..||+.||++||+++++.+.|+.+
T Consensus       235 ~~-------------~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         235 TP-------------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             SC-------------HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             CC-------------hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            00             0001    123445789999999999999999999998888764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=358.82  Aligned_cols=267  Identities=24%  Similarity=0.305  Sum_probs=194.2

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC----eEE
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT----KTKEFMAEMKILCKVHHSNLVELIGYAATED----ELF  419 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~  419 (639)
                      +++|+..++||+|+||+||+|...  ++.||||+++..    ..+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            356888999999999999999875  688999998643    2456889999999999999999999986543    234


Q ss_pred             EEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          420 LIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       420 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ++++++.+|+|.+++..      ..+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus        87 ~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence            44556679999999863      24899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCCCcceeeeeccccccCCccccc-cCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHh
Q 036507          500 LVGKTSDGEATVTKVVGTFGYLAPEYLT-DGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAAL  578 (639)
Q Consensus       500 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~  578 (639)
                      ................||+.|+|||++. +..++.++||||+||++|||++|+.||.....        .+........+
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--------~~~~~~~~~~~  229 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--------LDQLNHILGIL  229 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--------HHHHHHHhhhc
Confidence            7654433333345568999999999985 45678999999999999999999999954332        11111111111


Q ss_pred             hcCCCcccccc----ccc--ccCCcccC----CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          579 RNSPDSMSMSS----LKD--YIDPNMMD----LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       579 ~~~~~~~~~~~----~~~--~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...........    ...  ...+....    ........++.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11110000000    000  00000000    001122346889999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-41  Score=343.88  Aligned_cols=264  Identities=19%  Similarity=0.304  Sum_probs=203.5

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCCeEEEEEe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATEDELFLIYE  423 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~e  423 (639)
                      ++|+..++||+|+||+||+|++.  ++.||||+++..     ..+.+.+|+.+|++++||||+++++++.+.+..++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57888999999999999999985  578999998533     24678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCCceecCC
Q 036507          424 YAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGLAKLVGK  503 (639)
Q Consensus       424 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  503 (639)
                      ++.+++|..++..     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++....
T Consensus        82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence            9999999888754     345788999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCCCcceeeeeccccccCCccccccCC-CCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHHhhcCC
Q 036507          504 TSDGEATVTKVVGTFGYLAPEYLTDGL-ATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAALRNSP  582 (639)
Q Consensus       504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  582 (639)
                      ..   .......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.....       .......+........
T Consensus       154 ~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         154 PV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-------VDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             CC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-------HHHHHHHHHHHHCCCC
T ss_pred             CC---ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-------HHHHHHHHHhhcCCCC
Confidence            22   2223356788999999987654 68999999999999999999999854332       1112222222222221


Q ss_pred             CcccccccccccC---------CcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          583 DSMSMSSLKDYID---------PNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       583 ~~~~~~~~~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      . ..........+         ..............+.+|+.+||+.||++|||++|+++
T Consensus       224 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         224 E-EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             T-TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             h-hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1 11111111100         00011122344567899999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-41  Score=345.39  Aligned_cols=259  Identities=18%  Similarity=0.194  Sum_probs=203.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-cHHHHHHHHHHHHhcCC-CCeeEEEeeeecCCeEEEEEeecc
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-KTKEFMAEMKILCKVHH-SNLVELIGYAATEDELFLIYEYAQ  426 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  426 (639)
                      ++|+..++||+|+||+||+|++.  ++.||||.++.. ..+.+.+|+++++.++| +|++.+++++..+...++||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            57888999999999999999975  678999988543 33457789999999975 89999999999999999999999 


Q ss_pred             CCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECC-----CCCEEEeccCCceec
Q 036507          427 KGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDS-----AFRAKISDFGLAKLV  501 (639)
Q Consensus       427 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~~  501 (639)
                      +++|.++++..    ...+++.....++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.+
T Consensus        84 ~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            78999988642    345899999999999999999999987   999999999999974     578999999999987


Q ss_pred             CCCCCCc----ceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHHH
Q 036507          502 GKTSDGE----ATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLAA  577 (639)
Q Consensus       502 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~~  577 (639)
                      .......    .......||+.|||||.+.+..++.++|||||||++|||++|+.||.........     .....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-----~~~~~i~~~  231 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERIGEK  231 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-----HHHHHHHhc
Confidence            5432211    1233468999999999999999999999999999999999999999644321110     011111110


Q ss_pred             hhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 036507          578 LRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVISLSQI  638 (639)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i  638 (639)
                      ....+       ..     .    ....++.++.+++..|+..+|++||+++.+.+.|+++
T Consensus       232 ~~~~~-------~~-----~----l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         232 KQSTP-------LR-----E----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHSC-------HH-----H----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cCCCC-------hH-----H----hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            00000       00     0    1123345789999999999999999999998888765

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=354.02  Aligned_cols=259  Identities=21%  Similarity=0.329  Sum_probs=191.3

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecCC------
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATED------  416 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  416 (639)
                      .++|+..++||+|+||+||+|...  ++.||||+++..     ..+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467888999999999999999975  688999998643     2456889999999999999999999987654      


Q ss_pred             eEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccC
Q 036507          417 ELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFG  496 (639)
Q Consensus       417 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  496 (639)
                      ++++||||+ +.+|..+.+.      ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+|++|||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence            579999999 6678777653      35899999999999999999999987   9999999999999999999999999


Q ss_pred             CceecCCCCCCcceeeeeccccccCCcccccc-CCCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          497 LAKLVGKTSDGEATVTKVVGTFGYLAPEYLTD-GLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       497 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      +++....      ..+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..        .......
T Consensus       167 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--------~~~~~~~  232 (346)
T d1cm8a_         167 LARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--------DQLKEIM  232 (346)
T ss_dssp             TCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred             ceeccCC------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--------HHHHHHH
Confidence            9987632      2344689999999999876 45689999999999999999999999654321        1111111


Q ss_pred             HHhhcCCCcccc-----------cccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          576 AALRNSPDSMSM-----------SSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~-----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ......+.....           ..+.+.....+.. ........+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccCCCcHHHHhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            111111100000           0000000111111 11233456889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=348.43  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=196.5

Q ss_pred             CCCCCCCceeecCceEEEEEEE-----cCceEEEEEeccc-------cHHHHHHHHHHHHhcCC-CCeeEEEeeeecCCe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNI-----RNQEVAIKRMTAT-------KTKEFMAEMKILCKVHH-SNLVELIGYAATEDE  417 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~vavK~~~~~-------~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~  417 (639)
                      ++|+..+.||+|+||+||+|..     .++.||||.++..       ..+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5588889999999999999986     2578999988532       23567899999999976 899999999999999


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .+++|||+.+|+|.+++...     ..+.......++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence            99999999999999998642     34677788889999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccC--CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG--LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFML  575 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~  575 (639)
                      ++.+....  ........|++.|++||.+.+.  .++.++|||||||+||||++|+.||.......       .......
T Consensus       176 a~~~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-------~~~~i~~  246 (322)
T d1vzoa_         176 SKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-------SQAEISR  246 (322)
T ss_dssp             EEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-------CHHHHHH
T ss_pred             hhhhcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHH
Confidence            98764322  2223346899999999998754  46889999999999999999999996543211       1111111


Q ss_pred             HHhhcCCCcccccccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 036507          576 AALRNSPDSMSMSSLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPD-----MKQVVI  633 (639)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  633 (639)
                      ......+                  ..+.....++.+++.+||+.||++|||     ++|+++
T Consensus       247 ~~~~~~~------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         247 RILKSEP------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHCCC------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             hcccCCC------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1111111                  123345667999999999999999995     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=346.87  Aligned_cols=267  Identities=20%  Similarity=0.262  Sum_probs=186.8

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeec------CCe
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAAT------EDE  417 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~~  417 (639)
                      ++|++.++||+|+||+||+|.+.  ++.||||+++..     ..+.+.+|+.+|++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67889999999999999999985  689999998643     23568899999999999999999999864      367


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      +|+||||+.++.+ +.+.       ..+++...+.++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+
T Consensus        97 ~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence            8999999966544 4443       23788999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhh-----------h
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQ-----------E  566 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~-----------~  566 (639)
                      ++....    ....+...||+.|+|||++.+..+++++||||+||+++||++|+.||...+.......           .
T Consensus       166 ~~~~~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         166 ARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             hhcccc----ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            886533    2233456899999999999999999999999999999999999999854321000000           0


Q ss_pred             hhhHHHHHHHHhhcCCCcccccccccccCCcccC---CCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          567 RRSLASFMLAALRNSPDSMSMSSLKDYIDPNMMD---LYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       567 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      ...............+... .......+......   .........+.+|+.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYA-GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCC-CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhHHHHhhcCcccc-ccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000011111111000 00111111111110   112345667999999999999999999999984

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-40  Score=344.83  Aligned_cols=260  Identities=22%  Similarity=0.288  Sum_probs=191.6

Q ss_pred             hCCCCCCCceeecCceEEEEEEEc--CceEEEEEeccc-----cHHHHHHHHHHHHhcCCCCeeEEEeeeecC-----Ce
Q 036507          350 TEGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTAT-----KTKEFMAEMKILCKVHHSNLVELIGYAATE-----DE  417 (639)
Q Consensus       350 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  417 (639)
                      .++|+..++||+|+||+||+|...  ++.||||+++..     ..+.+.+|+++|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            567999999999999999999875  689999998643     235688999999999999999999988643     33


Q ss_pred             EEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEEeccCC
Q 036507          418 LFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKISDFGL  497 (639)
Q Consensus       418 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  497 (639)
                      .++++||+.+|+|.+++..      ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence            4666777889999999853      34899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCCCCcceeeeeccccccCCccccccC-CCCCcchHHHHHHHHHHHHcCCccccccccccchhhhhhhHHHHHHH
Q 036507          498 AKLVGKTSDGEATVTKVVGTFGYLAPEYLTDG-LATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQERRSLASFMLA  576 (639)
Q Consensus       498 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~~~~l~~~~~~  576 (639)
                      +.....      ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+.        ......+..
T Consensus       168 a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--------~~~~~~i~~  233 (348)
T d2gfsa1         168 ARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--------IDQLKLILR  233 (348)
T ss_dssp             --CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHH
T ss_pred             hcccCc------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHH
Confidence            975432      22345799999999987664 568999999999999999999999964332        111111222


Q ss_pred             HhhcCCCcccc----c-------ccccccCCcccCCCChhHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 036507          577 ALRNSPDSMSM----S-------SLKDYIDPNMMDLYPHDCLFKMAMLAKQCVDEDPILRPDMKQVVI  633 (639)
Q Consensus       577 ~~~~~~~~~~~----~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  633 (639)
                      .....+.....    .       .........+.. ........+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcCCCChHHhhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            21111100000    0       000000000000 01123456889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.2e-36  Score=312.31  Aligned_cols=270  Identities=22%  Similarity=0.309  Sum_probs=189.2

Q ss_pred             CCCCCCCceeecCceEEEEEEEc--CceEEEEEecccc--HHHHHHHHHHHHhcC-----------CCCeeEEEeeeecC
Q 036507          351 EGFSDSSLLGHGTYGSVYYGNIR--NQEVAIKRMTATK--TKEFMAEMKILCKVH-----------HSNLVELIGYAATE  415 (639)
Q Consensus       351 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~E~~il~~l~-----------h~niv~l~~~~~~~  415 (639)
                      .+|+..++||+|+||+||+|+..  ++.||||+++.+.  .+.+.+|++++++++           |+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            35888999999999999999874  6899999997653  356788999998875           57899999887543


Q ss_pred             --CeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEECCCCC---
Q 036507          416 --DELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHE-HTKTHYVHRDIKSSNILLDSAFR---  489 (639)
Q Consensus       416 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIll~~~~~---  489 (639)
                        ...+++++++..+........  ......+++..+..++.|++.||+|||+ ++   |+||||||+|||++.++.   
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred             cccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence              456667776655443332221  1334567888899999999999999998 55   999999999999986653   


Q ss_pred             ---EEEeccCCceecCCCCCCcceeeeeccccccCCccccccCCCCCcchHHHHHHHHHHHHcCCccccccccccchhhh
Q 036507          490 ---AKISDFGLAKLVGKTSDGEATVTKVVGTFGYLAPEYLTDGLATAKSDVYAFGVVLFEIISGKEAIIRTEGMVSKNQE  566 (639)
Q Consensus       490 ---~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVws~Gvvl~elltG~~p~~~~~~~~~~~~~  566 (639)
                         ++++|||.+......      .....||+.|+|||++.+..++.++||||+||+++||++|+.||......... ..
T Consensus       168 ~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~-~~  240 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT-KD  240 (362)
T ss_dssp             EEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CH
T ss_pred             cceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc-ch
Confidence               999999999865322      23457999999999999999999999999999999999999998654321111 11


Q ss_pred             hhhHHHHHHHHhhcCCCccccc-----------ccccccCCc----------ccCCCChhHHHHHHHHHHHhcccCCCCC
Q 036507          567 RRSLASFMLAALRNSPDSMSMS-----------SLKDYIDPN----------MMDLYPHDCLFKMAMLAKQCVDEDPILR  625 (639)
Q Consensus       567 ~~~l~~~~~~~~~~~~~~~~~~-----------~~~~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~R  625 (639)
                      ...+.. ....+...+......           .....+...          ...........++.+|+.+||..||.+|
T Consensus       241 ~~~~~~-~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         241 DDHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHH-HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence            111111 112222211111000           000000000          0112345677889999999999999999


Q ss_pred             CCHHHHHH
Q 036507          626 PDMKQVVI  633 (639)
Q Consensus       626 Ps~~evl~  633 (639)
                      ||++|+|+
T Consensus       320 pta~e~L~  327 (362)
T d1q8ya_         320 ADAGGLVN  327 (362)
T ss_dssp             BCHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=8.5e-22  Score=185.55  Aligned_cols=158  Identities=15%  Similarity=0.112  Sum_probs=115.1

Q ss_pred             CCCceeecCceEEEEEEEc-CceEEEEEecccc---------------------HHHHHHHHHHHHhcCCCCeeEEEeee
Q 036507          355 DSSLLGHGTYGSVYYGNIR-NQEVAIKRMTATK---------------------TKEFMAEMKILCKVHHSNLVELIGYA  412 (639)
Q Consensus       355 ~~~~lG~G~~g~Vy~~~~~-~~~vavK~~~~~~---------------------~~~~~~E~~il~~l~h~niv~l~~~~  412 (639)
                      ..++||+|+||.||+|... ++.||||.++...                     .....+|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4678999999999999874 6889999864210                     12345688899999999999888664


Q ss_pred             ecCCeEEEEEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEECCCCCEEE
Q 036507          413 ATEDELFLIYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHTKTHYVHRDIKSSNILLDSAFRAKI  492 (639)
Q Consensus       413 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  492 (639)
                      .    .+++|||+++..+.++.            ......++.|++++++|||+++   |+||||||+|||++++ .++|
T Consensus        84 ~----~~lvme~~~~~~~~~l~------------~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          84 G----NAVLMELIDAKELYRVR------------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             T----TEEEEECCCCEEGGGCC------------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             C----CEEEEEeeccccccchh------------hHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            2    37999999876654432            1223568899999999999987   9999999999999965 5899


Q ss_pred             eccCCceecCCCCCCcceeeeeccccccCC------ccccccCCCCCcchHHHHHHHH
Q 036507          493 SDFGLAKLVGKTSDGEATVTKVVGTFGYLA------PEYLTDGLATAKSDVYAFGVVL  544 (639)
Q Consensus       493 ~Dfgla~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DVws~Gvvl  544 (639)
                      +|||+|.........           .|..      .|. ....|+.++|+||..--+
T Consensus       144 iDFG~a~~~~~~~~~-----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWR-----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHH-----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcH-----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999999865322110           0111      011 135678889999976444

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.56  E-value=1.2e-15  Score=105.89  Aligned_cols=46  Identities=26%  Similarity=0.528  Sum_probs=42.7

Q ss_pred             EEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecCC
Q 036507          152 MSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPLN  199 (639)
Q Consensus       152 ~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~~  199 (639)
                      ++|+|++|||||+||++||+++++|++||++.  +.|+|||+|.||++
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~--~~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG--GGCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc--ccCcCCCEEEEEeC
Confidence            57999999999999999999999999999985  46999999999974

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.53  E-value=1e-15  Score=106.89  Aligned_cols=46  Identities=35%  Similarity=0.565  Sum_probs=43.4

Q ss_pred             EEEEecCCCcHHHHHHHhCCChHHHHHHcCCCCCCCccCCceEEecC
Q 036507          152 MSYVMKDGDTVQSLASRFGVSMDSIEQVNGIVNPNNVTAGDLFYIPL  198 (639)
Q Consensus       152 ~~y~v~~Gdtl~~Ia~~~~~~~~~l~~~N~~~~~~~l~~g~~l~ip~  198 (639)
                      ++|+||+|||||+||++||+++++|++||++.++ .|++||+|.||.
T Consensus         2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~-~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQA-GLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCS-SCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCC-CCCCCCEEEeCC
Confidence            6899999999999999999999999999999875 699999999994

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=98.82  E-value=1.4e-09  Score=75.19  Aligned_cols=38  Identities=21%  Similarity=0.329  Sum_probs=34.4

Q ss_pred             eEEEeCCCCCHHHHHHHhcCCcccceeccC-------CCceEeee
Q 036507           44 LAYEMQPNQTLSVIQSMFDVLPKDVTVEGN-------EKNYIFIK   81 (639)
Q Consensus        44 ~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n-------~~~~l~ip   81 (639)
                      ++|+|++||||+.||++||+++++|+.+|+       .||.|.||
T Consensus         2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~~l~~Gq~L~IP   46 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIP   46 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCSSCCTTCEEEET
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCCCCCCCCEEEeC
Confidence            689999999999999999999999997777       56888887

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=98.75  E-value=1.4e-09  Score=74.80  Aligned_cols=40  Identities=20%  Similarity=0.184  Sum_probs=35.6

Q ss_pred             eeEEEeCCCCCHHHHHHHhcCCcccceeccC------CCceEeeee
Q 036507           43 FLAYEMQPNQTLSVIQSMFDVLPKDVTVEGN------EKNYIFIKK   82 (639)
Q Consensus        43 ~~~y~v~~g~~l~~ia~~~~~~~~~i~~~~n------~~~~l~ip~   82 (639)
                      .++|+|++||||+.||++||+++++|+.+|+      +||.|.||+
T Consensus         2 ~v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~~~l~~Gq~L~i~v   47 (48)
T d1e0ga_           2 SITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFV   47 (48)
T ss_dssp             CCEEEECTTCCHHHHHHHHTCCHHHHHHHCSCGGGCCTTEEEECCC
T ss_pred             cEEEEECCCCCHHHHHHHHCCCHHHHHHHcCCcccCcCCCEEEEEe
Confidence            3689999999999999999999999997777      578888876

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.41  E-value=4.4e-07  Score=87.55  Aligned_cols=145  Identities=15%  Similarity=0.104  Sum_probs=99.6

Q ss_pred             HHHhhhCCCCCCCceeecCceEEEEEEEcCceEEEEEecccc---HHHHHHHHHHHHhcC-CCCeeEEEeeeecCCeEEE
Q 036507          345 EILFATEGFSDSSLLGHGTYGSVYYGNIRNQEVAIKRMTATK---TKEFMAEMKILCKVH-HSNLVELIGYAATEDELFL  420 (639)
Q Consensus       345 e~~~a~~~f~~~~~lG~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~l  420 (639)
                      |+...-++|+..+..+.++.+.||+....++.+.+|+.....   ...+.+|..++..+. +-.+.+++.+..+++..++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            344444566555554445557899988788889999876542   334678888888775 4446677788777888999


Q ss_pred             EEeeccCCChhhhccCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 036507          421 IYEYAQKGSLKSHLHDPQNRGQTSLSWIMRVQIALDAARGLEYIHEHT--------------------------------  468 (639)
Q Consensus       421 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--------------------------------  468 (639)
                      ||+++++.++.+.....       ..   ...++.++++.+..||+..                                
T Consensus        88 v~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            99999998886554221       11   1234455566666666411                                


Q ss_pred             ------------------------CCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          469 ------------------------KTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       469 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                                              ...++|+|+.|.|||++++...-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    1128999999999999987667799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=8.9e-06  Score=77.60  Aligned_cols=128  Identities=13%  Similarity=0.092  Sum_probs=85.2

Q ss_pred             eeecCc-eEEEEEEEcC-ceEEEEEeccccHHHHHHHHHHHHhcCC--CCeeEEEeeeecCCeEEEEEeeccCCChhhhc
Q 036507          359 LGHGTY-GSVYYGNIRN-QEVAIKRMTATKTKEFMAEMKILCKVHH--SNLVELIGYAATEDELFLIYEYAQKGSLKSHL  434 (639)
Q Consensus       359 lG~G~~-g~Vy~~~~~~-~~vavK~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l  434 (639)
                      +..|.. +.||+....+ ..+.+|........++..|.+.++.+..  -.+.+++.+..+.+..+++||+++|.++.+..
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~   97 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH   97 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc
Confidence            444443 6789887765 4588898776665667788888887753  33566788878888899999999886664321


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 036507          435 HDPQNRGQTSLSWIMRVQIALDAARGLEYIHE------------------------------------------------  466 (639)
Q Consensus       435 ~~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~------------------------------------------------  466 (639)
                      .          .   ....+.++++.|.-||+                                                
T Consensus        98 ~----------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          98 L----------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             C----------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             c----------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            1          0   01112223333333332                                                


Q ss_pred             ---c----CCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          467 ---H----TKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       467 ---~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                         .    ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               1    11238999999999999987667899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.87  E-value=0.00082  Score=68.03  Aligned_cols=71  Identities=13%  Similarity=0.099  Sum_probs=46.4

Q ss_pred             CceeecCceEEEEEEEc--CceEEEEEecc------c----cHHHHHHHHHHHHhcC-C--CCeeEEEeeeecCCeEEEE
Q 036507          357 SLLGHGTYGSVYYGNIR--NQEVAIKRMTA------T----KTKEFMAEMKILCKVH-H--SNLVELIGYAATEDELFLI  421 (639)
Q Consensus       357 ~~lG~G~~g~Vy~~~~~--~~~vavK~~~~------~----~~~~~~~E~~il~~l~-h--~niv~l~~~~~~~~~~~lv  421 (639)
                      +.||.|....||+....  ++.++||.-..      +    .......|.+.|+.+. +  ..+.+++.+.  .+..+++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence            45899999999998754  46789996431      1    1233556888887663 2  3455666553  4556889


Q ss_pred             EeeccCCC
Q 036507          422 YEYAQKGS  429 (639)
Q Consensus       422 ~e~~~~gs  429 (639)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.29  E-value=0.0061  Score=59.15  Aligned_cols=159  Identities=11%  Similarity=0.039  Sum_probs=83.7

Q ss_pred             cchHHHHhhhCCCCCCCce-----eecCceEEEEEEEcCceEEEEEeccc-cHHHHHHHHHHHHhcCCCCee--EEEe--
Q 036507          341 FTYDEILFATEGFSDSSLL-----GHGTYGSVYYGNIRNQEVAIKRMTAT-KTKEFMAEMKILCKVHHSNLV--ELIG--  410 (639)
Q Consensus       341 ~~~~e~~~a~~~f~~~~~l-----G~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~h~niv--~l~~--  410 (639)
                      .+.+|+..-.++|...+..     ..|---+.|+.+.++..+++|+.... ..++...|++++..|.+.++.  ..+.  
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceec
Confidence            3456676666777765443     35555788999888888999998653 345566788888877532221  1111  


Q ss_pred             ----eeecCCeEEEEEeeccCCChhhh--------------cc----CCCCC-CCCCCCHHH-----------------H
Q 036507          411 ----YAATEDELFLIYEYAQKGSLKSH--------------LH----DPQNR-GQTSLSWIM-----------------R  450 (639)
Q Consensus       411 ----~~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~~~-~~~~l~~~~-----------------~  450 (639)
                          +....+....++.+..+......              ++    ..... ......+..                 .
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence                11123445566666655333110              00    00000 000011100                 0


Q ss_pred             HHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEECCCCCEEEeccCCce
Q 036507          451 VQIALDAARGLEYIHE-HTKTHYVHRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       451 ~~i~~~ia~al~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      ...+......+.-.+. .-+.+++|+|+.++||+++.+...-++||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1111112222222221 123459999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.87  E-value=0.014  Score=58.65  Aligned_cols=71  Identities=17%  Similarity=0.215  Sum_probs=47.7

Q ss_pred             CCceeecCceEEEEEEEcC---------ceEEEEEecc-ccHHHHHHHHHHHHhcCCCCe-eEEEeeeecCCeEEEEEee
Q 036507          356 SSLLGHGTYGSVYYGNIRN---------QEVAIKRMTA-TKTKEFMAEMKILCKVHHSNL-VELIGYAATEDELFLIYEY  424 (639)
Q Consensus       356 ~~~lG~G~~g~Vy~~~~~~---------~~vavK~~~~-~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~e~  424 (639)
                      .+.|+.|-.-.+|+....+         ..|.+++... ....+..+|..+++.+.-.++ .++++++.+    .+|+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            3468888888999988643         3466666542 233456688999888863343 467777643    688999


Q ss_pred             ccCCCh
Q 036507          425 AQKGSL  430 (639)
Q Consensus       425 ~~~gsL  430 (639)
                      +++..|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.58  E-value=0.023  Score=55.28  Aligned_cols=133  Identities=10%  Similarity=0.127  Sum_probs=74.6

Q ss_pred             eEEEEEEEc-CceEEEEEeccc--cHHHHHHHHHHHHhcCCCCe--eEEEe-----eeecCCeEEEEEeeccCCChhh--
Q 036507          365 GSVYYGNIR-NQEVAIKRMTAT--KTKEFMAEMKILCKVHHSNL--VELIG-----YAATEDELFLIYEYAQKGSLKS--  432 (639)
Q Consensus       365 g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~E~~il~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~--  432 (639)
                      -.||+.+.. +..+++|..+..  ..+++..|.+.+..|...++  +..+.     .....+..+.++++++|..+..  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            489999875 567999998654  45678889988888753222  11111     1233556788999987643311  


Q ss_pred             ----------------hccCCCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHH----hcCCCCee
Q 036507          433 ----------------HLHDPQNRGQTSLSWIM-------------------RVQIALDAARGLEYIH----EHTKTHYV  473 (639)
Q Consensus       433 ----------------~l~~~~~~~~~~l~~~~-------------------~~~i~~~ia~al~~LH----~~~~~~iv  473 (639)
                                      .............++..                   +..+...+.+.++.+.    +..+..++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence                            11111111111222211                   1111111222233332    22345699


Q ss_pred             eCCCCCCcEEECCCCCEEEeccCCce
Q 036507          474 HRDIKSSNILLDSAFRAKISDFGLAK  499 (639)
Q Consensus       474 H~Dlkp~NIll~~~~~~kl~Dfgla~  499 (639)
                      |+|+.+.|||++++  ..++||+.+.
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             cCCCCcccEEEeCC--ceEEechhcc
Confidence            99999999999754  4589999875

>d1ijwc_ a.4.1.2 (C:) HIN recombinase (DNA-binding domain) {Synthetic}

class: All alpha proteins
fold: DNA/RNA-binding 3-helical bundle
superfamily: Homeodomain-like
family: Recombinase DNA-binding domain
domain: HIN recombinase (DNA-binding domain)
species: Synthetic

Probab=81.11  E-value=0.47  Score=30.94  Aligned_cols=25  Identities=24%  Similarity=0.438  Sum_probs=22.5

Q ss_pred             ecCCCcHHHHHHHhCCChHHHHHHc
Q 036507          156 MKDGDTVQSLASRFGVSMDSIEQVN  180 (639)
Q Consensus       156 v~~Gdtl~~Ia~~~~~~~~~l~~~N  180 (639)
                      +..|.+...||+.|||+...|-++=
T Consensus        18 ~~~G~s~~~iA~~~gVSr~TiYry~   42 (47)
T d1ijwc_          18 LEKGHPRQQLAIIFGIGVSTLYRYF   42 (47)
T ss_dssp             HHTTCCHHHHHHHHTCCHHHHHHHS
T ss_pred             HHCCCCHHHHHHHHCcCHHHHHhhC
Confidence            4679999999999999999998874